data_2g0q_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2g0q _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 N--CA 1.434 -1.259 0 N-CA-C 107.862 -1.162 . . . . 70.35 107.862 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.545 ' CG ' ' HG ' ' A' ' 84' ' ' LEU . 39.2 m-70 -121.39 160.6 23.75 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 116.249 -0.432 . . . . 75.34 111.078 -171.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -132.38 130.58 40.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.596 -0.729 . . . . 71.33 111.425 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.65 142.05 44.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.41 -0.814 . . . . 72.35 109.986 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -94.05 122.51 36.64 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.75 -1.204 . . . . 74.52 107.75 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.4 m -97.51 161.33 2.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.208 0.527 . . . . 54.15 112.361 -176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.468 ' HA ' ' NH2' ' A' ' 52' ' ' ARG . 9.1 p90 -144.08 -60.2 0.39 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.177 0.806 . . . . 75.2 113.177 -172.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.0 -101.62 2.5 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 119.928 -1.129 . . . . 54.43 113.461 -175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 t -59.31 -36.61 75.94 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.828 0.851 . . . . 65.34 112.644 -173.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -92.25 17.38 9.77 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.65 0.982 . . . . 73.12 113.65 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -85.67 7.16 24.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 119.576 -0.85 . . . . 70.25 109.988 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.529 ' O ' HG12 ' A' ' 32' ' ' ILE . 19.0 t70 -119.74 127.36 26.45 Favored Pre-proline 0 C--N 1.305 -1.359 0 CA-C-N 115.87 -0.605 . . . . 73.24 109.849 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.45 -25.26 30.18 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.102 1.868 . . . . 72.4 113.504 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.59 -41.18 84.5 Favored 'General case' 0 C--N 1.312 -1.034 0 O-C-N 121.817 -0.552 . . . . 72.15 110.819 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 28' ' ' ASP . 11.2 p -68.45 -28.65 41.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.416 -0.587 . . . . 71.54 109.416 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 28' ' ' ASP . 48.7 mm -67.09 -47.04 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 116.308 -0.405 . . . . 62.22 110.394 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.521 ' ND2' ' HG1' ' A' ' 39' ' ' THR . 49.2 m-80 -57.28 -35.26 69.56 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.059 0.457 . . . . 64.14 111.691 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.1 t -81.76 -47.44 19.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.069 0.396 . . . . 75.1 112.069 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.542 ' HE1' ' OD1' ' A' ' 86' ' ' ASN . 7.9 tmm? -64.91 -35.9 82.63 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 110.321 -0.252 . . . . 53.33 110.321 -174.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.464 HD22 HG22 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -115.38 -72.82 0.67 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 120.16 -0.616 . . . . 71.44 112.095 174.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.2 t70 179.26 -49.48 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.453 0.644 . . . . 72.12 109.892 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.411 ' O ' HG23 ' A' ' 32' ' ' ILE . 99.4 mtt180 -128.81 173.06 10.69 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 115.262 -0.881 . . . . 71.54 109.155 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.521 ' HG1' ' ND2' ' A' ' 33' ' ' ASN . 36.7 m -120.95 111.59 34.05 Favored Pre-proline 0 N--CA 1.433 -1.322 0 O-C-N 123.579 0.549 . . . . 75.34 110.336 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.36 152.71 14.92 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 124.262 3.308 . . . . 73.52 111.565 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.03 125.87 23.44 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.358 -0.608 . . . . 62.32 109.358 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.4 mt -102.11 137.29 30.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.592 -0.731 . . . . 74.4 109.651 -174.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.469 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 7.3 p -130.1 143.69 40.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.634 -0.712 . . . . 72.33 110.145 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.2 m -77.0 125.81 29.93 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.986 -1.116 . . . . 71.21 107.986 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.07 156.63 47.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.404 0.621 . . . . 73.4 111.07 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 71.4 m -114.61 125.39 53.7 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.205 -0.907 . . . . 75.34 110.149 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.19 100.29 14.94 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 116.049 -0.523 . . . . 73.13 109.644 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 46' ' ' THR . 3.0 Cg_endo -83.85 136.87 7.33 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.5 2.133 . . . . 73.33 111.838 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.33 11.09 53.0 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.566 -0.825 . . . . 38.42 111.755 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.428 ' HA ' ' H ' ' A' ' 66' ' ' SER . 86.1 m-85 -141.67 159.68 41.72 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 108.855 -0.795 . . . . 73.2 108.855 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -140.21 141.71 35.91 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.773 -0.455 . . . . 64.04 109.773 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 38.6 ttm180 -102.79 137.53 40.88 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.192 -1.04 . . . . 74.33 108.192 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 10.2 m-85 -108.79 167.52 10.01 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 107.505 -1.294 . . . . 72.5 107.505 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 . . . . . 0 C--N 1.304 -1.39 0 C-N-CA 119.489 -0.885 . . . . 73.34 111.965 -172.885 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 108.59 -0.892 . . . . 74.51 108.59 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 52.8 Cg_exo -58.95 117.8 4.59 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.064 1.842 . . . . 44.13 110.825 175.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 26.3 p -115.47 168.47 9.97 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.097 -0.502 . . . . 61.42 110.663 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 mm -123.04 119.97 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.615 -0.513 . . . . 74.12 109.615 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.11 146.06 59.91 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 110.455 -0.202 . . . . 64.41 110.455 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.59 111.79 1.27 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.121 2.547 . . . . 72.42 112.911 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.428 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 34.0 t -126.25 116.5 21.36 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.582 -0.895 . . . . 61.15 108.582 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.74 -32.07 71.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.366 0.603 . . . . 73.51 111.328 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -95.62 7.11 47.22 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.771 -0.65 . . . . 74.43 112.012 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.77 167.66 14.49 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 119.578 -1.296 . . . . 72.42 114.03 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 144.07 23.23 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.111 1.365 . . . . 72.24 107.733 175.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.8 t -113.06 119.67 61.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.392 -0.596 . . . . 73.02 109.392 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -93.22 116.05 28.64 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.761 -1.57 . . . . 63.25 106.761 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.51 -158.05 7.6 Favored Glycine 0 N--CA 1.418 -2.521 0 N-CA-C 110.732 -0.947 . . . . 74.1 110.732 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.401 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 13.8 mptt -124.41 148.65 47.44 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.435 0.636 . . . . 63.31 111.948 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.6 t -111.04 130.94 63.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.549 -1.205 . . . . 73.44 111.334 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 77.5 mt -96.71 108.89 21.6 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.452 -1.314 . . . . 70.1 107.452 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.4 ptp -115.64 137.38 52.13 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.29 0.567 . . . . 74.24 112.47 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.91 25.01 7.37 Favored Glycine 0 N--CA 1.427 -1.933 0 CA-C-N 114.982 -1.008 . . . . 44.13 111.568 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.1 p -88.57 142.23 13.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 110.2 -0.296 . . . . 74.11 110.2 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -73.72 161.4 30.29 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 123.836 0.854 . . . . 75.42 112.358 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.2 m -68.87 -35.36 76.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.419 1.266 . . . . 71.3 114.419 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -63.61 -43.74 96.0 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.472 0.653 . . . . 75.23 109.986 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.573 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 9.5 mp0 -69.81 -36.31 75.53 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.776 -1.102 . . . . 75.32 109.843 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.545 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.4 tm? -60.52 -43.73 96.8 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.757 -0.46 . . . . 74.24 109.757 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -71.95 -32.27 67.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.969 0.414 . . . . 73.23 110.863 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.542 ' OD1' ' HE1' ' A' ' 35' ' ' MET . 0.1 OUTLIER -65.58 -38.32 89.18 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.14 -0.482 . . . . 74.4 110.887 177.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 96.9 mt -62.23 -42.03 98.94 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.168 -0.678 . . . . 64.45 109.168 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -64.13 -36.06 82.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.348 -0.842 . . . . 63.11 110.417 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.66 -45.37 71.93 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.619 -0.719 . . . . 75.24 110.845 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.79 -51.45 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.918 -0.583 . . . . 73.23 112.368 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.94 -29.23 55.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.909 0.385 . . . . 75.21 111.607 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.62 -17.57 27.52 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 114.717 0.647 . . . . 38.42 114.717 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -59.95 -31.7 70.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.837 0.351 . . . . 71.31 111.515 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.471 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 9.8 pt-20 -142.07 6.21 1.75 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.383 0.512 . . . . 71.04 112.383 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.471 ' CD2' ' HG3' ' A' ' 94' ' ' GLU . 95.4 m-85 -138.08 168.26 20.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.881 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -124.69 145.47 49.66 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.576 -0.898 . . . . 64.0 108.576 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -87.62 113.85 23.69 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.93 -0.767 . . . . 75.51 108.93 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.518 HG12 ' HE3' ' A' ' 117' ' ' MET . 33.6 m -125.34 161.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 116.054 -0.521 . . . . 73.42 111.477 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.0 t -98.97 136.27 39.18 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.185 -0.672 . . . . 75.45 109.185 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.7 165.18 24.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 116.397 -0.365 . . . . 75.23 110.685 -177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.14 120.31 6.14 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.691 -0.964 . . . . 71.15 110.691 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.24 152.04 17.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 122.308 0.243 . . . . 71.41 110.719 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.7 t -113.6 131.28 65.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 110.132 -0.322 . . . . 64.14 110.132 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.444 ' CZ ' HG22 ' A' ' 43' ' ' VAL . 11.0 mmm180 -58.61 124.41 19.57 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.778 0.831 . . . . 74.31 109.276 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.67 8.38 12.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.926 0.87 . . . . 54.32 109.842 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.62 -66.33 0.91 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.812 -1.551 . . . . 71.41 106.812 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -99.53 -108.55 0.2 Allowed 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.606 -0.887 . . . . 63.13 108.606 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.9 m -159.67 19.31 0.17 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 126.424 1.89 . . . . 74.41 106.28 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.33 143.97 38.37 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 114.846 -1.07 . . . . 72.03 110.472 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -108.04 147.09 31.63 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.909 -0.774 . . . . 73.52 108.909 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 88.1 mtp -141.02 161.06 38.74 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 123.645 0.778 . . . . 63.23 110.333 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -112.71 120.01 40.06 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.228 -0.897 . . . . 73.31 109.328 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.2 173.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 110.106 -0.331 . . . . 74.51 110.106 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -96.6 155.01 16.95 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.128 -0.693 . . . . 61.42 109.128 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.8 t -155.36 172.0 18.94 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.509 -1.663 . . . . 74.22 106.509 174.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -111.83 119.69 39.45 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.948 -0.76 . . . . 70.14 108.948 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.518 ' HE3' HG12 ' A' ' 98' ' ' VAL . 42.5 ttp -105.8 145.51 31.08 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.029 -0.987 . . . . 74.3 110.196 -173.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 71.8 t-105 -72.21 124.81 25.82 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.899 -1.149 . . . . 72.21 107.899 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -72.36 -41.27 65.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 114.797 -1.092 . . . . 75.31 111.603 -171.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -81.22 102.5 10.39 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-O 121.147 0.498 . . . . 61.14 109.947 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -75.03 -28.41 60.45 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.347 0.499 . . . . 74.42 112.347 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.3 93.86 4.78 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.588 -0.893 . . . . 41.01 108.588 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.459 ' HB3' ' HE3' ' A' ' 126' ' ' MET . 14.3 t70 -137.93 126.13 14.22 Favored Pre-proline 0 C--N 1.308 -1.212 0 C-N-CA 121.041 -0.263 . . . . 75.14 110.788 -175.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -87.5 -9.67 5.74 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.515 2.143 . . . . 73.5 113.819 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -80.96 -34.9 32.82 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 120.91 0.386 . . . . 44.34 111.016 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.459 ' HE3' ' HB3' ' A' ' 123' ' ' ASP . 26.4 ptt? . . . . . 0 C--N 1.312 -1.041 0 CA-C-N 116.11 -0.495 . . . . 74.12 111.497 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.589 ' O ' HG12 ' A' ' 144' ' ' ILE . 6.0 ttpm? . . . . . 0 CA--C 1.512 -0.496 0 N-CA-C 109.559 -0.534 . . . . 75.54 109.559 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 38.7 ttpt -57.28 -31.26 65.44 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.647 -0.706 . . . . 70.13 111.499 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.5 -37.16 82.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.453 -0.34 . . . . 73.0 110.381 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.612 ' O ' HG23 ' A' ' 146' ' ' THR . 92.9 m-85 -76.76 -39.23 52.39 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 109.029 -0.73 . . . . 74.43 109.029 175.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.2 mm -60.22 -33.03 52.11 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.859 0 CA-C-N 115.216 -0.902 . . . . 74.44 110.953 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 148' ' ' LYS . 63.1 mm-40 -51.36 -39.27 56.75 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.246 0.832 . . . . 72.55 113.246 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 143' ' ' PHE . 15.2 t -74.9 -29.06 60.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 119.675 -0.81 . . . . 73.32 109.493 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.418 ' CD1' HD11 ' A' ' 150' ' ' ILE . 22.7 m-85 -76.41 -35.12 58.75 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 116.121 -0.491 . . . . 72.35 112.239 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.477 ' HG3' HG21 ' A' ' 144' ' ' ILE . 57.3 mtpt -55.66 -31.07 62.05 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 123.96 0.787 . . . . 73.53 112.107 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 14.1 ptmm? -75.05 -34.57 61.86 Favored 'General case' 0 C--O 1.206 -1.198 0 C-N-CA 118.209 -1.397 . . . . 75.34 109.723 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.418 HD11 ' CD1' ' A' ' 147' ' ' PHE . 64.8 mt -55.52 -29.62 24.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 C-N-CA 124.819 1.247 . . . . 51.24 112.884 -176.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -54.82 -26.01 32.2 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.503 0.557 . . . . 73.32 112.503 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 149' ' ' LYS . 13.9 pt-20 -57.08 -40.96 77.93 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.084 0.469 . . . . 72.11 110.896 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 50.6 t -71.79 -31.83 67.0 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.556 0.693 . . . . 74.21 109.771 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.436 -1.133 0 CA-C-N 115.069 -0.969 . . . . 72.41 111.292 -175.469 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.438 -1.061 0 CA-C-O 121.131 0.491 . . . . 72.25 110.286 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.437 ' O ' HG12 ' A' ' 79' ' ' VAL . 35.7 m-70 -117.39 161.43 19.57 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.341 -0.845 . . . . 72.34 110.606 -173.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -122.65 127.1 48.9 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.471 -0.937 . . . . 72.23 108.471 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.0 t -125.86 137.94 56.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 116.878 -0.147 . . . . 73.45 110.668 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.452 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.0 t80 -94.72 122.42 37.31 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.589 -1.263 . . . . 73.24 107.589 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.43 123.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.738 0.78 . . . . 74.43 111.598 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -77.85 -40.43 40.29 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.869 -1.059 . . . . 71.11 113.46 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.84 -40.66 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 118.814 -1.66 . . . . 74.43 113.539 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.6 m -58.02 -27.79 63.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.736 0.643 . . . . 74.44 112.736 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.455 ' O ' HD12 ' A' ' 32' ' ' ILE . 40.9 m-85 -134.5 28.37 3.66 Favored 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 110.053 -0.351 . . . . 74.44 110.053 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -78.04 -19.11 54.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.103 0.779 . . . . 73.43 113.103 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.518 ' O ' HG22 ' A' ' 31' ' ' VAL . 23.3 t70 -105.47 130.43 23.09 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.193 -0.299 . . . . 62.14 110.193 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.92 -25.57 78.17 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.941 2.427 . . . . 60.22 114.742 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.06 -43.15 93.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.064 0.459 . . . . 73.31 110.598 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 28' ' ' ASP . 23.4 m -71.28 -28.1 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 115.753 -0.658 . . . . 74.4 110.715 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.466 HG22 HD23 ' A' ' 36' ' ' LEU . 48.4 mm -62.98 -51.69 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 122.699 0.4 . . . . 74.14 111.631 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -57.73 -32.61 67.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.168 0.509 . . . . 60.23 111.641 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.0 t -82.02 -43.74 19.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.932 -0.576 . . . . 45.52 112.034 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.7 tmm? -70.97 -37.35 72.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.631 -0.259 . . . . 45.51 110.562 -173.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.466 HD23 HG22 ' A' ' 32' ' ' ILE 0.261 0.6 OUTLIER -115.05 -67.26 1.01 Allowed 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.903 -0.719 . . . . 74.52 112.378 176.797 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.1 t70 172.11 -50.01 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.092 0.472 . . . . 73.32 109.932 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -123.98 160.55 27.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.934 -0.576 . . . . 73.31 109.671 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.443 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 32.1 m -107.28 106.19 57.72 Favored Pre-proline 0 N--CA 1.436 -1.135 0 O-C-N 123.388 0.43 . . . . 70.25 110.441 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.58 152.25 63.57 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 123.394 2.73 . . . . 74.15 110.155 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -56.43 129.12 39.27 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.094 0.473 . . . . 73.55 110.174 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 32.2 mt -103.62 136.22 37.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.149 -0.686 . . . . 42.02 109.149 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.494 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 15.0 p -129.86 146.99 33.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 116.021 -0.536 . . . . 71.0 110.323 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -75.69 124.25 26.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.351 -0.981 . . . . 72.22 108.351 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.4 158.66 43.57 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.615 0.722 . . . . 75.22 112.33 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.1 m -118.5 132.03 56.23 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.129 -0.941 . . . . 75.21 109.34 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.3 tp -104.4 101.85 29.82 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 109.385 -0.598 . . . . 71.14 109.385 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.1 138.13 9.99 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.702 2.268 . . . . 75.34 111.814 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.04 9.45 53.95 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.892 -0.67 . . . . 38.11 111.721 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.507 ' HE2' ' SD ' ' A' ' 117' ' ' MET . 93.3 m-85 -143.12 152.75 42.17 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -139.98 147.09 39.95 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.993 -0.743 . . . . 60.32 108.993 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -100.26 132.23 45.75 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.153 -0.684 . . . . 62.24 109.153 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.9 m-30 -107.71 134.95 49.94 Favored 'General case' 0 CA--C 1.472 -2.032 0 N-CA-C 107.195 -1.409 . . . . 74.5 107.195 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 . . . . . 0 C--N 1.291 -1.977 0 C-N-CA 119.195 -1.002 . . . . 75.01 112.368 -178.535 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.429 -1.516 0 N-CA-C 107.318 -1.364 . . . . 73.44 107.318 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 34.8 Cg_exo -63.71 94.14 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.957 1.772 . . . . 73.1 111.554 174.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 14.3 p -97.0 167.46 11.06 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 124.604 1.161 . . . . 71.2 112.3 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -104.48 139.68 24.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 N-CA-C 108.642 -0.873 . . . . 74.12 108.642 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.68 152.66 60.18 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.499 -0.926 . . . . 72.41 108.499 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.486 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 27.8 Cg_endo -65.54 123.51 11.53 Favored 'Trans proline' 0 C--O 1.249 1.032 0 C-N-CA 122.494 2.129 . . . . 72.51 112.063 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 t -125.14 142.07 51.72 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.364 -0.976 . . . . 71.13 108.364 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.04 -36.38 66.92 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.255 -0.578 . . . . 64.51 111.652 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -109.49 2.81 20.73 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.396 -0.365 . . . . 73.32 111.755 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.11 156.87 21.42 Favored Glycine 0 N--CA 1.434 -1.484 0 C-N-CA 120.067 -1.063 . . . . 52.42 114.374 -174.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 142.66 29.72 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 124.574 1.15 . . . . 55.25 108.056 175.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.6 t -113.65 133.68 58.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 109.513 -0.551 . . . . 63.0 109.513 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -107.28 116.76 32.5 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.279 -1.008 . . . . 74.14 108.279 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.456 ' C ' ' HD3' ' A' ' 74' ' ' LYS . . . -148.95 -154.86 6.48 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 110.987 -0.845 . . . . 65.21 110.987 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.456 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 3.2 mppt? -122.82 150.45 42.82 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 113.218 0.821 . . . . 65.41 113.218 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 44.1 t -110.94 129.16 66.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 114.091 -1.413 . . . . 73.13 111.207 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.6 mt -95.7 109.28 21.58 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.078 -1.452 . . . . 75.23 107.078 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.9 ptp -113.3 127.43 56.15 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.651 0.739 . . . . 75.33 112.36 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 111.36 28.88 3.63 Favored Glycine 0 C--N 1.292 -1.874 0 CA-C-N 114.678 -1.146 . . . . 55.14 111.668 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 18' ' ' HIS . 13.0 p -92.2 132.63 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 109.349 -0.612 . . . . 64.25 109.349 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -73.54 158.56 34.62 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 110.0 -0.37 . . . . 52.53 110.0 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.2 m -62.17 -35.36 78.59 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.265 0.468 . . . . 72.55 112.265 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.86 -36.45 84.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.22 0.533 . . . . 63.44 110.673 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.422 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 4.4 mm-40 -77.49 -30.54 53.13 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 108.056 -1.09 . . . . 74.32 108.056 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.8 -41.7 95.59 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.82 -0.807 . . . . 71.12 108.82 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.22 -29.76 70.08 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.614 -0.721 . . . . 74.42 110.047 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -72.2 -42.16 66.13 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.771 -0.65 . . . . 61.11 111.663 177.136 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.0 mt -61.67 -41.95 98.25 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.193 -1.04 . . . . 71.2 108.193 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.433 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 30.9 t70 -65.58 -30.9 71.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.897 -1.501 . . . . 64.42 110.813 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.65 -41.69 53.43 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.934 -0.575 . . . . 61.32 110.529 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.0 t -72.99 -58.31 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 113.013 0.746 . . . . 72.41 113.013 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.68 -23.6 45.57 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.933 -0.479 . . . . 73.54 111.847 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.41 -15.82 18.36 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 114.941 -1.027 . . . . 64.43 115.246 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -57.0 -41.72 78.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.381 0.59 . . . . 73.3 111.618 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -132.42 -0.83 3.57 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.84 0.682 . . . . 61.2 112.84 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -121.53 167.45 12.85 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.281 -1.007 . . . . 73.52 108.281 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.42 ' HB3' HD13 ' A' ' 119' ' ' ILE . 9.9 tp10 -127.84 152.35 47.93 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.308 -0.997 . . . . 74.31 108.308 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -87.84 112.59 22.64 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.776 -0.824 . . . . 61.11 108.776 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.474 HG12 ' HE3' ' A' ' 117' ' ' MET . 26.8 m -115.42 158.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.823 -0.626 . . . . 73.11 110.082 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 t -96.49 132.53 41.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.411 -0.589 . . . . 73.52 109.411 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.65 167.13 24.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 116.147 -0.479 . . . . 72.12 112.063 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.62 127.14 7.57 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 110.663 -0.975 . . . . 71.43 110.663 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -119.98 163.79 17.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 122.538 0.335 . . . . 70.24 111.094 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 59.1 t -120.33 126.37 75.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.039 -0.726 . . . . 73.22 109.039 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.69 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 22.4 mtp180 -73.16 116.11 13.31 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.915 -0.584 . . . . 63.05 110.234 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -79.08 -0.84 33.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 122.451 1.12 . . . . 75.32 108.746 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -67.27 -30.46 70.34 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.319 -1.764 . . . . 71.44 109.193 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.429 ' HB2' ' H ' ' A' ' 108' ' ' SER . 13.8 m-80 -137.41 -95.99 0.21 Allowed 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.238 -1.023 . . . . 74.41 108.238 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.429 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 67.6 m -175.83 27.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.319 -2.104 . . . . 62.51 105.319 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.25 143.92 41.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.141 -0.936 . . . . 72.12 111.633 -170.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 21.9 ptmt -96.19 148.88 22.26 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.879 -0.6 . . . . 74.15 111.616 -176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.69 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.2 mtp -143.65 161.05 39.54 Favored 'General case' 0 CA--C 1.484 -1.576 0 C-N-CA 123.83 0.852 . . . . 73.12 111.325 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.8 129.79 54.6 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 114.636 -1.165 . . . . 72.54 108.932 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 21' ' ' PHE . 34.1 m -143.93 174.52 4.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.865 -0.791 . . . . 64.12 108.865 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -115.34 152.71 32.3 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.926 -0.71 . . . . 73.12 109.631 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 t -148.3 172.89 13.65 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.534 -0.543 . . . . 62.23 109.534 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -117.42 109.16 16.43 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.07 -0.514 . . . . 74.54 109.826 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.507 ' SD ' ' HE2' ' A' ' 50' ' ' PHE . 24.2 ptt? -111.56 156.6 21.5 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.622 -0.717 . . . . 74.41 109.677 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -69.4 116.62 10.03 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.284 -1.376 . . . . 75.34 107.284 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.42 HD13 ' HB3' ' A' ' 96' ' ' GLU . 47.7 mm -73.7 -41.53 54.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 113.009 0.744 . . . . 74.44 113.009 -171.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -61.77 -35.38 77.98 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.186 -0.672 . . . . 74.41 109.186 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.264 9.7 ptpp? 58.16 -37.04 0.05 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 127.721 2.408 . . . . 75.33 115.908 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.01 85.69 4.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.551 0.691 . . . . 63.34 110.952 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -132.25 105.96 13.49 Favored Pre-proline 0 CA--C 1.486 -1.501 0 CA-C-N 115.067 -0.97 . . . . 75.23 110.507 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.42 -17.54 58.31 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.66 2.24 . . . . 72.33 110.801 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.47 -36.51 78.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.023 -0.989 . . . . 72.33 111.159 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.751 0 C-N-CA 120.452 -0.499 . . . . 73.24 111.311 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.565 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.0 ttpt . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 108.79 -0.819 . . . . 74.21 108.79 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 64.6 tttp -59.53 -35.47 74.26 Favored 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.54 -0.755 . . . . 75.22 112.153 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -55.6 -47.99 75.62 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.359 1.076 . . . . 54.01 108.548 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -66.57 -39.64 88.56 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.273 -1.785 . . . . 73.23 108.993 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 140' ' ' LYS . 28.6 mm -72.56 -40.95 63.49 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.332 0 CA-C-N 116.133 -0.485 . . . . 75.1 110.292 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 28.2 mm-40 -61.78 -34.08 75.23 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.972 0.415 . . . . 71.24 110.017 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.535 ' O ' HG13 ' A' ' 150' ' ' ILE . 86.9 m -65.39 -48.18 73.76 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.595 -0.73 . . . . 75.52 109.261 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -70.77 -30.12 66.53 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.155 0.798 . . . . 71.33 113.155 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 ttpt -55.66 -45.77 77.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.588 -1.264 . . . . 71.31 107.588 175.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.53 -34.89 70.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.014 -1.448 . . . . 62.01 110.307 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 146' ' ' THR . 80.2 mt -67.4 -37.22 78.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.28 -0.418 . . . . 71.33 110.285 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.14 -33.09 74.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 75.15 110.129 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 15.3 mm-40 -73.2 -31.07 63.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.077 0.465 . . . . 74.42 110.02 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 51.3 t -69.06 -31.81 70.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.654 -0.703 . . . . 64.44 109.787 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 34.7 mmtp . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 108.967 -0.753 . . . . 73.2 108.967 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 N--CA 1.436 -1.169 0 N-CA-C 108.186 -1.042 . . . . 73.43 108.186 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.497 ' ND1' ' HG ' ' A' ' 84' ' ' LEU . 52.8 m-70 -114.8 160.28 19.62 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.07 0.462 . . . . 74.43 112.16 -171.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 21.6 p30 -131.84 125.64 32.3 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.283 -1.326 . . . . 65.13 110.506 174.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 65.5 t -126.3 140.58 48.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.189 -0.914 . . . . 74.24 110.17 -174.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.418 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.5 t80 -94.66 122.97 37.81 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.675 -0.861 . . . . 75.23 108.675 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -100.69 144.33 12.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 116.252 -0.431 . . . . 71.43 109.886 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -83.51 -0.19 49.19 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.967 0.728 . . . . 74.44 112.967 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.13 -22.92 4.42 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.066 -1.064 . . . . 65.43 112.169 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.1 p -58.76 -36.4 74.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.135 0.493 . . . . 73.51 112.168 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.531 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 53.0 m-85 -125.84 35.9 4.62 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.709 -0.678 . . . . 75.14 110.908 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -77.79 -14.97 59.42 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.052 0.453 . . . . 75.03 110.728 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.57 121.23 63.7 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.736 -0.666 . . . . 75.4 109.472 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.49 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 30.7 Cg_endo -63.98 -28.86 66.43 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.858 2.372 . . . . 64.2 114.069 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.435 ' O ' HG21 ' A' ' 34' ' ' VAL . 24.2 t70 -69.1 -38.12 78.77 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.49 -0.484 . . . . 75.32 110.142 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.78 -38.94 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.548 -0.751 . . . . 63.14 109.423 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 29' ' ' PRO . 34.1 mm -58.46 -51.76 67.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.63 -0.713 . . . . 51.52 110.893 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -54.21 -34.27 60.19 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.236 0.458 . . . . 64.02 112.236 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 30' ' ' ASP . 47.3 t -81.03 -45.34 21.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 116.261 -0.427 . . . . 75.2 111.366 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.598 ' HE1' ' OD1' ' A' ' 86' ' ' ASN . 7.0 tmm? -67.21 -37.38 83.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.501 -0.318 . . . . 64.23 110.309 -173.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 32' ' ' ILE 0.282 0.9 OUTLIER -116.24 -67.18 1.01 Allowed 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 119.188 -1.005 . . . . 74.21 112.738 176.728 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.419 ' OD2' ' HG2' ' A' ' 38' ' ' ARG . 35.0 t70 174.98 -49.07 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.274 0.359 . . . . 73.22 111.364 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 20.1 mmt180 -131.11 162.73 29.22 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.257 -0.646 . . . . 64.24 109.257 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.453 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 20.4 m -102.87 112.44 65.74 Favored Pre-proline 0 N--CA 1.437 -1.115 0 O-C-N 123.26 0.35 . . . . 73.55 111.525 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.69 152.85 74.18 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.173 2.582 . . . . 65.42 109.336 170.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.54 130.96 47.29 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.131 0.491 . . . . 62.33 110.332 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 44.3 mt -114.47 138.94 42.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.583 -0.525 . . . . 74.13 109.583 -175.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.91 146.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.921 -0.77 . . . . 75.52 108.921 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.7 m -77.06 133.76 38.98 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.432 -1.321 . . . . 72.24 107.432 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.53 159.76 41.42 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.089 0.471 . . . . 73.33 111.697 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.5 m -110.51 125.27 53.15 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.327 -0.851 . . . . 71.12 110.812 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.8 tp -102.4 103.65 32.64 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 123.502 0.721 . . . . 61.13 109.307 175.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.0 142.44 12.39 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.261 1.974 . . . . 70.34 111.535 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.74 5.75 61.15 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.978 -0.556 . . . . 63.25 112.633 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -141.86 155.93 45.54 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 122.186 -0.596 . . . . 74.54 109.76 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -140.75 146.94 38.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.746 -0.464 . . . . 72.14 109.746 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 41.0 ptt180 -101.32 129.92 47.4 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.626 0.727 . . . . 73.32 111.286 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 18.3 m-85 -107.77 153.49 22.9 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.545 -1.28 . . . . 75.14 107.545 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.215 0 N-CA-C 114.902 1.445 . . . . 74.51 114.902 -167.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 N--CA 1.44 -0.942 0 N-CA-C 107.838 -1.171 . . . . 75.35 107.838 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 20.5 Cg_exo -65.98 90.98 0.25 Allowed 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.579 1.519 . . . . 73.53 110.859 175.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 19.3 p -83.11 127.65 33.78 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 115.278 -0.874 . . . . 72.32 111.152 -174.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 117' ' ' MET . 49.4 mm -84.66 111.24 20.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.636 -0.711 . . . . 65.02 109.574 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.56 143.86 42.73 Favored Pre-proline 0 C--N 1.289 -2.049 0 N-CA-C 109.684 -0.487 . . . . 74.43 109.684 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.9 125.72 17.86 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.46 2.107 . . . . 64.22 112.799 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.3 t -124.58 122.3 37.18 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.099 -1.815 . . . . 75.42 106.099 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.61 -30.87 65.68 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.129 0.418 . . . . 70.45 112.129 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -136.54 77.35 1.64 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.6 0.714 . . . . 75.23 111.024 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.98 166.81 30.5 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 109.317 -1.513 . . . . 74.15 109.317 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -151.9 141.34 21.59 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 117.745 0.773 . . . . 62.4 110.541 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.07 131.45 64.67 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 109.001 -0.74 . . . . 74.34 109.001 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -107.78 115.8 30.79 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.222 -1.399 . . . . 74.14 107.222 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.65 -147.76 4.93 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.846 -0.901 . . . . 54.24 110.846 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -125.29 145.59 49.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 112.566 0.58 . . . . 74.32 112.566 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 46.8 t -110.58 124.88 67.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 114.64 -1.164 . . . . 62.43 110.502 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 67.2 mt -95.75 109.77 22.02 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.594 -1.262 . . . . 74.34 107.594 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.9 ptp -117.35 142.63 46.87 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.28 0.562 . . . . 65.32 111.738 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.23 29.12 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.291 -0.868 . . . . 55.33 111.195 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 83' ' ' GLU . 12.9 p -86.44 142.0 13.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 108.516 -0.92 . . . . 52.43 108.516 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -82.9 174.48 10.89 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.471 -0.492 . . . . 73.41 111.552 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.1 p -61.34 -45.26 95.16 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.75 1.018 . . . . 63.31 113.75 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.1 -36.56 84.0 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.673 0.749 . . . . 72.2 110.838 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 41.5 mt-10 -78.54 -28.49 46.11 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.225 -0.898 . . . . 73.22 109.432 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HG ' ' ND1' ' A' ' 18' ' ' HIS . 2.9 tm? -67.68 -41.56 83.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.862 -0.608 . . . . 75.21 109.689 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.39 -29.4 61.52 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.203 -0.453 . . . . 70.44 109.796 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.598 ' OD1' ' HE1' ' A' ' 35' ' ' MET . 14.0 t-20 -56.45 -47.57 78.88 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.745 0.818 . . . . 74.44 110.282 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.7 mt -60.82 -33.8 73.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.39 -0.823 . . . . 63.14 111.031 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.422 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 18.8 t70 -73.06 -36.93 66.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.309 0.576 . . . . 52.14 109.589 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.77 -47.27 72.7 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.693 -0.685 . . . . 60.23 110.62 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.463 HG11 ' HA ' ' A' ' 87' ' ' LEU . 12.2 p -72.59 -56.49 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 113.119 0.785 . . . . 52.21 113.119 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -77.54 -22.96 50.26 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.995 -0.44 . . . . 50.11 111.575 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -60.03 -17.49 44.57 Favored Glycine 0 C--O 1.221 -0.675 0 N-CA-C 115.194 0.837 . . . . 54.42 115.194 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.86 -38.36 76.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.471 0.635 . . . . 74.52 111.228 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.82 -28.47 11.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.036 0.446 . . . . 72.4 111.838 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.408 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 91.3 m-85 -124.28 170.21 11.0 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.406 0.682 . . . . 71.51 111.703 -174.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -123.23 151.61 42.12 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.846 -0.798 . . . . 75.42 108.846 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.2 ttm-85 -86.7 119.63 27.14 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.826 -0.805 . . . . 75.34 108.826 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.423 HG12 ' CE ' ' A' ' 117' ' ' MET . 27.7 m -124.7 162.16 27.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 121.019 0.438 . . . . 73.41 111.584 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.0 t -104.01 129.19 51.6 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.302 -0.863 . . . . 71.31 108.884 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -141.79 171.44 11.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.082 0.468 . . . . 65.03 111.989 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.58 139.24 15.45 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.792 -1.323 . . . . 71.54 109.792 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.07 164.99 33.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.139 0.469 . . . . 55.4 111.109 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.2 t -129.03 131.11 68.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.396 -1.335 . . . . 71.53 107.396 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -74.16 146.3 43.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.935 0.398 . . . . 72.12 110.648 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -88.85 -8.98 53.32 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.084 -0.507 . . . . 74.04 111.326 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -79.56 -48.21 14.21 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.567 -0.288 . . . . 70.32 111.243 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.478 ' ND2' ' HG2' ' A' ' 109' ' ' GLU . 3.0 p-10 -146.6 22.18 1.3 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.699 0.629 . . . . 73.13 112.699 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m 66.88 27.45 9.0 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 115.789 1.774 . . . . 74.22 115.789 170.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HG2' ' ND2' ' A' ' 107' ' ' ASN . 20.2 mm-40 -77.04 141.02 40.48 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.511 -0.876 . . . . 75.42 108.947 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -98.48 139.46 34.18 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.624 -0.509 . . . . 71.44 109.624 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.7 mtm -142.15 163.88 31.68 Favored 'General case' 0 CA--C 1.473 -1.989 0 CA-C-O 121.8 0.81 . . . . 55.24 111.387 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -112.24 122.99 49.3 Favored 'General case' 0 C--N 1.267 -3.003 0 CA-C-N 113.919 -1.492 . . . . 71.2 107.993 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.1 m -138.16 173.53 12.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.404 0.621 . . . . 70.52 110.881 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -104.4 150.85 24.16 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.982 -1.118 . . . . 70.43 107.982 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.7 t -146.83 172.23 13.98 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.404 -0.961 . . . . 74.34 108.404 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.412 ' HH ' ' CB ' ' A' ' 87' ' ' LEU . 96.5 m-85 -111.91 112.82 24.74 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.585 0.707 . . . . 74.54 109.779 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 63' ' ' ILE . 12.9 tmm? -106.07 146.67 29.85 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.412 -1.267 . . . . 75.51 110.871 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -72.8 117.3 14.34 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.309 -0.859 . . . . 74.32 110.307 -174.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.8 mt -57.81 -41.2 79.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 113.796 -1.547 . . . . 75.32 113.004 -172.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -89.27 91.11 8.63 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 119.904 -0.718 . . . . 72.01 110.435 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.11 -30.82 71.9 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.608 -0.724 . . . . 75.12 110.417 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.37 85.95 2.22 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.879 -0.785 . . . . 51.15 108.879 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.49 122.06 28.15 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-N 115.292 -0.867 . . . . 75.12 108.769 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -84.29 0.56 9.12 Favored 'Trans proline' 0 C--N 1.328 -0.536 0 C-N-CA 122.852 2.368 . . . . 72.42 113.918 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.12 -23.81 11.82 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 119.951 -0.699 . . . . 63.43 112.271 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.46 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.8 ptt? . . . . . 0 C--N 1.317 -0.825 0 N-CA-C 112.098 0.407 . . . . 75.23 112.098 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.606 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.7 ttpt . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 120.816 0.341 . . . . 72.32 110.107 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -53.13 -36.23 60.57 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.9 1.28 . . . . 74.21 110.586 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.6 -42.41 98.24 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.113 0.483 . . . . 70.31 110.63 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -73.77 -31.77 63.47 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.341 0.591 . . . . 72.51 109.56 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.2 mm -59.75 -32.76 50.24 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.911 0 CA-C-N 115.283 -0.872 . . . . 74.01 110.551 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -61.49 -36.3 80.07 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.209 0.528 . . . . 71.12 110.99 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.8 m -72.46 -47.93 44.97 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.861 -0.792 . . . . 71.42 108.861 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.615 ' O ' ' HG2' ' A' ' 151' ' ' MET . 58.9 m-85 -66.54 -28.87 68.88 Favored 'General case' 0 C--O 1.2 -1.528 0 N-CA-C 113.454 0.909 . . . . 74.42 113.454 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -52.62 -47.63 66.88 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.973 0.909 . . . . 53.21 109.902 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -39.39 73.48 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.857 -0.794 . . . . 75.02 108.857 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.64 -52.28 42.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.179 -0.464 . . . . 73.13 111.927 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.615 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 26.5 ptt? -76.37 -40.55 50.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.927 1.084 . . . . 72.21 113.927 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -62.77 -30.24 71.3 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 112.945 0.72 . . . . 74.54 112.945 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 82.1 m -71.41 -30.06 65.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.01 0.374 . . . . 71.12 112.01 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 121.984 0.897 . . . . 71.31 108.752 175.545 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.434 -1.247 0 N-CA-C 108.044 -1.095 . . . . 70.43 108.044 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.408 ' CE1' HD22 ' A' ' 84' ' ' LEU . 30.4 m-70 -114.56 159.62 20.2 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 109.847 -0.427 . . . . 74.43 109.847 -170.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 18.1 p30 -130.41 133.34 46.29 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.331 -0.85 . . . . 75.13 110.518 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.84 140.31 49.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.442 -0.799 . . . . 62.14 110.223 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -94.61 122.47 37.24 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.467 -0.938 . . . . 73.32 108.467 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.47 143.01 12.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.043 0.449 . . . . 73.01 110.767 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.461 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 16.9 p90 -122.1 -1.94 9.22 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.951 1.463 . . . . 74.11 114.951 -168.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.81 -67.42 0.24 Allowed Glycine 0 C--N 1.314 -0.689 0 C-N-CA 119.329 -1.415 . . . . 55.14 112.528 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 p -58.12 -34.87 70.7 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.22 0.608 . . . . 74.33 111.7 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.452 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 26.8 m-85 -118.95 27.49 8.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.044 -0.526 . . . . 73.33 110.519 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -78.98 15.34 1.12 Allowed 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 121.963 0.887 . . . . 71.2 110.834 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -137.84 128.47 15.67 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.322 -0.992 . . . . 71.53 108.322 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.49 -31.28 87.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.787 2.324 . . . . 73.15 114.423 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.95 -37.9 82.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.292 0.567 . . . . 72.21 109.654 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.64 -38.85 83.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.176 -0.92 . . . . 74.14 109.468 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.401 HG22 HD22 ' A' ' 36' ' ' LEU . 6.5 mm -62.58 -50.51 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-O 122.125 0.964 . . . . 54.52 109.91 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -54.01 -43.63 70.23 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.266 -1.788 . . . . 74.13 111.607 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.5 t -81.72 -32.44 11.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.912 -0.585 . . . . 63.42 111.936 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.452 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.7 tmm? -70.55 -37.46 74.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.989 -0.284 . . . . 64.52 110.774 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.401 HD22 HG22 ' A' ' 32' ' ' ILE 0.277 0.4 OUTLIER -109.8 -71.86 0.75 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.599 0.963 . . . . 74.45 113.599 179.266 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.8 t70 176.11 -45.03 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.25 0.548 . . . . 73.01 109.838 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -120.79 176.2 5.65 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.53 -0.759 . . . . 73.33 109.487 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 m -123.03 100.68 39.63 Favored Pre-proline 0 N--CA 1.425 -1.689 0 N-CA-C 106.624 -1.621 . . . . 74.32 106.624 170.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.496 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 34.1 Cg_exo -58.71 151.57 62.61 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.833 2.355 . . . . 65.04 111.74 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.5 122.91 13.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.496 0.718 . . . . 71.52 111.167 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.532 HG12 ' HG ' ' A' ' 76' ' ' LEU . 24.0 mt -97.72 140.37 18.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.292 -0.867 . . . . 73.34 110.384 -173.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.14 145.47 35.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.794 -1.187 . . . . 75.1 107.794 172.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.9 m -81.05 123.73 28.61 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.939 -0.763 . . . . 64.53 108.939 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.17 159.14 42.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.266 0.555 . . . . 70.33 111.849 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.411 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 90.7 m -117.55 132.93 56.45 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.093 -0.958 . . . . 75.42 110.094 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.0 tp -102.56 100.94 17.5 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 123.018 0.527 . . . . 74.04 109.702 176.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 46' ' ' THR . 6.0 Cg_endo -85.98 145.22 8.69 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.581 2.187 . . . . 62.52 111.843 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.8 11.09 59.45 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 111.263 -0.735 . . . . 64.22 111.263 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -144.44 157.07 44.42 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 108.168 -1.049 . . . . 74.2 108.168 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -138.37 146.22 42.03 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.189 -0.671 . . . . 65.52 109.189 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.442 ' HA ' HD11 ' A' ' 63' ' ' ILE . 38.1 ptt180 -90.36 126.69 35.95 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.963 -1.017 . . . . 71.04 111.959 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.53 ' C ' ' HE ' ' A' ' 54' ' ' ARG . 10.3 m-85 -109.92 135.75 50.3 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.127 -1.434 . . . . 64.52 107.127 174.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.53 ' HE ' ' C ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.541 0 O-C-N 122.175 -0.328 . . . . 73.11 111.823 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 . . . . . 0 C--O 1.237 0.438 0 N-CA-C 109.848 -0.427 . . . . 74.34 109.848 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 7.1 Cg_exo -73.58 86.51 1.19 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.591 1.527 . . . . 72.55 110.687 173.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 27.8 p -98.15 -178.41 4.05 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.844 -0.617 . . . . 60.22 112.126 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CG1' ' HB2' ' A' ' 23' ' ' TYR . 47.8 mm -132.43 142.15 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.09 -1.448 . . . . 64.14 107.09 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -144.64 154.71 56.37 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.456 -0.942 . . . . 72.14 108.456 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -60.99 128.67 26.1 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.432 2.088 . . . . 74.34 112.125 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -125.79 145.3 50.27 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 116.152 -0.476 . . . . 72.13 110.011 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.48 -35.21 65.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.505 -0.924 . . . . 61.24 108.505 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -128.93 77.22 1.77 Allowed 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.148 -0.933 . . . . 74.4 110.797 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.59 151.0 19.83 Favored Glycine 0 N--CA 1.412 -2.936 0 CA-C-N 114.917 -1.038 . . . . 54.43 111.917 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.76 138.11 18.5 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.447 1.099 . . . . 74.32 108.501 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t -113.38 119.95 62.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 120.737 0.303 . . . . 64.01 110.615 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -91.91 116.55 29.01 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.45 -0.945 . . . . 70.31 108.45 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.11 -146.6 4.37 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.508 -0.853 . . . . 54.13 112.41 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.431 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.0 mmtm -127.77 141.56 51.55 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.724 0.297 . . . . 63.02 111.022 -175.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 47.5 t -111.52 129.51 66.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 115.913 -0.585 . . . . 75.45 110.358 173.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.532 ' HG ' HG12 ' A' ' 42' ' ' ILE . 6.5 mp -106.11 114.12 28.06 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.447 -0.797 . . . . 71.54 110.922 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 58.1 mtp -104.14 145.04 30.76 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.217 -1.356 . . . . 73.23 110.366 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.02 9.27 32.53 Favored Glycine 0 C--N 1.299 -1.519 0 C-N-CA 120.113 -1.041 . . . . 71.21 111.955 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 80' ' ' THR . 57.8 t -67.75 127.49 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.082 -0.71 . . . . 75.14 109.082 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 79' ' ' VAL . 65.3 p -82.17 167.62 18.52 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.388 -0.968 . . . . 73.14 108.388 176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 34.6 t -55.26 -45.63 76.08 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 117.529 0.15 . . . . 61.25 110.946 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -58.26 -42.18 85.88 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.041 0.385 . . . . 55.42 112.041 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.22 -40.63 64.56 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.467 -0.568 . . . . 74.53 109.467 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.408 HD22 ' CE1' ' A' ' 18' ' ' HIS . 33.6 tp -55.91 -50.75 69.85 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.296 0.569 . . . . 73.23 109.896 175.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 81' ' ' SER . 43.1 mt-10 -64.82 -29.13 70.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.062 -0.972 . . . . 61.15 110.251 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -44.7 64.62 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 123.804 0.842 . . . . 71.43 112.139 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.6 mt -62.5 -40.95 98.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.227 -1.027 . . . . 63.51 108.227 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.484 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 16.7 t70 -66.37 -29.29 69.44 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 114.463 -1.244 . . . . 71.23 110.886 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.0 -45.32 42.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.115 0.483 . . . . 74.33 110.398 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.2 t -72.16 -58.41 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-N 115.749 -0.66 . . . . 74.11 112.189 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.52 -24.52 42.16 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.855 0.687 . . . . 73.51 112.855 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -63.74 -16.15 58.71 Favored Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.809 -0.632 . . . . 43.13 114.391 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -67.49 -30.39 70.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.886 0.343 . . . . 73.41 111.685 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -127.14 -0.25 6.46 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.022 0.379 . . . . 72.41 112.022 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -132.7 168.18 18.78 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.112 0.565 . . . . 74.23 110.332 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -124.56 148.71 47.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.533 -0.543 . . . . 74.03 109.533 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 -88.13 113.45 23.76 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.595 -0.891 . . . . 54.22 108.595 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.53 HG11 ' HE1' ' A' ' 117' ' ' MET . 15.8 m -115.84 161.41 14.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 116.28 -0.418 . . . . 73.22 111.805 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.6 t -107.68 124.7 50.37 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.173 -1.047 . . . . 74.24 108.173 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.21 170.87 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 116.121 -0.491 . . . . 74.12 111.285 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.91 118.78 4.85 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 111.052 -0.819 . . . . 64.24 111.052 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.7 pp -111.01 165.05 6.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 110.031 -0.359 . . . . 70.02 110.031 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.3 t -122.68 124.68 71.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.519 -0.548 . . . . 72.1 109.519 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -72.66 121.4 19.72 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.177 -0.92 . . . . 74.32 110.722 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.19 -23.59 65.7 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.611 0.765 . . . . 70.5 111.945 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -64.42 -57.65 8.69 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.311 0.485 . . . . 75.55 112.311 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -127.05 7.41 6.6 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.086 0.773 . . . . 71.42 113.086 -169.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.2 t 71.46 12.23 6.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.058 0.943 . . . . 74.43 112.418 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -82.17 147.03 29.24 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.058 0.456 . . . . 75.11 111.231 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -92.02 147.4 22.99 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.421 -0.809 . . . . 74.1 110.094 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.436 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 89.1 mtp -136.22 160.38 38.85 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.378 -0.828 . . . . 74.15 109.524 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.17 117.03 33.06 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 115.534 -0.757 . . . . 60.03 109.603 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.3 m -131.68 173.21 15.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 116.128 -0.487 . . . . 73.24 110.186 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -106.1 149.59 26.6 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.089 -0.708 . . . . 74.44 109.089 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -153.15 172.88 16.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.977 -0.749 . . . . 73.1 108.977 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -119.95 109.76 15.91 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.288 0.566 . . . . 75.01 110.623 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.53 ' HE1' HG11 ' A' ' 98' ' ' VAL . 25.7 ptt? -106.71 157.16 17.93 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.178 -0.919 . . . . 74.24 108.719 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.429 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 70.7 t-105 -67.99 143.51 55.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.211 -0.663 . . . . 75.13 109.211 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.6 mm -72.44 -42.33 64.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 113.499 0.925 . . . . 61.3 113.499 -170.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -88.9 -41.17 12.59 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 114.055 1.132 . . . . 73.52 114.055 -171.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.407 0.0 OUTLIER 56.12 1.57 0.07 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.56 2.43 . . . . 75.41 117.56 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.82 9.93 28.78 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.982 -0.747 . . . . 64.55 108.982 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.426 ' CG ' ' HE1' ' A' ' 118' ' ' TRP . 2.9 m-20 -68.13 123.44 87.31 Favored Pre-proline 0 C--N 1.312 -1.023 0 C-N-CA 124.715 1.206 . . . . 72.12 111.4 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.7 -7.3 10.56 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.411 2.074 . . . . 74.52 112.18 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.89 -2.9 56.59 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.238 0.829 . . . . 63.3 113.238 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 C--N 1.308 -1.205 0 N-CA-C 108.67 -0.863 . . . . 72.31 108.67 175.233 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.5 ttpt . . . . . 0 C--O 1.206 -1.187 0 N-CA-C 109.679 -0.489 . . . . 74.02 109.679 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -52.78 -31.75 40.11 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.015 0.926 . . . . 72.14 112.241 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -66.05 -40.31 90.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.854 0.835 . . . . 73.5 109.354 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.469 ' O ' HG21 ' A' ' 146' ' ' THR . 23.9 t80 -76.29 -32.23 58.67 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.57 -1.195 . . . . 75.34 108.328 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.1 mm -59.05 -31.99 46.88 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.486 0 CA-C-N 114.731 -1.122 . . . . 70.2 111.815 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -52.07 -45.18 64.67 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.124 0.42 . . . . 64.44 111.806 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.469 HG21 ' O ' ' A' ' 143' ' ' PHE . 15.1 t -79.14 -29.89 43.36 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.564 0.697 . . . . 72.3 109.824 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -75.63 -30.33 59.45 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.397 -0.819 . . . . 74.51 110.502 -173.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -58.24 -36.93 73.93 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.603 1.161 . . . . 75.02 109.845 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -74.34 -38.79 63.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.103 0.477 . . . . 75.1 110.025 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 72.3 mt -63.61 -39.93 87.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.644 -0.707 . . . . 71.1 109.47 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.4 ttt -60.12 -31.68 70.29 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 124.267 1.027 . . . . 73.4 111.493 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.93 -36.93 85.96 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.476 0.655 . . . . 73.11 109.765 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.82 -34.38 69.29 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.222 -0.899 . . . . 75.44 110.227 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 9.7 mmpt? . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 43.42 111.884 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.415 -2.186 0 N-CA-C 109.476 -0.564 . . . . 75.44 109.476 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.554 ' O ' HG11 ' A' ' 79' ' ' VAL . 56.7 m-70 -114.86 160.6 19.29 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 115.428 -0.805 . . . . 75.51 109.851 -173.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 27.2 p-10 -131.08 125.08 32.24 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.647 0.737 . . . . 70.42 110.617 176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.28 142.82 40.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.156 -0.929 . . . . 64.32 109.944 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -95.07 123.23 38.45 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.728 -0.842 . . . . 74.35 108.728 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -102.59 137.79 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.659 -0.497 . . . . 73.01 109.659 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -87.62 -28.39 21.92 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.516 0.932 . . . . 74.21 113.516 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.29 -20.81 0.18 Allowed Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 118.917 -1.611 . . . . 71.23 113.108 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.7 p -63.65 -28.48 69.94 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.147 0.499 . . . . 63.31 111.845 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.467 ' HB3' HD12 ' A' ' 32' ' ' ILE . 78.5 m-85 -139.9 57.12 1.62 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.531 0.732 . . . . 75.01 109.232 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -88.86 -21.44 23.68 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.354 0.501 . . . . 53.45 112.354 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.587 ' O ' HG23 ' A' ' 31' ' ' VAL . 24.1 t70 -95.28 129.25 35.76 Favored Pre-proline 0 C--N 1.303 -1.424 0 CA-C-N 116.585 -0.28 . . . . 65.51 110.576 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.24 -25.04 57.69 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.694 2.263 . . . . 53.34 113.392 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.44 -30.0 62.92 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.536 -0.727 . . . . 63.31 110.965 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 28' ' ' ASP . 18.4 m -72.44 -28.3 28.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.256 -0.646 . . . . 64.44 109.256 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 26' ' ' PHE . 49.7 mm -64.31 -40.41 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.697 -0.683 . . . . 73.32 110.588 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -61.44 -30.15 70.4 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.148 0.499 . . . . 74.22 111.002 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.36 -50.79 15.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.812 -0.631 . . . . 74.44 110.291 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -67.63 -35.71 79.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.728 -0.669 . . . . 51.34 110.121 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.3 mt -103.65 -77.31 0.57 Allowed 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.287 0.565 . . . . 73.03 109.749 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.4 t70 162.57 -30.15 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 125.533 1.533 . . . . 72.41 107.287 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -146.58 159.11 43.86 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 114.648 -1.16 . . . . 74.12 109.722 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.3 m -107.52 120.52 47.23 Favored Pre-proline 0 N--CA 1.426 -1.671 0 O-C-N 123.573 0.546 . . . . 73.04 110.83 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -65.79 151.58 83.93 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.641 2.227 . . . . 75.34 109.259 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.7 130.26 45.61 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 122.144 0.973 . . . . 51.13 112.976 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 47.5 mt -103.39 139.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.041 0 CA-C-N 113.973 -1.467 . . . . 74.14 110.462 -174.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.418 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 13.5 p -126.34 146.45 32.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 107.79 -1.189 . . . . 51.32 107.79 172.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 m -76.27 125.46 29.22 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 106.429 -1.693 . . . . 74.43 106.429 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.64 151.31 45.86 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.528 -0.869 . . . . 65.23 113.339 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -115.0 125.93 54.17 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.589 -1.187 . . . . 72.42 109.491 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 tp -98.7 102.78 15.87 Favored Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 123.49 0.716 . . . . 64.41 109.594 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 73.5 Cg_endo -81.06 141.38 13.04 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.197 1.931 . . . . 64.34 111.942 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.7 10.91 57.42 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.609 -0.805 . . . . 61.54 112.1 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -139.82 163.21 33.22 Favored 'General case' 0 C--O 1.2 -1.5 0 N-CA-C 108.719 -0.845 . . . . 65.32 108.719 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -138.39 143.59 39.85 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.303 0.573 . . . . 75.12 109.82 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.64 124.75 35.32 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.893 -1.521 . . . . 72.42 106.893 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -109.45 147.76 32.31 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.13 -0.693 . . . . 72.51 109.13 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.479 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 3.8 tmt_? . . . . . 0 N--CA 1.414 -2.25 0 N-CA-C 108.961 -0.755 . . . . 74.23 108.961 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 110.718 -0.104 . . . . 74.04 110.718 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HB3' ' HA ' ' A' ' 54' ' ' ARG . 23.3 Cg_exo -69.63 96.98 0.6 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.703 2.268 . . . . 73.31 109.871 171.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 24.5 p -92.73 -179.42 5.15 Favored 'General case' 0 C--O 1.253 1.244 0 N-CA-C 113.422 0.897 . . . . 73.25 113.422 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.6 mm -131.87 120.78 45.52 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 108.146 -1.057 . . . . 73.22 108.146 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.06 149.35 73.48 Favored Pre-proline 0 C--N 1.313 -1.017 0 N-CA-C 110.208 -0.293 . . . . 72.02 110.208 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.23 119.39 6.45 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.107 2.538 . . . . 74.13 113.435 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.4 t -125.91 131.28 52.35 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.792 -0.818 . . . . 65.31 108.792 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.19 -34.48 78.12 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.144 0.497 . . . . 73.53 110.485 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -102.49 23.87 11.25 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.443 -0.799 . . . . 65.01 111.331 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.94 165.67 23.39 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 118.863 -1.636 . . . . 44.45 114.209 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.25 145.75 24.88 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 124.682 1.193 . . . . 71.33 108.596 174.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.4 t -113.02 125.11 70.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.695 -0.483 . . . . 74.23 109.695 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -95.86 116.55 29.08 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.288 -1.004 . . . . 74.32 108.288 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.22 -152.43 5.63 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 110.879 -0.889 . . . . 62.45 110.879 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 34.7 mmtp -129.03 143.92 51.02 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 116.785 0.293 . . . . 70.11 110.28 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 47.3 t -110.08 127.52 66.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 120.834 0.349 . . . . 43.41 110.794 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 70.7 mt -95.48 104.25 16.15 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.07 -1.085 . . . . 71.11 108.07 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.2 ptp -113.55 147.7 37.48 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.825 -0.435 . . . . 71.21 109.825 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.39 13.55 55.5 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.327 -1.416 . . . . 63.21 110.01 -172.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.554 HG11 ' O ' ' A' ' 18' ' ' HIS . 11.4 p -86.76 131.6 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 N-CA-C 109.007 -0.738 . . . . 65.21 109.007 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.489 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 3.2 m -74.44 159.73 31.92 Favored 'General case' 0 N--CA 1.409 -2.484 0 N-CA-C 108.947 -0.76 . . . . 75.53 108.947 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.8 p -56.85 -34.86 68.21 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.614 0.766 . . . . 71.02 111.829 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.09 -46.04 79.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.574 -0.285 . . . . 73.54 111.691 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.525 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 1.8 mp0 -70.26 -31.04 68.24 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.623 -0.51 . . . . 73.52 109.623 175.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.4 tp -58.71 -51.87 68.11 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.202 0.525 . . . . 74.32 109.996 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.59 -28.74 67.21 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.448 -0.796 . . . . 64.13 110.309 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.476 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.1 OUTLIER -65.69 -47.51 75.19 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 108.65 -0.87 . . . . 54.33 108.65 177.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.2 mt -61.13 -46.43 90.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.972 -0.751 . . . . 74.01 108.972 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.53 -29.75 70.79 Favored 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 114.46 -1.245 . . . . 75.21 111.162 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.18 -40.47 59.38 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.082 -0.508 . . . . 64.42 110.848 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 86' ' ' ASN . 59.1 t -72.82 -49.33 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 112.308 0.485 . . . . 73.32 112.308 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -79.92 -27.91 39.84 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 112.859 0.689 . . . . 45.31 112.859 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.81 -21.29 36.19 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 119.585 2.594 . . . . 53.3 119.585 -168.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -71.23 -35.5 71.5 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 119.505 1.653 . . . . 71.02 113.814 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -120.44 -0.03 10.43 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.836 -0.745 . . . . 63.33 112.822 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -130.49 159.01 38.37 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.615 0.366 . . . . 75.11 110.072 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -123.05 137.15 55.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.869 0.366 . . . . 72.5 110.582 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -87.41 114.51 24.08 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.814 -0.63 . . . . 64.14 110.653 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.5 HG13 ' HE3' ' A' ' 117' ' ' MET . 35.9 m -121.27 161.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.528 -0.76 . . . . 75.01 111.679 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 p -92.45 123.04 35.47 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.724 -0.671 . . . . 74.42 110.988 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.59 172.41 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 112.86 0.689 . . . . 61.3 112.86 -175.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -116.14 136.36 12.83 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.173 -0.771 . . . . 74.32 111.173 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.78 160.99 34.31 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 C-N-CA 123.373 0.669 . . . . 73.14 111.322 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 48.2 t -117.17 129.96 72.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.439 -0.578 . . . . 73.4 109.439 177.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.59 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 19.0 mtp180 -73.38 116.54 14.06 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 122.805 0.442 . . . . 72.24 110.206 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -73.81 -20.48 60.45 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.719 -0.673 . . . . 72.14 110.019 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -73.93 -16.6 61.09 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 112.461 0.541 . . . . 73.43 112.461 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.422 ' CG ' ' H ' ' A' ' 108' ' ' SER . 33.0 p-10 -138.32 -83.49 0.3 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.238 -0.585 . . . . 64.54 111.048 173.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.422 ' H ' ' CG ' ' A' ' 107' ' ' ASN . 73.1 m 177.49 -13.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.266 1.427 . . . . 62.4 111.18 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -77.98 149.34 34.12 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 113.157 0.799 . . . . 64.42 113.157 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 62.7 pttt -103.87 147.2 27.6 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.53 -0.759 . . . . 74.4 110.211 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.59 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 89.8 mtp -139.24 162.24 35.48 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.578 0.704 . . . . 73.31 112.234 -175.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.24 130.89 46.41 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 114.349 -1.296 . . . . 64.35 109.359 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.506 HG11 ' ND2' ' A' ' 19' ' ' ASN . 35.8 m -143.41 175.86 3.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 123.366 0.666 . . . . 74.04 109.72 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -116.12 145.1 43.32 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.216 -1.031 . . . . 62.14 108.216 172.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.7 t -136.26 172.04 13.6 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.167 -0.679 . . . . 72.21 109.167 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -104.07 118.53 36.87 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.407 -0.59 . . . . 74.41 109.407 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.5 ' HE3' HG13 ' A' ' 98' ' ' VAL . 52.0 ttp -111.91 148.84 32.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.024 -0.989 . . . . 64.52 109.546 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -73.75 130.54 40.17 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.752 -1.203 . . . . 72.43 107.752 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.436 ' H ' HD11 ' A' ' 119' ' ' ILE . 2.5 mp -73.45 -43.85 55.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 119.91 -0.716 . . . . 73.53 111.242 -171.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 123' ' ' ASP . 9.9 t30 -93.58 67.74 3.97 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.961 1.362 . . . . 74.01 107.952 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -81.73 17.15 1.54 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.485 -1.689 . . . . 63.55 114.382 -170.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -121.97 19.73 10.84 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.315 -0.624 . . . . 44.21 109.315 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.446 ' HB2' ' ND2' ' A' ' 120' ' ' ASN . 11.9 t70 -64.88 126.9 92.03 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.627 -0.715 . . . . 62.14 110.882 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -92.47 16.57 1.36 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 122.388 2.059 . . . . 60.33 113.604 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.77 -32.93 5.97 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.918 0.39 . . . . 73.41 110.857 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 113.674 0.991 . . . . 63.11 113.674 -177.181 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.471 ' O ' HG12 ' A' ' 144' ' ' ILE . 54.0 tptt . . . . . 0 C--O 1.235 0.314 0 CA-C-O 121.027 0.442 . . . . 63.43 110.09 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 34.8 mmtp -53.88 -31.6 50.37 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 114.714 1.376 . . . . 71.24 114.714 -174.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -57.91 -46.27 85.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.932 0.873 . . . . 53.51 108.971 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -76.72 -33.49 58.17 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.73 -1.123 . . . . 72.33 109.389 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.5 mm -63.25 -34.69 68.45 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.343 0 CA-C-N 115.497 -0.774 . . . . 63.42 112.082 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 48.8 mt-10 -56.71 -34.57 67.6 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.522 0.677 . . . . 73.21 110.582 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.6 m -80.98 -47.1 14.09 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.371 -0.831 . . . . 70.44 110.703 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.528 ' O ' ' HG3' ' A' ' 151' ' ' MET . 2.8 t80 -70.96 -30.29 66.54 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.506 -0.77 . . . . 74.34 112.373 -171.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 87.5 tttt -57.9 -40.18 79.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.239 0.616 . . . . 73.43 110.289 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -64.23 -38.53 91.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.922 -0.77 . . . . 55.25 108.922 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.4 mt -68.43 -38.13 78.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.845 -1.07 . . . . 72.02 109.758 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.528 ' HG3' ' O ' ' A' ' 147' ' ' PHE . 64.2 mtt -63.54 -41.77 98.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.085 -0.507 . . . . 72.21 109.729 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 49.7 mt-10 -70.47 -33.86 71.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.847 -0.615 . . . . 71.4 110.461 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 46.4 t -62.15 -49.76 74.57 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.703 -0.681 . . . . 62.34 110.211 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 CA--C 1.513 -0.45 0 CA-C-O 121.212 0.53 . . . . 73.35 110.367 177.395 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.435 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 87.5 mt . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 120.963 0.411 . . . . 64.22 110.299 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.462 ' O ' HG11 ' A' ' 79' ' ' VAL . 44.2 m-70 -128.67 161.74 28.97 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.772 -0.649 . . . . 71.34 111.067 -172.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 9.5 p30 -120.09 128.54 53.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.493 -0.776 . . . . 61.23 112.032 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.2 t -131.78 140.79 47.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.359 -0.837 . . . . 63.14 108.947 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.407 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.8 t80 -98.58 121.61 40.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.813 -0.81 . . . . 74.51 108.813 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 74' ' ' LYS . 14.9 m -93.59 152.36 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.077 -0.51 . . . . 73.24 109.791 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -121.4 -51.66 2.07 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 115.818 1.785 . . . . 75.34 115.818 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.02 -75.11 0.15 Allowed Glycine 0 C--O 1.225 -0.442 0 C-N-CA 118.599 -1.762 . . . . 63.44 114.4 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -58.53 -36.4 73.8 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.594 0.758 . . . . 71.41 112.505 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.469 ' HB3' HD12 ' A' ' 32' ' ' ILE . 70.1 m-85 -110.51 29.9 7.29 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-O 121.14 0.495 . . . . 72.34 111.053 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.585 HE21 ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.91 -7.86 53.9 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.768 0.794 . . . . 62.0 109.648 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 13.0 t70 -114.02 134.44 22.16 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.338 -1.301 . . . . 75.41 111.01 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -72.27 -25.12 19.03 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.577 2.185 . . . . 75.3 112.938 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.497 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 17.8 t70 -64.03 -43.33 95.9 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.185 -0.322 . . . . 64.3 110.471 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.24 -29.58 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 116.238 -0.437 . . . . 72.11 110.058 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 26' ' ' PHE . 31.6 mm -65.77 -47.43 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 122.441 -0.162 . . . . 72.43 110.725 177.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -55.84 -32.7 63.84 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.831 0.348 . . . . 44.04 111.454 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.57 -36.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.471 -0.331 . . . . 65.45 111.473 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.504 ' HE2' ' CD2' ' A' ' 87' ' ' LEU . 50.6 ttp -63.92 -36.5 84.13 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.771 0.319 . . . . 75.21 110.21 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.543 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.1 pt? -125.18 -76.42 0.59 Allowed 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 112.918 0.71 . . . . 65.24 112.918 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.543 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 23.6 m-20 -169.77 -55.9 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 122.012 0.91 . . . . 72.22 108.606 -170.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -121.23 -177.27 3.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.105 -1.407 . . . . 75.24 110.097 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -134.97 120.59 14.21 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 115.757 -0.656 . . . . 73.24 109.629 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.61 150.87 66.7 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.793 2.328 . . . . 72.11 111.073 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -56.7 116.96 3.45 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.718 0.636 . . . . 74.21 110.037 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 49.2 mt -97.0 141.04 16.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.753 -0.658 . . . . 72.42 110.861 -174.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.25 144.78 36.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.519 -0.919 . . . . 75.11 108.519 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.5 m -76.22 122.66 24.69 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.858 -0.793 . . . . 75.02 108.858 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.36 155.94 49.38 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.708 0.766 . . . . 71.44 111.601 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.3 m -113.05 128.87 56.61 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.29 -1.323 . . . . 73.41 108.382 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HG ' ' HB2' ' A' ' 50' ' ' PHE . 48.0 tp -103.7 99.57 16.36 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 108.863 -0.791 . . . . 71.44 108.863 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.8 146.63 10.51 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.016 1.811 . . . . 62.34 111.143 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.66 9.84 65.95 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.349 -0.929 . . . . 73.43 111.76 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.413 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 88.0 m-85 -145.36 159.3 43.27 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 107.503 -1.295 . . . . 74.22 107.503 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -139.3 139.63 37.37 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.059 -0.656 . . . . 72.32 109.613 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 58.7 ttp180 -99.77 135.66 40.85 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.762 -1.108 . . . . 75.22 108.429 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.639 ' HB3' ' O ' ' A' ' 126' ' ' MET . 54.1 m-85 -109.03 168.58 9.26 Favored 'General case' 0 C--N 1.277 -2.55 0 O-C-N 123.595 0.559 . . . . 74.0 109.508 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.086 0 N-CA-C 115.097 1.517 . . . . 53.23 115.097 -174.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 109.433 -0.581 . . . . 73.05 109.433 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 17.1 Cg_exo -69.25 112.41 2.98 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.878 1.719 . . . . 52.3 110.65 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 19.6 p -116.98 160.35 21.07 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 123.372 0.42 . . . . 72.11 111.666 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 71' ' ' VAL . 46.5 mm -96.77 142.68 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 108.209 -1.034 . . . . 72.13 108.209 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 m -146.02 150.73 43.11 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 107.286 -1.375 . . . . 73.13 107.286 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.11 124.97 13.79 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.197 1.931 . . . . 73.04 112.248 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.3 t -124.98 145.38 49.9 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.606 -0.724 . . . . 61.34 109.279 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.23 -36.85 63.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.447 0.536 . . . . 64.3 112.447 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -131.7 15.68 4.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.697 0.629 . . . . 74.31 112.697 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.63 172.78 30.34 Favored Glycine 0 C--O 1.247 0.961 0 C-N-CA 120.486 -0.864 . . . . 72.43 112.391 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -154.64 156.33 36.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.641 -0.874 . . . . 61.4 108.641 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.426 HG23 HD13 ' A' ' 63' ' ' ILE . 40.4 t -124.64 137.69 56.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.131 -0.692 . . . . 74.02 109.131 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -107.95 116.12 31.38 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.518 -0.919 . . . . 73.54 108.518 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.499 ' HA2' ' OE1' ' A' ' 27' ' ' GLN . . . -141.45 -150.09 5.32 Favored Glycine 0 N--CA 1.404 -3.446 0 C-N-CA 119.918 -1.134 . . . . 72.41 112.15 -176.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.507 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 34.5 mmtp -131.3 141.54 49.97 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.712 -0.847 . . . . 73.24 108.712 -174.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.4 t -110.11 130.85 62.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 110.254 -0.276 . . . . 63.3 110.254 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 77.4 mt -95.09 105.63 17.57 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.643 -0.708 . . . . 72.23 109.421 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.494 ' HE2' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -98.65 125.45 43.94 Favored 'General case' 0 CA--C 1.479 -1.786 0 CA-C-O 121.77 0.795 . . . . 70.34 112.072 176.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 17' ' ' LEU . . . 102.46 26.39 7.3 Favored Glycine 0 C--N 1.28 -2.581 0 CA-C-N 114.363 -1.29 . . . . 71.01 112.849 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.462 HG11 ' O ' ' A' ' 18' ' ' HIS . 11.6 p -87.78 125.16 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.471 -0.937 . . . . 73.41 108.471 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.35 164.32 26.84 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 109.386 -0.598 . . . . 65.34 109.386 -176.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.5 m -58.36 -36.92 74.19 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 112.831 0.678 . . . . 55.01 112.831 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.74 -44.71 80.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.672 0.273 . . . . 72.2 110.447 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 1.2 mp0 -68.61 -30.53 69.28 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 116.406 -0.361 . . . . 64.53 110.24 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.4 tp -60.36 -50.25 74.36 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.287 -1.005 . . . . 74.03 108.287 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.02 -28.59 69.6 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.65 -1.159 . . . . 74.42 111.243 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.3 t-20 -62.03 -49.41 76.11 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 123.331 0.652 . . . . 73.35 110.633 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.504 ' CD2' ' HE2' ' A' ' 35' ' ' MET . 92.3 mt -64.4 -38.74 92.09 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.651 0.739 . . . . 72.12 109.25 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.469 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 22.5 t70 -64.95 -35.52 81.44 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.537 -1.211 . . . . 70.2 110.829 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.64 -48.28 22.83 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.205 0.526 . . . . 73.23 110.129 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.7 t -62.99 -56.98 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 124.72 1.208 . . . . 73.44 113.168 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -79.97 -24.27 41.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.328 0.585 . . . . 75.21 112.524 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.7 -16.09 21.69 Favored Glycine 0 C--N 1.309 -0.97 0 N-CA-C 116.041 1.177 . . . . 71.32 116.041 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -57.94 -37.81 74.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 117.509 0.655 . . . . 73.4 112.344 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.63 10.17 3.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.889 0.376 . . . . 65.32 111.668 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -132.2 167.45 19.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.098 -0.704 . . . . 73.23 109.098 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.27 150.88 52.06 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.136 -1.061 . . . . 73.14 108.136 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -87.49 114.06 23.76 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.139 -0.689 . . . . 73.24 109.139 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.503 HG13 ' HE3' ' A' ' 117' ' ' MET . 34.2 m -121.21 160.52 22.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 116.678 -0.237 . . . . 71.52 111.171 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 t -92.29 134.21 35.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.349 -0.612 . . . . 64.5 109.349 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -139.85 161.38 26.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.599 -0.273 . . . . 55.13 110.924 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.68 123.94 7.84 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.646 -0.981 . . . . 73.24 110.646 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.17 158.79 16.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 110.399 -0.222 . . . . 75.04 110.399 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 56.6 t -121.99 123.86 70.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.327 -0.99 . . . . 64.23 108.327 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.54 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 28.1 mtp180 -68.71 121.88 17.39 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 116.185 -0.462 . . . . 61.22 110.496 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -72.22 -21.16 61.44 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 122.183 0.992 . . . . 73.55 108.806 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.81 -39.54 81.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.288 -1.778 . . . . 62.35 112.61 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -147.31 6.03 0.85 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.31 0.856 . . . . 74.04 113.31 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.5 t 73.08 12.58 4.98 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.586 1.154 . . . . 71.33 112.338 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -96.49 149.07 22.15 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.698 -0.626 . . . . 73.14 111.571 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -96.33 150.12 20.92 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 112.817 0.673 . . . . 64.23 112.817 -175.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.54 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.6 mtp -143.26 160.62 40.14 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.853 -1.067 . . . . 72.55 110.153 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.23 130.76 54.7 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.751 -0.833 . . . . 72.04 108.751 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 21' ' ' PHE . 35.3 m -142.27 173.96 6.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 120.894 0.378 . . . . 72.23 110.536 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -104.11 146.57 28.54 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.421 -0.955 . . . . 64.54 108.421 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.0 t -149.33 172.5 14.79 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.829 -0.804 . . . . 72.35 108.829 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -117.74 113.98 22.64 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.125 0.488 . . . . 75.52 109.953 -176.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.503 ' HE3' HG13 ' A' ' 98' ' ' VAL . 24.3 ptt? -109.0 156.38 19.8 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.848 -0.615 . . . . 60.33 110.794 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -68.4 128.85 38.08 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.498 -1.297 . . . . 74.04 107.498 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.6 mm -72.53 -38.51 59.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 112.653 0.612 . . . . 63.32 112.653 -170.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -76.28 -37.66 57.24 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.695 -0.402 . . . . 73.11 111.216 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.337 0.0 OUTLIER 37.77 65.01 0.6 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.123 1.157 . . . . 75.41 114.123 -173.174 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.29 -26.62 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.635 -0.711 . . . . 72.03 111.198 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.32 136.23 50.74 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 122.929 0.491 . . . . 61.11 112.052 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.16 -2.29 11.94 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.612 2.208 . . . . 71.44 110.677 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -63.88 -45.51 89.08 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 115.665 -0.698 . . . . 74.21 110.917 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.639 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.0 ptt? . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 116.324 -0.398 . . . . 72.5 110.763 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.573 ' O ' HG12 ' A' ' 144' ' ' ILE . 37.5 ttpt . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 109.752 -0.462 . . . . 74.31 109.752 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.81 -30.93 47.23 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.425 1.09 . . . . 64.35 111.78 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -65.37 -39.23 92.04 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.04 0.448 . . . . 73.23 109.917 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 146' ' ' THR . 92.6 m-85 -76.73 -32.84 58.06 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.572 0.701 . . . . 74.31 109.291 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.9 mm -58.53 -31.21 43.0 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 CA-C-N 114.845 -1.07 . . . . 74.32 111.713 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -50.64 -44.72 57.49 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.296 0.48 . . . . 63.45 112.296 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 143' ' ' PHE . 12.0 t -68.76 -40.58 79.69 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 120.221 -0.592 . . . . 71.33 110.25 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -69.65 -29.95 67.53 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 112.93 0.715 . . . . 64.35 112.93 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 38.2 ttpt -59.64 -43.2 93.95 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.534 -0.913 . . . . 74.54 108.534 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -72.58 -28.55 62.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.798 -0.637 . . . . 75.44 110.235 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 146' ' ' THR . 83.7 mt -73.76 -43.16 54.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.757 -0.656 . . . . 75.15 110.397 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.2 ptm -70.75 -29.89 66.25 Favored 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 121.089 -0.244 . . . . 64.01 111.579 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 8.2 mm-40 -66.1 -33.32 75.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.079 0.466 . . . . 75.21 110.728 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 41.8 t -71.95 -33.83 68.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.048 -0.523 . . . . 72.32 110.066 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.241 0.628 0 CA-C-O 121.56 0.695 . . . . 72.11 111.099 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.416 -2.158 0 CA-C-O 121.619 0.723 . . . . 71.54 109.413 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.519 ' O ' HG11 ' A' ' 79' ' ' VAL . 37.5 m-70 -115.01 160.66 19.33 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 114.811 -1.086 . . . . 62.12 108.818 -174.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 22.5 p30 -131.14 127.03 37.21 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.548 0.69 . . . . 73.34 110.868 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.5 t -121.05 141.78 40.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.101 -0.954 . . . . 72.01 110.492 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -94.56 124.37 38.56 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.514 -0.921 . . . . 73.53 108.514 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 m -109.12 126.4 66.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.364 0.602 . . . . 75.21 111.673 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -66.88 -34.09 77.03 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.803 1.038 . . . . 74.25 113.803 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 169.42 -28.44 0.13 Allowed Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 118.752 -1.69 . . . . 52.24 113.318 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.2 p -62.97 -36.8 84.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.143 0.497 . . . . 64.4 111.143 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.508 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 63.5 m-85 -124.67 28.79 6.44 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.669 -0.696 . . . . 73.12 112.23 -176.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -87.14 9.18 20.78 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.795 0.807 . . . . 72.44 108.848 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.535 ' O ' HG12 ' A' ' 32' ' ' ILE . 13.1 t70 -117.25 129.44 25.33 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.544 -1.207 . . . . 74.44 109.354 -176.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -71.08 -28.8 18.58 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.915 1.744 . . . . 55.21 112.558 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.443 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 24.0 t70 -62.35 -44.63 96.02 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 116.348 -0.387 . . . . 75.43 110.761 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.94 -29.3 36.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.997 -0.547 . . . . 72.5 109.93 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 28' ' ' ASP . 44.2 mm -65.76 -41.57 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 116.434 -0.348 . . . . 74.14 110.356 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.86 -46.21 71.21 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.296 0.569 . . . . 37.75 110.622 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -82.75 -36.14 13.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 114.371 1.249 . . . . 73.21 114.371 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.594 ' HE3' ' ND2' ' A' ' 86' ' ' ASN . 12.0 tmm? -67.84 -36.58 80.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.792 0.33 . . . . 74.33 110.701 -174.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.436 HD21 HG22 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -119.13 -71.69 0.72 Allowed 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.681 -0.808 . . . . 51.23 111.535 175.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.424 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 27.8 t70 167.96 -46.73 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.405 0.682 . . . . 72.53 109.481 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -111.75 160.3 17.44 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.355 -0.839 . . . . 75.01 110.345 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.411 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 40.3 m -119.55 111.1 36.56 Favored Pre-proline 0 N--CA 1.429 -1.509 0 CA-C-N 116.34 -0.391 . . . . 75.14 111.262 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -60.72 151.51 76.03 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.025 2.483 . . . . 70.55 110.378 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -62.57 121.47 13.4 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.117 0.484 . . . . 65.44 109.855 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 25.2 mt -99.08 131.05 47.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.379 -0.828 . . . . 71.2 109.385 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.4 148.05 33.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.899 -0.591 . . . . 74.41 110.352 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.413 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 34.5 m -75.59 124.19 26.79 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.024 0.44 . . . . 71.23 110.096 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.7 159.27 42.51 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.439 0.638 . . . . 63.42 111.513 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.47 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 78.3 m -118.23 129.43 55.48 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.479 -0.782 . . . . 74.34 109.892 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.6 tp -104.43 99.31 17.21 Favored Pre-proline 0 N--CA 1.426 -1.652 0 N-CA-C 109.733 -0.469 . . . . 73.32 109.733 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.5 Cg_endo -84.29 141.69 9.23 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.694 2.263 . . . . 72.32 110.752 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.36 4.14 57.41 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.616 -0.802 . . . . 71.05 111.492 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 66' ' ' SER . 82.4 m-85 -138.76 157.77 45.48 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.967 -0.753 . . . . 73.22 108.967 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -138.93 148.3 43.39 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.595 -0.52 . . . . 65.34 109.595 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -100.6 126.35 47.06 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.265 -0.88 . . . . 74.51 110.564 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 68.1 m-85 -109.04 134.85 51.12 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.03 -1.47 . . . . 72.12 107.03 174.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.561 ' C ' ' HD3' ' A' ' 54' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.404 -2.757 0 N-CA-C 113.798 1.036 . . . . 64.02 113.798 -166.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 N--CA 1.444 -0.752 0 N-CA-C 107.439 -1.319 . . . . 73.11 107.439 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 7.1 Cg_exo -73.73 81.17 1.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 121.022 1.148 . . . . 74.3 109.932 170.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.0 m -85.74 157.17 20.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.801 -0.636 . . . . 63.24 112.109 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.414 HD12 HG23 ' A' ' 71' ' ' VAL . 49.2 mm -103.95 140.9 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 115.153 -0.931 . . . . 75.31 109.23 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.31 153.96 56.6 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.278 -1.008 . . . . 62.3 108.278 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.12 112.97 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.543 2.162 . . . . 65.2 112.378 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 33.5 t -125.54 126.64 45.16 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.329 -0.989 . . . . 72.42 108.329 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.48 -36.17 77.65 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.468 0.914 . . . . 72.31 113.468 -174.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -107.52 19.85 19.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.698 0.285 . . . . 74.52 111.495 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -109.31 160.13 13.68 Favored Glycine 0 N--CA 1.426 -1.989 0 C-N-CA 119.873 -1.156 . . . . 73.53 112.997 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.69 131.63 8.08 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.988 -1.116 . . . . 74.22 107.988 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.414 HG23 HD12 ' A' ' 63' ' ' ILE . 56.6 t -112.43 123.43 68.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 109.762 -0.458 . . . . 73.13 109.762 -176.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -97.01 115.88 28.23 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.366 -1.346 . . . . 75.51 107.366 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -144.69 -149.69 5.09 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 110.323 -1.111 . . . . 54.4 110.323 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.489 ' HD3' ' O ' ' A' ' 73' ' ' GLY . 2.2 mppt? -127.44 150.79 49.49 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 112.989 0.737 . . . . 70.21 112.989 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 28.1 t -110.87 131.88 60.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 114.593 -1.185 . . . . 73.3 112.016 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 78.8 mt -96.91 106.95 19.36 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.278 -1.008 . . . . 72.01 108.278 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.1 ptp -114.56 150.01 35.62 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 120.487 0.184 . . . . 73.1 110.714 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.71 15.86 47.89 Favored Glycine 0 N--CA 1.433 -1.513 0 C-N-CA 119.483 -1.342 . . . . 63.42 111.006 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.519 HG11 ' O ' ' A' ' 18' ' ' HIS . 11.3 p -87.43 126.24 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.119 -1.067 . . . . 53.02 108.119 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.6 p -76.29 172.66 12.52 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.809 -0.356 . . . . 72.24 110.276 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.9 p -59.87 -41.18 90.93 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 112.25 0.463 . . . . 55.42 112.25 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.04 -36.65 85.06 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.777 0.798 . . . . 63.44 110.888 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 42.2 mt-10 -78.06 -31.21 50.16 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.397 -0.819 . . . . 73.05 109.171 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.433 HD23 ' CE1' ' A' ' 18' ' ' HIS . 35.5 tp -66.27 -47.32 74.09 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.233 -0.44 . . . . 61.5 110.615 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.01 -29.37 70.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.268 0.556 . . . . 75.22 109.63 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.594 ' ND2' ' HE3' ' A' ' 35' ' ' MET . 7.7 t30 -67.21 -44.07 80.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.308 -0.86 . . . . 72.1 109.629 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.77 -43.17 94.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.747 -0.661 . . . . 71.41 109.758 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.534 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 31.3 t70 -65.65 -27.59 68.48 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.927 -1.033 . . . . 63.31 110.288 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.47 -48.5 22.37 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.053 -0.521 . . . . 70.4 110.286 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.501 HG21 ' SD ' ' A' ' 35' ' ' MET . 92.7 t -69.86 -58.27 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 112.473 0.546 . . . . 75.14 112.473 -175.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.95 -33.86 44.92 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.136 0.493 . . . . 73.53 111.351 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -60.11 -16.53 41.41 Favored Glycine 0 N--CA 1.465 0.587 0 CA-C-N 115.795 -0.639 . . . . 37.75 113.507 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -57.74 -37.44 73.61 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.695 0.398 . . . . 73.25 110.518 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -132.93 7.91 4.05 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.169 0.509 . . . . 74.42 111.84 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -131.07 168.84 16.73 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 122.709 0.404 . . . . 75.24 110.837 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.55 ' HB2' ' CD1' ' A' ' 119' ' ' ILE . 43.3 tt0 -122.46 129.97 52.59 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.536 -0.912 . . . . 60.3 108.536 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 115' ' ' THR . 60.0 ttp180 -86.14 114.16 22.77 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.912 -1.144 . . . . 74.11 107.912 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.488 HG12 ' HE2' ' A' ' 117' ' ' MET . 30.9 m -125.77 162.24 29.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.673 -0.694 . . . . 62.51 111.987 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -86.13 124.62 32.74 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.242 -0.89 . . . . 75.43 109.257 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.8 170.72 19.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.72 -0.673 . . . . 70.44 111.896 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -121.24 120.51 4.47 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 110.587 -1.005 . . . . 63.02 110.587 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -115.41 163.02 13.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 116.597 0.198 . . . . 61.52 110.64 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 59.5 t -117.3 125.38 73.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 107.603 -1.258 . . . . 74.14 107.603 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.511 ' HE ' ' HB3' ' A' ' 106' ' ' ASP . 29.4 ttp180 -79.2 118.67 21.36 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.082 -1.081 . . . . 72.41 108.082 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.413 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 45.4 mt-10 -66.94 -7.52 22.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.203 0.601 . . . . 72.24 111.081 -176.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.511 ' HB3' ' HE ' ' A' ' 104' ' ' ARG . 30.1 t70 -54.78 -46.51 74.45 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.996 -1.002 . . . . 74.21 108.92 172.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -133.8 -103.27 0.24 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.152 -1.055 . . . . 74.32 108.152 170.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.2 p -152.47 16.14 0.61 Allowed 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 106.374 -1.713 . . . . 74.05 106.374 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.89 128.5 35.67 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 114.458 -1.246 . . . . 75.23 108.183 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 60.8 pttt -99.36 147.39 25.28 Favored 'General case' 0 C--N 1.251 -3.678 0 CA-C-N 115.273 -0.876 . . . . 74.34 109.801 -176.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 32.8 mtm -136.14 163.44 30.34 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.721 0.772 . . . . 65.13 110.686 -176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.63 118.15 35.8 Favored 'General case' 0 C--N 1.258 -3.41 0 CA-C-N 114.301 -1.318 . . . . 65.44 108.604 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.425 HG11 ' OD1' ' A' ' 19' ' ' ASN . 22.8 m -134.15 174.67 12.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.316 -0.624 . . . . 75.1 109.316 -176.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -113.25 146.27 39.61 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.985 -0.746 . . . . 54.03 108.985 175.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 14.4 t -136.04 171.4 14.53 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.354 -0.61 . . . . 62.41 109.354 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 80.1 m-85 -112.57 112.68 24.4 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.852 -0.613 . . . . 71.52 110.317 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.488 ' HE2' HG12 ' A' ' 98' ' ' VAL . 20.7 ptt? -112.67 157.83 20.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.656 -0.702 . . . . 71.41 109.582 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -67.64 139.91 56.83 Favored 'General case' 0 C--O 1.254 1.335 0 N-CA-C 109.104 -0.702 . . . . 75.51 109.104 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 96' ' ' GLU . 16.9 mm -72.24 -44.74 63.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 120.34 -0.544 . . . . 64.32 110.788 -172.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -70.32 -35.74 73.84 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 115.629 -0.714 . . . . 74.13 109.868 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.483 ' HZ1' ' HB3' ' A' ' 121' ' ' LYS . 0.1 OUTLIER 56.17 -4.45 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.082 2.153 . . . . 73.24 115.587 176.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.81 26.15 6.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.507 0.67 . . . . 51.04 109.407 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.591 ' O ' ' HG2' ' A' ' 126' ' ' MET . 10.2 t70 -62.78 125.66 86.9 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.131 -0.94 . . . . 75.25 109.558 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.44 -13.76 16.51 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.832 2.355 . . . . 61.42 113.204 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -89.3 -24.0 22.14 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.228 -0.442 . . . . 53.15 110.69 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.591 ' HG2' ' O ' ' A' ' 123' ' ' ASP . 21.4 ptp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.724 0.297 . . . . 60.34 111.262 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.499 ' O ' HG12 ' A' ' 144' ' ' ILE . 34.7 ttpt . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 113.219 0.822 . . . . 70.21 113.219 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 88.2 tttt -53.85 -34.58 59.75 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.678 0.622 . . . . 72.12 112.678 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 142' ' ' LYS . 10.7 tmtt? -58.97 -43.6 91.38 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.387 -0.597 . . . . 72.44 109.387 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -76.74 -32.85 58.04 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.703 -0.68 . . . . 73.3 109.83 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 140' ' ' LYS . 51.6 mm -63.28 -33.38 60.76 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 CA-C-N 115.603 -0.726 . . . . 72.33 110.551 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 7.7 mm-40 -51.8 -39.05 58.01 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.281 0.845 . . . . 71.41 113.281 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -80.63 -39.33 27.57 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 119.973 -0.691 . . . . 74.45 110.511 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -67.89 -29.21 68.25 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 112.577 0.584 . . . . 72.4 112.577 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -53.76 -42.22 67.97 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 124.095 0.958 . . . . 52.23 109.315 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -75.32 -42.04 55.44 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.584 -0.735 . . . . 62.12 110.126 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.2 mt -61.52 -39.56 83.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.735 -0.666 . . . . 64.22 111.654 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 57.8 ttp -62.14 -45.91 91.32 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 122.809 0.444 . . . . 61.23 110.1 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -66.39 -30.94 71.42 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.165 0.507 . . . . 65.42 110.071 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 45.1 t -69.17 -33.44 73.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.156 -0.475 . . . . 61.31 111.058 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 CA--C 1.506 -0.721 0 CA-C-O 121.412 0.625 . . . . 75.45 110.084 176.921 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' N ' HD21 ' A' ' 17' ' ' LEU . 1.8 mm? . . . . . 0 N--CA 1.395 -3.214 0 CA-C-O 121.451 0.643 . . . . 74.01 110.982 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.467 ' O ' HG11 ' A' ' 79' ' ' VAL . 56.6 m-70 -123.61 159.77 28.55 Favored 'General case' 0 C--N 1.27 -2.858 0 CA-C-N 114.82 -1.082 . . . . 73.34 109.406 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 15.3 p30 -125.59 126.19 44.37 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.021 -0.99 . . . . 55.34 110.322 174.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.61 138.76 53.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.436 -0.802 . . . . 72.44 109.395 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -93.55 121.92 35.46 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.138 -1.43 . . . . 75.03 107.138 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 19.2 m -103.24 154.81 5.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 115.737 -0.665 . . . . 61.43 110.878 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -139.9 -30.05 0.7 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.989 0.737 . . . . 74.22 112.989 -170.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.49 -91.29 0.44 Allowed Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 118.875 -1.631 . . . . 72.53 113.523 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 m -58.69 -31.29 68.09 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.22 0.822 . . . . 73.43 113.22 -173.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 27.6 m-85 -117.49 21.56 12.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.677 0.992 . . . . 74.41 113.677 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.412 ' HA ' ' CG2' ' A' ' 22' ' ' VAL . 9.8 tt0 -82.67 -2.63 54.62 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 121.974 0.892 . . . . 71.23 110.131 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 32' ' ' ILE . 20.4 t70 -112.52 125.21 30.38 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 115.392 -0.822 . . . . 60.53 109.56 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.3 -31.12 36.0 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.716 2.277 . . . . 60.33 113.572 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -62.78 -38.14 89.45 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 120.686 0.279 . . . . 73.45 111.591 -176.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 28' ' ' ASP . 29.0 m -73.38 -28.19 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.147 -0.479 . . . . 64.15 110.752 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 28' ' ' ASP . 47.9 mm -61.49 -38.61 80.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 CA-C-O 121.046 0.451 . . . . 73.43 110.866 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -59.6 -35.13 73.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.698 -0.683 . . . . 71.31 110.275 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.9 t -82.07 -51.12 15.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.406 -0.815 . . . . 72.41 111.667 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.619 ' HE2' ' OD1' ' A' ' 86' ' ' ASN . 10.7 tmm? -63.68 -36.63 84.48 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.523 -0.308 . . . . 74.21 111.002 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.545 HD11 ' N ' ' A' ' 37' ' ' ASP 0.386 3.6 pp -121.56 -59.55 1.68 Allowed 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 114.702 1.371 . . . . 73.13 114.702 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.545 ' N ' HD11 ' A' ' 36' ' ' LEU . 17.2 t70 172.72 -55.44 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.127 0.489 . . . . 62.3 110.825 -176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.473 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 56.8 mmt-85 -138.75 159.1 42.95 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.828 -0.624 . . . . 51.0 110.195 -176.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.3 m -94.3 122.09 62.16 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 112.144 0.424 . . . . 74.31 112.144 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.61 153.26 68.19 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.066 3.177 . . . . 70.34 111.392 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -56.77 132.08 51.16 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.226 -0.657 . . . . 72.25 109.226 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 54.9 mt -115.49 134.67 57.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 109.307 -0.627 . . . . 75.23 109.307 -174.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.29 144.13 36.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 108.505 -0.924 . . . . 73.53 108.505 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.5 m -81.12 127.69 32.92 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 108.826 -0.805 . . . . 71.23 108.826 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.48 158.74 43.37 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.221 0.534 . . . . 74.35 110.834 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.485 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 97.1 m -113.58 127.69 56.16 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.187 -0.915 . . . . 73.04 110.082 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.8 tp -100.59 100.22 11.82 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 109.415 -0.587 . . . . 73.21 109.415 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 46' ' ' THR . 97.2 Cg_endo -88.09 135.21 3.23 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.649 2.233 . . . . 63.34 111.646 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.11 11.83 38.33 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.402 -0.904 . . . . 55.42 111.165 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.498 ' HA ' ' H ' ' A' ' 66' ' ' SER . 87.0 m-85 -145.31 159.69 42.66 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.876 -0.787 . . . . 74.13 108.876 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.42 143.8 37.8 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.662 -0.495 . . . . 73.22 109.662 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -104.41 132.68 50.39 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.825 -1.176 . . . . 73.01 107.825 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -108.76 169.82 8.42 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 113.378 0.881 . . . . 73.55 113.378 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 . . . . . 0 C--N 1.288 -2.094 0 CA-C-N 114.251 -1.34 . . . . 74.11 109.163 -175.149 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 . . . . . 0 C--O 1.241 0.635 0 N-CA-C 108.993 -0.743 . . . . 62.54 108.993 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.39 98.05 1.14 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.823 1.682 . . . . 64.12 108.915 172.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 23.3 p -109.89 169.15 8.91 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.146 -0.479 . . . . 73.4 112.189 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.8 mm -108.82 141.24 24.62 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.022 0 C-N-CA 123.533 0.733 . . . . 73.41 109.232 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.3 153.62 52.56 Favored Pre-proline 0 N--CA 1.476 0.873 0 N-CA-C 107.762 -1.199 . . . . 74.43 107.762 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 30.7 Cg_endo -65.03 115.45 3.29 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.555 2.17 . . . . 72.3 113.966 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.498 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 47.3 t -125.82 112.95 16.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.25 -1.018 . . . . 64.22 108.25 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.62 -22.31 66.65 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.396 0.517 . . . . 74.03 112.396 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -109.63 14.82 23.23 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.86 0.362 . . . . 73.21 110.937 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.13 167.22 15.39 Favored Glycine 0 C--O 1.249 1.082 0 C-N-CA 120.684 -0.769 . . . . 38.77 112.663 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.41 143.54 18.94 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 123.834 0.854 . . . . 74.12 109.569 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.44 120.02 63.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 110.13 -0.322 . . . . 70.23 110.13 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -91.77 115.45 28.07 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.782 -1.562 . . . . 74.22 106.782 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.05 -150.37 5.29 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.573 -0.822 . . . . 64.44 111.866 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.43 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 73.5 mmtt -126.04 141.54 51.91 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.854 0.359 . . . . 75.51 110.339 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.3 t -111.09 131.04 63.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.966 -0.561 . . . . 75.24 110.78 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 66.9 mt -95.57 104.71 16.63 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.887 -0.783 . . . . 75.41 108.887 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.41 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 55.3 mtp -102.61 161.03 14.05 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.326 -0.99 . . . . 63.21 108.326 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.67 17.09 78.14 Favored Glycine 0 C--N 1.302 -1.346 0 C-N-CA 119.29 -1.433 . . . . 73.4 112.792 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.467 HG11 ' O ' ' A' ' 18' ' ' HIS . 10.9 p -91.82 136.02 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.28 -1.007 . . . . 64.12 108.28 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 79.2 p -78.93 168.39 19.76 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.899 -0.72 . . . . 72.24 111.766 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 m -63.0 -33.43 75.4 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.206 -0.452 . . . . 73.01 111.978 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.72 -39.17 93.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.795 0.807 . . . . 70.15 110.47 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.529 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.8 mt-10 -78.27 -28.36 47.62 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.979 -1.01 . . . . 73.14 109.296 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.445 HD23 ' CE1' ' A' ' 18' ' ' HIS . 53.3 tp -66.13 -50.29 64.53 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 109.882 -0.414 . . . . 63.45 109.882 175.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.99 -28.87 69.87 Favored 'General case' 0 C--O 1.208 -1.12 0 CA-C-O 121.379 0.609 . . . . 73.3 109.441 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.619 ' OD1' ' HE2' ' A' ' 35' ' ' MET . 12.6 t-20 -65.44 -49.06 70.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.171 -0.922 . . . . 62.54 110.537 176.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.4 mt -65.07 -38.85 92.12 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.824 0.821 . . . . 75.01 109.639 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.651 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 24.6 t70 -65.13 -31.68 73.0 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.231 -1.35 . . . . 73.55 109.737 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.21 -48.4 17.67 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.258 -0.883 . . . . 64.51 111.514 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.3 p -72.33 -59.14 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 113.957 1.095 . . . . 73.13 113.957 -173.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.38 -32.93 37.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 119.643 -0.823 . . . . 74.4 110.847 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.46 -16.35 21.12 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.83 -1.077 . . . . 74.44 115.55 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.16 -24.58 51.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 118.277 1.038 . . . . 65.44 111.604 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -111.05 -11.59 14.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.42 0.629 . . . . 73.03 110.327 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -134.53 170.91 15.06 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.771 0.829 . . . . 74.12 110.416 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -121.62 138.03 54.49 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.335 -0.987 . . . . 73.02 108.335 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 115' ' ' THR . 39.6 ttp180 -87.48 119.13 27.45 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.794 -0.817 . . . . 73.25 108.794 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.508 HG12 ' HE3' ' A' ' 117' ' ' MET . 19.0 m -123.54 161.16 26.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 112.378 0.51 . . . . 75.42 112.378 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -91.5 122.96 34.55 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.014 -0.993 . . . . 73.12 108.955 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.42 158.96 43.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.104 0.478 . . . . 74.14 111.605 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.06 119.75 6.14 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 111.032 -0.827 . . . . 70.41 111.032 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.03 154.88 13.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 122.296 0.238 . . . . 64.23 110.431 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.74 117.72 55.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.181 0.515 . . . . 73.45 109.788 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -64.5 124.67 22.43 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 124.509 1.124 . . . . 73.44 111.414 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -61.41 -35.59 77.95 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.739 0.816 . . . . 74.01 112.115 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.2 -53.02 62.73 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.031 0.752 . . . . 71.41 113.031 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -128.96 10.86 5.98 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 113.5 0.926 . . . . 72.35 113.5 -167.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.4 t 63.93 12.44 6.83 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.403 0.681 . . . . 73.41 112.504 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -81.07 152.14 28.01 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.24 -0.652 . . . . 72.33 109.24 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -105.78 147.18 28.92 Favored 'General case' 0 C--N 1.278 -2.515 0 C-N-CA 120.263 -0.575 . . . . 62.53 109.789 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 40.9 mtm -137.55 163.05 32.13 Favored 'General case' 0 CA--C 1.465 -2.308 0 CA-C-O 121.412 0.625 . . . . 63.22 110.186 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.75 118.32 36.22 Favored 'General case' 0 C--N 1.262 -3.226 0 CA-C-N 114.612 -1.176 . . . . 70.23 108.474 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.428 HG12 ' CG ' ' A' ' 19' ' ' ASN . 30.8 m -128.22 173.52 13.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 116.062 -0.517 . . . . 73.33 110.172 -176.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -101.99 149.42 24.25 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.214 -1.402 . . . . 64.03 107.214 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.7 t -152.3 171.69 17.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.561 -0.903 . . . . 73.21 108.561 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -119.1 116.75 27.02 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.043 -0.725 . . . . 72.22 109.043 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.508 ' HE3' HG12 ' A' ' 98' ' ' VAL . 24.5 ptt? -112.63 156.79 22.12 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.054 -0.521 . . . . 73.15 109.777 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.45 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 64.4 t-105 -68.08 123.98 22.16 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.572 -0.899 . . . . 70.42 108.572 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.6 mt -67.86 -41.76 85.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.069 -0.968 . . . . 74.51 112.022 -172.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -88.12 75.76 8.62 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.973 0.892 . . . . 64.41 108.673 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -76.67 0.05 21.75 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.005 -0.998 . . . . 71.52 112.877 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.88 8.96 41.05 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.104 -0.498 . . . . 71.12 109.871 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.94 138.59 96.4 Favored Pre-proline 0 C--O 1.214 -0.774 0 CA-C-N 115.772 -0.649 . . . . 72.41 109.96 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -99.56 17.56 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.181 1.921 . . . . 44.3 113.308 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -118.01 -9.0 10.65 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.311 1.226 . . . . 75.3 114.311 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 119.333 -0.947 . . . . 72.21 110.247 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.606 ' O ' HG12 ' A' ' 144' ' ' ILE . 6.3 ttpm? . . . . . 0 C--O 1.209 -1.047 0 N-CA-C 114.053 1.131 . . . . 72.52 114.053 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -55.83 -35.08 65.99 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.314 0.857 . . . . 74.11 113.314 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 0.6 OUTLIER -66.74 -36.57 82.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.879 0.847 . . . . 74.33 108.749 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -77.03 -35.96 56.52 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 113.679 -1.6 . . . . 74.35 110.678 -175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 140' ' ' LYS . 50.1 mm -61.37 -32.67 53.86 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.981 0 N-CA-C 113.182 0.808 . . . . 72.42 113.182 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -51.77 -42.31 62.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 113.792 1.034 . . . . 71.12 113.792 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 150' ' ' ILE . 13.1 t -70.77 -33.67 71.02 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 120.128 -0.629 . . . . 74.22 109.811 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.475 ' O ' ' HG3' ' A' ' 151' ' ' MET . 64.0 m-85 -71.71 -30.36 65.56 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 116.125 -0.489 . . . . 63.33 111.679 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 152' ' ' GLU . 29.8 mtpp -59.83 -36.84 77.64 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.254 -1.017 . . . . 72.22 108.254 174.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -74.56 -36.68 63.08 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.778 -0.646 . . . . 74.43 112.201 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.545 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 94.6 mt -63.28 -41.45 92.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.904 0.383 . . . . 63.54 110.09 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.475 ' HG3' ' O ' ' A' ' 147' ' ' PHE . 65.4 mtt -66.58 -40.64 89.02 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.656 -0.498 . . . . 70.11 109.656 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 148' ' ' LYS . 1.3 tm-20 -62.28 -34.29 76.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 124.87 1.268 . . . . 44.12 109.765 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 74.9 m -71.13 -34.07 70.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.188 -0.46 . . . . 70.3 110.553 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 34.6 mmtp . . . . . 0 C--O 1.24 0.598 0 N-CA-C 109.261 -0.644 . . . . 71.12 109.261 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.429 ' N ' HD21 ' A' ' 17' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.418 -2.071 0 CA-C-O 121.325 0.583 . . . . 63.34 112.14 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.9 m-70 -113.9 161.25 17.85 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.016 -0.993 . . . . 74.31 109.191 -173.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 24.9 p30 -128.27 134.58 48.97 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.336 0.589 . . . . 73.35 112.117 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 53.9 t -131.52 137.97 54.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.659 -0.7 . . . . 73.44 110.345 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.406 ' HB2' HG21 ' A' ' 113' ' ' VAL . 93.2 t80 -94.67 123.83 38.34 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.195 0.598 . . . . 74.3 109.659 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 26' ' ' PHE . 13.1 p -138.56 155.46 28.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.416 -0.587 . . . . 71.15 109.416 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.428 ' CE1' HD11 ' A' ' 63' ' ' ILE . 2.0 p90 -148.97 6.31 0.69 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.923 0.392 . . . . 75.1 110.145 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.81 -92.61 1.02 Allowed Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 119.812 -1.185 . . . . 72.11 113.293 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.7 m -58.6 -36.11 73.49 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.441 0.696 . . . . 52.2 112.835 -174.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 22' ' ' VAL . 72.6 m-85 -120.04 29.78 7.35 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.259 0.552 . . . . 71.43 111.561 -175.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -62.95 -31.51 72.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.929 -1.032 . . . . 73.34 110.633 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 21.2 t70 -108.49 129.7 23.68 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.642 -0.708 . . . . 75.15 111.719 -176.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.23 -24.68 58.18 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.437 2.758 . . . . 71.23 113.915 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 16.4 t70 -70.46 -29.09 65.56 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.709 -0.619 . . . . 54.12 110.119 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.58 -39.57 84.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.345 -0.843 . . . . 75.24 108.824 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.431 HD12 ' HB3' ' A' ' 26' ' ' PHE . 29.0 mm -62.77 -45.03 99.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.253 -0.885 . . . . 74.22 110.526 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -53.2 -42.85 66.7 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.492 0.553 . . . . 71.3 112.492 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.55 -36.75 14.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 112.525 0.565 . . . . 71.5 112.525 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.7 tmm? -65.22 -35.85 82.33 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 121.32 -0.152 . . . . 62.05 110.683 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.539 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 0.8 OUTLIER -120.35 -74.7 0.6 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 119.967 -0.693 . . . . 75.01 112.444 172.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.539 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 16.3 t70 173.6 -48.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.528 0.731 . . . . 75.24 109.163 -174.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -109.13 164.95 11.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.604 -1.18 . . . . 60.01 109.094 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.4 m -123.93 129.35 24.81 Favored Pre-proline 0 C--N 1.307 -1.247 0 C-N-CA 122.361 0.264 . . . . 63.2 111.164 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -68.0 152.57 76.63 Favored 'Trans proline' 0 C--O 1.25 1.085 0 C-N-CA 123.278 2.652 . . . . 51.45 111.431 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.89 140.13 58.79 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.193 -0.669 . . . . 63.31 109.193 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 52.6 mt -118.35 142.66 32.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 120.889 0.376 . . . . 51.51 110.655 -173.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 104' ' ' ARG . 9.1 p -130.13 145.08 36.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.092 -0.707 . . . . 71.31 109.092 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.1 m -76.54 124.79 28.14 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.888 -0.782 . . . . 63.25 108.888 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.66 156.69 47.76 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.981 0.896 . . . . 72.34 112.042 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.422 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 64.8 m -116.16 128.89 56.02 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.398 -1.274 . . . . 73.24 108.153 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.0 tp -102.03 99.61 12.78 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 46' ' ' THR . 95.6 Cg_endo -85.47 148.37 10.03 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.349 2.033 . . . . 72.44 111.354 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.39 13.45 68.06 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.433 -0.889 . . . . 37.99 111.225 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -143.25 152.26 41.49 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.991 -1.114 . . . . 72.22 107.991 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -139.55 142.86 37.17 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.783 -0.767 . . . . 74.12 109.154 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.584 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -90.27 134.81 34.07 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.83 -1.174 . . . . 73.13 107.83 176.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB3' ' O ' ' A' ' 126' ' ' MET . 84.2 m-85 -116.64 169.11 9.6 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 112.097 0.406 . . . . 74.34 112.097 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 114.692 1.367 . . . . 72.31 114.692 -169.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 108.302 -0.999 . . . . 73.35 108.302 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 21.9 Cg_exo -66.37 101.05 0.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 N-CA-C 108.639 -1.331 . . . . 61.0 108.639 171.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 9.3 p -102.54 153.3 20.21 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.547 -0.751 . . . . 73.33 112.969 -173.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.428 HD11 ' CE1' ' A' ' 23' ' ' TYR . 41.8 mm -106.13 117.94 52.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.297 -0.865 . . . . 72.24 110.289 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.36 146.58 62.58 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.46 -0.57 . . . . 70.43 109.46 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.1 109.05 1.05 Allowed 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.757 2.305 . . . . 72.23 112.303 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 t -124.64 121.76 35.61 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.01 -1.478 . . . . 53.43 107.01 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.61 -36.77 67.3 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.476 1.287 . . . . 74.32 114.476 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -109.1 20.05 18.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.193 0.52 . . . . 61.11 110.661 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.7 162.72 14.11 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.041 -1.076 . . . . 62.23 112.731 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -150.97 145.13 25.36 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 108.709 -0.849 . . . . 72.12 108.709 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.7 t -123.3 133.27 69.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.468 -0.568 . . . . 65.21 109.468 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -107.41 126.51 52.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.058 -1.09 . . . . 71.03 108.058 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.01 -154.91 7.08 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.753 -0.939 . . . . 63.01 110.753 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.51 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.2 mmtm -125.75 148.72 48.99 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 120.719 0.295 . . . . 73.12 110.221 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.5 t -109.75 126.41 66.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 116.154 -0.476 . . . . 63.24 110.289 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 69.4 mt -94.98 107.39 19.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.67 -1.233 . . . . 74.44 107.67 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.3 ptp -116.82 144.86 43.99 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.892 -0.41 . . . . 71.52 109.892 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.11 5.92 52.38 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.471 -1.347 . . . . 41.51 110.139 -173.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 18' ' ' HIS . 8.8 p -79.81 141.43 15.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 N-CA-C 108.107 -1.072 . . . . 73.42 108.107 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.464 ' HG1' ' CD ' ' A' ' 83' ' ' GLU . 36.3 p -87.97 175.78 7.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.359 -0.936 . . . . 43.03 110.452 -176.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.2 m -65.83 -26.79 67.83 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.504 -0.771 . . . . 75.22 110.933 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.6 -41.78 53.56 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.311 -0.556 . . . . 64.5 110.781 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.516 ' HA ' ' HB3' ' A' ' 86' ' ' ASN . 4.9 mp0 -70.16 -28.11 65.07 Favored 'General case' 0 C--O 1.203 -1.389 0 C-N-CA 119.004 -1.078 . . . . 72.21 108.854 173.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.6 tp -58.97 -51.24 70.9 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 109.644 -0.502 . . . . 75.44 109.644 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.79 -30.83 71.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.125 0.488 . . . . 70.04 110.163 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 2.2 t-20 -63.67 -49.76 71.93 Favored 'General case' 0 C--O 1.201 -1.46 0 CA-C-N 115.349 -0.841 . . . . 74.53 111.313 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.5 mt -69.74 -34.18 73.47 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.304 -0.628 . . . . 45.21 109.304 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.581 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 33.6 t70 -63.39 -36.86 85.11 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 114.651 -1.159 . . . . 72.22 109.011 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.98 -49.98 14.21 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.783 -0.644 . . . . 74.25 111.494 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.24 -57.63 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 123.752 0.821 . . . . 65.42 113.171 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -80.22 -26.67 39.03 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.415 0.626 . . . . 74.2 111.481 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.581 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -59.49 -16.08 34.83 Favored Glycine 0 N--CA 1.461 0.328 0 CA-C-N 114.693 -1.139 . . . . 72.3 115.909 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -57.47 -34.21 68.79 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 117.519 0.66 . . . . 63.14 111.833 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -131.95 -0.69 3.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.758 0.651 . . . . 73.23 112.758 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -122.91 166.35 15.19 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.584 -0.28 . . . . 72.3 110.246 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -122.6 142.72 50.33 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.488 -0.56 . . . . 73.44 109.488 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.438 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 15.6 ttp85 -87.01 114.63 23.78 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.765 -0.652 . . . . 74.43 110.153 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.505 HG13 ' HE3' ' A' ' 117' ' ' MET . 35.0 m -128.17 162.42 34.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.284 -0.871 . . . . 75.55 110.89 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -101.24 131.75 47.09 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.215 -0.661 . . . . 64.25 109.215 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.82 166.77 25.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 116.182 -0.463 . . . . 51.53 111.065 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.23 117.97 5.92 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 111.013 -0.835 . . . . 62.41 111.013 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.7 157.17 13.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.532 -0.544 . . . . 71.12 109.532 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.36 127.47 75.44 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 N-CA-C 107.89 -1.152 . . . . 71.41 107.89 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.45 ' HB2' ' OE2' ' A' ' 109' ' ' GLU . 60.7 mtm180 -71.48 141.83 50.2 Favored 'General case' 0 CA--C 1.489 -1.37 0 C-N-CA 119.501 -0.88 . . . . 72.02 110.151 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.24 5.6 25.96 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.303 -0.862 . . . . 73.41 111.042 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -94.02 -29.45 15.21 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.64 -0.709 . . . . 73.41 109.942 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.463 ' HB2' ' OE2' ' A' ' 109' ' ' GLU . 2.5 m-20 -118.9 -121.46 0.3 Allowed 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 108.487 -0.931 . . . . 65.33 108.487 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.3 m -167.03 17.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.485 1.914 . . . . 75.43 107.236 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.463 ' OE2' ' HB2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -105.43 157.84 17.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.646 -0.706 . . . . 73.44 111.735 -174.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -106.08 147.28 29.12 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.173 0.511 . . . . 45.41 110.743 -177.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 36.9 mtm -132.23 162.85 29.93 Favored 'General case' 0 CA--C 1.47 -2.134 0 CA-C-N 115.056 -0.975 . . . . 75.12 108.451 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.41 126.77 53.26 Favored 'General case' 0 C--N 1.249 -3.77 0 CA-C-N 114.853 -1.067 . . . . 54.53 108.851 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 21' ' ' PHE . 32.6 m -139.0 173.01 12.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.617 -0.512 . . . . 74.35 109.617 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 3.6 mptp? -97.99 149.51 22.37 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.252 -1.018 . . . . 74.22 108.252 175.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.6 t -152.41 172.23 16.82 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.185 -1.043 . . . . 73.31 108.185 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 97' ' ' ARG . 96.6 m-85 -108.45 111.07 22.76 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-O 121.745 0.783 . . . . 74.33 110.191 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.505 ' HE3' HG13 ' A' ' 98' ' ' VAL . 56.9 ttp -105.37 146.63 29.18 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.321 -1.309 . . . . 64.42 109.04 -174.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 65.8 t-105 -74.96 132.78 41.65 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.146 -1.427 . . . . 75.4 107.146 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 119' ' ' ILE . 2.5 mp -71.85 -41.87 69.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 120.428 -0.509 . . . . 71.42 111.189 -171.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -89.3 94.34 9.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.62 0.724 . . . . 70.11 110.729 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -81.68 12.03 4.25 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.538 -0.755 . . . . 74.34 111.291 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.25 22.54 7.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.739 -0.664 . . . . 60.41 110.047 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.54 121.29 78.45 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 109.889 -0.411 . . . . 74.22 109.889 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.97 -0.51 9.21 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.572 2.181 . . . . 64.45 113.769 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -96.61 -37.31 10.41 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 120.675 -0.41 . . . . 53.12 112.073 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.656 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 25.7 ptt? . . . . . 0 C--N 1.313 -1.015 0 N-CA-C 112.17 0.433 . . . . 54.55 112.17 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.568 ' O ' HG12 ' A' ' 144' ' ' ILE . 22.7 ptmt . . . . . 0 C--O 1.201 -1.453 0 N-CA-C 110.038 -0.356 . . . . 74.24 110.038 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -48.85 -39.26 24.99 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.411 1.084 . . . . 63.35 111.107 -175.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.54 -44.45 85.17 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.083 0.468 . . . . 72.53 110.698 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.0 -35.58 59.52 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.14 -0.689 . . . . 74.11 109.14 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 140' ' ' LYS . 45.9 mm -60.99 -32.61 52.98 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.708 0 CA-C-N 115.615 -0.72 . . . . 60.35 110.848 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 43.9 mt-10 -55.08 -44.57 74.98 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.917 -0.313 . . . . 72.31 111.39 176.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.46 ' O ' HG13 ' A' ' 150' ' ' ILE . 9.9 t -80.19 -36.73 34.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 119.828 -0.749 . . . . 72.24 110.342 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.486 ' O ' ' HG2' ' A' ' 151' ' ' MET . 54.8 m-85 -66.94 -30.68 70.88 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.942 1.089 . . . . 75.02 113.942 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 87.8 tttt -62.08 -36.95 83.22 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.132 -1.062 . . . . 51.43 108.132 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 146' ' ' THR . 86.5 tttt -74.05 -37.89 64.14 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.425 -1.261 . . . . 63.14 109.526 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 146' ' ' THR . 83.6 mt -67.02 -33.76 65.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.756 -0.656 . . . . 71.23 110.206 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 26.3 mmt -66.33 -30.46 70.87 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.009 -0.367 . . . . 73.54 110.009 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 23.1 mm-40 -72.31 -30.52 64.87 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.988 -0.551 . . . . 73.34 109.647 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 66.6 m -70.65 -31.46 68.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.403 0.62 . . . . 74.32 109.608 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 95.5 mttt . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 74.31 109.514 175.786 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.406 -2.63 0 N-CA-C 107.748 -1.205 . . . . 60.1 107.748 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' O ' HG13 ' A' ' 79' ' ' VAL . 39.7 m-70 -112.5 159.32 18.9 Favored 'General case' 0 C--N 1.262 -3.233 0 N-CA-C 108.085 -1.08 . . . . 73.04 108.085 -173.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -117.04 125.83 51.92 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.108 -1.441 . . . . 73.33 107.108 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.2 t -119.38 137.72 52.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 110.391 -0.225 . . . . 70.12 110.391 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.404 ' HB2' HG21 ' A' ' 113' ' ' VAL . 70.1 t80 -94.91 122.08 37.17 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.442 -0.948 . . . . 74.12 108.442 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 15.6 m -103.2 105.71 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.224 1.011 . . . . 63.42 111.135 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.416 ' HB2' HD11 ' A' ' 63' ' ' ILE . 43.2 p90 -72.08 -18.87 61.89 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.003 -1.453 . . . . 74.44 114.272 -173.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.72 -40.22 0.3 Allowed Glycine 0 CA--C 1.499 -0.921 0 C-N-CA 118.979 -1.581 . . . . 72.43 112.947 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -58.06 -36.49 72.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.869 0.467 . . . . 70.1 112.189 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.618 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 49.3 m-85 -134.75 37.35 3.08 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.472 0.654 . . . . 75.33 109.435 -176.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.404 ' HA ' ' CG2' ' A' ' 22' ' ' VAL . 34.2 tt0 -86.18 -4.78 59.24 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.6 -0.727 . . . . 64.3 110.962 -175.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -105.8 121.12 46.92 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 109.381 -0.6 . . . . 74.32 109.381 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.422 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 11.7 Cg_endo -56.89 -31.53 89.48 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.159 2.573 . . . . 65.44 113.934 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.03 -33.64 74.98 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.409 0.624 . . . . 63.32 109.973 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.28 -39.15 82.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.172 -0.922 . . . . 64.42 108.792 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.488 HG22 HD23 ' A' ' 36' ' ' LEU . 44.5 mm -62.56 -37.41 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.285 -0.871 . . . . 71.24 110.361 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.87 -50.17 66.88 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.57 0.7 . . . . 73.42 110.287 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.85 -44.9 19.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 114.222 1.194 . . . . 72.03 114.222 -173.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.618 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 5.9 tmm? -62.33 -36.55 82.52 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.06 0.457 . . . . 74.34 110.707 -173.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.488 HD23 HG22 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -116.71 -75.13 0.58 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 120.491 -0.484 . . . . 72.05 111.926 178.241 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.9 t70 173.18 -47.74 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.292 0.568 . . . . 72.32 111.116 -175.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.525 ' HD2' ' OE2' ' A' ' 83' ' ' GLU . 4.6 ptp180 -126.57 164.47 21.15 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.507 -0.769 . . . . 72.31 109.75 -174.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.6 m -124.63 108.87 28.6 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-O 120.59 0.233 . . . . 75.34 110.704 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -63.57 152.07 82.03 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.58 2.853 . . . . 74.14 111.768 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -56.51 137.56 53.14 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 123.635 0.584 . . . . 64.24 109.591 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.4 mt -115.59 137.33 49.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 116.297 -0.41 . . . . 74.54 111.179 -170.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.3 146.46 34.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.096 -0.705 . . . . 73.53 109.096 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 m -77.0 127.37 32.57 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.085 -0.709 . . . . 64.53 109.085 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.412 ' CB ' HD11 ' A' ' 102' ' ' ILE . . . -143.58 159.41 42.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.208 0.528 . . . . 74.42 111.994 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.4 m -119.45 131.89 55.7 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.585 -0.734 . . . . 74.43 110.779 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -101.6 103.41 27.67 Favored Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-N 115.55 -0.75 . . . . 54.4 109.484 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.2 142.61 7.48 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.241 1.96 . . . . 62.44 111.553 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.46 7.75 60.26 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.451 -0.88 . . . . 71.1 111.556 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -145.35 143.53 30.19 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 107.0 -1.481 . . . . 74.13 107.0 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.413 ' HB2' ' HA3' ' A' ' 69' ' ' GLY . 62.4 tt0 -143.04 142.82 31.67 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.705 -1.22 . . . . 74.24 107.705 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -91.21 125.83 36.11 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 119.978 -0.689 . . . . 75.51 109.542 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 11.6 m-30 -107.67 135.64 48.77 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.942 -1.026 . . . . 73.22 108.653 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 . . . . . 0 C--N 1.288 -2.097 0 CA-C-O 121.774 0.797 . . . . 73.34 112.525 -175.464 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 107.895 -1.15 . . . . 72.12 107.895 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 9.7 Cg_exo -72.19 99.91 1.06 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 121.529 1.486 . . . . 74.25 108.758 171.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.493 ' SG ' ' HG2' ' A' ' 126' ' ' MET . 27.7 p -105.36 160.01 15.46 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.039 -0.528 . . . . 73.04 112.054 -172.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 23' ' ' TYR . 48.8 mm -94.64 125.08 47.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.764 -0.653 . . . . 72.42 109.656 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.13 146.94 63.22 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.54 -0.541 . . . . 74.41 109.54 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.32 104.91 0.27 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.653 2.235 . . . . 71.4 112.573 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -125.47 108.12 11.32 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.945 -1.132 . . . . 71.54 107.945 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.27 -27.25 68.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.946 0.403 . . . . 74.2 111.807 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -90.62 8.09 36.0 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.151 -0.477 . . . . 74.51 111.447 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 51' ' ' GLN . . . -129.23 171.35 20.02 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.791 -1.195 . . . . 43.31 114.103 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.8 143.65 17.3 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.231 1.012 . . . . 73.53 108.483 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.18 122.9 69.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.772 -0.455 . . . . 63.03 109.772 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -95.46 116.31 28.63 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.938 -1.134 . . . . 74.52 107.938 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.463 ' C ' ' HD3' ' A' ' 74' ' ' LYS . . . -148.47 -155.43 6.67 Favored Glycine 0 N--CA 1.415 -2.711 0 C-N-CA 120.242 -0.98 . . . . 63.54 111.558 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 2.7 mppt? -122.56 149.2 44.28 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 112.916 0.709 . . . . 54.32 112.916 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.1 t -110.2 129.21 65.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-N 113.99 -1.459 . . . . 75.32 111.552 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.68 108.37 20.66 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.127 -1.435 . . . . 74.02 107.127 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.8 ptp -111.49 147.53 35.12 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 120.922 0.392 . . . . 73.42 111.459 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.65 17.12 53.41 Favored Glycine 0 N--CA 1.42 -2.384 0 C-N-CA 119.533 -1.318 . . . . 72.03 111.311 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 18' ' ' HIS . 9.5 p -80.72 132.29 31.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.028 -0.73 . . . . 74.41 109.028 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -75.75 159.91 30.57 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 108.464 -0.939 . . . . 72.21 108.464 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.4 m -59.32 -26.6 65.16 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 112.547 0.573 . . . . 73.21 112.547 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -70.87 -47.22 60.44 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.036 0.446 . . . . 75.13 110.766 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 1.2 mp0 -68.7 -28.79 67.16 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.153 -0.684 . . . . 74.24 109.153 176.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.508 ' HG ' ' NH2' ' A' ' 97' ' ' ARG . 42.1 tp -62.77 -50.85 69.4 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 120.882 0.372 . . . . 71.14 110.345 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.82 -29.8 70.33 Favored 'General case' 0 C--O 1.208 -1.106 0 N-CA-C 109.687 -0.486 . . . . 61.12 109.687 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.612 ' OD1' ' HE1' ' A' ' 35' ' ' MET . 16.9 t-20 -59.16 -47.86 83.76 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.627 0.771 . . . . 70.3 109.964 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.481 ' HA ' HG13 ' A' ' 90' ' ' VAL . 97.5 mt -64.65 -37.01 86.11 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.225 -0.898 . . . . 71.31 111.27 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.513 ' HB2' ' NH2' ' A' ' 97' ' ' ARG . 19.1 t70 -73.54 -30.7 63.24 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 121.211 0.529 . . . . 72.31 110.096 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.24 -46.56 64.19 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.051 0.453 . . . . 75.13 110.323 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 87' ' ' LEU . 13.6 p -72.35 -50.56 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.531 0 CA-C-N 115.819 -0.628 . . . . 63.33 112.325 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -77.85 -30.29 50.87 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 112.731 0.641 . . . . 74.44 112.731 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.02 -17.36 22.45 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 114.704 0.641 . . . . 63.13 114.704 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.56 -37.4 81.16 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 122.132 0.173 . . . . 52.23 110.54 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.53 -9.57 3.63 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.39 0.515 . . . . 52.13 112.39 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -126.28 167.38 15.56 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.281 -0.262 . . . . 72.22 111.076 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 38.4 tt0 -123.7 146.39 48.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.444 -0.576 . . . . 43.44 109.444 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.513 ' NH2' ' HB2' ' A' ' 88' ' ' ASP . 34.4 ttm180 -89.41 128.74 35.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.759 0.314 . . . . 71.43 110.838 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 m -133.08 162.34 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.023 0 CA-C-N 115.894 -0.594 . . . . 70.12 111.42 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.5 t -103.72 124.04 48.15 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 114.972 -1.013 . . . . 71.11 108.272 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.29 165.21 32.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 116.213 -0.449 . . . . 63.33 111.419 -173.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.35 123.68 7.88 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.982 -0.847 . . . . 61.51 110.982 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.412 HD11 ' CB ' ' A' ' 45' ' ' ALA . 2.7 pp -117.42 165.1 13.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 110.244 -0.28 . . . . 70.52 110.244 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 80.6 t -128.25 125.83 64.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.554 -0.535 . . . . 54.53 109.554 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.607 ' HB3' ' OD1' ' A' ' 106' ' ' ASP . 34.4 mtp180 -64.71 128.55 36.26 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 124.369 1.068 . . . . 74.3 111.845 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -71.36 -18.62 62.36 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.482 0.713 . . . . 60.02 110.952 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.607 ' OD1' ' HB3' ' A' ' 104' ' ' ARG . 7.8 p-10 -78.51 -41.61 31.89 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.113 -0.494 . . . . 74.21 112.237 -173.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.79 16.45 1.78 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.188 0.81 . . . . 73.31 113.188 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.9 m 68.0 14.62 9.39 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.99 1.107 . . . . 74.32 113.99 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -75.59 145.85 40.84 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.052 -0.405 . . . . 61.31 110.905 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -96.51 147.78 23.49 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.165 -0.47 . . . . 73.11 109.895 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 35.4 mtm -145.43 163.15 35.52 Favored 'General case' 0 CA--C 1.473 -1.99 0 CA-C-O 121.306 0.574 . . . . 74.11 110.347 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.84 123.03 48.41 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 114.31 -1.314 . . . . 75.42 108.435 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.7 m -132.96 169.66 21.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.232 0.539 . . . . 64.24 111.446 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -103.87 134.15 47.65 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.72 -1.215 . . . . 73.03 107.72 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.4 t -135.92 171.11 14.94 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.832 -0.803 . . . . 75.23 108.832 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.0 m-85 -121.51 125.88 47.87 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.824 -0.806 . . . . 74.54 108.824 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.39 157.97 41.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.348 -0.387 . . . . 74.44 110.121 -176.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 61.1 t-105 -67.54 130.94 44.62 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.188 0.595 . . . . 75.2 109.88 -175.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 119' ' ' ILE . 2.5 mp -73.57 -44.19 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 112.252 0.464 . . . . 71.52 112.252 -172.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -67.35 -43.63 81.03 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.42 -0.585 . . . . 74.53 109.42 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? 51.07 17.97 0.51 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.158 1.783 . . . . 71.54 113.968 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.34 1.73 5.7 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.422 0.527 . . . . 63.21 112.422 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.22 121.46 56.07 Favored Pre-proline 0 N--CA 1.483 1.217 0 N-CA-C 111.649 0.24 . . . . 64.24 111.649 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.24 -17.79 50.21 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.568 2.179 . . . . 54.44 111.41 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.82 -41.08 73.69 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.137 -0.938 . . . . 71.43 110.754 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.493 ' HG2' ' SG ' ' A' ' 62' ' ' CYS 0.329 0.0 OUTLIER . . . . . 0 N--CA 1.419 -1.979 0 CA-C-O 122.809 1.29 . . . . 72.23 113.106 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.601 ' O ' HG12 ' A' ' 144' ' ' ILE . 64.9 tttm . . . . . 0 N--CA 1.462 0.174 0 N-CA-C 109.775 -0.454 . . . . 70.43 109.775 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.1 mmmt -54.67 -40.31 68.93 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 114.206 1.187 . . . . 71.1 114.206 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -55.44 -43.48 75.44 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.542 1.163 . . . . 73.22 109.507 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -73.9 -35.27 64.64 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 113.719 -1.582 . . . . 74.23 109.192 -175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 140' ' ' LYS . 33.4 mm -72.19 -38.65 63.1 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.054 0 CA-C-N 115.747 -0.661 . . . . 64.55 110.831 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 17.1 mm-40 -59.69 -32.43 70.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.227 0.537 . . . . 73.31 110.471 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.2 m -70.29 -47.21 62.21 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.021 -0.991 . . . . 74.41 108.904 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -71.06 -28.62 64.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.412 1.264 . . . . 72.42 114.412 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -57.75 -38.07 74.73 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.751 -1.203 . . . . 61.43 107.751 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -71.46 -28.83 64.22 Favored 'General case' 0 C--O 1.227 -0.09 0 CA-C-N 115.742 -0.663 . . . . 73.01 110.459 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 68.3 mt -72.62 -31.31 36.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.664 -0.698 . . . . 74.3 109.453 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 65.0 mtt -63.36 -41.16 98.81 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.667 -0.864 . . . . 64.14 108.667 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -61.68 -35.92 79.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.092 -0.958 . . . . 74.54 110.045 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 84.3 m -67.41 -31.25 71.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.667 -0.697 . . . . 64.44 111.431 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 74.7 mmtt . . . . . 0 C--O 1.236 0.346 0 N-CA-C 108.362 -0.977 . . . . 64.23 108.362 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.41 -2.443 0 N-CA-C 108.406 -0.961 . . . . 73.4 108.406 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.509 ' O ' HG13 ' A' ' 79' ' ' VAL . 47.3 m-70 -114.0 159.99 19.34 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 115.785 -0.643 . . . . 73.3 110.043 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 17.0 p30 -130.31 128.22 41.07 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.905 -1.043 . . . . 73.44 111.483 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.7 t -127.53 142.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.771 -1.104 . . . . 55.1 109.516 -174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -93.81 123.23 37.01 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.582 -1.266 . . . . 74.15 107.582 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -96.8 136.98 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-O 121.285 0.564 . . . . 75.11 111.54 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.489 ' HD2' ' O ' ' A' ' 61' ' ' PRO . 24.1 p90 -109.27 -50.2 3.03 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.817 1.043 . . . . 65.44 113.817 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -151.43 -49.83 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 118.093 -2.003 . . . . 38.51 115.411 -174.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.8 m -58.88 -37.02 75.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.583 0.692 . . . . 53.14 111.559 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 36.6 m-85 -119.76 37.67 4.13 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.898 -0.592 . . . . 74.14 110.763 -176.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.41 23.14 0.07 Allowed 'General case' 0 CA--C 1.576 1.943 0 CA-C-O 121.647 0.737 . . . . 71.04 110.754 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 26' ' ' PHE . 25.9 t70 -150.15 129.97 6.64 Favored Pre-proline 0 C--N 1.308 -1.229 0 C-N-CA 123.707 0.803 . . . . 72.45 109.321 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.542 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 63.5 Cg_endo -73.22 -24.48 16.8 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.233 1.956 . . . . 74.03 113.177 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.85 -38.65 83.41 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.78 0.324 . . . . 73.12 110.969 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.22 -28.93 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.108 0.48 . . . . 74.01 110.044 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 29' ' ' PRO . 37.1 mm -58.99 -37.78 69.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.918 -0.583 . . . . 64.31 110.258 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.83 -44.51 70.32 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.688 0.756 . . . . 64.12 110.342 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.58 -41.88 17.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 114.701 -1.136 . . . . 73.53 113.256 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.513 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.5 tmm? -65.95 -37.48 86.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.871 -0.332 . . . . 74.45 111.14 -171.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.46 HD23 HG23 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -116.88 -66.74 1.05 Allowed 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.656 -0.818 . . . . 71.45 111.383 176.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 167.51 -52.22 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 123.785 0.678 . . . . 72.35 109.47 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -108.52 164.1 12.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.198 -0.91 . . . . 72.35 109.619 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 m -114.0 106.01 53.77 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 108.514 -0.921 . . . . 73.22 108.514 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.86 151.56 32.47 Favored 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 123.397 2.731 . . . . 64.42 111.952 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -64.62 128.68 36.83 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.306 -0.998 . . . . 64.43 108.306 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 38.3 mt -109.28 136.65 44.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 116.02 -0.536 . . . . 72.51 110.1 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.71 146.13 34.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.059 -0.519 . . . . 65.54 109.711 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.5 m -76.35 126.18 30.53 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.769 -0.826 . . . . 65.22 108.769 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.12 156.04 46.73 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.623 0.725 . . . . 63.31 111.156 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 57.3 m -113.5 126.71 55.62 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.336 -0.847 . . . . 74.23 108.972 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 50' ' ' PHE . 45.5 tp -100.21 101.03 13.12 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 109.507 -0.553 . . . . 74.52 109.507 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 46' ' ' THR . 77.9 Cg_endo -86.99 144.12 7.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.383 2.056 . . . . 71.03 111.828 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.14 5.74 62.09 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.234 -0.747 . . . . 65.54 111.234 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.532 ' HA ' ' H ' ' A' ' 66' ' ' SER . 90.0 m-85 -144.23 152.23 40.55 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 107.664 -1.236 . . . . 74.05 107.664 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -139.65 145.78 38.88 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 108.653 -0.869 . . . . 61.51 108.653 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -90.69 132.15 35.96 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.614 -0.721 . . . . 74.52 109.552 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 3.8 m-85 -107.04 133.57 51.47 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 107.388 -1.338 . . . . 72.21 107.388 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 . . . . . 0 C--N 1.273 -2.749 0 CA-C-N 114.237 -1.347 . . . . 73.05 113.296 -167.139 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 109.721 -0.474 . . . . 75.34 109.721 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 35.7 Cg_exo -61.73 103.98 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.129 1.886 . . . . 62.31 110.799 175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 12.9 p -111.21 151.65 28.0 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.357 -0.838 . . . . 72.4 110.515 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.1 mm -93.98 139.25 18.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.405 -0.591 . . . . 73.21 109.405 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -142.48 151.46 57.74 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 107.948 -1.13 . . . . 72.33 107.948 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.522 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 34.3 Cg_endo -66.8 104.81 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.554 2.169 . . . . 63.41 112.613 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.532 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 33.4 t -125.09 102.17 7.37 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.172 -1.788 . . . . 75.31 106.172 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -55.1 -33.21 62.62 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.767 0.655 . . . . 64.2 112.767 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.98 5.42 44.3 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.799 -0.637 . . . . 73.14 111.732 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.84 171.83 14.13 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.257 -0.973 . . . . 71.22 113.395 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.67 149.1 24.88 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.791 1.236 . . . . 72.12 107.97 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.05 124.77 70.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.965 -0.383 . . . . 60.22 109.965 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -93.17 114.71 27.28 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.598 -1.26 . . . . 65.14 107.598 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.49 ' C ' ' HD2' ' A' ' 74' ' ' LYS . . . -146.96 -155.56 6.59 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 109.808 -1.317 . . . . 64.55 109.808 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.49 ' HD2' ' C ' ' A' ' 73' ' ' GLY . 14.0 mptt -127.22 152.21 47.68 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.815 0.817 . . . . 45.42 112.494 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 46.9 t -110.27 128.7 66.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 113.83 -1.532 . . . . 51.31 111.155 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 72.1 mt -96.59 109.99 22.49 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.719 -1.215 . . . . 74.33 107.719 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.426 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 17.0 ptp -121.67 151.25 40.66 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.571 0.224 . . . . 61.04 110.995 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.98 13.27 37.39 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 119.669 -1.253 . . . . 73.44 111.525 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 18' ' ' HIS . 10.3 p -85.37 136.32 23.05 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 108.946 -0.761 . . . . 64.44 108.946 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 m -74.05 159.44 32.66 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.265 -0.642 . . . . 73.34 109.265 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -59.06 -38.37 79.25 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.575 0.584 . . . . 75.43 112.575 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.17 -48.72 80.54 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.547 0.689 . . . . 71.32 110.23 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 86' ' ' ASN . 38.8 mt-10 -69.21 -31.58 70.25 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 114.947 -1.024 . . . . 73.52 109.259 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.0 tm? -62.67 -40.16 96.19 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.449 -0.575 . . . . 64.54 109.449 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.58 -29.5 63.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.143 -0.481 . . . . 63.11 109.954 176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -67.59 -42.07 83.08 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.765 -0.652 . . . . 73.44 111.009 176.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 97.2 mt -61.42 -43.6 98.59 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.962 -0.755 . . . . 72.11 108.962 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.405 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 28.3 t70 -64.94 -34.09 77.58 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.013 -0.994 . . . . 55.42 110.521 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.5 -44.01 68.49 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.025 -0.534 . . . . 64.24 111.024 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.4 t -72.71 -57.36 7.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 112.911 0.708 . . . . 73.43 112.911 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.45 -22.77 50.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.338 0.59 . . . . 74.43 111.397 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -63.07 -15.95 56.96 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.2 -0.909 . . . . 70.34 114.979 -177.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -68.01 -45.75 73.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.629 0.715 . . . . 63.31 112.237 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.27 -10.4 12.72 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.395 -0.522 . . . . 63.1 111.8 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -125.6 167.1 15.54 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.61 -0.885 . . . . 71.14 108.61 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 35.0 tt0 -123.19 145.92 48.23 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.175 -0.676 . . . . 74.31 109.175 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -87.08 114.5 23.74 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.87 -0.789 . . . . 73.34 108.87 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.508 HG12 ' HE1' ' A' ' 117' ' ' MET . 24.5 m -120.99 160.42 21.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 116.117 -0.492 . . . . 60.53 110.052 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.1 t -99.81 127.28 45.98 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.484 -0.932 . . . . 72.22 108.484 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.89 172.06 16.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.192 -0.458 . . . . 71.33 111.489 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.421 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -115.32 128.64 8.17 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.499 -0.64 . . . . 62.43 111.499 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.12 161.95 16.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 123.132 0.573 . . . . 72.44 110.144 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 51.1 t -121.63 123.84 70.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 106.73 -1.581 . . . . 72.21 106.73 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.669 ' HD3' ' SD ' ' A' ' 111' ' ' MET . 12.4 mtm180 -79.15 135.62 36.87 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.054 -1.059 . . . . 75.0 110.327 -175.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.61 12.44 5.77 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 122.919 1.342 . . . . 70.01 108.131 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 104' ' ' ARG . 10.1 t70 -89.32 -53.07 4.72 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 126.564 1.946 . . . . 72.3 111.201 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -138.43 7.23 2.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.21 -0.45 . . . . 64.51 112.018 -174.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.3 t 71.57 8.68 6.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.211 1.004 . . . . 72.52 112.541 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -85.51 148.4 25.98 Favored 'General case' 0 CA--C 1.492 -1.264 0 C-N-CA 120.73 -0.388 . . . . 71.03 110.228 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 64.0 pttt -98.93 140.99 32.26 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-N 115.753 -0.658 . . . . 71.02 109.762 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.669 ' SD ' ' HD3' ' A' ' 104' ' ' ARG . 87.9 mtp -134.81 161.16 35.97 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.171 -0.922 . . . . 72.31 111.269 -175.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.11 130.05 50.15 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.632 -1.167 . . . . 64.1 109.092 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.0 m -141.5 174.03 7.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 108.43 -0.952 . . . . 75.44 108.43 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.456 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -107.15 150.56 26.45 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.206 -0.664 . . . . 71.04 109.206 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.9 t -144.32 170.98 14.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.166 -1.05 . . . . 71.44 108.166 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 70.8 m-85 -117.54 121.52 41.19 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.536 -0.913 . . . . 71.44 108.536 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.522 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 25.7 ptt? -115.96 155.13 28.58 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.26 -0.427 . . . . 63.33 110.57 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.415 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 60.1 t-105 -73.27 124.92 26.63 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.105 0.878 . . . . 72.02 108.688 -178.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.43 ' N ' HD13 ' A' ' 119' ' ' ILE . 2.8 mp -73.49 -41.78 56.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 112.572 0.582 . . . . 73.03 112.572 -172.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -69.8 -40.52 75.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 121.002 -0.279 . . . . 72.25 111.718 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 68.99 -4.36 1.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.155 1.169 . . . . 72.12 114.155 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.87 12.84 6.28 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.094 1.516 . . . . 73.15 115.094 -171.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.47 130.7 93.26 Favored Pre-proline 0 N--CA 1.483 1.213 0 O-C-N 122.274 -0.266 . . . . 71.21 111.347 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.33 14.02 0.81 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.477 2.785 . . . . 73.24 113.888 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -89.96 -11.38 41.86 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.353 0.597 . . . . 72.2 110.496 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.784 0 CA-C-N 115.154 -0.93 . . . . 64.34 109.218 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.604 ' O ' HG12 ' A' ' 144' ' ' ILE . 86.3 tttt . . . . . 0 C--O 1.221 -0.406 0 N-CA-C 109.358 -0.608 . . . . 70.25 109.358 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -48.44 -39.69 23.66 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.806 1.642 . . . . 71.04 111.627 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.29 -40.03 95.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.843 -0.617 . . . . 54.11 111.109 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -76.19 -32.25 58.9 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.489 -0.56 . . . . 75.43 109.489 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 140' ' ' LYS . 50.7 mm -56.58 -33.42 39.56 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.757 0 CA-C-N 115.371 -0.831 . . . . 63.32 111.803 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.4 -31.25 65.64 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.229 0.468 . . . . 73.21 111.931 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.9 m -80.67 -41.94 22.9 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.941 -0.763 . . . . 73.33 108.941 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -70.88 -30.05 66.32 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 115.357 1.614 . . . . 74.31 115.357 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 60.1 mtpt -55.52 -38.69 69.56 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 117.926 0.33 . . . . 70.1 110.712 176.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -67.3 -38.79 85.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.733 0.777 . . . . 74.2 109.363 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 67.5 mt -69.94 -41.41 79.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.83 -1.077 . . . . 64.22 109.665 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 67.1 mtt -67.92 -48.53 65.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.898 -0.592 . . . . 71.01 110.978 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 37.3 mt-10 -62.12 -30.55 71.11 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 111.89 0.33 . . . . 75.12 111.89 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 42.7 t -61.46 -42.46 98.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.414 -0.357 . . . . 75.24 110.396 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 C--N 1.324 -0.5 0 C-N-CA 121.004 -0.279 . . . . 63.14 110.872 179.398 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 N--CA 1.428 -1.562 0 CA-C-O 120.913 0.387 . . . . 74.24 110.27 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -124.73 161.25 26.78 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.597 -0.89 . . . . 62.23 108.597 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -128.66 134.43 48.52 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.443 0.64 . . . . 74.21 111.81 172.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.6 142.95 41.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.419 -0.81 . . . . 74.03 110.078 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.444 ' HB2' HG21 ' A' ' 113' ' ' VAL . 76.1 t80 -94.74 122.61 37.53 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.707 -1.22 . . . . 75.02 107.707 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 m -93.16 120.03 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 CA-C-O 121.857 0.837 . . . . 71.0 110.01 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.405 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 8.2 p90 -88.48 -79.05 0.32 Allowed 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 114.629 1.344 . . . . 71.55 114.629 -172.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.93 -44.25 0.24 Allowed Glycine 0 CA--C 1.492 -1.392 0 C-N-CA 119.624 -1.275 . . . . 52.41 112.044 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 p -62.39 -36.48 82.45 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 112.358 0.503 . . . . 72.2 112.358 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.405 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 59.5 m-85 -124.67 26.66 7.11 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 112.564 0.579 . . . . 75.23 112.564 -177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 23' ' ' TYR . 28.5 pt20 -68.07 -1.05 5.17 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.208 0.818 . . . . 75.21 113.208 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 31' ' ' VAL . 20.1 t70 -129.56 138.81 33.96 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 108.755 -0.832 . . . . 74.21 108.755 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.4 -32.9 94.48 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.296 1.998 . . . . 73.21 114.017 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.78 -35.94 81.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 120.999 -0.281 . . . . 64.53 111.641 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 28' ' ' ASP . 11.6 p -70.64 -29.83 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 119.779 -0.768 . . . . 71.41 110.153 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.2 mm -70.85 -43.52 76.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-O 122.073 0.94 . . . . 65.11 108.938 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -54.19 -51.68 63.6 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 112.997 -1.91 . . . . 72.12 110.607 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.8 p -78.09 -35.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.56 -0.746 . . . . 73.22 112.042 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.5 tmm? -67.62 -37.08 81.97 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 121.247 -0.181 . . . . 60.44 111.213 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.486 HD11 ' H ' ' A' ' 37' ' ' ASP 0.402 3.0 pp -115.0 -56.48 2.37 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 115.448 1.647 . . . . 75.11 115.448 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.486 ' H ' HD11 ' A' ' 36' ' ' LEU . 27.1 t70 162.78 -52.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.133 0.973 . . . . 71.23 109.665 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -106.64 -168.0 1.36 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.512 -1.222 . . . . 71.45 109.815 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.9 m -149.69 108.28 3.3 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 108.823 -0.806 . . . . 74.51 108.823 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.29 150.73 72.64 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.941 2.427 . . . . 73.15 111.705 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.12 123.26 16.6 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.082 0.553 . . . . 75.31 110.449 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.569 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 51.3 mt -97.84 143.53 12.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.812 -0.631 . . . . 74.31 111.117 -173.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 14.6 p -128.94 146.75 33.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.566 -0.901 . . . . 74.04 108.566 175.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.435 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 19.0 m -77.03 123.92 27.04 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.36 -0.607 . . . . 64.42 109.36 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.0 157.58 45.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.784 0.802 . . . . 51.52 112.351 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 m -119.7 126.55 51.37 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.864 -1.062 . . . . 75.51 108.96 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.7 tp -98.75 104.91 27.5 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 109.747 -0.464 . . . . 70.42 109.747 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 74.7 Cg_endo -84.03 137.68 7.53 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 122.471 2.114 . . . . 41.25 112.658 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.6 11.75 56.59 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.814 -0.63 . . . . 62.52 112.748 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -140.6 161.66 37.23 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.995 -0.743 . . . . 74.41 108.995 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -139.83 146.06 38.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.802 -0.444 . . . . 73.22 109.802 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HE ' HG12 ' A' ' 71' ' ' VAL . 13.9 ptp180 -102.69 142.12 34.37 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.248 -1.019 . . . . 74.34 108.248 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.57 ' HB3' ' O ' ' A' ' 126' ' ' MET . 28.1 m-85 -113.45 135.16 54.18 Favored 'General case' 0 C--N 1.265 -3.092 0 N-CA-C 107.95 -1.13 . . . . 71.45 107.95 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 . . . . . 0 C--N 1.314 -0.959 0 C-N-CA 119.557 -0.857 . . . . 70.01 110.494 -177.38 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 109.037 -0.727 . . . . 73.1 109.037 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 18.5 Cg_endo -67.38 96.8 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.697 1.598 . . . . 74.11 109.927 173.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.0 p -100.05 166.79 10.86 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 113.299 0.851 . . . . 72.13 113.299 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.1 mm -109.52 143.13 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 115.052 -0.977 . . . . 62.41 109.28 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.9 m -143.93 151.45 52.76 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.815 -1.18 . . . . 71.14 107.815 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.512 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 18.5 Cg_endo -60.57 133.48 48.89 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.224 1.95 . . . . 71.5 111.187 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.6 t -124.8 144.08 50.46 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 116.215 -0.448 . . . . 55.44 109.884 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -73.11 -34.43 66.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 74.05 110.363 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.9 81.07 1.88 Allowed 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.254 -0.647 . . . . 72.35 109.254 174.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.26 153.17 24.08 Favored Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 119.735 -1.222 . . . . 36.93 112.431 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.31 139.92 24.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.871 -0.789 . . . . 75.45 108.871 175.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.475 HG12 ' HE ' ' A' ' 52' ' ' ARG . 51.7 t -113.77 119.95 62.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 120.831 0.348 . . . . 73.22 110.78 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -89.33 116.4 27.51 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.689 -1.226 . . . . 74.42 107.689 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.08 -151.21 5.48 Favored Glycine 0 N--CA 1.421 -2.342 0 N-CA-C 110.939 -0.864 . . . . 55.02 110.939 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.569 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.5 mmtm -132.26 146.59 52.1 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 110.099 -0.334 . . . . 72.41 110.099 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.3 t -111.33 138.53 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 122.35 0.26 . . . . 73.4 111.199 175.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.408 HD23 HG12 ' A' ' 42' ' ' ILE . 82.9 mt -94.97 112.02 23.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.43 -0.952 . . . . 71.23 108.43 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 84.2 mmm -93.91 154.93 17.44 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 123.537 0.735 . . . . 71.04 111.097 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.32 36.08 92.56 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 114.778 -1.101 . . . . 62.11 113.436 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.02 127.39 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 108.816 -0.809 . . . . 75.13 108.816 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.8 p -77.65 169.93 17.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.183 -0.673 . . . . 72.2 109.183 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.506 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 34.2 t -55.25 -48.15 74.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.673 -0.24 . . . . 61.22 110.548 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.47 -37.47 75.56 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.911 0.884 . . . . 64.41 112.76 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 39.5 mt-10 -76.51 -46.27 27.35 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 116.046 -0.525 . . . . 75.34 110.198 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.426 ' C ' HD22 ' A' ' 84' ' ' LEU . 7.0 tt -68.92 -41.25 78.41 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.447 -0.501 . . . . 75.34 112.053 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 81' ' ' SER . 12.3 pt-20 -62.78 -29.8 70.98 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.414 0.626 . . . . 74.11 109.869 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -74.96 -42.61 57.3 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 114.993 -1.003 . . . . 74.41 109.553 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.8 mt -60.41 -42.47 96.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.387 0.613 . . . . 62.34 109.66 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.01 -36.33 81.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.807 -1.088 . . . . 73.2 110.04 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.36 -48.71 21.76 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.379 -0.828 . . . . 62.31 112.021 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' A' ' 87' ' ' LEU . 14.4 p -63.97 -47.94 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.277 0 C-N-CA 122.36 0.264 . . . . 64.41 111.643 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.33 -19.84 52.63 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.817 0.818 . . . . 71.01 110.654 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.86 -16.34 12.12 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 116.997 1.559 . . . . 53.05 116.997 -173.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -58.64 -44.56 90.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 118.088 0.944 . . . . 54.04 112.428 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.07 -1.73 3.65 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.002 1.112 . . . . 63.3 114.002 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -113.13 157.12 22.04 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.569 -0.53 . . . . 73.31 109.569 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HB3' HD11 ' A' ' 119' ' ' ILE . 39.2 tt0 -123.94 155.11 38.75 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.29 -1.374 . . . . 65.01 107.29 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -86.96 114.57 23.7 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.11 -1.07 . . . . 75.53 108.11 -176.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.509 HG11 ' HE1' ' A' ' 117' ' ' MET . 34.3 m -117.32 153.76 19.12 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 120.883 -0.327 . . . . 65.24 110.162 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -95.63 132.83 40.37 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.218 -0.66 . . . . 55.41 109.218 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.75 162.76 31.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 120.964 0.411 . . . . 74.1 111.052 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.403 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -103.75 119.79 6.47 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.464 -1.055 . . . . 54.24 110.464 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.69 158.22 12.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 110.017 -0.364 . . . . 62.33 110.017 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 99.6 t -121.23 120.58 62.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.472 -0.566 . . . . 75.35 109.472 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 108' ' ' SER . 39.3 mtp180 -62.24 137.32 58.24 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.145 -0.48 . . . . 74.32 111.244 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.435 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 43.4 mt-10 -83.38 -3.89 57.95 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.556 0.693 . . . . 74.43 110.044 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.11 -68.07 0.36 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.776 -1.102 . . . . 74.42 110.399 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -129.08 0.63 5.24 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.484 -1.234 . . . . 73.34 111.328 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 49.6 m 64.34 80.46 0.23 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.048 0.928 . . . . 64.13 112.694 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 10.1 pt-20 -137.4 152.45 49.65 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.627 -1.249 . . . . 71.24 107.627 175.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -91.45 147.22 23.18 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.358 -0.608 . . . . 73.3 109.358 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 51.4 ttp -143.98 158.66 43.56 Favored 'General case' 0 N--CA 1.415 -2.225 0 N-CA-C 107.642 -1.244 . . . . 71.01 107.642 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.63 118.0 35.64 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.879 -0.328 . . . . 61.12 110.521 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.1 m -129.01 173.42 13.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 120.996 0.426 . . . . 70.23 110.287 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -101.74 143.41 31.71 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.63 -0.878 . . . . 73.32 108.63 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.8 t -143.51 171.5 14.07 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.069 -1.086 . . . . 75.24 108.069 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -121.24 117.77 27.9 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.274 -1.01 . . . . 73.44 108.274 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.512 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 23.5 ptt? -118.04 156.4 28.67 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.796 -0.638 . . . . 74.11 110.798 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -68.78 118.96 12.41 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.239 -0.891 . . . . 70.52 108.599 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 96' ' ' GLU . 45.2 mm -72.74 -42.42 61.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.08 0.77 . . . . 64.34 113.08 -170.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -68.07 -28.61 67.52 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.197 -0.601 . . . . 65.52 110.378 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.288 9.6 ptpp? 56.38 -18.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.683 2.475 . . . . 74.21 117.683 173.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -116.66 84.21 2.1 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.459 0.647 . . . . 71.22 110.036 177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 126' ' ' MET . 10.3 m-20 -139.77 116.8 8.33 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.135 -0.939 . . . . 72.45 109.765 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -65.99 -13.6 40.6 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.54 2.16 . . . . 70.54 111.149 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.72 -34.68 74.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.118 0.967 . . . . 63.43 111.878 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.57 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.1 ptt? . . . . . 0 C--O 1.213 -0.83 0 CA-C-N 116.46 -0.336 . . . . 72.14 111.421 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.564 ' O ' HG12 ' A' ' 144' ' ' ILE . 38.7 ttpt . . . . . 0 C--O 1.211 -0.926 0 N-CA-C 110.287 -0.264 . . . . 61.13 110.287 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.467 ' HA ' ' HE2' ' A' ' 141' ' ' LYS . 0.6 OUTLIER -52.1 -31.66 31.63 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.831 0.852 . . . . 75.1 111.44 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -67.46 -44.13 79.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.029 0.918 . . . . 62.2 109.367 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.48 ' O ' HG22 ' A' ' 146' ' ' THR . 40.4 t80 -71.68 -36.44 70.62 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.817 -1.538 . . . . 71.34 110.151 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.2 mm -55.07 -32.7 27.89 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 CA-C-N 115.252 -0.885 . . . . 74.43 111.496 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -56.01 -38.48 70.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.197 0.814 . . . . 74.44 113.197 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 143' ' ' PHE . 7.6 t -77.97 -32.84 51.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.63 -0.878 . . . . 71.31 108.63 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -77.57 -33.56 53.92 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.267 -0.879 . . . . 71.34 111.094 -173.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 47.3 tttm -56.54 -42.19 78.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.343 -0.844 . . . . 64.34 110.187 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -66.89 -31.01 71.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.869 0.843 . . . . 65.12 110.34 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 73.6 mt -73.29 -47.32 46.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.185 -0.916 . . . . 73.53 109.345 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.9 ttt -64.18 -40.52 96.28 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.368 -0.833 . . . . 73.23 110.733 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 45.0 mt-10 -64.06 -29.83 70.95 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 116.451 -0.34 . . . . 75.03 111.914 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -70.83 -31.78 68.61 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.193 0.52 . . . . 74.32 109.974 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 C--O 1.241 0.655 0 N-CA-C 112.61 0.596 . . . . 73.42 112.61 -178.428 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.411 -2.422 0 N-CA-C 106.102 -1.814 . . . . 70.02 106.102 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 79' ' ' VAL . 27.0 m-70 -116.73 160.59 20.54 Favored 'General case' 0 C--N 1.266 -3.062 0 N-CA-C 109.244 -0.65 . . . . 74.21 109.244 -172.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 22.1 p-10 -130.74 129.39 42.44 Favored 'General case' 0 C--N 1.259 -3.335 0 CA-C-N 115.493 -0.776 . . . . 74.2 109.657 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.1 t -119.77 139.59 46.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.146 -0.934 . . . . 74.15 110.31 -173.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -93.89 122.34 36.27 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.303 -1.369 . . . . 54.41 107.303 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 m -104.19 129.97 55.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.551 0.691 . . . . 62.12 111.712 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -75.74 -22.01 56.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.956 -1.02 . . . . 75.42 113.238 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.04 -34.23 0.39 Allowed Glycine 0 CA--C 1.504 -0.615 0 C-N-CA 119.36 -1.4 . . . . 74.24 112.749 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.3 p -58.43 -36.6 73.89 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.213 0.605 . . . . 71.24 112.329 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -127.91 32.82 4.88 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.74 -0.664 . . . . 75.14 110.315 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -84.24 20.09 1.7 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.259 1.028 . . . . 54.03 109.647 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.505 ' O ' HG22 ' A' ' 31' ' ' VAL . 12.6 t70 -134.8 128.78 18.98 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.551 -1.277 . . . . 62.2 107.551 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.47 -32.65 39.54 Favored 'Trans proline' 0 C--O 1.219 -0.474 0 C-N-CA 121.873 1.715 . . . . 73.34 113.16 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.06 -34.7 66.42 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.555 -0.293 . . . . 72.35 111.197 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 28' ' ' ASP . 17.8 m -66.2 -29.48 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 119.852 -0.739 . . . . 74.15 109.963 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 mm -73.03 -41.35 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 122.013 0.911 . . . . 74.22 109.22 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -57.92 -39.43 77.96 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 113.732 -1.576 . . . . 73.12 110.227 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.32 -29.93 11.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.383 -0.826 . . . . 75.42 111.389 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -69.96 -31.89 69.84 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 120.982 0.42 . . . . 74.2 110.295 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.6 pt? -129.56 -69.74 0.68 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 120.282 -0.567 . . . . 71.11 112.371 172.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.481 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 26.4 t70 169.98 -48.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.149 0.976 . . . . 74.53 109.114 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -92.17 176.8 6.36 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.249 -1.341 . . . . 74.21 109.972 -176.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -149.41 124.41 4.85 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 116.341 -0.391 . . . . 61.23 110.063 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.14 151.68 81.05 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.928 2.419 . . . . 37.16 110.69 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.42 136.18 51.26 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.638 -0.875 . . . . 74.45 108.638 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 3.5 mp -105.64 139.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 120.614 -0.434 . . . . 75.45 110.981 -172.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -131.67 146.11 34.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.83 -0.623 . . . . 71.21 109.795 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.7 m -77.74 123.34 26.58 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.213 -0.662 . . . . 75.42 109.213 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.95 157.29 47.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.489 0.661 . . . . 75.25 111.105 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.421 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 87.4 m -110.4 126.97 54.85 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.243 -0.89 . . . . 63.43 109.656 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.2 tp -102.81 97.25 8.95 Favored Pre-proline 0 N--CA 1.429 -1.511 0 N-CA-C 109.241 -0.651 . . . . 72.43 109.241 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 46' ' ' THR . 67.0 Cg_endo -83.29 143.66 11.3 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.199 1.933 . . . . 72.21 111.221 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.35 10.96 60.2 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.538 -0.839 . . . . 64.43 111.908 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -141.67 161.08 38.81 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 122.712 0.405 . . . . 72.4 110.05 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 6.5 tp-100 -140.86 149.2 41.65 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 123.068 0.23 . . . . 74.1 110.819 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.26 130.96 54.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.036 -0.728 . . . . 73.44 109.036 173.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 38.2 m-85 -108.36 135.33 49.83 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.43 -1.322 . . . . 74.33 107.43 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.42 -1.972 0 C-N-CA 117.816 -1.554 . . . . 74.44 111.491 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 N--CA 1.437 -1.118 0 N-CA-C 108.958 -0.756 . . . . 74.21 108.958 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 6.7 Cg_exo -73.78 79.38 2.27 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.587 1.525 . . . . 75.42 109.949 173.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.8 m -79.66 150.74 30.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.115 -0.948 . . . . 75.24 111.238 -174.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 51' ' ' GLN . 49.3 mm -103.8 138.99 26.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 CA-C-N 115.517 -0.765 . . . . 71.2 109.481 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.0 m -146.03 155.31 51.29 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 107.951 -1.129 . . . . 72.2 107.951 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.39 125.7 18.12 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.268 1.979 . . . . 40.14 112.55 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.3 t -124.09 128.5 49.39 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.443 -1.317 . . . . 73.14 107.443 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.27 -16.73 61.38 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 112.287 0.477 . . . . 63.5 112.287 -172.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -130.75 13.9 5.35 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.745 0.276 . . . . 61.0 111.745 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -111.42 169.63 13.33 Favored Glycine 0 C--O 1.244 0.728 0 C-N-CA 119.64 -1.267 . . . . 72.32 114.088 -175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -154.82 138.16 15.8 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.647 -0.871 . . . . 63.52 108.647 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -113.28 122.26 67.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.792 -0.447 . . . . 70.51 109.792 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -96.05 116.81 29.53 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.255 -1.387 . . . . 74.41 107.255 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.96 -155.32 6.45 Favored Glycine 0 N--CA 1.417 -2.585 0 N-CA-C 110.912 -0.875 . . . . 71.54 110.912 -176.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -122.38 144.98 48.69 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.57 0.7 . . . . 62.4 111.939 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.0 t -111.17 131.73 61.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 114.357 -1.292 . . . . 72.22 111.319 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 81.0 mt -95.76 104.88 16.83 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.371 -0.974 . . . . 74.42 108.371 176.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.405 ' HE1' ' HB3' ' A' ' 77' ' ' MET . 64.3 mtp -100.13 139.04 36.37 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 120.977 0.417 . . . . 75.3 111.044 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.13 18.67 10.95 Favored Glycine 0 C--N 1.29 -2.021 0 C-N-CA 120.435 -0.888 . . . . 73.32 111.637 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.669 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 88.4 t -70.3 128.17 33.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.667 -0.494 . . . . 54.53 109.667 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -77.86 167.77 20.98 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.771 -0.826 . . . . 74.53 108.771 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.3 p -64.37 -32.34 73.91 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.987 -0.685 . . . . 74.42 110.293 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.03 -51.07 51.15 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.757 -0.656 . . . . 74.33 110.058 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.669 ' OE1' ' HA ' ' A' ' 79' ' ' VAL . 44.5 tt0 -60.32 -39.57 87.52 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.727 -0.669 . . . . 73.31 110.175 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -57.35 -51.17 70.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.102 0.477 . . . . 74.42 110.411 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.56 -29.27 67.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.968 -0.56 . . . . 75.23 111.326 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.417 ' O ' HG21 ' A' ' 90' ' ' VAL . 7.0 t30 -65.57 -46.3 79.98 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.935 -0.765 . . . . 53.43 108.935 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 97.1 mt -64.93 -41.06 95.85 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.388 -0.824 . . . . 60.41 109.898 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.12 -32.81 73.43 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.649 -0.705 . . . . 71.4 110.722 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.22 62.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.011 -0.541 . . . . 74.21 110.854 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 86' ' ' ASN . 99.3 t -72.27 -56.71 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 123.16 0.584 . . . . 75.51 112.319 -178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.48 -22.76 47.02 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.041 0.448 . . . . 75.42 111.852 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.2 -17.02 36.41 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 115.519 0.967 . . . . 54.3 115.519 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.8 -45.17 93.9 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.772 0.786 . . . . 73.04 111.323 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -112.65 -9.21 13.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.44 -0.345 . . . . 73.54 111.721 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -129.74 167.48 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.58 0.228 . . . . 64.21 110.969 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -123.08 144.65 49.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.118 -0.697 . . . . 73.04 109.118 175.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -88.12 114.14 24.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.782 -0.821 . . . . 75.53 108.782 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.516 HG11 ' HE2' ' A' ' 117' ' ' MET . 33.6 m -127.51 160.54 36.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 116.316 -0.402 . . . . 64.41 110.755 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.1 t -95.41 132.08 40.85 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.626 -0.509 . . . . 74.15 109.626 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -138.11 165.17 26.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.904 -0.589 . . . . 75.5 110.759 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.413 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -104.27 123.11 7.6 Favored Glycine 0 N--CA 1.421 -2.337 0 CA-C-N 115.66 -0.7 . . . . 45.24 111.427 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.8 pp -118.18 152.78 20.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.669 -0.493 . . . . 65.43 109.669 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.8 131.47 65.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 108.49 -0.929 . . . . 52.53 108.49 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -70.52 125.65 27.42 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.444 0.465 . . . . 65.31 110.225 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.11 -4.21 46.26 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 123.208 0.317 . . . . 74.02 111.562 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.46 -60.53 3.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.1 -1.074 . . . . 62.34 108.1 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -117.79 -93.31 0.51 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.155 -1.384 . . . . 73.32 111.885 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.9 p -173.94 13.11 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.757 0.28 . . . . 74.43 111.757 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -85.02 145.43 27.7 Favored 'General case' 0 C--O 1.251 1.153 0 C-N-CA 120.302 -0.559 . . . . 70.44 111.211 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -93.72 144.66 25.2 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.901 0.857 . . . . 64.0 110.491 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.401 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 76.5 mmm -131.64 162.23 30.87 Favored 'General case' 0 C--N 1.275 -2.633 0 C-N-CA 124.973 1.309 . . . . 72.03 110.922 -175.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.54 126.82 53.24 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.156 -0.929 . . . . 72.41 109.073 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.448 HG11 ' CG ' ' A' ' 19' ' ' ASN . 32.7 m -141.07 173.32 9.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.742 -0.466 . . . . 74.3 109.742 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.65 151.74 22.6 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.461 -0.57 . . . . 72.44 109.461 171.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.4 t -147.28 172.04 14.48 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.696 -1.224 . . . . 73.31 107.696 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -117.36 108.36 15.49 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.604 -0.517 . . . . 74.03 109.604 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.516 ' HE2' HG11 ' A' ' 98' ' ' VAL . 24.7 ptt? -107.2 156.79 18.45 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.545 -0.752 . . . . 74.52 110.276 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.524 ' HD1' ' O ' ' A' ' 120' ' ' ASN . 33.7 t-105 -68.14 134.81 51.13 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 106.183 -1.784 . . . . 71.11 106.183 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.2 mp -67.81 -41.73 85.34 Favored 'Isoleucine or valine' 0 C--O 1.26 1.61 0 C-N-CA 118.894 -1.122 . . . . 73.52 110.506 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.524 ' O ' ' HD1' ' A' ' 118' ' ' TRP . 42.6 t30 -82.41 105.41 13.45 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.775 0.798 . . . . 75.04 109.353 177.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -77.24 -12.24 59.92 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.276 -0.875 . . . . 71.3 111.557 -172.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.52 76.36 1.71 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.763 -0.828 . . . . 72.33 108.763 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.42 ' HB3' ' HE1' ' A' ' 126' ' ' MET . 13.9 t70 -93.34 130.42 35.67 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 115.115 -0.948 . . . . 71.34 108.989 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -81.0 -0.48 10.62 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.855 2.37 . . . . 73.54 114.174 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -94.23 -51.03 4.99 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 120.246 -0.582 . . . . 74.12 110.943 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.423 ' O ' ' HG3' ' A' ' 126' ' ' MET . 23.7 ptt? . . . . . 0 N--CA 1.437 -1.082 0 C-N-CA 119.334 -0.946 . . . . 71.31 110.445 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.526 ' O ' HG12 ' A' ' 144' ' ' ILE . 37.6 ttmt . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 120.924 0.392 . . . . 71.32 110.617 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 38.6 ttpt -52.78 -35.29 56.35 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.811 0.844 . . . . 74.43 112.234 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.51 -35.79 78.7 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.187 0.518 . . . . 74.33 110.307 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -76.48 -43.26 40.53 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.605 -0.887 . . . . 74.52 108.605 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.4 mm -59.54 -33.93 53.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-N 114.807 -1.088 . . . . 72.02 111.534 -176.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.2 mt-10 -54.28 -31.64 54.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.166 0.508 . . . . 75.23 111.337 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.7 m -81.09 -47.99 12.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.337 0.589 . . . . 37.16 110.868 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -76.69 -30.68 56.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 113.698 0.999 . . . . 72.34 113.698 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -56.13 -39.42 72.21 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.094 0.474 . . . . 74.03 110.778 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -71.76 -33.89 69.02 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.57 . . . . 74.13 109.848 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.2 mt -68.83 -38.76 79.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.494 -0.776 . . . . 72.45 109.497 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.8 ttt -64.68 -37.82 88.89 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.842 -0.617 . . . . 62.42 110.118 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.83 -30.89 65.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.092 -0.504 . . . . 64.02 110.514 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.2 -34.64 76.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.991 -0.55 . . . . 64.33 110.528 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 CA--C 1.507 -0.676 0 CA-C-O 121.42 0.628 . . . . 61.52 111.218 178.391 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.417 -2.09 0 N-CA-C 108.858 -0.793 . . . . 71.23 108.858 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' O ' HG13 ' A' ' 79' ' ' VAL . 48.9 m-70 -113.28 159.3 19.5 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 108.282 -1.007 . . . . 64.52 108.282 -173.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.451 ' CB ' HG13 ' A' ' 113' ' ' VAL . 36.9 m-20 -122.3 126.94 49.19 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.276 -1.379 . . . . 73.24 107.276 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -127.84 137.5 57.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 110.105 -0.332 . . . . 74.3 110.105 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -95.3 121.77 37.3 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.892 -0.781 . . . . 74.41 108.892 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 m -96.03 119.51 44.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 121.92 0.867 . . . . 65.51 111.019 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -74.97 -34.22 62.0 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 115.354 1.613 . . . . 74.23 115.354 -172.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.57 -50.49 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.172 0 C-N-CA 118.578 -1.772 . . . . 61.54 113.041 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.0 m -57.85 -35.62 71.18 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 122.75 0.42 . . . . 64.12 111.984 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.486 ' HB3' HD13 ' A' ' 32' ' ' ILE . 50.4 m-85 -122.95 29.23 6.87 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.47 -0.332 . . . . 71.52 110.658 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -85.78 31.02 0.62 Allowed 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.154 0.978 . . . . 74.03 109.86 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 31' ' ' VAL . 17.3 t70 -142.06 129.42 11.43 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 107.59 -1.263 . . . . 53.53 107.59 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HB3' HG22 ' A' ' 39' ' ' THR . 19.0 Cg_exo -66.92 -32.95 34.51 Favored 'Trans proline' 0 N--CA 1.478 0.573 0 C-N-CA 122.385 2.057 . . . . 52.31 112.525 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.23 -40.09 88.96 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.622 -0.263 . . . . 74.31 111.247 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 28' ' ' ASP . 13.7 p -74.21 -29.45 24.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.58 -0.448 . . . . 41.35 110.182 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 38' ' ' ARG . 43.5 mm -64.88 -45.5 94.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 N-CA-C 109.89 -0.411 . . . . 75.42 109.89 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -57.08 -36.99 71.23 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.132 0.491 . . . . 74.54 111.249 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.3 t -80.24 -42.85 21.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 116.098 -0.501 . . . . 74.14 111.2 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.617 ' HE1' ' OD1' ' A' ' 86' ' ' ASN . 13.1 tmm? -69.44 -36.84 77.03 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.704 -0.225 . . . . 75.13 111.195 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.566 HD11 ' N ' ' A' ' 37' ' ' ASP 0.353 3.8 pp -119.66 -57.59 1.96 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 115.092 1.515 . . . . 74.34 115.092 178.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.566 ' N ' HD11 ' A' ' 36' ' ' LEU . 29.2 t70 176.09 -55.04 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.453 0.644 . . . . 75.12 110.19 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.598 ' O ' HG23 ' A' ' 32' ' ' ILE . 36.5 mmt180 -136.84 -165.05 1.67 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.175 -0.92 . . . . 74.41 108.894 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 29' ' ' PRO . 37.7 m -137.76 125.0 13.72 Favored Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 120.329 -0.549 . . . . 41.15 111.467 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.87 150.87 87.43 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.758 2.305 . . . . 62.45 109.503 172.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.39 135.94 56.58 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 113.832 1.049 . . . . 65.21 113.832 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 3.5 mp -108.4 135.51 46.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 114.054 -1.43 . . . . 64.12 111.538 -172.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.29 146.48 33.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.99 -0.744 . . . . 75.32 108.99 173.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m -76.74 126.97 31.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.049 0.452 . . . . 73.12 109.806 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.8 157.14 45.83 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.013 0.435 . . . . 72.14 110.942 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.0 m -112.89 126.71 55.76 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 115.192 -0.913 . . . . 73.42 110.423 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.6 tp -101.82 102.83 25.09 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 115.712 -0.676 . . . . 61.42 109.216 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.05 140.88 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.562 2.175 . . . . 74.01 112.366 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.5 4.15 62.49 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 115.733 -0.667 . . . . 73.43 111.865 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.437 ' HE2' ' SD ' ' A' ' 117' ' ' MET . 91.5 m-85 -132.01 162.04 31.71 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.734 -0.469 . . . . 75.2 109.734 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 31.0 tt0 -139.74 140.15 36.68 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.63 -0.428 . . . . 71.1 111.362 -173.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HA ' HD11 ' A' ' 63' ' ' ILE . 11.6 ttm180 -94.51 142.83 26.98 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.749 -1.574 . . . . 75.34 106.749 177.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -106.82 168.89 8.88 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 116.167 -0.47 . . . . 75.52 110.376 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 . . . . . 0 C--N 1.284 -2.261 0 N-CA-C 107.657 -1.238 . . . . 74.53 107.657 -175.803 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.019 -0.734 . . . . 74.53 109.019 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.49 96.82 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.196 1.931 . . . . 64.11 111.52 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 26.3 p -102.0 177.37 4.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.812 -0.631 . . . . 75.22 109.924 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.44 HD11 ' HA ' ' A' ' 52' ' ' ARG . 47.1 mm -124.53 131.29 72.94 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 109.456 -0.572 . . . . 74.2 109.456 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -142.2 153.24 62.96 Favored Pre-proline 0 C--N 1.286 -2.163 0 N-CA-C 107.253 -1.388 . . . . 74.33 107.253 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.482 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 11.7 Cg_endo -59.97 137.0 73.26 Favored 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 122.198 1.932 . . . . 70.53 111.509 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 51' ' ' GLN . 30.1 t -124.99 147.79 48.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.353 -0.61 . . . . 72.43 109.353 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.424 ' O ' ' HD2' ' A' ' 68' ' ' LYS . 37.5 mt-10 -69.0 -36.98 78.44 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.941 -0.763 . . . . 74.04 108.941 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 67' ' ' GLU . 30.8 mmmt -134.3 80.1 1.84 Allowed 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.239 -0.891 . . . . 73.14 109.14 175.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.12 153.6 24.95 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 119.879 -1.153 . . . . 70.54 113.212 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.82 138.21 16.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.109 -1.071 . . . . 74.13 108.109 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.66 119.46 61.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.971 -0.381 . . . . 73.13 109.971 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -92.14 116.42 28.93 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.232 -2.136 . . . . 64.0 105.232 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.31 -145.33 4.4 Favored Glycine 0 N--CA 1.417 -2.582 0 C-N-CA 120.465 -0.874 . . . . 55.14 111.694 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 48.4 mmtm -129.94 141.53 50.76 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 120.747 0.308 . . . . 75.52 110.831 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 44.0 t -110.21 129.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.867 -0.606 . . . . 70.51 111.097 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.01 111.11 23.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.296 -1.372 . . . . 64.34 107.296 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.9 ptp -117.99 149.35 41.08 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 120.66 0.267 . . . . 72.5 110.561 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.68 16.05 55.55 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.64 -1.267 . . . . 74.25 110.535 -174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 18' ' ' HIS . 10.6 p -83.86 135.76 24.17 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 N-CA-C 108.302 -0.999 . . . . 72.44 108.302 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.4 p -82.96 167.0 18.38 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.31 -0.556 . . . . 73.04 110.64 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.9 m -61.05 -33.22 72.96 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.076 0.399 . . . . 75.11 112.076 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -68.31 -36.13 78.86 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.444 0.64 . . . . 74.25 110.685 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 39.1 mt-10 -78.14 -28.36 48.41 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.441 -0.948 . . . . 64.43 108.441 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.5 tp -65.9 -51.61 57.22 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.697 -0.483 . . . . 72.04 109.697 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.65 -29.03 70.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.317 0.579 . . . . 64.2 110.513 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.617 ' OD1' ' HE1' ' A' ' 35' ' ' MET . 7.5 t-20 -59.86 -48.5 81.45 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.096 -0.956 . . . . 72.34 109.744 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 96.7 mt -67.42 -38.99 85.46 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.15 -0.932 . . . . 63.44 110.567 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.619 ' OD1' ' HD3' ' A' ' 97' ' ' ARG . 65.7 m-20 -60.33 -45.22 94.21 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.937 -0.574 . . . . 71.32 109.801 175.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.88 -46.96 79.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.604 -0.725 . . . . 73.2 111.702 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 86' ' ' ASN . 7.9 p -72.62 -56.7 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 N-CA-C 112.999 0.74 . . . . 73.14 112.999 -177.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.11 -30.95 49.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.323 0.49 . . . . 72.52 112.323 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 95' ' ' TYR . . . -60.03 -17.26 43.7 Favored Glycine 0 N--CA 1.463 0.439 0 CA-C-N 115.769 -0.65 . . . . 64.03 114.313 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.89 -33.44 71.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.507 0.194 . . . . 64.03 110.926 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.25 -8.81 3.78 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.317 0.488 . . . . 64.3 112.317 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.405 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 69.1 m-85 -122.16 165.72 15.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.183 -0.303 . . . . 74.3 110.183 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.0 tp10 -123.12 143.24 50.12 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.845 -0.342 . . . . 63.3 110.105 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.619 ' HD3' ' OD1' ' A' ' 88' ' ' ASP . 60.5 ttp180 -87.59 114.24 24.02 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.156 -0.683 . . . . 74.33 109.156 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.529 HG11 ' HE2' ' A' ' 117' ' ' MET . 31.5 m -122.72 160.34 25.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 116.179 -0.464 . . . . 71.23 111.051 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 21.8 p -90.31 122.03 32.84 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.733 -0.667 . . . . 71.43 110.074 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.88 160.7 41.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.241 0.544 . . . . 63.14 112.288 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.59 124.88 6.86 Favored Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 110.512 -1.035 . . . . 61.33 110.512 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.84 154.89 13.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 116.548 0.174 . . . . 70.1 110.587 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 97.0 t -116.84 117.86 56.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 107.445 -1.317 . . . . 65.34 107.445 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.514 ' HD3' ' SD ' ' A' ' 111' ' ' MET . 58.8 mtm180 -69.8 137.75 52.1 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 119.813 -0.755 . . . . 73.34 111.051 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -75.44 -5.68 46.24 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.083 -1.08 . . . . 74.14 108.083 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.2 -58.4 3.45 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.271 -1.332 . . . . 74.24 111.248 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.468 ' ND2' HH21 ' A' ' 104' ' ' ARG . 30.9 p-10 -126.23 3.81 7.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.037 0.755 . . . . 75.33 113.037 -173.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 t 69.6 13.85 8.24 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.29 0.636 . . . . 51.45 111.785 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -104.91 155.84 18.57 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 122.063 -0.398 . . . . 44.22 111.136 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -88.78 148.43 23.94 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.634 0.731 . . . . 37.75 111.228 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.514 ' SD ' ' HD3' ' A' ' 104' ' ' ARG . 88.6 mtp -136.83 160.07 39.98 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.818 -1.083 . . . . 73.13 109.541 175.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.56 131.01 45.85 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.202 -0.908 . . . . 64.24 109.997 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.451 HG13 ' CB ' ' A' ' 19' ' ' ASN . 33.7 m -145.16 173.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.483 -0.932 . . . . 64.14 108.483 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -119.46 151.17 39.01 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.367 -0.975 . . . . 72.22 108.367 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.8 t -144.3 172.14 13.34 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.284 -0.635 . . . . 64.35 109.284 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 89.4 m-85 -116.75 108.48 15.93 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 123.847 0.717 . . . . 72.15 109.537 -177.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.529 ' HE2' HG11 ' A' ' 98' ' ' VAL . 22.3 ptt? -107.38 156.05 19.35 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.829 -0.623 . . . . 72.1 110.124 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -68.75 130.7 43.59 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.161 -1.052 . . . . 71.24 108.161 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.4 mp -73.7 -42.9 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 119.357 -0.937 . . . . 74.5 111.732 -173.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -84.05 93.77 8.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.78 0.8 . . . . 73.43 110.28 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -78.8 -6.13 55.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.108 -0.951 . . . . 72.51 113.167 -170.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.03 84.75 2.26 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.299 0.571 . . . . 75.24 110.179 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -133.49 120.61 15.85 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.836 -0.62 . . . . 72.51 109.767 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.17 -11.87 19.35 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.524 2.149 . . . . 71.12 113.439 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -90.63 -20.43 22.55 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 113.742 1.016 . . . . 74.11 113.742 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.6 ptt? . . . . . 0 N--CA 1.43 -1.443 0 CA-C-O 122.489 1.138 . . . . 65.44 108.667 170.908 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt . . . . . 0 C--O 1.235 0.316 0 CA-C-O 121.017 0.437 . . . . 73.1 110.679 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 61.6 tttm -50.83 -30.9 15.55 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 125.427 1.491 . . . . 72.43 112.121 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -54.5 -46.65 73.51 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.215 0.606 . . . . 72.12 110.272 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -77.49 -34.03 54.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.467 -0.788 . . . . 75.11 109.603 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.445 ' HB ' ' HA ' ' A' ' 141' ' ' LYS . 50.4 mm -64.49 -33.43 62.91 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.365 0 CA-C-N 114.898 -1.046 . . . . 74.2 111.796 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 38.2 mm-40 -55.37 -34.86 64.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.236 0.541 . . . . 71.42 110.693 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.3 m -73.9 -46.38 44.92 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.842 -0.617 . . . . 71.34 109.615 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -68.35 -29.76 68.56 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 114.346 1.239 . . . . 72.44 114.346 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 88.7 tttt -54.45 -41.09 69.03 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 123.357 0.663 . . . . 74.32 110.039 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.27 -36.45 84.14 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.62 0.724 . . . . 65.21 109.457 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.46 -37.38 50.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.055 -0.975 . . . . 73.34 109.942 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 87.7 mtp -67.58 -40.41 84.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.155 -0.475 . . . . 75.33 110.634 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 51.5 mt-10 -64.95 -32.16 73.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.378 0.609 . . . . 71.42 109.77 175.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.18 -44.46 65.42 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.503 -0.771 . . . . 74.53 111.166 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.502 -0.891 0 N-CA-C 112.871 0.693 . . . . 75.11 112.871 -178.024 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.414 -2.248 0 N-CA-C 106.658 -1.608 . . . . 73.32 106.658 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -120.07 157.74 28.31 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 109.09 -0.707 . . . . 72.13 109.09 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.601 ' HA ' ' O ' ' A' ' 76' ' ' LEU 0.272 0.7 OUTLIER -126.31 125.9 43.06 Favored 'General case' 0 C--N 1.284 -2.251 0 O-C-N 124.086 0.866 . . . . 74.33 111.424 174.365 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.56 137.61 55.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 114.723 -1.126 . . . . 71.32 109.913 -173.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 113' ' ' VAL . 89.6 t80 -97.97 122.9 41.64 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.518 -0.919 . . . . 65.45 108.518 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.1 m -103.27 138.01 29.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.323 0.582 . . . . 71.51 111.815 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.415 ' HB3' ' CG1' ' A' ' 63' ' ' ILE . 39.8 p90 -81.28 -15.06 56.63 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 115.015 1.487 . . . . 71.55 115.015 -175.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . 160.0 -46.9 0.41 Allowed Glycine 0 C--O 1.212 -1.247 0 C-N-CA 118.658 -1.734 . . . . 43.5 113.321 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 m -58.26 -31.63 67.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.693 0.627 . . . . 73.23 112.693 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.421 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 63.7 m-85 -123.72 31.27 5.93 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 122.253 -0.279 . . . . 74.31 111.486 -176.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -92.18 -1.72 56.98 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 119.254 -0.978 . . . . 65.43 112.236 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.425 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.0 t70 -99.65 123.1 49.09 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 115.375 -0.83 . . . . 74.2 109.194 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.75 -31.61 78.49 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.569 2.179 . . . . 70.24 113.366 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -67.3 -40.26 86.02 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.334 -0.617 . . . . 64.42 109.334 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.79 -37.55 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.624 -0.717 . . . . 62.43 109.87 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 38' ' ' ARG . 44.4 mm -63.06 -44.27 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 115.777 -0.647 . . . . 73.14 110.667 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -59.47 -35.87 74.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.017 0.437 . . . . 75.33 111.15 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.09 -35.64 14.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 116.084 -0.507 . . . . 75.34 112.179 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.421 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 9.0 tmm? -75.06 -37.16 61.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 120.241 -0.584 . . . . 74.42 110.16 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 32' ' ' ILE 0.254 0.9 OUTLIER -119.73 -62.44 1.49 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.464 1.283 . . . . 72.12 114.464 179.472 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.498 ' OD2' ' HG3' ' A' ' 38' ' ' ARG . 20.8 t70 178.67 -55.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.095 0.474 . . . . 72.23 111.398 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.498 ' HG3' ' OD2' ' A' ' 37' ' ' ASP . 88.6 mtm180 -135.75 -174.62 3.7 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.828 -0.804 . . . . 65.34 108.828 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.5 m -118.55 112.5 37.16 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 120.916 -0.313 . . . . 64.43 111.649 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.53 152.0 76.24 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 123.004 2.47 . . . . 62.13 109.293 170.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.74 118.8 5.66 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.536 0.684 . . . . 64.32 112.138 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 48.6 mt -100.12 137.49 27.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 115.242 -0.89 . . . . 65.14 109.239 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.48 146.68 33.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 109.339 -0.615 . . . . 72.3 109.339 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.9 m -77.69 130.77 37.22 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.515 -0.55 . . . . 73.42 109.515 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.23 159.23 42.66 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.463 0.542 . . . . 73.12 112.463 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.5 m -107.42 132.21 53.44 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.826 0.851 . . . . 73.02 109.816 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.401 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 45.3 tp -111.96 96.76 35.35 Favored Pre-proline 0 C--N 1.3 -1.545 0 N-CA-C 108.474 -0.935 . . . . 64.12 108.474 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.64 141.06 9.64 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.462 2.108 . . . . 73.52 112.656 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.27 10.53 59.41 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.679 -0.772 . . . . 73.32 111.713 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -139.49 159.1 42.95 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 106.796 -1.557 . . . . 75.01 106.796 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -139.49 142.07 37.33 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 120.282 -0.567 . . . . 61.23 109.859 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HB2' ' NH1' ' A' ' 54' ' ' ARG . 28.4 ptt180 -102.23 126.45 49.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.981 -0.554 . . . . 75.24 109.619 176.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.511 ' O ' ' HD2' ' A' ' 54' ' ' ARG . 91.0 m-85 -108.68 162.16 14.42 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.224 -1.028 . . . . 74.14 108.224 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.511 ' HD2' ' O ' ' A' ' 53' ' ' PHE . 3.0 mpt_? . . . . . 0 CA--C 1.485 -1.545 0 CA-C-O 121.358 0.599 . . . . 74.14 112.087 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.425 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 12.4 m-85 . . . . . 0 N--CA 1.443 -0.823 0 N-CA-C 109.882 -0.414 . . . . 75.03 109.882 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 31.7 Cg_exo -68.3 47.69 0.39 Allowed 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 124.073 3.182 . . . . 65.4 112.849 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.9 p -61.65 163.18 7.45 Favored 'General case' 0 C--O 1.252 1.233 0 C-N-CA 125.277 1.431 . . . . 64.15 114.838 -174.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.415 ' CG1' ' HB3' ' A' ' 23' ' ' TYR . 49.8 mm -109.7 142.02 23.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 C-N-CA 124.917 1.287 . . . . 74.54 108.584 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 118' ' ' TRP . 26.9 m -148.19 154.66 42.79 Favored Pre-proline 0 C--N 1.309 -1.189 0 N-CA-C 107.654 -1.239 . . . . 73.3 107.654 171.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.2 111.33 1.99 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.226 1.951 . . . . 54.34 112.042 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 t -124.89 135.98 53.37 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.228 -0.656 . . . . 63.03 109.228 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.423 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 10.3 mp0 -73.17 -21.76 60.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.986 0.422 . . . . 71.21 110.005 -176.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -100.24 5.64 44.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.904 -0.589 . . . . 63.14 112.339 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -132.24 177.13 18.96 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 118.18 -1.962 . . . . 64.51 115.094 -174.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.47 ' OE2' ' HD3' ' A' ' 140' ' ' LYS . 14.3 pt-20 -156.82 143.4 18.37 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 104.409 -2.441 . . . . 62.22 104.409 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.407 HG23 HD13 ' A' ' 63' ' ' ILE . 47.0 t -113.56 119.75 61.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 C-N-CA 120.173 -0.611 . . . . 70.51 110.316 -176.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -98.66 115.43 28.67 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 119.466 -0.894 . . . . 74.31 108.686 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.22 -157.79 7.39 Favored Glycine 0 N--CA 1.418 -2.564 0 C-N-CA 120.379 -0.915 . . . . 75.33 111.002 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.467 ' HE2' ' HB2' ' A' ' 27' ' ' GLN . 3.1 mppt? -122.72 148.34 45.43 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 113.263 0.838 . . . . 73.34 113.263 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.5 t -111.01 131.87 61.04 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 113.643 -1.617 . . . . 64.11 110.951 178.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 68.8 mt -95.63 107.74 19.96 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.434 -0.95 . . . . 75.43 108.434 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 61.2 mtp -103.63 155.68 18.37 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.657 -0.498 . . . . 75.21 109.657 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.45 16.24 66.87 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.083 -1.056 . . . . 72.04 111.47 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.7 t -72.1 120.12 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 109.457 -0.571 . . . . 63.41 109.457 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.5 p -74.03 163.52 27.78 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.464 -0.939 . . . . 73.41 108.464 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 p -55.15 -36.94 66.35 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 112.151 0.426 . . . . 73.15 112.151 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.76 -51.51 69.45 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.554 0.742 . . . . 74.43 111.038 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.8 mt-10 -67.95 -35.48 78.48 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.914 0.886 . . . . 71.05 109.342 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.89 -49.66 75.96 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.287 -0.635 . . . . 73.4 109.287 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.63 -33.52 75.13 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-O 121.05 0.453 . . . . 71.52 109.888 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.487 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -60.34 -48.97 79.47 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.411 1.085 . . . . 74.11 109.22 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.2 mt -66.86 -42.76 85.15 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.111 -0.495 . . . . 75.42 110.511 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.26 -31.96 73.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.203 -0.908 . . . . 73.43 110.676 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.86 -45.37 51.45 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.491 -0.777 . . . . 52.14 110.904 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 86' ' ' ASN . 99.4 t -65.23 -56.99 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.441 -0.345 . . . . 65.33 111.487 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -77.95 -22.54 49.37 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.83 0.678 . . . . 72.13 112.83 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.88 -16.83 48.67 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 115.912 -0.585 . . . . 43.25 114.463 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -61.4 -27.86 68.83 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.636 0.606 . . . . 72.21 112.636 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -145.23 -0.88 0.85 Allowed 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 120.136 -0.625 . . . . 75.22 112.124 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.425 ' OH ' ' HB2' ' A' ' 60' ' ' TYR . 80.4 m-85 -122.09 167.79 12.72 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 122.101 -0.374 . . . . 75.41 110.462 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -123.04 139.67 53.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.38 -1.341 . . . . 64.44 107.38 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -87.14 114.4 23.72 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.289 -0.634 . . . . 74.32 109.289 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.54 HG11 ' HE1' ' A' ' 117' ' ' MET . 35.3 m -119.13 160.53 19.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.698 -0.683 . . . . 54.05 109.865 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.7 t -107.39 133.18 52.29 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.988 -0.745 . . . . 54.4 108.988 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.41 171.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 116.238 -0.437 . . . . 75.33 110.65 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.95 124.74 7.28 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 111.008 -0.837 . . . . 54.23 111.008 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.6 pp -117.6 165.14 13.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 116.621 0.21 . . . . 73.31 110.634 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 110' ' ' LYS . 46.1 t -124.11 119.43 56.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.929 -0.767 . . . . 55.24 108.929 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.441 ' HE ' ' HB3' ' A' ' 106' ' ' ASP . 72.7 ttt180 -65.77 116.35 6.88 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.091 0.956 . . . . 71.52 111.005 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -53.74 -48.44 69.65 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.941 0.896 . . . . 64.32 109.215 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.441 ' HB3' ' HE ' ' A' ' 104' ' ' ARG . 33.9 t70 -48.9 -42.61 37.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.09 -1.868 . . . . 75.32 115.395 -172.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -138.92 6.64 2.43 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 118.627 -1.229 . . . . 74.34 112.41 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.3 t 59.71 70.17 0.66 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.073 0.949 . . . . 71.23 111.486 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -131.16 146.33 52.3 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 115.176 -0.92 . . . . 73.22 108.857 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.429 ' HG2' HG22 ' A' ' 103' ' ' VAL . 58.0 mtpt -97.3 126.19 42.36 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.456 0.646 . . . . 65.43 109.339 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.417 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 89.2 mtp -125.38 161.24 27.47 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.479 -0.782 . . . . 73.5 110.853 -177.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.51 117.43 31.65 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.216 -0.902 . . . . 64.52 109.197 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.468 HG11 ' OD1' ' A' ' 19' ' ' ASN . 34.0 m -129.98 173.37 14.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 121.264 0.554 . . . . 63.52 110.821 -174.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -108.81 147.25 32.36 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.079 -1.082 . . . . 75.5 108.079 175.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.4 t -148.73 172.56 14.4 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.935 -0.765 . . . . 53.44 108.935 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.17 108.28 13.59 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.816 -0.809 . . . . 75.04 108.816 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.54 ' HE1' HG11 ' A' ' 98' ' ' VAL . 24.9 ptt? -110.88 156.37 21.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.808 -0.633 . . . . 74.53 109.615 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.474 ' HB3' ' CG1' ' A' ' 64' ' ' VAL . 55.9 t-105 -68.35 123.27 20.31 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.065 -1.087 . . . . 75.35 108.065 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.43 ' H ' HD11 ' A' ' 119' ' ' ILE . 2.4 mp -65.23 -40.92 90.22 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 CA-C-O 120.921 0.391 . . . . 73.21 111.197 -171.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -59.17 -28.64 66.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.687 -0.688 . . . . 73.52 111.09 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.438 ' HA ' ' CG1' ' A' ' 64' ' ' VAL 0.302 9.0 ptpp? 58.06 -52.02 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 126.555 1.942 . . . . 71.22 115.217 178.307 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.88 82.64 2.61 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.357 -1.349 . . . . 65.22 107.357 174.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -112.38 127.19 27.18 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.172 -0.922 . . . . 73.11 109.062 -176.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.3 -17.78 21.16 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.852 2.368 . . . . 73.13 113.991 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -80.4 -29.63 37.73 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 112.739 0.644 . . . . 73.23 112.739 -175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.428 -1.532 0 CA-C-O 121.838 0.828 . . . . 71.0 112.445 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 144' ' ' ILE . 36.0 ttpt . . . . . 0 C--O 1.208 -1.109 0 N-CA-C 112.169 0.433 . . . . 73.24 112.169 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -48.8 -32.56 8.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 112.231 0.456 . . . . 71.12 112.231 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.523 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -58.76 -48.21 82.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.871 0.843 . . . . 74.11 109.716 175.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -76.15 -32.78 59.26 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.674 -1.603 . . . . 74.02 108.943 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 140' ' ' LYS . 46.7 mm -61.6 -32.77 54.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.143 0 CA-C-N 114.646 -1.161 . . . . 75.21 112.642 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -51.84 -41.3 61.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.128 0.422 . . . . 75.24 111.413 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.5 m -70.98 -47.6 57.98 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.736 -0.665 . . . . 73.41 109.858 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . 0.257 62.9 m-85 -70.18 -29.88 66.86 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 115.133 1.531 . . . . 74.32 115.133 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 57.6 tptt -59.3 -42.55 91.6 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.51 -0.922 . . . . 62.45 108.51 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -64.12 -40.31 95.92 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.253 -0.885 . . . . 71.31 109.463 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.3 mt -68.58 -41.64 83.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.313 -0.858 . . . . 64.41 110.663 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.38 -42.54 96.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.51 -0.314 . . . . 74.44 110.743 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 49.2 mt-10 -67.56 -30.8 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.931 0.396 . . . . 61.24 110.416 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 51.2 t -65.66 -37.59 86.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.871 -0.604 . . . . 74.14 109.957 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 116.054 -0.521 . . . . 72.23 110.048 177.301 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.417 -2.092 0 CA-C-O 121.06 0.457 . . . . 70.25 110.565 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.439 ' O ' HG13 ' A' ' 79' ' ' VAL . 49.0 m-70 -115.41 160.21 20.16 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.298 -0.865 . . . . 73.33 110.208 -173.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.432 ' CG ' HG11 ' A' ' 113' ' ' VAL . 18.1 p30 -133.15 138.48 46.64 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.113 -0.949 . . . . 64.2 111.305 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.1 t -132.12 139.41 50.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.436 -0.802 . . . . 64.2 109.727 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.404 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.1 t80 -94.16 123.1 37.33 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.456 -1.312 . . . . 73.12 107.456 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.1 m -102.81 166.96 2.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 112.519 0.563 . . . . 65.34 112.519 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -153.56 -45.3 0.09 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.069 -0.969 . . . . 73.52 111.623 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.02 -92.71 1.26 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.03 -1.081 . . . . 63.11 113.97 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -58.35 -17.49 20.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.138 1.162 . . . . 74.33 114.138 -173.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -123.36 20.15 9.68 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 121.079 -0.248 . . . . 75.44 111.003 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.08 -18.86 60.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.649 -0.421 . . . . 74.02 111.609 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.524 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 20.8 t70 -116.81 128.29 26.12 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 116.331 -0.395 . . . . 71.1 111.856 -173.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HB3' HG23 ' A' ' 39' ' ' THR . 32.0 Cg_endo -65.12 -32.71 52.28 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.074 2.516 . . . . 54.3 112.81 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.524 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 19.3 t70 -63.29 -38.19 90.2 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.532 -0.544 . . . . 73.33 109.532 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.69 -42.98 93.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.257 -0.883 . . . . 73.44 109.656 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 28' ' ' ASP . 45.7 mm -60.73 -43.79 95.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.018 -0.537 . . . . 73.35 111.894 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -55.37 -36.4 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.226 0.536 . . . . 64.03 111.2 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.5 t -82.03 -37.49 14.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.609 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.515 ' HE1' ' ND2' ' A' ' 86' ' ' ASN . 9.0 tmm? -63.49 -35.54 80.79 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.388 -0.597 . . . . 71.31 109.388 -174.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.55 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.2 pt? -128.09 -74.69 0.57 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.092 -0.504 . . . . 75.14 111.862 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.55 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 22.4 m-20 -167.36 -58.26 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.861 0.865 . . . . 71.23 108.668 -172.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -131.2 165.59 23.0 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.444 -1.253 . . . . 73.24 112.222 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.444 HG23 ' HB3' ' A' ' 29' ' ' PRO . 29.9 m -111.69 128.47 25.37 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.956 -0.566 . . . . 73.14 111.729 -174.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.45 153.15 68.2 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 123.453 2.769 . . . . 70.0 111.403 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.2 123.95 16.26 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.25 -0.648 . . . . 64.45 109.25 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 32.9 mt -104.91 136.03 40.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.086 0.47 . . . . 75.3 110.364 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.483 HG22 ' HD2' ' A' ' 104' ' ' ARG . 14.4 p -130.85 147.72 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.711 -0.677 . . . . 62.43 109.869 176.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.3 m -75.69 126.53 31.18 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.548 -0.908 . . . . 63.1 108.548 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.91 157.38 46.14 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.517 0.675 . . . . 64.43 111.819 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 m -114.59 125.12 53.41 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 114.537 -1.21 . . . . 73.33 108.627 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.8 tp -99.97 101.97 15.99 Favored Pre-proline 0 C--N 1.29 -2.007 0 N-CA-C 109.092 -0.707 . . . . 73.34 109.092 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 71.9 Cg_endo -80.84 141.1 13.23 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 122.188 1.926 . . . . 74.0 112.091 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.12 14.23 57.85 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.963 -0.636 . . . . 72.43 112.427 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -140.49 163.3 33.2 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.674 -0.491 . . . . 73.31 109.674 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.427 ' CG ' ' HB2' ' A' ' 66' ' ' SER . 26.9 pt20 -140.27 166.38 24.85 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.164 -0.68 . . . . 74.34 109.164 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HD3' HG12 ' A' ' 71' ' ' VAL . 14.9 ptt180 -128.01 128.46 45.03 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.597 -0.729 . . . . 74.31 111.719 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.536 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 17.1 m-85 -109.14 164.88 12.04 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.274 -0.876 . . . . 73.44 110.147 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 . . . . . 0 CA--C 1.487 -1.473 0 N-CA-C 109.442 -0.577 . . . . 71.33 109.442 -168.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 12.7 p90 . . . . . 0 N--CA 1.419 -2.024 0 N-CA-C 108.569 -0.9 . . . . 62.24 108.569 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 5.7 Cg_exo -37.24 120.49 0.31 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 124.344 3.363 . . . . 74.34 114.427 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 53' ' ' PHE . 12.4 p -130.11 150.0 51.57 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.037 -0.983 . . . . 74.15 110.468 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.7 mm -110.06 141.36 25.59 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 N-CA-C 108.742 -0.836 . . . . 74.01 108.742 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 118' ' ' TRP . 29.9 m -146.87 150.33 38.85 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 109.101 -0.703 . . . . 73.11 109.101 175.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.33 134.68 60.39 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.66 2.24 . . . . 71.44 112.246 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.427 ' HB2' ' CG ' ' A' ' 51' ' ' GLN . 34.8 t -125.68 141.51 51.98 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.934 -0.575 . . . . 72.42 110.343 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -75.29 -32.79 61.11 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.512 -0.551 . . . . 55.15 109.512 173.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . 0.287 0.1 OUTLIER -131.93 72.91 1.51 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 114.031 1.123 . . . . 75.41 114.031 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.35 168.59 40.58 Favored Glycine 0 C--O 1.257 1.579 0 C-N-CA 119.224 -1.465 . . . . 61.22 113.283 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.44 147.73 29.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.799 -1.186 . . . . 63.34 107.799 176.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.404 HG12 ' HD3' ' A' ' 52' ' ' ARG . 59.8 t -114.5 119.66 62.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 109.582 -0.525 . . . . 70.22 109.582 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -95.63 116.32 28.69 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.534 -0.913 . . . . 75.03 108.534 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.87 -143.87 4.14 Favored Glycine 0 N--CA 1.418 -2.517 0 C-N-CA 120.718 -0.753 . . . . 52.21 111.26 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 75.5 mmtt -134.24 145.13 48.86 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.56 -0.533 . . . . 74.51 109.56 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.7 t -110.58 129.55 65.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 123.104 0.252 . . . . 52.33 111.148 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.416 ' CD2' HG12 ' A' ' 42' ' ' ILE . 71.0 mt -95.62 111.31 23.26 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.022 -1.473 . . . . 71.03 107.022 174.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.9 ptp -119.65 144.08 47.36 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.398 -0.521 . . . . 75.31 111.842 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.26 23.97 7.78 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 115.459 -0.791 . . . . 70.51 111.73 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 83' ' ' GLU . 13.2 p -95.02 138.89 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 110.017 -0.364 . . . . 74.31 110.017 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.548 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 3.9 m -79.02 162.05 26.19 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 109.169 -0.678 . . . . 74.03 109.169 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.5 m -58.51 -32.7 69.07 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 112.801 0.667 . . . . 55.0 112.801 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.64 -49.39 68.87 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 112.322 0.489 . . . . 73.33 112.322 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.575 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 1.4 mp0 -65.25 -29.49 70.28 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 109.612 -0.514 . . . . 70.04 109.612 177.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.87 -40.33 92.59 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.021 0.439 . . . . 71.42 109.868 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -69.02 -36.99 78.4 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.152 -0.685 . . . . 75.45 109.152 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.515 ' ND2' ' HE1' ' A' ' 35' ' ' MET . 7.7 t30 -63.85 -43.04 97.33 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.114 -0.948 . . . . 64.13 110.489 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.8 mt -61.72 -43.07 99.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.748 0.785 . . . . 74.31 108.935 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.25 -32.17 71.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.278 -1.328 . . . . 65.43 111.115 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.21 -42.16 56.19 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.814 -0.63 . . . . 72.44 110.474 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 86' ' ' ASN . 99.3 t -67.04 -53.23 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.306 0.643 . . . . 73.34 112.4 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -78.28 -20.65 51.16 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.224 0.535 . . . . 70.1 111.95 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.19 -17.03 16.07 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.74 1.456 . . . . 61.15 116.74 -173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.06 -29.64 69.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 118.56 1.18 . . . . 73.42 112.533 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.56 -0.74 2.36 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 113.359 0.874 . . . . 63.22 113.359 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -127.41 166.08 18.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.663 0.616 . . . . 75.53 112.663 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.3 tp10 -125.17 146.04 49.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.121 -0.945 . . . . 73.43 108.86 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -92.92 114.12 26.59 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.014 -0.736 . . . . 61.13 109.014 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 m -126.49 161.59 32.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 120.865 0.364 . . . . 71.11 111.83 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.7 t -88.14 130.97 34.89 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.249 -0.887 . . . . 74.1 110.31 -177.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.84 165.61 25.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.974 -0.557 . . . . 71.22 111.522 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -114.67 124.24 6.31 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.477 -1.049 . . . . 70.01 110.477 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.88 160.51 15.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 120.697 0.284 . . . . 74.01 110.868 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 66.2 t -120.38 114.68 44.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.115 -1.439 . . . . 73.01 107.115 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 108' ' ' SER . 54.8 mtm180 -69.67 135.56 50.01 Favored 'General case' 0 CA--C 1.478 -1.817 0 C-N-CA 119.981 -0.688 . . . . 72.33 109.771 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.92 5.55 18.68 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.82 0.819 . . . . 72.23 109.074 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -56.85 -62.09 1.99 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.087 -1.415 . . . . 73.55 109.559 175.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -137.76 12.3 2.92 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.512 -0.767 . . . . 62.24 109.288 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 23.0 t 62.86 78.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.688 -1.142 . . . . 64.01 110.486 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 10.2 pt-20 -137.11 151.3 48.71 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 108.133 -1.062 . . . . 71.32 108.133 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -94.05 140.93 29.12 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 120.35 -0.54 . . . . 71.22 110.245 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.6 mtp -141.8 161.5 37.81 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 123.772 0.829 . . . . 74.1 110.218 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.57 129.19 55.31 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 115.459 -0.792 . . . . 38.31 109.671 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.432 HG11 ' CG ' ' A' ' 19' ' ' ASN . 29.5 m -142.84 174.68 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.441 -0.948 . . . . 71.33 108.441 -177.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -113.8 157.62 22.06 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.863 -0.735 . . . . 74.44 109.601 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.2 t -149.74 172.64 14.78 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.558 -0.904 . . . . 64.14 108.558 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 88.5 m-85 -114.51 115.35 27.1 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.192 -0.669 . . . . 75.33 109.192 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . 0.256 0.0 OUTLIER -113.42 156.27 23.78 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.001 -0.545 . . . . 73.11 111.773 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.437 ' HB3' ' CG1' ' A' ' 64' ' ' VAL . 68.1 t-105 -67.76 118.01 10.43 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.688 -0.856 . . . . 74.25 108.688 -175.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.7 mt -58.91 -35.75 58.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.91 -1.041 . . . . 73.13 113.156 -171.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -70.69 -31.23 68.05 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.023 0.439 . . . . 72.01 110.596 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 67.67 -60.1 0.4 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.011 1.325 . . . . 74.35 113.658 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.03 102.01 13.59 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 110.149 -0.315 . . . . 72.44 110.149 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -141.98 123.91 9.01 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 116.014 -0.539 . . . . 73.5 110.906 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -87.06 2.67 6.88 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.797 2.332 . . . . 72.55 113.443 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -94.99 -31.43 13.63 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.669 0.271 . . . . 70.21 111.387 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.521 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 27.0 ptt? . . . . . 0 N--CA 1.476 0.865 0 C-N-CA 122.824 0.45 . . . . 61.04 112.17 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.474 ' O ' HG12 ' A' ' 144' ' ' ILE . 88.2 tttt . . . . . 0 C--O 1.205 -1.281 0 N-CA-C 110.329 -0.248 . . . . 62.33 110.329 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 23.7 tptm -46.77 -38.51 10.18 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.459 1.104 . . . . 73.42 113.006 -177.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.75 -40.3 91.93 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.947 0.88 . . . . 72.53 109.95 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -76.71 -32.98 58.2 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.503 -1.226 . . . . 74.41 107.908 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.3 mm -65.82 -32.81 59.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 CA-C-N 114.629 -1.169 . . . . 53.53 111.524 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 45.0 mt-10 -55.24 -32.06 62.01 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.376 0.608 . . . . 70.24 110.054 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.9 m -80.24 -47.19 14.98 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.704 -0.68 . . . . 64.35 109.45 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.558 ' O ' ' HG2' ' A' ' 151' ' ' MET 0.294 26.9 m-85 -64.13 -30.63 71.68 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 116.128 1.899 . . . . 72.35 116.128 -178.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 37.6 mmtm -58.76 -38.85 79.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.474 0.579 . . . . 64.2 111.679 175.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -71.23 -33.26 69.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.106 -0.701 . . . . 64.53 109.106 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 68.3 mt -69.95 -39.0 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.39 -0.823 . . . . 73.52 109.136 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 14.4 mmt -61.25 -40.69 94.99 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.329 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 46.0 mt-10 -60.29 -41.54 93.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.151 0.501 . . . . 62.03 110.319 177.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 49.0 t -71.56 -31.83 67.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.568 -0.742 . . . . 61.12 110.845 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 75.9 mmtt . . . . . 0 CA--C 1.514 -0.437 0 C-N-CA 120.457 -0.497 . . . . 74.53 110.204 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.413 -2.31 0 N-CA-C 107.958 -1.127 . . . . 65.11 107.958 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.479 ' O ' HG11 ' A' ' 79' ' ' VAL . 49.9 m-70 -109.39 159.67 16.82 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 108.702 -0.851 . . . . 74.2 108.702 -173.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 21.1 p30 -134.56 128.48 33.34 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.114 -0.948 . . . . 64.12 111.94 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.63 144.48 34.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 114.575 -1.193 . . . . 74.3 111.041 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -94.13 123.14 37.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.75 -0.833 . . . . 72.41 108.75 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.725 ' HB ' ' O ' ' A' ' 26' ' ' PHE . 20.4 m -94.44 172.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.853 -0.612 . . . . 62.23 110.54 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -149.4 -62.41 0.22 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.291 1.96 . . . . 65.34 116.291 -168.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -116.28 -79.48 0.77 Allowed Glycine 0 C--O 1.215 -1.085 0 C-N-CA 119.314 -1.422 . . . . 73.35 114.504 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -65.98 -36.31 82.97 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.98 0.895 . . . . 75.03 109.187 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.725 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 48.5 m-85 -101.29 100.17 10.64 Favored 'General case' 0 N--CA 1.401 -2.902 0 CA-C-N 114.622 -1.172 . . . . 75.42 108.196 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -156.18 3.83 0.17 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.177 -0.919 . . . . 73.15 112.509 173.321 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -124.71 134.59 25.75 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.369 -0.604 . . . . 73.13 109.369 -176.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 29.6 Cg_endo -63.35 -30.76 73.22 Favored 'Trans proline' 0 C--O 1.211 -0.859 0 C-N-CA 122.879 2.386 . . . . 74.42 113.988 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.26 -35.35 73.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.19 0.519 . . . . 72.12 109.629 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.42 -42.42 95.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.617 -0.883 . . . . 71.42 108.617 175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.485 HG21 HD23 ' A' ' 36' ' ' LEU . 24.0 mm -66.17 -43.66 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.947 -1.024 . . . . 71.33 109.584 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 3.5 t-20 -55.36 -43.85 75.44 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.648 -1.614 . . . . 64.11 110.742 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.99 -39.36 17.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.882 -0.599 . . . . 75.12 111.481 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -64.99 -36.39 84.24 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 110.482 -0.192 . . . . 72.51 110.482 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.485 HD23 HG21 ' A' ' 32' ' ' ILE 0.264 0.4 OUTLIER -111.24 -75.36 0.62 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 113.088 0.773 . . . . 64.12 113.088 174.268 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.6 t70 174.51 -49.08 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 108.328 -0.99 . . . . 73.33 108.328 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -110.78 175.66 5.34 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.185 -1.371 . . . . 73.41 109.029 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.0 m -129.29 104.72 17.85 Favored Pre-proline 0 N--CA 1.414 -2.228 0 N-CA-C 108.694 -0.854 . . . . 75.11 108.694 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.17 150.86 46.35 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 123.01 2.473 . . . . 75.52 110.35 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.71 132.0 51.98 Favored 'General case' 0 CA--C 1.465 -2.318 0 CA-C-O 122.224 1.011 . . . . 63.11 112.043 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 46.3 mt -107.0 131.73 56.2 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.8 0 CA-C-N 113.219 -1.809 . . . . 71.35 108.95 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.13 146.17 30.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.967 -1.123 . . . . 72.02 107.967 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.5 m -77.36 127.95 33.45 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 107.329 -1.36 . . . . 71.3 107.329 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.27 154.41 44.72 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.039 0.447 . . . . 74.53 110.95 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.484 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 93.9 m -109.16 125.64 52.41 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.374 -0.83 . . . . 75.33 110.276 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.0 tp -101.43 99.59 11.69 Favored Pre-proline 0 N--CA 1.432 -1.368 0 CA-C-N 116.077 -0.511 . . . . 72.11 109.936 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.1 Cg_endo -83.96 135.53 6.62 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.767 2.311 . . . . 70.32 111.562 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.11 5.88 46.17 Favored Glycine 0 N--CA 1.434 -1.438 0 C-N-CA 120.552 -0.832 . . . . 71.3 111.679 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.471 ' HA ' ' H ' ' A' ' 66' ' ' SER . 96.0 m-85 -146.98 150.17 34.62 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.121 -0.696 . . . . 74.33 109.121 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -140.85 148.56 40.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.632 -0.877 . . . . 73.01 108.632 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.03 142.47 33.25 Favored 'General case' 0 N--CA 1.424 -1.734 0 C-N-CA 119.517 -0.873 . . . . 74.51 108.997 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.491 ' CB ' ' HB2' ' A' ' 126' ' ' MET . 7.0 m-85 -108.3 171.22 7.54 Favored 'General case' 0 C--N 1.258 -3.375 0 CA-C-N 114.646 -1.161 . . . . 74.41 111.152 -175.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? . . . . . 0 C--N 1.316 -0.865 0 N-CA-C 113.624 0.972 . . . . 75.1 113.624 -173.21 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.443 -0.81 0 N-CA-C 107.293 -1.373 . . . . 65.55 107.293 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 16.0 Cg_exo -68.79 93.23 0.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 N-CA-C 108.219 -1.493 . . . . 71.34 108.219 171.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 22.0 p -99.53 154.94 17.85 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.653 -0.703 . . . . 61.51 112.509 -174.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.4 mm -94.86 127.39 46.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.056 -0.975 . . . . 53.55 109.469 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.44 144.38 52.03 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 109.201 -0.666 . . . . 74.34 109.201 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.94 108.96 0.36 Allowed 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.552 2.168 . . . . 62.44 112.983 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.471 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 32.3 t -125.13 98.6 5.73 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 106.09 -1.819 . . . . 61.23 106.09 176.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.38 -36.6 64.08 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 123.667 0.787 . . . . 71.52 112.252 -172.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HZ1' ' CD ' ' A' ' 145' ' ' GLU . 8.4 tppt? -86.15 -23.9 26.39 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.337 0.589 . . . . 74.53 110.24 -176.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.74 173.89 45.77 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 115.41 -0.814 . . . . 64.14 113.099 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -160.4 144.43 14.05 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.331 -0.988 . . . . 75.54 108.331 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.12 119.83 61.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 109.035 -0.728 . . . . 74.21 109.035 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -91.45 114.85 27.49 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.537 -2.023 . . . . 73.44 105.537 174.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.44 -143.81 3.9 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.279 -0.962 . . . . 38.05 112.359 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.461 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.5 mmtm -123.34 140.61 52.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.946 0.403 . . . . 73.45 111.325 -173.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 41.0 t -111.08 130.05 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.827 -0.624 . . . . 73.02 110.376 172.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 78.3 mt -95.71 109.91 22.12 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.863 -1.162 . . . . 64.21 107.863 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.8 ptp -119.7 137.43 53.92 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.128 0.489 . . . . 63.43 110.43 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.72 18.87 10.96 Favored Glycine 0 N--CA 1.421 -2.33 0 C-N-CA 120.037 -1.078 . . . . 44.14 111.254 -174.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 18' ' ' HIS . 10.0 p -89.69 138.2 19.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 N-CA-C 109.009 -0.737 . . . . 74.33 109.009 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.6 p -76.84 159.92 29.67 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.422 -0.354 . . . . 65.24 110.77 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.1 m -58.71 -32.03 68.8 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.33 0.493 . . . . 62.12 112.33 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -67.37 -41.09 85.63 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.432 0.634 . . . . 71.22 109.984 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 63.0 mm-40 -80.2 -28.65 38.63 Favored 'General case' 0 C--O 1.201 -1.499 0 C-N-CA 119.576 -0.85 . . . . 73.42 112.426 176.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.41 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.1 tm? -60.79 -45.21 95.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.059 -0.719 . . . . 73.11 109.059 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -67.86 -29.92 69.17 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.855 -0.424 . . . . 74.04 109.855 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -72.95 -40.34 65.45 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 116.116 -0.493 . . . . 75.31 110.129 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.6 mt -60.17 -40.45 89.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.947 0.879 . . . . 74.32 109.295 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.45 ' CG ' HH21 ' A' ' 97' ' ' ARG . 23.8 t70 -71.48 -29.52 64.92 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.445 -1.252 . . . . 55.41 111.089 177.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.69 -48.21 22.93 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.347 -0.388 . . . . 64.13 110.394 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 87' ' ' LEU . 13.7 p -65.28 -53.41 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-N 115.843 -0.617 . . . . 74.32 111.483 -176.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -78.02 -27.82 48.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.167 0.432 . . . . 71.42 112.167 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.91 -17.81 44.78 Favored Glycine 0 N--CA 1.464 0.529 0 N-CA-C 115.007 0.763 . . . . 75.34 115.007 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -61.52 -32.33 72.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.126 0.463 . . . . 74.43 111.198 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -130.86 3.83 4.48 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.589 -0.444 . . . . 63.04 111.793 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -138.46 168.0 20.7 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.796 0.295 . . . . 74.24 111.796 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 35.9 tt0 -121.62 144.55 48.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.323 -0.399 . . . . 73.15 110.123 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.45 HH21 ' CG ' ' A' ' 88' ' ' ASP . 16.3 ttm180 -87.45 118.45 26.92 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.328 -0.619 . . . . 75.12 109.328 -176.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.23 162.98 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 113.123 0.786 . . . . 74.02 113.123 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.5 p -94.14 124.38 38.11 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.118 -1.401 . . . . 75.34 109.965 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.92 158.31 43.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 120.844 0.354 . . . . 71.35 111.251 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.58 115.8 5.22 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 111.394 -0.682 . . . . 72.32 111.394 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.04 155.76 12.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 110.189 -0.3 . . . . 54.41 110.189 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.9 120.08 62.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 108.701 -0.851 . . . . 63.33 108.701 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.447 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 39.7 mtp180 -64.38 134.92 55.56 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.946 0.403 . . . . 64.43 111.017 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.89 -6.93 53.15 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.892 -1.151 . . . . 52.12 107.892 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.88 -64.6 0.77 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 125.719 1.607 . . . . 74.43 110.938 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -144.89 15.34 1.55 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 120.741 -0.384 . . . . 74.02 110.293 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 56.7 m 63.53 63.09 0.89 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.651 -0.704 . . . . 74.25 111.656 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.47 137.57 52.44 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.373 -1.343 . . . . 64.44 107.373 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -98.19 140.97 31.7 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-O 121.433 0.635 . . . . 75.24 111.32 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.447 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 89.0 mtp -138.51 162.58 34.16 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-N 114.977 -1.011 . . . . 71.44 110.358 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.44 122.35 47.2 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.963 -1.017 . . . . 63.34 109.199 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.06 174.46 13.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 109.109 -0.7 . . . . 73.23 109.109 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -98.26 161.25 13.8 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.565 -0.854 . . . . 62.14 109.14 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.0 t -156.93 172.57 18.43 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.737 -1.208 . . . . 72.34 107.737 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.1 m-85 -124.41 113.9 18.79 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.094 -0.706 . . . . 64.5 109.094 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.94 157.52 22.31 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.935 0.398 . . . . 72.43 110.974 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.411 ' NE1' ' HB3' ' A' ' 120' ' ' ASN . 55.4 t-105 -67.52 128.82 37.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.573 -0.899 . . . . 74.12 108.573 -177.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.447 HD11 ' N ' ' A' ' 119' ' ' ILE . 2.7 mp -72.02 -41.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.643 -0.253 . . . . 73.24 111.159 -173.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.411 ' HB3' ' NE1' ' A' ' 118' ' ' TRP . 27.1 t-20 -62.31 -37.17 84.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.768 -0.651 . . . . 72.24 111.377 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.475 ' O ' ' HE1' ' A' ' 126' ' ' MET . 57.2 mttp 68.29 -38.7 0.38 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.427 1.491 . . . . 72.25 114.361 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -115.63 76.09 0.99 Allowed 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.903 -0.498 . . . . 73.33 110.502 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.515 ' H ' ' HE3' ' A' ' 126' ' ' MET . 11.1 t70 -106.12 132.95 20.47 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 108.542 -0.91 . . . . 74.13 108.542 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.19 -19.07 29.97 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.763 2.309 . . . . 75.11 114.361 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -76.52 -37.32 56.92 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 113.222 0.823 . . . . 75.42 113.222 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.515 ' HE3' ' H ' ' A' ' 123' ' ' ASP . 26.4 ptt? . . . . . 0 C--O 1.247 0.95 0 CA-C-O 121.439 0.638 . . . . 71.04 109.933 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.668 ' O ' HG12 ' A' ' 144' ' ' ILE . 38.8 ttpt . . . . . 0 C--O 1.2 -1.52 0 N-CA-C 110.589 -0.152 . . . . 71.15 110.589 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.548 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 38.7 ttmt -54.76 -41.94 71.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.996 0.519 . . . . 73.01 110.192 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -61.75 -44.41 96.96 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.126 0.965 . . . . 72.11 108.66 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -67.44 -38.25 84.23 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.404 -1.725 . . . . 75.24 109.977 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 140' ' ' LYS . 42.4 mm -67.05 -35.53 74.77 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.455 0 CA-C-N 115.609 -0.723 . . . . 71.4 110.174 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.5 mt-10 -59.88 -30.91 69.32 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.748 0.309 . . . . 61.32 111.134 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.53 ' O ' HG13 ' A' ' 150' ' ' ILE . 33.3 m -73.59 -48.44 32.76 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.904 -0.776 . . . . 71.23 108.904 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.516 ' O ' ' HG2' ' A' ' 151' ' ' MET . 51.1 m-85 -71.62 -36.29 70.73 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 115.271 1.582 . . . . 73.22 115.271 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.507 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 88.5 tttt -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.47 -0.937 . . . . 72.43 108.47 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . 0.55 ' HB2' ' NZ ' ' A' ' 149' ' ' LYS . 4.1 ttmp? -75.19 -37.85 61.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.686 -1.143 . . . . 71.4 109.855 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 146' ' ' THR . 88.8 mt -64.49 -33.49 63.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.815 -0.629 . . . . 70.41 109.503 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.516 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 24.8 mmt -72.74 -27.96 62.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.288 -0.415 . . . . 71.35 110.648 176.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 43.3 mt-10 -68.7 -30.69 69.41 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 108.709 -0.849 . . . . 73.43 108.709 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 150' ' ' ILE . 52.3 t -70.48 -32.87 70.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.317 -0.856 . . . . 73.43 109.959 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 75.0 mmtt . . . . . 0 C--O 1.236 0.384 0 N-CA-C 109.385 -0.598 . . . . 71.4 109.385 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.436 -1.135 0 N-CA-C 108.821 -0.807 . . . . 74.14 108.821 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -115.71 159.74 20.99 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.513 -0.312 . . . . 73.33 110.608 -172.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -121.28 127.57 51.49 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.496 -1.298 . . . . 75.32 107.496 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.64 130.26 62.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 122.357 -0.214 . . . . 73.32 110.832 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -94.48 121.64 36.23 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.185 -1.413 . . . . 64.25 107.185 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 26' ' ' PHE . 4.0 p -97.0 139.73 18.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.592 -0.731 . . . . 74.43 110.666 -176.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -77.65 -36.85 51.05 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 115.092 1.516 . . . . 73.0 115.092 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.41 -74.49 0.02 OUTLIER Glycine 0 C--O 1.225 -0.463 0 C-N-CA 117.584 -2.246 . . . . 72.33 115.774 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 t -58.57 -36.24 73.63 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.733 1.012 . . . . 74.55 113.733 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.487 ' HB3' HD13 ' A' ' 32' ' ' ILE . 62.4 m-85 -99.38 22.67 10.32 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.221 -0.992 . . . . 63.35 112.501 -175.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -74.29 -11.23 60.21 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 120.633 0.254 . . . . 72.34 111.279 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -101.76 128.77 28.06 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.455 -0.338 . . . . 65.22 111.431 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.485 ' HB3' HG23 ' A' ' 39' ' ' THR . 18.0 Cg_endo -62.95 -37.04 56.55 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.943 2.429 . . . . 51.5 113.114 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 34' ' ' VAL . 4.8 m-20 -65.62 -33.79 76.72 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.718 -0.614 . . . . 72.25 110.818 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.52 -40.82 89.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.736 -0.666 . . . . 73.42 109.589 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 38' ' ' ARG . 43.6 mm -65.84 -42.1 91.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 CA-C-N 115.966 -0.561 . . . . 72.41 111.103 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -58.77 -34.55 71.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.892 0.377 . . . . 74.2 110.692 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 30' ' ' ASP . 94.4 t -77.65 -46.6 27.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.089 -0.505 . . . . 71.43 110.841 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.461 ' HE1' ' ND2' ' A' ' 86' ' ' ASN . 62.0 ttp -63.56 -36.81 85.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.02 0.378 . . . . 70.3 112.02 -177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 37' ' ' ASP 0.374 3.6 pp -126.01 -58.77 1.36 Allowed 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 115.379 1.622 . . . . 75.23 115.379 -178.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.496 ' N ' HD12 ' A' ' 36' ' ' LEU . 22.7 t70 170.56 -53.22 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.307 0.575 . . . . 70.44 110.618 -177.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.548 ' O ' HG22 ' A' ' 32' ' ' ILE . 88.8 mtt180 -123.21 -167.35 1.59 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.548 -0.908 . . . . 71.43 108.548 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.485 HG23 ' HB3' ' A' ' 29' ' ' PRO . 76.2 m -139.55 121.13 9.8 Favored Pre-proline 0 N--CA 1.432 -1.369 0 CA-C-O 120.502 0.191 . . . . 72.2 111.203 171.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.25 153.47 46.37 Favored 'Trans proline' 0 C--O 1.247 0.949 0 C-N-CA 123.56 2.84 . . . . 74.14 110.815 173.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.02 129.56 38.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.379 0.609 . . . . 74.12 110.204 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 54.2 mt -111.77 139.51 35.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.982 -0.554 . . . . 53.04 109.754 -175.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 12.0 p -127.98 145.85 34.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.467 -0.568 . . . . 73.15 109.467 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.452 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 40.3 m -78.32 122.44 25.76 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.353 -0.98 . . . . 74.02 108.353 176.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.26 159.41 42.28 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.921 0.867 . . . . 61.14 112.27 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 56.1 m -120.08 129.37 54.18 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.809 -1.087 . . . . 73.22 108.632 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.0 tp -98.85 104.02 22.75 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 108.864 -0.791 . . . . 65.34 108.864 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.0 OUTLIER -82.44 148.84 14.63 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.533 2.155 . . . . 72.02 111.543 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.33 16.7 66.1 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.888 -0.672 . . . . 63.34 112.255 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -145.4 159.89 42.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.956 -1.128 . . . . 61.42 107.956 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.455 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 11.1 pt20 -139.24 163.74 31.67 Favored 'General case' 0 CA--C 1.481 -1.682 0 C-N-CA 119.313 -0.955 . . . . 71.53 111.401 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.573 ' HD3' ' NH1' ' A' ' 54' ' ' ARG . 0.8 OUTLIER -107.94 129.83 55.07 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.892 -1.504 . . . . 72.52 112.858 -176.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.455 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 5.4 m-85 -109.11 158.21 18.0 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.104 -0.953 . . . . 75.34 109.905 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.573 ' NH1' ' HD3' ' A' ' 52' ' ' ARG . 6.0 mpt_? . . . . . 0 C--N 1.304 -1.405 0 CA-C-N 116.442 -0.345 . . . . 75.24 110.21 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 N--CA 1.432 -1.374 0 N-CA-C 106.755 -1.572 . . . . 70.22 106.755 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.23 89.47 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.691 1.594 . . . . 63.12 110.002 172.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 20.5 p -100.1 164.69 11.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 112.48 0.548 . . . . 64.45 112.48 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.12 140.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.405 -0.961 . . . . 73.43 108.405 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -145.68 154.71 52.38 Favored Pre-proline 0 C--O 1.251 1.146 0 N-CA-C 108.057 -1.09 . . . . 73.02 108.057 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -56.91 131.73 47.33 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 122.572 2.181 . . . . 64.2 112.013 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.2 t -124.46 140.58 52.82 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.286 -0.87 . . . . 41.3 108.936 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -74.35 -37.22 63.57 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.242 0.544 . . . . 70.04 109.582 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -130.94 82.33 2.04 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.611 -0.722 . . . . 75.42 110.231 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.06 164.28 37.75 Favored Glycine 0 C--N 1.299 -1.491 0 C-N-CA 119.528 -1.32 . . . . 70.3 112.811 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.22 148.19 30.24 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.832 -0.803 . . . . 72.4 108.832 176.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.16 122.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.442 -0.577 . . . . 65.3 109.442 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -97.53 116.54 29.94 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.727 -0.472 . . . . 62.45 109.727 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -152.48 -154.68 6.76 Favored Glycine 0 N--CA 1.418 -2.566 0 N-CA-C 110.317 -1.113 . . . . 44.24 110.317 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 73' ' ' GLY . 14.3 mptt -125.76 153.4 44.03 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.586 0.708 . . . . 75.52 111.88 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 69.9 t -110.81 130.18 64.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 114.206 -1.361 . . . . 74.12 110.599 177.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.7 mt -95.41 111.14 23.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 105.954 -1.869 . . . . 51.42 105.954 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.0 ptp -124.28 152.27 43.23 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.089 0.471 . . . . 72.33 112.006 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.92 18.72 53.68 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 109.189 -1.564 . . . . 63.03 109.189 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 80' ' ' THR . 54.7 t -71.91 127.24 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 114.253 -0.974 . . . . 73.14 109.716 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.442 ' O ' HG11 ' A' ' 79' ' ' VAL . 54.7 p -74.88 161.08 29.86 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.852 -1.166 . . . . 75.42 107.852 174.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.3 m -61.19 -26.83 67.98 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 122.182 -0.324 . . . . 73.53 111.837 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.43 -40.73 93.67 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.588 0.709 . . . . 52.54 110.793 176.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 38.1 mt-10 -78.0 -35.03 50.48 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.559 -0.746 . . . . 74.23 109.048 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.559 HD11 ' NH1' ' A' ' 97' ' ' ARG . 3.1 tm? -62.17 -51.41 67.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.478 -0.783 . . . . 70.12 110.11 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.05 -29.36 70.51 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 109.819 -0.437 . . . . 74.11 109.819 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.1 t30 -59.71 -46.56 88.73 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.956 -0.757 . . . . 54.22 108.956 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.44 -36.78 68.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.881 -0.599 . . . . 75.04 110.949 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.413 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 26.3 t70 -64.36 -31.45 72.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.901 0.858 . . . . 65.55 109.241 177.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.86 -47.21 21.95 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.591 -0.731 . . . . 71.42 111.458 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 86' ' ' ASN . 90.5 t -72.16 -60.2 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 112.77 0.655 . . . . 65.53 112.77 -176.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -83.0 -41.84 18.24 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.87 0.843 . . . . 72.04 111.822 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -59.58 -16.58 37.58 Favored Glycine 0 C--O 1.215 -1.041 0 N-CA-C 118.238 2.055 . . . . 62.45 118.238 -171.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -69.96 -45.16 67.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 120.154 1.977 . . . . 74.11 112.22 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -98.09 -3.61 37.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.242 0.544 . . . . 60.05 111.266 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 83.5 m-85 -122.24 169.43 10.91 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.769 0.828 . . . . 71.13 110.012 -178.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -122.62 132.35 54.24 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.869 -0.789 . . . . 62.34 108.869 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.559 ' NH1' HD11 ' A' ' 84' ' ' LEU . 9.6 ttp180 -87.01 114.1 23.33 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.902 -1.045 . . . . 75.23 109.704 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.498 HG11 ' HE3' ' A' ' 117' ' ' MET . 27.4 m -123.87 161.93 25.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 114.712 -1.131 . . . . 75.42 110.813 -177.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.2 t -94.42 129.28 41.22 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.763 -0.828 . . . . 71.31 108.763 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.94 170.32 17.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 120.963 0.411 . . . . 63.24 111.132 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.84 124.5 6.66 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.971 -0.852 . . . . 65.42 110.971 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.88 160.07 11.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 122.874 0.469 . . . . 74.22 110.117 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.4 t -120.73 127.07 75.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.467 -0.938 . . . . 73.22 108.467 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.606 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 28.2 mtp180 -68.79 135.63 51.5 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.011 -0.54 . . . . 72.03 110.676 -177.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.452 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 49.2 mt-10 -79.56 -5.73 55.55 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.07 -0.514 . . . . 74.32 109.748 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.12 -67.62 0.42 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.033 -0.985 . . . . 63.11 110.528 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -132.16 12.29 4.65 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.635 -1.166 . . . . 61.12 112.289 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.9 t 69.85 18.78 7.28 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.795 0.838 . . . . 75.31 113.133 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -88.21 149.96 23.56 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.855 -0.528 . . . . 71.2 110.923 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -95.02 147.53 23.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.122 0.487 . . . . 74.54 111.092 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.606 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.6 mtp -141.56 160.92 39.16 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 123.625 0.77 . . . . 52.23 110.329 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.16 130.88 51.91 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.552 -0.749 . . . . 73.45 110.779 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -142.83 174.02 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 73.33 110.402 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.21 149.46 23.53 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.445 -1.687 . . . . 73.32 106.445 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 6.7 t -150.35 172.09 15.95 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.085 -0.709 . . . . 74.45 109.085 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 95' ' ' TYR . 81.0 m-85 -120.91 108.89 14.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 123.452 0.47 . . . . 75.13 109.951 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.498 ' HE3' HG11 ' A' ' 98' ' ' VAL . 24.0 ptt? -112.42 155.87 23.49 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.093 -0.503 . . . . 53.11 109.728 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -69.56 129.44 39.68 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.461 -0.941 . . . . 74.44 108.461 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.447 HD12 ' H ' ' A' ' 119' ' ' ILE . 2.7 mp -72.65 -42.81 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.763 0.316 . . . . 64.34 111.762 -171.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -71.1 -36.91 72.36 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.136 -0.69 . . . . 63.14 109.136 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt 52.34 9.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.318 1.847 . . . . 74.41 114.908 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.96 14.14 4.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.386 0.513 . . . . 74.51 112.386 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.08 122.42 82.58 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 110.182 -0.303 . . . . 70.42 110.182 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.28 -5.96 18.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.587 2.191 . . . . 75.41 112.974 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -59.71 -53.3 59.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.305 0.574 . . . . 64.31 110.225 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 C--N 1.308 -1.214 0 CA-C-N 114.801 -1.091 . . . . 64.45 112.233 -175.256 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.53 ' O ' HG12 ' A' ' 144' ' ' ILE . 63.9 pttt . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 110.199 -0.297 . . . . 73.01 110.199 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.507 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 50.2 mtmt -48.58 -35.15 12.83 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.818 0.847 . . . . 73.31 112.589 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -58.96 -45.39 90.62 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.3 0.572 . . . . 73.25 110.826 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -76.12 -34.87 59.48 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.918 -0.771 . . . . 64.52 108.918 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.1 mm -61.43 -33.97 59.2 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.759 0 CA-C-N 115.081 -0.963 . . . . 75.34 110.193 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.3 mt-10 -54.15 -35.88 62.72 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.742 0.306 . . . . 72.51 110.843 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.9 m -70.6 -47.37 60.48 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 116.128 -0.487 . . . . 73.24 110.018 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -71.84 -30.51 65.53 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 113.238 0.829 . . . . 71.04 113.238 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.9 -42.87 80.69 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.981 -0.748 . . . . 74.43 108.981 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -70.92 -38.43 72.93 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.785 -1.098 . . . . 74.42 108.931 -177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.55 -41.08 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.754 -0.657 . . . . 61.03 110.355 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 70.9 mtm -67.79 -37.75 82.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.514 -0.312 . . . . 74.14 110.818 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -67.84 -31.29 71.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.806 0.336 . . . . 74.43 111.016 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.91 -47.1 55.04 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.354 -0.385 . . . . 63.32 111.459 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--N 1.326 -0.414 0 N-CA-C 112.617 0.599 . . . . 65.23 112.617 -176.206 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.411 -2.407 0 N-CA-C 108.4 -0.963 . . . . 73.21 108.4 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.432 ' O ' HG11 ' A' ' 79' ' ' VAL . 40.8 m-70 -115.15 159.56 20.76 Favored 'General case' 0 C--N 1.271 -2.848 0 N-CA-C 108.933 -0.765 . . . . 72.22 108.933 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -116.97 125.34 51.25 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.824 -1.176 . . . . 63.1 107.824 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.7 t -125.47 142.08 43.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 109.759 -0.46 . . . . 71.22 109.759 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.433 ' HB2' HG22 ' A' ' 113' ' ' VAL . 91.1 t80 -94.34 123.13 37.55 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.044 -1.095 . . . . 73.11 108.044 177.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.424 HG23 ' HB2' ' A' ' 26' ' ' PHE . 14.8 p -107.89 148.41 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 121.445 0.64 . . . . 72.33 110.609 -176.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -118.02 -59.75 1.87 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.175 -0.92 . . . . 74.43 113.046 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.22 -60.14 0.08 OUTLIER Glycine 0 C--N 1.336 0.564 0 C-N-CA 118.663 -1.732 . . . . 64.14 115.41 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.2 m -57.84 -24.34 56.98 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.388 0.884 . . . . 55.01 113.388 -172.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HB2' HG23 ' A' ' 22' ' ' VAL . 49.8 m-85 -132.0 25.13 4.61 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.723 -0.843 . . . . 70.23 108.723 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.46 -30.18 68.02 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.308 0.575 . . . . 63.32 112.478 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' HG12 ' A' ' 31' ' ' VAL . 31.0 t70 -96.65 130.89 29.3 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.893 -0.594 . . . . 72.4 111.334 -176.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.468 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 19.0 Cg_endo -60.24 -28.25 86.52 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.52 2.147 . . . . 52.24 113.692 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.441 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 22.0 t70 -70.52 -41.74 72.18 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.567 -0.453 . . . . 74.31 110.926 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 28' ' ' ASP . 9.8 p -65.92 -28.57 44.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 C-N-CA 119.887 -0.725 . . . . 64.43 109.33 177.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.481 HG22 HD21 ' A' ' 36' ' ' LEU . 37.5 mm -61.52 -46.75 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.598 -0.519 . . . . 75.41 109.598 175.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -60.89 -32.19 71.66 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.925 -0.58 . . . . 53.41 111.94 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.4 t -81.71 -38.91 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 120.636 -0.425 . . . . 74.33 111.59 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -74.75 -36.81 62.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.482 -0.326 . . . . 72.11 110.776 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.481 HD21 HG22 ' A' ' 32' ' ' ILE 0.275 0.4 OUTLIER -117.02 -60.78 1.8 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.169 -0.612 . . . . 52.51 111.987 176.764 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.43 ' OD2' ' HG2' ' A' ' 38' ' ' ARG . 30.5 t70 162.13 -50.99 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 124.597 1.159 . . . . 71.42 110.236 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 4.6 mmp_? -118.88 152.76 35.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.957 -0.565 . . . . 63.52 110.636 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.414 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 5.0 m -95.74 120.2 63.71 Favored Pre-proline 0 C--O 1.245 0.829 0 CA-C-N 116.647 -0.251 . . . . 75.23 111.009 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -67.47 152.71 78.26 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 122.77 2.313 . . . . 71.42 109.36 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.42 129.0 39.86 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.331 -0.547 . . . . 74.21 109.85 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 53.9 mt -110.28 124.93 67.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.495 -0.775 . . . . 73.14 109.226 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.478 HG22 ' HD2' ' A' ' 104' ' ' ARG . 14.0 p -116.41 146.56 20.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 109.007 -0.738 . . . . 74.4 109.007 177.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.6 m -81.44 124.29 29.31 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.627 -0.509 . . . . 65.12 109.627 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.83 159.49 42.13 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.171 0.51 . . . . 74.41 111.161 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.6 m -116.51 131.63 56.9 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.313 -0.858 . . . . 72.22 110.8 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.7 tp -99.3 99.9 9.27 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 123.984 0.913 . . . . 73.41 110.014 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 66.4 Cg_endo -78.3 143.29 19.65 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.149 1.9 . . . . 73.52 111.693 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.01 5.12 58.48 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 116.077 -0.511 . . . . 63.5 112.306 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.2 168.91 18.51 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 122.358 0.263 . . . . 72.21 110.43 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -139.94 164.7 29.31 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.12 -0.696 . . . . 71.32 109.12 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -130.97 126.41 35.95 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.434 -0.803 . . . . 71.44 110.676 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 37.4 m-85 -114.83 163.89 14.88 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.668 -0.696 . . . . 75.3 109.742 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.839 0 O-C-N 123.485 0.491 . . . . 71.11 111.235 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 N--CA 1.432 -1.373 0 N-CA-C 106.913 -1.514 . . . . 74.24 106.913 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 12.2 Cg_endo -59.57 120.79 8.82 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 107.752 -1.672 . . . . 71.22 107.752 166.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.5 p -132.82 160.32 37.25 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.962 0.411 . . . . 73.13 111.128 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mm -110.38 138.18 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.411 -0.959 . . . . 72.24 108.411 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.9 151.99 46.9 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 108.157 -1.053 . . . . 70.25 108.157 175.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.426 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 10.4 Cg_endo -58.53 134.67 62.59 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.645 2.23 . . . . 72.2 112.645 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.4 t -120.51 147.36 45.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.738 -0.838 . . . . 53.41 108.738 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.31 -37.83 68.85 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.341 0.4 . . . . 73.32 110.284 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -142.52 75.81 1.51 Allowed 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 108.751 -0.833 . . . . 72.12 108.751 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.55 168.63 28.52 Favored Glycine 0 C--N 1.287 -2.166 0 C-N-CA 119.538 -1.315 . . . . 53.24 112.68 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -154.51 141.47 19.24 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.64 -0.874 . . . . 64.32 108.64 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.07 119.16 59.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.308 -0.627 . . . . 64.33 109.308 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -89.85 116.07 27.65 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.979 -1.489 . . . . 65.45 106.979 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.86 -148.05 4.72 Favored Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 120.718 -0.753 . . . . 64.21 111.563 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.521 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 46.0 mmtm -127.12 147.11 50.18 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.692 0.282 . . . . 63.11 110.92 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 39.2 t -110.35 127.42 67.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 116.12 -0.491 . . . . 72.44 110.658 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.8 mt -95.32 103.99 15.86 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.347 -1.353 . . . . 73.02 107.347 177.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.6 ptp -109.4 138.63 45.47 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.881 -0.414 . . . . 71.32 109.881 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.81 13.93 26.36 Favored Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 119.462 -1.352 . . . . 73.55 111.743 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 18' ' ' HIS . 11.3 p -83.06 129.42 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.588 -0.893 . . . . 71.41 108.588 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 m -73.77 159.82 32.38 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 109.825 -0.435 . . . . 74.4 109.825 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 19.7 m -56.58 -42.32 78.47 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.25 0.463 . . . . 73.34 112.25 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.78 -41.46 99.26 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-O 120.843 0.354 . . . . 62.53 111.372 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.583 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 47.2 mt-10 -70.61 -28.21 64.68 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.269 -0.641 . . . . 72.31 109.269 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 81' ' ' SER . 55.2 tp -63.26 -47.15 83.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.496 -0.927 . . . . 63.24 108.496 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 88' ' ' ASP . 47.7 mt-10 -68.52 -29.15 67.67 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.056 -0.974 . . . . 73.12 110.173 176.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.583 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 2.3 t-20 -63.15 -45.97 89.39 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.498 1.119 . . . . 72.03 109.052 175.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.5 mt -64.2 -38.76 92.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.611 -0.722 . . . . 72.11 109.367 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 9.7 t70 -58.95 -47.2 85.95 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 115.486 -0.779 . . . . 52.32 110.425 173.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.62 -48.07 83.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.693 -0.685 . . . . 72.51 111.315 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.49 -57.99 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 N-CA-C 113.332 0.864 . . . . 52.12 113.332 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -79.84 -36.43 36.8 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.409 0.623 . . . . 65.12 111.825 -174.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.17 -17.16 22.75 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-N 115.098 -0.956 . . . . 44.41 115.113 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -58.98 -32.41 69.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 111.736 0.273 . . . . 75.11 111.736 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.51 0.51 4.03 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 111.629 0.233 . . . . 63.15 111.629 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -132.05 164.22 26.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.166 0.432 . . . . 64.32 112.166 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.7 tp10 -124.66 143.55 50.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.409 -0.589 . . . . 74.54 109.409 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' THR . 46.0 ttp180 -97.13 114.72 26.43 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.514 -0.55 . . . . 74.02 109.514 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.472 HG12 ' HE1' ' A' ' 117' ' ' MET . 22.8 m -116.75 162.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 115.731 -0.668 . . . . 74.03 112.002 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.7 p -86.13 121.9 29.38 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.892 -1.049 . . . . 65.45 109.932 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.57 166.08 29.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 115.88 -0.6 . . . . 62.2 112.091 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -118.95 127.72 7.35 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.023 -1.231 . . . . 38.4 110.023 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.01 161.0 16.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 117.096 0.448 . . . . 63.33 111.115 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.6 t -128.53 124.42 61.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.671 -0.862 . . . . 74.54 108.671 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.478 ' HD2' HG22 ' A' ' 43' ' ' VAL . 55.9 mtm180 -63.74 147.52 51.49 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.185 0.517 . . . . 75.25 112.387 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -82.73 -1.49 51.57 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.573 -1.194 . . . . 72.25 110.129 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.18 -59.23 3.01 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.564 -0.743 . . . . 72.41 111.616 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -140.83 5.82 1.98 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 119.788 -0.765 . . . . 75.31 111.415 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.8 t 69.77 78.04 0.2 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.212 0.945 . . . . 73.0 110.99 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -137.09 151.96 49.48 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.231 -1.396 . . . . 70.14 107.231 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -104.76 148.33 26.73 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.764 -0.774 . . . . 73.33 112.888 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.3 mtm -136.4 163.26 30.89 Favored 'General case' 0 CA--C 1.475 -1.935 0 CA-C-N 115.334 -0.848 . . . . 75.23 109.38 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.36 117.97 35.49 Favored 'General case' 0 C--N 1.268 -2.972 0 CA-C-N 114.837 -1.074 . . . . 40.54 109.581 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 21' ' ' PHE . 30.9 m -135.52 174.02 13.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.723 -0.473 . . . . 61.01 109.723 -176.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -116.96 154.24 31.21 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.058 -1.09 . . . . 72.51 108.058 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.2 t -146.02 171.57 14.67 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.182 -0.674 . . . . 73.14 109.182 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.2 m-85 -113.73 112.35 23.31 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.352 -0.61 . . . . 73.5 109.352 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.472 ' HE1' HG12 ' A' ' 98' ' ' VAL . 24.5 ptt? -112.95 158.15 20.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.703 -0.681 . . . . 62.45 109.834 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -66.76 124.82 23.98 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 107.797 -1.186 . . . . 73.41 107.797 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.21 -43.29 84.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 113.969 1.1 . . . . 62.43 113.969 -165.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -86.24 -9.69 56.03 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.245 -0.982 . . . . 63.34 110.657 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt 55.58 -27.15 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 118.136 2.643 . . . . 74.31 118.136 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -110.58 96.37 6.14 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.56 -0.712 . . . . 72.33 112.348 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -128.1 118.87 20.77 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.036 -0.984 . . . . 74.25 111.326 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.79 -15.87 44.95 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.622 2.215 . . . . 73.45 110.034 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.8 -41.71 87.37 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.205 -1.361 . . . . 75.4 112.409 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 20.3 ptt? . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 122.496 1.141 . . . . 64.34 113.451 -176.419 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.401 ' O ' HG12 ' A' ' 144' ' ' ILE . 87.0 tttt . . . . . 0 C--O 1.243 0.734 0 CA-C-O 120.709 0.29 . . . . 73.43 110.672 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 32.7 mmtp -48.99 -31.36 7.34 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.369 1.248 . . . . 73.41 114.369 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -54.58 -46.47 73.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.128 0.49 . . . . 72.34 110.849 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -76.29 -36.1 58.54 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.569 0.699 . . . . 72.43 109.205 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.484 ' HB ' ' HA ' ' A' ' 141' ' ' LYS . 50.7 mm -62.04 -33.21 57.22 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 CA-C-N 114.721 -1.127 . . . . 73.41 112.313 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 64.4 mm-40 -54.27 -36.22 63.39 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.045 0.45 . . . . 63.54 110.616 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 89.3 m -74.42 -42.74 58.66 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.403 -0.591 . . . . 74.03 109.403 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -67.75 -29.45 68.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 114.598 1.332 . . . . 72.24 114.598 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.622 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 99.3 mttt -53.38 -49.05 68.03 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 109.278 -0.638 . . . . 70.53 109.278 176.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -68.01 -36.24 79.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.206 -0.906 . . . . 72.34 110.55 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.3 -39.83 86.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.594 -0.73 . . . . 70.32 109.688 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 56.9 ttp -73.43 -38.53 65.49 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.508 -0.769 . . . . 74.52 110.599 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.622 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 52.1 mt-10 -62.85 -34.63 77.76 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.2 0.524 . . . . 74.53 110.592 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 46.9 t -65.91 -36.22 82.78 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.273 -0.876 . . . . 61.42 109.953 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 N--CA 1.448 -0.558 0 CA-C-N 116.223 -0.444 . . . . 71.21 111.887 -179.287 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 107.988 -1.116 . . . . 72.24 107.988 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.501 ' O ' HG11 ' A' ' 79' ' ' VAL . 54.3 m-70 -112.94 159.26 19.27 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 109.291 -0.633 . . . . 73.14 109.291 -171.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -123.25 125.74 45.64 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.408 -1.33 . . . . 74.03 107.408 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.5 t -129.64 140.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 110.329 -0.248 . . . . 71.01 110.329 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -94.27 123.79 37.88 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.764 -0.828 . . . . 74.44 108.764 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 74' ' ' LYS . 20.0 m -88.6 154.21 3.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.997 -0.547 . . . . 74.3 110.778 -176.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.412 ' CD2' HG12 ' A' ' 63' ' ' ILE . 1.5 p90 -135.46 -44.84 0.68 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.616 0.969 . . . . 71.12 113.616 -176.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.614 ' O ' ' HG2' ' A' ' 27' ' ' GLN . . . -146.43 -62.28 0.01 OUTLIER Glycine 0 C--O 1.219 -0.81 0 C-N-CA 119.611 -1.28 . . . . 51.53 112.667 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 p -60.81 -22.52 64.25 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 123.894 0.878 . . . . 65.05 112.813 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.403 ' HB3' HD11 ' A' ' 32' ' ' ILE . 25.3 m-85 -127.47 17.41 7.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.155 -0.475 . . . . 75.2 111.116 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 24' ' ' GLY . 16.7 pt20 -78.36 3.51 15.44 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 120.418 -0.513 . . . . 73.14 112.381 -175.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 31' ' ' VAL . 15.3 t70 -130.09 125.66 22.03 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.676 -176.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -62.25 -29.58 80.41 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.254 1.969 . . . . 72.23 113.478 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 14.9 t70 -64.9 -42.84 94.42 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.228 -0.295 . . . . 64.52 110.781 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 28' ' ' ASP . 8.3 p -67.97 -28.72 42.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 N-CA-C 109.263 -0.643 . . . . 75.44 109.263 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 28' ' ' ASP . 49.9 mm -64.82 -44.01 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 116.323 -0.399 . . . . 71.32 110.436 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -58.7 -35.56 72.83 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.933 0.397 . . . . 75.32 111.204 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -82.14 -47.44 19.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 116.218 -0.447 . . . . 71.13 112.168 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -62.82 -36.34 82.86 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.953 -0.388 . . . . 64.35 109.953 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.408 HD22 HG22 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -119.81 -73.02 0.66 Allowed 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 120.233 -0.587 . . . . 71.54 112.252 174.15 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.5 t70 169.24 -50.2 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.854 -0.795 . . . . 72.23 108.854 -174.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -106.76 150.25 26.5 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 114.898 -1.047 . . . . 65.13 109.938 -174.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 m -103.28 110.21 63.26 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 108.102 -1.073 . . . . 63.34 108.102 170.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.67 151.56 79.64 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 122.802 2.335 . . . . 73.23 110.009 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -56.81 132.76 53.26 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.844 -0.428 . . . . 75.33 109.844 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 27.2 mt -109.59 137.84 39.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.751 -0.658 . . . . 74.02 110.542 -172.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 14.4 p -130.66 147.07 33.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.961 -0.563 . . . . 73.52 109.952 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.4 m -75.99 123.31 25.54 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.581 -0.896 . . . . 72.02 108.581 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.52 155.86 46.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.503 0.668 . . . . 42.0 111.643 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.466 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 95.4 m -115.36 125.93 53.8 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.012 -0.994 . . . . 54.33 110.515 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.5 tp -99.37 100.77 11.16 Favored Pre-proline 0 C--N 1.299 -1.616 0 C-N-CA 123.026 0.53 . . . . 64.34 109.873 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.6 Cg_endo -81.63 136.0 9.42 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.899 2.4 . . . . 73.22 112.829 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.49 15.42 37.75 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.632 -0.713 . . . . 72.02 111.886 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.03 161.15 40.77 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.001 -0.74 . . . . 75.54 109.001 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.6 tp60 -140.33 140.91 35.71 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.272 0.558 . . . . 72.2 110.675 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.7 tpt85 -94.88 126.2 40.05 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.722 -1.126 . . . . 75.1 109.673 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -124.89 159.42 31.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.263 -0.643 . . . . 73.43 109.263 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HE ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.859 0 CA-C-O 119.344 -0.36 . . . . 75.13 111.451 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 N--CA 1.419 -2.009 0 N-CA-C 108.273 -1.01 . . . . 70.1 108.273 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -55.71 115.33 2.38 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.478 2.118 . . . . 63.22 109.621 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.1 p -132.33 159.67 38.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.278 0.473 . . . . 74.32 112.278 -174.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.412 HG12 ' CD2' ' A' ' 23' ' ' TYR . 45.4 mm -115.82 141.92 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.449 -0.945 . . . . 73.43 108.449 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.6 m -143.67 154.53 59.56 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 107.509 -1.293 . . . . 71.1 107.509 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.39 136.4 59.19 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.385 2.057 . . . . 74.12 112.789 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.3 t -124.86 144.06 50.51 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.217 -1.031 . . . . 72.12 108.217 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.07 -37.34 64.25 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.968 -0.382 . . . . 63.53 109.968 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 2.7 mppt? -131.68 75.22 1.63 Allowed 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.713 -0.477 . . . . 74.3 109.713 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.76 157.83 30.46 Favored Glycine 0 N--CA 1.42 -2.376 0 C-N-CA 119.566 -1.302 . . . . 64.21 111.584 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -147.65 150.59 34.67 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 107.688 -1.227 . . . . 73.55 107.688 175.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.9 t -112.05 127.65 69.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 109.159 -0.682 . . . . 63.22 109.159 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -99.1 115.54 29.24 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.919 -1.512 . . . . 73.24 106.919 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.412 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -149.55 -149.63 5.04 Favored Glycine 0 N--CA 1.411 -2.975 0 N-CA-C 110.27 -1.132 . . . . 73.32 110.27 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.493 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.7 mptm? -128.18 155.08 45.06 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.682 0.753 . . . . 71.21 112.655 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 31.2 t -113.38 132.72 61.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 114.262 -1.335 . . . . 74.05 112.067 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.404 HD21 HG12 ' A' ' 42' ' ' ILE . 85.9 mt -95.82 123.38 39.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.214 -1.402 . . . . 65.14 107.214 172.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 22.0 ptp -127.48 146.46 50.49 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 121.04 -0.264 . . . . 74.14 111.139 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.21 25.73 15.88 Favored Glycine 0 N--CA 1.43 -1.765 0 C-N-CA 119.572 -1.299 . . . . 54.24 111.622 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.501 HG11 ' O ' ' A' ' 18' ' ' HIS . 10.1 p -94.38 129.55 44.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 109.601 -0.518 . . . . 75.31 109.601 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.457 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 15.6 m -73.6 159.57 32.89 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 122.874 0.47 . . . . 63.22 110.64 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.3 m -55.4 -37.36 67.52 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.276 0.843 . . . . 73.2 113.276 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -58.92 -51.06 71.65 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 120.868 0.366 . . . . 63.55 110.719 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.646 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 2.3 mp0 -67.49 -28.13 67.58 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 115.937 -0.574 . . . . 71.2 110.516 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 18' ' ' HIS . 42.4 tp -63.6 -42.83 98.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.093 -0.706 . . . . 74.14 109.093 174.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.31 -31.88 69.4 Favored 'General case' 0 C--O 1.198 -1.624 0 CA-C-N 115.524 -0.762 . . . . 74.21 109.359 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.596 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 2.3 t-20 -61.11 -49.49 77.09 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.452 1.101 . . . . 65.31 109.832 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 86.1 mt -62.25 -42.43 99.32 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.819 -0.808 . . . . 73.45 108.819 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.2 -38.56 90.85 Favored 'General case' 0 C--O 1.205 -1.241 0 CA-C-N 114.68 -1.145 . . . . 72.13 110.402 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.63 -43.68 84.03 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.996 0.518 . . . . 62.11 110.762 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 86' ' ' ASN . 88.7 t -72.29 -58.3 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 116.221 -0.445 . . . . 70.23 111.941 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -79.88 -42.58 23.89 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.721 1.008 . . . . 75.33 113.721 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.52 -17.11 18.4 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 115.659 1.024 . . . . 73.13 115.659 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -63.37 -39.51 94.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.361 -0.607 . . . . 53.22 109.361 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.68 0.33 9.83 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.977 0.418 . . . . 73.43 111.533 -176.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -134.3 168.91 18.03 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.648 0.779 . . . . 73.4 109.97 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 15.7 pt-20 -122.8 137.33 54.96 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.937 -0.394 . . . . 71.44 109.937 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -87.76 112.78 22.78 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.309 -1.367 . . . . 73.04 107.309 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.494 HG13 ' HE2' ' A' ' 117' ' ' MET . 23.0 m -123.04 162.49 23.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 113.237 0.828 . . . . 75.13 113.237 -176.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.8 p -85.07 122.32 29.12 Favored 'General case' 0 N--CA 1.405 -2.716 0 CA-C-N 114.473 -1.239 . . . . 73.21 109.174 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.99 171.23 18.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.319 0.581 . . . . 73.13 111.732 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -123.9 129.2 7.16 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 109.871 -1.292 . . . . 37.42 109.871 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 111' ' ' MET . 2.8 pp -119.3 152.91 21.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 117.039 0.419 . . . . 52.42 111.199 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 63.7 t -110.81 114.82 48.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 108.708 -0.849 . . . . 50.33 108.708 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -65.56 112.51 3.64 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.394 -0.821 . . . . 71.22 109.747 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.9 -14.28 61.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.244 1.021 . . . . 75.23 108.815 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.66 -48.55 74.83 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.04 -1.891 . . . . 55.0 111.628 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -128.87 -15.21 4.37 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 121.955 -0.466 . . . . 73.21 111.754 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.8 m 77.15 73.24 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.705 1.202 . . . . 72.54 111.882 -176.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -155.01 153.16 30.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.11 1.364 . . . . 62.44 108.056 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 65.1 pttt -93.27 147.17 23.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.24 -0.984 . . . . 63.52 110.732 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.416 ' HB3' ' CD1' ' A' ' 102' ' ' ILE . 27.1 ttt -140.7 154.12 46.23 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 124.324 1.05 . . . . 70.53 108.85 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.47 130.09 46.5 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.825 0.345 . . . . 75.1 110.983 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.4 m -146.04 175.28 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.585 -0.894 . . . . 70.12 108.585 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.67 157.98 24.52 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.031 -0.729 . . . . 51.44 109.031 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.0 t -152.09 172.94 15.55 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.969 -0.752 . . . . 71.01 108.969 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 74.3 m-85 -114.77 122.07 45.25 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 123.584 0.553 . . . . 75.03 110.215 -177.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.494 ' HE2' HG13 ' A' ' 98' ' ' VAL . 24.6 ptt? -119.07 156.95 28.8 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.858 -0.61 . . . . 74.23 109.454 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 63.8 t-105 -67.49 135.27 52.79 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.871 -0.789 . . . . 74.11 108.871 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 96' ' ' GLU . 20.4 mm -68.96 -44.4 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 120.553 -0.459 . . . . 72.31 112.097 -170.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 122' ' ' ALA . 47.9 t30 -69.81 -32.49 70.97 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.135 0.493 . . . . 75.42 109.76 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.345 9.2 ptpp? 54.91 -1.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.637 2.088 . . . . 65.45 116.637 176.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 120' ' ' ASN . . . -127.85 83.85 2.2 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.628 -1.249 . . . . 74.1 107.628 172.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.41 ' HB3' ' HE2' ' A' ' 126' ' ' MET . 14.2 t70 -120.77 130.33 24.9 Favored Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 115.262 -0.881 . . . . 74.21 110.493 -176.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.49 2.7 8.2 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.89 2.393 . . . . 73.32 114.766 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.61 -34.5 11.39 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 121.834 -0.541 . . . . 63.03 111.653 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.41 ' HE2' ' HB3' ' A' ' 123' ' ' ASP 0.352 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.05 0 N-CA-C 114.478 1.288 . . . . 74.05 114.478 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.58 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.1 ttpt . . . . . 0 CA--C 1.508 -0.673 0 N-CA-C 109.309 -0.626 . . . . 75.3 109.309 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 51.4 tttm -50.68 -35.13 29.41 Favored 'General case' 0 C--O 1.217 -0.638 0 C-N-CA 124.074 0.95 . . . . 74.12 111.884 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -68.86 -33.73 74.28 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.241 0.544 . . . . 71.04 110.611 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -77.38 -35.62 54.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.307 -0.627 . . . . 64.41 109.307 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 140' ' ' LYS . 45.3 mm -64.05 -33.51 62.74 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.441 0 CA-C-N 115.253 -0.885 . . . . 62.35 110.379 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.0 mt-10 -54.27 -30.47 50.79 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 113.277 0.843 . . . . 73.12 113.277 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.1 m -64.34 -41.82 96.57 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 108.876 -0.787 . . . . 73.3 108.876 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -76.38 -28.66 56.83 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.446 -0.797 . . . . 71.33 113.003 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.666 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 27.2 mmmt -52.95 -44.26 66.96 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 123.229 0.331 . . . . 74.12 110.746 175.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.18 -43.76 82.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.76 0.791 . . . . 71.21 109.275 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.424 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 71.2 mt -66.72 -45.69 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 114.596 -1.183 . . . . 73.44 111.248 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' MET . . . . . 0.448 ' HG2' ' HA ' ' A' ' 148' ' ' LYS . 26.1 ptm -74.25 -32.29 62.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.88 0.696 . . . . 73.25 112.88 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.666 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 18.1 mm-40 -63.27 -39.33 94.28 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.45 -0.574 . . . . 73.4 109.45 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 81.9 m -69.23 -31.33 69.83 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.664 -0.698 . . . . 71.51 111.419 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 150' ' ' ILE . 98.4 mttt . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 121.577 0.703 . . . . 75.23 109.53 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 121.274 0.559 . . . . 64.2 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.9 m -146.35 18.38 1.36 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.775 -0.824 . . . . 72.12 108.775 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.5 p -84.37 -13.15 53.07 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.762 -1.108 . . . . 72.45 111.563 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.9 t70 65.07 89.06 0.1 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.622 0.769 . . . . 71.42 110.144 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.6 p -106.58 74.52 1.01 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 113.633 0.975 . . . . 65.23 113.633 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 mp -110.26 -63.59 1.37 Allowed 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.599 -1.182 . . . . 55.13 109.53 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -96.39 -10.05 28.52 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.506 -1.224 . . . . 74.24 109.245 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.4 mt -98.02 153.17 18.57 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.621 -1.627 . . . . 70.35 107.862 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.545 ' CG ' ' HG ' ' A' ' 84' ' ' LEU . 39.2 m-70 -121.39 160.6 23.75 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 116.249 -0.432 . . . . 75.34 111.078 -171.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -132.38 130.58 40.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.596 -0.729 . . . . 71.33 111.425 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.65 142.05 44.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.41 -0.814 . . . . 72.35 109.986 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -94.05 122.51 36.64 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.75 -1.204 . . . . 74.52 107.75 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.4 m -97.51 161.33 2.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.208 0.527 . . . . 54.15 112.361 -176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.468 ' HA ' ' NH2' ' A' ' 52' ' ' ARG . 9.1 p90 -144.08 -60.2 0.39 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.177 0.806 . . . . 75.2 113.177 -172.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.0 -101.62 2.5 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 119.928 -1.129 . . . . 54.43 113.461 -175.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 t -59.31 -36.61 75.94 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.828 0.851 . . . . 65.34 112.644 -173.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -92.25 17.38 9.77 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.65 0.982 . . . . 73.12 113.65 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -85.67 7.16 24.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 119.576 -0.85 . . . . 70.25 109.988 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.529 ' O ' HG12 ' A' ' 32' ' ' ILE . 19.0 t70 -119.74 127.36 26.45 Favored Pre-proline 0 C--N 1.305 -1.359 0 CA-C-N 115.87 -0.605 . . . . 73.24 109.849 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.45 -25.26 30.18 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.102 1.868 . . . . 72.4 113.504 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.59 -41.18 84.5 Favored 'General case' 0 C--N 1.312 -1.034 0 O-C-N 121.817 -0.552 . . . . 72.15 110.819 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 28' ' ' ASP . 11.2 p -68.45 -28.65 41.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.416 -0.587 . . . . 71.54 109.416 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 28' ' ' ASP . 48.7 mm -67.09 -47.04 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 116.308 -0.405 . . . . 62.22 110.394 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.521 ' ND2' ' HG1' ' A' ' 39' ' ' THR . 49.2 m-80 -57.28 -35.26 69.56 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.059 0.457 . . . . 64.14 111.691 176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.1 t -81.76 -47.44 19.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.069 0.396 . . . . 75.1 112.069 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.542 ' HE1' ' OD1' ' A' ' 86' ' ' ASN . 7.9 tmm? -64.91 -35.9 82.63 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 110.321 -0.252 . . . . 53.33 110.321 -174.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.464 HD22 HG22 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -115.38 -72.82 0.67 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 120.16 -0.616 . . . . 71.44 112.095 174.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.2 t70 179.26 -49.48 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.453 0.644 . . . . 72.12 109.892 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.411 ' O ' HG23 ' A' ' 32' ' ' ILE . 99.4 mtt180 -128.81 173.06 10.69 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 115.262 -0.881 . . . . 71.54 109.155 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.521 ' HG1' ' ND2' ' A' ' 33' ' ' ASN . 36.7 m -120.95 111.59 34.05 Favored Pre-proline 0 N--CA 1.433 -1.322 0 O-C-N 123.579 0.549 . . . . 75.34 110.336 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.36 152.71 14.92 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 124.262 3.308 . . . . 73.52 111.565 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.03 125.87 23.44 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.358 -0.608 . . . . 62.32 109.358 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.4 mt -102.11 137.29 30.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.592 -0.731 . . . . 74.4 109.651 -174.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.469 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 7.3 p -130.1 143.69 40.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.634 -0.712 . . . . 72.33 110.145 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.2 m -77.0 125.81 29.93 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.986 -1.116 . . . . 71.21 107.986 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.07 156.63 47.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.404 0.621 . . . . 73.4 111.07 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 71.4 m -114.61 125.39 53.7 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.205 -0.907 . . . . 75.34 110.149 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.19 100.29 14.94 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 116.049 -0.523 . . . . 73.13 109.644 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 46' ' ' THR . 3.0 Cg_endo -83.85 136.87 7.33 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.5 2.133 . . . . 73.33 111.838 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.33 11.09 53.0 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.566 -0.825 . . . . 38.42 111.755 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.428 ' HA ' ' H ' ' A' ' 66' ' ' SER . 86.1 m-85 -141.67 159.68 41.72 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 108.855 -0.795 . . . . 73.2 108.855 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -140.21 141.71 35.91 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.773 -0.455 . . . . 64.04 109.773 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 38.6 ttm180 -102.79 137.53 40.88 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.192 -1.04 . . . . 74.33 108.192 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 10.2 m-85 -108.79 167.52 10.01 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 107.505 -1.294 . . . . 72.5 107.505 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.421 ' HD2' ' HA ' ' A' ' 130' ' ' TRP . 12.0 ptm180 -135.85 141.72 44.69 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.489 -0.885 . . . . 73.34 111.965 -172.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.424 HD21 ' HB3' ' A' ' 59' ' ' LEU . 42.2 tp 176.09 162.15 0.34 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.526 -1.287 . . . . 70.34 107.526 176.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -150.13 136.35 18.78 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.49 -0.559 . . . . 73.32 109.49 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.59 -77.78 0.39 Allowed Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.651 -0.98 . . . . 73.44 110.651 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -49.25 6.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.481 -1.674 . . . . 74.42 106.481 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.424 ' HB3' HD21 ' A' ' 55' ' ' LEU . 28.2 tp -125.18 164.69 19.72 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.074 -0.713 . . . . 65.41 109.074 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -127.27 173.85 4.9 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 108.59 -0.892 . . . . 74.51 108.59 -170.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 52.8 Cg_exo -58.95 117.8 4.59 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.064 1.842 . . . . 44.13 110.825 175.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 26.3 p -115.47 168.47 9.97 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.097 -0.502 . . . . 61.42 110.663 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 mm -123.04 119.97 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.615 -0.513 . . . . 74.12 109.615 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.11 146.06 59.91 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 110.455 -0.202 . . . . 64.41 110.455 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.59 111.79 1.27 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.121 2.547 . . . . 72.42 112.911 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.428 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 34.0 t -126.25 116.5 21.36 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.582 -0.895 . . . . 61.15 108.582 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -60.74 -32.07 71.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.366 0.603 . . . . 73.51 111.328 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -95.62 7.11 47.22 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.771 -0.65 . . . . 74.43 112.012 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.77 167.66 14.49 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 119.578 -1.296 . . . . 72.42 114.03 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 144.07 23.23 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.111 1.365 . . . . 72.24 107.733 175.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.8 t -113.06 119.67 61.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.392 -0.596 . . . . 73.02 109.392 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -93.22 116.05 28.64 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.761 -1.57 . . . . 63.25 106.761 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.51 -158.05 7.6 Favored Glycine 0 N--CA 1.418 -2.521 0 N-CA-C 110.732 -0.947 . . . . 74.1 110.732 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.401 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 13.8 mptt -124.41 148.65 47.44 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.435 0.636 . . . . 63.31 111.948 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.6 t -111.04 130.94 63.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.549 -1.205 . . . . 73.44 111.334 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 77.5 mt -96.71 108.89 21.6 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.452 -1.314 . . . . 70.1 107.452 174.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.4 ptp -115.64 137.38 52.13 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.29 0.567 . . . . 74.24 112.47 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.91 25.01 7.37 Favored Glycine 0 N--CA 1.427 -1.933 0 CA-C-N 114.982 -1.008 . . . . 44.13 111.568 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.1 p -88.57 142.23 13.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 110.2 -0.296 . . . . 74.11 110.2 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -73.72 161.4 30.29 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 123.836 0.854 . . . . 75.42 112.358 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.2 m -68.87 -35.36 76.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.419 1.266 . . . . 71.3 114.419 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -63.61 -43.74 96.0 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.472 0.653 . . . . 75.23 109.986 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.573 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 9.5 mp0 -69.81 -36.31 75.53 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.776 -1.102 . . . . 75.32 109.843 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.545 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.4 tm? -60.52 -43.73 96.8 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.757 -0.46 . . . . 74.24 109.757 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -71.95 -32.27 67.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.969 0.414 . . . . 73.23 110.863 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.542 ' OD1' ' HE1' ' A' ' 35' ' ' MET . 0.1 OUTLIER -65.58 -38.32 89.18 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.14 -0.482 . . . . 74.4 110.887 177.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 96.9 mt -62.23 -42.03 98.94 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.168 -0.678 . . . . 64.45 109.168 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -64.13 -36.06 82.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.348 -0.842 . . . . 63.11 110.417 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.66 -45.37 71.93 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.619 -0.719 . . . . 75.24 110.845 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.79 -51.45 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.918 -0.583 . . . . 73.23 112.368 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.94 -29.23 55.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.909 0.385 . . . . 75.21 111.607 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.62 -17.57 27.52 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 114.717 0.647 . . . . 38.42 114.717 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -59.95 -31.7 70.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.837 0.351 . . . . 71.31 111.515 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.471 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 9.8 pt-20 -142.07 6.21 1.75 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.383 0.512 . . . . 71.04 112.383 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.471 ' CD2' ' HG3' ' A' ' 94' ' ' GLU . 95.4 m-85 -138.08 168.26 20.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.175 -0.466 . . . . 71.52 110.881 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -124.69 145.47 49.66 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.576 -0.898 . . . . 64.0 108.576 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -87.62 113.85 23.69 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.93 -0.767 . . . . 75.51 108.93 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.518 HG12 ' HE3' ' A' ' 117' ' ' MET . 33.6 m -125.34 161.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 116.054 -0.521 . . . . 73.42 111.477 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.0 t -98.97 136.27 39.18 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.185 -0.672 . . . . 75.45 109.185 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.3 m -138.7 165.18 24.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 116.397 -0.365 . . . . 75.23 110.685 -177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.14 120.31 6.14 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.691 -0.964 . . . . 71.15 110.691 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.24 152.04 17.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 122.308 0.243 . . . . 71.41 110.719 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.7 t -113.6 131.28 65.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 110.132 -0.322 . . . . 64.14 110.132 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.444 ' CZ ' HG22 ' A' ' 43' ' ' VAL . 11.0 mmm180 -58.61 124.41 19.57 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.778 0.831 . . . . 74.31 109.276 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.67 8.38 12.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.926 0.87 . . . . 54.32 109.842 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.62 -66.33 0.91 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.812 -1.551 . . . . 71.41 106.812 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -99.53 -108.55 0.2 Allowed 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.606 -0.887 . . . . 63.13 108.606 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 57.9 m -159.67 19.31 0.17 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 126.424 1.89 . . . . 74.41 106.28 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -77.33 143.97 38.37 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 114.846 -1.07 . . . . 72.03 110.472 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.549 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -108.04 147.09 31.63 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.909 -0.774 . . . . 73.52 108.909 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 88.1 mtp -141.02 161.06 38.74 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 123.645 0.778 . . . . 63.23 110.333 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -112.71 120.01 40.06 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.228 -0.897 . . . . 73.31 109.328 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.2 173.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 110.106 -0.331 . . . . 74.51 110.106 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -96.6 155.01 16.95 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.128 -0.693 . . . . 61.42 109.128 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.8 t -155.36 172.0 18.94 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.509 -1.663 . . . . 74.22 106.509 174.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -111.83 119.69 39.45 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.948 -0.76 . . . . 70.14 108.948 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.518 ' HE3' HG12 ' A' ' 98' ' ' VAL . 42.5 ttp -105.8 145.51 31.08 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.029 -0.987 . . . . 74.3 110.196 -173.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.495 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 71.8 t-105 -72.21 124.81 25.82 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.899 -1.149 . . . . 72.21 107.899 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -72.36 -41.27 65.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 114.797 -1.092 . . . . 75.31 111.603 -171.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -81.22 102.5 10.39 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-O 121.147 0.498 . . . . 61.14 109.947 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -75.03 -28.41 60.45 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.347 0.499 . . . . 74.42 112.347 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.3 93.86 4.78 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.588 -0.893 . . . . 41.01 108.588 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.459 ' HB3' ' HE3' ' A' ' 126' ' ' MET . 14.3 t70 -137.93 126.13 14.22 Favored Pre-proline 0 C--N 1.308 -1.212 0 C-N-CA 121.041 -0.263 . . . . 75.14 110.788 -175.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -87.5 -9.67 5.74 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.515 2.143 . . . . 73.5 113.819 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -80.96 -34.9 32.82 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 120.91 0.386 . . . . 44.34 111.016 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.459 ' HE3' ' HB3' ' A' ' 123' ' ' ASP . 26.4 ptt? -77.49 -11.05 59.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.11 -0.495 . . . . 74.12 111.497 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -58.79 105.4 0.3 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.952 0.723 . . . . 75.33 112.952 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.71 147.53 12.13 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 108.059 -2.016 . . . . 53.22 108.059 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.23 127.4 33.6 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 117.967 0.883 . . . . 62.45 110.237 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.421 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 11.1 t90 -77.22 155.54 32.12 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.963 -0.562 . . . . 75.14 110.126 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -49.82 -46.62 51.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.994 0.918 . . . . 71.33 109.99 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -64.12 -31.77 73.09 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 114.968 -1.015 . . . . 74.13 113.438 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -67.64 -45.67 74.65 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.91 -0.404 . . . . 64.04 109.91 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.523 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 8.5 tp10 -64.38 -43.26 95.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.381 -0.827 . . . . 73.31 108.917 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -67.09 -37.72 84.45 Favored 'General case' 0 C--O 1.198 -1.627 0 CA-C-N 115.959 -0.564 . . . . 73.2 111.182 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -55.88 -31.92 63.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.064 0.946 . . . . 71.2 110.384 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 53.3 ttt180 -65.68 -51.98 55.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.973 -1.012 . . . . 73.31 111.308 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.25 -19.59 50.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.558 0.694 . . . . 74.43 110.66 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.88 -24.42 64.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.185 -0.916 . . . . 75.42 109.28 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.589 ' O ' HG12 ' A' ' 144' ' ' ILE . 6.0 ttpm? -60.15 -41.92 93.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.52 -0.763 . . . . 75.54 109.559 175.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 38.7 ttpt -57.28 -31.26 65.44 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.647 -0.706 . . . . 70.13 111.499 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.5 -37.16 82.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.453 -0.34 . . . . 73.0 110.381 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.612 ' O ' HG23 ' A' ' 146' ' ' THR . 92.9 m-85 -76.76 -39.23 52.39 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 109.029 -0.73 . . . . 74.43 109.029 175.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.2 mm -60.22 -33.03 52.11 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.859 0 CA-C-N 115.216 -0.902 . . . . 74.44 110.953 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 148' ' ' LYS . 63.1 mm-40 -51.36 -39.27 56.75 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.246 0.832 . . . . 72.55 113.246 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 143' ' ' PHE . 15.2 t -74.9 -29.06 60.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 119.675 -0.81 . . . . 73.32 109.493 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.418 ' CD1' HD11 ' A' ' 150' ' ' ILE . 22.7 m-85 -76.41 -35.12 58.75 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 116.121 -0.491 . . . . 72.35 112.239 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.477 ' HG3' HG21 ' A' ' 144' ' ' ILE . 57.3 mtpt -55.66 -31.07 62.05 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 123.96 0.787 . . . . 73.53 112.107 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 14.1 ptmm? -75.05 -34.57 61.86 Favored 'General case' 0 C--O 1.206 -1.198 0 C-N-CA 118.209 -1.397 . . . . 75.34 109.723 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.418 HD11 ' CD1' ' A' ' 147' ' ' PHE . 64.8 mt -55.52 -29.62 24.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 C-N-CA 124.819 1.247 . . . . 51.24 112.884 -176.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -54.82 -26.01 32.2 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.503 0.557 . . . . 73.32 112.503 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 149' ' ' LYS . 13.9 pt-20 -57.08 -40.96 77.93 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.084 0.469 . . . . 72.11 110.896 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 50.6 t -71.79 -31.83 67.0 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.556 0.693 . . . . 74.21 109.771 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -75.71 -44.4 42.19 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.069 -0.969 . . . . 72.41 111.292 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -177.72 -42.01 0.01 OUTLIER 'General case' 0 C--O 1.239 0.522 0 N-CA-C 112.542 0.571 . . . . 71.53 112.542 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -140.33 116.25 7.81 Favored Pre-proline 0 C--N 1.309 -1.165 0 C-N-CA 120.393 -0.523 . . . . 65.13 111.478 -171.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.34 130.19 26.2 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.796 2.331 . . . . 72.45 110.99 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.631 HE21 ' HA ' ' A' ' 158' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.005 0 CA-C-O 120.586 0.231 . . . . 73.3 111.063 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.421 -1.879 0 N-CA-C 109.241 -0.652 . . . . 44.31 109.241 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.0 t -116.09 108.37 16.1 Favored 'General case' 0 N--CA 1.404 -2.73 0 N-CA-C 108.514 -0.921 . . . . 73.02 108.514 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 m -70.64 -37.03 73.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.899 -0.591 . . . . 73.2 110.556 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 60.22 107.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.983 1.475 . . . . 65.4 114.983 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -154.24 154.94 34.31 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.37 -1.345 . . . . 60.03 107.37 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.58 -15.76 62.79 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 115.242 1.571 . . . . 75.32 115.242 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -90.18 2.46 55.33 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.491 0.663 . . . . 62.22 110.97 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.1 mt -90.78 146.59 23.84 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.431 -0.804 . . . . 72.25 110.286 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.437 ' O ' HG12 ' A' ' 79' ' ' VAL . 35.7 m-70 -117.39 161.43 19.57 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.341 -0.845 . . . . 72.34 110.606 -173.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -122.65 127.1 48.9 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.471 -0.937 . . . . 72.23 108.471 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.0 t -125.86 137.94 56.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 116.878 -0.147 . . . . 73.45 110.668 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.452 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.0 t80 -94.72 122.42 37.31 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.589 -1.263 . . . . 73.24 107.589 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.2 m -111.43 123.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.738 0.78 . . . . 74.43 111.598 -175.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -77.85 -40.43 40.29 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.869 -1.059 . . . . 71.11 113.46 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.84 -40.66 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 118.814 -1.66 . . . . 74.43 113.539 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.6 m -58.02 -27.79 63.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.736 0.643 . . . . 74.44 112.736 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.455 ' O ' HD12 ' A' ' 32' ' ' ILE . 40.9 m-85 -134.5 28.37 3.66 Favored 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 110.053 -0.351 . . . . 74.44 110.053 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -78.04 -19.11 54.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.103 0.779 . . . . 73.43 113.103 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.518 ' O ' HG22 ' A' ' 31' ' ' VAL . 23.3 t70 -105.47 130.43 23.09 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.193 -0.299 . . . . 62.14 110.193 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.92 -25.57 78.17 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.941 2.427 . . . . 60.22 114.742 -175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.06 -43.15 93.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.064 0.459 . . . . 73.31 110.598 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 28' ' ' ASP . 23.4 m -71.28 -28.1 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 115.753 -0.658 . . . . 74.4 110.715 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.466 HG22 HD23 ' A' ' 36' ' ' LEU . 48.4 mm -62.98 -51.69 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 122.699 0.4 . . . . 74.14 111.631 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -57.73 -32.61 67.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.168 0.509 . . . . 60.23 111.641 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.0 t -82.02 -43.74 19.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.932 -0.576 . . . . 45.52 112.034 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.7 tmm? -70.97 -37.35 72.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.631 -0.259 . . . . 45.51 110.562 -173.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.466 HD23 HG22 ' A' ' 32' ' ' ILE 0.261 0.6 OUTLIER -115.05 -67.26 1.01 Allowed 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.903 -0.719 . . . . 74.52 112.378 176.797 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.1 t70 172.11 -50.01 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.092 0.472 . . . . 73.32 109.932 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -123.98 160.55 27.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.934 -0.576 . . . . 73.31 109.671 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.443 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 32.1 m -107.28 106.19 57.72 Favored Pre-proline 0 N--CA 1.436 -1.135 0 O-C-N 123.388 0.43 . . . . 70.25 110.441 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.58 152.25 63.57 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 123.394 2.73 . . . . 74.15 110.155 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -56.43 129.12 39.27 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.094 0.473 . . . . 73.55 110.174 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 32.2 mt -103.62 136.22 37.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.149 -0.686 . . . . 42.02 109.149 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.494 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 15.0 p -129.86 146.99 33.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 116.021 -0.536 . . . . 71.0 110.323 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -75.69 124.25 26.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.351 -0.981 . . . . 72.22 108.351 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.4 158.66 43.57 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.615 0.722 . . . . 75.22 112.33 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.1 m -118.5 132.03 56.23 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.129 -0.941 . . . . 75.21 109.34 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.3 tp -104.4 101.85 29.82 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 109.385 -0.598 . . . . 71.14 109.385 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.1 138.13 9.99 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.702 2.268 . . . . 75.34 111.814 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.04 9.45 53.95 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.892 -0.67 . . . . 38.11 111.721 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.507 ' HE2' ' SD ' ' A' ' 117' ' ' MET . 93.3 m-85 -143.12 152.75 42.17 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -139.98 147.09 39.95 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.993 -0.743 . . . . 60.32 108.993 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -100.26 132.23 45.75 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.153 -0.684 . . . . 62.24 109.153 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.9 m-30 -107.71 134.95 49.94 Favored 'General case' 0 CA--C 1.472 -2.032 0 N-CA-C 107.195 -1.409 . . . . 74.5 107.195 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -115.68 126.2 53.81 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.195 -1.002 . . . . 75.01 112.368 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -171.53 125.47 0.61 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.267 -2.494 . . . . 73.34 104.267 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -120.41 112.31 18.83 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.803 -0.759 . . . . 73.52 111.134 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.19 -93.9 0.1 Allowed Glycine 0 C--N 1.292 -1.908 0 N-CA-C 109.517 -1.433 . . . . 64.43 109.517 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.44 ' C ' ' HD2' ' A' ' 58' ' ' ARG . 1.4 ppt_? -92.8 -15.08 26.96 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.967 -1.123 . . . . 73.03 107.967 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.43 HD12 ' H ' ' A' ' 60' ' ' TYR . 45.1 tp -125.71 165.08 19.27 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 113.959 -1.473 . . . . 73.54 108.594 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.43 ' H ' HD12 ' A' ' 59' ' ' LEU . 47.7 m-85 -115.96 169.61 6.78 Favored Pre-proline 0 C--N 1.296 -1.722 0 N-CA-C 107.318 -1.364 . . . . 73.44 107.318 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 34.8 Cg_exo -63.71 94.14 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.957 1.772 . . . . 73.1 111.554 174.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 14.3 p -97.0 167.46 11.06 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 124.604 1.161 . . . . 71.2 112.3 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.5 mm -104.48 139.68 24.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 N-CA-C 108.642 -0.873 . . . . 74.12 108.642 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.68 152.66 60.18 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.499 -0.926 . . . . 72.41 108.499 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.486 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 27.8 Cg_endo -65.54 123.51 11.53 Favored 'Trans proline' 0 C--O 1.249 1.032 0 C-N-CA 122.494 2.129 . . . . 72.51 112.063 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 t -125.14 142.07 51.72 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.364 -0.976 . . . . 71.13 108.364 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.04 -36.38 66.92 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.255 -0.578 . . . . 64.51 111.652 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -109.49 2.81 20.73 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.396 -0.365 . . . . 73.32 111.755 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.11 156.87 21.42 Favored Glycine 0 N--CA 1.434 -1.484 0 C-N-CA 120.067 -1.063 . . . . 52.42 114.374 -174.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 142.66 29.72 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 124.574 1.15 . . . . 55.25 108.056 175.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 54.6 t -113.65 133.68 58.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 109.513 -0.551 . . . . 63.0 109.513 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -107.28 116.76 32.5 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.279 -1.008 . . . . 74.14 108.279 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.456 ' C ' ' HD3' ' A' ' 74' ' ' LYS . . . -148.95 -154.86 6.48 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 110.987 -0.845 . . . . 65.21 110.987 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.456 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 3.2 mppt? -122.82 150.45 42.82 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 113.218 0.821 . . . . 65.41 113.218 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 44.1 t -110.94 129.16 66.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 114.091 -1.413 . . . . 73.13 111.207 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.6 mt -95.7 109.28 21.58 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.078 -1.452 . . . . 75.23 107.078 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.9 ptp -113.3 127.43 56.15 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.651 0.739 . . . . 75.33 112.36 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 111.36 28.88 3.63 Favored Glycine 0 C--N 1.292 -1.874 0 CA-C-N 114.678 -1.146 . . . . 55.14 111.668 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 18' ' ' HIS . 13.0 p -92.2 132.63 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 109.349 -0.612 . . . . 64.25 109.349 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -73.54 158.56 34.62 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 110.0 -0.37 . . . . 52.53 110.0 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.2 m -62.17 -35.36 78.59 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.265 0.468 . . . . 72.55 112.265 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.86 -36.45 84.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.22 0.533 . . . . 63.44 110.673 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.422 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 4.4 mm-40 -77.49 -30.54 53.13 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 108.056 -1.09 . . . . 74.32 108.056 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.8 -41.7 95.59 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.82 -0.807 . . . . 71.12 108.82 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.22 -29.76 70.08 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.614 -0.721 . . . . 74.42 110.047 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -72.2 -42.16 66.13 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.771 -0.65 . . . . 61.11 111.663 177.136 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.0 mt -61.67 -41.95 98.25 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.193 -1.04 . . . . 71.2 108.193 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.433 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 30.9 t70 -65.58 -30.9 71.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.897 -1.501 . . . . 64.42 110.813 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.65 -41.69 53.43 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.934 -0.575 . . . . 61.32 110.529 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.0 t -72.99 -58.31 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 113.013 0.746 . . . . 72.41 113.013 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.68 -23.6 45.57 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.933 -0.479 . . . . 73.54 111.847 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.41 -15.82 18.36 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 114.941 -1.027 . . . . 64.43 115.246 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -57.0 -41.72 78.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.381 0.59 . . . . 73.3 111.618 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -132.42 -0.83 3.57 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.84 0.682 . . . . 61.2 112.84 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -121.53 167.45 12.85 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.281 -1.007 . . . . 73.52 108.281 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.42 ' HB3' HD13 ' A' ' 119' ' ' ILE . 9.9 tp10 -127.84 152.35 47.93 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.308 -0.997 . . . . 74.31 108.308 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -87.84 112.59 22.64 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.776 -0.824 . . . . 61.11 108.776 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.474 HG12 ' HE3' ' A' ' 117' ' ' MET . 26.8 m -115.42 158.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.823 -0.626 . . . . 73.11 110.082 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 t -96.49 132.53 41.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.411 -0.589 . . . . 73.52 109.411 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.65 167.13 24.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 116.147 -0.479 . . . . 72.12 112.063 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.62 127.14 7.57 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 110.663 -0.975 . . . . 71.43 110.663 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -119.98 163.79 17.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 122.538 0.335 . . . . 70.24 111.094 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 59.1 t -120.33 126.37 75.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.039 -0.726 . . . . 73.22 109.039 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.69 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 22.4 mtp180 -73.16 116.11 13.31 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.915 -0.584 . . . . 63.05 110.234 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -79.08 -0.84 33.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 122.451 1.12 . . . . 75.32 108.746 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -67.27 -30.46 70.34 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.319 -1.764 . . . . 71.44 109.193 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.429 ' HB2' ' H ' ' A' ' 108' ' ' SER . 13.8 m-80 -137.41 -95.99 0.21 Allowed 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.238 -1.023 . . . . 74.41 108.238 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.429 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 67.6 m -175.83 27.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.319 -2.104 . . . . 62.51 105.319 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.25 143.92 41.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.141 -0.936 . . . . 72.12 111.633 -170.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 21.9 ptmt -96.19 148.88 22.26 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.879 -0.6 . . . . 74.15 111.616 -176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.69 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.2 mtp -143.65 161.05 39.54 Favored 'General case' 0 CA--C 1.484 -1.576 0 C-N-CA 123.83 0.852 . . . . 73.12 111.325 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.8 129.79 54.6 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 114.636 -1.165 . . . . 72.54 108.932 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.452 HG21 ' HB2' ' A' ' 21' ' ' PHE . 34.1 m -143.93 174.52 4.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.865 -0.791 . . . . 64.12 108.865 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -115.34 152.71 32.3 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.926 -0.71 . . . . 73.12 109.631 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 t -148.3 172.89 13.65 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.534 -0.543 . . . . 62.23 109.534 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -117.42 109.16 16.43 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.07 -0.514 . . . . 74.54 109.826 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.507 ' SD ' ' HE2' ' A' ' 50' ' ' PHE . 24.2 ptt? -111.56 156.6 21.5 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.622 -0.717 . . . . 74.41 109.677 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -69.4 116.62 10.03 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.284 -1.376 . . . . 75.34 107.284 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.42 HD13 ' HB3' ' A' ' 96' ' ' GLU . 47.7 mm -73.7 -41.53 54.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 113.009 0.744 . . . . 74.44 113.009 -171.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -61.77 -35.38 77.98 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.186 -0.672 . . . . 74.41 109.186 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.264 9.7 ptpp? 58.16 -37.04 0.05 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 127.721 2.408 . . . . 75.33 115.908 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.01 85.69 4.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.551 0.691 . . . . 63.34 110.952 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -132.25 105.96 13.49 Favored Pre-proline 0 CA--C 1.486 -1.501 0 CA-C-N 115.067 -0.97 . . . . 75.23 110.507 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.42 -17.54 58.31 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.66 2.24 . . . . 72.33 110.801 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.47 -36.51 78.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.023 -0.989 . . . . 72.33 111.159 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.16 135.98 48.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.452 -0.499 . . . . 73.24 111.311 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -171.69 128.49 0.64 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.738 -0.838 . . . . 70.33 108.738 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 168.16 137.78 2.32 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 109.209 -1.557 . . . . 51.43 109.209 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -85.03 130.94 34.53 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.208 -1.034 . . . . 73.44 108.208 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 25.6 t90 -78.66 156.36 29.05 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.472 -0.936 . . . . 70.03 108.472 178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -78.59 79.12 5.03 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.575 0.702 . . . . 71.23 112.412 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -73.5 -32.47 64.29 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.213 -0.903 . . . . 73.52 108.607 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -58.67 -37.73 76.66 Favored 'General case' 0 N--CA 1.417 -2.085 0 C-N-CA 125.245 1.418 . . . . 64.03 109.511 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 6.1 tp10 -66.44 -40.43 89.47 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.017 -0.538 . . . . 72.42 109.733 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -73.01 -35.9 66.89 Favored 'General case' 0 C--O 1.2 -1.542 0 C-N-CA 119.572 -0.851 . . . . 72.12 110.401 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.8 -31.64 69.89 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.292 0.567 . . . . 71.35 109.802 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 17.1 tpp180 -62.51 -53.37 55.75 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.168 -0.924 . . . . 74.24 110.05 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 134' ' ' GLU . 8.2 mp -74.3 -16.43 60.93 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.407 -1.269 . . . . 64.43 110.778 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -67.63 -6.63 21.3 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.49 -1.232 . . . . 63.12 111.517 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.565 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.0 ttpt -57.03 -34.65 68.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.79 -0.819 . . . . 74.21 108.79 172.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 64.6 tttp -59.53 -35.47 74.26 Favored 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.54 -0.755 . . . . 75.22 112.153 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -55.6 -47.99 75.62 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.359 1.076 . . . . 54.01 108.548 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -66.57 -39.64 88.56 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.273 -1.785 . . . . 73.23 108.993 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 140' ' ' LYS . 28.6 mm -72.56 -40.95 63.49 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.332 0 CA-C-N 116.133 -0.485 . . . . 75.1 110.292 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 28.2 mm-40 -61.78 -34.08 75.23 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.972 0.415 . . . . 71.24 110.017 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.535 ' O ' HG13 ' A' ' 150' ' ' ILE . 86.9 m -65.39 -48.18 73.76 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.595 -0.73 . . . . 75.52 109.261 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -70.77 -30.12 66.53 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.155 0.798 . . . . 71.33 113.155 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.44 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 ttpt -55.66 -45.77 77.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.588 -1.264 . . . . 71.31 107.588 175.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.53 -34.89 70.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.014 -1.448 . . . . 62.01 110.307 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 146' ' ' THR . 80.2 mt -67.4 -37.22 78.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.28 -0.418 . . . . 71.33 110.285 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.14 -33.09 74.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 75.15 110.129 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 15.3 mm-40 -73.2 -31.07 63.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.077 0.465 . . . . 74.42 110.02 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 51.3 t -69.06 -31.81 70.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.654 -0.703 . . . . 64.44 109.787 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 34.7 mmtp -74.98 -38.88 61.54 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.967 -0.753 . . . . 73.2 108.967 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -58.71 -59.47 5.35 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.042 -0.981 . . . . 62.23 110.255 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.75 112.11 16.17 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 115.022 -0.99 . . . . 63.51 110.274 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -73.84 98.74 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.989 2.46 . . . . 52.4 115.213 -173.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 114.799 -1.092 . . . . 72.15 108.314 172.182 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 108.253 -1.017 . . . . 72.34 108.253 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.8 m -71.8 101.31 2.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.329 0.585 . . . . 72.34 110.235 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 m -67.23 -29.63 69.33 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.079 -0.964 . . . . 74.43 110.923 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 58.04 88.02 0.06 Allowed 'General case' 0 C--N 1.341 0.212 0 O-C-N 124.15 0.906 . . . . 75.31 111.272 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.4 t -161.73 -174.96 4.45 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.934 -1.506 . . . . 73.52 106.934 -175.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.07 106.3 4.88 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-O 121.216 0.531 . . . . 75.14 109.606 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -140.8 -172.09 3.38 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.99 -1.855 . . . . 72.25 105.99 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.3 mt -84.94 153.55 22.76 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.186 -1.042 . . . . 73.43 108.186 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.497 ' ND1' ' HG ' ' A' ' 84' ' ' LEU . 52.8 m-70 -114.8 160.28 19.62 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.07 0.462 . . . . 74.43 112.16 -171.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 21.6 p30 -131.84 125.64 32.3 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.283 -1.326 . . . . 65.13 110.506 174.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 65.5 t -126.3 140.58 48.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.189 -0.914 . . . . 74.24 110.17 -174.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.418 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.5 t80 -94.66 122.97 37.81 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.675 -0.861 . . . . 75.23 108.675 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -100.69 144.33 12.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 116.252 -0.431 . . . . 71.43 109.886 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -83.51 -0.19 49.19 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.967 0.728 . . . . 74.44 112.967 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.13 -22.92 4.42 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.066 -1.064 . . . . 65.43 112.169 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.1 p -58.76 -36.4 74.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.135 0.493 . . . . 73.51 112.168 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.531 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 53.0 m-85 -125.84 35.9 4.62 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.709 -0.678 . . . . 75.14 110.908 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -77.79 -14.97 59.42 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.052 0.453 . . . . 75.03 110.728 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.57 121.23 63.7 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.736 -0.666 . . . . 75.4 109.472 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.49 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 30.7 Cg_endo -63.98 -28.86 66.43 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.858 2.372 . . . . 64.2 114.069 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.435 ' O ' HG21 ' A' ' 34' ' ' VAL . 24.2 t70 -69.1 -38.12 78.77 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.49 -0.484 . . . . 75.32 110.142 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.78 -38.94 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.548 -0.751 . . . . 63.14 109.423 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 29' ' ' PRO . 34.1 mm -58.46 -51.76 67.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.63 -0.713 . . . . 51.52 110.893 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -54.21 -34.27 60.19 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.236 0.458 . . . . 64.02 112.236 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 30' ' ' ASP . 47.3 t -81.03 -45.34 21.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 116.261 -0.427 . . . . 75.2 111.366 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.598 ' HE1' ' OD1' ' A' ' 86' ' ' ASN . 7.0 tmm? -67.21 -37.38 83.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.501 -0.318 . . . . 64.23 110.309 -173.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 32' ' ' ILE 0.282 0.9 OUTLIER -116.24 -67.18 1.01 Allowed 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 119.188 -1.005 . . . . 74.21 112.738 176.728 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.419 ' OD2' ' HG2' ' A' ' 38' ' ' ARG . 35.0 t70 174.98 -49.07 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.274 0.359 . . . . 73.22 111.364 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 20.1 mmt180 -131.11 162.73 29.22 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.257 -0.646 . . . . 64.24 109.257 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.453 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 20.4 m -102.87 112.44 65.74 Favored Pre-proline 0 N--CA 1.437 -1.115 0 O-C-N 123.26 0.35 . . . . 73.55 111.525 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.69 152.85 74.18 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.173 2.582 . . . . 65.42 109.336 170.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.54 130.96 47.29 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.131 0.491 . . . . 62.33 110.332 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 44.3 mt -114.47 138.94 42.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.583 -0.525 . . . . 74.13 109.583 -175.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.91 146.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.921 -0.77 . . . . 75.52 108.921 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.7 m -77.06 133.76 38.98 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.432 -1.321 . . . . 72.24 107.432 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.53 159.76 41.42 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.089 0.471 . . . . 73.33 111.697 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.5 m -110.51 125.27 53.15 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.327 -0.851 . . . . 71.12 110.812 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.8 tp -102.4 103.65 32.64 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 123.502 0.721 . . . . 61.13 109.307 175.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -82.0 142.44 12.39 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.261 1.974 . . . . 70.34 111.535 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.74 5.75 61.15 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.978 -0.556 . . . . 63.25 112.633 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -141.86 155.93 45.54 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 122.186 -0.596 . . . . 74.54 109.76 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -140.75 146.94 38.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.746 -0.464 . . . . 72.14 109.746 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 41.0 ptt180 -101.32 129.92 47.4 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.626 0.727 . . . . 73.32 111.286 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.653 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 18.3 m-85 -107.77 153.49 22.9 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.545 -1.28 . . . . 75.14 107.545 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.73 165.71 26.74 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 114.902 1.445 . . . . 74.51 114.902 -167.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 76.4 mt -141.85 -71.71 0.34 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.895 -1.891 . . . . 71.32 105.895 167.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt 161.62 -70.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.737 1.615 . . . . 75.4 110.352 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.63 -30.08 2.49 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.968 -0.634 . . . . 44.11 112.49 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -57.68 5.66 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 104.24 -2.504 . . . . 75.35 104.24 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.468 HD11 ' CH2' ' A' ' 118' ' ' TRP . 24.4 tp -127.4 163.26 24.43 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 108.432 -0.951 . . . . 75.43 108.432 173.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -113.18 176.45 1.48 Allowed Pre-proline 0 C--N 1.286 -2.158 0 N-CA-C 107.838 -1.171 . . . . 75.35 107.838 -169.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 20.5 Cg_exo -65.98 90.98 0.25 Allowed 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.579 1.519 . . . . 73.53 110.859 175.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 19.3 p -83.11 127.65 33.78 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 115.278 -0.874 . . . . 72.32 111.152 -174.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 117' ' ' MET . 49.4 mm -84.66 111.24 20.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.636 -0.711 . . . . 65.02 109.574 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.56 143.86 42.73 Favored Pre-proline 0 C--N 1.289 -2.049 0 N-CA-C 109.684 -0.487 . . . . 74.43 109.684 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.9 125.72 17.86 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.46 2.107 . . . . 64.22 112.799 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.3 t -124.58 122.3 37.18 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.099 -1.815 . . . . 75.42 106.099 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.61 -30.87 65.68 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.129 0.418 . . . . 70.45 112.129 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -136.54 77.35 1.64 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.6 0.714 . . . . 75.23 111.024 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.98 166.81 30.5 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 109.317 -1.513 . . . . 74.15 109.317 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -151.9 141.34 21.59 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 117.745 0.773 . . . . 62.4 110.541 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.07 131.45 64.67 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 109.001 -0.74 . . . . 74.34 109.001 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -107.78 115.8 30.79 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.222 -1.399 . . . . 74.14 107.222 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.65 -147.76 4.93 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.846 -0.901 . . . . 54.24 110.846 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -125.29 145.59 49.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 112.566 0.58 . . . . 74.32 112.566 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 46.8 t -110.58 124.88 67.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 114.64 -1.164 . . . . 62.43 110.502 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 67.2 mt -95.75 109.77 22.02 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.594 -1.262 . . . . 74.34 107.594 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.9 ptp -117.35 142.63 46.87 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.28 0.562 . . . . 65.32 111.738 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.23 29.12 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.291 -0.868 . . . . 55.33 111.195 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 83' ' ' GLU . 12.9 p -86.44 142.0 13.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 108.516 -0.92 . . . . 52.43 108.516 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -82.9 174.48 10.89 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.471 -0.492 . . . . 73.41 111.552 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.1 p -61.34 -45.26 95.16 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.75 1.018 . . . . 63.31 113.75 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.1 -36.56 84.0 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.673 0.749 . . . . 72.2 110.838 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 41.5 mt-10 -78.54 -28.49 46.11 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.225 -0.898 . . . . 73.22 109.432 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HG ' ' ND1' ' A' ' 18' ' ' HIS . 2.9 tm? -67.68 -41.56 83.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.862 -0.608 . . . . 75.21 109.689 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.39 -29.4 61.52 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.203 -0.453 . . . . 70.44 109.796 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.598 ' OD1' ' HE1' ' A' ' 35' ' ' MET . 14.0 t-20 -56.45 -47.57 78.88 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.745 0.818 . . . . 74.44 110.282 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.7 mt -60.82 -33.8 73.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.39 -0.823 . . . . 63.14 111.031 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.422 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 18.8 t70 -73.06 -36.93 66.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.309 0.576 . . . . 52.14 109.589 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.77 -47.27 72.7 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.693 -0.685 . . . . 60.23 110.62 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.463 HG11 ' HA ' ' A' ' 87' ' ' LEU . 12.2 p -72.59 -56.49 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 113.119 0.785 . . . . 52.21 113.119 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -77.54 -22.96 50.26 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.995 -0.44 . . . . 50.11 111.575 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -60.03 -17.49 44.57 Favored Glycine 0 C--O 1.221 -0.675 0 N-CA-C 115.194 0.837 . . . . 54.42 115.194 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.86 -38.36 76.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.471 0.635 . . . . 74.52 111.228 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.82 -28.47 11.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.036 0.446 . . . . 72.4 111.838 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.408 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 91.3 m-85 -124.28 170.21 11.0 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.406 0.682 . . . . 71.51 111.703 -174.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -123.23 151.61 42.12 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.846 -0.798 . . . . 75.42 108.846 178.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.2 ttm-85 -86.7 119.63 27.14 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.826 -0.805 . . . . 75.34 108.826 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.423 HG12 ' CE ' ' A' ' 117' ' ' MET . 27.7 m -124.7 162.16 27.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 121.019 0.438 . . . . 73.41 111.584 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.0 t -104.01 129.19 51.6 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.302 -0.863 . . . . 71.31 108.884 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -141.79 171.44 11.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.082 0.468 . . . . 65.03 111.989 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.58 139.24 15.45 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.792 -1.323 . . . . 71.54 109.792 176.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.07 164.99 33.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.139 0.469 . . . . 55.4 111.109 -178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.2 t -129.03 131.11 68.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.396 -1.335 . . . . 71.53 107.396 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -74.16 146.3 43.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.935 0.398 . . . . 72.12 110.648 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -88.85 -8.98 53.32 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.084 -0.507 . . . . 74.04 111.326 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -79.56 -48.21 14.21 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.567 -0.288 . . . . 70.32 111.243 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.478 ' ND2' ' HG2' ' A' ' 109' ' ' GLU . 3.0 p-10 -146.6 22.18 1.3 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.699 0.629 . . . . 73.13 112.699 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m 66.88 27.45 9.0 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 115.789 1.774 . . . . 74.22 115.789 170.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HG2' ' ND2' ' A' ' 107' ' ' ASN . 20.2 mm-40 -77.04 141.02 40.48 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.511 -0.876 . . . . 75.42 108.947 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -98.48 139.46 34.18 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.624 -0.509 . . . . 71.44 109.624 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.7 mtm -142.15 163.88 31.68 Favored 'General case' 0 CA--C 1.473 -1.989 0 CA-C-O 121.8 0.81 . . . . 55.24 111.387 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -112.24 122.99 49.3 Favored 'General case' 0 C--N 1.267 -3.003 0 CA-C-N 113.919 -1.492 . . . . 71.2 107.993 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.1 m -138.16 173.53 12.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.404 0.621 . . . . 70.52 110.881 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -104.4 150.85 24.16 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.982 -1.118 . . . . 70.43 107.982 175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.7 t -146.83 172.23 13.98 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.404 -0.961 . . . . 74.34 108.404 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.412 ' HH ' ' CB ' ' A' ' 87' ' ' LEU . 96.5 m-85 -111.91 112.82 24.74 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.585 0.707 . . . . 74.54 109.779 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' A' ' 63' ' ' ILE . 12.9 tmm? -106.07 146.67 29.85 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.412 -1.267 . . . . 75.51 110.871 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.468 ' CH2' HD11 ' A' ' 59' ' ' LEU . 70.0 t-105 -72.8 117.3 14.34 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.309 -0.859 . . . . 74.32 110.307 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.8 mt -57.81 -41.2 79.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 113.796 -1.547 . . . . 75.32 113.004 -172.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -89.27 91.11 8.63 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 119.904 -0.718 . . . . 72.01 110.435 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.11 -30.82 71.9 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.608 -0.724 . . . . 75.12 110.417 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.37 85.95 2.22 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.879 -0.785 . . . . 51.15 108.879 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.49 122.06 28.15 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-N 115.292 -0.867 . . . . 75.12 108.769 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -84.29 0.56 9.12 Favored 'Trans proline' 0 C--N 1.328 -0.536 0 C-N-CA 122.852 2.368 . . . . 72.42 113.918 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.12 -23.81 11.82 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 119.951 -0.699 . . . . 63.43 112.271 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.46 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.8 ptt? -76.55 1.01 17.94 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.098 0.407 . . . . 75.23 112.098 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -61.05 115.24 3.59 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 122.61 1.195 . . . . 74.41 113.461 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 147.69 98.66 0.21 Allowed Glycine 0 N--CA 1.411 -2.972 0 N-CA-C 105.991 -2.844 . . . . 54.05 105.991 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -88.44 146.98 24.92 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.964 -0.754 . . . . 73.2 108.964 -170.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -68.99 135.7 51.32 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.196 -1.039 . . . . 72.11 108.196 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -64.75 87.13 0.05 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.023 0.916 . . . . 74.53 112.398 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -73.34 -35.37 66.0 Favored 'General case' 0 N--CA 1.384 -3.74 0 CA-C-N 113.886 -1.506 . . . . 74.52 112.49 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.14 -31.64 72.14 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 111.74 0.274 . . . . 74.14 111.74 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.669 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 44.9 tt0 -66.95 -37.0 83.49 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 120.824 0.345 . . . . 73.41 110.776 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -73.14 -36.88 66.76 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.977 -0.689 . . . . 73.41 109.339 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -60.14 -31.33 69.98 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.267 -0.879 . . . . 71.54 109.87 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.669 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 22.5 tpt180 -55.79 -51.27 68.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.997 0.919 . . . . 73.04 111.324 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.73 -16.48 44.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.456 0.646 . . . . 72.53 110.691 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -64.69 -16.06 62.3 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.309 -0.86 . . . . 65.04 112.091 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.606 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.7 ttpt -55.55 -35.2 65.45 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.816 0.341 . . . . 72.32 110.107 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -53.13 -36.23 60.57 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.9 1.28 . . . . 74.21 110.586 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.6 -42.41 98.24 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.113 0.483 . . . . 70.31 110.63 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -73.77 -31.77 63.47 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.341 0.591 . . . . 72.51 109.56 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.2 mm -59.75 -32.76 50.24 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.911 0 CA-C-N 115.283 -0.872 . . . . 74.01 110.551 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -61.49 -36.3 80.07 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.209 0.528 . . . . 71.12 110.99 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.8 m -72.46 -47.93 44.97 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.861 -0.792 . . . . 71.42 108.861 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.615 ' O ' ' HG2' ' A' ' 151' ' ' MET . 58.9 m-85 -66.54 -28.87 68.88 Favored 'General case' 0 C--O 1.2 -1.528 0 N-CA-C 113.454 0.909 . . . . 74.42 113.454 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -52.62 -47.63 66.88 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.973 0.909 . . . . 53.21 109.902 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -39.39 73.48 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.857 -0.794 . . . . 75.02 108.857 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.64 -52.28 42.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.179 -0.464 . . . . 73.13 111.927 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.615 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 26.5 ptt? -76.37 -40.55 50.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.927 1.084 . . . . 72.21 113.927 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -62.77 -30.24 71.3 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 112.945 0.72 . . . . 74.54 112.945 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 82.1 m -71.41 -30.06 65.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.01 0.374 . . . . 71.12 112.01 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.49 -39.85 44.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.984 0.897 . . . . 71.31 108.752 175.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -47.93 78.74 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 125.533 1.533 . . . . 73.22 110.133 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -133.8 101.0 13.05 Favored Pre-proline 0 C--N 1.311 -1.078 0 N-CA-C 107.877 -1.157 . . . . 73.54 107.877 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -53.53 -38.3 83.43 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 123.669 2.912 . . . . 64.01 114.009 -175.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 120.988 0.423 . . . . 64.11 110.29 179.855 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 113.428 0.899 . . . . 70.2 113.428 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 p -141.96 18.52 2.13 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.052 -1.092 . . . . 70.23 108.052 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 p -71.93 -19.68 61.87 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.655 -1.157 . . . . 74.43 112.503 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -92.05 -178.97 5.15 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.177 -0.675 . . . . 73.54 109.177 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 t -96.29 96.0 8.48 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 108.833 -0.803 . . . . 73.45 108.833 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -99.62 179.58 4.5 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 116.45 -0.341 . . . . 72.31 111.201 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 66.68 -167.02 0.21 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.214 1.006 . . . . 61.21 109.722 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.91 153.82 27.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.044 -1.095 . . . . 70.43 108.044 176.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.408 ' CE1' HD22 ' A' ' 84' ' ' LEU . 30.4 m-70 -114.56 159.62 20.2 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 109.847 -0.427 . . . . 74.43 109.847 -170.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 18.1 p30 -130.41 133.34 46.29 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.331 -0.85 . . . . 75.13 110.518 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.84 140.31 49.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.442 -0.799 . . . . 62.14 110.223 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -94.61 122.47 37.24 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.467 -0.938 . . . . 73.32 108.467 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.47 143.01 12.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.043 0.449 . . . . 73.01 110.767 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.461 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 16.9 p90 -122.1 -1.94 9.22 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.951 1.463 . . . . 74.11 114.951 -168.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.81 -67.42 0.24 Allowed Glycine 0 C--N 1.314 -0.689 0 C-N-CA 119.329 -1.415 . . . . 55.14 112.528 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 p -58.12 -34.87 70.7 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.22 0.608 . . . . 74.33 111.7 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.452 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 26.8 m-85 -118.95 27.49 8.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.044 -0.526 . . . . 73.33 110.519 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -78.98 15.34 1.12 Allowed 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 121.963 0.887 . . . . 71.2 110.834 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -137.84 128.47 15.67 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.322 -0.992 . . . . 71.53 108.322 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.49 -31.28 87.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.787 2.324 . . . . 73.15 114.423 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.95 -37.9 82.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.292 0.567 . . . . 72.21 109.654 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.64 -38.85 83.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.176 -0.92 . . . . 74.14 109.468 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.401 HG22 HD22 ' A' ' 36' ' ' LEU . 6.5 mm -62.58 -50.51 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-O 122.125 0.964 . . . . 54.52 109.91 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -54.01 -43.63 70.23 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.266 -1.788 . . . . 74.13 111.607 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.5 t -81.72 -32.44 11.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.912 -0.585 . . . . 63.42 111.936 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.452 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.7 tmm? -70.55 -37.46 74.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.989 -0.284 . . . . 64.52 110.774 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.401 HD22 HG22 ' A' ' 32' ' ' ILE 0.277 0.4 OUTLIER -109.8 -71.86 0.75 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.599 0.963 . . . . 74.45 113.599 179.266 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.8 t70 176.11 -45.03 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.25 0.548 . . . . 73.01 109.838 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -120.79 176.2 5.65 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.53 -0.759 . . . . 73.33 109.487 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 m -123.03 100.68 39.63 Favored Pre-proline 0 N--CA 1.425 -1.689 0 N-CA-C 106.624 -1.621 . . . . 74.32 106.624 170.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.496 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 34.1 Cg_exo -58.71 151.57 62.61 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.833 2.355 . . . . 65.04 111.74 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.5 122.91 13.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.496 0.718 . . . . 71.52 111.167 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.532 HG12 ' HG ' ' A' ' 76' ' ' LEU . 24.0 mt -97.72 140.37 18.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.292 -0.867 . . . . 73.34 110.384 -173.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.14 145.47 35.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.794 -1.187 . . . . 75.1 107.794 172.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.9 m -81.05 123.73 28.61 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.939 -0.763 . . . . 64.53 108.939 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.17 159.14 42.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.266 0.555 . . . . 70.33 111.849 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.411 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 90.7 m -117.55 132.93 56.45 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.093 -0.958 . . . . 75.42 110.094 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.0 tp -102.56 100.94 17.5 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 123.018 0.527 . . . . 74.04 109.702 176.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 46' ' ' THR . 6.0 Cg_endo -85.98 145.22 8.69 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.581 2.187 . . . . 62.52 111.843 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.8 11.09 59.45 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 111.263 -0.735 . . . . 64.22 111.263 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -144.44 157.07 44.42 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 108.168 -1.049 . . . . 74.2 108.168 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -138.37 146.22 42.03 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.189 -0.671 . . . . 65.52 109.189 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.442 ' HA ' HD11 ' A' ' 63' ' ' ILE . 38.1 ptt180 -90.36 126.69 35.95 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.963 -1.017 . . . . 71.04 111.959 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.53 ' C ' ' HE ' ' A' ' 54' ' ' ARG . 10.3 m-85 -109.92 135.75 50.3 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.127 -1.434 . . . . 64.52 107.127 174.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.679 ' HG2' ' CD1' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -106.28 166.17 10.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.175 -0.328 . . . . 73.11 111.823 -176.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.75 85.13 3.36 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 106.982 -1.488 . . . . 70.32 106.982 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.466 ' O ' ' HD3' ' A' ' 56' ' ' LYS . 13.8 tmtt? -124.11 -5.09 7.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.406 -1.27 . . . . 72.33 107.66 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.11 -136.9 4.78 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 108.068 -2.013 . . . . 50.23 108.068 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.35 5.18 44.38 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 118.005 0.902 . . . . 74.25 112.391 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.517 HD12 ' CH2' ' A' ' 118' ' ' TRP . 43.8 tp -111.85 163.1 14.57 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.451 -0.5 . . . . 72.2 110.162 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -75.38 169.02 22.42 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 124.321 1.048 . . . . 74.34 109.848 -173.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 7.1 Cg_exo -73.58 86.51 1.19 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.591 1.527 . . . . 72.55 110.687 173.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 27.8 p -98.15 -178.41 4.05 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.844 -0.617 . . . . 60.22 112.126 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.461 ' CG1' ' HB2' ' A' ' 23' ' ' TYR . 47.8 mm -132.43 142.15 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.09 -1.448 . . . . 64.14 107.09 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -144.64 154.71 56.37 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.456 -0.942 . . . . 72.14 108.456 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -60.99 128.67 26.1 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.432 2.088 . . . . 74.34 112.125 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -125.79 145.3 50.27 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 116.152 -0.476 . . . . 72.13 110.011 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.48 -35.21 65.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.505 -0.924 . . . . 61.24 108.505 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -128.93 77.22 1.77 Allowed 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.148 -0.933 . . . . 74.4 110.797 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.59 151.0 19.83 Favored Glycine 0 N--CA 1.412 -2.936 0 CA-C-N 114.917 -1.038 . . . . 54.43 111.917 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.76 138.11 18.5 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.447 1.099 . . . . 74.32 108.501 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t -113.38 119.95 62.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 120.737 0.303 . . . . 64.01 110.615 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -91.91 116.55 29.01 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.45 -0.945 . . . . 70.31 108.45 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.11 -146.6 4.37 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.508 -0.853 . . . . 54.13 112.41 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.431 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.0 mmtm -127.77 141.56 51.55 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.724 0.297 . . . . 63.02 111.022 -175.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.502 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 47.5 t -111.52 129.51 66.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 115.913 -0.585 . . . . 75.45 110.358 173.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.532 ' HG ' HG12 ' A' ' 42' ' ' ILE . 6.5 mp -106.11 114.12 28.06 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.447 -0.797 . . . . 71.54 110.922 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 58.1 mtp -104.14 145.04 30.76 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.217 -1.356 . . . . 73.23 110.366 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.02 9.27 32.53 Favored Glycine 0 C--N 1.299 -1.519 0 C-N-CA 120.113 -1.041 . . . . 71.21 111.955 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 80' ' ' THR . 57.8 t -67.75 127.49 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.082 -0.71 . . . . 75.14 109.082 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.413 ' O ' HG12 ' A' ' 79' ' ' VAL . 65.3 p -82.17 167.62 18.52 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.388 -0.968 . . . . 73.14 108.388 176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 34.6 t -55.26 -45.63 76.08 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 117.529 0.15 . . . . 61.25 110.946 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -58.26 -42.18 85.88 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.041 0.385 . . . . 55.42 112.041 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.22 -40.63 64.56 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.467 -0.568 . . . . 74.53 109.467 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.408 HD22 ' CE1' ' A' ' 18' ' ' HIS . 33.6 tp -55.91 -50.75 69.85 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.296 0.569 . . . . 73.23 109.896 175.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 81' ' ' SER . 43.1 mt-10 -64.82 -29.13 70.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.062 -0.972 . . . . 61.15 110.251 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -44.7 64.62 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 123.804 0.842 . . . . 71.43 112.139 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.6 mt -62.5 -40.95 98.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.227 -1.027 . . . . 63.51 108.227 176.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.484 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 16.7 t70 -66.37 -29.29 69.44 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 114.463 -1.244 . . . . 71.23 110.886 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.0 -45.32 42.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.115 0.483 . . . . 74.33 110.398 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.2 t -72.16 -58.41 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-N 115.749 -0.66 . . . . 74.11 112.189 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.52 -24.52 42.16 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.855 0.687 . . . . 73.51 112.855 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -63.74 -16.15 58.71 Favored Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.809 -0.632 . . . . 43.13 114.391 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -67.49 -30.39 70.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.886 0.343 . . . . 73.41 111.685 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -127.14 -0.25 6.46 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.022 0.379 . . . . 72.41 112.022 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -132.7 168.18 18.78 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.112 0.565 . . . . 74.23 110.332 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -124.56 148.71 47.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.533 -0.543 . . . . 74.03 109.533 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 -88.13 113.45 23.76 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.595 -0.891 . . . . 54.22 108.595 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.53 HG11 ' HE1' ' A' ' 117' ' ' MET . 15.8 m -115.84 161.41 14.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 116.28 -0.418 . . . . 73.22 111.805 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.6 t -107.68 124.7 50.37 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.173 -1.047 . . . . 74.24 108.173 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.21 170.87 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 116.121 -0.491 . . . . 74.12 111.285 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.91 118.78 4.85 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 111.052 -0.819 . . . . 64.24 111.052 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.436 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.7 pp -111.01 165.05 6.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 110.031 -0.359 . . . . 70.02 110.031 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.3 t -122.68 124.68 71.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.519 -0.548 . . . . 72.1 109.519 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -72.66 121.4 19.72 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.177 -0.92 . . . . 74.32 110.722 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.19 -23.59 65.7 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.611 0.765 . . . . 70.5 111.945 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -64.42 -57.65 8.69 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.311 0.485 . . . . 75.55 112.311 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -127.05 7.41 6.6 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.086 0.773 . . . . 71.42 113.086 -169.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.2 t 71.46 12.23 6.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.058 0.943 . . . . 74.43 112.418 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -82.17 147.03 29.24 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.058 0.456 . . . . 75.11 111.231 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -92.02 147.4 22.99 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.421 -0.809 . . . . 74.1 110.094 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.436 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 89.1 mtp -136.22 160.38 38.85 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.378 -0.828 . . . . 74.15 109.524 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.17 117.03 33.06 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 115.534 -0.757 . . . . 60.03 109.603 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.3 m -131.68 173.21 15.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 116.128 -0.487 . . . . 73.24 110.186 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -106.1 149.59 26.6 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.089 -0.708 . . . . 74.44 109.089 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -153.15 172.88 16.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.977 -0.749 . . . . 73.1 108.977 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -119.95 109.76 15.91 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.288 0.566 . . . . 75.01 110.623 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.53 ' HE1' HG11 ' A' ' 98' ' ' VAL . 25.7 ptt? -106.71 157.16 17.93 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.178 -0.919 . . . . 74.24 108.719 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.517 ' CH2' HD12 ' A' ' 59' ' ' LEU . 70.7 t-105 -67.99 143.51 55.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.211 -0.663 . . . . 75.13 109.211 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.6 mm -72.44 -42.33 64.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 113.499 0.925 . . . . 61.3 113.499 -170.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -88.9 -41.17 12.59 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 114.055 1.132 . . . . 73.52 114.055 -171.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.407 0.0 OUTLIER 56.12 1.57 0.07 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.56 2.43 . . . . 75.41 117.56 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.82 9.93 28.78 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.982 -0.747 . . . . 64.55 108.982 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.426 ' CG ' ' HE1' ' A' ' 118' ' ' TRP . 2.9 m-20 -68.13 123.44 87.31 Favored Pre-proline 0 C--N 1.312 -1.023 0 C-N-CA 124.715 1.206 . . . . 72.12 111.4 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.7 -7.3 10.56 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.411 2.074 . . . . 74.52 112.18 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.89 -2.9 56.59 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.238 0.829 . . . . 63.3 113.238 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.475 ' HB3' HD22 ' A' ' 59' ' ' LEU . 25.7 ptt? -102.4 143.06 32.62 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.67 -0.863 . . . . 72.31 108.67 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -131.2 132.72 44.89 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 120.888 0.375 . . . . 73.42 110.021 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -82.14 53.28 4.75 Favored Glycine 0 CA--C 1.499 -0.942 0 N-CA-C 111.225 -0.75 . . . . 74.23 111.225 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.82 126.35 45.46 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-O 121.966 0.889 . . . . 75.13 111.111 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.679 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 6.2 t90 -130.95 157.36 43.16 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 101.967 -3.346 . . . . 74.41 101.967 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -51.09 -44.58 61.27 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 120.36 1.436 . . . . 52.13 111.561 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -73.93 -39.09 64.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.872 0.368 . . . . 75.11 111.863 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.567 ' HB2' ' H ' ' A' ' 130' ' ' TRP . 15.9 mm-40 -64.15 -28.27 69.65 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.297 -0.411 . . . . 75.44 110.792 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 45.1 tt0 -63.48 -37.74 88.47 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.863 -0.421 . . . . 63.52 109.863 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -74.44 -33.79 63.03 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.779 -0.768 . . . . 73.32 109.415 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 53.8 tttp -57.16 -45.1 83.91 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.105 -1.072 . . . . 71.41 108.105 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.507 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 55.5 ttt180 -53.54 -51.2 63.65 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.484 -1.235 . . . . 71.21 112.045 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.2 mt -77.8 -26.05 49.37 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.08 -0.509 . . . . 72.24 111.89 -174.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -68.04 -39.68 83.02 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.401 -0.962 . . . . 65.04 108.401 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.5 ttpt -69.57 -37.07 76.83 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.587 -0.733 . . . . 74.02 109.679 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -52.78 -31.75 40.11 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.015 0.926 . . . . 72.14 112.241 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -66.05 -40.31 90.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.854 0.835 . . . . 73.5 109.354 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.469 ' O ' HG21 ' A' ' 146' ' ' THR . 23.9 t80 -76.29 -32.23 58.67 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.57 -1.195 . . . . 75.34 108.328 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.1 mm -59.05 -31.99 46.88 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.486 0 CA-C-N 114.731 -1.122 . . . . 70.2 111.815 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -52.07 -45.18 64.67 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.124 0.42 . . . . 64.44 111.806 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.469 HG21 ' O ' ' A' ' 143' ' ' PHE . 15.1 t -79.14 -29.89 43.36 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.564 0.697 . . . . 72.3 109.824 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -75.63 -30.33 59.45 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.397 -0.819 . . . . 74.51 110.502 -173.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -58.24 -36.93 73.93 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.603 1.161 . . . . 75.02 109.845 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -74.34 -38.79 63.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.103 0.477 . . . . 75.1 110.025 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 72.3 mt -63.61 -39.93 87.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.644 -0.707 . . . . 71.1 109.47 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.4 ttt -60.12 -31.68 70.29 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 124.267 1.027 . . . . 73.4 111.493 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.93 -36.93 85.96 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.476 0.655 . . . . 73.11 109.765 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.82 -34.38 69.29 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.222 -0.899 . . . . 75.44 110.227 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 9.7 mmpt? -81.36 -44.9 16.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 43.42 111.884 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -149.99 100.9 2.98 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.767 -0.827 . . . . 75.14 108.767 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -69.15 146.83 97.28 Favored Pre-proline 0 C--N 1.303 -1.441 0 CA-C-N 115.677 -0.692 . . . . 75.45 109.386 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.8 98.24 0.13 Allowed 'Trans proline' 0 C--O 1.249 1.059 0 C-N-CA 122.533 2.156 . . . . 72.24 112.064 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 . . . . . 0 C--N 1.308 -1.2 0 CA-C-N 115.049 -0.978 . . . . 75.15 108.501 -179.746 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.42 -1.926 0 N-CA-C 106.912 -1.514 . . . . 61.25 106.912 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -157.14 83.97 0.93 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.19 0.519 . . . . 74.34 111.889 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 m -88.45 -32.82 18.09 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.774 -1.565 . . . . 73.34 106.774 170.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 59.88 -87.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.209 1.804 . . . . 72.13 113.887 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.1 t -128.74 1.74 5.45 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.886 0.85 . . . . 73.44 109.054 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.29 89.33 3.73 Favored 'General case' 0 N--CA 1.393 -3.308 0 CA-C-N 115.543 -0.753 . . . . 74.15 110.774 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -144.52 144.8 31.51 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 108.564 -0.902 . . . . 75.02 108.564 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -82.04 154.71 25.5 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.476 -0.564 . . . . 75.44 109.476 175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.554 ' O ' HG11 ' A' ' 79' ' ' VAL . 56.7 m-70 -114.86 160.6 19.29 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 115.428 -0.805 . . . . 75.51 109.851 -173.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.551 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 27.2 p-10 -131.08 125.08 32.24 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.647 0.737 . . . . 70.42 110.617 176.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.28 142.82 40.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.156 -0.929 . . . . 64.32 109.944 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -95.07 123.23 38.45 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.728 -0.842 . . . . 74.35 108.728 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -102.59 137.79 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.659 -0.497 . . . . 73.01 109.659 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -87.62 -28.39 21.92 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.516 0.932 . . . . 74.21 113.516 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.29 -20.81 0.18 Allowed Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 118.917 -1.611 . . . . 71.23 113.108 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.7 p -63.65 -28.48 69.94 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.147 0.499 . . . . 63.31 111.845 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.467 ' HB3' HD12 ' A' ' 32' ' ' ILE . 78.5 m-85 -139.9 57.12 1.62 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.531 0.732 . . . . 75.01 109.232 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -88.86 -21.44 23.68 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.354 0.501 . . . . 53.45 112.354 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.587 ' O ' HG23 ' A' ' 31' ' ' VAL . 24.1 t70 -95.28 129.25 35.76 Favored Pre-proline 0 C--N 1.303 -1.424 0 CA-C-N 116.585 -0.28 . . . . 65.51 110.576 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.24 -25.04 57.69 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.694 2.263 . . . . 53.34 113.392 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.44 -30.0 62.92 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.536 -0.727 . . . . 63.31 110.965 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 28' ' ' ASP . 18.4 m -72.44 -28.3 28.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.256 -0.646 . . . . 64.44 109.256 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 26' ' ' PHE . 49.7 mm -64.31 -40.41 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.697 -0.683 . . . . 73.32 110.588 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -61.44 -30.15 70.4 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.148 0.499 . . . . 74.22 111.002 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.36 -50.79 15.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.812 -0.631 . . . . 74.44 110.291 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -67.63 -35.71 79.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.728 -0.669 . . . . 51.34 110.121 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.3 mt -103.65 -77.31 0.57 Allowed 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.287 0.565 . . . . 73.03 109.749 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.4 t70 162.57 -30.15 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 125.533 1.533 . . . . 72.41 107.287 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -146.58 159.11 43.86 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 114.648 -1.16 . . . . 74.12 109.722 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.3 m -107.52 120.52 47.23 Favored Pre-proline 0 N--CA 1.426 -1.671 0 O-C-N 123.573 0.546 . . . . 73.04 110.83 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -65.79 151.58 83.93 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.641 2.227 . . . . 75.34 109.259 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.7 130.26 45.61 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 122.144 0.973 . . . . 51.13 112.976 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 47.5 mt -103.39 139.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.041 0 CA-C-N 113.973 -1.467 . . . . 74.14 110.462 -174.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.418 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 13.5 p -126.34 146.45 32.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 107.79 -1.189 . . . . 51.32 107.79 172.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 m -76.27 125.46 29.22 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 106.429 -1.693 . . . . 74.43 106.429 177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.64 151.31 45.86 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.528 -0.869 . . . . 65.23 113.339 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -115.0 125.93 54.17 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.589 -1.187 . . . . 72.42 109.491 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 tp -98.7 102.78 15.87 Favored Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 123.49 0.716 . . . . 64.41 109.594 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 73.5 Cg_endo -81.06 141.38 13.04 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.197 1.931 . . . . 64.34 111.942 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.7 10.91 57.42 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.609 -0.805 . . . . 61.54 112.1 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -139.82 163.21 33.22 Favored 'General case' 0 C--O 1.2 -1.5 0 N-CA-C 108.719 -0.845 . . . . 65.32 108.719 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -138.39 143.59 39.85 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.303 0.573 . . . . 75.12 109.82 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.64 124.75 35.32 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.893 -1.521 . . . . 72.42 106.893 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -109.45 147.76 32.31 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.13 -0.693 . . . . 72.51 109.13 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.566 ' HG3' ' CD1' ' A' ' 130' ' ' TRP . 3.8 tmt_? -134.47 126.21 28.98 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.961 -0.755 . . . . 74.23 108.961 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.7 tp -143.54 147.38 34.36 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.062 -1.088 . . . . 72.22 108.062 -174.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -125.88 16.21 8.0 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.039 0.447 . . . . 74.23 111.063 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.08 -136.77 8.3 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 115.813 -0.631 . . . . 71.22 112.766 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -84.96 -7.61 59.08 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.076 0.465 . . . . 74.13 112.018 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.467 HD13 ' CH2' ' A' ' 118' ' ' TRP . 53.6 tp -113.61 164.59 13.47 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.342 -0.614 . . . . 73.34 109.342 177.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -95.33 159.99 31.62 Favored Pre-proline 0 C--N 1.313 -1.011 0 C-N-CA 122.98 0.512 . . . . 74.04 110.718 -170.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.479 ' HB3' ' HA ' ' A' ' 54' ' ' ARG . 23.3 Cg_exo -69.63 96.98 0.6 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.703 2.268 . . . . 73.31 109.871 171.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 24.5 p -92.73 -179.42 5.15 Favored 'General case' 0 C--O 1.253 1.244 0 N-CA-C 113.422 0.897 . . . . 73.25 113.422 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.6 mm -131.87 120.78 45.52 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 108.146 -1.057 . . . . 73.22 108.146 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.06 149.35 73.48 Favored Pre-proline 0 C--N 1.313 -1.017 0 N-CA-C 110.208 -0.293 . . . . 72.02 110.208 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -63.23 119.39 6.45 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.107 2.538 . . . . 74.13 113.435 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.4 t -125.91 131.28 52.35 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.792 -0.818 . . . . 65.31 108.792 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.19 -34.48 78.12 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.144 0.497 . . . . 73.53 110.485 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -102.49 23.87 11.25 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.443 -0.799 . . . . 65.01 111.331 -176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.94 165.67 23.39 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 118.863 -1.636 . . . . 44.45 114.209 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.456 ' CD ' ' HZ3' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -152.25 145.75 24.88 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 124.682 1.193 . . . . 71.33 108.596 174.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.4 t -113.02 125.11 70.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.695 -0.483 . . . . 74.23 109.695 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -95.86 116.55 29.08 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.288 -1.004 . . . . 74.32 108.288 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.22 -152.43 5.63 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 110.879 -0.889 . . . . 62.45 110.879 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 34.7 mmtp -129.03 143.92 51.02 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 116.785 0.293 . . . . 70.11 110.28 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.569 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 47.3 t -110.08 127.52 66.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 120.834 0.349 . . . . 43.41 110.794 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 70.7 mt -95.48 104.25 16.15 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.07 -1.085 . . . . 71.11 108.07 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.2 ptp -113.55 147.7 37.48 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.825 -0.435 . . . . 71.21 109.825 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.39 13.55 55.5 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.327 -1.416 . . . . 63.21 110.01 -172.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.554 HG11 ' O ' ' A' ' 18' ' ' HIS . 11.4 p -86.76 131.6 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 N-CA-C 109.007 -0.738 . . . . 65.21 109.007 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.489 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 3.2 m -74.44 159.73 31.92 Favored 'General case' 0 N--CA 1.409 -2.484 0 N-CA-C 108.947 -0.76 . . . . 75.53 108.947 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.8 p -56.85 -34.86 68.21 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.614 0.766 . . . . 71.02 111.829 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.09 -46.04 79.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.574 -0.285 . . . . 73.54 111.691 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.525 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 1.8 mp0 -70.26 -31.04 68.24 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.623 -0.51 . . . . 73.52 109.623 175.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.4 tp -58.71 -51.87 68.11 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.202 0.525 . . . . 74.32 109.996 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.59 -28.74 67.21 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.448 -0.796 . . . . 64.13 110.309 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.476 ' C ' HD21 ' A' ' 86' ' ' ASN . 0.1 OUTLIER -65.69 -47.51 75.19 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 108.65 -0.87 . . . . 54.33 108.65 177.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.2 mt -61.13 -46.43 90.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.972 -0.751 . . . . 74.01 108.972 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.53 -29.75 70.79 Favored 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 114.46 -1.245 . . . . 75.21 111.162 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.18 -40.47 59.38 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.082 -0.508 . . . . 64.42 110.848 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 86' ' ' ASN . 59.1 t -72.82 -49.33 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 112.308 0.485 . . . . 73.32 112.308 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -79.92 -27.91 39.84 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 112.859 0.689 . . . . 45.31 112.859 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.81 -21.29 36.19 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 119.585 2.594 . . . . 53.3 119.585 -168.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -71.23 -35.5 71.5 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 119.505 1.653 . . . . 71.02 113.814 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -120.44 -0.03 10.43 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.836 -0.745 . . . . 63.33 112.822 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -130.49 159.01 38.37 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.615 0.366 . . . . 75.11 110.072 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -123.05 137.15 55.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.869 0.366 . . . . 72.5 110.582 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -87.41 114.51 24.08 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.814 -0.63 . . . . 64.14 110.653 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.5 HG13 ' HE3' ' A' ' 117' ' ' MET . 35.9 m -121.27 161.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.528 -0.76 . . . . 75.01 111.679 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 p -92.45 123.04 35.47 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.724 -0.671 . . . . 74.42 110.988 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.59 172.41 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 112.86 0.689 . . . . 61.3 112.86 -175.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -116.14 136.36 12.83 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.173 -0.771 . . . . 74.32 111.173 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -126.78 160.99 34.31 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 C-N-CA 123.373 0.669 . . . . 73.14 111.322 -178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 48.2 t -117.17 129.96 72.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.439 -0.578 . . . . 73.4 109.439 177.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.59 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 19.0 mtp180 -73.38 116.54 14.06 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 122.805 0.442 . . . . 72.24 110.206 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -73.81 -20.48 60.45 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.719 -0.673 . . . . 72.14 110.019 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -73.93 -16.6 61.09 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 112.461 0.541 . . . . 73.43 112.461 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.422 ' CG ' ' H ' ' A' ' 108' ' ' SER . 33.0 p-10 -138.32 -83.49 0.3 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.238 -0.585 . . . . 64.54 111.048 173.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.422 ' H ' ' CG ' ' A' ' 107' ' ' ASN . 73.1 m 177.49 -13.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.266 1.427 . . . . 62.4 111.18 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -77.98 149.34 34.12 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 113.157 0.799 . . . . 64.42 113.157 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 62.7 pttt -103.87 147.2 27.6 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.53 -0.759 . . . . 74.4 110.211 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.59 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 89.8 mtp -139.24 162.24 35.48 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.578 0.704 . . . . 73.31 112.234 -175.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.24 130.89 46.41 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 114.349 -1.296 . . . . 64.35 109.359 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.506 HG11 ' ND2' ' A' ' 19' ' ' ASN . 35.8 m -143.41 175.86 3.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 123.366 0.666 . . . . 74.04 109.72 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -116.12 145.1 43.32 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.216 -1.031 . . . . 62.14 108.216 172.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.7 t -136.26 172.04 13.6 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.167 -0.679 . . . . 72.21 109.167 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -104.07 118.53 36.87 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.407 -0.59 . . . . 74.41 109.407 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.5 ' HE3' HG13 ' A' ' 98' ' ' VAL . 52.0 ttp -111.91 148.84 32.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.024 -0.989 . . . . 64.52 109.546 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.467 ' CH2' HD13 ' A' ' 59' ' ' LEU . 65.6 t-105 -73.75 130.54 40.17 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.752 -1.203 . . . . 72.43 107.752 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.436 ' H ' HD11 ' A' ' 119' ' ' ILE . 2.5 mp -73.45 -43.85 55.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 119.91 -0.716 . . . . 73.53 111.242 -171.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 123' ' ' ASP . 9.9 t30 -93.58 67.74 3.97 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.961 1.362 . . . . 74.01 107.952 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -81.73 17.15 1.54 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.485 -1.689 . . . . 63.55 114.382 -170.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -121.97 19.73 10.84 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.315 -0.624 . . . . 44.21 109.315 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.446 ' HB2' ' ND2' ' A' ' 120' ' ' ASN . 11.9 t70 -64.88 126.9 92.03 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.627 -0.715 . . . . 62.14 110.882 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -92.47 16.57 1.36 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 122.388 2.059 . . . . 60.33 113.604 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.77 -32.93 5.97 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.918 0.39 . . . . 73.41 110.857 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -70.16 13.32 0.16 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.674 0.991 . . . . 63.11 113.674 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -69.13 92.88 0.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.465 0.65 . . . . 53.14 111.787 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -125.55 133.63 8.44 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 108.329 -1.908 . . . . 74.52 108.329 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.48 140.76 37.06 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.905 0.86 . . . . 61.34 113.119 -172.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.566 ' CD1' ' HG3' ' A' ' 54' ' ' ARG . 2.3 t90 -113.97 136.38 52.97 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 104.416 -2.438 . . . . 75.25 104.416 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -61.96 0.19 0.42 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.251 1.575 . . . . 61.33 115.251 -171.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -69.09 -32.89 72.64 Favored 'General case' 0 N--CA 1.4 -2.964 0 C-N-CA 123.867 0.867 . . . . 73.23 109.676 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.538 ' HG3' ' O ' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -72.67 -33.65 66.68 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.445 0.641 . . . . 75.51 111.263 177.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 39.4 tt0 -63.55 -40.39 96.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.63 -1.168 . . . . 64.3 109.265 172.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -67.09 -41.75 85.81 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.864 -0.607 . . . . 75.34 110.465 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.456 ' HZ3' ' CD ' ' A' ' 70' ' ' GLU . 88.0 tttt -62.64 -33.53 75.21 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 110.136 -0.32 . . . . 73.1 110.136 178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 21.1 tpt180 -59.79 -50.36 74.13 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.447 0.642 . . . . 73.5 110.836 174.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -74.22 -26.43 60.25 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.856 0.836 . . . . 71.24 110.958 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -83.73 -20.82 32.74 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.855 -1.066 . . . . 71.53 110.262 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.471 ' O ' HG12 ' A' ' 144' ' ' ILE . 54.0 tptt -61.98 -34.78 76.78 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.424 1.089 . . . . 63.43 110.09 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 34.8 mmtp -53.88 -31.6 50.37 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 114.714 1.376 . . . . 71.24 114.714 -174.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -57.91 -46.27 85.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.932 0.873 . . . . 53.51 108.971 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -76.72 -33.49 58.17 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.73 -1.123 . . . . 72.33 109.389 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.5 mm -63.25 -34.69 68.45 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.343 0 CA-C-N 115.497 -0.774 . . . . 63.42 112.082 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 48.8 mt-10 -56.71 -34.57 67.6 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.522 0.677 . . . . 73.21 110.582 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.6 m -80.98 -47.1 14.09 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.371 -0.831 . . . . 70.44 110.703 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.528 ' O ' ' HG3' ' A' ' 151' ' ' MET . 2.8 t80 -70.96 -30.29 66.54 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.506 -0.77 . . . . 74.34 112.373 -171.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 87.5 tttt -57.9 -40.18 79.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.239 0.616 . . . . 73.43 110.289 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -64.23 -38.53 91.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.922 -0.77 . . . . 55.25 108.922 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.4 mt -68.43 -38.13 78.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.845 -1.07 . . . . 72.02 109.758 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.528 ' HG3' ' O ' ' A' ' 147' ' ' PHE . 64.2 mtt -63.54 -41.77 98.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.085 -0.507 . . . . 72.21 109.729 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 49.7 mt-10 -70.47 -33.86 71.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.847 -0.615 . . . . 71.4 110.461 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 46.4 t -62.15 -49.76 74.57 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.703 -0.681 . . . . 62.34 110.211 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -70.57 -23.49 62.61 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.212 0.53 . . . . 73.35 110.367 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? 67.23 77.32 0.27 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.358 1.463 . . . . 75.23 109.247 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -141.03 96.29 7.31 Favored Pre-proline 0 C--O 1.251 1.139 0 CA-C-N 114.283 -1.326 . . . . 75.04 109.217 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.96 152.51 73.38 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.621 2.214 . . . . 74.43 110.7 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 . . . . . 0 C--N 1.307 -1.273 0 CA-C-O 120.53 0.205 . . . . 72.13 111.229 -178.943 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 109.088 -0.708 . . . . 62.43 109.088 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.1 m -63.19 154.25 31.9 Favored 'General case' 0 C--O 1.25 1.114 0 O-C-N 123.383 0.427 . . . . 71.55 110.742 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -63.36 -47.76 80.77 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.059 -0.719 . . . . 62.13 109.059 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -95.84 95.17 8.09 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.009 -0.541 . . . . 75.54 109.681 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.6 t -103.81 143.69 32.48 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.674 -1.232 . . . . 63.34 107.674 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.92 110.49 5.05 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.555 -0.535 . . . . 64.34 109.555 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.98 155.38 49.26 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.905 -0.589 . . . . 64.12 109.594 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.435 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 87.5 mt -98.72 153.83 18.43 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 120.963 0.411 . . . . 64.22 110.299 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.462 ' O ' HG11 ' A' ' 79' ' ' VAL . 44.2 m-70 -128.67 161.74 28.97 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.772 -0.649 . . . . 71.34 111.067 -172.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 9.5 p30 -120.09 128.54 53.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.493 -0.776 . . . . 61.23 112.032 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.2 t -131.78 140.79 47.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.359 -0.837 . . . . 63.14 108.947 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.407 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.8 t80 -98.58 121.61 40.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.813 -0.81 . . . . 74.51 108.813 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 74' ' ' LYS . 14.9 m -93.59 152.36 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.077 -0.51 . . . . 73.24 109.791 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -121.4 -51.66 2.07 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 115.818 1.785 . . . . 75.34 115.818 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.02 -75.11 0.15 Allowed Glycine 0 C--O 1.225 -0.442 0 C-N-CA 118.599 -1.762 . . . . 63.44 114.4 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -58.53 -36.4 73.8 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.594 0.758 . . . . 71.41 112.505 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.469 ' HB3' HD12 ' A' ' 32' ' ' ILE . 70.1 m-85 -110.51 29.9 7.29 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-O 121.14 0.495 . . . . 72.34 111.053 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.585 HE21 ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.91 -7.86 53.9 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.768 0.794 . . . . 62.0 109.648 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 13.0 t70 -114.02 134.44 22.16 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.338 -1.301 . . . . 75.41 111.01 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -72.27 -25.12 19.03 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.577 2.185 . . . . 75.3 112.938 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.497 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 17.8 t70 -64.03 -43.33 95.9 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.185 -0.322 . . . . 64.3 110.471 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.24 -29.58 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 116.238 -0.437 . . . . 72.11 110.058 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' A' ' 26' ' ' PHE . 31.6 mm -65.77 -47.43 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 122.441 -0.162 . . . . 72.43 110.725 177.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -55.84 -32.7 63.84 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.831 0.348 . . . . 44.04 111.454 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.57 -36.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.471 -0.331 . . . . 65.45 111.473 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.504 ' HE2' ' CD2' ' A' ' 87' ' ' LEU . 50.6 ttp -63.92 -36.5 84.13 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.771 0.319 . . . . 75.21 110.21 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.543 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.1 pt? -125.18 -76.42 0.59 Allowed 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 112.918 0.71 . . . . 65.24 112.918 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.543 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 23.6 m-20 -169.77 -55.9 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 122.012 0.91 . . . . 72.22 108.606 -170.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -121.23 -177.27 3.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.105 -1.407 . . . . 75.24 110.097 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -134.97 120.59 14.21 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 115.757 -0.656 . . . . 73.24 109.629 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.61 150.87 66.7 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.793 2.328 . . . . 72.11 111.073 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -56.7 116.96 3.45 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.718 0.636 . . . . 74.21 110.037 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.592 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 49.2 mt -97.0 141.04 16.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.753 -0.658 . . . . 72.42 110.861 -174.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.25 144.78 36.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.519 -0.919 . . . . 75.11 108.519 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.5 m -76.22 122.66 24.69 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.858 -0.793 . . . . 75.02 108.858 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.36 155.94 49.38 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.708 0.766 . . . . 71.44 111.601 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.3 m -113.05 128.87 56.61 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.29 -1.323 . . . . 73.41 108.382 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HG ' ' HB2' ' A' ' 50' ' ' PHE . 48.0 tp -103.7 99.57 16.36 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 108.863 -0.791 . . . . 71.44 108.863 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.8 146.63 10.51 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.016 1.811 . . . . 62.34 111.143 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.66 9.84 65.95 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.349 -0.929 . . . . 73.43 111.76 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.413 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 88.0 m-85 -145.36 159.3 43.27 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 107.503 -1.295 . . . . 74.22 107.503 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -139.3 139.63 37.37 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.059 -0.656 . . . . 72.32 109.613 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 58.7 ttp180 -99.77 135.66 40.85 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.762 -1.108 . . . . 75.22 108.429 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.639 ' HB3' ' O ' ' A' ' 126' ' ' MET . 54.1 m-85 -109.03 168.58 9.26 Favored 'General case' 0 C--N 1.277 -2.55 0 O-C-N 123.595 0.559 . . . . 74.0 109.508 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.825 ' HG2' ' CD1' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -98.3 166.26 11.47 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 115.097 1.517 . . . . 53.23 115.097 -174.061 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.446 ' H ' HD22 ' A' ' 55' ' ' LEU . 1.4 pt? -95.98 126.86 41.51 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.611 -1.632 . . . . 72.3 108.552 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -130.83 19.44 5.06 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.979 0.418 . . . . 62.33 111.913 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 136.0 -56.26 0.7 Allowed Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 119.319 -1.419 . . . . 63.2 114.516 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.431 ' C ' ' HD3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -91.05 -47.36 7.6 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.42 -0.512 . . . . 71.33 110.28 -174.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.5 tp -113.72 163.39 15.08 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.646 -0.822 . . . . 72.32 110.857 -177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -103.82 172.17 4.44 Favored Pre-proline 0 C--N 1.306 -1.288 0 C-N-CA 124.378 1.071 . . . . 73.05 109.433 -175.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 17.1 Cg_exo -69.25 112.41 2.98 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.878 1.719 . . . . 52.3 110.65 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 19.6 p -116.98 160.35 21.07 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 123.372 0.42 . . . . 72.11 111.666 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.426 HD13 HG23 ' A' ' 71' ' ' VAL . 46.5 mm -96.77 142.68 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 108.209 -1.034 . . . . 72.13 108.209 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 m -146.02 150.73 43.11 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 107.286 -1.375 . . . . 73.13 107.286 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.11 124.97 13.79 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.197 1.931 . . . . 73.04 112.248 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.3 t -124.98 145.38 49.9 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.606 -0.724 . . . . 61.34 109.279 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.23 -36.85 63.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.447 0.536 . . . . 64.3 112.447 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -131.7 15.68 4.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.697 0.629 . . . . 74.31 112.697 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.63 172.78 30.34 Favored Glycine 0 C--O 1.247 0.961 0 C-N-CA 120.486 -0.864 . . . . 72.43 112.391 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -154.64 156.33 36.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.641 -0.874 . . . . 61.4 108.641 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.426 HG23 HD13 ' A' ' 63' ' ' ILE . 40.4 t -124.64 137.69 56.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.131 -0.692 . . . . 74.02 109.131 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -107.95 116.12 31.38 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.518 -0.919 . . . . 73.54 108.518 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' HA2' ' OE1' ' A' ' 27' ' ' GLN . . . -141.45 -150.09 5.32 Favored Glycine 0 N--CA 1.404 -3.446 0 C-N-CA 119.918 -1.134 . . . . 72.41 112.15 -176.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.507 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 34.5 mmtp -131.3 141.54 49.97 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.712 -0.847 . . . . 73.24 108.712 -174.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.4 t -110.11 130.85 62.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 110.254 -0.276 . . . . 63.3 110.254 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 77.4 mt -95.09 105.63 17.57 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.643 -0.708 . . . . 72.23 109.421 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.494 ' HE2' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -98.65 125.45 43.94 Favored 'General case' 0 CA--C 1.479 -1.786 0 CA-C-O 121.77 0.795 . . . . 70.34 112.072 176.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 17' ' ' LEU . . . 102.46 26.39 7.3 Favored Glycine 0 C--N 1.28 -2.581 0 CA-C-N 114.363 -1.29 . . . . 71.01 112.849 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.462 HG11 ' O ' ' A' ' 18' ' ' HIS . 11.6 p -87.78 125.16 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.471 -0.937 . . . . 73.41 108.471 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.35 164.32 26.84 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 109.386 -0.598 . . . . 65.34 109.386 -176.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.5 m -58.36 -36.92 74.19 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 112.831 0.678 . . . . 55.01 112.831 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.74 -44.71 80.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.672 0.273 . . . . 72.2 110.447 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 1.2 mp0 -68.61 -30.53 69.28 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 116.406 -0.361 . . . . 64.53 110.24 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.4 tp -60.36 -50.25 74.36 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.287 -1.005 . . . . 74.03 108.287 174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.02 -28.59 69.6 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.65 -1.159 . . . . 74.42 111.243 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.555 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.3 t-20 -62.03 -49.41 76.11 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 123.331 0.652 . . . . 73.35 110.633 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.504 ' CD2' ' HE2' ' A' ' 35' ' ' MET . 92.3 mt -64.4 -38.74 92.09 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.651 0.739 . . . . 72.12 109.25 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.469 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 22.5 t70 -64.95 -35.52 81.44 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.537 -1.211 . . . . 70.2 110.829 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.64 -48.28 22.83 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.205 0.526 . . . . 73.23 110.129 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.7 t -62.99 -56.98 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 124.72 1.208 . . . . 73.44 113.168 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -79.97 -24.27 41.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.328 0.585 . . . . 75.21 112.524 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.7 -16.09 21.69 Favored Glycine 0 C--N 1.309 -0.97 0 N-CA-C 116.041 1.177 . . . . 71.32 116.041 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -57.94 -37.81 74.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 117.509 0.655 . . . . 73.4 112.344 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.63 10.17 3.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.889 0.376 . . . . 65.32 111.668 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -132.2 167.45 19.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.098 -0.704 . . . . 73.23 109.098 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.27 150.88 52.06 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.136 -1.061 . . . . 73.14 108.136 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -87.49 114.06 23.76 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.139 -0.689 . . . . 73.24 109.139 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.503 HG13 ' HE3' ' A' ' 117' ' ' MET . 34.2 m -121.21 160.52 22.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 116.678 -0.237 . . . . 71.52 111.171 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 t -92.29 134.21 35.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.349 -0.612 . . . . 64.5 109.349 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -139.85 161.38 26.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.599 -0.273 . . . . 55.13 110.924 -178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.68 123.94 7.84 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.646 -0.981 . . . . 73.24 110.646 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.17 158.79 16.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 110.399 -0.222 . . . . 75.04 110.399 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 56.6 t -121.99 123.86 70.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.327 -0.99 . . . . 64.23 108.327 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.54 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 28.1 mtp180 -68.71 121.88 17.39 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 116.185 -0.462 . . . . 61.22 110.496 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -72.22 -21.16 61.44 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 122.183 0.992 . . . . 73.55 108.806 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.81 -39.54 81.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.288 -1.778 . . . . 62.35 112.61 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -147.31 6.03 0.85 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.31 0.856 . . . . 74.04 113.31 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.5 t 73.08 12.58 4.98 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.586 1.154 . . . . 71.33 112.338 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -96.49 149.07 22.15 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.698 -0.626 . . . . 73.14 111.571 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -96.33 150.12 20.92 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 112.817 0.673 . . . . 64.23 112.817 -175.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.54 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.6 mtp -143.26 160.62 40.14 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.853 -1.067 . . . . 72.55 110.153 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.23 130.76 54.7 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.751 -0.833 . . . . 72.04 108.751 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 21' ' ' PHE . 35.3 m -142.27 173.96 6.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 120.894 0.378 . . . . 72.23 110.536 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -104.11 146.57 28.54 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.421 -0.955 . . . . 64.54 108.421 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.0 t -149.33 172.5 14.79 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.829 -0.804 . . . . 72.35 108.829 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -117.74 113.98 22.64 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.125 0.488 . . . . 75.52 109.953 -176.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.503 ' HE3' HG13 ' A' ' 98' ' ' VAL . 24.3 ptt? -109.0 156.38 19.8 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.848 -0.615 . . . . 60.33 110.794 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -68.4 128.85 38.08 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.498 -1.297 . . . . 74.04 107.498 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.6 mm -72.53 -38.51 59.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 112.653 0.612 . . . . 63.32 112.653 -170.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -76.28 -37.66 57.24 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.695 -0.402 . . . . 73.11 111.216 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.337 0.0 OUTLIER 37.77 65.01 0.6 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.123 1.157 . . . . 75.41 114.123 -173.174 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.29 -26.62 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.635 -0.711 . . . . 72.03 111.198 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.32 136.23 50.74 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 122.929 0.491 . . . . 61.11 112.052 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.16 -2.29 11.94 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.612 2.208 . . . . 71.44 110.677 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -63.88 -45.51 89.08 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 115.665 -0.698 . . . . 74.21 110.917 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.639 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.0 ptt? -75.89 -17.9 59.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.324 -0.398 . . . . 72.5 110.763 -178.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -62.39 107.96 1.02 Allowed 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.539 0.685 . . . . 74.43 110.737 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.66 135.39 2.0 Favored Glycine 0 N--CA 1.414 -2.827 0 CA-C-N 115.215 -0.902 . . . . 72.54 111.069 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 9.6 pt-20 -116.96 144.27 44.76 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.085 0.469 . . . . 70.31 110.999 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.825 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 14.1 m0 -104.4 156.51 17.87 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.568 -0.742 . . . . 75.54 110.16 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -57.94 -30.89 66.32 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 124.013 0.925 . . . . 71.44 112.393 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -62.42 -47.6 83.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.955 0.407 . . . . 72.23 110.989 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.534 ' HG3' ' CZ ' ' A' ' 54' ' ' ARG . 5.8 mm-40 -74.2 -32.2 62.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.846 -0.615 . . . . 75.43 109.764 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.464 ' HG3' HH21 ' A' ' 137' ' ' ARG . 41.3 tt0 -58.95 -53.96 52.51 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.792 -0.64 . . . . 64.33 110.595 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -65.46 -40.89 93.75 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 119.864 -0.734 . . . . 75.41 111.072 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -55.71 -41.55 74.0 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.98 0.419 . . . . 61.31 110.203 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.464 HH21 ' HG3' ' A' ' 134' ' ' GLU . 51.3 ttp180 -60.06 -52.09 66.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.84 -0.618 . . . . 75.35 111.951 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.89 -20.33 62.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.113 0.483 . . . . 74.43 111.925 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -80.83 -40.1 25.47 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.005 -0.739 . . . . 73.21 109.005 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.573 ' O ' HG12 ' A' ' 144' ' ' ILE . 37.5 ttpt -69.38 -39.85 77.76 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.752 -0.462 . . . . 74.31 109.752 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.81 -30.93 47.23 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.425 1.09 . . . . 64.35 111.78 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -65.37 -39.23 92.04 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.04 0.448 . . . . 73.23 109.917 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.488 ' O ' HG23 ' A' ' 146' ' ' THR . 92.6 m-85 -76.73 -32.84 58.06 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.572 0.701 . . . . 74.31 109.291 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.9 mm -58.53 -31.21 43.0 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 CA-C-N 114.845 -1.07 . . . . 74.32 111.713 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -50.64 -44.72 57.49 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.296 0.48 . . . . 63.45 112.296 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.488 HG23 ' O ' ' A' ' 143' ' ' PHE . 12.0 t -68.76 -40.58 79.69 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 120.221 -0.592 . . . . 71.33 110.25 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -69.65 -29.95 67.53 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 112.93 0.715 . . . . 64.35 112.93 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 38.2 ttpt -59.64 -43.2 93.95 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.534 -0.913 . . . . 74.54 108.534 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -72.58 -28.55 62.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.798 -0.637 . . . . 75.44 110.235 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 146' ' ' THR . 83.7 mt -73.76 -43.16 54.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.757 -0.656 . . . . 75.15 110.397 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.2 ptm -70.75 -29.89 66.25 Favored 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 121.089 -0.244 . . . . 64.01 111.579 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 8.2 mm-40 -66.1 -33.32 75.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.079 0.466 . . . . 75.21 110.728 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 41.8 t -71.95 -33.83 68.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.048 -0.523 . . . . 72.32 110.066 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -76.44 -44.81 34.13 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.56 0.695 . . . . 72.11 111.099 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -103.08 85.77 2.57 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.115 -0.948 . . . . 74.4 109.384 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -77.04 141.45 67.56 Favored Pre-proline 0 C--N 1.283 -2.325 0 CA-C-N 114.045 -1.434 . . . . 75.41 111.068 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -65.11 128.07 19.78 Favored 'Trans proline' 0 C--O 1.254 1.301 0 C-N-CA 122.19 1.927 . . . . 74.34 108.633 170.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 C--N 1.294 -1.81 0 CA-C-N 116.397 -0.365 . . . . 62.23 110.547 -176.683 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.41 -2.45 0 N-CA-C 107.369 -1.345 . . . . 71.43 107.369 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 m -71.12 153.14 42.77 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 109.112 -0.699 . . . . 70.41 109.112 177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.6 m -76.82 -44.77 31.16 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 109.323 -0.621 . . . . 64.44 109.323 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 65.98 -52.09 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.309 1.444 . . . . 62.41 113.707 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.7 t -74.41 159.13 32.74 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.092 -0.707 . . . . 74.44 109.092 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.54 79.19 6.04 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 121.735 0.779 . . . . 71.33 110.045 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.23 26.57 7.38 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.502 -1.226 . . . . 63.02 109.106 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.81 154.95 29.47 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 114.747 -1.115 . . . . 71.54 109.413 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.519 ' O ' HG11 ' A' ' 79' ' ' VAL . 37.5 m-70 -115.01 160.66 19.33 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 114.811 -1.086 . . . . 62.12 108.818 -174.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 22.5 p30 -131.14 127.03 37.21 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.548 0.69 . . . . 73.34 110.868 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.5 t -121.05 141.78 40.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.101 -0.954 . . . . 72.01 110.492 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -94.56 124.37 38.56 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.514 -0.921 . . . . 73.53 108.514 176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 m -109.12 126.4 66.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.364 0.602 . . . . 75.21 111.673 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -66.88 -34.09 77.03 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.803 1.038 . . . . 74.25 113.803 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 169.42 -28.44 0.13 Allowed Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 118.752 -1.69 . . . . 52.24 113.318 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.2 p -62.97 -36.8 84.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.143 0.497 . . . . 64.4 111.143 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.508 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 63.5 m-85 -124.67 28.79 6.44 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.669 -0.696 . . . . 73.12 112.23 -176.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -87.14 9.18 20.78 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.795 0.807 . . . . 72.44 108.848 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.535 ' O ' HG12 ' A' ' 32' ' ' ILE . 13.1 t70 -117.25 129.44 25.33 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.544 -1.207 . . . . 74.44 109.354 -176.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -71.08 -28.8 18.58 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.915 1.744 . . . . 55.21 112.558 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.443 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 24.0 t70 -62.35 -44.63 96.02 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 116.348 -0.387 . . . . 75.43 110.761 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.94 -29.3 36.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.997 -0.547 . . . . 72.5 109.93 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.535 HG12 ' O ' ' A' ' 28' ' ' ASP . 44.2 mm -65.76 -41.57 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 116.434 -0.348 . . . . 74.14 110.356 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.86 -46.21 71.21 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.296 0.569 . . . . 37.75 110.622 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -82.75 -36.14 13.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 114.371 1.249 . . . . 73.21 114.371 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.594 ' HE3' ' ND2' ' A' ' 86' ' ' ASN . 12.0 tmm? -67.84 -36.58 80.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.792 0.33 . . . . 74.33 110.701 -174.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.436 HD21 HG22 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -119.13 -71.69 0.72 Allowed 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.681 -0.808 . . . . 51.23 111.535 175.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.424 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 27.8 t70 167.96 -46.73 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.405 0.682 . . . . 72.53 109.481 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -111.75 160.3 17.44 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.355 -0.839 . . . . 75.01 110.345 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.411 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 40.3 m -119.55 111.1 36.56 Favored Pre-proline 0 N--CA 1.429 -1.509 0 CA-C-N 116.34 -0.391 . . . . 75.14 111.262 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -60.72 151.51 76.03 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.025 2.483 . . . . 70.55 110.378 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -62.57 121.47 13.4 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.117 0.484 . . . . 65.44 109.855 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.528 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 25.2 mt -99.08 131.05 47.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.379 -0.828 . . . . 71.2 109.385 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 p -130.4 148.05 33.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.899 -0.591 . . . . 74.41 110.352 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.413 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 34.5 m -75.59 124.19 26.79 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.024 0.44 . . . . 71.23 110.096 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.7 159.27 42.51 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.439 0.638 . . . . 63.42 111.513 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.47 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 78.3 m -118.23 129.43 55.48 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.479 -0.782 . . . . 74.34 109.892 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.6 tp -104.43 99.31 17.21 Favored Pre-proline 0 N--CA 1.426 -1.652 0 N-CA-C 109.733 -0.469 . . . . 73.32 109.733 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.5 Cg_endo -84.29 141.69 9.23 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.694 2.263 . . . . 72.32 110.752 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.36 4.14 57.41 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.616 -0.802 . . . . 71.05 111.492 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.403 ' HA ' ' H ' ' A' ' 66' ' ' SER . 82.4 m-85 -138.76 157.77 45.48 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.967 -0.753 . . . . 73.22 108.967 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -138.93 148.3 43.39 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.595 -0.52 . . . . 65.34 109.595 -175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.521 ' HD3' ' CZ3' ' A' ' 135' ' ' TRP . 5.7 ptm180 -100.6 126.35 47.06 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.265 -0.88 . . . . 74.51 110.564 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 68.1 m-85 -109.04 134.85 51.12 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.03 -1.47 . . . . 72.12 107.03 174.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.562 ' HB3' ' CD1' ' A' ' 130' ' ' TRP . 0.7 OUTLIER -129.27 130.89 46.77 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 113.798 1.036 . . . . 64.02 113.798 -166.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.8 162.54 29.54 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 103.224 -2.88 . . . . 75.43 103.224 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -144.73 97.53 3.04 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.314 -0.955 . . . . 74.11 109.963 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.77 -80.86 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 114.601 -1.181 . . . . 74.41 110.383 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.46 HH21 ' HB3' ' A' ' 125' ' ' ASP . 2.0 tmm_? -81.06 -51.2 8.75 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 106.969 -1.493 . . . . 74.52 106.969 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.9 tp -113.54 165.68 12.25 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 114.909 -1.041 . . . . 70.42 109.541 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -103.32 173.19 3.61 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 107.439 -1.319 . . . . 73.11 107.439 -173.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 7.1 Cg_exo -73.73 81.17 1.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 121.022 1.148 . . . . 74.3 109.932 170.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.0 m -85.74 157.17 20.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.801 -0.636 . . . . 63.24 112.109 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.414 HD12 HG23 ' A' ' 71' ' ' VAL . 49.2 mm -103.95 140.9 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 115.153 -0.931 . . . . 75.31 109.23 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.31 153.96 56.6 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.278 -1.008 . . . . 62.3 108.278 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.12 112.97 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.543 2.162 . . . . 65.2 112.378 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 33.5 t -125.54 126.64 45.16 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.329 -0.989 . . . . 72.42 108.329 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.48 -36.17 77.65 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.468 0.914 . . . . 72.31 113.468 -174.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -107.52 19.85 19.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.698 0.285 . . . . 74.52 111.495 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -109.31 160.13 13.68 Favored Glycine 0 N--CA 1.426 -1.989 0 C-N-CA 119.873 -1.156 . . . . 73.53 112.997 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.69 131.63 8.08 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.988 -1.116 . . . . 74.22 107.988 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.414 HG23 HD12 ' A' ' 63' ' ' ILE . 56.6 t -112.43 123.43 68.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 109.762 -0.458 . . . . 73.13 109.762 -176.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -97.01 115.88 28.23 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.366 -1.346 . . . . 75.51 107.366 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -144.69 -149.69 5.09 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 110.323 -1.111 . . . . 54.4 110.323 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.489 ' HD3' ' O ' ' A' ' 73' ' ' GLY . 2.2 mppt? -127.44 150.79 49.49 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 112.989 0.737 . . . . 70.21 112.989 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 28.1 t -110.87 131.88 60.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 114.593 -1.185 . . . . 73.3 112.016 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 78.8 mt -96.91 106.95 19.36 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.278 -1.008 . . . . 72.01 108.278 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.1 ptp -114.56 150.01 35.62 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 120.487 0.184 . . . . 73.1 110.714 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.71 15.86 47.89 Favored Glycine 0 N--CA 1.433 -1.513 0 C-N-CA 119.483 -1.342 . . . . 63.42 111.006 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.519 HG11 ' O ' ' A' ' 18' ' ' HIS . 11.3 p -87.43 126.24 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.119 -1.067 . . . . 53.02 108.119 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.6 p -76.29 172.66 12.52 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.809 -0.356 . . . . 72.24 110.276 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.9 p -59.87 -41.18 90.93 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 112.25 0.463 . . . . 55.42 112.25 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.04 -36.65 85.06 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.777 0.798 . . . . 63.44 110.888 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 42.2 mt-10 -78.06 -31.21 50.16 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.397 -0.819 . . . . 73.05 109.171 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.433 HD23 ' CE1' ' A' ' 18' ' ' HIS . 35.5 tp -66.27 -47.32 74.09 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.233 -0.44 . . . . 61.5 110.615 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.01 -29.37 70.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.268 0.556 . . . . 75.22 109.63 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.594 ' ND2' ' HE3' ' A' ' 35' ' ' MET . 7.7 t30 -67.21 -44.07 80.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.308 -0.86 . . . . 72.1 109.629 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.77 -43.17 94.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.747 -0.661 . . . . 71.41 109.758 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.534 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 31.3 t70 -65.65 -27.59 68.48 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.927 -1.033 . . . . 63.31 110.288 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.47 -48.5 22.37 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.053 -0.521 . . . . 70.4 110.286 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.501 HG21 ' SD ' ' A' ' 35' ' ' MET . 92.7 t -69.86 -58.27 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 112.473 0.546 . . . . 75.14 112.473 -175.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.95 -33.86 44.92 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.136 0.493 . . . . 73.53 111.351 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -60.11 -16.53 41.41 Favored Glycine 0 N--CA 1.465 0.587 0 CA-C-N 115.795 -0.639 . . . . 37.75 113.507 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -57.74 -37.44 73.61 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.695 0.398 . . . . 73.25 110.518 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -132.93 7.91 4.05 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.169 0.509 . . . . 74.42 111.84 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -131.07 168.84 16.73 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 122.709 0.404 . . . . 75.24 110.837 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.55 ' HB2' ' CD1' ' A' ' 119' ' ' ILE . 43.3 tt0 -122.46 129.97 52.59 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.536 -0.912 . . . . 60.3 108.536 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 115' ' ' THR . 60.0 ttp180 -86.14 114.16 22.77 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.912 -1.144 . . . . 74.11 107.912 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.488 HG12 ' HE2' ' A' ' 117' ' ' MET . 30.9 m -125.77 162.24 29.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.673 -0.694 . . . . 62.51 111.987 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -86.13 124.62 32.74 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.242 -0.89 . . . . 75.43 109.257 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.8 170.72 19.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.72 -0.673 . . . . 70.44 111.896 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -121.24 120.51 4.47 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 110.587 -1.005 . . . . 63.02 110.587 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -115.41 163.02 13.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 116.597 0.198 . . . . 61.52 110.64 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.498 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 59.5 t -117.3 125.38 73.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 107.603 -1.258 . . . . 74.14 107.603 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.511 ' HE ' ' HB3' ' A' ' 106' ' ' ASP . 29.4 ttp180 -79.2 118.67 21.36 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.082 -1.081 . . . . 72.41 108.082 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.413 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 45.4 mt-10 -66.94 -7.52 22.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.203 0.601 . . . . 72.24 111.081 -176.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.511 ' HB3' ' HE ' ' A' ' 104' ' ' ARG . 30.1 t70 -54.78 -46.51 74.45 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.996 -1.002 . . . . 74.21 108.92 172.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -133.8 -103.27 0.24 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.152 -1.055 . . . . 74.32 108.152 170.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 21.2 p -152.47 16.14 0.61 Allowed 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 106.374 -1.713 . . . . 74.05 106.374 174.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.89 128.5 35.67 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 114.458 -1.246 . . . . 75.23 108.183 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 60.8 pttt -99.36 147.39 25.28 Favored 'General case' 0 C--N 1.251 -3.678 0 CA-C-N 115.273 -0.876 . . . . 74.34 109.801 -176.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 32.8 mtm -136.14 163.44 30.34 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.721 0.772 . . . . 65.13 110.686 -176.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.63 118.15 35.8 Favored 'General case' 0 C--N 1.258 -3.41 0 CA-C-N 114.301 -1.318 . . . . 65.44 108.604 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.425 HG11 ' OD1' ' A' ' 19' ' ' ASN . 22.8 m -134.15 174.67 12.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.316 -0.624 . . . . 75.1 109.316 -176.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -113.25 146.27 39.61 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.985 -0.746 . . . . 54.03 108.985 175.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 14.4 t -136.04 171.4 14.53 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.354 -0.61 . . . . 62.41 109.354 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 80.1 m-85 -112.57 112.68 24.4 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.852 -0.613 . . . . 71.52 110.317 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.488 ' HE2' HG12 ' A' ' 98' ' ' VAL . 20.7 ptt? -112.67 157.83 20.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.656 -0.702 . . . . 71.41 109.582 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -67.64 139.91 56.83 Favored 'General case' 0 C--O 1.254 1.335 0 N-CA-C 109.104 -0.702 . . . . 75.51 109.104 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 96' ' ' GLU . 16.9 mm -72.24 -44.74 63.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 120.34 -0.544 . . . . 64.32 110.788 -172.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -70.32 -35.74 73.84 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 115.629 -0.714 . . . . 74.13 109.868 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.483 ' HZ1' ' HB3' ' A' ' 121' ' ' LYS . 0.1 OUTLIER 56.17 -4.45 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.082 2.153 . . . . 73.24 115.587 176.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.81 26.15 6.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.507 0.67 . . . . 51.04 109.407 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.591 ' O ' ' HG2' ' A' ' 126' ' ' MET . 10.2 t70 -62.78 125.66 86.9 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.131 -0.94 . . . . 75.25 109.558 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.44 -13.76 16.51 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.832 2.355 . . . . 61.42 113.204 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.46 ' HB3' HH21 ' A' ' 58' ' ' ARG . 22.2 t70 -89.3 -24.0 22.14 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.228 -0.442 . . . . 53.15 110.69 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.591 ' HG2' ' O ' ' A' ' 123' ' ' ASP . 21.4 ptp -64.94 -21.69 66.87 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.724 0.297 . . . . 60.34 111.262 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -71.64 107.57 4.56 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.243 -1.021 . . . . 75.44 108.243 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -140.15 -169.13 11.57 Favored Glycine 0 CA--C 1.489 -1.579 0 C-N-CA 120.507 -0.854 . . . . 53.25 112.239 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.29 127.21 36.64 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 109.4 -0.593 . . . . 75.13 109.4 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.562 ' CD1' ' HB3' ' A' ' 54' ' ' ARG . 18.5 m-90 -97.7 158.86 15.27 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 108.073 -1.084 . . . . 75.51 108.073 176.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.401 ' HB2' ' HB3' ' A' ' 134' ' ' GLU . 63.1 m-20 -70.28 96.34 1.1 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 102.82 -3.03 . . . . 74.01 102.82 165.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.418 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 81.4 m-85 -62.13 -37.38 84.95 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 113.43 0.9 . . . . 73.23 113.43 -166.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.22 -28.82 62.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.03 0.443 . . . . 63.55 110.02 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 131' ' ' ASN . 1.2 tm-20 -70.46 -47.33 61.13 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.577 -0.897 . . . . 73.22 108.577 175.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . 0.521 ' CZ3' ' HD3' ' A' ' 52' ' ' ARG . 8.7 t-105 -67.14 -44.51 79.65 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.1 -0.5 . . . . 72.12 112.301 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 132' ' ' PHE . 35.3 mmtp -60.74 -31.21 70.54 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.793 0.33 . . . . 73.02 111.005 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -65.79 -52.05 54.0 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.511 -0.768 . . . . 75.44 111.609 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.05 -33.86 63.86 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.332 0.587 . . . . 72.43 111.515 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -84.18 -3.14 57.95 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.861 -0.609 . . . . 74.35 111.264 -175.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.499 ' O ' HG12 ' A' ' 144' ' ' ILE . 34.7 ttpt -46.58 -43.92 17.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.284 1.434 . . . . 70.21 113.219 -176.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 88.2 tttt -53.85 -34.58 59.75 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.678 0.622 . . . . 72.12 112.678 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 142' ' ' LYS . 10.7 tmtt? -58.97 -43.6 91.38 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.387 -0.597 . . . . 72.44 109.387 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -76.74 -32.85 58.04 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.703 -0.68 . . . . 73.3 109.83 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 140' ' ' LYS . 51.6 mm -63.28 -33.38 60.76 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 CA-C-N 115.603 -0.726 . . . . 72.33 110.551 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 7.7 mm-40 -51.8 -39.05 58.01 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.281 0.845 . . . . 71.41 113.281 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -80.63 -39.33 27.57 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 119.973 -0.691 . . . . 74.45 110.511 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -67.89 -29.21 68.25 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 112.577 0.584 . . . . 72.4 112.577 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -53.76 -42.22 67.97 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 124.095 0.958 . . . . 52.23 109.315 173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -75.32 -42.04 55.44 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.584 -0.735 . . . . 62.12 110.126 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.2 mt -61.52 -39.56 83.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.735 -0.666 . . . . 64.22 111.654 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 57.8 ttp -62.14 -45.91 91.32 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 122.809 0.444 . . . . 61.23 110.1 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -66.39 -30.94 71.42 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.165 0.507 . . . . 65.42 110.071 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 45.1 t -69.17 -33.44 73.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.156 -0.475 . . . . 61.31 111.058 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -77.15 -27.52 53.84 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.412 0.625 . . . . 75.45 110.084 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -67.35 -31.45 71.71 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.916 -1.038 . . . . 65.43 109.736 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.538 ' HZ1' ' HB3' ' A' ' 156' ' ' LYS . 8.9 mtpm? -62.78 139.75 97.17 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 115.495 -0.775 . . . . 72.31 109.261 173.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.01 106.34 2.13 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.105 1.87 . . . . 54.02 112.543 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? . . . . . 0 N--CA 1.428 -1.528 0 N-CA-C 106.173 -1.788 . . . . 73.32 106.173 176.16 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.425 -1.679 0 CA-C-O 121.23 0.538 . . . . 74.13 110.267 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 t -96.41 152.34 18.7 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.879 -1.156 . . . . 72.54 107.879 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 m -76.57 -24.68 53.55 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.587 -0.523 . . . . 74.53 109.587 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.0 t70 41.72 74.96 0.09 Allowed 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 125.077 1.351 . . . . 75.31 112.097 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.5 m -135.38 33.32 3.05 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.526 -1.215 . . . . 60.14 107.791 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.92 86.86 1.3 Allowed 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 115.104 -0.953 . . . . 61.22 111.93 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -129.65 132.79 46.8 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 104.595 -2.372 . . . . 71.35 104.595 171.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' N ' HD21 ' A' ' 17' ' ' LEU . 1.8 mm? -90.64 153.59 20.2 Favored 'General case' 0 N--CA 1.395 -3.214 0 C-N-CA 119.664 -0.814 . . . . 74.01 110.982 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.467 ' O ' HG11 ' A' ' 79' ' ' VAL . 56.6 m-70 -123.61 159.77 28.55 Favored 'General case' 0 C--N 1.27 -2.858 0 CA-C-N 114.82 -1.082 . . . . 73.34 109.406 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 15.3 p30 -125.59 126.19 44.37 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.021 -0.99 . . . . 55.34 110.322 174.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.61 138.76 53.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.436 -0.802 . . . . 72.44 109.395 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -93.55 121.92 35.46 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.138 -1.43 . . . . 75.03 107.138 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.412 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 19.2 m -103.24 154.81 5.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 115.737 -0.665 . . . . 61.43 110.878 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -139.9 -30.05 0.7 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.989 0.737 . . . . 74.22 112.989 -170.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.49 -91.29 0.44 Allowed Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 118.875 -1.631 . . . . 72.53 113.523 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 m -58.69 -31.29 68.09 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.22 0.822 . . . . 73.43 113.22 -173.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.439 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 27.6 m-85 -117.49 21.56 12.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.677 0.992 . . . . 74.41 113.677 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.412 ' HA ' ' CG2' ' A' ' 22' ' ' VAL . 9.8 tt0 -82.67 -2.63 54.62 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 121.974 0.892 . . . . 71.23 110.131 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 32' ' ' ILE . 20.4 t70 -112.52 125.21 30.38 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 115.392 -0.822 . . . . 60.53 109.56 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.3 -31.12 36.0 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.716 2.277 . . . . 60.33 113.572 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -62.78 -38.14 89.45 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 120.686 0.279 . . . . 73.45 111.591 -176.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 28' ' ' ASP . 29.0 m -73.38 -28.19 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.147 -0.479 . . . . 64.15 110.752 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 28' ' ' ASP . 47.9 mm -61.49 -38.61 80.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 CA-C-O 121.046 0.451 . . . . 73.43 110.866 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -59.6 -35.13 73.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.698 -0.683 . . . . 71.31 110.275 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.9 t -82.07 -51.12 15.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.406 -0.815 . . . . 72.41 111.667 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.619 ' HE2' ' OD1' ' A' ' 86' ' ' ASN . 10.7 tmm? -63.68 -36.63 84.48 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.523 -0.308 . . . . 74.21 111.002 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.545 HD11 ' N ' ' A' ' 37' ' ' ASP 0.386 3.6 pp -121.56 -59.55 1.68 Allowed 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 114.702 1.371 . . . . 73.13 114.702 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.545 ' N ' HD11 ' A' ' 36' ' ' LEU . 17.2 t70 172.72 -55.44 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.127 0.489 . . . . 62.3 110.825 -176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.473 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 56.8 mmt-85 -138.75 159.1 42.95 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.828 -0.624 . . . . 51.0 110.195 -176.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.3 m -94.3 122.09 62.16 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 112.144 0.424 . . . . 74.31 112.144 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.61 153.26 68.19 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.066 3.177 . . . . 70.34 111.392 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -56.77 132.08 51.16 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.226 -0.657 . . . . 72.25 109.226 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 54.9 mt -115.49 134.67 57.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 109.307 -0.627 . . . . 75.23 109.307 -174.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.29 144.13 36.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 108.505 -0.924 . . . . 73.53 108.505 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.5 m -81.12 127.69 32.92 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 108.826 -0.805 . . . . 71.23 108.826 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.48 158.74 43.37 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.221 0.534 . . . . 74.35 110.834 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.485 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 97.1 m -113.58 127.69 56.16 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.187 -0.915 . . . . 73.04 110.082 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.8 tp -100.59 100.22 11.82 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 109.415 -0.587 . . . . 73.21 109.415 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 46' ' ' THR . 97.2 Cg_endo -88.09 135.21 3.23 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.649 2.233 . . . . 63.34 111.646 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.11 11.83 38.33 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.402 -0.904 . . . . 55.42 111.165 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.498 ' HA ' ' H ' ' A' ' 66' ' ' SER . 87.0 m-85 -145.31 159.69 42.66 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.876 -0.787 . . . . 74.13 108.876 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.42 143.8 37.8 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.662 -0.495 . . . . 73.22 109.662 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.527 ' HB3' ' CE2' ' A' ' 132' ' ' PHE . 59.1 ttt180 -104.41 132.68 50.39 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.825 -1.176 . . . . 73.01 107.825 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -108.76 169.82 8.42 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 113.378 0.881 . . . . 73.55 113.378 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -88.42 145.19 25.92 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 114.251 -1.34 . . . . 74.11 109.163 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 55' ' ' LEU . 1.6 pp -64.24 98.95 0.25 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 122.576 1.179 . . . . 64.5 110.529 173.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.4 ' HD3' ' CA ' ' A' ' 128' ' ' GLY . 49.8 tptt -104.53 100.23 9.91 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 114.796 -1.093 . . . . 73.32 110.29 -172.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.46 -87.16 0.15 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.569 -0.741 . . . . 62.52 114.742 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.411 ' HD2' ' H ' ' A' ' 58' ' ' ARG . 0.6 OUTLIER -104.39 2.07 30.84 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.272 0.471 . . . . 73.31 112.272 -172.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.512 HD22 ' HB3' ' A' ' 126' ' ' MET . 28.6 tp -125.89 163.95 21.83 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.256 -0.978 . . . . 73.0 112.351 -172.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -91.05 169.24 11.97 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 124.334 1.054 . . . . 62.54 108.993 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.39 98.05 1.14 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.823 1.682 . . . . 64.12 108.915 172.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 23.3 p -109.89 169.15 8.91 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.146 -0.479 . . . . 73.4 112.189 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.8 mm -108.82 141.24 24.62 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.022 0 C-N-CA 123.533 0.733 . . . . 73.41 109.232 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.3 153.62 52.56 Favored Pre-proline 0 N--CA 1.476 0.873 0 N-CA-C 107.762 -1.199 . . . . 74.43 107.762 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.416 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 30.7 Cg_endo -65.03 115.45 3.29 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.555 2.17 . . . . 72.3 113.966 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.498 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 47.3 t -125.82 112.95 16.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.25 -1.018 . . . . 64.22 108.25 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.62 -22.31 66.65 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.396 0.517 . . . . 74.03 112.396 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -109.63 14.82 23.23 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.86 0.362 . . . . 73.21 110.937 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.13 167.22 15.39 Favored Glycine 0 C--O 1.249 1.082 0 C-N-CA 120.684 -0.769 . . . . 38.77 112.663 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.41 143.54 18.94 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 123.834 0.854 . . . . 74.12 109.569 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.44 120.02 63.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 110.13 -0.322 . . . . 70.23 110.13 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -91.77 115.45 28.07 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.782 -1.562 . . . . 74.22 106.782 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.05 -150.37 5.29 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.573 -0.822 . . . . 64.44 111.866 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.43 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 73.5 mmtt -126.04 141.54 51.91 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.854 0.359 . . . . 75.51 110.339 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.3 t -111.09 131.04 63.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.966 -0.561 . . . . 75.24 110.78 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 66.9 mt -95.57 104.71 16.63 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.887 -0.783 . . . . 75.41 108.887 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.41 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 55.3 mtp -102.61 161.03 14.05 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.326 -0.99 . . . . 63.21 108.326 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.67 17.09 78.14 Favored Glycine 0 C--N 1.302 -1.346 0 C-N-CA 119.29 -1.433 . . . . 73.4 112.792 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.467 HG11 ' O ' ' A' ' 18' ' ' HIS . 10.9 p -91.82 136.02 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.28 -1.007 . . . . 64.12 108.28 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 79.2 p -78.93 168.39 19.76 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.899 -0.72 . . . . 72.24 111.766 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 m -63.0 -33.43 75.4 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.206 -0.452 . . . . 73.01 111.978 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.72 -39.17 93.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.795 0.807 . . . . 70.15 110.47 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.529 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.8 mt-10 -78.27 -28.36 47.62 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.979 -1.01 . . . . 73.14 109.296 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.445 HD23 ' CE1' ' A' ' 18' ' ' HIS . 53.3 tp -66.13 -50.29 64.53 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 109.882 -0.414 . . . . 63.45 109.882 175.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.99 -28.87 69.87 Favored 'General case' 0 C--O 1.208 -1.12 0 CA-C-O 121.379 0.609 . . . . 73.3 109.441 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.619 ' OD1' ' HE2' ' A' ' 35' ' ' MET . 12.6 t-20 -65.44 -49.06 70.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.171 -0.922 . . . . 62.54 110.537 176.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.4 mt -65.07 -38.85 92.12 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.824 0.821 . . . . 75.01 109.639 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.651 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 24.6 t70 -65.13 -31.68 73.0 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.231 -1.35 . . . . 73.55 109.737 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.21 -48.4 17.67 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.258 -0.883 . . . . 64.51 111.514 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 87' ' ' LEU . 7.3 p -72.33 -59.14 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 113.957 1.095 . . . . 73.13 113.957 -173.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.38 -32.93 37.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 119.643 -0.823 . . . . 74.4 110.847 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.651 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.46 -16.35 21.12 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.83 -1.077 . . . . 74.44 115.55 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.16 -24.58 51.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 118.277 1.038 . . . . 65.44 111.604 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -111.05 -11.59 14.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.42 0.629 . . . . 73.03 110.327 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -134.53 170.91 15.06 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.771 0.829 . . . . 74.12 110.416 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -121.62 138.03 54.49 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.335 -0.987 . . . . 73.02 108.335 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 115' ' ' THR . 39.6 ttp180 -87.48 119.13 27.45 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.794 -0.817 . . . . 73.25 108.794 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.508 HG12 ' HE3' ' A' ' 117' ' ' MET . 19.0 m -123.54 161.16 26.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 112.378 0.51 . . . . 75.42 112.378 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -91.5 122.96 34.55 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.014 -0.993 . . . . 73.12 108.955 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.42 158.96 43.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.104 0.478 . . . . 74.14 111.605 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.06 119.75 6.14 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 111.032 -0.827 . . . . 70.41 111.032 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.03 154.88 13.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 122.296 0.238 . . . . 64.23 110.431 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.74 117.72 55.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.181 0.515 . . . . 73.45 109.788 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -64.5 124.67 22.43 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 124.509 1.124 . . . . 73.44 111.414 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -61.41 -35.59 77.95 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.739 0.816 . . . . 74.01 112.115 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.2 -53.02 62.73 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.031 0.752 . . . . 71.41 113.031 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -128.96 10.86 5.98 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 113.5 0.926 . . . . 72.35 113.5 -167.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.4 t 63.93 12.44 6.83 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.403 0.681 . . . . 73.41 112.504 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -81.07 152.14 28.01 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.24 -0.652 . . . . 72.33 109.24 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -105.78 147.18 28.92 Favored 'General case' 0 C--N 1.278 -2.515 0 C-N-CA 120.263 -0.575 . . . . 62.53 109.789 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 40.9 mtm -137.55 163.05 32.13 Favored 'General case' 0 CA--C 1.465 -2.308 0 CA-C-O 121.412 0.625 . . . . 63.22 110.186 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.75 118.32 36.22 Favored 'General case' 0 C--N 1.262 -3.226 0 CA-C-N 114.612 -1.176 . . . . 70.23 108.474 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.428 HG12 ' CG ' ' A' ' 19' ' ' ASN . 30.8 m -128.22 173.52 13.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 116.062 -0.517 . . . . 73.33 110.172 -176.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -101.99 149.42 24.25 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.214 -1.402 . . . . 64.03 107.214 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.7 t -152.3 171.69 17.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.561 -0.903 . . . . 73.21 108.561 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -119.1 116.75 27.02 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.043 -0.725 . . . . 72.22 109.043 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.508 ' HE3' HG12 ' A' ' 98' ' ' VAL . 24.5 ptt? -112.63 156.79 22.12 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.054 -0.521 . . . . 73.15 109.777 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.45 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 64.4 t-105 -68.08 123.98 22.16 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.572 -0.899 . . . . 70.42 108.572 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.6 mt -67.86 -41.76 85.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.069 -0.968 . . . . 74.51 112.022 -172.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -88.12 75.76 8.62 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.973 0.892 . . . . 64.41 108.673 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -76.67 0.05 21.75 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.005 -0.998 . . . . 71.52 112.877 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.88 8.96 41.05 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.104 -0.498 . . . . 71.12 109.871 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.94 138.59 96.4 Favored Pre-proline 0 C--O 1.214 -0.774 0 CA-C-N 115.772 -0.649 . . . . 72.41 109.96 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -99.56 17.56 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.181 1.921 . . . . 44.3 113.308 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -118.01 -9.0 10.65 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.311 1.226 . . . . 75.3 114.311 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.512 ' HB3' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -86.65 -2.59 58.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 119.333 -0.947 . . . . 72.21 110.247 175.351 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -71.82 93.6 1.33 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.458 0.647 . . . . 74.15 111.295 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.4 ' CA ' ' HD3' ' A' ' 56' ' ' LYS . . . -128.53 168.6 20.31 Favored Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 109.255 -1.538 . . . . 61.22 109.255 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -90.76 125.13 35.6 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.714 -0.476 . . . . 74.15 109.714 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -128.96 158.44 38.84 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.145 -0.687 . . . . 75.51 109.145 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.465 ' O ' ' HB3' ' A' ' 134' ' ' GLU . 15.5 m120 -52.2 -3.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.451 1.648 . . . . 73.31 115.451 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.527 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 86.4 m-85 -67.73 -34.32 76.61 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.228 -0.92 . . . . 72.23 108.637 174.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -71.65 -28.62 63.88 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.91 -1.041 . . . . 55.3 109.464 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.576 ' HG3' ' NH2' ' A' ' 137' ' ' ARG . 39.2 tt0 -62.64 -40.69 97.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.316 -0.856 . . . . 64.24 109.425 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -71.46 -43.35 66.8 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.259 -0.428 . . . . 73.53 109.96 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -55.19 -31.01 61.07 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 116.016 -0.538 . . . . 65.45 110.932 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.576 ' NH2' ' HG3' ' A' ' 134' ' ' GLU . 44.2 ttp180 -59.12 -48.68 80.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.695 0.798 . . . . 62.02 112.72 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.65 -21.91 40.97 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.754 0.787 . . . . 74.11 110.221 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -84.52 -4.25 58.85 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.679 -1.146 . . . . 73.41 110.041 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.606 ' O ' HG12 ' A' ' 144' ' ' ILE . 6.3 ttpm? -48.63 -40.95 29.54 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 124.601 1.16 . . . . 72.52 114.053 -171.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -55.83 -35.08 65.99 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.314 0.857 . . . . 74.11 113.314 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 0.6 OUTLIER -66.74 -36.57 82.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.879 0.847 . . . . 74.33 108.749 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -77.03 -35.96 56.52 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 113.679 -1.6 . . . . 74.35 110.678 -175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 140' ' ' LYS . 50.1 mm -61.37 -32.67 53.86 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.981 0 N-CA-C 113.182 0.808 . . . . 72.42 113.182 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -51.77 -42.31 62.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 113.792 1.034 . . . . 71.12 113.792 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 150' ' ' ILE . 13.1 t -70.77 -33.67 71.02 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 120.128 -0.629 . . . . 74.22 109.811 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.475 ' O ' ' HG3' ' A' ' 151' ' ' MET . 64.0 m-85 -71.71 -30.36 65.56 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 116.125 -0.489 . . . . 63.33 111.679 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 152' ' ' GLU . 29.8 mtpp -59.83 -36.84 77.64 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.254 -1.017 . . . . 72.22 108.254 174.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 48.4 mmtt -74.56 -36.68 63.08 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.778 -0.646 . . . . 74.43 112.201 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.545 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 94.6 mt -63.28 -41.45 92.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.904 0.383 . . . . 63.54 110.09 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.475 ' HG3' ' O ' ' A' ' 147' ' ' PHE . 65.4 mtt -66.58 -40.64 89.02 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.656 -0.498 . . . . 70.11 109.656 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 148' ' ' LYS . 1.3 tm-20 -62.28 -34.29 76.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 124.87 1.268 . . . . 44.12 109.765 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 74.9 m -71.13 -34.07 70.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.188 -0.46 . . . . 70.3 110.553 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 34.6 mmtp -73.31 -45.25 56.5 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.261 -0.644 . . . . 71.12 109.261 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -165.54 -75.35 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.358 -0.837 . . . . 74.31 109.107 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -161.53 147.26 10.76 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 124.33 1.052 . . . . 74.51 110.784 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . 0.407 ' HB3' ' HB2' ' A' ' 151' ' ' MET . 54.5 Cg_endo -99.79 -169.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.138 2.559 . . . . 75.14 108.905 171.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 158' ' ' GLN . 11.7 mm-40 . . . . . 0 C--N 1.305 -1.357 0 N-CA-C 107.557 -1.275 . . . . 73.54 107.557 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m . . . . . 0 N--CA 1.428 -1.529 0 N-CA-C 108.427 -0.953 . . . . 71.24 108.427 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 p -74.54 75.8 1.97 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.926 0.869 . . . . 72.32 111.365 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.0 m -82.89 -25.18 32.73 Favored 'General case' 0 N--CA 1.422 -1.875 0 CA-C-N 114.553 -1.203 . . . . 72.44 109.889 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.0 t70 57.72 75.29 0.38 Allowed 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 124.267 0.98 . . . . 73.31 110.288 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.512 ' OG ' ' HB ' ' A' ' 80' ' ' THR . 44.9 m -154.05 105.51 2.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.477 -0.783 . . . . 64.0 111.628 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -100.39 -3.98 29.98 Favored 'General case' 0 N--CA 1.398 -3.063 0 CA-C-O 122.777 1.275 . . . . 72.03 108.3 173.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -133.15 129.18 37.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.913 -1.494 . . . . 71.32 107.445 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.429 ' N ' HD21 ' A' ' 17' ' ' LEU . 2.2 mm? -95.37 156.71 16.21 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.325 0.583 . . . . 63.34 112.14 -177.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.589 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.9 m-70 -113.9 161.25 17.85 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.016 -0.993 . . . . 74.31 109.191 -173.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 24.9 p30 -128.27 134.58 48.97 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.336 0.589 . . . . 73.35 112.117 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 53.9 t -131.52 137.97 54.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.659 -0.7 . . . . 73.44 110.345 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.406 ' HB2' HG21 ' A' ' 113' ' ' VAL . 93.2 t80 -94.67 123.83 38.34 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.195 0.598 . . . . 74.3 109.659 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 26' ' ' PHE . 13.1 p -138.56 155.46 28.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.416 -0.587 . . . . 71.15 109.416 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.428 ' CE1' HD11 ' A' ' 63' ' ' ILE . 2.0 p90 -148.97 6.31 0.69 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.923 0.392 . . . . 75.1 110.145 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.81 -92.61 1.02 Allowed Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 119.812 -1.185 . . . . 72.11 113.293 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.7 m -58.6 -36.11 73.49 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.441 0.696 . . . . 52.2 112.835 -174.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 22' ' ' VAL . 72.6 m-85 -120.04 29.78 7.35 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.259 0.552 . . . . 71.43 111.561 -175.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -62.95 -31.51 72.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.929 -1.032 . . . . 73.34 110.633 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 21.2 t70 -108.49 129.7 23.68 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.642 -0.708 . . . . 75.15 111.719 -176.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.23 -24.68 58.18 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.437 2.758 . . . . 71.23 113.915 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 16.4 t70 -70.46 -29.09 65.56 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.709 -0.619 . . . . 54.12 110.119 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.58 -39.57 84.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.345 -0.843 . . . . 75.24 108.824 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.431 HD12 ' HB3' ' A' ' 26' ' ' PHE . 29.0 mm -62.77 -45.03 99.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.253 -0.885 . . . . 74.22 110.526 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -53.2 -42.85 66.7 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.492 0.553 . . . . 71.3 112.492 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.55 -36.75 14.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 112.525 0.565 . . . . 71.5 112.525 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.7 tmm? -65.22 -35.85 82.33 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 121.32 -0.152 . . . . 62.05 110.683 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.539 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 0.8 OUTLIER -120.35 -74.7 0.6 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 119.967 -0.693 . . . . 75.01 112.444 172.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.539 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 16.3 t70 173.6 -48.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.528 0.731 . . . . 75.24 109.163 -174.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -109.13 164.95 11.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.604 -1.18 . . . . 60.01 109.094 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.4 m -123.93 129.35 24.81 Favored Pre-proline 0 C--N 1.307 -1.247 0 C-N-CA 122.361 0.264 . . . . 63.2 111.164 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -68.0 152.57 76.63 Favored 'Trans proline' 0 C--O 1.25 1.085 0 C-N-CA 123.278 2.652 . . . . 51.45 111.431 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.89 140.13 58.79 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.193 -0.669 . . . . 63.31 109.193 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 52.6 mt -118.35 142.66 32.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 120.889 0.376 . . . . 51.51 110.655 -173.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 104' ' ' ARG . 9.1 p -130.13 145.08 36.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.092 -0.707 . . . . 71.31 109.092 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.1 m -76.54 124.79 28.14 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.888 -0.782 . . . . 63.25 108.888 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.66 156.69 47.76 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.981 0.896 . . . . 72.34 112.042 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.422 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 64.8 m -116.16 128.89 56.02 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.398 -1.274 . . . . 73.24 108.153 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.0 tp -102.03 99.61 12.78 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 46' ' ' THR . 95.6 Cg_endo -85.47 148.37 10.03 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.349 2.033 . . . . 72.44 111.354 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.39 13.45 68.06 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.433 -0.889 . . . . 37.99 111.225 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -143.25 152.26 41.49 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.991 -1.114 . . . . 72.22 107.991 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -139.55 142.86 37.17 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.783 -0.767 . . . . 74.12 109.154 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.584 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -90.27 134.81 34.07 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.83 -1.174 . . . . 73.13 107.83 176.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB3' ' O ' ' A' ' 126' ' ' MET . 84.2 m-85 -116.64 169.11 9.6 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 112.097 0.406 . . . . 74.34 112.097 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -139.21 137.85 36.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.692 1.367 . . . . 72.31 114.692 -169.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 125' ' ' ASP . 1.1 tt -177.84 48.02 0.01 OUTLIER 'General case' 0 C--O 1.246 0.887 0 N-CA-C 104.133 -2.543 . . . . 65.52 104.133 169.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.673 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 86.1 tttt -67.3 116.81 8.48 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.821 -1.081 . . . . 61.53 110.124 -173.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.46 -28.65 2.43 Favored Glycine 0 C--N 1.296 -1.678 0 N-CA-C 107.907 -2.077 . . . . 73.44 107.907 -173.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.493 ' C ' ' HD3' ' A' ' 58' ' ' ARG . 0.3 OUTLIER -125.89 -41.06 1.99 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.018 -1.104 . . . . 73.34 108.018 175.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.673 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 37.5 tp -132.57 164.45 26.62 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.948 -0.76 . . . . 74.23 108.948 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -102.15 168.06 9.54 Favored Pre-proline 0 C--N 1.291 -1.957 0 N-CA-C 108.302 -0.999 . . . . 73.35 108.302 -172.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 21.9 Cg_exo -66.37 101.05 0.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 N-CA-C 108.639 -1.331 . . . . 61.0 108.639 171.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 9.3 p -102.54 153.3 20.21 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.547 -0.751 . . . . 73.33 112.969 -173.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.428 HD11 ' CE1' ' A' ' 23' ' ' TYR . 41.8 mm -106.13 117.94 52.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.297 -0.865 . . . . 72.24 110.289 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.36 146.58 62.58 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.46 -0.57 . . . . 70.43 109.46 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.1 109.05 1.05 Allowed 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.757 2.305 . . . . 72.23 112.303 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 t -124.64 121.76 35.61 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.01 -1.478 . . . . 53.43 107.01 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.61 -36.77 67.3 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.476 1.287 . . . . 74.32 114.476 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -109.1 20.05 18.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.193 0.52 . . . . 61.11 110.661 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.7 162.72 14.11 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.041 -1.076 . . . . 62.23 112.731 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -150.97 145.13 25.36 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 108.709 -0.849 . . . . 72.12 108.709 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.7 t -123.3 133.27 69.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.468 -0.568 . . . . 65.21 109.468 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -107.41 126.51 52.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.058 -1.09 . . . . 71.03 108.058 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.01 -154.91 7.08 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.753 -0.939 . . . . 63.01 110.753 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.51 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.2 mmtm -125.75 148.72 48.99 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 120.719 0.295 . . . . 73.12 110.221 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.5 t -109.75 126.41 66.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 116.154 -0.476 . . . . 63.24 110.289 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 69.4 mt -94.98 107.39 19.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.67 -1.233 . . . . 74.44 107.67 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.3 ptp -116.82 144.86 43.99 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.892 -0.41 . . . . 71.52 109.892 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.11 5.92 52.38 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.471 -1.347 . . . . 41.51 110.139 -173.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.589 HG12 ' O ' ' A' ' 18' ' ' HIS . 8.8 p -79.81 141.43 15.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 N-CA-C 108.107 -1.072 . . . . 73.42 108.107 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.512 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 36.3 p -87.97 175.78 7.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.359 -0.936 . . . . 43.03 110.452 -176.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.2 m -65.83 -26.79 67.83 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.504 -0.771 . . . . 75.22 110.933 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.6 -41.78 53.56 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.311 -0.556 . . . . 64.5 110.781 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.516 ' HA ' ' HB3' ' A' ' 86' ' ' ASN . 4.9 mp0 -70.16 -28.11 65.07 Favored 'General case' 0 C--O 1.203 -1.389 0 C-N-CA 119.004 -1.078 . . . . 72.21 108.854 173.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.6 tp -58.97 -51.24 70.9 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 109.644 -0.502 . . . . 75.44 109.644 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.79 -30.83 71.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.125 0.488 . . . . 70.04 110.163 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 2.2 t-20 -63.67 -49.76 71.93 Favored 'General case' 0 C--O 1.201 -1.46 0 CA-C-N 115.349 -0.841 . . . . 74.53 111.313 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.5 mt -69.74 -34.18 73.47 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.304 -0.628 . . . . 45.21 109.304 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.581 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 33.6 t70 -63.39 -36.86 85.11 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 114.651 -1.159 . . . . 72.22 109.011 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.98 -49.98 14.21 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.783 -0.644 . . . . 74.25 111.494 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.24 -57.63 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 123.752 0.821 . . . . 65.42 113.171 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -80.22 -26.67 39.03 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.415 0.626 . . . . 74.2 111.481 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.581 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -59.49 -16.08 34.83 Favored Glycine 0 N--CA 1.461 0.328 0 CA-C-N 114.693 -1.139 . . . . 72.3 115.909 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -57.47 -34.21 68.79 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 117.519 0.66 . . . . 63.14 111.833 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -131.95 -0.69 3.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.758 0.651 . . . . 73.23 112.758 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -122.91 166.35 15.19 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.584 -0.28 . . . . 72.3 110.246 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -122.6 142.72 50.33 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.488 -0.56 . . . . 73.44 109.488 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.438 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 15.6 ttp85 -87.01 114.63 23.78 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.765 -0.652 . . . . 74.43 110.153 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.505 HG13 ' HE3' ' A' ' 117' ' ' MET . 35.0 m -128.17 162.42 34.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.284 -0.871 . . . . 75.55 110.89 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -101.24 131.75 47.09 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.215 -0.661 . . . . 64.25 109.215 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.82 166.77 25.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 116.182 -0.463 . . . . 51.53 111.065 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.23 117.97 5.92 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 111.013 -0.835 . . . . 62.41 111.013 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.7 157.17 13.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.532 -0.544 . . . . 71.12 109.532 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.36 127.47 75.44 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 N-CA-C 107.89 -1.152 . . . . 71.41 107.89 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.45 ' HB2' ' OE2' ' A' ' 109' ' ' GLU . 60.7 mtm180 -71.48 141.83 50.2 Favored 'General case' 0 CA--C 1.489 -1.37 0 C-N-CA 119.501 -0.88 . . . . 72.02 110.151 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.24 5.6 25.96 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.303 -0.862 . . . . 73.41 111.042 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -94.02 -29.45 15.21 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.64 -0.709 . . . . 73.41 109.942 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.463 ' HB2' ' OE2' ' A' ' 109' ' ' GLU . 2.5 m-20 -118.9 -121.46 0.3 Allowed 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 108.487 -0.931 . . . . 65.33 108.487 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.3 m -167.03 17.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.485 1.914 . . . . 75.43 107.236 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.463 ' OE2' ' HB2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -105.43 157.84 17.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.646 -0.706 . . . . 73.44 111.735 -174.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -106.08 147.28 29.12 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.173 0.511 . . . . 45.41 110.743 -177.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 36.9 mtm -132.23 162.85 29.93 Favored 'General case' 0 CA--C 1.47 -2.134 0 CA-C-N 115.056 -0.975 . . . . 75.12 108.451 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.41 126.77 53.26 Favored 'General case' 0 C--N 1.249 -3.77 0 CA-C-N 114.853 -1.067 . . . . 54.53 108.851 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.406 HG21 ' HB2' ' A' ' 21' ' ' PHE . 32.6 m -139.0 173.01 12.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.617 -0.512 . . . . 74.35 109.617 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 3.6 mptp? -97.99 149.51 22.37 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.252 -1.018 . . . . 74.22 108.252 175.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.6 t -152.41 172.23 16.82 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.185 -1.043 . . . . 73.31 108.185 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 97' ' ' ARG . 96.6 m-85 -108.45 111.07 22.76 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-O 121.745 0.783 . . . . 74.33 110.191 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.505 ' HE3' HG13 ' A' ' 98' ' ' VAL . 56.9 ttp -105.37 146.63 29.18 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.321 -1.309 . . . . 64.42 109.04 -174.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.439 ' CZ2' HD13 ' A' ' 59' ' ' LEU . 65.8 t-105 -74.96 132.78 41.65 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.146 -1.427 . . . . 75.4 107.146 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 119' ' ' ILE . 2.5 mp -71.85 -41.87 69.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 120.428 -0.509 . . . . 71.42 111.189 -171.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -89.3 94.34 9.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.62 0.724 . . . . 70.11 110.729 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -81.68 12.03 4.25 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.538 -0.755 . . . . 74.34 111.291 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.25 22.54 7.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.739 -0.664 . . . . 60.41 110.047 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.54 121.29 78.45 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 109.889 -0.411 . . . . 74.22 109.889 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.97 -0.51 9.21 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.572 2.181 . . . . 64.45 113.769 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.501 ' O ' HD12 ' A' ' 55' ' ' LEU . 30.8 m-20 -96.61 -37.31 10.41 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 120.675 -0.41 . . . . 53.12 112.073 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.656 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 25.7 ptt? -63.25 -23.31 67.37 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 112.17 0.433 . . . . 54.55 112.17 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.71 103.7 0.72 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.229 0.538 . . . . 72.32 112.012 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -170.67 168.34 41.42 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.418 -1.073 . . . . 73.03 110.418 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.525 ' O ' ' HD3' ' A' ' 54' ' ' ARG . 10.1 pt-20 -89.08 134.46 33.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.415 0.626 . . . . 70.15 112.376 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.534 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 6.4 t90 -120.51 156.19 32.04 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.872 -1.899 . . . . 73.42 105.872 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -52.36 -33.83 44.86 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 113.517 0.932 . . . . 71.44 113.517 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -54.32 -30.08 49.95 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.603 0.964 . . . . 72.11 113.603 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 130' ' ' TRP . 0.8 OUTLIER -61.58 -28.25 69.21 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.141 0.423 . . . . 73.54 112.141 -177.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 42.5 tt0 -60.95 -41.05 95.55 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.517 -0.765 . . . . 73.21 109.307 174.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -73.38 -31.4 63.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.711 -0.477 . . . . 74.22 109.711 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -60.47 -37.17 80.16 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 108.394 -0.965 . . . . 72.34 108.394 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.677 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 61.8 ttt180 -63.43 -51.02 67.47 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.187 -0.915 . . . . 74.2 111.543 176.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.9 -14.9 62.07 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.472 0.545 . . . . 75.32 112.472 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -95.55 -28.78 14.7 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.967 -0.293 . . . . 70.45 111.215 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.677 ' HG2' ' O ' ' A' ' 137' ' ' ARG . 22.7 ptmt -62.07 -32.73 73.3 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 110.038 -0.356 . . . . 74.24 110.038 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -48.85 -39.26 24.99 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.411 1.084 . . . . 63.35 111.107 -175.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.54 -44.45 85.17 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.083 0.468 . . . . 72.53 110.698 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.0 -35.58 59.52 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.14 -0.689 . . . . 74.11 109.14 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.568 HG12 ' O ' ' A' ' 140' ' ' LYS . 45.9 mm -60.99 -32.61 52.98 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.708 0 CA-C-N 115.615 -0.72 . . . . 60.35 110.848 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 43.9 mt-10 -55.08 -44.57 74.98 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.917 -0.313 . . . . 72.31 111.39 176.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.46 ' O ' HG13 ' A' ' 150' ' ' ILE . 9.9 t -80.19 -36.73 34.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 119.828 -0.749 . . . . 72.24 110.342 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.486 ' O ' ' HG2' ' A' ' 151' ' ' MET . 54.8 m-85 -66.94 -30.68 70.88 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.942 1.089 . . . . 75.02 113.942 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 87.8 tttt -62.08 -36.95 83.22 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.132 -1.062 . . . . 51.43 108.132 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 146' ' ' THR . 86.5 tttt -74.05 -37.89 64.14 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.425 -1.261 . . . . 63.14 109.526 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 146' ' ' THR . 83.6 mt -67.02 -33.76 65.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.756 -0.656 . . . . 71.23 110.206 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 26.3 mmt -66.33 -30.46 70.87 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.009 -0.367 . . . . 73.54 110.009 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 23.1 mm-40 -72.31 -30.52 64.87 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.988 -0.551 . . . . 73.34 109.647 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 66.6 m -70.65 -31.46 68.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.403 0.62 . . . . 74.32 109.608 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -79.95 -19.79 47.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 74.31 109.514 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.2 tttm 62.36 60.64 1.38 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 125.629 1.572 . . . . 64.41 109.735 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -140.9 112.16 6.82 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 114.685 -1.143 . . . . 74.54 109.412 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.57 165.09 23.11 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.648 2.232 . . . . 73.33 112.831 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 C--N 1.304 -1.389 0 CA-C-O 122.132 0.968 . . . . 73.0 109.307 176.349 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.2 p . . . . . 0 N--CA 1.434 -1.262 0 N-CA-C 108.413 -0.958 . . . . 54.3 108.413 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.3 m -85.22 71.93 10.8 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.772 0.796 . . . . 72.22 111.843 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.2 m -89.35 -10.68 45.77 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 114.54 -1.209 . . . . 70.45 109.622 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 78.89 179.25 0.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.623 1.569 . . . . 72.33 108.171 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -89.51 99.57 12.54 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.53 -0.731 . . . . 72.43 110.27 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.9 98.97 7.34 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.606 -0.887 . . . . 61.23 108.606 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -138.63 147.9 43.45 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.472 0.653 . . . . 75.13 111.436 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.15 156.38 25.75 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 107.748 -1.205 . . . . 60.1 107.748 174.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' O ' HG13 ' A' ' 79' ' ' VAL . 39.7 m-70 -112.5 159.32 18.9 Favored 'General case' 0 C--N 1.262 -3.233 0 N-CA-C 108.085 -1.08 . . . . 73.04 108.085 -173.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -117.04 125.83 51.92 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.108 -1.441 . . . . 73.33 107.108 177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.2 t -119.38 137.72 52.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 110.391 -0.225 . . . . 70.12 110.391 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.404 ' HB2' HG21 ' A' ' 113' ' ' VAL . 70.1 t80 -94.91 122.08 37.17 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.442 -0.948 . . . . 74.12 108.442 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.404 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 15.6 m -103.2 105.71 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.224 1.011 . . . . 63.42 111.135 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.416 ' HB2' HD11 ' A' ' 63' ' ' ILE . 43.2 p90 -72.08 -18.87 61.89 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.003 -1.453 . . . . 74.44 114.272 -173.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.72 -40.22 0.3 Allowed Glycine 0 CA--C 1.499 -0.921 0 C-N-CA 118.979 -1.581 . . . . 72.43 112.947 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -58.06 -36.49 72.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.869 0.467 . . . . 70.1 112.189 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.618 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 49.3 m-85 -134.75 37.35 3.08 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.472 0.654 . . . . 75.33 109.435 -176.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.404 ' HA ' ' CG2' ' A' ' 22' ' ' VAL . 34.2 tt0 -86.18 -4.78 59.24 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.6 -0.727 . . . . 64.3 110.962 -175.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -105.8 121.12 46.92 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 109.381 -0.6 . . . . 74.32 109.381 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.422 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 11.7 Cg_endo -56.89 -31.53 89.48 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.159 2.573 . . . . 65.44 113.934 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.03 -33.64 74.98 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.409 0.624 . . . . 63.32 109.973 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.28 -39.15 82.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.172 -0.922 . . . . 64.42 108.792 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.488 HG22 HD23 ' A' ' 36' ' ' LEU . 44.5 mm -62.56 -37.41 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.285 -0.871 . . . . 71.24 110.361 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.87 -50.17 66.88 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.57 0.7 . . . . 73.42 110.287 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.85 -44.9 19.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 114.222 1.194 . . . . 72.03 114.222 -173.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.618 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 5.9 tmm? -62.33 -36.55 82.52 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.06 0.457 . . . . 74.34 110.707 -173.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.488 HD23 HG22 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -116.71 -75.13 0.58 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 120.491 -0.484 . . . . 72.05 111.926 178.241 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.9 t70 173.18 -47.74 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.292 0.568 . . . . 72.32 111.116 -175.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.525 ' HD2' ' OE2' ' A' ' 83' ' ' GLU . 4.6 ptp180 -126.57 164.47 21.15 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.507 -0.769 . . . . 72.31 109.75 -174.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.6 m -124.63 108.87 28.6 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-O 120.59 0.233 . . . . 75.34 110.704 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -63.57 152.07 82.03 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.58 2.853 . . . . 74.14 111.768 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -56.51 137.56 53.14 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 123.635 0.584 . . . . 64.24 109.591 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.4 mt -115.59 137.33 49.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 116.297 -0.41 . . . . 74.54 111.179 -170.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.3 146.46 34.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.096 -0.705 . . . . 73.53 109.096 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 m -77.0 127.37 32.57 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.085 -0.709 . . . . 64.53 109.085 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.412 ' CB ' HD11 ' A' ' 102' ' ' ILE . . . -143.58 159.41 42.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.208 0.528 . . . . 74.42 111.994 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.4 m -119.45 131.89 55.7 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.585 -0.734 . . . . 74.43 110.779 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -101.6 103.41 27.67 Favored Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-N 115.55 -0.75 . . . . 54.4 109.484 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.2 142.61 7.48 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.241 1.96 . . . . 62.44 111.553 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.46 7.75 60.26 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.451 -0.88 . . . . 71.1 111.556 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -145.35 143.53 30.19 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 107.0 -1.481 . . . . 74.13 107.0 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.413 ' HB2' ' HA3' ' A' ' 69' ' ' GLY . 62.4 tt0 -143.04 142.82 31.67 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.705 -1.22 . . . . 74.24 107.705 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -91.21 125.83 36.11 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 119.978 -0.689 . . . . 75.51 109.542 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.603 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 11.6 m-30 -107.67 135.64 48.77 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.942 -1.026 . . . . 73.22 108.653 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -108.91 165.26 11.71 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.774 0.797 . . . . 73.34 112.525 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 125' ' ' ASP . 64.9 tp -154.3 -50.31 0.09 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.225 -1.352 . . . . 71.22 107.666 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? 62.0 74.04 0.45 Allowed 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 124.895 1.372 . . . . 71.01 107.708 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.46 -114.4 0.36 Allowed Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.29 -0.868 . . . . 63.03 111.169 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -77.14 -26.2 52.85 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.976 -0.75 . . . . 72.41 108.976 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.9 tp -116.19 163.43 15.99 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.913 -1.04 . . . . 61.44 108.631 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -107.0 170.18 5.96 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.895 -1.15 . . . . 72.12 107.895 -171.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.603 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 9.7 Cg_exo -72.19 99.91 1.06 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 121.529 1.486 . . . . 74.25 108.758 171.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.493 ' SG ' ' HG2' ' A' ' 126' ' ' MET . 27.7 p -105.36 160.01 15.46 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.039 -0.528 . . . . 73.04 112.054 -172.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 23' ' ' TYR . 48.8 mm -94.64 125.08 47.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.764 -0.653 . . . . 72.42 109.656 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.13 146.94 63.22 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.54 -0.541 . . . . 74.41 109.54 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.32 104.91 0.27 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.653 2.235 . . . . 71.4 112.573 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -125.47 108.12 11.32 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.945 -1.132 . . . . 71.54 107.945 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.27 -27.25 68.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.946 0.403 . . . . 74.2 111.807 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -90.62 8.09 36.0 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.151 -0.477 . . . . 74.51 111.447 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 51' ' ' GLN . . . -129.23 171.35 20.02 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.791 -1.195 . . . . 43.31 114.103 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.8 143.65 17.3 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.231 1.012 . . . . 73.53 108.483 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.18 122.9 69.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.772 -0.455 . . . . 63.03 109.772 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -95.46 116.31 28.63 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.938 -1.134 . . . . 74.52 107.938 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.463 ' C ' ' HD3' ' A' ' 74' ' ' LYS . . . -148.47 -155.43 6.67 Favored Glycine 0 N--CA 1.415 -2.711 0 C-N-CA 120.242 -0.98 . . . . 63.54 111.558 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.463 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 2.7 mppt? -122.56 149.2 44.28 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 112.916 0.709 . . . . 54.32 112.916 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.1 t -110.2 129.21 65.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-N 113.99 -1.459 . . . . 75.32 111.552 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.0 mt -95.68 108.37 20.66 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.127 -1.435 . . . . 74.02 107.127 175.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.8 ptp -111.49 147.53 35.12 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 120.922 0.392 . . . . 73.42 111.459 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.65 17.12 53.41 Favored Glycine 0 N--CA 1.42 -2.384 0 C-N-CA 119.533 -1.318 . . . . 72.03 111.311 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 18' ' ' HIS . 9.5 p -80.72 132.29 31.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.028 -0.73 . . . . 74.41 109.028 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -75.75 159.91 30.57 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 108.464 -0.939 . . . . 72.21 108.464 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.4 m -59.32 -26.6 65.16 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 112.547 0.573 . . . . 73.21 112.547 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -70.87 -47.22 60.44 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.036 0.446 . . . . 75.13 110.766 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 1.2 mp0 -68.7 -28.79 67.16 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.153 -0.684 . . . . 74.24 109.153 176.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.508 ' HG ' ' NH2' ' A' ' 97' ' ' ARG . 42.1 tp -62.77 -50.85 69.4 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 120.882 0.372 . . . . 71.14 110.345 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.82 -29.8 70.33 Favored 'General case' 0 C--O 1.208 -1.106 0 N-CA-C 109.687 -0.486 . . . . 61.12 109.687 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.612 ' OD1' ' HE1' ' A' ' 35' ' ' MET . 16.9 t-20 -59.16 -47.86 83.76 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.627 0.771 . . . . 70.3 109.964 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.481 ' HA ' HG13 ' A' ' 90' ' ' VAL . 97.5 mt -64.65 -37.01 86.11 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.225 -0.898 . . . . 71.31 111.27 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.513 ' HB2' ' NH2' ' A' ' 97' ' ' ARG . 19.1 t70 -73.54 -30.7 63.24 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 121.211 0.529 . . . . 72.31 110.096 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.24 -46.56 64.19 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.051 0.453 . . . . 75.13 110.323 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 87' ' ' LEU . 13.6 p -72.35 -50.56 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.531 0 CA-C-N 115.819 -0.628 . . . . 63.33 112.325 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -77.85 -30.29 50.87 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 112.731 0.641 . . . . 74.44 112.731 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.02 -17.36 22.45 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 114.704 0.641 . . . . 63.13 114.704 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.56 -37.4 81.16 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 122.132 0.173 . . . . 52.23 110.54 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.53 -9.57 3.63 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.39 0.515 . . . . 52.13 112.39 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -126.28 167.38 15.56 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.281 -0.262 . . . . 72.22 111.076 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 38.4 tt0 -123.7 146.39 48.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.444 -0.576 . . . . 43.44 109.444 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.513 ' NH2' ' HB2' ' A' ' 88' ' ' ASP . 34.4 ttm180 -89.41 128.74 35.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.759 0.314 . . . . 71.43 110.838 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 m -133.08 162.34 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.023 0 CA-C-N 115.894 -0.594 . . . . 70.12 111.42 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.5 t -103.72 124.04 48.15 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 114.972 -1.013 . . . . 71.11 108.272 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.29 165.21 32.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 116.213 -0.449 . . . . 63.33 111.419 -173.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.35 123.68 7.88 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.982 -0.847 . . . . 61.51 110.982 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.412 HD11 ' CB ' ' A' ' 45' ' ' ALA . 2.7 pp -117.42 165.1 13.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 110.244 -0.28 . . . . 70.52 110.244 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 80.6 t -128.25 125.83 64.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.554 -0.535 . . . . 54.53 109.554 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.607 ' HB3' ' OD1' ' A' ' 106' ' ' ASP . 34.4 mtp180 -64.71 128.55 36.26 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 124.369 1.068 . . . . 74.3 111.845 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -71.36 -18.62 62.36 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.482 0.713 . . . . 60.02 110.952 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.607 ' OD1' ' HB3' ' A' ' 104' ' ' ARG . 7.8 p-10 -78.51 -41.61 31.89 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.113 -0.494 . . . . 74.21 112.237 -173.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.79 16.45 1.78 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.188 0.81 . . . . 73.31 113.188 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.9 m 68.0 14.62 9.39 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.99 1.107 . . . . 74.32 113.99 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -75.59 145.85 40.84 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.052 -0.405 . . . . 61.31 110.905 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -96.51 147.78 23.49 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.165 -0.47 . . . . 73.11 109.895 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 35.4 mtm -145.43 163.15 35.52 Favored 'General case' 0 CA--C 1.473 -1.99 0 CA-C-O 121.306 0.574 . . . . 74.11 110.347 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.84 123.03 48.41 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 114.31 -1.314 . . . . 75.42 108.435 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.7 m -132.96 169.66 21.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.232 0.539 . . . . 64.24 111.446 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -103.87 134.15 47.65 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.72 -1.215 . . . . 73.03 107.72 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.4 t -135.92 171.11 14.94 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.832 -0.803 . . . . 75.23 108.832 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.0 m-85 -121.51 125.88 47.87 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.824 -0.806 . . . . 74.54 108.824 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.39 157.97 41.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.348 -0.387 . . . . 74.44 110.121 -176.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 61.1 t-105 -67.54 130.94 44.62 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.188 0.595 . . . . 75.2 109.88 -175.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 119' ' ' ILE . 2.5 mp -73.57 -44.19 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 112.252 0.464 . . . . 71.52 112.252 -172.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -67.35 -43.63 81.03 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.42 -0.585 . . . . 74.53 109.42 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? 51.07 17.97 0.51 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.158 1.783 . . . . 71.54 113.968 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.34 1.73 5.7 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.422 0.527 . . . . 63.21 112.422 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.22 121.46 56.07 Favored Pre-proline 0 N--CA 1.483 1.217 0 N-CA-C 111.649 0.24 . . . . 64.24 111.649 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.24 -17.79 50.21 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.568 2.179 . . . . 54.44 111.41 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.467 ' HB3' HD21 ' A' ' 55' ' ' LEU . 2.2 m-20 -55.82 -41.08 73.69 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.137 -0.938 . . . . 71.43 110.754 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.493 ' HG2' ' SG ' ' A' ' 62' ' ' CYS 0.329 0.0 OUTLIER -96.94 84.83 3.63 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-O 122.809 1.29 . . . . 72.23 113.106 -178.915 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -135.8 89.16 2.46 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.945 -1.132 . . . . 73.55 107.945 174.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 169.67 131.6 1.34 Allowed Glycine 0 N--CA 1.414 -2.796 0 N-CA-C 107.011 -2.436 . . . . 74.01 107.011 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -95.35 149.64 21.14 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 117.396 0.598 . . . . 63.23 110.076 -173.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -79.19 157.54 27.84 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 105.833 -1.914 . . . . 73.52 105.833 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -55.04 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 117.409 2.374 . . . . 70.12 117.409 -172.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -56.65 -30.54 63.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.425 0.557 . . . . 72.31 110.99 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -51.86 -33.48 36.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.188 0.995 . . . . 72.25 112.01 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 33.9 tt0 -71.41 -45.61 62.32 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 120.784 -0.366 . . . . 74.25 111.007 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 38.3 t-105 -73.97 -30.4 62.49 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.028 0.442 . . . . 74.13 110.219 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -57.76 -40.23 79.25 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.568 -0.901 . . . . 73.41 108.568 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.529 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 22.2 tpt180 -55.78 -50.92 69.14 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.059 -0.973 . . . . 73.32 111.056 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.74 -20.29 59.88 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.105 -0.498 . . . . 71.3 111.684 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -69.6 -33.89 73.33 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.314 -0.625 . . . . 74.13 109.314 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.601 ' O ' HG12 ' A' ' 144' ' ' ILE . 64.9 tttm -62.74 -35.14 78.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.483 -0.78 . . . . 70.43 109.775 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.1 mmmt -54.67 -40.31 68.93 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 114.206 1.187 . . . . 71.1 114.206 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -55.44 -43.48 75.44 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.542 1.163 . . . . 73.22 109.507 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -73.9 -35.27 64.64 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 113.719 -1.582 . . . . 74.23 109.192 -175.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 140' ' ' LYS . 33.4 mm -72.19 -38.65 63.1 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.054 0 CA-C-N 115.747 -0.661 . . . . 64.55 110.831 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 17.1 mm-40 -59.69 -32.43 70.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.227 0.537 . . . . 73.31 110.471 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.2 m -70.29 -47.21 62.21 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.021 -0.991 . . . . 74.41 108.904 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -71.06 -28.62 64.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.412 1.264 . . . . 72.42 114.412 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -57.75 -38.07 74.73 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.751 -1.203 . . . . 61.43 107.751 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -71.46 -28.83 64.22 Favored 'General case' 0 C--O 1.227 -0.09 0 CA-C-N 115.742 -0.663 . . . . 73.01 110.459 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.417 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 68.3 mt -72.62 -31.31 36.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.664 -0.698 . . . . 74.3 109.453 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 65.0 mtt -63.36 -41.16 98.81 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.667 -0.864 . . . . 64.14 108.667 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -61.68 -35.92 79.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.092 -0.958 . . . . 74.54 110.045 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 84.3 m -67.41 -31.25 71.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.667 -0.697 . . . . 64.44 111.431 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 74.7 mmtt -71.13 -27.71 63.77 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.362 -0.977 . . . . 64.23 108.362 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt 72.89 -70.62 0.16 Allowed 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 126.05 1.74 . . . . 63.21 112.981 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt 64.93 161.19 0.12 Allowed Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.256 1.022 . . . . 38.07 111.696 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -75.75 94.86 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.691 1.594 . . . . 70.01 110.006 173.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 . . . . . 0 C--N 1.308 -1.197 0 C-N-CA 123.553 0.741 . . . . 73.12 109.029 -177.127 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 14' ' ' SER . 49.5 t . . . . . 0 N--CA 1.431 -1.422 0 CA-C-O 120.675 0.274 . . . . 72.23 110.306 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -92.01 -162.71 0.95 Allowed 'General case' 0 C--O 1.249 1.041 0 N-CA-C 107.034 -1.469 . . . . 65.2 107.034 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.5 p -61.79 -39.66 92.49 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.502 -0.925 . . . . 73.51 108.502 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.23 149.18 28.01 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.195 -1.366 . . . . 73.12 108.626 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.584 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 15.7 t -97.89 72.49 2.24 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 106.186 -1.783 . . . . 60.23 106.186 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt 58.9 85.15 0.1 Allowed 'General case' 0 N--CA 1.413 -2.29 0 C-N-CA 125.376 1.471 . . . . 72.22 110.559 -172.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -76.32 153.53 35.79 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.565 -0.743 . . . . 74.45 111.522 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.87 155.39 25.36 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 108.406 -0.961 . . . . 73.4 108.406 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.509 ' O ' HG13 ' A' ' 79' ' ' VAL . 47.3 m-70 -114.0 159.99 19.34 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 115.785 -0.643 . . . . 73.3 110.043 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 17.0 p30 -130.31 128.22 41.07 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.905 -1.043 . . . . 73.44 111.483 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.7 t -127.53 142.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.771 -1.104 . . . . 55.1 109.516 -174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -93.81 123.23 37.01 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.582 -1.266 . . . . 74.15 107.582 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -96.8 136.98 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-O 121.285 0.564 . . . . 75.11 111.54 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.489 ' HD2' ' O ' ' A' ' 61' ' ' PRO . 24.1 p90 -109.27 -50.2 3.03 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.817 1.043 . . . . 65.44 113.817 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -151.43 -49.83 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 118.093 -2.003 . . . . 38.51 115.411 -174.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.8 m -58.88 -37.02 75.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.583 0.692 . . . . 53.14 111.559 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 36.6 m-85 -119.76 37.67 4.13 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.898 -0.592 . . . . 74.14 110.763 -176.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.41 23.14 0.07 Allowed 'General case' 0 CA--C 1.576 1.943 0 CA-C-O 121.647 0.737 . . . . 71.04 110.754 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 26' ' ' PHE . 25.9 t70 -150.15 129.97 6.64 Favored Pre-proline 0 C--N 1.308 -1.229 0 C-N-CA 123.707 0.803 . . . . 72.45 109.321 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.542 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 63.5 Cg_endo -73.22 -24.48 16.8 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.233 1.956 . . . . 74.03 113.177 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.85 -38.65 83.41 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.78 0.324 . . . . 73.12 110.969 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.22 -28.93 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.108 0.48 . . . . 74.01 110.044 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 29' ' ' PRO . 37.1 mm -58.99 -37.78 69.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.918 -0.583 . . . . 64.31 110.258 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.83 -44.51 70.32 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.688 0.756 . . . . 64.12 110.342 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.58 -41.88 17.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 114.701 -1.136 . . . . 73.53 113.256 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.513 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.5 tmm? -65.95 -37.48 86.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.871 -0.332 . . . . 74.45 111.14 -171.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.46 HD23 HG23 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -116.88 -66.74 1.05 Allowed 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.656 -0.818 . . . . 71.45 111.383 176.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 27.6 t70 167.51 -52.22 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 123.785 0.678 . . . . 72.35 109.47 -177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -108.52 164.1 12.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.198 -0.91 . . . . 72.35 109.619 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 m -114.0 106.01 53.77 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 108.514 -0.921 . . . . 73.22 108.514 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.86 151.56 32.47 Favored 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 123.397 2.731 . . . . 64.42 111.952 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -64.62 128.68 36.83 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.306 -0.998 . . . . 64.43 108.306 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 38.3 mt -109.28 136.65 44.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 116.02 -0.536 . . . . 72.51 110.1 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.71 146.13 34.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.059 -0.519 . . . . 65.54 109.711 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.5 m -76.35 126.18 30.53 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.769 -0.826 . . . . 65.22 108.769 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.12 156.04 46.73 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.623 0.725 . . . . 63.31 111.156 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 57.3 m -113.5 126.71 55.62 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.336 -0.847 . . . . 74.23 108.972 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 50' ' ' PHE . 45.5 tp -100.21 101.03 13.12 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 109.507 -0.553 . . . . 74.52 109.507 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 46' ' ' THR . 77.9 Cg_endo -86.99 144.12 7.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.383 2.056 . . . . 71.03 111.828 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.14 5.74 62.09 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.234 -0.747 . . . . 65.54 111.234 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.532 ' HA ' ' H ' ' A' ' 66' ' ' SER . 90.0 m-85 -144.23 152.23 40.55 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 107.664 -1.236 . . . . 74.05 107.664 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -139.65 145.78 38.88 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 108.653 -0.869 . . . . 61.51 108.653 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -90.69 132.15 35.96 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.614 -0.721 . . . . 74.52 109.552 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.599 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 3.8 m-85 -107.04 133.57 51.47 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 107.388 -1.338 . . . . 72.21 107.388 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 129' ' ' GLU . 22.3 ptt180 -119.1 164.87 14.9 Favored 'General case' 0 C--N 1.273 -2.749 0 CA-C-N 114.237 -1.347 . . . . 73.05 113.296 -167.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -61.94 128.24 35.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 116.388 1.996 . . . . 72.42 116.388 -172.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -147.73 23.72 1.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.487 -2.412 . . . . 65.14 104.487 169.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.14 -140.87 2.98 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 112.882 -1.963 . . . . 61.04 109.029 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.69 16.88 24.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.817 1.043 . . . . 70.11 113.817 -178.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 52.1 tp -111.26 160.51 16.92 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.539 -0.864 . . . . 62.42 109.726 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -96.03 168.23 11.07 Favored Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 123.268 0.627 . . . . 75.34 109.721 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.599 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 35.7 Cg_exo -61.73 103.98 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.129 1.886 . . . . 62.31 110.799 175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 12.9 p -111.21 151.65 28.0 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.357 -0.838 . . . . 72.4 110.515 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.1 mm -93.98 139.25 18.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.405 -0.591 . . . . 73.21 109.405 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -142.48 151.46 57.74 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 107.948 -1.13 . . . . 72.33 107.948 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.522 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 34.3 Cg_endo -66.8 104.81 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.554 2.169 . . . . 63.41 112.613 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.532 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 33.4 t -125.09 102.17 7.37 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.172 -1.788 . . . . 75.31 106.172 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -55.1 -33.21 62.62 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.767 0.655 . . . . 64.2 112.767 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.98 5.42 44.3 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.799 -0.637 . . . . 73.14 111.732 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.84 171.83 14.13 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.257 -0.973 . . . . 71.22 113.395 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.67 149.1 24.88 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.791 1.236 . . . . 72.12 107.97 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.05 124.77 70.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.965 -0.383 . . . . 60.22 109.965 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -93.17 114.71 27.28 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.598 -1.26 . . . . 65.14 107.598 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.49 ' C ' ' HD2' ' A' ' 74' ' ' LYS . . . -146.96 -155.56 6.59 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 109.808 -1.317 . . . . 64.55 109.808 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.49 ' HD2' ' C ' ' A' ' 73' ' ' GLY . 14.0 mptt -127.22 152.21 47.68 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.815 0.817 . . . . 45.42 112.494 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 46.9 t -110.27 128.7 66.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 113.83 -1.532 . . . . 51.31 111.155 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 72.1 mt -96.59 109.99 22.49 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.719 -1.215 . . . . 74.33 107.719 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.426 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 17.0 ptp -121.67 151.25 40.66 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.571 0.224 . . . . 61.04 110.995 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.98 13.27 37.39 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 119.669 -1.253 . . . . 73.44 111.525 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 18' ' ' HIS . 10.3 p -85.37 136.32 23.05 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 108.946 -0.761 . . . . 64.44 108.946 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 m -74.05 159.44 32.66 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.265 -0.642 . . . . 73.34 109.265 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -59.06 -38.37 79.25 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.575 0.584 . . . . 75.43 112.575 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.17 -48.72 80.54 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.547 0.689 . . . . 71.32 110.23 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.466 ' HA ' ' HB3' ' A' ' 86' ' ' ASN . 38.8 mt-10 -69.21 -31.58 70.25 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 114.947 -1.024 . . . . 73.52 109.259 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.405 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.0 tm? -62.67 -40.16 96.19 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.449 -0.575 . . . . 64.54 109.449 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.58 -29.5 63.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.143 -0.481 . . . . 63.11 109.954 176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -67.59 -42.07 83.08 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.765 -0.652 . . . . 73.44 111.009 176.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 97.2 mt -61.42 -43.6 98.59 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.962 -0.755 . . . . 72.11 108.962 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.405 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 28.3 t70 -64.94 -34.09 77.58 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.013 -0.994 . . . . 55.42 110.521 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.5 -44.01 68.49 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.025 -0.534 . . . . 64.24 111.024 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.4 t -72.71 -57.36 7.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 112.911 0.708 . . . . 73.43 112.911 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.45 -22.77 50.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.338 0.59 . . . . 74.43 111.397 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -63.07 -15.95 56.96 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.2 -0.909 . . . . 70.34 114.979 -177.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -68.01 -45.75 73.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.629 0.715 . . . . 63.31 112.237 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.27 -10.4 12.72 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.395 -0.522 . . . . 63.1 111.8 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -125.6 167.1 15.54 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.61 -0.885 . . . . 71.14 108.61 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 35.0 tt0 -123.19 145.92 48.23 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.175 -0.676 . . . . 74.31 109.175 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -87.08 114.5 23.74 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.87 -0.789 . . . . 73.34 108.87 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.508 HG12 ' HE1' ' A' ' 117' ' ' MET . 24.5 m -120.99 160.42 21.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 116.117 -0.492 . . . . 60.53 110.052 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.1 t -99.81 127.28 45.98 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.484 -0.932 . . . . 72.22 108.484 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.89 172.06 16.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.192 -0.458 . . . . 71.33 111.489 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.421 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -115.32 128.64 8.17 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.499 -0.64 . . . . 62.43 111.499 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.12 161.95 16.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 123.132 0.573 . . . . 72.44 110.144 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 51.1 t -121.63 123.84 70.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 106.73 -1.581 . . . . 72.21 106.73 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.669 ' HD3' ' SD ' ' A' ' 111' ' ' MET . 12.4 mtm180 -79.15 135.62 36.87 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.054 -1.059 . . . . 75.0 110.327 -175.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.61 12.44 5.77 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 122.919 1.342 . . . . 70.01 108.131 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 104' ' ' ARG . 10.1 t70 -89.32 -53.07 4.72 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 126.564 1.946 . . . . 72.3 111.201 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -138.43 7.23 2.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.21 -0.45 . . . . 64.51 112.018 -174.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.3 t 71.57 8.68 6.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.211 1.004 . . . . 72.52 112.541 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -85.51 148.4 25.98 Favored 'General case' 0 CA--C 1.492 -1.264 0 C-N-CA 120.73 -0.388 . . . . 71.03 110.228 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 64.0 pttt -98.93 140.99 32.26 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-N 115.753 -0.658 . . . . 71.02 109.762 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.669 ' SD ' ' HD3' ' A' ' 104' ' ' ARG . 87.9 mtp -134.81 161.16 35.97 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.171 -0.922 . . . . 72.31 111.269 -175.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.11 130.05 50.15 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.632 -1.167 . . . . 64.1 109.092 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.0 m -141.5 174.03 7.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 108.43 -0.952 . . . . 75.44 108.43 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.456 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -107.15 150.56 26.45 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.206 -0.664 . . . . 71.04 109.206 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.9 t -144.32 170.98 14.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.166 -1.05 . . . . 71.44 108.166 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 70.8 m-85 -117.54 121.52 41.19 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.536 -0.913 . . . . 71.44 108.536 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.522 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 25.7 ptt? -115.96 155.13 28.58 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.26 -0.427 . . . . 63.33 110.57 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.415 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 60.1 t-105 -73.27 124.92 26.63 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.105 0.878 . . . . 72.02 108.688 -178.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.43 ' N ' HD13 ' A' ' 119' ' ' ILE . 2.8 mp -73.49 -41.78 56.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 112.572 0.582 . . . . 73.03 112.572 -172.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -69.8 -40.52 75.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 121.002 -0.279 . . . . 72.25 111.718 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 68.99 -4.36 1.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.155 1.169 . . . . 72.12 114.155 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.87 12.84 6.28 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.094 1.516 . . . . 73.15 115.094 -171.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.47 130.7 93.26 Favored Pre-proline 0 N--CA 1.483 1.213 0 O-C-N 122.274 -0.266 . . . . 71.21 111.347 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.33 14.02 0.81 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.477 2.785 . . . . 73.24 113.888 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -89.96 -11.38 41.86 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.353 0.597 . . . . 72.2 110.496 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 143.23 37.27 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.154 -0.93 . . . . 64.34 109.218 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -136.61 -4.68 2.02 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.076 0.465 . . . . 71.1 110.367 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.46 12.25 54.31 Favored Glycine 0 C--N 1.306 -1.102 0 N-CA-C 109.432 -1.467 . . . . 38.51 109.432 -173.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 54' ' ' ARG . 52.3 mt-10 -115.81 144.21 44.32 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 107.274 -1.38 . . . . 71.11 107.274 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.446 ' HB2' ' HD2' ' A' ' 54' ' ' ARG . 6.0 t90 -99.76 143.64 29.76 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.511 -1.663 . . . . 75.12 106.511 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -79.76 73.91 6.48 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.419 1.104 . . . . 73.42 109.655 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -59.5 -43.3 93.4 Favored 'General case' 0 N--CA 1.411 -2.395 0 C-N-CA 126.075 1.75 . . . . 72.31 111.909 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.55 -37.91 76.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.882 0.697 . . . . 74.43 112.882 -175.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.566 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 7.8 tp10 -66.1 -47.52 73.93 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.662 -0.495 . . . . 75.52 109.662 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 66.4 t-105 -68.56 -39.33 81.08 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.66 -0.416 . . . . 74.51 111.078 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -58.99 -33.82 71.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.36 -0.607 . . . . 74.43 109.36 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.566 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 63.8 ttt180 -62.59 -50.0 73.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.052 -0.976 . . . . 74.23 111.316 175.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.24 -30.22 69.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.216 0.532 . . . . 74.45 110.647 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -68.79 -39.26 80.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.2 -0.909 . . . . 73.31 108.672 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.604 ' O ' HG12 ' A' ' 144' ' ' ILE . 86.3 tttt -67.25 -45.47 76.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.149 -0.932 . . . . 70.25 109.358 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -48.44 -39.69 23.66 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.806 1.642 . . . . 71.04 111.627 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.29 -40.03 95.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.843 -0.617 . . . . 54.11 111.109 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -76.19 -32.25 58.9 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.489 -0.56 . . . . 75.43 109.489 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 140' ' ' LYS . 50.7 mm -56.58 -33.42 39.56 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.757 0 CA-C-N 115.371 -0.831 . . . . 63.32 111.803 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.4 -31.25 65.64 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.229 0.468 . . . . 73.21 111.931 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.9 m -80.67 -41.94 22.9 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.941 -0.763 . . . . 73.33 108.941 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -70.88 -30.05 66.32 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 115.357 1.614 . . . . 74.31 115.357 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 60.1 mtpt -55.52 -38.69 69.56 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 117.926 0.33 . . . . 70.1 110.712 176.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -67.3 -38.79 85.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.733 0.777 . . . . 74.2 109.363 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 67.5 mt -69.94 -41.41 79.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.83 -1.077 . . . . 64.22 109.665 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 67.1 mtt -67.92 -48.53 65.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.898 -0.592 . . . . 71.01 110.978 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 37.3 mt-10 -62.12 -30.55 71.11 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 111.89 0.33 . . . . 75.12 111.89 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 42.7 t -61.46 -42.46 98.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.414 -0.357 . . . . 75.24 110.396 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -82.8 -44.98 14.89 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.004 -0.279 . . . . 63.14 110.872 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt 179.11 110.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.99 0.916 . . . . 74.11 108.59 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.463 ' NZ ' ' HB2' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -72.76 152.01 91.21 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 111.867 0.321 . . . . 73.02 111.867 -177.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.09 155.51 64.34 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 121.897 1.731 . . . . 64.35 108.898 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.817 0 C-N-CA 120.58 -0.448 . . . . 65.51 111.353 -178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.428 -1.529 0 N-CA-C 110.046 -0.353 . . . . 73.33 110.046 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.4 p -86.04 -179.84 6.84 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.53 -0.915 . . . . 73.3 108.53 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.5 t -77.69 -56.79 4.22 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.68 -0.859 . . . . 70.33 108.68 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.9 t70 59.4 126.25 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.42 1.088 . . . . 74.45 113.935 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.5 p -87.85 120.7 29.44 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.544 -0.753 . . . . 64.02 110.342 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.03 -26.56 43.18 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.467 0.651 . . . . 70.45 110.582 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.448 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 16.1 mm-40 -81.46 98.81 8.42 Favored 'General case' 0 CA--C 1.478 -1.824 0 CA-C-O 122.692 1.234 . . . . 74.34 111.94 177.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.3 mt -84.8 153.64 22.85 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 112.93 -1.941 . . . . 74.24 110.27 -177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -124.73 161.25 26.78 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.597 -0.89 . . . . 62.23 108.597 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -128.66 134.43 48.52 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.443 0.64 . . . . 74.21 111.81 172.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.6 142.95 41.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.419 -0.81 . . . . 74.03 110.078 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.444 ' HB2' HG21 ' A' ' 113' ' ' VAL . 76.1 t80 -94.74 122.61 37.53 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.707 -1.22 . . . . 75.02 107.707 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 m -93.16 120.03 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 CA-C-O 121.857 0.837 . . . . 71.0 110.01 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.405 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 8.2 p90 -88.48 -79.05 0.32 Allowed 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 114.629 1.344 . . . . 71.55 114.629 -172.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.93 -44.25 0.24 Allowed Glycine 0 CA--C 1.492 -1.392 0 C-N-CA 119.624 -1.275 . . . . 52.41 112.044 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 p -62.39 -36.48 82.45 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 112.358 0.503 . . . . 72.2 112.358 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.405 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 59.5 m-85 -124.67 26.66 7.11 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 112.564 0.579 . . . . 75.23 112.564 -177.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.405 ' HB3' ' O ' ' A' ' 23' ' ' TYR . 28.5 pt20 -68.07 -1.05 5.17 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.208 0.818 . . . . 75.21 113.208 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 31' ' ' VAL . 20.1 t70 -129.56 138.81 33.96 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 108.755 -0.832 . . . . 74.21 108.755 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.4 -32.9 94.48 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.296 1.998 . . . . 73.21 114.017 -177.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.78 -35.94 81.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 120.999 -0.281 . . . . 64.53 111.641 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 28' ' ' ASP . 11.6 p -70.64 -29.83 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 119.779 -0.768 . . . . 71.41 110.153 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.2 mm -70.85 -43.52 76.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-O 122.073 0.94 . . . . 65.11 108.938 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -54.19 -51.68 63.6 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 112.997 -1.91 . . . . 72.12 110.607 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.8 p -78.09 -35.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.56 -0.746 . . . . 73.22 112.042 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.5 tmm? -67.62 -37.08 81.97 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 121.247 -0.181 . . . . 60.44 111.213 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.486 HD11 ' H ' ' A' ' 37' ' ' ASP 0.402 3.0 pp -115.0 -56.48 2.37 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 115.448 1.647 . . . . 75.11 115.448 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.486 ' H ' HD11 ' A' ' 36' ' ' LEU . 27.1 t70 162.78 -52.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.133 0.973 . . . . 71.23 109.665 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -106.64 -168.0 1.36 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.512 -1.222 . . . . 71.45 109.815 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.9 m -149.69 108.28 3.3 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 108.823 -0.806 . . . . 74.51 108.823 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -59.29 150.73 72.64 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.941 2.427 . . . . 73.15 111.705 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.12 123.26 16.6 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.082 0.553 . . . . 75.31 110.449 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.569 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 51.3 mt -97.84 143.53 12.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.812 -0.631 . . . . 74.31 111.117 -173.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.495 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 14.6 p -128.94 146.75 33.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.566 -0.901 . . . . 74.04 108.566 175.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.435 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 19.0 m -77.03 123.92 27.04 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.36 -0.607 . . . . 64.42 109.36 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.0 157.58 45.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.784 0.802 . . . . 51.52 112.351 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 m -119.7 126.55 51.37 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.864 -1.062 . . . . 75.51 108.96 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.7 tp -98.75 104.91 27.5 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 109.747 -0.464 . . . . 70.42 109.747 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 74.7 Cg_endo -84.03 137.68 7.53 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 122.471 2.114 . . . . 41.25 112.658 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.6 11.75 56.59 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.814 -0.63 . . . . 62.52 112.748 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -140.6 161.66 37.23 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.995 -0.743 . . . . 74.41 108.995 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -139.83 146.06 38.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.802 -0.444 . . . . 73.22 109.802 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HE ' HG12 ' A' ' 71' ' ' VAL . 13.9 ptp180 -102.69 142.12 34.37 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.248 -1.019 . . . . 74.34 108.248 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.57 ' HB3' ' O ' ' A' ' 126' ' ' MET . 28.1 m-85 -113.45 135.16 54.18 Favored 'General case' 0 C--N 1.265 -3.092 0 N-CA-C 107.95 -1.13 . . . . 71.45 107.95 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.507 ' O ' ' HA3' ' A' ' 128' ' ' GLY . 39.0 ptt180 -94.32 126.38 39.55 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.557 -0.857 . . . . 70.01 110.494 -177.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -162.71 131.46 4.07 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.732 -1.581 . . . . 75.04 106.732 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.66 144.63 37.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.932 -0.396 . . . . 63.24 109.932 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.12 -82.78 0.26 Allowed Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.789 -1.324 . . . . 72.32 109.789 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.27 -38.31 8.13 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.649 -0.5 . . . . 73.45 109.649 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.8 tp -113.13 164.26 13.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.031 -0.729 . . . . 75.15 109.031 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -107.41 160.68 25.7 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.037 -0.727 . . . . 73.1 109.037 -173.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 18.5 Cg_endo -67.38 96.8 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.697 1.598 . . . . 74.11 109.927 173.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.0 p -100.05 166.79 10.86 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 113.299 0.851 . . . . 72.13 113.299 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.1 mm -109.52 143.13 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 115.052 -0.977 . . . . 62.41 109.28 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.9 m -143.93 151.45 52.76 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.815 -1.18 . . . . 71.14 107.815 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.512 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 18.5 Cg_endo -60.57 133.48 48.89 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.224 1.95 . . . . 71.5 111.187 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.6 t -124.8 144.08 50.46 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 116.215 -0.448 . . . . 55.44 109.884 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -73.11 -34.43 66.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 74.05 110.363 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.9 81.07 1.88 Allowed 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.254 -0.647 . . . . 72.35 109.254 174.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.26 153.17 24.08 Favored Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 119.735 -1.222 . . . . 36.93 112.431 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.31 139.92 24.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.871 -0.789 . . . . 75.45 108.871 175.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.475 HG12 ' HE ' ' A' ' 52' ' ' ARG . 51.7 t -113.77 119.95 62.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 120.831 0.348 . . . . 73.22 110.78 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -89.33 116.4 27.51 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.689 -1.226 . . . . 74.42 107.689 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.08 -151.21 5.48 Favored Glycine 0 N--CA 1.421 -2.342 0 N-CA-C 110.939 -0.864 . . . . 55.02 110.939 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.569 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.5 mmtm -132.26 146.59 52.1 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 110.099 -0.334 . . . . 72.41 110.099 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.3 t -111.33 138.53 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 122.35 0.26 . . . . 73.4 111.199 175.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.408 HD23 HG12 ' A' ' 42' ' ' ILE . 82.9 mt -94.97 112.02 23.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.43 -0.952 . . . . 71.23 108.43 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 84.2 mmm -93.91 154.93 17.44 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 123.537 0.735 . . . . 71.04 111.097 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 62.32 36.08 92.56 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 114.778 -1.101 . . . . 62.11 113.436 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.02 127.39 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 108.816 -0.809 . . . . 75.13 108.816 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.8 p -77.65 169.93 17.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.183 -0.673 . . . . 72.2 109.183 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.506 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 34.2 t -55.25 -48.15 74.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.673 -0.24 . . . . 61.22 110.548 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.47 -37.47 75.56 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.911 0.884 . . . . 64.41 112.76 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 39.5 mt-10 -76.51 -46.27 27.35 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 116.046 -0.525 . . . . 75.34 110.198 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.426 ' C ' HD22 ' A' ' 84' ' ' LEU . 7.0 tt -68.92 -41.25 78.41 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.447 -0.501 . . . . 75.34 112.053 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 81' ' ' SER . 12.3 pt-20 -62.78 -29.8 70.98 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.414 0.626 . . . . 74.11 109.869 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -74.96 -42.61 57.3 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 114.993 -1.003 . . . . 74.41 109.553 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.8 mt -60.41 -42.47 96.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.387 0.613 . . . . 62.34 109.66 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.01 -36.33 81.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.807 -1.088 . . . . 73.2 110.04 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.36 -48.71 21.76 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.379 -0.828 . . . . 62.31 112.021 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' A' ' 87' ' ' LEU . 14.4 p -63.97 -47.94 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.277 0 C-N-CA 122.36 0.264 . . . . 64.41 111.643 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.33 -19.84 52.63 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.817 0.818 . . . . 71.01 110.654 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.86 -16.34 12.12 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 116.997 1.559 . . . . 53.05 116.997 -173.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -58.64 -44.56 90.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 118.088 0.944 . . . . 54.04 112.428 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.07 -1.73 3.65 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.002 1.112 . . . . 63.3 114.002 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -113.13 157.12 22.04 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.569 -0.53 . . . . 73.31 109.569 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.433 ' HB3' HD11 ' A' ' 119' ' ' ILE . 39.2 tt0 -123.94 155.11 38.75 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.29 -1.374 . . . . 65.01 107.29 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -86.96 114.57 23.7 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.11 -1.07 . . . . 75.53 108.11 -176.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.509 HG11 ' HE1' ' A' ' 117' ' ' MET . 34.3 m -117.32 153.76 19.12 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 120.883 -0.327 . . . . 65.24 110.162 178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -95.63 132.83 40.37 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.218 -0.66 . . . . 55.41 109.218 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.75 162.76 31.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 120.964 0.411 . . . . 74.1 111.052 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.403 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -103.75 119.79 6.47 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.464 -1.055 . . . . 54.24 110.464 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.69 158.22 12.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 110.017 -0.364 . . . . 62.33 110.017 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 99.6 t -121.23 120.58 62.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.472 -0.566 . . . . 75.35 109.472 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 108' ' ' SER . 39.3 mtp180 -62.24 137.32 58.24 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.145 -0.48 . . . . 74.32 111.244 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.435 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 43.4 mt-10 -83.38 -3.89 57.95 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.556 0.693 . . . . 74.43 110.044 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.11 -68.07 0.36 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.776 -1.102 . . . . 74.42 110.399 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -129.08 0.63 5.24 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.484 -1.234 . . . . 73.34 111.328 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 49.6 m 64.34 80.46 0.23 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.048 0.928 . . . . 64.13 112.694 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 10.1 pt-20 -137.4 152.45 49.65 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.627 -1.249 . . . . 71.24 107.627 175.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -91.45 147.22 23.18 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.358 -0.608 . . . . 73.3 109.358 -178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 51.4 ttp -143.98 158.66 43.56 Favored 'General case' 0 N--CA 1.415 -2.225 0 N-CA-C 107.642 -1.244 . . . . 71.01 107.642 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.63 118.0 35.64 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.879 -0.328 . . . . 61.12 110.521 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.1 m -129.01 173.42 13.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 120.996 0.426 . . . . 70.23 110.287 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -101.74 143.41 31.71 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.63 -0.878 . . . . 73.32 108.63 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.8 t -143.51 171.5 14.07 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.069 -1.086 . . . . 75.24 108.069 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -121.24 117.77 27.9 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.274 -1.01 . . . . 73.44 108.274 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.512 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 23.5 ptt? -118.04 156.4 28.67 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.796 -0.638 . . . . 74.11 110.798 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -68.78 118.96 12.41 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.239 -0.891 . . . . 70.52 108.599 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 96' ' ' GLU . 45.2 mm -72.74 -42.42 61.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.08 0.77 . . . . 64.34 113.08 -170.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -68.07 -28.61 67.52 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.197 -0.601 . . . . 65.52 110.378 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.288 9.6 ptpp? 56.38 -18.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.683 2.475 . . . . 74.21 117.683 173.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -116.66 84.21 2.1 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.459 0.647 . . . . 71.22 110.036 177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 126' ' ' MET . 10.3 m-20 -139.77 116.8 8.33 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.135 -0.939 . . . . 72.45 109.765 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -65.99 -13.6 40.6 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.54 2.16 . . . . 70.54 111.149 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.72 -34.68 74.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.118 0.967 . . . . 63.43 111.878 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.57 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.1 ptt? -93.76 8.58 40.5 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 116.46 -0.336 . . . . 72.14 111.421 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -66.35 106.25 1.66 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.637 -0.825 . . . . 74.32 112.25 -174.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 54' ' ' ARG . . . -147.68 127.6 2.67 Favored Glycine 0 N--CA 1.415 -2.743 0 N-CA-C 108.904 -1.679 . . . . 51.33 108.904 176.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.64 126.17 40.73 Favored 'General case' 0 C--O 1.193 -1.875 0 CA-C-O 120.878 0.37 . . . . 74.25 110.572 -176.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.455 ' CD2' ' HD2' ' A' ' 52' ' ' ARG . 74.1 t90 -127.66 140.03 52.35 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 111.967 0.358 . . . . 74.42 111.967 -169.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 66.38 -54.93 0.4 Allowed 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 125.554 1.542 . . . . 72.4 112.984 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -52.43 -29.87 26.59 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 125.54 1.536 . . . . 64.14 113.445 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -56.13 -32.16 63.98 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.134 0.492 . . . . 72.22 110.764 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -63.46 -48.59 77.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.061 0.945 . . . . 61.2 110.007 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -64.12 -37.66 88.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 120.419 -0.512 . . . . 74.24 110.574 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -59.03 -31.74 69.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.554 -0.294 . . . . 64.13 111.0 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -68.67 -51.94 36.45 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 116.257 -0.429 . . . . 75.21 111.528 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.97 -24.58 64.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.996 0.427 . . . . 62.13 111.827 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.08 -38.67 56.76 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.559 -0.904 . . . . 72.11 108.559 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.564 ' O ' HG12 ' A' ' 144' ' ' ILE . 38.7 ttpt -65.34 -34.19 77.73 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.698 -0.683 . . . . 61.13 110.287 177.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.467 ' HA ' ' HE2' ' A' ' 141' ' ' LYS . 0.6 OUTLIER -52.1 -31.66 31.63 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.831 0.852 . . . . 75.1 111.44 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -67.46 -44.13 79.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.029 0.918 . . . . 62.2 109.367 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.48 ' O ' HG22 ' A' ' 146' ' ' THR . 40.4 t80 -71.68 -36.44 70.62 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.817 -1.538 . . . . 71.34 110.151 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.2 mm -55.07 -32.7 27.89 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 CA-C-N 115.252 -0.885 . . . . 74.43 111.496 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -56.01 -38.48 70.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.197 0.814 . . . . 74.44 113.197 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 143' ' ' PHE . 7.6 t -77.97 -32.84 51.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.63 -0.878 . . . . 71.31 108.63 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -77.57 -33.56 53.92 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.267 -0.879 . . . . 71.34 111.094 -173.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 47.3 tttm -56.54 -42.19 78.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.343 -0.844 . . . . 64.34 110.187 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -66.89 -31.01 71.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.869 0.843 . . . . 65.12 110.34 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 73.6 mt -73.29 -47.32 46.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.185 -0.916 . . . . 73.53 109.345 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.9 ttt -64.18 -40.52 96.28 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.368 -0.833 . . . . 73.23 110.733 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 45.0 mt-10 -64.06 -29.83 70.95 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 116.451 -0.34 . . . . 75.03 111.914 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -70.83 -31.78 68.61 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.193 0.52 . . . . 74.32 109.974 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -82.77 -45.83 13.87 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 112.61 0.596 . . . . 73.42 112.61 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -94.38 -27.87 15.83 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.955 -0.566 . . . . 74.22 112.296 -173.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.525 ' HZ2' ' HB2' ' A' ' 156' ' ' LYS 0.279 0.0 OUTLIER 48.01 96.4 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 125.525 1.53 . . . . 55.33 114.779 -177.126 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -65.95 170.28 11.88 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.95 2.433 . . . . 73.14 111.544 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? . . . . . 0 C--N 1.32 -0.714 0 C-N-CA 122.771 0.428 . . . . 74.12 110.597 -178.757 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.429 -1.478 0 CA-C-O 121.683 0.754 . . . . 72.42 110.324 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.4 p -158.34 151.08 22.33 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 115.237 -0.892 . . . . 74.44 110.098 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.9 m -76.0 -18.35 59.32 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.02 -1.104 . . . . 74.45 108.02 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 74.59 -63.07 0.44 Allowed 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 125.759 1.624 . . . . 74.31 113.948 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -109.39 93.05 4.3 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 112.704 0.631 . . . . 71.21 112.704 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.91 109.01 20.59 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 106.502 -1.666 . . . . 74.23 106.502 172.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -132.59 157.06 45.71 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 116.046 -0.525 . . . . 72.43 109.79 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.29 149.43 23.8 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 106.102 -1.814 . . . . 70.02 106.102 169.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 79' ' ' VAL . 27.0 m-70 -116.73 160.59 20.54 Favored 'General case' 0 C--N 1.266 -3.062 0 N-CA-C 109.244 -0.65 . . . . 74.21 109.244 -172.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 22.1 p-10 -130.74 129.39 42.44 Favored 'General case' 0 C--N 1.259 -3.335 0 CA-C-N 115.493 -0.776 . . . . 74.2 109.657 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.1 t -119.77 139.59 46.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.146 -0.934 . . . . 74.15 110.31 -173.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -93.89 122.34 36.27 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.303 -1.369 . . . . 54.41 107.303 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 m -104.19 129.97 55.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.551 0.691 . . . . 62.12 111.712 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -75.74 -22.01 56.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.956 -1.02 . . . . 75.42 113.238 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.04 -34.23 0.39 Allowed Glycine 0 CA--C 1.504 -0.615 0 C-N-CA 119.36 -1.4 . . . . 74.24 112.749 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.3 p -58.43 -36.6 73.89 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.213 0.605 . . . . 71.24 112.329 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -127.91 32.82 4.88 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.74 -0.664 . . . . 75.14 110.315 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -84.24 20.09 1.7 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.259 1.028 . . . . 54.03 109.647 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.505 ' O ' HG22 ' A' ' 31' ' ' VAL . 12.6 t70 -134.8 128.78 18.98 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.551 -1.277 . . . . 62.2 107.551 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -66.47 -32.65 39.54 Favored 'Trans proline' 0 C--O 1.219 -0.474 0 C-N-CA 121.873 1.715 . . . . 73.34 113.16 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.06 -34.7 66.42 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.555 -0.293 . . . . 72.35 111.197 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 28' ' ' ASP . 17.8 m -66.2 -29.48 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 119.852 -0.739 . . . . 74.15 109.963 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 mm -73.03 -41.35 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 122.013 0.911 . . . . 74.22 109.22 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -57.92 -39.43 77.96 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 113.732 -1.576 . . . . 73.12 110.227 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.32 -29.93 11.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.383 -0.826 . . . . 75.42 111.389 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -69.96 -31.89 69.84 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 120.982 0.42 . . . . 74.2 110.295 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.6 pt? -129.56 -69.74 0.68 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 120.282 -0.567 . . . . 71.11 112.371 172.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.481 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 26.4 t70 169.98 -48.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.149 0.976 . . . . 74.53 109.114 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -92.17 176.8 6.36 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.249 -1.341 . . . . 74.21 109.972 -176.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.1 m -149.41 124.41 4.85 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 116.341 -0.391 . . . . 61.23 110.063 178.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.14 151.68 81.05 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.928 2.419 . . . . 37.16 110.69 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.42 136.18 51.26 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.638 -0.875 . . . . 74.45 108.638 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 3.5 mp -105.64 139.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 120.614 -0.434 . . . . 75.45 110.981 -172.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -131.67 146.11 34.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.83 -0.623 . . . . 71.21 109.795 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.7 m -77.74 123.34 26.58 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.213 -0.662 . . . . 75.42 109.213 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.95 157.29 47.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.489 0.661 . . . . 75.25 111.105 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.421 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 87.4 m -110.4 126.97 54.85 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.243 -0.89 . . . . 63.43 109.656 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.2 tp -102.81 97.25 8.95 Favored Pre-proline 0 N--CA 1.429 -1.511 0 N-CA-C 109.241 -0.651 . . . . 72.43 109.241 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 46' ' ' THR . 67.0 Cg_endo -83.29 143.66 11.3 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.199 1.933 . . . . 72.21 111.221 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.35 10.96 60.2 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.538 -0.839 . . . . 64.43 111.908 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -141.67 161.08 38.81 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 122.712 0.405 . . . . 72.4 110.05 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.488 ' NE2' ' HG2' ' A' ' 133' ' ' GLU . 6.5 tp-100 -140.86 149.2 41.65 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 123.068 0.23 . . . . 74.1 110.819 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.26 130.96 54.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.036 -0.728 . . . . 73.44 109.036 173.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.643 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 38.2 m-85 -108.36 135.33 49.83 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.43 -1.322 . . . . 74.33 107.43 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.92 125.71 54.35 Favored 'General case' 0 N--CA 1.42 -1.972 0 C-N-CA 117.816 -1.554 . . . . 74.44 111.491 -176.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.7 tp -141.95 39.57 1.64 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 105.262 -2.125 . . . . 75.54 105.262 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -51.24 108.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.128 -1.851 . . . . 74.11 112.508 -173.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.42 -51.42 0.79 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 109.774 -1.331 . . . . 72.4 109.774 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.527 ' C ' ' HD3' ' A' ' 58' ' ' ARG . 2.3 tmt_? -96.28 -44.39 7.27 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.791 -0.818 . . . . 65.52 108.791 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.466 HD13 ' CH2' ' A' ' 118' ' ' TRP . 36.8 tp -135.48 165.33 25.75 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 108.783 -0.821 . . . . 70.13 108.783 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -92.63 168.96 11.47 Favored Pre-proline 0 C--N 1.279 -2.464 0 N-CA-C 108.958 -0.756 . . . . 74.21 108.958 -173.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.643 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 6.7 Cg_exo -73.78 79.38 2.27 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.587 1.525 . . . . 75.42 109.949 173.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.8 m -79.66 150.74 30.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.115 -0.948 . . . . 75.24 111.238 -174.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 51' ' ' GLN . 49.3 mm -103.8 138.99 26.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 CA-C-N 115.517 -0.765 . . . . 71.2 109.481 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.0 m -146.03 155.31 51.29 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 107.951 -1.129 . . . . 72.2 107.951 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.39 125.7 18.12 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.268 1.979 . . . . 40.14 112.55 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.3 t -124.09 128.5 49.39 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.443 -1.317 . . . . 73.14 107.443 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.27 -16.73 61.38 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 112.287 0.477 . . . . 63.5 112.287 -172.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -130.75 13.9 5.35 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.745 0.276 . . . . 61.0 111.745 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -111.42 169.63 13.33 Favored Glycine 0 C--O 1.244 0.728 0 C-N-CA 119.64 -1.267 . . . . 72.32 114.088 -175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -154.82 138.16 15.8 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.647 -0.871 . . . . 63.52 108.647 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -113.28 122.26 67.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.792 -0.447 . . . . 70.51 109.792 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -96.05 116.81 29.53 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.255 -1.387 . . . . 74.41 107.255 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.96 -155.32 6.45 Favored Glycine 0 N--CA 1.417 -2.585 0 N-CA-C 110.912 -0.875 . . . . 71.54 110.912 -176.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -122.38 144.98 48.69 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.57 0.7 . . . . 62.4 111.939 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.0 t -111.17 131.73 61.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 114.357 -1.292 . . . . 72.22 111.319 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 81.0 mt -95.76 104.88 16.83 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.371 -0.974 . . . . 74.42 108.371 176.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.405 ' HE1' ' HB3' ' A' ' 77' ' ' MET . 64.3 mtp -100.13 139.04 36.37 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 120.977 0.417 . . . . 75.3 111.044 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.13 18.67 10.95 Favored Glycine 0 C--N 1.29 -2.021 0 C-N-CA 120.435 -0.888 . . . . 73.32 111.637 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.669 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 88.4 t -70.3 128.17 33.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.667 -0.494 . . . . 54.53 109.667 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -77.86 167.77 20.98 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.771 -0.826 . . . . 74.53 108.771 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.3 p -64.37 -32.34 73.91 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.987 -0.685 . . . . 74.42 110.293 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.03 -51.07 51.15 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.757 -0.656 . . . . 74.33 110.058 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.669 ' OE1' ' HA ' ' A' ' 79' ' ' VAL . 44.5 tt0 -60.32 -39.57 87.52 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.727 -0.669 . . . . 73.31 110.175 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -57.35 -51.17 70.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.102 0.477 . . . . 74.42 110.411 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.56 -29.27 67.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.968 -0.56 . . . . 75.23 111.326 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.417 ' O ' HG21 ' A' ' 90' ' ' VAL . 7.0 t30 -65.57 -46.3 79.98 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.935 -0.765 . . . . 53.43 108.935 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 97.1 mt -64.93 -41.06 95.85 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.388 -0.824 . . . . 60.41 109.898 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.12 -32.81 73.43 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.649 -0.705 . . . . 71.4 110.722 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.22 62.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.011 -0.541 . . . . 74.21 110.854 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 86' ' ' ASN . 99.3 t -72.27 -56.71 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 123.16 0.584 . . . . 75.51 112.319 -178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.48 -22.76 47.02 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.041 0.448 . . . . 75.42 111.852 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.2 -17.02 36.41 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 115.519 0.967 . . . . 54.3 115.519 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.8 -45.17 93.9 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.772 0.786 . . . . 73.04 111.323 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -112.65 -9.21 13.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.44 -0.345 . . . . 73.54 111.721 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -129.74 167.48 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.58 0.228 . . . . 64.21 110.969 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -123.08 144.65 49.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.118 -0.697 . . . . 73.04 109.118 175.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -88.12 114.14 24.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.782 -0.821 . . . . 75.53 108.782 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.516 HG11 ' HE2' ' A' ' 117' ' ' MET . 33.6 m -127.51 160.54 36.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 116.316 -0.402 . . . . 64.41 110.755 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.1 t -95.41 132.08 40.85 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.626 -0.509 . . . . 74.15 109.626 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -138.11 165.17 26.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.904 -0.589 . . . . 75.5 110.759 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.413 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -104.27 123.11 7.6 Favored Glycine 0 N--CA 1.421 -2.337 0 CA-C-N 115.66 -0.7 . . . . 45.24 111.427 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.401 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.8 pp -118.18 152.78 20.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.669 -0.493 . . . . 65.43 109.669 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.8 131.47 65.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 108.49 -0.929 . . . . 52.53 108.49 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -70.52 125.65 27.42 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.444 0.465 . . . . 65.31 110.225 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.11 -4.21 46.26 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 123.208 0.317 . . . . 74.02 111.562 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.46 -60.53 3.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.1 -1.074 . . . . 62.34 108.1 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -117.79 -93.31 0.51 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.155 -1.384 . . . . 73.32 111.885 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.9 p -173.94 13.11 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.757 0.28 . . . . 74.43 111.757 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -85.02 145.43 27.7 Favored 'General case' 0 C--O 1.251 1.153 0 C-N-CA 120.302 -0.559 . . . . 70.44 111.211 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -93.72 144.66 25.2 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.901 0.857 . . . . 64.0 110.491 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.401 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 76.5 mmm -131.64 162.23 30.87 Favored 'General case' 0 C--N 1.275 -2.633 0 C-N-CA 124.973 1.309 . . . . 72.03 110.922 -175.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.54 126.82 53.24 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.156 -0.929 . . . . 72.41 109.073 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.448 HG11 ' CG ' ' A' ' 19' ' ' ASN . 32.7 m -141.07 173.32 9.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.742 -0.466 . . . . 74.3 109.742 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.65 151.74 22.6 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.461 -0.57 . . . . 72.44 109.461 171.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.4 t -147.28 172.04 14.48 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.696 -1.224 . . . . 73.31 107.696 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -117.36 108.36 15.49 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.604 -0.517 . . . . 74.03 109.604 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.516 ' HE2' HG11 ' A' ' 98' ' ' VAL . 24.7 ptt? -107.2 156.79 18.45 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.545 -0.752 . . . . 74.52 110.276 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.524 ' HD1' ' O ' ' A' ' 120' ' ' ASN . 33.7 t-105 -68.14 134.81 51.13 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 106.183 -1.784 . . . . 71.11 106.183 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.432 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.2 mp -67.81 -41.73 85.34 Favored 'Isoleucine or valine' 0 C--O 1.26 1.61 0 C-N-CA 118.894 -1.122 . . . . 73.52 110.506 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.524 ' O ' ' HD1' ' A' ' 118' ' ' TRP . 42.6 t30 -82.41 105.41 13.45 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.775 0.798 . . . . 75.04 109.353 177.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -77.24 -12.24 59.92 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.276 -0.875 . . . . 71.3 111.557 -172.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.52 76.36 1.71 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.763 -0.828 . . . . 72.33 108.763 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.42 ' HB3' ' HE1' ' A' ' 126' ' ' MET . 13.9 t70 -93.34 130.42 35.67 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 115.115 -0.948 . . . . 71.34 108.989 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -81.0 -0.48 10.62 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.855 2.37 . . . . 73.54 114.174 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -94.23 -51.03 4.99 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 120.246 -0.582 . . . . 74.12 110.943 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.433 ' HB3' HD23 ' A' ' 59' ' ' LEU . 23.7 ptt? -76.51 103.29 6.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.334 -0.946 . . . . 71.31 110.445 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -131.85 132.31 43.56 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 106.368 -1.716 . . . . 73.43 106.368 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.83 90.24 0.91 Allowed Glycine 0 N--CA 1.401 -3.644 0 N-CA-C 109.696 -1.362 . . . . 61.2 109.696 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -78.15 147.44 34.56 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.348 -1.723 . . . . 62.25 106.348 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.668 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 0.5 OUTLIER -68.31 132.96 48.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.32 -0.552 . . . . 74.04 109.857 -172.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -53.29 -4.45 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 116.137 1.903 . . . . 75.12 116.137 -171.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -73.2 -36.6 66.55 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 109.521 -0.548 . . . . 75.04 109.521 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.668 ' HG3' ' O ' ' A' ' 130' ' ' TRP . 0.7 OUTLIER -72.24 -26.34 61.98 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.685 0.755 . . . . 61.31 110.437 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.692 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 44.8 tt0 -56.81 -50.6 71.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.898 -1.501 . . . . 62.01 109.65 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -65.48 -32.62 74.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 119.41 -0.916 . . . . 70.25 111.151 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -59.22 -51.51 69.67 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.838 -0.43 . . . . 62.44 109.838 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.2 ptt85 -70.54 -30.87 67.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.04 0.756 . . . . 72.33 113.04 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 134' ' ' GLU . 82.3 mt -70.48 -34.03 71.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.062 0.458 . . . . 72.34 110.26 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -75.56 -39.48 58.11 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.942 -0.762 . . . . 62.43 108.942 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.526 ' O ' HG12 ' A' ' 144' ' ' ILE . 37.6 ttmt -63.26 -35.7 81.22 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.688 -0.687 . . . . 71.32 110.617 176.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.536 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 38.6 ttpt -52.78 -35.29 56.35 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.811 0.844 . . . . 74.43 112.234 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.51 -35.79 78.7 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.187 0.518 . . . . 74.33 110.307 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -76.48 -43.26 40.53 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.605 -0.887 . . . . 74.52 108.605 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.4 mm -59.54 -33.93 53.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-N 114.807 -1.088 . . . . 72.02 111.534 -176.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.2 mt-10 -54.28 -31.64 54.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.166 0.508 . . . . 75.23 111.337 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.7 m -81.09 -47.99 12.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.337 0.589 . . . . 37.16 110.868 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -76.69 -30.68 56.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 113.698 0.999 . . . . 72.34 113.698 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -56.13 -39.42 72.21 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.094 0.474 . . . . 74.03 110.778 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -71.76 -33.89 69.02 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.57 . . . . 74.13 109.848 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.2 mt -68.83 -38.76 79.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.494 -0.776 . . . . 72.45 109.497 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.8 ttt -64.68 -37.82 88.89 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.842 -0.617 . . . . 62.42 110.118 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.83 -30.89 65.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.092 -0.504 . . . . 64.02 110.514 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.2 -34.64 76.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.991 -0.55 . . . . 64.33 110.528 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -75.86 -18.2 59.53 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.42 0.628 . . . . 61.52 111.218 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.6 76.36 1.08 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 122.315 1.055 . . . . 54.32 110.623 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -140.72 169.27 12.02 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 106.629 -1.619 . . . . 73.11 106.629 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.75 87.67 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.889 1.726 . . . . 72.54 111.718 175.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? . . . . . 0 C--N 1.31 -1.118 0 CA-C-O 121.959 0.885 . . . . 72.14 110.878 179.259 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.426 -1.629 0 CA-C-O 120.724 0.297 . . . . 75.43 110.4 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.4 m -66.48 -19.68 65.85 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.359 0.6 . . . . 62.1 110.852 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.3 p -84.47 -10.6 57.33 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.754 -0.657 . . . . 44.32 109.81 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.8 t70 72.43 139.75 0.05 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.676 1.591 . . . . 62.42 110.437 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.0 m -76.27 103.96 6.56 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.079 -0.648 . . . . 75.32 110.037 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.407 ' H ' HD23 ' A' ' 15' ' ' LEU . 2.6 mm? -61.89 116.24 4.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.445 -0.576 . . . . 74.11 109.445 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -143.22 139.42 30.25 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.139 0.495 . . . . 62.12 110.728 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -83.04 155.84 23.69 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.858 -0.793 . . . . 71.23 108.858 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' O ' HG13 ' A' ' 79' ' ' VAL . 48.9 m-70 -113.28 159.3 19.5 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 108.282 -1.007 . . . . 64.52 108.282 -173.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' CB ' HG13 ' A' ' 113' ' ' VAL . 36.9 m-20 -122.3 126.94 49.19 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.276 -1.379 . . . . 73.24 107.276 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -127.84 137.5 57.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 110.105 -0.332 . . . . 74.3 110.105 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -95.3 121.77 37.3 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.892 -0.781 . . . . 74.41 108.892 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 m -96.03 119.51 44.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 121.92 0.867 . . . . 65.51 111.019 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -74.97 -34.22 62.0 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 115.354 1.613 . . . . 74.23 115.354 -172.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.57 -50.49 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.172 0 C-N-CA 118.578 -1.772 . . . . 61.54 113.041 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.0 m -57.85 -35.62 71.18 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 122.75 0.42 . . . . 64.12 111.984 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.486 ' HB3' HD13 ' A' ' 32' ' ' ILE . 50.4 m-85 -122.95 29.23 6.87 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.47 -0.332 . . . . 71.52 110.658 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -85.78 31.02 0.62 Allowed 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.154 0.978 . . . . 74.03 109.86 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' O ' HG13 ' A' ' 31' ' ' VAL . 17.3 t70 -142.06 129.42 11.43 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 107.59 -1.263 . . . . 53.53 107.59 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HB3' HG22 ' A' ' 39' ' ' THR . 19.0 Cg_exo -66.92 -32.95 34.51 Favored 'Trans proline' 0 N--CA 1.478 0.573 0 C-N-CA 122.385 2.057 . . . . 52.31 112.525 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -60.23 -40.09 88.96 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.622 -0.263 . . . . 74.31 111.247 -178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 28' ' ' ASP . 13.7 p -74.21 -29.45 24.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.58 -0.448 . . . . 41.35 110.182 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 38' ' ' ARG . 43.5 mm -64.88 -45.5 94.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 N-CA-C 109.89 -0.411 . . . . 75.42 109.89 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -57.08 -36.99 71.23 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.132 0.491 . . . . 74.54 111.249 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.3 t -80.24 -42.85 21.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 116.098 -0.501 . . . . 74.14 111.2 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.617 ' HE1' ' OD1' ' A' ' 86' ' ' ASN . 13.1 tmm? -69.44 -36.84 77.03 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.704 -0.225 . . . . 75.13 111.195 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.566 HD11 ' N ' ' A' ' 37' ' ' ASP 0.353 3.8 pp -119.66 -57.59 1.96 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 115.092 1.515 . . . . 74.34 115.092 178.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.566 ' N ' HD11 ' A' ' 36' ' ' LEU . 29.2 t70 176.09 -55.04 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.453 0.644 . . . . 75.12 110.19 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.598 ' O ' HG23 ' A' ' 32' ' ' ILE . 36.5 mmt180 -136.84 -165.05 1.67 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.175 -0.92 . . . . 74.41 108.894 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.406 HG22 ' HB3' ' A' ' 29' ' ' PRO . 37.7 m -137.76 125.0 13.72 Favored Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 120.329 -0.549 . . . . 41.15 111.467 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.87 150.87 87.43 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.758 2.305 . . . . 62.45 109.503 172.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.39 135.94 56.58 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 113.832 1.049 . . . . 65.21 113.832 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 3.5 mp -108.4 135.51 46.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 114.054 -1.43 . . . . 64.12 111.538 -172.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.29 146.48 33.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.99 -0.744 . . . . 75.32 108.99 173.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m -76.74 126.97 31.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.049 0.452 . . . . 73.12 109.806 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.8 157.14 45.83 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.013 0.435 . . . . 72.14 110.942 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.0 m -112.89 126.71 55.76 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 115.192 -0.913 . . . . 73.42 110.423 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.6 tp -101.82 102.83 25.09 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 115.712 -0.676 . . . . 61.42 109.216 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.05 140.88 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.562 2.175 . . . . 74.01 112.366 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.5 4.15 62.49 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 115.733 -0.667 . . . . 73.43 111.865 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.437 ' HE2' ' SD ' ' A' ' 117' ' ' MET . 91.5 m-85 -132.01 162.04 31.71 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.734 -0.469 . . . . 75.2 109.734 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 31.0 tt0 -139.74 140.15 36.68 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.63 -0.428 . . . . 71.1 111.362 -173.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HA ' HD11 ' A' ' 63' ' ' ILE . 11.6 ttm180 -94.51 142.83 26.98 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.749 -1.574 . . . . 75.34 106.749 177.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -106.82 168.89 8.88 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 116.167 -0.47 . . . . 75.52 110.376 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.529 ' HG2' ' O ' ' A' ' 129' ' ' GLU . 12.1 tpt180 -122.31 156.71 33.31 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.657 -1.238 . . . . 74.53 107.657 -175.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.497 ' H ' HD22 ' A' ' 55' ' ' LEU . 1.9 pt? -91.95 130.49 37.69 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.014 0.435 . . . . 74.21 111.189 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -163.2 -47.92 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.263 -1.014 . . . . 65.11 108.263 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.36 -105.14 0.98 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.445 -0.798 . . . . 64.23 112.822 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.444 ' CB ' ' HB3' ' A' ' 125' ' ' ASP . 10.2 ttp180 -95.53 -45.48 7.06 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 113.798 1.036 . . . . 64.41 113.798 -177.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.69 160.13 17.56 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 113.393 0.886 . . . . 75.44 113.393 -159.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.96 169.69 19.04 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 114.443 -1.253 . . . . 74.53 109.019 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.49 96.82 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.196 1.931 . . . . 64.11 111.52 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 26.3 p -102.0 177.37 4.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.812 -0.631 . . . . 75.22 109.924 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.44 HD11 ' HA ' ' A' ' 52' ' ' ARG . 47.1 mm -124.53 131.29 72.94 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 109.456 -0.572 . . . . 74.2 109.456 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -142.2 153.24 62.96 Favored Pre-proline 0 C--N 1.286 -2.163 0 N-CA-C 107.253 -1.388 . . . . 74.33 107.253 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.482 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 11.7 Cg_endo -59.97 137.0 73.26 Favored 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 122.198 1.932 . . . . 70.53 111.509 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.406 ' HB2' ' HB2' ' A' ' 51' ' ' GLN . 30.1 t -124.99 147.79 48.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.353 -0.61 . . . . 72.43 109.353 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.424 ' O ' ' HD2' ' A' ' 68' ' ' LYS . 37.5 mt-10 -69.0 -36.98 78.44 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.941 -0.763 . . . . 74.04 108.941 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 67' ' ' GLU . 30.8 mmmt -134.3 80.1 1.84 Allowed 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.239 -0.891 . . . . 73.14 109.14 175.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.12 153.6 24.95 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 119.879 -1.153 . . . . 70.54 113.212 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.82 138.21 16.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.109 -1.071 . . . . 74.13 108.109 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.5 t -113.66 119.46 61.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.971 -0.381 . . . . 73.13 109.971 -178.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -92.14 116.42 28.93 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.232 -2.136 . . . . 64.0 105.232 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.31 -145.33 4.4 Favored Glycine 0 N--CA 1.417 -2.582 0 C-N-CA 120.465 -0.874 . . . . 55.14 111.694 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 48.4 mmtm -129.94 141.53 50.76 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 120.747 0.308 . . . . 75.52 110.831 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 44.0 t -110.21 129.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.867 -0.606 . . . . 70.51 111.097 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.01 111.11 23.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.296 -1.372 . . . . 64.34 107.296 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.9 ptp -117.99 149.35 41.08 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 120.66 0.267 . . . . 72.5 110.561 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.68 16.05 55.55 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.64 -1.267 . . . . 74.25 110.535 -174.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 18' ' ' HIS . 10.6 p -83.86 135.76 24.17 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 N-CA-C 108.302 -0.999 . . . . 72.44 108.302 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.4 p -82.96 167.0 18.38 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.31 -0.556 . . . . 73.04 110.64 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.9 m -61.05 -33.22 72.96 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.076 0.399 . . . . 75.11 112.076 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -68.31 -36.13 78.86 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.444 0.64 . . . . 74.25 110.685 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 39.1 mt-10 -78.14 -28.36 48.41 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.441 -0.948 . . . . 64.43 108.441 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.5 tp -65.9 -51.61 57.22 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.697 -0.483 . . . . 72.04 109.697 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.65 -29.03 70.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.317 0.579 . . . . 64.2 110.513 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.617 ' OD1' ' HE1' ' A' ' 35' ' ' MET . 7.5 t-20 -59.86 -48.5 81.45 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.096 -0.956 . . . . 72.34 109.744 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 96.7 mt -67.42 -38.99 85.46 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.15 -0.932 . . . . 63.44 110.567 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.619 ' OD1' ' HD3' ' A' ' 97' ' ' ARG . 65.7 m-20 -60.33 -45.22 94.21 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.937 -0.574 . . . . 71.32 109.801 175.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.88 -46.96 79.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.604 -0.725 . . . . 73.2 111.702 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 86' ' ' ASN . 7.9 p -72.62 -56.7 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 N-CA-C 112.999 0.74 . . . . 73.14 112.999 -177.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.11 -30.95 49.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.323 0.49 . . . . 72.52 112.323 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 95' ' ' TYR . . . -60.03 -17.26 43.7 Favored Glycine 0 N--CA 1.463 0.439 0 CA-C-N 115.769 -0.65 . . . . 64.03 114.313 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.89 -33.44 71.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.507 0.194 . . . . 64.03 110.926 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.25 -8.81 3.78 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.317 0.488 . . . . 64.3 112.317 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.405 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 69.1 m-85 -122.16 165.72 15.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.183 -0.303 . . . . 74.3 110.183 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.0 tp10 -123.12 143.24 50.12 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.845 -0.342 . . . . 63.3 110.105 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.619 ' HD3' ' OD1' ' A' ' 88' ' ' ASP . 60.5 ttp180 -87.59 114.24 24.02 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.156 -0.683 . . . . 74.33 109.156 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.529 HG11 ' HE2' ' A' ' 117' ' ' MET . 31.5 m -122.72 160.34 25.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 116.179 -0.464 . . . . 71.23 111.051 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 21.8 p -90.31 122.03 32.84 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.733 -0.667 . . . . 71.43 110.074 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.88 160.7 41.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.241 0.544 . . . . 63.14 112.288 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.59 124.88 6.86 Favored Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 110.512 -1.035 . . . . 61.33 110.512 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.84 154.89 13.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 116.548 0.174 . . . . 70.1 110.587 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 97.0 t -116.84 117.86 56.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 107.445 -1.317 . . . . 65.34 107.445 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.514 ' HD3' ' SD ' ' A' ' 111' ' ' MET . 58.8 mtm180 -69.8 137.75 52.1 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 119.813 -0.755 . . . . 73.34 111.051 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -75.44 -5.68 46.24 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.083 -1.08 . . . . 74.14 108.083 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.2 -58.4 3.45 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.271 -1.332 . . . . 74.24 111.248 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.468 ' ND2' HH21 ' A' ' 104' ' ' ARG . 30.9 p-10 -126.23 3.81 7.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.037 0.755 . . . . 75.33 113.037 -173.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 t 69.6 13.85 8.24 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.29 0.636 . . . . 51.45 111.785 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -104.91 155.84 18.57 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 122.063 -0.398 . . . . 44.22 111.136 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -88.78 148.43 23.94 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.634 0.731 . . . . 37.75 111.228 -176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.514 ' SD ' ' HD3' ' A' ' 104' ' ' ARG . 88.6 mtp -136.83 160.07 39.98 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.818 -1.083 . . . . 73.13 109.541 175.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.56 131.01 45.85 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.202 -0.908 . . . . 64.24 109.997 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.451 HG13 ' CB ' ' A' ' 19' ' ' ASN . 33.7 m -145.16 173.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.483 -0.932 . . . . 64.14 108.483 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -119.46 151.17 39.01 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.367 -0.975 . . . . 72.22 108.367 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.8 t -144.3 172.14 13.34 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.284 -0.635 . . . . 64.35 109.284 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.532 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 89.4 m-85 -116.75 108.48 15.93 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 123.847 0.717 . . . . 72.15 109.537 -177.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.529 ' HE2' HG11 ' A' ' 98' ' ' VAL . 22.3 ptt? -107.38 156.05 19.35 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.829 -0.623 . . . . 72.1 110.124 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -68.75 130.7 43.59 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.161 -1.052 . . . . 71.24 108.161 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.4 mp -73.7 -42.9 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 119.357 -0.937 . . . . 74.5 111.732 -173.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -84.05 93.77 8.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.78 0.8 . . . . 73.43 110.28 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -78.8 -6.13 55.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.108 -0.951 . . . . 72.51 113.167 -170.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.03 84.75 2.26 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.299 0.571 . . . . 75.24 110.179 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -133.49 120.61 15.85 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.836 -0.62 . . . . 72.51 109.767 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.17 -11.87 19.35 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.524 2.149 . . . . 71.12 113.439 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.444 ' HB3' ' CB ' ' A' ' 58' ' ' ARG . 16.2 m-20 -90.63 -20.43 22.55 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 113.742 1.016 . . . . 74.11 113.742 -176.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -80.31 88.17 5.55 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.489 1.138 . . . . 65.44 108.667 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -141.56 122.48 14.5 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.425 -1.261 . . . . 74.44 108.899 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -146.67 168.22 28.03 Favored Glycine 0 C--N 1.276 -2.772 0 N-CA-C 108.526 -1.83 . . . . 53.21 108.526 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 37.1 mt-10 -108.16 125.52 51.71 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.112 -1.035 . . . . 55.44 110.326 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -125.25 156.17 38.95 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.014 -1.847 . . . . 75.44 106.014 -172.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -61.71 -38.56 88.34 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.365 0.602 . . . . 62.15 111.295 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -61.3 -39.66 91.29 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 124.724 1.21 . . . . 73.23 109.897 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -71.46 -26.88 62.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.136 -0.938 . . . . 64.35 111.565 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.538 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 40.4 tt0 -58.03 -41.44 83.19 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 121.048 -0.261 . . . . 71.51 111.564 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -65.54 -38.12 88.69 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.099 -1.041 . . . . 74.13 110.897 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.92 -43.08 99.78 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.44 -0.346 . . . . 74.01 111.337 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.448 ' HE ' ' HG3' ' A' ' 134' ' ' GLU . 41.0 ptt180 -68.1 -35.1 77.61 Favored 'General case' 0 C--O 1.194 -1.826 0 C-N-CA 120.643 -0.423 . . . . 65.21 110.683 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 134' ' ' GLU . 89.2 mt -69.74 -35.69 75.19 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.469 0.652 . . . . 73.41 110.214 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -71.63 -39.17 70.59 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.557 -0.747 . . . . 75.22 109.161 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -70.13 -34.84 73.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.164 -0.925 . . . . 73.1 110.679 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 61.6 tttm -50.83 -30.9 15.55 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 125.427 1.491 . . . . 72.43 112.121 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -54.5 -46.65 73.51 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.215 0.606 . . . . 72.12 110.272 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -77.49 -34.03 54.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.467 -0.788 . . . . 75.11 109.603 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.445 ' HB ' ' HA ' ' A' ' 141' ' ' LYS . 50.4 mm -64.49 -33.43 62.91 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.365 0 CA-C-N 114.898 -1.046 . . . . 74.2 111.796 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 38.2 mm-40 -55.37 -34.86 64.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.236 0.541 . . . . 71.42 110.693 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.3 m -73.9 -46.38 44.92 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.842 -0.617 . . . . 71.34 109.615 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -68.35 -29.76 68.56 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 114.346 1.239 . . . . 72.44 114.346 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 88.7 tttt -54.45 -41.09 69.03 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 123.357 0.663 . . . . 74.32 110.039 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.27 -36.45 84.14 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.62 0.724 . . . . 65.21 109.457 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.46 -37.38 50.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.055 -0.975 . . . . 73.34 109.942 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 87.7 mtp -67.58 -40.41 84.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.155 -0.475 . . . . 75.33 110.634 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 51.5 mt-10 -64.95 -32.16 73.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.378 0.609 . . . . 71.42 109.77 175.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.18 -44.46 65.42 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.503 -0.771 . . . . 74.53 111.166 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.99 -45.28 43.08 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 112.871 0.693 . . . . 75.11 112.871 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -98.84 -74.96 0.57 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 112.685 0.624 . . . . 61.12 112.685 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.51 150.2 7.78 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 109.953 -0.388 . . . . 74.31 109.953 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.33 -15.13 38.49 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.959 2.439 . . . . 71.14 112.579 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.437 -1.114 0 CA-C-O 121.193 0.52 . . . . 72.1 110.59 179.17 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.9 m . . . . . 0 N--CA 1.435 -1.181 0 N-CA-C 109.913 -0.403 . . . . 73.22 109.913 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -76.96 100.73 5.7 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 106.0 -1.852 . . . . 72.33 106.0 172.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 t -80.38 -9.99 59.75 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.569 0.581 . . . . 62.3 112.569 -171.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 77.95 -53.08 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.921 0.888 . . . . 65.52 109.307 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -64.93 135.84 56.14 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.355 -2.091 . . . . 64.51 105.355 169.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.46 85.27 3.18 Favored 'General case' 0 N--CA 1.413 -2.275 0 N-CA-C 114.192 1.182 . . . . 64.55 114.192 -170.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 60.09 178.54 0.09 Allowed 'General case' 0 C--O 1.25 1.13 0 C-N-CA 124.64 1.176 . . . . 54.41 113.451 170.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.22 154.34 20.51 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.658 -1.608 . . . . 73.32 106.658 167.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -120.07 157.74 28.31 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 109.09 -0.707 . . . . 72.13 109.09 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.601 ' HA ' ' O ' ' A' ' 76' ' ' LEU 0.272 0.7 OUTLIER -126.31 125.9 43.06 Favored 'General case' 0 C--N 1.284 -2.251 0 O-C-N 124.086 0.866 . . . . 74.33 111.424 174.365 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.56 137.61 55.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 114.723 -1.126 . . . . 71.32 109.913 -173.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.44 ' HB2' HG22 ' A' ' 113' ' ' VAL . 89.6 t80 -97.97 122.9 41.64 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.518 -0.919 . . . . 65.45 108.518 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.1 m -103.27 138.01 29.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.323 0.582 . . . . 71.51 111.815 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.415 ' HB3' ' CG1' ' A' ' 63' ' ' ILE . 39.8 p90 -81.28 -15.06 56.63 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 115.015 1.487 . . . . 71.55 115.015 -175.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.516 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . 160.0 -46.9 0.41 Allowed Glycine 0 C--O 1.212 -1.247 0 C-N-CA 118.658 -1.734 . . . . 43.5 113.321 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 m -58.26 -31.63 67.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.693 0.627 . . . . 73.23 112.693 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.421 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 63.7 m-85 -123.72 31.27 5.93 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 122.253 -0.279 . . . . 74.31 111.486 -176.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -92.18 -1.72 56.98 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 119.254 -0.978 . . . . 65.43 112.236 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.425 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.0 t70 -99.65 123.1 49.09 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 115.375 -0.83 . . . . 74.2 109.194 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.75 -31.61 78.49 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.569 2.179 . . . . 70.24 113.366 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -67.3 -40.26 86.02 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.334 -0.617 . . . . 64.42 109.334 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.79 -37.55 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.624 -0.717 . . . . 62.43 109.87 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 38' ' ' ARG . 44.4 mm -63.06 -44.27 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 115.777 -0.647 . . . . 73.14 110.667 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -59.47 -35.87 74.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.017 0.437 . . . . 75.33 111.15 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.09 -35.64 14.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 116.084 -0.507 . . . . 75.34 112.179 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.421 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 9.0 tmm? -75.06 -37.16 61.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 120.241 -0.584 . . . . 74.42 110.16 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 32' ' ' ILE 0.254 0.9 OUTLIER -119.73 -62.44 1.49 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.464 1.283 . . . . 72.12 114.464 179.472 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.498 ' OD2' ' HG3' ' A' ' 38' ' ' ARG . 20.8 t70 178.67 -55.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.095 0.474 . . . . 72.23 111.398 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.498 ' HG3' ' OD2' ' A' ' 37' ' ' ASP . 88.6 mtm180 -135.75 -174.62 3.7 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.828 -0.804 . . . . 65.34 108.828 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.5 m -118.55 112.5 37.16 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 120.916 -0.313 . . . . 64.43 111.649 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.53 152.0 76.24 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 123.004 2.47 . . . . 62.13 109.293 170.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.74 118.8 5.66 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.536 0.684 . . . . 64.32 112.138 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.5 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 48.6 mt -100.12 137.49 27.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 115.242 -0.89 . . . . 65.14 109.239 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.48 146.68 33.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 109.339 -0.615 . . . . 72.3 109.339 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.9 m -77.69 130.77 37.22 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.515 -0.55 . . . . 73.42 109.515 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.23 159.23 42.66 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.463 0.542 . . . . 73.12 112.463 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.5 m -107.42 132.21 53.44 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.826 0.851 . . . . 73.02 109.816 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.401 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 45.3 tp -111.96 96.76 35.35 Favored Pre-proline 0 C--N 1.3 -1.545 0 N-CA-C 108.474 -0.935 . . . . 64.12 108.474 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.64 141.06 9.64 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.462 2.108 . . . . 73.52 112.656 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.27 10.53 59.41 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.679 -0.772 . . . . 73.32 111.713 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -139.49 159.1 42.95 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 106.796 -1.557 . . . . 75.01 106.796 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -139.49 142.07 37.33 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 120.282 -0.567 . . . . 61.23 109.859 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HB2' ' NH1' ' A' ' 54' ' ' ARG . 28.4 ptt180 -102.23 126.45 49.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.981 -0.554 . . . . 75.24 109.619 176.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.511 ' O ' ' HD2' ' A' ' 54' ' ' ARG . 91.0 m-85 -108.68 162.16 14.42 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.224 -1.028 . . . . 74.14 108.224 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.511 ' HD2' ' O ' ' A' ' 53' ' ' PHE . 3.0 mpt_? -118.28 126.02 51.3 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.358 0.599 . . . . 74.14 112.087 177.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.31 133.82 17.6 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.139 -2.912 . . . . 75.33 103.139 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -103.43 -38.48 7.17 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 114.38 1.252 . . . . 70.54 114.38 -172.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.67 125.88 6.88 Favored Glycine 0 C--N 1.308 -0.994 0 C-N-CA 119.199 -1.477 . . . . 62.43 113.527 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.416 ' HD3' ' O ' ' A' ' 58' ' ' ARG . 1.6 tmt_? 84.61 -23.17 0.18 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.229 1.412 . . . . 73.11 110.809 175.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 30.8 tp -137.73 163.31 31.63 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 107.555 -1.276 . . . . 72.31 107.555 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.425 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 12.4 m-85 -119.43 171.88 5.0 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 109.882 -0.414 . . . . 75.03 109.882 -169.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 31.7 Cg_exo -68.3 47.69 0.39 Allowed 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 124.073 3.182 . . . . 65.4 112.849 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.9 p -61.65 163.18 7.45 Favored 'General case' 0 C--O 1.252 1.233 0 C-N-CA 125.277 1.431 . . . . 64.15 114.838 -174.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.415 ' CG1' ' HB3' ' A' ' 23' ' ' TYR . 49.8 mm -109.7 142.02 23.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 C-N-CA 124.917 1.287 . . . . 74.54 108.584 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 118' ' ' TRP . 26.9 m -148.19 154.66 42.79 Favored Pre-proline 0 C--N 1.309 -1.189 0 N-CA-C 107.654 -1.239 . . . . 73.3 107.654 171.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.2 111.33 1.99 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.226 1.951 . . . . 54.34 112.042 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 t -124.89 135.98 53.37 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.228 -0.656 . . . . 63.03 109.228 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.423 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 10.3 mp0 -73.17 -21.76 60.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.986 0.422 . . . . 71.21 110.005 -176.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -100.24 5.64 44.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.904 -0.589 . . . . 63.14 112.339 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -132.24 177.13 18.96 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 118.18 -1.962 . . . . 64.51 115.094 -174.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.47 ' OE2' ' HD3' ' A' ' 140' ' ' LYS . 14.3 pt-20 -156.82 143.4 18.37 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 104.409 -2.441 . . . . 62.22 104.409 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.407 HG23 HD13 ' A' ' 63' ' ' ILE . 47.0 t -113.56 119.75 61.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 C-N-CA 120.173 -0.611 . . . . 70.51 110.316 -176.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.522 ' NE2' ' HD2' ' A' ' 136' ' ' LYS . 56.1 m-70 -98.66 115.43 28.67 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 119.466 -0.894 . . . . 74.31 108.686 173.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.22 -157.79 7.39 Favored Glycine 0 N--CA 1.418 -2.564 0 C-N-CA 120.379 -0.915 . . . . 75.33 111.002 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' HE2' ' HB2' ' A' ' 27' ' ' GLN . 3.1 mppt? -122.72 148.34 45.43 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 113.263 0.838 . . . . 73.34 113.263 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.5 t -111.01 131.87 61.04 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 113.643 -1.617 . . . . 64.11 110.951 178.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.601 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 68.8 mt -95.63 107.74 19.96 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.434 -0.95 . . . . 75.43 108.434 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 61.2 mtp -103.63 155.68 18.37 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.657 -0.498 . . . . 75.21 109.657 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.45 16.24 66.87 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.083 -1.056 . . . . 72.04 111.47 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.7 t -72.1 120.12 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 109.457 -0.571 . . . . 63.41 109.457 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.5 p -74.03 163.52 27.78 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.464 -0.939 . . . . 73.41 108.464 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 p -55.15 -36.94 66.35 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 112.151 0.426 . . . . 73.15 112.151 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.76 -51.51 69.45 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.554 0.742 . . . . 74.43 111.038 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.8 mt-10 -67.95 -35.48 78.48 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.914 0.886 . . . . 71.05 109.342 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.89 -49.66 75.96 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.287 -0.635 . . . . 73.4 109.287 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.63 -33.52 75.13 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-O 121.05 0.453 . . . . 71.52 109.888 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.487 ' O ' HG22 ' A' ' 90' ' ' VAL . 0.1 OUTLIER -60.34 -48.97 79.47 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.411 1.085 . . . . 74.11 109.22 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.2 mt -66.86 -42.76 85.15 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.111 -0.495 . . . . 75.42 110.511 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.26 -31.96 73.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.203 -0.908 . . . . 73.43 110.676 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.86 -45.37 51.45 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.491 -0.777 . . . . 52.14 110.904 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 86' ' ' ASN . 99.4 t -65.23 -56.99 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.441 -0.345 . . . . 65.33 111.487 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -77.95 -22.54 49.37 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.83 0.678 . . . . 72.13 112.83 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.88 -16.83 48.67 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 115.912 -0.585 . . . . 43.25 114.463 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -61.4 -27.86 68.83 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.636 0.606 . . . . 72.21 112.636 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -145.23 -0.88 0.85 Allowed 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 120.136 -0.625 . . . . 75.22 112.124 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.425 ' OH ' ' HB2' ' A' ' 60' ' ' TYR . 80.4 m-85 -122.09 167.79 12.72 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 122.101 -0.374 . . . . 75.41 110.462 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -123.04 139.67 53.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.38 -1.341 . . . . 64.44 107.38 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -87.14 114.4 23.72 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.289 -0.634 . . . . 74.32 109.289 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.54 HG11 ' HE1' ' A' ' 117' ' ' MET . 35.3 m -119.13 160.53 19.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.698 -0.683 . . . . 54.05 109.865 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.7 t -107.39 133.18 52.29 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.988 -0.745 . . . . 54.4 108.988 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.41 171.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 116.238 -0.437 . . . . 75.33 110.65 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.95 124.74 7.28 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 111.008 -0.837 . . . . 54.23 111.008 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.417 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.6 pp -117.6 165.14 13.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 116.621 0.21 . . . . 73.31 110.634 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 110' ' ' LYS . 46.1 t -124.11 119.43 56.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.929 -0.767 . . . . 55.24 108.929 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.441 ' HE ' ' HB3' ' A' ' 106' ' ' ASP . 72.7 ttt180 -65.77 116.35 6.88 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.091 0.956 . . . . 71.52 111.005 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -53.74 -48.44 69.65 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.941 0.896 . . . . 64.32 109.215 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.441 ' HB3' ' HE ' ' A' ' 104' ' ' ARG . 33.9 t70 -48.9 -42.61 37.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.09 -1.868 . . . . 75.32 115.395 -172.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -138.92 6.64 2.43 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 118.627 -1.229 . . . . 74.34 112.41 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.3 t 59.71 70.17 0.66 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.073 0.949 . . . . 71.23 111.486 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -131.16 146.33 52.3 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 115.176 -0.92 . . . . 73.22 108.857 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.429 ' HG2' HG22 ' A' ' 103' ' ' VAL . 58.0 mtpt -97.3 126.19 42.36 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.456 0.646 . . . . 65.43 109.339 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.417 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 89.2 mtp -125.38 161.24 27.47 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.479 -0.782 . . . . 73.5 110.853 -177.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.51 117.43 31.65 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.216 -0.902 . . . . 64.52 109.197 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.468 HG11 ' OD1' ' A' ' 19' ' ' ASN . 34.0 m -129.98 173.37 14.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 121.264 0.554 . . . . 63.52 110.821 -174.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.475 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -108.81 147.25 32.36 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.079 -1.082 . . . . 75.5 108.079 175.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.4 t -148.73 172.56 14.4 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.935 -0.765 . . . . 53.44 108.935 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.17 108.28 13.59 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.816 -0.809 . . . . 75.04 108.816 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.54 ' HE1' HG11 ' A' ' 98' ' ' VAL . 24.9 ptt? -110.88 156.37 21.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.808 -0.633 . . . . 74.53 109.615 -179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.474 ' HB3' ' CG1' ' A' ' 64' ' ' VAL . 55.9 t-105 -68.35 123.27 20.31 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.065 -1.087 . . . . 75.35 108.065 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.43 ' H ' HD11 ' A' ' 119' ' ' ILE . 2.4 mp -65.23 -40.92 90.22 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 CA-C-O 120.921 0.391 . . . . 73.21 111.197 -171.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -59.17 -28.64 66.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.687 -0.688 . . . . 73.52 111.09 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.438 ' HA ' ' CG1' ' A' ' 64' ' ' VAL 0.302 9.0 ptpp? 58.06 -52.02 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 126.555 1.942 . . . . 71.22 115.217 178.307 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.88 82.64 2.61 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.357 -1.349 . . . . 65.22 107.357 174.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -112.38 127.19 27.18 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.172 -0.922 . . . . 73.11 109.062 -176.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.3 -17.78 21.16 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.852 2.368 . . . . 73.13 113.991 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -80.4 -29.63 37.73 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 112.739 0.644 . . . . 73.23 112.739 -175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.56 141.49 28.66 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.838 0.828 . . . . 71.0 112.445 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -170.52 145.08 2.53 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.011 -1.848 . . . . 73.31 106.011 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.98 161.32 8.67 Favored Glycine 0 C--N 1.29 -1.995 0 C-N-CA 119.401 -1.381 . . . . 43.32 112.838 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.34 151.8 48.3 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.019 -1.845 . . . . 74.54 106.019 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -89.86 156.75 18.26 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 117.195 -1.802 . . . . 73.33 106.987 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -42.37 -54.86 3.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.557 0.743 . . . . 75.53 112.596 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.3 m-85 -66.16 -38.0 87.02 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 112.096 0.406 . . . . 72.23 112.096 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -70.18 -29.33 66.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.062 0.458 . . . . 54.53 111.486 -176.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.484 ' O ' HD11 ' A' ' 138' ' ' LEU . 37.1 tt0 -68.19 -52.9 29.13 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.853 -0.795 . . . . 54.1 108.853 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -63.16 -30.41 71.57 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.526 0.679 . . . . 74.51 110.281 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.689 ' HE2' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -56.96 -50.47 72.53 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 124.562 1.145 . . . . 71.13 108.536 178.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.429 ' HA ' ' HB3' ' A' ' 140' ' ' LYS . 19.9 ptt85 -69.74 -30.57 68.2 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.172 -1.011 . . . . 63.21 112.539 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 134' ' ' GLU . 8.7 mp -67.82 -31.19 70.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.945 0.403 . . . . 73.31 110.489 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -79.17 -33.84 43.64 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.474 -0.565 . . . . 64.33 109.474 173.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.496 ' O ' HG12 ' A' ' 144' ' ' ILE . 36.0 ttpt -61.04 -33.28 73.05 Favored 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 115.588 -0.733 . . . . 73.24 112.169 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -48.8 -32.56 8.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 112.231 0.456 . . . . 71.12 112.231 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.523 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -58.76 -48.21 82.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.871 0.843 . . . . 74.11 109.716 175.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -76.15 -32.78 59.26 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.674 -1.603 . . . . 74.02 108.943 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 140' ' ' LYS . 46.7 mm -61.6 -32.77 54.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.143 0 CA-C-N 114.646 -1.161 . . . . 75.21 112.642 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -51.84 -41.3 61.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.128 0.422 . . . . 75.24 111.413 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.5 m -70.98 -47.6 57.98 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.736 -0.665 . . . . 73.41 109.858 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . 0.257 62.9 m-85 -70.18 -29.88 66.86 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 115.133 1.531 . . . . 74.32 115.133 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 57.6 tptt -59.3 -42.55 91.6 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.51 -0.922 . . . . 62.45 108.51 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -64.12 -40.31 95.92 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.253 -0.885 . . . . 71.31 109.463 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.3 mt -68.58 -41.64 83.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.313 -0.858 . . . . 64.41 110.663 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.38 -42.54 96.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.51 -0.314 . . . . 74.44 110.743 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 49.2 mt-10 -67.56 -30.8 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.931 0.396 . . . . 61.24 110.416 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 51.2 t -65.66 -37.59 86.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.871 -0.604 . . . . 74.14 109.957 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.2 -37.78 37.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.054 -0.521 . . . . 72.23 110.048 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 87.8 tttt 67.02 94.59 0.07 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.063 1.345 . . . . 74.04 112.4 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -103.75 150.38 38.1 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.621 -0.881 . . . . 71.22 108.621 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.92 135.1 66.94 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.814 2.343 . . . . 71.53 112.396 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 115.63 -0.713 . . . . 75.41 109.83 -178.662 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 82.2 m . . . . . 0 N--CA 1.429 -1.503 0 N-CA-C 107.433 -1.321 . . . . 72.22 107.433 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.3 t -70.63 106.91 3.67 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 121.393 0.616 . . . . 72.52 110.395 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 p -85.76 -22.49 27.71 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.062 -0.972 . . . . 62.12 109.494 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.252 12.7 m-20 60.49 82.27 0.16 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 122.468 1.128 . . . . 62.0 113.139 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.0 t -93.27 115.33 27.93 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 105.711 -1.959 . . . . 63.21 105.711 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.23 72.13 2.29 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-O 122.117 0.96 . . . . 72.53 112.94 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -141.37 98.06 3.29 Favored 'General case' 0 CA--C 1.472 -2.044 0 CA-C-N 113.194 -1.821 . . . . 63.23 107.279 174.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.75 153.86 18.42 Favored 'General case' 0 C--N 1.263 -3.187 0 CA-C-N 115.101 -0.954 . . . . 70.25 110.565 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.439 ' O ' HG13 ' A' ' 79' ' ' VAL . 49.0 m-70 -115.41 160.21 20.16 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.298 -0.865 . . . . 73.33 110.208 -173.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.432 ' CG ' HG11 ' A' ' 113' ' ' VAL . 18.1 p30 -133.15 138.48 46.64 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.113 -0.949 . . . . 64.2 111.305 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.1 t -132.12 139.41 50.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.436 -0.802 . . . . 64.2 109.727 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.404 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.1 t80 -94.16 123.1 37.33 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.456 -1.312 . . . . 73.12 107.456 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.1 m -102.81 166.96 2.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 112.519 0.563 . . . . 65.34 112.519 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -153.56 -45.3 0.09 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.069 -0.969 . . . . 73.52 111.623 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.02 -92.71 1.26 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.03 -1.081 . . . . 63.11 113.97 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -58.35 -17.49 20.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.138 1.162 . . . . 74.33 114.138 -173.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -123.36 20.15 9.68 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 121.079 -0.248 . . . . 75.44 111.003 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.08 -18.86 60.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.649 -0.421 . . . . 74.02 111.609 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.524 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 20.8 t70 -116.81 128.29 26.12 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 116.331 -0.395 . . . . 71.1 111.856 -173.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HB3' HG23 ' A' ' 39' ' ' THR . 32.0 Cg_endo -65.12 -32.71 52.28 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.074 2.516 . . . . 54.3 112.81 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.524 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 19.3 t70 -63.29 -38.19 90.2 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.532 -0.544 . . . . 73.33 109.532 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.69 -42.98 93.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.257 -0.883 . . . . 73.44 109.656 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 28' ' ' ASP . 45.7 mm -60.73 -43.79 95.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.018 -0.537 . . . . 73.35 111.894 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -55.37 -36.4 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.226 0.536 . . . . 64.03 111.2 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.5 t -82.03 -37.49 14.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.609 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.515 ' HE1' ' ND2' ' A' ' 86' ' ' ASN . 9.0 tmm? -63.49 -35.54 80.79 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.388 -0.597 . . . . 71.31 109.388 -174.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.55 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.2 pt? -128.09 -74.69 0.57 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.092 -0.504 . . . . 75.14 111.862 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.55 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 22.4 m-20 -167.36 -58.26 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.861 0.865 . . . . 71.23 108.668 -172.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -131.2 165.59 23.0 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.444 -1.253 . . . . 73.24 112.222 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.444 HG23 ' HB3' ' A' ' 29' ' ' PRO . 29.9 m -111.69 128.47 25.37 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.956 -0.566 . . . . 73.14 111.729 -174.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.45 153.15 68.2 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 123.453 2.769 . . . . 70.0 111.403 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.2 123.95 16.26 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.25 -0.648 . . . . 64.45 109.25 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 32.9 mt -104.91 136.03 40.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.086 0.47 . . . . 75.3 110.364 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.483 HG22 ' HD2' ' A' ' 104' ' ' ARG . 14.4 p -130.85 147.72 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.711 -0.677 . . . . 62.43 109.869 176.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.3 m -75.69 126.53 31.18 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.548 -0.908 . . . . 63.1 108.548 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.91 157.38 46.14 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.517 0.675 . . . . 64.43 111.819 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 m -114.59 125.12 53.41 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 114.537 -1.21 . . . . 73.33 108.627 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.8 tp -99.97 101.97 15.99 Favored Pre-proline 0 C--N 1.29 -2.007 0 N-CA-C 109.092 -0.707 . . . . 73.34 109.092 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 71.9 Cg_endo -80.84 141.1 13.23 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 122.188 1.926 . . . . 74.0 112.091 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.12 14.23 57.85 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.963 -0.636 . . . . 72.43 112.427 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -140.49 163.3 33.2 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.674 -0.491 . . . . 73.31 109.674 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.427 ' CG ' ' HB2' ' A' ' 66' ' ' SER . 26.9 pt20 -140.27 166.38 24.85 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.164 -0.68 . . . . 74.34 109.164 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HD3' HG12 ' A' ' 71' ' ' VAL . 14.9 ptt180 -128.01 128.46 45.03 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.597 -0.729 . . . . 74.31 111.719 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.536 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 17.1 m-85 -109.14 164.88 12.04 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.274 -0.876 . . . . 73.44 110.147 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.549 ' HD2' ' N ' ' A' ' 130' ' ' TRP . 6.9 mtm180 -149.55 152.84 36.2 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.442 -0.577 . . . . 71.33 109.442 -168.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 56' ' ' LYS . 1.8 tm? -159.35 142.6 14.45 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 105.537 -2.023 . . . . 72.15 105.537 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.476 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -114.47 81.87 1.62 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.618 0.723 . . . . 74.22 111.48 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.68 -101.8 0.17 Allowed Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.152 -0.931 . . . . 43.2 112.21 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.478 ' C ' ' HD3' ' A' ' 58' ' ' ARG . 0.6 OUTLIER -80.05 -36.65 35.38 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.221 0.534 . . . . 54.34 110.046 -177.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.462 ' HG ' ' H ' ' A' ' 60' ' ' TYR . 37.2 tp -111.9 165.51 12.02 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.483 -0.562 . . . . 71.25 109.483 -178.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.462 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 12.7 p90 -141.33 168.72 13.18 Favored Pre-proline 0 C--N 1.28 -2.429 0 C-N-CA 125.698 1.599 . . . . 62.24 108.569 -170.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 5.7 Cg_exo -37.24 120.49 0.31 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 124.344 3.363 . . . . 74.34 114.427 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.536 ' SG ' ' HB2' ' A' ' 53' ' ' PHE . 12.4 p -130.11 150.0 51.57 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.037 -0.983 . . . . 74.15 110.468 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.7 mm -110.06 141.36 25.59 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 N-CA-C 108.742 -0.836 . . . . 74.01 108.742 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.437 ' CG1' ' HB3' ' A' ' 118' ' ' TRP . 29.9 m -146.87 150.33 38.85 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 109.101 -0.703 . . . . 73.11 109.101 175.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.33 134.68 60.39 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.66 2.24 . . . . 71.44 112.246 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.427 ' HB2' ' CG ' ' A' ' 51' ' ' GLN . 34.8 t -125.68 141.51 51.98 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.934 -0.575 . . . . 72.42 110.343 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -75.29 -32.79 61.11 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.512 -0.551 . . . . 55.15 109.512 173.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . 0.287 0.1 OUTLIER -131.93 72.91 1.51 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 114.031 1.123 . . . . 75.41 114.031 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.35 168.59 40.58 Favored Glycine 0 C--O 1.257 1.579 0 C-N-CA 119.224 -1.465 . . . . 61.22 113.283 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.44 147.73 29.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.799 -1.186 . . . . 63.34 107.799 176.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.404 HG12 ' HD3' ' A' ' 52' ' ' ARG . 59.8 t -114.5 119.66 62.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 109.582 -0.525 . . . . 70.22 109.582 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -95.63 116.32 28.69 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.534 -0.913 . . . . 75.03 108.534 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.87 -143.87 4.14 Favored Glycine 0 N--CA 1.418 -2.517 0 C-N-CA 120.718 -0.753 . . . . 52.21 111.26 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.459 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 75.5 mmtt -134.24 145.13 48.86 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.56 -0.533 . . . . 74.51 109.56 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.7 t -110.58 129.55 65.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 123.104 0.252 . . . . 52.33 111.148 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.416 ' CD2' HG12 ' A' ' 42' ' ' ILE . 71.0 mt -95.62 111.31 23.26 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.022 -1.473 . . . . 71.03 107.022 174.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.9 ptp -119.65 144.08 47.36 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.398 -0.521 . . . . 75.31 111.842 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.26 23.97 7.78 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 115.459 -0.791 . . . . 70.51 111.73 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 83' ' ' GLU . 13.2 p -95.02 138.89 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 110.017 -0.364 . . . . 74.31 110.017 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.548 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 3.9 m -79.02 162.05 26.19 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 109.169 -0.678 . . . . 74.03 109.169 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.5 m -58.51 -32.7 69.07 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 112.801 0.667 . . . . 55.0 112.801 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.64 -49.39 68.87 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 112.322 0.489 . . . . 73.33 112.322 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.575 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 1.4 mp0 -65.25 -29.49 70.28 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 109.612 -0.514 . . . . 70.04 109.612 177.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.87 -40.33 92.59 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.021 0.439 . . . . 71.42 109.868 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -69.02 -36.99 78.4 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.152 -0.685 . . . . 75.45 109.152 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.515 ' ND2' ' HE1' ' A' ' 35' ' ' MET . 7.7 t30 -63.85 -43.04 97.33 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.114 -0.948 . . . . 64.13 110.489 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.8 mt -61.72 -43.07 99.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.748 0.785 . . . . 74.31 108.935 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.25 -32.17 71.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.278 -1.328 . . . . 65.43 111.115 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.21 -42.16 56.19 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.814 -0.63 . . . . 72.44 110.474 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 86' ' ' ASN . 99.3 t -67.04 -53.23 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.306 0.643 . . . . 73.34 112.4 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -78.28 -20.65 51.16 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.224 0.535 . . . . 70.1 111.95 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.19 -17.03 16.07 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.74 1.456 . . . . 61.15 116.74 -173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.06 -29.64 69.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 118.56 1.18 . . . . 73.42 112.533 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.56 -0.74 2.36 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 113.359 0.874 . . . . 63.22 113.359 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -127.41 166.08 18.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.663 0.616 . . . . 75.53 112.663 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.3 tp10 -125.17 146.04 49.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.121 -0.945 . . . . 73.43 108.86 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -92.92 114.12 26.59 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.014 -0.736 . . . . 61.13 109.014 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 m -126.49 161.59 32.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 120.865 0.364 . . . . 71.11 111.83 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.7 t -88.14 130.97 34.89 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.249 -0.887 . . . . 74.1 110.31 -177.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.84 165.61 25.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.974 -0.557 . . . . 71.22 111.522 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -114.67 124.24 6.31 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.477 -1.049 . . . . 70.01 110.477 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.88 160.51 15.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 120.697 0.284 . . . . 74.01 110.868 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 66.2 t -120.38 114.68 44.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.115 -1.439 . . . . 73.01 107.115 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 108' ' ' SER . 54.8 mtm180 -69.67 135.56 50.01 Favored 'General case' 0 CA--C 1.478 -1.817 0 C-N-CA 119.981 -0.688 . . . . 72.33 109.771 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.92 5.55 18.68 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.82 0.819 . . . . 72.23 109.074 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -56.85 -62.09 1.99 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.087 -1.415 . . . . 73.55 109.559 175.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -137.76 12.3 2.92 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.512 -0.767 . . . . 62.24 109.288 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 23.0 t 62.86 78.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.688 -1.142 . . . . 64.01 110.486 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 10.2 pt-20 -137.11 151.3 48.71 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 108.133 -1.062 . . . . 71.32 108.133 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -94.05 140.93 29.12 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 120.35 -0.54 . . . . 71.22 110.245 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.6 mtp -141.8 161.5 37.81 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 123.772 0.829 . . . . 74.1 110.218 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.57 129.19 55.31 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 115.459 -0.792 . . . . 38.31 109.671 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.432 HG11 ' CG ' ' A' ' 19' ' ' ASN . 29.5 m -142.84 174.68 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.441 -0.948 . . . . 71.33 108.441 -177.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -113.8 157.62 22.06 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.863 -0.735 . . . . 74.44 109.601 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.2 t -149.74 172.64 14.78 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.558 -0.904 . . . . 64.14 108.558 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 88.5 m-85 -114.51 115.35 27.1 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.192 -0.669 . . . . 75.33 109.192 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . 0.256 0.0 OUTLIER -113.42 156.27 23.78 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.001 -0.545 . . . . 73.11 111.773 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.437 ' HB3' ' CG1' ' A' ' 64' ' ' VAL . 68.1 t-105 -67.76 118.01 10.43 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.688 -0.856 . . . . 74.25 108.688 -175.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.7 mt -58.91 -35.75 58.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.91 -1.041 . . . . 73.13 113.156 -171.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -70.69 -31.23 68.05 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.023 0.439 . . . . 72.01 110.596 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 67.67 -60.1 0.4 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.011 1.325 . . . . 74.35 113.658 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.03 102.01 13.59 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 110.149 -0.315 . . . . 72.44 110.149 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -141.98 123.91 9.01 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 116.014 -0.539 . . . . 73.5 110.906 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -87.06 2.67 6.88 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.797 2.332 . . . . 72.55 113.443 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -94.99 -31.43 13.63 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.669 0.271 . . . . 70.21 111.387 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.521 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 27.0 ptt? -80.18 17.86 0.95 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.824 0.45 . . . . 61.04 112.17 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -79.74 117.77 20.94 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 121.961 -0.462 . . . . 75.13 110.046 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.04 167.13 39.09 Favored Glycine 0 CA--C 1.484 -1.878 0 C-N-CA 121.056 -0.592 . . . . 52.12 111.886 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.3 151.88 34.97 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.565 -0.902 . . . . 70.12 108.565 177.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.549 ' N ' ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -87.96 153.2 21.48 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 105.522 -2.029 . . . . 72.3 105.522 177.271 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -60.44 -34.39 73.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 118.7 0.682 . . . . 61.32 111.774 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -73.58 -32.67 64.25 Favored 'General case' 0 N--CA 1.415 -2.194 0 C-N-CA 123.199 0.6 . . . . 73.11 110.604 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.454 ' HG3' ' NH1' ' A' ' 54' ' ' ARG . 78.9 mm-40 -67.24 -33.47 75.4 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 112.972 0.73 . . . . 73.21 112.972 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.473 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 5.7 tp10 -64.43 -41.39 96.61 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.089 -1.078 . . . . 62.22 108.089 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -70.0 -31.22 68.79 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.224 -0.898 . . . . 72.23 112.812 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 137' ' ' ARG 0.308 0.5 OUTLIER -61.25 -36.67 80.63 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 118.701 -1.2 . . . . 60.12 112.444 -178.494 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.457 ' N ' ' HD2' ' A' ' 136' ' ' LYS . 38.9 ptt180 -75.87 -29.84 58.67 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 119.844 -0.742 . . . . 63.01 111.33 176.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 134' ' ' GLU . 84.9 mt -71.26 -26.63 62.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.383 0.611 . . . . 73.03 109.988 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -73.21 -39.06 65.84 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.186 -1.042 . . . . 73.14 108.186 172.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.474 ' O ' HG12 ' A' ' 144' ' ' ILE . 88.2 tttt -62.51 -30.59 71.39 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 114.656 -1.156 . . . . 62.33 110.329 176.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 23.7 tptm -46.77 -38.51 10.18 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.459 1.104 . . . . 73.42 113.006 -177.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.75 -40.3 91.93 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.947 0.88 . . . . 72.53 109.95 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -76.71 -32.98 58.2 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.503 -1.226 . . . . 74.41 107.908 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.3 mm -65.82 -32.81 59.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 CA-C-N 114.629 -1.169 . . . . 53.53 111.524 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 45.0 mt-10 -55.24 -32.06 62.01 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.376 0.608 . . . . 70.24 110.054 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.9 m -80.24 -47.19 14.98 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.704 -0.68 . . . . 64.35 109.45 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.558 ' O ' ' HG2' ' A' ' 151' ' ' MET 0.294 26.9 m-85 -64.13 -30.63 71.68 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 116.128 1.899 . . . . 72.35 116.128 -178.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 37.6 mmtm -58.76 -38.85 79.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.474 0.579 . . . . 64.2 111.679 175.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -71.23 -33.26 69.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.106 -0.701 . . . . 64.53 109.106 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 68.3 mt -69.95 -39.0 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.39 -0.823 . . . . 73.52 109.136 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.558 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 14.4 mmt -61.25 -40.69 94.99 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.329 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 46.0 mt-10 -60.29 -41.54 93.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.151 0.501 . . . . 62.03 110.319 177.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 49.0 t -71.56 -31.83 67.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.568 -0.742 . . . . 61.12 110.845 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 75.9 mmtt -74.28 -47.98 31.45 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.457 -0.497 . . . . 74.53 110.204 178.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -154.7 -68.84 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.453 0.644 . . . . 72.54 110.358 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -166.47 160.81 12.12 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 107.809 -1.182 . . . . 75.4 107.809 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.84 127.2 24.25 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.542 2.162 . . . . 65.34 111.166 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 C--N 1.317 -0.843 0 N-CA-C 109.741 -0.466 . . . . 74.34 109.741 -177.235 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.0 m . . . . . 0 C--O 1.24 0.602 0 CA-C-O 121.596 0.712 . . . . 73.32 112.011 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.5 m -72.87 177.36 4.93 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.434 -0.803 . . . . 71.35 110.43 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.9 m -65.37 -51.37 60.89 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.978 -0.556 . . . . 75.3 110.625 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 71.36 106.53 0.06 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.78 0.832 . . . . 71.22 112.34 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.1 t 63.02 -159.56 0.32 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.274 -0.876 . . . . 74.54 109.902 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.49 -11.2 59.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.351 0.66 . . . . 72.13 110.254 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 69.04 -179.09 0.23 Allowed 'General case' 0 C--O 1.246 0.897 0 N-CA-C 114.74 1.385 . . . . 64.34 114.74 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.97 160.37 23.35 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 112.497 -2.138 . . . . 65.11 107.958 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.479 ' O ' HG11 ' A' ' 79' ' ' VAL . 49.9 m-70 -109.39 159.67 16.82 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 108.702 -0.851 . . . . 74.2 108.702 -173.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.541 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 21.1 p30 -134.56 128.48 33.34 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.114 -0.948 . . . . 64.12 111.94 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.63 144.48 34.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 114.575 -1.193 . . . . 74.3 111.041 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -94.13 123.14 37.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.75 -0.833 . . . . 72.41 108.75 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.725 ' HB ' ' O ' ' A' ' 26' ' ' PHE . 20.4 m -94.44 172.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.853 -0.612 . . . . 62.23 110.54 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -149.4 -62.41 0.22 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.291 1.96 . . . . 65.34 116.291 -168.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -116.28 -79.48 0.77 Allowed Glycine 0 C--O 1.215 -1.085 0 C-N-CA 119.314 -1.422 . . . . 73.35 114.504 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -65.98 -36.31 82.97 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.98 0.895 . . . . 75.03 109.187 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.725 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 48.5 m-85 -101.29 100.17 10.64 Favored 'General case' 0 N--CA 1.401 -2.902 0 CA-C-N 114.622 -1.172 . . . . 75.42 108.196 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -156.18 3.83 0.17 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.177 -0.919 . . . . 73.15 112.509 173.321 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -124.71 134.59 25.75 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.369 -0.604 . . . . 73.13 109.369 -176.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 29.6 Cg_endo -63.35 -30.76 73.22 Favored 'Trans proline' 0 C--O 1.211 -0.859 0 C-N-CA 122.879 2.386 . . . . 74.42 113.988 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.26 -35.35 73.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.19 0.519 . . . . 72.12 109.629 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.2 t -62.42 -42.42 95.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.617 -0.883 . . . . 71.42 108.617 175.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.485 HG21 HD23 ' A' ' 36' ' ' LEU . 24.0 mm -66.17 -43.66 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.947 -1.024 . . . . 71.33 109.584 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 3.5 t-20 -55.36 -43.85 75.44 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.648 -1.614 . . . . 64.11 110.742 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.99 -39.36 17.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.882 -0.599 . . . . 75.12 111.481 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -64.99 -36.39 84.24 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 110.482 -0.192 . . . . 72.51 110.482 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.485 HD23 HG21 ' A' ' 32' ' ' ILE 0.264 0.4 OUTLIER -111.24 -75.36 0.62 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 113.088 0.773 . . . . 64.12 113.088 174.268 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.6 t70 174.51 -49.08 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 108.328 -0.99 . . . . 73.33 108.328 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -110.78 175.66 5.34 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.185 -1.371 . . . . 73.41 109.029 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.0 m -129.29 104.72 17.85 Favored Pre-proline 0 N--CA 1.414 -2.228 0 N-CA-C 108.694 -0.854 . . . . 75.11 108.694 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.17 150.86 46.35 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 123.01 2.473 . . . . 75.52 110.35 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.71 132.0 51.98 Favored 'General case' 0 CA--C 1.465 -2.318 0 CA-C-O 122.224 1.011 . . . . 63.11 112.043 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.561 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 46.3 mt -107.0 131.73 56.2 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.8 0 CA-C-N 113.219 -1.809 . . . . 71.35 108.95 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.13 146.17 30.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.967 -1.123 . . . . 72.02 107.967 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.5 m -77.36 127.95 33.45 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 107.329 -1.36 . . . . 71.3 107.329 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.27 154.41 44.72 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.039 0.447 . . . . 74.53 110.95 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.484 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 93.9 m -109.16 125.64 52.41 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.374 -0.83 . . . . 75.33 110.276 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.0 tp -101.43 99.59 11.69 Favored Pre-proline 0 N--CA 1.432 -1.368 0 CA-C-N 116.077 -0.511 . . . . 72.11 109.936 175.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.1 Cg_endo -83.96 135.53 6.62 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.767 2.311 . . . . 70.32 111.562 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.11 5.88 46.17 Favored Glycine 0 N--CA 1.434 -1.438 0 C-N-CA 120.552 -0.832 . . . . 71.3 111.679 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.471 ' HA ' ' H ' ' A' ' 66' ' ' SER . 96.0 m-85 -146.98 150.17 34.62 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.121 -0.696 . . . . 74.33 109.121 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -140.85 148.56 40.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.632 -0.877 . . . . 73.01 108.632 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -102.03 142.47 33.25 Favored 'General case' 0 N--CA 1.424 -1.734 0 C-N-CA 119.517 -0.873 . . . . 74.51 108.997 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.491 ' CB ' ' HB2' ' A' ' 126' ' ' MET . 7.0 m-85 -108.3 171.22 7.54 Favored 'General case' 0 C--N 1.258 -3.375 0 CA-C-N 114.646 -1.161 . . . . 74.41 111.152 -175.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -88.06 137.98 31.85 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.624 0.972 . . . . 75.1 113.624 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 5.9 tt -54.69 -63.07 1.27 Allowed 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.814 1.645 . . . . 61.55 110.722 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 62.63 -68.28 0.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.637 1.347 . . . . 64.54 114.637 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.51 -107.15 0.99 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.329 -0.939 . . . . 62.43 113.683 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.4 -0.49 33.04 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.636 1.347 . . . . 75.12 114.636 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 31.6 tp -113.67 163.89 14.4 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.202 -0.666 . . . . 63.22 109.202 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -108.49 170.9 4.98 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.293 -1.373 . . . . 65.55 107.293 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 16.0 Cg_exo -68.79 93.23 0.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 N-CA-C 108.219 -1.493 . . . . 71.34 108.219 171.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 22.0 p -99.53 154.94 17.85 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.653 -0.703 . . . . 61.51 112.509 -174.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.4 mm -94.86 127.39 46.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.056 -0.975 . . . . 53.55 109.469 177.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.44 144.38 52.03 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 109.201 -0.666 . . . . 74.34 109.201 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.94 108.96 0.36 Allowed 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.552 2.168 . . . . 62.44 112.983 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.471 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 32.3 t -125.13 98.6 5.73 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 106.09 -1.819 . . . . 61.23 106.09 176.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.38 -36.6 64.08 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 123.667 0.787 . . . . 71.52 112.252 -172.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.495 ' HZ1' ' CD ' ' A' ' 145' ' ' GLU . 8.4 tppt? -86.15 -23.9 26.39 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.337 0.589 . . . . 74.53 110.24 -176.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.74 173.89 45.77 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 115.41 -0.814 . . . . 64.14 113.099 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -160.4 144.43 14.05 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.331 -0.988 . . . . 75.54 108.331 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.12 119.83 61.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 109.035 -0.728 . . . . 74.21 109.035 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -91.45 114.85 27.49 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.537 -2.023 . . . . 73.44 105.537 174.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.44 -143.81 3.9 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.279 -0.962 . . . . 38.05 112.359 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.461 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.5 mmtm -123.34 140.61 52.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.946 0.403 . . . . 73.45 111.325 -173.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.561 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 41.0 t -111.08 130.05 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.827 -0.624 . . . . 73.02 110.376 172.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 78.3 mt -95.71 109.91 22.12 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.863 -1.162 . . . . 64.21 107.863 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.8 ptp -119.7 137.43 53.92 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.128 0.489 . . . . 63.43 110.43 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.72 18.87 10.96 Favored Glycine 0 N--CA 1.421 -2.33 0 C-N-CA 120.037 -1.078 . . . . 44.14 111.254 -174.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.479 HG11 ' O ' ' A' ' 18' ' ' HIS . 10.0 p -89.69 138.2 19.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 N-CA-C 109.009 -0.737 . . . . 74.33 109.009 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.6 p -76.84 159.92 29.67 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.422 -0.354 . . . . 65.24 110.77 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.1 m -58.71 -32.03 68.8 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.33 0.493 . . . . 62.12 112.33 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -67.37 -41.09 85.63 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.432 0.634 . . . . 71.22 109.984 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 63.0 mm-40 -80.2 -28.65 38.63 Favored 'General case' 0 C--O 1.201 -1.499 0 C-N-CA 119.576 -0.85 . . . . 73.42 112.426 176.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.41 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.1 tm? -60.79 -45.21 95.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.059 -0.719 . . . . 73.11 109.059 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -67.86 -29.92 69.17 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.855 -0.424 . . . . 74.04 109.855 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -72.95 -40.34 65.45 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 116.116 -0.493 . . . . 75.31 110.129 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.6 mt -60.17 -40.45 89.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.947 0.879 . . . . 74.32 109.295 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.45 ' CG ' HH21 ' A' ' 97' ' ' ARG . 23.8 t70 -71.48 -29.52 64.92 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.445 -1.252 . . . . 55.41 111.089 177.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.69 -48.21 22.93 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.347 -0.388 . . . . 64.13 110.394 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 87' ' ' LEU . 13.7 p -65.28 -53.41 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-N 115.843 -0.617 . . . . 74.32 111.483 -176.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -78.02 -27.82 48.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.167 0.432 . . . . 71.42 112.167 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.91 -17.81 44.78 Favored Glycine 0 N--CA 1.464 0.529 0 N-CA-C 115.007 0.763 . . . . 75.34 115.007 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -61.52 -32.33 72.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.126 0.463 . . . . 74.43 111.198 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -130.86 3.83 4.48 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.589 -0.444 . . . . 63.04 111.793 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -138.46 168.0 20.7 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.796 0.295 . . . . 74.24 111.796 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 35.9 tt0 -121.62 144.55 48.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.323 -0.399 . . . . 73.15 110.123 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.45 HH21 ' CG ' ' A' ' 88' ' ' ASP . 16.3 ttm180 -87.45 118.45 26.92 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.328 -0.619 . . . . 75.12 109.328 -176.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.23 162.98 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 113.123 0.786 . . . . 74.02 113.123 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.5 p -94.14 124.38 38.11 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.118 -1.401 . . . . 75.34 109.965 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.92 158.31 43.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 120.844 0.354 . . . . 71.35 111.251 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.58 115.8 5.22 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 111.394 -0.682 . . . . 72.32 111.394 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.04 155.76 12.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 110.189 -0.3 . . . . 54.41 110.189 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.9 120.08 62.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 108.701 -0.851 . . . . 63.33 108.701 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.447 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 39.7 mtp180 -64.38 134.92 55.56 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.946 0.403 . . . . 64.43 111.017 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.89 -6.93 53.15 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.892 -1.151 . . . . 52.12 107.892 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.88 -64.6 0.77 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 125.719 1.607 . . . . 74.43 110.938 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -144.89 15.34 1.55 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 120.741 -0.384 . . . . 74.02 110.293 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 56.7 m 63.53 63.09 0.89 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.651 -0.704 . . . . 74.25 111.656 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.47 137.57 52.44 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.373 -1.343 . . . . 64.44 107.373 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -98.19 140.97 31.7 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-O 121.433 0.635 . . . . 75.24 111.32 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.447 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 89.0 mtp -138.51 162.58 34.16 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-N 114.977 -1.011 . . . . 71.44 110.358 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.44 122.35 47.2 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.963 -1.017 . . . . 63.34 109.199 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.06 174.46 13.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 109.109 -0.7 . . . . 73.23 109.109 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -98.26 161.25 13.8 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.565 -0.854 . . . . 62.14 109.14 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.0 t -156.93 172.57 18.43 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.737 -1.208 . . . . 72.34 107.737 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.1 m-85 -124.41 113.9 18.79 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.094 -0.706 . . . . 64.5 109.094 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.94 157.52 22.31 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.935 0.398 . . . . 72.43 110.974 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.411 ' NE1' ' HB3' ' A' ' 120' ' ' ASN . 55.4 t-105 -67.52 128.82 37.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.573 -0.899 . . . . 74.12 108.573 -177.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.447 HD11 ' N ' ' A' ' 119' ' ' ILE . 2.7 mp -72.02 -41.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.643 -0.253 . . . . 73.24 111.159 -173.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.411 ' HB3' ' NE1' ' A' ' 118' ' ' TRP . 27.1 t-20 -62.31 -37.17 84.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.768 -0.651 . . . . 72.24 111.377 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.475 ' O ' ' HE1' ' A' ' 126' ' ' MET . 57.2 mttp 68.29 -38.7 0.38 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.427 1.491 . . . . 72.25 114.361 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -115.63 76.09 0.99 Allowed 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.903 -0.498 . . . . 73.33 110.502 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.515 ' H ' ' HE3' ' A' ' 126' ' ' MET . 11.1 t70 -106.12 132.95 20.47 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 108.542 -0.91 . . . . 74.13 108.542 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.19 -19.07 29.97 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.763 2.309 . . . . 75.11 114.361 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -76.52 -37.32 56.92 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 113.222 0.823 . . . . 75.42 113.222 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.515 ' HE3' ' H ' ' A' ' 123' ' ' ASP . 26.4 ptt? -73.06 -16.7 61.48 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.439 0.638 . . . . 71.04 109.933 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -77.19 85.2 3.65 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.137 -1.431 . . . . 74.55 107.137 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.58 -144.33 6.68 Favored Glycine 0 CA--C 1.464 -3.096 0 CA-C-N 114.62 -1.173 . . . . 51.14 111.364 -176.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -105.12 126.4 52.04 Favored 'General case' 0 N--CA 1.392 -3.364 0 N-CA-C 105.278 -2.119 . . . . 72.52 105.278 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -110.17 159.28 17.5 Favored 'General case' 0 C--N 1.262 -3.229 0 N-CA-C 106.065 -1.828 . . . . 72.53 106.065 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 134' ' ' GLU . 17.3 m120 -61.57 95.79 0.05 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.045 -1.095 . . . . 70.31 108.045 174.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -61.27 -33.09 72.97 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 123.585 0.754 . . . . 74.21 111.634 -176.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.93 -28.28 69.42 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.513 0.673 . . . . 73.23 110.016 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 35.6 tt0 -79.34 -54.32 6.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.08 -0.964 . . . . 73.42 109.467 175.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -58.53 -40.42 82.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.752 -0.658 . . . . 75.12 112.771 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -53.12 -34.18 55.61 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.53 0.732 . . . . 72.51 110.607 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.451 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 67.5 ttt180 -63.31 -51.62 65.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.06 -0.518 . . . . 75.34 111.396 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -76.88 -25.58 53.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.291 0.567 . . . . 74.22 110.357 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -67.76 -24.57 65.36 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.375 -0.83 . . . . 65.43 109.937 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.668 ' O ' HG12 ' A' ' 144' ' ' ILE . 38.8 ttpt -56.31 -35.79 67.94 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 116.278 -0.419 . . . . 71.15 110.589 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.548 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 38.7 ttmt -54.76 -41.94 71.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.996 0.519 . . . . 73.01 110.192 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -61.75 -44.41 96.96 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.126 0.965 . . . . 72.11 108.66 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -67.44 -38.25 84.23 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.404 -1.725 . . . . 75.24 109.977 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 140' ' ' LYS . 42.4 mm -67.05 -35.53 74.77 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.455 0 CA-C-N 115.609 -0.723 . . . . 71.4 110.174 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.5 mt-10 -59.88 -30.91 69.32 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.748 0.309 . . . . 61.32 111.134 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.53 ' O ' HG13 ' A' ' 150' ' ' ILE . 33.3 m -73.59 -48.44 32.76 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.904 -0.776 . . . . 71.23 108.904 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.516 ' O ' ' HG2' ' A' ' 151' ' ' MET . 51.1 m-85 -71.62 -36.29 70.73 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 115.271 1.582 . . . . 73.22 115.271 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.507 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 88.5 tttt -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.47 -0.937 . . . . 72.43 108.47 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . 0.55 ' HB2' ' NZ ' ' A' ' 149' ' ' LYS . 4.1 ttmp? -75.19 -37.85 61.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.686 -1.143 . . . . 71.4 109.855 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 146' ' ' THR . 88.8 mt -64.49 -33.49 63.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.815 -0.629 . . . . 70.41 109.503 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.516 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 24.8 mmt -72.74 -27.96 62.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.288 -0.415 . . . . 71.35 110.648 176.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 43.3 mt-10 -68.7 -30.69 69.41 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 108.709 -0.849 . . . . 73.43 108.709 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 150' ' ' ILE . 52.3 t -70.48 -32.87 70.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.317 -0.856 . . . . 73.43 109.959 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 75.0 mmtt -72.43 -38.15 68.43 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.385 -0.598 . . . . 71.4 109.385 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 74.54 120.87 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 124.845 1.258 . . . . 74.31 113.087 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.01 120.76 75.3 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 106.79 -1.559 . . . . 71.33 106.79 173.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.6 89.01 0.1 OUTLIER 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.993 2.462 . . . . 71.34 113.901 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 . . . . . 0 C--O 1.246 0.883 0 C-N-CA 125.188 1.395 . . . . 65.12 108.139 179.827 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.8 t . . . . . 0 N--CA 1.428 -1.57 0 N-CA-C 109.369 -0.604 . . . . 60.52 109.369 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -91.29 88.49 6.9 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.517 -0.549 . . . . 75.41 109.517 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 m -88.73 -10.8 47.05 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.538 -0.756 . . . . 61.32 111.683 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 77.05 -37.67 0.28 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 124.773 1.229 . . . . 73.44 113.382 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 p -71.05 -171.29 0.54 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 123.017 0.527 . . . . 70.11 111.283 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.93 113.07 4.13 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 107.066 -1.457 . . . . 63.24 107.066 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -142.39 -164.98 1.93 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.043 -0.526 . . . . 71.2 109.725 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.2 mt -81.94 152.92 26.54 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.821 -0.807 . . . . 74.14 108.821 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -115.71 159.74 20.99 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.513 -0.312 . . . . 73.33 110.608 -172.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 49.2 m-20 -121.28 127.57 51.49 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.496 -1.298 . . . . 75.32 107.496 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.64 130.26 62.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 122.357 -0.214 . . . . 73.32 110.832 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -94.48 121.64 36.23 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.185 -1.413 . . . . 64.25 107.185 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 26' ' ' PHE . 4.0 p -97.0 139.73 18.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.592 -0.731 . . . . 74.43 110.666 -176.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -77.65 -36.85 51.05 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 115.092 1.516 . . . . 73.0 115.092 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.41 -74.49 0.02 OUTLIER Glycine 0 C--O 1.225 -0.463 0 C-N-CA 117.584 -2.246 . . . . 72.33 115.774 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 t -58.57 -36.24 73.63 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.733 1.012 . . . . 74.55 113.733 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.487 ' HB3' HD13 ' A' ' 32' ' ' ILE . 62.4 m-85 -99.38 22.67 10.32 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.221 -0.992 . . . . 63.35 112.501 -175.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -74.29 -11.23 60.21 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 120.633 0.254 . . . . 72.34 111.279 176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -101.76 128.77 28.06 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.455 -0.338 . . . . 65.22 111.431 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.485 ' HB3' HG23 ' A' ' 39' ' ' THR . 18.0 Cg_endo -62.95 -37.04 56.55 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.943 2.429 . . . . 51.5 113.114 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.434 ' O ' HG22 ' A' ' 34' ' ' VAL . 4.8 m-20 -65.62 -33.79 76.72 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.718 -0.614 . . . . 72.25 110.818 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.52 -40.82 89.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.736 -0.666 . . . . 73.42 109.589 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.548 HG22 ' O ' ' A' ' 38' ' ' ARG . 43.6 mm -65.84 -42.1 91.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 CA-C-N 115.966 -0.561 . . . . 72.41 111.103 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -58.77 -34.55 71.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.892 0.377 . . . . 74.2 110.692 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.434 HG22 ' O ' ' A' ' 30' ' ' ASP . 94.4 t -77.65 -46.6 27.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.089 -0.505 . . . . 71.43 110.841 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.461 ' HE1' ' ND2' ' A' ' 86' ' ' ASN . 62.0 ttp -63.56 -36.81 85.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.02 0.378 . . . . 70.3 112.02 -177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 37' ' ' ASP 0.374 3.6 pp -126.01 -58.77 1.36 Allowed 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 115.379 1.622 . . . . 75.23 115.379 -178.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.496 ' N ' HD12 ' A' ' 36' ' ' LEU . 22.7 t70 170.56 -53.22 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.307 0.575 . . . . 70.44 110.618 -177.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.548 ' O ' HG22 ' A' ' 32' ' ' ILE . 88.8 mtt180 -123.21 -167.35 1.59 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.548 -0.908 . . . . 71.43 108.548 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.485 HG23 ' HB3' ' A' ' 29' ' ' PRO . 76.2 m -139.55 121.13 9.8 Favored Pre-proline 0 N--CA 1.432 -1.369 0 CA-C-O 120.502 0.191 . . . . 72.2 111.203 171.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.25 153.47 46.37 Favored 'Trans proline' 0 C--O 1.247 0.949 0 C-N-CA 123.56 2.84 . . . . 74.14 110.815 173.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.02 129.56 38.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.379 0.609 . . . . 74.12 110.204 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 54.2 mt -111.77 139.51 35.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.982 -0.554 . . . . 53.04 109.754 -175.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 12.0 p -127.98 145.85 34.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.467 -0.568 . . . . 73.15 109.467 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.452 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 40.3 m -78.32 122.44 25.76 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.353 -0.98 . . . . 74.02 108.353 176.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.26 159.41 42.28 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.921 0.867 . . . . 61.14 112.27 -175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 56.1 m -120.08 129.37 54.18 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.809 -1.087 . . . . 73.22 108.632 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.0 tp -98.85 104.02 22.75 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 108.864 -0.791 . . . . 65.34 108.864 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.0 OUTLIER -82.44 148.84 14.63 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.533 2.155 . . . . 72.02 111.543 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.33 16.7 66.1 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.888 -0.672 . . . . 63.34 112.255 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -145.4 159.89 42.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.956 -1.128 . . . . 61.42 107.956 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.455 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 11.1 pt20 -139.24 163.74 31.67 Favored 'General case' 0 CA--C 1.481 -1.682 0 C-N-CA 119.313 -0.955 . . . . 71.53 111.401 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.573 ' HD3' ' NH1' ' A' ' 54' ' ' ARG . 0.8 OUTLIER -107.94 129.83 55.07 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.892 -1.504 . . . . 72.52 112.858 -176.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.476 ' HA ' ' HA2' ' A' ' 128' ' ' GLY . 5.4 m-85 -109.11 158.21 18.0 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.104 -0.953 . . . . 75.34 109.905 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.573 ' NH1' ' HD3' ' A' ' 52' ' ' ARG . 6.0 mpt_? -125.68 133.35 52.19 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.442 -0.345 . . . . 75.24 110.21 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.452 HD13 ' N ' ' A' ' 56' ' ' LYS . 2.9 tm? -170.55 137.74 1.41 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.247 -1.39 . . . . 64.42 107.247 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.452 ' N ' HD13 ' A' ' 55' ' ' LEU . 97.4 mttt -125.45 113.6 17.71 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.125 0.488 . . . . 74.44 110.151 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.84 -120.11 0.92 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.413 -1.475 . . . . 71.51 109.413 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -20.98 60.58 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.412 0.625 . . . . 72.32 110.856 177.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.408 HD13 ' H ' ' A' ' 60' ' ' TYR . 33.0 tp -119.66 163.5 17.3 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 115.362 -0.835 . . . . 75.43 109.033 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.408 ' H ' HD13 ' A' ' 59' ' ' LEU . 9.2 m-85 -122.3 175.55 2.53 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 106.755 -1.572 . . . . 70.22 106.755 -172.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.23 89.47 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.691 1.594 . . . . 63.12 110.002 172.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 20.5 p -100.1 164.69 11.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 112.48 0.548 . . . . 64.45 112.48 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.12 140.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.405 -0.961 . . . . 73.43 108.405 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -145.68 154.71 52.38 Favored Pre-proline 0 C--O 1.251 1.146 0 N-CA-C 108.057 -1.09 . . . . 73.02 108.057 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -56.91 131.73 47.33 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 122.572 2.181 . . . . 64.2 112.013 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.2 t -124.46 140.58 52.82 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.286 -0.87 . . . . 41.3 108.936 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -74.35 -37.22 63.57 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.242 0.544 . . . . 70.04 109.582 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -130.94 82.33 2.04 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.611 -0.722 . . . . 75.42 110.231 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.06 164.28 37.75 Favored Glycine 0 C--N 1.299 -1.491 0 C-N-CA 119.528 -1.32 . . . . 70.3 112.811 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.22 148.19 30.24 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.832 -0.803 . . . . 72.4 108.832 176.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.16 122.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.442 -0.577 . . . . 65.3 109.442 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -97.53 116.54 29.94 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.727 -0.472 . . . . 62.45 109.727 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -152.48 -154.68 6.76 Favored Glycine 0 N--CA 1.418 -2.566 0 N-CA-C 110.317 -1.113 . . . . 44.24 110.317 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 73' ' ' GLY . 14.3 mptt -125.76 153.4 44.03 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.586 0.708 . . . . 75.52 111.88 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 69.9 t -110.81 130.18 64.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 114.206 -1.361 . . . . 74.12 110.599 177.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 65.7 mt -95.41 111.14 23.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 105.954 -1.869 . . . . 51.42 105.954 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.0 ptp -124.28 152.27 43.23 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.089 0.471 . . . . 72.33 112.006 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.92 18.72 53.68 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 109.189 -1.564 . . . . 63.03 109.189 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 80' ' ' THR . 54.7 t -71.91 127.24 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 114.253 -0.974 . . . . 73.14 109.716 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.442 ' O ' HG11 ' A' ' 79' ' ' VAL . 54.7 p -74.88 161.08 29.86 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.852 -1.166 . . . . 75.42 107.852 174.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.3 m -61.19 -26.83 67.98 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 122.182 -0.324 . . . . 73.53 111.837 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.43 -40.73 93.67 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.588 0.709 . . . . 52.54 110.793 176.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 38.1 mt-10 -78.0 -35.03 50.48 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.559 -0.746 . . . . 74.23 109.048 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.559 HD11 ' NH1' ' A' ' 97' ' ' ARG . 3.1 tm? -62.17 -51.41 67.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.478 -0.783 . . . . 70.12 110.11 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.05 -29.36 70.51 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 109.819 -0.437 . . . . 74.11 109.819 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.1 t30 -59.71 -46.56 88.73 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.956 -0.757 . . . . 54.22 108.956 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.44 -36.78 68.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.881 -0.599 . . . . 75.04 110.949 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.413 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 26.3 t70 -64.36 -31.45 72.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.901 0.858 . . . . 65.55 109.241 177.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.86 -47.21 21.95 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.591 -0.731 . . . . 71.42 111.458 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 86' ' ' ASN . 90.5 t -72.16 -60.2 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 112.77 0.655 . . . . 65.53 112.77 -176.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -83.0 -41.84 18.24 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.87 0.843 . . . . 72.04 111.822 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -59.58 -16.58 37.58 Favored Glycine 0 C--O 1.215 -1.041 0 N-CA-C 118.238 2.055 . . . . 62.45 118.238 -171.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -69.96 -45.16 67.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 120.154 1.977 . . . . 74.11 112.22 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -98.09 -3.61 37.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.242 0.544 . . . . 60.05 111.266 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 83.5 m-85 -122.24 169.43 10.91 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.769 0.828 . . . . 71.13 110.012 -178.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -122.62 132.35 54.24 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.869 -0.789 . . . . 62.34 108.869 176.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.559 ' NH1' HD11 ' A' ' 84' ' ' LEU . 9.6 ttp180 -87.01 114.1 23.33 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.902 -1.045 . . . . 75.23 109.704 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.498 HG11 ' HE3' ' A' ' 117' ' ' MET . 27.4 m -123.87 161.93 25.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 114.712 -1.131 . . . . 75.42 110.813 -177.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.2 t -94.42 129.28 41.22 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.763 -0.828 . . . . 71.31 108.763 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.94 170.32 17.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 120.963 0.411 . . . . 63.24 111.132 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.84 124.5 6.66 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.971 -0.852 . . . . 65.42 110.971 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.88 160.07 11.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 122.874 0.469 . . . . 74.22 110.117 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.4 t -120.73 127.07 75.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.467 -0.938 . . . . 73.22 108.467 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.606 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 28.2 mtp180 -68.79 135.63 51.5 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.011 -0.54 . . . . 72.03 110.676 -177.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.452 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 49.2 mt-10 -79.56 -5.73 55.55 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.07 -0.514 . . . . 74.32 109.748 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.12 -67.62 0.42 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.033 -0.985 . . . . 63.11 110.528 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -132.16 12.29 4.65 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.635 -1.166 . . . . 61.12 112.289 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.9 t 69.85 18.78 7.28 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.795 0.838 . . . . 75.31 113.133 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -88.21 149.96 23.56 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.855 -0.528 . . . . 71.2 110.923 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -95.02 147.53 23.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.122 0.487 . . . . 74.54 111.092 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.606 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.6 mtp -141.56 160.92 39.16 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 123.625 0.77 . . . . 52.23 110.329 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.16 130.88 51.91 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.552 -0.749 . . . . 73.45 110.779 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -142.83 174.02 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 73.33 110.402 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.21 149.46 23.53 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.445 -1.687 . . . . 73.32 106.445 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 6.7 t -150.35 172.09 15.95 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.085 -0.709 . . . . 74.45 109.085 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.416 ' HB3' ' HB3' ' A' ' 95' ' ' TYR . 81.0 m-85 -120.91 108.89 14.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 123.452 0.47 . . . . 75.13 109.951 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.498 ' HE3' HG11 ' A' ' 98' ' ' VAL . 24.0 ptt? -112.42 155.87 23.49 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.093 -0.503 . . . . 53.11 109.728 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -69.56 129.44 39.68 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.461 -0.941 . . . . 74.44 108.461 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.447 HD12 ' H ' ' A' ' 119' ' ' ILE . 2.7 mp -72.65 -42.81 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.763 0.316 . . . . 64.34 111.762 -171.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -71.1 -36.91 72.36 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.136 -0.69 . . . . 63.14 109.136 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt 52.34 9.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.318 1.847 . . . . 74.41 114.908 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.96 14.14 4.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.386 0.513 . . . . 74.51 112.386 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.08 122.42 82.58 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 110.182 -0.303 . . . . 70.42 110.182 176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.28 -5.96 18.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.587 2.191 . . . . 75.41 112.974 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -59.71 -53.3 59.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.305 0.574 . . . . 64.31 110.225 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.7 ptt? -73.67 141.73 46.45 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.801 -1.091 . . . . 64.45 112.233 -175.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -116.06 134.48 54.91 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.554 -0.906 . . . . 73.34 108.554 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -84.5 29.34 4.05 Favored Glycine 0 CA--C 1.492 -1.365 0 C-N-CA 121.056 -0.592 . . . . 51.25 113.481 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.63 149.91 46.59 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-O 121.853 0.835 . . . . 72.04 111.519 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . 0.439 ' C ' ' H ' ' A' ' 132' ' ' PHE . 15.1 t90 -111.83 162.08 15.66 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 106.284 -1.747 . . . . 75.02 106.284 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.476 ' HA ' ' OE2' ' A' ' 133' ' ' GLU . 17.6 m120 -45.59 3.66 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 116.353 1.983 . . . . 71.12 116.353 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.439 ' H ' ' C ' ' A' ' 130' ' ' TRP . 59.9 m-85 -61.14 -31.36 71.08 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 107.649 -1.241 . . . . 74.54 107.649 170.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.476 ' OE2' ' HA ' ' A' ' 131' ' ' ASN . 0.0 OUTLIER -56.28 -34.65 66.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.324 0.861 . . . . 75.31 113.324 177.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 36.5 tt0 -68.32 -39.74 81.89 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.801 -0.444 . . . . 71.22 109.801 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -63.5 -30.02 71.2 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.856 -0.611 . . . . 72.44 110.316 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -52.21 -39.13 59.76 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 123.19 0.596 . . . . 75.13 110.299 177.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.434 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 61.9 ttt180 -57.04 -48.28 78.9 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.276 0.63 . . . . 75.32 111.742 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.97 -26.8 30.96 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.154 0.502 . . . . 63.4 110.703 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -82.03 -27.3 33.13 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.685 -0.689 . . . . 74.11 112.116 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.53 ' O ' HG12 ' A' ' 144' ' ' ILE . 63.9 pttt -66.59 -32.52 73.91 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 110.199 -0.297 . . . . 73.01 110.199 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.507 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 50.2 mtmt -48.58 -35.15 12.83 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.818 0.847 . . . . 73.31 112.589 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -58.96 -45.39 90.62 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.3 0.572 . . . . 73.25 110.826 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -76.12 -34.87 59.48 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.918 -0.771 . . . . 64.52 108.918 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.1 mm -61.43 -33.97 59.2 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.759 0 CA-C-N 115.081 -0.963 . . . . 75.34 110.193 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.3 mt-10 -54.15 -35.88 62.72 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.742 0.306 . . . . 72.51 110.843 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.9 m -70.6 -47.37 60.48 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 116.128 -0.487 . . . . 73.24 110.018 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -71.84 -30.51 65.53 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 113.238 0.829 . . . . 71.04 113.238 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.9 -42.87 80.69 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.981 -0.748 . . . . 74.43 108.981 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -70.92 -38.43 72.93 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.785 -1.098 . . . . 74.42 108.931 -177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.55 -41.08 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.754 -0.657 . . . . 61.03 110.355 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 70.9 mtm -67.79 -37.75 82.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.514 -0.312 . . . . 74.14 110.818 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 156' ' ' LYS . 45.1 mt-10 -67.84 -31.29 71.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.806 0.336 . . . . 74.43 111.016 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.91 -47.1 55.04 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.354 -0.385 . . . . 63.32 111.459 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -80.52 -45.11 18.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.617 0.599 . . . . 65.23 112.617 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.56 -45.01 4.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.202 0.445 . . . . 74.41 112.202 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 87.5 tttt 69.52 75.07 0.26 Allowed Pre-proline 0 C--N 1.312 -1.027 0 C-N-CA 124.193 0.997 . . . . 74.44 111.454 -174.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -101.39 -176.43 0.13 Allowed 'Trans proline' 0 N--CA 1.426 -2.443 0 C-N-CA 122.662 2.241 . . . . 53.53 110.546 173.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 C--N 1.298 -1.663 0 N-CA-C 109.272 -0.64 . . . . 74.04 109.272 175.648 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.429 -1.481 0 CA-C-O 121.493 0.663 . . . . 53.35 111.563 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.7 m -120.98 17.65 11.72 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.127 -1.064 . . . . 73.23 108.127 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.6 m -55.07 -45.05 75.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.908 -1.496 . . . . 74.31 111.736 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t70 64.62 85.49 0.14 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.778 0.831 . . . . 74.15 110.883 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 m -164.49 -177.21 4.73 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.362 -1.348 . . . . 73.51 107.362 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -74.78 -76.5 0.14 Allowed 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 117.76 0.254 . . . . 71.4 110.39 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 48.57 -156.47 0.07 Allowed 'General case' 0 C--O 1.25 1.088 0 O-C-N 124.933 1.396 . . . . 71.43 110.875 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -86.62 154.04 21.33 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 108.4 -0.963 . . . . 73.21 108.4 172.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.432 ' O ' HG11 ' A' ' 79' ' ' VAL . 40.8 m-70 -115.15 159.56 20.76 Favored 'General case' 0 C--N 1.271 -2.848 0 N-CA-C 108.933 -0.765 . . . . 72.22 108.933 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -116.97 125.34 51.25 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.824 -1.176 . . . . 63.1 107.824 176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.7 t -125.47 142.08 43.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 109.759 -0.46 . . . . 71.22 109.759 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.433 ' HB2' HG22 ' A' ' 113' ' ' VAL . 91.1 t80 -94.34 123.13 37.55 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.044 -1.095 . . . . 73.11 108.044 177.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.424 HG23 ' HB2' ' A' ' 26' ' ' PHE . 14.8 p -107.89 148.41 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 121.445 0.64 . . . . 72.33 110.609 -176.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -118.02 -59.75 1.87 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.175 -0.92 . . . . 74.43 113.046 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.22 -60.14 0.08 OUTLIER Glycine 0 C--N 1.336 0.564 0 C-N-CA 118.663 -1.732 . . . . 64.14 115.41 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.2 m -57.84 -24.34 56.98 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.388 0.884 . . . . 55.01 113.388 -172.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HB2' HG23 ' A' ' 22' ' ' VAL . 49.8 m-85 -132.0 25.13 4.61 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.723 -0.843 . . . . 70.23 108.723 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.46 -30.18 68.02 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.308 0.575 . . . . 63.32 112.478 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' HG12 ' A' ' 31' ' ' VAL . 31.0 t70 -96.65 130.89 29.3 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.893 -0.594 . . . . 72.4 111.334 -176.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 19.0 Cg_endo -60.24 -28.25 86.52 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.52 2.147 . . . . 52.24 113.692 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.441 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 22.0 t70 -70.52 -41.74 72.18 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.567 -0.453 . . . . 74.31 110.926 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 28' ' ' ASP . 9.8 p -65.92 -28.57 44.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 C-N-CA 119.887 -0.725 . . . . 64.43 109.33 177.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.481 HG22 HD21 ' A' ' 36' ' ' LEU . 37.5 mm -61.52 -46.75 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.598 -0.519 . . . . 75.41 109.598 175.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -60.89 -32.19 71.66 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.925 -0.58 . . . . 53.41 111.94 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.4 t -81.71 -38.91 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 120.636 -0.425 . . . . 74.33 111.59 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -74.75 -36.81 62.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.482 -0.326 . . . . 72.11 110.776 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.481 HD21 HG22 ' A' ' 32' ' ' ILE 0.275 0.4 OUTLIER -117.02 -60.78 1.8 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.169 -0.612 . . . . 52.51 111.987 176.764 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.43 ' OD2' ' HG2' ' A' ' 38' ' ' ARG . 30.5 t70 162.13 -50.99 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 124.597 1.159 . . . . 71.42 110.236 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 4.6 mmp_? -118.88 152.76 35.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.957 -0.565 . . . . 63.52 110.636 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.414 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 5.0 m -95.74 120.2 63.71 Favored Pre-proline 0 C--O 1.245 0.829 0 CA-C-N 116.647 -0.251 . . . . 75.23 111.009 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -67.47 152.71 78.26 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 122.77 2.313 . . . . 71.42 109.36 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.42 129.0 39.86 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.331 -0.547 . . . . 74.21 109.85 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 53.9 mt -110.28 124.93 67.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.495 -0.775 . . . . 73.14 109.226 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.478 HG22 ' HD2' ' A' ' 104' ' ' ARG . 14.0 p -116.41 146.56 20.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 109.007 -0.738 . . . . 74.4 109.007 177.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.6 m -81.44 124.29 29.31 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.627 -0.509 . . . . 65.12 109.627 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.83 159.49 42.13 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.171 0.51 . . . . 74.41 111.161 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.6 m -116.51 131.63 56.9 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.313 -0.858 . . . . 72.22 110.8 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.7 tp -99.3 99.9 9.27 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 123.984 0.913 . . . . 73.41 110.014 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 66.4 Cg_endo -78.3 143.29 19.65 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.149 1.9 . . . . 73.52 111.693 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.01 5.12 58.48 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 116.077 -0.511 . . . . 63.5 112.306 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.2 168.91 18.51 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 122.358 0.263 . . . . 72.21 110.43 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -139.94 164.7 29.31 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.12 -0.696 . . . . 71.32 109.12 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -130.97 126.41 35.95 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.434 -0.803 . . . . 71.44 110.676 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.521 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 37.4 m-85 -114.83 163.89 14.88 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.668 -0.696 . . . . 75.3 109.742 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.501 ' O ' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -140.29 125.25 18.43 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 123.485 0.491 . . . . 71.11 111.235 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 tp -155.46 169.99 22.99 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.634 -1.247 . . . . 74.43 107.634 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -135.86 154.93 51.01 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.774 -0.454 . . . . 62.14 109.774 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.95 -114.41 2.51 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.02 -0.832 . . . . 60.23 111.02 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.481 HH21 ' CG ' ' A' ' 125' ' ' ASP . 3.7 ppt_? -88.88 -18.11 28.26 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.02 -1.104 . . . . 73.31 108.02 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.4 tp -115.71 163.75 15.36 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.061 -0.972 . . . . 72.02 108.845 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -137.67 176.88 2.42 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 106.913 -1.514 . . . . 74.24 106.913 -168.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 12.2 Cg_endo -59.57 120.79 8.82 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 107.752 -1.672 . . . . 71.22 107.752 166.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.5 p -132.82 160.32 37.25 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.962 0.411 . . . . 73.13 111.128 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mm -110.38 138.18 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.411 -0.959 . . . . 72.24 108.411 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 m -145.9 151.99 46.9 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 108.157 -1.053 . . . . 70.25 108.157 175.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.426 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 10.4 Cg_endo -58.53 134.67 62.59 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.645 2.23 . . . . 72.2 112.645 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.4 t -120.51 147.36 45.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.738 -0.838 . . . . 53.41 108.738 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.31 -37.83 68.85 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.341 0.4 . . . . 73.32 110.284 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' O ' ' HE3' ' A' ' 136' ' ' LYS . 49.6 mtmt -142.52 75.81 1.51 Allowed 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 108.751 -0.833 . . . . 72.12 108.751 173.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.55 168.63 28.52 Favored Glycine 0 C--N 1.287 -2.166 0 C-N-CA 119.538 -1.315 . . . . 53.24 112.68 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -154.51 141.47 19.24 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.64 -0.874 . . . . 64.32 108.64 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.07 119.16 59.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.308 -0.627 . . . . 64.33 109.308 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -89.85 116.07 27.65 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.979 -1.489 . . . . 65.45 106.979 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.86 -148.05 4.72 Favored Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 120.718 -0.753 . . . . 64.21 111.563 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.521 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 46.0 mmtm -127.12 147.11 50.18 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.692 0.282 . . . . 63.11 110.92 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 39.2 t -110.35 127.42 67.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 116.12 -0.491 . . . . 72.44 110.658 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 73.8 mt -95.32 103.99 15.86 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.347 -1.353 . . . . 73.02 107.347 177.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.6 ptp -109.4 138.63 45.47 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.881 -0.414 . . . . 71.32 109.881 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.81 13.93 26.36 Favored Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 119.462 -1.352 . . . . 73.55 111.743 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 18' ' ' HIS . 11.3 p -83.06 129.42 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.588 -0.893 . . . . 71.41 108.588 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 m -73.77 159.82 32.38 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 109.825 -0.435 . . . . 74.4 109.825 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 19.7 m -56.58 -42.32 78.47 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.25 0.463 . . . . 73.34 112.25 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.78 -41.46 99.26 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-O 120.843 0.354 . . . . 62.53 111.372 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.583 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 47.2 mt-10 -70.61 -28.21 64.68 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.269 -0.641 . . . . 72.31 109.269 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 81' ' ' SER . 55.2 tp -63.26 -47.15 83.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.496 -0.927 . . . . 63.24 108.496 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' O ' ' HB3' ' A' ' 88' ' ' ASP . 47.7 mt-10 -68.52 -29.15 67.67 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.056 -0.974 . . . . 73.12 110.173 176.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.583 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 2.3 t-20 -63.15 -45.97 89.39 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.498 1.119 . . . . 72.03 109.052 175.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.5 mt -64.2 -38.76 92.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.611 -0.722 . . . . 72.11 109.367 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.435 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 9.7 t70 -58.95 -47.2 85.95 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 115.486 -0.779 . . . . 52.32 110.425 173.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.62 -48.07 83.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.693 -0.685 . . . . 72.51 111.315 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.49 -57.99 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 N-CA-C 113.332 0.864 . . . . 52.12 113.332 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -79.84 -36.43 36.8 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.409 0.623 . . . . 65.12 111.825 -174.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.17 -17.16 22.75 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-N 115.098 -0.956 . . . . 44.41 115.113 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -58.98 -32.41 69.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 111.736 0.273 . . . . 75.11 111.736 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.51 0.51 4.03 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 111.629 0.233 . . . . 63.15 111.629 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -132.05 164.22 26.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.166 0.432 . . . . 64.32 112.166 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.7 tp10 -124.66 143.55 50.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.409 -0.589 . . . . 74.54 109.409 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 115' ' ' THR . 46.0 ttp180 -97.13 114.72 26.43 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.514 -0.55 . . . . 74.02 109.514 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.472 HG12 ' HE1' ' A' ' 117' ' ' MET . 22.8 m -116.75 162.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 115.731 -0.668 . . . . 74.03 112.002 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.7 p -86.13 121.9 29.38 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.892 -1.049 . . . . 65.45 109.932 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.57 166.08 29.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 115.88 -0.6 . . . . 62.2 112.091 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -118.95 127.72 7.35 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.023 -1.231 . . . . 38.4 110.023 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.01 161.0 16.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 117.096 0.448 . . . . 63.33 111.115 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.6 t -128.53 124.42 61.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.671 -0.862 . . . . 74.54 108.671 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.478 ' HD2' HG22 ' A' ' 43' ' ' VAL . 55.9 mtm180 -63.74 147.52 51.49 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.185 0.517 . . . . 75.25 112.387 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -82.73 -1.49 51.57 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.573 -1.194 . . . . 72.25 110.129 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.18 -59.23 3.01 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.564 -0.743 . . . . 72.41 111.616 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -140.83 5.82 1.98 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 119.788 -0.765 . . . . 75.31 111.415 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.8 t 69.77 78.04 0.2 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.212 0.945 . . . . 73.0 110.99 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -137.09 151.96 49.48 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.231 -1.396 . . . . 70.14 107.231 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -104.76 148.33 26.73 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.764 -0.774 . . . . 73.33 112.888 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.3 mtm -136.4 163.26 30.89 Favored 'General case' 0 CA--C 1.475 -1.935 0 CA-C-N 115.334 -0.848 . . . . 75.23 109.38 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.36 117.97 35.49 Favored 'General case' 0 C--N 1.268 -2.972 0 CA-C-N 114.837 -1.074 . . . . 40.54 109.581 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 21' ' ' PHE . 30.9 m -135.52 174.02 13.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.723 -0.473 . . . . 61.01 109.723 -176.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -116.96 154.24 31.21 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.058 -1.09 . . . . 72.51 108.058 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.2 t -146.02 171.57 14.67 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.182 -0.674 . . . . 73.14 109.182 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.2 m-85 -113.73 112.35 23.31 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.352 -0.61 . . . . 73.5 109.352 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.472 ' HE1' HG12 ' A' ' 98' ' ' VAL . 24.5 ptt? -112.95 158.15 20.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.703 -0.681 . . . . 62.45 109.834 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -66.76 124.82 23.98 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 107.797 -1.186 . . . . 73.41 107.797 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.21 -43.29 84.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 113.969 1.1 . . . . 62.43 113.969 -165.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -86.24 -9.69 56.03 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.245 -0.982 . . . . 63.34 110.657 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt 55.58 -27.15 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 118.136 2.643 . . . . 74.31 118.136 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -110.58 96.37 6.14 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.56 -0.712 . . . . 72.33 112.348 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -128.1 118.87 20.77 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.036 -0.984 . . . . 74.25 111.326 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.79 -15.87 44.95 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.622 2.215 . . . . 73.45 110.034 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.481 ' CG ' HH21 ' A' ' 58' ' ' ARG . 1.2 m-20 -58.8 -41.71 87.37 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.205 -1.361 . . . . 75.4 112.409 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -72.67 80.57 1.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 122.496 1.141 . . . . 64.34 113.451 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -103.52 103.92 13.93 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 105.185 -2.154 . . . . 74.12 105.185 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 54' ' ' ARG . . . 165.77 86.29 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.576 0 N-CA-C 108.419 -1.872 . . . . 73.23 108.419 -172.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -81.77 126.68 32.12 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 114.805 -0.697 . . . . 74.24 109.521 -173.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.9 t90 -74.45 158.68 33.42 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.614 -0.721 . . . . 74.21 110.496 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -37.75 -47.9 1.04 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.672 1.589 . . . . 61.4 112.525 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -73.02 -47.35 45.75 Favored 'General case' 0 N--CA 1.407 -2.589 0 CA-C-O 119.282 -0.39 . . . . 74.21 111.297 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -56.52 -31.52 64.2 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.411 0.624 . . . . 74.22 110.445 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.502 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.9 tp10 -65.8 -53.64 37.54 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.391 -0.822 . . . . 75.11 109.707 176.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -64.89 -36.55 84.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.318 0.58 . . . . 75.02 110.389 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 68' ' ' LYS . 86.9 tttt -52.77 -50.35 63.7 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 125.018 1.327 . . . . 72.14 110.124 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.561 ' O ' ' HG2' ' A' ' 141' ' ' LYS . 40.0 ptt180 -71.11 -30.69 66.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 120.563 -0.455 . . . . 70.31 111.886 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 134' ' ' GLU . 86.0 mt -69.71 -32.8 71.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.293 0.568 . . . . 73.51 110.424 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -75.66 -36.88 60.01 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.494 -0.775 . . . . 72.03 108.96 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.401 ' O ' HG12 ' A' ' 144' ' ' ILE . 87.0 tttt -61.72 -34.21 75.4 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.137 1.375 . . . . 73.43 110.672 176.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 137' ' ' ARG . 32.7 mmtp -48.99 -31.36 7.34 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.369 1.248 . . . . 73.41 114.369 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -54.58 -46.47 73.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.128 0.49 . . . . 72.34 110.849 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -76.29 -36.1 58.54 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.569 0.699 . . . . 72.43 109.205 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.484 ' HB ' ' HA ' ' A' ' 141' ' ' LYS . 50.7 mm -62.04 -33.21 57.22 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 CA-C-N 114.721 -1.127 . . . . 73.41 112.313 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 64.4 mm-40 -54.27 -36.22 63.39 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.045 0.45 . . . . 63.54 110.616 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 89.3 m -74.42 -42.74 58.66 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.403 -0.591 . . . . 74.03 109.403 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -67.75 -29.45 68.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 114.598 1.332 . . . . 72.24 114.598 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.622 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 99.3 mttt -53.38 -49.05 68.03 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 109.278 -0.638 . . . . 70.53 109.278 176.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -68.01 -36.24 79.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.206 -0.906 . . . . 72.34 110.55 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.3 -39.83 86.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.594 -0.73 . . . . 70.32 109.688 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 56.9 ttp -73.43 -38.53 65.49 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.508 -0.769 . . . . 74.52 110.599 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.622 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 52.1 mt-10 -62.85 -34.63 77.76 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.2 0.524 . . . . 74.53 110.592 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 46.9 t -65.91 -36.22 82.78 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.273 -0.876 . . . . 61.42 109.953 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -82.5 -44.63 15.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.223 -0.444 . . . . 71.21 111.887 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -97.24 -91.14 0.25 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.419 -0.355 . . . . 75.34 111.361 -178.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -154.55 153.06 27.29 Favored Pre-proline 0 C--O 1.241 0.636 0 C-N-CA 124.591 1.157 . . . . 73.42 107.907 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.4 148.37 60.8 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 122.21 1.94 . . . . 75.01 111.446 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 C--N 1.294 -1.825 0 N-CA-C 108.278 -1.008 . . . . 53.22 108.278 179.811 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 106.177 -1.786 . . . . 71.33 106.177 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.3 m -62.9 104.98 0.61 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.647 0.61 . . . . 71.1 112.647 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.7 m -70.63 -31.48 68.45 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.53 -0.915 . . . . 71.44 108.53 174.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t70 54.59 -81.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.013 1.725 . . . . 62.23 114.487 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.9 t -101.72 -19.57 15.33 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 120.648 0.261 . . . . 72.41 111.35 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -88.75 153.13 21.33 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.173 0.434 . . . . 74.35 112.173 -176.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 59.98 -159.57 0.3 Allowed 'General case' 0 C--O 1.248 0.977 0 C-N-CA 124.442 1.097 . . . . 73.53 112.076 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.67 155.56 27.99 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.988 -1.116 . . . . 72.24 107.988 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.501 ' O ' HG11 ' A' ' 79' ' ' VAL . 54.3 m-70 -112.94 159.26 19.27 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 109.291 -0.633 . . . . 73.14 109.291 -171.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -123.25 125.74 45.64 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.408 -1.33 . . . . 74.03 107.408 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.5 t -129.64 140.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 110.329 -0.248 . . . . 71.01 110.329 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -94.27 123.79 37.88 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.764 -0.828 . . . . 74.44 108.764 177.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 74' ' ' LYS . 20.0 m -88.6 154.21 3.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.997 -0.547 . . . . 74.3 110.778 -176.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.412 ' CD2' HG12 ' A' ' 63' ' ' ILE . 1.5 p90 -135.46 -44.84 0.68 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.616 0.969 . . . . 71.12 113.616 -176.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.614 ' O ' ' HG2' ' A' ' 27' ' ' GLN . . . -146.43 -62.28 0.01 OUTLIER Glycine 0 C--O 1.219 -0.81 0 C-N-CA 119.611 -1.28 . . . . 51.53 112.667 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 p -60.81 -22.52 64.25 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 123.894 0.878 . . . . 65.05 112.813 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.403 ' HB3' HD11 ' A' ' 32' ' ' ILE . 25.3 m-85 -127.47 17.41 7.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.155 -0.475 . . . . 75.2 111.116 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 24' ' ' GLY . 16.7 pt20 -78.36 3.51 15.44 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 120.418 -0.513 . . . . 73.14 112.381 -175.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.594 ' O ' HG12 ' A' ' 31' ' ' VAL . 15.3 t70 -130.09 125.66 22.03 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.676 -176.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -62.25 -29.58 80.41 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.254 1.969 . . . . 72.23 113.478 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.48 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 14.9 t70 -64.9 -42.84 94.42 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.228 -0.295 . . . . 64.52 110.781 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.594 HG12 ' O ' ' A' ' 28' ' ' ASP . 8.3 p -67.97 -28.72 42.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 N-CA-C 109.263 -0.643 . . . . 75.44 109.263 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 28' ' ' ASP . 49.9 mm -64.82 -44.01 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 116.323 -0.399 . . . . 71.32 110.436 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -58.7 -35.56 72.83 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.933 0.397 . . . . 75.32 111.204 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -82.14 -47.44 19.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 116.218 -0.447 . . . . 71.13 112.168 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -62.82 -36.34 82.86 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.953 -0.388 . . . . 64.35 109.953 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.408 HD22 HG22 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -119.81 -73.02 0.66 Allowed 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 120.233 -0.587 . . . . 71.54 112.252 174.15 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.5 t70 169.24 -50.2 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.854 -0.795 . . . . 72.23 108.854 -174.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -106.76 150.25 26.5 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 114.898 -1.047 . . . . 65.13 109.938 -174.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 m -103.28 110.21 63.26 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 108.102 -1.073 . . . . 63.34 108.102 170.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.67 151.56 79.64 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 122.802 2.335 . . . . 73.23 110.009 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -56.81 132.76 53.26 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.844 -0.428 . . . . 75.33 109.844 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 27.2 mt -109.59 137.84 39.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.751 -0.658 . . . . 74.02 110.542 -172.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 14.4 p -130.66 147.07 33.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.961 -0.563 . . . . 73.52 109.952 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.4 m -75.99 123.31 25.54 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.581 -0.896 . . . . 72.02 108.581 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.52 155.86 46.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.503 0.668 . . . . 42.0 111.643 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.466 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 95.4 m -115.36 125.93 53.8 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.012 -0.994 . . . . 54.33 110.515 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.5 tp -99.37 100.77 11.16 Favored Pre-proline 0 C--N 1.299 -1.616 0 C-N-CA 123.026 0.53 . . . . 64.34 109.873 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.6 Cg_endo -81.63 136.0 9.42 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.899 2.4 . . . . 73.22 112.829 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.49 15.42 37.75 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.632 -0.713 . . . . 72.02 111.886 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.03 161.15 40.77 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.001 -0.74 . . . . 75.54 109.001 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.6 tp60 -140.33 140.91 35.71 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.272 0.558 . . . . 72.2 110.675 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 37.7 tpt85 -94.88 126.2 40.05 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.722 -1.126 . . . . 75.1 109.673 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -124.89 159.42 31.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.263 -0.643 . . . . 73.43 109.263 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.433 ' HE ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -143.78 153.47 42.43 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 119.344 -0.36 . . . . 75.13 111.451 178.364 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 125' ' ' ASP . 6.8 tt 170.45 109.37 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 106.644 -1.613 . . . . 65.14 106.644 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -79.73 150.83 30.7 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.119 0.485 . . . . 74.42 112.258 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.68 -105.24 0.28 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.59 -1.004 . . . . 63.41 110.59 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.47 ' C ' ' HD2' ' A' ' 58' ' ' ARG . 6.4 ppt_? -97.18 -15.55 20.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.724 -0.473 . . . . 71.12 109.724 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.6 tp -112.3 164.34 13.34 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.792 -0.64 . . . . 64.32 109.96 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -122.37 164.49 25.79 Favored Pre-proline 0 N--CA 1.419 -2.009 0 N-CA-C 108.273 -1.01 . . . . 70.1 108.273 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -55.71 115.33 2.38 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.478 2.118 . . . . 63.22 109.621 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.1 p -132.33 159.67 38.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.278 0.473 . . . . 74.32 112.278 -174.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.412 HG12 ' CD2' ' A' ' 23' ' ' TYR . 45.4 mm -115.82 141.92 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.449 -0.945 . . . . 73.43 108.449 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.6 m -143.67 154.53 59.56 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 107.509 -1.293 . . . . 71.1 107.509 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.39 136.4 59.19 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.385 2.057 . . . . 74.12 112.789 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.3 t -124.86 144.06 50.51 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.217 -1.031 . . . . 72.12 108.217 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.07 -37.34 64.25 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.968 -0.382 . . . . 63.53 109.968 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 68' ' ' LYS . 2.7 mppt? -131.68 75.22 1.63 Allowed 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.713 -0.477 . . . . 74.3 109.713 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.76 157.83 30.46 Favored Glycine 0 N--CA 1.42 -2.376 0 C-N-CA 119.566 -1.302 . . . . 64.21 111.584 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -147.65 150.59 34.67 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 107.688 -1.227 . . . . 73.55 107.688 175.019 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.9 t -112.05 127.65 69.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 109.159 -0.682 . . . . 63.22 109.159 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -99.1 115.54 29.24 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.919 -1.512 . . . . 73.24 106.919 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.412 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -149.55 -149.63 5.04 Favored Glycine 0 N--CA 1.411 -2.975 0 N-CA-C 110.27 -1.132 . . . . 73.32 110.27 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.493 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.7 mptm? -128.18 155.08 45.06 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.682 0.753 . . . . 71.21 112.655 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 31.2 t -113.38 132.72 61.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 114.262 -1.335 . . . . 74.05 112.067 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.404 HD21 HG12 ' A' ' 42' ' ' ILE . 85.9 mt -95.82 123.38 39.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.214 -1.402 . . . . 65.14 107.214 172.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 22.0 ptp -127.48 146.46 50.49 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 121.04 -0.264 . . . . 74.14 111.139 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.21 25.73 15.88 Favored Glycine 0 N--CA 1.43 -1.765 0 C-N-CA 119.572 -1.299 . . . . 54.24 111.622 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.501 HG11 ' O ' ' A' ' 18' ' ' HIS . 10.1 p -94.38 129.55 44.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 109.601 -0.518 . . . . 75.31 109.601 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.457 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 15.6 m -73.6 159.57 32.89 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 122.874 0.47 . . . . 63.22 110.64 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.3 m -55.4 -37.36 67.52 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.276 0.843 . . . . 73.2 113.276 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -58.92 -51.06 71.65 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 120.868 0.366 . . . . 63.55 110.719 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.646 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 2.3 mp0 -67.49 -28.13 67.58 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 115.937 -0.574 . . . . 71.2 110.516 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' A' ' 18' ' ' HIS . 42.4 tp -63.6 -42.83 98.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.093 -0.706 . . . . 74.14 109.093 174.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.31 -31.88 69.4 Favored 'General case' 0 C--O 1.198 -1.624 0 CA-C-N 115.524 -0.762 . . . . 74.21 109.359 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.596 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 2.3 t-20 -61.11 -49.49 77.09 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.452 1.101 . . . . 65.31 109.832 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 86.1 mt -62.25 -42.43 99.32 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.819 -0.808 . . . . 73.45 108.819 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.2 -38.56 90.85 Favored 'General case' 0 C--O 1.205 -1.241 0 CA-C-N 114.68 -1.145 . . . . 72.13 110.402 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.63 -43.68 84.03 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.996 0.518 . . . . 62.11 110.762 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 86' ' ' ASN . 88.7 t -72.29 -58.3 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 116.221 -0.445 . . . . 70.23 111.941 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -79.88 -42.58 23.89 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.721 1.008 . . . . 75.33 113.721 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.52 -17.11 18.4 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 115.659 1.024 . . . . 73.13 115.659 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -63.37 -39.51 94.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.361 -0.607 . . . . 53.22 109.361 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.68 0.33 9.83 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.977 0.418 . . . . 73.43 111.533 -176.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -134.3 168.91 18.03 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.648 0.779 . . . . 73.4 109.97 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 15.7 pt-20 -122.8 137.33 54.96 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.937 -0.394 . . . . 71.44 109.937 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -87.76 112.78 22.78 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.309 -1.367 . . . . 73.04 107.309 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.494 HG13 ' HE2' ' A' ' 117' ' ' MET . 23.0 m -123.04 162.49 23.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 113.237 0.828 . . . . 75.13 113.237 -176.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.8 p -85.07 122.32 29.12 Favored 'General case' 0 N--CA 1.405 -2.716 0 CA-C-N 114.473 -1.239 . . . . 73.21 109.174 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.99 171.23 18.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.319 0.581 . . . . 73.13 111.732 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -123.9 129.2 7.16 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 109.871 -1.292 . . . . 37.42 109.871 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.416 ' CD1' ' HB3' ' A' ' 111' ' ' MET . 2.8 pp -119.3 152.91 21.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 117.039 0.419 . . . . 52.42 111.199 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 63.7 t -110.81 114.82 48.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 108.708 -0.849 . . . . 50.33 108.708 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -65.56 112.51 3.64 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.394 -0.821 . . . . 71.22 109.747 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.9 -14.28 61.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.244 1.021 . . . . 75.23 108.815 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.66 -48.55 74.83 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.04 -1.891 . . . . 55.0 111.628 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -128.87 -15.21 4.37 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 121.955 -0.466 . . . . 73.21 111.754 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.8 m 77.15 73.24 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.705 1.202 . . . . 72.54 111.882 -176.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -155.01 153.16 30.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.11 1.364 . . . . 62.44 108.056 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 65.1 pttt -93.27 147.17 23.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.24 -0.984 . . . . 63.52 110.732 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.416 ' HB3' ' CD1' ' A' ' 102' ' ' ILE . 27.1 ttt -140.7 154.12 46.23 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 124.324 1.05 . . . . 70.53 108.85 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.47 130.09 46.5 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.825 0.345 . . . . 75.1 110.983 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.4 m -146.04 175.28 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.585 -0.894 . . . . 70.12 108.585 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.67 157.98 24.52 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.031 -0.729 . . . . 51.44 109.031 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.0 t -152.09 172.94 15.55 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.969 -0.752 . . . . 71.01 108.969 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.493 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 74.3 m-85 -114.77 122.07 45.25 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 123.584 0.553 . . . . 75.03 110.215 -177.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.494 ' HE2' HG13 ' A' ' 98' ' ' VAL . 24.6 ptt? -119.07 156.95 28.8 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.858 -0.61 . . . . 74.23 109.454 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 63.8 t-105 -67.49 135.27 52.79 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.871 -0.789 . . . . 74.11 108.871 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 96' ' ' GLU . 20.4 mm -68.96 -44.4 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 120.553 -0.459 . . . . 72.31 112.097 -170.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 122' ' ' ALA . 47.9 t30 -69.81 -32.49 70.97 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.135 0.493 . . . . 75.42 109.76 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.345 9.2 ptpp? 54.91 -1.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.637 2.088 . . . . 65.45 116.637 176.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 120' ' ' ASN . . . -127.85 83.85 2.2 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.628 -1.249 . . . . 74.1 107.628 172.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.41 ' HB3' ' HE2' ' A' ' 126' ' ' MET . 14.2 t70 -120.77 130.33 24.9 Favored Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 115.262 -0.881 . . . . 74.21 110.493 -176.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.49 2.7 8.2 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.89 2.393 . . . . 73.32 114.766 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.459 ' O ' HD13 ' A' ' 55' ' ' LEU . 5.3 m-20 -96.61 -34.5 11.39 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 121.834 -0.541 . . . . 63.03 111.653 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.41 ' HE2' ' HB3' ' A' ' 123' ' ' ASP 0.352 0.0 OUTLIER -76.11 95.31 3.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 114.478 1.288 . . . . 74.05 114.478 179.785 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -150.91 125.03 9.31 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.989 -1.005 . . . . 65.53 110.079 175.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 149.36 134.18 2.3 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.654 -0.978 . . . . 73.41 110.654 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.99 149.92 30.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.182 0.515 . . . . 60.52 111.109 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -121.88 158.73 28.32 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.618 -2.364 . . . . 75.31 104.618 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -45.11 -13.82 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 115.053 1.501 . . . . 64.03 115.053 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -65.54 -33.02 74.95 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.796 -0.565 . . . . 74.52 109.725 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -63.77 -28.66 70.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.806 -0.634 . . . . 74.52 111.112 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.52 ' O ' HD13 ' A' ' 138' ' ' LEU . 10.5 tp10 -61.4 -50.24 73.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.001 -0.74 . . . . 75.23 109.001 176.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -68.99 -30.79 69.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.092 0.472 . . . . 75.12 110.441 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -60.9 -40.92 94.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.983 -0.553 . . . . 61.43 111.025 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -74.88 -32.83 61.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 120.18 -0.608 . . . . 72.33 112.141 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 134' ' ' GLU . 9.5 mp -68.71 -21.69 64.39 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.197 0.522 . . . . 73.1 111.57 176.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -63.7 -19.0 64.58 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.655 -0.702 . . . . 65.24 110.775 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.58 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.1 ttpt -60.06 -39.97 87.88 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.309 -0.626 . . . . 75.3 109.309 176.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 51.4 tttm -50.68 -35.13 29.41 Favored 'General case' 0 C--O 1.217 -0.638 0 C-N-CA 124.074 0.95 . . . . 74.12 111.884 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -68.86 -33.73 74.28 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.241 0.544 . . . . 71.04 110.611 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -77.38 -35.62 54.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.307 -0.627 . . . . 64.41 109.307 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 140' ' ' LYS . 45.3 mm -64.05 -33.51 62.74 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.441 0 CA-C-N 115.253 -0.885 . . . . 62.35 110.379 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.0 mt-10 -54.27 -30.47 50.79 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 113.277 0.843 . . . . 73.12 113.277 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.1 m -64.34 -41.82 96.57 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 108.876 -0.787 . . . . 73.3 108.876 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -76.38 -28.66 56.83 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.446 -0.797 . . . . 71.33 113.003 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.666 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 27.2 mmmt -52.95 -44.26 66.96 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 123.229 0.331 . . . . 74.12 110.746 175.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.18 -43.76 82.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.76 0.791 . . . . 71.21 109.275 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.424 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 71.2 mt -66.72 -45.69 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 114.596 -1.183 . . . . 73.44 111.248 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' MET . . . . . 0.448 ' HG2' ' HA ' ' A' ' 148' ' ' LYS . 26.1 ptm -74.25 -32.29 62.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.88 0.696 . . . . 73.25 112.88 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.666 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 18.1 mm-40 -63.27 -39.33 94.28 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.45 -0.574 . . . . 73.4 109.45 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 81.9 m -69.23 -31.33 69.83 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.664 -0.698 . . . . 71.51 111.419 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 150' ' ' ILE . 98.4 mttt -74.12 -21.44 59.88 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.577 0.703 . . . . 75.23 109.53 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt 78.73 78.86 0.06 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 126.319 1.848 . . . . 74.11 112.193 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -144.23 81.24 11.59 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 113.932 -1.486 . . . . 73.33 107.453 174.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.05 138.76 9.21 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.706 2.27 . . . . 73.1 112.738 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.315 0 CA-C-N 115.645 -0.707 . . . . 74.12 109.714 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 N--CA 1.434 -1.259 0 N-CA-C 107.862 -1.162 . . . . 70.35 107.862 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.552 ' CG ' ' HG ' ' A' ' 84' ' ' LEU . 39.2 m-70 -121.39 160.6 23.75 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 116.249 -0.432 . . . . 75.03 111.078 -171.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 23.6 p30 -132.38 130.58 40.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.596 -0.729 . . . . 71.33 111.425 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.65 142.05 44.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.41 -0.814 . . . . 72.35 109.986 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -94.05 122.51 36.64 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.75 -1.204 . . . . 74.52 107.75 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.4 m -97.51 161.33 2.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.208 0.527 . . . . 54.15 112.361 -176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.467 ' HA ' ' NH2' ' A' ' 52' ' ' ARG . 9.1 p90 -144.08 -60.2 0.39 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.177 0.806 . . . . 75.2 113.177 -172.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.0 -101.62 2.5 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 119.928 -1.129 . . . . 54.43 113.461 -175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 t -59.31 -36.61 75.94 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.828 0.851 . . . . 60.21 112.644 -173.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -92.25 17.38 9.77 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.65 0.982 . . . . 73.12 113.65 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -85.67 7.16 24.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 119.576 -0.85 . . . . 64.24 109.988 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 32' ' ' ILE . 19.0 t70 -119.74 127.36 26.45 Favored Pre-proline 0 C--N 1.305 -1.359 0 CA-C-N 115.87 -0.605 . . . . 73.24 109.849 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HB3' HG21 ' A' ' 39' ' ' THR . 38.0 Cg_endo -69.45 -25.26 30.18 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.102 1.868 . . . . 72.4 113.504 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 17.3 t70 -67.59 -41.18 84.5 Favored 'General case' 0 C--N 1.312 -1.034 0 O-C-N 121.817 -0.552 . . . . 72.15 110.819 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 28' ' ' ASP . 11.2 p -68.45 -28.65 41.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.416 -0.587 . . . . 71.54 109.416 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.608 HG23 HD21 ' A' ' 36' ' ' LEU . 48.7 mm -67.09 -47.04 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 116.308 -0.405 . . . . 62.22 110.394 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -57.28 -35.26 69.56 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.059 0.457 . . . . 64.14 111.691 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.1 t -81.76 -47.44 19.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.069 0.396 . . . . 62.51 112.069 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.406 ' HE1' HD23 ' A' ' 87' ' ' LEU . 7.9 tmm? -64.91 -35.9 82.63 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 110.321 -0.252 . . . . 53.33 110.321 -174.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -115.38 -72.82 0.67 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 120.16 -0.616 . . . . 71.44 112.095 174.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.2 t70 179.26 -49.48 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.453 0.644 . . . . 72.12 109.892 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.435 ' O ' HG22 ' A' ' 32' ' ' ILE . 99.4 mtt180 -128.81 173.06 10.69 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 115.262 -0.881 . . . . 71.54 109.155 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.408 HG21 ' HB3' ' A' ' 29' ' ' PRO . 36.7 m -120.95 111.59 34.05 Favored Pre-proline 0 N--CA 1.433 -1.322 0 O-C-N 123.579 0.549 . . . . 75.34 110.336 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.36 152.71 14.92 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 124.262 3.308 . . . . 73.52 111.565 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.03 125.87 23.44 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.358 -0.608 . . . . 62.32 109.358 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.4 mt -102.11 137.29 30.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.592 -0.731 . . . . 74.4 109.651 -174.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.479 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 7.3 p -130.1 143.69 40.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.634 -0.712 . . . . 71.43 110.145 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.2 m -77.0 125.81 29.93 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.986 -1.116 . . . . 71.21 107.986 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.07 156.63 47.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.404 0.621 . . . . 73.4 111.07 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.428 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 71.4 m -114.61 125.39 53.7 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.205 -0.907 . . . . 75.34 110.149 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.41 ' HB2' HG22 ' A' ' 102' ' ' ILE . 35.3 tp -102.19 100.29 14.94 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 116.049 -0.523 . . . . 73.13 109.644 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 46' ' ' THR . 3.0 Cg_endo -83.85 136.87 7.33 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.5 2.133 . . . . 73.33 111.838 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.33 11.09 53.0 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.566 -0.825 . . . . 33.11 111.755 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.431 ' HA ' ' H ' ' A' ' 66' ' ' SER . 86.1 m-85 -141.67 159.68 41.72 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 108.855 -0.795 . . . . 73.2 108.855 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -140.21 141.71 35.91 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.773 -0.455 . . . . 55.53 109.773 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 38.6 ttm180 -102.79 137.53 40.88 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.192 -1.04 . . . . 74.33 108.192 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 10.2 m-85 -108.79 167.52 10.01 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 107.505 -1.294 . . . . 72.5 107.505 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 . . . . . 0 C--N 1.304 -1.39 0 C-N-CA 119.489 -0.885 . . . . 73.34 111.965 -172.885 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 108.59 -0.892 . . . . 74.51 108.59 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 52.8 Cg_exo -58.95 117.8 4.59 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.064 1.842 . . . . 44.13 110.825 175.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 26.3 p -115.47 168.47 9.97 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.097 -0.502 . . . . 50.53 110.663 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 mm -123.04 119.97 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.615 -0.513 . . . . 71.24 109.615 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.11 146.06 59.91 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 110.455 -0.202 . . . . 64.41 110.455 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.59 111.79 1.27 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.121 2.547 . . . . 72.42 112.911 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.431 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 34.0 t -126.25 116.5 21.36 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.582 -0.895 . . . . 61.15 108.582 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 67' ' ' GLU . 1.7 mp0 -60.74 -32.07 71.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.366 0.603 . . . . 73.51 111.328 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -95.62 7.11 47.22 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.771 -0.65 . . . . 74.43 112.012 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.77 167.66 14.49 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 119.578 -1.296 . . . . 72.42 114.03 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 144.07 23.23 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.111 1.365 . . . . 72.24 107.733 175.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.8 t -113.06 119.67 61.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.392 -0.596 . . . . 73.02 109.392 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -93.22 116.05 28.64 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.761 -1.57 . . . . 62.24 106.761 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.51 -158.05 7.6 Favored Glycine 0 N--CA 1.418 -2.521 0 N-CA-C 110.732 -0.947 . . . . 74.1 110.732 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.41 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 13.8 mptt -124.41 148.65 47.44 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.435 0.636 . . . . 62.14 111.948 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.6 t -111.04 130.94 63.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.549 -1.205 . . . . 71.42 111.334 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 77.5 mt -96.71 108.89 21.6 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.452 -1.314 . . . . 70.1 107.452 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.4 ptp -115.64 137.38 52.13 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.29 0.567 . . . . 74.24 112.47 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.91 25.01 7.37 Favored Glycine 0 N--CA 1.427 -1.933 0 CA-C-N 114.982 -1.008 . . . . 44.13 111.568 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.1 p -88.57 142.23 13.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 110.2 -0.296 . . . . 74.11 110.2 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -73.72 161.4 30.29 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 123.836 0.854 . . . . 75.42 112.358 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.2 m -68.87 -35.36 76.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.419 1.266 . . . . 71.3 114.419 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -63.61 -43.74 96.0 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.472 0.653 . . . . 75.23 109.986 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.584 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 9.5 mp0 -69.81 -36.31 75.53 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.776 -1.102 . . . . 75.32 109.843 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.552 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.4 tm? -60.52 -43.73 96.8 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.757 -0.46 . . . . 74.24 109.757 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -71.95 -32.27 67.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.969 0.414 . . . . 71.15 110.863 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -38.32 89.18 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.14 -0.482 . . . . 74.4 110.887 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 96.9 mt -62.23 -42.03 98.94 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.168 -0.678 . . . . 64.45 109.168 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -64.13 -36.06 82.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.348 -0.842 . . . . 63.11 110.417 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.66 -45.37 71.93 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.619 -0.719 . . . . 62.53 110.845 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.79 -51.45 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.918 -0.583 . . . . 73.23 112.368 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.94 -29.23 55.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.909 0.385 . . . . 75.21 111.607 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.62 -17.57 27.52 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 114.717 0.647 . . . . 34.13 114.717 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -59.95 -31.7 70.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.837 0.351 . . . . 71.31 111.515 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.488 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 9.8 pt-20 -142.07 6.21 1.75 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.383 0.512 . . . . 71.04 112.383 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.488 ' CD2' ' HG3' ' A' ' 94' ' ' GLU . 95.4 m-85 -138.08 168.26 20.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.175 -0.466 . . . . 61.45 110.881 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -124.69 145.47 49.66 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.576 -0.898 . . . . 64.0 108.576 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -87.62 113.85 23.69 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.93 -0.767 . . . . 75.51 108.93 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.628 HG11 ' HE1' ' A' ' 117' ' ' MET . 33.6 m -125.34 161.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 116.054 -0.521 . . . . 73.42 111.477 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.0 t -98.97 136.27 39.18 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.185 -0.672 . . . . 75.45 109.185 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' A' ' 47' ' ' LEU . 29.3 m -138.7 165.18 24.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 116.397 -0.365 . . . . 75.23 110.685 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.14 120.31 6.14 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.691 -0.964 . . . . 71.15 110.691 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.41 HG22 ' HB2' ' A' ' 47' ' ' LEU . 2.7 pp -116.24 152.04 17.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 122.308 0.243 . . . . 71.41 110.719 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.7 t -113.6 131.28 65.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 110.132 -0.322 . . . . 64.14 110.132 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.47 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 11.0 mmm180 -58.61 124.41 19.57 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.778 0.831 . . . . 74.31 109.276 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.67 8.38 12.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.926 0.87 . . . . 54.32 109.842 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.62 -66.33 0.91 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.812 -1.551 . . . . 71.41 106.812 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.427 ' HB2' ' HG3' ' A' ' 109' ' ' GLU . 16.6 m-80 -99.53 -108.55 0.2 Allowed 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.606 -0.887 . . . . 63.13 108.606 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.409 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 57.9 m -159.67 19.31 0.17 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 126.424 1.89 . . . . 73.52 106.28 175.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 107' ' ' ASN . 48.1 mt-10 -77.33 143.97 38.37 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 114.846 -1.07 . . . . 72.03 110.472 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.691 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -108.04 147.09 31.63 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.909 -0.774 . . . . 73.52 108.909 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 88.1 mtp -141.02 161.06 38.74 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 123.645 0.778 . . . . 63.23 110.333 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -112.71 120.01 40.06 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.228 -0.897 . . . . 73.31 109.328 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.2 173.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 110.106 -0.331 . . . . 74.51 110.106 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -96.6 155.01 16.95 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.128 -0.693 . . . . 61.42 109.128 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.8 t -155.36 172.0 18.94 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.509 -1.663 . . . . 74.22 106.509 174.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -111.83 119.69 39.45 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.948 -0.76 . . . . 64.32 108.948 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.628 ' HE1' HG11 ' A' ' 98' ' ' VAL . 42.5 ttp -105.8 145.51 31.08 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.029 -0.987 . . . . 74.3 110.196 -173.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.548 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 71.8 t-105 -72.21 124.81 25.82 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.899 -1.149 . . . . 72.21 107.899 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -72.36 -41.27 65.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 114.797 -1.092 . . . . 75.31 111.603 -171.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -81.22 102.5 10.39 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-O 121.147 0.498 . . . . 61.14 109.947 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -75.03 -28.41 60.45 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.347 0.499 . . . . 74.42 112.347 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.3 93.86 4.78 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.588 -0.893 . . . . 41.01 108.588 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -137.93 126.13 14.22 Favored Pre-proline 0 C--N 1.308 -1.212 0 C-N-CA 121.041 -0.263 . . . . 75.14 110.788 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -87.5 -9.67 5.74 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.515 2.143 . . . . 73.5 113.819 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -80.96 -34.9 32.82 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 120.91 0.386 . . . . 44.34 111.016 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 C--N 1.312 -1.041 0 CA-C-N 116.11 -0.495 . . . . 74.12 111.497 -178.747 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.595 ' O ' HG12 ' A' ' 144' ' ' ILE . 6.0 ttpm? . . . . . 0 CA--C 1.512 -0.496 0 N-CA-C 109.559 -0.534 . . . . 75.54 109.559 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 38.7 ttpt -57.28 -31.26 65.44 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.647 -0.706 . . . . 70.13 111.499 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.5 -37.16 82.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.453 -0.34 . . . . 73.0 110.381 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.622 ' O ' HG22 ' A' ' 146' ' ' THR . 92.9 m-85 -76.76 -39.23 52.39 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 109.029 -0.73 . . . . 73.13 109.029 175.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.2 mm -60.22 -33.03 52.11 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.859 0 CA-C-N 115.216 -0.902 . . . . 74.44 110.953 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 148' ' ' LYS . 63.1 mm-40 -51.36 -39.27 56.75 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.246 0.832 . . . . 72.55 113.246 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 143' ' ' PHE . 15.2 t -74.9 -29.06 60.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 119.675 -0.81 . . . . 62.12 109.493 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 150' ' ' ILE . 22.7 m-85 -76.41 -35.12 58.75 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 116.121 -0.491 . . . . 72.35 112.239 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.574 ' HG3' HG22 ' A' ' 144' ' ' ILE . 57.3 mtpt -55.66 -31.07 62.05 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 123.96 0.787 . . . . 73.53 112.107 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 14.1 ptmm? -75.05 -34.57 61.86 Favored 'General case' 0 C--O 1.206 -1.198 0 C-N-CA 118.209 -1.397 . . . . 75.34 109.723 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 147' ' ' PHE . 64.8 mt -55.52 -29.62 24.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 C-N-CA 124.819 1.247 . . . . 51.24 112.884 -176.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -54.82 -26.01 32.2 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.503 0.557 . . . . 73.32 112.503 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 149' ' ' LYS . 13.9 pt-20 -57.08 -40.96 77.93 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.084 0.469 . . . . 72.11 110.896 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 50.6 t -71.79 -31.83 67.0 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.556 0.693 . . . . 74.21 109.771 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.436 -1.133 0 CA-C-N 115.069 -0.969 . . . . 72.41 111.292 -175.469 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.438 -1.061 0 CA-C-O 121.131 0.491 . . . . 72.25 110.286 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.433 ' O ' HG12 ' A' ' 79' ' ' VAL . 35.7 m-70 -117.39 161.43 19.57 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.341 -0.845 . . . . 72.34 110.606 -173.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -122.65 127.1 48.9 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.471 -0.937 . . . . 72.23 108.471 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.0 t -125.86 137.94 56.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 116.878 -0.147 . . . . 63.0 110.668 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.538 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.0 t80 -94.72 122.42 37.31 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.589 -1.263 . . . . 73.24 107.589 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG11 ' HB2' ' A' ' 26' ' ' PHE . 27.2 m -111.43 123.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.738 0.78 . . . . 74.43 111.598 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -77.85 -40.43 40.29 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.869 -1.059 . . . . 65.22 113.46 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.84 -40.66 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 118.814 -1.66 . . . . 74.43 113.539 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.6 m -58.02 -27.79 63.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.736 0.643 . . . . 74.44 112.736 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.463 ' O ' HD11 ' A' ' 32' ' ' ILE . 40.9 m-85 -134.5 28.37 3.66 Favored 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 110.053 -0.351 . . . . 74.44 110.053 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -78.04 -19.11 54.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.103 0.779 . . . . 73.43 113.103 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 31' ' ' VAL . 23.3 t70 -105.47 130.43 23.09 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.193 -0.299 . . . . 62.14 110.193 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HB3' HG21 ' A' ' 39' ' ' THR . 23.3 Cg_endo -61.92 -25.57 78.17 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.941 2.427 . . . . 60.22 114.742 -175.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.06 -43.15 93.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.064 0.459 . . . . 73.31 110.598 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 28' ' ' ASP . 23.4 m -71.28 -28.1 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 115.753 -0.658 . . . . 74.4 110.715 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.526 HG23 HD21 ' A' ' 36' ' ' LEU . 48.4 mm -62.98 -51.69 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 122.699 0.4 . . . . 74.14 111.631 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -57.73 -32.61 67.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.168 0.509 . . . . 60.23 111.641 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.0 t -82.02 -43.74 19.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.932 -0.576 . . . . 45.52 112.034 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.474 ' HE1' HD23 ' A' ' 87' ' ' LEU . 6.7 tmm? -70.97 -37.35 72.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.631 -0.259 . . . . 45.51 110.562 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 32' ' ' ILE 0.261 0.6 OUTLIER -115.05 -67.26 1.01 Allowed 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.903 -0.719 . . . . 72.41 112.378 176.797 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.1 t70 172.11 -50.01 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.092 0.472 . . . . 73.32 109.932 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -123.98 160.55 27.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.934 -0.576 . . . . 73.31 109.671 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.462 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 32.1 m -107.28 106.19 57.72 Favored Pre-proline 0 N--CA 1.436 -1.135 0 O-C-N 123.388 0.43 . . . . 70.25 110.441 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.58 152.25 63.57 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 123.394 2.73 . . . . 74.15 110.155 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -56.43 129.12 39.27 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.094 0.473 . . . . 73.55 110.174 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 32.2 mt -103.62 136.22 37.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.149 -0.686 . . . . 42.02 109.149 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.506 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 15.0 p -129.86 146.99 33.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 116.021 -0.536 . . . . 62.51 110.323 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -75.69 124.25 26.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.351 -0.981 . . . . 72.22 108.351 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.4 158.66 43.57 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.615 0.722 . . . . 75.22 112.33 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.1 m -118.5 132.03 56.23 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.129 -0.941 . . . . 75.21 109.34 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.3 tp -104.4 101.85 29.82 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 109.385 -0.598 . . . . 63.23 109.385 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.1 138.13 9.99 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.702 2.268 . . . . 73.24 111.814 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.04 9.45 53.95 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.892 -0.67 . . . . 25.04 111.721 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.507 ' HE2' ' SD ' ' A' ' 117' ' ' MET . 93.3 m-85 -143.12 152.75 42.17 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.773 -0.825 . . . . 71.11 108.773 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -139.98 147.09 39.95 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.993 -0.743 . . . . 60.32 108.993 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -100.26 132.23 45.75 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.153 -0.684 . . . . 62.24 109.153 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.9 m-30 -107.71 134.95 49.94 Favored 'General case' 0 CA--C 1.472 -2.032 0 N-CA-C 107.195 -1.409 . . . . 74.5 107.195 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 . . . . . 0 C--N 1.291 -1.977 0 C-N-CA 119.195 -1.002 . . . . 75.01 112.368 -178.535 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.429 -1.516 0 N-CA-C 107.318 -1.364 . . . . 73.44 107.318 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 34.8 Cg_exo -63.71 94.14 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.957 1.772 . . . . 73.1 111.554 174.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 14.3 p -97.0 167.46 11.06 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 124.604 1.161 . . . . 71.2 112.3 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 71' ' ' VAL . 49.5 mm -104.48 139.68 24.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 N-CA-C 108.642 -0.873 . . . . 74.12 108.642 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.68 152.66 60.18 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.499 -0.926 . . . . 72.41 108.499 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.492 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 27.8 Cg_endo -65.54 123.51 11.53 Favored 'Trans proline' 0 C--O 1.249 1.032 0 C-N-CA 122.494 2.129 . . . . 72.51 112.063 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 t -125.14 142.07 51.72 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.364 -0.976 . . . . 71.13 108.364 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.04 -36.38 66.92 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.255 -0.578 . . . . 64.51 111.652 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -109.49 2.81 20.73 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.396 -0.365 . . . . 73.32 111.755 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.11 156.87 21.42 Favored Glycine 0 N--CA 1.434 -1.484 0 C-N-CA 120.067 -1.063 . . . . 52.42 114.374 -174.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 142.66 29.72 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 124.574 1.15 . . . . 55.25 108.056 175.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.446 HG21 HD12 ' A' ' 63' ' ' ILE . 54.6 t -113.65 133.68 58.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 109.513 -0.551 . . . . 60.32 109.513 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -107.28 116.76 32.5 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.279 -1.008 . . . . 74.14 108.279 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.449 ' C ' ' HD3' ' A' ' 74' ' ' LYS . . . -148.95 -154.86 6.48 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 110.987 -0.845 . . . . 65.21 110.987 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.449 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 3.2 mppt? -122.82 150.45 42.82 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 113.218 0.821 . . . . 64.34 113.218 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 44.1 t -110.94 129.16 66.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 114.091 -1.413 . . . . 73.13 111.207 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.6 mt -95.7 109.28 21.58 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.078 -1.452 . . . . 72.34 107.078 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.9 ptp -113.3 127.43 56.15 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.651 0.739 . . . . 75.33 112.36 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 111.36 28.88 3.63 Favored Glycine 0 C--N 1.292 -1.874 0 CA-C-N 114.678 -1.146 . . . . 55.14 111.668 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 83' ' ' GLU . 13.0 p -92.2 132.63 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 109.349 -0.612 . . . . 64.25 109.349 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -73.54 158.56 34.62 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 110.0 -0.37 . . . . 52.53 110.0 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.2 m -62.17 -35.36 78.59 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.265 0.468 . . . . 55.33 112.265 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.86 -36.45 84.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.22 0.533 . . . . 63.44 110.673 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.472 ' HB2' HG22 ' A' ' 79' ' ' VAL . 4.4 mm-40 -77.49 -30.54 53.13 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 108.056 -1.09 . . . . 74.32 108.056 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.8 -41.7 95.59 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.82 -0.807 . . . . 71.12 108.82 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.22 -29.76 70.08 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.614 -0.721 . . . . 74.42 110.047 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -72.2 -42.16 66.13 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.771 -0.65 . . . . 60.33 111.663 177.136 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.474 HD23 ' HE1' ' A' ' 35' ' ' MET . 91.0 mt -61.67 -41.95 98.25 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.193 -1.04 . . . . 71.2 108.193 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.434 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 30.9 t70 -65.58 -30.9 71.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.897 -1.501 . . . . 64.42 110.813 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.65 -41.69 53.43 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.934 -0.575 . . . . 61.32 110.529 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.0 t -72.99 -58.31 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 113.013 0.746 . . . . 72.41 113.013 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.68 -23.6 45.57 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.933 -0.479 . . . . 73.54 111.847 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.41 -15.82 18.36 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 114.941 -1.027 . . . . 64.43 115.246 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -57.0 -41.72 78.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.381 0.59 . . . . 73.3 111.618 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -132.42 -0.83 3.57 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.84 0.682 . . . . 61.2 112.84 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -121.53 167.45 12.85 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.281 -1.007 . . . . 73.52 108.281 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HB3' HD11 ' A' ' 119' ' ' ILE . 9.9 tp10 -127.84 152.35 47.93 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.308 -0.997 . . . . 74.31 108.308 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -87.84 112.59 22.64 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.776 -0.824 . . . . 53.45 108.776 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.42 158.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.823 -0.626 . . . . 73.11 110.082 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 t -96.49 132.53 41.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.411 -0.589 . . . . 51.21 109.411 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.65 167.13 24.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 116.147 -0.479 . . . . 72.12 112.063 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.62 127.14 7.57 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 110.663 -0.975 . . . . 71.43 110.663 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -119.98 163.79 17.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 122.538 0.335 . . . . 70.24 111.094 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 59.1 t -120.33 126.37 75.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.039 -0.726 . . . . 73.22 109.039 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.701 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 22.4 mtp180 -73.16 116.11 13.31 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.915 -0.584 . . . . 63.05 110.234 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -79.08 -0.84 33.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 122.451 1.12 . . . . 75.32 108.746 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -67.27 -30.46 70.34 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.319 -1.764 . . . . 71.44 109.193 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.456 ' HB2' ' H ' ' A' ' 108' ' ' SER . 13.8 m-80 -137.41 -95.99 0.21 Allowed 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.238 -1.023 . . . . 74.41 108.238 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 67.6 m -175.83 27.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.319 -2.104 . . . . 62.51 105.319 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.25 143.92 41.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.141 -0.936 . . . . 72.12 111.633 -170.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 21.9 ptmt -96.19 148.88 22.26 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.879 -0.6 . . . . 74.15 111.616 -176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.701 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.2 mtp -143.65 161.05 39.54 Favored 'General case' 0 CA--C 1.484 -1.576 0 C-N-CA 123.83 0.852 . . . . 73.12 111.325 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.8 129.79 54.6 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 114.636 -1.165 . . . . 72.54 108.932 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.538 HG21 ' HB2' ' A' ' 21' ' ' PHE . 34.1 m -143.93 174.52 4.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.865 -0.791 . . . . 51.1 108.865 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -115.34 152.71 32.3 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.926 -0.71 . . . . 73.12 109.631 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 t -148.3 172.89 13.65 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.534 -0.543 . . . . 40.0 109.534 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -117.42 109.16 16.43 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.07 -0.514 . . . . 74.13 109.826 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.507 ' SD ' ' HE2' ' A' ' 50' ' ' PHE . 24.2 ptt? -111.56 156.6 21.5 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.622 -0.717 . . . . 74.41 109.677 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -69.4 116.62 10.03 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.284 -1.376 . . . . 75.34 107.284 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.481 HD11 ' HB3' ' A' ' 96' ' ' GLU . 47.7 mm -73.7 -41.53 54.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 113.009 0.744 . . . . 63.33 113.009 -171.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -61.77 -35.38 77.98 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.186 -0.672 . . . . 74.41 109.186 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.264 9.7 ptpp? 58.16 -37.04 0.05 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 127.721 2.408 . . . . 75.33 115.908 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.01 85.69 4.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.551 0.691 . . . . 63.34 110.952 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -132.25 105.96 13.49 Favored Pre-proline 0 CA--C 1.486 -1.501 0 CA-C-N 115.067 -0.97 . . . . 75.23 110.507 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.42 -17.54 58.31 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.66 2.24 . . . . 72.33 110.801 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.47 -36.51 78.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.023 -0.989 . . . . 72.33 111.159 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.751 0 C-N-CA 120.452 -0.499 . . . . 73.24 111.311 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.569 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.0 ttpt . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 108.79 -0.819 . . . . 74.21 108.79 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 64.6 tttp -59.53 -35.47 74.26 Favored 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.54 -0.755 . . . . 75.22 112.153 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -55.6 -47.99 75.62 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.359 1.076 . . . . 54.01 108.548 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -66.57 -39.64 88.56 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.273 -1.785 . . . . 73.23 108.993 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 140' ' ' LYS . 28.6 mm -72.56 -40.95 63.49 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.332 0 CA-C-N 116.133 -0.485 . . . . 65.51 110.292 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 28.2 mm-40 -61.78 -34.08 75.23 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.972 0.415 . . . . 70.32 110.017 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.537 ' O ' HG13 ' A' ' 150' ' ' ILE . 86.9 m -65.39 -48.18 73.76 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.595 -0.73 . . . . 75.52 109.261 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -70.77 -30.12 66.53 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.155 0.798 . . . . 70.34 113.155 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 ttpt -55.66 -45.77 77.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.588 -1.264 . . . . 71.31 107.588 175.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.53 -34.89 70.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.014 -1.448 . . . . 62.01 110.307 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 146' ' ' THR . 80.2 mt -67.4 -37.22 78.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.28 -0.418 . . . . 71.33 110.285 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.14 -33.09 74.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 75.15 110.129 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 15.3 mm-40 -73.2 -31.07 63.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.077 0.465 . . . . 74.42 110.02 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 51.3 t -69.06 -31.81 70.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.654 -0.703 . . . . 64.44 109.787 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 34.7 mmtp . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 108.967 -0.753 . . . . 73.2 108.967 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 N--CA 1.436 -1.169 0 N-CA-C 108.186 -1.042 . . . . 73.12 108.186 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.497 ' ND1' ' HG ' ' A' ' 84' ' ' LEU . 52.8 m-70 -114.8 160.28 19.62 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.07 0.462 . . . . 74.43 112.16 -171.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 21.6 p30 -131.84 125.64 32.3 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.283 -1.326 . . . . 65.13 110.506 174.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 65.5 t -126.3 140.58 48.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.189 -0.914 . . . . 64.42 110.17 -174.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.495 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.5 t80 -94.66 122.97 37.81 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.675 -0.861 . . . . 75.23 108.675 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -100.69 144.33 12.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 116.252 -0.431 . . . . 71.43 109.886 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -83.51 -0.19 49.19 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.967 0.728 . . . . 71.52 112.967 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.13 -22.92 4.42 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.066 -1.064 . . . . 65.43 112.169 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.1 p -58.76 -36.4 74.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.135 0.493 . . . . 73.51 112.168 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.59 ' HB3' HD11 ' A' ' 32' ' ' ILE . 53.0 m-85 -125.84 35.9 4.62 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.709 -0.678 . . . . 72.22 110.908 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -77.79 -14.97 59.42 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.052 0.453 . . . . 75.03 110.728 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.57 121.23 63.7 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.736 -0.666 . . . . 75.4 109.472 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 30.7 Cg_endo -63.98 -28.86 66.43 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.858 2.372 . . . . 64.2 114.069 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 34' ' ' VAL . 24.2 t70 -69.1 -38.12 78.77 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.49 -0.484 . . . . 75.32 110.142 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.78 -38.94 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.548 -0.751 . . . . 53.32 109.423 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.59 HD11 ' HB3' ' A' ' 26' ' ' PHE . 34.1 mm -58.46 -51.76 67.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.63 -0.713 . . . . 50.32 110.893 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -54.21 -34.27 60.19 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.236 0.458 . . . . 64.02 112.236 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 30' ' ' ASP . 47.3 t -81.03 -45.34 21.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 116.261 -0.427 . . . . 75.2 111.366 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.554 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.0 tmm? -67.21 -37.38 83.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.501 -0.318 . . . . 64.23 110.309 -173.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.485 HD21 HG23 ' A' ' 32' ' ' ILE 0.282 0.9 OUTLIER -116.24 -67.18 1.01 Allowed 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 119.188 -1.005 . . . . 74.21 112.738 176.728 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 38' ' ' ARG . 35.0 t70 174.98 -49.07 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.274 0.359 . . . . 73.22 111.364 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.426 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 20.1 mmt180 -131.11 162.73 29.22 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.257 -0.646 . . . . 64.24 109.257 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.457 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 20.4 m -102.87 112.44 65.74 Favored Pre-proline 0 N--CA 1.437 -1.115 0 O-C-N 123.26 0.35 . . . . 65.22 111.525 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.69 152.85 74.18 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.173 2.582 . . . . 65.42 109.336 170.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.54 130.96 47.29 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.131 0.491 . . . . 62.33 110.332 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 44.3 mt -114.47 138.94 42.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.583 -0.525 . . . . 74.13 109.583 -175.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.91 146.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.921 -0.77 . . . . 75.52 108.921 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.7 m -77.06 133.76 38.98 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.432 -1.321 . . . . 72.24 107.432 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.53 159.76 41.42 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.089 0.471 . . . . 45.55 111.697 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.5 m -110.51 125.27 53.15 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.327 -0.851 . . . . 64.34 110.812 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.8 tp -102.4 103.65 32.64 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 123.502 0.721 . . . . 61.13 109.307 175.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 74.2 Cg_endo -82.0 142.44 12.39 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.261 1.974 . . . . 70.34 111.535 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.74 5.75 61.15 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.978 -0.556 . . . . 63.25 112.633 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -141.86 155.93 45.54 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 122.186 -0.596 . . . . 74.14 109.76 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.434 ' HA ' ' OE1' ' A' ' 51' ' ' GLN . 4.7 tp60 -140.75 146.94 38.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.746 -0.464 . . . . 72.14 109.746 176.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 41.0 ptt180 -101.32 129.92 47.4 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.626 0.727 . . . . 62.04 111.286 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.683 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 18.3 m-85 -107.77 153.49 22.9 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.545 -1.28 . . . . 62.54 107.545 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.215 0 N-CA-C 114.902 1.445 . . . . 74.51 114.902 -167.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 N--CA 1.44 -0.942 0 N-CA-C 107.838 -1.171 . . . . 75.35 107.838 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.683 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 20.5 Cg_exo -65.98 90.98 0.25 Allowed 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.579 1.519 . . . . 73.53 110.859 175.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 19.3 p -83.11 127.65 33.78 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 115.278 -0.874 . . . . 72.32 111.152 -174.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' MET . 49.4 mm -84.66 111.24 20.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.636 -0.711 . . . . 55.41 109.574 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.56 143.86 42.73 Favored Pre-proline 0 C--N 1.289 -2.049 0 N-CA-C 109.684 -0.487 . . . . 51.44 109.684 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.9 125.72 17.86 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.46 2.107 . . . . 64.22 112.799 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.3 t -124.58 122.3 37.18 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.099 -1.815 . . . . 60.14 106.099 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.61 -30.87 65.68 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.129 0.418 . . . . 70.45 112.129 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -136.54 77.35 1.64 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.6 0.714 . . . . 75.23 111.024 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.98 166.81 30.5 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 109.317 -1.513 . . . . 74.15 109.317 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -151.9 141.34 21.59 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 117.745 0.773 . . . . 62.4 110.541 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.07 131.45 64.67 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 109.001 -0.74 . . . . 74.34 109.001 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -107.78 115.8 30.79 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.222 -1.399 . . . . 65.42 107.222 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.65 -147.76 4.93 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.846 -0.901 . . . . 54.24 110.846 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -125.29 145.59 49.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 112.566 0.58 . . . . 74.32 112.566 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 46.8 t -110.58 124.88 67.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 114.64 -1.164 . . . . 62.43 110.502 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 67.2 mt -95.75 109.77 22.02 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.594 -1.262 . . . . 73.14 107.594 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.413 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 14.9 ptp -117.35 142.63 46.87 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.28 0.562 . . . . 65.32 111.738 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.23 29.12 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.291 -0.868 . . . . 55.33 111.195 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 83' ' ' GLU . 12.9 p -86.44 142.0 13.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 108.516 -0.92 . . . . 51.23 108.516 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -82.9 174.48 10.89 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.471 -0.492 . . . . 73.41 111.552 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.1 p -61.34 -45.26 95.16 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.75 1.018 . . . . 63.31 113.75 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.1 -36.56 84.0 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.673 0.749 . . . . 72.2 110.838 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.526 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.5 mt-10 -78.54 -28.49 46.11 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.225 -0.898 . . . . 73.22 109.432 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HG ' ' ND1' ' A' ' 18' ' ' HIS . 2.9 tm? -67.68 -41.56 83.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.862 -0.608 . . . . 75.21 109.689 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.39 -29.4 61.52 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.203 -0.453 . . . . 70.44 109.796 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 14.0 t-20 -56.45 -47.57 78.88 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.745 0.818 . . . . 74.44 110.282 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.7 mt -60.82 -33.8 73.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.39 -0.823 . . . . 63.14 111.031 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 18.8 t70 -73.06 -36.93 66.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.309 0.576 . . . . 52.14 109.589 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.77 -47.27 72.7 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.693 -0.685 . . . . 60.23 110.62 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 87' ' ' LEU . 12.2 p -72.59 -56.49 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 113.119 0.785 . . . . 52.21 113.119 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -77.54 -22.96 50.26 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.995 -0.44 . . . . 44.14 111.575 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -60.03 -17.49 44.57 Favored Glycine 0 C--O 1.221 -0.675 0 N-CA-C 115.194 0.837 . . . . 54.42 115.194 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -69.86 -38.36 76.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.471 0.635 . . . . 74.52 111.228 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.82 -28.47 11.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.036 0.446 . . . . 70.22 111.838 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.404 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 91.3 m-85 -124.28 170.21 11.0 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.406 0.682 . . . . 71.51 111.703 -174.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 41.0 tt0 -123.23 151.61 42.12 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.846 -0.798 . . . . 75.42 108.846 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 88' ' ' ASP . 11.2 ttm-85 -86.7 119.63 27.14 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.826 -0.805 . . . . 75.34 108.826 -175.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.482 HG11 ' CE ' ' A' ' 117' ' ' MET . 27.7 m -124.7 162.16 27.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 121.019 0.438 . . . . 73.41 111.584 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.0 t -104.01 129.19 51.6 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.302 -0.863 . . . . 71.31 108.884 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -141.79 171.44 11.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.082 0.468 . . . . 65.03 111.989 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -114.58 139.24 15.45 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.792 -1.323 . . . . 71.54 109.792 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.463 HD11 ' HE2' ' A' ' 111' ' ' MET . 2.6 pp -134.07 164.99 33.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.139 0.469 . . . . 51.24 111.109 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.2 t -129.03 131.11 68.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.396 -1.335 . . . . 71.53 107.396 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -74.16 146.3 43.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.935 0.398 . . . . 72.12 110.648 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -88.85 -8.98 53.32 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.084 -0.507 . . . . 74.04 111.326 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -79.56 -48.21 14.21 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.567 -0.288 . . . . 62.41 111.243 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.498 ' ND2' ' HG2' ' A' ' 109' ' ' GLU . 3.0 p-10 -146.6 22.18 1.3 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.699 0.629 . . . . 73.13 112.699 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m 66.88 27.45 9.0 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 115.789 1.774 . . . . 73.25 115.789 170.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.498 ' HG2' ' ND2' ' A' ' 107' ' ' ASN . 20.2 mm-40 -77.04 141.02 40.48 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.511 -0.876 . . . . 75.42 108.947 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -98.48 139.46 34.18 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.624 -0.509 . . . . 71.22 109.624 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.463 ' HE2' HD11 ' A' ' 102' ' ' ILE . 38.7 mtm -142.15 163.88 31.68 Favored 'General case' 0 CA--C 1.473 -1.989 0 CA-C-O 121.8 0.81 . . . . 51.13 111.387 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -112.24 122.99 49.3 Favored 'General case' 0 C--N 1.267 -3.003 0 CA-C-N 113.919 -1.492 . . . . 71.2 107.993 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.1 m -138.16 173.53 12.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.404 0.621 . . . . 70.52 110.881 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -104.4 150.85 24.16 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.982 -1.118 . . . . 70.43 107.982 175.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.7 t -146.83 172.23 13.98 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.404 -0.961 . . . . 74.34 108.404 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 96.5 m-85 -111.91 112.82 24.74 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.585 0.707 . . . . 73.33 109.779 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.482 ' CE ' HG11 ' A' ' 98' ' ' VAL . 12.9 tmm? -106.07 146.67 29.85 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.412 -1.267 . . . . 75.51 110.871 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 70.0 t-105 -72.8 117.3 14.34 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.309 -0.859 . . . . 74.32 110.307 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.8 mt -57.81 -41.2 79.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 113.796 -1.547 . . . . 75.32 113.004 -172.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -89.27 91.11 8.63 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 119.904 -0.718 . . . . 72.01 110.435 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.11 -30.82 71.9 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.608 -0.724 . . . . 75.12 110.417 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.37 85.95 2.22 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.879 -0.785 . . . . 51.15 108.879 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.49 122.06 28.15 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-N 115.292 -0.867 . . . . 75.12 108.769 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -84.29 0.56 9.12 Favored 'Trans proline' 0 C--N 1.328 -0.536 0 C-N-CA 122.852 2.368 . . . . 71.22 113.918 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.12 -23.81 11.82 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 119.951 -0.699 . . . . 63.43 112.271 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.8 ptt? . . . . . 0 C--N 1.317 -0.825 0 N-CA-C 112.098 0.407 . . . . 75.23 112.098 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.612 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.7 ttpt . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 120.816 0.341 . . . . 72.32 110.107 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -53.13 -36.23 60.57 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.9 1.28 . . . . 74.21 110.586 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.6 -42.41 98.24 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.113 0.483 . . . . 70.31 110.63 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -73.77 -31.77 63.47 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.341 0.591 . . . . 72.51 109.56 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.2 mm -59.75 -32.76 50.24 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.911 0 CA-C-N 115.283 -0.872 . . . . 74.01 110.551 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -61.49 -36.3 80.07 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.209 0.528 . . . . 44.23 110.99 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.8 m -72.46 -47.93 44.97 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.861 -0.792 . . . . 71.42 108.861 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.614 ' O ' ' HG2' ' A' ' 151' ' ' MET . 58.9 m-85 -66.54 -28.87 68.88 Favored 'General case' 0 C--O 1.2 -1.528 0 N-CA-C 113.454 0.909 . . . . 74.42 113.454 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -52.62 -47.63 66.88 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.973 0.909 . . . . 53.21 109.902 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -39.39 73.48 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.857 -0.794 . . . . 75.02 108.857 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.64 -52.28 42.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.179 -0.464 . . . . 63.34 111.927 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.614 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 26.5 ptt? -76.37 -40.55 50.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.927 1.084 . . . . 72.21 113.927 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -62.77 -30.24 71.3 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 112.945 0.72 . . . . 74.54 112.945 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 82.1 m -71.41 -30.06 65.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.01 0.374 . . . . 71.12 112.01 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 121.984 0.897 . . . . 71.31 108.752 175.545 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.434 -1.247 0 N-CA-C 108.044 -1.095 . . . . 70.43 108.044 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.416 ' CE1' HD22 ' A' ' 84' ' ' LEU . 30.4 m-70 -114.56 159.62 20.2 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 109.847 -0.427 . . . . 71.31 109.847 -170.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 18.1 p30 -130.41 133.34 46.29 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.331 -0.85 . . . . 75.13 110.518 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.84 140.31 49.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.442 -0.799 . . . . 62.14 110.223 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -94.61 122.47 37.24 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.467 -0.938 . . . . 73.32 108.467 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.47 143.01 12.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.043 0.449 . . . . 73.01 110.767 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.487 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 16.9 p90 -122.1 -1.94 9.22 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.951 1.463 . . . . 74.11 114.951 -168.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.81 -67.42 0.24 Allowed Glycine 0 C--N 1.314 -0.689 0 C-N-CA 119.329 -1.415 . . . . 55.14 112.528 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 p -58.12 -34.87 70.7 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.22 0.608 . . . . 74.33 111.7 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 26.8 m-85 -118.95 27.49 8.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.044 -0.526 . . . . 51.34 110.519 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -78.98 15.34 1.12 Allowed 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 121.963 0.887 . . . . 71.2 110.834 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -137.84 128.47 15.67 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.322 -0.992 . . . . 71.53 108.322 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.49 -31.28 87.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.787 2.324 . . . . 73.15 114.423 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.95 -37.9 82.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.292 0.567 . . . . 72.21 109.654 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.64 -38.85 83.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.176 -0.92 . . . . 74.14 109.468 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 26' ' ' PHE . 6.5 mm -62.58 -50.51 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-O 122.125 0.964 . . . . 54.52 109.91 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -54.01 -43.63 70.23 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.266 -1.788 . . . . 74.13 111.607 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.5 t -81.72 -32.44 11.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.912 -0.585 . . . . 61.31 111.936 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.453 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.7 tmm? -70.55 -37.46 74.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.989 -0.284 . . . . 64.52 110.774 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 32' ' ' ILE 0.277 0.4 OUTLIER -109.8 -71.86 0.75 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.599 0.963 . . . . 74.45 113.599 179.266 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.8 t70 176.11 -45.03 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.25 0.548 . . . . 73.01 109.838 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -120.79 176.2 5.65 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.53 -0.759 . . . . 73.33 109.487 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 m -123.03 100.68 39.63 Favored Pre-proline 0 N--CA 1.425 -1.689 0 N-CA-C 106.624 -1.621 . . . . 72.21 106.624 170.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 34.1 Cg_exo -58.71 151.57 62.61 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.833 2.355 . . . . 65.04 111.74 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.5 122.91 13.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.496 0.718 . . . . 71.52 111.167 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.58 HG12 ' HG ' ' A' ' 76' ' ' LEU . 24.0 mt -97.72 140.37 18.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.292 -0.867 . . . . 71.34 110.384 -173.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.14 145.47 35.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.794 -1.187 . . . . 75.1 107.794 172.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.9 m -81.05 123.73 28.61 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.939 -0.763 . . . . 61.25 108.939 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.17 159.14 42.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.266 0.555 . . . . 70.33 111.849 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 90.7 m -117.55 132.93 56.45 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.093 -0.958 . . . . 75.42 110.094 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.0 tp -102.56 100.94 17.5 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 123.018 0.527 . . . . 74.04 109.702 176.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 46' ' ' THR . 6.0 Cg_endo -85.98 145.22 8.69 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.581 2.187 . . . . 62.52 111.843 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.8 11.09 59.45 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 111.263 -0.735 . . . . 64.22 111.263 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -144.44 157.07 44.42 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 108.168 -1.049 . . . . 64.1 108.168 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -138.37 146.22 42.03 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.189 -0.671 . . . . 65.52 109.189 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' A' ' 63' ' ' ILE . 38.1 ptt180 -90.36 126.69 35.95 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.963 -1.017 . . . . 71.04 111.959 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.556 ' C ' ' HE ' ' A' ' 54' ' ' ARG . 10.3 m-85 -109.92 135.75 50.3 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.127 -1.434 . . . . 64.52 107.127 174.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.556 ' HE ' ' C ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.541 0 O-C-N 122.175 -0.328 . . . . 72.21 111.823 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 . . . . . 0 C--O 1.237 0.438 0 N-CA-C 109.848 -0.427 . . . . 74.34 109.848 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 7.1 Cg_exo -73.58 86.51 1.19 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.591 1.527 . . . . 72.55 110.687 173.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 27.8 p -98.15 -178.41 4.05 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.844 -0.617 . . . . 60.22 112.126 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.487 ' CG1' ' HB2' ' A' ' 23' ' ' TYR . 47.8 mm -132.43 142.15 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.09 -1.448 . . . . 64.14 107.09 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' A' ' 118' ' ' TRP . 34.1 m -144.64 154.71 56.37 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.456 -0.942 . . . . 62.24 108.456 175.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -60.99 128.67 26.1 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.432 2.088 . . . . 74.34 112.125 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -125.79 145.3 50.27 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 116.152 -0.476 . . . . 72.13 110.011 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.48 -35.21 65.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.505 -0.924 . . . . 61.24 108.505 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -128.93 77.22 1.77 Allowed 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.148 -0.933 . . . . 74.4 110.797 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.59 151.0 19.83 Favored Glycine 0 N--CA 1.412 -2.936 0 CA-C-N 114.917 -1.038 . . . . 54.43 111.917 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.76 138.11 18.5 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.447 1.099 . . . . 74.32 108.501 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t -113.38 119.95 62.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 120.737 0.303 . . . . 51.44 110.615 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -91.91 116.55 29.01 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.45 -0.945 . . . . 64.22 108.45 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.11 -146.6 4.37 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.508 -0.853 . . . . 54.13 112.41 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.0 mmtm -127.77 141.56 51.55 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.724 0.297 . . . . 63.02 111.022 -175.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 47.5 t -111.52 129.51 66.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 115.913 -0.585 . . . . 75.45 110.358 173.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.58 ' HG ' HG12 ' A' ' 42' ' ' ILE . 6.5 mp -106.11 114.12 28.06 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.447 -0.797 . . . . 70.14 110.922 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 58.1 mtp -104.14 145.04 30.76 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.217 -1.356 . . . . 73.23 110.366 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.02 9.27 32.53 Favored Glycine 0 C--N 1.299 -1.519 0 C-N-CA 120.113 -1.041 . . . . 71.21 111.955 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 80' ' ' THR . 57.8 t -67.75 127.49 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.082 -0.71 . . . . 75.14 109.082 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.416 ' O ' HG12 ' A' ' 79' ' ' VAL . 65.3 p -82.17 167.62 18.52 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.388 -0.968 . . . . 60.44 108.388 176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 34.6 t -55.26 -45.63 76.08 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 117.529 0.15 . . . . 61.25 110.946 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -58.26 -42.18 85.88 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.041 0.385 . . . . 55.42 112.041 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 39.7 mt-10 -73.22 -40.63 64.56 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.467 -0.568 . . . . 74.53 109.467 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.416 HD22 ' CE1' ' A' ' 18' ' ' HIS . 33.6 tp -55.91 -50.75 69.85 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.296 0.569 . . . . 73.23 109.896 175.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 81' ' ' SER . 43.1 mt-10 -64.82 -29.13 70.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.062 -0.972 . . . . 61.15 110.251 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -44.7 64.62 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 123.804 0.842 . . . . 71.43 112.139 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 92.6 mt -62.5 -40.95 98.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.227 -1.027 . . . . 63.51 108.227 176.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.481 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 16.7 t70 -66.37 -29.29 69.44 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 114.463 -1.244 . . . . 71.23 110.886 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.0 -45.32 42.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.115 0.483 . . . . 74.33 110.398 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.2 t -72.16 -58.41 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-N 115.749 -0.66 . . . . 74.11 112.189 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.52 -24.52 42.16 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.855 0.687 . . . . 73.51 112.855 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -63.74 -16.15 58.71 Favored Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.809 -0.632 . . . . 43.13 114.391 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -67.49 -30.39 70.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.886 0.343 . . . . 73.41 111.685 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -127.14 -0.25 6.46 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.022 0.379 . . . . 72.41 112.022 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -132.7 168.18 18.78 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.112 0.565 . . . . 74.23 110.332 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -124.56 148.71 47.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.533 -0.543 . . . . 74.03 109.533 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 -88.13 113.45 23.76 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.595 -0.891 . . . . 54.22 108.595 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.8 m -115.84 161.41 14.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 116.28 -0.418 . . . . 73.22 111.805 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.6 t -107.68 124.7 50.37 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.173 -1.047 . . . . 50.12 108.173 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.21 170.87 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 116.121 -0.491 . . . . 74.12 111.285 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.91 118.78 4.85 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 111.052 -0.819 . . . . 64.24 111.052 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.7 pp -111.01 165.05 6.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 110.031 -0.359 . . . . 64.54 110.031 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.3 t -122.68 124.68 71.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.519 -0.548 . . . . 72.1 109.519 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -72.66 121.4 19.72 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.177 -0.92 . . . . 74.12 110.722 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.19 -23.59 65.7 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.611 0.765 . . . . 70.5 111.945 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -64.42 -57.65 8.69 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.311 0.485 . . . . 75.55 112.311 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -127.05 7.41 6.6 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.086 0.773 . . . . 71.42 113.086 -169.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.2 t 71.46 12.23 6.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.058 0.943 . . . . 74.43 112.418 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -82.17 147.03 29.24 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.058 0.456 . . . . 75.11 111.231 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -92.02 147.4 22.99 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.421 -0.809 . . . . 74.1 110.094 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.45 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 89.1 mtp -136.22 160.38 38.85 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.378 -0.828 . . . . 74.15 109.524 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.17 117.03 33.06 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 115.534 -0.757 . . . . 60.03 109.603 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.3 m -131.68 173.21 15.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 116.128 -0.487 . . . . 73.24 110.186 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -106.1 149.59 26.6 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.089 -0.708 . . . . 74.44 109.089 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -153.15 172.88 16.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.977 -0.749 . . . . 70.14 108.977 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -119.95 109.76 15.91 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.288 0.566 . . . . 73.32 110.623 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -106.71 157.16 17.93 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.178 -0.919 . . . . 74.24 108.719 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 70.7 t-105 -67.99 143.51 55.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.211 -0.663 . . . . 73.22 109.211 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.6 mm -72.44 -42.33 64.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 113.499 0.925 . . . . 61.3 113.499 -170.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -88.9 -41.17 12.59 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 114.055 1.132 . . . . 73.52 114.055 -171.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.418 ' H ' ' HD1' ' A' ' 118' ' ' TRP 0.407 0.0 OUTLIER 56.12 1.57 0.07 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.56 2.43 . . . . 75.41 117.56 179.621 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.82 9.93 28.78 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.982 -0.747 . . . . 64.55 108.982 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.435 ' CG ' ' HE1' ' A' ' 118' ' ' TRP . 2.9 m-20 -68.13 123.44 87.31 Favored Pre-proline 0 C--N 1.312 -1.023 0 C-N-CA 124.715 1.206 . . . . 72.04 111.4 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.7 -7.3 10.56 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.411 2.074 . . . . 74.52 112.18 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.89 -2.9 56.59 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.238 0.829 . . . . 63.3 113.238 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 C--N 1.308 -1.205 0 N-CA-C 108.67 -0.863 . . . . 72.31 108.67 175.233 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.551 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.5 ttpt . . . . . 0 C--O 1.206 -1.187 0 N-CA-C 109.679 -0.489 . . . . 74.02 109.679 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -52.78 -31.75 40.11 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.015 0.926 . . . . 72.14 112.241 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -66.05 -40.31 90.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.854 0.835 . . . . 73.5 109.354 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 146' ' ' THR . 23.9 t80 -76.29 -32.23 58.67 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.57 -1.195 . . . . 75.34 108.328 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.1 mm -59.05 -31.99 46.88 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.486 0 CA-C-N 114.731 -1.122 . . . . 70.2 111.815 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -52.07 -45.18 64.67 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.124 0.42 . . . . 64.44 111.806 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 143' ' ' PHE . 15.1 t -79.14 -29.89 43.36 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.564 0.697 . . . . 72.3 109.824 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -75.63 -30.33 59.45 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.397 -0.819 . . . . 74.51 110.502 -173.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -58.24 -36.93 73.93 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.603 1.161 . . . . 75.02 109.845 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -74.34 -38.79 63.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.103 0.477 . . . . 75.1 110.025 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 72.3 mt -63.61 -39.93 87.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.644 -0.707 . . . . 71.1 109.47 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.4 ttt -60.12 -31.68 70.29 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 124.267 1.027 . . . . 73.4 111.493 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.93 -36.93 85.96 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.476 0.655 . . . . 73.11 109.765 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.82 -34.38 69.29 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.222 -0.899 . . . . 75.44 110.227 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.629 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 9.7 mmpt? . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 31.14 111.884 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.415 -2.186 0 N-CA-C 109.476 -0.564 . . . . 61.31 109.476 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.558 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.7 m-70 -114.86 160.6 19.29 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 115.428 -0.805 . . . . 55.3 109.851 -173.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 27.2 p-10 -131.08 125.08 32.24 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.647 0.737 . . . . 70.42 110.617 176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.28 142.82 40.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.156 -0.929 . . . . 64.32 109.944 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.414 ' HB2' HG21 ' A' ' 113' ' ' VAL . 85.9 t80 -95.07 123.23 38.45 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.728 -0.842 . . . . 72.43 108.728 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -102.59 137.79 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.659 -0.497 . . . . 73.01 109.659 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -87.62 -28.39 21.92 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.516 0.932 . . . . 74.21 113.516 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.29 -20.81 0.18 Allowed Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 118.917 -1.611 . . . . 71.23 113.108 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.7 p -63.65 -28.48 69.94 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.147 0.499 . . . . 63.31 111.845 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.57 ' HB3' HD11 ' A' ' 32' ' ' ILE . 78.5 m-85 -139.9 57.12 1.62 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.531 0.732 . . . . 75.01 109.232 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -88.86 -21.44 23.68 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.354 0.501 . . . . 53.45 112.354 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.602 ' O ' HG22 ' A' ' 31' ' ' VAL . 24.1 t70 -95.28 129.25 35.76 Favored Pre-proline 0 C--N 1.303 -1.424 0 CA-C-N 116.585 -0.28 . . . . 65.51 110.576 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.24 -25.04 57.69 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.694 2.263 . . . . 50.24 113.392 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.44 -30.0 62.92 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.536 -0.727 . . . . 63.31 110.965 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 28' ' ' ASP . 18.4 m -72.44 -28.3 28.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.256 -0.646 . . . . 64.44 109.256 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.57 HD11 ' HB3' ' A' ' 26' ' ' PHE . 49.7 mm -64.31 -40.41 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.697 -0.683 . . . . 73.32 110.588 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -61.44 -30.15 70.4 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.148 0.499 . . . . 74.22 111.002 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.36 -50.79 15.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.812 -0.631 . . . . 64.13 110.291 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -67.63 -35.71 79.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.728 -0.669 . . . . 51.34 110.121 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.3 mt -103.65 -77.31 0.57 Allowed 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.287 0.565 . . . . 73.03 109.749 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.4 t70 162.57 -30.15 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 125.533 1.533 . . . . 72.41 107.287 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -146.58 159.11 43.86 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 114.648 -1.16 . . . . 74.12 109.722 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.3 m -107.52 120.52 47.23 Favored Pre-proline 0 N--CA 1.426 -1.671 0 O-C-N 123.573 0.546 . . . . 53.2 110.83 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -65.79 151.58 83.93 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.641 2.227 . . . . 75.34 109.259 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.7 130.26 45.61 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 122.144 0.973 . . . . 51.13 112.976 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 47.5 mt -103.39 139.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.041 0 CA-C-N 113.973 -1.467 . . . . 74.14 110.462 -174.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 13.5 p -126.34 146.45 32.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 107.79 -1.189 . . . . 45.24 107.79 172.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 12.0 m -76.27 125.46 29.22 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 106.429 -1.693 . . . . 74.43 106.429 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -139.64 151.31 45.86 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.528 -0.869 . . . . 65.23 113.339 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -115.0 125.93 54.17 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.589 -1.187 . . . . 72.42 109.491 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 tp -98.7 102.78 15.87 Favored Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 123.49 0.716 . . . . 64.41 109.594 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 73.5 Cg_endo -81.06 141.38 13.04 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.197 1.931 . . . . 64.34 111.942 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.7 10.91 57.42 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.609 -0.805 . . . . 61.54 112.1 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 81.0 m-85 -139.82 163.21 33.22 Favored 'General case' 0 C--O 1.2 -1.5 0 N-CA-C 108.719 -0.845 . . . . 65.32 108.719 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -138.39 143.59 39.85 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.303 0.573 . . . . 75.12 109.82 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.64 124.75 35.32 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.893 -1.521 . . . . 72.42 106.893 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -109.45 147.76 32.31 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.13 -0.693 . . . . 51.54 109.13 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 3.8 tmt_? . . . . . 0 N--CA 1.414 -2.25 0 N-CA-C 108.961 -0.755 . . . . 74.23 108.961 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 110.718 -0.104 . . . . 74.04 110.718 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' A' ' 54' ' ' ARG . 23.3 Cg_exo -69.63 96.98 0.6 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.703 2.268 . . . . 73.31 109.871 171.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 24.5 p -92.73 -179.42 5.15 Favored 'General case' 0 C--O 1.253 1.244 0 N-CA-C 113.422 0.897 . . . . 73.25 113.422 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.6 mm -131.87 120.78 45.52 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 108.146 -1.057 . . . . 73.22 108.146 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.06 149.35 73.48 Favored Pre-proline 0 C--N 1.313 -1.017 0 N-CA-C 110.208 -0.293 . . . . 72.02 110.208 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 25.3 Cg_endo -63.23 119.39 6.45 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.107 2.538 . . . . 74.13 113.435 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.4 t -125.91 131.28 52.35 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.792 -0.818 . . . . 65.31 108.792 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.425 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . 42.6 mt-10 -66.19 -34.48 78.12 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.144 0.497 . . . . 73.53 110.485 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' A' ' 67' ' ' GLU . 3.2 mppt? -102.49 23.87 11.25 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.443 -0.799 . . . . 65.01 111.331 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.94 165.67 23.39 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 118.863 -1.636 . . . . 44.45 114.209 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.25 145.75 24.88 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 124.682 1.193 . . . . 71.33 108.596 174.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.4 t -113.02 125.11 70.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.695 -0.483 . . . . 73.44 109.695 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -95.86 116.55 29.08 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.288 -1.004 . . . . 74.32 108.288 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.22 -152.43 5.63 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 110.879 -0.889 . . . . 62.45 110.879 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.446 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 34.7 mmtp -129.03 143.92 51.02 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 116.785 0.293 . . . . 70.11 110.28 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 47.3 t -110.08 127.52 66.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 120.834 0.349 . . . . 42.54 110.794 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 70.7 mt -95.48 104.25 16.15 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.07 -1.085 . . . . 71.11 108.07 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.2 ptp -113.55 147.7 37.48 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.825 -0.435 . . . . 71.21 109.825 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.39 13.55 55.5 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.327 -1.416 . . . . 63.21 110.01 -172.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.4 p -86.76 131.6 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 N-CA-C 109.007 -0.738 . . . . 65.21 109.007 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.484 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 3.2 m -74.44 159.73 31.92 Favored 'General case' 0 N--CA 1.409 -2.484 0 N-CA-C 108.947 -0.76 . . . . 75.53 108.947 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.8 p -56.85 -34.86 68.21 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.614 0.766 . . . . 71.02 111.829 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.09 -46.04 79.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.574 -0.285 . . . . 73.54 111.691 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.532 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 1.8 mp0 -70.26 -31.04 68.24 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.623 -0.51 . . . . 73.52 109.623 175.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.4 tp -58.71 -51.87 68.11 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.202 0.525 . . . . 52.11 109.996 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.59 -28.74 67.21 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.448 -0.796 . . . . 64.13 110.309 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 90' ' ' VAL . 38.9 t-20 -65.69 -47.51 75.19 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 108.65 -0.87 . . . . 54.33 108.65 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.2 mt -61.13 -46.43 90.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.972 -0.751 . . . . 74.01 108.972 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.53 -29.75 70.79 Favored 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 114.46 -1.245 . . . . 75.21 111.162 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.18 -40.47 59.38 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.082 -0.508 . . . . 64.42 110.848 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 86' ' ' ASN . 59.1 t -72.82 -49.33 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 112.308 0.485 . . . . 73.32 112.308 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -79.92 -27.91 39.84 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 112.859 0.689 . . . . 45.31 112.859 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.81 -21.29 36.19 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 119.585 2.594 . . . . 53.3 119.585 -168.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -71.23 -35.5 71.5 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 119.505 1.653 . . . . 71.02 113.814 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -120.44 -0.03 10.43 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.836 -0.745 . . . . 63.33 112.822 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -130.49 159.01 38.37 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.615 0.366 . . . . 75.11 110.072 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -123.05 137.15 55.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.869 0.366 . . . . 71.41 110.582 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -87.41 114.51 24.08 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.814 -0.63 . . . . 64.14 110.653 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.448 HG11 ' CE ' ' A' ' 117' ' ' MET . 35.9 m -121.27 161.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.528 -0.76 . . . . 75.01 111.679 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 p -92.45 123.04 35.47 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.724 -0.671 . . . . 74.42 110.988 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.59 172.41 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 112.86 0.689 . . . . 61.3 112.86 -175.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -116.14 136.36 12.83 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.173 -0.771 . . . . 74.32 111.173 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.416 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 2.8 pp -126.78 160.99 34.31 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 C-N-CA 123.373 0.669 . . . . 64.35 111.322 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 48.2 t -117.17 129.96 72.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.439 -0.578 . . . . 73.4 109.439 177.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.591 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 19.0 mtp180 -73.38 116.54 14.06 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 122.805 0.442 . . . . 72.24 110.206 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 39.5 mt-10 -73.81 -20.48 60.45 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.719 -0.673 . . . . 72.14 110.019 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -73.93 -16.6 61.09 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 112.461 0.541 . . . . 73.43 112.461 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.406 ' CG ' ' H ' ' A' ' 108' ' ' SER . 33.0 p-10 -138.32 -83.49 0.3 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.238 -0.585 . . . . 64.54 111.048 173.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.406 ' H ' ' CG ' ' A' ' 107' ' ' ASN . 73.1 m 177.49 -13.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.266 1.427 . . . . 62.4 111.18 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -77.98 149.34 34.12 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 113.157 0.799 . . . . 64.42 113.157 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 62.7 pttt -103.87 147.2 27.6 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.53 -0.759 . . . . 74.4 110.211 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.591 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 89.8 mtp -139.24 162.24 35.48 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.578 0.704 . . . . 73.31 112.234 -175.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.24 130.89 46.41 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 114.349 -1.296 . . . . 64.35 109.359 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' ND2' ' A' ' 19' ' ' ASN . 35.8 m -143.41 175.86 3.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 123.366 0.666 . . . . 74.04 109.72 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -116.12 145.1 43.32 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.216 -1.031 . . . . 62.14 108.216 172.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.7 t -136.26 172.04 13.6 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.167 -0.679 . . . . 62.43 109.167 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -104.07 118.53 36.87 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.407 -0.59 . . . . 74.41 109.407 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.448 ' CE ' HG11 ' A' ' 98' ' ' VAL . 52.0 ttp -111.91 148.84 32.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.024 -0.989 . . . . 64.04 109.546 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -73.75 130.54 40.17 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.752 -1.203 . . . . 72.43 107.752 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.518 HD12 ' H ' ' A' ' 119' ' ' ILE . 2.5 mp -73.45 -43.85 55.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 119.91 -0.716 . . . . 73.53 111.242 -171.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -93.58 67.74 3.97 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.961 1.362 . . . . 74.01 107.952 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -81.73 17.15 1.54 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.485 -1.689 . . . . 63.55 114.382 -170.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -121.97 19.73 10.84 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.315 -0.624 . . . . 34.3 109.315 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -64.88 126.9 92.03 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.627 -0.715 . . . . 62.14 110.882 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -92.47 16.57 1.36 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 122.388 2.059 . . . . 33.43 113.604 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.77 -32.93 5.97 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.918 0.39 . . . . 73.41 110.857 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 113.674 0.991 . . . . 63.11 113.674 -177.181 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.489 ' O ' HG12 ' A' ' 144' ' ' ILE . 54.0 tptt . . . . . 0 C--O 1.235 0.314 0 CA-C-O 121.027 0.442 . . . . 44.33 110.09 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 34.8 mmtp -53.88 -31.6 50.37 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 114.714 1.376 . . . . 71.24 114.714 -174.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -57.91 -46.27 85.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.932 0.873 . . . . 53.51 108.971 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -76.72 -33.49 58.17 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.73 -1.123 . . . . 72.33 109.389 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.5 mm -63.25 -34.69 68.45 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.343 0 CA-C-N 115.497 -0.774 . . . . 63.42 112.082 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 48.8 mt-10 -56.71 -34.57 67.6 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.522 0.677 . . . . 73.21 110.582 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.6 m -80.98 -47.1 14.09 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.371 -0.831 . . . . 70.44 110.703 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.536 ' O ' ' HG3' ' A' ' 151' ' ' MET . 2.8 t80 -70.96 -30.29 66.54 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.506 -0.77 . . . . 65.34 112.373 -171.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 87.5 tttt -57.9 -40.18 79.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.239 0.616 . . . . 73.43 110.289 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -64.23 -38.53 91.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.922 -0.77 . . . . 55.25 108.922 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.4 mt -68.43 -38.13 78.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.845 -1.07 . . . . 72.02 109.758 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 147' ' ' PHE . 64.2 mtt -63.54 -41.77 98.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.085 -0.507 . . . . 72.02 109.729 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 49.7 mt-10 -70.47 -33.86 71.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.847 -0.615 . . . . 71.4 110.461 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 46.4 t -62.15 -49.76 74.57 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.703 -0.681 . . . . 62.34 110.211 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 CA--C 1.513 -0.45 0 CA-C-O 121.212 0.53 . . . . 73.35 110.367 177.395 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.529 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 87.5 mt . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 120.963 0.411 . . . . 64.12 110.299 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.458 ' O ' HG12 ' A' ' 79' ' ' VAL . 44.2 m-70 -128.67 161.74 28.97 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.772 -0.649 . . . . 71.34 111.067 -172.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 9.5 p30 -120.09 128.54 53.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.493 -0.776 . . . . 61.23 112.032 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.2 t -131.78 140.79 47.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.359 -0.837 . . . . 51.21 108.947 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.494 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.8 t80 -98.58 121.61 40.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.813 -0.81 . . . . 74.51 108.813 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 74' ' ' LYS . 14.9 m -93.59 152.36 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.077 -0.51 . . . . 73.24 109.791 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -121.4 -51.66 2.07 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 115.818 1.785 . . . . 75.34 115.818 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.02 -75.11 0.15 Allowed Glycine 0 C--O 1.225 -0.442 0 C-N-CA 118.599 -1.762 . . . . 63.44 114.4 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -58.53 -36.4 73.8 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.594 0.758 . . . . 71.22 112.505 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.64 ' HB3' HD11 ' A' ' 32' ' ' ILE . 70.1 m-85 -110.51 29.9 7.29 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-O 121.14 0.495 . . . . 72.34 111.053 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.612 HE21 ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.91 -7.86 53.9 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.768 0.794 . . . . 62.0 109.648 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.503 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 13.0 t70 -114.02 134.44 22.16 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.338 -1.301 . . . . 75.41 111.01 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -72.27 -25.12 19.03 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.577 2.185 . . . . 75.3 112.938 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.503 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 17.8 t70 -64.03 -43.33 95.9 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.185 -0.322 . . . . 64.3 110.471 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.24 -29.58 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 116.238 -0.437 . . . . 72.11 110.058 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 26' ' ' PHE . 31.6 mm -65.77 -47.43 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 122.441 -0.162 . . . . 63.44 110.725 177.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -55.84 -32.7 63.84 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.831 0.348 . . . . 44.04 111.454 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.57 -36.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.471 -0.331 . . . . 65.45 111.473 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.425 ' HE1' HD23 ' A' ' 87' ' ' LEU . 50.6 ttp -63.92 -36.5 84.13 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.771 0.319 . . . . 75.21 110.21 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.638 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.1 pt? -125.18 -76.42 0.59 Allowed 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 112.918 0.71 . . . . 65.24 112.918 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.638 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 23.6 m-20 -169.77 -55.9 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 122.012 0.91 . . . . 62.2 108.606 -170.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -121.23 -177.27 3.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.105 -1.407 . . . . 75.24 110.097 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -134.97 120.59 14.21 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 115.757 -0.656 . . . . 73.24 109.629 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.61 150.87 66.7 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.793 2.328 . . . . 72.11 111.073 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -56.7 116.96 3.45 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.718 0.636 . . . . 74.21 110.037 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 49.2 mt -97.0 141.04 16.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.753 -0.658 . . . . 72.42 110.861 -174.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.25 144.78 36.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.519 -0.919 . . . . 75.11 108.519 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.5 m -76.22 122.66 24.69 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.858 -0.793 . . . . 75.02 108.858 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.36 155.94 49.38 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.708 0.766 . . . . 71.44 111.601 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.3 m -113.05 128.87 56.61 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.29 -1.323 . . . . 72.33 108.382 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 48.0 tp -103.7 99.57 16.36 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 108.863 -0.791 . . . . 71.44 108.863 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.8 146.63 10.51 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.016 1.811 . . . . 62.34 111.143 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.66 9.84 65.95 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.349 -0.929 . . . . 73.43 111.76 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 88.0 m-85 -145.36 159.3 43.27 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 107.503 -1.295 . . . . 74.22 107.503 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -139.3 139.63 37.37 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.059 -0.656 . . . . 72.32 109.613 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 58.7 ttp180 -99.77 135.66 40.85 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.762 -1.108 . . . . 75.22 108.429 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.649 ' HB3' ' O ' ' A' ' 126' ' ' MET . 54.1 m-85 -109.03 168.58 9.26 Favored 'General case' 0 C--N 1.277 -2.55 0 O-C-N 123.595 0.559 . . . . 74.0 109.508 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.086 0 N-CA-C 115.097 1.517 . . . . 53.23 115.097 -174.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 109.433 -0.581 . . . . 73.05 109.433 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 17.1 Cg_exo -69.25 112.41 2.98 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.878 1.719 . . . . 52.3 110.65 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 19.6 p -116.98 160.35 21.07 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 123.372 0.42 . . . . 72.11 111.666 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.503 HD12 HG21 ' A' ' 71' ' ' VAL . 46.5 mm -96.77 142.68 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 108.209 -1.034 . . . . 72.13 108.209 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 118' ' ' TRP . 21.2 m -146.02 150.73 43.11 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 107.286 -1.375 . . . . 51.1 107.286 173.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.11 124.97 13.79 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.197 1.931 . . . . 73.04 112.248 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.3 t -124.98 145.38 49.9 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.606 -0.724 . . . . 50.32 109.279 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.23 -36.85 63.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.447 0.536 . . . . 64.3 112.447 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -131.7 15.68 4.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.697 0.629 . . . . 74.31 112.697 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.63 172.78 30.34 Favored Glycine 0 C--O 1.247 0.961 0 C-N-CA 120.486 -0.864 . . . . 72.43 112.391 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -154.64 156.33 36.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.641 -0.874 . . . . 61.4 108.641 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 63' ' ' ILE . 40.4 t -124.64 137.69 56.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.131 -0.692 . . . . 74.02 109.131 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -107.95 116.12 31.38 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.518 -0.919 . . . . 73.54 108.518 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.514 ' HA2' ' OE1' ' A' ' 27' ' ' GLN . . . -141.45 -150.09 5.32 Favored Glycine 0 N--CA 1.404 -3.446 0 C-N-CA 119.918 -1.134 . . . . 72.41 112.15 -176.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.518 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 34.5 mmtp -131.3 141.54 49.97 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.712 -0.847 . . . . 73.24 108.712 -174.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.4 t -110.11 130.85 62.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 110.254 -0.276 . . . . 63.3 110.254 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 77.4 mt -95.09 105.63 17.57 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.643 -0.708 . . . . 72.23 109.421 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.532 ' HE3' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -98.65 125.45 43.94 Favored 'General case' 0 CA--C 1.479 -1.786 0 CA-C-O 121.77 0.795 . . . . 70.34 112.072 176.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 17' ' ' LEU . . . 102.46 26.39 7.3 Favored Glycine 0 C--N 1.28 -2.581 0 CA-C-N 114.363 -1.29 . . . . 71.01 112.849 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.6 p -87.78 125.16 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.471 -0.937 . . . . 73.41 108.471 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.35 164.32 26.84 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 109.386 -0.598 . . . . 64.23 109.386 -176.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 41.5 m -58.36 -36.92 74.19 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 112.831 0.678 . . . . 55.01 112.831 -176.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.74 -44.71 80.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.672 0.273 . . . . 72.2 110.447 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 1.2 mp0 -68.61 -30.53 69.28 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 116.406 -0.361 . . . . 64.53 110.24 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 81' ' ' SER . 48.4 tp -60.36 -50.25 74.36 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.287 -1.005 . . . . 74.03 108.287 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.02 -28.59 69.6 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.65 -1.159 . . . . 74.42 111.243 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.536 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.3 t-20 -62.03 -49.41 76.11 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 123.331 0.652 . . . . 73.35 110.633 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.425 HD23 ' HE1' ' A' ' 35' ' ' MET . 92.3 mt -64.4 -38.74 92.09 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.651 0.739 . . . . 72.12 109.25 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.467 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 22.5 t70 -64.95 -35.52 81.44 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.537 -1.211 . . . . 61.54 110.829 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.64 -48.28 22.83 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.205 0.526 . . . . 73.23 110.129 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.7 t -62.99 -56.98 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 124.72 1.208 . . . . 73.44 113.168 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -79.97 -24.27 41.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.328 0.585 . . . . 75.21 112.524 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.7 -16.09 21.69 Favored Glycine 0 C--N 1.309 -0.97 0 N-CA-C 116.041 1.177 . . . . 71.32 116.041 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -57.94 -37.81 74.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 117.509 0.655 . . . . 73.4 112.344 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.63 10.17 3.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.889 0.376 . . . . 65.32 111.668 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -132.2 167.45 19.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.098 -0.704 . . . . 73.23 109.098 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.27 150.88 52.06 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.136 -1.061 . . . . 73.14 108.136 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -87.49 114.06 23.76 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.139 -0.689 . . . . 73.24 109.139 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.2 m -121.21 160.52 22.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 116.678 -0.237 . . . . 71.52 111.171 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 t -92.29 134.21 35.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.349 -0.612 . . . . 64.5 109.349 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.403 ' HB ' HD11 ' A' ' 47' ' ' LEU . 27.5 m -139.85 161.38 26.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.599 -0.273 . . . . 55.13 110.924 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.68 123.94 7.84 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.646 -0.981 . . . . 73.24 110.646 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.17 158.79 16.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 110.399 -0.222 . . . . 75.04 110.399 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 56.6 t -121.99 123.86 70.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.327 -0.99 . . . . 64.23 108.327 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.554 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 28.1 mtp180 -68.71 121.88 17.39 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 116.185 -0.462 . . . . 61.22 110.496 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -72.22 -21.16 61.44 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 122.183 0.992 . . . . 62.21 108.806 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.81 -39.54 81.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.288 -1.778 . . . . 62.35 112.61 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -147.31 6.03 0.85 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.31 0.856 . . . . 74.04 113.31 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.5 t 73.08 12.58 4.98 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.586 1.154 . . . . 71.33 112.338 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -96.49 149.07 22.15 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.698 -0.626 . . . . 73.14 111.571 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' O ' ' HD2' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -96.33 150.12 20.92 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 112.817 0.673 . . . . 64.23 112.817 -175.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.554 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.6 mtp -143.26 160.62 40.14 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.853 -1.067 . . . . 72.55 110.153 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.23 130.76 54.7 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.751 -0.833 . . . . 54.54 108.751 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 21' ' ' PHE . 35.3 m -142.27 173.96 6.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 120.894 0.378 . . . . 71.31 110.536 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -104.11 146.57 28.54 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.421 -0.955 . . . . 64.54 108.421 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.0 t -149.33 172.5 14.79 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.829 -0.804 . . . . 72.35 108.829 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -117.74 113.98 22.64 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.125 0.488 . . . . 74.22 109.953 -176.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -109.0 156.38 19.8 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.848 -0.615 . . . . 60.33 110.794 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.403 ' HB3' HG12 ' A' ' 64' ' ' VAL . 59.2 t-105 -68.4 128.85 38.08 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.498 -1.297 . . . . 74.04 107.498 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.6 mm -72.53 -38.51 59.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 112.653 0.612 . . . . 62.2 112.653 -170.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -76.28 -37.66 57.24 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.695 -0.402 . . . . 73.11 111.216 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.337 0.0 OUTLIER 37.77 65.01 0.6 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.123 1.157 . . . . 75.41 114.123 -173.174 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.29 -26.62 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.635 -0.711 . . . . 72.03 111.198 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.32 136.23 50.74 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 122.929 0.491 . . . . 61.11 112.052 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.16 -2.29 11.94 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.612 2.208 . . . . 71.44 110.677 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -63.88 -45.51 89.08 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 115.665 -0.698 . . . . 74.21 110.917 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.649 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.0 ptt? . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 116.324 -0.398 . . . . 72.5 110.763 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.578 ' O ' HG12 ' A' ' 144' ' ' ILE . 37.5 ttpt . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 109.752 -0.462 . . . . 74.31 109.752 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.81 -30.93 47.23 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.425 1.09 . . . . 64.35 111.78 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -65.37 -39.23 92.04 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.04 0.448 . . . . 73.23 109.917 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.495 ' O ' HG22 ' A' ' 146' ' ' THR . 92.6 m-85 -76.73 -32.84 58.06 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.572 0.701 . . . . 74.31 109.291 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.9 mm -58.53 -31.21 43.0 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 CA-C-N 114.845 -1.07 . . . . 74.32 111.713 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -50.64 -44.72 57.49 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.296 0.48 . . . . 63.45 112.296 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 143' ' ' PHE . 12.0 t -68.76 -40.58 79.69 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 120.221 -0.592 . . . . 71.33 110.25 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -69.65 -29.95 67.53 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 112.93 0.715 . . . . 63.52 112.93 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 38.2 ttpt -59.64 -43.2 93.95 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.534 -0.913 . . . . 72.45 108.534 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -72.58 -28.55 62.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.798 -0.637 . . . . 64.23 110.235 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 146' ' ' THR . 83.7 mt -73.76 -43.16 54.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.757 -0.656 . . . . 75.15 110.397 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.2 ptm -70.75 -29.89 66.25 Favored 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 121.089 -0.244 . . . . 64.01 111.579 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 8.2 mm-40 -66.1 -33.32 75.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.079 0.466 . . . . 75.21 110.728 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 41.8 t -71.95 -33.83 68.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.048 -0.523 . . . . 72.32 110.066 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.241 0.628 0 CA-C-O 121.56 0.695 . . . . 72.11 111.099 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.416 -2.158 0 CA-C-O 121.619 0.723 . . . . 60.22 109.413 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.522 ' O ' HG12 ' A' ' 79' ' ' VAL . 37.5 m-70 -115.01 160.66 19.33 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 114.811 -1.086 . . . . 62.12 108.818 -174.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 22.5 p30 -131.14 127.03 37.21 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.548 0.69 . . . . 73.34 110.868 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.5 t -121.05 141.78 40.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.101 -0.954 . . . . 72.01 110.492 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.459 ' HB2' HG21 ' A' ' 113' ' ' VAL . 90.3 t80 -94.56 124.37 38.56 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.514 -0.921 . . . . 73.53 108.514 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 m -109.12 126.4 66.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.364 0.602 . . . . 75.21 111.673 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.404 ' HB3' ' CG1' ' A' ' 63' ' ' ILE . 42.6 p90 -66.88 -34.09 77.03 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.803 1.038 . . . . 74.25 113.803 -177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 169.42 -28.44 0.13 Allowed Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 118.752 -1.69 . . . . 52.24 113.318 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.2 p -62.97 -36.8 84.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.143 0.497 . . . . 64.4 111.143 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.588 ' HB3' HD11 ' A' ' 32' ' ' ILE . 63.5 m-85 -124.67 28.79 6.44 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.669 -0.696 . . . . 73.12 112.23 -176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -87.14 9.18 20.78 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.795 0.807 . . . . 72.44 108.848 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.556 ' O ' HG12 ' A' ' 32' ' ' ILE . 13.1 t70 -117.25 129.44 25.33 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.544 -1.207 . . . . 74.44 109.354 -176.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' ASP . 2.8 Cg_exo -71.08 -28.8 18.58 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.915 1.744 . . . . 55.21 112.558 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.454 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 24.0 t70 -62.35 -44.63 96.02 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 116.348 -0.387 . . . . 75.43 110.761 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.94 -29.3 36.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.997 -0.547 . . . . 72.5 109.93 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.588 HD11 ' HB3' ' A' ' 26' ' ' PHE . 44.2 mm -65.76 -41.57 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 116.434 -0.348 . . . . 72.02 110.356 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -53.86 -46.21 71.21 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.296 0.569 . . . . 35.32 110.622 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -82.75 -36.14 13.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 114.371 1.249 . . . . 55.24 114.371 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.514 ' HE2' HD23 ' A' ' 87' ' ' LEU . 12.0 tmm? -67.84 -36.58 80.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.792 0.33 . . . . 74.33 110.701 -174.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.507 HD21 HG23 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -119.13 -71.69 0.72 Allowed 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.681 -0.808 . . . . 51.23 111.535 175.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.481 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 27.8 t70 167.96 -46.73 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.405 0.682 . . . . 72.53 109.481 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -111.75 160.3 17.44 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.355 -0.839 . . . . 62.54 110.345 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.411 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 40.3 m -119.55 111.1 36.56 Favored Pre-proline 0 N--CA 1.429 -1.509 0 CA-C-N 116.34 -0.391 . . . . 55.01 111.262 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -60.72 151.51 76.03 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.025 2.483 . . . . 70.55 110.378 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -62.57 121.47 13.4 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.117 0.484 . . . . 65.44 109.855 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 25.2 mt -99.08 131.05 47.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.379 -0.828 . . . . 71.2 109.385 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG21 ' HD2' ' A' ' 104' ' ' ARG . 11.6 p -130.4 148.05 33.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.899 -0.591 . . . . 74.15 110.352 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.426 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 34.5 m -75.59 124.19 26.79 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.024 0.44 . . . . 71.23 110.096 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB1' HD13 ' A' ' 102' ' ' ILE . . . -138.7 159.27 42.51 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.439 0.638 . . . . 63.42 111.513 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.475 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 78.3 m -118.23 129.43 55.48 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.479 -0.782 . . . . 50.13 109.892 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.6 tp -104.43 99.31 17.21 Favored Pre-proline 0 N--CA 1.426 -1.652 0 N-CA-C 109.733 -0.469 . . . . 73.32 109.733 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.5 Cg_endo -84.29 141.69 9.23 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.694 2.263 . . . . 72.32 110.752 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.36 4.14 57.41 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.616 -0.802 . . . . 71.05 111.492 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' HA ' ' H ' ' A' ' 66' ' ' SER . 82.4 m-85 -138.76 157.77 45.48 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.967 -0.753 . . . . 73.22 108.967 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 7.1 tp60 -138.93 148.3 43.39 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.595 -0.52 . . . . 65.34 109.595 -175.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -100.6 126.35 47.06 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.265 -0.88 . . . . 74.51 110.564 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 68.1 m-85 -109.04 134.85 51.12 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.03 -1.47 . . . . 72.12 107.03 174.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.536 ' C ' ' HD3' ' A' ' 54' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.404 -2.757 0 N-CA-C 113.798 1.036 . . . . 64.02 113.798 -166.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 N--CA 1.444 -0.752 0 N-CA-C 107.439 -1.319 . . . . 64.13 107.439 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.649 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 7.1 Cg_exo -73.73 81.17 1.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 121.022 1.148 . . . . 74.3 109.932 170.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.0 m -85.74 157.17 20.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.801 -0.636 . . . . 61.02 112.109 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.459 HD12 HG21 ' A' ' 71' ' ' VAL . 49.2 mm -103.95 140.9 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 115.153 -0.931 . . . . 62.03 109.23 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.31 153.96 56.6 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.278 -1.008 . . . . 62.3 108.278 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.12 112.97 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.543 2.162 . . . . 65.2 112.378 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 51' ' ' GLN . 33.5 t -125.54 126.64 45.16 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.329 -0.989 . . . . 72.42 108.329 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.48 -36.17 77.65 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.468 0.914 . . . . 72.31 113.468 -174.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -107.52 19.85 19.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.698 0.285 . . . . 74.52 111.495 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -109.31 160.13 13.68 Favored Glycine 0 N--CA 1.426 -1.989 0 C-N-CA 119.873 -1.156 . . . . 73.53 112.997 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.69 131.63 8.08 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.988 -1.116 . . . . 74.22 107.988 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.459 HG21 HD12 ' A' ' 63' ' ' ILE . 56.6 t -112.43 123.43 68.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 109.762 -0.458 . . . . 73.13 109.762 -176.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -97.01 115.88 28.23 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.366 -1.346 . . . . 75.51 107.366 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.491 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -144.69 -149.69 5.09 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 110.323 -1.111 . . . . 54.4 110.323 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 73' ' ' GLY . 2.2 mppt? -127.44 150.79 49.49 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 112.989 0.737 . . . . 70.21 112.989 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 28.1 t -110.87 131.88 60.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 114.593 -1.185 . . . . 60.41 112.016 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 78.8 mt -96.91 106.95 19.36 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.278 -1.008 . . . . 72.01 108.278 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.1 ptp -114.56 150.01 35.62 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 120.487 0.184 . . . . 73.1 110.714 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.71 15.86 47.89 Favored Glycine 0 N--CA 1.433 -1.513 0 C-N-CA 119.483 -1.342 . . . . 63.42 111.006 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.3 p -87.43 126.24 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.119 -1.067 . . . . 53.02 108.119 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.6 p -76.29 172.66 12.52 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.809 -0.356 . . . . 62.42 110.276 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.9 p -59.87 -41.18 90.93 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 112.25 0.463 . . . . 55.42 112.25 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.04 -36.65 85.06 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.777 0.798 . . . . 63.44 110.888 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 42.2 mt-10 -78.06 -31.21 50.16 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.397 -0.819 . . . . 73.05 109.171 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.438 HD22 ' CE1' ' A' ' 18' ' ' HIS . 35.5 tp -66.27 -47.32 74.09 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.233 -0.44 . . . . 61.5 110.615 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.01 -29.37 70.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.268 0.556 . . . . 72.33 109.63 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 28.1 t-20 -67.21 -44.07 80.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.308 -0.86 . . . . 72.1 109.629 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.514 HD23 ' HE2' ' A' ' 35' ' ' MET . 96.0 mt -64.77 -43.17 94.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.747 -0.661 . . . . 71.41 109.758 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.536 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 31.3 t70 -65.65 -27.59 68.48 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.927 -1.033 . . . . 63.31 110.288 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.47 -48.5 22.37 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.053 -0.521 . . . . 70.4 110.286 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.514 HG21 ' SD ' ' A' ' 35' ' ' MET . 92.7 t -69.86 -58.27 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 112.473 0.546 . . . . 61.24 112.473 -175.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.95 -33.86 44.92 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.136 0.493 . . . . 73.53 111.351 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -60.11 -16.53 41.41 Favored Glycine 0 N--CA 1.465 0.587 0 CA-C-N 115.795 -0.639 . . . . 32.44 113.507 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -57.74 -37.44 73.61 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.695 0.398 . . . . 73.25 110.518 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -132.93 7.91 4.05 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.169 0.509 . . . . 74.42 111.84 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 96.1 m-85 -131.07 168.84 16.73 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 122.709 0.404 . . . . 75.24 110.837 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.573 ' HB2' ' CD1' ' A' ' 119' ' ' ILE . 43.3 tt0 -122.46 129.97 52.59 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.536 -0.912 . . . . 55.1 108.536 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' THR . 60.0 ttp180 -86.14 114.16 22.77 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.912 -1.144 . . . . 65.44 107.912 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.4 HG13 ' HG2' ' A' ' 96' ' ' GLU . 30.9 m -125.77 162.24 29.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.673 -0.694 . . . . 62.51 111.987 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -86.13 124.62 32.74 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.242 -0.89 . . . . 75.43 109.257 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.8 170.72 19.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.72 -0.673 . . . . 70.44 111.896 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -121.24 120.51 4.47 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 110.587 -1.005 . . . . 63.02 110.587 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.457 HD11 ' HE2' ' A' ' 111' ' ' MET . 2.6 pp -115.41 163.02 13.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 116.597 0.198 . . . . 61.52 110.64 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 59.5 t -117.3 125.38 73.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 107.603 -1.258 . . . . 74.14 107.603 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.617 ' HE ' ' HB3' ' A' ' 106' ' ' ASP . 29.4 ttp180 -79.2 118.67 21.36 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.082 -1.081 . . . . 72.41 108.082 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.426 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 45.4 mt-10 -66.94 -7.52 22.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.203 0.601 . . . . 72.24 111.081 -176.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.617 ' HB3' ' HE ' ' A' ' 104' ' ' ARG . 30.1 t70 -54.78 -46.51 74.45 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.996 -1.002 . . . . 74.21 108.92 172.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.433 ' HB2' ' H ' ' A' ' 108' ' ' SER . 16.5 m-80 -133.8 -103.27 0.24 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.152 -1.055 . . . . 74.32 108.152 170.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.433 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 21.2 p -152.47 16.14 0.61 Allowed 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 106.374 -1.713 . . . . 74.05 106.374 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.89 128.5 35.67 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 114.458 -1.246 . . . . 75.23 108.183 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 60.8 pttt -99.36 147.39 25.28 Favored 'General case' 0 C--N 1.251 -3.678 0 CA-C-N 115.273 -0.876 . . . . 74.34 109.801 -176.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.457 ' HE2' HD11 ' A' ' 102' ' ' ILE . 32.8 mtm -136.14 163.44 30.34 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.721 0.772 . . . . 65.13 110.686 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.63 118.15 35.8 Favored 'General case' 0 C--N 1.258 -3.41 0 CA-C-N 114.301 -1.318 . . . . 65.44 108.604 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 21' ' ' PHE . 22.8 m -134.15 174.67 12.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.316 -0.624 . . . . 75.1 109.316 -176.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -113.25 146.27 39.61 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.985 -0.746 . . . . 54.03 108.985 175.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 14.4 t -136.04 171.4 14.53 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.354 -0.61 . . . . 61.5 109.354 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 95' ' ' TYR . 80.1 m-85 -112.57 112.68 24.4 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.852 -0.613 . . . . 61.0 110.317 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -112.67 157.83 20.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.656 -0.702 . . . . 71.41 109.582 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -67.64 139.91 56.83 Favored 'General case' 0 C--O 1.254 1.335 0 N-CA-C 109.104 -0.702 . . . . 75.51 109.104 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 96' ' ' GLU . 16.9 mm -72.24 -44.74 63.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 120.34 -0.544 . . . . 64.32 110.788 -172.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -70.32 -35.74 73.84 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 115.629 -0.714 . . . . 74.13 109.868 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.533 ' HB3' ' HZ3' ' A' ' 121' ' ' LYS . 0.1 OUTLIER 56.17 -4.45 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.082 2.153 . . . . 73.24 115.587 176.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.81 26.15 6.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.507 0.67 . . . . 51.04 109.407 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.606 ' O ' ' HG2' ' A' ' 126' ' ' MET . 10.2 t70 -62.78 125.66 86.9 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.131 -0.94 . . . . 75.25 109.558 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.44 -13.76 16.51 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.832 2.355 . . . . 61.42 113.204 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -89.3 -24.0 22.14 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.228 -0.442 . . . . 51.14 110.69 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 123' ' ' ASP . 21.4 ptp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.724 0.297 . . . . 55.4 111.262 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.51 ' O ' HG12 ' A' ' 144' ' ' ILE . 34.7 ttpt . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 113.219 0.822 . . . . 70.21 113.219 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 88.2 tttt -53.85 -34.58 59.75 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.678 0.622 . . . . 72.12 112.678 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 142' ' ' LYS . 10.7 tmtt? -58.97 -43.6 91.38 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.387 -0.597 . . . . 72.44 109.387 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -76.74 -32.85 58.04 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.703 -0.68 . . . . 73.3 109.83 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 140' ' ' LYS . 51.6 mm -63.28 -33.38 60.76 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 CA-C-N 115.603 -0.726 . . . . 72.33 110.551 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 7.7 mm-40 -51.8 -39.05 58.01 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.281 0.845 . . . . 71.41 113.281 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -80.63 -39.33 27.57 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 119.973 -0.691 . . . . 65.53 110.511 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -67.89 -29.21 68.25 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 112.577 0.584 . . . . 72.4 112.577 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 148' ' ' LYS . 37.6 ttpt -53.76 -42.22 67.97 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 124.095 0.958 . . . . 52.23 109.315 173.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -75.32 -42.04 55.44 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.584 -0.735 . . . . 61.34 110.126 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.2 mt -61.52 -39.56 83.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.735 -0.666 . . . . 64.22 111.654 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 57.8 ttp -62.14 -45.91 91.32 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 122.809 0.444 . . . . 61.23 110.1 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -66.39 -30.94 71.42 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.165 0.507 . . . . 65.42 110.071 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 45.1 t -69.17 -33.44 73.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.156 -0.475 . . . . 45.22 111.058 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 CA--C 1.506 -0.721 0 CA-C-O 121.412 0.625 . . . . 75.45 110.084 176.921 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 17' ' ' LEU . 1.8 mm? . . . . . 0 N--CA 1.395 -3.214 0 CA-C-O 121.451 0.643 . . . . 74.01 110.982 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.47 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.6 m-70 -123.61 159.77 28.55 Favored 'General case' 0 C--N 1.27 -2.858 0 CA-C-N 114.82 -1.082 . . . . 73.34 109.406 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 15.3 p30 -125.59 126.19 44.37 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.021 -0.99 . . . . 55.34 110.322 174.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.61 138.76 53.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.436 -0.802 . . . . 72.44 109.395 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.466 ' HB2' HG21 ' A' ' 113' ' ' VAL . 87.5 t80 -93.55 121.92 35.46 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.138 -1.43 . . . . 73.22 107.138 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 19.2 m -103.24 154.81 5.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 115.737 -0.665 . . . . 61.43 110.878 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -139.9 -30.05 0.7 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.989 0.737 . . . . 72.14 112.989 -170.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.49 -91.29 0.44 Allowed Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 118.875 -1.631 . . . . 72.53 113.523 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 m -58.69 -31.29 68.09 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.22 0.822 . . . . 73.43 113.22 -173.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 32' ' ' ILE . 27.6 m-85 -117.49 21.56 12.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.677 0.992 . . . . 63.33 113.677 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 22' ' ' VAL . 63.2 tt0 -82.67 -2.63 54.62 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 121.974 0.892 . . . . 71.23 110.131 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 32' ' ' ILE . 20.4 t70 -112.52 125.21 30.38 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 115.392 -0.822 . . . . 60.53 109.56 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.3 -31.12 36.0 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.716 2.277 . . . . 60.33 113.572 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 21.9 t70 -62.78 -38.14 89.45 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 120.686 0.279 . . . . 43.25 111.591 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 28' ' ' ASP . 29.0 m -73.38 -28.19 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.147 -0.479 . . . . 64.15 110.752 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 28' ' ' ASP . 47.9 mm -61.49 -38.61 80.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 CA-C-O 121.046 0.451 . . . . 73.43 110.866 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -59.6 -35.13 73.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.698 -0.683 . . . . 71.31 110.275 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.9 t -82.07 -51.12 15.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.406 -0.815 . . . . 72.41 111.667 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.424 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 10.7 tmm? -63.68 -36.63 84.48 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.523 -0.308 . . . . 74.21 111.002 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 37' ' ' ASP 0.386 3.6 pp -121.56 -59.55 1.68 Allowed 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 114.702 1.371 . . . . 54.12 114.702 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.555 ' N ' HD12 ' A' ' 36' ' ' LEU . 17.2 t70 172.72 -55.44 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.127 0.489 . . . . 62.3 110.825 -176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 56.8 mmt-85 -138.75 159.1 42.95 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.828 -0.624 . . . . 51.0 110.195 -176.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.3 m -94.3 122.09 62.16 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 112.144 0.424 . . . . 74.31 112.144 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.61 153.26 68.19 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.066 3.177 . . . . 70.34 111.392 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -56.77 132.08 51.16 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.226 -0.657 . . . . 72.25 109.226 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 54.9 mt -115.49 134.67 57.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 109.307 -0.627 . . . . 75.23 109.307 -174.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.29 144.13 36.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 108.505 -0.924 . . . . 73.53 108.505 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.5 m -81.12 127.69 32.92 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 108.826 -0.805 . . . . 54.44 108.826 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.48 158.74 43.37 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.221 0.534 . . . . 74.35 110.834 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.503 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 97.1 m -113.58 127.69 56.16 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.187 -0.915 . . . . 50.33 110.082 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.8 tp -100.59 100.22 11.82 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 109.415 -0.587 . . . . 73.21 109.415 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 46' ' ' THR . 97.2 Cg_endo -88.09 135.21 3.23 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.649 2.233 . . . . 63.34 111.646 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.11 11.83 38.33 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.402 -0.904 . . . . 55.42 111.165 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.507 ' HA ' ' H ' ' A' ' 66' ' ' SER . 87.0 m-85 -145.31 159.69 42.66 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.876 -0.787 . . . . 73.02 108.876 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.42 143.8 37.8 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.662 -0.495 . . . . 73.22 109.662 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -104.41 132.68 50.39 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.825 -1.176 . . . . 73.01 107.825 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -108.76 169.82 8.42 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 113.378 0.881 . . . . 73.31 113.378 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 . . . . . 0 C--N 1.288 -2.094 0 CA-C-N 114.251 -1.34 . . . . 74.11 109.163 -175.149 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 . . . . . 0 C--O 1.241 0.635 0 N-CA-C 108.993 -0.743 . . . . 62.54 108.993 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.39 98.05 1.14 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.823 1.682 . . . . 64.12 108.915 172.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 23.3 p -109.89 169.15 8.91 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.146 -0.479 . . . . 70.22 112.189 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.8 mm -108.82 141.24 24.62 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.022 0 C-N-CA 123.533 0.733 . . . . 73.41 109.232 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.3 153.62 52.56 Favored Pre-proline 0 N--CA 1.476 0.873 0 N-CA-C 107.762 -1.199 . . . . 74.43 107.762 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.432 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 30.7 Cg_endo -65.03 115.45 3.29 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.555 2.17 . . . . 72.3 113.966 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.507 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 47.3 t -125.82 112.95 16.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.25 -1.018 . . . . 64.22 108.25 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.62 -22.31 66.65 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.396 0.517 . . . . 74.03 112.396 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -109.63 14.82 23.23 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.86 0.362 . . . . 73.21 110.937 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.13 167.22 15.39 Favored Glycine 0 C--O 1.249 1.082 0 C-N-CA 120.684 -0.769 . . . . 33.43 112.663 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.41 143.54 18.94 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 123.834 0.854 . . . . 74.12 109.569 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.44 120.02 63.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 110.13 -0.322 . . . . 63.54 110.13 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -91.77 115.45 28.07 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.782 -1.562 . . . . 74.22 106.782 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.05 -150.37 5.29 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.573 -0.822 . . . . 64.44 111.866 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 73.5 mmtt -126.04 141.54 51.91 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.854 0.359 . . . . 75.51 110.339 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.3 t -111.09 131.04 63.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.966 -0.561 . . . . 75.24 110.78 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 66.9 mt -95.57 104.71 16.63 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.887 -0.783 . . . . 75.41 108.887 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.474 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 55.3 mtp -102.61 161.03 14.05 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.326 -0.99 . . . . 63.21 108.326 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.67 17.09 78.14 Favored Glycine 0 C--N 1.302 -1.346 0 C-N-CA 119.29 -1.433 . . . . 73.4 112.792 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 83' ' ' GLU . 10.9 p -91.82 136.02 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.28 -1.007 . . . . 64.12 108.28 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 79.2 p -78.93 168.39 19.76 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.899 -0.72 . . . . 72.24 111.766 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 m -63.0 -33.43 75.4 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.206 -0.452 . . . . 73.01 111.978 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.72 -39.17 93.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.795 0.807 . . . . 70.15 110.47 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.535 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.8 mt-10 -78.27 -28.36 47.62 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.979 -1.01 . . . . 63.21 109.296 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.454 HD22 ' CE1' ' A' ' 18' ' ' HIS . 53.3 tp -66.13 -50.29 64.53 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 109.882 -0.414 . . . . 63.45 109.882 175.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.99 -28.87 69.87 Favored 'General case' 0 C--O 1.208 -1.12 0 CA-C-O 121.379 0.609 . . . . 73.11 109.441 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 12.6 t-20 -65.44 -49.06 70.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.171 -0.922 . . . . 62.54 110.537 176.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.597 ' HA ' HG12 ' A' ' 90' ' ' VAL . 95.4 mt -65.07 -38.85 92.12 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.824 0.821 . . . . 73.44 109.639 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.655 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 24.6 t70 -65.13 -31.68 73.0 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.231 -1.35 . . . . 73.55 109.737 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.21 -48.4 17.67 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.258 -0.883 . . . . 64.51 111.514 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 87' ' ' LEU . 7.3 p -72.33 -59.14 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 113.957 1.095 . . . . 73.13 113.957 -173.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.38 -32.93 37.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 119.643 -0.823 . . . . 74.4 110.847 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.46 -16.35 21.12 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.83 -1.077 . . . . 74.44 115.55 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -77.16 -24.58 51.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 118.277 1.038 . . . . 65.44 111.604 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -111.05 -11.59 14.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.42 0.629 . . . . 73.03 110.327 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -134.53 170.91 15.06 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.771 0.829 . . . . 74.12 110.416 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -121.62 138.03 54.49 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.335 -0.987 . . . . 54.32 108.335 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 115' ' ' THR . 39.6 ttp180 -87.48 119.13 27.45 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.794 -0.817 . . . . 73.25 108.794 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.54 161.16 26.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 112.378 0.51 . . . . 75.42 112.378 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -91.5 122.96 34.55 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.014 -0.993 . . . . 73.12 108.955 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.42 158.96 43.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.104 0.478 . . . . 74.14 111.605 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.06 119.75 6.14 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 111.032 -0.827 . . . . 70.41 111.032 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.03 154.88 13.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 122.296 0.238 . . . . 64.23 110.431 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.74 117.72 55.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.181 0.515 . . . . 42.53 109.788 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -64.5 124.67 22.43 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 124.509 1.124 . . . . 73.44 111.414 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -61.41 -35.59 77.95 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.739 0.816 . . . . 74.01 112.115 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.2 -53.02 62.73 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.031 0.752 . . . . 71.41 113.031 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -128.96 10.86 5.98 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 113.5 0.926 . . . . 72.35 113.5 -167.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.4 t 63.93 12.44 6.83 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.403 0.681 . . . . 73.41 112.504 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -81.07 152.14 28.01 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.24 -0.652 . . . . 72.33 109.24 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -105.78 147.18 28.92 Favored 'General case' 0 C--N 1.278 -2.515 0 C-N-CA 120.263 -0.575 . . . . 62.53 109.789 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 40.9 mtm -137.55 163.05 32.13 Favored 'General case' 0 CA--C 1.465 -2.308 0 CA-C-O 121.412 0.625 . . . . 63.22 110.186 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.75 118.32 36.22 Favored 'General case' 0 C--N 1.262 -3.226 0 CA-C-N 114.612 -1.176 . . . . 70.23 108.474 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 21' ' ' PHE . 30.8 m -128.22 173.52 13.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 116.062 -0.517 . . . . 73.33 110.172 -176.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -101.99 149.42 24.25 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.214 -1.402 . . . . 64.03 107.214 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.7 t -152.3 171.69 17.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.561 -0.903 . . . . 73.21 108.561 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -119.1 116.75 27.02 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.043 -0.725 . . . . 72.04 109.043 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.432 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 24.5 ptt? -112.63 156.79 22.12 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.054 -0.521 . . . . 73.15 109.777 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 64.4 t-105 -68.08 123.98 22.16 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.572 -0.899 . . . . 70.42 108.572 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.6 mt -67.86 -41.76 85.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.069 -0.968 . . . . 74.51 112.022 -172.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -88.12 75.76 8.62 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.973 0.892 . . . . 64.41 108.673 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -76.67 0.05 21.75 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.005 -0.998 . . . . 71.52 112.877 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.88 8.96 41.05 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.104 -0.498 . . . . 71.12 109.871 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.94 138.59 96.4 Favored Pre-proline 0 C--O 1.214 -0.774 0 CA-C-N 115.772 -0.649 . . . . 72.41 109.96 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -99.56 17.56 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.181 1.921 . . . . 35.33 113.308 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -118.01 -9.0 10.65 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.311 1.226 . . . . 75.3 114.311 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 119.333 -0.947 . . . . 72.21 110.247 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 144' ' ' ILE . 6.3 ttpm? . . . . . 0 C--O 1.209 -1.047 0 N-CA-C 114.053 1.131 . . . . 72.52 114.053 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -55.83 -35.08 65.99 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.314 0.857 . . . . 74.11 113.314 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.62 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 0.6 OUTLIER -66.74 -36.57 82.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.879 0.847 . . . . 74.33 108.749 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -77.03 -35.96 56.52 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 113.679 -1.6 . . . . 74.35 110.678 -175.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 140' ' ' LYS . 50.1 mm -61.37 -32.67 53.86 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.981 0 N-CA-C 113.182 0.808 . . . . 71.1 113.182 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -51.77 -42.31 62.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 113.792 1.034 . . . . 71.12 113.792 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.431 ' O ' HG13 ' A' ' 150' ' ' ILE . 13.1 t -70.77 -33.67 71.02 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 120.128 -0.629 . . . . 74.22 109.811 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.469 ' O ' ' HG3' ' A' ' 151' ' ' MET . 64.0 m-85 -71.71 -30.36 65.56 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 116.125 -0.489 . . . . 63.33 111.679 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.492 ' HG3' HG22 ' A' ' 144' ' ' ILE . 29.8 mtpp -59.83 -36.84 77.64 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.254 -1.017 . . . . 72.22 108.254 174.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 149' ' ' LYS . 48.4 mmtt -74.56 -36.68 63.08 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.778 -0.646 . . . . 74.43 112.201 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.556 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 94.6 mt -63.28 -41.45 92.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.904 0.383 . . . . 63.54 110.09 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 147' ' ' PHE . 65.4 mtt -66.58 -40.64 89.02 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.656 -0.498 . . . . 70.11 109.656 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 148' ' ' LYS . 1.3 tm-20 -62.28 -34.29 76.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 124.87 1.268 . . . . 44.12 109.765 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 74.9 m -71.13 -34.07 70.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.188 -0.46 . . . . 70.3 110.553 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 34.6 mmtp . . . . . 0 C--O 1.24 0.598 0 N-CA-C 109.261 -0.644 . . . . 71.12 109.261 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 17' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.418 -2.071 0 CA-C-O 121.325 0.583 . . . . 63.34 112.14 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.59 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.9 m-70 -113.9 161.25 17.85 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.016 -0.993 . . . . 74.31 109.191 -173.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 24.9 p30 -128.27 134.58 48.97 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.336 0.589 . . . . 73.35 112.117 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 53.9 t -131.52 137.97 54.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.659 -0.7 . . . . 73.44 110.345 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.475 ' HB2' HG21 ' A' ' 113' ' ' VAL . 93.2 t80 -94.67 123.83 38.34 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.195 0.598 . . . . 63.12 109.659 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 26' ' ' PHE . 13.1 p -138.56 155.46 28.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.416 -0.587 . . . . 71.15 109.416 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.428 ' CE1' HD11 ' A' ' 63' ' ' ILE . 2.0 p90 -148.97 6.31 0.69 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.923 0.392 . . . . 62.25 110.145 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.81 -92.61 1.02 Allowed Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 119.812 -1.185 . . . . 72.11 113.293 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.7 m -58.6 -36.11 73.49 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.441 0.696 . . . . 52.2 112.835 -174.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.51 ' HB2' HG21 ' A' ' 22' ' ' VAL . 72.6 m-85 -120.04 29.78 7.35 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.259 0.552 . . . . 71.43 111.561 -175.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -62.95 -31.51 72.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.929 -1.032 . . . . 73.34 110.633 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 21.2 t70 -108.49 129.7 23.68 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.642 -0.708 . . . . 75.15 111.719 -176.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.23 -24.68 58.18 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.437 2.758 . . . . 71.23 113.915 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.447 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 16.4 t70 -70.46 -29.09 65.56 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.709 -0.619 . . . . 54.12 110.119 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.58 -39.57 84.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.345 -0.843 . . . . 75.24 108.824 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 26' ' ' PHE . 29.0 mm -62.77 -45.03 99.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.253 -0.885 . . . . 74.22 110.526 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -53.2 -42.85 66.7 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.492 0.553 . . . . 71.3 112.492 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.55 -36.75 14.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 112.525 0.565 . . . . 71.5 112.525 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.7 tmm? -65.22 -35.85 82.33 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 121.32 -0.152 . . . . 62.05 110.683 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.622 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 0.8 OUTLIER -120.35 -74.7 0.6 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 119.967 -0.693 . . . . 75.01 112.444 172.454 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.622 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 16.3 t70 173.6 -48.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.528 0.731 . . . . 75.24 109.163 -174.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -109.13 164.95 11.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.604 -1.18 . . . . 60.01 109.094 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.4 m -123.93 129.35 24.81 Favored Pre-proline 0 C--N 1.307 -1.247 0 C-N-CA 122.361 0.264 . . . . 63.2 111.164 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -68.0 152.57 76.63 Favored 'Trans proline' 0 C--O 1.25 1.085 0 C-N-CA 123.278 2.652 . . . . 42.14 111.431 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.89 140.13 58.79 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.193 -0.669 . . . . 63.31 109.193 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 52.6 mt -118.35 142.66 32.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 120.889 0.376 . . . . 51.51 110.655 -173.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.464 HG21 ' HD2' ' A' ' 104' ' ' ARG . 9.1 p -130.13 145.08 36.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.092 -0.707 . . . . 51.43 109.092 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.1 m -76.54 124.79 28.14 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.888 -0.782 . . . . 63.25 108.888 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.66 156.69 47.76 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.981 0.896 . . . . 72.34 112.042 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 64.8 m -116.16 128.89 56.02 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.398 -1.274 . . . . 73.24 108.153 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.0 tp -102.03 99.61 12.78 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 46' ' ' THR . 95.6 Cg_endo -85.47 148.37 10.03 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.349 2.033 . . . . 72.44 111.354 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.39 13.45 68.06 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.433 -0.889 . . . . 33.51 111.225 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -143.25 152.26 41.49 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.991 -1.114 . . . . 72.22 107.991 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -139.55 142.86 37.17 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.783 -0.767 . . . . 74.12 109.154 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.708 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -90.27 134.81 34.07 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.83 -1.174 . . . . 73.13 107.83 176.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.668 ' HB3' ' O ' ' A' ' 126' ' ' MET . 84.2 m-85 -116.64 169.11 9.6 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 112.097 0.406 . . . . 74.34 112.097 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HE ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 114.692 1.367 . . . . 72.31 114.692 -169.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 108.302 -0.999 . . . . 73.35 108.302 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 21.9 Cg_exo -66.37 101.05 0.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 N-CA-C 108.639 -1.331 . . . . 61.0 108.639 171.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 9.3 p -102.54 153.3 20.21 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.547 -0.751 . . . . 73.33 112.969 -173.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.428 HD11 ' CE1' ' A' ' 23' ' ' TYR . 41.8 mm -106.13 117.94 52.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.297 -0.865 . . . . 72.24 110.289 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.36 146.58 62.58 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.46 -0.57 . . . . 70.43 109.46 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.1 109.05 1.05 Allowed 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.757 2.305 . . . . 72.22 112.303 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 t -124.64 121.76 35.61 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.01 -1.478 . . . . 53.43 107.01 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.61 -36.77 67.3 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.476 1.287 . . . . 74.32 114.476 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -109.1 20.05 18.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.193 0.52 . . . . 61.11 110.661 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.7 162.72 14.11 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.041 -1.076 . . . . 62.23 112.731 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -150.97 145.13 25.36 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 108.709 -0.849 . . . . 62.13 108.709 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.427 HG21 HD12 ' A' ' 63' ' ' ILE . 50.7 t -123.3 133.27 69.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.468 -0.568 . . . . 65.21 109.468 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -107.41 126.51 52.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.058 -1.09 . . . . 71.03 108.058 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.01 -154.91 7.08 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.753 -0.939 . . . . 63.01 110.753 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.52 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.2 mmtm -125.75 148.72 48.99 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 120.719 0.295 . . . . 73.12 110.221 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.5 t -109.75 126.41 66.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 116.154 -0.476 . . . . 63.24 110.289 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 69.4 mt -94.98 107.39 19.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.67 -1.233 . . . . 74.44 107.67 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.404 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 14.3 ptp -116.82 144.86 43.99 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.892 -0.41 . . . . 71.52 109.892 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.11 5.92 52.38 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.471 -1.347 . . . . 41.51 110.139 -173.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 18' ' ' HIS . 8.8 p -79.81 141.43 15.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 N-CA-C 108.107 -1.072 . . . . 73.42 108.107 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.3 p -87.97 175.78 7.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.359 -0.936 . . . . 43.03 110.452 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.2 m -65.83 -26.79 67.83 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.504 -0.771 . . . . 74.4 110.933 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.6 -41.78 53.56 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.311 -0.556 . . . . 64.5 110.781 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.581 ' HB2' HG22 ' A' ' 79' ' ' VAL . 4.9 mp0 -70.16 -28.11 65.07 Favored 'General case' 0 C--O 1.203 -1.389 0 C-N-CA 119.004 -1.078 . . . . 72.21 108.854 173.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.6 tp -58.97 -51.24 70.9 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 109.644 -0.502 . . . . 75.44 109.644 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.79 -30.83 71.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.125 0.488 . . . . 70.04 110.163 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 2.2 t-20 -63.67 -49.76 71.93 Favored 'General case' 0 C--O 1.201 -1.46 0 CA-C-N 115.349 -0.841 . . . . 74.53 111.313 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.5 mt -69.74 -34.18 73.47 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.304 -0.628 . . . . 41.03 109.304 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.585 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 33.6 t70 -63.39 -36.86 85.11 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 114.651 -1.159 . . . . 72.22 109.011 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.98 -49.98 14.21 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.783 -0.644 . . . . 74.25 111.494 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.24 -57.63 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 123.752 0.821 . . . . 65.42 113.171 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -80.22 -26.67 39.03 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.415 0.626 . . . . 74.2 111.481 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -59.49 -16.08 34.83 Favored Glycine 0 N--CA 1.461 0.328 0 CA-C-N 114.693 -1.139 . . . . 72.3 115.909 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -57.47 -34.21 68.79 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 117.519 0.66 . . . . 62.12 111.833 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -131.95 -0.69 3.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.758 0.651 . . . . 73.23 112.758 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -122.91 166.35 15.19 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.584 -0.28 . . . . 72.3 110.246 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -122.6 142.72 50.33 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.488 -0.56 . . . . 73.44 109.488 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.443 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 15.6 ttp85 -87.01 114.63 23.78 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.765 -0.652 . . . . 74.43 110.153 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.451 HG11 ' CE ' ' A' ' 117' ' ' MET . 35.0 m -128.17 162.42 34.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.284 -0.871 . . . . 75.55 110.89 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -101.24 131.75 47.09 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.215 -0.661 . . . . 64.25 109.215 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.82 166.77 25.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 116.182 -0.463 . . . . 51.53 111.065 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.23 117.97 5.92 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 111.013 -0.835 . . . . 62.41 111.013 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.404 HD11 ' HE2' ' A' ' 111' ' ' MET . 2.7 pp -112.7 157.17 13.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.532 -0.544 . . . . 71.12 109.532 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.36 127.47 75.44 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 N-CA-C 107.89 -1.152 . . . . 71.41 107.89 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.464 ' HD2' HG21 ' A' ' 43' ' ' VAL . 60.7 mtm180 -71.48 141.83 50.2 Favored 'General case' 0 CA--C 1.489 -1.37 0 C-N-CA 119.501 -0.88 . . . . 72.02 110.151 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.24 5.6 25.96 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.303 -0.862 . . . . 73.41 111.042 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -94.02 -29.45 15.21 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.64 -0.709 . . . . 73.41 109.942 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.458 ' HB2' ' OE2' ' A' ' 109' ' ' GLU . 2.5 m-20 -118.9 -121.46 0.3 Allowed 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 108.487 -0.931 . . . . 65.33 108.487 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.3 m -167.03 17.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.485 1.914 . . . . 75.43 107.236 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -105.43 157.84 17.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.646 -0.706 . . . . 73.44 111.735 -174.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -106.08 147.28 29.12 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.173 0.511 . . . . 45.41 110.743 -177.25 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.404 ' HE2' HD11 ' A' ' 102' ' ' ILE . 36.9 mtm -132.23 162.85 29.93 Favored 'General case' 0 CA--C 1.47 -2.134 0 CA-C-N 115.056 -0.975 . . . . 75.12 108.451 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.41 126.77 53.26 Favored 'General case' 0 C--N 1.249 -3.77 0 CA-C-N 114.853 -1.067 . . . . 54.53 108.851 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 21' ' ' PHE . 32.6 m -139.0 173.01 12.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.617 -0.512 . . . . 74.35 109.617 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 3.6 mptp? -97.99 149.51 22.37 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.252 -1.018 . . . . 74.22 108.252 175.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.6 t -152.41 172.23 16.82 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.185 -1.043 . . . . 73.31 108.185 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 97' ' ' ARG . 96.6 m-85 -108.45 111.07 22.76 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-O 121.745 0.783 . . . . 74.33 110.191 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.469 ' HB3' ' HE2' ' A' ' 117' ' ' MET . 56.9 ttp -105.37 146.63 29.18 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.321 -1.309 . . . . 64.42 109.04 -174.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 65.8 t-105 -74.96 132.78 41.65 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.146 -1.427 . . . . 75.4 107.146 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.5 mp -71.85 -41.87 69.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 120.428 -0.509 . . . . 71.42 111.189 -171.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -89.3 94.34 9.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.62 0.724 . . . . 54.5 110.729 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -81.68 12.03 4.25 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.538 -0.755 . . . . 74.34 111.291 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.25 22.54 7.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.739 -0.664 . . . . 60.41 110.047 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.54 121.29 78.45 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 109.889 -0.411 . . . . 74.22 109.889 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.97 -0.51 9.21 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.572 2.181 . . . . 60.24 113.769 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -96.61 -37.31 10.41 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 120.675 -0.41 . . . . 53.12 112.073 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.668 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 25.7 ptt? . . . . . 0 C--N 1.313 -1.015 0 N-CA-C 112.17 0.433 . . . . 54.55 112.17 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.581 ' O ' HG12 ' A' ' 144' ' ' ILE . 22.7 ptmt . . . . . 0 C--O 1.201 -1.453 0 N-CA-C 110.038 -0.356 . . . . 74.24 110.038 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -48.85 -39.26 24.99 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.411 1.084 . . . . 63.35 111.107 -175.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.54 -44.45 85.17 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.083 0.468 . . . . 72.53 110.698 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.0 -35.58 59.52 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.14 -0.689 . . . . 74.11 109.14 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 140' ' ' LYS . 45.9 mm -60.99 -32.61 52.98 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.708 0 CA-C-N 115.615 -0.72 . . . . 60.35 110.848 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 43.9 mt-10 -55.08 -44.57 74.98 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.917 -0.313 . . . . 72.31 111.39 176.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.465 ' O ' HG13 ' A' ' 150' ' ' ILE . 9.9 t -80.19 -36.73 34.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 119.828 -0.749 . . . . 72.24 110.342 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.494 ' O ' ' HG2' ' A' ' 151' ' ' MET . 54.8 m-85 -66.94 -30.68 70.88 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.942 1.089 . . . . 74.15 113.942 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 87.8 tttt -62.08 -36.95 83.22 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.132 -1.062 . . . . 51.43 108.132 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 146' ' ' THR . 86.5 tttt -74.05 -37.89 64.14 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.425 -1.261 . . . . 63.14 109.526 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 146' ' ' THR . 83.6 mt -67.02 -33.76 65.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.756 -0.656 . . . . 71.23 110.206 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 26.3 mmt -66.33 -30.46 70.87 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.009 -0.367 . . . . 73.54 110.009 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 23.1 mm-40 -72.31 -30.52 64.87 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.988 -0.551 . . . . 73.34 109.647 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 66.6 m -70.65 -31.46 68.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.403 0.62 . . . . 74.32 109.608 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 95.5 mttt . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 72.44 109.514 175.786 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 17' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.406 -2.63 0 N-CA-C 107.748 -1.205 . . . . 60.1 107.748 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.584 ' O ' HG12 ' A' ' 79' ' ' VAL . 39.7 m-70 -112.5 159.32 18.9 Favored 'General case' 0 C--N 1.262 -3.233 0 N-CA-C 108.085 -1.08 . . . . 73.04 108.085 -173.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.442 ' HB2' HG12 ' A' ' 113' ' ' VAL . 46.3 m-20 -117.04 125.83 51.92 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.108 -1.441 . . . . 73.33 107.108 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.2 t -119.38 137.72 52.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 110.391 -0.225 . . . . 70.12 110.391 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.482 ' HB2' HG21 ' A' ' 113' ' ' VAL . 70.1 t80 -94.91 122.08 37.17 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.442 -0.948 . . . . 61.03 108.442 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -103.2 105.71 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.224 1.011 . . . . 63.42 111.135 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.487 ' HB2' HD11 ' A' ' 63' ' ' ILE . 43.2 p90 -72.08 -18.87 61.89 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.003 -1.453 . . . . 74.44 114.272 -173.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.72 -40.22 0.3 Allowed Glycine 0 CA--C 1.499 -0.921 0 C-N-CA 118.979 -1.581 . . . . 72.43 112.947 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -58.06 -36.49 72.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.869 0.467 . . . . 53.04 112.189 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.661 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 49.3 m-85 -134.75 37.35 3.08 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.472 0.654 . . . . 51.11 109.435 -176.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -86.18 -4.78 59.24 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.6 -0.727 . . . . 43.45 110.962 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -105.8 121.12 46.92 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 109.381 -0.6 . . . . 74.21 109.381 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 11.7 Cg_endo -56.89 -31.53 89.48 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.159 2.573 . . . . 65.44 113.934 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.03 -33.64 74.98 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.409 0.624 . . . . 63.32 109.973 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.28 -39.15 82.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.172 -0.922 . . . . 64.42 108.792 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.562 HG23 HD21 ' A' ' 36' ' ' LEU . 44.5 mm -62.56 -37.41 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.285 -0.871 . . . . 71.24 110.361 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -53.87 -50.17 66.88 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.57 0.7 . . . . 73.42 110.287 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.85 -44.9 19.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 114.222 1.194 . . . . 72.03 114.222 -173.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.661 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 5.9 tmm? -62.33 -36.55 82.52 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.06 0.457 . . . . 74.34 110.707 -173.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.562 HD21 HG23 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -116.71 -75.13 0.58 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 120.491 -0.484 . . . . 71.34 111.926 178.241 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.9 t70 173.18 -47.74 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.292 0.568 . . . . 72.32 111.116 -175.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HD2' ' OE2' ' A' ' 83' ' ' GLU . 4.6 ptp180 -126.57 164.47 21.15 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.507 -0.769 . . . . 72.31 109.75 -174.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.6 m -124.63 108.87 28.6 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-O 120.59 0.233 . . . . 75.31 110.704 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -63.57 152.07 82.03 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.58 2.853 . . . . 74.14 111.768 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -56.51 137.56 53.14 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 123.635 0.584 . . . . 64.24 109.591 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.4 mt -115.59 137.33 49.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 116.297 -0.41 . . . . 74.54 111.179 -170.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.3 146.46 34.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.096 -0.705 . . . . 73.53 109.096 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 m -77.0 127.37 32.57 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.085 -0.709 . . . . 64.53 109.085 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' A' ' 102' ' ' ILE . . . -143.58 159.41 42.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.208 0.528 . . . . 74.42 111.994 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.4 m -119.45 131.89 55.7 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.585 -0.734 . . . . 54.51 110.779 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -101.6 103.41 27.67 Favored Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-N 115.55 -0.75 . . . . 54.4 109.484 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.2 142.61 7.48 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.241 1.96 . . . . 62.44 111.553 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.46 7.75 60.26 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.451 -0.88 . . . . 71.1 111.556 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -145.35 143.53 30.19 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 107.0 -1.481 . . . . 54.32 107.0 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.434 ' HB2' ' HA3' ' A' ' 69' ' ' GLY . 62.4 tt0 -143.04 142.82 31.67 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.705 -1.22 . . . . 74.24 107.705 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -91.21 125.83 36.11 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 119.978 -0.689 . . . . 75.51 109.542 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 11.6 m-30 -107.67 135.64 48.77 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.942 -1.026 . . . . 73.22 108.653 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 . . . . . 0 C--N 1.288 -2.097 0 CA-C-O 121.774 0.797 . . . . 63.35 112.525 -175.464 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 107.895 -1.15 . . . . 63.14 107.895 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 9.7 Cg_exo -72.19 99.91 1.06 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 121.529 1.486 . . . . 71.31 108.758 171.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.496 ' SG ' ' HG2' ' A' ' 126' ' ' MET . 27.7 p -105.36 160.01 15.46 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.039 -0.528 . . . . 73.04 112.054 -172.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 23' ' ' TYR . 48.8 mm -94.64 125.08 47.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.764 -0.653 . . . . 61.32 109.656 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.13 146.94 63.22 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.54 -0.541 . . . . 74.41 109.54 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.32 104.91 0.27 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.653 2.235 . . . . 63.22 112.573 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -125.47 108.12 11.32 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.945 -1.132 . . . . 71.54 107.945 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.27 -27.25 68.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.946 0.403 . . . . 74.2 111.807 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -90.62 8.09 36.0 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.151 -0.477 . . . . 74.51 111.447 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 51' ' ' GLN . . . -129.23 171.35 20.02 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.791 -1.195 . . . . 43.31 114.103 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.8 143.65 17.3 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.231 1.012 . . . . 73.53 108.483 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.439 HG21 HD12 ' A' ' 63' ' ' ILE . 57.5 t -114.18 122.9 69.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.772 -0.455 . . . . 63.03 109.772 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -95.46 116.31 28.63 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.938 -1.134 . . . . 74.52 107.938 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.453 ' C ' ' HD3' ' A' ' 74' ' ' LYS . . . -148.47 -155.43 6.67 Favored Glycine 0 N--CA 1.415 -2.711 0 C-N-CA 120.242 -0.98 . . . . 63.54 111.558 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 2.7 mppt? -122.56 149.2 44.28 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 112.916 0.709 . . . . 44.25 112.916 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.1 t -110.2 129.21 65.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-N 113.99 -1.459 . . . . 73.04 111.552 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.429 HD23 HG12 ' A' ' 42' ' ' ILE . 83.0 mt -95.68 108.37 20.66 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.127 -1.435 . . . . 62.23 107.127 175.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.8 ptp -111.49 147.53 35.12 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 120.922 0.392 . . . . 73.42 111.459 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.65 17.12 53.41 Favored Glycine 0 N--CA 1.42 -2.384 0 C-N-CA 119.533 -1.318 . . . . 72.03 111.311 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 18' ' ' HIS . 9.5 p -80.72 132.29 31.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.028 -0.73 . . . . 71.14 109.028 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -75.75 159.91 30.57 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 108.464 -0.939 . . . . 72.21 108.464 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.4 m -59.32 -26.6 65.16 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 112.547 0.573 . . . . 73.21 112.547 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -70.87 -47.22 60.44 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.036 0.446 . . . . 64.03 110.766 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 1.2 mp0 -68.7 -28.79 67.16 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.153 -0.684 . . . . 74.24 109.153 176.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.515 ' HG ' ' NH2' ' A' ' 97' ' ' ARG . 42.1 tp -62.77 -50.85 69.4 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 120.882 0.372 . . . . 71.14 110.345 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.82 -29.8 70.33 Favored 'General case' 0 C--O 1.208 -1.106 0 N-CA-C 109.687 -0.486 . . . . 61.12 109.687 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 16.9 t-20 -59.16 -47.86 83.76 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.627 0.771 . . . . 70.3 109.964 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.544 ' HA ' HG12 ' A' ' 90' ' ' VAL . 97.5 mt -64.65 -37.01 86.11 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.225 -0.898 . . . . 71.31 111.27 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.543 ' HB2' ' NH2' ' A' ' 97' ' ' ARG . 19.1 t70 -73.54 -30.7 63.24 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 121.211 0.529 . . . . 72.31 110.096 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.24 -46.56 64.19 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.051 0.453 . . . . 75.13 110.323 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 87' ' ' LEU . 13.6 p -72.35 -50.56 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.531 0 CA-C-N 115.819 -0.628 . . . . 63.33 112.325 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -77.85 -30.29 50.87 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 112.731 0.641 . . . . 71.44 112.731 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.02 -17.36 22.45 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 114.704 0.641 . . . . 63.13 114.704 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.56 -37.4 81.16 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 122.132 0.173 . . . . 52.23 110.54 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.53 -9.57 3.63 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.39 0.515 . . . . 52.13 112.39 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -126.28 167.38 15.56 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.281 -0.262 . . . . 72.22 111.076 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 38.4 tt0 -123.7 146.39 48.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.444 -0.576 . . . . 43.44 109.444 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.543 ' NH2' ' HB2' ' A' ' 88' ' ' ASP . 34.4 ttm180 -89.41 128.74 35.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.759 0.314 . . . . 71.43 110.838 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 m -133.08 162.34 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.023 0 CA-C-N 115.894 -0.594 . . . . 70.12 111.42 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.5 t -103.72 124.04 48.15 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 114.972 -1.013 . . . . 71.11 108.272 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.29 165.21 32.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 116.213 -0.449 . . . . 63.33 111.419 -173.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.35 123.68 7.88 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.982 -0.847 . . . . 61.51 110.982 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.443 HD13 ' HB1' ' A' ' 45' ' ' ALA . 2.7 pp -117.42 165.1 13.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 110.244 -0.28 . . . . 70.52 110.244 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 80.6 t -128.25 125.83 64.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.554 -0.535 . . . . 54.53 109.554 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.619 ' HB3' ' OD1' ' A' ' 106' ' ' ASP . 34.4 mtp180 -64.71 128.55 36.26 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 124.369 1.068 . . . . 74.3 111.845 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -71.36 -18.62 62.36 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.482 0.713 . . . . 60.02 110.952 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.619 ' OD1' ' HB3' ' A' ' 104' ' ' ARG . 7.8 p-10 -78.51 -41.61 31.89 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.113 -0.494 . . . . 74.21 112.237 -173.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -143.79 16.45 1.78 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.188 0.81 . . . . 73.31 113.188 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.9 m 68.0 14.62 9.39 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.99 1.107 . . . . 74.32 113.99 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -75.59 145.85 40.84 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.052 -0.405 . . . . 61.31 110.905 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -96.51 147.78 23.49 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.165 -0.47 . . . . 73.11 109.895 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.411 ' HE2' HD11 ' A' ' 102' ' ' ILE . 35.4 mtm -145.43 163.15 35.52 Favored 'General case' 0 CA--C 1.473 -1.99 0 CA-C-O 121.306 0.574 . . . . 74.11 110.347 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.84 123.03 48.41 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 114.31 -1.314 . . . . 75.42 108.435 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.7 m -132.96 169.66 21.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.232 0.539 . . . . 64.24 111.446 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -103.87 134.15 47.65 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.72 -1.215 . . . . 73.03 107.72 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.4 t -135.92 171.11 14.94 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.832 -0.803 . . . . 75.23 108.832 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.0 m-85 -121.51 125.88 47.87 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.824 -0.806 . . . . 74.54 108.824 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.39 157.97 41.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.348 -0.387 . . . . 74.44 110.121 -176.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.469 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 61.1 t-105 -67.54 130.94 44.62 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.188 0.595 . . . . 74.2 109.88 -175.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.5 mp -73.57 -44.19 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 112.252 0.464 . . . . 71.52 112.252 -172.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -67.35 -43.63 81.03 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.42 -0.585 . . . . 51.13 109.42 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? 51.07 17.97 0.51 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.158 1.783 . . . . 71.54 113.968 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.34 1.73 5.7 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.422 0.527 . . . . 63.21 112.422 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.22 121.46 56.07 Favored Pre-proline 0 N--CA 1.483 1.217 0 N-CA-C 111.649 0.24 . . . . 64.24 111.649 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.24 -17.79 50.21 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.568 2.179 . . . . 54.44 111.41 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.82 -41.08 73.69 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.137 -0.938 . . . . 71.43 110.754 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.496 ' HG2' ' SG ' ' A' ' 62' ' ' CYS 0.329 0.0 OUTLIER . . . . . 0 N--CA 1.419 -1.979 0 CA-C-O 122.809 1.29 . . . . 72.23 113.106 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.606 ' O ' HG12 ' A' ' 144' ' ' ILE . 64.9 tttm . . . . . 0 N--CA 1.462 0.174 0 N-CA-C 109.775 -0.454 . . . . 70.43 109.775 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.1 mmmt -54.67 -40.31 68.93 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 114.206 1.187 . . . . 71.1 114.206 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -55.44 -43.48 75.44 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.542 1.163 . . . . 73.22 109.507 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -73.9 -35.27 64.64 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 113.719 -1.582 . . . . 74.23 109.192 -175.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 140' ' ' LYS . 33.4 mm -72.19 -38.65 63.1 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.054 0 CA-C-N 115.747 -0.661 . . . . 64.55 110.831 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 17.1 mm-40 -59.69 -32.43 70.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.227 0.537 . . . . 73.31 110.471 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.2 m -70.29 -47.21 62.21 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.021 -0.991 . . . . 74.41 108.904 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -71.06 -28.62 64.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.412 1.264 . . . . 64.15 114.412 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -57.75 -38.07 74.73 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.751 -1.203 . . . . 61.43 107.751 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -71.46 -28.83 64.22 Favored 'General case' 0 C--O 1.227 -0.09 0 CA-C-N 115.742 -0.663 . . . . 73.01 110.459 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.426 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 68.3 mt -72.62 -31.31 36.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.664 -0.698 . . . . 74.3 109.453 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 65.0 mtt -63.36 -41.16 98.81 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.667 -0.864 . . . . 64.14 108.667 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -61.68 -35.92 79.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.092 -0.958 . . . . 74.54 110.045 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 84.3 m -67.41 -31.25 71.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.667 -0.697 . . . . 64.34 111.431 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 74.7 mmtt . . . . . 0 C--O 1.236 0.346 0 N-CA-C 108.362 -0.977 . . . . 64.23 108.362 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.41 -2.443 0 N-CA-C 108.406 -0.961 . . . . 73.4 108.406 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.514 ' O ' HG12 ' A' ' 79' ' ' VAL . 47.3 m-70 -114.0 159.99 19.34 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 115.785 -0.643 . . . . 73.3 110.043 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 77' ' ' MET . 17.0 p30 -130.31 128.22 41.07 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.905 -1.043 . . . . 73.44 111.483 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.7 t -127.53 142.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.771 -1.104 . . . . 44.31 109.516 -174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -93.81 123.23 37.01 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.582 -1.266 . . . . 74.15 107.582 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -96.8 136.98 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-O 121.285 0.564 . . . . 75.11 111.54 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.49 ' HD2' ' O ' ' A' ' 61' ' ' PRO . 24.1 p90 -109.27 -50.2 3.03 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.817 1.043 . . . . 64.22 113.817 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -151.43 -49.83 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 118.093 -2.003 . . . . 31.21 115.411 -174.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.8 m -58.88 -37.02 75.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.583 0.692 . . . . 42.45 111.559 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.659 ' HB3' HD11 ' A' ' 32' ' ' ILE . 36.6 m-85 -119.76 37.67 4.13 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.898 -0.592 . . . . 74.14 110.763 -176.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.41 23.14 0.07 Allowed 'General case' 0 CA--C 1.576 1.943 0 CA-C-O 121.647 0.737 . . . . 71.04 110.754 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 26' ' ' PHE . 25.9 t70 -150.15 129.97 6.64 Favored Pre-proline 0 C--N 1.308 -1.229 0 C-N-CA 123.707 0.803 . . . . 72.45 109.321 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.553 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 63.5 Cg_endo -73.22 -24.48 16.8 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.233 1.956 . . . . 74.03 113.177 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.85 -38.65 83.41 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.78 0.324 . . . . 73.12 110.969 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.22 -28.93 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.108 0.48 . . . . 74.01 110.044 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 26' ' ' PHE . 37.1 mm -58.99 -37.78 69.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.918 -0.583 . . . . 64.31 110.258 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -53.83 -44.51 70.32 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.688 0.756 . . . . 64.12 110.342 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.58 -41.88 17.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 114.701 -1.136 . . . . 73.53 113.256 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.524 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.5 tmm? -65.95 -37.48 86.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.871 -0.332 . . . . 74.45 111.14 -171.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.583 HD21 HG23 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -116.88 -66.74 1.05 Allowed 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.656 -0.818 . . . . 71.45 111.383 176.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 27.6 t70 167.51 -52.22 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 123.785 0.678 . . . . 72.35 109.47 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -108.52 164.1 12.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.198 -0.91 . . . . 72.35 109.619 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 m -114.0 106.01 53.77 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 108.514 -0.921 . . . . 64.22 108.514 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.86 151.56 32.47 Favored 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 123.397 2.731 . . . . 64.42 111.952 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -64.62 128.68 36.83 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.306 -0.998 . . . . 64.43 108.306 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 38.3 mt -109.28 136.65 44.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 116.02 -0.536 . . . . 72.51 110.1 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.71 146.13 34.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.059 -0.519 . . . . 65.54 109.711 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.5 m -76.35 126.18 30.53 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.769 -0.826 . . . . 65.22 108.769 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.4 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -140.12 156.04 46.73 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.623 0.725 . . . . 63.31 111.156 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.459 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 57.3 m -113.5 126.71 55.62 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.336 -0.847 . . . . 63.24 108.972 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 50' ' ' PHE . 45.5 tp -100.21 101.03 13.12 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 109.507 -0.553 . . . . 74.52 109.507 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 46' ' ' THR . 77.9 Cg_endo -86.99 144.12 7.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.383 2.056 . . . . 71.03 111.828 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.14 5.74 62.09 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.234 -0.747 . . . . 65.54 111.234 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.553 ' HA ' ' H ' ' A' ' 66' ' ' SER . 90.0 m-85 -144.23 152.23 40.55 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 107.664 -1.236 . . . . 74.05 107.664 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -139.65 145.78 38.88 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 108.653 -0.869 . . . . 61.51 108.653 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -90.69 132.15 35.96 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.614 -0.721 . . . . 74.52 109.552 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.63 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 3.8 m-85 -107.04 133.57 51.47 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 107.388 -1.338 . . . . 72.21 107.388 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 . . . . . 0 C--N 1.273 -2.749 0 CA-C-N 114.237 -1.347 . . . . 73.05 113.296 -167.139 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 109.721 -0.474 . . . . 75.34 109.721 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 35.7 Cg_exo -61.73 103.98 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.129 1.886 . . . . 62.31 110.799 175.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 12.9 p -111.21 151.65 28.0 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.357 -0.838 . . . . 72.4 110.515 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.1 mm -93.98 139.25 18.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.405 -0.591 . . . . 54.35 109.405 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -142.48 151.46 57.74 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 107.948 -1.13 . . . . 72.33 107.948 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.532 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 34.3 Cg_endo -66.8 104.81 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.554 2.169 . . . . 63.41 112.613 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.553 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 33.4 t -125.09 102.17 7.37 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.172 -1.788 . . . . 75.31 106.172 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -55.1 -33.21 62.62 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.767 0.655 . . . . 64.2 112.767 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.98 5.42 44.3 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.799 -0.637 . . . . 73.14 111.732 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.84 171.83 14.13 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.257 -0.973 . . . . 71.22 113.395 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.67 149.1 24.88 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.791 1.236 . . . . 72.12 107.97 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.05 124.77 70.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.965 -0.383 . . . . 60.22 109.965 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -93.17 114.71 27.28 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.598 -1.26 . . . . 65.14 107.598 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.499 ' C ' ' HD2' ' A' ' 74' ' ' LYS . . . -146.96 -155.56 6.59 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 109.808 -1.317 . . . . 64.55 109.808 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.499 ' HD2' ' C ' ' A' ' 73' ' ' GLY . 14.0 mptt -127.22 152.21 47.68 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.815 0.817 . . . . 45.42 112.494 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 46.9 t -110.27 128.7 66.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 113.83 -1.532 . . . . 51.31 111.155 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 72.1 mt -96.59 109.99 22.49 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.719 -1.215 . . . . 63.03 107.719 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.51 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 17.0 ptp -121.67 151.25 40.66 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.571 0.224 . . . . 61.04 110.995 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.98 13.27 37.39 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 119.669 -1.253 . . . . 73.44 111.525 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.3 p -85.37 136.32 23.05 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 108.946 -0.761 . . . . 64.44 108.946 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 m -74.05 159.44 32.66 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.265 -0.642 . . . . 71.55 109.265 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -59.06 -38.37 79.25 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.575 0.584 . . . . 75.43 112.575 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.17 -48.72 80.54 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.547 0.689 . . . . 71.32 110.23 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 86' ' ' ASN . 38.8 mt-10 -69.21 -31.58 70.25 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 114.947 -1.024 . . . . 62.12 109.259 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.415 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.0 tm? -62.67 -40.16 96.19 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.449 -0.575 . . . . 64.54 109.449 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.58 -29.5 63.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.143 -0.481 . . . . 63.11 109.954 176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -67.59 -42.07 83.08 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.765 -0.652 . . . . 73.44 111.009 176.383 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.466 HD23 ' HE1' ' A' ' 35' ' ' MET . 97.2 mt -61.42 -43.6 98.59 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.962 -0.755 . . . . 72.11 108.962 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 28.3 t70 -64.94 -34.09 77.58 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.013 -0.994 . . . . 55.42 110.521 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.5 -44.01 68.49 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.025 -0.534 . . . . 64.24 111.024 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.4 t -72.71 -57.36 7.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 112.911 0.708 . . . . 73.43 112.911 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.45 -22.77 50.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.338 0.59 . . . . 51.04 111.397 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -63.07 -15.95 56.96 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.2 -0.909 . . . . 70.34 114.979 -177.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -68.01 -45.75 73.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.629 0.715 . . . . 63.31 112.237 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.27 -10.4 12.72 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.395 -0.522 . . . . 63.1 111.8 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -125.6 167.1 15.54 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.61 -0.885 . . . . 71.14 108.61 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 35.0 tt0 -123.19 145.92 48.23 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.175 -0.676 . . . . 74.31 109.175 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -87.08 114.5 23.74 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.87 -0.789 . . . . 73.34 108.87 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.5 m -120.99 160.42 21.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 116.117 -0.492 . . . . 51.2 110.052 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.1 t -99.81 127.28 45.98 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.484 -0.932 . . . . 72.22 108.484 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.89 172.06 16.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.192 -0.458 . . . . 71.33 111.489 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -115.32 128.64 8.17 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.499 -0.64 . . . . 62.43 111.499 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.12 161.95 16.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 123.132 0.573 . . . . 72.44 110.144 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 51.1 t -121.63 123.84 70.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 106.73 -1.581 . . . . 72.21 106.73 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.674 ' HD3' ' SD ' ' A' ' 111' ' ' MET . 12.4 mtm180 -79.15 135.62 36.87 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.054 -1.059 . . . . 75.0 110.327 -175.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.61 12.44 5.77 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 122.919 1.342 . . . . 70.01 108.131 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 104' ' ' ARG . 10.1 t70 -89.32 -53.07 4.72 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 126.564 1.946 . . . . 72.3 111.201 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -138.43 7.23 2.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.21 -0.45 . . . . 64.51 112.018 -174.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.3 t 71.57 8.68 6.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.211 1.004 . . . . 72.52 112.541 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -85.51 148.4 25.98 Favored 'General case' 0 CA--C 1.492 -1.264 0 C-N-CA 120.73 -0.388 . . . . 71.03 110.228 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 64.0 pttt -98.93 140.99 32.26 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-N 115.753 -0.658 . . . . 71.02 109.762 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.674 ' SD ' ' HD3' ' A' ' 104' ' ' ARG . 87.9 mtp -134.81 161.16 35.97 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.171 -0.922 . . . . 72.31 111.269 -175.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.11 130.05 50.15 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.632 -1.167 . . . . 64.1 109.092 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.0 m -141.5 174.03 7.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 108.43 -0.952 . . . . 75.22 108.43 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -107.15 150.56 26.45 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.206 -0.664 . . . . 71.04 109.206 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.9 t -144.32 170.98 14.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.166 -1.05 . . . . 71.44 108.166 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 70.8 m-85 -117.54 121.52 41.19 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.536 -0.913 . . . . 71.44 108.536 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.532 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 25.7 ptt? -115.96 155.13 28.58 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.26 -0.427 . . . . 63.33 110.57 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 60.1 t-105 -73.27 124.92 26.63 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.105 0.878 . . . . 72.02 108.688 -178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.8 mp -73.49 -41.78 56.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 112.572 0.582 . . . . 71.2 112.572 -172.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -69.8 -40.52 75.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 121.002 -0.279 . . . . 72.25 111.718 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 68.99 -4.36 1.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.155 1.169 . . . . 72.12 114.155 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.87 12.84 6.28 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.094 1.516 . . . . 73.15 115.094 -171.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.47 130.7 93.26 Favored Pre-proline 0 N--CA 1.483 1.213 0 O-C-N 122.274 -0.266 . . . . 71.21 111.347 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.33 14.02 0.81 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.477 2.785 . . . . 73.24 113.888 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -89.96 -11.38 41.86 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.353 0.597 . . . . 72.2 110.496 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.784 0 CA-C-N 115.154 -0.93 . . . . 64.34 109.218 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.612 ' O ' HG12 ' A' ' 144' ' ' ILE . 86.3 tttt . . . . . 0 C--O 1.221 -0.406 0 N-CA-C 109.358 -0.608 . . . . 70.25 109.358 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -48.44 -39.69 23.66 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.806 1.642 . . . . 71.04 111.627 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.29 -40.03 95.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.843 -0.617 . . . . 54.11 111.109 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -76.19 -32.25 58.9 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.489 -0.56 . . . . 75.14 109.489 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 140' ' ' LYS . 50.7 mm -56.58 -33.42 39.56 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.757 0 CA-C-N 115.371 -0.831 . . . . 63.32 111.803 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.4 -31.25 65.64 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.229 0.468 . . . . 73.21 111.931 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.9 m -80.67 -41.94 22.9 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.941 -0.763 . . . . 73.33 108.941 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -70.88 -30.05 66.32 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 115.357 1.614 . . . . 61.44 115.357 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 60.1 mtpt -55.52 -38.69 69.56 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 117.926 0.33 . . . . 70.1 110.712 176.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -67.3 -38.79 85.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.733 0.777 . . . . 74.2 109.363 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 67.5 mt -69.94 -41.41 79.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.83 -1.077 . . . . 62.44 109.665 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 67.1 mtt -67.92 -48.53 65.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.898 -0.592 . . . . 71.01 110.978 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 37.3 mt-10 -62.12 -30.55 71.11 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 111.89 0.33 . . . . 75.12 111.89 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 42.7 t -61.46 -42.46 98.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.414 -0.357 . . . . 75.24 110.396 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 C--N 1.324 -0.5 0 C-N-CA 121.004 -0.279 . . . . 63.14 110.872 179.398 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.401 HD13 ' HA2' ' A' ' 78' ' ' GLY . 87.3 mt . . . . . 0 N--CA 1.428 -1.562 0 CA-C-O 120.913 0.387 . . . . 74.24 110.27 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -124.73 161.25 26.78 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.597 -0.89 . . . . 62.23 108.597 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 14.7 p30 -128.66 134.43 48.52 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.443 0.64 . . . . 74.21 111.81 172.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.6 142.95 41.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.419 -0.81 . . . . 74.03 110.078 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.529 ' HB2' HG21 ' A' ' 113' ' ' VAL . 76.1 t80 -94.74 122.61 37.53 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.707 -1.22 . . . . 75.02 107.707 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 m -93.16 120.03 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 CA-C-O 121.857 0.837 . . . . 71.0 110.01 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.415 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 8.2 p90 -88.48 -79.05 0.32 Allowed 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 114.629 1.344 . . . . 71.55 114.629 -172.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.93 -44.25 0.24 Allowed Glycine 0 CA--C 1.492 -1.392 0 C-N-CA 119.624 -1.275 . . . . 52.41 112.044 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 p -62.39 -36.48 82.45 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 112.358 0.503 . . . . 72.2 112.358 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 59.5 m-85 -124.67 26.66 7.11 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 112.564 0.579 . . . . 65.14 112.564 -177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 23' ' ' TYR . 28.5 pt20 -68.07 -1.05 5.17 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.208 0.818 . . . . 75.21 113.208 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 31' ' ' VAL . 20.1 t70 -129.56 138.81 33.96 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 108.755 -0.832 . . . . 74.21 108.755 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 18.9 Cg_endo -60.4 -32.9 94.48 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.296 1.998 . . . . 73.21 114.017 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.78 -35.94 81.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 120.999 -0.281 . . . . 64.53 111.641 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 28' ' ' ASP . 11.6 p -70.64 -29.83 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 119.779 -0.768 . . . . 71.41 110.153 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.2 mm -70.85 -43.52 76.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-O 122.073 0.94 . . . . 64.43 108.938 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 7.4 t-20 -54.19 -51.68 63.6 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 112.997 -1.91 . . . . 71.51 110.607 -177.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.8 p -78.09 -35.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.56 -0.746 . . . . 73.22 112.042 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.5 tmm? -67.62 -37.08 81.97 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 121.247 -0.181 . . . . 60.44 111.213 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.531 HD12 ' H ' ' A' ' 37' ' ' ASP 0.402 3.0 pp -115.0 -56.48 2.37 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 115.448 1.647 . . . . 73.43 115.448 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.531 ' H ' HD12 ' A' ' 36' ' ' LEU . 27.1 t70 162.78 -52.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.133 0.973 . . . . 71.23 109.665 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -106.64 -168.0 1.36 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.512 -1.222 . . . . 65.33 109.815 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.9 m -149.69 108.28 3.3 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 108.823 -0.806 . . . . 74.51 108.823 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 46.6 Cg_exo -59.29 150.73 72.64 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.941 2.427 . . . . 73.15 111.705 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.12 123.26 16.6 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.082 0.553 . . . . 75.31 110.449 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.582 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 51.3 mt -97.84 143.53 12.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.812 -0.631 . . . . 74.1 111.117 -173.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.509 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 14.6 p -128.94 146.75 33.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.566 -0.901 . . . . 74.04 108.566 175.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.446 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 19.0 m -77.03 123.92 27.04 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.36 -0.607 . . . . 55.32 109.36 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -140.0 157.58 45.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.784 0.802 . . . . 51.52 112.351 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 m -119.7 126.55 51.37 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.864 -1.062 . . . . 75.51 108.96 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.7 tp -98.75 104.91 27.5 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 109.747 -0.464 . . . . 70.42 109.747 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 74.7 Cg_endo -84.03 137.68 7.53 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 122.471 2.114 . . . . 41.25 112.658 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.6 11.75 56.59 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.814 -0.63 . . . . 62.52 112.748 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -140.6 161.66 37.23 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.995 -0.743 . . . . 74.41 108.995 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -139.83 146.06 38.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.802 -0.444 . . . . 73.22 109.802 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HE ' HG13 ' A' ' 71' ' ' VAL . 13.9 ptp180 -102.69 142.12 34.37 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.248 -1.019 . . . . 74.34 108.248 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 126' ' ' MET . 28.1 m-85 -113.45 135.16 54.18 Favored 'General case' 0 C--N 1.265 -3.092 0 N-CA-C 107.95 -1.13 . . . . 71.45 107.95 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 . . . . . 0 C--N 1.314 -0.959 0 C-N-CA 119.557 -0.857 . . . . 63.43 110.494 -177.38 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 109.037 -0.727 . . . . 73.1 109.037 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 18.5 Cg_endo -67.38 96.8 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.697 1.598 . . . . 74.11 109.927 173.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.0 p -100.05 166.79 10.86 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 113.299 0.851 . . . . 72.13 113.299 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 71' ' ' VAL . 45.1 mm -109.52 143.13 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 115.052 -0.977 . . . . 62.41 109.28 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.9 m -143.93 151.45 52.76 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.815 -1.18 . . . . 71.14 107.815 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 18.5 Cg_endo -60.57 133.48 48.89 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.224 1.95 . . . . 71.5 111.187 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.6 t -124.8 144.08 50.46 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 116.215 -0.448 . . . . 55.44 109.884 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -73.11 -34.43 66.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 74.05 110.363 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.9 81.07 1.88 Allowed 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.254 -0.647 . . . . 72.35 109.254 174.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.26 153.17 24.08 Favored Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 119.735 -1.222 . . . . 21.22 112.431 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.31 139.92 24.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.871 -0.789 . . . . 75.45 108.871 175.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.537 HG13 ' HE ' ' A' ' 52' ' ' ARG . 51.7 t -113.77 119.95 62.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 120.831 0.348 . . . . 73.22 110.78 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -89.33 116.4 27.51 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.689 -1.226 . . . . 73.1 107.689 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.08 -151.21 5.48 Favored Glycine 0 N--CA 1.421 -2.342 0 N-CA-C 110.939 -0.864 . . . . 55.02 110.939 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.582 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.5 mmtm -132.26 146.59 52.1 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 110.099 -0.334 . . . . 72.41 110.099 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.509 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 42.3 t -111.33 138.53 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 122.35 0.26 . . . . 73.4 111.199 175.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.453 HD23 HG12 ' A' ' 42' ' ' ILE . 82.9 mt -94.97 112.02 23.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.43 -0.952 . . . . 71.23 108.43 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 84.2 mmm -93.91 154.93 17.44 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 123.537 0.735 . . . . 71.04 111.097 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.401 ' HA2' HD13 ' A' ' 17' ' ' LEU . . . 62.32 36.08 92.56 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 114.778 -1.101 . . . . 62.11 113.436 177.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.02 127.39 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 108.816 -0.809 . . . . 53.51 108.816 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.8 p -77.65 169.93 17.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.183 -0.673 . . . . 72.2 109.183 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 34.2 t -55.25 -48.15 74.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.673 -0.24 . . . . 21.03 110.548 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.47 -37.47 75.56 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.911 0.884 . . . . 64.41 112.76 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.542 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 39.5 mt-10 -76.51 -46.27 27.35 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 116.046 -0.525 . . . . 75.34 110.198 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.419 ' C ' HD23 ' A' ' 84' ' ' LEU . 7.0 tt -68.92 -41.25 78.41 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.447 -0.501 . . . . 75.34 112.053 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 81' ' ' SER . 12.3 pt-20 -62.78 -29.8 70.98 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.414 0.626 . . . . 74.11 109.869 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -74.96 -42.61 57.3 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 114.993 -1.003 . . . . 74.41 109.553 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.8 mt -60.41 -42.47 96.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.387 0.613 . . . . 62.34 109.66 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.01 -36.33 81.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.807 -1.088 . . . . 41.2 110.04 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.36 -48.71 21.76 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.379 -0.828 . . . . 62.31 112.021 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 87' ' ' LEU . 14.4 p -63.97 -47.94 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.277 0 C-N-CA 122.36 0.264 . . . . 64.41 111.643 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.33 -19.84 52.63 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.817 0.818 . . . . 71.01 110.654 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.86 -16.34 12.12 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 116.997 1.559 . . . . 53.05 116.997 -173.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -58.64 -44.56 90.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 118.088 0.944 . . . . 52.5 112.428 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.07 -1.73 3.65 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.002 1.112 . . . . 63.3 114.002 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -113.13 157.12 22.04 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.569 -0.53 . . . . 72.53 109.569 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.513 ' HB3' HD11 ' A' ' 119' ' ' ILE . 39.2 tt0 -123.94 155.11 38.75 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.29 -1.374 . . . . 65.01 107.29 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -86.96 114.57 23.7 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.11 -1.07 . . . . 75.53 108.11 -176.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.3 m -117.32 153.76 19.12 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 120.883 -0.327 . . . . 65.24 110.162 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -95.63 132.83 40.37 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.218 -0.66 . . . . 55.41 109.218 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.75 162.76 31.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 120.964 0.411 . . . . 71.12 111.052 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.422 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -103.75 119.79 6.47 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.464 -1.055 . . . . 54.24 110.464 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 2.7 pp -111.69 158.22 12.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 110.017 -0.364 . . . . 62.33 110.017 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 99.6 t -121.23 120.58 62.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.472 -0.566 . . . . 75.35 109.472 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -62.24 137.32 58.24 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.145 -0.48 . . . . 74.32 111.244 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 43.4 mt-10 -83.38 -3.89 57.95 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.556 0.693 . . . . 74.43 110.044 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.11 -68.07 0.36 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.776 -1.102 . . . . 74.42 110.399 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -129.08 0.63 5.24 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.484 -1.234 . . . . 73.34 111.328 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m 64.34 80.46 0.23 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.048 0.928 . . . . 64.13 112.694 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 10.1 pt-20 -137.4 152.45 49.65 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.627 -1.249 . . . . 71.24 107.627 175.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 21.2 pttp -91.45 147.22 23.18 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.358 -0.608 . . . . 54.45 109.358 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 51.4 ttp -143.98 158.66 43.56 Favored 'General case' 0 N--CA 1.415 -2.225 0 N-CA-C 107.642 -1.244 . . . . 71.01 107.642 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.63 118.0 35.64 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.879 -0.328 . . . . 61.12 110.521 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.529 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.1 m -129.01 173.42 13.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 120.996 0.426 . . . . 70.23 110.287 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -101.74 143.41 31.71 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.63 -0.878 . . . . 73.32 108.63 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.8 t -143.51 171.5 14.07 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.069 -1.086 . . . . 75.24 108.069 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.407 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 62.9 m-85 -121.24 117.77 27.9 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.274 -1.01 . . . . 73.44 108.274 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.529 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 23.5 ptt? -118.04 156.4 28.67 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.796 -0.638 . . . . 74.11 110.798 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -68.78 118.96 12.41 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.239 -0.891 . . . . 70.52 108.599 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 96' ' ' GLU . 45.2 mm -72.74 -42.42 61.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.08 0.77 . . . . 64.34 113.08 -170.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -68.07 -28.61 67.52 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.197 -0.601 . . . . 65.52 110.378 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.288 9.6 ptpp? 56.38 -18.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.683 2.475 . . . . 74.21 117.683 173.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -116.66 84.21 2.1 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.459 0.647 . . . . 55.11 110.036 177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 126' ' ' MET . 10.3 m-20 -139.77 116.8 8.33 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.135 -0.939 . . . . 72.45 109.765 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -65.99 -13.6 40.6 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.54 2.16 . . . . 70.54 111.149 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.72 -34.68 74.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.118 0.967 . . . . 63.43 111.878 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.578 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.1 ptt? . . . . . 0 C--O 1.213 -0.83 0 CA-C-N 116.46 -0.336 . . . . 72.14 111.421 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.574 ' O ' HG12 ' A' ' 144' ' ' ILE . 38.7 ttpt . . . . . 0 C--O 1.211 -0.926 0 N-CA-C 110.287 -0.264 . . . . 61.13 110.287 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.556 ' HA ' ' HE2' ' A' ' 141' ' ' LYS . 0.6 OUTLIER -52.1 -31.66 31.63 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.831 0.852 . . . . 75.1 111.44 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -67.46 -44.13 79.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.029 0.918 . . . . 62.2 109.367 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.483 ' O ' HG22 ' A' ' 146' ' ' THR . 40.4 t80 -71.68 -36.44 70.62 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.817 -1.538 . . . . 63.52 110.151 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.2 mm -55.07 -32.7 27.89 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 CA-C-N 115.252 -0.885 . . . . 65.11 111.496 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -56.01 -38.48 70.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.197 0.814 . . . . 74.03 113.197 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 143' ' ' PHE . 7.6 t -77.97 -32.84 51.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.63 -0.878 . . . . 71.31 108.63 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -77.57 -33.56 53.92 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.267 -0.879 . . . . 71.34 111.094 -173.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 47.3 tttm -56.54 -42.19 78.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.343 -0.844 . . . . 64.34 110.187 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -66.89 -31.01 71.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.869 0.843 . . . . 65.12 110.34 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 73.6 mt -73.29 -47.32 46.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.185 -0.916 . . . . 73.53 109.345 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.9 ttt -64.18 -40.52 96.28 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.368 -0.833 . . . . 71.21 110.733 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 45.0 mt-10 -64.06 -29.83 70.95 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 116.451 -0.34 . . . . 75.03 111.914 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -70.83 -31.78 68.61 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.193 0.52 . . . . 74.32 109.974 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 C--O 1.241 0.655 0 N-CA-C 112.61 0.596 . . . . 73.42 112.61 -178.428 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.411 -2.422 0 N-CA-C 106.102 -1.814 . . . . 70.02 106.102 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.51 ' CD2' HD22 ' A' ' 84' ' ' LEU . 21.4 m80 -116.73 160.59 20.54 Favored 'General case' 0 C--N 1.266 -3.062 0 N-CA-C 109.244 -0.65 . . . . 74.21 109.244 -172.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 22.1 p-10 -130.74 129.39 42.44 Favored 'General case' 0 C--N 1.259 -3.335 0 CA-C-N 115.493 -0.776 . . . . 74.2 109.657 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.1 t -119.77 139.59 46.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.146 -0.934 . . . . 74.15 110.31 -173.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.437 ' HB2' HG21 ' A' ' 113' ' ' VAL . 88.7 t80 -93.89 122.34 36.27 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.303 -1.369 . . . . 54.41 107.303 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 m -104.19 129.97 55.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.551 0.691 . . . . 62.12 111.712 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -75.74 -22.01 56.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.956 -1.02 . . . . 54.22 113.238 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.04 -34.23 0.39 Allowed Glycine 0 CA--C 1.504 -0.615 0 C-N-CA 119.36 -1.4 . . . . 74.24 112.749 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.3 p -58.43 -36.6 73.89 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.213 0.605 . . . . 71.24 112.329 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -127.91 32.82 4.88 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.74 -0.664 . . . . 74.14 110.315 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -84.24 20.09 1.7 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.259 1.028 . . . . 54.03 109.647 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 31' ' ' VAL . 12.6 t70 -134.8 128.78 18.98 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.551 -1.277 . . . . 54.42 107.551 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.401 ' CB ' HG21 ' A' ' 39' ' ' THR . 34.9 Cg_endo -66.47 -32.65 39.54 Favored 'Trans proline' 0 C--O 1.219 -0.474 0 C-N-CA 121.873 1.715 . . . . 73.34 113.16 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.06 -34.7 66.42 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.555 -0.293 . . . . 72.35 111.197 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 28' ' ' ASP . 17.8 m -66.2 -29.48 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 119.852 -0.739 . . . . 62.35 109.963 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 mm -73.03 -41.35 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 122.013 0.911 . . . . 74.22 109.22 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -57.92 -39.43 77.96 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 113.732 -1.576 . . . . 73.12 110.227 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.32 -29.93 11.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.383 -0.826 . . . . 75.42 111.389 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -69.96 -31.89 69.84 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 120.982 0.42 . . . . 73.33 110.295 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.53 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.6 pt? -129.56 -69.74 0.68 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 120.282 -0.567 . . . . 71.11 112.371 172.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.53 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 26.4 t70 169.98 -48.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.149 0.976 . . . . 74.53 109.114 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -92.17 176.8 6.36 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.249 -1.341 . . . . 74.21 109.972 -176.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.401 HG21 ' CB ' ' A' ' 29' ' ' PRO . 55.1 m -149.41 124.41 4.85 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 116.341 -0.391 . . . . 55.44 110.063 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 23.7 Cg_exo -67.14 151.68 81.05 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.928 2.419 . . . . 31.42 110.69 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.42 136.18 51.26 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.638 -0.875 . . . . 74.45 108.638 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 3.5 mp -105.64 139.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 120.614 -0.434 . . . . 75.45 110.981 -172.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -131.67 146.11 34.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.83 -0.623 . . . . 71.21 109.795 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.7 m -77.74 123.34 26.58 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.213 -0.662 . . . . 75.42 109.213 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.95 157.29 47.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.489 0.661 . . . . 75.25 111.105 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 87.4 m -110.4 126.97 54.85 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.243 -0.89 . . . . 51.11 109.656 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.2 tp -102.81 97.25 8.95 Favored Pre-proline 0 N--CA 1.429 -1.511 0 N-CA-C 109.241 -0.651 . . . . 72.43 109.241 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 46' ' ' THR . 67.0 Cg_endo -83.29 143.66 11.3 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.199 1.933 . . . . 72.21 111.221 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.35 10.96 60.2 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.538 -0.839 . . . . 64.43 111.908 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -141.67 161.08 38.81 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 122.712 0.405 . . . . 72.4 110.05 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 6.5 tp-100 -140.86 149.2 41.65 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 123.068 0.23 . . . . 74.1 110.819 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.26 130.96 54.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.036 -0.728 . . . . 73.44 109.036 173.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 38.2 m-85 -108.36 135.33 49.83 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.43 -1.322 . . . . 74.33 107.43 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.42 -1.972 0 C-N-CA 117.816 -1.554 . . . . 74.44 111.491 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 N--CA 1.437 -1.118 0 N-CA-C 108.958 -0.756 . . . . 74.21 108.958 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 6.7 Cg_exo -73.78 79.38 2.27 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.587 1.525 . . . . 75.42 109.949 173.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 35.8 m -79.66 150.74 30.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.115 -0.948 . . . . 75.24 111.238 -174.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' GLN . 49.3 mm -103.8 138.99 26.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 CA-C-N 115.517 -0.765 . . . . 71.2 109.481 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.0 m -146.03 155.31 51.29 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 107.951 -1.129 . . . . 71.01 107.951 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.39 125.7 18.12 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.268 1.979 . . . . 40.14 112.55 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.3 t -124.09 128.5 49.39 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.443 -1.317 . . . . 72.01 107.443 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.27 -16.73 61.38 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 112.287 0.477 . . . . 63.5 112.287 -172.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -130.75 13.9 5.35 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.745 0.276 . . . . 61.0 111.745 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -111.42 169.63 13.33 Favored Glycine 0 C--O 1.244 0.728 0 C-N-CA 119.64 -1.267 . . . . 72.32 114.088 -175.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -154.82 138.16 15.8 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.647 -0.871 . . . . 63.52 108.647 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -113.28 122.26 67.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.792 -0.447 . . . . 70.51 109.792 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -96.05 116.81 29.53 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.255 -1.387 . . . . 62.34 107.255 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.96 -155.32 6.45 Favored Glycine 0 N--CA 1.417 -2.585 0 N-CA-C 110.912 -0.875 . . . . 71.54 110.912 -176.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -122.38 144.98 48.69 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.57 0.7 . . . . 62.4 111.939 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.0 t -111.17 131.73 61.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 114.357 -1.292 . . . . 72.22 111.319 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 81.0 mt -95.76 104.88 16.83 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.371 -0.974 . . . . 74.42 108.371 176.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 64.3 mtp -100.13 139.04 36.37 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 120.977 0.417 . . . . 75.3 111.044 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.13 18.67 10.95 Favored Glycine 0 C--N 1.29 -2.021 0 C-N-CA 120.435 -0.888 . . . . 73.32 111.637 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.676 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 88.4 t -70.3 128.17 33.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.667 -0.494 . . . . 54.53 109.667 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -77.86 167.77 20.98 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.771 -0.826 . . . . 74.53 108.771 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.3 p -64.37 -32.34 73.91 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.987 -0.685 . . . . 71.5 110.293 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.03 -51.07 51.15 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.757 -0.656 . . . . 74.33 110.058 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.676 ' OE1' ' HA ' ' A' ' 79' ' ' VAL . 44.5 tt0 -60.32 -39.57 87.52 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.727 -0.669 . . . . 73.31 110.175 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.51 HD22 ' CD2' ' A' ' 18' ' ' HIS . 42.8 tp -57.35 -51.17 70.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.102 0.477 . . . . 74.42 110.411 175.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.56 -29.27 67.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.968 -0.56 . . . . 75.23 111.326 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.429 ' O ' HG23 ' A' ' 90' ' ' VAL . 7.0 t30 -65.57 -46.3 79.98 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.935 -0.765 . . . . 53.43 108.935 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 97.1 mt -64.93 -41.06 95.85 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.388 -0.824 . . . . 60.41 109.898 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.12 -32.81 73.43 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.649 -0.705 . . . . 71.4 110.722 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.22 62.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.011 -0.541 . . . . 74.21 110.854 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 86' ' ' ASN . 99.3 t -72.27 -56.71 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 123.16 0.584 . . . . 75.51 112.319 -178.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.48 -22.76 47.02 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.041 0.448 . . . . 75.42 111.852 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.2 -17.02 36.41 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 115.519 0.967 . . . . 54.3 115.519 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.8 -45.17 93.9 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.772 0.786 . . . . 73.04 111.323 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -112.65 -9.21 13.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.44 -0.345 . . . . 73.54 111.721 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -129.74 167.48 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.58 0.228 . . . . 64.21 110.969 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 9.4 tp10 -123.08 144.65 49.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.118 -0.697 . . . . 73.04 109.118 175.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -88.12 114.14 24.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.782 -0.821 . . . . 75.53 108.782 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.51 160.54 36.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 116.316 -0.402 . . . . 64.41 110.755 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.1 t -95.41 132.08 40.85 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.626 -0.509 . . . . 74.15 109.626 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -138.11 165.17 26.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.904 -0.589 . . . . 75.5 110.759 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -104.27 123.11 7.6 Favored Glycine 0 N--CA 1.421 -2.337 0 CA-C-N 115.66 -0.7 . . . . 45.24 111.427 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 111' ' ' MET . 2.8 pp -118.18 152.78 20.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.669 -0.493 . . . . 65.43 109.669 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.8 131.47 65.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 108.49 -0.929 . . . . 35.4 108.49 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -70.52 125.65 27.42 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.444 0.465 . . . . 65.31 110.225 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.11 -4.21 46.26 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 123.208 0.317 . . . . 74.02 111.562 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.46 -60.53 3.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.1 -1.074 . . . . 62.34 108.1 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -117.79 -93.31 0.51 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.155 -1.384 . . . . 73.32 111.885 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.9 p -173.94 13.11 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.757 0.28 . . . . 74.43 111.757 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -85.02 145.43 27.7 Favored 'General case' 0 C--O 1.251 1.153 0 C-N-CA 120.302 -0.559 . . . . 70.44 111.211 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -93.72 144.66 25.2 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.901 0.857 . . . . 64.0 110.491 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.54 ' HB2' HD12 ' A' ' 102' ' ' ILE . 76.5 mmm -131.64 162.23 30.87 Favored 'General case' 0 C--N 1.275 -2.633 0 C-N-CA 124.973 1.309 . . . . 72.03 110.922 -175.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.54 126.82 53.24 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.156 -0.929 . . . . 61.31 109.073 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.457 HG12 ' CG ' ' A' ' 19' ' ' ASN . 32.7 m -141.07 173.32 9.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.742 -0.466 . . . . 74.3 109.742 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.65 151.74 22.6 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.461 -0.57 . . . . 72.44 109.461 171.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.4 t -147.28 172.04 14.48 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.696 -1.224 . . . . 73.31 107.696 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 92.1 m-85 -117.36 108.36 15.49 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.604 -0.517 . . . . 74.03 109.604 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -107.2 156.79 18.45 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.545 -0.752 . . . . 74.52 110.276 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.533 ' HD1' ' O ' ' A' ' 120' ' ' ASN . 33.7 t-105 -68.14 134.81 51.13 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 106.183 -1.784 . . . . 64.45 106.183 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.2 mp -67.81 -41.73 85.34 Favored 'Isoleucine or valine' 0 C--O 1.26 1.61 0 C-N-CA 118.894 -1.122 . . . . 71.43 110.506 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.533 ' O ' ' HD1' ' A' ' 118' ' ' TRP . 42.6 t30 -82.41 105.41 13.45 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.775 0.798 . . . . 72.31 109.353 177.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -77.24 -12.24 59.92 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.276 -0.875 . . . . 71.3 111.557 -172.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.52 76.36 1.71 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.763 -0.828 . . . . 72.33 108.763 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -93.34 130.42 35.67 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 115.115 -0.948 . . . . 41.02 108.989 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -81.0 -0.48 10.62 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.855 2.37 . . . . 73.54 114.174 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -94.23 -51.03 4.99 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 120.246 -0.582 . . . . 74.12 110.943 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 126' ' ' MET . 23.7 ptt? . . . . . 0 N--CA 1.437 -1.082 0 C-N-CA 119.334 -0.946 . . . . 71.0 110.445 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.542 ' O ' HG12 ' A' ' 144' ' ' ILE . 37.6 ttmt . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 120.924 0.392 . . . . 71.32 110.617 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 38.6 ttpt -52.78 -35.29 56.35 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.811 0.844 . . . . 74.43 112.234 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.51 -35.79 78.7 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.187 0.518 . . . . 64.15 110.307 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -76.48 -43.26 40.53 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.605 -0.887 . . . . 73.12 108.605 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.4 mm -59.54 -33.93 53.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-N 114.807 -1.088 . . . . 54.3 111.534 -176.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.2 mt-10 -54.28 -31.64 54.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.166 0.508 . . . . 75.23 111.337 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.7 m -81.09 -47.99 12.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.337 0.589 . . . . 23.13 110.868 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -76.69 -30.68 56.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 113.698 0.999 . . . . 72.34 113.698 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -56.13 -39.42 72.21 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.094 0.474 . . . . 74.03 110.778 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -71.76 -33.89 69.02 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.57 . . . . 74.13 109.848 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.2 mt -68.83 -38.76 79.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.494 -0.776 . . . . 72.45 109.497 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.8 ttt -64.68 -37.82 88.89 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.842 -0.617 . . . . 62.42 110.118 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.83 -30.89 65.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.092 -0.504 . . . . 64.02 110.514 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.2 -34.64 76.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.991 -0.55 . . . . 64.33 110.528 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 CA--C 1.507 -0.676 0 CA-C-O 121.42 0.628 . . . . 61.52 111.218 178.391 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.417 -2.09 0 N-CA-C 108.858 -0.793 . . . . 71.23 108.858 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' O ' HG12 ' A' ' 79' ' ' VAL . 48.9 m-70 -113.28 159.3 19.5 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 108.282 -1.007 . . . . 64.43 108.282 -173.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.464 ' CB ' HG12 ' A' ' 113' ' ' VAL . 36.9 m-20 -122.3 126.94 49.19 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.276 -1.379 . . . . 73.24 107.276 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -127.84 137.5 57.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 110.105 -0.332 . . . . 61.14 110.105 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.441 ' HB2' HG21 ' A' ' 113' ' ' VAL . 88.3 t80 -95.3 121.77 37.3 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.892 -0.781 . . . . 74.41 108.892 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 m -96.03 119.51 44.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 121.92 0.867 . . . . 65.51 111.019 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -74.97 -34.22 62.0 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 115.354 1.613 . . . . 72.35 115.354 -172.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.57 -50.49 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.172 0 C-N-CA 118.578 -1.772 . . . . 61.54 113.041 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.0 m -57.85 -35.62 71.18 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 122.75 0.42 . . . . 64.12 111.984 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.696 ' HB3' HD11 ' A' ' 32' ' ' ILE . 50.4 m-85 -122.95 29.23 6.87 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.47 -0.332 . . . . 70.05 110.658 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -85.78 31.02 0.62 Allowed 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.154 0.978 . . . . 74.03 109.86 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 31' ' ' VAL . 17.3 t70 -142.06 129.42 11.43 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 107.59 -1.263 . . . . 53.53 107.59 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HB3' HG21 ' A' ' 39' ' ' THR . 19.0 Cg_exo -66.92 -32.95 34.51 Favored 'Trans proline' 0 N--CA 1.478 0.573 0 C-N-CA 122.385 2.057 . . . . 52.31 112.525 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . 25.6 t70 -60.23 -40.09 88.96 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.622 -0.263 . . . . 74.31 111.247 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 28' ' ' ASP . 13.7 p -74.21 -29.45 24.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.58 -0.448 . . . . 41.35 110.182 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 26' ' ' PHE . 43.5 mm -64.88 -45.5 94.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 N-CA-C 109.89 -0.411 . . . . 75.42 109.89 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -57.08 -36.99 71.23 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.132 0.491 . . . . 51.23 111.249 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.3 t -80.24 -42.85 21.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 116.098 -0.501 . . . . 74.14 111.2 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.446 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 13.1 tmm? -69.44 -36.84 77.03 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.704 -0.225 . . . . 75.13 111.195 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 37' ' ' ASP 0.353 3.8 pp -119.66 -57.59 1.96 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 115.092 1.515 . . . . 74.34 115.092 178.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.571 ' N ' HD12 ' A' ' 36' ' ' LEU . 29.2 t70 176.09 -55.04 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.453 0.644 . . . . 75.12 110.19 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.592 ' O ' HG22 ' A' ' 32' ' ' ILE . 36.5 mmt180 -136.84 -165.05 1.67 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.175 -0.92 . . . . 74.41 108.894 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 29' ' ' PRO . 37.7 m -137.76 125.0 13.72 Favored Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 120.329 -0.549 . . . . 41.15 111.467 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.87 150.87 87.43 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.758 2.305 . . . . 62.45 109.503 172.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.39 135.94 56.58 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 113.832 1.049 . . . . 65.21 113.832 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 3.5 mp -108.4 135.51 46.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 114.054 -1.43 . . . . 64.12 111.538 -172.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG21 ' HD2' ' A' ' 104' ' ' ARG . 14.7 p -131.29 146.48 33.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.99 -0.744 . . . . 63.12 108.99 173.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m -76.74 126.97 31.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.049 0.452 . . . . 73.12 109.806 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.8 157.14 45.83 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.013 0.435 . . . . 72.14 110.942 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.0 m -112.89 126.71 55.76 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 115.192 -0.913 . . . . 61.43 110.423 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.6 tp -101.82 102.83 25.09 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 115.712 -0.676 . . . . 61.42 109.216 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.05 140.88 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.562 2.175 . . . . 74.01 112.366 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.5 4.15 62.49 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 115.733 -0.667 . . . . 73.43 111.865 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.437 ' HE2' ' SD ' ' A' ' 117' ' ' MET . 91.5 m-85 -132.01 162.04 31.71 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.734 -0.469 . . . . 75.2 109.734 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 31.0 tt0 -139.74 140.15 36.68 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.63 -0.428 . . . . 71.1 111.362 -173.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.505 ' HA ' HD13 ' A' ' 63' ' ' ILE . 11.6 ttm180 -94.51 142.83 26.98 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.749 -1.574 . . . . 75.34 106.749 177.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -106.82 168.89 8.88 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 116.167 -0.47 . . . . 75.52 110.376 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 . . . . . 0 C--N 1.284 -2.261 0 N-CA-C 107.657 -1.238 . . . . 74.53 107.657 -175.803 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.019 -0.734 . . . . 74.12 109.019 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.49 96.82 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.196 1.931 . . . . 64.11 111.52 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 26.3 p -102.0 177.37 4.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.812 -0.631 . . . . 75.22 109.924 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 52' ' ' ARG . 47.1 mm -124.53 131.29 72.94 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 109.456 -0.572 . . . . 74.2 109.456 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -142.2 153.24 62.96 Favored Pre-proline 0 C--N 1.286 -2.163 0 N-CA-C 107.253 -1.388 . . . . 74.33 107.253 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.503 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 11.7 Cg_endo -59.97 137.0 73.26 Favored 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 122.198 1.932 . . . . 70.53 111.509 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 51' ' ' GLN . 30.1 t -124.99 147.79 48.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.353 -0.61 . . . . 54.32 109.353 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 68' ' ' LYS . 37.5 mt-10 -69.0 -36.98 78.44 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.941 -0.763 . . . . 74.04 108.941 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 67' ' ' GLU . 30.8 mmmt -134.3 80.1 1.84 Allowed 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.239 -0.891 . . . . 73.14 109.14 175.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.12 153.6 24.95 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 119.879 -1.153 . . . . 70.54 113.212 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.82 138.21 16.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.109 -1.071 . . . . 74.13 108.109 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.441 HG21 HD12 ' A' ' 63' ' ' ILE . 41.5 t -113.66 119.46 61.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.971 -0.381 . . . . 72.41 109.971 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -92.14 116.42 28.93 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.232 -2.136 . . . . 64.0 105.232 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.31 -145.33 4.4 Favored Glycine 0 N--CA 1.417 -2.582 0 C-N-CA 120.465 -0.874 . . . . 55.14 111.694 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 48.4 mmtm -129.94 141.53 50.76 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 120.747 0.308 . . . . 75.52 110.831 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 44.0 t -110.21 129.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.867 -0.606 . . . . 70.51 111.097 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.413 HD23 HG13 ' A' ' 42' ' ' ILE . 80.4 mt -96.01 111.11 23.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.296 -1.372 . . . . 64.34 107.296 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.9 ptp -117.99 149.35 41.08 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 120.66 0.267 . . . . 72.25 110.561 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.68 16.05 55.55 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.64 -1.267 . . . . 74.25 110.535 -174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.6 p -83.86 135.76 24.17 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 N-CA-C 108.302 -0.999 . . . . 72.44 108.302 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.4 p -82.96 167.0 18.38 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.31 -0.556 . . . . 72.44 110.64 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.9 m -61.05 -33.22 72.96 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.076 0.399 . . . . 75.11 112.076 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -68.31 -36.13 78.86 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.444 0.64 . . . . 74.25 110.685 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 39.1 mt-10 -78.14 -28.36 48.41 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.441 -0.948 . . . . 64.43 108.441 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.5 tp -65.9 -51.61 57.22 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.697 -0.483 . . . . 72.04 109.697 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.65 -29.03 70.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.317 0.579 . . . . 64.2 110.513 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.5 t-20 -59.86 -48.5 81.45 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.096 -0.956 . . . . 72.34 109.744 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 90' ' ' VAL . 96.7 mt -67.42 -38.99 85.46 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.15 -0.932 . . . . 63.44 110.567 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.627 ' OD1' ' HD3' ' A' ' 97' ' ' ARG . 65.7 m-20 -60.33 -45.22 94.21 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.937 -0.574 . . . . 71.32 109.801 175.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.88 -46.96 79.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.604 -0.725 . . . . 73.2 111.702 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 87' ' ' LEU . 7.9 p -72.62 -56.7 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 N-CA-C 112.999 0.74 . . . . 72.52 112.999 -177.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.11 -30.95 49.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.323 0.49 . . . . 72.52 112.323 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 95' ' ' TYR . . . -60.03 -17.26 43.7 Favored Glycine 0 N--CA 1.463 0.439 0 CA-C-N 115.769 -0.65 . . . . 64.03 114.313 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.89 -33.44 71.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.507 0.194 . . . . 61.04 110.926 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.25 -8.81 3.78 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.317 0.488 . . . . 52.43 112.317 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.409 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 69.1 m-85 -122.16 165.72 15.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.183 -0.303 . . . . 74.3 110.183 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.0 tp10 -123.12 143.24 50.12 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.845 -0.342 . . . . 63.3 110.105 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.627 ' HD3' ' OD1' ' A' ' 88' ' ' ASP . 60.5 ttp180 -87.59 114.24 24.02 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.156 -0.683 . . . . 74.33 109.156 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.72 160.34 25.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 116.179 -0.464 . . . . 71.23 111.051 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 21.8 p -90.31 122.03 32.84 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.733 -0.667 . . . . 71.43 110.074 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.88 160.7 41.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.241 0.544 . . . . 63.14 112.288 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.59 124.88 6.86 Favored Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 110.512 -1.035 . . . . 61.33 110.512 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.84 154.89 13.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 116.548 0.174 . . . . 70.1 110.587 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 97.0 t -116.84 117.86 56.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 107.445 -1.317 . . . . 65.34 107.445 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.51 ' HD3' ' SD ' ' A' ' 111' ' ' MET . 58.8 mtm180 -69.8 137.75 52.1 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 119.813 -0.755 . . . . 73.34 111.051 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -75.44 -5.68 46.24 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.083 -1.08 . . . . 74.14 108.083 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.2 -58.4 3.45 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.271 -1.332 . . . . 74.24 111.248 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.482 ' ND2' HH21 ' A' ' 104' ' ' ARG . 30.9 p-10 -126.23 3.81 7.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.037 0.755 . . . . 75.33 113.037 -173.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 t 69.6 13.85 8.24 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.29 0.636 . . . . 51.45 111.785 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -104.91 155.84 18.57 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 122.063 -0.398 . . . . 43.51 111.136 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 58.0 pttt -88.78 148.43 23.94 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.634 0.731 . . . . 34.33 111.228 -176.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.51 ' SD ' ' HD3' ' A' ' 104' ' ' ARG . 88.6 mtp -136.83 160.07 39.98 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.818 -1.083 . . . . 73.13 109.541 175.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.56 131.01 45.85 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.202 -0.908 . . . . 64.24 109.997 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.464 HG12 ' CB ' ' A' ' 19' ' ' ASN . 33.7 m -145.16 173.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.483 -0.932 . . . . 64.14 108.483 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -119.46 151.17 39.01 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.367 -0.975 . . . . 72.22 108.367 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.8 t -144.3 172.14 13.34 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.284 -0.635 . . . . 64.35 109.284 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 89.4 m-85 -116.75 108.48 15.93 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 123.847 0.717 . . . . 72.15 109.537 -177.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.503 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 22.3 ptt? -107.38 156.05 19.35 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.829 -0.623 . . . . 63.43 110.124 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -68.75 130.7 43.59 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.161 -1.052 . . . . 71.24 108.161 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.4 mp -73.7 -42.9 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 119.357 -0.937 . . . . 74.5 111.732 -173.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -84.05 93.77 8.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.78 0.8 . . . . 73.43 110.28 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -78.8 -6.13 55.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.108 -0.951 . . . . 72.51 113.167 -170.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.03 84.75 2.26 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.299 0.571 . . . . 73.41 110.179 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -133.49 120.61 15.85 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.836 -0.62 . . . . 64.4 109.767 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.17 -11.87 19.35 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.524 2.149 . . . . 71.12 113.439 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -90.63 -20.43 22.55 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 113.742 1.016 . . . . 73.3 113.742 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.6 ptt? . . . . . 0 N--CA 1.43 -1.443 0 CA-C-O 122.489 1.138 . . . . 65.44 108.667 170.908 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt . . . . . 0 C--O 1.235 0.316 0 CA-C-O 121.017 0.437 . . . . 73.1 110.679 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 61.6 tttm -50.83 -30.9 15.55 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 125.427 1.491 . . . . 71.21 112.121 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -54.5 -46.65 73.51 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.215 0.606 . . . . 71.1 110.272 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -77.49 -34.03 54.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.467 -0.788 . . . . 75.11 109.603 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 141' ' ' LYS . 50.4 mm -64.49 -33.43 62.91 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.365 0 CA-C-N 114.898 -1.046 . . . . 74.2 111.796 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 38.2 mm-40 -55.37 -34.86 64.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.236 0.541 . . . . 71.42 110.693 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.3 m -73.9 -46.38 44.92 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.842 -0.617 . . . . 64.4 109.615 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -68.35 -29.76 68.56 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 114.346 1.239 . . . . 72.44 114.346 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 88.7 tttt -54.45 -41.09 69.03 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 123.357 0.663 . . . . 74.32 110.039 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.27 -36.45 84.14 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.62 0.724 . . . . 65.21 109.457 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.46 -37.38 50.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.055 -0.975 . . . . 73.34 109.942 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 87.7 mtp -67.58 -40.41 84.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.155 -0.475 . . . . 75.33 110.634 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 51.5 mt-10 -64.95 -32.16 73.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.378 0.609 . . . . 71.42 109.77 175.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.18 -44.46 65.42 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.503 -0.771 . . . . 73.35 111.166 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.502 -0.891 0 N-CA-C 112.871 0.693 . . . . 75.11 112.871 -178.024 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.414 -2.248 0 N-CA-C 106.658 -1.608 . . . . 73.32 106.658 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -120.07 157.74 28.31 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 109.09 -0.707 . . . . 72.13 109.09 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.642 ' HA ' ' O ' ' A' ' 76' ' ' LEU 0.272 0.7 OUTLIER -126.31 125.9 43.06 Favored 'General case' 0 C--N 1.284 -2.251 0 O-C-N 124.086 0.866 . . . . 74.33 111.424 174.365 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.56 137.61 55.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 114.723 -1.126 . . . . 65.21 109.913 -173.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.554 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.6 t80 -97.97 122.9 41.64 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.518 -0.919 . . . . 65.45 108.518 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.1 m -103.27 138.01 29.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.323 0.582 . . . . 31.31 111.815 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.446 ' HB3' ' CG1' ' A' ' 63' ' ' ILE . 39.8 p90 -81.28 -15.06 56.63 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 115.015 1.487 . . . . 71.55 115.015 -175.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . 160.0 -46.9 0.41 Allowed Glycine 0 C--O 1.212 -1.247 0 C-N-CA 118.658 -1.734 . . . . 43.5 113.321 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 m -58.26 -31.63 67.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.693 0.627 . . . . 65.43 112.693 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 63.7 m-85 -123.72 31.27 5.93 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 122.253 -0.279 . . . . 73.54 111.486 -176.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HB2' ' HE2' ' A' ' 74' ' ' LYS . 0.7 OUTLIER -92.18 -1.72 56.98 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 119.254 -0.978 . . . . 65.43 112.236 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.0 t70 -99.65 123.1 49.09 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 115.375 -0.83 . . . . 63.31 109.194 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.75 -31.61 78.49 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.569 2.179 . . . . 33.01 113.366 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -67.3 -40.26 86.02 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.334 -0.617 . . . . 64.42 109.334 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.79 -37.55 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.624 -0.717 . . . . 62.43 109.87 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.528 HG23 HD21 ' A' ' 36' ' ' LEU . 44.4 mm -63.06 -44.27 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 115.777 -0.647 . . . . 73.14 110.667 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -59.47 -35.87 74.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.017 0.437 . . . . 64.41 111.15 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.09 -35.64 14.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 116.084 -0.507 . . . . 75.34 112.179 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.433 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 9.0 tmm? -75.06 -37.16 61.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 120.241 -0.584 . . . . 74.42 110.16 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.528 HD21 HG23 ' A' ' 32' ' ' ILE 0.254 0.9 OUTLIER -119.73 -62.44 1.49 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.464 1.283 . . . . 72.12 114.464 179.472 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.499 ' OD2' ' HG3' ' A' ' 38' ' ' ARG . 20.8 t70 178.67 -55.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.095 0.474 . . . . 64.43 111.398 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.499 ' HG3' ' OD2' ' A' ' 37' ' ' ASP . 88.6 mtm180 -135.75 -174.62 3.7 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.828 -0.804 . . . . 65.34 108.828 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.5 m -118.55 112.5 37.16 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 120.916 -0.313 . . . . 64.43 111.649 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.53 152.0 76.24 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 123.004 2.47 . . . . 62.13 109.293 170.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.74 118.8 5.66 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.536 0.684 . . . . 64.32 112.138 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 48.6 mt -100.12 137.49 27.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 115.242 -0.89 . . . . 60.33 109.239 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.48 146.68 33.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 109.339 -0.615 . . . . 72.3 109.339 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.9 m -77.69 130.77 37.22 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.515 -0.55 . . . . 73.42 109.515 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.23 159.23 42.66 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.463 0.542 . . . . 73.12 112.463 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.5 m -107.42 132.21 53.44 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.826 0.851 . . . . 73.02 109.816 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.427 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 45.3 tp -111.96 96.76 35.35 Favored Pre-proline 0 C--N 1.3 -1.545 0 N-CA-C 108.474 -0.935 . . . . 64.12 108.474 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.64 141.06 9.64 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.462 2.108 . . . . 73.52 112.656 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.27 10.53 59.41 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.679 -0.772 . . . . 73.32 111.713 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -139.49 159.1 42.95 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 106.796 -1.557 . . . . 75.01 106.796 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -139.49 142.07 37.33 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 120.282 -0.567 . . . . 61.23 109.859 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HB2' ' NH1' ' A' ' 54' ' ' ARG . 28.4 ptt180 -102.23 126.45 49.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.981 -0.554 . . . . 75.24 109.619 176.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.517 ' O ' ' HD2' ' A' ' 54' ' ' ARG . 91.0 m-85 -108.68 162.16 14.42 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.224 -1.028 . . . . 74.14 108.224 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 53' ' ' PHE . 3.0 mpt_? . . . . . 0 CA--C 1.485 -1.545 0 CA-C-O 121.358 0.599 . . . . 74.14 112.087 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 12.4 m-85 . . . . . 0 N--CA 1.443 -0.823 0 N-CA-C 109.882 -0.414 . . . . 70.14 109.882 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 31.7 Cg_exo -68.3 47.69 0.39 Allowed 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 124.073 3.182 . . . . 64.24 112.849 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.9 p -61.65 163.18 7.45 Favored 'General case' 0 C--O 1.252 1.233 0 C-N-CA 125.277 1.431 . . . . 64.15 114.838 -174.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 71' ' ' VAL . 49.8 mm -109.7 142.02 23.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 C-N-CA 124.917 1.287 . . . . 74.54 108.584 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 118' ' ' TRP . 26.9 m -148.19 154.66 42.79 Favored Pre-proline 0 C--N 1.309 -1.189 0 N-CA-C 107.654 -1.239 . . . . 73.3 107.654 171.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.2 111.33 1.99 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.226 1.951 . . . . 54.34 112.042 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 t -124.89 135.98 53.37 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.228 -0.656 . . . . 63.03 109.228 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' A' ' 67' ' ' GLU . 10.3 mp0 -73.17 -21.76 60.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.986 0.422 . . . . 71.21 110.005 -176.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -100.24 5.64 44.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.904 -0.589 . . . . 63.14 112.339 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -132.24 177.13 18.96 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 118.18 -1.962 . . . . 64.51 115.094 -174.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.48 ' OE2' ' HD3' ' A' ' 140' ' ' LYS . 14.3 pt-20 -156.82 143.4 18.37 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 104.409 -2.441 . . . . 62.22 104.409 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 63' ' ' ILE . 47.0 t -113.56 119.75 61.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 C-N-CA 120.173 -0.611 . . . . 70.51 110.316 -176.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -98.66 115.43 28.67 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 119.466 -0.894 . . . . 72.2 108.686 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.22 -157.79 7.39 Favored Glycine 0 N--CA 1.418 -2.564 0 C-N-CA 120.379 -0.915 . . . . 75.33 111.002 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HE2' ' HB2' ' A' ' 27' ' ' GLN . 3.1 mppt? -122.72 148.34 45.43 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 113.263 0.838 . . . . 73.34 113.263 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.5 t -111.01 131.87 61.04 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 113.643 -1.617 . . . . 64.11 110.951 178.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 68.8 mt -95.63 107.74 19.96 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.434 -0.95 . . . . 75.43 108.434 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 61.2 mtp -103.63 155.68 18.37 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.657 -0.498 . . . . 71.23 109.657 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.45 16.24 66.87 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.083 -1.056 . . . . 72.04 111.47 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 83' ' ' GLU . 86.7 t -72.1 120.12 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 109.457 -0.571 . . . . 63.41 109.457 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.5 p -74.03 163.52 27.78 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.464 -0.939 . . . . 73.41 108.464 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 p -55.15 -36.94 66.35 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 112.151 0.426 . . . . 61.44 112.151 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.76 -51.51 69.45 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.554 0.742 . . . . 74.43 111.038 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.51 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.8 mt-10 -67.95 -35.48 78.48 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.914 0.886 . . . . 71.05 109.342 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.89 -49.66 75.96 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.287 -0.635 . . . . 73.4 109.287 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.63 -33.52 75.13 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-O 121.05 0.453 . . . . 71.52 109.888 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.484 ' O ' HG23 ' A' ' 90' ' ' VAL . 43.9 t-20 -60.34 -48.97 79.47 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.411 1.085 . . . . 74.11 109.22 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.2 mt -66.86 -42.76 85.15 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.111 -0.495 . . . . 75.42 110.511 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.26 -31.96 73.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.203 -0.908 . . . . 73.43 110.676 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.86 -45.37 51.45 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.491 -0.777 . . . . 52.14 110.904 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 86' ' ' ASN . 99.4 t -65.23 -56.99 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.441 -0.345 . . . . 63.23 111.487 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -77.95 -22.54 49.37 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.83 0.678 . . . . 72.13 112.83 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.88 -16.83 48.67 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 115.912 -0.585 . . . . 43.25 114.463 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -61.4 -27.86 68.83 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.636 0.606 . . . . 72.12 112.636 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -145.23 -0.88 0.85 Allowed 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 120.136 -0.625 . . . . 75.22 112.124 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.428 ' OH ' ' HB2' ' A' ' 60' ' ' TYR . 80.4 m-85 -122.09 167.79 12.72 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 122.101 -0.374 . . . . 75.41 110.462 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -123.04 139.67 53.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.38 -1.341 . . . . 55.31 107.38 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -87.14 114.4 23.72 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.289 -0.634 . . . . 74.32 109.289 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.13 160.53 19.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.698 -0.683 . . . . 53.4 109.865 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.7 t -107.39 133.18 52.29 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.988 -0.745 . . . . 54.4 108.988 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.41 171.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 116.238 -0.437 . . . . 75.33 110.65 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.95 124.74 7.28 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 111.008 -0.837 . . . . 54.23 111.008 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.6 pp -117.6 165.14 13.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 116.621 0.21 . . . . 73.31 110.634 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.493 HG22 ' HG2' ' A' ' 110' ' ' LYS . 46.1 t -124.11 119.43 56.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.929 -0.767 . . . . 43.42 108.929 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.472 ' HE ' ' HB3' ' A' ' 106' ' ' ASP . 72.7 ttt180 -65.77 116.35 6.88 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.091 0.956 . . . . 71.52 111.005 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -53.74 -48.44 69.65 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.941 0.896 . . . . 64.32 109.215 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.472 ' HB3' ' HE ' ' A' ' 104' ' ' ARG . 33.9 t70 -48.9 -42.61 37.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.09 -1.868 . . . . 75.32 115.395 -172.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -138.92 6.64 2.43 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 118.627 -1.229 . . . . 74.34 112.41 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.3 t 59.71 70.17 0.66 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.073 0.949 . . . . 54.22 111.486 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -131.16 146.33 52.3 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 115.176 -0.92 . . . . 73.22 108.857 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.493 ' HG2' HG22 ' A' ' 103' ' ' VAL . 58.0 mtpt -97.3 126.19 42.36 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.456 0.646 . . . . 65.43 109.339 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.433 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 89.2 mtp -125.38 161.24 27.47 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.479 -0.782 . . . . 73.5 110.853 -177.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.51 117.43 31.65 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.216 -0.902 . . . . 64.52 109.197 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 21' ' ' PHE . 34.0 m -129.98 173.37 14.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 121.264 0.554 . . . . 63.52 110.821 -174.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -108.81 147.25 32.36 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.079 -1.082 . . . . 75.5 108.079 175.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.4 t -148.73 172.56 14.4 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.935 -0.765 . . . . 53.44 108.935 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.17 108.28 13.59 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.816 -0.809 . . . . 73.31 108.816 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -110.88 156.37 21.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.808 -0.633 . . . . 74.53 109.615 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.489 ' HB3' ' CG1' ' A' ' 64' ' ' VAL . 55.9 t-105 -68.35 123.27 20.31 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.065 -1.087 . . . . 75.35 108.065 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.509 HD12 ' H ' ' A' ' 119' ' ' ILE . 2.4 mp -65.23 -40.92 90.22 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 CA-C-O 120.921 0.391 . . . . 73.21 111.197 -171.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -59.17 -28.64 66.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.687 -0.688 . . . . 71.01 111.09 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.444 ' HA ' ' CG1' ' A' ' 64' ' ' VAL 0.302 9.0 ptpp? 58.06 -52.02 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 126.555 1.942 . . . . 71.22 115.217 178.307 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.88 82.64 2.61 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.357 -1.349 . . . . 61.02 107.357 174.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.401 ' HB3' ' HE3' ' A' ' 126' ' ' MET . 13.0 t70 -112.38 127.19 27.18 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.172 -0.922 . . . . 73.11 109.062 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.3 -17.78 21.16 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.852 2.368 . . . . 72.32 113.991 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -80.4 -29.63 37.73 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 112.739 0.644 . . . . 73.23 112.739 -175.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.401 ' HE3' ' HB3' ' A' ' 123' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.428 -1.532 0 CA-C-O 121.838 0.828 . . . . 71.0 112.445 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.508 ' O ' HG12 ' A' ' 144' ' ' ILE . 36.0 ttpt . . . . . 0 C--O 1.208 -1.109 0 N-CA-C 112.169 0.433 . . . . 73.24 112.169 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -48.8 -32.56 8.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 112.231 0.456 . . . . 71.12 112.231 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.574 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -58.76 -48.21 82.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.871 0.843 . . . . 74.11 109.716 175.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -76.15 -32.78 59.26 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.674 -1.603 . . . . 71.12 108.943 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 140' ' ' LYS . 46.7 mm -61.6 -32.77 54.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.143 0 CA-C-N 114.646 -1.161 . . . . 75.21 112.642 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -51.84 -41.3 61.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.128 0.422 . . . . 75.24 111.413 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.5 m -70.98 -47.6 57.98 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.736 -0.665 . . . . 73.41 109.858 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . 0.257 62.9 m-85 -70.18 -29.88 66.86 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 115.133 1.531 . . . . 74.32 115.133 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 57.6 tptt -59.3 -42.55 91.6 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.51 -0.922 . . . . 62.45 108.51 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -64.12 -40.31 95.92 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.253 -0.885 . . . . 71.31 109.463 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.3 mt -68.58 -41.64 83.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.313 -0.858 . . . . 64.41 110.663 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.38 -42.54 96.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.51 -0.314 . . . . 74.44 110.743 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 49.2 mt-10 -67.56 -30.8 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.931 0.396 . . . . 61.24 110.416 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 51.2 t -65.66 -37.59 86.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.871 -0.604 . . . . 74.14 109.957 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 116.054 -0.521 . . . . 72.23 110.048 177.301 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.417 -2.092 0 CA-C-O 121.06 0.457 . . . . 70.25 110.565 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.503 ' HB2' HG13 ' A' ' 79' ' ' VAL . 49.0 m-70 -115.41 160.21 20.16 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.298 -0.865 . . . . 73.33 110.208 -173.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.442 ' CG ' HG12 ' A' ' 113' ' ' VAL . 18.1 p30 -133.15 138.48 46.64 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.113 -0.949 . . . . 64.2 111.305 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.1 t -132.12 139.41 50.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.436 -0.802 . . . . 64.2 109.727 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.1 t80 -94.16 123.1 37.33 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.456 -1.312 . . . . 73.12 107.456 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.1 m -102.81 166.96 2.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 112.519 0.563 . . . . 65.34 112.519 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -153.56 -45.3 0.09 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.069 -0.969 . . . . 72.35 111.623 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.02 -92.71 1.26 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.03 -1.081 . . . . 63.11 113.97 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -58.35 -17.49 20.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.138 1.162 . . . . 74.33 114.138 -173.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -123.36 20.15 9.68 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 121.079 -0.248 . . . . 75.44 111.003 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.08 -18.86 60.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.649 -0.421 . . . . 74.02 111.609 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 20.8 t70 -116.81 128.29 26.12 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 116.331 -0.395 . . . . 71.1 111.856 -173.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HB3' HG21 ' A' ' 39' ' ' THR . 32.0 Cg_endo -65.12 -32.71 52.28 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.074 2.516 . . . . 54.3 112.81 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.53 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 19.3 t70 -63.29 -38.19 90.2 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.532 -0.544 . . . . 73.33 109.532 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.69 -42.98 93.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.257 -0.883 . . . . 73.44 109.656 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 28' ' ' ASP . 45.7 mm -60.73 -43.79 95.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.018 -0.537 . . . . 73.35 111.894 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -55.37 -36.4 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.226 0.536 . . . . 64.03 111.2 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.5 t -82.03 -37.49 14.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.609 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -63.49 -35.54 80.79 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.388 -0.597 . . . . 71.31 109.388 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.632 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.2 pt? -128.09 -74.69 0.57 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.092 -0.504 . . . . 75.14 111.862 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.632 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 22.4 m-20 -167.36 -58.26 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.861 0.865 . . . . 71.23 108.668 -172.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -131.2 165.59 23.0 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.444 -1.253 . . . . 73.24 112.222 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 29' ' ' PRO . 29.9 m -111.69 128.47 25.37 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.956 -0.566 . . . . 73.14 111.729 -174.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.45 153.15 68.2 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 123.453 2.769 . . . . 70.0 111.403 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.2 123.95 16.26 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.25 -0.648 . . . . 64.45 109.25 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 32.9 mt -104.91 136.03 40.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.086 0.47 . . . . 75.3 110.364 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.537 HG21 ' HD2' ' A' ' 104' ' ' ARG . 14.4 p -130.85 147.72 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.711 -0.677 . . . . 62.43 109.869 176.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.3 m -75.69 126.53 31.18 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.548 -0.908 . . . . 63.1 108.548 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.91 157.38 46.14 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.517 0.675 . . . . 64.43 111.819 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 m -114.59 125.12 53.41 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 114.537 -1.21 . . . . 73.33 108.627 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 50.8 tp -99.97 101.97 15.99 Favored Pre-proline 0 C--N 1.29 -2.007 0 N-CA-C 109.092 -0.707 . . . . 73.34 109.092 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 71.9 Cg_endo -80.84 141.1 13.23 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 122.188 1.926 . . . . 74.0 112.091 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.12 14.23 57.85 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.963 -0.636 . . . . 72.43 112.427 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -140.49 163.3 33.2 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.674 -0.491 . . . . 73.31 109.674 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.434 ' CG ' ' HB2' ' A' ' 66' ' ' SER . 26.9 pt20 -140.27 166.38 24.85 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.164 -0.68 . . . . 74.34 109.164 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HD3' HG13 ' A' ' 71' ' ' VAL . 14.9 ptt180 -128.01 128.46 45.03 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.597 -0.729 . . . . 74.31 111.719 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.559 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 17.1 m-85 -109.14 164.88 12.04 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.274 -0.876 . . . . 73.44 110.147 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 . . . . . 0 CA--C 1.487 -1.473 0 N-CA-C 109.442 -0.577 . . . . 61.01 109.442 -168.985 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.409 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 12.7 p90 . . . . . 0 N--CA 1.419 -2.024 0 N-CA-C 108.569 -0.9 . . . . 62.24 108.569 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 5.7 Cg_exo -37.24 120.49 0.31 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 124.344 3.363 . . . . 74.34 114.427 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 53' ' ' PHE . 12.4 p -130.11 150.0 51.57 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.037 -0.983 . . . . 74.15 110.468 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.7 mm -110.06 141.36 25.59 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 N-CA-C 108.742 -0.836 . . . . 74.01 108.742 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' A' ' 118' ' ' TRP . 29.9 m -146.87 150.33 38.85 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 109.101 -0.703 . . . . 73.11 109.101 175.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.33 134.68 60.39 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.66 2.24 . . . . 71.44 112.246 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.434 ' HB2' ' CG ' ' A' ' 51' ' ' GLN . 34.8 t -125.68 141.51 51.98 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.934 -0.575 . . . . 72.42 110.343 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -75.29 -32.79 61.11 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.512 -0.551 . . . . 55.15 109.512 173.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . 0.287 0.1 OUTLIER -131.93 72.91 1.51 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 114.031 1.123 . . . . 75.41 114.031 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.35 168.59 40.58 Favored Glycine 0 C--O 1.257 1.579 0 C-N-CA 119.224 -1.465 . . . . 61.22 113.283 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.44 147.73 29.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.799 -1.186 . . . . 63.34 107.799 176.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.44 HG13 ' HD3' ' A' ' 52' ' ' ARG . 59.8 t -114.5 119.66 62.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 109.582 -0.525 . . . . 70.22 109.582 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -95.63 116.32 28.69 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.534 -0.913 . . . . 71.41 108.534 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.87 -143.87 4.14 Favored Glycine 0 N--CA 1.418 -2.517 0 C-N-CA 120.718 -0.753 . . . . 52.21 111.26 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.468 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 75.5 mmtt -134.24 145.13 48.86 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.56 -0.533 . . . . 74.51 109.56 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.7 t -110.58 129.55 65.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 123.104 0.252 . . . . 33.41 111.148 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.452 HD23 HG12 ' A' ' 42' ' ' ILE . 71.0 mt -95.62 111.31 23.26 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.022 -1.473 . . . . 71.03 107.022 174.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.9 ptp -119.65 144.08 47.36 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.398 -0.521 . . . . 75.31 111.842 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.26 23.97 7.78 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 115.459 -0.791 . . . . 70.51 111.73 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 18' ' ' HIS . 13.2 p -95.02 138.89 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 110.017 -0.364 . . . . 74.31 110.017 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.552 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 3.9 m -79.02 162.05 26.19 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 109.169 -0.678 . . . . 74.03 109.169 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.5 m -58.51 -32.7 69.07 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 112.801 0.667 . . . . 41.12 112.801 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.64 -49.39 68.87 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 112.322 0.489 . . . . 73.33 112.322 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.591 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 1.4 mp0 -65.25 -29.49 70.28 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 109.612 -0.514 . . . . 70.04 109.612 177.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.87 -40.33 92.59 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.021 0.439 . . . . 71.42 109.868 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -69.02 -36.99 78.4 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.152 -0.685 . . . . 75.45 109.152 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.457 ' O ' HG23 ' A' ' 90' ' ' VAL . 7.7 t30 -63.85 -43.04 97.33 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.114 -0.948 . . . . 64.13 110.489 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.8 mt -61.72 -43.07 99.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.748 0.785 . . . . 74.31 108.935 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.25 -32.17 71.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.278 -1.328 . . . . 52.02 111.115 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.21 -42.16 56.19 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.814 -0.63 . . . . 72.44 110.474 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 86' ' ' ASN . 99.3 t -67.04 -53.23 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.306 0.643 . . . . 73.34 112.4 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -78.28 -20.65 51.16 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.224 0.535 . . . . 70.1 111.95 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.19 -17.03 16.07 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.74 1.456 . . . . 61.15 116.74 -173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -67.06 -29.64 69.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 118.56 1.18 . . . . 73.42 112.533 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.56 -0.74 2.36 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 113.359 0.874 . . . . 63.22 113.359 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -127.41 166.08 18.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.663 0.616 . . . . 72.4 112.663 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.3 tp10 -125.17 146.04 49.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.121 -0.945 . . . . 73.43 108.86 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -92.92 114.12 26.59 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.014 -0.736 . . . . 61.13 109.014 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.412 HG11 ' HE3' ' A' ' 117' ' ' MET . 28.3 m -126.49 161.59 32.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 120.865 0.364 . . . . 71.11 111.83 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.7 t -88.14 130.97 34.89 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.249 -0.887 . . . . 74.1 110.31 -177.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.413 ' HB ' HD11 ' A' ' 47' ' ' LEU . 29.4 m -137.84 165.61 25.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.974 -0.557 . . . . 71.22 111.522 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.481 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -114.67 124.24 6.31 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.477 -1.049 . . . . 70.01 110.477 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.88 160.51 15.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 120.697 0.284 . . . . 74.01 110.868 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 66.2 t -120.38 114.68 44.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.115 -1.439 . . . . 73.01 107.115 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.537 ' HD2' HG21 ' A' ' 43' ' ' VAL . 54.8 mtm180 -69.67 135.56 50.01 Favored 'General case' 0 CA--C 1.478 -1.817 0 C-N-CA 119.981 -0.688 . . . . 72.33 109.771 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.92 5.55 18.68 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.82 0.819 . . . . 72.13 109.074 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -56.85 -62.09 1.99 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.087 -1.415 . . . . 73.55 109.559 175.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -137.76 12.3 2.92 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.512 -0.767 . . . . 62.24 109.288 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 23.0 t 62.86 78.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.688 -1.142 . . . . 64.01 110.486 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 10.2 pt-20 -137.11 151.3 48.71 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 108.133 -1.062 . . . . 71.32 108.133 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -94.05 140.93 29.12 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 120.35 -0.54 . . . . 71.22 110.245 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.6 mtp -141.8 161.5 37.81 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 123.772 0.829 . . . . 74.1 110.218 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.57 129.19 55.31 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 115.459 -0.792 . . . . 34.34 109.671 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 21' ' ' PHE . 29.5 m -142.84 174.68 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.441 -0.948 . . . . 71.33 108.441 -177.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -113.8 157.62 22.06 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.863 -0.735 . . . . 74.44 109.601 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.2 t -149.74 172.64 14.78 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.558 -0.904 . . . . 64.14 108.558 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 88.5 m-85 -114.51 115.35 27.1 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.192 -0.669 . . . . 75.33 109.192 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.412 ' HE3' HG11 ' A' ' 98' ' ' VAL 0.256 0.0 OUTLIER -113.42 156.27 23.78 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.001 -0.545 . . . . 73.11 111.773 -179.772 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.447 ' HB3' ' CG1' ' A' ' 64' ' ' VAL . 68.1 t-105 -67.76 118.01 10.43 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.688 -0.856 . . . . 63.31 108.688 -175.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.7 mt -58.91 -35.75 58.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.91 -1.041 . . . . 73.13 113.156 -171.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -70.69 -31.23 68.05 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.023 0.439 . . . . 72.01 110.596 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 67.67 -60.1 0.4 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.011 1.325 . . . . 74.35 113.658 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.03 102.01 13.59 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 110.149 -0.315 . . . . 72.44 110.149 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -141.98 123.91 9.01 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 116.014 -0.539 . . . . 73.5 110.906 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -87.06 2.67 6.88 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.797 2.332 . . . . 72.55 113.443 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -94.99 -31.43 13.63 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.669 0.271 . . . . 70.21 111.387 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.524 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 27.0 ptt? . . . . . 0 N--CA 1.476 0.865 0 C-N-CA 122.824 0.45 . . . . 61.04 112.17 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.601 ' HE2' HD11 ' A' ' 144' ' ' ILE . 88.2 tttt . . . . . 0 C--O 1.205 -1.281 0 N-CA-C 110.329 -0.248 . . . . 62.33 110.329 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 23.7 tptm -46.77 -38.51 10.18 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.459 1.104 . . . . 73.42 113.006 -177.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.75 -40.3 91.93 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.947 0.88 . . . . 72.53 109.95 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -76.71 -32.98 58.2 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.503 -1.226 . . . . 74.41 107.908 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.601 HD11 ' HE2' ' A' ' 140' ' ' LYS . 48.3 mm -65.82 -32.81 59.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 CA-C-N 114.629 -1.169 . . . . 53.53 111.524 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 45.0 mt-10 -55.24 -32.06 62.01 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.376 0.608 . . . . 53.45 110.054 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.9 m -80.24 -47.19 14.98 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.704 -0.68 . . . . 61.14 109.45 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.564 ' O ' ' HG2' ' A' ' 151' ' ' MET 0.294 26.9 m-85 -64.13 -30.63 71.68 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 116.128 1.899 . . . . 72.35 116.128 -178.822 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 37.6 mmtm -58.76 -38.85 79.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.474 0.579 . . . . 64.2 111.679 175.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -71.23 -33.26 69.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.106 -0.701 . . . . 64.53 109.106 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.442 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 68.3 mt -69.95 -39.0 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.39 -0.823 . . . . 73.52 109.136 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 14.4 mmt -61.25 -40.69 94.99 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.175 -0.466 . . . . 61.44 110.329 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 46.0 mt-10 -60.29 -41.54 93.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.151 0.501 . . . . 62.03 110.319 177.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 49.0 t -71.56 -31.83 67.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.568 -0.742 . . . . 61.12 110.845 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 75.9 mmtt . . . . . 0 CA--C 1.514 -0.437 0 C-N-CA 120.457 -0.497 . . . . 74.53 110.204 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.413 -2.31 0 N-CA-C 107.958 -1.127 . . . . 65.11 107.958 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.483 ' O ' HG12 ' A' ' 79' ' ' VAL . 49.9 m-70 -109.39 159.67 16.82 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 108.702 -0.851 . . . . 74.2 108.702 -173.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 21.1 p30 -134.56 128.48 33.34 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.114 -0.948 . . . . 64.12 111.94 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.63 144.48 34.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 114.575 -1.193 . . . . 74.3 111.041 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -94.13 123.14 37.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.75 -0.833 . . . . 72.41 108.75 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.74 ' HB ' ' O ' ' A' ' 26' ' ' PHE . 20.4 m -94.44 172.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.853 -0.612 . . . . 62.23 110.54 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -149.4 -62.41 0.22 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.291 1.96 . . . . 64.2 116.291 -168.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -116.28 -79.48 0.77 Allowed Glycine 0 C--O 1.215 -1.085 0 C-N-CA 119.314 -1.422 . . . . 73.35 114.504 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -65.98 -36.31 82.97 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.98 0.895 . . . . 75.03 109.187 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.74 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 48.5 m-85 -101.29 100.17 10.64 Favored 'General case' 0 N--CA 1.401 -2.902 0 CA-C-N 114.622 -1.172 . . . . 75.42 108.196 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -156.18 3.83 0.17 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.177 -0.919 . . . . 72.21 112.509 173.321 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HB3' HG23 ' A' ' 31' ' ' VAL . 16.0 t70 -124.71 134.59 25.75 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.369 -0.604 . . . . 73.13 109.369 -176.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 29.6 Cg_endo -63.35 -30.76 73.22 Favored 'Trans proline' 0 C--O 1.211 -0.859 0 C-N-CA 122.879 2.386 . . . . 74.42 113.988 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.26 -35.35 73.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.19 0.519 . . . . 72.12 109.629 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 28' ' ' ASP . 94.2 t -62.42 -42.42 95.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.617 -0.883 . . . . 63.01 108.617 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 36' ' ' LEU . 24.0 mm -66.17 -43.66 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.947 -1.024 . . . . 71.33 109.584 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 3.5 t-20 -55.36 -43.85 75.44 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.648 -1.614 . . . . 64.11 110.742 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.99 -39.36 17.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.882 -0.599 . . . . 75.12 111.481 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -64.99 -36.39 84.24 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 110.482 -0.192 . . . . 72.51 110.482 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 32' ' ' ILE 0.264 0.4 OUTLIER -111.24 -75.36 0.62 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 113.088 0.773 . . . . 64.12 113.088 174.268 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.6 t70 174.51 -49.08 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 108.328 -0.99 . . . . 73.33 108.328 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -110.78 175.66 5.34 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.185 -1.371 . . . . 73.01 109.029 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.0 m -129.29 104.72 17.85 Favored Pre-proline 0 N--CA 1.414 -2.228 0 N-CA-C 108.694 -0.854 . . . . 75.11 108.694 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.17 150.86 46.35 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 123.01 2.473 . . . . 75.52 110.35 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.71 132.0 51.98 Favored 'General case' 0 CA--C 1.465 -2.318 0 CA-C-O 122.224 1.011 . . . . 63.11 112.043 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 46.3 mt -107.0 131.73 56.2 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.8 0 CA-C-N 113.219 -1.809 . . . . 71.35 108.95 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.13 146.17 30.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.967 -1.123 . . . . 72.02 107.967 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.5 m -77.36 127.95 33.45 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 107.329 -1.36 . . . . 71.3 107.329 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -142.27 154.41 44.72 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.039 0.447 . . . . 74.53 110.95 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.49 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 93.9 m -109.16 125.64 52.41 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.374 -0.83 . . . . 75.33 110.276 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.405 HD11 ' HB ' ' A' ' 100' ' ' VAL . 35.0 tp -101.43 99.59 11.69 Favored Pre-proline 0 N--CA 1.432 -1.368 0 CA-C-N 116.077 -0.511 . . . . 72.1 109.936 175.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.1 Cg_endo -83.96 135.53 6.62 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.767 2.311 . . . . 70.32 111.562 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.11 5.88 46.17 Favored Glycine 0 N--CA 1.434 -1.438 0 C-N-CA 120.552 -0.832 . . . . 71.3 111.679 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.517 ' HA ' ' H ' ' A' ' 66' ' ' SER . 96.0 m-85 -146.98 150.17 34.62 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.121 -0.696 . . . . 65.52 109.121 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -140.85 148.56 40.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.632 -0.877 . . . . 73.01 108.632 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -102.03 142.47 33.25 Favored 'General case' 0 N--CA 1.424 -1.734 0 C-N-CA 119.517 -0.873 . . . . 74.51 108.997 176.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CB ' ' HB2' ' A' ' 126' ' ' MET . 7.0 m-85 -108.3 171.22 7.54 Favored 'General case' 0 C--N 1.258 -3.375 0 CA-C-N 114.646 -1.161 . . . . 74.41 111.152 -175.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? . . . . . 0 C--N 1.316 -0.865 0 N-CA-C 113.624 0.972 . . . . 50.15 113.624 -173.21 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.443 -0.81 0 N-CA-C 107.293 -1.373 . . . . 65.55 107.293 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 16.0 Cg_exo -68.79 93.23 0.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 N-CA-C 108.219 -1.493 . . . . 71.34 108.219 171.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 22.0 p -99.53 154.94 17.85 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.653 -0.703 . . . . 61.51 112.509 -174.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 50' ' ' PHE . 35.4 mm -94.86 127.39 46.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.056 -0.975 . . . . 53.55 109.469 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.44 144.38 52.03 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 109.201 -0.666 . . . . 74.34 109.201 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.94 108.96 0.36 Allowed 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.552 2.168 . . . . 62.44 112.983 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.517 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 32.3 t -125.13 98.6 5.73 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 106.09 -1.819 . . . . 61.23 106.09 176.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.38 -36.6 64.08 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 123.667 0.787 . . . . 71.52 112.252 -172.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -86.15 -23.9 26.39 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.337 0.589 . . . . 74.53 110.24 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.74 173.89 45.77 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 115.41 -0.814 . . . . 64.14 113.099 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -160.4 144.43 14.05 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.331 -0.988 . . . . 75.54 108.331 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.12 119.83 61.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 109.035 -0.728 . . . . 65.24 109.035 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -91.45 114.85 27.49 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.537 -2.023 . . . . 73.44 105.537 174.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.44 -143.81 3.9 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.279 -0.962 . . . . 33.44 112.359 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.5 mmtm -123.34 140.61 52.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.946 0.403 . . . . 73.45 111.325 -173.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 41.0 t -111.08 130.05 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.827 -0.624 . . . . 60.04 110.376 172.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 78.3 mt -95.71 109.91 22.12 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.863 -1.162 . . . . 62.01 107.863 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.8 ptp -119.7 137.43 53.92 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.128 0.489 . . . . 63.43 110.43 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.72 18.87 10.96 Favored Glycine 0 N--CA 1.421 -2.33 0 C-N-CA 120.037 -1.078 . . . . 44.14 111.254 -174.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.0 p -89.69 138.2 19.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 N-CA-C 109.009 -0.737 . . . . 74.33 109.009 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.6 p -76.84 159.92 29.67 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.422 -0.354 . . . . 63.44 110.77 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.1 m -58.71 -32.03 68.8 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.33 0.493 . . . . 62.12 112.33 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -67.37 -41.09 85.63 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.432 0.634 . . . . 71.22 109.984 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 63.0 mm-40 -80.2 -28.65 38.63 Favored 'General case' 0 C--O 1.201 -1.499 0 C-N-CA 119.576 -0.85 . . . . 73.42 112.426 176.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.423 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.1 tm? -60.79 -45.21 95.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.059 -0.719 . . . . 73.11 109.059 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -67.86 -29.92 69.17 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.855 -0.424 . . . . 74.04 109.855 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -72.95 -40.34 65.45 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 116.116 -0.493 . . . . 75.31 110.129 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.522 ' HA ' HG12 ' A' ' 90' ' ' VAL . 95.6 mt -60.17 -40.45 89.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.947 0.879 . . . . 64.4 109.295 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.491 ' CG ' HH21 ' A' ' 97' ' ' ARG . 23.8 t70 -71.48 -29.52 64.92 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.445 -1.252 . . . . 55.41 111.089 177.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.69 -48.21 22.93 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.347 -0.388 . . . . 64.13 110.394 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 87' ' ' LEU . 13.7 p -65.28 -53.41 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-N 115.843 -0.617 . . . . 62.32 111.483 -176.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -78.02 -27.82 48.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.167 0.432 . . . . 71.42 112.167 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.91 -17.81 44.78 Favored Glycine 0 N--CA 1.464 0.529 0 N-CA-C 115.007 0.763 . . . . 75.34 115.007 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -61.52 -32.33 72.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.126 0.463 . . . . 74.43 111.198 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -130.86 3.83 4.48 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.589 -0.444 . . . . 63.04 111.793 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 92.7 m-85 -138.46 168.0 20.7 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.796 0.295 . . . . 74.24 111.796 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 35.9 tt0 -121.62 144.55 48.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.323 -0.399 . . . . 73.15 110.123 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.491 HH21 ' CG ' ' A' ' 88' ' ' ASP . 16.3 ttm180 -87.45 118.45 26.92 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.328 -0.619 . . . . 75.12 109.328 -176.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.23 162.98 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 113.123 0.786 . . . . 60.04 113.123 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.5 p -94.14 124.38 38.11 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.118 -1.401 . . . . 75.34 109.965 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 47' ' ' LEU . 29.3 m -130.92 158.31 43.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 120.844 0.354 . . . . 65.11 111.251 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.58 115.8 5.22 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 111.394 -0.682 . . . . 72.32 111.394 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.04 155.76 12.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 110.189 -0.3 . . . . 54.41 110.189 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.9 120.08 62.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 108.701 -0.851 . . . . 63.33 108.701 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.468 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 39.7 mtp180 -64.38 134.92 55.56 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.946 0.403 . . . . 60.32 111.017 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.89 -6.93 53.15 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.892 -1.151 . . . . 51.01 107.892 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.88 -64.6 0.77 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 125.719 1.607 . . . . 74.43 110.938 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -144.89 15.34 1.55 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 120.741 -0.384 . . . . 71.31 110.293 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 56.7 m 63.53 63.09 0.89 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.651 -0.704 . . . . 74.25 111.656 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.47 137.57 52.44 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.373 -1.343 . . . . 64.44 107.373 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -98.19 140.97 31.7 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-O 121.433 0.635 . . . . 75.24 111.32 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.468 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 89.0 mtp -138.51 162.58 34.16 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-N 114.977 -1.011 . . . . 71.44 110.358 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.44 122.35 47.2 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.963 -1.017 . . . . 63.34 109.199 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.06 174.46 13.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 109.109 -0.7 . . . . 73.23 109.109 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -98.26 161.25 13.8 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.565 -0.854 . . . . 62.14 109.14 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.0 t -156.93 172.57 18.43 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.737 -1.208 . . . . 72.34 107.737 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.1 m-85 -124.41 113.9 18.79 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.094 -0.706 . . . . 60.14 109.094 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.94 157.52 22.31 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.935 0.398 . . . . 72.43 110.974 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.424 ' NE1' ' HB3' ' A' ' 120' ' ' ASN . 55.4 t-105 -67.52 128.82 37.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.573 -0.899 . . . . 74.12 108.573 -177.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.7 mp -72.02 -41.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.643 -0.253 . . . . 73.24 111.159 -173.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.424 ' HB3' ' NE1' ' A' ' 118' ' ' TRP . 27.1 t-20 -62.31 -37.17 84.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.768 -0.651 . . . . 72.24 111.377 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 119' ' ' ILE . 57.2 mttp 68.29 -38.7 0.38 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.427 1.491 . . . . 72.25 114.361 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -115.63 76.09 0.99 Allowed 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.903 -0.498 . . . . 73.33 110.502 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -106.12 132.95 20.47 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 108.542 -0.91 . . . . 61.13 108.542 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.19 -19.07 29.97 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.763 2.309 . . . . 75.11 114.361 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -76.52 -37.32 56.92 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 113.222 0.823 . . . . 75.42 113.222 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.496 ' HB2' ' CB ' ' A' ' 53' ' ' PHE . 26.4 ptt? . . . . . 0 C--O 1.247 0.95 0 CA-C-O 121.439 0.638 . . . . 71.04 109.933 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.677 ' O ' HG12 ' A' ' 144' ' ' ILE . 38.8 ttpt . . . . . 0 C--O 1.2 -1.52 0 N-CA-C 110.589 -0.152 . . . . 71.15 110.589 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 38.7 ttmt -54.76 -41.94 71.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.996 0.519 . . . . 73.01 110.192 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -61.75 -44.41 96.96 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.126 0.965 . . . . 72.11 108.66 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -67.44 -38.25 84.23 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.404 -1.725 . . . . 75.24 109.977 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 140' ' ' LYS . 42.4 mm -67.05 -35.53 74.77 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.455 0 CA-C-N 115.609 -0.723 . . . . 71.4 110.174 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.5 mt-10 -59.88 -30.91 69.32 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.748 0.309 . . . . 61.32 111.134 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 150' ' ' ILE . 33.3 m -73.59 -48.44 32.76 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.904 -0.776 . . . . 71.23 108.904 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.522 ' O ' ' HG2' ' A' ' 151' ' ' MET . 51.1 m-85 -71.62 -36.29 70.73 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 115.271 1.582 . . . . 73.22 115.271 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 88.5 tttt -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.47 -0.937 . . . . 72.43 108.47 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LYS . . . . . 0.563 ' HB2' ' NZ ' ' A' ' 149' ' ' LYS . 4.1 ttmp? -75.19 -37.85 61.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.686 -1.143 . . . . 71.31 109.855 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 146' ' ' THR . 88.8 mt -64.49 -33.49 63.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.815 -0.629 . . . . 70.41 109.503 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 24.8 mmt -72.74 -27.96 62.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.288 -0.415 . . . . 61.23 110.648 176.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 43.3 mt-10 -68.7 -30.69 69.41 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 108.709 -0.849 . . . . 73.43 108.709 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 150' ' ' ILE . 52.3 t -70.48 -32.87 70.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.317 -0.856 . . . . 63.5 109.959 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 75.0 mmtt . . . . . 0 C--O 1.236 0.384 0 N-CA-C 109.385 -0.598 . . . . 71.4 109.385 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.436 -1.135 0 N-CA-C 108.821 -0.807 . . . . 74.14 108.821 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -115.71 159.74 20.99 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.513 -0.312 . . . . 73.33 110.608 -172.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.47 ' HB3' HG12 ' A' ' 113' ' ' VAL . 49.2 m-20 -121.28 127.57 51.49 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.496 -1.298 . . . . 75.32 107.496 176.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.64 130.26 62.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 122.357 -0.214 . . . . 73.32 110.832 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.41 ' HB2' HG21 ' A' ' 113' ' ' VAL . 93.8 t80 -94.48 121.64 36.23 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.185 -1.413 . . . . 64.25 107.185 174.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.566 HG21 ' HB2' ' A' ' 26' ' ' PHE . 4.0 p -97.0 139.73 18.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.592 -0.731 . . . . 74.43 110.666 -176.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -77.65 -36.85 51.05 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 115.092 1.516 . . . . 73.0 115.092 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.41 -74.49 0.02 OUTLIER Glycine 0 C--O 1.225 -0.463 0 C-N-CA 117.584 -2.246 . . . . 72.33 115.774 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 t -58.57 -36.24 73.63 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.733 1.012 . . . . 74.55 113.733 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.599 ' HB3' HD11 ' A' ' 32' ' ' ILE . 62.4 m-85 -99.38 22.67 10.32 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.221 -0.992 . . . . 63.35 112.501 -175.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.447 ' HG2' HG13 ' A' ' 22' ' ' VAL . 80.5 mt-30 -74.29 -11.23 60.21 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 120.633 0.254 . . . . 72.34 111.279 176.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -101.76 128.77 28.06 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.455 -0.338 . . . . 65.22 111.431 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HB3' HG21 ' A' ' 39' ' ' THR . 18.0 Cg_endo -62.95 -37.04 56.55 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.943 2.429 . . . . 51.5 113.114 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.8 m-20 -65.62 -33.79 76.72 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.718 -0.614 . . . . 72.25 110.818 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.52 -40.82 89.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.736 -0.666 . . . . 71.22 109.589 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 26' ' ' PHE . 43.6 mm -65.84 -42.1 91.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 CA-C-N 115.966 -0.561 . . . . 72.41 111.103 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -58.77 -34.55 71.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.892 0.377 . . . . 74.2 110.692 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 30' ' ' ASP . 94.4 t -77.65 -46.6 27.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.089 -0.505 . . . . 71.43 110.841 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 62.0 ttp -63.56 -36.81 85.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.02 0.378 . . . . 70.3 112.02 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.51 HD12 ' H ' ' A' ' 37' ' ' ASP 0.374 3.6 pp -126.01 -58.77 1.36 Allowed 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 115.379 1.622 . . . . 75.23 115.379 -178.537 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.51 ' H ' HD12 ' A' ' 36' ' ' LEU . 22.7 t70 170.56 -53.22 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.307 0.575 . . . . 70.44 110.618 -177.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.551 ' O ' HG22 ' A' ' 32' ' ' ILE . 88.8 mtt180 -123.21 -167.35 1.59 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.548 -0.908 . . . . 71.43 108.548 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 29' ' ' PRO . 76.2 m -139.55 121.13 9.8 Favored Pre-proline 0 N--CA 1.432 -1.369 0 CA-C-O 120.502 0.191 . . . . 63.32 111.203 171.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.25 153.47 46.37 Favored 'Trans proline' 0 C--O 1.247 0.949 0 C-N-CA 123.56 2.84 . . . . 74.14 110.815 173.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.02 129.56 38.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.379 0.609 . . . . 74.12 110.204 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 54.2 mt -111.77 139.51 35.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.982 -0.554 . . . . 53.04 109.754 -175.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 12.0 p -127.98 145.85 34.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.467 -0.568 . . . . 61.54 109.467 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.463 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 40.3 m -78.32 122.44 25.76 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.353 -0.98 . . . . 74.02 108.353 176.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -141.26 159.41 42.28 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.921 0.867 . . . . 61.14 112.27 -175.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.401 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 56.1 m -120.08 129.37 54.18 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.809 -1.087 . . . . 73.22 108.632 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.0 tp -98.85 104.02 22.75 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 108.864 -0.791 . . . . 65.34 108.864 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.0 OUTLIER -82.44 148.84 14.63 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.533 2.155 . . . . 72.02 111.543 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.33 16.7 66.1 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.888 -0.672 . . . . 63.34 112.255 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -145.4 159.89 42.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.956 -1.128 . . . . 53.33 107.956 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.561 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 11.1 pt20 -139.24 163.74 31.67 Favored 'General case' 0 CA--C 1.481 -1.682 0 C-N-CA 119.313 -0.955 . . . . 71.53 111.401 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.574 ' HD3' ' NH1' ' A' ' 54' ' ' ARG . 0.8 OUTLIER -107.94 129.83 55.07 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.892 -1.504 . . . . 72.52 112.858 -176.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.561 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 5.4 m-85 -109.11 158.21 18.0 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.104 -0.953 . . . . 75.34 109.905 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.574 ' NH1' ' HD3' ' A' ' 52' ' ' ARG . 6.0 mpt_? . . . . . 0 C--N 1.304 -1.405 0 CA-C-N 116.442 -0.345 . . . . 73.3 110.21 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 N--CA 1.432 -1.374 0 N-CA-C 106.755 -1.572 . . . . 70.22 106.755 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.23 89.47 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.691 1.594 . . . . 63.12 110.002 172.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 20.5 p -100.1 164.69 11.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 112.48 0.548 . . . . 63.41 112.48 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.12 140.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.405 -0.961 . . . . 73.43 108.405 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -145.68 154.71 52.38 Favored Pre-proline 0 C--O 1.251 1.146 0 N-CA-C 108.057 -1.09 . . . . 73.02 108.057 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.41 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 8.4 Cg_endo -56.91 131.73 47.33 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 122.572 2.181 . . . . 64.2 112.013 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.2 t -124.46 140.58 52.82 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.286 -0.87 . . . . 34.44 108.936 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -74.35 -37.22 63.57 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.242 0.544 . . . . 70.04 109.582 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -130.94 82.33 2.04 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.611 -0.722 . . . . 75.42 110.231 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.06 164.28 37.75 Favored Glycine 0 C--N 1.299 -1.491 0 C-N-CA 119.528 -1.32 . . . . 70.3 112.811 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.22 148.19 30.24 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.832 -0.803 . . . . 72.4 108.832 176.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.16 122.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.442 -0.577 . . . . 63.33 109.442 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -97.53 116.54 29.94 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.727 -0.472 . . . . 62.45 109.727 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -152.48 -154.68 6.76 Favored Glycine 0 N--CA 1.418 -2.566 0 N-CA-C 110.317 -1.113 . . . . 44.24 110.317 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' A' ' 73' ' ' GLY . 14.3 mptt -125.76 153.4 44.03 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.586 0.708 . . . . 75.52 111.88 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 69.9 t -110.81 130.18 64.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 114.206 -1.361 . . . . 74.12 110.599 177.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.413 HD23 HG12 ' A' ' 42' ' ' ILE . 65.7 mt -95.41 111.14 23.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 105.954 -1.869 . . . . 51.42 105.954 175.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.0 ptp -124.28 152.27 43.23 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.089 0.471 . . . . 64.21 112.006 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.92 18.72 53.68 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 109.189 -1.564 . . . . 63.03 109.189 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 83' ' ' GLU . 54.7 t -71.91 127.24 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 114.253 -0.974 . . . . 73.14 109.716 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 79' ' ' VAL . 54.7 p -74.88 161.08 29.86 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.852 -1.166 . . . . 75.42 107.852 174.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.3 m -61.19 -26.83 67.98 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 122.182 -0.324 . . . . 73.53 111.837 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.43 -40.73 93.67 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.588 0.709 . . . . 41.54 110.793 176.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.511 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 38.1 mt-10 -78.0 -35.03 50.48 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.559 -0.746 . . . . 74.23 109.048 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.569 HD11 ' NH1' ' A' ' 97' ' ' ARG . 3.1 tm? -62.17 -51.41 67.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.478 -0.783 . . . . 70.12 110.11 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.05 -29.36 70.51 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 109.819 -0.437 . . . . 74.11 109.819 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 26.1 t-20 -59.71 -46.56 88.73 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.956 -0.757 . . . . 54.22 108.956 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.44 -36.78 68.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.881 -0.599 . . . . 75.04 110.949 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.426 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 26.3 t70 -64.36 -31.45 72.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.901 0.858 . . . . 65.55 109.241 177.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.86 -47.21 21.95 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.591 -0.731 . . . . 71.42 111.458 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 86' ' ' ASN . 90.5 t -72.16 -60.2 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 112.77 0.655 . . . . 65.53 112.77 -176.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -83.0 -41.84 18.24 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.87 0.843 . . . . 72.04 111.822 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -59.58 -16.58 37.58 Favored Glycine 0 C--O 1.215 -1.041 0 N-CA-C 118.238 2.055 . . . . 62.45 118.238 -171.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -69.96 -45.16 67.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 120.154 1.977 . . . . 63.1 112.22 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -98.09 -3.61 37.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.242 0.544 . . . . 60.05 111.266 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 83.5 m-85 -122.24 169.43 10.91 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.769 0.828 . . . . 64.42 110.012 -178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.423 ' HB2' HG13 ' A' ' 119' ' ' ILE . 35.3 tt0 -122.62 132.35 54.24 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.869 -0.789 . . . . 62.34 108.869 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.569 ' NH1' HD11 ' A' ' 84' ' ' LEU . 9.6 ttp180 -87.01 114.1 23.33 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.902 -1.045 . . . . 75.23 109.704 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.87 161.93 25.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 114.712 -1.131 . . . . 75.42 110.813 -177.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.2 t -94.42 129.28 41.22 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.763 -0.828 . . . . 43.02 108.763 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.94 170.32 17.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 120.963 0.411 . . . . 63.04 111.132 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.84 124.5 6.66 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.971 -0.852 . . . . 65.42 110.971 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.88 160.07 11.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 122.874 0.469 . . . . 74.22 110.117 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.4 t -120.73 127.07 75.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.467 -0.938 . . . . 73.22 108.467 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.612 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 28.2 mtp180 -68.79 135.63 51.5 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.011 -0.54 . . . . 72.03 110.676 -177.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.463 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 49.2 mt-10 -79.56 -5.73 55.55 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.07 -0.514 . . . . 74.32 109.748 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.12 -67.62 0.42 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.033 -0.985 . . . . 63.11 110.528 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -132.16 12.29 4.65 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.635 -1.166 . . . . 61.12 112.289 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.9 t 69.85 18.78 7.28 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.795 0.838 . . . . 75.31 113.133 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -88.21 149.96 23.56 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.855 -0.528 . . . . 71.2 110.923 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -95.02 147.53 23.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.122 0.487 . . . . 74.54 111.092 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.612 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.6 mtp -141.56 160.92 39.16 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 123.625 0.77 . . . . 52.23 110.329 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.16 130.88 51.91 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.552 -0.749 . . . . 44.4 110.779 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 19' ' ' ASN . 28.8 m -142.83 174.02 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 73.33 110.402 -177.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.21 149.46 23.53 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.445 -1.687 . . . . 73.32 106.445 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 6.7 t -150.35 172.09 15.95 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.085 -0.709 . . . . 74.45 109.085 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 95' ' ' TYR . 81.0 m-85 -120.91 108.89 14.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 123.452 0.47 . . . . 51.31 109.951 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.41 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 24.0 ptt? -112.42 155.87 23.49 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.093 -0.503 . . . . 43.42 109.728 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -69.56 129.44 39.68 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.461 -0.941 . . . . 74.44 108.461 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.54 HD12 ' H ' ' A' ' 119' ' ' ILE . 2.7 mp -72.65 -42.81 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.763 0.316 . . . . 64.34 111.762 -171.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -71.1 -36.91 72.36 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.136 -0.69 . . . . 63.14 109.136 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt 52.34 9.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.318 1.847 . . . . 74.41 114.908 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.96 14.14 4.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.386 0.513 . . . . 74.51 112.386 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 4.8 m-20 -67.08 122.42 82.58 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 110.182 -0.303 . . . . 70.15 110.182 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 123' ' ' ASP . 12.2 Cg_exo -72.28 -5.96 18.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.587 2.191 . . . . 75.41 112.974 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -59.71 -53.3 59.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.305 0.574 . . . . 64.31 110.225 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 C--N 1.308 -1.214 0 CA-C-N 114.801 -1.091 . . . . 64.45 112.233 -175.256 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.544 ' O ' HG12 ' A' ' 144' ' ' ILE . 63.9 pttt . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 110.199 -0.297 . . . . 73.01 110.199 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 50.2 mtmt -48.58 -35.15 12.83 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.818 0.847 . . . . 73.31 112.589 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -58.96 -45.39 90.62 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.3 0.572 . . . . 73.25 110.826 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -76.12 -34.87 59.48 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.918 -0.771 . . . . 61.14 108.918 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.1 mm -61.43 -33.97 59.2 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.759 0 CA-C-N 115.081 -0.963 . . . . 75.34 110.193 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.3 mt-10 -54.15 -35.88 62.72 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.742 0.306 . . . . 72.51 110.843 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.9 m -70.6 -47.37 60.48 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 116.128 -0.487 . . . . 73.24 110.018 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -71.84 -30.51 65.53 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 113.238 0.829 . . . . 71.04 113.238 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.9 -42.87 80.69 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.981 -0.748 . . . . 73.33 108.981 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -70.92 -38.43 72.93 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.785 -1.098 . . . . 74.42 108.931 -177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.55 -41.08 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.754 -0.657 . . . . 61.03 110.355 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 70.9 mtm -67.79 -37.75 82.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.514 -0.312 . . . . 74.14 110.818 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -67.84 -31.29 71.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.806 0.336 . . . . 74.43 111.016 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.91 -47.1 55.04 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.354 -0.385 . . . . 63.32 111.459 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--N 1.326 -0.414 0 N-CA-C 112.617 0.599 . . . . 65.23 112.617 -176.206 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.411 -2.407 0 N-CA-C 108.4 -0.963 . . . . 73.21 108.4 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.429 ' O ' HG12 ' A' ' 79' ' ' VAL . 40.8 m-70 -115.15 159.56 20.76 Favored 'General case' 0 C--N 1.271 -2.848 0 N-CA-C 108.933 -0.765 . . . . 53.13 108.933 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.43 ' HB2' HG12 ' A' ' 113' ' ' VAL . 34.6 m-20 -116.97 125.34 51.25 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.824 -1.176 . . . . 63.1 107.824 176.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.7 t -125.47 142.08 43.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 109.759 -0.46 . . . . 70.11 109.759 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.554 ' HB2' HG21 ' A' ' 113' ' ' VAL . 91.1 t80 -94.34 123.13 37.55 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.044 -1.095 . . . . 64.24 108.044 177.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.563 HG21 ' HB2' ' A' ' 26' ' ' PHE . 14.8 p -107.89 148.41 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 121.445 0.64 . . . . 52.13 110.609 -176.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -118.02 -59.75 1.87 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.175 -0.92 . . . . 74.43 113.046 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.22 -60.14 0.08 OUTLIER Glycine 0 C--N 1.336 0.564 0 C-N-CA 118.663 -1.732 . . . . 64.14 115.41 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.2 m -57.84 -24.34 56.98 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.388 0.884 . . . . 55.01 113.388 -172.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.563 ' HB2' HG21 ' A' ' 22' ' ' VAL . 49.8 m-85 -132.0 25.13 4.61 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.723 -0.843 . . . . 61.22 108.723 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.46 -30.18 68.02 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.308 0.575 . . . . 63.32 112.478 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 31' ' ' VAL . 31.0 t70 -96.65 130.89 29.3 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.893 -0.594 . . . . 72.4 111.334 -176.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.478 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 19.0 Cg_endo -60.24 -28.25 86.52 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.52 2.147 . . . . 52.24 113.692 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.451 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 22.0 t70 -70.52 -41.74 72.18 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.567 -0.453 . . . . 74.31 110.926 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 28' ' ' ASP . 9.8 p -65.92 -28.57 44.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 C-N-CA 119.887 -0.725 . . . . 64.43 109.33 177.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.528 HG23 HD21 ' A' ' 36' ' ' LEU . 37.5 mm -61.52 -46.75 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.598 -0.519 . . . . 75.41 109.598 175.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -60.89 -32.19 71.66 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.925 -0.58 . . . . 53.41 111.94 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.4 t -81.71 -38.91 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 120.636 -0.425 . . . . 74.33 111.59 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -74.75 -36.81 62.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.482 -0.326 . . . . 72.11 110.776 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.528 HD21 HG23 ' A' ' 32' ' ' ILE 0.275 0.4 OUTLIER -117.02 -60.78 1.8 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.169 -0.612 . . . . 52.51 111.987 176.764 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.431 ' OD2' ' HG2' ' A' ' 38' ' ' ARG . 30.5 t70 162.13 -50.99 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 124.597 1.159 . . . . 71.42 110.236 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 4.6 mmp_? -118.88 152.76 35.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.957 -0.565 . . . . 63.52 110.636 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.421 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 5.0 m -95.74 120.2 63.71 Favored Pre-proline 0 C--O 1.245 0.829 0 CA-C-N 116.647 -0.251 . . . . 75.23 111.009 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -67.47 152.71 78.26 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 122.77 2.313 . . . . 71.42 109.36 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.42 129.0 39.86 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.331 -0.547 . . . . 74.21 109.85 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 53.9 mt -110.28 124.93 67.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.495 -0.775 . . . . 73.14 109.226 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.616 HG21 ' HD2' ' A' ' 104' ' ' ARG . 14.0 p -116.41 146.56 20.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 109.007 -0.738 . . . . 74.4 109.007 177.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.6 m -81.44 124.29 29.31 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.627 -0.509 . . . . 65.12 109.627 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -142.83 159.49 42.13 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.171 0.51 . . . . 74.41 111.161 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.6 m -116.51 131.63 56.9 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.313 -0.858 . . . . 72.22 110.8 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.414 HD11 ' HB ' ' A' ' 100' ' ' VAL . 37.7 tp -99.3 99.9 9.27 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 123.984 0.913 . . . . 73.41 110.014 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 66.4 Cg_endo -78.3 143.29 19.65 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.149 1.9 . . . . 73.52 111.693 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.01 5.12 58.48 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 116.077 -0.511 . . . . 63.5 112.306 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.2 168.91 18.51 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 122.358 0.263 . . . . 72.21 110.43 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -139.94 164.7 29.31 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.12 -0.696 . . . . 71.32 109.12 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -130.97 126.41 35.95 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.434 -0.803 . . . . 71.44 110.676 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 37.4 m-85 -114.83 163.89 14.88 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.668 -0.696 . . . . 74.51 109.742 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.839 0 O-C-N 123.485 0.491 . . . . 53.13 111.235 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.401 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 13.5 m-85 . . . . . 0 N--CA 1.432 -1.373 0 N-CA-C 106.913 -1.514 . . . . 74.24 106.913 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 12.2 Cg_endo -59.57 120.79 8.82 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 107.752 -1.672 . . . . 71.22 107.752 166.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.5 p -132.82 160.32 37.25 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.962 0.411 . . . . 73.13 111.128 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mm -110.38 138.18 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.411 -0.959 . . . . 72.24 108.411 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 118' ' ' TRP . 31.1 m -145.9 151.99 46.9 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 108.157 -1.053 . . . . 70.25 108.157 175.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 10.4 Cg_endo -58.53 134.67 62.59 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.645 2.23 . . . . 72.2 112.645 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.4 t -120.51 147.36 45.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.738 -0.838 . . . . 53.41 108.738 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.31 -37.83 68.85 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.341 0.4 . . . . 73.32 110.284 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -142.52 75.81 1.51 Allowed 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 108.751 -0.833 . . . . 72.12 108.751 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.55 168.63 28.52 Favored Glycine 0 C--N 1.287 -2.166 0 C-N-CA 119.538 -1.315 . . . . 53.24 112.68 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -154.51 141.47 19.24 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.64 -0.874 . . . . 64.32 108.64 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.07 119.16 59.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.308 -0.627 . . . . 64.33 109.308 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -89.85 116.07 27.65 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.979 -1.489 . . . . 65.45 106.979 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.86 -148.05 4.72 Favored Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 120.718 -0.753 . . . . 64.21 111.563 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.532 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 46.0 mmtm -127.12 147.11 50.18 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.692 0.282 . . . . 63.11 110.92 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 39.2 t -110.35 127.42 67.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 116.12 -0.491 . . . . 72.44 110.658 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.426 HD23 HG12 ' A' ' 42' ' ' ILE . 73.8 mt -95.32 103.99 15.86 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.347 -1.353 . . . . 73.02 107.347 177.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.6 ptp -109.4 138.63 45.47 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.881 -0.414 . . . . 71.32 109.881 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.81 13.93 26.36 Favored Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 119.462 -1.352 . . . . 73.55 111.743 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.3 p -83.06 129.42 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.588 -0.893 . . . . 71.41 108.588 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 m -73.77 159.82 32.38 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 109.825 -0.435 . . . . 54.53 109.825 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 19.7 m -56.58 -42.32 78.47 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.25 0.463 . . . . 73.34 112.25 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.78 -41.46 99.26 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-O 120.843 0.354 . . . . 62.53 111.372 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.575 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 47.2 mt-10 -70.61 -28.21 64.68 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.269 -0.641 . . . . 72.31 109.269 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.432 ' HB3' ' O ' ' A' ' 81' ' ' SER . 55.2 tp -63.26 -47.15 83.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.496 -0.927 . . . . 63.24 108.496 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 88' ' ' ASP . 47.7 mt-10 -68.52 -29.15 67.67 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.056 -0.974 . . . . 73.12 110.173 176.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 2.3 t-20 -63.15 -45.97 89.39 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.498 1.119 . . . . 72.03 109.052 175.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.5 mt -64.2 -38.76 92.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.611 -0.722 . . . . 72.11 109.367 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 9.7 t70 -58.95 -47.2 85.95 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 115.486 -0.779 . . . . 52.32 110.425 173.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.62 -48.07 83.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.693 -0.685 . . . . 72.51 111.315 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.49 -57.99 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 N-CA-C 113.332 0.864 . . . . 52.12 113.332 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -79.84 -36.43 36.8 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.409 0.623 . . . . 65.12 111.825 -174.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.17 -17.16 22.75 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-N 115.098 -0.956 . . . . 44.41 115.113 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -58.98 -32.41 69.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 111.736 0.273 . . . . 75.11 111.736 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.51 0.51 4.03 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 111.629 0.233 . . . . 63.15 111.629 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -132.05 164.22 26.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.166 0.432 . . . . 64.32 112.166 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.7 tp10 -124.66 143.55 50.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.409 -0.589 . . . . 74.54 109.409 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 115' ' ' THR . 46.0 ttp180 -97.13 114.72 26.43 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.514 -0.55 . . . . 74.02 109.514 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.8 m -116.75 162.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 115.731 -0.668 . . . . 74.03 112.002 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.7 p -86.13 121.9 29.38 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.892 -1.049 . . . . 65.45 109.932 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.414 ' HB ' HD11 ' A' ' 47' ' ' LEU . 33.1 m -134.57 166.08 29.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 115.88 -0.6 . . . . 62.2 112.091 -176.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -118.95 127.72 7.35 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.023 -1.231 . . . . 31.33 110.023 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.01 161.0 16.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 117.096 0.448 . . . . 63.33 111.115 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.6 t -128.53 124.42 61.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.671 -0.862 . . . . 74.54 108.671 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.616 ' HD2' HG21 ' A' ' 43' ' ' VAL . 55.9 mtm180 -63.74 147.52 51.49 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.185 0.517 . . . . 75.25 112.387 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -82.73 -1.49 51.57 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.573 -1.194 . . . . 64.31 110.129 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.18 -59.23 3.01 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.564 -0.743 . . . . 72.41 111.616 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -140.83 5.82 1.98 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 119.788 -0.765 . . . . 64.53 111.415 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.8 t 69.77 78.04 0.2 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.212 0.945 . . . . 73.0 110.99 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -137.09 151.96 49.48 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.231 -1.396 . . . . 70.14 107.231 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -104.76 148.33 26.73 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.764 -0.774 . . . . 73.33 112.888 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.3 mtm -136.4 163.26 30.89 Favored 'General case' 0 CA--C 1.475 -1.935 0 CA-C-N 115.334 -0.848 . . . . 75.23 109.38 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.36 117.97 35.49 Favored 'General case' 0 C--N 1.268 -2.972 0 CA-C-N 114.837 -1.074 . . . . 40.54 109.581 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 21' ' ' PHE . 30.9 m -135.52 174.02 13.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.723 -0.473 . . . . 61.01 109.723 -176.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -116.96 154.24 31.21 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.058 -1.09 . . . . 72.51 108.058 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.2 t -146.02 171.57 14.67 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.182 -0.674 . . . . 73.14 109.182 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.2 m-85 -113.73 112.35 23.31 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.352 -0.61 . . . . 73.5 109.352 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.438 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 24.5 ptt? -112.95 158.15 20.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.703 -0.681 . . . . 62.45 109.834 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.403 ' HB3' HG12 ' A' ' 64' ' ' VAL . 67.6 t-105 -66.76 124.82 23.98 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 107.797 -1.186 . . . . 64.41 107.797 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.21 -43.29 84.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 113.969 1.1 . . . . 62.43 113.969 -165.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -86.24 -9.69 56.03 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.245 -0.982 . . . . 63.34 110.657 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt 55.58 -27.15 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 118.136 2.643 . . . . 74.31 118.136 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -110.58 96.37 6.14 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.56 -0.712 . . . . 72.33 112.348 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -128.1 118.87 20.77 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.036 -0.984 . . . . 74.25 111.326 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.79 -15.87 44.95 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.622 2.215 . . . . 70.23 110.034 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.8 -41.71 87.37 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.205 -1.361 . . . . 65.55 112.409 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 20.3 ptt? . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 122.496 1.141 . . . . 64.34 113.451 -176.419 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' O ' HG12 ' A' ' 144' ' ' ILE . 87.0 tttt . . . . . 0 C--O 1.243 0.734 0 CA-C-O 120.709 0.29 . . . . 73.43 110.672 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.509 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . 32.7 mmtp -48.99 -31.36 7.34 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.369 1.248 . . . . 73.41 114.369 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -54.58 -46.47 73.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.128 0.49 . . . . 72.34 110.849 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -76.29 -36.1 58.54 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.569 0.699 . . . . 72.43 109.205 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 141' ' ' LYS . 50.7 mm -62.04 -33.21 57.22 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 CA-C-N 114.721 -1.127 . . . . 73.3 112.313 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 64.4 mm-40 -54.27 -36.22 63.39 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.045 0.45 . . . . 63.54 110.616 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 89.3 m -74.42 -42.74 58.66 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.403 -0.591 . . . . 74.03 109.403 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -67.75 -29.45 68.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 114.598 1.332 . . . . 71.54 114.598 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 99.3 mttt -53.38 -49.05 68.03 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 109.278 -0.638 . . . . 70.53 109.278 176.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -68.01 -36.24 79.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.206 -0.906 . . . . 64.1 110.55 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.3 -39.83 86.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.594 -0.73 . . . . 70.32 109.688 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 56.9 ttp -73.43 -38.53 65.49 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.508 -0.769 . . . . 74.52 110.599 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 52.1 mt-10 -62.85 -34.63 77.76 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.2 0.524 . . . . 74.53 110.592 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 46.9 t -65.91 -36.22 82.78 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.273 -0.876 . . . . 61.42 109.953 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 N--CA 1.448 -0.558 0 CA-C-N 116.223 -0.444 . . . . 71.21 111.887 -179.287 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 107.988 -1.116 . . . . 64.55 107.988 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.507 ' O ' HG12 ' A' ' 79' ' ' VAL . 54.3 m-70 -112.94 159.26 19.27 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 109.291 -0.633 . . . . 73.14 109.291 -171.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -123.25 125.74 45.64 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.408 -1.33 . . . . 74.03 107.408 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.5 t -129.64 140.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 110.329 -0.248 . . . . 71.01 110.329 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.427 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.6 t80 -94.27 123.79 37.88 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.764 -0.828 . . . . 71.13 108.764 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 74' ' ' LYS . 20.0 m -88.6 154.21 3.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.997 -0.547 . . . . 74.3 110.778 -176.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.431 ' CD2' HG12 ' A' ' 63' ' ' ILE . 1.5 p90 -135.46 -44.84 0.68 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.616 0.969 . . . . 71.12 113.616 -176.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.623 ' O ' ' HG2' ' A' ' 27' ' ' GLN . . . -146.43 -62.28 0.01 OUTLIER Glycine 0 C--O 1.219 -0.81 0 C-N-CA 119.611 -1.28 . . . . 51.53 112.667 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 p -60.81 -22.52 64.25 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 123.894 0.878 . . . . 65.05 112.813 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.466 ' HB3' HD11 ' A' ' 32' ' ' ILE . 25.3 m-85 -127.47 17.41 7.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.155 -0.475 . . . . 75.2 111.116 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 24' ' ' GLY . 16.7 pt20 -78.36 3.51 15.44 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 120.418 -0.513 . . . . 73.12 112.381 -175.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.599 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.3 t70 -130.09 125.66 22.03 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.676 -176.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -62.25 -29.58 80.41 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.254 1.969 . . . . 72.23 113.478 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.486 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 14.9 t70 -64.9 -42.84 94.42 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.228 -0.295 . . . . 64.52 110.781 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 28' ' ' ASP . 8.3 p -67.97 -28.72 42.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 N-CA-C 109.263 -0.643 . . . . 75.44 109.263 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 28' ' ' ASP . 49.9 mm -64.82 -44.01 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 116.323 -0.399 . . . . 71.32 110.436 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -58.7 -35.56 72.83 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.933 0.397 . . . . 75.32 111.204 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -82.14 -47.44 19.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 116.218 -0.447 . . . . 71.13 112.168 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.593 ' HE1' HD23 ' A' ' 87' ' ' LEU . 7.1 tmm? -62.82 -36.34 82.86 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.953 -0.388 . . . . 64.35 109.953 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.491 HD21 HG23 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -119.81 -73.02 0.66 Allowed 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 120.233 -0.587 . . . . 71.54 112.252 174.15 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.439 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 15.5 t70 169.24 -50.2 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.854 -0.795 . . . . 72.23 108.854 -174.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 32' ' ' ILE . 76.0 mtt180 -106.76 150.25 26.5 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 114.898 -1.047 . . . . 65.13 109.938 -174.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 m -103.28 110.21 63.26 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 108.102 -1.073 . . . . 63.34 108.102 170.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.67 151.56 79.64 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 122.802 2.335 . . . . 73.23 110.009 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -56.81 132.76 53.26 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.844 -0.428 . . . . 75.33 109.844 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 27.2 mt -109.59 137.84 39.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.751 -0.658 . . . . 74.02 110.542 -172.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 14.4 p -130.66 147.07 33.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.961 -0.563 . . . . 72.51 109.952 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.4 m -75.99 123.31 25.54 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.581 -0.896 . . . . 71.52 108.581 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.52 155.86 46.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.503 0.668 . . . . 42.0 111.643 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.46 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 95.4 m -115.36 125.93 53.8 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.012 -0.994 . . . . 54.33 110.515 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.5 tp -99.37 100.77 11.16 Favored Pre-proline 0 C--N 1.299 -1.616 0 C-N-CA 123.026 0.53 . . . . 64.34 109.873 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.6 Cg_endo -81.63 136.0 9.42 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.899 2.4 . . . . 73.22 112.829 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.49 15.42 37.75 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.632 -0.713 . . . . 72.02 111.886 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.03 161.15 40.77 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.001 -0.74 . . . . 75.54 109.001 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -140.33 140.91 35.71 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.272 0.558 . . . . 72.2 110.675 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.427 HH12 ' HB3' ' A' ' 54' ' ' ARG . 37.7 tpt85 -94.88 126.2 40.05 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.722 -1.126 . . . . 75.1 109.673 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -124.89 159.42 31.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.263 -0.643 . . . . 73.43 109.263 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.448 ' HE ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.859 0 CA-C-O 119.344 -0.36 . . . . 75.13 111.451 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 N--CA 1.419 -2.009 0 N-CA-C 108.273 -1.01 . . . . 70.1 108.273 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -55.71 115.33 2.38 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.478 2.118 . . . . 63.22 109.621 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.1 p -132.33 159.67 38.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.278 0.473 . . . . 74.32 112.278 -174.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.431 HG12 ' CD2' ' A' ' 23' ' ' TYR . 45.4 mm -115.82 141.92 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.449 -0.945 . . . . 73.43 108.449 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.6 m -143.67 154.53 59.56 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 107.509 -1.293 . . . . 71.1 107.509 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.39 136.4 59.19 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.385 2.057 . . . . 73.41 112.789 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.3 t -124.86 144.06 50.51 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.217 -1.031 . . . . 72.12 108.217 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.07 -37.34 64.25 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.968 -0.382 . . . . 63.53 109.968 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -131.68 75.22 1.63 Allowed 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.713 -0.477 . . . . 74.3 109.713 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.76 157.83 30.46 Favored Glycine 0 N--CA 1.42 -2.376 0 C-N-CA 119.566 -1.302 . . . . 64.21 111.584 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -147.65 150.59 34.67 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 107.688 -1.227 . . . . 73.55 107.688 175.019 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.9 t -112.05 127.65 69.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 109.159 -0.682 . . . . 63.22 109.159 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -99.1 115.54 29.24 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.919 -1.512 . . . . 73.24 106.919 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -149.55 -149.63 5.04 Favored Glycine 0 N--CA 1.411 -2.975 0 N-CA-C 110.27 -1.132 . . . . 73.32 110.27 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.495 ' O ' HG22 ' A' ' 22' ' ' VAL . 1.7 mptm? -128.18 155.08 45.06 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.682 0.753 . . . . 71.21 112.655 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 31.2 t -113.38 132.72 61.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 114.262 -1.335 . . . . 72.11 112.067 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.447 HD23 HG12 ' A' ' 42' ' ' ILE . 85.9 mt -95.82 123.38 39.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.214 -1.402 . . . . 61.21 107.214 172.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 22.0 ptp -127.48 146.46 50.49 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 121.04 -0.264 . . . . 74.14 111.139 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.21 25.73 15.88 Favored Glycine 0 N--CA 1.43 -1.765 0 C-N-CA 119.572 -1.299 . . . . 54.24 111.622 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.1 p -94.38 129.55 44.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 109.601 -0.518 . . . . 54.31 109.601 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.449 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 15.6 m -73.6 159.57 32.89 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 122.874 0.47 . . . . 63.22 110.64 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.3 m -55.4 -37.36 67.52 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.276 0.843 . . . . 73.2 113.276 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -58.92 -51.06 71.65 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 120.868 0.366 . . . . 63.55 110.719 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.653 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 2.3 mp0 -67.49 -28.13 67.58 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 115.937 -0.574 . . . . 71.2 110.516 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.442 HD22 ' CE1' ' A' ' 18' ' ' HIS . 42.4 tp -63.6 -42.83 98.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.093 -0.706 . . . . 74.14 109.093 174.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.31 -31.88 69.4 Favored 'General case' 0 C--O 1.198 -1.624 0 CA-C-N 115.524 -0.762 . . . . 74.21 109.359 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.582 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 2.3 t-20 -61.11 -49.49 77.09 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.452 1.101 . . . . 65.31 109.832 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 86.1 mt -62.25 -42.43 99.32 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.819 -0.808 . . . . 73.45 108.819 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.2 -38.56 90.85 Favored 'General case' 0 C--O 1.205 -1.241 0 CA-C-N 114.68 -1.145 . . . . 72.13 110.402 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.63 -43.68 84.03 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.996 0.518 . . . . 53.23 110.762 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 86' ' ' ASN . 88.7 t -72.29 -58.3 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 116.221 -0.445 . . . . 70.23 111.941 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -79.88 -42.58 23.89 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.721 1.008 . . . . 75.33 113.721 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.52 -17.11 18.4 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 115.659 1.024 . . . . 73.13 115.659 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -63.37 -39.51 94.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.361 -0.607 . . . . 53.22 109.361 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.68 0.33 9.83 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.977 0.418 . . . . 73.43 111.533 -176.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -134.3 168.91 18.03 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.648 0.779 . . . . 73.4 109.97 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 15.7 pt-20 -122.8 137.33 54.96 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.937 -0.394 . . . . 71.44 109.937 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -87.76 112.78 22.78 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.309 -1.367 . . . . 71.41 107.309 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.487 HG11 ' HE2' ' A' ' 117' ' ' MET . 23.0 m -123.04 162.49 23.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 113.237 0.828 . . . . 75.13 113.237 -176.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.8 p -85.07 122.32 29.12 Favored 'General case' 0 N--CA 1.405 -2.716 0 CA-C-N 114.473 -1.239 . . . . 73.21 109.174 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.99 171.23 18.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.319 0.581 . . . . 73.13 111.732 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -123.9 129.2 7.16 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 109.871 -1.292 . . . . 22.24 109.871 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.448 HD12 ' HB3' ' A' ' 111' ' ' MET . 2.8 pp -119.3 152.91 21.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 117.039 0.419 . . . . 52.42 111.199 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 63.7 t -110.81 114.82 48.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 108.708 -0.849 . . . . 33.41 108.708 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -65.56 112.51 3.64 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.394 -0.821 . . . . 71.22 109.747 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.9 -14.28 61.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.244 1.021 . . . . 75.23 108.815 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.66 -48.55 74.83 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.04 -1.891 . . . . 55.0 111.628 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -128.87 -15.21 4.37 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 121.955 -0.466 . . . . 73.21 111.754 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.8 m 77.15 73.24 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.705 1.202 . . . . 72.41 111.882 -176.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -155.01 153.16 30.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.11 1.364 . . . . 62.44 108.056 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 65.1 pttt -93.27 147.17 23.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.24 -0.984 . . . . 63.52 110.732 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.448 ' HB3' HD12 ' A' ' 102' ' ' ILE . 27.1 ttt -140.7 154.12 46.23 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 124.324 1.05 . . . . 70.53 108.85 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.47 130.09 46.5 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.825 0.345 . . . . 75.1 110.983 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 21' ' ' PHE . 27.4 m -146.04 175.28 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.585 -0.894 . . . . 70.12 108.585 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.67 157.98 24.52 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.031 -0.729 . . . . 51.44 109.031 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.0 t -152.09 172.94 15.55 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.969 -0.752 . . . . 71.01 108.969 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 74.3 m-85 -114.77 122.07 45.25 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 123.584 0.553 . . . . 75.03 110.215 -177.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.487 ' HE2' HG11 ' A' ' 98' ' ' VAL . 24.6 ptt? -119.07 156.95 28.8 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.858 -0.61 . . . . 74.23 109.454 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 63.8 t-105 -67.49 135.27 52.79 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.871 -0.789 . . . . 74.11 108.871 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 96' ' ' GLU . 20.4 mm -68.96 -44.4 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 120.553 -0.459 . . . . 72.31 112.097 -170.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -69.81 -32.49 70.97 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.135 0.493 . . . . 75.42 109.76 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.345 9.2 ptpp? 54.91 -1.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.637 2.088 . . . . 64.13 116.637 176.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.85 83.85 2.2 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.628 -1.249 . . . . 74.1 107.628 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.563 ' H ' ' HE3' ' A' ' 126' ' ' MET . 14.2 t70 -120.77 130.33 24.9 Favored Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 115.262 -0.881 . . . . 74.21 110.493 -176.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.49 2.7 8.2 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.89 2.393 . . . . 73.32 114.766 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.61 -34.5 11.39 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 121.834 -0.541 . . . . 63.03 111.653 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.563 ' HE3' ' H ' ' A' ' 123' ' ' ASP 0.352 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.05 0 N-CA-C 114.478 1.288 . . . . 74.05 114.478 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.593 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.1 ttpt . . . . . 0 CA--C 1.508 -0.673 0 N-CA-C 109.309 -0.626 . . . . 73.33 109.309 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 51.4 tttm -50.68 -35.13 29.41 Favored 'General case' 0 C--O 1.217 -0.638 0 C-N-CA 124.074 0.95 . . . . 74.12 111.884 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -68.86 -33.73 74.28 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.241 0.544 . . . . 71.04 110.611 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -77.38 -35.62 54.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.307 -0.627 . . . . 62.12 109.307 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 140' ' ' LYS . 45.3 mm -64.05 -33.51 62.74 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.441 0 CA-C-N 115.253 -0.885 . . . . 62.35 110.379 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.0 mt-10 -54.27 -30.47 50.79 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 113.277 0.843 . . . . 73.12 113.277 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.1 m -64.34 -41.82 96.57 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 108.876 -0.787 . . . . 73.3 108.876 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -76.38 -28.66 56.83 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.446 -0.797 . . . . 71.33 113.003 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 27.2 mmmt -52.95 -44.26 66.96 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 123.229 0.331 . . . . 72.21 110.746 175.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.18 -43.76 82.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.76 0.791 . . . . 71.21 109.275 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 71.2 mt -66.72 -45.69 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 114.596 -1.183 . . . . 73.44 111.248 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' MET . . . . . 0.511 ' HG2' ' HA ' ' A' ' 148' ' ' LYS . 26.1 ptm -74.25 -32.29 62.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.88 0.696 . . . . 73.25 112.88 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 18.1 mm-40 -63.27 -39.33 94.28 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.45 -0.574 . . . . 73.4 109.45 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 81.9 m -69.23 -31.33 69.83 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.664 -0.698 . . . . 71.51 111.419 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 150' ' ' ILE . 98.4 mttt . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 121.577 0.703 . . . . 75.23 109.53 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 121.274 0.559 . . . . 64.2 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.9 m -146.35 18.38 1.36 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.775 -0.824 . . . . 72.12 108.775 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.5 p -84.37 -13.15 53.07 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.762 -1.108 . . . . 72.45 111.563 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.9 t70 65.07 89.06 0.1 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.622 0.769 . . . . 63.21 110.144 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.6 p -106.58 74.52 1.01 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 113.633 0.975 . . . . 65.23 113.633 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 mp -110.26 -63.59 1.37 Allowed 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.599 -1.182 . . . . 55.13 109.53 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -96.39 -10.05 28.52 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.506 -1.224 . . . . 74.24 109.245 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.4 mt -98.02 153.17 18.57 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.621 -1.627 . . . . 70.35 107.862 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.552 ' CG ' ' HG ' ' A' ' 84' ' ' LEU . 39.2 m-70 -121.39 160.6 23.75 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 116.249 -0.432 . . . . 75.03 111.078 -171.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 23.6 p30 -132.38 130.58 40.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.596 -0.729 . . . . 71.33 111.425 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.65 142.05 44.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.41 -0.814 . . . . 72.35 109.986 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -94.05 122.51 36.64 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.75 -1.204 . . . . 74.52 107.75 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.4 m -97.51 161.33 2.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.208 0.527 . . . . 54.15 112.361 -176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.467 ' HA ' ' NH2' ' A' ' 52' ' ' ARG . 9.1 p90 -144.08 -60.2 0.39 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.177 0.806 . . . . 75.2 113.177 -172.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.0 -101.62 2.5 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 119.928 -1.129 . . . . 54.43 113.461 -175.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 t -59.31 -36.61 75.94 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.828 0.851 . . . . 60.21 112.644 -173.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -92.25 17.38 9.77 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.65 0.982 . . . . 73.12 113.65 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -85.67 7.16 24.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 119.576 -0.85 . . . . 64.24 109.988 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 32' ' ' ILE . 19.0 t70 -119.74 127.36 26.45 Favored Pre-proline 0 C--N 1.305 -1.359 0 CA-C-N 115.87 -0.605 . . . . 73.24 109.849 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HB3' HG21 ' A' ' 39' ' ' THR . 38.0 Cg_endo -69.45 -25.26 30.18 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.102 1.868 . . . . 72.4 113.504 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 17.3 t70 -67.59 -41.18 84.5 Favored 'General case' 0 C--N 1.312 -1.034 0 O-C-N 121.817 -0.552 . . . . 72.15 110.819 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 28' ' ' ASP . 11.2 p -68.45 -28.65 41.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.416 -0.587 . . . . 71.54 109.416 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.608 HG23 HD21 ' A' ' 36' ' ' LEU . 48.7 mm -67.09 -47.04 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 116.308 -0.405 . . . . 62.22 110.394 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -57.28 -35.26 69.56 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.059 0.457 . . . . 64.14 111.691 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.1 t -81.76 -47.44 19.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.069 0.396 . . . . 62.51 112.069 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.406 ' HE1' HD23 ' A' ' 87' ' ' LEU . 7.9 tmm? -64.91 -35.9 82.63 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 110.321 -0.252 . . . . 53.33 110.321 -174.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -115.38 -72.82 0.67 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 120.16 -0.616 . . . . 71.44 112.095 174.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.2 t70 179.26 -49.48 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.453 0.644 . . . . 72.12 109.892 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.435 ' O ' HG22 ' A' ' 32' ' ' ILE . 99.4 mtt180 -128.81 173.06 10.69 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 115.262 -0.881 . . . . 71.54 109.155 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.408 HG21 ' HB3' ' A' ' 29' ' ' PRO . 36.7 m -120.95 111.59 34.05 Favored Pre-proline 0 N--CA 1.433 -1.322 0 O-C-N 123.579 0.549 . . . . 75.34 110.336 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.36 152.71 14.92 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 124.262 3.308 . . . . 73.52 111.565 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.03 125.87 23.44 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.358 -0.608 . . . . 62.32 109.358 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.4 mt -102.11 137.29 30.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.592 -0.731 . . . . 74.4 109.651 -174.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.479 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 7.3 p -130.1 143.69 40.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.634 -0.712 . . . . 71.43 110.145 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.2 m -77.0 125.81 29.93 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.986 -1.116 . . . . 71.21 107.986 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.07 156.63 47.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.404 0.621 . . . . 73.4 111.07 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.428 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 71.4 m -114.61 125.39 53.7 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.205 -0.907 . . . . 75.34 110.149 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.41 ' HB2' HG22 ' A' ' 102' ' ' ILE . 35.3 tp -102.19 100.29 14.94 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 116.049 -0.523 . . . . 73.13 109.644 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 46' ' ' THR . 3.0 Cg_endo -83.85 136.87 7.33 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.5 2.133 . . . . 73.33 111.838 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.33 11.09 53.0 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.566 -0.825 . . . . 33.11 111.755 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.431 ' HA ' ' H ' ' A' ' 66' ' ' SER . 86.1 m-85 -141.67 159.68 41.72 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 108.855 -0.795 . . . . 73.2 108.855 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -140.21 141.71 35.91 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.773 -0.455 . . . . 55.53 109.773 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 38.6 ttm180 -102.79 137.53 40.88 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.192 -1.04 . . . . 74.33 108.192 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 10.2 m-85 -108.79 167.52 10.01 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 107.505 -1.294 . . . . 72.5 107.505 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' A' ' 130' ' ' TRP . 12.0 ptm180 -135.85 141.72 44.69 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.489 -0.885 . . . . 73.34 111.965 -172.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 59' ' ' LEU . 42.2 tp 176.09 162.15 0.34 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.526 -1.287 . . . . 70.34 107.526 176.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -150.13 136.35 18.78 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.49 -0.559 . . . . 73.32 109.49 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.59 -77.78 0.39 Allowed Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.651 -0.98 . . . . 73.44 110.651 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -49.25 6.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.481 -1.674 . . . . 74.42 106.481 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.465 ' HB3' HD23 ' A' ' 55' ' ' LEU . 28.2 tp -125.18 164.69 19.72 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.074 -0.713 . . . . 65.41 109.074 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -127.27 173.85 4.9 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 108.59 -0.892 . . . . 74.51 108.59 -170.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 52.8 Cg_exo -58.95 117.8 4.59 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.064 1.842 . . . . 44.13 110.825 175.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 26.3 p -115.47 168.47 9.97 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.097 -0.502 . . . . 50.53 110.663 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 mm -123.04 119.97 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.615 -0.513 . . . . 71.24 109.615 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.11 146.06 59.91 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 110.455 -0.202 . . . . 64.41 110.455 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.59 111.79 1.27 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.121 2.547 . . . . 72.42 112.911 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.431 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 34.0 t -126.25 116.5 21.36 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.582 -0.895 . . . . 61.15 108.582 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 67' ' ' GLU . 1.7 mp0 -60.74 -32.07 71.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.366 0.603 . . . . 73.51 111.328 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -95.62 7.11 47.22 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.771 -0.65 . . . . 74.43 112.012 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.77 167.66 14.49 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 119.578 -1.296 . . . . 72.42 114.03 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 144.07 23.23 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.111 1.365 . . . . 72.24 107.733 175.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.8 t -113.06 119.67 61.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.392 -0.596 . . . . 73.02 109.392 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -93.22 116.05 28.64 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.761 -1.57 . . . . 62.24 106.761 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.51 -158.05 7.6 Favored Glycine 0 N--CA 1.418 -2.521 0 N-CA-C 110.732 -0.947 . . . . 74.1 110.732 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.41 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 13.8 mptt -124.41 148.65 47.44 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.435 0.636 . . . . 62.14 111.948 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.6 t -111.04 130.94 63.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.549 -1.205 . . . . 71.42 111.334 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 77.5 mt -96.71 108.89 21.6 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.452 -1.314 . . . . 70.1 107.452 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.4 ptp -115.64 137.38 52.13 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.29 0.567 . . . . 74.24 112.47 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.91 25.01 7.37 Favored Glycine 0 N--CA 1.427 -1.933 0 CA-C-N 114.982 -1.008 . . . . 44.13 111.568 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.1 p -88.57 142.23 13.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 110.2 -0.296 . . . . 74.11 110.2 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -73.72 161.4 30.29 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 123.836 0.854 . . . . 75.42 112.358 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.2 m -68.87 -35.36 76.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.419 1.266 . . . . 71.3 114.419 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -63.61 -43.74 96.0 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.472 0.653 . . . . 75.23 109.986 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.584 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 9.5 mp0 -69.81 -36.31 75.53 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.776 -1.102 . . . . 75.32 109.843 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.552 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.4 tm? -60.52 -43.73 96.8 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.757 -0.46 . . . . 74.24 109.757 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -71.95 -32.27 67.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.969 0.414 . . . . 71.15 110.863 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -38.32 89.18 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.14 -0.482 . . . . 74.4 110.887 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 96.9 mt -62.23 -42.03 98.94 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.168 -0.678 . . . . 64.45 109.168 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -64.13 -36.06 82.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.348 -0.842 . . . . 63.11 110.417 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.66 -45.37 71.93 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.619 -0.719 . . . . 62.53 110.845 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.79 -51.45 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.918 -0.583 . . . . 73.23 112.368 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.94 -29.23 55.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.909 0.385 . . . . 75.21 111.607 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.62 -17.57 27.52 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 114.717 0.647 . . . . 34.13 114.717 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -59.95 -31.7 70.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.837 0.351 . . . . 71.31 111.515 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.488 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 9.8 pt-20 -142.07 6.21 1.75 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.383 0.512 . . . . 71.04 112.383 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.488 ' CD2' ' HG3' ' A' ' 94' ' ' GLU . 95.4 m-85 -138.08 168.26 20.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.175 -0.466 . . . . 61.45 110.881 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -124.69 145.47 49.66 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.576 -0.898 . . . . 64.0 108.576 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -87.62 113.85 23.69 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.93 -0.767 . . . . 75.51 108.93 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.628 HG11 ' HE1' ' A' ' 117' ' ' MET . 33.6 m -125.34 161.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 116.054 -0.521 . . . . 73.42 111.477 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.0 t -98.97 136.27 39.18 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.185 -0.672 . . . . 75.45 109.185 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' A' ' 47' ' ' LEU . 29.3 m -138.7 165.18 24.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 116.397 -0.365 . . . . 75.23 110.685 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.14 120.31 6.14 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.691 -0.964 . . . . 71.15 110.691 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.41 HG22 ' HB2' ' A' ' 47' ' ' LEU . 2.7 pp -116.24 152.04 17.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 122.308 0.243 . . . . 71.41 110.719 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.7 t -113.6 131.28 65.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 110.132 -0.322 . . . . 64.14 110.132 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.47 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 11.0 mmm180 -58.61 124.41 19.57 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.778 0.831 . . . . 74.31 109.276 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.67 8.38 12.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.926 0.87 . . . . 54.32 109.842 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.62 -66.33 0.91 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.812 -1.551 . . . . 71.41 106.812 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.427 ' HB2' ' HG3' ' A' ' 109' ' ' GLU . 16.6 m-80 -99.53 -108.55 0.2 Allowed 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.606 -0.887 . . . . 63.13 108.606 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.409 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 57.9 m -159.67 19.31 0.17 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 126.424 1.89 . . . . 73.52 106.28 175.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 107' ' ' ASN . 48.1 mt-10 -77.33 143.97 38.37 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 114.846 -1.07 . . . . 72.03 110.472 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.691 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -108.04 147.09 31.63 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.909 -0.774 . . . . 73.52 108.909 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 88.1 mtp -141.02 161.06 38.74 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 123.645 0.778 . . . . 63.23 110.333 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -112.71 120.01 40.06 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.228 -0.897 . . . . 73.31 109.328 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.2 173.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 110.106 -0.331 . . . . 74.51 110.106 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -96.6 155.01 16.95 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.128 -0.693 . . . . 61.42 109.128 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.8 t -155.36 172.0 18.94 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.509 -1.663 . . . . 74.22 106.509 174.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -111.83 119.69 39.45 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.948 -0.76 . . . . 64.32 108.948 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.628 ' HE1' HG11 ' A' ' 98' ' ' VAL . 42.5 ttp -105.8 145.51 31.08 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.029 -0.987 . . . . 74.3 110.196 -173.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.548 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 71.8 t-105 -72.21 124.81 25.82 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.899 -1.149 . . . . 72.21 107.899 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -72.36 -41.27 65.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 114.797 -1.092 . . . . 75.31 111.603 -171.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -81.22 102.5 10.39 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-O 121.147 0.498 . . . . 61.14 109.947 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -75.03 -28.41 60.45 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.347 0.499 . . . . 74.42 112.347 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.3 93.86 4.78 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.588 -0.893 . . . . 41.01 108.588 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -137.93 126.13 14.22 Favored Pre-proline 0 C--N 1.308 -1.212 0 C-N-CA 121.041 -0.263 . . . . 75.14 110.788 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -87.5 -9.67 5.74 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.515 2.143 . . . . 73.5 113.819 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -80.96 -34.9 32.82 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 120.91 0.386 . . . . 44.34 111.016 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -77.49 -11.05 59.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.11 -0.495 . . . . 74.12 111.497 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -58.79 105.4 0.3 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.952 0.723 . . . . 75.33 112.952 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.71 147.53 12.13 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 108.059 -2.016 . . . . 53.22 108.059 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.23 127.4 33.6 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 117.967 0.883 . . . . 62.45 110.237 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.481 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 11.1 t90 -77.22 155.54 32.12 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.963 -0.562 . . . . 75.14 110.126 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -49.82 -46.62 51.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.994 0.918 . . . . 71.33 109.99 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -64.12 -31.77 73.09 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 114.968 -1.015 . . . . 52.01 113.438 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -67.64 -45.67 74.65 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.91 -0.404 . . . . 64.04 109.91 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 8.5 tp10 -64.38 -43.26 95.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.381 -0.827 . . . . 65.31 108.917 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -67.09 -37.72 84.45 Favored 'General case' 0 C--O 1.198 -1.627 0 CA-C-N 115.959 -0.564 . . . . 73.2 111.182 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -55.88 -31.92 63.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.064 0.946 . . . . 71.2 110.384 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 53.3 ttt180 -65.68 -51.98 55.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.973 -1.012 . . . . 73.31 111.308 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.25 -19.59 50.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.558 0.694 . . . . 74.43 110.66 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -68.88 -24.42 64.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.185 -0.916 . . . . 72.33 109.28 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.595 ' O ' HG12 ' A' ' 144' ' ' ILE . 6.0 ttpm? -60.15 -41.92 93.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.52 -0.763 . . . . 75.54 109.559 175.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 38.7 ttpt -57.28 -31.26 65.44 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.647 -0.706 . . . . 70.13 111.499 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.5 -37.16 82.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.453 -0.34 . . . . 73.0 110.381 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.622 ' O ' HG22 ' A' ' 146' ' ' THR . 92.9 m-85 -76.76 -39.23 52.39 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 109.029 -0.73 . . . . 73.13 109.029 175.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.2 mm -60.22 -33.03 52.11 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.859 0 CA-C-N 115.216 -0.902 . . . . 74.44 110.953 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 148' ' ' LYS . 63.1 mm-40 -51.36 -39.27 56.75 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.246 0.832 . . . . 72.55 113.246 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 143' ' ' PHE . 15.2 t -74.9 -29.06 60.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 119.675 -0.81 . . . . 62.12 109.493 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 150' ' ' ILE . 22.7 m-85 -76.41 -35.12 58.75 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 116.121 -0.491 . . . . 72.35 112.239 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.574 ' HG3' HG22 ' A' ' 144' ' ' ILE . 57.3 mtpt -55.66 -31.07 62.05 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 123.96 0.787 . . . . 73.53 112.107 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 14.1 ptmm? -75.05 -34.57 61.86 Favored 'General case' 0 C--O 1.206 -1.198 0 C-N-CA 118.209 -1.397 . . . . 75.34 109.723 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 147' ' ' PHE . 64.8 mt -55.52 -29.62 24.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 C-N-CA 124.819 1.247 . . . . 51.24 112.884 -176.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -54.82 -26.01 32.2 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.503 0.557 . . . . 73.32 112.503 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 149' ' ' LYS . 13.9 pt-20 -57.08 -40.96 77.93 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.084 0.469 . . . . 72.11 110.896 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 50.6 t -71.79 -31.83 67.0 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.556 0.693 . . . . 74.21 109.771 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -75.71 -44.4 42.19 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.069 -0.969 . . . . 72.41 111.292 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -177.72 -42.01 0.01 OUTLIER 'General case' 0 C--O 1.239 0.522 0 N-CA-C 112.542 0.571 . . . . 71.53 112.542 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -140.33 116.25 7.81 Favored Pre-proline 0 C--N 1.309 -1.165 0 C-N-CA 120.393 -0.523 . . . . 53.25 111.478 -171.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.34 130.19 26.2 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.796 2.331 . . . . 72.45 110.99 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 14.8 mm-40 . . . . . 0 C--N 1.313 -1.005 0 CA-C-O 120.586 0.231 . . . . 73.3 111.063 -177.825 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.421 -1.879 0 N-CA-C 109.241 -0.652 . . . . 44.31 109.241 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.0 t -116.09 108.37 16.1 Favored 'General case' 0 N--CA 1.404 -2.73 0 N-CA-C 108.514 -0.921 . . . . 73.02 108.514 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 m -70.64 -37.03 73.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.899 -0.591 . . . . 73.2 110.556 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 60.22 107.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.983 1.475 . . . . 65.4 114.983 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -154.24 154.94 34.31 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.37 -1.345 . . . . 60.03 107.37 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.58 -15.76 62.79 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 115.242 1.571 . . . . 75.32 115.242 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -90.18 2.46 55.33 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.491 0.663 . . . . 62.22 110.97 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.1 mt -90.78 146.59 23.84 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.431 -0.804 . . . . 72.25 110.286 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.433 ' O ' HG12 ' A' ' 79' ' ' VAL . 35.7 m-70 -117.39 161.43 19.57 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.341 -0.845 . . . . 72.34 110.606 -173.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -122.65 127.1 48.9 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.471 -0.937 . . . . 72.23 108.471 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.0 t -125.86 137.94 56.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 116.878 -0.147 . . . . 63.0 110.668 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.538 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.0 t80 -94.72 122.42 37.31 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.589 -1.263 . . . . 73.24 107.589 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.446 HG11 ' HB2' ' A' ' 26' ' ' PHE . 27.2 m -111.43 123.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.738 0.78 . . . . 74.43 111.598 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -77.85 -40.43 40.29 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.869 -1.059 . . . . 65.22 113.46 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.84 -40.66 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 118.814 -1.66 . . . . 74.43 113.539 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.6 m -58.02 -27.79 63.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.736 0.643 . . . . 74.44 112.736 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.463 ' O ' HD11 ' A' ' 32' ' ' ILE . 40.9 m-85 -134.5 28.37 3.66 Favored 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 110.053 -0.351 . . . . 74.44 110.053 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -78.04 -19.11 54.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.103 0.779 . . . . 73.43 113.103 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 31' ' ' VAL . 23.3 t70 -105.47 130.43 23.09 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.193 -0.299 . . . . 62.14 110.193 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HB3' HG21 ' A' ' 39' ' ' THR . 23.3 Cg_endo -61.92 -25.57 78.17 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.941 2.427 . . . . 60.22 114.742 -175.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.06 -43.15 93.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.064 0.459 . . . . 73.31 110.598 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 28' ' ' ASP . 23.4 m -71.28 -28.1 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 115.753 -0.658 . . . . 74.4 110.715 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.526 HG23 HD21 ' A' ' 36' ' ' LEU . 48.4 mm -62.98 -51.69 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 122.699 0.4 . . . . 74.14 111.631 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -57.73 -32.61 67.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.168 0.509 . . . . 60.23 111.641 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.0 t -82.02 -43.74 19.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.932 -0.576 . . . . 45.52 112.034 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.474 ' HE1' HD23 ' A' ' 87' ' ' LEU . 6.7 tmm? -70.97 -37.35 72.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.631 -0.259 . . . . 45.51 110.562 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 32' ' ' ILE 0.261 0.6 OUTLIER -115.05 -67.26 1.01 Allowed 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.903 -0.719 . . . . 72.41 112.378 176.797 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.1 t70 172.11 -50.01 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.092 0.472 . . . . 73.32 109.932 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -123.98 160.55 27.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.934 -0.576 . . . . 73.31 109.671 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.462 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 32.1 m -107.28 106.19 57.72 Favored Pre-proline 0 N--CA 1.436 -1.135 0 O-C-N 123.388 0.43 . . . . 70.25 110.441 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.58 152.25 63.57 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 123.394 2.73 . . . . 74.15 110.155 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -56.43 129.12 39.27 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.094 0.473 . . . . 73.55 110.174 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 32.2 mt -103.62 136.22 37.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.149 -0.686 . . . . 42.02 109.149 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.506 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 15.0 p -129.86 146.99 33.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 116.021 -0.536 . . . . 62.51 110.323 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -75.69 124.25 26.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.351 -0.981 . . . . 72.22 108.351 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.4 158.66 43.57 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.615 0.722 . . . . 75.22 112.33 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.1 m -118.5 132.03 56.23 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.129 -0.941 . . . . 75.21 109.34 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.3 tp -104.4 101.85 29.82 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 109.385 -0.598 . . . . 63.23 109.385 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.1 138.13 9.99 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.702 2.268 . . . . 73.24 111.814 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.04 9.45 53.95 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.892 -0.67 . . . . 25.04 111.721 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.507 ' HE2' ' SD ' ' A' ' 117' ' ' MET . 93.3 m-85 -143.12 152.75 42.17 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.773 -0.825 . . . . 71.11 108.773 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -139.98 147.09 39.95 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.993 -0.743 . . . . 60.32 108.993 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -100.26 132.23 45.75 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.153 -0.684 . . . . 62.24 109.153 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.9 m-30 -107.71 134.95 49.94 Favored 'General case' 0 CA--C 1.472 -2.032 0 N-CA-C 107.195 -1.409 . . . . 74.5 107.195 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 130' ' ' TRP . 14.5 ptm180 -115.68 126.2 53.81 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.195 -1.002 . . . . 75.01 112.368 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -171.53 125.47 0.61 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.267 -2.494 . . . . 73.34 104.267 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -120.41 112.31 18.83 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.803 -0.759 . . . . 73.52 111.134 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.19 -93.9 0.1 Allowed Glycine 0 C--N 1.292 -1.908 0 N-CA-C 109.517 -1.433 . . . . 64.43 109.517 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.446 ' C ' ' HD2' ' A' ' 58' ' ' ARG . 1.4 ppt_? -92.8 -15.08 26.96 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.967 -1.123 . . . . 73.03 107.967 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.47 HD12 ' H ' ' A' ' 60' ' ' TYR . 45.1 tp -125.71 165.08 19.27 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 113.959 -1.473 . . . . 73.54 108.594 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.47 ' H ' HD12 ' A' ' 59' ' ' LEU . 47.7 m-85 -115.96 169.61 6.78 Favored Pre-proline 0 C--N 1.296 -1.722 0 N-CA-C 107.318 -1.364 . . . . 73.44 107.318 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 34.8 Cg_exo -63.71 94.14 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.957 1.772 . . . . 73.1 111.554 174.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 14.3 p -97.0 167.46 11.06 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 124.604 1.161 . . . . 71.2 112.3 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 71' ' ' VAL . 49.5 mm -104.48 139.68 24.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 N-CA-C 108.642 -0.873 . . . . 74.12 108.642 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.68 152.66 60.18 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.499 -0.926 . . . . 72.41 108.499 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.492 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 27.8 Cg_endo -65.54 123.51 11.53 Favored 'Trans proline' 0 C--O 1.249 1.032 0 C-N-CA 122.494 2.129 . . . . 72.51 112.063 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 t -125.14 142.07 51.72 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.364 -0.976 . . . . 71.13 108.364 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.04 -36.38 66.92 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.255 -0.578 . . . . 64.51 111.652 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -109.49 2.81 20.73 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.396 -0.365 . . . . 73.32 111.755 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.11 156.87 21.42 Favored Glycine 0 N--CA 1.434 -1.484 0 C-N-CA 120.067 -1.063 . . . . 52.42 114.374 -174.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 142.66 29.72 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 124.574 1.15 . . . . 55.25 108.056 175.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.446 HG21 HD12 ' A' ' 63' ' ' ILE . 54.6 t -113.65 133.68 58.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 109.513 -0.551 . . . . 60.32 109.513 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -107.28 116.76 32.5 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.279 -1.008 . . . . 74.14 108.279 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.449 ' C ' ' HD3' ' A' ' 74' ' ' LYS . . . -148.95 -154.86 6.48 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 110.987 -0.845 . . . . 65.21 110.987 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.449 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 3.2 mppt? -122.82 150.45 42.82 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 113.218 0.821 . . . . 64.34 113.218 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 44.1 t -110.94 129.16 66.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 114.091 -1.413 . . . . 73.13 111.207 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.6 mt -95.7 109.28 21.58 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.078 -1.452 . . . . 72.34 107.078 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.9 ptp -113.3 127.43 56.15 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.651 0.739 . . . . 75.33 112.36 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 111.36 28.88 3.63 Favored Glycine 0 C--N 1.292 -1.874 0 CA-C-N 114.678 -1.146 . . . . 55.14 111.668 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 83' ' ' GLU . 13.0 p -92.2 132.63 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 109.349 -0.612 . . . . 64.25 109.349 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -73.54 158.56 34.62 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 110.0 -0.37 . . . . 52.53 110.0 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.2 m -62.17 -35.36 78.59 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.265 0.468 . . . . 55.33 112.265 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.86 -36.45 84.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.22 0.533 . . . . 63.44 110.673 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' HB2' HG22 ' A' ' 79' ' ' VAL . 4.4 mm-40 -77.49 -30.54 53.13 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 108.056 -1.09 . . . . 74.32 108.056 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.8 -41.7 95.59 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.82 -0.807 . . . . 71.12 108.82 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.22 -29.76 70.08 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.614 -0.721 . . . . 74.42 110.047 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -72.2 -42.16 66.13 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.771 -0.65 . . . . 60.33 111.663 177.136 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.474 HD23 ' HE1' ' A' ' 35' ' ' MET . 91.0 mt -61.67 -41.95 98.25 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.193 -1.04 . . . . 71.2 108.193 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.434 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 30.9 t70 -65.58 -30.9 71.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.897 -1.501 . . . . 64.42 110.813 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.65 -41.69 53.43 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.934 -0.575 . . . . 61.32 110.529 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.0 t -72.99 -58.31 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 113.013 0.746 . . . . 72.41 113.013 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.68 -23.6 45.57 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.933 -0.479 . . . . 73.54 111.847 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.41 -15.82 18.36 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 114.941 -1.027 . . . . 64.43 115.246 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -57.0 -41.72 78.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.381 0.59 . . . . 73.3 111.618 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -132.42 -0.83 3.57 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.84 0.682 . . . . 61.2 112.84 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -121.53 167.45 12.85 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.281 -1.007 . . . . 73.52 108.281 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HB3' HD11 ' A' ' 119' ' ' ILE . 9.9 tp10 -127.84 152.35 47.93 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.308 -0.997 . . . . 74.31 108.308 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -87.84 112.59 22.64 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.776 -0.824 . . . . 53.45 108.776 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.42 158.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.823 -0.626 . . . . 73.11 110.082 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 t -96.49 132.53 41.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.411 -0.589 . . . . 51.21 109.411 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.65 167.13 24.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 116.147 -0.479 . . . . 72.12 112.063 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.62 127.14 7.57 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 110.663 -0.975 . . . . 71.43 110.663 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -119.98 163.79 17.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 122.538 0.335 . . . . 70.24 111.094 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 59.1 t -120.33 126.37 75.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.039 -0.726 . . . . 73.22 109.039 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.701 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 22.4 mtp180 -73.16 116.11 13.31 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.915 -0.584 . . . . 63.05 110.234 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -79.08 -0.84 33.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 122.451 1.12 . . . . 75.32 108.746 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -67.27 -30.46 70.34 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.319 -1.764 . . . . 71.44 109.193 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.456 ' HB2' ' H ' ' A' ' 108' ' ' SER . 13.8 m-80 -137.41 -95.99 0.21 Allowed 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.238 -1.023 . . . . 74.41 108.238 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 67.6 m -175.83 27.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.319 -2.104 . . . . 62.51 105.319 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.25 143.92 41.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.141 -0.936 . . . . 72.12 111.633 -170.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 21.9 ptmt -96.19 148.88 22.26 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.879 -0.6 . . . . 74.15 111.616 -176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.701 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.2 mtp -143.65 161.05 39.54 Favored 'General case' 0 CA--C 1.484 -1.576 0 C-N-CA 123.83 0.852 . . . . 73.12 111.325 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.8 129.79 54.6 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 114.636 -1.165 . . . . 72.54 108.932 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.538 HG21 ' HB2' ' A' ' 21' ' ' PHE . 34.1 m -143.93 174.52 4.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.865 -0.791 . . . . 51.1 108.865 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -115.34 152.71 32.3 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.926 -0.71 . . . . 73.12 109.631 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 t -148.3 172.89 13.65 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.534 -0.543 . . . . 40.0 109.534 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -117.42 109.16 16.43 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.07 -0.514 . . . . 74.13 109.826 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.507 ' SD ' ' HE2' ' A' ' 50' ' ' PHE . 24.2 ptt? -111.56 156.6 21.5 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.622 -0.717 . . . . 74.41 109.677 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -69.4 116.62 10.03 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.284 -1.376 . . . . 75.34 107.284 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.481 HD11 ' HB3' ' A' ' 96' ' ' GLU . 47.7 mm -73.7 -41.53 54.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 113.009 0.744 . . . . 63.33 113.009 -171.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -61.77 -35.38 77.98 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.186 -0.672 . . . . 74.41 109.186 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.264 9.7 ptpp? 58.16 -37.04 0.05 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 127.721 2.408 . . . . 75.33 115.908 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.01 85.69 4.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.551 0.691 . . . . 63.34 110.952 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -132.25 105.96 13.49 Favored Pre-proline 0 CA--C 1.486 -1.501 0 CA-C-N 115.067 -0.97 . . . . 75.23 110.507 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.42 -17.54 58.31 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.66 2.24 . . . . 72.33 110.801 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.47 -36.51 78.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.023 -0.989 . . . . 72.33 111.159 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.16 135.98 48.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.452 -0.499 . . . . 73.24 111.311 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -171.69 128.49 0.64 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.738 -0.838 . . . . 70.33 108.738 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 168.16 137.78 2.32 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 109.209 -1.557 . . . . 51.43 109.209 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -85.03 130.94 34.53 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.208 -1.034 . . . . 73.44 108.208 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.41 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 25.6 t90 -78.66 156.36 29.05 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.472 -0.936 . . . . 70.03 108.472 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -78.59 79.12 5.03 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.575 0.702 . . . . 71.23 112.412 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -73.5 -32.47 64.29 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.213 -0.903 . . . . 73.52 108.607 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -58.67 -37.73 76.66 Favored 'General case' 0 N--CA 1.417 -2.085 0 C-N-CA 125.245 1.418 . . . . 64.03 109.511 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 6.1 tp10 -66.44 -40.43 89.47 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.017 -0.538 . . . . 72.42 109.733 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -73.01 -35.9 66.89 Favored 'General case' 0 C--O 1.2 -1.542 0 C-N-CA 119.572 -0.851 . . . . 71.21 110.401 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.8 -31.64 69.89 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.292 0.567 . . . . 71.35 109.802 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 17.1 tpp180 -62.51 -53.37 55.75 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.168 -0.924 . . . . 72.43 110.05 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 134' ' ' GLU . 8.2 mp -74.3 -16.43 60.93 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.407 -1.269 . . . . 64.43 110.778 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -67.63 -6.63 21.3 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.49 -1.232 . . . . 63.12 111.517 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.569 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.0 ttpt -57.03 -34.65 68.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.79 -0.819 . . . . 74.21 108.79 172.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 64.6 tttp -59.53 -35.47 74.26 Favored 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.54 -0.755 . . . . 75.22 112.153 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -55.6 -47.99 75.62 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.359 1.076 . . . . 54.01 108.548 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -66.57 -39.64 88.56 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.273 -1.785 . . . . 73.23 108.993 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 140' ' ' LYS . 28.6 mm -72.56 -40.95 63.49 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.332 0 CA-C-N 116.133 -0.485 . . . . 65.51 110.292 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 28.2 mm-40 -61.78 -34.08 75.23 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.972 0.415 . . . . 70.32 110.017 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.537 ' O ' HG13 ' A' ' 150' ' ' ILE . 86.9 m -65.39 -48.18 73.76 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.595 -0.73 . . . . 75.52 109.261 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -70.77 -30.12 66.53 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.155 0.798 . . . . 70.34 113.155 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 ttpt -55.66 -45.77 77.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.588 -1.264 . . . . 71.31 107.588 175.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.53 -34.89 70.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.014 -1.448 . . . . 62.01 110.307 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 146' ' ' THR . 80.2 mt -67.4 -37.22 78.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.28 -0.418 . . . . 71.33 110.285 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.14 -33.09 74.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 75.15 110.129 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 15.3 mm-40 -73.2 -31.07 63.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.077 0.465 . . . . 74.42 110.02 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 51.3 t -69.06 -31.81 70.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.654 -0.703 . . . . 64.44 109.787 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 34.7 mmtp -74.98 -38.88 61.54 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.967 -0.753 . . . . 73.2 108.967 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -58.71 -59.47 5.35 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.042 -0.981 . . . . 62.23 110.255 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.75 112.11 16.17 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 115.022 -0.99 . . . . 63.51 110.274 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -73.84 98.74 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.989 2.46 . . . . 52.4 115.213 -173.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 114.799 -1.092 . . . . 72.15 108.314 172.182 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 108.253 -1.017 . . . . 72.34 108.253 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.8 m -71.8 101.31 2.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.329 0.585 . . . . 72.34 110.235 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 m -67.23 -29.63 69.33 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.079 -0.964 . . . . 74.43 110.923 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 58.04 88.02 0.06 Allowed 'General case' 0 C--N 1.341 0.212 0 O-C-N 124.15 0.906 . . . . 75.31 111.272 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.4 t -161.73 -174.96 4.45 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.934 -1.506 . . . . 73.52 106.934 -175.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.07 106.3 4.88 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-O 121.216 0.531 . . . . 75.14 109.606 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -140.8 -172.09 3.38 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.99 -1.855 . . . . 72.25 105.99 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.3 mt -84.94 153.55 22.76 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.186 -1.042 . . . . 73.12 108.186 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.497 ' ND1' ' HG ' ' A' ' 84' ' ' LEU . 52.8 m-70 -114.8 160.28 19.62 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.07 0.462 . . . . 74.43 112.16 -171.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 21.6 p30 -131.84 125.64 32.3 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.283 -1.326 . . . . 65.13 110.506 174.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 65.5 t -126.3 140.58 48.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.189 -0.914 . . . . 64.42 110.17 -174.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.495 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.5 t80 -94.66 122.97 37.81 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.675 -0.861 . . . . 75.23 108.675 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -100.69 144.33 12.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 116.252 -0.431 . . . . 71.43 109.886 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -83.51 -0.19 49.19 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.967 0.728 . . . . 71.52 112.967 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.13 -22.92 4.42 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.066 -1.064 . . . . 65.43 112.169 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.1 p -58.76 -36.4 74.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.135 0.493 . . . . 73.51 112.168 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.59 ' HB3' HD11 ' A' ' 32' ' ' ILE . 53.0 m-85 -125.84 35.9 4.62 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.709 -0.678 . . . . 72.22 110.908 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -77.79 -14.97 59.42 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.052 0.453 . . . . 75.03 110.728 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.57 121.23 63.7 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.736 -0.666 . . . . 75.4 109.472 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 30.7 Cg_endo -63.98 -28.86 66.43 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.858 2.372 . . . . 64.2 114.069 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 34' ' ' VAL . 24.2 t70 -69.1 -38.12 78.77 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.49 -0.484 . . . . 75.32 110.142 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.78 -38.94 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.548 -0.751 . . . . 53.32 109.423 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.59 HD11 ' HB3' ' A' ' 26' ' ' PHE . 34.1 mm -58.46 -51.76 67.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.63 -0.713 . . . . 50.32 110.893 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -54.21 -34.27 60.19 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.236 0.458 . . . . 64.02 112.236 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 30' ' ' ASP . 47.3 t -81.03 -45.34 21.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 116.261 -0.427 . . . . 75.2 111.366 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.554 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.0 tmm? -67.21 -37.38 83.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.501 -0.318 . . . . 64.23 110.309 -173.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.485 HD21 HG23 ' A' ' 32' ' ' ILE 0.282 0.9 OUTLIER -116.24 -67.18 1.01 Allowed 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 119.188 -1.005 . . . . 74.21 112.738 176.728 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 38' ' ' ARG . 35.0 t70 174.98 -49.07 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.274 0.359 . . . . 73.22 111.364 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.426 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 20.1 mmt180 -131.11 162.73 29.22 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.257 -0.646 . . . . 64.24 109.257 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.457 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 20.4 m -102.87 112.44 65.74 Favored Pre-proline 0 N--CA 1.437 -1.115 0 O-C-N 123.26 0.35 . . . . 65.22 111.525 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.69 152.85 74.18 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.173 2.582 . . . . 65.42 109.336 170.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.54 130.96 47.29 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.131 0.491 . . . . 62.33 110.332 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 44.3 mt -114.47 138.94 42.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.583 -0.525 . . . . 74.13 109.583 -175.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.91 146.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.921 -0.77 . . . . 75.52 108.921 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.7 m -77.06 133.76 38.98 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.432 -1.321 . . . . 72.24 107.432 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.53 159.76 41.42 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.089 0.471 . . . . 45.55 111.697 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.5 m -110.51 125.27 53.15 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.327 -0.851 . . . . 64.34 110.812 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.8 tp -102.4 103.65 32.64 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 123.502 0.721 . . . . 61.13 109.307 175.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 74.2 Cg_endo -82.0 142.44 12.39 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.261 1.974 . . . . 70.34 111.535 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.74 5.75 61.15 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.978 -0.556 . . . . 63.25 112.633 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -141.86 155.93 45.54 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 122.186 -0.596 . . . . 74.14 109.76 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.434 ' HA ' ' OE1' ' A' ' 51' ' ' GLN . 4.7 tp60 -140.75 146.94 38.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.746 -0.464 . . . . 72.14 109.746 176.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 41.0 ptt180 -101.32 129.92 47.4 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.626 0.727 . . . . 62.04 111.286 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.683 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 18.3 m-85 -107.77 153.49 22.9 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.545 -1.28 . . . . 62.54 107.545 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.73 165.71 26.74 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 114.902 1.445 . . . . 74.51 114.902 -167.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 76.4 mt -141.85 -71.71 0.34 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.895 -1.891 . . . . 71.32 105.895 167.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt 161.62 -70.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.737 1.615 . . . . 75.4 110.352 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.63 -30.08 2.49 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.968 -0.634 . . . . 44.11 112.49 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -57.68 5.66 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 104.24 -2.504 . . . . 75.35 104.24 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.45 HD11 ' CH2' ' A' ' 118' ' ' TRP . 24.4 tp -127.4 163.26 24.43 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 108.432 -0.951 . . . . 64.22 108.432 173.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -113.18 176.45 1.48 Allowed Pre-proline 0 C--N 1.286 -2.158 0 N-CA-C 107.838 -1.171 . . . . 75.35 107.838 -169.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.683 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 20.5 Cg_exo -65.98 90.98 0.25 Allowed 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.579 1.519 . . . . 73.53 110.859 175.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 19.3 p -83.11 127.65 33.78 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 115.278 -0.874 . . . . 72.32 111.152 -174.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' MET . 49.4 mm -84.66 111.24 20.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.636 -0.711 . . . . 55.41 109.574 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.56 143.86 42.73 Favored Pre-proline 0 C--N 1.289 -2.049 0 N-CA-C 109.684 -0.487 . . . . 51.44 109.684 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.9 125.72 17.86 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.46 2.107 . . . . 64.22 112.799 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.3 t -124.58 122.3 37.18 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.099 -1.815 . . . . 60.14 106.099 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.61 -30.87 65.68 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.129 0.418 . . . . 70.45 112.129 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -136.54 77.35 1.64 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.6 0.714 . . . . 75.23 111.024 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.98 166.81 30.5 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 109.317 -1.513 . . . . 74.15 109.317 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -151.9 141.34 21.59 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 117.745 0.773 . . . . 62.4 110.541 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.07 131.45 64.67 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 109.001 -0.74 . . . . 74.34 109.001 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -107.78 115.8 30.79 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.222 -1.399 . . . . 65.42 107.222 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.65 -147.76 4.93 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.846 -0.901 . . . . 54.24 110.846 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -125.29 145.59 49.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 112.566 0.58 . . . . 74.32 112.566 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 46.8 t -110.58 124.88 67.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 114.64 -1.164 . . . . 62.43 110.502 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 67.2 mt -95.75 109.77 22.02 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.594 -1.262 . . . . 73.14 107.594 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.413 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 14.9 ptp -117.35 142.63 46.87 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.28 0.562 . . . . 65.32 111.738 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.23 29.12 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.291 -0.868 . . . . 55.33 111.195 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 83' ' ' GLU . 12.9 p -86.44 142.0 13.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 108.516 -0.92 . . . . 51.23 108.516 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -82.9 174.48 10.89 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.471 -0.492 . . . . 73.41 111.552 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.1 p -61.34 -45.26 95.16 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.75 1.018 . . . . 63.31 113.75 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.1 -36.56 84.0 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.673 0.749 . . . . 72.2 110.838 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.526 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.5 mt-10 -78.54 -28.49 46.11 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.225 -0.898 . . . . 73.22 109.432 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HG ' ' ND1' ' A' ' 18' ' ' HIS . 2.9 tm? -67.68 -41.56 83.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.862 -0.608 . . . . 75.21 109.689 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.39 -29.4 61.52 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.203 -0.453 . . . . 70.44 109.796 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 14.0 t-20 -56.45 -47.57 78.88 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.745 0.818 . . . . 74.44 110.282 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.7 mt -60.82 -33.8 73.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.39 -0.823 . . . . 63.14 111.031 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 18.8 t70 -73.06 -36.93 66.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.309 0.576 . . . . 52.14 109.589 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.77 -47.27 72.7 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.693 -0.685 . . . . 60.23 110.62 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 87' ' ' LEU . 12.2 p -72.59 -56.49 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 113.119 0.785 . . . . 52.21 113.119 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -77.54 -22.96 50.26 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.995 -0.44 . . . . 44.14 111.575 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -60.03 -17.49 44.57 Favored Glycine 0 C--O 1.221 -0.675 0 N-CA-C 115.194 0.837 . . . . 54.42 115.194 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -69.86 -38.36 76.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.471 0.635 . . . . 74.52 111.228 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.82 -28.47 11.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.036 0.446 . . . . 70.22 111.838 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.404 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 91.3 m-85 -124.28 170.21 11.0 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.406 0.682 . . . . 71.51 111.703 -174.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 41.0 tt0 -123.23 151.61 42.12 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.846 -0.798 . . . . 75.42 108.846 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 88' ' ' ASP . 11.2 ttm-85 -86.7 119.63 27.14 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.826 -0.805 . . . . 75.34 108.826 -175.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.482 HG11 ' CE ' ' A' ' 117' ' ' MET . 27.7 m -124.7 162.16 27.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 121.019 0.438 . . . . 73.41 111.584 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.0 t -104.01 129.19 51.6 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.302 -0.863 . . . . 71.31 108.884 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -141.79 171.44 11.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.082 0.468 . . . . 65.03 111.989 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -114.58 139.24 15.45 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.792 -1.323 . . . . 71.54 109.792 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.463 HD11 ' HE2' ' A' ' 111' ' ' MET . 2.6 pp -134.07 164.99 33.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.139 0.469 . . . . 51.24 111.109 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.2 t -129.03 131.11 68.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.396 -1.335 . . . . 71.53 107.396 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -74.16 146.3 43.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.935 0.398 . . . . 72.12 110.648 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -88.85 -8.98 53.32 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.084 -0.507 . . . . 74.04 111.326 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -79.56 -48.21 14.21 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.567 -0.288 . . . . 62.41 111.243 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.498 ' ND2' ' HG2' ' A' ' 109' ' ' GLU . 3.0 p-10 -146.6 22.18 1.3 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.699 0.629 . . . . 73.13 112.699 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m 66.88 27.45 9.0 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 115.789 1.774 . . . . 73.25 115.789 170.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.498 ' HG2' ' ND2' ' A' ' 107' ' ' ASN . 20.2 mm-40 -77.04 141.02 40.48 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.511 -0.876 . . . . 75.42 108.947 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -98.48 139.46 34.18 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.624 -0.509 . . . . 71.22 109.624 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.463 ' HE2' HD11 ' A' ' 102' ' ' ILE . 38.7 mtm -142.15 163.88 31.68 Favored 'General case' 0 CA--C 1.473 -1.989 0 CA-C-O 121.8 0.81 . . . . 51.13 111.387 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -112.24 122.99 49.3 Favored 'General case' 0 C--N 1.267 -3.003 0 CA-C-N 113.919 -1.492 . . . . 71.2 107.993 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.1 m -138.16 173.53 12.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.404 0.621 . . . . 70.52 110.881 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -104.4 150.85 24.16 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.982 -1.118 . . . . 70.43 107.982 175.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.7 t -146.83 172.23 13.98 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.404 -0.961 . . . . 74.34 108.404 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 96.5 m-85 -111.91 112.82 24.74 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.585 0.707 . . . . 73.33 109.779 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.482 ' CE ' HG11 ' A' ' 98' ' ' VAL . 12.9 tmm? -106.07 146.67 29.85 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.412 -1.267 . . . . 75.51 110.871 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.45 ' CH2' HD11 ' A' ' 59' ' ' LEU . 70.0 t-105 -72.8 117.3 14.34 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.309 -0.859 . . . . 74.32 110.307 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.8 mt -57.81 -41.2 79.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 113.796 -1.547 . . . . 75.32 113.004 -172.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -89.27 91.11 8.63 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 119.904 -0.718 . . . . 72.01 110.435 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.11 -30.82 71.9 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.608 -0.724 . . . . 75.12 110.417 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.37 85.95 2.22 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.879 -0.785 . . . . 51.15 108.879 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.49 122.06 28.15 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-N 115.292 -0.867 . . . . 75.12 108.769 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -84.29 0.56 9.12 Favored 'Trans proline' 0 C--N 1.328 -0.536 0 C-N-CA 122.852 2.368 . . . . 71.22 113.918 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.12 -23.81 11.82 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 119.951 -0.699 . . . . 63.43 112.271 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.8 ptt? -76.55 1.01 17.94 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.098 0.407 . . . . 75.23 112.098 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -61.05 115.24 3.59 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 122.61 1.195 . . . . 74.41 113.461 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 147.69 98.66 0.21 Allowed Glycine 0 N--CA 1.411 -2.972 0 N-CA-C 105.991 -2.844 . . . . 54.05 105.991 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -88.44 146.98 24.92 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.964 -0.754 . . . . 73.2 108.964 -170.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -68.99 135.7 51.32 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.196 -1.039 . . . . 72.11 108.196 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -64.75 87.13 0.05 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.023 0.916 . . . . 74.53 112.398 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -73.34 -35.37 66.0 Favored 'General case' 0 N--CA 1.384 -3.74 0 CA-C-N 113.886 -1.506 . . . . 74.52 112.49 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.14 -31.64 72.14 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 111.74 0.274 . . . . 61.51 111.74 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.676 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 44.9 tt0 -66.95 -37.0 83.49 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 120.824 0.345 . . . . 73.41 110.776 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -73.14 -36.88 66.76 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.977 -0.689 . . . . 71.35 109.339 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 136' ' ' LYS . 38.8 ttmt -60.14 -31.33 69.98 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.267 -0.879 . . . . 62.44 109.87 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.676 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 22.5 tpt180 -55.79 -51.27 68.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.997 0.919 . . . . 73.04 111.324 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.73 -16.48 44.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.456 0.646 . . . . 72.53 110.691 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -64.69 -16.06 62.3 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.309 -0.86 . . . . 65.04 112.091 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.612 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.7 ttpt -55.55 -35.2 65.45 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.816 0.341 . . . . 72.32 110.107 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -53.13 -36.23 60.57 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.9 1.28 . . . . 74.21 110.586 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.6 -42.41 98.24 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.113 0.483 . . . . 70.31 110.63 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -73.77 -31.77 63.47 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.341 0.591 . . . . 72.51 109.56 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.2 mm -59.75 -32.76 50.24 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.911 0 CA-C-N 115.283 -0.872 . . . . 74.01 110.551 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -61.49 -36.3 80.07 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.209 0.528 . . . . 44.23 110.99 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.8 m -72.46 -47.93 44.97 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.861 -0.792 . . . . 71.42 108.861 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.614 ' O ' ' HG2' ' A' ' 151' ' ' MET . 58.9 m-85 -66.54 -28.87 68.88 Favored 'General case' 0 C--O 1.2 -1.528 0 N-CA-C 113.454 0.909 . . . . 74.42 113.454 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -52.62 -47.63 66.88 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.973 0.909 . . . . 53.21 109.902 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -39.39 73.48 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.857 -0.794 . . . . 75.02 108.857 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.64 -52.28 42.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.179 -0.464 . . . . 63.34 111.927 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.614 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 26.5 ptt? -76.37 -40.55 50.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.927 1.084 . . . . 72.21 113.927 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -62.77 -30.24 71.3 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 112.945 0.72 . . . . 74.54 112.945 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 82.1 m -71.41 -30.06 65.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.01 0.374 . . . . 71.12 112.01 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.49 -39.85 44.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.984 0.897 . . . . 71.31 108.752 175.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -47.93 78.74 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 125.533 1.533 . . . . 73.22 110.133 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -133.8 101.0 13.05 Favored Pre-proline 0 C--N 1.311 -1.078 0 N-CA-C 107.877 -1.157 . . . . 73.54 107.877 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -53.53 -38.3 83.43 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 123.669 2.912 . . . . 64.01 114.009 -175.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 120.988 0.423 . . . . 60.24 110.29 179.855 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 113.428 0.899 . . . . 70.2 113.428 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 p -141.96 18.52 2.13 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.052 -1.092 . . . . 65.11 108.052 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 p -71.93 -19.68 61.87 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.655 -1.157 . . . . 74.43 112.503 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -92.05 -178.97 5.15 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.177 -0.675 . . . . 73.54 109.177 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 t -96.29 96.0 8.48 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 108.833 -0.803 . . . . 73.45 108.833 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -99.62 179.58 4.5 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 116.45 -0.341 . . . . 72.31 111.201 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 66.68 -167.02 0.21 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.214 1.006 . . . . 61.21 109.722 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.91 153.82 27.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.044 -1.095 . . . . 70.43 108.044 176.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.416 ' CE1' HD22 ' A' ' 84' ' ' LEU . 30.4 m-70 -114.56 159.62 20.2 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 109.847 -0.427 . . . . 71.31 109.847 -170.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 18.1 p30 -130.41 133.34 46.29 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.331 -0.85 . . . . 75.13 110.518 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.84 140.31 49.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.442 -0.799 . . . . 62.14 110.223 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -94.61 122.47 37.24 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.467 -0.938 . . . . 73.32 108.467 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.47 143.01 12.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.043 0.449 . . . . 73.01 110.767 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.487 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 16.9 p90 -122.1 -1.94 9.22 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.951 1.463 . . . . 74.11 114.951 -168.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.81 -67.42 0.24 Allowed Glycine 0 C--N 1.314 -0.689 0 C-N-CA 119.329 -1.415 . . . . 55.14 112.528 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 p -58.12 -34.87 70.7 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.22 0.608 . . . . 74.33 111.7 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 26.8 m-85 -118.95 27.49 8.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.044 -0.526 . . . . 51.34 110.519 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -78.98 15.34 1.12 Allowed 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 121.963 0.887 . . . . 71.2 110.834 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -137.84 128.47 15.67 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.322 -0.992 . . . . 71.53 108.322 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.49 -31.28 87.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.787 2.324 . . . . 73.15 114.423 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.95 -37.9 82.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.292 0.567 . . . . 72.21 109.654 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.64 -38.85 83.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.176 -0.92 . . . . 74.14 109.468 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 26' ' ' PHE . 6.5 mm -62.58 -50.51 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-O 122.125 0.964 . . . . 54.52 109.91 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -54.01 -43.63 70.23 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.266 -1.788 . . . . 74.13 111.607 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.5 t -81.72 -32.44 11.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.912 -0.585 . . . . 61.31 111.936 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.453 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.7 tmm? -70.55 -37.46 74.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.989 -0.284 . . . . 64.52 110.774 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 32' ' ' ILE 0.277 0.4 OUTLIER -109.8 -71.86 0.75 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.599 0.963 . . . . 74.45 113.599 179.266 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.8 t70 176.11 -45.03 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.25 0.548 . . . . 73.01 109.838 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -120.79 176.2 5.65 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.53 -0.759 . . . . 73.33 109.487 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 m -123.03 100.68 39.63 Favored Pre-proline 0 N--CA 1.425 -1.689 0 N-CA-C 106.624 -1.621 . . . . 72.21 106.624 170.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 34.1 Cg_exo -58.71 151.57 62.61 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.833 2.355 . . . . 65.04 111.74 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.5 122.91 13.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.496 0.718 . . . . 71.52 111.167 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.58 HG12 ' HG ' ' A' ' 76' ' ' LEU . 24.0 mt -97.72 140.37 18.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.292 -0.867 . . . . 71.34 110.384 -173.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.14 145.47 35.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.794 -1.187 . . . . 75.1 107.794 172.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.9 m -81.05 123.73 28.61 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.939 -0.763 . . . . 61.25 108.939 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.17 159.14 42.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.266 0.555 . . . . 70.33 111.849 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 90.7 m -117.55 132.93 56.45 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.093 -0.958 . . . . 75.42 110.094 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.0 tp -102.56 100.94 17.5 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 123.018 0.527 . . . . 74.04 109.702 176.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 46' ' ' THR . 6.0 Cg_endo -85.98 145.22 8.69 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.581 2.187 . . . . 62.52 111.843 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.8 11.09 59.45 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 111.263 -0.735 . . . . 64.22 111.263 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -144.44 157.07 44.42 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 108.168 -1.049 . . . . 64.1 108.168 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -138.37 146.22 42.03 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.189 -0.671 . . . . 65.52 109.189 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' A' ' 63' ' ' ILE . 38.1 ptt180 -90.36 126.69 35.95 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.963 -1.017 . . . . 71.04 111.959 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.56 ' HA ' ' HA2' ' A' ' 128' ' ' GLY . 10.3 m-85 -109.92 135.75 50.3 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.127 -1.434 . . . . 64.52 107.127 174.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.702 ' HG2' ' CD1' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -106.28 166.17 10.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.175 -0.328 . . . . 72.21 111.823 -176.554 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.75 85.13 3.36 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 106.982 -1.488 . . . . 70.32 106.982 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.465 ' O ' ' HD3' ' A' ' 56' ' ' LYS . 13.8 tmtt? -124.11 -5.09 7.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.406 -1.27 . . . . 72.33 107.66 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.11 -136.9 4.78 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 108.068 -2.013 . . . . 50.23 108.068 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.35 5.18 44.38 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 118.005 0.902 . . . . 74.25 112.391 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.647 HD23 ' HB3' ' A' ' 126' ' ' MET . 43.8 tp -111.85 163.1 14.57 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.451 -0.5 . . . . 72.2 110.162 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -75.38 169.02 22.42 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 124.321 1.048 . . . . 74.34 109.848 -173.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 7.1 Cg_exo -73.58 86.51 1.19 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.591 1.527 . . . . 72.55 110.687 173.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 27.8 p -98.15 -178.41 4.05 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.844 -0.617 . . . . 60.22 112.126 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.487 ' CG1' ' HB2' ' A' ' 23' ' ' TYR . 47.8 mm -132.43 142.15 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.09 -1.448 . . . . 64.14 107.09 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' A' ' 118' ' ' TRP . 34.1 m -144.64 154.71 56.37 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.456 -0.942 . . . . 62.24 108.456 175.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -60.99 128.67 26.1 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.432 2.088 . . . . 74.34 112.125 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -125.79 145.3 50.27 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 116.152 -0.476 . . . . 72.13 110.011 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.48 -35.21 65.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.505 -0.924 . . . . 61.24 108.505 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -128.93 77.22 1.77 Allowed 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.148 -0.933 . . . . 74.4 110.797 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.59 151.0 19.83 Favored Glycine 0 N--CA 1.412 -2.936 0 CA-C-N 114.917 -1.038 . . . . 54.43 111.917 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.76 138.11 18.5 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.447 1.099 . . . . 74.32 108.501 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t -113.38 119.95 62.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 120.737 0.303 . . . . 51.44 110.615 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -91.91 116.55 29.01 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.45 -0.945 . . . . 64.22 108.45 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.11 -146.6 4.37 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.508 -0.853 . . . . 54.13 112.41 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.0 mmtm -127.77 141.56 51.55 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.724 0.297 . . . . 63.02 111.022 -175.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 47.5 t -111.52 129.51 66.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 115.913 -0.585 . . . . 75.45 110.358 173.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.58 ' HG ' HG12 ' A' ' 42' ' ' ILE . 6.5 mp -106.11 114.12 28.06 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.447 -0.797 . . . . 70.14 110.922 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 58.1 mtp -104.14 145.04 30.76 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.217 -1.356 . . . . 73.23 110.366 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.02 9.27 32.53 Favored Glycine 0 C--N 1.299 -1.519 0 C-N-CA 120.113 -1.041 . . . . 71.21 111.955 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 80' ' ' THR . 57.8 t -67.75 127.49 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.082 -0.71 . . . . 75.14 109.082 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.416 ' O ' HG12 ' A' ' 79' ' ' VAL . 65.3 p -82.17 167.62 18.52 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.388 -0.968 . . . . 60.44 108.388 176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 34.6 t -55.26 -45.63 76.08 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 117.529 0.15 . . . . 61.25 110.946 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -58.26 -42.18 85.88 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.041 0.385 . . . . 55.42 112.041 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 39.7 mt-10 -73.22 -40.63 64.56 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.467 -0.568 . . . . 74.53 109.467 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.416 HD22 ' CE1' ' A' ' 18' ' ' HIS . 33.6 tp -55.91 -50.75 69.85 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.296 0.569 . . . . 73.23 109.896 175.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 81' ' ' SER . 43.1 mt-10 -64.82 -29.13 70.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.062 -0.972 . . . . 61.15 110.251 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -44.7 64.62 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 123.804 0.842 . . . . 71.43 112.139 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 92.6 mt -62.5 -40.95 98.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.227 -1.027 . . . . 63.51 108.227 176.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.481 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 16.7 t70 -66.37 -29.29 69.44 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 114.463 -1.244 . . . . 71.23 110.886 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.0 -45.32 42.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.115 0.483 . . . . 74.33 110.398 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.2 t -72.16 -58.41 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-N 115.749 -0.66 . . . . 74.11 112.189 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.52 -24.52 42.16 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.855 0.687 . . . . 73.51 112.855 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -63.74 -16.15 58.71 Favored Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.809 -0.632 . . . . 43.13 114.391 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -67.49 -30.39 70.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.886 0.343 . . . . 73.41 111.685 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -127.14 -0.25 6.46 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.022 0.379 . . . . 72.41 112.022 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -132.7 168.18 18.78 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.112 0.565 . . . . 74.23 110.332 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -124.56 148.71 47.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.533 -0.543 . . . . 74.03 109.533 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 -88.13 113.45 23.76 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.595 -0.891 . . . . 54.22 108.595 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.8 m -115.84 161.41 14.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 116.28 -0.418 . . . . 73.22 111.805 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.6 t -107.68 124.7 50.37 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.173 -1.047 . . . . 50.12 108.173 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.21 170.87 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 116.121 -0.491 . . . . 74.12 111.285 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.91 118.78 4.85 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 111.052 -0.819 . . . . 64.24 111.052 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.7 pp -111.01 165.05 6.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 110.031 -0.359 . . . . 64.54 110.031 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.3 t -122.68 124.68 71.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.519 -0.548 . . . . 72.1 109.519 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -72.66 121.4 19.72 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.177 -0.92 . . . . 74.12 110.722 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.19 -23.59 65.7 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.611 0.765 . . . . 70.5 111.945 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -64.42 -57.65 8.69 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.311 0.485 . . . . 75.55 112.311 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -127.05 7.41 6.6 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.086 0.773 . . . . 71.42 113.086 -169.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.2 t 71.46 12.23 6.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.058 0.943 . . . . 74.43 112.418 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -82.17 147.03 29.24 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.058 0.456 . . . . 75.11 111.231 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -92.02 147.4 22.99 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.421 -0.809 . . . . 74.1 110.094 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.45 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 89.1 mtp -136.22 160.38 38.85 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.378 -0.828 . . . . 74.15 109.524 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.17 117.03 33.06 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 115.534 -0.757 . . . . 60.03 109.603 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.3 m -131.68 173.21 15.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 116.128 -0.487 . . . . 73.24 110.186 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -106.1 149.59 26.6 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.089 -0.708 . . . . 74.44 109.089 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -153.15 172.88 16.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.977 -0.749 . . . . 70.14 108.977 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -119.95 109.76 15.91 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.288 0.566 . . . . 73.32 110.623 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -106.71 157.16 17.93 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.178 -0.919 . . . . 74.24 108.719 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.528 ' CH2' HD11 ' A' ' 59' ' ' LEU . 70.7 t-105 -67.99 143.51 55.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.211 -0.663 . . . . 73.22 109.211 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.6 mm -72.44 -42.33 64.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 113.499 0.925 . . . . 61.3 113.499 -170.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -88.9 -41.17 12.59 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 114.055 1.132 . . . . 73.52 114.055 -171.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.418 ' H ' ' HD1' ' A' ' 118' ' ' TRP 0.407 0.0 OUTLIER 56.12 1.57 0.07 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.56 2.43 . . . . 75.41 117.56 179.621 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.82 9.93 28.78 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.982 -0.747 . . . . 64.55 108.982 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.435 ' CG ' ' HE1' ' A' ' 118' ' ' TRP . 2.9 m-20 -68.13 123.44 87.31 Favored Pre-proline 0 C--N 1.312 -1.023 0 C-N-CA 124.715 1.206 . . . . 72.04 111.4 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.7 -7.3 10.56 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.411 2.074 . . . . 74.52 112.18 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.89 -2.9 56.59 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.238 0.829 . . . . 63.3 113.238 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.647 ' HB3' HD23 ' A' ' 59' ' ' LEU . 25.7 ptt? -102.4 143.06 32.62 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.67 -0.863 . . . . 72.31 108.67 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -131.2 132.72 44.89 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 120.888 0.375 . . . . 73.42 110.021 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -82.14 53.28 4.75 Favored Glycine 0 CA--C 1.499 -0.942 0 N-CA-C 111.225 -0.75 . . . . 74.23 111.225 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.82 126.35 45.46 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-O 121.966 0.889 . . . . 75.13 111.111 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.702 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 6.2 t90 -130.95 157.36 43.16 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 101.967 -3.346 . . . . 74.41 101.967 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -51.09 -44.58 61.27 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 120.36 1.436 . . . . 52.13 111.561 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -73.93 -39.09 64.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.872 0.368 . . . . 75.11 111.863 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.657 ' HB2' ' H ' ' A' ' 130' ' ' TRP . 15.9 mm-40 -64.15 -28.27 69.65 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.297 -0.411 . . . . 75.44 110.792 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 45.1 tt0 -63.48 -37.74 88.47 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.863 -0.421 . . . . 63.52 109.863 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -74.44 -33.79 63.03 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.779 -0.768 . . . . 63.43 109.415 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 53.8 tttp -57.16 -45.1 83.91 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.105 -1.072 . . . . 71.41 108.105 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 55.5 ttt180 -53.54 -51.2 63.65 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.484 -1.235 . . . . 71.21 112.045 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.2 mt -77.8 -26.05 49.37 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.08 -0.509 . . . . 72.24 111.89 -174.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -68.04 -39.68 83.02 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.401 -0.962 . . . . 55.0 108.401 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.551 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.5 ttpt -69.57 -37.07 76.83 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.587 -0.733 . . . . 74.02 109.679 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -52.78 -31.75 40.11 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.015 0.926 . . . . 72.14 112.241 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -66.05 -40.31 90.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.854 0.835 . . . . 73.5 109.354 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 146' ' ' THR . 23.9 t80 -76.29 -32.23 58.67 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.57 -1.195 . . . . 75.34 108.328 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.1 mm -59.05 -31.99 46.88 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.486 0 CA-C-N 114.731 -1.122 . . . . 70.2 111.815 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -52.07 -45.18 64.67 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.124 0.42 . . . . 64.44 111.806 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 143' ' ' PHE . 15.1 t -79.14 -29.89 43.36 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.564 0.697 . . . . 72.3 109.824 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -75.63 -30.33 59.45 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.397 -0.819 . . . . 74.51 110.502 -173.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -58.24 -36.93 73.93 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.603 1.161 . . . . 75.02 109.845 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -74.34 -38.79 63.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.103 0.477 . . . . 75.1 110.025 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 72.3 mt -63.61 -39.93 87.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.644 -0.707 . . . . 71.1 109.47 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.4 ttt -60.12 -31.68 70.29 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 124.267 1.027 . . . . 73.4 111.493 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.93 -36.93 85.96 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.476 0.655 . . . . 73.11 109.765 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.82 -34.38 69.29 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.222 -0.899 . . . . 75.44 110.227 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.629 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 9.7 mmpt? -81.36 -44.9 16.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 31.14 111.884 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -149.99 100.9 2.98 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.767 -0.827 . . . . 75.14 108.767 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -69.15 146.83 97.28 Favored Pre-proline 0 C--N 1.303 -1.441 0 CA-C-N 115.677 -0.692 . . . . 75.45 109.386 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.8 98.24 0.13 Allowed 'Trans proline' 0 C--O 1.249 1.059 0 C-N-CA 122.533 2.156 . . . . 72.24 112.064 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 . . . . . 0 C--N 1.308 -1.2 0 CA-C-N 115.049 -0.978 . . . . 75.15 108.501 -179.746 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.42 -1.926 0 N-CA-C 106.912 -1.514 . . . . 61.25 106.912 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -157.14 83.97 0.93 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.19 0.519 . . . . 52.41 111.889 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 m -88.45 -32.82 18.09 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.774 -1.565 . . . . 73.34 106.774 170.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 59.88 -87.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.209 1.804 . . . . 72.13 113.887 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.1 t -128.74 1.74 5.45 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.886 0.85 . . . . 73.44 109.054 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.29 89.33 3.73 Favored 'General case' 0 N--CA 1.393 -3.308 0 CA-C-N 115.543 -0.753 . . . . 74.15 110.774 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -144.52 144.8 31.51 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 108.564 -0.902 . . . . 75.02 108.564 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -82.04 154.71 25.5 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.476 -0.564 . . . . 61.31 109.476 175.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.558 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.7 m-70 -114.86 160.6 19.29 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 115.428 -0.805 . . . . 55.3 109.851 -173.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 27.2 p-10 -131.08 125.08 32.24 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.647 0.737 . . . . 70.42 110.617 176.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.28 142.82 40.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.156 -0.929 . . . . 64.32 109.944 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.414 ' HB2' HG21 ' A' ' 113' ' ' VAL . 85.9 t80 -95.07 123.23 38.45 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.728 -0.842 . . . . 72.43 108.728 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -102.59 137.79 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.659 -0.497 . . . . 73.01 109.659 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -87.62 -28.39 21.92 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.516 0.932 . . . . 74.21 113.516 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.29 -20.81 0.18 Allowed Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 118.917 -1.611 . . . . 71.23 113.108 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.7 p -63.65 -28.48 69.94 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.147 0.499 . . . . 63.31 111.845 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.57 ' HB3' HD11 ' A' ' 32' ' ' ILE . 78.5 m-85 -139.9 57.12 1.62 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.531 0.732 . . . . 75.01 109.232 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -88.86 -21.44 23.68 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.354 0.501 . . . . 53.45 112.354 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.602 ' O ' HG22 ' A' ' 31' ' ' VAL . 24.1 t70 -95.28 129.25 35.76 Favored Pre-proline 0 C--N 1.303 -1.424 0 CA-C-N 116.585 -0.28 . . . . 65.51 110.576 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.24 -25.04 57.69 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.694 2.263 . . . . 50.24 113.392 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.44 -30.0 62.92 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.536 -0.727 . . . . 63.31 110.965 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 28' ' ' ASP . 18.4 m -72.44 -28.3 28.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.256 -0.646 . . . . 64.44 109.256 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.57 HD11 ' HB3' ' A' ' 26' ' ' PHE . 49.7 mm -64.31 -40.41 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.697 -0.683 . . . . 73.32 110.588 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -61.44 -30.15 70.4 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.148 0.499 . . . . 74.22 111.002 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.36 -50.79 15.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.812 -0.631 . . . . 64.13 110.291 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -67.63 -35.71 79.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.728 -0.669 . . . . 51.34 110.121 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.3 mt -103.65 -77.31 0.57 Allowed 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.287 0.565 . . . . 73.03 109.749 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.4 t70 162.57 -30.15 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 125.533 1.533 . . . . 72.41 107.287 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -146.58 159.11 43.86 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 114.648 -1.16 . . . . 74.12 109.722 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.3 m -107.52 120.52 47.23 Favored Pre-proline 0 N--CA 1.426 -1.671 0 O-C-N 123.573 0.546 . . . . 53.2 110.83 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -65.79 151.58 83.93 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.641 2.227 . . . . 75.34 109.259 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.7 130.26 45.61 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 122.144 0.973 . . . . 51.13 112.976 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 47.5 mt -103.39 139.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.041 0 CA-C-N 113.973 -1.467 . . . . 74.14 110.462 -174.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 13.5 p -126.34 146.45 32.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 107.79 -1.189 . . . . 45.24 107.79 172.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 12.0 m -76.27 125.46 29.22 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 106.429 -1.693 . . . . 74.43 106.429 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -139.64 151.31 45.86 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.528 -0.869 . . . . 65.23 113.339 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -115.0 125.93 54.17 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.589 -1.187 . . . . 72.42 109.491 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 tp -98.7 102.78 15.87 Favored Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 123.49 0.716 . . . . 64.41 109.594 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 73.5 Cg_endo -81.06 141.38 13.04 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.197 1.931 . . . . 64.34 111.942 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.7 10.91 57.42 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.609 -0.805 . . . . 61.54 112.1 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 81.0 m-85 -139.82 163.21 33.22 Favored 'General case' 0 C--O 1.2 -1.5 0 N-CA-C 108.719 -0.845 . . . . 65.32 108.719 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -138.39 143.59 39.85 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.303 0.573 . . . . 75.12 109.82 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.64 124.75 35.32 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.893 -1.521 . . . . 72.42 106.893 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -109.45 147.76 32.31 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.13 -0.693 . . . . 51.54 109.13 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.58 ' HG3' ' CD1' ' A' ' 130' ' ' TRP . 3.8 tmt_? -134.47 126.21 28.98 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.961 -0.755 . . . . 74.23 108.961 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.7 tp -143.54 147.38 34.36 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.062 -1.088 . . . . 72.22 108.062 -174.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -125.88 16.21 8.0 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.039 0.447 . . . . 74.23 111.063 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.08 -136.77 8.3 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 115.813 -0.631 . . . . 71.22 112.766 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -84.96 -7.61 59.08 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.076 0.465 . . . . 74.13 112.018 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.474 HD11 ' CH2' ' A' ' 118' ' ' TRP . 53.6 tp -113.61 164.59 13.47 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.342 -0.614 . . . . 73.34 109.342 177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -95.33 159.99 31.62 Favored Pre-proline 0 C--N 1.313 -1.011 0 C-N-CA 122.98 0.512 . . . . 74.04 110.718 -170.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' A' ' 54' ' ' ARG . 23.3 Cg_exo -69.63 96.98 0.6 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.703 2.268 . . . . 73.31 109.871 171.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 24.5 p -92.73 -179.42 5.15 Favored 'General case' 0 C--O 1.253 1.244 0 N-CA-C 113.422 0.897 . . . . 73.25 113.422 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.6 mm -131.87 120.78 45.52 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 108.146 -1.057 . . . . 73.22 108.146 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.06 149.35 73.48 Favored Pre-proline 0 C--N 1.313 -1.017 0 N-CA-C 110.208 -0.293 . . . . 72.02 110.208 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 25.3 Cg_endo -63.23 119.39 6.45 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.107 2.538 . . . . 74.13 113.435 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.4 t -125.91 131.28 52.35 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.792 -0.818 . . . . 65.31 108.792 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.425 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . 42.6 mt-10 -66.19 -34.48 78.12 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.144 0.497 . . . . 73.53 110.485 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' A' ' 67' ' ' GLU . 3.2 mppt? -102.49 23.87 11.25 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.443 -0.799 . . . . 65.01 111.331 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.94 165.67 23.39 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 118.863 -1.636 . . . . 44.45 114.209 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.25 145.75 24.88 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 124.682 1.193 . . . . 71.33 108.596 174.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.4 t -113.02 125.11 70.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.695 -0.483 . . . . 73.44 109.695 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -95.86 116.55 29.08 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.288 -1.004 . . . . 74.32 108.288 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.22 -152.43 5.63 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 110.879 -0.889 . . . . 62.45 110.879 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.446 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 34.7 mmtp -129.03 143.92 51.02 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 116.785 0.293 . . . . 70.11 110.28 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 47.3 t -110.08 127.52 66.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 120.834 0.349 . . . . 42.54 110.794 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 70.7 mt -95.48 104.25 16.15 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.07 -1.085 . . . . 71.11 108.07 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.2 ptp -113.55 147.7 37.48 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.825 -0.435 . . . . 71.21 109.825 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.39 13.55 55.5 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.327 -1.416 . . . . 63.21 110.01 -172.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.4 p -86.76 131.6 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 N-CA-C 109.007 -0.738 . . . . 65.21 109.007 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.484 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 3.2 m -74.44 159.73 31.92 Favored 'General case' 0 N--CA 1.409 -2.484 0 N-CA-C 108.947 -0.76 . . . . 75.53 108.947 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.8 p -56.85 -34.86 68.21 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.614 0.766 . . . . 71.02 111.829 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.09 -46.04 79.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.574 -0.285 . . . . 73.54 111.691 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.532 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 1.8 mp0 -70.26 -31.04 68.24 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.623 -0.51 . . . . 73.52 109.623 175.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.4 tp -58.71 -51.87 68.11 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.202 0.525 . . . . 52.11 109.996 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.59 -28.74 67.21 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.448 -0.796 . . . . 64.13 110.309 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 90' ' ' VAL . 38.9 t-20 -65.69 -47.51 75.19 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 108.65 -0.87 . . . . 54.33 108.65 177.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.2 mt -61.13 -46.43 90.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.972 -0.751 . . . . 74.01 108.972 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.53 -29.75 70.79 Favored 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 114.46 -1.245 . . . . 75.21 111.162 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.18 -40.47 59.38 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.082 -0.508 . . . . 64.42 110.848 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 86' ' ' ASN . 59.1 t -72.82 -49.33 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 112.308 0.485 . . . . 73.32 112.308 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -79.92 -27.91 39.84 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 112.859 0.689 . . . . 45.31 112.859 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.81 -21.29 36.19 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 119.585 2.594 . . . . 53.3 119.585 -168.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -71.23 -35.5 71.5 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 119.505 1.653 . . . . 71.02 113.814 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -120.44 -0.03 10.43 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.836 -0.745 . . . . 63.33 112.822 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -130.49 159.01 38.37 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.615 0.366 . . . . 75.11 110.072 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -123.05 137.15 55.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.869 0.366 . . . . 71.41 110.582 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -87.41 114.51 24.08 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.814 -0.63 . . . . 64.14 110.653 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.448 HG11 ' CE ' ' A' ' 117' ' ' MET . 35.9 m -121.27 161.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.528 -0.76 . . . . 75.01 111.679 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 p -92.45 123.04 35.47 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.724 -0.671 . . . . 74.42 110.988 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.59 172.41 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 112.86 0.689 . . . . 61.3 112.86 -175.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -116.14 136.36 12.83 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.173 -0.771 . . . . 74.32 111.173 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.416 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 2.8 pp -126.78 160.99 34.31 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 C-N-CA 123.373 0.669 . . . . 64.35 111.322 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 48.2 t -117.17 129.96 72.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.439 -0.578 . . . . 73.4 109.439 177.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.591 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 19.0 mtp180 -73.38 116.54 14.06 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 122.805 0.442 . . . . 72.24 110.206 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 39.5 mt-10 -73.81 -20.48 60.45 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.719 -0.673 . . . . 72.14 110.019 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -73.93 -16.6 61.09 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 112.461 0.541 . . . . 73.43 112.461 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.406 ' CG ' ' H ' ' A' ' 108' ' ' SER . 33.0 p-10 -138.32 -83.49 0.3 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.238 -0.585 . . . . 64.54 111.048 173.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.406 ' H ' ' CG ' ' A' ' 107' ' ' ASN . 73.1 m 177.49 -13.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.266 1.427 . . . . 62.4 111.18 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -77.98 149.34 34.12 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 113.157 0.799 . . . . 64.42 113.157 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 62.7 pttt -103.87 147.2 27.6 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.53 -0.759 . . . . 74.4 110.211 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.591 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 89.8 mtp -139.24 162.24 35.48 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.578 0.704 . . . . 73.31 112.234 -175.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.24 130.89 46.41 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 114.349 -1.296 . . . . 64.35 109.359 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' ND2' ' A' ' 19' ' ' ASN . 35.8 m -143.41 175.86 3.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 123.366 0.666 . . . . 74.04 109.72 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -116.12 145.1 43.32 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.216 -1.031 . . . . 62.14 108.216 172.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.7 t -136.26 172.04 13.6 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.167 -0.679 . . . . 62.43 109.167 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -104.07 118.53 36.87 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.407 -0.59 . . . . 74.41 109.407 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.448 ' CE ' HG11 ' A' ' 98' ' ' VAL . 52.0 ttp -111.91 148.84 32.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.024 -0.989 . . . . 64.04 109.546 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.474 ' CH2' HD11 ' A' ' 59' ' ' LEU . 65.6 t-105 -73.75 130.54 40.17 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.752 -1.203 . . . . 72.43 107.752 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.518 HD12 ' H ' ' A' ' 119' ' ' ILE . 2.5 mp -73.45 -43.85 55.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 119.91 -0.716 . . . . 73.53 111.242 -171.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -93.58 67.74 3.97 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.961 1.362 . . . . 74.01 107.952 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -81.73 17.15 1.54 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.485 -1.689 . . . . 63.55 114.382 -170.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -121.97 19.73 10.84 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.315 -0.624 . . . . 34.3 109.315 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -64.88 126.9 92.03 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.627 -0.715 . . . . 62.14 110.882 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -92.47 16.57 1.36 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 122.388 2.059 . . . . 33.43 113.604 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.77 -32.93 5.97 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.918 0.39 . . . . 73.41 110.857 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -70.16 13.32 0.16 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.674 0.991 . . . . 63.11 113.674 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -69.13 92.88 0.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.465 0.65 . . . . 53.14 111.787 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -125.55 133.63 8.44 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 108.329 -1.908 . . . . 74.52 108.329 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.48 140.76 37.06 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.905 0.86 . . . . 61.34 113.119 -172.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.58 ' CD1' ' HG3' ' A' ' 54' ' ' ARG . 2.3 t90 -113.97 136.38 52.97 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 104.416 -2.438 . . . . 75.25 104.416 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -61.96 0.19 0.42 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.251 1.575 . . . . 61.33 115.251 -171.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -69.09 -32.89 72.64 Favored 'General case' 0 N--CA 1.4 -2.964 0 C-N-CA 123.867 0.867 . . . . 73.23 109.676 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -72.67 -33.65 66.68 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.445 0.641 . . . . 75.51 111.263 177.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 39.4 tt0 -63.55 -40.39 96.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.63 -1.168 . . . . 64.14 109.265 172.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -67.09 -41.75 85.81 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.864 -0.607 . . . . 71.51 110.465 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.64 -33.53 75.21 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 110.136 -0.32 . . . . 73.1 110.136 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 21.1 tpt180 -59.79 -50.36 74.13 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.447 0.642 . . . . 73.5 110.836 174.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -74.22 -26.43 60.25 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.856 0.836 . . . . 71.24 110.958 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -83.73 -20.82 32.74 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.855 -1.066 . . . . 62.3 110.262 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.489 ' O ' HG12 ' A' ' 144' ' ' ILE . 54.0 tptt -61.98 -34.78 76.78 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.424 1.089 . . . . 44.33 110.09 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 34.8 mmtp -53.88 -31.6 50.37 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 114.714 1.376 . . . . 71.24 114.714 -174.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -57.91 -46.27 85.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.932 0.873 . . . . 53.51 108.971 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -76.72 -33.49 58.17 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.73 -1.123 . . . . 72.33 109.389 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.5 mm -63.25 -34.69 68.45 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.343 0 CA-C-N 115.497 -0.774 . . . . 63.42 112.082 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 48.8 mt-10 -56.71 -34.57 67.6 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.522 0.677 . . . . 73.21 110.582 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.6 m -80.98 -47.1 14.09 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.371 -0.831 . . . . 70.44 110.703 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.536 ' O ' ' HG3' ' A' ' 151' ' ' MET . 2.8 t80 -70.96 -30.29 66.54 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.506 -0.77 . . . . 65.34 112.373 -171.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 87.5 tttt -57.9 -40.18 79.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.239 0.616 . . . . 73.43 110.289 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -64.23 -38.53 91.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.922 -0.77 . . . . 55.25 108.922 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.4 mt -68.43 -38.13 78.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.845 -1.07 . . . . 72.02 109.758 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 147' ' ' PHE . 64.2 mtt -63.54 -41.77 98.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.085 -0.507 . . . . 72.02 109.729 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 49.7 mt-10 -70.47 -33.86 71.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.847 -0.615 . . . . 71.4 110.461 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 46.4 t -62.15 -49.76 74.57 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.703 -0.681 . . . . 62.34 110.211 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -70.57 -23.49 62.61 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.212 0.53 . . . . 73.35 110.367 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? 67.23 77.32 0.27 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.358 1.463 . . . . 75.23 109.247 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -141.03 96.29 7.31 Favored Pre-proline 0 C--O 1.251 1.139 0 CA-C-N 114.283 -1.326 . . . . 75.04 109.217 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.96 152.51 73.38 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.621 2.214 . . . . 74.43 110.7 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 . . . . . 0 C--N 1.307 -1.273 0 CA-C-O 120.53 0.205 . . . . 72.13 111.229 -178.943 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 109.088 -0.708 . . . . 62.24 109.088 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.1 m -63.19 154.25 31.9 Favored 'General case' 0 C--O 1.25 1.114 0 O-C-N 123.383 0.427 . . . . 64.1 110.742 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -63.36 -47.76 80.77 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.059 -0.719 . . . . 51.44 109.059 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -95.84 95.17 8.09 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.009 -0.541 . . . . 75.54 109.681 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.6 t -103.81 143.69 32.48 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.674 -1.232 . . . . 63.34 107.674 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.92 110.49 5.05 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.555 -0.535 . . . . 64.34 109.555 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.98 155.38 49.26 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.905 -0.589 . . . . 64.12 109.594 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.529 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 87.5 mt -98.72 153.83 18.43 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 120.963 0.411 . . . . 64.12 110.299 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.458 ' O ' HG12 ' A' ' 79' ' ' VAL . 44.2 m-70 -128.67 161.74 28.97 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.772 -0.649 . . . . 71.34 111.067 -172.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 9.5 p30 -120.09 128.54 53.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.493 -0.776 . . . . 61.23 112.032 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.2 t -131.78 140.79 47.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.359 -0.837 . . . . 51.21 108.947 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.494 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.8 t80 -98.58 121.61 40.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.813 -0.81 . . . . 74.51 108.813 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 74' ' ' LYS . 14.9 m -93.59 152.36 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.077 -0.51 . . . . 73.24 109.791 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -121.4 -51.66 2.07 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 115.818 1.785 . . . . 75.34 115.818 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.02 -75.11 0.15 Allowed Glycine 0 C--O 1.225 -0.442 0 C-N-CA 118.599 -1.762 . . . . 63.44 114.4 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -58.53 -36.4 73.8 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.594 0.758 . . . . 71.22 112.505 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.64 ' HB3' HD11 ' A' ' 32' ' ' ILE . 70.1 m-85 -110.51 29.9 7.29 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-O 121.14 0.495 . . . . 72.34 111.053 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.612 HE21 ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.91 -7.86 53.9 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.768 0.794 . . . . 62.0 109.648 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.503 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 13.0 t70 -114.02 134.44 22.16 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.338 -1.301 . . . . 75.41 111.01 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -72.27 -25.12 19.03 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.577 2.185 . . . . 75.3 112.938 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.503 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 17.8 t70 -64.03 -43.33 95.9 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.185 -0.322 . . . . 64.3 110.471 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.24 -29.58 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 116.238 -0.437 . . . . 72.11 110.058 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 26' ' ' PHE . 31.6 mm -65.77 -47.43 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 122.441 -0.162 . . . . 63.44 110.725 177.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -55.84 -32.7 63.84 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.831 0.348 . . . . 44.04 111.454 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.57 -36.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.471 -0.331 . . . . 65.45 111.473 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.425 ' HE1' HD23 ' A' ' 87' ' ' LEU . 50.6 ttp -63.92 -36.5 84.13 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.771 0.319 . . . . 75.21 110.21 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.638 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.1 pt? -125.18 -76.42 0.59 Allowed 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 112.918 0.71 . . . . 65.24 112.918 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.638 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 23.6 m-20 -169.77 -55.9 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 122.012 0.91 . . . . 62.2 108.606 -170.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -121.23 -177.27 3.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.105 -1.407 . . . . 75.24 110.097 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -134.97 120.59 14.21 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 115.757 -0.656 . . . . 73.24 109.629 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.61 150.87 66.7 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.793 2.328 . . . . 72.11 111.073 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -56.7 116.96 3.45 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.718 0.636 . . . . 74.21 110.037 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 49.2 mt -97.0 141.04 16.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.753 -0.658 . . . . 72.42 110.861 -174.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.25 144.78 36.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.519 -0.919 . . . . 75.11 108.519 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.5 m -76.22 122.66 24.69 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.858 -0.793 . . . . 75.02 108.858 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.36 155.94 49.38 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.708 0.766 . . . . 71.44 111.601 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.3 m -113.05 128.87 56.61 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.29 -1.323 . . . . 72.33 108.382 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 48.0 tp -103.7 99.57 16.36 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 108.863 -0.791 . . . . 71.44 108.863 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.8 146.63 10.51 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.016 1.811 . . . . 62.34 111.143 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.66 9.84 65.95 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.349 -0.929 . . . . 73.43 111.76 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 88.0 m-85 -145.36 159.3 43.27 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 107.503 -1.295 . . . . 74.22 107.503 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -139.3 139.63 37.37 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.059 -0.656 . . . . 72.32 109.613 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 58.7 ttp180 -99.77 135.66 40.85 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.762 -1.108 . . . . 75.22 108.429 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.649 ' HB3' ' O ' ' A' ' 126' ' ' MET . 54.1 m-85 -109.03 168.58 9.26 Favored 'General case' 0 C--N 1.277 -2.55 0 O-C-N 123.595 0.559 . . . . 74.0 109.508 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.829 ' HG2' ' CD1' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -98.3 166.26 11.47 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 115.097 1.517 . . . . 53.23 115.097 -174.061 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.545 ' H ' HD23 ' A' ' 55' ' ' LEU . 1.4 pt? -95.98 126.86 41.51 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.611 -1.632 . . . . 72.3 108.552 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -130.83 19.44 5.06 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.979 0.418 . . . . 62.33 111.913 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 136.0 -56.26 0.7 Allowed Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 119.319 -1.419 . . . . 63.2 114.516 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.436 ' C ' ' HD3' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -91.05 -47.36 7.6 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.42 -0.512 . . . . 71.33 110.28 -174.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.488 HD23 ' HB3' ' A' ' 126' ' ' MET . 37.5 tp -113.72 163.39 15.08 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.646 -0.822 . . . . 72.32 110.857 -177.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -103.82 172.17 4.44 Favored Pre-proline 0 C--N 1.306 -1.288 0 C-N-CA 124.378 1.071 . . . . 73.05 109.433 -175.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 17.1 Cg_exo -69.25 112.41 2.98 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.878 1.719 . . . . 52.3 110.65 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 19.6 p -116.98 160.35 21.07 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 123.372 0.42 . . . . 72.11 111.666 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.503 HD12 HG21 ' A' ' 71' ' ' VAL . 46.5 mm -96.77 142.68 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 108.209 -1.034 . . . . 72.13 108.209 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 118' ' ' TRP . 21.2 m -146.02 150.73 43.11 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 107.286 -1.375 . . . . 51.1 107.286 173.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.11 124.97 13.79 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.197 1.931 . . . . 73.04 112.248 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.3 t -124.98 145.38 49.9 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.606 -0.724 . . . . 50.32 109.279 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.23 -36.85 63.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.447 0.536 . . . . 64.3 112.447 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -131.7 15.68 4.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.697 0.629 . . . . 74.31 112.697 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.63 172.78 30.34 Favored Glycine 0 C--O 1.247 0.961 0 C-N-CA 120.486 -0.864 . . . . 72.43 112.391 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -154.64 156.33 36.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.641 -0.874 . . . . 61.4 108.641 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 63' ' ' ILE . 40.4 t -124.64 137.69 56.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.131 -0.692 . . . . 74.02 109.131 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -107.95 116.12 31.38 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.518 -0.919 . . . . 73.54 108.518 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.514 ' HA2' ' OE1' ' A' ' 27' ' ' GLN . . . -141.45 -150.09 5.32 Favored Glycine 0 N--CA 1.404 -3.446 0 C-N-CA 119.918 -1.134 . . . . 72.41 112.15 -176.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.518 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 34.5 mmtp -131.3 141.54 49.97 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.712 -0.847 . . . . 73.24 108.712 -174.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.4 t -110.11 130.85 62.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 110.254 -0.276 . . . . 63.3 110.254 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 77.4 mt -95.09 105.63 17.57 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.643 -0.708 . . . . 72.23 109.421 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.532 ' HE3' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -98.65 125.45 43.94 Favored 'General case' 0 CA--C 1.479 -1.786 0 CA-C-O 121.77 0.795 . . . . 70.34 112.072 176.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 17' ' ' LEU . . . 102.46 26.39 7.3 Favored Glycine 0 C--N 1.28 -2.581 0 CA-C-N 114.363 -1.29 . . . . 71.01 112.849 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.6 p -87.78 125.16 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.471 -0.937 . . . . 73.41 108.471 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.35 164.32 26.84 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 109.386 -0.598 . . . . 64.23 109.386 -176.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 41.5 m -58.36 -36.92 74.19 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 112.831 0.678 . . . . 55.01 112.831 -176.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.74 -44.71 80.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.672 0.273 . . . . 72.2 110.447 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 1.2 mp0 -68.61 -30.53 69.28 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 116.406 -0.361 . . . . 64.53 110.24 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 81' ' ' SER . 48.4 tp -60.36 -50.25 74.36 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.287 -1.005 . . . . 74.03 108.287 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.02 -28.59 69.6 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.65 -1.159 . . . . 74.42 111.243 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.536 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.3 t-20 -62.03 -49.41 76.11 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 123.331 0.652 . . . . 73.35 110.633 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.425 HD23 ' HE1' ' A' ' 35' ' ' MET . 92.3 mt -64.4 -38.74 92.09 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.651 0.739 . . . . 72.12 109.25 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.467 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 22.5 t70 -64.95 -35.52 81.44 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.537 -1.211 . . . . 61.54 110.829 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.64 -48.28 22.83 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.205 0.526 . . . . 73.23 110.129 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.7 t -62.99 -56.98 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 124.72 1.208 . . . . 73.44 113.168 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -79.97 -24.27 41.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.328 0.585 . . . . 75.21 112.524 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.7 -16.09 21.69 Favored Glycine 0 C--N 1.309 -0.97 0 N-CA-C 116.041 1.177 . . . . 71.32 116.041 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -57.94 -37.81 74.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 117.509 0.655 . . . . 73.4 112.344 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.63 10.17 3.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.889 0.376 . . . . 65.32 111.668 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -132.2 167.45 19.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.098 -0.704 . . . . 73.23 109.098 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.27 150.88 52.06 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.136 -1.061 . . . . 73.14 108.136 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -87.49 114.06 23.76 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.139 -0.689 . . . . 73.24 109.139 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.2 m -121.21 160.52 22.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 116.678 -0.237 . . . . 71.52 111.171 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 t -92.29 134.21 35.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.349 -0.612 . . . . 64.5 109.349 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.403 ' HB ' HD11 ' A' ' 47' ' ' LEU . 27.5 m -139.85 161.38 26.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.599 -0.273 . . . . 55.13 110.924 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.68 123.94 7.84 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.646 -0.981 . . . . 73.24 110.646 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.17 158.79 16.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 110.399 -0.222 . . . . 75.04 110.399 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 56.6 t -121.99 123.86 70.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.327 -0.99 . . . . 64.23 108.327 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.554 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 28.1 mtp180 -68.71 121.88 17.39 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 116.185 -0.462 . . . . 61.22 110.496 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -72.22 -21.16 61.44 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 122.183 0.992 . . . . 62.21 108.806 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.81 -39.54 81.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.288 -1.778 . . . . 62.35 112.61 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -147.31 6.03 0.85 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.31 0.856 . . . . 74.04 113.31 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.5 t 73.08 12.58 4.98 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.586 1.154 . . . . 71.33 112.338 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -96.49 149.07 22.15 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.698 -0.626 . . . . 73.14 111.571 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' O ' ' HD2' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -96.33 150.12 20.92 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 112.817 0.673 . . . . 64.23 112.817 -175.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.554 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.6 mtp -143.26 160.62 40.14 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.853 -1.067 . . . . 72.55 110.153 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.23 130.76 54.7 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.751 -0.833 . . . . 54.54 108.751 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 21' ' ' PHE . 35.3 m -142.27 173.96 6.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 120.894 0.378 . . . . 71.31 110.536 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -104.11 146.57 28.54 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.421 -0.955 . . . . 64.54 108.421 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.0 t -149.33 172.5 14.79 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.829 -0.804 . . . . 72.35 108.829 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -117.74 113.98 22.64 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.125 0.488 . . . . 74.22 109.953 -176.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -109.0 156.38 19.8 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.848 -0.615 . . . . 60.33 110.794 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.403 ' HB3' HG12 ' A' ' 64' ' ' VAL . 59.2 t-105 -68.4 128.85 38.08 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.498 -1.297 . . . . 74.04 107.498 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.6 mm -72.53 -38.51 59.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 112.653 0.612 . . . . 62.2 112.653 -170.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -76.28 -37.66 57.24 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.695 -0.402 . . . . 73.11 111.216 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.337 0.0 OUTLIER 37.77 65.01 0.6 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.123 1.157 . . . . 75.41 114.123 -173.174 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.29 -26.62 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.635 -0.711 . . . . 72.03 111.198 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.32 136.23 50.74 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 122.929 0.491 . . . . 61.11 112.052 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.16 -2.29 11.94 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.612 2.208 . . . . 71.44 110.677 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -63.88 -45.51 89.08 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 115.665 -0.698 . . . . 74.21 110.917 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.649 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.0 ptt? -75.89 -17.9 59.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.324 -0.398 . . . . 72.5 110.763 -178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -62.39 107.96 1.02 Allowed 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.539 0.685 . . . . 74.43 110.737 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.66 135.39 2.0 Favored Glycine 0 N--CA 1.414 -2.827 0 CA-C-N 115.215 -0.902 . . . . 72.54 111.069 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.486 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 9.6 pt-20 -116.96 144.27 44.76 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.085 0.469 . . . . 70.31 110.999 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.829 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 14.1 m0 -104.4 156.51 17.87 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.568 -0.742 . . . . 75.54 110.16 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -57.94 -30.89 66.32 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 124.013 0.925 . . . . 71.44 112.393 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -62.42 -47.6 83.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.955 0.407 . . . . 71.54 110.989 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.543 ' HG3' ' CZ ' ' A' ' 54' ' ' ARG . 5.8 mm-40 -74.2 -32.2 62.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.846 -0.615 . . . . 71.32 109.764 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.466 ' HG3' HH21 ' A' ' 137' ' ' ARG . 41.3 tt0 -58.95 -53.96 52.51 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.792 -0.64 . . . . 64.33 110.595 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -65.46 -40.89 93.75 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 119.864 -0.734 . . . . 75.41 111.072 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -55.71 -41.55 74.0 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.98 0.419 . . . . 61.31 110.203 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.466 HH21 ' HG3' ' A' ' 134' ' ' GLU . 51.3 ttp180 -60.06 -52.09 66.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.84 -0.618 . . . . 75.35 111.951 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.89 -20.33 62.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.113 0.483 . . . . 65.15 111.925 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -80.83 -40.1 25.47 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.005 -0.739 . . . . 73.21 109.005 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.578 ' O ' HG12 ' A' ' 144' ' ' ILE . 37.5 ttpt -69.38 -39.85 77.76 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.752 -0.462 . . . . 74.31 109.752 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.81 -30.93 47.23 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.425 1.09 . . . . 64.35 111.78 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -65.37 -39.23 92.04 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.04 0.448 . . . . 73.23 109.917 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.495 ' O ' HG22 ' A' ' 146' ' ' THR . 92.6 m-85 -76.73 -32.84 58.06 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.572 0.701 . . . . 74.31 109.291 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.9 mm -58.53 -31.21 43.0 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 CA-C-N 114.845 -1.07 . . . . 74.32 111.713 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -50.64 -44.72 57.49 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.296 0.48 . . . . 63.45 112.296 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 143' ' ' PHE . 12.0 t -68.76 -40.58 79.69 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 120.221 -0.592 . . . . 71.33 110.25 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -69.65 -29.95 67.53 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 112.93 0.715 . . . . 63.52 112.93 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 38.2 ttpt -59.64 -43.2 93.95 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.534 -0.913 . . . . 72.45 108.534 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -72.58 -28.55 62.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.798 -0.637 . . . . 64.23 110.235 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 146' ' ' THR . 83.7 mt -73.76 -43.16 54.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.757 -0.656 . . . . 75.15 110.397 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.2 ptm -70.75 -29.89 66.25 Favored 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 121.089 -0.244 . . . . 64.01 111.579 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 8.2 mm-40 -66.1 -33.32 75.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.079 0.466 . . . . 75.21 110.728 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 41.8 t -71.95 -33.83 68.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.048 -0.523 . . . . 72.32 110.066 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -76.44 -44.81 34.13 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.56 0.695 . . . . 72.11 111.099 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -103.08 85.77 2.57 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.115 -0.948 . . . . 74.4 109.384 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -77.04 141.45 67.56 Favored Pre-proline 0 C--N 1.283 -2.325 0 CA-C-N 114.045 -1.434 . . . . 75.41 111.068 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -65.11 128.07 19.78 Favored 'Trans proline' 0 C--O 1.254 1.301 0 C-N-CA 122.19 1.927 . . . . 74.34 108.633 170.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 C--N 1.294 -1.81 0 CA-C-N 116.397 -0.365 . . . . 62.23 110.547 -176.683 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.41 -2.45 0 N-CA-C 107.369 -1.345 . . . . 71.43 107.369 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 m -71.12 153.14 42.77 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 109.112 -0.699 . . . . 70.41 109.112 177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.6 m -76.82 -44.77 31.16 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 109.323 -0.621 . . . . 60.01 109.323 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 65.98 -52.09 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.309 1.444 . . . . 62.41 113.707 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.7 t -74.41 159.13 32.74 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.092 -0.707 . . . . 74.44 109.092 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.54 79.19 6.04 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 121.735 0.779 . . . . 71.33 110.045 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.23 26.57 7.38 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.502 -1.226 . . . . 63.02 109.106 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.81 154.95 29.47 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 114.747 -1.115 . . . . 60.22 109.413 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.522 ' O ' HG12 ' A' ' 79' ' ' VAL . 37.5 m-70 -115.01 160.66 19.33 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 114.811 -1.086 . . . . 62.12 108.818 -174.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 22.5 p30 -131.14 127.03 37.21 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.548 0.69 . . . . 73.34 110.868 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.5 t -121.05 141.78 40.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.101 -0.954 . . . . 72.01 110.492 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.459 ' HB2' HG21 ' A' ' 113' ' ' VAL . 90.3 t80 -94.56 124.37 38.56 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.514 -0.921 . . . . 73.53 108.514 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 m -109.12 126.4 66.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.364 0.602 . . . . 75.21 111.673 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.404 ' HB3' ' CG1' ' A' ' 63' ' ' ILE . 42.6 p90 -66.88 -34.09 77.03 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.803 1.038 . . . . 74.25 113.803 -177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 169.42 -28.44 0.13 Allowed Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 118.752 -1.69 . . . . 52.24 113.318 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.2 p -62.97 -36.8 84.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.143 0.497 . . . . 64.4 111.143 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.588 ' HB3' HD11 ' A' ' 32' ' ' ILE . 63.5 m-85 -124.67 28.79 6.44 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.669 -0.696 . . . . 73.12 112.23 -176.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -87.14 9.18 20.78 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.795 0.807 . . . . 72.44 108.848 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.556 ' O ' HG12 ' A' ' 32' ' ' ILE . 13.1 t70 -117.25 129.44 25.33 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.544 -1.207 . . . . 74.44 109.354 -176.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' ASP . 2.8 Cg_exo -71.08 -28.8 18.58 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.915 1.744 . . . . 55.21 112.558 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.454 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 24.0 t70 -62.35 -44.63 96.02 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 116.348 -0.387 . . . . 75.43 110.761 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.94 -29.3 36.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.997 -0.547 . . . . 72.5 109.93 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.588 HD11 ' HB3' ' A' ' 26' ' ' PHE . 44.2 mm -65.76 -41.57 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 116.434 -0.348 . . . . 72.02 110.356 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -53.86 -46.21 71.21 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.296 0.569 . . . . 35.32 110.622 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -82.75 -36.14 13.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 114.371 1.249 . . . . 55.24 114.371 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.514 ' HE2' HD23 ' A' ' 87' ' ' LEU . 12.0 tmm? -67.84 -36.58 80.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.792 0.33 . . . . 74.33 110.701 -174.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.507 HD21 HG23 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -119.13 -71.69 0.72 Allowed 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.681 -0.808 . . . . 51.23 111.535 175.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.481 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 27.8 t70 167.96 -46.73 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.405 0.682 . . . . 72.53 109.481 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -111.75 160.3 17.44 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.355 -0.839 . . . . 62.54 110.345 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.411 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 40.3 m -119.55 111.1 36.56 Favored Pre-proline 0 N--CA 1.429 -1.509 0 CA-C-N 116.34 -0.391 . . . . 55.01 111.262 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -60.72 151.51 76.03 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.025 2.483 . . . . 70.55 110.378 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -62.57 121.47 13.4 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.117 0.484 . . . . 65.44 109.855 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 25.2 mt -99.08 131.05 47.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.379 -0.828 . . . . 71.2 109.385 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG21 ' HD2' ' A' ' 104' ' ' ARG . 11.6 p -130.4 148.05 33.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.899 -0.591 . . . . 74.15 110.352 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.426 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 34.5 m -75.59 124.19 26.79 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.024 0.44 . . . . 71.23 110.096 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB1' HD13 ' A' ' 102' ' ' ILE . . . -138.7 159.27 42.51 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.439 0.638 . . . . 63.42 111.513 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.475 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 78.3 m -118.23 129.43 55.48 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.479 -0.782 . . . . 50.13 109.892 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.6 tp -104.43 99.31 17.21 Favored Pre-proline 0 N--CA 1.426 -1.652 0 N-CA-C 109.733 -0.469 . . . . 73.32 109.733 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.5 Cg_endo -84.29 141.69 9.23 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.694 2.263 . . . . 72.32 110.752 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.36 4.14 57.41 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.616 -0.802 . . . . 71.05 111.492 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.415 ' HA ' ' H ' ' A' ' 66' ' ' SER . 82.4 m-85 -138.76 157.77 45.48 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.967 -0.753 . . . . 73.22 108.967 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 7.1 tp60 -138.93 148.3 43.39 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.595 -0.52 . . . . 65.34 109.595 -175.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.526 ' HD3' ' CZ3' ' A' ' 135' ' ' TRP . 5.7 ptm180 -100.6 126.35 47.06 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.265 -0.88 . . . . 74.51 110.564 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 68.1 m-85 -109.04 134.85 51.12 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.03 -1.47 . . . . 72.12 107.03 174.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.602 ' HB3' ' CD1' ' A' ' 130' ' ' TRP . 0.7 OUTLIER -129.27 130.89 46.77 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 113.798 1.036 . . . . 64.02 113.798 -166.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.8 162.54 29.54 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 103.224 -2.88 . . . . 75.43 103.224 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -144.73 97.53 3.04 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.314 -0.955 . . . . 74.11 109.963 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.77 -80.86 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 114.601 -1.181 . . . . 74.41 110.383 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.498 HH21 ' HB3' ' A' ' 125' ' ' ASP . 2.0 tmm_? -81.06 -51.2 8.75 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 106.969 -1.493 . . . . 74.52 106.969 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.9 tp -113.54 165.68 12.25 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 114.909 -1.041 . . . . 44.22 109.541 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -103.32 173.19 3.61 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 107.439 -1.319 . . . . 64.13 107.439 -173.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.649 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 7.1 Cg_exo -73.73 81.17 1.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 121.022 1.148 . . . . 74.3 109.932 170.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.0 m -85.74 157.17 20.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.801 -0.636 . . . . 61.02 112.109 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.459 HD12 HG21 ' A' ' 71' ' ' VAL . 49.2 mm -103.95 140.9 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 115.153 -0.931 . . . . 62.03 109.23 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.31 153.96 56.6 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.278 -1.008 . . . . 62.3 108.278 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.12 112.97 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.543 2.162 . . . . 65.2 112.378 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 51' ' ' GLN . 33.5 t -125.54 126.64 45.16 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.329 -0.989 . . . . 72.42 108.329 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.48 -36.17 77.65 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.468 0.914 . . . . 72.31 113.468 -174.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -107.52 19.85 19.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.698 0.285 . . . . 74.52 111.495 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -109.31 160.13 13.68 Favored Glycine 0 N--CA 1.426 -1.989 0 C-N-CA 119.873 -1.156 . . . . 73.53 112.997 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.69 131.63 8.08 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.988 -1.116 . . . . 74.22 107.988 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.459 HG21 HD12 ' A' ' 63' ' ' ILE . 56.6 t -112.43 123.43 68.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 109.762 -0.458 . . . . 73.13 109.762 -176.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -97.01 115.88 28.23 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.366 -1.346 . . . . 75.51 107.366 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.491 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -144.69 -149.69 5.09 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 110.323 -1.111 . . . . 54.4 110.323 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 73' ' ' GLY . 2.2 mppt? -127.44 150.79 49.49 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 112.989 0.737 . . . . 70.21 112.989 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 28.1 t -110.87 131.88 60.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 114.593 -1.185 . . . . 60.41 112.016 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 78.8 mt -96.91 106.95 19.36 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.278 -1.008 . . . . 72.01 108.278 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.1 ptp -114.56 150.01 35.62 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 120.487 0.184 . . . . 73.1 110.714 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.71 15.86 47.89 Favored Glycine 0 N--CA 1.433 -1.513 0 C-N-CA 119.483 -1.342 . . . . 63.42 111.006 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.3 p -87.43 126.24 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.119 -1.067 . . . . 53.02 108.119 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.6 p -76.29 172.66 12.52 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.809 -0.356 . . . . 62.42 110.276 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.9 p -59.87 -41.18 90.93 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 112.25 0.463 . . . . 55.42 112.25 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.04 -36.65 85.06 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.777 0.798 . . . . 63.44 110.888 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 42.2 mt-10 -78.06 -31.21 50.16 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.397 -0.819 . . . . 73.05 109.171 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.438 HD22 ' CE1' ' A' ' 18' ' ' HIS . 35.5 tp -66.27 -47.32 74.09 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.233 -0.44 . . . . 61.5 110.615 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.01 -29.37 70.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.268 0.556 . . . . 72.33 109.63 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 28.1 t-20 -67.21 -44.07 80.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.308 -0.86 . . . . 72.1 109.629 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.514 HD23 ' HE2' ' A' ' 35' ' ' MET . 96.0 mt -64.77 -43.17 94.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.747 -0.661 . . . . 71.41 109.758 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.536 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 31.3 t70 -65.65 -27.59 68.48 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.927 -1.033 . . . . 63.31 110.288 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.47 -48.5 22.37 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.053 -0.521 . . . . 70.4 110.286 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.514 HG21 ' SD ' ' A' ' 35' ' ' MET . 92.7 t -69.86 -58.27 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 112.473 0.546 . . . . 61.24 112.473 -175.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.95 -33.86 44.92 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.136 0.493 . . . . 73.53 111.351 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -60.11 -16.53 41.41 Favored Glycine 0 N--CA 1.465 0.587 0 CA-C-N 115.795 -0.639 . . . . 32.44 113.507 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -57.74 -37.44 73.61 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.695 0.398 . . . . 73.25 110.518 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -132.93 7.91 4.05 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.169 0.509 . . . . 74.42 111.84 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 96.1 m-85 -131.07 168.84 16.73 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 122.709 0.404 . . . . 75.24 110.837 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.573 ' HB2' ' CD1' ' A' ' 119' ' ' ILE . 43.3 tt0 -122.46 129.97 52.59 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.536 -0.912 . . . . 55.1 108.536 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' THR . 60.0 ttp180 -86.14 114.16 22.77 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.912 -1.144 . . . . 65.44 107.912 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.4 HG13 ' HG2' ' A' ' 96' ' ' GLU . 30.9 m -125.77 162.24 29.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.673 -0.694 . . . . 62.51 111.987 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -86.13 124.62 32.74 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.242 -0.89 . . . . 75.43 109.257 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.8 170.72 19.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.72 -0.673 . . . . 70.44 111.896 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -121.24 120.51 4.47 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 110.587 -1.005 . . . . 63.02 110.587 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.457 HD11 ' HE2' ' A' ' 111' ' ' MET . 2.6 pp -115.41 163.02 13.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 116.597 0.198 . . . . 61.52 110.64 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 59.5 t -117.3 125.38 73.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 107.603 -1.258 . . . . 74.14 107.603 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.617 ' HE ' ' HB3' ' A' ' 106' ' ' ASP . 29.4 ttp180 -79.2 118.67 21.36 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.082 -1.081 . . . . 72.41 108.082 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.426 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 45.4 mt-10 -66.94 -7.52 22.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.203 0.601 . . . . 72.24 111.081 -176.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.617 ' HB3' ' HE ' ' A' ' 104' ' ' ARG . 30.1 t70 -54.78 -46.51 74.45 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.996 -1.002 . . . . 74.21 108.92 172.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.433 ' HB2' ' H ' ' A' ' 108' ' ' SER . 16.5 m-80 -133.8 -103.27 0.24 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.152 -1.055 . . . . 74.32 108.152 170.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.433 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 21.2 p -152.47 16.14 0.61 Allowed 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 106.374 -1.713 . . . . 74.05 106.374 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.89 128.5 35.67 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 114.458 -1.246 . . . . 75.23 108.183 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 60.8 pttt -99.36 147.39 25.28 Favored 'General case' 0 C--N 1.251 -3.678 0 CA-C-N 115.273 -0.876 . . . . 74.34 109.801 -176.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.457 ' HE2' HD11 ' A' ' 102' ' ' ILE . 32.8 mtm -136.14 163.44 30.34 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.721 0.772 . . . . 65.13 110.686 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.63 118.15 35.8 Favored 'General case' 0 C--N 1.258 -3.41 0 CA-C-N 114.301 -1.318 . . . . 65.44 108.604 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 21' ' ' PHE . 22.8 m -134.15 174.67 12.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.316 -0.624 . . . . 75.1 109.316 -176.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -113.25 146.27 39.61 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.985 -0.746 . . . . 54.03 108.985 175.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 14.4 t -136.04 171.4 14.53 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.354 -0.61 . . . . 61.5 109.354 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 95' ' ' TYR . 80.1 m-85 -112.57 112.68 24.4 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.852 -0.613 . . . . 61.0 110.317 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -112.67 157.83 20.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.656 -0.702 . . . . 71.41 109.582 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -67.64 139.91 56.83 Favored 'General case' 0 C--O 1.254 1.335 0 N-CA-C 109.104 -0.702 . . . . 75.51 109.104 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 96' ' ' GLU . 16.9 mm -72.24 -44.74 63.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 120.34 -0.544 . . . . 64.32 110.788 -172.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -70.32 -35.74 73.84 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 115.629 -0.714 . . . . 74.13 109.868 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.443 ' HB3' ' HZ3' ' A' ' 121' ' ' LYS . 0.1 OUTLIER 56.17 -4.45 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.082 2.153 . . . . 73.24 115.587 176.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.81 26.15 6.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.507 0.67 . . . . 51.04 109.407 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.606 ' O ' ' HG2' ' A' ' 126' ' ' MET . 10.2 t70 -62.78 125.66 86.9 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.131 -0.94 . . . . 75.25 109.558 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.44 -13.76 16.51 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.832 2.355 . . . . 61.42 113.204 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.498 ' HB3' HH21 ' A' ' 58' ' ' ARG . 22.2 t70 -89.3 -24.0 22.14 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.228 -0.442 . . . . 51.14 110.69 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 123' ' ' ASP . 21.4 ptp -64.94 -21.69 66.87 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.724 0.297 . . . . 55.4 111.262 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -71.64 107.57 4.56 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.243 -1.021 . . . . 75.44 108.243 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -140.15 -169.13 11.57 Favored Glycine 0 CA--C 1.489 -1.579 0 C-N-CA 120.507 -0.854 . . . . 53.25 112.239 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.29 127.21 36.64 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 109.4 -0.593 . . . . 75.13 109.4 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.602 ' CD1' ' HB3' ' A' ' 54' ' ' ARG . 18.5 m-90 -97.7 158.86 15.27 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 108.073 -1.084 . . . . 72.13 108.073 176.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 134' ' ' GLU . 63.1 m-20 -70.28 96.34 1.1 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 102.82 -3.03 . . . . 74.01 102.82 165.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.426 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 81.4 m-85 -62.13 -37.38 84.95 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 113.43 0.9 . . . . 65.11 113.43 -166.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.22 -28.82 62.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.03 0.443 . . . . 63.55 110.02 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 131' ' ' ASN . 1.2 tm-20 -70.46 -47.33 61.13 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.577 -0.897 . . . . 73.22 108.577 175.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TRP . . . . . 0.526 ' CZ3' ' HD3' ' A' ' 52' ' ' ARG . 8.7 t-105 -67.14 -44.51 79.65 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.1 -0.5 . . . . 72.12 112.301 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 132' ' ' PHE . 35.3 mmtp -60.74 -31.21 70.54 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.793 0.33 . . . . 64.45 111.005 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 31.5 tpt180 -65.79 -52.05 54.0 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.511 -0.768 . . . . 75.44 111.609 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.05 -33.86 63.86 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.332 0.587 . . . . 72.43 111.515 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -84.18 -3.14 57.95 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.861 -0.609 . . . . 74.35 111.264 -175.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.51 ' O ' HG12 ' A' ' 144' ' ' ILE . 34.7 ttpt -46.58 -43.92 17.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.284 1.434 . . . . 70.21 113.219 -176.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 88.2 tttt -53.85 -34.58 59.75 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.678 0.622 . . . . 72.12 112.678 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 142' ' ' LYS . 10.7 tmtt? -58.97 -43.6 91.38 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.387 -0.597 . . . . 72.44 109.387 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -76.74 -32.85 58.04 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.703 -0.68 . . . . 73.3 109.83 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 140' ' ' LYS . 51.6 mm -63.28 -33.38 60.76 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 CA-C-N 115.603 -0.726 . . . . 72.33 110.551 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 7.7 mm-40 -51.8 -39.05 58.01 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.281 0.845 . . . . 71.41 113.281 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -80.63 -39.33 27.57 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 119.973 -0.691 . . . . 65.53 110.511 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -67.89 -29.21 68.25 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 112.577 0.584 . . . . 72.4 112.577 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 148' ' ' LYS . 37.6 ttpt -53.76 -42.22 67.97 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 124.095 0.958 . . . . 52.23 109.315 173.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -75.32 -42.04 55.44 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.584 -0.735 . . . . 61.34 110.126 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.2 mt -61.52 -39.56 83.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.735 -0.666 . . . . 64.22 111.654 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 57.8 ttp -62.14 -45.91 91.32 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 122.809 0.444 . . . . 61.23 110.1 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -66.39 -30.94 71.42 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.165 0.507 . . . . 65.42 110.071 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 45.1 t -69.17 -33.44 73.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.156 -0.475 . . . . 45.22 111.058 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -77.15 -27.52 53.84 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.412 0.625 . . . . 75.45 110.084 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -67.35 -31.45 71.71 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.916 -1.038 . . . . 65.43 109.736 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -62.78 139.75 97.17 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 115.495 -0.775 . . . . 72.31 109.261 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.01 106.34 2.13 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.105 1.87 . . . . 54.02 112.543 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? . . . . . 0 N--CA 1.428 -1.528 0 N-CA-C 106.173 -1.788 . . . . 73.32 106.173 176.16 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.425 -1.679 0 CA-C-O 121.23 0.538 . . . . 74.13 110.267 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 t -96.41 152.34 18.7 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.879 -1.156 . . . . 72.54 107.879 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 m -76.57 -24.68 53.55 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.587 -0.523 . . . . 74.53 109.587 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.0 t70 41.72 74.96 0.09 Allowed 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 125.077 1.351 . . . . 75.31 112.097 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.5 m -135.38 33.32 3.05 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.526 -1.215 . . . . 60.02 107.791 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.92 86.86 1.3 Allowed 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 115.104 -0.953 . . . . 41.51 111.93 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -129.65 132.79 46.8 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 104.595 -2.372 . . . . 71.35 104.595 171.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 17' ' ' LEU . 1.8 mm? -90.64 153.59 20.2 Favored 'General case' 0 N--CA 1.395 -3.214 0 C-N-CA 119.664 -0.814 . . . . 74.01 110.982 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.47 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.6 m-70 -123.61 159.77 28.55 Favored 'General case' 0 C--N 1.27 -2.858 0 CA-C-N 114.82 -1.082 . . . . 73.34 109.406 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 15.3 p30 -125.59 126.19 44.37 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.021 -0.99 . . . . 55.34 110.322 174.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.61 138.76 53.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.436 -0.802 . . . . 72.44 109.395 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.466 ' HB2' HG21 ' A' ' 113' ' ' VAL . 87.5 t80 -93.55 121.92 35.46 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.138 -1.43 . . . . 73.22 107.138 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 19.2 m -103.24 154.81 5.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 115.737 -0.665 . . . . 61.43 110.878 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -139.9 -30.05 0.7 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.989 0.737 . . . . 72.14 112.989 -170.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.49 -91.29 0.44 Allowed Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 118.875 -1.631 . . . . 72.53 113.523 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 m -58.69 -31.29 68.09 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.22 0.822 . . . . 73.43 113.22 -173.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 32' ' ' ILE . 27.6 m-85 -117.49 21.56 12.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.677 0.992 . . . . 63.33 113.677 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 22' ' ' VAL . 63.2 tt0 -82.67 -2.63 54.62 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 121.974 0.892 . . . . 71.23 110.131 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 32' ' ' ILE . 20.4 t70 -112.52 125.21 30.38 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 115.392 -0.822 . . . . 60.53 109.56 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.3 -31.12 36.0 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.716 2.277 . . . . 60.33 113.572 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 21.9 t70 -62.78 -38.14 89.45 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 120.686 0.279 . . . . 43.25 111.591 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 28' ' ' ASP . 29.0 m -73.38 -28.19 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.147 -0.479 . . . . 64.15 110.752 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 28' ' ' ASP . 47.9 mm -61.49 -38.61 80.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 CA-C-O 121.046 0.451 . . . . 73.43 110.866 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -59.6 -35.13 73.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.698 -0.683 . . . . 71.31 110.275 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.9 t -82.07 -51.12 15.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.406 -0.815 . . . . 72.41 111.667 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.424 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 10.7 tmm? -63.68 -36.63 84.48 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.523 -0.308 . . . . 74.21 111.002 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 37' ' ' ASP 0.386 3.6 pp -121.56 -59.55 1.68 Allowed 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 114.702 1.371 . . . . 54.12 114.702 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.555 ' N ' HD12 ' A' ' 36' ' ' LEU . 17.2 t70 172.72 -55.44 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.127 0.489 . . . . 62.3 110.825 -176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 56.8 mmt-85 -138.75 159.1 42.95 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.828 -0.624 . . . . 51.0 110.195 -176.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.3 m -94.3 122.09 62.16 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 112.144 0.424 . . . . 74.31 112.144 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.61 153.26 68.19 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.066 3.177 . . . . 70.34 111.392 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -56.77 132.08 51.16 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.226 -0.657 . . . . 72.25 109.226 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 54.9 mt -115.49 134.67 57.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 109.307 -0.627 . . . . 75.23 109.307 -174.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.29 144.13 36.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 108.505 -0.924 . . . . 73.53 108.505 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.5 m -81.12 127.69 32.92 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 108.826 -0.805 . . . . 54.44 108.826 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.48 158.74 43.37 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.221 0.534 . . . . 74.35 110.834 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.503 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 97.1 m -113.58 127.69 56.16 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.187 -0.915 . . . . 50.33 110.082 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.8 tp -100.59 100.22 11.82 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 109.415 -0.587 . . . . 73.21 109.415 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 46' ' ' THR . 97.2 Cg_endo -88.09 135.21 3.23 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.649 2.233 . . . . 63.34 111.646 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.11 11.83 38.33 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.402 -0.904 . . . . 55.42 111.165 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.507 ' HA ' ' H ' ' A' ' 66' ' ' SER . 87.0 m-85 -145.31 159.69 42.66 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.876 -0.787 . . . . 73.02 108.876 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.42 143.8 37.8 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.662 -0.495 . . . . 73.22 109.662 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HB3' ' CE2' ' A' ' 132' ' ' PHE . 59.1 ttt180 -104.41 132.68 50.39 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.825 -1.176 . . . . 73.01 107.825 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -108.76 169.82 8.42 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 113.378 0.881 . . . . 73.31 113.378 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -88.42 145.19 25.92 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 114.251 -1.34 . . . . 74.11 109.163 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.453 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.6 pp -64.24 98.95 0.25 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 122.576 1.179 . . . . 64.5 110.529 173.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HD3' ' CA ' ' A' ' 128' ' ' GLY . 49.8 tptt -104.53 100.23 9.91 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 114.796 -1.093 . . . . 65.52 110.29 -172.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.46 -87.16 0.15 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.569 -0.741 . . . . 62.52 114.742 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.527 ' HD2' ' H ' ' A' ' 58' ' ' ARG . 0.6 OUTLIER -104.39 2.07 30.84 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.272 0.471 . . . . 73.31 112.272 -172.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.68 HD23 ' HB3' ' A' ' 126' ' ' MET . 28.6 tp -125.89 163.95 21.83 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.256 -0.978 . . . . 73.0 112.351 -172.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -91.05 169.24 11.97 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 124.334 1.054 . . . . 62.54 108.993 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.39 98.05 1.14 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.823 1.682 . . . . 64.12 108.915 172.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 23.3 p -109.89 169.15 8.91 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.146 -0.479 . . . . 70.22 112.189 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.8 mm -108.82 141.24 24.62 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.022 0 C-N-CA 123.533 0.733 . . . . 73.41 109.232 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.3 153.62 52.56 Favored Pre-proline 0 N--CA 1.476 0.873 0 N-CA-C 107.762 -1.199 . . . . 74.43 107.762 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.432 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 30.7 Cg_endo -65.03 115.45 3.29 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.555 2.17 . . . . 72.3 113.966 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.507 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 47.3 t -125.82 112.95 16.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.25 -1.018 . . . . 64.22 108.25 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.62 -22.31 66.65 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.396 0.517 . . . . 74.03 112.396 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -109.63 14.82 23.23 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.86 0.362 . . . . 73.21 110.937 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.13 167.22 15.39 Favored Glycine 0 C--O 1.249 1.082 0 C-N-CA 120.684 -0.769 . . . . 33.43 112.663 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.41 143.54 18.94 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 123.834 0.854 . . . . 74.12 109.569 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.44 120.02 63.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 110.13 -0.322 . . . . 63.54 110.13 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -91.77 115.45 28.07 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.782 -1.562 . . . . 74.22 106.782 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.05 -150.37 5.29 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.573 -0.822 . . . . 64.44 111.866 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 73.5 mmtt -126.04 141.54 51.91 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.854 0.359 . . . . 75.51 110.339 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.3 t -111.09 131.04 63.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.966 -0.561 . . . . 75.24 110.78 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 66.9 mt -95.57 104.71 16.63 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.887 -0.783 . . . . 75.41 108.887 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.474 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 55.3 mtp -102.61 161.03 14.05 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.326 -0.99 . . . . 63.21 108.326 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.67 17.09 78.14 Favored Glycine 0 C--N 1.302 -1.346 0 C-N-CA 119.29 -1.433 . . . . 73.4 112.792 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 83' ' ' GLU . 10.9 p -91.82 136.02 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.28 -1.007 . . . . 64.12 108.28 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 79.2 p -78.93 168.39 19.76 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.899 -0.72 . . . . 72.24 111.766 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 m -63.0 -33.43 75.4 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.206 -0.452 . . . . 73.01 111.978 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.72 -39.17 93.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.795 0.807 . . . . 70.15 110.47 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.535 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.8 mt-10 -78.27 -28.36 47.62 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.979 -1.01 . . . . 63.21 109.296 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.454 HD22 ' CE1' ' A' ' 18' ' ' HIS . 53.3 tp -66.13 -50.29 64.53 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 109.882 -0.414 . . . . 63.45 109.882 175.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.99 -28.87 69.87 Favored 'General case' 0 C--O 1.208 -1.12 0 CA-C-O 121.379 0.609 . . . . 73.11 109.441 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 12.6 t-20 -65.44 -49.06 70.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.171 -0.922 . . . . 62.54 110.537 176.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.597 ' HA ' HG12 ' A' ' 90' ' ' VAL . 95.4 mt -65.07 -38.85 92.12 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.824 0.821 . . . . 73.44 109.639 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.655 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 24.6 t70 -65.13 -31.68 73.0 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.231 -1.35 . . . . 73.55 109.737 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.21 -48.4 17.67 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.258 -0.883 . . . . 64.51 111.514 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 87' ' ' LEU . 7.3 p -72.33 -59.14 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 113.957 1.095 . . . . 73.13 113.957 -173.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.38 -32.93 37.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 119.643 -0.823 . . . . 74.4 110.847 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.46 -16.35 21.12 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.83 -1.077 . . . . 74.44 115.55 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -77.16 -24.58 51.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 118.277 1.038 . . . . 65.44 111.604 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -111.05 -11.59 14.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.42 0.629 . . . . 73.03 110.327 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -134.53 170.91 15.06 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.771 0.829 . . . . 74.12 110.416 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -121.62 138.03 54.49 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.335 -0.987 . . . . 54.32 108.335 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 115' ' ' THR . 39.6 ttp180 -87.48 119.13 27.45 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.794 -0.817 . . . . 73.25 108.794 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.54 161.16 26.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 112.378 0.51 . . . . 75.42 112.378 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -91.5 122.96 34.55 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.014 -0.993 . . . . 73.12 108.955 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.42 158.96 43.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.104 0.478 . . . . 74.14 111.605 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.06 119.75 6.14 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 111.032 -0.827 . . . . 70.41 111.032 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.03 154.88 13.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 122.296 0.238 . . . . 64.23 110.431 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.74 117.72 55.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.181 0.515 . . . . 42.53 109.788 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -64.5 124.67 22.43 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 124.509 1.124 . . . . 73.44 111.414 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -61.41 -35.59 77.95 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.739 0.816 . . . . 74.01 112.115 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.2 -53.02 62.73 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.031 0.752 . . . . 71.41 113.031 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -128.96 10.86 5.98 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 113.5 0.926 . . . . 72.35 113.5 -167.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.4 t 63.93 12.44 6.83 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.403 0.681 . . . . 73.41 112.504 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -81.07 152.14 28.01 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.24 -0.652 . . . . 72.33 109.24 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -105.78 147.18 28.92 Favored 'General case' 0 C--N 1.278 -2.515 0 C-N-CA 120.263 -0.575 . . . . 62.53 109.789 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 40.9 mtm -137.55 163.05 32.13 Favored 'General case' 0 CA--C 1.465 -2.308 0 CA-C-O 121.412 0.625 . . . . 63.22 110.186 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.75 118.32 36.22 Favored 'General case' 0 C--N 1.262 -3.226 0 CA-C-N 114.612 -1.176 . . . . 70.23 108.474 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 21' ' ' PHE . 30.8 m -128.22 173.52 13.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 116.062 -0.517 . . . . 73.33 110.172 -176.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -101.99 149.42 24.25 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.214 -1.402 . . . . 64.03 107.214 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.7 t -152.3 171.69 17.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.561 -0.903 . . . . 73.21 108.561 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -119.1 116.75 27.02 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.043 -0.725 . . . . 72.04 109.043 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.432 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 24.5 ptt? -112.63 156.79 22.12 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.054 -0.521 . . . . 73.15 109.777 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 64.4 t-105 -68.08 123.98 22.16 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.572 -0.899 . . . . 70.42 108.572 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.6 mt -67.86 -41.76 85.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.069 -0.968 . . . . 74.51 112.022 -172.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -88.12 75.76 8.62 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.973 0.892 . . . . 64.41 108.673 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -76.67 0.05 21.75 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.005 -0.998 . . . . 71.52 112.877 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.88 8.96 41.05 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.104 -0.498 . . . . 71.12 109.871 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.94 138.59 96.4 Favored Pre-proline 0 C--O 1.214 -0.774 0 CA-C-N 115.772 -0.649 . . . . 72.41 109.96 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -99.56 17.56 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.181 1.921 . . . . 35.33 113.308 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -118.01 -9.0 10.65 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.311 1.226 . . . . 75.3 114.311 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.68 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -86.65 -2.59 58.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 119.333 -0.947 . . . . 72.21 110.247 175.351 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -71.82 93.6 1.33 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.458 0.647 . . . . 74.15 111.295 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.405 ' CA ' ' HD3' ' A' ' 56' ' ' LYS . . . -128.53 168.6 20.31 Favored Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 109.255 -1.538 . . . . 61.22 109.255 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -90.76 125.13 35.6 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.714 -0.476 . . . . 74.15 109.714 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -128.96 158.44 38.84 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.145 -0.687 . . . . 75.34 109.145 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HB3' ' A' ' 134' ' ' GLU . 15.5 m120 -52.2 -3.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.451 1.648 . . . . 73.31 115.451 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 86.4 m-85 -67.73 -34.32 76.61 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.228 -0.92 . . . . 71.11 108.637 174.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -71.65 -28.62 63.88 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.91 -1.041 . . . . 55.3 109.464 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.584 ' HG3' ' NH2' ' A' ' 137' ' ' ARG . 39.2 tt0 -62.64 -40.69 97.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.316 -0.856 . . . . 64.24 109.425 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -71.46 -43.35 66.8 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.259 -0.428 . . . . 71.45 109.96 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -55.19 -31.01 61.07 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 116.016 -0.538 . . . . 65.45 110.932 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.584 ' NH2' ' HG3' ' A' ' 134' ' ' GLU . 44.2 ttp180 -59.12 -48.68 80.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.695 0.798 . . . . 62.02 112.72 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.65 -21.91 40.97 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.754 0.787 . . . . 74.11 110.221 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -84.52 -4.25 58.85 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.679 -1.146 . . . . 73.41 110.041 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 144' ' ' ILE . 6.3 ttpm? -48.63 -40.95 29.54 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 124.601 1.16 . . . . 72.52 114.053 -171.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -55.83 -35.08 65.99 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.314 0.857 . . . . 74.11 113.314 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.62 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 0.6 OUTLIER -66.74 -36.57 82.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.879 0.847 . . . . 74.33 108.749 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -77.03 -35.96 56.52 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 113.679 -1.6 . . . . 74.35 110.678 -175.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 140' ' ' LYS . 50.1 mm -61.37 -32.67 53.86 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.981 0 N-CA-C 113.182 0.808 . . . . 71.1 113.182 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -51.77 -42.31 62.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 113.792 1.034 . . . . 71.12 113.792 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.431 ' O ' HG13 ' A' ' 150' ' ' ILE . 13.1 t -70.77 -33.67 71.02 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 120.128 -0.629 . . . . 74.22 109.811 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.469 ' O ' ' HG3' ' A' ' 151' ' ' MET . 64.0 m-85 -71.71 -30.36 65.56 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 116.125 -0.489 . . . . 63.33 111.679 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.492 ' HG3' HG22 ' A' ' 144' ' ' ILE . 29.8 mtpp -59.83 -36.84 77.64 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.254 -1.017 . . . . 72.22 108.254 174.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 149' ' ' LYS . 48.4 mmtt -74.56 -36.68 63.08 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.778 -0.646 . . . . 74.43 112.201 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.556 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 94.6 mt -63.28 -41.45 92.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.904 0.383 . . . . 63.54 110.09 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 147' ' ' PHE . 65.4 mtt -66.58 -40.64 89.02 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.656 -0.498 . . . . 70.11 109.656 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 148' ' ' LYS . 1.3 tm-20 -62.28 -34.29 76.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 124.87 1.268 . . . . 44.12 109.765 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 74.9 m -71.13 -34.07 70.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.188 -0.46 . . . . 70.3 110.553 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 34.6 mmtp -73.31 -45.25 56.5 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.261 -0.644 . . . . 71.12 109.261 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -165.54 -75.35 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.358 -0.837 . . . . 71.0 109.107 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -161.53 147.26 10.76 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 124.33 1.052 . . . . 74.51 110.784 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' A' ' 151' ' ' MET . 54.5 Cg_endo -99.79 -169.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.138 2.559 . . . . 75.14 108.905 171.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.495 ' HA ' ' OE1' ' A' ' 158' ' ' GLN . 11.7 mm-40 . . . . . 0 C--N 1.305 -1.357 0 N-CA-C 107.557 -1.275 . . . . 73.54 107.557 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m . . . . . 0 N--CA 1.428 -1.529 0 N-CA-C 108.427 -0.953 . . . . 71.24 108.427 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 p -74.54 75.8 1.97 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.926 0.869 . . . . 72.32 111.365 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.0 m -82.89 -25.18 32.73 Favored 'General case' 0 N--CA 1.422 -1.875 0 CA-C-N 114.553 -1.203 . . . . 72.44 109.889 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.0 t70 57.72 75.29 0.38 Allowed 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 124.267 0.98 . . . . 73.31 110.288 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.524 ' OG ' ' HB ' ' A' ' 80' ' ' THR . 44.9 m -154.05 105.51 2.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.477 -0.783 . . . . 64.0 111.628 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -100.39 -3.98 29.98 Favored 'General case' 0 N--CA 1.398 -3.063 0 CA-C-O 122.777 1.275 . . . . 72.03 108.3 173.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -133.15 129.18 37.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.913 -1.494 . . . . 71.32 107.445 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 17' ' ' LEU . 2.2 mm? -95.37 156.71 16.21 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.325 0.583 . . . . 63.34 112.14 -177.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.59 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.9 m-70 -113.9 161.25 17.85 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.016 -0.993 . . . . 74.31 109.191 -173.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 24.9 p30 -128.27 134.58 48.97 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.336 0.589 . . . . 73.35 112.117 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 53.9 t -131.52 137.97 54.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.659 -0.7 . . . . 73.44 110.345 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.475 ' HB2' HG21 ' A' ' 113' ' ' VAL . 93.2 t80 -94.67 123.83 38.34 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.195 0.598 . . . . 63.12 109.659 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 26' ' ' PHE . 13.1 p -138.56 155.46 28.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.416 -0.587 . . . . 71.15 109.416 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.428 ' CE1' HD11 ' A' ' 63' ' ' ILE . 2.0 p90 -148.97 6.31 0.69 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.923 0.392 . . . . 62.25 110.145 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.81 -92.61 1.02 Allowed Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 119.812 -1.185 . . . . 72.11 113.293 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.7 m -58.6 -36.11 73.49 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.441 0.696 . . . . 52.2 112.835 -174.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.51 ' HB2' HG21 ' A' ' 22' ' ' VAL . 72.6 m-85 -120.04 29.78 7.35 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.259 0.552 . . . . 71.43 111.561 -175.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -62.95 -31.51 72.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.929 -1.032 . . . . 73.34 110.633 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 21.2 t70 -108.49 129.7 23.68 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.642 -0.708 . . . . 75.15 111.719 -176.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.23 -24.68 58.18 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.437 2.758 . . . . 71.23 113.915 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.447 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 16.4 t70 -70.46 -29.09 65.56 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.709 -0.619 . . . . 54.12 110.119 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.58 -39.57 84.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.345 -0.843 . . . . 75.24 108.824 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 26' ' ' PHE . 29.0 mm -62.77 -45.03 99.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.253 -0.885 . . . . 74.22 110.526 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -53.2 -42.85 66.7 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.492 0.553 . . . . 71.3 112.492 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.55 -36.75 14.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 112.525 0.565 . . . . 71.5 112.525 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.7 tmm? -65.22 -35.85 82.33 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 121.32 -0.152 . . . . 62.05 110.683 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.622 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 0.8 OUTLIER -120.35 -74.7 0.6 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 119.967 -0.693 . . . . 75.01 112.444 172.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.622 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 16.3 t70 173.6 -48.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.528 0.731 . . . . 75.24 109.163 -174.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -109.13 164.95 11.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.604 -1.18 . . . . 60.01 109.094 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.4 m -123.93 129.35 24.81 Favored Pre-proline 0 C--N 1.307 -1.247 0 C-N-CA 122.361 0.264 . . . . 63.2 111.164 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -68.0 152.57 76.63 Favored 'Trans proline' 0 C--O 1.25 1.085 0 C-N-CA 123.278 2.652 . . . . 42.14 111.431 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.89 140.13 58.79 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.193 -0.669 . . . . 63.31 109.193 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 52.6 mt -118.35 142.66 32.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 120.889 0.376 . . . . 51.51 110.655 -173.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.464 HG21 ' HD2' ' A' ' 104' ' ' ARG . 9.1 p -130.13 145.08 36.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.092 -0.707 . . . . 51.43 109.092 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.1 m -76.54 124.79 28.14 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.888 -0.782 . . . . 63.25 108.888 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.66 156.69 47.76 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.981 0.896 . . . . 72.34 112.042 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 64.8 m -116.16 128.89 56.02 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.398 -1.274 . . . . 73.24 108.153 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.0 tp -102.03 99.61 12.78 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 46' ' ' THR . 95.6 Cg_endo -85.47 148.37 10.03 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.349 2.033 . . . . 72.44 111.354 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.39 13.45 68.06 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.433 -0.889 . . . . 33.51 111.225 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -143.25 152.26 41.49 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.991 -1.114 . . . . 72.22 107.991 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -139.55 142.86 37.17 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.783 -0.767 . . . . 74.12 109.154 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.708 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -90.27 134.81 34.07 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.83 -1.174 . . . . 73.13 107.83 176.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.668 ' HB3' ' O ' ' A' ' 126' ' ' MET . 84.2 m-85 -116.64 169.11 9.6 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 112.097 0.406 . . . . 74.34 112.097 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -139.21 137.85 36.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.692 1.367 . . . . 72.31 114.692 -169.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 125' ' ' ASP . 1.1 tt -177.84 48.02 0.01 OUTLIER 'General case' 0 C--O 1.246 0.887 0 N-CA-C 104.133 -2.543 . . . . 65.52 104.133 169.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 86.1 tttt -67.3 116.81 8.48 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.821 -1.081 . . . . 61.53 110.124 -173.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.46 -28.65 2.43 Favored Glycine 0 C--N 1.296 -1.678 0 N-CA-C 107.907 -2.077 . . . . 73.44 107.907 -173.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.495 ' C ' ' HD3' ' A' ' 58' ' ' ARG . 0.3 OUTLIER -125.89 -41.06 1.99 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.018 -1.104 . . . . 73.34 108.018 175.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 37.5 tp -132.57 164.45 26.62 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.948 -0.76 . . . . 74.23 108.948 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -102.15 168.06 9.54 Favored Pre-proline 0 C--N 1.291 -1.957 0 N-CA-C 108.302 -0.999 . . . . 73.35 108.302 -172.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 21.9 Cg_exo -66.37 101.05 0.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 N-CA-C 108.639 -1.331 . . . . 61.0 108.639 171.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 9.3 p -102.54 153.3 20.21 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.547 -0.751 . . . . 73.33 112.969 -173.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.428 HD11 ' CE1' ' A' ' 23' ' ' TYR . 41.8 mm -106.13 117.94 52.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.297 -0.865 . . . . 72.24 110.289 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.36 146.58 62.58 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.46 -0.57 . . . . 70.43 109.46 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.1 109.05 1.05 Allowed 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.757 2.305 . . . . 72.22 112.303 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 t -124.64 121.76 35.61 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.01 -1.478 . . . . 53.43 107.01 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.61 -36.77 67.3 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.476 1.287 . . . . 74.32 114.476 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -109.1 20.05 18.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.193 0.52 . . . . 61.11 110.661 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.7 162.72 14.11 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.041 -1.076 . . . . 62.23 112.731 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -150.97 145.13 25.36 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 108.709 -0.849 . . . . 62.13 108.709 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.427 HG21 HD12 ' A' ' 63' ' ' ILE . 50.7 t -123.3 133.27 69.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.468 -0.568 . . . . 65.21 109.468 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -107.41 126.51 52.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.058 -1.09 . . . . 71.03 108.058 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.01 -154.91 7.08 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.753 -0.939 . . . . 63.01 110.753 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.52 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.2 mmtm -125.75 148.72 48.99 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 120.719 0.295 . . . . 73.12 110.221 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.5 t -109.75 126.41 66.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 116.154 -0.476 . . . . 63.24 110.289 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 69.4 mt -94.98 107.39 19.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.67 -1.233 . . . . 74.44 107.67 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.404 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 14.3 ptp -116.82 144.86 43.99 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.892 -0.41 . . . . 71.52 109.892 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.11 5.92 52.38 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.471 -1.347 . . . . 41.51 110.139 -173.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 18' ' ' HIS . 8.8 p -79.81 141.43 15.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 N-CA-C 108.107 -1.072 . . . . 73.42 108.107 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.524 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 36.3 p -87.97 175.78 7.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.359 -0.936 . . . . 43.03 110.452 -176.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.2 m -65.83 -26.79 67.83 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.504 -0.771 . . . . 74.4 110.933 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.6 -41.78 53.56 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.311 -0.556 . . . . 64.5 110.781 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.581 ' HB2' HG22 ' A' ' 79' ' ' VAL . 4.9 mp0 -70.16 -28.11 65.07 Favored 'General case' 0 C--O 1.203 -1.389 0 C-N-CA 119.004 -1.078 . . . . 72.21 108.854 173.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.6 tp -58.97 -51.24 70.9 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 109.644 -0.502 . . . . 75.44 109.644 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.79 -30.83 71.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.125 0.488 . . . . 70.04 110.163 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 2.2 t-20 -63.67 -49.76 71.93 Favored 'General case' 0 C--O 1.201 -1.46 0 CA-C-N 115.349 -0.841 . . . . 74.53 111.313 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.5 mt -69.74 -34.18 73.47 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.304 -0.628 . . . . 41.03 109.304 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.585 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 33.6 t70 -63.39 -36.86 85.11 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 114.651 -1.159 . . . . 72.22 109.011 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.98 -49.98 14.21 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.783 -0.644 . . . . 74.25 111.494 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.24 -57.63 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 123.752 0.821 . . . . 65.42 113.171 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -80.22 -26.67 39.03 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.415 0.626 . . . . 74.2 111.481 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -59.49 -16.08 34.83 Favored Glycine 0 N--CA 1.461 0.328 0 CA-C-N 114.693 -1.139 . . . . 72.3 115.909 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -57.47 -34.21 68.79 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 117.519 0.66 . . . . 62.12 111.833 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -131.95 -0.69 3.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.758 0.651 . . . . 73.23 112.758 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -122.91 166.35 15.19 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.584 -0.28 . . . . 72.3 110.246 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -122.6 142.72 50.33 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.488 -0.56 . . . . 73.44 109.488 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.443 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 15.6 ttp85 -87.01 114.63 23.78 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.765 -0.652 . . . . 74.43 110.153 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.451 HG11 ' CE ' ' A' ' 117' ' ' MET . 35.0 m -128.17 162.42 34.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.284 -0.871 . . . . 75.55 110.89 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -101.24 131.75 47.09 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.215 -0.661 . . . . 64.25 109.215 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.82 166.77 25.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 116.182 -0.463 . . . . 51.53 111.065 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.23 117.97 5.92 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 111.013 -0.835 . . . . 62.41 111.013 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.404 HD11 ' HE2' ' A' ' 111' ' ' MET . 2.7 pp -112.7 157.17 13.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.532 -0.544 . . . . 71.12 109.532 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.36 127.47 75.44 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 N-CA-C 107.89 -1.152 . . . . 71.41 107.89 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.464 ' HD2' HG21 ' A' ' 43' ' ' VAL . 60.7 mtm180 -71.48 141.83 50.2 Favored 'General case' 0 CA--C 1.489 -1.37 0 C-N-CA 119.501 -0.88 . . . . 72.02 110.151 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.24 5.6 25.96 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.303 -0.862 . . . . 73.41 111.042 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -94.02 -29.45 15.21 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.64 -0.709 . . . . 73.41 109.942 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.458 ' HB2' ' OE2' ' A' ' 109' ' ' GLU . 2.5 m-20 -118.9 -121.46 0.3 Allowed 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 108.487 -0.931 . . . . 65.33 108.487 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.3 m -167.03 17.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.485 1.914 . . . . 75.43 107.236 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -105.43 157.84 17.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.646 -0.706 . . . . 73.44 111.735 -174.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -106.08 147.28 29.12 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.173 0.511 . . . . 45.41 110.743 -177.25 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.404 ' HE2' HD11 ' A' ' 102' ' ' ILE . 36.9 mtm -132.23 162.85 29.93 Favored 'General case' 0 CA--C 1.47 -2.134 0 CA-C-N 115.056 -0.975 . . . . 75.12 108.451 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.41 126.77 53.26 Favored 'General case' 0 C--N 1.249 -3.77 0 CA-C-N 114.853 -1.067 . . . . 54.53 108.851 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 21' ' ' PHE . 32.6 m -139.0 173.01 12.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.617 -0.512 . . . . 74.35 109.617 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 3.6 mptp? -97.99 149.51 22.37 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.252 -1.018 . . . . 74.22 108.252 175.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.6 t -152.41 172.23 16.82 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.185 -1.043 . . . . 73.31 108.185 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 97' ' ' ARG . 96.6 m-85 -108.45 111.07 22.76 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-O 121.745 0.783 . . . . 74.33 110.191 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.469 ' HB3' ' HE2' ' A' ' 117' ' ' MET . 56.9 ttp -105.37 146.63 29.18 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.321 -1.309 . . . . 64.42 109.04 -174.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 65.8 t-105 -74.96 132.78 41.65 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.146 -1.427 . . . . 75.4 107.146 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.5 mp -71.85 -41.87 69.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 120.428 -0.509 . . . . 71.42 111.189 -171.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -89.3 94.34 9.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.62 0.724 . . . . 54.5 110.729 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -81.68 12.03 4.25 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.538 -0.755 . . . . 74.34 111.291 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.25 22.54 7.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.739 -0.664 . . . . 60.41 110.047 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.54 121.29 78.45 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 109.889 -0.411 . . . . 74.22 109.889 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.97 -0.51 9.21 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.572 2.181 . . . . 60.24 113.769 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.506 ' O ' HD12 ' A' ' 55' ' ' LEU . 30.8 m-20 -96.61 -37.31 10.41 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 120.675 -0.41 . . . . 53.12 112.073 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.668 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 25.7 ptt? -63.25 -23.31 67.37 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 112.17 0.433 . . . . 54.55 112.17 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.71 103.7 0.72 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.229 0.538 . . . . 72.32 112.012 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -170.67 168.34 41.42 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.418 -1.073 . . . . 73.03 110.418 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.538 ' O ' ' HD3' ' A' ' 54' ' ' ARG . 10.1 pt-20 -89.08 134.46 33.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.415 0.626 . . . . 70.15 112.376 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.532 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 6.4 t90 -120.51 156.19 32.04 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.872 -1.899 . . . . 73.42 105.872 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -52.36 -33.83 44.86 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 113.517 0.932 . . . . 71.44 113.517 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -54.32 -30.08 49.95 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.603 0.964 . . . . 72.11 113.603 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 130' ' ' TRP . 0.8 OUTLIER -61.58 -28.25 69.21 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.141 0.423 . . . . 73.54 112.141 -177.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 42.5 tt0 -60.95 -41.05 95.55 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.517 -0.765 . . . . 73.21 109.307 174.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -73.38 -31.4 63.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.711 -0.477 . . . . 73.4 109.711 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -60.47 -37.17 80.16 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 108.394 -0.965 . . . . 72.34 108.394 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.687 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 61.8 ttt180 -63.43 -51.02 67.47 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.187 -0.915 . . . . 74.2 111.543 176.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.9 -14.9 62.07 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.472 0.545 . . . . 75.32 112.472 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -95.55 -28.78 14.7 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.967 -0.293 . . . . 60.21 111.215 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.687 ' HG2' ' O ' ' A' ' 137' ' ' ARG . 22.7 ptmt -62.07 -32.73 73.3 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 110.038 -0.356 . . . . 74.24 110.038 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -48.85 -39.26 24.99 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.411 1.084 . . . . 63.35 111.107 -175.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.54 -44.45 85.17 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.083 0.468 . . . . 72.53 110.698 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.0 -35.58 59.52 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.14 -0.689 . . . . 74.11 109.14 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 140' ' ' LYS . 45.9 mm -60.99 -32.61 52.98 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.708 0 CA-C-N 115.615 -0.72 . . . . 60.35 110.848 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 43.9 mt-10 -55.08 -44.57 74.98 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.917 -0.313 . . . . 72.31 111.39 176.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.465 ' O ' HG13 ' A' ' 150' ' ' ILE . 9.9 t -80.19 -36.73 34.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 119.828 -0.749 . . . . 72.24 110.342 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.494 ' O ' ' HG2' ' A' ' 151' ' ' MET . 54.8 m-85 -66.94 -30.68 70.88 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.942 1.089 . . . . 74.15 113.942 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 87.8 tttt -62.08 -36.95 83.22 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.132 -1.062 . . . . 51.43 108.132 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 146' ' ' THR . 86.5 tttt -74.05 -37.89 64.14 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.425 -1.261 . . . . 63.14 109.526 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 146' ' ' THR . 83.6 mt -67.02 -33.76 65.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.756 -0.656 . . . . 71.23 110.206 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 26.3 mmt -66.33 -30.46 70.87 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.009 -0.367 . . . . 73.54 110.009 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 23.1 mm-40 -72.31 -30.52 64.87 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.988 -0.551 . . . . 73.34 109.647 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 66.6 m -70.65 -31.46 68.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.403 0.62 . . . . 74.32 109.608 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -79.95 -19.79 47.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 72.44 109.514 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.2 tttm 62.36 60.64 1.38 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 125.629 1.572 . . . . 64.41 109.735 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -140.9 112.16 6.82 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 114.685 -1.143 . . . . 74.54 109.412 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.57 165.09 23.11 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.648 2.232 . . . . 64.54 112.831 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 C--N 1.304 -1.389 0 CA-C-O 122.132 0.968 . . . . 73.0 109.307 176.349 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.2 p . . . . . 0 N--CA 1.434 -1.262 0 N-CA-C 108.413 -0.958 . . . . 43.43 108.413 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.3 m -85.22 71.93 10.8 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.772 0.796 . . . . 72.22 111.843 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.2 m -89.35 -10.68 45.77 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 114.54 -1.209 . . . . 70.45 109.622 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 78.89 179.25 0.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.623 1.569 . . . . 72.33 108.171 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -89.51 99.57 12.54 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.53 -0.731 . . . . 72.43 110.27 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.9 98.97 7.34 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.606 -0.887 . . . . 61.23 108.606 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -138.63 147.9 43.45 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.472 0.653 . . . . 75.13 111.436 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 17' ' ' LEU . 2.4 mm? -81.15 156.38 25.75 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 107.748 -1.205 . . . . 60.1 107.748 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.584 ' O ' HG12 ' A' ' 79' ' ' VAL . 39.7 m-70 -112.5 159.32 18.9 Favored 'General case' 0 C--N 1.262 -3.233 0 N-CA-C 108.085 -1.08 . . . . 73.04 108.085 -173.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.442 ' HB2' HG12 ' A' ' 113' ' ' VAL . 46.3 m-20 -117.04 125.83 51.92 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.108 -1.441 . . . . 73.33 107.108 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.2 t -119.38 137.72 52.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 110.391 -0.225 . . . . 70.12 110.391 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.482 ' HB2' HG21 ' A' ' 113' ' ' VAL . 70.1 t80 -94.91 122.08 37.17 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.442 -0.948 . . . . 61.03 108.442 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -103.2 105.71 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.224 1.011 . . . . 63.42 111.135 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.487 ' HB2' HD11 ' A' ' 63' ' ' ILE . 43.2 p90 -72.08 -18.87 61.89 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.003 -1.453 . . . . 74.44 114.272 -173.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.72 -40.22 0.3 Allowed Glycine 0 CA--C 1.499 -0.921 0 C-N-CA 118.979 -1.581 . . . . 72.43 112.947 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -58.06 -36.49 72.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.869 0.467 . . . . 53.04 112.189 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.661 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 49.3 m-85 -134.75 37.35 3.08 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.472 0.654 . . . . 51.11 109.435 -176.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -86.18 -4.78 59.24 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.6 -0.727 . . . . 43.45 110.962 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -105.8 121.12 46.92 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 109.381 -0.6 . . . . 74.21 109.381 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 11.7 Cg_endo -56.89 -31.53 89.48 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.159 2.573 . . . . 65.44 113.934 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.03 -33.64 74.98 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.409 0.624 . . . . 63.32 109.973 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.28 -39.15 82.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.172 -0.922 . . . . 64.42 108.792 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.562 HG23 HD21 ' A' ' 36' ' ' LEU . 44.5 mm -62.56 -37.41 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.285 -0.871 . . . . 71.24 110.361 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -53.87 -50.17 66.88 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.57 0.7 . . . . 73.42 110.287 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.85 -44.9 19.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 114.222 1.194 . . . . 72.03 114.222 -173.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.661 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 5.9 tmm? -62.33 -36.55 82.52 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.06 0.457 . . . . 74.34 110.707 -173.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.562 HD21 HG23 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -116.71 -75.13 0.58 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 120.491 -0.484 . . . . 71.34 111.926 178.241 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.9 t70 173.18 -47.74 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.292 0.568 . . . . 72.32 111.116 -175.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HD2' ' OE2' ' A' ' 83' ' ' GLU . 4.6 ptp180 -126.57 164.47 21.15 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.507 -0.769 . . . . 72.31 109.75 -174.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.6 m -124.63 108.87 28.6 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-O 120.59 0.233 . . . . 75.31 110.704 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -63.57 152.07 82.03 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.58 2.853 . . . . 74.14 111.768 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -56.51 137.56 53.14 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 123.635 0.584 . . . . 64.24 109.591 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.4 mt -115.59 137.33 49.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 116.297 -0.41 . . . . 74.54 111.179 -170.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.3 146.46 34.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.096 -0.705 . . . . 73.53 109.096 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 m -77.0 127.37 32.57 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.085 -0.709 . . . . 64.53 109.085 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' A' ' 102' ' ' ILE . . . -143.58 159.41 42.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.208 0.528 . . . . 74.42 111.994 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.4 m -119.45 131.89 55.7 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.585 -0.734 . . . . 54.51 110.779 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -101.6 103.41 27.67 Favored Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-N 115.55 -0.75 . . . . 54.4 109.484 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.2 142.61 7.48 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.241 1.96 . . . . 62.44 111.553 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.46 7.75 60.26 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.451 -0.88 . . . . 71.1 111.556 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -145.35 143.53 30.19 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 107.0 -1.481 . . . . 54.32 107.0 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.434 ' HB2' ' HA3' ' A' ' 69' ' ' GLY . 62.4 tt0 -143.04 142.82 31.67 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.705 -1.22 . . . . 74.24 107.705 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -91.21 125.83 36.11 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 119.978 -0.689 . . . . 75.51 109.542 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 11.6 m-30 -107.67 135.64 48.77 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.942 -1.026 . . . . 73.22 108.653 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -108.91 165.26 11.71 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.774 0.797 . . . . 63.35 112.525 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.599 HD22 ' HB3' ' A' ' 125' ' ' ASP . 64.9 tp -154.3 -50.31 0.09 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.225 -1.352 . . . . 62.23 107.666 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? 62.0 74.04 0.45 Allowed 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 124.895 1.372 . . . . 71.01 107.708 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.46 -114.4 0.36 Allowed Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.29 -0.868 . . . . 63.03 111.169 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -77.14 -26.2 52.85 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.976 -0.75 . . . . 72.41 108.976 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB3' HD23 ' A' ' 55' ' ' LEU . 44.9 tp -116.19 163.43 15.99 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.913 -1.04 . . . . 61.44 108.631 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -107.0 170.18 5.96 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.895 -1.15 . . . . 63.14 107.895 -171.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 9.7 Cg_exo -72.19 99.91 1.06 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 121.529 1.486 . . . . 71.31 108.758 171.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.496 ' SG ' ' HG2' ' A' ' 126' ' ' MET . 27.7 p -105.36 160.01 15.46 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.039 -0.528 . . . . 73.04 112.054 -172.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 23' ' ' TYR . 48.8 mm -94.64 125.08 47.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.764 -0.653 . . . . 61.32 109.656 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.13 146.94 63.22 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.54 -0.541 . . . . 74.41 109.54 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.32 104.91 0.27 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.653 2.235 . . . . 63.22 112.573 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -125.47 108.12 11.32 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.945 -1.132 . . . . 71.54 107.945 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.27 -27.25 68.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.946 0.403 . . . . 74.2 111.807 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -90.62 8.09 36.0 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.151 -0.477 . . . . 74.51 111.447 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 51' ' ' GLN . . . -129.23 171.35 20.02 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.791 -1.195 . . . . 43.31 114.103 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.8 143.65 17.3 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.231 1.012 . . . . 73.53 108.483 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.439 HG21 HD12 ' A' ' 63' ' ' ILE . 57.5 t -114.18 122.9 69.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.772 -0.455 . . . . 63.03 109.772 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -95.46 116.31 28.63 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.938 -1.134 . . . . 74.52 107.938 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.453 ' C ' ' HD3' ' A' ' 74' ' ' LYS . . . -148.47 -155.43 6.67 Favored Glycine 0 N--CA 1.415 -2.711 0 C-N-CA 120.242 -0.98 . . . . 63.54 111.558 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 2.7 mppt? -122.56 149.2 44.28 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 112.916 0.709 . . . . 44.25 112.916 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.1 t -110.2 129.21 65.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-N 113.99 -1.459 . . . . 73.04 111.552 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.429 HD23 HG12 ' A' ' 42' ' ' ILE . 83.0 mt -95.68 108.37 20.66 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.127 -1.435 . . . . 62.23 107.127 175.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.8 ptp -111.49 147.53 35.12 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 120.922 0.392 . . . . 73.42 111.459 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.65 17.12 53.41 Favored Glycine 0 N--CA 1.42 -2.384 0 C-N-CA 119.533 -1.318 . . . . 72.03 111.311 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 18' ' ' HIS . 9.5 p -80.72 132.29 31.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.028 -0.73 . . . . 71.14 109.028 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -75.75 159.91 30.57 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 108.464 -0.939 . . . . 72.21 108.464 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.4 m -59.32 -26.6 65.16 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 112.547 0.573 . . . . 73.21 112.547 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -70.87 -47.22 60.44 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.036 0.446 . . . . 64.03 110.766 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 1.2 mp0 -68.7 -28.79 67.16 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.153 -0.684 . . . . 74.24 109.153 176.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.515 ' HG ' ' NH2' ' A' ' 97' ' ' ARG . 42.1 tp -62.77 -50.85 69.4 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 120.882 0.372 . . . . 71.14 110.345 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.82 -29.8 70.33 Favored 'General case' 0 C--O 1.208 -1.106 0 N-CA-C 109.687 -0.486 . . . . 61.12 109.687 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 16.9 t-20 -59.16 -47.86 83.76 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.627 0.771 . . . . 70.3 109.964 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.544 ' HA ' HG12 ' A' ' 90' ' ' VAL . 97.5 mt -64.65 -37.01 86.11 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.225 -0.898 . . . . 71.31 111.27 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.543 ' HB2' ' NH2' ' A' ' 97' ' ' ARG . 19.1 t70 -73.54 -30.7 63.24 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 121.211 0.529 . . . . 72.31 110.096 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.24 -46.56 64.19 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.051 0.453 . . . . 75.13 110.323 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 87' ' ' LEU . 13.6 p -72.35 -50.56 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.531 0 CA-C-N 115.819 -0.628 . . . . 63.33 112.325 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -77.85 -30.29 50.87 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 112.731 0.641 . . . . 71.44 112.731 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.02 -17.36 22.45 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 114.704 0.641 . . . . 63.13 114.704 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.56 -37.4 81.16 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 122.132 0.173 . . . . 52.23 110.54 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.53 -9.57 3.63 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.39 0.515 . . . . 52.13 112.39 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -126.28 167.38 15.56 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.281 -0.262 . . . . 72.22 111.076 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 38.4 tt0 -123.7 146.39 48.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.444 -0.576 . . . . 43.44 109.444 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.543 ' NH2' ' HB2' ' A' ' 88' ' ' ASP . 34.4 ttm180 -89.41 128.74 35.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.759 0.314 . . . . 71.43 110.838 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 m -133.08 162.34 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.023 0 CA-C-N 115.894 -0.594 . . . . 70.12 111.42 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.5 t -103.72 124.04 48.15 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 114.972 -1.013 . . . . 71.11 108.272 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.29 165.21 32.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 116.213 -0.449 . . . . 63.33 111.419 -173.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.35 123.68 7.88 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.982 -0.847 . . . . 61.51 110.982 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.443 HD13 ' HB1' ' A' ' 45' ' ' ALA . 2.7 pp -117.42 165.1 13.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 110.244 -0.28 . . . . 70.52 110.244 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 80.6 t -128.25 125.83 64.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.554 -0.535 . . . . 54.53 109.554 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.619 ' HB3' ' OD1' ' A' ' 106' ' ' ASP . 34.4 mtp180 -64.71 128.55 36.26 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 124.369 1.068 . . . . 74.3 111.845 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -71.36 -18.62 62.36 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.482 0.713 . . . . 60.02 110.952 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.619 ' OD1' ' HB3' ' A' ' 104' ' ' ARG . 7.8 p-10 -78.51 -41.61 31.89 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.113 -0.494 . . . . 74.21 112.237 -173.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -143.79 16.45 1.78 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.188 0.81 . . . . 73.31 113.188 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.9 m 68.0 14.62 9.39 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.99 1.107 . . . . 74.32 113.99 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -75.59 145.85 40.84 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.052 -0.405 . . . . 61.31 110.905 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -96.51 147.78 23.49 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.165 -0.47 . . . . 73.11 109.895 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.411 ' HE2' HD11 ' A' ' 102' ' ' ILE . 35.4 mtm -145.43 163.15 35.52 Favored 'General case' 0 CA--C 1.473 -1.99 0 CA-C-O 121.306 0.574 . . . . 74.11 110.347 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.84 123.03 48.41 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 114.31 -1.314 . . . . 75.42 108.435 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.7 m -132.96 169.66 21.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.232 0.539 . . . . 64.24 111.446 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -103.87 134.15 47.65 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.72 -1.215 . . . . 73.03 107.72 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.4 t -135.92 171.11 14.94 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.832 -0.803 . . . . 75.23 108.832 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.0 m-85 -121.51 125.88 47.87 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.824 -0.806 . . . . 74.54 108.824 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.39 157.97 41.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.348 -0.387 . . . . 74.44 110.121 -176.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.469 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 61.1 t-105 -67.54 130.94 44.62 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.188 0.595 . . . . 74.2 109.88 -175.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.5 mp -73.57 -44.19 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 112.252 0.464 . . . . 71.52 112.252 -172.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -67.35 -43.63 81.03 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.42 -0.585 . . . . 51.13 109.42 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? 51.07 17.97 0.51 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.158 1.783 . . . . 71.54 113.968 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.34 1.73 5.7 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.422 0.527 . . . . 63.21 112.422 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.22 121.46 56.07 Favored Pre-proline 0 N--CA 1.483 1.217 0 N-CA-C 111.649 0.24 . . . . 64.24 111.649 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.24 -17.79 50.21 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.568 2.179 . . . . 54.44 111.41 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.599 ' HB3' HD22 ' A' ' 55' ' ' LEU . 2.2 m-20 -55.82 -41.08 73.69 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.137 -0.938 . . . . 71.43 110.754 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.496 ' HG2' ' SG ' ' A' ' 62' ' ' CYS 0.329 0.0 OUTLIER -96.94 84.83 3.63 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-O 122.809 1.29 . . . . 72.23 113.106 -178.915 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -135.8 89.16 2.46 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.945 -1.132 . . . . 73.55 107.945 174.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 169.67 131.6 1.34 Allowed Glycine 0 N--CA 1.414 -2.796 0 N-CA-C 107.011 -2.436 . . . . 74.01 107.011 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -95.35 149.64 21.14 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 117.396 0.598 . . . . 62.43 110.076 -173.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -79.19 157.54 27.84 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 105.833 -1.914 . . . . 73.52 105.833 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -55.04 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 117.409 2.374 . . . . 70.12 117.409 -172.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -56.65 -30.54 63.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.425 0.557 . . . . 72.31 110.99 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -51.86 -33.48 36.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.188 0.995 . . . . 72.25 112.01 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 33.9 tt0 -71.41 -45.61 62.32 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 120.784 -0.366 . . . . 74.25 111.007 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 38.3 t-105 -73.97 -30.4 62.49 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.028 0.442 . . . . 74.13 110.219 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -57.76 -40.23 79.25 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.568 -0.901 . . . . 73.41 108.568 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 22.2 tpt180 -55.78 -50.92 69.14 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.059 -0.973 . . . . 73.32 111.056 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.74 -20.29 59.88 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.105 -0.498 . . . . 65.45 111.684 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -69.6 -33.89 73.33 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.314 -0.625 . . . . 74.13 109.314 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.606 ' O ' HG12 ' A' ' 144' ' ' ILE . 64.9 tttm -62.74 -35.14 78.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.483 -0.78 . . . . 70.43 109.775 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.1 mmmt -54.67 -40.31 68.93 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 114.206 1.187 . . . . 71.1 114.206 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -55.44 -43.48 75.44 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.542 1.163 . . . . 73.22 109.507 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -73.9 -35.27 64.64 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 113.719 -1.582 . . . . 74.23 109.192 -175.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 140' ' ' LYS . 33.4 mm -72.19 -38.65 63.1 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.054 0 CA-C-N 115.747 -0.661 . . . . 64.55 110.831 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 17.1 mm-40 -59.69 -32.43 70.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.227 0.537 . . . . 73.31 110.471 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.2 m -70.29 -47.21 62.21 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.021 -0.991 . . . . 74.41 108.904 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -71.06 -28.62 64.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.412 1.264 . . . . 64.15 114.412 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -57.75 -38.07 74.73 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.751 -1.203 . . . . 61.43 107.751 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -71.46 -28.83 64.22 Favored 'General case' 0 C--O 1.227 -0.09 0 CA-C-N 115.742 -0.663 . . . . 73.01 110.459 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.426 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 68.3 mt -72.62 -31.31 36.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.664 -0.698 . . . . 74.3 109.453 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 65.0 mtt -63.36 -41.16 98.81 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.667 -0.864 . . . . 64.14 108.667 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -61.68 -35.92 79.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.092 -0.958 . . . . 74.54 110.045 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 84.3 m -67.41 -31.25 71.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.667 -0.697 . . . . 64.34 111.431 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 74.7 mmtt -71.13 -27.71 63.77 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.362 -0.977 . . . . 64.23 108.362 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt 72.89 -70.62 0.16 Allowed 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 126.05 1.74 . . . . 62.41 112.981 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt 64.93 161.19 0.12 Allowed Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.256 1.022 . . . . 33.12 111.696 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -75.75 94.86 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.691 1.594 . . . . 65.42 110.006 173.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 . . . . . 0 C--N 1.308 -1.197 0 C-N-CA 123.553 0.741 . . . . 73.12 109.029 -177.127 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 14' ' ' SER . 49.5 t . . . . . 0 N--CA 1.431 -1.422 0 CA-C-O 120.675 0.274 . . . . 72.23 110.306 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -92.01 -162.71 0.95 Allowed 'General case' 0 C--O 1.249 1.041 0 N-CA-C 107.034 -1.469 . . . . 65.2 107.034 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.5 p -61.79 -39.66 92.49 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.502 -0.925 . . . . 52.11 108.502 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.23 149.18 28.01 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.195 -1.366 . . . . 73.12 108.626 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.595 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 15.7 t -97.89 72.49 2.24 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 106.186 -1.783 . . . . 60.23 106.186 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt 58.9 85.15 0.1 Allowed 'General case' 0 N--CA 1.413 -2.29 0 C-N-CA 125.376 1.471 . . . . 72.22 110.559 -172.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -76.32 153.53 35.79 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.565 -0.743 . . . . 74.45 111.522 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.87 155.39 25.36 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 108.406 -0.961 . . . . 73.4 108.406 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.514 ' O ' HG12 ' A' ' 79' ' ' VAL . 47.3 m-70 -114.0 159.99 19.34 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 115.785 -0.643 . . . . 73.3 110.043 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 77' ' ' MET . 17.0 p30 -130.31 128.22 41.07 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.905 -1.043 . . . . 73.44 111.483 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.7 t -127.53 142.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.771 -1.104 . . . . 44.31 109.516 -174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -93.81 123.23 37.01 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.582 -1.266 . . . . 74.15 107.582 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -96.8 136.98 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-O 121.285 0.564 . . . . 75.11 111.54 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.49 ' HD2' ' O ' ' A' ' 61' ' ' PRO . 24.1 p90 -109.27 -50.2 3.03 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.817 1.043 . . . . 64.22 113.817 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -151.43 -49.83 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 118.093 -2.003 . . . . 31.21 115.411 -174.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.8 m -58.88 -37.02 75.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.583 0.692 . . . . 42.45 111.559 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.659 ' HB3' HD11 ' A' ' 32' ' ' ILE . 36.6 m-85 -119.76 37.67 4.13 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.898 -0.592 . . . . 74.14 110.763 -176.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.41 23.14 0.07 Allowed 'General case' 0 CA--C 1.576 1.943 0 CA-C-O 121.647 0.737 . . . . 71.04 110.754 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 26' ' ' PHE . 25.9 t70 -150.15 129.97 6.64 Favored Pre-proline 0 C--N 1.308 -1.229 0 C-N-CA 123.707 0.803 . . . . 72.45 109.321 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.553 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 63.5 Cg_endo -73.22 -24.48 16.8 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.233 1.956 . . . . 74.03 113.177 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.85 -38.65 83.41 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.78 0.324 . . . . 73.12 110.969 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.22 -28.93 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.108 0.48 . . . . 74.01 110.044 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 26' ' ' PHE . 37.1 mm -58.99 -37.78 69.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.918 -0.583 . . . . 64.31 110.258 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -53.83 -44.51 70.32 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.688 0.756 . . . . 64.12 110.342 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.58 -41.88 17.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 114.701 -1.136 . . . . 73.53 113.256 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.524 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.5 tmm? -65.95 -37.48 86.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.871 -0.332 . . . . 74.45 111.14 -171.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.583 HD21 HG23 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -116.88 -66.74 1.05 Allowed 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.656 -0.818 . . . . 71.45 111.383 176.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 27.6 t70 167.51 -52.22 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 123.785 0.678 . . . . 72.35 109.47 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -108.52 164.1 12.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.198 -0.91 . . . . 72.35 109.619 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 m -114.0 106.01 53.77 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 108.514 -0.921 . . . . 64.22 108.514 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.86 151.56 32.47 Favored 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 123.397 2.731 . . . . 64.42 111.952 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -64.62 128.68 36.83 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.306 -0.998 . . . . 64.43 108.306 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 38.3 mt -109.28 136.65 44.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 116.02 -0.536 . . . . 72.51 110.1 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.71 146.13 34.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.059 -0.519 . . . . 65.54 109.711 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.5 m -76.35 126.18 30.53 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.769 -0.826 . . . . 65.22 108.769 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.4 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -140.12 156.04 46.73 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.623 0.725 . . . . 63.31 111.156 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.459 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 57.3 m -113.5 126.71 55.62 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.336 -0.847 . . . . 63.24 108.972 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 50' ' ' PHE . 45.5 tp -100.21 101.03 13.12 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 109.507 -0.553 . . . . 74.52 109.507 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 46' ' ' THR . 77.9 Cg_endo -86.99 144.12 7.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.383 2.056 . . . . 71.03 111.828 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.14 5.74 62.09 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.234 -0.747 . . . . 65.54 111.234 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.553 ' HA ' ' H ' ' A' ' 66' ' ' SER . 90.0 m-85 -144.23 152.23 40.55 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 107.664 -1.236 . . . . 74.05 107.664 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -139.65 145.78 38.88 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 108.653 -0.869 . . . . 61.51 108.653 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -90.69 132.15 35.96 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.614 -0.721 . . . . 74.52 109.552 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.63 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 3.8 m-85 -107.04 133.57 51.47 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 107.388 -1.338 . . . . 72.21 107.388 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.544 ' HD2' ' HB2' ' A' ' 130' ' ' TRP . 22.3 ptt180 -119.1 164.87 14.9 Favored 'General case' 0 C--N 1.273 -2.749 0 CA-C-N 114.237 -1.347 . . . . 73.05 113.296 -167.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.526 HD13 ' H ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -61.94 128.24 35.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 116.388 1.996 . . . . 72.42 116.388 -172.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -147.73 23.72 1.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.487 -2.412 . . . . 65.14 104.487 169.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.14 -140.87 2.98 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 112.882 -1.963 . . . . 61.04 109.029 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.69 16.88 24.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.817 1.043 . . . . 63.53 113.817 -178.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.484 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 52.1 tp -111.26 160.51 16.92 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.539 -0.864 . . . . 62.42 109.726 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -96.03 168.23 11.07 Favored Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 123.268 0.627 . . . . 75.34 109.721 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 35.7 Cg_exo -61.73 103.98 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.129 1.886 . . . . 62.31 110.799 175.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 12.9 p -111.21 151.65 28.0 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.357 -0.838 . . . . 72.4 110.515 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.1 mm -93.98 139.25 18.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.405 -0.591 . . . . 54.35 109.405 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -142.48 151.46 57.74 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 107.948 -1.13 . . . . 72.33 107.948 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.532 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 34.3 Cg_endo -66.8 104.81 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.554 2.169 . . . . 63.41 112.613 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.553 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 33.4 t -125.09 102.17 7.37 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.172 -1.788 . . . . 75.31 106.172 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -55.1 -33.21 62.62 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.767 0.655 . . . . 64.2 112.767 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.98 5.42 44.3 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.799 -0.637 . . . . 73.14 111.732 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.84 171.83 14.13 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.257 -0.973 . . . . 71.22 113.395 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.67 149.1 24.88 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.791 1.236 . . . . 72.12 107.97 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.05 124.77 70.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.965 -0.383 . . . . 60.22 109.965 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -93.17 114.71 27.28 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.598 -1.26 . . . . 65.14 107.598 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' C ' ' HD2' ' A' ' 74' ' ' LYS . . . -146.96 -155.56 6.59 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 109.808 -1.317 . . . . 64.55 109.808 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.499 ' HD2' ' C ' ' A' ' 73' ' ' GLY . 14.0 mptt -127.22 152.21 47.68 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.815 0.817 . . . . 45.42 112.494 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 46.9 t -110.27 128.7 66.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 113.83 -1.532 . . . . 51.31 111.155 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 72.1 mt -96.59 109.99 22.49 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.719 -1.215 . . . . 63.03 107.719 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.51 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 17.0 ptp -121.67 151.25 40.66 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.571 0.224 . . . . 61.04 110.995 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.98 13.27 37.39 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 119.669 -1.253 . . . . 73.44 111.525 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.3 p -85.37 136.32 23.05 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 108.946 -0.761 . . . . 64.44 108.946 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 m -74.05 159.44 32.66 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.265 -0.642 . . . . 71.55 109.265 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -59.06 -38.37 79.25 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.575 0.584 . . . . 75.43 112.575 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.17 -48.72 80.54 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.547 0.689 . . . . 71.32 110.23 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 86' ' ' ASN . 38.8 mt-10 -69.21 -31.58 70.25 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 114.947 -1.024 . . . . 62.12 109.259 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.415 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.0 tm? -62.67 -40.16 96.19 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.449 -0.575 . . . . 64.54 109.449 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.58 -29.5 63.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.143 -0.481 . . . . 63.11 109.954 176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -67.59 -42.07 83.08 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.765 -0.652 . . . . 73.44 111.009 176.383 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.466 HD23 ' HE1' ' A' ' 35' ' ' MET . 97.2 mt -61.42 -43.6 98.59 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.962 -0.755 . . . . 72.11 108.962 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 28.3 t70 -64.94 -34.09 77.58 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.013 -0.994 . . . . 55.42 110.521 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.5 -44.01 68.49 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.025 -0.534 . . . . 64.24 111.024 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.4 t -72.71 -57.36 7.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 112.911 0.708 . . . . 73.43 112.911 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.45 -22.77 50.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.338 0.59 . . . . 51.04 111.397 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -63.07 -15.95 56.96 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.2 -0.909 . . . . 70.34 114.979 -177.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -68.01 -45.75 73.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.629 0.715 . . . . 63.31 112.237 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.27 -10.4 12.72 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.395 -0.522 . . . . 63.1 111.8 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -125.6 167.1 15.54 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.61 -0.885 . . . . 71.14 108.61 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 35.0 tt0 -123.19 145.92 48.23 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.175 -0.676 . . . . 74.31 109.175 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -87.08 114.5 23.74 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.87 -0.789 . . . . 73.34 108.87 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.5 m -120.99 160.42 21.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 116.117 -0.492 . . . . 51.2 110.052 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.1 t -99.81 127.28 45.98 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.484 -0.932 . . . . 72.22 108.484 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.89 172.06 16.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.192 -0.458 . . . . 71.33 111.489 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -115.32 128.64 8.17 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.499 -0.64 . . . . 62.43 111.499 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.12 161.95 16.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 123.132 0.573 . . . . 72.44 110.144 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 51.1 t -121.63 123.84 70.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 106.73 -1.581 . . . . 72.21 106.73 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.674 ' HD3' ' SD ' ' A' ' 111' ' ' MET . 12.4 mtm180 -79.15 135.62 36.87 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.054 -1.059 . . . . 75.0 110.327 -175.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.61 12.44 5.77 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 122.919 1.342 . . . . 70.01 108.131 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 104' ' ' ARG . 10.1 t70 -89.32 -53.07 4.72 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 126.564 1.946 . . . . 72.3 111.201 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -138.43 7.23 2.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.21 -0.45 . . . . 64.51 112.018 -174.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.3 t 71.57 8.68 6.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.211 1.004 . . . . 72.52 112.541 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -85.51 148.4 25.98 Favored 'General case' 0 CA--C 1.492 -1.264 0 C-N-CA 120.73 -0.388 . . . . 71.03 110.228 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 64.0 pttt -98.93 140.99 32.26 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-N 115.753 -0.658 . . . . 71.02 109.762 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.674 ' SD ' ' HD3' ' A' ' 104' ' ' ARG . 87.9 mtp -134.81 161.16 35.97 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.171 -0.922 . . . . 72.31 111.269 -175.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.11 130.05 50.15 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.632 -1.167 . . . . 64.1 109.092 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.0 m -141.5 174.03 7.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 108.43 -0.952 . . . . 75.22 108.43 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -107.15 150.56 26.45 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.206 -0.664 . . . . 71.04 109.206 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.9 t -144.32 170.98 14.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.166 -1.05 . . . . 71.44 108.166 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 70.8 m-85 -117.54 121.52 41.19 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.536 -0.913 . . . . 71.44 108.536 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.532 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 25.7 ptt? -115.96 155.13 28.58 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.26 -0.427 . . . . 63.33 110.57 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 60.1 t-105 -73.27 124.92 26.63 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.105 0.878 . . . . 72.02 108.688 -178.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.8 mp -73.49 -41.78 56.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 112.572 0.582 . . . . 71.2 112.572 -172.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -69.8 -40.52 75.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 121.002 -0.279 . . . . 72.25 111.718 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 68.99 -4.36 1.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.155 1.169 . . . . 72.12 114.155 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.87 12.84 6.28 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.094 1.516 . . . . 73.15 115.094 -171.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.47 130.7 93.26 Favored Pre-proline 0 N--CA 1.483 1.213 0 O-C-N 122.274 -0.266 . . . . 71.21 111.347 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.33 14.02 0.81 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.477 2.785 . . . . 73.24 113.888 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -89.96 -11.38 41.86 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.353 0.597 . . . . 72.2 110.496 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 143.23 37.27 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.154 -0.93 . . . . 64.34 109.218 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -136.61 -4.68 2.02 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.076 0.465 . . . . 71.1 110.367 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.46 12.25 54.31 Favored Glycine 0 C--N 1.306 -1.102 0 N-CA-C 109.432 -1.467 . . . . 32.15 109.432 -173.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 54' ' ' ARG . 52.3 mt-10 -115.81 144.21 44.32 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 107.274 -1.38 . . . . 71.11 107.274 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.544 ' HB2' ' HD2' ' A' ' 54' ' ' ARG . 6.0 t90 -99.76 143.64 29.76 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.511 -1.663 . . . . 75.12 106.511 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -79.76 73.91 6.48 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.419 1.104 . . . . 73.42 109.655 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -59.5 -43.3 93.4 Favored 'General case' 0 N--CA 1.411 -2.395 0 C-N-CA 126.075 1.75 . . . . 71.14 111.909 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.55 -37.91 76.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.882 0.697 . . . . 74.43 112.882 -175.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.575 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 7.8 tp10 -66.1 -47.52 73.93 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.662 -0.495 . . . . 75.52 109.662 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 66.4 t-105 -68.56 -39.33 81.08 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.66 -0.416 . . . . 74.51 111.078 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -58.99 -33.82 71.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.36 -0.607 . . . . 74.43 109.36 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.575 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 63.8 ttt180 -62.59 -50.0 73.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.052 -0.976 . . . . 74.23 111.316 175.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.24 -30.22 69.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.216 0.532 . . . . 74.45 110.647 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -68.79 -39.26 80.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.2 -0.909 . . . . 73.31 108.672 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.612 ' O ' HG12 ' A' ' 144' ' ' ILE . 86.3 tttt -67.25 -45.47 76.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.149 -0.932 . . . . 70.25 109.358 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -48.44 -39.69 23.66 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.806 1.642 . . . . 71.04 111.627 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.29 -40.03 95.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.843 -0.617 . . . . 54.11 111.109 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -76.19 -32.25 58.9 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.489 -0.56 . . . . 75.14 109.489 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 140' ' ' LYS . 50.7 mm -56.58 -33.42 39.56 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.757 0 CA-C-N 115.371 -0.831 . . . . 63.32 111.803 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.4 -31.25 65.64 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.229 0.468 . . . . 73.21 111.931 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.9 m -80.67 -41.94 22.9 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.941 -0.763 . . . . 73.33 108.941 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -70.88 -30.05 66.32 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 115.357 1.614 . . . . 61.44 115.357 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 60.1 mtpt -55.52 -38.69 69.56 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 117.926 0.33 . . . . 70.1 110.712 176.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -67.3 -38.79 85.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.733 0.777 . . . . 74.2 109.363 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 67.5 mt -69.94 -41.41 79.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.83 -1.077 . . . . 62.44 109.665 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 67.1 mtt -67.92 -48.53 65.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.898 -0.592 . . . . 71.01 110.978 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 37.3 mt-10 -62.12 -30.55 71.11 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 111.89 0.33 . . . . 75.12 111.89 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 42.7 t -61.46 -42.46 98.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.414 -0.357 . . . . 75.24 110.396 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -82.8 -44.98 14.89 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.004 -0.279 . . . . 63.14 110.872 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt 179.11 110.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.99 0.916 . . . . 74.11 108.59 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -72.76 152.01 91.21 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 111.867 0.321 . . . . 73.02 111.867 -177.017 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.09 155.51 64.34 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 121.897 1.731 . . . . 64.35 108.898 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? . . . . . 0 C--N 1.317 -0.817 0 C-N-CA 120.58 -0.448 . . . . 65.51 111.353 -178.289 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.428 -1.529 0 N-CA-C 110.046 -0.353 . . . . 73.33 110.046 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.4 p -86.04 -179.84 6.84 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.53 -0.915 . . . . 73.3 108.53 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.5 t -77.69 -56.79 4.22 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.68 -0.859 . . . . 70.33 108.68 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.9 t70 59.4 126.25 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.42 1.088 . . . . 74.45 113.935 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.5 p -87.85 120.7 29.44 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.544 -0.753 . . . . 64.02 110.342 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.03 -26.56 43.18 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.467 0.651 . . . . 70.45 110.582 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.505 ' HA ' ' OE1' ' A' ' 16' ' ' GLN . 16.1 mm-40 -81.46 98.81 8.42 Favored 'General case' 0 CA--C 1.478 -1.824 0 CA-C-O 122.692 1.234 . . . . 74.34 111.94 177.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD13 ' HA2' ' A' ' 78' ' ' GLY . 87.3 mt -84.8 153.64 22.85 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 112.93 -1.941 . . . . 74.24 110.27 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -124.73 161.25 26.78 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.597 -0.89 . . . . 62.23 108.597 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 14.7 p30 -128.66 134.43 48.52 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.443 0.64 . . . . 74.21 111.81 172.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.6 142.95 41.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.419 -0.81 . . . . 74.03 110.078 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.529 ' HB2' HG21 ' A' ' 113' ' ' VAL . 76.1 t80 -94.74 122.61 37.53 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.707 -1.22 . . . . 75.02 107.707 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 m -93.16 120.03 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 CA-C-O 121.857 0.837 . . . . 71.0 110.01 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.415 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 8.2 p90 -88.48 -79.05 0.32 Allowed 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 114.629 1.344 . . . . 71.55 114.629 -172.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.93 -44.25 0.24 Allowed Glycine 0 CA--C 1.492 -1.392 0 C-N-CA 119.624 -1.275 . . . . 52.41 112.044 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 p -62.39 -36.48 82.45 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 112.358 0.503 . . . . 72.2 112.358 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 59.5 m-85 -124.67 26.66 7.11 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 112.564 0.579 . . . . 65.14 112.564 -177.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 23' ' ' TYR . 28.5 pt20 -68.07 -1.05 5.17 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.208 0.818 . . . . 75.21 113.208 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 31' ' ' VAL . 20.1 t70 -129.56 138.81 33.96 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 108.755 -0.832 . . . . 74.21 108.755 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 18.9 Cg_endo -60.4 -32.9 94.48 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.296 1.998 . . . . 73.21 114.017 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.78 -35.94 81.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 120.999 -0.281 . . . . 64.53 111.641 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 28' ' ' ASP . 11.6 p -70.64 -29.83 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 119.779 -0.768 . . . . 71.41 110.153 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.2 mm -70.85 -43.52 76.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-O 122.073 0.94 . . . . 64.43 108.938 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 7.4 t-20 -54.19 -51.68 63.6 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 112.997 -1.91 . . . . 71.51 110.607 -177.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.8 p -78.09 -35.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.56 -0.746 . . . . 73.22 112.042 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.5 tmm? -67.62 -37.08 81.97 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 121.247 -0.181 . . . . 60.44 111.213 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.531 HD12 ' H ' ' A' ' 37' ' ' ASP 0.402 3.0 pp -115.0 -56.48 2.37 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 115.448 1.647 . . . . 73.43 115.448 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.531 ' H ' HD12 ' A' ' 36' ' ' LEU . 27.1 t70 162.78 -52.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.133 0.973 . . . . 71.23 109.665 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -106.64 -168.0 1.36 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.512 -1.222 . . . . 65.33 109.815 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.9 m -149.69 108.28 3.3 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 108.823 -0.806 . . . . 74.51 108.823 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 46.6 Cg_exo -59.29 150.73 72.64 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.941 2.427 . . . . 73.15 111.705 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.12 123.26 16.6 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.082 0.553 . . . . 75.31 110.449 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.582 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 51.3 mt -97.84 143.53 12.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.812 -0.631 . . . . 74.1 111.117 -173.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.509 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 14.6 p -128.94 146.75 33.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.566 -0.901 . . . . 74.04 108.566 175.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.446 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 19.0 m -77.03 123.92 27.04 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.36 -0.607 . . . . 55.32 109.36 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -140.0 157.58 45.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.784 0.802 . . . . 51.52 112.351 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 m -119.7 126.55 51.37 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.864 -1.062 . . . . 75.51 108.96 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.7 tp -98.75 104.91 27.5 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 109.747 -0.464 . . . . 70.42 109.747 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 74.7 Cg_endo -84.03 137.68 7.53 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 122.471 2.114 . . . . 41.25 112.658 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.6 11.75 56.59 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.814 -0.63 . . . . 62.52 112.748 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -140.6 161.66 37.23 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.995 -0.743 . . . . 74.41 108.995 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -139.83 146.06 38.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.802 -0.444 . . . . 73.22 109.802 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HE ' HG13 ' A' ' 71' ' ' VAL . 13.9 ptp180 -102.69 142.12 34.37 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.248 -1.019 . . . . 74.34 108.248 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 126' ' ' MET . 28.1 m-85 -113.45 135.16 54.18 Favored 'General case' 0 C--N 1.265 -3.092 0 N-CA-C 107.95 -1.13 . . . . 71.45 107.95 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.521 ' O ' ' HA3' ' A' ' 128' ' ' GLY . 39.0 ptt180 -94.32 126.38 39.55 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.557 -0.857 . . . . 63.43 110.494 -177.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -162.71 131.46 4.07 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.732 -1.581 . . . . 75.04 106.732 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.66 144.63 37.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.932 -0.396 . . . . 63.24 109.932 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.12 -82.78 0.26 Allowed Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.789 -1.324 . . . . 72.32 109.789 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.27 -38.31 8.13 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.649 -0.5 . . . . 73.45 109.649 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.8 tp -113.13 164.26 13.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.031 -0.729 . . . . 75.15 109.031 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -107.41 160.68 25.7 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.037 -0.727 . . . . 73.1 109.037 -173.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 18.5 Cg_endo -67.38 96.8 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.697 1.598 . . . . 74.11 109.927 173.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.0 p -100.05 166.79 10.86 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 113.299 0.851 . . . . 72.13 113.299 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 71' ' ' VAL . 45.1 mm -109.52 143.13 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 115.052 -0.977 . . . . 62.41 109.28 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.9 m -143.93 151.45 52.76 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.815 -1.18 . . . . 71.14 107.815 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 18.5 Cg_endo -60.57 133.48 48.89 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.224 1.95 . . . . 71.5 111.187 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.6 t -124.8 144.08 50.46 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 116.215 -0.448 . . . . 55.44 109.884 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -73.11 -34.43 66.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 74.05 110.363 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.9 81.07 1.88 Allowed 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.254 -0.647 . . . . 72.35 109.254 174.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.26 153.17 24.08 Favored Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 119.735 -1.222 . . . . 21.22 112.431 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.31 139.92 24.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.871 -0.789 . . . . 75.45 108.871 175.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.537 HG13 ' HE ' ' A' ' 52' ' ' ARG . 51.7 t -113.77 119.95 62.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 120.831 0.348 . . . . 73.22 110.78 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -89.33 116.4 27.51 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.689 -1.226 . . . . 73.1 107.689 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.08 -151.21 5.48 Favored Glycine 0 N--CA 1.421 -2.342 0 N-CA-C 110.939 -0.864 . . . . 55.02 110.939 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.582 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.5 mmtm -132.26 146.59 52.1 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 110.099 -0.334 . . . . 72.41 110.099 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.509 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 42.3 t -111.33 138.53 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 122.35 0.26 . . . . 73.4 111.199 175.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.453 HD23 HG12 ' A' ' 42' ' ' ILE . 82.9 mt -94.97 112.02 23.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.43 -0.952 . . . . 71.23 108.43 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 84.2 mmm -93.91 154.93 17.44 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 123.537 0.735 . . . . 71.04 111.097 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.401 ' HA2' HD13 ' A' ' 17' ' ' LEU . . . 62.32 36.08 92.56 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 114.778 -1.101 . . . . 62.11 113.436 177.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.02 127.39 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 108.816 -0.809 . . . . 53.51 108.816 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.8 p -77.65 169.93 17.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.183 -0.673 . . . . 72.2 109.183 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 34.2 t -55.25 -48.15 74.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.673 -0.24 . . . . 21.03 110.548 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.47 -37.47 75.56 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.911 0.884 . . . . 64.41 112.76 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.542 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 39.5 mt-10 -76.51 -46.27 27.35 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 116.046 -0.525 . . . . 75.34 110.198 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.419 ' C ' HD23 ' A' ' 84' ' ' LEU . 7.0 tt -68.92 -41.25 78.41 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.447 -0.501 . . . . 75.34 112.053 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 81' ' ' SER . 12.3 pt-20 -62.78 -29.8 70.98 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.414 0.626 . . . . 74.11 109.869 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -74.96 -42.61 57.3 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 114.993 -1.003 . . . . 74.41 109.553 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.8 mt -60.41 -42.47 96.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.387 0.613 . . . . 62.34 109.66 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.01 -36.33 81.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.807 -1.088 . . . . 41.2 110.04 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.36 -48.71 21.76 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.379 -0.828 . . . . 62.31 112.021 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 87' ' ' LEU . 14.4 p -63.97 -47.94 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.277 0 C-N-CA 122.36 0.264 . . . . 64.41 111.643 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.33 -19.84 52.63 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.817 0.818 . . . . 71.01 110.654 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.86 -16.34 12.12 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 116.997 1.559 . . . . 53.05 116.997 -173.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -58.64 -44.56 90.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 118.088 0.944 . . . . 52.5 112.428 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.07 -1.73 3.65 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.002 1.112 . . . . 63.3 114.002 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -113.13 157.12 22.04 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.569 -0.53 . . . . 72.53 109.569 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.513 ' HB3' HD11 ' A' ' 119' ' ' ILE . 39.2 tt0 -123.94 155.11 38.75 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.29 -1.374 . . . . 65.01 107.29 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -86.96 114.57 23.7 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.11 -1.07 . . . . 75.53 108.11 -176.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.3 m -117.32 153.76 19.12 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 120.883 -0.327 . . . . 65.24 110.162 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -95.63 132.83 40.37 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.218 -0.66 . . . . 55.41 109.218 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.75 162.76 31.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 120.964 0.411 . . . . 71.12 111.052 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.422 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -103.75 119.79 6.47 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.464 -1.055 . . . . 54.24 110.464 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 2.7 pp -111.69 158.22 12.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 110.017 -0.364 . . . . 62.33 110.017 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 99.6 t -121.23 120.58 62.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.472 -0.566 . . . . 75.35 109.472 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -62.24 137.32 58.24 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.145 -0.48 . . . . 74.32 111.244 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 43.4 mt-10 -83.38 -3.89 57.95 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.556 0.693 . . . . 74.43 110.044 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.11 -68.07 0.36 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.776 -1.102 . . . . 74.42 110.399 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -129.08 0.63 5.24 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.484 -1.234 . . . . 73.34 111.328 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m 64.34 80.46 0.23 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.048 0.928 . . . . 64.13 112.694 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 10.1 pt-20 -137.4 152.45 49.65 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.627 -1.249 . . . . 71.24 107.627 175.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 21.2 pttp -91.45 147.22 23.18 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.358 -0.608 . . . . 54.45 109.358 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 51.4 ttp -143.98 158.66 43.56 Favored 'General case' 0 N--CA 1.415 -2.225 0 N-CA-C 107.642 -1.244 . . . . 71.01 107.642 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.63 118.0 35.64 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.879 -0.328 . . . . 61.12 110.521 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.529 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.1 m -129.01 173.42 13.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 120.996 0.426 . . . . 70.23 110.287 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -101.74 143.41 31.71 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.63 -0.878 . . . . 73.32 108.63 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.8 t -143.51 171.5 14.07 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.069 -1.086 . . . . 75.24 108.069 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.407 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 62.9 m-85 -121.24 117.77 27.9 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.274 -1.01 . . . . 73.44 108.274 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.529 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 23.5 ptt? -118.04 156.4 28.67 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.796 -0.638 . . . . 74.11 110.798 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -68.78 118.96 12.41 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.239 -0.891 . . . . 70.52 108.599 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 96' ' ' GLU . 45.2 mm -72.74 -42.42 61.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.08 0.77 . . . . 64.34 113.08 -170.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -68.07 -28.61 67.52 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.197 -0.601 . . . . 65.52 110.378 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.288 9.6 ptpp? 56.38 -18.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.683 2.475 . . . . 74.21 117.683 173.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -116.66 84.21 2.1 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.459 0.647 . . . . 55.11 110.036 177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 126' ' ' MET . 10.3 m-20 -139.77 116.8 8.33 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.135 -0.939 . . . . 72.45 109.765 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -65.99 -13.6 40.6 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.54 2.16 . . . . 70.54 111.149 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.72 -34.68 74.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.118 0.967 . . . . 63.43 111.878 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.578 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.1 ptt? -93.76 8.58 40.5 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 116.46 -0.336 . . . . 72.14 111.421 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -66.35 106.25 1.66 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.637 -0.825 . . . . 62.0 112.25 -174.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 54' ' ' ARG . . . -147.68 127.6 2.67 Favored Glycine 0 N--CA 1.415 -2.743 0 N-CA-C 108.904 -1.679 . . . . 51.33 108.904 176.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.64 126.17 40.73 Favored 'General case' 0 C--O 1.193 -1.875 0 CA-C-O 120.878 0.37 . . . . 74.25 110.572 -176.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.464 ' CD2' ' HD2' ' A' ' 52' ' ' ARG . 74.1 t90 -127.66 140.03 52.35 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 111.967 0.358 . . . . 74.22 111.967 -169.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 66.38 -54.93 0.4 Allowed 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 125.554 1.542 . . . . 72.4 112.984 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.414 ' HD1' ' O ' ' A' ' 130' ' ' TRP . 59.9 m-85 -52.43 -29.87 26.59 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 125.54 1.536 . . . . 55.01 113.445 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -56.13 -32.16 63.98 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.134 0.492 . . . . 72.22 110.764 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 36.1 tt0 -63.46 -48.59 77.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.061 0.945 . . . . 54.01 110.007 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -64.12 -37.66 88.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 120.419 -0.512 . . . . 74.24 110.574 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -59.03 -31.74 69.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.554 -0.294 . . . . 64.13 111.0 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 41.7 ttp180 -68.67 -51.94 36.45 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 116.257 -0.429 . . . . 75.21 111.528 175.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.97 -24.58 64.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.996 0.427 . . . . 62.13 111.827 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.08 -38.67 56.76 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.559 -0.904 . . . . 72.11 108.559 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.574 ' O ' HG12 ' A' ' 144' ' ' ILE . 38.7 ttpt -65.34 -34.19 77.73 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.698 -0.683 . . . . 61.13 110.287 177.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.556 ' HA ' ' HE2' ' A' ' 141' ' ' LYS . 0.6 OUTLIER -52.1 -31.66 31.63 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.831 0.852 . . . . 75.1 111.44 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -67.46 -44.13 79.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.029 0.918 . . . . 62.2 109.367 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.483 ' O ' HG22 ' A' ' 146' ' ' THR . 40.4 t80 -71.68 -36.44 70.62 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.817 -1.538 . . . . 63.52 110.151 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.2 mm -55.07 -32.7 27.89 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 CA-C-N 115.252 -0.885 . . . . 65.11 111.496 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -56.01 -38.48 70.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.197 0.814 . . . . 74.03 113.197 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 143' ' ' PHE . 7.6 t -77.97 -32.84 51.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.63 -0.878 . . . . 71.31 108.63 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -77.57 -33.56 53.92 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.267 -0.879 . . . . 71.34 111.094 -173.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 47.3 tttm -56.54 -42.19 78.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.343 -0.844 . . . . 64.34 110.187 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -66.89 -31.01 71.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.869 0.843 . . . . 65.12 110.34 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 73.6 mt -73.29 -47.32 46.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.185 -0.916 . . . . 73.53 109.345 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.9 ttt -64.18 -40.52 96.28 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.368 -0.833 . . . . 71.21 110.733 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 45.0 mt-10 -64.06 -29.83 70.95 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 116.451 -0.34 . . . . 75.03 111.914 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -70.83 -31.78 68.61 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.193 0.52 . . . . 74.32 109.974 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -82.77 -45.83 13.87 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 112.61 0.596 . . . . 73.42 112.61 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -94.38 -27.87 15.83 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.955 -0.566 . . . . 74.22 112.296 -173.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . 0.279 0.0 OUTLIER 48.01 96.4 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 125.525 1.53 . . . . 55.33 114.779 -177.126 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -65.95 170.28 11.88 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.95 2.433 . . . . 43.55 111.544 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? . . . . . 0 C--N 1.32 -0.714 0 C-N-CA 122.771 0.428 . . . . 74.12 110.597 -178.757 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.429 -1.478 0 CA-C-O 121.683 0.754 . . . . 72.42 110.324 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.4 p -158.34 151.08 22.33 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 115.237 -0.892 . . . . 72.1 110.098 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.9 m -76.0 -18.35 59.32 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.02 -1.104 . . . . 74.45 108.02 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 74.59 -63.07 0.44 Allowed 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 125.759 1.624 . . . . 74.31 113.948 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -109.39 93.05 4.3 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 112.704 0.631 . . . . 71.21 112.704 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.91 109.01 20.59 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 106.502 -1.666 . . . . 74.23 106.502 172.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -132.59 157.06 45.71 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 116.046 -0.525 . . . . 72.43 109.79 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.29 149.43 23.8 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 106.102 -1.814 . . . . 70.02 106.102 169.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.51 ' CD2' HD22 ' A' ' 84' ' ' LEU . 21.4 m80 -116.73 160.59 20.54 Favored 'General case' 0 C--N 1.266 -3.062 0 N-CA-C 109.244 -0.65 . . . . 74.21 109.244 -172.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 22.1 p-10 -130.74 129.39 42.44 Favored 'General case' 0 C--N 1.259 -3.335 0 CA-C-N 115.493 -0.776 . . . . 74.2 109.657 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.1 t -119.77 139.59 46.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.146 -0.934 . . . . 74.15 110.31 -173.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.437 ' HB2' HG21 ' A' ' 113' ' ' VAL . 88.7 t80 -93.89 122.34 36.27 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.303 -1.369 . . . . 54.41 107.303 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 m -104.19 129.97 55.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.551 0.691 . . . . 62.12 111.712 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -75.74 -22.01 56.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.956 -1.02 . . . . 54.22 113.238 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.04 -34.23 0.39 Allowed Glycine 0 CA--C 1.504 -0.615 0 C-N-CA 119.36 -1.4 . . . . 74.24 112.749 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.3 p -58.43 -36.6 73.89 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.213 0.605 . . . . 71.24 112.329 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -127.91 32.82 4.88 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.74 -0.664 . . . . 74.14 110.315 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -84.24 20.09 1.7 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.259 1.028 . . . . 54.03 109.647 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 31' ' ' VAL . 12.6 t70 -134.8 128.78 18.98 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.551 -1.277 . . . . 54.42 107.551 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.401 ' CB ' HG21 ' A' ' 39' ' ' THR . 34.9 Cg_endo -66.47 -32.65 39.54 Favored 'Trans proline' 0 C--O 1.219 -0.474 0 C-N-CA 121.873 1.715 . . . . 73.34 113.16 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.06 -34.7 66.42 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.555 -0.293 . . . . 72.35 111.197 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 28' ' ' ASP . 17.8 m -66.2 -29.48 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 119.852 -0.739 . . . . 62.35 109.963 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 mm -73.03 -41.35 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 122.013 0.911 . . . . 74.22 109.22 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -57.92 -39.43 77.96 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 113.732 -1.576 . . . . 73.12 110.227 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.32 -29.93 11.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.383 -0.826 . . . . 75.42 111.389 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -69.96 -31.89 69.84 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 120.982 0.42 . . . . 73.33 110.295 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.53 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.6 pt? -129.56 -69.74 0.68 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 120.282 -0.567 . . . . 71.11 112.371 172.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.53 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 26.4 t70 169.98 -48.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.149 0.976 . . . . 74.53 109.114 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -92.17 176.8 6.36 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.249 -1.341 . . . . 74.21 109.972 -176.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.401 HG21 ' CB ' ' A' ' 29' ' ' PRO . 55.1 m -149.41 124.41 4.85 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 116.341 -0.391 . . . . 55.44 110.063 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 23.7 Cg_exo -67.14 151.68 81.05 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.928 2.419 . . . . 31.42 110.69 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.42 136.18 51.26 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.638 -0.875 . . . . 74.45 108.638 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 3.5 mp -105.64 139.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 120.614 -0.434 . . . . 75.45 110.981 -172.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -131.67 146.11 34.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.83 -0.623 . . . . 71.21 109.795 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.7 m -77.74 123.34 26.58 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.213 -0.662 . . . . 75.42 109.213 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.95 157.29 47.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.489 0.661 . . . . 75.25 111.105 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 87.4 m -110.4 126.97 54.85 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.243 -0.89 . . . . 51.11 109.656 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.2 tp -102.81 97.25 8.95 Favored Pre-proline 0 N--CA 1.429 -1.511 0 N-CA-C 109.241 -0.651 . . . . 72.43 109.241 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 46' ' ' THR . 67.0 Cg_endo -83.29 143.66 11.3 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.199 1.933 . . . . 72.21 111.221 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.35 10.96 60.2 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.538 -0.839 . . . . 64.43 111.908 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -141.67 161.08 38.81 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 122.712 0.405 . . . . 72.4 110.05 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.483 ' NE2' ' HG2' ' A' ' 133' ' ' GLU . 6.5 tp-100 -140.86 149.2 41.65 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 123.068 0.23 . . . . 74.1 110.819 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.26 130.96 54.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.036 -0.728 . . . . 73.44 109.036 173.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 38.2 m-85 -108.36 135.33 49.83 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.43 -1.322 . . . . 74.33 107.43 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.92 125.71 54.35 Favored 'General case' 0 N--CA 1.42 -1.972 0 C-N-CA 117.816 -1.554 . . . . 74.44 111.491 -176.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.7 tp -141.95 39.57 1.64 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 105.262 -2.125 . . . . 75.54 105.262 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -51.24 108.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.128 -1.851 . . . . 74.11 112.508 -173.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.42 -51.42 0.79 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 109.774 -1.331 . . . . 72.4 109.774 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.528 ' C ' ' HD3' ' A' ' 58' ' ' ARG . 2.3 tmt_? -96.28 -44.39 7.27 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.791 -0.818 . . . . 65.52 108.791 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.498 HD23 ' HB3' ' A' ' 126' ' ' MET . 36.8 tp -135.48 165.33 25.75 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 108.783 -0.821 . . . . 70.13 108.783 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -92.63 168.96 11.47 Favored Pre-proline 0 C--N 1.279 -2.464 0 N-CA-C 108.958 -0.756 . . . . 74.21 108.958 -173.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 6.7 Cg_exo -73.78 79.38 2.27 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.587 1.525 . . . . 75.42 109.949 173.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 35.8 m -79.66 150.74 30.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.115 -0.948 . . . . 75.24 111.238 -174.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' GLN . 49.3 mm -103.8 138.99 26.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 CA-C-N 115.517 -0.765 . . . . 71.2 109.481 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.0 m -146.03 155.31 51.29 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 107.951 -1.129 . . . . 71.01 107.951 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.39 125.7 18.12 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.268 1.979 . . . . 40.14 112.55 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.3 t -124.09 128.5 49.39 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.443 -1.317 . . . . 72.01 107.443 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.27 -16.73 61.38 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 112.287 0.477 . . . . 63.5 112.287 -172.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -130.75 13.9 5.35 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.745 0.276 . . . . 61.0 111.745 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -111.42 169.63 13.33 Favored Glycine 0 C--O 1.244 0.728 0 C-N-CA 119.64 -1.267 . . . . 72.32 114.088 -175.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -154.82 138.16 15.8 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.647 -0.871 . . . . 63.52 108.647 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -113.28 122.26 67.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.792 -0.447 . . . . 70.51 109.792 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -96.05 116.81 29.53 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.255 -1.387 . . . . 62.34 107.255 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.96 -155.32 6.45 Favored Glycine 0 N--CA 1.417 -2.585 0 N-CA-C 110.912 -0.875 . . . . 71.54 110.912 -176.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -122.38 144.98 48.69 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.57 0.7 . . . . 62.4 111.939 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.0 t -111.17 131.73 61.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 114.357 -1.292 . . . . 72.22 111.319 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 81.0 mt -95.76 104.88 16.83 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.371 -0.974 . . . . 74.42 108.371 176.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 64.3 mtp -100.13 139.04 36.37 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 120.977 0.417 . . . . 75.3 111.044 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.13 18.67 10.95 Favored Glycine 0 C--N 1.29 -2.021 0 C-N-CA 120.435 -0.888 . . . . 73.32 111.637 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.676 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 88.4 t -70.3 128.17 33.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.667 -0.494 . . . . 54.53 109.667 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -77.86 167.77 20.98 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.771 -0.826 . . . . 74.53 108.771 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.3 p -64.37 -32.34 73.91 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.987 -0.685 . . . . 71.5 110.293 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.03 -51.07 51.15 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.757 -0.656 . . . . 74.33 110.058 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.676 ' OE1' ' HA ' ' A' ' 79' ' ' VAL . 44.5 tt0 -60.32 -39.57 87.52 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.727 -0.669 . . . . 73.31 110.175 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.51 HD22 ' CD2' ' A' ' 18' ' ' HIS . 42.8 tp -57.35 -51.17 70.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.102 0.477 . . . . 74.42 110.411 175.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.56 -29.27 67.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.968 -0.56 . . . . 75.23 111.326 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.429 ' O ' HG23 ' A' ' 90' ' ' VAL . 7.0 t30 -65.57 -46.3 79.98 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.935 -0.765 . . . . 53.43 108.935 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 97.1 mt -64.93 -41.06 95.85 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.388 -0.824 . . . . 60.41 109.898 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.12 -32.81 73.43 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.649 -0.705 . . . . 71.4 110.722 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.22 62.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.011 -0.541 . . . . 74.21 110.854 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 86' ' ' ASN . 99.3 t -72.27 -56.71 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 123.16 0.584 . . . . 75.51 112.319 -178.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.48 -22.76 47.02 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.041 0.448 . . . . 75.42 111.852 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.2 -17.02 36.41 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 115.519 0.967 . . . . 54.3 115.519 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.8 -45.17 93.9 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.772 0.786 . . . . 73.04 111.323 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -112.65 -9.21 13.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.44 -0.345 . . . . 73.54 111.721 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -129.74 167.48 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.58 0.228 . . . . 64.21 110.969 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 9.4 tp10 -123.08 144.65 49.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.118 -0.697 . . . . 73.04 109.118 175.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -88.12 114.14 24.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.782 -0.821 . . . . 75.53 108.782 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.51 160.54 36.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 116.316 -0.402 . . . . 64.41 110.755 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.1 t -95.41 132.08 40.85 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.626 -0.509 . . . . 74.15 109.626 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -138.11 165.17 26.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.904 -0.589 . . . . 75.5 110.759 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -104.27 123.11 7.6 Favored Glycine 0 N--CA 1.421 -2.337 0 CA-C-N 115.66 -0.7 . . . . 45.24 111.427 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 111' ' ' MET . 2.8 pp -118.18 152.78 20.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.669 -0.493 . . . . 65.43 109.669 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.8 131.47 65.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 108.49 -0.929 . . . . 35.4 108.49 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -70.52 125.65 27.42 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.444 0.465 . . . . 65.31 110.225 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.11 -4.21 46.26 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 123.208 0.317 . . . . 74.02 111.562 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.46 -60.53 3.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.1 -1.074 . . . . 62.34 108.1 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -117.79 -93.31 0.51 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.155 -1.384 . . . . 73.32 111.885 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.9 p -173.94 13.11 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.757 0.28 . . . . 74.43 111.757 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -85.02 145.43 27.7 Favored 'General case' 0 C--O 1.251 1.153 0 C-N-CA 120.302 -0.559 . . . . 70.44 111.211 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -93.72 144.66 25.2 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.901 0.857 . . . . 64.0 110.491 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.54 ' HB2' HD12 ' A' ' 102' ' ' ILE . 76.5 mmm -131.64 162.23 30.87 Favored 'General case' 0 C--N 1.275 -2.633 0 C-N-CA 124.973 1.309 . . . . 72.03 110.922 -175.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.54 126.82 53.24 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.156 -0.929 . . . . 61.31 109.073 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.457 HG12 ' CG ' ' A' ' 19' ' ' ASN . 32.7 m -141.07 173.32 9.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.742 -0.466 . . . . 74.3 109.742 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.65 151.74 22.6 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.461 -0.57 . . . . 72.44 109.461 171.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.4 t -147.28 172.04 14.48 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.696 -1.224 . . . . 73.31 107.696 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 92.1 m-85 -117.36 108.36 15.49 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.604 -0.517 . . . . 74.03 109.604 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -107.2 156.79 18.45 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.545 -0.752 . . . . 74.52 110.276 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.533 ' HD1' ' O ' ' A' ' 120' ' ' ASN . 33.7 t-105 -68.14 134.81 51.13 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 106.183 -1.784 . . . . 64.45 106.183 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.421 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.2 mp -67.81 -41.73 85.34 Favored 'Isoleucine or valine' 0 C--O 1.26 1.61 0 C-N-CA 118.894 -1.122 . . . . 71.43 110.506 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.533 ' O ' ' HD1' ' A' ' 118' ' ' TRP . 42.6 t30 -82.41 105.41 13.45 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.775 0.798 . . . . 72.31 109.353 177.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -77.24 -12.24 59.92 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.276 -0.875 . . . . 71.3 111.557 -172.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.52 76.36 1.71 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.763 -0.828 . . . . 72.33 108.763 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -93.34 130.42 35.67 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 115.115 -0.948 . . . . 41.02 108.989 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -81.0 -0.48 10.62 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.855 2.37 . . . . 73.54 114.174 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -94.23 -51.03 4.99 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 120.246 -0.582 . . . . 74.12 110.943 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.498 ' HB3' HD23 ' A' ' 59' ' ' LEU . 23.7 ptt? -76.51 103.29 6.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.334 -0.946 . . . . 71.0 110.445 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -131.85 132.31 43.56 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 106.368 -1.716 . . . . 62.21 106.368 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.83 90.24 0.91 Allowed Glycine 0 N--CA 1.401 -3.644 0 N-CA-C 109.696 -1.362 . . . . 61.2 109.696 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -78.15 147.44 34.56 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.348 -1.723 . . . . 62.25 106.348 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.676 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 0.5 OUTLIER -68.31 132.96 48.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.32 -0.552 . . . . 74.04 109.857 -172.223 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -53.29 -4.45 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 116.137 1.903 . . . . 75.12 116.137 -171.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -73.2 -36.6 66.55 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 109.521 -0.548 . . . . 75.04 109.521 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.676 ' HG3' ' O ' ' A' ' 130' ' ' TRP . 0.7 OUTLIER -72.24 -26.34 61.98 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.685 0.755 . . . . 61.31 110.437 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.699 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 44.8 tt0 -56.81 -50.6 71.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.898 -1.501 . . . . 62.01 109.65 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -65.48 -32.62 74.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 119.41 -0.916 . . . . 70.25 111.151 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -59.22 -51.51 69.67 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.838 -0.43 . . . . 62.44 109.838 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.2 ptt85 -70.54 -30.87 67.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.04 0.756 . . . . 41.11 113.04 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 134' ' ' GLU . 82.3 mt -70.48 -34.03 71.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.062 0.458 . . . . 72.34 110.26 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -75.56 -39.48 58.11 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.942 -0.762 . . . . 62.31 108.942 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.542 ' O ' HG12 ' A' ' 144' ' ' ILE . 37.6 ttmt -63.26 -35.7 81.22 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.688 -0.687 . . . . 71.32 110.617 176.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 38.6 ttpt -52.78 -35.29 56.35 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.811 0.844 . . . . 74.43 112.234 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.51 -35.79 78.7 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.187 0.518 . . . . 64.15 110.307 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -76.48 -43.26 40.53 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.605 -0.887 . . . . 73.12 108.605 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.4 mm -59.54 -33.93 53.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-N 114.807 -1.088 . . . . 54.3 111.534 -176.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.2 mt-10 -54.28 -31.64 54.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.166 0.508 . . . . 75.23 111.337 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.7 m -81.09 -47.99 12.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.337 0.589 . . . . 23.13 110.868 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -76.69 -30.68 56.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 113.698 0.999 . . . . 72.34 113.698 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -56.13 -39.42 72.21 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.094 0.474 . . . . 74.03 110.778 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -71.76 -33.89 69.02 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.57 . . . . 74.13 109.848 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.2 mt -68.83 -38.76 79.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.494 -0.776 . . . . 72.45 109.497 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.8 ttt -64.68 -37.82 88.89 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.842 -0.617 . . . . 62.42 110.118 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.83 -30.89 65.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.092 -0.504 . . . . 64.02 110.514 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.2 -34.64 76.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.991 -0.55 . . . . 64.33 110.528 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -75.86 -18.2 59.53 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.42 0.628 . . . . 61.52 111.218 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.6 76.36 1.08 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 122.315 1.055 . . . . 54.32 110.623 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -140.72 169.27 12.02 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 106.629 -1.619 . . . . 73.11 106.629 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.75 87.67 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.889 1.726 . . . . 72.54 111.718 175.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? . . . . . 0 C--N 1.31 -1.118 0 CA-C-O 121.959 0.885 . . . . 72.14 110.878 179.259 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.426 -1.629 0 CA-C-O 120.724 0.297 . . . . 75.43 110.4 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.4 m -66.48 -19.68 65.85 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.359 0.6 . . . . 62.1 110.852 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.3 p -84.47 -10.6 57.33 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.754 -0.657 . . . . 44.32 109.81 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.8 t70 72.43 139.75 0.05 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.676 1.591 . . . . 62.42 110.437 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.0 m -76.27 103.96 6.56 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.079 -0.648 . . . . 75.32 110.037 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.48 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -61.89 116.24 4.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.445 -0.576 . . . . 74.11 109.445 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -143.22 139.42 30.25 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.139 0.495 . . . . 62.12 110.728 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -83.04 155.84 23.69 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.858 -0.793 . . . . 71.23 108.858 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' O ' HG12 ' A' ' 79' ' ' VAL . 48.9 m-70 -113.28 159.3 19.5 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 108.282 -1.007 . . . . 64.43 108.282 -173.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.464 ' CB ' HG12 ' A' ' 113' ' ' VAL . 36.9 m-20 -122.3 126.94 49.19 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.276 -1.379 . . . . 73.24 107.276 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -127.84 137.5 57.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 110.105 -0.332 . . . . 61.14 110.105 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.441 ' HB2' HG21 ' A' ' 113' ' ' VAL . 88.3 t80 -95.3 121.77 37.3 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.892 -0.781 . . . . 74.41 108.892 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 m -96.03 119.51 44.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 121.92 0.867 . . . . 65.51 111.019 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -74.97 -34.22 62.0 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 115.354 1.613 . . . . 72.35 115.354 -172.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.57 -50.49 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.172 0 C-N-CA 118.578 -1.772 . . . . 61.54 113.041 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.0 m -57.85 -35.62 71.18 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 122.75 0.42 . . . . 64.12 111.984 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.696 ' HB3' HD11 ' A' ' 32' ' ' ILE . 50.4 m-85 -122.95 29.23 6.87 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.47 -0.332 . . . . 70.05 110.658 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -85.78 31.02 0.62 Allowed 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.154 0.978 . . . . 74.03 109.86 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 31' ' ' VAL . 17.3 t70 -142.06 129.42 11.43 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 107.59 -1.263 . . . . 53.53 107.59 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HB3' HG21 ' A' ' 39' ' ' THR . 19.0 Cg_exo -66.92 -32.95 34.51 Favored 'Trans proline' 0 N--CA 1.478 0.573 0 C-N-CA 122.385 2.057 . . . . 52.31 112.525 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . 25.6 t70 -60.23 -40.09 88.96 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.622 -0.263 . . . . 74.31 111.247 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 28' ' ' ASP . 13.7 p -74.21 -29.45 24.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.58 -0.448 . . . . 41.35 110.182 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 26' ' ' PHE . 43.5 mm -64.88 -45.5 94.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 N-CA-C 109.89 -0.411 . . . . 75.42 109.89 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -57.08 -36.99 71.23 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.132 0.491 . . . . 51.23 111.249 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.3 t -80.24 -42.85 21.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 116.098 -0.501 . . . . 74.14 111.2 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.446 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 13.1 tmm? -69.44 -36.84 77.03 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.704 -0.225 . . . . 75.13 111.195 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 37' ' ' ASP 0.353 3.8 pp -119.66 -57.59 1.96 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 115.092 1.515 . . . . 74.34 115.092 178.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.571 ' N ' HD12 ' A' ' 36' ' ' LEU . 29.2 t70 176.09 -55.04 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.453 0.644 . . . . 75.12 110.19 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.592 ' O ' HG22 ' A' ' 32' ' ' ILE . 36.5 mmt180 -136.84 -165.05 1.67 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.175 -0.92 . . . . 74.41 108.894 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 29' ' ' PRO . 37.7 m -137.76 125.0 13.72 Favored Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 120.329 -0.549 . . . . 41.15 111.467 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.87 150.87 87.43 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.758 2.305 . . . . 62.45 109.503 172.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.39 135.94 56.58 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 113.832 1.049 . . . . 65.21 113.832 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 3.5 mp -108.4 135.51 46.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 114.054 -1.43 . . . . 64.12 111.538 -172.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG21 ' HD2' ' A' ' 104' ' ' ARG . 14.7 p -131.29 146.48 33.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.99 -0.744 . . . . 63.12 108.99 173.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m -76.74 126.97 31.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.049 0.452 . . . . 73.12 109.806 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.8 157.14 45.83 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.013 0.435 . . . . 72.14 110.942 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.0 m -112.89 126.71 55.76 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 115.192 -0.913 . . . . 61.43 110.423 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.6 tp -101.82 102.83 25.09 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 115.712 -0.676 . . . . 61.42 109.216 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.05 140.88 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.562 2.175 . . . . 74.01 112.366 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.5 4.15 62.49 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 115.733 -0.667 . . . . 73.43 111.865 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.437 ' HE2' ' SD ' ' A' ' 117' ' ' MET . 91.5 m-85 -132.01 162.04 31.71 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.734 -0.469 . . . . 75.2 109.734 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 31.0 tt0 -139.74 140.15 36.68 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.63 -0.428 . . . . 71.1 111.362 -173.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.505 ' HA ' HD13 ' A' ' 63' ' ' ILE . 11.6 ttm180 -94.51 142.83 26.98 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.749 -1.574 . . . . 75.34 106.749 177.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -106.82 168.89 8.88 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 116.167 -0.47 . . . . 75.52 110.376 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 129' ' ' GLU . 12.1 tpt180 -122.31 156.71 33.31 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.657 -1.238 . . . . 74.53 107.657 -175.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 55' ' ' LEU . 1.9 pt? -91.95 130.49 37.69 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.014 0.435 . . . . 74.21 111.189 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -163.2 -47.92 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.263 -1.014 . . . . 65.11 108.263 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.36 -105.14 0.98 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.445 -0.798 . . . . 64.23 112.822 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.468 ' CB ' ' HB3' ' A' ' 125' ' ' ASP . 10.2 ttp180 -95.53 -45.48 7.06 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 113.798 1.036 . . . . 64.41 113.798 -177.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.425 HD23 ' HB3' ' A' ' 126' ' ' MET . 37.9 tp -111.69 160.13 17.56 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 113.393 0.886 . . . . 75.44 113.393 -159.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.96 169.69 19.04 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 114.443 -1.253 . . . . 74.12 109.019 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.49 96.82 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.196 1.931 . . . . 64.11 111.52 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 26.3 p -102.0 177.37 4.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.812 -0.631 . . . . 75.22 109.924 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 52' ' ' ARG . 47.1 mm -124.53 131.29 72.94 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 109.456 -0.572 . . . . 74.2 109.456 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -142.2 153.24 62.96 Favored Pre-proline 0 C--N 1.286 -2.163 0 N-CA-C 107.253 -1.388 . . . . 74.33 107.253 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.503 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 11.7 Cg_endo -59.97 137.0 73.26 Favored 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 122.198 1.932 . . . . 70.53 111.509 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 51' ' ' GLN . 30.1 t -124.99 147.79 48.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.353 -0.61 . . . . 54.32 109.353 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 68' ' ' LYS . 37.5 mt-10 -69.0 -36.98 78.44 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.941 -0.763 . . . . 74.04 108.941 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 67' ' ' GLU . 30.8 mmmt -134.3 80.1 1.84 Allowed 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.239 -0.891 . . . . 73.14 109.14 175.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.12 153.6 24.95 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 119.879 -1.153 . . . . 70.54 113.212 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.82 138.21 16.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.109 -1.071 . . . . 74.13 108.109 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.441 HG21 HD12 ' A' ' 63' ' ' ILE . 41.5 t -113.66 119.46 61.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.971 -0.381 . . . . 72.41 109.971 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -92.14 116.42 28.93 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.232 -2.136 . . . . 64.0 105.232 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.31 -145.33 4.4 Favored Glycine 0 N--CA 1.417 -2.582 0 C-N-CA 120.465 -0.874 . . . . 55.14 111.694 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 48.4 mmtm -129.94 141.53 50.76 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 120.747 0.308 . . . . 75.52 110.831 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 44.0 t -110.21 129.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.867 -0.606 . . . . 70.51 111.097 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.413 HD23 HG13 ' A' ' 42' ' ' ILE . 80.4 mt -96.01 111.11 23.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.296 -1.372 . . . . 64.34 107.296 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.9 ptp -117.99 149.35 41.08 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 120.66 0.267 . . . . 72.25 110.561 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.68 16.05 55.55 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.64 -1.267 . . . . 74.25 110.535 -174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.6 p -83.86 135.76 24.17 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 N-CA-C 108.302 -0.999 . . . . 72.44 108.302 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.4 p -82.96 167.0 18.38 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.31 -0.556 . . . . 72.44 110.64 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.9 m -61.05 -33.22 72.96 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.076 0.399 . . . . 75.11 112.076 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -68.31 -36.13 78.86 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.444 0.64 . . . . 74.25 110.685 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 39.1 mt-10 -78.14 -28.36 48.41 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.441 -0.948 . . . . 64.43 108.441 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.5 tp -65.9 -51.61 57.22 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.697 -0.483 . . . . 72.04 109.697 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.65 -29.03 70.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.317 0.579 . . . . 64.2 110.513 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.5 t-20 -59.86 -48.5 81.45 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.096 -0.956 . . . . 72.34 109.744 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 90' ' ' VAL . 96.7 mt -67.42 -38.99 85.46 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.15 -0.932 . . . . 63.44 110.567 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.627 ' OD1' ' HD3' ' A' ' 97' ' ' ARG . 65.7 m-20 -60.33 -45.22 94.21 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.937 -0.574 . . . . 71.32 109.801 175.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.88 -46.96 79.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.604 -0.725 . . . . 73.2 111.702 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 87' ' ' LEU . 7.9 p -72.62 -56.7 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 N-CA-C 112.999 0.74 . . . . 72.52 112.999 -177.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.11 -30.95 49.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.323 0.49 . . . . 72.52 112.323 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 95' ' ' TYR . . . -60.03 -17.26 43.7 Favored Glycine 0 N--CA 1.463 0.439 0 CA-C-N 115.769 -0.65 . . . . 64.03 114.313 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.89 -33.44 71.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.507 0.194 . . . . 61.04 110.926 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.25 -8.81 3.78 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.317 0.488 . . . . 52.43 112.317 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.409 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 69.1 m-85 -122.16 165.72 15.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.183 -0.303 . . . . 74.3 110.183 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.0 tp10 -123.12 143.24 50.12 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.845 -0.342 . . . . 63.3 110.105 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.627 ' HD3' ' OD1' ' A' ' 88' ' ' ASP . 60.5 ttp180 -87.59 114.24 24.02 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.156 -0.683 . . . . 74.33 109.156 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.72 160.34 25.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 116.179 -0.464 . . . . 71.23 111.051 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 21.8 p -90.31 122.03 32.84 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.733 -0.667 . . . . 71.43 110.074 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.88 160.7 41.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.241 0.544 . . . . 63.14 112.288 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.59 124.88 6.86 Favored Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 110.512 -1.035 . . . . 61.33 110.512 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.84 154.89 13.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 116.548 0.174 . . . . 70.1 110.587 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 97.0 t -116.84 117.86 56.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 107.445 -1.317 . . . . 65.34 107.445 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.51 ' HD3' ' SD ' ' A' ' 111' ' ' MET . 58.8 mtm180 -69.8 137.75 52.1 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 119.813 -0.755 . . . . 73.34 111.051 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -75.44 -5.68 46.24 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.083 -1.08 . . . . 74.14 108.083 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.2 -58.4 3.45 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.271 -1.332 . . . . 74.24 111.248 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.482 ' ND2' HH21 ' A' ' 104' ' ' ARG . 30.9 p-10 -126.23 3.81 7.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.037 0.755 . . . . 75.33 113.037 -173.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 t 69.6 13.85 8.24 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.29 0.636 . . . . 51.45 111.785 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -104.91 155.84 18.57 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 122.063 -0.398 . . . . 43.51 111.136 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 58.0 pttt -88.78 148.43 23.94 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.634 0.731 . . . . 34.33 111.228 -176.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.51 ' SD ' ' HD3' ' A' ' 104' ' ' ARG . 88.6 mtp -136.83 160.07 39.98 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.818 -1.083 . . . . 73.13 109.541 175.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.56 131.01 45.85 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.202 -0.908 . . . . 64.24 109.997 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.464 HG12 ' CB ' ' A' ' 19' ' ' ASN . 33.7 m -145.16 173.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.483 -0.932 . . . . 64.14 108.483 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -119.46 151.17 39.01 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.367 -0.975 . . . . 72.22 108.367 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.8 t -144.3 172.14 13.34 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.284 -0.635 . . . . 64.35 109.284 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 89.4 m-85 -116.75 108.48 15.93 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 123.847 0.717 . . . . 72.15 109.537 -177.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.503 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 22.3 ptt? -107.38 156.05 19.35 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.829 -0.623 . . . . 63.43 110.124 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -68.75 130.7 43.59 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.161 -1.052 . . . . 71.24 108.161 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.4 mp -73.7 -42.9 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 119.357 -0.937 . . . . 74.5 111.732 -173.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -84.05 93.77 8.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.78 0.8 . . . . 73.43 110.28 -177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -78.8 -6.13 55.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.108 -0.951 . . . . 72.51 113.167 -170.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.03 84.75 2.26 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.299 0.571 . . . . 73.41 110.179 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -133.49 120.61 15.85 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.836 -0.62 . . . . 64.4 109.767 178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.17 -11.87 19.35 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.524 2.149 . . . . 71.12 113.439 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.468 ' HB3' ' CB ' ' A' ' 58' ' ' ARG . 16.2 m-20 -90.63 -20.43 22.55 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 113.742 1.016 . . . . 73.3 113.742 -176.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.425 ' HB3' HD23 ' A' ' 59' ' ' LEU . 23.6 ptt? -80.31 88.17 5.55 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.489 1.138 . . . . 65.44 108.667 170.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -141.56 122.48 14.5 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.425 -1.261 . . . . 71.23 108.899 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -146.67 168.22 28.03 Favored Glycine 0 C--N 1.276 -2.772 0 N-CA-C 108.526 -1.83 . . . . 53.21 108.526 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 37.1 mt-10 -108.16 125.52 51.71 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.112 -1.035 . . . . 55.44 110.326 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.408 ' CE3' ' HB3' ' A' ' 132' ' ' PHE . 6.0 t90 -125.25 156.17 38.95 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.014 -1.847 . . . . 75.44 106.014 -172.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -61.71 -38.56 88.34 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.365 0.602 . . . . 62.15 111.295 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.408 ' HB3' ' CE3' ' A' ' 130' ' ' TRP . 74.5 t80 -61.3 -39.66 91.29 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 124.724 1.21 . . . . 72.12 109.897 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -71.46 -26.88 62.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.136 -0.938 . . . . 64.35 111.565 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.547 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 40.4 tt0 -58.03 -41.44 83.19 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 121.048 -0.261 . . . . 71.51 111.564 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -65.54 -38.12 88.69 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.099 -1.041 . . . . 74.13 110.897 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.92 -43.08 99.78 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.44 -0.346 . . . . 74.01 111.337 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.52 ' HE ' ' HG3' ' A' ' 134' ' ' GLU . 41.0 ptt180 -68.1 -35.1 77.61 Favored 'General case' 0 C--O 1.194 -1.826 0 C-N-CA 120.643 -0.423 . . . . 65.21 110.683 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 134' ' ' GLU . 89.2 mt -69.74 -35.69 75.19 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.469 0.652 . . . . 73.41 110.214 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -71.63 -39.17 70.59 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.557 -0.747 . . . . 75.22 109.161 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -70.13 -34.84 73.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.164 -0.925 . . . . 73.1 110.679 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 61.6 tttm -50.83 -30.9 15.55 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 125.427 1.491 . . . . 71.21 112.121 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -54.5 -46.65 73.51 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.215 0.606 . . . . 71.1 110.272 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -77.49 -34.03 54.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.467 -0.788 . . . . 75.11 109.603 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 141' ' ' LYS . 50.4 mm -64.49 -33.43 62.91 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.365 0 CA-C-N 114.898 -1.046 . . . . 74.2 111.796 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 38.2 mm-40 -55.37 -34.86 64.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.236 0.541 . . . . 71.42 110.693 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.3 m -73.9 -46.38 44.92 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.842 -0.617 . . . . 64.4 109.615 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -68.35 -29.76 68.56 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 114.346 1.239 . . . . 72.44 114.346 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 88.7 tttt -54.45 -41.09 69.03 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 123.357 0.663 . . . . 74.32 110.039 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.27 -36.45 84.14 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.62 0.724 . . . . 65.21 109.457 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.46 -37.38 50.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.055 -0.975 . . . . 73.34 109.942 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 87.7 mtp -67.58 -40.41 84.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.155 -0.475 . . . . 75.33 110.634 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 51.5 mt-10 -64.95 -32.16 73.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.378 0.609 . . . . 71.42 109.77 175.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.18 -44.46 65.42 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.503 -0.771 . . . . 73.35 111.166 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.99 -45.28 43.08 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 112.871 0.693 . . . . 75.11 112.871 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -98.84 -74.96 0.57 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 112.685 0.624 . . . . 61.12 112.685 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.51 150.2 7.78 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 109.953 -0.388 . . . . 74.31 109.953 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.33 -15.13 38.49 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.959 2.439 . . . . 71.14 112.579 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.437 -1.114 0 CA-C-O 121.193 0.52 . . . . 72.1 110.59 179.17 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.9 m . . . . . 0 N--CA 1.435 -1.181 0 N-CA-C 109.913 -0.403 . . . . 54.44 109.913 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -76.96 100.73 5.7 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 106.0 -1.852 . . . . 62.31 106.0 172.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 t -80.38 -9.99 59.75 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.569 0.581 . . . . 61.2 112.569 -171.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 77.95 -53.08 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.921 0.888 . . . . 65.52 109.307 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -64.93 135.84 56.14 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.355 -2.091 . . . . 64.51 105.355 169.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.46 85.27 3.18 Favored 'General case' 0 N--CA 1.413 -2.275 0 N-CA-C 114.192 1.182 . . . . 64.55 114.192 -170.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 60.09 178.54 0.09 Allowed 'General case' 0 C--O 1.25 1.13 0 C-N-CA 124.64 1.176 . . . . 54.41 113.451 170.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.22 154.34 20.51 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.658 -1.608 . . . . 73.32 106.658 167.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -120.07 157.74 28.31 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 109.09 -0.707 . . . . 72.13 109.09 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.642 ' HA ' ' O ' ' A' ' 76' ' ' LEU 0.272 0.7 OUTLIER -126.31 125.9 43.06 Favored 'General case' 0 C--N 1.284 -2.251 0 O-C-N 124.086 0.866 . . . . 74.33 111.424 174.365 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.56 137.61 55.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 114.723 -1.126 . . . . 65.21 109.913 -173.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.554 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.6 t80 -97.97 122.9 41.64 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.518 -0.919 . . . . 65.45 108.518 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.1 m -103.27 138.01 29.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.323 0.582 . . . . 31.31 111.815 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.446 ' HB3' ' CG1' ' A' ' 63' ' ' ILE . 39.8 p90 -81.28 -15.06 56.63 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 115.015 1.487 . . . . 71.55 115.015 -175.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . 160.0 -46.9 0.41 Allowed Glycine 0 C--O 1.212 -1.247 0 C-N-CA 118.658 -1.734 . . . . 43.5 113.321 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 m -58.26 -31.63 67.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.693 0.627 . . . . 65.43 112.693 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 63.7 m-85 -123.72 31.27 5.93 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 122.253 -0.279 . . . . 73.54 111.486 -176.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HB2' ' HE2' ' A' ' 74' ' ' LYS . 0.7 OUTLIER -92.18 -1.72 56.98 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 119.254 -0.978 . . . . 65.43 112.236 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.0 t70 -99.65 123.1 49.09 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 115.375 -0.83 . . . . 63.31 109.194 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.75 -31.61 78.49 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.569 2.179 . . . . 33.01 113.366 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -67.3 -40.26 86.02 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.334 -0.617 . . . . 64.42 109.334 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.79 -37.55 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.624 -0.717 . . . . 62.43 109.87 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.528 HG23 HD21 ' A' ' 36' ' ' LEU . 44.4 mm -63.06 -44.27 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 115.777 -0.647 . . . . 73.14 110.667 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -59.47 -35.87 74.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.017 0.437 . . . . 64.41 111.15 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.09 -35.64 14.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 116.084 -0.507 . . . . 75.34 112.179 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.433 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 9.0 tmm? -75.06 -37.16 61.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 120.241 -0.584 . . . . 74.42 110.16 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.528 HD21 HG23 ' A' ' 32' ' ' ILE 0.254 0.9 OUTLIER -119.73 -62.44 1.49 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.464 1.283 . . . . 72.12 114.464 179.472 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.499 ' OD2' ' HG3' ' A' ' 38' ' ' ARG . 20.8 t70 178.67 -55.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.095 0.474 . . . . 64.43 111.398 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.499 ' HG3' ' OD2' ' A' ' 37' ' ' ASP . 88.6 mtm180 -135.75 -174.62 3.7 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.828 -0.804 . . . . 65.34 108.828 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.5 m -118.55 112.5 37.16 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 120.916 -0.313 . . . . 64.43 111.649 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.53 152.0 76.24 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 123.004 2.47 . . . . 62.13 109.293 170.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.74 118.8 5.66 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.536 0.684 . . . . 64.32 112.138 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 48.6 mt -100.12 137.49 27.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 115.242 -0.89 . . . . 60.33 109.239 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.48 146.68 33.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 109.339 -0.615 . . . . 72.3 109.339 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.9 m -77.69 130.77 37.22 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.515 -0.55 . . . . 73.42 109.515 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.23 159.23 42.66 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.463 0.542 . . . . 73.12 112.463 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.5 m -107.42 132.21 53.44 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.826 0.851 . . . . 73.02 109.816 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.427 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 45.3 tp -111.96 96.76 35.35 Favored Pre-proline 0 C--N 1.3 -1.545 0 N-CA-C 108.474 -0.935 . . . . 64.12 108.474 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.64 141.06 9.64 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.462 2.108 . . . . 73.52 112.656 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.27 10.53 59.41 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.679 -0.772 . . . . 73.32 111.713 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -139.49 159.1 42.95 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 106.796 -1.557 . . . . 75.01 106.796 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -139.49 142.07 37.33 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 120.282 -0.567 . . . . 61.23 109.859 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HB2' ' NH1' ' A' ' 54' ' ' ARG . 28.4 ptt180 -102.23 126.45 49.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.981 -0.554 . . . . 75.24 109.619 176.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.517 ' O ' ' HD2' ' A' ' 54' ' ' ARG . 91.0 m-85 -108.68 162.16 14.42 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.224 -1.028 . . . . 74.14 108.224 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 53' ' ' PHE . 3.0 mpt_? -118.28 126.02 51.3 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.358 0.599 . . . . 74.14 112.087 177.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.31 133.82 17.6 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.139 -2.912 . . . . 75.33 103.139 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -103.43 -38.48 7.17 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 114.38 1.252 . . . . 70.54 114.38 -172.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.67 125.88 6.88 Favored Glycine 0 C--N 1.308 -0.994 0 C-N-CA 119.199 -1.477 . . . . 62.43 113.527 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 58' ' ' ARG . 1.6 tmt_? 84.61 -23.17 0.18 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.229 1.412 . . . . 73.11 110.809 175.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 59' ' ' LEU . 30.8 tp -137.73 163.31 31.63 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 107.555 -1.276 . . . . 72.31 107.555 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 12.4 m-85 -119.43 171.88 5.0 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 109.882 -0.414 . . . . 70.14 109.882 -169.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 31.7 Cg_exo -68.3 47.69 0.39 Allowed 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 124.073 3.182 . . . . 64.24 112.849 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.9 p -61.65 163.18 7.45 Favored 'General case' 0 C--O 1.252 1.233 0 C-N-CA 125.277 1.431 . . . . 64.15 114.838 -174.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 71' ' ' VAL . 49.8 mm -109.7 142.02 23.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 C-N-CA 124.917 1.287 . . . . 74.54 108.584 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 118' ' ' TRP . 26.9 m -148.19 154.66 42.79 Favored Pre-proline 0 C--N 1.309 -1.189 0 N-CA-C 107.654 -1.239 . . . . 73.3 107.654 171.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.2 111.33 1.99 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.226 1.951 . . . . 54.34 112.042 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 t -124.89 135.98 53.37 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.228 -0.656 . . . . 63.03 109.228 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' CD ' ' H ' ' A' ' 67' ' ' GLU . 10.3 mp0 -73.17 -21.76 60.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.986 0.422 . . . . 71.21 110.005 -176.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -100.24 5.64 44.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.904 -0.589 . . . . 63.14 112.339 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -132.24 177.13 18.96 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 118.18 -1.962 . . . . 64.51 115.094 -174.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.48 ' OE2' ' HD3' ' A' ' 140' ' ' LYS . 14.3 pt-20 -156.82 143.4 18.37 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 104.409 -2.441 . . . . 62.22 104.409 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 63' ' ' ILE . 47.0 t -113.56 119.75 61.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 C-N-CA 120.173 -0.611 . . . . 70.51 110.316 -176.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.531 ' NE2' ' HD2' ' A' ' 136' ' ' LYS . 56.1 m-70 -98.66 115.43 28.67 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 119.466 -0.894 . . . . 72.2 108.686 173.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.22 -157.79 7.39 Favored Glycine 0 N--CA 1.418 -2.564 0 C-N-CA 120.379 -0.915 . . . . 75.33 111.002 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HE2' ' HB2' ' A' ' 27' ' ' GLN . 3.1 mppt? -122.72 148.34 45.43 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 113.263 0.838 . . . . 73.34 113.263 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.5 t -111.01 131.87 61.04 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 113.643 -1.617 . . . . 64.11 110.951 178.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 68.8 mt -95.63 107.74 19.96 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.434 -0.95 . . . . 75.43 108.434 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 61.2 mtp -103.63 155.68 18.37 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.657 -0.498 . . . . 71.23 109.657 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.45 16.24 66.87 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.083 -1.056 . . . . 72.04 111.47 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 83' ' ' GLU . 86.7 t -72.1 120.12 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 109.457 -0.571 . . . . 63.41 109.457 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.5 p -74.03 163.52 27.78 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.464 -0.939 . . . . 73.41 108.464 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 p -55.15 -36.94 66.35 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 112.151 0.426 . . . . 61.44 112.151 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.76 -51.51 69.45 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.554 0.742 . . . . 74.43 111.038 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.51 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.8 mt-10 -67.95 -35.48 78.48 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.914 0.886 . . . . 71.05 109.342 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.89 -49.66 75.96 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.287 -0.635 . . . . 73.4 109.287 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.63 -33.52 75.13 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-O 121.05 0.453 . . . . 71.52 109.888 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.484 ' O ' HG23 ' A' ' 90' ' ' VAL . 43.9 t-20 -60.34 -48.97 79.47 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.411 1.085 . . . . 74.11 109.22 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.2 mt -66.86 -42.76 85.15 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.111 -0.495 . . . . 75.42 110.511 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.26 -31.96 73.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.203 -0.908 . . . . 73.43 110.676 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.86 -45.37 51.45 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.491 -0.777 . . . . 52.14 110.904 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 86' ' ' ASN . 99.4 t -65.23 -56.99 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.441 -0.345 . . . . 63.23 111.487 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -77.95 -22.54 49.37 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.83 0.678 . . . . 72.13 112.83 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.88 -16.83 48.67 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 115.912 -0.585 . . . . 43.25 114.463 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -61.4 -27.86 68.83 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.636 0.606 . . . . 72.12 112.636 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -145.23 -0.88 0.85 Allowed 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 120.136 -0.625 . . . . 75.22 112.124 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.428 ' OH ' ' HB2' ' A' ' 60' ' ' TYR . 80.4 m-85 -122.09 167.79 12.72 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 122.101 -0.374 . . . . 75.41 110.462 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -123.04 139.67 53.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.38 -1.341 . . . . 55.31 107.38 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -87.14 114.4 23.72 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.289 -0.634 . . . . 74.32 109.289 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.13 160.53 19.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.698 -0.683 . . . . 53.4 109.865 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.7 t -107.39 133.18 52.29 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.988 -0.745 . . . . 54.4 108.988 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.41 171.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 116.238 -0.437 . . . . 75.33 110.65 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.95 124.74 7.28 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 111.008 -0.837 . . . . 54.23 111.008 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.6 pp -117.6 165.14 13.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 116.621 0.21 . . . . 73.31 110.634 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.493 HG22 ' HG2' ' A' ' 110' ' ' LYS . 46.1 t -124.11 119.43 56.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.929 -0.767 . . . . 43.42 108.929 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.472 ' HE ' ' HB3' ' A' ' 106' ' ' ASP . 72.7 ttt180 -65.77 116.35 6.88 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.091 0.956 . . . . 71.52 111.005 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -53.74 -48.44 69.65 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.941 0.896 . . . . 64.32 109.215 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.472 ' HB3' ' HE ' ' A' ' 104' ' ' ARG . 33.9 t70 -48.9 -42.61 37.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.09 -1.868 . . . . 75.32 115.395 -172.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -138.92 6.64 2.43 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 118.627 -1.229 . . . . 74.34 112.41 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.3 t 59.71 70.17 0.66 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.073 0.949 . . . . 54.22 111.486 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -131.16 146.33 52.3 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 115.176 -0.92 . . . . 73.22 108.857 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.493 ' HG2' HG22 ' A' ' 103' ' ' VAL . 58.0 mtpt -97.3 126.19 42.36 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.456 0.646 . . . . 65.43 109.339 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.433 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 89.2 mtp -125.38 161.24 27.47 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.479 -0.782 . . . . 73.5 110.853 -177.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.51 117.43 31.65 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.216 -0.902 . . . . 64.52 109.197 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 21' ' ' PHE . 34.0 m -129.98 173.37 14.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 121.264 0.554 . . . . 63.52 110.821 -174.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -108.81 147.25 32.36 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.079 -1.082 . . . . 75.5 108.079 175.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.4 t -148.73 172.56 14.4 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.935 -0.765 . . . . 53.44 108.935 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.17 108.28 13.59 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.816 -0.809 . . . . 73.31 108.816 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -110.88 156.37 21.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.808 -0.633 . . . . 74.53 109.615 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.489 ' HB3' ' CG1' ' A' ' 64' ' ' VAL . 55.9 t-105 -68.35 123.27 20.31 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.065 -1.087 . . . . 75.35 108.065 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.509 HD12 ' H ' ' A' ' 119' ' ' ILE . 2.4 mp -65.23 -40.92 90.22 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 CA-C-O 120.921 0.391 . . . . 73.21 111.197 -171.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -59.17 -28.64 66.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.687 -0.688 . . . . 71.01 111.09 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.444 ' HA ' ' CG1' ' A' ' 64' ' ' VAL 0.302 9.0 ptpp? 58.06 -52.02 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 126.555 1.942 . . . . 71.22 115.217 178.307 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.88 82.64 2.61 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.357 -1.349 . . . . 61.02 107.357 174.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.401 ' HB3' ' HE3' ' A' ' 126' ' ' MET . 13.0 t70 -112.38 127.19 27.18 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.172 -0.922 . . . . 73.11 109.062 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.3 -17.78 21.16 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.852 2.368 . . . . 72.32 113.991 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -80.4 -29.63 37.73 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 112.739 0.644 . . . . 73.23 112.739 -175.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.401 ' HE3' ' HB3' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -91.56 141.49 28.66 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.838 0.828 . . . . 71.0 112.445 178.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -170.52 145.08 2.53 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.011 -1.848 . . . . 73.31 106.011 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.98 161.32 8.67 Favored Glycine 0 C--N 1.29 -1.995 0 C-N-CA 119.401 -1.381 . . . . 43.32 112.838 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.34 151.8 48.3 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.019 -1.845 . . . . 74.54 106.019 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -89.86 156.75 18.26 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 117.195 -1.802 . . . . 73.33 106.987 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -42.37 -54.86 3.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.557 0.743 . . . . 75.53 112.596 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.54 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.3 m-85 -66.16 -38.0 87.02 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 112.096 0.406 . . . . 64.32 112.096 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 52' ' ' ARG . 10.8 mm-40 -70.18 -29.33 66.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.062 0.458 . . . . 54.53 111.486 -176.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.482 ' O ' HD13 ' A' ' 138' ' ' LEU . 37.1 tt0 -68.19 -52.9 29.13 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.853 -0.795 . . . . 54.1 108.853 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -63.16 -30.41 71.57 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.526 0.679 . . . . 64.55 110.281 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.696 ' HE2' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -56.96 -50.47 72.53 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 124.562 1.145 . . . . 71.13 108.536 178.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.47 ' HA ' ' HB3' ' A' ' 140' ' ' LYS . 19.9 ptt85 -69.74 -30.57 68.2 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.172 -1.011 . . . . 63.21 112.539 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 134' ' ' GLU . 8.7 mp -67.82 -31.19 70.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.945 0.403 . . . . 73.31 110.489 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -79.17 -33.84 43.64 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.474 -0.565 . . . . 64.33 109.474 173.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.508 ' O ' HG12 ' A' ' 144' ' ' ILE . 36.0 ttpt -61.04 -33.28 73.05 Favored 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 115.588 -0.733 . . . . 73.24 112.169 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -48.8 -32.56 8.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 112.231 0.456 . . . . 71.12 112.231 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.574 ' HA ' ' HE2' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -58.76 -48.21 82.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.871 0.843 . . . . 74.11 109.716 175.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -76.15 -32.78 59.26 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.674 -1.603 . . . . 71.12 108.943 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 140' ' ' LYS . 46.7 mm -61.6 -32.77 54.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.143 0 CA-C-N 114.646 -1.161 . . . . 75.21 112.642 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -51.84 -41.3 61.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.128 0.422 . . . . 75.24 111.413 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.5 m -70.98 -47.6 57.98 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.736 -0.665 . . . . 73.41 109.858 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . 0.257 62.9 m-85 -70.18 -29.88 66.86 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 115.133 1.531 . . . . 74.32 115.133 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 57.6 tptt -59.3 -42.55 91.6 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.51 -0.922 . . . . 62.45 108.51 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -64.12 -40.31 95.92 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.253 -0.885 . . . . 71.31 109.463 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.3 mt -68.58 -41.64 83.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.313 -0.858 . . . . 64.41 110.663 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.38 -42.54 96.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.51 -0.314 . . . . 74.44 110.743 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 49.2 mt-10 -67.56 -30.8 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.931 0.396 . . . . 61.24 110.416 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 51.2 t -65.66 -37.59 86.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.871 -0.604 . . . . 74.14 109.957 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.2 -37.78 37.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.054 -0.521 . . . . 72.23 110.048 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 87.8 tttt 67.02 94.59 0.07 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.063 1.345 . . . . 73.44 112.4 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -103.75 150.38 38.1 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.621 -0.881 . . . . 71.22 108.621 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.92 135.1 66.94 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.814 2.343 . . . . 71.53 112.396 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 115.63 -0.713 . . . . 75.41 109.83 -178.662 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 82.2 m . . . . . 0 N--CA 1.429 -1.503 0 N-CA-C 107.433 -1.321 . . . . 72.22 107.433 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.3 t -70.63 106.91 3.67 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 121.393 0.616 . . . . 72.52 110.395 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 p -85.76 -22.49 27.71 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.062 -0.972 . . . . 55.51 109.494 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.252 12.7 m-20 60.49 82.27 0.16 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 122.468 1.128 . . . . 62.0 113.139 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.0 t -93.27 115.33 27.93 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 105.711 -1.959 . . . . 63.21 105.711 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.23 72.13 2.29 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-O 122.117 0.96 . . . . 72.53 112.94 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -141.37 98.06 3.29 Favored 'General case' 0 CA--C 1.472 -2.044 0 CA-C-N 113.194 -1.821 . . . . 63.23 107.279 174.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.75 153.86 18.42 Favored 'General case' 0 C--N 1.263 -3.187 0 CA-C-N 115.101 -0.954 . . . . 70.25 110.565 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.503 ' HB2' HG13 ' A' ' 79' ' ' VAL . 49.0 m-70 -115.41 160.21 20.16 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.298 -0.865 . . . . 73.33 110.208 -173.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.442 ' CG ' HG12 ' A' ' 113' ' ' VAL . 18.1 p30 -133.15 138.48 46.64 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.113 -0.949 . . . . 64.2 111.305 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.1 t -132.12 139.41 50.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.436 -0.802 . . . . 64.2 109.727 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.1 t80 -94.16 123.1 37.33 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.456 -1.312 . . . . 73.12 107.456 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.1 m -102.81 166.96 2.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 112.519 0.563 . . . . 65.34 112.519 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -153.56 -45.3 0.09 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.069 -0.969 . . . . 72.35 111.623 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.02 -92.71 1.26 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.03 -1.081 . . . . 63.11 113.97 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -58.35 -17.49 20.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.138 1.162 . . . . 74.33 114.138 -173.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -123.36 20.15 9.68 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 121.079 -0.248 . . . . 75.44 111.003 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.08 -18.86 60.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.649 -0.421 . . . . 74.02 111.609 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 20.8 t70 -116.81 128.29 26.12 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 116.331 -0.395 . . . . 71.1 111.856 -173.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HB3' HG21 ' A' ' 39' ' ' THR . 32.0 Cg_endo -65.12 -32.71 52.28 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.074 2.516 . . . . 54.3 112.81 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.53 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 19.3 t70 -63.29 -38.19 90.2 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.532 -0.544 . . . . 73.33 109.532 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.69 -42.98 93.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.257 -0.883 . . . . 73.44 109.656 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 28' ' ' ASP . 45.7 mm -60.73 -43.79 95.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.018 -0.537 . . . . 73.35 111.894 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -55.37 -36.4 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.226 0.536 . . . . 64.03 111.2 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.5 t -82.03 -37.49 14.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.149 -0.478 . . . . 74.21 111.609 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -63.49 -35.54 80.79 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.388 -0.597 . . . . 71.31 109.388 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.632 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.2 pt? -128.09 -74.69 0.57 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.092 -0.504 . . . . 75.14 111.862 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.632 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 22.4 m-20 -167.36 -58.26 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.861 0.865 . . . . 71.23 108.668 -172.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -131.2 165.59 23.0 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.444 -1.253 . . . . 73.24 112.222 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 29' ' ' PRO . 29.9 m -111.69 128.47 25.37 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.956 -0.566 . . . . 73.14 111.729 -174.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.45 153.15 68.2 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 123.453 2.769 . . . . 70.0 111.403 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.2 123.95 16.26 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.25 -0.648 . . . . 64.45 109.25 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 32.9 mt -104.91 136.03 40.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.086 0.47 . . . . 75.3 110.364 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.537 HG21 ' HD2' ' A' ' 104' ' ' ARG . 14.4 p -130.85 147.72 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.711 -0.677 . . . . 62.43 109.869 176.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.3 m -75.69 126.53 31.18 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.548 -0.908 . . . . 63.1 108.548 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.91 157.38 46.14 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.517 0.675 . . . . 64.43 111.819 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 m -114.59 125.12 53.41 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 114.537 -1.21 . . . . 73.33 108.627 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 50.8 tp -99.97 101.97 15.99 Favored Pre-proline 0 C--N 1.29 -2.007 0 N-CA-C 109.092 -0.707 . . . . 73.34 109.092 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 71.9 Cg_endo -80.84 141.1 13.23 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 122.188 1.926 . . . . 74.0 112.091 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.12 14.23 57.85 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.963 -0.636 . . . . 72.43 112.427 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -140.49 163.3 33.2 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.674 -0.491 . . . . 73.31 109.674 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.434 ' CG ' ' HB2' ' A' ' 66' ' ' SER . 26.9 pt20 -140.27 166.38 24.85 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.164 -0.68 . . . . 74.34 109.164 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HD3' HG13 ' A' ' 71' ' ' VAL . 14.9 ptt180 -128.01 128.46 45.03 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.597 -0.729 . . . . 74.31 111.719 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.559 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 17.1 m-85 -109.14 164.88 12.04 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.274 -0.876 . . . . 73.44 110.147 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.582 ' HD2' ' N ' ' A' ' 130' ' ' TRP . 6.9 mtm180 -149.55 152.84 36.2 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.442 -0.577 . . . . 61.01 109.442 -168.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 56' ' ' LYS . 1.8 tm? -159.35 142.6 14.45 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 105.537 -2.023 . . . . 65.23 105.537 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.469 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -114.47 81.87 1.62 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.618 0.723 . . . . 74.22 111.48 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.68 -101.8 0.17 Allowed Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.152 -0.931 . . . . 43.2 112.21 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.478 ' C ' ' HD3' ' A' ' 58' ' ' ARG . 0.6 OUTLIER -80.05 -36.65 35.38 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.221 0.534 . . . . 54.34 110.046 -177.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' A' ' 60' ' ' TYR . 37.2 tp -111.9 165.51 12.02 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.483 -0.562 . . . . 71.25 109.483 -178.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.437 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 12.7 p90 -141.33 168.72 13.18 Favored Pre-proline 0 C--N 1.28 -2.429 0 C-N-CA 125.698 1.599 . . . . 62.24 108.569 -170.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 5.7 Cg_exo -37.24 120.49 0.31 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 124.344 3.363 . . . . 74.34 114.427 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 53' ' ' PHE . 12.4 p -130.11 150.0 51.57 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.037 -0.983 . . . . 74.15 110.468 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.7 mm -110.06 141.36 25.59 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 N-CA-C 108.742 -0.836 . . . . 74.01 108.742 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' A' ' 118' ' ' TRP . 29.9 m -146.87 150.33 38.85 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 109.101 -0.703 . . . . 73.11 109.101 175.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.33 134.68 60.39 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.66 2.24 . . . . 71.44 112.246 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.434 ' HB2' ' CG ' ' A' ' 51' ' ' GLN . 34.8 t -125.68 141.51 51.98 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.934 -0.575 . . . . 72.42 110.343 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -75.29 -32.79 61.11 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.512 -0.551 . . . . 55.15 109.512 173.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . 0.287 0.1 OUTLIER -131.93 72.91 1.51 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 114.031 1.123 . . . . 75.41 114.031 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.35 168.59 40.58 Favored Glycine 0 C--O 1.257 1.579 0 C-N-CA 119.224 -1.465 . . . . 61.22 113.283 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.44 147.73 29.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.799 -1.186 . . . . 63.34 107.799 176.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.44 HG13 ' HD3' ' A' ' 52' ' ' ARG . 59.8 t -114.5 119.66 62.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 109.582 -0.525 . . . . 70.22 109.582 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -95.63 116.32 28.69 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.534 -0.913 . . . . 71.41 108.534 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.87 -143.87 4.14 Favored Glycine 0 N--CA 1.418 -2.517 0 C-N-CA 120.718 -0.753 . . . . 52.21 111.26 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.468 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 75.5 mmtt -134.24 145.13 48.86 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.56 -0.533 . . . . 74.51 109.56 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.7 t -110.58 129.55 65.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 123.104 0.252 . . . . 33.41 111.148 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.452 HD23 HG12 ' A' ' 42' ' ' ILE . 71.0 mt -95.62 111.31 23.26 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.022 -1.473 . . . . 71.03 107.022 174.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.9 ptp -119.65 144.08 47.36 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.398 -0.521 . . . . 75.31 111.842 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.26 23.97 7.78 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 115.459 -0.791 . . . . 70.51 111.73 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 18' ' ' HIS . 13.2 p -95.02 138.89 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 110.017 -0.364 . . . . 74.31 110.017 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.552 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 3.9 m -79.02 162.05 26.19 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 109.169 -0.678 . . . . 74.03 109.169 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.5 m -58.51 -32.7 69.07 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 112.801 0.667 . . . . 41.12 112.801 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.64 -49.39 68.87 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 112.322 0.489 . . . . 73.33 112.322 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.591 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 1.4 mp0 -65.25 -29.49 70.28 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 109.612 -0.514 . . . . 70.04 109.612 177.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.87 -40.33 92.59 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.021 0.439 . . . . 71.42 109.868 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -69.02 -36.99 78.4 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.152 -0.685 . . . . 75.45 109.152 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.457 ' O ' HG23 ' A' ' 90' ' ' VAL . 7.7 t30 -63.85 -43.04 97.33 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.114 -0.948 . . . . 64.13 110.489 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.8 mt -61.72 -43.07 99.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.748 0.785 . . . . 74.31 108.935 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.25 -32.17 71.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.278 -1.328 . . . . 52.02 111.115 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.21 -42.16 56.19 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.814 -0.63 . . . . 72.44 110.474 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 86' ' ' ASN . 99.3 t -67.04 -53.23 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.306 0.643 . . . . 73.34 112.4 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -78.28 -20.65 51.16 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.224 0.535 . . . . 70.1 111.95 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.19 -17.03 16.07 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.74 1.456 . . . . 61.15 116.74 -173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -67.06 -29.64 69.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 118.56 1.18 . . . . 73.42 112.533 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.56 -0.74 2.36 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 113.359 0.874 . . . . 63.22 113.359 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -127.41 166.08 18.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.663 0.616 . . . . 72.4 112.663 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.3 tp10 -125.17 146.04 49.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.121 -0.945 . . . . 73.43 108.86 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -92.92 114.12 26.59 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.014 -0.736 . . . . 61.13 109.014 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.412 HG11 ' HE3' ' A' ' 117' ' ' MET . 28.3 m -126.49 161.59 32.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 120.865 0.364 . . . . 71.11 111.83 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.7 t -88.14 130.97 34.89 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.249 -0.887 . . . . 74.1 110.31 -177.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.413 ' HB ' HD11 ' A' ' 47' ' ' LEU . 29.4 m -137.84 165.61 25.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.974 -0.557 . . . . 71.22 111.522 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.481 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -114.67 124.24 6.31 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.477 -1.049 . . . . 70.01 110.477 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.88 160.51 15.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 120.697 0.284 . . . . 74.01 110.868 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 66.2 t -120.38 114.68 44.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.115 -1.439 . . . . 73.01 107.115 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.537 ' HD2' HG21 ' A' ' 43' ' ' VAL . 54.8 mtm180 -69.67 135.56 50.01 Favored 'General case' 0 CA--C 1.478 -1.817 0 C-N-CA 119.981 -0.688 . . . . 72.33 109.771 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.92 5.55 18.68 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.82 0.819 . . . . 72.13 109.074 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -56.85 -62.09 1.99 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.087 -1.415 . . . . 73.55 109.559 175.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -137.76 12.3 2.92 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.512 -0.767 . . . . 62.24 109.288 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 23.0 t 62.86 78.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.688 -1.142 . . . . 64.01 110.486 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 10.2 pt-20 -137.11 151.3 48.71 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 108.133 -1.062 . . . . 71.32 108.133 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -94.05 140.93 29.12 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 120.35 -0.54 . . . . 71.22 110.245 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.6 mtp -141.8 161.5 37.81 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 123.772 0.829 . . . . 74.1 110.218 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.57 129.19 55.31 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 115.459 -0.792 . . . . 34.34 109.671 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 21' ' ' PHE . 29.5 m -142.84 174.68 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.441 -0.948 . . . . 71.33 108.441 -177.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -113.8 157.62 22.06 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.863 -0.735 . . . . 74.44 109.601 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.2 t -149.74 172.64 14.78 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.558 -0.904 . . . . 64.14 108.558 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 88.5 m-85 -114.51 115.35 27.1 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.192 -0.669 . . . . 75.33 109.192 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.412 ' HE3' HG11 ' A' ' 98' ' ' VAL 0.256 0.0 OUTLIER -113.42 156.27 23.78 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.001 -0.545 . . . . 73.11 111.773 -179.772 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.447 ' HB3' ' CG1' ' A' ' 64' ' ' VAL . 68.1 t-105 -67.76 118.01 10.43 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.688 -0.856 . . . . 63.31 108.688 -175.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.7 mt -58.91 -35.75 58.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.91 -1.041 . . . . 73.13 113.156 -171.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -70.69 -31.23 68.05 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.023 0.439 . . . . 72.01 110.596 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 67.67 -60.1 0.4 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.011 1.325 . . . . 74.35 113.658 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.03 102.01 13.59 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 110.149 -0.315 . . . . 72.44 110.149 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -141.98 123.91 9.01 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 116.014 -0.539 . . . . 73.5 110.906 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -87.06 2.67 6.88 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.797 2.332 . . . . 72.55 113.443 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -94.99 -31.43 13.63 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.669 0.271 . . . . 70.21 111.387 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.524 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 27.0 ptt? -80.18 17.86 0.95 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.824 0.45 . . . . 61.04 112.17 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -79.74 117.77 20.94 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 121.961 -0.462 . . . . 75.13 110.046 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.04 167.13 39.09 Favored Glycine 0 CA--C 1.484 -1.878 0 C-N-CA 121.056 -0.592 . . . . 52.12 111.886 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.3 151.88 34.97 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.565 -0.902 . . . . 70.12 108.565 177.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.582 ' N ' ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -87.96 153.2 21.48 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 105.522 -2.029 . . . . 72.3 105.522 177.271 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -60.44 -34.39 73.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 118.7 0.682 . . . . 61.32 111.774 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -73.58 -32.67 64.25 Favored 'General case' 0 N--CA 1.415 -2.194 0 C-N-CA 123.199 0.6 . . . . 73.11 110.604 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.461 ' HG3' ' NH1' ' A' ' 54' ' ' ARG . 78.9 mm-40 -67.24 -33.47 75.4 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 112.972 0.73 . . . . 72.24 112.972 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 5.7 tp10 -64.43 -41.39 96.61 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.089 -1.078 . . . . 62.22 108.089 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -70.0 -31.22 68.79 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.224 -0.898 . . . . 72.23 112.812 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 137' ' ' ARG 0.308 0.5 OUTLIER -61.25 -36.67 80.63 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 118.701 -1.2 . . . . 60.12 112.444 -178.494 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 136' ' ' LYS . 38.9 ptt180 -75.87 -29.84 58.67 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 119.844 -0.742 . . . . 63.01 111.33 176.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 134' ' ' GLU . 84.9 mt -71.26 -26.63 62.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.383 0.611 . . . . 73.03 109.988 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -73.21 -39.06 65.84 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.186 -1.042 . . . . 63.05 108.186 172.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.601 ' HE2' HD11 ' A' ' 144' ' ' ILE . 88.2 tttt -62.51 -30.59 71.39 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 114.656 -1.156 . . . . 62.33 110.329 176.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 23.7 tptm -46.77 -38.51 10.18 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.459 1.104 . . . . 73.42 113.006 -177.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.75 -40.3 91.93 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.947 0.88 . . . . 72.53 109.95 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -76.71 -32.98 58.2 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.503 -1.226 . . . . 74.41 107.908 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.601 HD11 ' HE2' ' A' ' 140' ' ' LYS . 48.3 mm -65.82 -32.81 59.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 CA-C-N 114.629 -1.169 . . . . 53.53 111.524 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 45.0 mt-10 -55.24 -32.06 62.01 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.376 0.608 . . . . 53.45 110.054 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.9 m -80.24 -47.19 14.98 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.704 -0.68 . . . . 61.14 109.45 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.564 ' O ' ' HG2' ' A' ' 151' ' ' MET 0.294 26.9 m-85 -64.13 -30.63 71.68 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 116.128 1.899 . . . . 72.35 116.128 -178.822 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 37.6 mmtm -58.76 -38.85 79.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.474 0.579 . . . . 64.2 111.679 175.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -71.23 -33.26 69.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.106 -0.701 . . . . 64.53 109.106 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.442 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 68.3 mt -69.95 -39.0 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.39 -0.823 . . . . 73.52 109.136 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 14.4 mmt -61.25 -40.69 94.99 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.175 -0.466 . . . . 61.44 110.329 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.443 ' HG2' ' HG3' ' A' ' 157' ' ' PRO . 46.0 mt-10 -60.29 -41.54 93.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.151 0.501 . . . . 62.03 110.319 177.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 49.0 t -71.56 -31.83 67.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.568 -0.742 . . . . 61.12 110.845 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 75.9 mmtt -74.28 -47.98 31.45 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.457 -0.497 . . . . 74.53 110.204 178.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -154.7 -68.84 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.453 0.644 . . . . 72.54 110.358 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -166.47 160.81 12.12 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 107.809 -1.182 . . . . 75.4 107.809 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.443 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 39.7 Cg_exo -57.84 127.2 24.25 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.542 2.162 . . . . 65.34 111.166 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 C--N 1.317 -0.843 0 N-CA-C 109.741 -0.466 . . . . 74.34 109.741 -177.235 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.0 m . . . . . 0 C--O 1.24 0.602 0 CA-C-O 121.596 0.712 . . . . 73.32 112.011 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.5 m -72.87 177.36 4.93 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.434 -0.803 . . . . 71.35 110.43 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.9 m -65.37 -51.37 60.89 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.978 -0.556 . . . . 75.3 110.625 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 71.36 106.53 0.06 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.78 0.832 . . . . 71.22 112.34 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.1 t 63.02 -159.56 0.32 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.274 -0.876 . . . . 74.54 109.902 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.49 -11.2 59.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.351 0.66 . . . . 72.13 110.254 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 69.04 -179.09 0.23 Allowed 'General case' 0 C--O 1.246 0.897 0 N-CA-C 114.74 1.385 . . . . 64.34 114.74 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.97 160.37 23.35 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 112.497 -2.138 . . . . 65.11 107.958 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.483 ' O ' HG12 ' A' ' 79' ' ' VAL . 49.9 m-70 -109.39 159.67 16.82 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 108.702 -0.851 . . . . 74.2 108.702 -173.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 21.1 p30 -134.56 128.48 33.34 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.114 -0.948 . . . . 64.12 111.94 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.63 144.48 34.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 114.575 -1.193 . . . . 74.3 111.041 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -94.13 123.14 37.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.75 -0.833 . . . . 72.41 108.75 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.74 ' HB ' ' O ' ' A' ' 26' ' ' PHE . 20.4 m -94.44 172.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.853 -0.612 . . . . 62.23 110.54 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -149.4 -62.41 0.22 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.291 1.96 . . . . 64.2 116.291 -168.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -116.28 -79.48 0.77 Allowed Glycine 0 C--O 1.215 -1.085 0 C-N-CA 119.314 -1.422 . . . . 73.35 114.504 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -65.98 -36.31 82.97 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.98 0.895 . . . . 75.03 109.187 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.74 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 48.5 m-85 -101.29 100.17 10.64 Favored 'General case' 0 N--CA 1.401 -2.902 0 CA-C-N 114.622 -1.172 . . . . 75.42 108.196 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -156.18 3.83 0.17 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.177 -0.919 . . . . 72.21 112.509 173.321 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HB3' HG23 ' A' ' 31' ' ' VAL . 16.0 t70 -124.71 134.59 25.75 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.369 -0.604 . . . . 73.13 109.369 -176.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 29.6 Cg_endo -63.35 -30.76 73.22 Favored 'Trans proline' 0 C--O 1.211 -0.859 0 C-N-CA 122.879 2.386 . . . . 74.42 113.988 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.26 -35.35 73.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.19 0.519 . . . . 72.12 109.629 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 28' ' ' ASP . 94.2 t -62.42 -42.42 95.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.617 -0.883 . . . . 63.01 108.617 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 36' ' ' LEU . 24.0 mm -66.17 -43.66 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.947 -1.024 . . . . 71.33 109.584 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 3.5 t-20 -55.36 -43.85 75.44 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.648 -1.614 . . . . 64.11 110.742 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.99 -39.36 17.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.882 -0.599 . . . . 75.12 111.481 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -64.99 -36.39 84.24 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 110.482 -0.192 . . . . 72.51 110.482 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 32' ' ' ILE 0.264 0.4 OUTLIER -111.24 -75.36 0.62 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 113.088 0.773 . . . . 64.12 113.088 174.268 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.6 t70 174.51 -49.08 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 108.328 -0.99 . . . . 73.33 108.328 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -110.78 175.66 5.34 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.185 -1.371 . . . . 73.01 109.029 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.0 m -129.29 104.72 17.85 Favored Pre-proline 0 N--CA 1.414 -2.228 0 N-CA-C 108.694 -0.854 . . . . 75.11 108.694 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.17 150.86 46.35 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 123.01 2.473 . . . . 75.52 110.35 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.71 132.0 51.98 Favored 'General case' 0 CA--C 1.465 -2.318 0 CA-C-O 122.224 1.011 . . . . 63.11 112.043 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 46.3 mt -107.0 131.73 56.2 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.8 0 CA-C-N 113.219 -1.809 . . . . 71.35 108.95 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.13 146.17 30.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.967 -1.123 . . . . 72.02 107.967 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.5 m -77.36 127.95 33.45 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 107.329 -1.36 . . . . 71.3 107.329 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -142.27 154.41 44.72 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.039 0.447 . . . . 74.53 110.95 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.49 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 93.9 m -109.16 125.64 52.41 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.374 -0.83 . . . . 75.33 110.276 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.405 HD11 ' HB ' ' A' ' 100' ' ' VAL . 35.0 tp -101.43 99.59 11.69 Favored Pre-proline 0 N--CA 1.432 -1.368 0 CA-C-N 116.077 -0.511 . . . . 72.1 109.936 175.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.1 Cg_endo -83.96 135.53 6.62 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.767 2.311 . . . . 70.32 111.562 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.11 5.88 46.17 Favored Glycine 0 N--CA 1.434 -1.438 0 C-N-CA 120.552 -0.832 . . . . 71.3 111.679 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.517 ' HA ' ' H ' ' A' ' 66' ' ' SER . 96.0 m-85 -146.98 150.17 34.62 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.121 -0.696 . . . . 65.52 109.121 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -140.85 148.56 40.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.632 -0.877 . . . . 73.01 108.632 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -102.03 142.47 33.25 Favored 'General case' 0 N--CA 1.424 -1.734 0 C-N-CA 119.517 -0.873 . . . . 74.51 108.997 176.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CB ' ' HB2' ' A' ' 126' ' ' MET . 7.0 m-85 -108.3 171.22 7.54 Favored 'General case' 0 C--N 1.258 -3.375 0 CA-C-N 114.646 -1.161 . . . . 74.41 111.152 -175.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -88.06 137.98 31.85 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.624 0.972 . . . . 50.15 113.624 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 5.9 tt -54.69 -63.07 1.27 Allowed 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.814 1.645 . . . . 50.41 110.722 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 62.63 -68.28 0.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.637 1.347 . . . . 64.54 114.637 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.51 -107.15 0.99 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.329 -0.939 . . . . 62.43 113.683 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.4 -0.49 33.04 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.636 1.347 . . . . 72.34 114.636 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.528 HD23 ' HB3' ' A' ' 126' ' ' MET . 31.6 tp -113.67 163.89 14.4 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.202 -0.666 . . . . 63.22 109.202 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -108.49 170.9 4.98 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.293 -1.373 . . . . 65.55 107.293 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 16.0 Cg_exo -68.79 93.23 0.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 N-CA-C 108.219 -1.493 . . . . 71.34 108.219 171.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 22.0 p -99.53 154.94 17.85 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.653 -0.703 . . . . 61.51 112.509 -174.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 50' ' ' PHE . 35.4 mm -94.86 127.39 46.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.056 -0.975 . . . . 53.55 109.469 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.44 144.38 52.03 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 109.201 -0.666 . . . . 74.34 109.201 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.94 108.96 0.36 Allowed 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.552 2.168 . . . . 62.44 112.983 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.517 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 32.3 t -125.13 98.6 5.73 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 106.09 -1.819 . . . . 61.23 106.09 176.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.38 -36.6 64.08 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 123.667 0.787 . . . . 71.52 112.252 -172.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -86.15 -23.9 26.39 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.337 0.589 . . . . 74.53 110.24 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.74 173.89 45.77 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 115.41 -0.814 . . . . 64.14 113.099 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -160.4 144.43 14.05 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.331 -0.988 . . . . 75.54 108.331 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.12 119.83 61.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 109.035 -0.728 . . . . 65.24 109.035 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -91.45 114.85 27.49 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.537 -2.023 . . . . 73.44 105.537 174.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.44 -143.81 3.9 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.279 -0.962 . . . . 33.44 112.359 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.5 mmtm -123.34 140.61 52.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.946 0.403 . . . . 73.45 111.325 -173.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 41.0 t -111.08 130.05 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.827 -0.624 . . . . 60.04 110.376 172.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 78.3 mt -95.71 109.91 22.12 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.863 -1.162 . . . . 62.01 107.863 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.8 ptp -119.7 137.43 53.92 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.128 0.489 . . . . 63.43 110.43 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.72 18.87 10.96 Favored Glycine 0 N--CA 1.421 -2.33 0 C-N-CA 120.037 -1.078 . . . . 44.14 111.254 -174.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.0 p -89.69 138.2 19.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 N-CA-C 109.009 -0.737 . . . . 74.33 109.009 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.6 p -76.84 159.92 29.67 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.422 -0.354 . . . . 63.44 110.77 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.1 m -58.71 -32.03 68.8 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.33 0.493 . . . . 62.12 112.33 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -67.37 -41.09 85.63 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.432 0.634 . . . . 71.22 109.984 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 63.0 mm-40 -80.2 -28.65 38.63 Favored 'General case' 0 C--O 1.201 -1.499 0 C-N-CA 119.576 -0.85 . . . . 73.42 112.426 176.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.423 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.1 tm? -60.79 -45.21 95.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.059 -0.719 . . . . 73.11 109.059 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -67.86 -29.92 69.17 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.855 -0.424 . . . . 74.04 109.855 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -72.95 -40.34 65.45 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 116.116 -0.493 . . . . 75.31 110.129 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.522 ' HA ' HG12 ' A' ' 90' ' ' VAL . 95.6 mt -60.17 -40.45 89.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.947 0.879 . . . . 64.4 109.295 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.491 ' CG ' HH21 ' A' ' 97' ' ' ARG . 23.8 t70 -71.48 -29.52 64.92 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.445 -1.252 . . . . 55.41 111.089 177.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.69 -48.21 22.93 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.347 -0.388 . . . . 64.13 110.394 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 87' ' ' LEU . 13.7 p -65.28 -53.41 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-N 115.843 -0.617 . . . . 62.32 111.483 -176.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -78.02 -27.82 48.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.167 0.432 . . . . 71.42 112.167 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.91 -17.81 44.78 Favored Glycine 0 N--CA 1.464 0.529 0 N-CA-C 115.007 0.763 . . . . 75.34 115.007 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -61.52 -32.33 72.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.126 0.463 . . . . 74.43 111.198 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -130.86 3.83 4.48 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.589 -0.444 . . . . 63.04 111.793 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 92.7 m-85 -138.46 168.0 20.7 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.796 0.295 . . . . 74.24 111.796 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 35.9 tt0 -121.62 144.55 48.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.323 -0.399 . . . . 73.15 110.123 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.491 HH21 ' CG ' ' A' ' 88' ' ' ASP . 16.3 ttm180 -87.45 118.45 26.92 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.328 -0.619 . . . . 75.12 109.328 -176.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.23 162.98 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 113.123 0.786 . . . . 60.04 113.123 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.5 p -94.14 124.38 38.11 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.118 -1.401 . . . . 75.34 109.965 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 47' ' ' LEU . 29.3 m -130.92 158.31 43.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 120.844 0.354 . . . . 65.11 111.251 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.58 115.8 5.22 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 111.394 -0.682 . . . . 72.32 111.394 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.04 155.76 12.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 110.189 -0.3 . . . . 54.41 110.189 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.9 120.08 62.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 108.701 -0.851 . . . . 63.33 108.701 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.468 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 39.7 mtp180 -64.38 134.92 55.56 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.946 0.403 . . . . 60.32 111.017 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.89 -6.93 53.15 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.892 -1.151 . . . . 51.01 107.892 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.88 -64.6 0.77 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 125.719 1.607 . . . . 74.43 110.938 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -144.89 15.34 1.55 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 120.741 -0.384 . . . . 71.31 110.293 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 56.7 m 63.53 63.09 0.89 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.651 -0.704 . . . . 74.25 111.656 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.47 137.57 52.44 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.373 -1.343 . . . . 64.44 107.373 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -98.19 140.97 31.7 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-O 121.433 0.635 . . . . 75.24 111.32 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.468 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 89.0 mtp -138.51 162.58 34.16 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-N 114.977 -1.011 . . . . 71.44 110.358 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.44 122.35 47.2 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.963 -1.017 . . . . 63.34 109.199 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.06 174.46 13.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 109.109 -0.7 . . . . 73.23 109.109 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -98.26 161.25 13.8 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.565 -0.854 . . . . 62.14 109.14 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.0 t -156.93 172.57 18.43 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.737 -1.208 . . . . 72.34 107.737 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.1 m-85 -124.41 113.9 18.79 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.094 -0.706 . . . . 60.14 109.094 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.94 157.52 22.31 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.935 0.398 . . . . 72.43 110.974 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.424 ' NE1' ' HB3' ' A' ' 120' ' ' ASN . 55.4 t-105 -67.52 128.82 37.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.573 -0.899 . . . . 74.12 108.573 -177.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 119' ' ' ILE . 2.7 mp -72.02 -41.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.643 -0.253 . . . . 73.24 111.159 -173.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.424 ' HB3' ' NE1' ' A' ' 118' ' ' TRP . 27.1 t-20 -62.31 -37.17 84.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.768 -0.651 . . . . 72.24 111.377 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 119' ' ' ILE . 57.2 mttp 68.29 -38.7 0.38 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.427 1.491 . . . . 72.25 114.361 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -115.63 76.09 0.99 Allowed 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.903 -0.498 . . . . 73.33 110.502 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -106.12 132.95 20.47 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 108.542 -0.91 . . . . 61.13 108.542 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.19 -19.07 29.97 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.763 2.309 . . . . 75.11 114.361 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -76.52 -37.32 56.92 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 113.222 0.823 . . . . 75.42 113.222 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.528 ' HB3' HD23 ' A' ' 59' ' ' LEU . 26.4 ptt? -73.06 -16.7 61.48 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.439 0.638 . . . . 71.04 109.933 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -77.19 85.2 3.65 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.137 -1.431 . . . . 74.55 107.137 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.58 -144.33 6.68 Favored Glycine 0 CA--C 1.464 -3.096 0 CA-C-N 114.62 -1.173 . . . . 51.14 111.364 -176.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -105.12 126.4 52.04 Favored 'General case' 0 N--CA 1.392 -3.364 0 N-CA-C 105.278 -2.119 . . . . 72.52 105.278 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -110.17 159.28 17.5 Favored 'General case' 0 C--N 1.262 -3.229 0 N-CA-C 106.065 -1.828 . . . . 71.3 106.065 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 134' ' ' GLU . 17.3 m120 -61.57 95.79 0.05 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.045 -1.095 . . . . 70.31 108.045 174.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -61.27 -33.09 72.97 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 123.585 0.754 . . . . 74.21 111.634 -176.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.93 -28.28 69.42 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.513 0.673 . . . . 73.23 110.016 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 35.6 tt0 -79.34 -54.32 6.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.08 -0.964 . . . . 73.42 109.467 175.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -58.53 -40.42 82.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.752 -0.658 . . . . 75.12 112.771 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -53.12 -34.18 55.61 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.53 0.732 . . . . 72.51 110.607 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 67.5 ttt180 -63.31 -51.62 65.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.06 -0.518 . . . . 75.34 111.396 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -76.88 -25.58 53.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.291 0.567 . . . . 74.22 110.357 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -67.76 -24.57 65.36 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.375 -0.83 . . . . 65.43 109.937 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.677 ' O ' HG12 ' A' ' 144' ' ' ILE . 38.8 ttpt -56.31 -35.79 67.94 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 116.278 -0.419 . . . . 71.15 110.589 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 38.7 ttmt -54.76 -41.94 71.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.996 0.519 . . . . 73.01 110.192 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -61.75 -44.41 96.96 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.126 0.965 . . . . 72.11 108.66 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -67.44 -38.25 84.23 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.404 -1.725 . . . . 75.24 109.977 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 140' ' ' LYS . 42.4 mm -67.05 -35.53 74.77 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.455 0 CA-C-N 115.609 -0.723 . . . . 71.4 110.174 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.5 mt-10 -59.88 -30.91 69.32 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.748 0.309 . . . . 61.32 111.134 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 150' ' ' ILE . 33.3 m -73.59 -48.44 32.76 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.904 -0.776 . . . . 71.23 108.904 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.522 ' O ' ' HG2' ' A' ' 151' ' ' MET . 51.1 m-85 -71.62 -36.29 70.73 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 115.271 1.582 . . . . 73.22 115.271 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 88.5 tttt -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.47 -0.937 . . . . 72.43 108.47 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LYS . . . . . 0.563 ' HB2' ' NZ ' ' A' ' 149' ' ' LYS . 4.1 ttmp? -75.19 -37.85 61.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.686 -1.143 . . . . 71.31 109.855 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 146' ' ' THR . 88.8 mt -64.49 -33.49 63.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.815 -0.629 . . . . 70.41 109.503 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 24.8 mmt -72.74 -27.96 62.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.288 -0.415 . . . . 61.23 110.648 176.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 43.3 mt-10 -68.7 -30.69 69.41 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 108.709 -0.849 . . . . 73.43 108.709 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 150' ' ' ILE . 52.3 t -70.48 -32.87 70.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.317 -0.856 . . . . 63.5 109.959 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 75.0 mmtt -72.43 -38.15 68.43 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.385 -0.598 . . . . 71.4 109.385 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 74.54 120.87 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 124.845 1.258 . . . . 74.31 113.087 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.01 120.76 75.3 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 106.79 -1.559 . . . . 71.33 106.79 173.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.6 89.01 0.1 OUTLIER 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.993 2.462 . . . . 71.34 113.901 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 . . . . . 0 C--O 1.246 0.883 0 C-N-CA 125.188 1.395 . . . . 51.41 108.139 179.827 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.8 t . . . . . 0 N--CA 1.428 -1.57 0 N-CA-C 109.369 -0.604 . . . . 43.02 109.369 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -91.29 88.49 6.9 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.517 -0.549 . . . . 75.41 109.517 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 m -88.73 -10.8 47.05 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.538 -0.756 . . . . 61.32 111.683 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 77.05 -37.67 0.28 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 124.773 1.229 . . . . 65.03 113.382 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 p -71.05 -171.29 0.54 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 123.017 0.527 . . . . 70.11 111.283 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.93 113.07 4.13 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 107.066 -1.457 . . . . 63.24 107.066 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -142.39 -164.98 1.93 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.043 -0.526 . . . . 71.2 109.725 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.2 mt -81.94 152.92 26.54 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.821 -0.807 . . . . 74.14 108.821 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -115.71 159.74 20.99 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.513 -0.312 . . . . 73.33 110.608 -172.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.47 ' HB3' HG12 ' A' ' 113' ' ' VAL . 49.2 m-20 -121.28 127.57 51.49 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.496 -1.298 . . . . 75.32 107.496 176.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.64 130.26 62.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 122.357 -0.214 . . . . 73.32 110.832 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.41 ' HB2' HG21 ' A' ' 113' ' ' VAL . 93.8 t80 -94.48 121.64 36.23 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.185 -1.413 . . . . 64.25 107.185 174.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.566 HG21 ' HB2' ' A' ' 26' ' ' PHE . 4.0 p -97.0 139.73 18.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.592 -0.731 . . . . 74.43 110.666 -176.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -77.65 -36.85 51.05 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 115.092 1.516 . . . . 73.0 115.092 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.41 -74.49 0.02 OUTLIER Glycine 0 C--O 1.225 -0.463 0 C-N-CA 117.584 -2.246 . . . . 72.33 115.774 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 t -58.57 -36.24 73.63 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.733 1.012 . . . . 74.55 113.733 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.599 ' HB3' HD11 ' A' ' 32' ' ' ILE . 62.4 m-85 -99.38 22.67 10.32 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.221 -0.992 . . . . 63.35 112.501 -175.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.447 ' HG2' HG13 ' A' ' 22' ' ' VAL . 80.5 mt-30 -74.29 -11.23 60.21 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 120.633 0.254 . . . . 72.34 111.279 176.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -101.76 128.77 28.06 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.455 -0.338 . . . . 65.22 111.431 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HB3' HG21 ' A' ' 39' ' ' THR . 18.0 Cg_endo -62.95 -37.04 56.55 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.943 2.429 . . . . 51.5 113.114 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.8 m-20 -65.62 -33.79 76.72 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.718 -0.614 . . . . 72.25 110.818 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.52 -40.82 89.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.736 -0.666 . . . . 71.22 109.589 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 26' ' ' PHE . 43.6 mm -65.84 -42.1 91.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 CA-C-N 115.966 -0.561 . . . . 72.41 111.103 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -58.77 -34.55 71.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.892 0.377 . . . . 74.2 110.692 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 30' ' ' ASP . 94.4 t -77.65 -46.6 27.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.089 -0.505 . . . . 71.43 110.841 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 62.0 ttp -63.56 -36.81 85.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.02 0.378 . . . . 70.3 112.02 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.51 HD12 ' H ' ' A' ' 37' ' ' ASP 0.374 3.6 pp -126.01 -58.77 1.36 Allowed 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 115.379 1.622 . . . . 75.23 115.379 -178.537 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.51 ' H ' HD12 ' A' ' 36' ' ' LEU . 22.7 t70 170.56 -53.22 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.307 0.575 . . . . 70.44 110.618 -177.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.551 ' O ' HG22 ' A' ' 32' ' ' ILE . 88.8 mtt180 -123.21 -167.35 1.59 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.548 -0.908 . . . . 71.43 108.548 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 29' ' ' PRO . 76.2 m -139.55 121.13 9.8 Favored Pre-proline 0 N--CA 1.432 -1.369 0 CA-C-O 120.502 0.191 . . . . 63.32 111.203 171.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.25 153.47 46.37 Favored 'Trans proline' 0 C--O 1.247 0.949 0 C-N-CA 123.56 2.84 . . . . 74.14 110.815 173.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.02 129.56 38.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.379 0.609 . . . . 74.12 110.204 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 54.2 mt -111.77 139.51 35.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.982 -0.554 . . . . 53.04 109.754 -175.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 12.0 p -127.98 145.85 34.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.467 -0.568 . . . . 61.54 109.467 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.463 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 40.3 m -78.32 122.44 25.76 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.353 -0.98 . . . . 74.02 108.353 176.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -141.26 159.41 42.28 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.921 0.867 . . . . 61.14 112.27 -175.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.401 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 56.1 m -120.08 129.37 54.18 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.809 -1.087 . . . . 73.22 108.632 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.0 tp -98.85 104.02 22.75 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 108.864 -0.791 . . . . 65.34 108.864 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.0 OUTLIER -82.44 148.84 14.63 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.533 2.155 . . . . 72.02 111.543 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.33 16.7 66.1 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.888 -0.672 . . . . 63.34 112.255 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -145.4 159.89 42.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.956 -1.128 . . . . 53.33 107.956 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.561 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 11.1 pt20 -139.24 163.74 31.67 Favored 'General case' 0 CA--C 1.481 -1.682 0 C-N-CA 119.313 -0.955 . . . . 71.53 111.401 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.574 ' HD3' ' NH1' ' A' ' 54' ' ' ARG . 0.8 OUTLIER -107.94 129.83 55.07 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.892 -1.504 . . . . 72.52 112.858 -176.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.561 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 5.4 m-85 -109.11 158.21 18.0 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.104 -0.953 . . . . 75.34 109.905 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.574 ' NH1' ' HD3' ' A' ' 52' ' ' ARG . 6.0 mpt_? -125.68 133.35 52.19 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.442 -0.345 . . . . 73.3 110.21 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.463 HD13 ' N ' ' A' ' 56' ' ' LYS . 2.9 tm? -170.55 137.74 1.41 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.247 -1.39 . . . . 64.42 107.247 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.463 ' N ' HD13 ' A' ' 55' ' ' LEU . 97.4 mttt -125.45 113.6 17.71 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.125 0.488 . . . . 74.23 110.151 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.84 -120.11 0.92 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.413 -1.475 . . . . 71.51 109.413 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -20.98 60.58 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.412 0.625 . . . . 72.32 110.856 177.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.443 HD12 ' H ' ' A' ' 60' ' ' TYR . 33.0 tp -119.66 163.5 17.3 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 115.362 -0.835 . . . . 75.43 109.033 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.443 ' H ' HD12 ' A' ' 59' ' ' LEU . 9.2 m-85 -122.3 175.55 2.53 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 106.755 -1.572 . . . . 70.22 106.755 -172.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.23 89.47 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.691 1.594 . . . . 63.12 110.002 172.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 20.5 p -100.1 164.69 11.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 112.48 0.548 . . . . 63.41 112.48 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.12 140.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.405 -0.961 . . . . 73.43 108.405 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -145.68 154.71 52.38 Favored Pre-proline 0 C--O 1.251 1.146 0 N-CA-C 108.057 -1.09 . . . . 73.02 108.057 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.41 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 8.4 Cg_endo -56.91 131.73 47.33 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 122.572 2.181 . . . . 64.2 112.013 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.2 t -124.46 140.58 52.82 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.286 -0.87 . . . . 34.44 108.936 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -74.35 -37.22 63.57 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.242 0.544 . . . . 70.04 109.582 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -130.94 82.33 2.04 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.611 -0.722 . . . . 75.42 110.231 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.06 164.28 37.75 Favored Glycine 0 C--N 1.299 -1.491 0 C-N-CA 119.528 -1.32 . . . . 70.3 112.811 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.22 148.19 30.24 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.832 -0.803 . . . . 72.4 108.832 176.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.16 122.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.442 -0.577 . . . . 63.33 109.442 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -97.53 116.54 29.94 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.727 -0.472 . . . . 62.45 109.727 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -152.48 -154.68 6.76 Favored Glycine 0 N--CA 1.418 -2.566 0 N-CA-C 110.317 -1.113 . . . . 44.24 110.317 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' A' ' 73' ' ' GLY . 14.3 mptt -125.76 153.4 44.03 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.586 0.708 . . . . 75.52 111.88 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 69.9 t -110.81 130.18 64.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 114.206 -1.361 . . . . 74.12 110.599 177.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.413 HD23 HG12 ' A' ' 42' ' ' ILE . 65.7 mt -95.41 111.14 23.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 105.954 -1.869 . . . . 51.42 105.954 175.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.0 ptp -124.28 152.27 43.23 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.089 0.471 . . . . 64.21 112.006 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.92 18.72 53.68 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 109.189 -1.564 . . . . 63.03 109.189 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 83' ' ' GLU . 54.7 t -71.91 127.24 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 114.253 -0.974 . . . . 73.14 109.716 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 79' ' ' VAL . 54.7 p -74.88 161.08 29.86 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.852 -1.166 . . . . 75.42 107.852 174.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.3 m -61.19 -26.83 67.98 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 122.182 -0.324 . . . . 73.53 111.837 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.43 -40.73 93.67 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.588 0.709 . . . . 41.54 110.793 176.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.511 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 38.1 mt-10 -78.0 -35.03 50.48 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.559 -0.746 . . . . 74.23 109.048 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.569 HD11 ' NH1' ' A' ' 97' ' ' ARG . 3.1 tm? -62.17 -51.41 67.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.478 -0.783 . . . . 70.12 110.11 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.05 -29.36 70.51 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 109.819 -0.437 . . . . 74.11 109.819 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 26.1 t-20 -59.71 -46.56 88.73 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.956 -0.757 . . . . 54.22 108.956 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.44 -36.78 68.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.881 -0.599 . . . . 75.04 110.949 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.426 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 26.3 t70 -64.36 -31.45 72.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.901 0.858 . . . . 65.55 109.241 177.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.86 -47.21 21.95 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.591 -0.731 . . . . 71.42 111.458 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 86' ' ' ASN . 90.5 t -72.16 -60.2 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 112.77 0.655 . . . . 65.53 112.77 -176.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -83.0 -41.84 18.24 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.87 0.843 . . . . 72.04 111.822 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -59.58 -16.58 37.58 Favored Glycine 0 C--O 1.215 -1.041 0 N-CA-C 118.238 2.055 . . . . 62.45 118.238 -171.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -69.96 -45.16 67.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 120.154 1.977 . . . . 63.1 112.22 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -98.09 -3.61 37.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.242 0.544 . . . . 60.05 111.266 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 83.5 m-85 -122.24 169.43 10.91 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.769 0.828 . . . . 64.42 110.012 -178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.423 ' HB2' HG13 ' A' ' 119' ' ' ILE . 35.3 tt0 -122.62 132.35 54.24 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.869 -0.789 . . . . 62.34 108.869 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.569 ' NH1' HD11 ' A' ' 84' ' ' LEU . 9.6 ttp180 -87.01 114.1 23.33 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.902 -1.045 . . . . 75.23 109.704 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.87 161.93 25.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 114.712 -1.131 . . . . 75.42 110.813 -177.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.2 t -94.42 129.28 41.22 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.763 -0.828 . . . . 43.02 108.763 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.94 170.32 17.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 120.963 0.411 . . . . 63.04 111.132 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.84 124.5 6.66 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.971 -0.852 . . . . 65.42 110.971 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.88 160.07 11.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 122.874 0.469 . . . . 74.22 110.117 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.4 t -120.73 127.07 75.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.467 -0.938 . . . . 73.22 108.467 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.612 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 28.2 mtp180 -68.79 135.63 51.5 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.011 -0.54 . . . . 72.03 110.676 -177.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.463 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 49.2 mt-10 -79.56 -5.73 55.55 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.07 -0.514 . . . . 74.32 109.748 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.12 -67.62 0.42 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.033 -0.985 . . . . 63.11 110.528 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -132.16 12.29 4.65 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.635 -1.166 . . . . 61.12 112.289 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.9 t 69.85 18.78 7.28 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.795 0.838 . . . . 75.31 113.133 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -88.21 149.96 23.56 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.855 -0.528 . . . . 71.2 110.923 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -95.02 147.53 23.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.122 0.487 . . . . 74.54 111.092 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.612 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.6 mtp -141.56 160.92 39.16 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 123.625 0.77 . . . . 52.23 110.329 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.16 130.88 51.91 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.552 -0.749 . . . . 44.4 110.779 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 19' ' ' ASN . 28.8 m -142.83 174.02 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 73.33 110.402 -177.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.21 149.46 23.53 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.445 -1.687 . . . . 73.32 106.445 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 6.7 t -150.35 172.09 15.95 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.085 -0.709 . . . . 74.45 109.085 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 95' ' ' TYR . 81.0 m-85 -120.91 108.89 14.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 123.452 0.47 . . . . 51.31 109.951 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.41 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 24.0 ptt? -112.42 155.87 23.49 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.093 -0.503 . . . . 43.42 109.728 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -69.56 129.44 39.68 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.461 -0.941 . . . . 74.44 108.461 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.54 HD12 ' H ' ' A' ' 119' ' ' ILE . 2.7 mp -72.65 -42.81 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.763 0.316 . . . . 64.34 111.762 -171.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -71.1 -36.91 72.36 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.136 -0.69 . . . . 63.14 109.136 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt 52.34 9.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.318 1.847 . . . . 74.41 114.908 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.96 14.14 4.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.386 0.513 . . . . 74.51 112.386 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 4.8 m-20 -67.08 122.42 82.58 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 110.182 -0.303 . . . . 70.15 110.182 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 123' ' ' ASP . 12.2 Cg_exo -72.28 -5.96 18.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.587 2.191 . . . . 75.41 112.974 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -59.71 -53.3 59.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.305 0.574 . . . . 64.31 110.225 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.403 ' HB3' HD23 ' A' ' 59' ' ' LEU . 23.7 ptt? -73.67 141.73 46.45 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.801 -1.091 . . . . 64.45 112.233 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -116.06 134.48 54.91 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.554 -0.906 . . . . 73.34 108.554 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -84.5 29.34 4.05 Favored Glycine 0 CA--C 1.492 -1.365 0 C-N-CA 121.056 -0.592 . . . . 51.25 113.481 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.63 149.91 46.59 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-O 121.853 0.835 . . . . 72.04 111.519 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TRP . . . . . 0.421 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 15.1 t90 -111.83 162.08 15.66 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 106.284 -1.747 . . . . 75.02 106.284 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.502 ' HA ' ' OE2' ' A' ' 133' ' ' GLU . 17.6 m120 -45.59 3.66 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 116.353 1.983 . . . . 71.12 116.353 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -61.14 -31.36 71.08 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 107.649 -1.241 . . . . 74.54 107.649 170.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 131' ' ' ASN . 0.0 OUTLIER -56.28 -34.65 66.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.324 0.861 . . . . 71.45 113.324 177.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 36.5 tt0 -68.32 -39.74 81.89 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.801 -0.444 . . . . 52.34 109.801 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -63.5 -30.02 71.2 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.856 -0.611 . . . . 72.44 110.316 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 23.3 tptm -52.21 -39.13 59.76 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 123.19 0.596 . . . . 75.13 110.299 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.442 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 61.9 ttt180 -57.04 -48.28 78.9 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.276 0.63 . . . . 74.54 111.742 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.97 -26.8 30.96 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.154 0.502 . . . . 63.4 110.703 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -82.03 -27.3 33.13 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.685 -0.689 . . . . 74.11 112.116 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.544 ' O ' HG12 ' A' ' 144' ' ' ILE . 63.9 pttt -66.59 -32.52 73.91 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 110.199 -0.297 . . . . 73.01 110.199 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 50.2 mtmt -48.58 -35.15 12.83 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.818 0.847 . . . . 73.31 112.589 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -58.96 -45.39 90.62 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.3 0.572 . . . . 73.25 110.826 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -76.12 -34.87 59.48 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.918 -0.771 . . . . 61.14 108.918 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.1 mm -61.43 -33.97 59.2 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.759 0 CA-C-N 115.081 -0.963 . . . . 75.34 110.193 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.3 mt-10 -54.15 -35.88 62.72 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.742 0.306 . . . . 72.51 110.843 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.9 m -70.6 -47.37 60.48 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 116.128 -0.487 . . . . 73.24 110.018 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -71.84 -30.51 65.53 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 113.238 0.829 . . . . 71.04 113.238 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.9 -42.87 80.69 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.981 -0.748 . . . . 73.33 108.981 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -70.92 -38.43 72.93 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.785 -1.098 . . . . 74.42 108.931 -177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.55 -41.08 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.754 -0.657 . . . . 61.03 110.355 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 70.9 mtm -67.79 -37.75 82.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.514 -0.312 . . . . 74.14 110.818 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.439 ' HG2' ' HD2' ' A' ' 157' ' ' PRO . 45.1 mt-10 -67.84 -31.29 71.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.806 0.336 . . . . 74.43 111.016 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.91 -47.1 55.04 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.354 -0.385 . . . . 63.32 111.459 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -80.52 -45.11 18.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.617 0.599 . . . . 65.23 112.617 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.56 -45.01 4.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.202 0.445 . . . . 74.41 112.202 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 87.5 tttt 69.52 75.07 0.26 Allowed Pre-proline 0 C--N 1.312 -1.027 0 C-N-CA 124.193 0.997 . . . . 74.44 111.454 -174.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PRO . . . . . 0.439 ' HD2' ' HG2' ' A' ' 152' ' ' GLU . 73.6 Cg_endo -101.39 -176.43 0.13 Allowed 'Trans proline' 0 N--CA 1.426 -2.443 0 C-N-CA 122.662 2.241 . . . . 53.53 110.546 173.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 C--N 1.298 -1.663 0 N-CA-C 109.272 -0.64 . . . . 74.04 109.272 175.648 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.429 -1.481 0 CA-C-O 121.493 0.663 . . . . 53.35 111.563 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.7 m -120.98 17.65 11.72 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.127 -1.064 . . . . 73.23 108.127 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.6 m -55.07 -45.05 75.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.908 -1.496 . . . . 74.31 111.736 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t70 64.62 85.49 0.14 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.778 0.831 . . . . 74.15 110.883 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 m -164.49 -177.21 4.73 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.362 -1.348 . . . . 73.51 107.362 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -74.78 -76.5 0.14 Allowed 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 117.76 0.254 . . . . 71.4 110.39 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 48.57 -156.47 0.07 Allowed 'General case' 0 C--O 1.25 1.088 0 O-C-N 124.933 1.396 . . . . 71.43 110.875 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -86.62 154.04 21.33 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 108.4 -0.963 . . . . 73.21 108.4 172.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.429 ' O ' HG12 ' A' ' 79' ' ' VAL . 40.8 m-70 -115.15 159.56 20.76 Favored 'General case' 0 C--N 1.271 -2.848 0 N-CA-C 108.933 -0.765 . . . . 53.13 108.933 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.43 ' HB2' HG12 ' A' ' 113' ' ' VAL . 34.6 m-20 -116.97 125.34 51.25 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.824 -1.176 . . . . 63.1 107.824 176.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.7 t -125.47 142.08 43.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 109.759 -0.46 . . . . 70.11 109.759 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.554 ' HB2' HG21 ' A' ' 113' ' ' VAL . 91.1 t80 -94.34 123.13 37.55 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.044 -1.095 . . . . 64.24 108.044 177.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.563 HG21 ' HB2' ' A' ' 26' ' ' PHE . 14.8 p -107.89 148.41 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 121.445 0.64 . . . . 52.13 110.609 -176.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -118.02 -59.75 1.87 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.175 -0.92 . . . . 74.43 113.046 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.22 -60.14 0.08 OUTLIER Glycine 0 C--N 1.336 0.564 0 C-N-CA 118.663 -1.732 . . . . 64.14 115.41 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.2 m -57.84 -24.34 56.98 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.388 0.884 . . . . 55.01 113.388 -172.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.563 ' HB2' HG21 ' A' ' 22' ' ' VAL . 49.8 m-85 -132.0 25.13 4.61 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.723 -0.843 . . . . 61.22 108.723 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.46 -30.18 68.02 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.308 0.575 . . . . 63.32 112.478 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 31' ' ' VAL . 31.0 t70 -96.65 130.89 29.3 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.893 -0.594 . . . . 72.4 111.334 -176.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.478 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 19.0 Cg_endo -60.24 -28.25 86.52 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.52 2.147 . . . . 52.24 113.692 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.451 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 22.0 t70 -70.52 -41.74 72.18 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.567 -0.453 . . . . 74.31 110.926 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 28' ' ' ASP . 9.8 p -65.92 -28.57 44.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 C-N-CA 119.887 -0.725 . . . . 64.43 109.33 177.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.528 HG23 HD21 ' A' ' 36' ' ' LEU . 37.5 mm -61.52 -46.75 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.598 -0.519 . . . . 75.41 109.598 175.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -60.89 -32.19 71.66 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.925 -0.58 . . . . 53.41 111.94 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.4 t -81.71 -38.91 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 120.636 -0.425 . . . . 74.33 111.59 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -74.75 -36.81 62.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.482 -0.326 . . . . 72.11 110.776 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.528 HD21 HG23 ' A' ' 32' ' ' ILE 0.275 0.4 OUTLIER -117.02 -60.78 1.8 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.169 -0.612 . . . . 52.51 111.987 176.764 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.431 ' OD2' ' HG2' ' A' ' 38' ' ' ARG . 30.5 t70 162.13 -50.99 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 124.597 1.159 . . . . 71.42 110.236 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 38' ' ' ARG . 4.6 mmp_? -118.88 152.76 35.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.957 -0.565 . . . . 63.52 110.636 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.421 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 5.0 m -95.74 120.2 63.71 Favored Pre-proline 0 C--O 1.245 0.829 0 CA-C-N 116.647 -0.251 . . . . 75.23 111.009 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -67.47 152.71 78.26 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 122.77 2.313 . . . . 71.42 109.36 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.42 129.0 39.86 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.331 -0.547 . . . . 74.21 109.85 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 53.9 mt -110.28 124.93 67.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.495 -0.775 . . . . 73.14 109.226 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.616 HG21 ' HD2' ' A' ' 104' ' ' ARG . 14.0 p -116.41 146.56 20.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 109.007 -0.738 . . . . 74.4 109.007 177.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.6 m -81.44 124.29 29.31 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.627 -0.509 . . . . 65.12 109.627 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -142.83 159.49 42.13 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.171 0.51 . . . . 74.41 111.161 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.6 m -116.51 131.63 56.9 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.313 -0.858 . . . . 72.22 110.8 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.414 HD11 ' HB ' ' A' ' 100' ' ' VAL . 37.7 tp -99.3 99.9 9.27 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 123.984 0.913 . . . . 73.41 110.014 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 66.4 Cg_endo -78.3 143.29 19.65 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.149 1.9 . . . . 73.52 111.693 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.01 5.12 58.48 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 116.077 -0.511 . . . . 63.5 112.306 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.2 168.91 18.51 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 122.358 0.263 . . . . 72.21 110.43 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -139.94 164.7 29.31 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.12 -0.696 . . . . 71.32 109.12 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -130.97 126.41 35.95 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.434 -0.803 . . . . 71.44 110.676 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 37.4 m-85 -114.83 163.89 14.88 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.668 -0.696 . . . . 74.51 109.742 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.501 ' O ' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -140.29 125.25 18.43 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 123.485 0.491 . . . . 53.13 111.235 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 tp -155.46 169.99 22.99 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.634 -1.247 . . . . 74.43 107.634 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -135.86 154.93 51.01 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.774 -0.454 . . . . 62.14 109.774 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.95 -114.41 2.51 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.02 -0.832 . . . . 60.23 111.02 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.487 HH21 ' CG ' ' A' ' 125' ' ' ASP . 3.7 ppt_? -88.88 -18.11 28.26 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.02 -1.104 . . . . 73.31 108.02 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.4 tp -115.71 163.75 15.36 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.061 -0.972 . . . . 71.03 108.845 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.401 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 13.5 m-85 -137.67 176.88 2.42 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 106.913 -1.514 . . . . 74.24 106.913 -168.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 12.2 Cg_endo -59.57 120.79 8.82 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 107.752 -1.672 . . . . 71.22 107.752 166.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.5 p -132.82 160.32 37.25 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.962 0.411 . . . . 73.13 111.128 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mm -110.38 138.18 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.411 -0.959 . . . . 72.24 108.411 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 118' ' ' TRP . 31.1 m -145.9 151.99 46.9 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 108.157 -1.053 . . . . 70.25 108.157 175.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 10.4 Cg_endo -58.53 134.67 62.59 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.645 2.23 . . . . 72.2 112.645 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.4 t -120.51 147.36 45.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.738 -0.838 . . . . 53.41 108.738 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.31 -37.83 68.85 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.341 0.4 . . . . 73.32 110.284 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' O ' ' HE3' ' A' ' 136' ' ' LYS . 49.6 mtmt -142.52 75.81 1.51 Allowed 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 108.751 -0.833 . . . . 72.12 108.751 173.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.55 168.63 28.52 Favored Glycine 0 C--N 1.287 -2.166 0 C-N-CA 119.538 -1.315 . . . . 53.24 112.68 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -154.51 141.47 19.24 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.64 -0.874 . . . . 64.32 108.64 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.07 119.16 59.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.308 -0.627 . . . . 64.33 109.308 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -89.85 116.07 27.65 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.979 -1.489 . . . . 65.45 106.979 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.86 -148.05 4.72 Favored Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 120.718 -0.753 . . . . 64.21 111.563 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.532 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 46.0 mmtm -127.12 147.11 50.18 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.692 0.282 . . . . 63.11 110.92 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 39.2 t -110.35 127.42 67.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 116.12 -0.491 . . . . 72.44 110.658 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.426 HD23 HG12 ' A' ' 42' ' ' ILE . 73.8 mt -95.32 103.99 15.86 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.347 -1.353 . . . . 73.02 107.347 177.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.6 ptp -109.4 138.63 45.47 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.881 -0.414 . . . . 71.32 109.881 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.81 13.93 26.36 Favored Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 119.462 -1.352 . . . . 73.55 111.743 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.3 p -83.06 129.42 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.588 -0.893 . . . . 71.41 108.588 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 m -73.77 159.82 32.38 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 109.825 -0.435 . . . . 54.53 109.825 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 19.7 m -56.58 -42.32 78.47 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.25 0.463 . . . . 73.34 112.25 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.78 -41.46 99.26 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-O 120.843 0.354 . . . . 62.53 111.372 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.575 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 47.2 mt-10 -70.61 -28.21 64.68 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.269 -0.641 . . . . 72.31 109.269 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.432 ' HB3' ' O ' ' A' ' 81' ' ' SER . 55.2 tp -63.26 -47.15 83.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.496 -0.927 . . . . 63.24 108.496 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 88' ' ' ASP . 47.7 mt-10 -68.52 -29.15 67.67 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.056 -0.974 . . . . 73.12 110.173 176.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 2.3 t-20 -63.15 -45.97 89.39 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.498 1.119 . . . . 72.03 109.052 175.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.5 mt -64.2 -38.76 92.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.611 -0.722 . . . . 72.11 109.367 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 9.7 t70 -58.95 -47.2 85.95 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 115.486 -0.779 . . . . 52.32 110.425 173.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.62 -48.07 83.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.693 -0.685 . . . . 72.51 111.315 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.49 -57.99 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 N-CA-C 113.332 0.864 . . . . 52.12 113.332 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -79.84 -36.43 36.8 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.409 0.623 . . . . 65.12 111.825 -174.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.17 -17.16 22.75 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-N 115.098 -0.956 . . . . 44.41 115.113 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -58.98 -32.41 69.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 111.736 0.273 . . . . 75.11 111.736 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.51 0.51 4.03 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 111.629 0.233 . . . . 63.15 111.629 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -132.05 164.22 26.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.166 0.432 . . . . 64.32 112.166 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.7 tp10 -124.66 143.55 50.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.409 -0.589 . . . . 74.54 109.409 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 115' ' ' THR . 46.0 ttp180 -97.13 114.72 26.43 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.514 -0.55 . . . . 74.02 109.514 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.8 m -116.75 162.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 115.731 -0.668 . . . . 74.03 112.002 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.7 p -86.13 121.9 29.38 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.892 -1.049 . . . . 65.45 109.932 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.414 ' HB ' HD11 ' A' ' 47' ' ' LEU . 33.1 m -134.57 166.08 29.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 115.88 -0.6 . . . . 62.2 112.091 -176.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -118.95 127.72 7.35 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.023 -1.231 . . . . 31.33 110.023 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.01 161.0 16.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 117.096 0.448 . . . . 63.33 111.115 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.6 t -128.53 124.42 61.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.671 -0.862 . . . . 74.54 108.671 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.616 ' HD2' HG21 ' A' ' 43' ' ' VAL . 55.9 mtm180 -63.74 147.52 51.49 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.185 0.517 . . . . 75.25 112.387 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -82.73 -1.49 51.57 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.573 -1.194 . . . . 64.31 110.129 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.18 -59.23 3.01 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.564 -0.743 . . . . 72.41 111.616 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -140.83 5.82 1.98 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 119.788 -0.765 . . . . 64.53 111.415 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.8 t 69.77 78.04 0.2 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.212 0.945 . . . . 73.0 110.99 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -137.09 151.96 49.48 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.231 -1.396 . . . . 70.14 107.231 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -104.76 148.33 26.73 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.764 -0.774 . . . . 73.33 112.888 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.3 mtm -136.4 163.26 30.89 Favored 'General case' 0 CA--C 1.475 -1.935 0 CA-C-N 115.334 -0.848 . . . . 75.23 109.38 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.36 117.97 35.49 Favored 'General case' 0 C--N 1.268 -2.972 0 CA-C-N 114.837 -1.074 . . . . 40.54 109.581 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 21' ' ' PHE . 30.9 m -135.52 174.02 13.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.723 -0.473 . . . . 61.01 109.723 -176.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -116.96 154.24 31.21 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.058 -1.09 . . . . 72.51 108.058 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.2 t -146.02 171.57 14.67 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.182 -0.674 . . . . 73.14 109.182 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.2 m-85 -113.73 112.35 23.31 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.352 -0.61 . . . . 73.5 109.352 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.438 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 24.5 ptt? -112.95 158.15 20.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.703 -0.681 . . . . 62.45 109.834 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.403 ' HB3' HG12 ' A' ' 64' ' ' VAL . 67.6 t-105 -66.76 124.82 23.98 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 107.797 -1.186 . . . . 64.41 107.797 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.21 -43.29 84.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 113.969 1.1 . . . . 62.43 113.969 -165.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -86.24 -9.69 56.03 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.245 -0.982 . . . . 63.34 110.657 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt 55.58 -27.15 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 118.136 2.643 . . . . 74.31 118.136 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -110.58 96.37 6.14 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.56 -0.712 . . . . 72.33 112.348 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -128.1 118.87 20.77 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.036 -0.984 . . . . 74.25 111.326 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.79 -15.87 44.95 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.622 2.215 . . . . 70.23 110.034 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.487 ' CG ' HH21 ' A' ' 58' ' ' ARG . 1.2 m-20 -58.8 -41.71 87.37 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.205 -1.361 . . . . 65.55 112.409 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -72.67 80.57 1.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 122.496 1.141 . . . . 64.34 113.451 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -103.52 103.92 13.93 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 105.185 -2.154 . . . . 74.12 105.185 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 54' ' ' ARG . . . 165.77 86.29 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.576 0 N-CA-C 108.419 -1.872 . . . . 73.23 108.419 -172.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -81.77 126.68 32.12 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 114.805 -0.697 . . . . 74.24 109.521 -173.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.9 t90 -74.45 158.68 33.42 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.614 -0.721 . . . . 74.21 110.496 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -37.75 -47.9 1.04 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.672 1.589 . . . . 61.4 112.525 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -73.02 -47.35 45.75 Favored 'General case' 0 N--CA 1.407 -2.589 0 CA-C-O 119.282 -0.39 . . . . 72.13 111.297 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -56.52 -31.52 64.2 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.411 0.624 . . . . 74.22 110.445 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.9 tp10 -65.8 -53.64 37.54 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.391 -0.822 . . . . 75.11 109.707 176.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -64.89 -36.55 84.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.318 0.58 . . . . 75.02 110.389 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 68' ' ' LYS . 86.9 tttt -52.77 -50.35 63.7 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 125.018 1.327 . . . . 72.14 110.124 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.554 ' O ' ' HG2' ' A' ' 141' ' ' LYS . 40.0 ptt180 -71.11 -30.69 66.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 120.563 -0.455 . . . . 70.31 111.886 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 134' ' ' GLU . 86.0 mt -69.71 -32.8 71.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.293 0.568 . . . . 64.35 110.424 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -75.66 -36.88 60.01 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.494 -0.775 . . . . 72.03 108.96 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' O ' HG12 ' A' ' 144' ' ' ILE . 87.0 tttt -61.72 -34.21 75.4 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.137 1.375 . . . . 73.43 110.672 176.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 137' ' ' ARG . 32.7 mmtp -48.99 -31.36 7.34 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.369 1.248 . . . . 73.41 114.369 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -54.58 -46.47 73.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.128 0.49 . . . . 72.34 110.849 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -76.29 -36.1 58.54 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.569 0.699 . . . . 72.43 109.205 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 141' ' ' LYS . 50.7 mm -62.04 -33.21 57.22 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 CA-C-N 114.721 -1.127 . . . . 73.3 112.313 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 64.4 mm-40 -54.27 -36.22 63.39 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.045 0.45 . . . . 63.54 110.616 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 89.3 m -74.42 -42.74 58.66 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.403 -0.591 . . . . 74.03 109.403 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -67.75 -29.45 68.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 114.598 1.332 . . . . 71.54 114.598 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 99.3 mttt -53.38 -49.05 68.03 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 109.278 -0.638 . . . . 70.53 109.278 176.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -68.01 -36.24 79.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.206 -0.906 . . . . 64.1 110.55 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.3 -39.83 86.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.594 -0.73 . . . . 70.32 109.688 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 56.9 ttp -73.43 -38.53 65.49 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.508 -0.769 . . . . 74.52 110.599 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 52.1 mt-10 -62.85 -34.63 77.76 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.2 0.524 . . . . 74.53 110.592 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 46.9 t -65.91 -36.22 82.78 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.273 -0.876 . . . . 61.42 109.953 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -82.5 -44.63 15.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.223 -0.444 . . . . 71.21 111.887 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -97.24 -91.14 0.25 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.419 -0.355 . . . . 75.34 111.361 -178.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -154.55 153.06 27.29 Favored Pre-proline 0 C--O 1.241 0.636 0 C-N-CA 124.591 1.157 . . . . 73.42 107.907 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.4 148.37 60.8 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 122.21 1.94 . . . . 75.01 111.446 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 C--N 1.294 -1.825 0 N-CA-C 108.278 -1.008 . . . . 53.22 108.278 179.811 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 106.177 -1.786 . . . . 71.33 106.177 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.3 m -62.9 104.98 0.61 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.647 0.61 . . . . 63.23 112.647 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.7 m -70.63 -31.48 68.45 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.53 -0.915 . . . . 51.33 108.53 174.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t70 54.59 -81.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.013 1.725 . . . . 62.23 114.487 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.9 t -101.72 -19.57 15.33 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 120.648 0.261 . . . . 43.4 111.35 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -88.75 153.13 21.33 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.173 0.434 . . . . 74.35 112.173 -176.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 59.98 -159.57 0.3 Allowed 'General case' 0 C--O 1.248 0.977 0 C-N-CA 124.442 1.097 . . . . 73.53 112.076 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.67 155.56 27.99 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.988 -1.116 . . . . 64.55 107.988 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.507 ' O ' HG12 ' A' ' 79' ' ' VAL . 54.3 m-70 -112.94 159.26 19.27 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 109.291 -0.633 . . . . 73.14 109.291 -171.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -123.25 125.74 45.64 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.408 -1.33 . . . . 74.03 107.408 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.5 t -129.64 140.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 110.329 -0.248 . . . . 71.01 110.329 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.427 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.6 t80 -94.27 123.79 37.88 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.764 -0.828 . . . . 71.13 108.764 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 74' ' ' LYS . 20.0 m -88.6 154.21 3.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.997 -0.547 . . . . 74.3 110.778 -176.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.431 ' CD2' HG12 ' A' ' 63' ' ' ILE . 1.5 p90 -135.46 -44.84 0.68 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.616 0.969 . . . . 71.12 113.616 -176.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.623 ' O ' ' HG2' ' A' ' 27' ' ' GLN . . . -146.43 -62.28 0.01 OUTLIER Glycine 0 C--O 1.219 -0.81 0 C-N-CA 119.611 -1.28 . . . . 51.53 112.667 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 p -60.81 -22.52 64.25 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 123.894 0.878 . . . . 65.05 112.813 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.466 ' HB3' HD11 ' A' ' 32' ' ' ILE . 25.3 m-85 -127.47 17.41 7.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.155 -0.475 . . . . 75.2 111.116 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 24' ' ' GLY . 16.7 pt20 -78.36 3.51 15.44 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 120.418 -0.513 . . . . 73.12 112.381 -175.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.599 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.3 t70 -130.09 125.66 22.03 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.206 -0.452 . . . . 73.11 110.676 -176.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -62.25 -29.58 80.41 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.254 1.969 . . . . 72.23 113.478 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.486 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 14.9 t70 -64.9 -42.84 94.42 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.228 -0.295 . . . . 64.52 110.781 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 28' ' ' ASP . 8.3 p -67.97 -28.72 42.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 N-CA-C 109.263 -0.643 . . . . 75.44 109.263 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 28' ' ' ASP . 49.9 mm -64.82 -44.01 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 116.323 -0.399 . . . . 71.32 110.436 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -58.7 -35.56 72.83 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.933 0.397 . . . . 75.32 111.204 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -82.14 -47.44 19.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 116.218 -0.447 . . . . 71.13 112.168 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.593 ' HE1' HD23 ' A' ' 87' ' ' LEU . 7.1 tmm? -62.82 -36.34 82.86 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.953 -0.388 . . . . 64.35 109.953 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.491 HD21 HG23 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -119.81 -73.02 0.66 Allowed 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 120.233 -0.587 . . . . 71.54 112.252 174.15 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 15.5 t70 169.24 -50.2 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.854 -0.795 . . . . 72.23 108.854 -174.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 32' ' ' ILE . 76.0 mtt180 -106.76 150.25 26.5 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 114.898 -1.047 . . . . 65.13 109.938 -174.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 m -103.28 110.21 63.26 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 108.102 -1.073 . . . . 63.34 108.102 170.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.67 151.56 79.64 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 122.802 2.335 . . . . 73.23 110.009 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -56.81 132.76 53.26 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.844 -0.428 . . . . 75.33 109.844 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 27.2 mt -109.59 137.84 39.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.751 -0.658 . . . . 74.02 110.542 -172.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 14.4 p -130.66 147.07 33.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.961 -0.563 . . . . 72.51 109.952 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.4 m -75.99 123.31 25.54 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.581 -0.896 . . . . 71.52 108.581 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.52 155.86 46.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.503 0.668 . . . . 42.0 111.643 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.46 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 95.4 m -115.36 125.93 53.8 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.012 -0.994 . . . . 54.33 110.515 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.5 tp -99.37 100.77 11.16 Favored Pre-proline 0 C--N 1.299 -1.616 0 C-N-CA 123.026 0.53 . . . . 64.34 109.873 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.6 Cg_endo -81.63 136.0 9.42 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.899 2.4 . . . . 73.22 112.829 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.49 15.42 37.75 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.632 -0.713 . . . . 72.02 111.886 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.03 161.15 40.77 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.001 -0.74 . . . . 75.54 109.001 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.425 HE21 ' H ' ' A' ' 52' ' ' ARG . 31.6 tp60 -140.33 140.91 35.71 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.272 0.558 . . . . 72.2 110.675 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.427 HH12 ' HB3' ' A' ' 54' ' ' ARG . 37.7 tpt85 -94.88 126.2 40.05 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.722 -1.126 . . . . 75.1 109.673 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -124.89 159.42 31.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.263 -0.643 . . . . 73.43 109.263 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.448 ' HE ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -143.78 153.47 42.43 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 119.344 -0.36 . . . . 75.13 111.451 178.364 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 125' ' ' ASP . 6.8 tt 170.45 109.37 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 106.644 -1.613 . . . . 61.21 106.644 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -79.73 150.83 30.7 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.119 0.485 . . . . 74.42 112.258 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.68 -105.24 0.28 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.59 -1.004 . . . . 63.41 110.59 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.478 ' C ' ' HD2' ' A' ' 58' ' ' ARG . 6.4 ppt_? -97.18 -15.55 20.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.724 -0.473 . . . . 71.12 109.724 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.6 tp -112.3 164.34 13.34 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.792 -0.64 . . . . 64.32 109.96 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -122.37 164.49 25.79 Favored Pre-proline 0 N--CA 1.419 -2.009 0 N-CA-C 108.273 -1.01 . . . . 70.1 108.273 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -55.71 115.33 2.38 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.478 2.118 . . . . 63.22 109.621 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.1 p -132.33 159.67 38.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.278 0.473 . . . . 74.32 112.278 -174.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.431 HG12 ' CD2' ' A' ' 23' ' ' TYR . 45.4 mm -115.82 141.92 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.449 -0.945 . . . . 73.43 108.449 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.6 m -143.67 154.53 59.56 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 107.509 -1.293 . . . . 71.1 107.509 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.39 136.4 59.19 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.385 2.057 . . . . 73.41 112.789 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.3 t -124.86 144.06 50.51 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.217 -1.031 . . . . 72.12 108.217 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.07 -37.34 64.25 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.968 -0.382 . . . . 63.53 109.968 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -131.68 75.22 1.63 Allowed 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.713 -0.477 . . . . 74.3 109.713 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.76 157.83 30.46 Favored Glycine 0 N--CA 1.42 -2.376 0 C-N-CA 119.566 -1.302 . . . . 64.21 111.584 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -147.65 150.59 34.67 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 107.688 -1.227 . . . . 73.55 107.688 175.019 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.9 t -112.05 127.65 69.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 109.159 -0.682 . . . . 63.22 109.159 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -99.1 115.54 29.24 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.919 -1.512 . . . . 73.24 106.919 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -149.55 -149.63 5.04 Favored Glycine 0 N--CA 1.411 -2.975 0 N-CA-C 110.27 -1.132 . . . . 73.32 110.27 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.495 ' O ' HG22 ' A' ' 22' ' ' VAL . 1.7 mptm? -128.18 155.08 45.06 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.682 0.753 . . . . 71.21 112.655 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 31.2 t -113.38 132.72 61.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 114.262 -1.335 . . . . 72.11 112.067 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.447 HD23 HG12 ' A' ' 42' ' ' ILE . 85.9 mt -95.82 123.38 39.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.214 -1.402 . . . . 61.21 107.214 172.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 22.0 ptp -127.48 146.46 50.49 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 121.04 -0.264 . . . . 74.14 111.139 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.21 25.73 15.88 Favored Glycine 0 N--CA 1.43 -1.765 0 C-N-CA 119.572 -1.299 . . . . 54.24 111.622 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.1 p -94.38 129.55 44.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 109.601 -0.518 . . . . 54.31 109.601 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.449 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 15.6 m -73.6 159.57 32.89 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 122.874 0.47 . . . . 63.22 110.64 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.3 m -55.4 -37.36 67.52 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.276 0.843 . . . . 73.2 113.276 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -58.92 -51.06 71.65 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 120.868 0.366 . . . . 63.55 110.719 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.653 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 2.3 mp0 -67.49 -28.13 67.58 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 115.937 -0.574 . . . . 71.2 110.516 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.442 HD22 ' CE1' ' A' ' 18' ' ' HIS . 42.4 tp -63.6 -42.83 98.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.093 -0.706 . . . . 74.14 109.093 174.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.31 -31.88 69.4 Favored 'General case' 0 C--O 1.198 -1.624 0 CA-C-N 115.524 -0.762 . . . . 74.21 109.359 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.582 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 2.3 t-20 -61.11 -49.49 77.09 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.452 1.101 . . . . 65.31 109.832 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 86.1 mt -62.25 -42.43 99.32 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.819 -0.808 . . . . 73.45 108.819 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.2 -38.56 90.85 Favored 'General case' 0 C--O 1.205 -1.241 0 CA-C-N 114.68 -1.145 . . . . 72.13 110.402 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.63 -43.68 84.03 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.996 0.518 . . . . 53.23 110.762 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 86' ' ' ASN . 88.7 t -72.29 -58.3 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 116.221 -0.445 . . . . 70.23 111.941 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -79.88 -42.58 23.89 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.721 1.008 . . . . 75.33 113.721 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.52 -17.11 18.4 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 115.659 1.024 . . . . 73.13 115.659 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -63.37 -39.51 94.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.361 -0.607 . . . . 53.22 109.361 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.68 0.33 9.83 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.977 0.418 . . . . 73.43 111.533 -176.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -134.3 168.91 18.03 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.648 0.779 . . . . 73.4 109.97 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 15.7 pt-20 -122.8 137.33 54.96 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.937 -0.394 . . . . 71.44 109.937 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -87.76 112.78 22.78 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.309 -1.367 . . . . 71.41 107.309 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.487 HG11 ' HE2' ' A' ' 117' ' ' MET . 23.0 m -123.04 162.49 23.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 113.237 0.828 . . . . 75.13 113.237 -176.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.8 p -85.07 122.32 29.12 Favored 'General case' 0 N--CA 1.405 -2.716 0 CA-C-N 114.473 -1.239 . . . . 73.21 109.174 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.99 171.23 18.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.319 0.581 . . . . 73.13 111.732 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -123.9 129.2 7.16 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 109.871 -1.292 . . . . 22.24 109.871 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.448 HD12 ' HB3' ' A' ' 111' ' ' MET . 2.8 pp -119.3 152.91 21.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 117.039 0.419 . . . . 52.42 111.199 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 63.7 t -110.81 114.82 48.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 108.708 -0.849 . . . . 33.41 108.708 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -65.56 112.51 3.64 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.394 -0.821 . . . . 71.22 109.747 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.9 -14.28 61.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.244 1.021 . . . . 75.23 108.815 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.66 -48.55 74.83 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.04 -1.891 . . . . 55.0 111.628 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -128.87 -15.21 4.37 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 121.955 -0.466 . . . . 73.21 111.754 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.8 m 77.15 73.24 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.705 1.202 . . . . 72.41 111.882 -176.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -155.01 153.16 30.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.11 1.364 . . . . 62.44 108.056 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 65.1 pttt -93.27 147.17 23.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.24 -0.984 . . . . 63.52 110.732 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.448 ' HB3' HD12 ' A' ' 102' ' ' ILE . 27.1 ttt -140.7 154.12 46.23 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 124.324 1.05 . . . . 70.53 108.85 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.47 130.09 46.5 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.825 0.345 . . . . 75.1 110.983 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 21' ' ' PHE . 27.4 m -146.04 175.28 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.585 -0.894 . . . . 70.12 108.585 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.67 157.98 24.52 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.031 -0.729 . . . . 51.44 109.031 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.0 t -152.09 172.94 15.55 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.969 -0.752 . . . . 71.01 108.969 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 74.3 m-85 -114.77 122.07 45.25 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 123.584 0.553 . . . . 75.03 110.215 -177.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.487 ' HE2' HG11 ' A' ' 98' ' ' VAL . 24.6 ptt? -119.07 156.95 28.8 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.858 -0.61 . . . . 74.23 109.454 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 63.8 t-105 -67.49 135.27 52.79 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.871 -0.789 . . . . 74.11 108.871 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 96' ' ' GLU . 20.4 mm -68.96 -44.4 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 120.553 -0.459 . . . . 72.31 112.097 -170.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -69.81 -32.49 70.97 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.135 0.493 . . . . 75.42 109.76 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.345 9.2 ptpp? 54.91 -1.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.637 2.088 . . . . 64.13 116.637 176.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.85 83.85 2.2 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.628 -1.249 . . . . 74.1 107.628 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.563 ' H ' ' HE3' ' A' ' 126' ' ' MET . 14.2 t70 -120.77 130.33 24.9 Favored Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 115.262 -0.881 . . . . 74.21 110.493 -176.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.49 2.7 8.2 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.89 2.393 . . . . 73.32 114.766 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.466 ' O ' HD13 ' A' ' 55' ' ' LEU . 5.3 m-20 -96.61 -34.5 11.39 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 121.834 -0.541 . . . . 63.03 111.653 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.563 ' HE3' ' H ' ' A' ' 123' ' ' ASP 0.352 0.0 OUTLIER -76.11 95.31 3.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 114.478 1.288 . . . . 74.05 114.478 179.785 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -150.91 125.03 9.31 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.989 -1.005 . . . . 65.53 110.079 175.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 149.36 134.18 2.3 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.654 -0.978 . . . . 73.41 110.654 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.99 149.92 30.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.182 0.515 . . . . 60.52 111.109 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -121.88 158.73 28.32 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.618 -2.364 . . . . 54.44 104.618 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -45.11 -13.82 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 115.053 1.501 . . . . 64.03 115.053 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -65.54 -33.02 74.95 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.796 -0.565 . . . . 74.52 109.725 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -63.77 -28.66 70.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.806 -0.634 . . . . 74.52 111.112 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.523 ' O ' HD13 ' A' ' 138' ' ' LEU . 10.5 tp10 -61.4 -50.24 73.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.001 -0.74 . . . . 75.23 109.001 176.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -68.99 -30.79 69.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.092 0.472 . . . . 63.44 110.441 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -60.9 -40.92 94.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.983 -0.553 . . . . 60.13 111.025 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -74.88 -32.83 61.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 120.18 -0.608 . . . . 72.33 112.141 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 134' ' ' GLU . 9.5 mp -68.71 -21.69 64.39 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.197 0.522 . . . . 73.1 111.57 176.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -63.7 -19.0 64.58 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.655 -0.702 . . . . 65.24 110.775 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.593 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.1 ttpt -60.06 -39.97 87.88 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.309 -0.626 . . . . 73.33 109.309 176.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 51.4 tttm -50.68 -35.13 29.41 Favored 'General case' 0 C--O 1.217 -0.638 0 C-N-CA 124.074 0.95 . . . . 74.12 111.884 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -68.86 -33.73 74.28 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.241 0.544 . . . . 71.04 110.611 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -77.38 -35.62 54.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.307 -0.627 . . . . 62.12 109.307 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 140' ' ' LYS . 45.3 mm -64.05 -33.51 62.74 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.441 0 CA-C-N 115.253 -0.885 . . . . 62.35 110.379 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.0 mt-10 -54.27 -30.47 50.79 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 113.277 0.843 . . . . 73.12 113.277 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.1 m -64.34 -41.82 96.57 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 108.876 -0.787 . . . . 73.3 108.876 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -76.38 -28.66 56.83 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.446 -0.797 . . . . 71.33 113.003 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 27.2 mmmt -52.95 -44.26 66.96 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 123.229 0.331 . . . . 72.21 110.746 175.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.18 -43.76 82.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.76 0.791 . . . . 71.21 109.275 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 71.2 mt -66.72 -45.69 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 114.596 -1.183 . . . . 73.44 111.248 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' MET . . . . . 0.511 ' HG2' ' HA ' ' A' ' 148' ' ' LYS . 26.1 ptm -74.25 -32.29 62.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.88 0.696 . . . . 73.25 112.88 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 18.1 mm-40 -63.27 -39.33 94.28 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.45 -0.574 . . . . 73.4 109.45 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 81.9 m -69.23 -31.33 69.83 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.664 -0.698 . . . . 71.51 111.419 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 150' ' ' ILE . 98.4 mttt -74.12 -21.44 59.88 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.577 0.703 . . . . 75.23 109.53 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt 78.73 78.86 0.06 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 126.319 1.848 . . . . 74.11 112.193 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -144.23 81.24 11.59 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 113.932 -1.486 . . . . 64.5 107.453 174.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.05 138.76 9.21 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.706 2.27 . . . . 73.1 112.738 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.315 0 CA-C-N 115.645 -0.707 . . . . 74.12 109.714 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.4 mt . . . . . 0 N--CA 1.434 -1.259 0 N-CA-C 107.862 -1.162 . . . . 70.349999999999994 107.862 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.552 ' CG ' ' HG ' ' A' ' 84' ' ' LEU . 39.2 m-70 -121.39 160.6 23.75 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 116.249 -0.432 . . . . 75.030000000000001 111.078 -171.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 23.6 p30 -132.38 130.58 40.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.596 -0.729 . . . . 71.329999999999998 111.425 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.65 142.05 44.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.41 -0.814 . . . . 72.349999999999994 109.986 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -94.05 122.51 36.64 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.75 -1.204 . . . . 74.519999999999996 107.75 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.4 m -97.51 161.33 2.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.208 0.527 . . . . 54.149999999999999 112.361 -176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.467 ' HA ' ' NH2' ' A' ' 52' ' ' ARG . 9.1 p90 -144.08 -60.2 0.39 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.177 0.806 . . . . 75.200000000000003 113.177 -172.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.0 -101.62 2.5 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 119.928 -1.129 . . . . 54.43 113.461 -175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 t -59.31 -36.61 75.94 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.828 0.851 . . . . 60.210000000000001 112.644 -173.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -92.25 17.38 9.77 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.65 0.982 . . . . 73.120000000000005 113.65 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -85.67 7.16 24.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 119.576 -0.85 . . . . 64.239999999999995 109.988 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 32' ' ' ILE . 19.0 t70 -119.74 127.36 26.45 Favored Pre-proline 0 C--N 1.305 -1.359 0 CA-C-N 115.87 -0.605 . . . . 73.239999999999995 109.849 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HB3' HG21 ' A' ' 39' ' ' THR . 38.0 Cg_endo -69.45 -25.26 30.18 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.102 1.868 . . . . 72.400000000000006 113.504 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 17.3 t70 -67.59 -41.18 84.5 Favored 'General case' 0 C--N 1.312 -1.034 0 O-C-N 121.817 -0.552 . . . . 72.150000000000006 110.819 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 28' ' ' ASP . 11.2 p -68.45 -28.65 41.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.416 -0.587 . . . . 71.540000000000006 109.416 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.608 HG23 HD21 ' A' ' 36' ' ' LEU . 48.7 mm -67.09 -47.04 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 116.308 -0.405 . . . . 62.219999999999999 110.394 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -57.28 -35.26 69.56 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.059 0.457 . . . . 64.140000000000001 111.691 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.1 t -81.76 -47.44 19.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.069 0.396 . . . . 62.509999999999998 112.069 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.406 ' HE1' HD23 ' A' ' 87' ' ' LEU . 7.9 tmm? -64.91 -35.9 82.63 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 110.321 -0.252 . . . . 53.329999999999998 110.321 -174.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -115.38 -72.82 0.67 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 120.16 -0.616 . . . . 71.439999999999998 112.095 174.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.2 t70 179.26 -49.48 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.453 0.644 . . . . 72.120000000000005 109.892 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.435 ' O ' HG22 ' A' ' 32' ' ' ILE . 99.4 mtt180 -128.81 173.06 10.69 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 115.262 -0.881 . . . . 71.540000000000006 109.155 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.408 HG21 ' HB3' ' A' ' 29' ' ' PRO . 36.7 m -120.95 111.59 34.05 Favored Pre-proline 0 N--CA 1.433 -1.322 0 O-C-N 123.579 0.549 . . . . 75.340000000000003 110.336 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.36 152.71 14.92 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 124.262 3.308 . . . . 73.519999999999996 111.565 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.03 125.87 23.44 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.358 -0.608 . . . . 62.32 109.358 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.4 mt -102.11 137.29 30.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.592 -0.731 . . . . 74.400000000000006 109.651 -174.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.479 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 7.3 p -130.1 143.69 40.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.634 -0.712 . . . . 71.430000000000007 110.145 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.2 m -77.0 125.81 29.93 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.986 -1.116 . . . . 71.209999999999994 107.986 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.07 156.63 47.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.404 0.621 . . . . 73.400000000000006 111.07 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.428 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 71.4 m -114.61 125.39 53.7 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.205 -0.907 . . . . 75.340000000000003 110.149 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.41 ' HB2' HG22 ' A' ' 102' ' ' ILE . 35.3 tp -102.19 100.29 14.94 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 116.049 -0.523 . . . . 73.129999999999995 109.644 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 46' ' ' THR . 3.0 Cg_endo -83.85 136.87 7.33 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.5 2.133 . . . . 73.329999999999998 111.838 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.33 11.09 53.0 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.566 -0.825 . . . . 33.109999999999999 111.755 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.431 ' HA ' ' H ' ' A' ' 66' ' ' SER . 86.1 m-85 -141.67 159.68 41.72 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 108.855 -0.795 . . . . 73.200000000000003 108.855 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -140.21 141.71 35.91 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.773 -0.455 . . . . 55.530000000000001 109.773 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 38.6 ttm180 -102.79 137.53 40.88 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.192 -1.04 . . . . 74.329999999999998 108.192 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 10.2 m-85 -108.79 167.52 10.01 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 107.505 -1.294 . . . . 72.5 107.505 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 . . . . . 0 C--N 1.304 -1.39 0 C-N-CA 119.489 -0.885 . . . . 73.340000000000003 111.965 -172.885 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 108.59 -0.892 . . . . 74.510000000000005 108.59 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 52.8 Cg_exo -58.95 117.8 4.59 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.064 1.842 . . . . 44.130000000000003 110.825 175.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 26.3 p -115.47 168.47 9.97 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.097 -0.502 . . . . 50.530000000000001 110.663 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 mm -123.04 119.97 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.615 -0.513 . . . . 71.239999999999995 109.615 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.11 146.06 59.91 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 110.455 -0.202 . . . . 64.409999999999997 110.455 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.59 111.79 1.27 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.121 2.547 . . . . 72.420000000000002 112.911 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.431 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 34.0 t -126.25 116.5 21.36 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.582 -0.895 . . . . 61.149999999999999 108.582 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 1.7 mp0 -60.74 -32.07 71.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.366 0.603 . . . . 73.510000000000005 111.328 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -95.62 7.11 47.22 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.771 -0.65 . . . . 74.430000000000007 112.012 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.77 167.66 14.49 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 119.578 -1.296 . . . . 72.420000000000002 114.03 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 144.07 23.23 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.111 1.365 . . . . 72.239999999999995 107.733 175.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.8 t -113.06 119.67 61.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.392 -0.596 . . . . 73.019999999999996 109.392 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -93.22 116.05 28.64 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.761 -1.57 . . . . 62.240000000000002 106.761 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.51 -158.05 7.6 Favored Glycine 0 N--CA 1.418 -2.521 0 N-CA-C 110.732 -0.947 . . . . 74.099999999999994 110.732 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.41 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 13.8 mptt -124.41 148.65 47.44 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.435 0.636 . . . . 62.140000000000001 111.948 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.6 t -111.04 130.94 63.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.549 -1.205 . . . . 71.420000000000002 111.334 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 77.5 mt -96.71 108.89 21.6 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.452 -1.314 . . . . 70.099999999999994 107.452 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.4 ptp -115.64 137.38 52.13 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.29 0.567 . . . . 74.239999999999995 112.47 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.91 25.01 7.37 Favored Glycine 0 N--CA 1.427 -1.933 0 CA-C-N 114.982 -1.008 . . . . 44.130000000000003 111.568 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.1 p -88.57 142.23 13.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 110.2 -0.296 . . . . 74.109999999999999 110.2 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -73.72 161.4 30.29 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 123.836 0.854 . . . . 75.420000000000002 112.358 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.2 m -68.87 -35.36 76.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.419 1.266 . . . . 71.299999999999997 114.419 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -63.61 -43.74 96.0 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.472 0.653 . . . . 75.230000000000004 109.986 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.584 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 9.5 mp0 -69.81 -36.31 75.53 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.776 -1.102 . . . . 75.319999999999993 109.843 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.552 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.4 tm? -60.52 -43.73 96.8 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.757 -0.46 . . . . 74.239999999999995 109.757 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -71.95 -32.27 67.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.969 0.414 . . . . 71.150000000000006 110.863 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -38.32 89.18 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.14 -0.482 . . . . 74.400000000000006 110.887 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 96.9 mt -62.23 -42.03 98.94 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.168 -0.678 . . . . 64.450000000000003 109.168 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -64.13 -36.06 82.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.348 -0.842 . . . . 63.109999999999999 110.417 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.66 -45.37 71.93 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.619 -0.719 . . . . 62.530000000000001 110.845 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.79 -51.45 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.918 -0.583 . . . . 73.230000000000004 112.368 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.94 -29.23 55.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.909 0.385 . . . . 75.209999999999994 111.607 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.62 -17.57 27.52 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 114.717 0.647 . . . . 34.130000000000003 114.717 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -59.95 -31.7 70.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.837 0.351 . . . . 71.310000000000002 111.515 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.488 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 9.8 pt-20 -142.07 6.21 1.75 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.383 0.512 . . . . 71.040000000000006 112.383 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.488 ' CD2' ' HG3' ' A' ' 94' ' ' GLU . 95.4 m-85 -138.08 168.26 20.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.175 -0.466 . . . . 61.450000000000003 110.881 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -124.69 145.47 49.66 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.576 -0.898 . . . . 64.0 108.576 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -87.62 113.85 23.69 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.93 -0.767 . . . . 75.510000000000005 108.93 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.628 HG11 ' HE1' ' A' ' 117' ' ' MET . 33.6 m -125.34 161.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 116.054 -0.521 . . . . 73.420000000000002 111.477 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.0 t -98.97 136.27 39.18 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.185 -0.672 . . . . 75.450000000000003 109.185 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' A' ' 47' ' ' LEU . 29.3 m -138.7 165.18 24.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 116.397 -0.365 . . . . 75.230000000000004 110.685 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.14 120.31 6.14 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.691 -0.964 . . . . 71.150000000000006 110.691 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.41 HG22 ' HB2' ' A' ' 47' ' ' LEU . 2.7 pp -116.24 152.04 17.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 122.308 0.243 . . . . 71.409999999999997 110.719 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.7 t -113.6 131.28 65.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 110.132 -0.322 . . . . 64.140000000000001 110.132 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.47 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 11.0 mmm180 -58.61 124.41 19.57 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.778 0.831 . . . . 74.310000000000002 109.276 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.67 8.38 12.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.926 0.87 . . . . 54.32 109.842 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.62 -66.33 0.91 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.812 -1.551 . . . . 71.409999999999997 106.812 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.427 ' HB2' ' HG3' ' A' ' 109' ' ' GLU . 16.6 m-80 -99.53 -108.55 0.2 Allowed 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.606 -0.887 . . . . 63.130000000000003 108.606 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.409 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 57.9 m -159.67 19.31 0.17 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 126.424 1.89 . . . . 73.519999999999996 106.28 175.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 107' ' ' ASN . 48.1 mt-10 -77.33 143.97 38.37 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 114.846 -1.07 . . . . 72.030000000000001 110.472 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.691 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -108.04 147.09 31.63 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.909 -0.774 . . . . 73.519999999999996 108.909 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 88.1 mtp -141.02 161.06 38.74 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 123.645 0.778 . . . . 63.229999999999997 110.333 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -112.71 120.01 40.06 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.228 -0.897 . . . . 73.310000000000002 109.328 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.2 173.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 110.106 -0.331 . . . . 74.510000000000005 110.106 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -96.6 155.01 16.95 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.128 -0.693 . . . . 61.420000000000002 109.128 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.8 t -155.36 172.0 18.94 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.509 -1.663 . . . . 74.219999999999999 106.509 174.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -111.83 119.69 39.45 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.948 -0.76 . . . . 64.319999999999993 108.948 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.628 ' HE1' HG11 ' A' ' 98' ' ' VAL . 42.5 ttp -105.8 145.51 31.08 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.029 -0.987 . . . . 74.299999999999997 110.196 -173.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.548 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 71.8 t-105 -72.21 124.81 25.82 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.899 -1.149 . . . . 72.209999999999994 107.899 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -72.36 -41.27 65.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 114.797 -1.092 . . . . 75.310000000000002 111.603 -171.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -81.22 102.5 10.39 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-O 121.147 0.498 . . . . 61.140000000000001 109.947 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -75.03 -28.41 60.45 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.347 0.499 . . . . 74.420000000000002 112.347 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.3 93.86 4.78 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.588 -0.893 . . . . 41.009999999999998 108.588 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -137.93 126.13 14.22 Favored Pre-proline 0 C--N 1.308 -1.212 0 C-N-CA 121.041 -0.263 . . . . 75.140000000000001 110.788 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -87.5 -9.67 5.74 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.515 2.143 . . . . 73.5 113.819 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -80.96 -34.9 32.82 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 120.91 0.386 . . . . 44.340000000000003 111.016 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 C--N 1.312 -1.041 0 CA-C-N 116.11 -0.495 . . . . 74.120000000000005 111.497 -178.747 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.595 ' O ' HG12 ' A' ' 144' ' ' ILE . 6.0 ttpm? . . . . . 0 CA--C 1.512 -0.496 0 N-CA-C 109.559 -0.534 . . . . 75.540000000000006 109.559 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 38.7 ttpt -57.28 -31.26 65.44 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.647 -0.706 . . . . 70.129999999999995 111.499 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.5 -37.16 82.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.453 -0.34 . . . . 73.0 110.381 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.622 ' O ' HG22 ' A' ' 146' ' ' THR . 92.9 m-85 -76.76 -39.23 52.39 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 109.029 -0.73 . . . . 73.129999999999995 109.029 175.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.2 mm -60.22 -33.03 52.11 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.859 0 CA-C-N 115.216 -0.902 . . . . 74.439999999999998 110.953 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 148' ' ' LYS . 63.1 mm-40 -51.36 -39.27 56.75 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.246 0.832 . . . . 72.549999999999997 113.246 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 143' ' ' PHE . 15.2 t -74.9 -29.06 60.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 119.675 -0.81 . . . . 62.119999999999997 109.493 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 150' ' ' ILE . 22.7 m-85 -76.41 -35.12 58.75 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 116.121 -0.491 . . . . 72.349999999999994 112.239 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.574 ' HG3' HG22 ' A' ' 144' ' ' ILE . 57.3 mtpt -55.66 -31.07 62.05 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 123.96 0.787 . . . . 73.530000000000001 112.107 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 14.1 ptmm? -75.05 -34.57 61.86 Favored 'General case' 0 C--O 1.206 -1.198 0 C-N-CA 118.209 -1.397 . . . . 75.340000000000003 109.723 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 147' ' ' PHE . 64.8 mt -55.52 -29.62 24.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 C-N-CA 124.819 1.247 . . . . 51.240000000000002 112.884 -176.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -54.82 -26.01 32.2 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.503 0.557 . . . . 73.319999999999993 112.503 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 149' ' ' LYS . 13.9 pt-20 -57.08 -40.96 77.93 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.084 0.469 . . . . 72.109999999999999 110.896 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 50.6 t -71.79 -31.83 67.0 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.556 0.693 . . . . 74.209999999999994 109.771 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.436 -1.133 0 CA-C-N 115.069 -0.969 . . . . 72.409999999999997 111.292 -175.469 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.438 -1.061 0 CA-C-O 121.131 0.491 . . . . 72.25 110.286 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.433 ' O ' HG12 ' A' ' 79' ' ' VAL . 35.7 m-70 -117.39 161.43 19.57 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.341 -0.845 . . . . 72.340000000000003 110.606 -173.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -122.65 127.1 48.9 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.471 -0.937 . . . . 72.230000000000004 108.471 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.0 t -125.86 137.94 56.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 116.878 -0.147 . . . . 63.0 110.668 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.538 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.0 t80 -94.72 122.42 37.31 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.589 -1.263 . . . . 73.239999999999995 107.589 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG11 ' HB2' ' A' ' 26' ' ' PHE . 27.2 m -111.43 123.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.738 0.78 . . . . 74.430000000000007 111.598 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -77.85 -40.43 40.29 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.869 -1.059 . . . . 65.219999999999999 113.46 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.84 -40.66 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 118.814 -1.66 . . . . 74.430000000000007 113.539 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.6 m -58.02 -27.79 63.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.736 0.643 . . . . 74.439999999999998 112.736 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.463 ' O ' HD11 ' A' ' 32' ' ' ILE . 40.9 m-85 -134.5 28.37 3.66 Favored 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 110.053 -0.351 . . . . 74.439999999999998 110.053 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -78.04 -19.11 54.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.103 0.779 . . . . 73.430000000000007 113.103 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 31' ' ' VAL . 23.3 t70 -105.47 130.43 23.09 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.193 -0.299 . . . . 62.140000000000001 110.193 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HB3' HG21 ' A' ' 39' ' ' THR . 23.3 Cg_endo -61.92 -25.57 78.17 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.941 2.427 . . . . 60.219999999999999 114.742 -175.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.06 -43.15 93.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.064 0.459 . . . . 73.310000000000002 110.598 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 28' ' ' ASP . 23.4 m -71.28 -28.1 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 115.753 -0.658 . . . . 74.400000000000006 110.715 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.526 HG23 HD21 ' A' ' 36' ' ' LEU . 48.4 mm -62.98 -51.69 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 122.699 0.4 . . . . 74.140000000000001 111.631 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -57.73 -32.61 67.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.168 0.509 . . . . 60.229999999999997 111.641 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.0 t -82.02 -43.74 19.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.932 -0.576 . . . . 45.520000000000003 112.034 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.474 ' HE1' HD23 ' A' ' 87' ' ' LEU . 6.7 tmm? -70.97 -37.35 72.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.631 -0.259 . . . . 45.509999999999998 110.562 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 32' ' ' ILE 0.261 0.6 OUTLIER -115.05 -67.26 1.01 Allowed 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.903 -0.719 . . . . 72.409999999999997 112.378 176.797 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.1 t70 172.11 -50.01 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.092 0.472 . . . . 73.319999999999993 109.932 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -123.98 160.55 27.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.934 -0.576 . . . . 73.310000000000002 109.671 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.462 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 32.1 m -107.28 106.19 57.72 Favored Pre-proline 0 N--CA 1.436 -1.135 0 O-C-N 123.388 0.43 . . . . 70.25 110.441 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.58 152.25 63.57 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 123.394 2.73 . . . . 74.150000000000006 110.155 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -56.43 129.12 39.27 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.094 0.473 . . . . 73.549999999999997 110.174 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 32.2 mt -103.62 136.22 37.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.149 -0.686 . . . . 42.020000000000003 109.149 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.506 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 15.0 p -129.86 146.99 33.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 116.021 -0.536 . . . . 62.509999999999998 110.323 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -75.69 124.25 26.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.351 -0.981 . . . . 72.219999999999999 108.351 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.4 158.66 43.57 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.615 0.722 . . . . 75.219999999999999 112.33 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.1 m -118.5 132.03 56.23 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.129 -0.941 . . . . 75.209999999999994 109.34 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.3 tp -104.4 101.85 29.82 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 109.385 -0.598 . . . . 63.229999999999997 109.385 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.1 138.13 9.99 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.702 2.268 . . . . 73.239999999999995 111.814 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.04 9.45 53.95 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.892 -0.67 . . . . 25.039999999999999 111.721 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.507 ' HE2' ' SD ' ' A' ' 117' ' ' MET . 93.3 m-85 -143.12 152.75 42.17 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.773 -0.825 . . . . 71.109999999999999 108.773 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -139.98 147.09 39.95 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.993 -0.743 . . . . 60.32 108.993 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -100.26 132.23 45.75 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.153 -0.684 . . . . 62.240000000000002 109.153 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.9 m-30 -107.71 134.95 49.94 Favored 'General case' 0 CA--C 1.472 -2.032 0 N-CA-C 107.195 -1.409 . . . . 74.5 107.195 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 . . . . . 0 C--N 1.291 -1.977 0 C-N-CA 119.195 -1.002 . . . . 75.010000000000005 112.368 -178.535 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 47.7 m-85 . . . . . 0 N--CA 1.429 -1.516 0 N-CA-C 107.318 -1.364 . . . . 73.439999999999998 107.318 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 34.8 Cg_exo -63.71 94.14 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.957 1.772 . . . . 73.099999999999994 111.554 174.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 14.3 p -97.0 167.46 11.06 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 124.604 1.161 . . . . 71.200000000000003 112.3 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 71' ' ' VAL . 49.5 mm -104.48 139.68 24.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 N-CA-C 108.642 -0.873 . . . . 74.120000000000005 108.642 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.68 152.66 60.18 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.499 -0.926 . . . . 72.409999999999997 108.499 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.492 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 27.8 Cg_endo -65.54 123.51 11.53 Favored 'Trans proline' 0 C--O 1.249 1.032 0 C-N-CA 122.494 2.129 . . . . 72.510000000000005 112.063 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 t -125.14 142.07 51.72 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.364 -0.976 . . . . 71.129999999999995 108.364 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.04 -36.38 66.92 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.255 -0.578 . . . . 64.510000000000005 111.652 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -109.49 2.81 20.73 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.396 -0.365 . . . . 73.319999999999993 111.755 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.11 156.87 21.42 Favored Glycine 0 N--CA 1.434 -1.484 0 C-N-CA 120.067 -1.063 . . . . 52.420000000000002 114.374 -174.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 142.66 29.72 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 124.574 1.15 . . . . 55.25 108.056 175.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.446 HG21 HD12 ' A' ' 63' ' ' ILE . 54.6 t -113.65 133.68 58.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 109.513 -0.551 . . . . 60.32 109.513 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -107.28 116.76 32.5 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.279 -1.008 . . . . 74.140000000000001 108.279 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.449 ' C ' ' HD3' ' A' ' 74' ' ' LYS . . . -148.95 -154.86 6.48 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 110.987 -0.845 . . . . 65.209999999999994 110.987 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.449 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 3.2 mppt? -122.82 150.45 42.82 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 113.218 0.821 . . . . 64.340000000000003 113.218 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 44.1 t -110.94 129.16 66.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 114.091 -1.413 . . . . 73.129999999999995 111.207 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.6 mt -95.7 109.28 21.58 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.078 -1.452 . . . . 72.340000000000003 107.078 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.9 ptp -113.3 127.43 56.15 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.651 0.739 . . . . 75.329999999999998 112.36 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 111.36 28.88 3.63 Favored Glycine 0 C--N 1.292 -1.874 0 CA-C-N 114.678 -1.146 . . . . 55.140000000000001 111.668 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 83' ' ' GLU . 13.0 p -92.2 132.63 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 109.349 -0.612 . . . . 64.25 109.349 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -73.54 158.56 34.62 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 110.0 -0.37 . . . . 52.530000000000001 110.0 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.2 m -62.17 -35.36 78.59 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.265 0.468 . . . . 55.329999999999998 112.265 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.86 -36.45 84.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.22 0.533 . . . . 63.439999999999998 110.673 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.472 ' HB2' HG22 ' A' ' 79' ' ' VAL . 4.4 mm-40 -77.49 -30.54 53.13 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 108.056 -1.09 . . . . 74.319999999999993 108.056 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.8 -41.7 95.59 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.82 -0.807 . . . . 71.120000000000005 108.82 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.22 -29.76 70.08 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.614 -0.721 . . . . 74.420000000000002 110.047 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -72.2 -42.16 66.13 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.771 -0.65 . . . . 60.329999999999998 111.663 177.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.474 HD23 ' HE1' ' A' ' 35' ' ' MET . 91.0 mt -61.67 -41.95 98.25 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.193 -1.04 . . . . 71.200000000000003 108.193 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.434 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 30.9 t70 -65.58 -30.9 71.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.897 -1.501 . . . . 64.420000000000002 110.813 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.65 -41.69 53.43 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.934 -0.575 . . . . 61.32 110.529 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.0 t -72.99 -58.31 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 113.013 0.746 . . . . 72.409999999999997 113.013 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.68 -23.6 45.57 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.933 -0.479 . . . . 73.540000000000006 111.847 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.41 -15.82 18.36 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 114.941 -1.027 . . . . 64.430000000000007 115.246 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -57.0 -41.72 78.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.381 0.59 . . . . 73.299999999999997 111.618 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -132.42 -0.83 3.57 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.84 0.682 . . . . 61.200000000000003 112.84 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -121.53 167.45 12.85 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.281 -1.007 . . . . 73.519999999999996 108.281 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HB3' HD11 ' A' ' 119' ' ' ILE . 9.9 tp10 -127.84 152.35 47.93 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.308 -0.997 . . . . 74.310000000000002 108.308 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -87.84 112.59 22.64 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.776 -0.824 . . . . 53.450000000000003 108.776 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.42 158.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.823 -0.626 . . . . 73.109999999999999 110.082 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 t -96.49 132.53 41.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.411 -0.589 . . . . 51.210000000000001 109.411 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.65 167.13 24.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 116.147 -0.479 . . . . 72.120000000000005 112.063 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.62 127.14 7.57 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 110.663 -0.975 . . . . 71.430000000000007 110.663 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -119.98 163.79 17.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 122.538 0.335 . . . . 70.239999999999995 111.094 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 59.1 t -120.33 126.37 75.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.039 -0.726 . . . . 73.219999999999999 109.039 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.701 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 22.4 mtp180 -73.16 116.11 13.31 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.915 -0.584 . . . . 63.049999999999997 110.234 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -79.08 -0.84 33.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 122.451 1.12 . . . . 75.319999999999993 108.746 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -67.27 -30.46 70.34 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.319 -1.764 . . . . 71.439999999999998 109.193 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.456 ' HB2' ' H ' ' A' ' 108' ' ' SER . 13.8 m-80 -137.41 -95.99 0.21 Allowed 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.238 -1.023 . . . . 74.409999999999997 108.238 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 67.6 m -175.83 27.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.319 -2.104 . . . . 62.509999999999998 105.319 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.25 143.92 41.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.141 -0.936 . . . . 72.120000000000005 111.633 -170.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 21.9 ptmt -96.19 148.88 22.26 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.879 -0.6 . . . . 74.150000000000006 111.616 -176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.701 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.2 mtp -143.65 161.05 39.54 Favored 'General case' 0 CA--C 1.484 -1.576 0 C-N-CA 123.83 0.852 . . . . 73.120000000000005 111.325 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.8 129.79 54.6 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 114.636 -1.165 . . . . 72.540000000000006 108.932 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.538 HG21 ' HB2' ' A' ' 21' ' ' PHE . 34.1 m -143.93 174.52 4.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.865 -0.791 . . . . 51.100000000000001 108.865 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -115.34 152.71 32.3 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.926 -0.71 . . . . 73.120000000000005 109.631 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 t -148.3 172.89 13.65 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.534 -0.543 . . . . 40.0 109.534 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -117.42 109.16 16.43 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.07 -0.514 . . . . 74.129999999999995 109.826 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.507 ' SD ' ' HE2' ' A' ' 50' ' ' PHE . 24.2 ptt? -111.56 156.6 21.5 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.622 -0.717 . . . . 74.409999999999997 109.677 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -69.4 116.62 10.03 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.284 -1.376 . . . . 75.340000000000003 107.284 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.481 HD11 ' HB3' ' A' ' 96' ' ' GLU . 47.7 mm -73.7 -41.53 54.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 113.009 0.744 . . . . 63.329999999999998 113.009 -171.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -61.77 -35.38 77.98 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.186 -0.672 . . . . 74.409999999999997 109.186 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.264 9.7 ptpp? 58.16 -37.04 0.05 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 127.721 2.408 . . . . 75.329999999999998 115.908 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.01 85.69 4.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.551 0.691 . . . . 63.340000000000003 110.952 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -132.25 105.96 13.49 Favored Pre-proline 0 CA--C 1.486 -1.501 0 CA-C-N 115.067 -0.97 . . . . 75.230000000000004 110.507 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.42 -17.54 58.31 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.66 2.24 . . . . 72.329999999999998 110.801 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.47 -36.51 78.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.023 -0.989 . . . . 72.329999999999998 111.159 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.751 0 C-N-CA 120.452 -0.499 . . . . 73.239999999999995 111.311 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.569 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.0 ttpt . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 108.79 -0.819 . . . . 74.209999999999994 108.79 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 64.6 tttp -59.53 -35.47 74.26 Favored 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.54 -0.755 . . . . 75.219999999999999 112.153 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -55.6 -47.99 75.62 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.359 1.076 . . . . 54.009999999999998 108.548 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -66.57 -39.64 88.56 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.273 -1.785 . . . . 73.230000000000004 108.993 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 140' ' ' LYS . 28.6 mm -72.56 -40.95 63.49 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.332 0 CA-C-N 116.133 -0.485 . . . . 65.510000000000005 110.292 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 28.2 mm-40 -61.78 -34.08 75.23 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.972 0.415 . . . . 70.319999999999993 110.017 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.537 ' O ' HG13 ' A' ' 150' ' ' ILE . 86.9 m -65.39 -48.18 73.76 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.595 -0.73 . . . . 75.519999999999996 109.261 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -70.77 -30.12 66.53 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.155 0.798 . . . . 70.340000000000003 113.155 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 ttpt -55.66 -45.77 77.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.588 -1.264 . . . . 71.310000000000002 107.588 175.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.53 -34.89 70.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.014 -1.448 . . . . 62.009999999999998 110.307 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 146' ' ' THR . 80.2 mt -67.4 -37.22 78.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.28 -0.418 . . . . 71.329999999999998 110.285 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.14 -33.09 74.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 75.150000000000006 110.129 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 15.3 mm-40 -73.2 -31.07 63.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.077 0.465 . . . . 74.420000000000002 110.02 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 51.3 t -69.06 -31.81 70.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.654 -0.703 . . . . 64.439999999999998 109.787 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 34.7 mmtp . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 108.967 -0.753 . . . . 73.200000000000003 108.967 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 N--CA 1.436 -1.169 0 N-CA-C 108.186 -1.042 . . . . 73.120000000000005 108.186 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.497 ' ND1' ' HG ' ' A' ' 84' ' ' LEU . 52.8 m-70 -114.8 160.28 19.62 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.07 0.462 . . . . 74.430000000000007 112.16 -171.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 21.6 p30 -131.84 125.64 32.3 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.283 -1.326 . . . . 65.129999999999995 110.506 174.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 65.5 t -126.3 140.58 48.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.189 -0.914 . . . . 64.420000000000002 110.17 -174.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.495 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.5 t80 -94.66 122.97 37.81 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.675 -0.861 . . . . 75.230000000000004 108.675 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -100.69 144.33 12.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 116.252 -0.431 . . . . 71.430000000000007 109.886 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -83.51 -0.19 49.19 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.967 0.728 . . . . 71.519999999999996 112.967 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.13 -22.92 4.42 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.066 -1.064 . . . . 65.430000000000007 112.169 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.1 p -58.76 -36.4 74.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.135 0.493 . . . . 73.510000000000005 112.168 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.59 ' HB3' HD11 ' A' ' 32' ' ' ILE . 53.0 m-85 -125.84 35.9 4.62 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.709 -0.678 . . . . 72.219999999999999 110.908 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -77.79 -14.97 59.42 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.052 0.453 . . . . 75.030000000000001 110.728 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.57 121.23 63.7 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.736 -0.666 . . . . 75.400000000000006 109.472 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.489 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 30.7 Cg_endo -63.98 -28.86 66.43 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.858 2.372 . . . . 64.200000000000003 114.069 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 34' ' ' VAL . 24.2 t70 -69.1 -38.12 78.77 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.49 -0.484 . . . . 75.319999999999993 110.142 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.78 -38.94 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.548 -0.751 . . . . 53.32 109.423 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.59 HD11 ' HB3' ' A' ' 26' ' ' PHE . 34.1 mm -58.46 -51.76 67.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.63 -0.713 . . . . 50.32 110.893 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -54.21 -34.27 60.19 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.236 0.458 . . . . 64.019999999999996 112.236 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 30' ' ' ASP . 47.3 t -81.03 -45.34 21.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 116.261 -0.427 . . . . 75.200000000000003 111.366 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.554 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.0 tmm? -67.21 -37.38 83.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.501 -0.318 . . . . 64.230000000000004 110.309 -173.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.485 HD21 HG23 ' A' ' 32' ' ' ILE 0.282 0.9 OUTLIER -116.24 -67.18 1.01 Allowed 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 119.188 -1.005 . . . . 74.209999999999994 112.738 176.728 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 38' ' ' ARG . 35.0 t70 174.98 -49.07 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.274 0.359 . . . . 73.219999999999999 111.364 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.426 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 20.1 mmt180 -131.11 162.73 29.22 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.257 -0.646 . . . . 64.239999999999995 109.257 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.457 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 20.4 m -102.87 112.44 65.74 Favored Pre-proline 0 N--CA 1.437 -1.115 0 O-C-N 123.26 0.35 . . . . 65.219999999999999 111.525 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.69 152.85 74.18 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.173 2.582 . . . . 65.420000000000002 109.336 170.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.54 130.96 47.29 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.131 0.491 . . . . 62.329999999999998 110.332 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 44.3 mt -114.47 138.94 42.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.583 -0.525 . . . . 74.129999999999995 109.583 -175.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.91 146.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.921 -0.77 . . . . 75.519999999999996 108.921 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.7 m -77.06 133.76 38.98 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.432 -1.321 . . . . 72.239999999999995 107.432 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.53 159.76 41.42 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.089 0.471 . . . . 45.549999999999997 111.697 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.5 m -110.51 125.27 53.15 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.327 -0.851 . . . . 64.340000000000003 110.812 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.8 tp -102.4 103.65 32.64 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 123.502 0.721 . . . . 61.130000000000003 109.307 175.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 74.2 Cg_endo -82.0 142.44 12.39 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.261 1.974 . . . . 70.340000000000003 111.535 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.74 5.75 61.15 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.978 -0.556 . . . . 63.25 112.633 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -141.86 155.93 45.54 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 122.186 -0.596 . . . . 74.140000000000001 109.76 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.434 ' HA ' ' OE1' ' A' ' 51' ' ' GLN . 4.7 tp60 -140.75 146.94 38.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.746 -0.464 . . . . 72.140000000000001 109.746 176.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 41.0 ptt180 -101.32 129.92 47.4 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.626 0.727 . . . . 62.039999999999999 111.286 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.683 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 18.3 m-85 -107.77 153.49 22.9 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.545 -1.28 . . . . 62.539999999999999 107.545 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.285 -2.215 0 N-CA-C 114.902 1.445 . . . . 74.510000000000005 114.902 -167.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 . . . . . 0 N--CA 1.44 -0.942 0 N-CA-C 107.838 -1.171 . . . . 75.349999999999994 107.838 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.683 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 20.5 Cg_exo -65.98 90.98 0.25 Allowed 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.579 1.519 . . . . 73.530000000000001 110.859 175.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 19.3 p -83.11 127.65 33.78 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 115.278 -0.874 . . . . 72.319999999999993 111.152 -174.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' MET . 49.4 mm -84.66 111.24 20.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.636 -0.711 . . . . 55.409999999999997 109.574 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.56 143.86 42.73 Favored Pre-proline 0 C--N 1.289 -2.049 0 N-CA-C 109.684 -0.487 . . . . 51.439999999999998 109.684 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.9 125.72 17.86 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.46 2.107 . . . . 64.219999999999999 112.799 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.3 t -124.58 122.3 37.18 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.099 -1.815 . . . . 60.140000000000001 106.099 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.61 -30.87 65.68 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.129 0.418 . . . . 70.450000000000003 112.129 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -136.54 77.35 1.64 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.6 0.714 . . . . 75.230000000000004 111.024 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.98 166.81 30.5 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 109.317 -1.513 . . . . 74.150000000000006 109.317 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -151.9 141.34 21.59 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 117.745 0.773 . . . . 62.399999999999999 110.541 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.07 131.45 64.67 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 109.001 -0.74 . . . . 74.340000000000003 109.001 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -107.78 115.8 30.79 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.222 -1.399 . . . . 65.420000000000002 107.222 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.65 -147.76 4.93 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.846 -0.901 . . . . 54.240000000000002 110.846 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -125.29 145.59 49.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 112.566 0.58 . . . . 74.319999999999993 112.566 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 46.8 t -110.58 124.88 67.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 114.64 -1.164 . . . . 62.43 110.502 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 67.2 mt -95.75 109.77 22.02 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.594 -1.262 . . . . 73.140000000000001 107.594 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.413 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 14.9 ptp -117.35 142.63 46.87 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.28 0.562 . . . . 65.319999999999993 111.738 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.23 29.12 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.291 -0.868 . . . . 55.329999999999998 111.195 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 83' ' ' GLU . 12.9 p -86.44 142.0 13.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 108.516 -0.92 . . . . 51.229999999999997 108.516 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -82.9 174.48 10.89 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.471 -0.492 . . . . 73.409999999999997 111.552 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.1 p -61.34 -45.26 95.16 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.75 1.018 . . . . 63.310000000000002 113.75 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.1 -36.56 84.0 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.673 0.749 . . . . 72.200000000000003 110.838 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.526 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.5 mt-10 -78.54 -28.49 46.11 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.225 -0.898 . . . . 73.219999999999999 109.432 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HG ' ' ND1' ' A' ' 18' ' ' HIS . 2.9 tm? -67.68 -41.56 83.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.862 -0.608 . . . . 75.209999999999994 109.689 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.39 -29.4 61.52 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.203 -0.453 . . . . 70.439999999999998 109.796 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 14.0 t-20 -56.45 -47.57 78.88 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.745 0.818 . . . . 74.439999999999998 110.282 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.7 mt -60.82 -33.8 73.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.39 -0.823 . . . . 63.140000000000001 111.031 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 18.8 t70 -73.06 -36.93 66.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.309 0.576 . . . . 52.140000000000001 109.589 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.77 -47.27 72.7 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.693 -0.685 . . . . 60.229999999999997 110.62 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 87' ' ' LEU . 12.2 p -72.59 -56.49 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 113.119 0.785 . . . . 52.210000000000001 113.119 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -77.54 -22.96 50.26 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.995 -0.44 . . . . 44.140000000000001 111.575 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -60.03 -17.49 44.57 Favored Glycine 0 C--O 1.221 -0.675 0 N-CA-C 115.194 0.837 . . . . 54.420000000000002 115.194 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.86 -38.36 76.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.471 0.635 . . . . 74.519999999999996 111.228 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.82 -28.47 11.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.036 0.446 . . . . 70.219999999999999 111.838 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.404 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 91.3 m-85 -124.28 170.21 11.0 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.406 0.682 . . . . 71.510000000000005 111.703 -174.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 41.0 tt0 -123.23 151.61 42.12 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.846 -0.798 . . . . 75.420000000000002 108.846 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 88' ' ' ASP . 11.2 ttm-85 -86.7 119.63 27.14 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.826 -0.805 . . . . 75.340000000000003 108.826 -175.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.482 HG11 ' CE ' ' A' ' 117' ' ' MET . 27.7 m -124.7 162.16 27.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 121.019 0.438 . . . . 73.409999999999997 111.584 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.0 t -104.01 129.19 51.6 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.302 -0.863 . . . . 71.310000000000002 108.884 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -141.79 171.44 11.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.082 0.468 . . . . 65.030000000000001 111.989 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -114.58 139.24 15.45 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.792 -1.323 . . . . 71.540000000000006 109.792 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.463 HD11 ' HE2' ' A' ' 111' ' ' MET . 2.6 pp -134.07 164.99 33.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.139 0.469 . . . . 51.240000000000002 111.109 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.2 t -129.03 131.11 68.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.396 -1.335 . . . . 71.530000000000001 107.396 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -74.16 146.3 43.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.935 0.398 . . . . 72.120000000000005 110.648 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -88.85 -8.98 53.32 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.084 -0.507 . . . . 74.040000000000006 111.326 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -79.56 -48.21 14.21 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.567 -0.288 . . . . 62.409999999999997 111.243 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.498 ' ND2' ' HG2' ' A' ' 109' ' ' GLU . 3.0 p-10 -146.6 22.18 1.3 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.699 0.629 . . . . 73.129999999999995 112.699 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m 66.88 27.45 9.0 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 115.789 1.774 . . . . 73.25 115.789 170.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.498 ' HG2' ' ND2' ' A' ' 107' ' ' ASN . 20.2 mm-40 -77.04 141.02 40.48 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.511 -0.876 . . . . 75.420000000000002 108.947 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -98.48 139.46 34.18 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.624 -0.509 . . . . 71.219999999999999 109.624 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.463 ' HE2' HD11 ' A' ' 102' ' ' ILE . 38.7 mtm -142.15 163.88 31.68 Favored 'General case' 0 CA--C 1.473 -1.989 0 CA-C-O 121.8 0.81 . . . . 51.130000000000003 111.387 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -112.24 122.99 49.3 Favored 'General case' 0 C--N 1.267 -3.003 0 CA-C-N 113.919 -1.492 . . . . 71.200000000000003 107.993 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.1 m -138.16 173.53 12.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.404 0.621 . . . . 70.519999999999996 110.881 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -104.4 150.85 24.16 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.982 -1.118 . . . . 70.430000000000007 107.982 175.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.7 t -146.83 172.23 13.98 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.404 -0.961 . . . . 74.340000000000003 108.404 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 96.5 m-85 -111.91 112.82 24.74 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.585 0.707 . . . . 73.329999999999998 109.779 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.482 ' CE ' HG11 ' A' ' 98' ' ' VAL . 12.9 tmm? -106.07 146.67 29.85 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.412 -1.267 . . . . 75.510000000000005 110.871 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 70.0 t-105 -72.8 117.3 14.34 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.309 -0.859 . . . . 74.319999999999993 110.307 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.8 mt -57.81 -41.2 79.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 113.796 -1.547 . . . . 75.319999999999993 113.004 -172.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -89.27 91.11 8.63 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 119.904 -0.718 . . . . 72.010000000000005 110.435 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.11 -30.82 71.9 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.608 -0.724 . . . . 75.120000000000005 110.417 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.37 85.95 2.22 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.879 -0.785 . . . . 51.149999999999999 108.879 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.49 122.06 28.15 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-N 115.292 -0.867 . . . . 75.120000000000005 108.769 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -84.29 0.56 9.12 Favored 'Trans proline' 0 C--N 1.328 -0.536 0 C-N-CA 122.852 2.368 . . . . 71.219999999999999 113.918 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.12 -23.81 11.82 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 119.951 -0.699 . . . . 63.43 112.271 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.8 ptt? . . . . . 0 C--N 1.317 -0.825 0 N-CA-C 112.098 0.407 . . . . 75.230000000000004 112.098 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.612 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.7 ttpt . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 120.816 0.341 . . . . 72.319999999999993 110.107 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -53.13 -36.23 60.57 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.9 1.28 . . . . 74.209999999999994 110.586 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.6 -42.41 98.24 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.113 0.483 . . . . 70.310000000000002 110.63 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -73.77 -31.77 63.47 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.341 0.591 . . . . 72.510000000000005 109.56 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.2 mm -59.75 -32.76 50.24 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.911 0 CA-C-N 115.283 -0.872 . . . . 74.010000000000005 110.551 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -61.49 -36.3 80.07 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.209 0.528 . . . . 44.229999999999997 110.99 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.8 m -72.46 -47.93 44.97 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.861 -0.792 . . . . 71.420000000000002 108.861 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.614 ' O ' ' HG2' ' A' ' 151' ' ' MET . 58.9 m-85 -66.54 -28.87 68.88 Favored 'General case' 0 C--O 1.2 -1.528 0 N-CA-C 113.454 0.909 . . . . 74.420000000000002 113.454 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -52.62 -47.63 66.88 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.973 0.909 . . . . 53.210000000000001 109.902 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -39.39 73.48 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.857 -0.794 . . . . 75.019999999999996 108.857 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.64 -52.28 42.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.179 -0.464 . . . . 63.340000000000003 111.927 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.614 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 26.5 ptt? -76.37 -40.55 50.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.927 1.084 . . . . 72.209999999999994 113.927 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -62.77 -30.24 71.3 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 112.945 0.72 . . . . 74.540000000000006 112.945 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 82.1 m -71.41 -30.06 65.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.01 0.374 . . . . 71.120000000000005 112.01 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 95.4 mttt . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 121.984 0.897 . . . . 71.310000000000002 108.752 175.545 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.434 -1.247 0 N-CA-C 108.044 -1.095 . . . . 70.430000000000007 108.044 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.416 ' CE1' HD22 ' A' ' 84' ' ' LEU . 30.4 m-70 -114.56 159.62 20.2 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 109.847 -0.427 . . . . 71.310000000000002 109.847 -170.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 18.1 p30 -130.41 133.34 46.29 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.331 -0.85 . . . . 75.129999999999995 110.518 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.84 140.31 49.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.442 -0.799 . . . . 62.140000000000001 110.223 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -94.61 122.47 37.24 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.467 -0.938 . . . . 73.319999999999993 108.467 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.47 143.01 12.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.043 0.449 . . . . 73.010000000000005 110.767 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.487 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 16.9 p90 -122.1 -1.94 9.22 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.951 1.463 . . . . 74.109999999999999 114.951 -168.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.81 -67.42 0.24 Allowed Glycine 0 C--N 1.314 -0.689 0 C-N-CA 119.329 -1.415 . . . . 55.140000000000001 112.528 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 p -58.12 -34.87 70.7 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.22 0.608 . . . . 74.329999999999998 111.7 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 26.8 m-85 -118.95 27.49 8.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.044 -0.526 . . . . 51.340000000000003 110.519 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -78.98 15.34 1.12 Allowed 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 121.963 0.887 . . . . 71.200000000000003 110.834 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -137.84 128.47 15.67 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.322 -0.992 . . . . 71.530000000000001 108.322 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.49 -31.28 87.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.787 2.324 . . . . 73.150000000000006 114.423 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.95 -37.9 82.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.292 0.567 . . . . 72.209999999999994 109.654 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.64 -38.85 83.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.176 -0.92 . . . . 74.140000000000001 109.468 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 26' ' ' PHE . 6.5 mm -62.58 -50.51 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-O 122.125 0.964 . . . . 54.520000000000003 109.91 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -54.01 -43.63 70.23 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.266 -1.788 . . . . 74.129999999999995 111.607 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.5 t -81.72 -32.44 11.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.912 -0.585 . . . . 61.310000000000002 111.936 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.453 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.7 tmm? -70.55 -37.46 74.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.989 -0.284 . . . . 64.519999999999996 110.774 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 32' ' ' ILE 0.277 0.4 OUTLIER -109.8 -71.86 0.75 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.599 0.963 . . . . 74.450000000000003 113.599 179.266 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.8 t70 176.11 -45.03 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.25 0.548 . . . . 73.010000000000005 109.838 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -120.79 176.2 5.65 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.53 -0.759 . . . . 73.329999999999998 109.487 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 m -123.03 100.68 39.63 Favored Pre-proline 0 N--CA 1.425 -1.689 0 N-CA-C 106.624 -1.621 . . . . 72.209999999999994 106.624 170.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 34.1 Cg_exo -58.71 151.57 62.61 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.833 2.355 . . . . 65.040000000000006 111.74 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.5 122.91 13.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.496 0.718 . . . . 71.519999999999996 111.167 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.58 HG12 ' HG ' ' A' ' 76' ' ' LEU . 24.0 mt -97.72 140.37 18.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.292 -0.867 . . . . 71.340000000000003 110.384 -173.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.14 145.47 35.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.794 -1.187 . . . . 75.099999999999994 107.794 172.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.9 m -81.05 123.73 28.61 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.939 -0.763 . . . . 61.25 108.939 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.17 159.14 42.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.266 0.555 . . . . 70.329999999999998 111.849 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 90.7 m -117.55 132.93 56.45 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.093 -0.958 . . . . 75.420000000000002 110.094 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.0 tp -102.56 100.94 17.5 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 123.018 0.527 . . . . 74.040000000000006 109.702 176.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 46' ' ' THR . 6.0 Cg_endo -85.98 145.22 8.69 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.581 2.187 . . . . 62.520000000000003 111.843 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.8 11.09 59.45 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 111.263 -0.735 . . . . 64.219999999999999 111.263 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -144.44 157.07 44.42 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 108.168 -1.049 . . . . 64.099999999999994 108.168 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.482 HE21 ' H ' ' A' ' 52' ' ' ARG . 28.4 tp60 -138.37 146.22 42.03 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.189 -0.671 . . . . 65.519999999999996 109.189 -177.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' A' ' 63' ' ' ILE . 38.1 ptt180 -90.36 126.69 35.95 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.963 -1.017 . . . . 71.040000000000006 111.959 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.556 ' C ' ' HE ' ' A' ' 54' ' ' ARG . 10.3 m-85 -109.92 135.75 50.3 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.127 -1.434 . . . . 64.519999999999996 107.127 174.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.556 ' HE ' ' C ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.541 0 O-C-N 122.175 -0.328 . . . . 72.209999999999994 111.823 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 . . . . . 0 C--O 1.237 0.438 0 N-CA-C 109.848 -0.427 . . . . 74.340000000000003 109.848 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 7.1 Cg_exo -73.58 86.51 1.19 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.591 1.527 . . . . 72.549999999999997 110.687 173.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 27.8 p -98.15 -178.41 4.05 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.844 -0.617 . . . . 60.219999999999999 112.126 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.487 ' CG1' ' HB2' ' A' ' 23' ' ' TYR . 47.8 mm -132.43 142.15 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.09 -1.448 . . . . 64.140000000000001 107.09 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' A' ' 118' ' ' TRP . 34.1 m -144.64 154.71 56.37 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.456 -0.942 . . . . 62.240000000000002 108.456 175.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -60.99 128.67 26.1 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.432 2.088 . . . . 74.340000000000003 112.125 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -125.79 145.3 50.27 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 110.011 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.48 -35.21 65.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.505 -0.924 . . . . 61.240000000000002 108.505 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -128.93 77.22 1.77 Allowed 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.148 -0.933 . . . . 74.400000000000006 110.797 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.59 151.0 19.83 Favored Glycine 0 N--CA 1.412 -2.936 0 CA-C-N 114.917 -1.038 . . . . 54.43 111.917 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.76 138.11 18.5 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.447 1.099 . . . . 74.319999999999993 108.501 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t -113.38 119.95 62.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 120.737 0.303 . . . . 51.439999999999998 110.615 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -91.91 116.55 29.01 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.45 -0.945 . . . . 64.219999999999999 108.45 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.11 -146.6 4.37 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.508 -0.853 . . . . 54.130000000000003 112.41 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.0 mmtm -127.77 141.56 51.55 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.724 0.297 . . . . 63.020000000000003 111.022 -175.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 47.5 t -111.52 129.51 66.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 115.913 -0.585 . . . . 75.450000000000003 110.358 173.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.58 ' HG ' HG12 ' A' ' 42' ' ' ILE . 6.5 mp -106.11 114.12 28.06 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.447 -0.797 . . . . 70.140000000000001 110.922 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 58.1 mtp -104.14 145.04 30.76 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.217 -1.356 . . . . 73.230000000000004 110.366 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.02 9.27 32.53 Favored Glycine 0 C--N 1.299 -1.519 0 C-N-CA 120.113 -1.041 . . . . 71.209999999999994 111.955 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 80' ' ' THR . 57.8 t -67.75 127.49 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.082 -0.71 . . . . 75.140000000000001 109.082 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.416 ' O ' HG12 ' A' ' 79' ' ' VAL . 65.3 p -82.17 167.62 18.52 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.388 -0.968 . . . . 60.439999999999998 108.388 176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 34.6 t -55.26 -45.63 76.08 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 117.529 0.15 . . . . 61.25 110.946 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -58.26 -42.18 85.88 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.041 0.385 . . . . 55.420000000000002 112.041 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 39.7 mt-10 -73.22 -40.63 64.56 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.467 -0.568 . . . . 74.530000000000001 109.467 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.416 HD22 ' CE1' ' A' ' 18' ' ' HIS . 33.6 tp -55.91 -50.75 69.85 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.296 0.569 . . . . 73.230000000000004 109.896 175.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 81' ' ' SER . 43.1 mt-10 -64.82 -29.13 70.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.062 -0.972 . . . . 61.149999999999999 110.251 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -44.7 64.62 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 123.804 0.842 . . . . 71.430000000000007 112.139 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 92.6 mt -62.5 -40.95 98.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.227 -1.027 . . . . 63.509999999999998 108.227 176.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.481 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 16.7 t70 -66.37 -29.29 69.44 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 114.463 -1.244 . . . . 71.230000000000004 110.886 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.0 -45.32 42.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.115 0.483 . . . . 74.329999999999998 110.398 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.2 t -72.16 -58.41 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-N 115.749 -0.66 . . . . 74.109999999999999 112.189 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.52 -24.52 42.16 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.855 0.687 . . . . 73.510000000000005 112.855 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -63.74 -16.15 58.71 Favored Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.809 -0.632 . . . . 43.130000000000003 114.391 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -67.49 -30.39 70.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.886 0.343 . . . . 73.409999999999997 111.685 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -127.14 -0.25 6.46 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.022 0.379 . . . . 72.409999999999997 112.022 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -132.7 168.18 18.78 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.112 0.565 . . . . 74.230000000000004 110.332 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -124.56 148.71 47.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.533 -0.543 . . . . 74.030000000000001 109.533 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 -88.13 113.45 23.76 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.595 -0.891 . . . . 54.219999999999999 108.595 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.8 m -115.84 161.41 14.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 116.28 -0.418 . . . . 73.219999999999999 111.805 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.6 t -107.68 124.7 50.37 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.173 -1.047 . . . . 50.119999999999997 108.173 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.21 170.87 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 116.121 -0.491 . . . . 74.120000000000005 111.285 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.91 118.78 4.85 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 111.052 -0.819 . . . . 64.239999999999995 111.052 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.7 pp -111.01 165.05 6.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 110.031 -0.359 . . . . 64.540000000000006 110.031 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.3 t -122.68 124.68 71.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.519 -0.548 . . . . 72.099999999999994 109.519 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -72.66 121.4 19.72 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.177 -0.92 . . . . 74.120000000000005 110.722 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.19 -23.59 65.7 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.611 0.765 . . . . 70.5 111.945 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -64.42 -57.65 8.69 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.311 0.485 . . . . 75.549999999999997 112.311 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -127.05 7.41 6.6 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.086 0.773 . . . . 71.420000000000002 113.086 -169.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.2 t 71.46 12.23 6.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.058 0.943 . . . . 74.430000000000007 112.418 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -82.17 147.03 29.24 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.058 0.456 . . . . 75.109999999999999 111.231 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -92.02 147.4 22.99 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.421 -0.809 . . . . 74.099999999999994 110.094 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.45 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 89.1 mtp -136.22 160.38 38.85 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.378 -0.828 . . . . 74.150000000000006 109.524 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.17 117.03 33.06 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 115.534 -0.757 . . . . 60.030000000000001 109.603 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.3 m -131.68 173.21 15.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 116.128 -0.487 . . . . 73.239999999999995 110.186 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -106.1 149.59 26.6 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.089 -0.708 . . . . 74.439999999999998 109.089 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -153.15 172.88 16.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.977 -0.749 . . . . 70.140000000000001 108.977 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -119.95 109.76 15.91 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.288 0.566 . . . . 73.319999999999993 110.623 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -106.71 157.16 17.93 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.178 -0.919 . . . . 74.239999999999995 108.719 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 70.7 t-105 -67.99 143.51 55.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.211 -0.663 . . . . 73.219999999999999 109.211 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.6 mm -72.44 -42.33 64.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 113.499 0.925 . . . . 61.299999999999997 113.499 -170.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -88.9 -41.17 12.59 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 114.055 1.132 . . . . 73.519999999999996 114.055 -171.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.418 ' H ' ' HD1' ' A' ' 118' ' ' TRP 0.407 0.0 OUTLIER 56.12 1.57 0.07 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.56 2.43 . . . . 75.409999999999997 117.56 179.621 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.82 9.93 28.78 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.982 -0.747 . . . . 64.549999999999997 108.982 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.435 ' CG ' ' HE1' ' A' ' 118' ' ' TRP . 2.9 m-20 -68.13 123.44 87.31 Favored Pre-proline 0 C--N 1.312 -1.023 0 C-N-CA 124.715 1.206 . . . . 72.040000000000006 111.4 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.7 -7.3 10.56 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.411 2.074 . . . . 74.519999999999996 112.18 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.89 -2.9 56.59 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.238 0.829 . . . . 63.299999999999997 113.238 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 25.7 ptt? . . . . . 0 C--N 1.308 -1.205 0 N-CA-C 108.67 -0.863 . . . . 72.310000000000002 108.67 175.233 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.551 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.5 ttpt . . . . . 0 C--O 1.206 -1.187 0 N-CA-C 109.679 -0.489 . . . . 74.019999999999996 109.679 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -52.78 -31.75 40.11 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.015 0.926 . . . . 72.140000000000001 112.241 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -66.05 -40.31 90.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.854 0.835 . . . . 73.5 109.354 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 146' ' ' THR . 23.9 t80 -76.29 -32.23 58.67 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.57 -1.195 . . . . 75.340000000000003 108.328 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.1 mm -59.05 -31.99 46.88 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.486 0 CA-C-N 114.731 -1.122 . . . . 70.200000000000003 111.815 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -52.07 -45.18 64.67 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.124 0.42 . . . . 64.439999999999998 111.806 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 143' ' ' PHE . 15.1 t -79.14 -29.89 43.36 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.564 0.697 . . . . 72.299999999999997 109.824 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -75.63 -30.33 59.45 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.397 -0.819 . . . . 74.510000000000005 110.502 -173.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -58.24 -36.93 73.93 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.603 1.161 . . . . 75.019999999999996 109.845 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -74.34 -38.79 63.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.103 0.477 . . . . 75.099999999999994 110.025 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 72.3 mt -63.61 -39.93 87.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.644 -0.707 . . . . 71.099999999999994 109.47 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.4 ttt -60.12 -31.68 70.29 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 124.267 1.027 . . . . 73.400000000000006 111.493 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.93 -36.93 85.96 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.476 0.655 . . . . 73.109999999999999 109.765 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.82 -34.38 69.29 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.222 -0.899 . . . . 75.439999999999998 110.227 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.629 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 9.7 mmpt? . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 31.140000000000001 111.884 -176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.415 -2.186 0 N-CA-C 109.476 -0.564 . . . . 61.310000000000002 109.476 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.558 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.7 m-70 -114.86 160.6 19.29 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 115.428 -0.805 . . . . 55.299999999999997 109.851 -173.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 27.2 p-10 -131.08 125.08 32.24 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.647 0.737 . . . . 70.420000000000002 110.617 176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.28 142.82 40.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.156 -0.929 . . . . 64.319999999999993 109.944 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.414 ' HB2' HG21 ' A' ' 113' ' ' VAL . 85.9 t80 -95.07 123.23 38.45 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.728 -0.842 . . . . 72.430000000000007 108.728 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -102.59 137.79 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.659 -0.497 . . . . 73.010000000000005 109.659 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -87.62 -28.39 21.92 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.516 0.932 . . . . 74.209999999999994 113.516 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.29 -20.81 0.18 Allowed Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 118.917 -1.611 . . . . 71.230000000000004 113.108 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.7 p -63.65 -28.48 69.94 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.147 0.499 . . . . 63.310000000000002 111.845 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.57 ' HB3' HD11 ' A' ' 32' ' ' ILE . 78.5 m-85 -139.9 57.12 1.62 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.531 0.732 . . . . 75.010000000000005 109.232 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -88.86 -21.44 23.68 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.354 0.501 . . . . 53.450000000000003 112.354 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.602 ' O ' HG22 ' A' ' 31' ' ' VAL . 24.1 t70 -95.28 129.25 35.76 Favored Pre-proline 0 C--N 1.303 -1.424 0 CA-C-N 116.585 -0.28 . . . . 65.510000000000005 110.576 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.24 -25.04 57.69 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.694 2.263 . . . . 50.240000000000002 113.392 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.44 -30.0 62.92 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.536 -0.727 . . . . 63.310000000000002 110.965 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 28' ' ' ASP . 18.4 m -72.44 -28.3 28.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.256 -0.646 . . . . 64.439999999999998 109.256 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.57 HD11 ' HB3' ' A' ' 26' ' ' PHE . 49.7 mm -64.31 -40.41 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.697 -0.683 . . . . 73.319999999999993 110.588 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -61.44 -30.15 70.4 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.148 0.499 . . . . 74.219999999999999 111.002 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.36 -50.79 15.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.812 -0.631 . . . . 64.129999999999995 110.291 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -67.63 -35.71 79.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.728 -0.669 . . . . 51.340000000000003 110.121 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.3 mt -103.65 -77.31 0.57 Allowed 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.287 0.565 . . . . 73.030000000000001 109.749 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.4 t70 162.57 -30.15 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 125.533 1.533 . . . . 72.409999999999997 107.287 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -146.58 159.11 43.86 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 114.648 -1.16 . . . . 74.120000000000005 109.722 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.3 m -107.52 120.52 47.23 Favored Pre-proline 0 N--CA 1.426 -1.671 0 O-C-N 123.573 0.546 . . . . 53.200000000000003 110.83 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -65.79 151.58 83.93 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.641 2.227 . . . . 75.340000000000003 109.259 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.7 130.26 45.61 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 122.144 0.973 . . . . 51.130000000000003 112.976 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 47.5 mt -103.39 139.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.041 0 CA-C-N 113.973 -1.467 . . . . 74.140000000000001 110.462 -174.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 13.5 p -126.34 146.45 32.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 107.79 -1.189 . . . . 45.240000000000002 107.79 172.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 12.0 m -76.27 125.46 29.22 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 106.429 -1.693 . . . . 74.430000000000007 106.429 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -139.64 151.31 45.86 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.528 -0.869 . . . . 65.230000000000004 113.339 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -115.0 125.93 54.17 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.589 -1.187 . . . . 72.420000000000002 109.491 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 tp -98.7 102.78 15.87 Favored Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 123.49 0.716 . . . . 64.409999999999997 109.594 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 73.5 Cg_endo -81.06 141.38 13.04 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.197 1.931 . . . . 64.340000000000003 111.942 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.7 10.91 57.42 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.609 -0.805 . . . . 61.539999999999999 112.1 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 81.0 m-85 -139.82 163.21 33.22 Favored 'General case' 0 C--O 1.2 -1.5 0 N-CA-C 108.719 -0.845 . . . . 65.319999999999993 108.719 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -138.39 143.59 39.85 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.303 0.573 . . . . 75.120000000000005 109.82 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.64 124.75 35.32 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.893 -1.521 . . . . 72.420000000000002 106.893 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -109.45 147.76 32.31 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.13 -0.693 . . . . 51.539999999999999 109.13 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.515 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 3.8 tmt_? . . . . . 0 N--CA 1.414 -2.25 0 N-CA-C 108.961 -0.755 . . . . 74.230000000000004 108.961 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 110.718 -0.104 . . . . 74.040000000000006 110.718 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' A' ' 54' ' ' ARG . 23.3 Cg_exo -69.63 96.98 0.6 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.703 2.268 . . . . 73.310000000000002 109.871 171.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 24.5 p -92.73 -179.42 5.15 Favored 'General case' 0 C--O 1.253 1.244 0 N-CA-C 113.422 0.897 . . . . 73.25 113.422 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.6 mm -131.87 120.78 45.52 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 108.146 -1.057 . . . . 73.219999999999999 108.146 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.06 149.35 73.48 Favored Pre-proline 0 C--N 1.313 -1.017 0 N-CA-C 110.208 -0.293 . . . . 72.019999999999996 110.208 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 25.3 Cg_endo -63.23 119.39 6.45 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.107 2.538 . . . . 74.129999999999995 113.435 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.4 t -125.91 131.28 52.35 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.792 -0.818 . . . . 65.310000000000002 108.792 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.425 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . 42.6 mt-10 -66.19 -34.48 78.12 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.144 0.497 . . . . 73.530000000000001 110.485 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' A' ' 67' ' ' GLU . 3.2 mppt? -102.49 23.87 11.25 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.443 -0.799 . . . . 65.010000000000005 111.331 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.94 165.67 23.39 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 118.863 -1.636 . . . . 44.450000000000003 114.209 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.25 145.75 24.88 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 124.682 1.193 . . . . 71.329999999999998 108.596 174.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.4 t -113.02 125.11 70.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.695 -0.483 . . . . 73.439999999999998 109.695 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -95.86 116.55 29.08 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.288 -1.004 . . . . 74.319999999999993 108.288 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.22 -152.43 5.63 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 110.879 -0.889 . . . . 62.450000000000003 110.879 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.446 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 34.7 mmtp -129.03 143.92 51.02 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 116.785 0.293 . . . . 70.109999999999999 110.28 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 47.3 t -110.08 127.52 66.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 120.834 0.349 . . . . 42.539999999999999 110.794 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 70.7 mt -95.48 104.25 16.15 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.07 -1.085 . . . . 71.109999999999999 108.07 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.2 ptp -113.55 147.7 37.48 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.825 -0.435 . . . . 71.209999999999994 109.825 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.39 13.55 55.5 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.327 -1.416 . . . . 63.210000000000001 110.01 -172.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.4 p -86.76 131.6 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 N-CA-C 109.007 -0.738 . . . . 65.209999999999994 109.007 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.484 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 3.2 m -74.44 159.73 31.92 Favored 'General case' 0 N--CA 1.409 -2.484 0 N-CA-C 108.947 -0.76 . . . . 75.530000000000001 108.947 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.8 p -56.85 -34.86 68.21 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.614 0.766 . . . . 71.019999999999996 111.829 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.09 -46.04 79.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.574 -0.285 . . . . 73.540000000000006 111.691 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.532 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 1.8 mp0 -70.26 -31.04 68.24 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.623 -0.51 . . . . 73.519999999999996 109.623 175.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.4 tp -58.71 -51.87 68.11 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.202 0.525 . . . . 52.109999999999999 109.996 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.59 -28.74 67.21 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.448 -0.796 . . . . 64.129999999999995 110.309 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.514 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -65.69 -47.51 75.19 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 108.65 -0.87 . . . . 54.329999999999998 108.65 177.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.2 mt -61.13 -46.43 90.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.972 -0.751 . . . . 74.010000000000005 108.972 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.53 -29.75 70.79 Favored 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 114.46 -1.245 . . . . 75.209999999999994 111.162 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.18 -40.47 59.38 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.082 -0.508 . . . . 64.420000000000002 110.848 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 86' ' ' ASN . 59.1 t -72.82 -49.33 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 112.308 0.485 . . . . 73.319999999999993 112.308 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -79.92 -27.91 39.84 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 112.859 0.689 . . . . 45.310000000000002 112.859 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.81 -21.29 36.19 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 119.585 2.594 . . . . 53.299999999999997 119.585 -168.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -71.23 -35.5 71.5 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 119.505 1.653 . . . . 71.019999999999996 113.814 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -120.44 -0.03 10.43 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.836 -0.745 . . . . 63.329999999999998 112.822 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -130.49 159.01 38.37 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.615 0.366 . . . . 75.109999999999999 110.072 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -123.05 137.15 55.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.869 0.366 . . . . 71.409999999999997 110.582 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -87.41 114.51 24.08 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.814 -0.63 . . . . 64.140000000000001 110.653 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.448 HG11 ' CE ' ' A' ' 117' ' ' MET . 35.9 m -121.27 161.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.528 -0.76 . . . . 75.010000000000005 111.679 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 p -92.45 123.04 35.47 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.724 -0.671 . . . . 74.420000000000002 110.988 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.59 172.41 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 112.86 0.689 . . . . 61.299999999999997 112.86 -175.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -116.14 136.36 12.83 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.173 -0.771 . . . . 74.319999999999993 111.173 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.416 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 2.8 pp -126.78 160.99 34.31 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 C-N-CA 123.373 0.669 . . . . 64.349999999999994 111.322 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 48.2 t -117.17 129.96 72.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.439 -0.578 . . . . 73.400000000000006 109.439 177.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.591 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 19.0 mtp180 -73.38 116.54 14.06 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 122.805 0.442 . . . . 72.239999999999995 110.206 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 39.5 mt-10 -73.81 -20.48 60.45 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.719 -0.673 . . . . 72.140000000000001 110.019 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -73.93 -16.6 61.09 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 112.461 0.541 . . . . 73.430000000000007 112.461 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.406 ' CG ' ' H ' ' A' ' 108' ' ' SER . 33.0 p-10 -138.32 -83.49 0.3 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.238 -0.585 . . . . 64.540000000000006 111.048 173.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.406 ' H ' ' CG ' ' A' ' 107' ' ' ASN . 73.1 m 177.49 -13.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.266 1.427 . . . . 62.399999999999999 111.18 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -77.98 149.34 34.12 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 113.157 0.799 . . . . 64.420000000000002 113.157 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 62.7 pttt -103.87 147.2 27.6 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.53 -0.759 . . . . 74.400000000000006 110.211 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.591 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 89.8 mtp -139.24 162.24 35.48 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.578 0.704 . . . . 73.310000000000002 112.234 -175.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.24 130.89 46.41 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 114.349 -1.296 . . . . 64.349999999999994 109.359 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' ND2' ' A' ' 19' ' ' ASN . 35.8 m -143.41 175.86 3.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 123.366 0.666 . . . . 74.040000000000006 109.72 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -116.12 145.1 43.32 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.216 -1.031 . . . . 62.140000000000001 108.216 172.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.7 t -136.26 172.04 13.6 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.167 -0.679 . . . . 62.43 109.167 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -104.07 118.53 36.87 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.407 -0.59 . . . . 74.409999999999997 109.407 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.448 ' CE ' HG11 ' A' ' 98' ' ' VAL . 52.0 ttp -111.91 148.84 32.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.024 -0.989 . . . . 64.040000000000006 109.546 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -73.75 130.54 40.17 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.752 -1.203 . . . . 72.430000000000007 107.752 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.518 ' H ' HD12 ' A' ' 119' ' ' ILE . 2.5 mp -73.45 -43.85 55.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 119.91 -0.716 . . . . 73.530000000000001 111.242 -171.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.491 HD22 ' HB2' ' A' ' 123' ' ' ASP . 9.9 t30 -93.58 67.74 3.97 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.961 1.362 . . . . 74.010000000000005 107.952 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -81.73 17.15 1.54 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.485 -1.689 . . . . 63.549999999999997 114.382 -170.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -121.97 19.73 10.84 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.315 -0.624 . . . . 34.299999999999997 109.315 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.491 ' HB2' HD22 ' A' ' 120' ' ' ASN . 11.9 t70 -64.88 126.9 92.03 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.627 -0.715 . . . . 62.140000000000001 110.882 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -92.47 16.57 1.36 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 122.388 2.059 . . . . 33.43 113.604 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.77 -32.93 5.97 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.918 0.39 . . . . 73.409999999999997 110.857 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.483 1.179 0 N-CA-C 113.674 0.991 . . . . 63.109999999999999 113.674 -177.181 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.489 ' O ' HG12 ' A' ' 144' ' ' ILE . 54.0 tptt . . . . . 0 C--O 1.235 0.314 0 CA-C-O 121.027 0.442 . . . . 44.329999999999998 110.09 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 34.8 mmtp -53.88 -31.6 50.37 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 114.714 1.376 . . . . 71.239999999999995 114.714 -174.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -57.91 -46.27 85.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.932 0.873 . . . . 53.509999999999998 108.971 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -76.72 -33.49 58.17 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.73 -1.123 . . . . 72.329999999999998 109.389 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.5 mm -63.25 -34.69 68.45 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.343 0 CA-C-N 115.497 -0.774 . . . . 63.420000000000002 112.082 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 48.8 mt-10 -56.71 -34.57 67.6 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.522 0.677 . . . . 73.209999999999994 110.582 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.6 m -80.98 -47.1 14.09 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.371 -0.831 . . . . 70.439999999999998 110.703 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.536 ' O ' ' HG3' ' A' ' 151' ' ' MET . 2.8 t80 -70.96 -30.29 66.54 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.506 -0.77 . . . . 65.340000000000003 112.373 -171.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 87.5 tttt -57.9 -40.18 79.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.239 0.616 . . . . 73.430000000000007 110.289 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -64.23 -38.53 91.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.922 -0.77 . . . . 55.25 108.922 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.4 mt -68.43 -38.13 78.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.845 -1.07 . . . . 72.019999999999996 109.758 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 147' ' ' PHE . 64.2 mtt -63.54 -41.77 98.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.085 -0.507 . . . . 72.019999999999996 109.729 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 49.7 mt-10 -70.47 -33.86 71.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.847 -0.615 . . . . 71.400000000000006 110.461 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 46.4 t -62.15 -49.76 74.57 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.703 -0.681 . . . . 62.340000000000003 110.211 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 CA--C 1.513 -0.45 0 CA-C-O 121.212 0.53 . . . . 73.349999999999994 110.367 177.395 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.529 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 87.5 mt . . . . . 0 N--CA 1.429 -1.496 0 CA-C-O 120.963 0.411 . . . . 64.120000000000005 110.299 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.458 ' O ' HG12 ' A' ' 79' ' ' VAL . 44.2 m-70 -128.67 161.74 28.97 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.772 -0.649 . . . . 71.340000000000003 111.067 -172.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 9.5 p30 -120.09 128.54 53.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.493 -0.776 . . . . 61.229999999999997 112.032 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.2 t -131.78 140.79 47.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.359 -0.837 . . . . 51.210000000000001 108.947 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.494 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.8 t80 -98.58 121.61 40.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.813 -0.81 . . . . 74.510000000000005 108.813 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 74' ' ' LYS . 14.9 m -93.59 152.36 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.077 -0.51 . . . . 73.239999999999995 109.791 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -121.4 -51.66 2.07 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 115.818 1.785 . . . . 75.340000000000003 115.818 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.02 -75.11 0.15 Allowed Glycine 0 C--O 1.225 -0.442 0 C-N-CA 118.599 -1.762 . . . . 63.439999999999998 114.4 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -58.53 -36.4 73.8 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.594 0.758 . . . . 71.219999999999999 112.505 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.64 ' HB3' HD11 ' A' ' 32' ' ' ILE . 70.1 m-85 -110.51 29.9 7.29 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-O 121.14 0.495 . . . . 72.340000000000003 111.053 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.612 HE21 ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.91 -7.86 53.9 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.768 0.794 . . . . 62.0 109.648 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.503 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 13.0 t70 -114.02 134.44 22.16 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.338 -1.301 . . . . 75.409999999999997 111.01 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -72.27 -25.12 19.03 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.577 2.185 . . . . 75.299999999999997 112.938 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.503 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 17.8 t70 -64.03 -43.33 95.9 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.185 -0.322 . . . . 64.299999999999997 110.471 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.24 -29.58 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 116.238 -0.437 . . . . 72.109999999999999 110.058 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 26' ' ' PHE . 31.6 mm -65.77 -47.43 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 122.441 -0.162 . . . . 63.439999999999998 110.725 177.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -55.84 -32.7 63.84 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.831 0.348 . . . . 44.039999999999999 111.454 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.57 -36.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.471 -0.331 . . . . 65.450000000000003 111.473 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.425 ' HE1' HD23 ' A' ' 87' ' ' LEU . 50.6 ttp -63.92 -36.5 84.13 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.771 0.319 . . . . 75.209999999999994 110.21 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.638 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.1 pt? -125.18 -76.42 0.59 Allowed 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 112.918 0.71 . . . . 65.239999999999995 112.918 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.638 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 23.6 m-20 -169.77 -55.9 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 122.012 0.91 . . . . 62.200000000000003 108.606 -170.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -121.23 -177.27 3.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.105 -1.407 . . . . 75.239999999999995 110.097 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -134.97 120.59 14.21 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 115.757 -0.656 . . . . 73.239999999999995 109.629 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.61 150.87 66.7 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.793 2.328 . . . . 72.109999999999999 111.073 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -56.7 116.96 3.45 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.718 0.636 . . . . 74.209999999999994 110.037 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 49.2 mt -97.0 141.04 16.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.753 -0.658 . . . . 72.420000000000002 110.861 -174.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.25 144.78 36.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.519 -0.919 . . . . 75.109999999999999 108.519 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.5 m -76.22 122.66 24.69 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.858 -0.793 . . . . 75.019999999999996 108.858 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.36 155.94 49.38 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.708 0.766 . . . . 71.439999999999998 111.601 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.3 m -113.05 128.87 56.61 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.29 -1.323 . . . . 72.329999999999998 108.382 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 48.0 tp -103.7 99.57 16.36 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 108.863 -0.791 . . . . 71.439999999999998 108.863 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.8 146.63 10.51 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.016 1.811 . . . . 62.340000000000003 111.143 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.66 9.84 65.95 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.349 -0.929 . . . . 73.430000000000007 111.76 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.425 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 88.0 m-85 -145.36 159.3 43.27 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 107.503 -1.295 . . . . 74.219999999999999 107.503 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.461 HE21 ' H ' ' A' ' 52' ' ' ARG . 28.7 tp60 -139.3 139.63 37.37 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.059 -0.656 . . . . 72.319999999999993 109.613 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 58.7 ttp180 -99.77 135.66 40.85 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.762 -1.108 . . . . 75.219999999999999 108.429 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.649 ' HB3' ' O ' ' A' ' 126' ' ' MET . 54.1 m-85 -109.03 168.58 9.26 Favored 'General case' 0 C--N 1.277 -2.55 0 O-C-N 123.595 0.559 . . . . 74.0 109.508 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.497 -1.086 0 N-CA-C 115.097 1.517 . . . . 53.229999999999997 115.097 -174.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 . . . . . 0 N--CA 1.442 -0.847 0 N-CA-C 109.433 -0.581 . . . . 73.049999999999997 109.433 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 17.1 Cg_exo -69.25 112.41 2.98 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.878 1.719 . . . . 52.299999999999997 110.65 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 19.6 p -116.98 160.35 21.07 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 123.372 0.42 . . . . 72.109999999999999 111.666 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.503 HD12 HG21 ' A' ' 71' ' ' VAL . 46.5 mm -96.77 142.68 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 108.209 -1.034 . . . . 72.129999999999995 108.209 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 118' ' ' TRP . 21.2 m -146.02 150.73 43.11 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 107.286 -1.375 . . . . 51.100000000000001 107.286 173.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.11 124.97 13.79 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.197 1.931 . . . . 73.040000000000006 112.248 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.3 t -124.98 145.38 49.9 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.606 -0.724 . . . . 50.32 109.279 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.23 -36.85 63.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.447 0.536 . . . . 64.299999999999997 112.447 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -131.7 15.68 4.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.697 0.629 . . . . 74.310000000000002 112.697 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.63 172.78 30.34 Favored Glycine 0 C--O 1.247 0.961 0 C-N-CA 120.486 -0.864 . . . . 72.430000000000007 112.391 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -154.64 156.33 36.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.641 -0.874 . . . . 61.399999999999999 108.641 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 63' ' ' ILE . 40.4 t -124.64 137.69 56.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.131 -0.692 . . . . 74.019999999999996 109.131 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -107.95 116.12 31.38 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.518 -0.919 . . . . 73.540000000000006 108.518 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.514 ' HA2' ' OE1' ' A' ' 27' ' ' GLN . . . -141.45 -150.09 5.32 Favored Glycine 0 N--CA 1.404 -3.446 0 C-N-CA 119.918 -1.134 . . . . 72.409999999999997 112.15 -176.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.518 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 34.5 mmtp -131.3 141.54 49.97 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.712 -0.847 . . . . 73.239999999999995 108.712 -174.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.4 t -110.11 130.85 62.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 110.254 -0.276 . . . . 63.299999999999997 110.254 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 77.4 mt -95.09 105.63 17.57 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.643 -0.708 . . . . 72.230000000000004 109.421 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.532 ' HE3' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -98.65 125.45 43.94 Favored 'General case' 0 CA--C 1.479 -1.786 0 CA-C-O 121.77 0.795 . . . . 70.340000000000003 112.072 176.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 17' ' ' LEU . . . 102.46 26.39 7.3 Favored Glycine 0 C--N 1.28 -2.581 0 CA-C-N 114.363 -1.29 . . . . 71.010000000000005 112.849 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.6 p -87.78 125.16 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.471 -0.937 . . . . 73.409999999999997 108.471 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.35 164.32 26.84 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 109.386 -0.598 . . . . 64.230000000000004 109.386 -176.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 41.5 m -58.36 -36.92 74.19 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 112.831 0.678 . . . . 55.009999999999998 112.831 -176.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.74 -44.71 80.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.672 0.273 . . . . 72.200000000000003 110.447 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 1.2 mp0 -68.61 -30.53 69.28 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 116.406 -0.361 . . . . 64.530000000000001 110.24 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 81' ' ' SER . 48.4 tp -60.36 -50.25 74.36 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.287 -1.005 . . . . 74.030000000000001 108.287 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.02 -28.59 69.6 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.65 -1.159 . . . . 74.420000000000002 111.243 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.536 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.3 t-20 -62.03 -49.41 76.11 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 123.331 0.652 . . . . 73.349999999999994 110.633 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.425 HD23 ' HE1' ' A' ' 35' ' ' MET . 92.3 mt -64.4 -38.74 92.09 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.651 0.739 . . . . 72.120000000000005 109.25 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.467 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 22.5 t70 -64.95 -35.52 81.44 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.537 -1.211 . . . . 61.539999999999999 110.829 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.64 -48.28 22.83 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.205 0.526 . . . . 73.230000000000004 110.129 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.7 t -62.99 -56.98 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 124.72 1.208 . . . . 73.439999999999998 113.168 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -79.97 -24.27 41.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.328 0.585 . . . . 75.209999999999994 112.524 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.7 -16.09 21.69 Favored Glycine 0 C--N 1.309 -0.97 0 N-CA-C 116.041 1.177 . . . . 71.319999999999993 116.041 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -57.94 -37.81 74.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 117.509 0.655 . . . . 73.400000000000006 112.344 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.63 10.17 3.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.889 0.376 . . . . 65.319999999999993 111.668 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -132.2 167.45 19.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.098 -0.704 . . . . 73.230000000000004 109.098 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.27 150.88 52.06 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.136 -1.061 . . . . 73.140000000000001 108.136 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -87.49 114.06 23.76 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.139 -0.689 . . . . 73.239999999999995 109.139 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.2 m -121.21 160.52 22.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 116.678 -0.237 . . . . 71.519999999999996 111.171 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 t -92.29 134.21 35.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.349 -0.612 . . . . 64.5 109.349 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.403 ' HB ' HD11 ' A' ' 47' ' ' LEU . 27.5 m -139.85 161.38 26.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.599 -0.273 . . . . 55.130000000000003 110.924 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.68 123.94 7.84 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.646 -0.981 . . . . 73.239999999999995 110.646 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.17 158.79 16.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 110.399 -0.222 . . . . 75.040000000000006 110.399 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 56.6 t -121.99 123.86 70.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.327 -0.99 . . . . 64.230000000000004 108.327 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.554 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 28.1 mtp180 -68.71 121.88 17.39 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 116.185 -0.462 . . . . 61.219999999999999 110.496 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -72.22 -21.16 61.44 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 122.183 0.992 . . . . 62.210000000000001 108.806 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.81 -39.54 81.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.288 -1.778 . . . . 62.350000000000001 112.61 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -147.31 6.03 0.85 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.31 0.856 . . . . 74.040000000000006 113.31 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.5 t 73.08 12.58 4.98 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.586 1.154 . . . . 71.329999999999998 112.338 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -96.49 149.07 22.15 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.698 -0.626 . . . . 73.140000000000001 111.571 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -96.33 150.12 20.92 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 112.817 0.673 . . . . 64.230000000000004 112.817 -175.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.554 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.6 mtp -143.26 160.62 40.14 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.853 -1.067 . . . . 72.549999999999997 110.153 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.23 130.76 54.7 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.751 -0.833 . . . . 54.539999999999999 108.751 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 21' ' ' PHE . 35.3 m -142.27 173.96 6.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 120.894 0.378 . . . . 71.310000000000002 110.536 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -104.11 146.57 28.54 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.421 -0.955 . . . . 64.540000000000006 108.421 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.0 t -149.33 172.5 14.79 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.829 -0.804 . . . . 72.349999999999994 108.829 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -117.74 113.98 22.64 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.125 0.488 . . . . 74.219999999999999 109.953 -176.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -109.0 156.38 19.8 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.848 -0.615 . . . . 60.329999999999998 110.794 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.403 ' HB3' HG12 ' A' ' 64' ' ' VAL . 59.2 t-105 -68.4 128.85 38.08 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.498 -1.297 . . . . 74.040000000000006 107.498 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.6 mm -72.53 -38.51 59.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 112.653 0.612 . . . . 62.200000000000003 112.653 -170.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -76.28 -37.66 57.24 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.695 -0.402 . . . . 73.109999999999999 111.216 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.337 0.0 OUTLIER 37.77 65.01 0.6 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.123 1.157 . . . . 75.409999999999997 114.123 -173.174 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.29 -26.62 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.635 -0.711 . . . . 72.030000000000001 111.198 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.32 136.23 50.74 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 122.929 0.491 . . . . 61.109999999999999 112.052 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.16 -2.29 11.94 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.612 2.208 . . . . 71.439999999999998 110.677 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -63.88 -45.51 89.08 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 115.665 -0.698 . . . . 74.209999999999994 110.917 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.649 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.0 ptt? . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 116.324 -0.398 . . . . 72.5 110.763 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.578 ' O ' HG12 ' A' ' 144' ' ' ILE . 37.5 ttpt . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 109.752 -0.462 . . . . 74.310000000000002 109.752 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.81 -30.93 47.23 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.425 1.09 . . . . 64.349999999999994 111.78 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -65.37 -39.23 92.04 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.04 0.448 . . . . 73.230000000000004 109.917 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.495 ' O ' HG22 ' A' ' 146' ' ' THR . 92.6 m-85 -76.73 -32.84 58.06 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.572 0.701 . . . . 74.310000000000002 109.291 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.9 mm -58.53 -31.21 43.0 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 CA-C-N 114.845 -1.07 . . . . 74.319999999999993 111.713 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -50.64 -44.72 57.49 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.296 0.48 . . . . 63.450000000000003 112.296 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 143' ' ' PHE . 12.0 t -68.76 -40.58 79.69 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 120.221 -0.592 . . . . 71.329999999999998 110.25 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -69.65 -29.95 67.53 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 112.93 0.715 . . . . 63.520000000000003 112.93 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 38.2 ttpt -59.64 -43.2 93.95 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.534 -0.913 . . . . 72.450000000000003 108.534 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -72.58 -28.55 62.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.798 -0.637 . . . . 64.230000000000004 110.235 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 146' ' ' THR . 83.7 mt -73.76 -43.16 54.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.757 -0.656 . . . . 75.150000000000006 110.397 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.2 ptm -70.75 -29.89 66.25 Favored 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 121.089 -0.244 . . . . 64.010000000000005 111.579 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 8.2 mm-40 -66.1 -33.32 75.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.079 0.466 . . . . 75.209999999999994 110.728 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 41.8 t -71.95 -33.83 68.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.048 -0.523 . . . . 72.319999999999993 110.066 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.241 0.628 0 CA-C-O 121.56 0.695 . . . . 72.109999999999999 111.099 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.416 -2.158 0 CA-C-O 121.619 0.723 . . . . 60.219999999999999 109.413 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.522 ' O ' HG12 ' A' ' 79' ' ' VAL . 37.5 m-70 -115.01 160.66 19.33 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 114.811 -1.086 . . . . 62.119999999999997 108.818 -174.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 22.5 p30 -131.14 127.03 37.21 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.548 0.69 . . . . 73.340000000000003 110.868 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.5 t -121.05 141.78 40.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.101 -0.954 . . . . 72.010000000000005 110.492 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.459 ' HB2' HG21 ' A' ' 113' ' ' VAL . 90.3 t80 -94.56 124.37 38.56 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.514 -0.921 . . . . 73.530000000000001 108.514 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 m -109.12 126.4 66.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.364 0.602 . . . . 75.209999999999994 111.673 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.404 ' HB3' ' CG1' ' A' ' 63' ' ' ILE . 42.6 p90 -66.88 -34.09 77.03 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.803 1.038 . . . . 74.25 113.803 -177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 169.42 -28.44 0.13 Allowed Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 118.752 -1.69 . . . . 52.240000000000002 113.318 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.2 p -62.97 -36.8 84.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.143 0.497 . . . . 64.400000000000006 111.143 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.588 ' HB3' HD11 ' A' ' 32' ' ' ILE . 63.5 m-85 -124.67 28.79 6.44 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.669 -0.696 . . . . 73.120000000000005 112.23 -176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -87.14 9.18 20.78 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.795 0.807 . . . . 72.439999999999998 108.848 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.556 ' O ' HG12 ' A' ' 32' ' ' ILE . 13.1 t70 -117.25 129.44 25.33 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.544 -1.207 . . . . 74.439999999999998 109.354 -176.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' ASP . 2.8 Cg_exo -71.08 -28.8 18.58 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.915 1.744 . . . . 55.210000000000001 112.558 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.454 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 24.0 t70 -62.35 -44.63 96.02 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 116.348 -0.387 . . . . 75.430000000000007 110.761 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.94 -29.3 36.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.997 -0.547 . . . . 72.5 109.93 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.588 HD11 ' HB3' ' A' ' 26' ' ' PHE . 44.2 mm -65.76 -41.57 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 116.434 -0.348 . . . . 72.019999999999996 110.356 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.86 -46.21 71.21 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.296 0.569 . . . . 35.32 110.622 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -82.75 -36.14 13.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 114.371 1.249 . . . . 55.240000000000002 114.371 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.609 ' HE1' HD23 ' A' ' 87' ' ' LEU . 12.0 tmm? -67.84 -36.58 80.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.792 0.33 . . . . 74.329999999999998 110.701 -174.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.507 HD21 HG23 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -119.13 -71.69 0.72 Allowed 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.681 -0.808 . . . . 51.229999999999997 111.535 175.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.481 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 27.8 t70 167.96 -46.73 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.405 0.682 . . . . 72.530000000000001 109.481 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -111.75 160.3 17.44 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.355 -0.839 . . . . 62.539999999999999 110.345 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.411 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 40.3 m -119.55 111.1 36.56 Favored Pre-proline 0 N--CA 1.429 -1.509 0 CA-C-N 116.34 -0.391 . . . . 55.009999999999998 111.262 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -60.72 151.51 76.03 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.025 2.483 . . . . 70.549999999999997 110.378 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -62.57 121.47 13.4 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.117 0.484 . . . . 65.439999999999998 109.855 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 25.2 mt -99.08 131.05 47.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.379 -0.828 . . . . 71.200000000000003 109.385 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG21 ' HD2' ' A' ' 104' ' ' ARG . 11.6 p -130.4 148.05 33.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.899 -0.591 . . . . 74.150000000000006 110.352 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.426 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 34.5 m -75.59 124.19 26.79 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.024 0.44 . . . . 71.230000000000004 110.096 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB1' HD13 ' A' ' 102' ' ' ILE . . . -138.7 159.27 42.51 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.439 0.638 . . . . 63.420000000000002 111.513 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.475 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 78.3 m -118.23 129.43 55.48 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.479 -0.782 . . . . 50.130000000000003 109.892 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.6 tp -104.43 99.31 17.21 Favored Pre-proline 0 N--CA 1.426 -1.652 0 N-CA-C 109.733 -0.469 . . . . 73.319999999999993 109.733 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.5 Cg_endo -84.29 141.69 9.23 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.694 2.263 . . . . 72.319999999999993 110.752 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.36 4.14 57.41 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.616 -0.802 . . . . 71.049999999999997 111.492 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' HA ' ' H ' ' A' ' 66' ' ' SER . 82.4 m-85 -138.76 157.77 45.48 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.967 -0.753 . . . . 73.219999999999999 108.967 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 7.1 tp60 -138.93 148.3 43.39 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.595 -0.52 . . . . 65.340000000000003 109.595 -175.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -100.6 126.35 47.06 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.265 -0.88 . . . . 74.510000000000005 110.564 178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 68.1 m-85 -109.04 134.85 51.12 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.03 -1.47 . . . . 72.120000000000005 107.03 174.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.536 ' HD3' ' C ' ' A' ' 54' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.404 -2.757 0 N-CA-C 113.798 1.036 . . . . 64.019999999999996 113.798 -166.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 N--CA 1.444 -0.752 0 N-CA-C 107.439 -1.319 . . . . 64.129999999999995 107.439 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.649 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 7.1 Cg_exo -73.73 81.17 1.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 121.022 1.148 . . . . 74.299999999999997 109.932 170.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.0 m -85.74 157.17 20.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.801 -0.636 . . . . 61.020000000000003 112.109 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.459 HD12 HG21 ' A' ' 71' ' ' VAL . 49.2 mm -103.95 140.9 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 115.153 -0.931 . . . . 62.030000000000001 109.23 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.31 153.96 56.6 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.278 -1.008 . . . . 62.299999999999997 108.278 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.12 112.97 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.543 2.162 . . . . 65.200000000000003 112.378 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 51' ' ' GLN . 33.5 t -125.54 126.64 45.16 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.329 -0.989 . . . . 72.420000000000002 108.329 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.48 -36.17 77.65 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.468 0.914 . . . . 72.310000000000002 113.468 -174.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -107.52 19.85 19.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.698 0.285 . . . . 74.519999999999996 111.495 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -109.31 160.13 13.68 Favored Glycine 0 N--CA 1.426 -1.989 0 C-N-CA 119.873 -1.156 . . . . 73.530000000000001 112.997 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.69 131.63 8.08 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.988 -1.116 . . . . 74.219999999999999 107.988 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.459 HG21 HD12 ' A' ' 63' ' ' ILE . 56.6 t -112.43 123.43 68.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 109.762 -0.458 . . . . 73.129999999999995 109.762 -176.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -97.01 115.88 28.23 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.366 -1.346 . . . . 75.510000000000005 107.366 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.491 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -144.69 -149.69 5.09 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 110.323 -1.111 . . . . 54.399999999999999 110.323 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 73' ' ' GLY . 2.2 mppt? -127.44 150.79 49.49 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 112.989 0.737 . . . . 70.209999999999994 112.989 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 28.1 t -110.87 131.88 60.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 114.593 -1.185 . . . . 60.409999999999997 112.016 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 78.8 mt -96.91 106.95 19.36 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.278 -1.008 . . . . 72.010000000000005 108.278 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.1 ptp -114.56 150.01 35.62 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 120.487 0.184 . . . . 73.099999999999994 110.714 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.71 15.86 47.89 Favored Glycine 0 N--CA 1.433 -1.513 0 C-N-CA 119.483 -1.342 . . . . 63.420000000000002 111.006 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.3 p -87.43 126.24 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.119 -1.067 . . . . 53.020000000000003 108.119 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.6 p -76.29 172.66 12.52 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.809 -0.356 . . . . 62.420000000000002 110.276 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.9 p -59.87 -41.18 90.93 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 112.25 0.463 . . . . 55.420000000000002 112.25 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.04 -36.65 85.06 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.777 0.798 . . . . 63.439999999999998 110.888 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 42.2 mt-10 -78.06 -31.21 50.16 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.397 -0.819 . . . . 73.049999999999997 109.171 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.438 HD22 ' CE1' ' A' ' 18' ' ' HIS . 35.5 tp -66.27 -47.32 74.09 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.233 -0.44 . . . . 61.5 110.615 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.01 -29.37 70.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.268 0.556 . . . . 72.329999999999998 109.63 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.7 t30 -67.21 -44.07 80.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.308 -0.86 . . . . 72.099999999999994 109.629 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.609 HD23 ' HE1' ' A' ' 35' ' ' MET . 96.0 mt -64.77 -43.17 94.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.747 -0.661 . . . . 71.409999999999997 109.758 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.536 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 31.3 t70 -65.65 -27.59 68.48 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.927 -1.033 . . . . 63.310000000000002 110.288 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.47 -48.5 22.37 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.053 -0.521 . . . . 70.400000000000006 110.286 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.514 HG21 ' SD ' ' A' ' 35' ' ' MET . 92.7 t -69.86 -58.27 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 112.473 0.546 . . . . 61.240000000000002 112.473 -175.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.95 -33.86 44.92 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.136 0.493 . . . . 73.530000000000001 111.351 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -60.11 -16.53 41.41 Favored Glycine 0 N--CA 1.465 0.587 0 CA-C-N 115.795 -0.639 . . . . 32.439999999999998 113.507 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -57.74 -37.44 73.61 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.695 0.398 . . . . 73.25 110.518 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -132.93 7.91 4.05 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.169 0.509 . . . . 74.420000000000002 111.84 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 96.1 m-85 -131.07 168.84 16.73 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 122.709 0.404 . . . . 75.239999999999995 110.837 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.573 ' HB2' ' CD1' ' A' ' 119' ' ' ILE . 43.3 tt0 -122.46 129.97 52.59 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.536 -0.912 . . . . 55.100000000000001 108.536 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' THR . 60.0 ttp180 -86.14 114.16 22.77 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.912 -1.144 . . . . 65.439999999999998 107.912 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.4 HG13 ' HG2' ' A' ' 96' ' ' GLU . 30.9 m -125.77 162.24 29.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.673 -0.694 . . . . 62.509999999999998 111.987 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -86.13 124.62 32.74 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.242 -0.89 . . . . 75.430000000000007 109.257 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.8 170.72 19.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.72 -0.673 . . . . 70.439999999999998 111.896 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -121.24 120.51 4.47 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 110.587 -1.005 . . . . 63.020000000000003 110.587 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.457 HD11 ' HE2' ' A' ' 111' ' ' MET . 2.6 pp -115.41 163.02 13.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 116.597 0.198 . . . . 61.520000000000003 110.64 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 59.5 t -117.3 125.38 73.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 107.603 -1.258 . . . . 74.140000000000001 107.603 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.617 ' HE ' ' HB3' ' A' ' 106' ' ' ASP . 29.4 ttp180 -79.2 118.67 21.36 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.082 -1.081 . . . . 72.409999999999997 108.082 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.426 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 45.4 mt-10 -66.94 -7.52 22.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.203 0.601 . . . . 72.239999999999995 111.081 -176.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.617 ' HB3' ' HE ' ' A' ' 104' ' ' ARG . 30.1 t70 -54.78 -46.51 74.45 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.996 -1.002 . . . . 74.209999999999994 108.92 172.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.433 ' HB2' ' H ' ' A' ' 108' ' ' SER . 16.5 m-80 -133.8 -103.27 0.24 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.152 -1.055 . . . . 74.319999999999993 108.152 170.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.433 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 21.2 p -152.47 16.14 0.61 Allowed 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 106.374 -1.713 . . . . 74.049999999999997 106.374 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.89 128.5 35.67 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 114.458 -1.246 . . . . 75.230000000000004 108.183 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 60.8 pttt -99.36 147.39 25.28 Favored 'General case' 0 C--N 1.251 -3.678 0 CA-C-N 115.273 -0.876 . . . . 74.340000000000003 109.801 -176.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.457 ' HE2' HD11 ' A' ' 102' ' ' ILE . 32.8 mtm -136.14 163.44 30.34 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.721 0.772 . . . . 65.129999999999995 110.686 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.63 118.15 35.8 Favored 'General case' 0 C--N 1.258 -3.41 0 CA-C-N 114.301 -1.318 . . . . 65.439999999999998 108.604 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 21' ' ' PHE . 22.8 m -134.15 174.67 12.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.316 -0.624 . . . . 75.099999999999994 109.316 -176.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -113.25 146.27 39.61 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.985 -0.746 . . . . 54.030000000000001 108.985 175.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 14.4 t -136.04 171.4 14.53 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.354 -0.61 . . . . 61.5 109.354 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 95' ' ' TYR . 80.1 m-85 -112.57 112.68 24.4 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.852 -0.613 . . . . 61.0 110.317 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -112.67 157.83 20.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.656 -0.702 . . . . 71.409999999999997 109.582 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -67.64 139.91 56.83 Favored 'General case' 0 C--O 1.254 1.335 0 N-CA-C 109.104 -0.702 . . . . 75.510000000000005 109.104 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 96' ' ' GLU . 16.9 mm -72.24 -44.74 63.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 120.34 -0.544 . . . . 64.319999999999993 110.788 -172.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -70.32 -35.74 73.84 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 115.629 -0.714 . . . . 74.129999999999995 109.868 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.533 ' HB3' ' HZ3' ' A' ' 121' ' ' LYS . 0.1 OUTLIER 56.17 -4.45 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.082 2.153 . . . . 73.239999999999995 115.587 176.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.81 26.15 6.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.507 0.67 . . . . 51.039999999999999 109.407 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.606 ' O ' ' HG2' ' A' ' 126' ' ' MET . 10.2 t70 -62.78 125.66 86.9 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.131 -0.94 . . . . 75.25 109.558 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.44 -13.76 16.51 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.832 2.355 . . . . 61.420000000000002 113.204 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -89.3 -24.0 22.14 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.228 -0.442 . . . . 51.140000000000001 110.69 -176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 123' ' ' ASP . 21.4 ptp . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.724 0.297 . . . . 55.399999999999999 111.262 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.51 ' O ' HG12 ' A' ' 144' ' ' ILE . 34.7 ttpt . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 113.219 0.822 . . . . 70.209999999999994 113.219 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 88.2 tttt -53.85 -34.58 59.75 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.678 0.622 . . . . 72.120000000000005 112.678 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 142' ' ' LYS . 10.7 tmtt? -58.97 -43.6 91.38 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.387 -0.597 . . . . 72.439999999999998 109.387 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -76.74 -32.85 58.04 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.703 -0.68 . . . . 73.299999999999997 109.83 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 140' ' ' LYS . 51.6 mm -63.28 -33.38 60.76 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 CA-C-N 115.603 -0.726 . . . . 72.329999999999998 110.551 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 7.7 mm-40 -51.8 -39.05 58.01 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.281 0.845 . . . . 71.409999999999997 113.281 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -80.63 -39.33 27.57 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 119.973 -0.691 . . . . 65.530000000000001 110.511 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -67.89 -29.21 68.25 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 112.577 0.584 . . . . 72.400000000000006 112.577 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 148' ' ' LYS . 37.6 ttpt -53.76 -42.22 67.97 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 124.095 0.958 . . . . 52.229999999999997 109.315 173.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -75.32 -42.04 55.44 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.584 -0.735 . . . . 61.340000000000003 110.126 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.2 mt -61.52 -39.56 83.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.735 -0.666 . . . . 64.219999999999999 111.654 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 57.8 ttp -62.14 -45.91 91.32 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 122.809 0.444 . . . . 61.229999999999997 110.1 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -66.39 -30.94 71.42 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.165 0.507 . . . . 65.420000000000002 110.071 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 45.1 t -69.17 -33.44 73.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.156 -0.475 . . . . 45.219999999999999 111.058 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 CA--C 1.506 -0.721 0 CA-C-O 121.412 0.625 . . . . 75.450000000000003 110.084 176.921 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 17' ' ' LEU . 1.8 mm? . . . . . 0 N--CA 1.395 -3.214 0 CA-C-O 121.451 0.643 . . . . 74.010000000000005 110.982 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.47 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.6 m-70 -123.61 159.77 28.55 Favored 'General case' 0 C--N 1.27 -2.858 0 CA-C-N 114.82 -1.082 . . . . 73.340000000000003 109.406 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 15.3 p30 -125.59 126.19 44.37 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.021 -0.99 . . . . 55.340000000000003 110.322 174.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.61 138.76 53.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.436 -0.802 . . . . 72.439999999999998 109.395 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.466 ' HB2' HG21 ' A' ' 113' ' ' VAL . 87.5 t80 -93.55 121.92 35.46 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.138 -1.43 . . . . 73.219999999999999 107.138 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.416 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 19.2 m -103.24 154.81 5.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 115.737 -0.665 . . . . 61.43 110.878 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -139.9 -30.05 0.7 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.989 0.737 . . . . 72.140000000000001 112.989 -170.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.49 -91.29 0.44 Allowed Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 118.875 -1.631 . . . . 72.530000000000001 113.523 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 m -58.69 -31.29 68.09 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.22 0.822 . . . . 73.430000000000007 113.22 -173.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 32' ' ' ILE . 27.6 m-85 -117.49 21.56 12.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.677 0.992 . . . . 63.329999999999998 113.677 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 22' ' ' VAL . 9.8 tt0 -82.67 -2.63 54.62 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 121.974 0.892 . . . . 71.230000000000004 110.131 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 32' ' ' ILE . 20.4 t70 -112.52 125.21 30.38 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 115.392 -0.822 . . . . 60.530000000000001 109.56 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.3 -31.12 36.0 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.716 2.277 . . . . 60.329999999999998 113.572 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 21.9 t70 -62.78 -38.14 89.45 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 120.686 0.279 . . . . 43.25 111.591 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 28' ' ' ASP . 29.0 m -73.38 -28.19 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.147 -0.479 . . . . 64.150000000000006 110.752 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 28' ' ' ASP . 47.9 mm -61.49 -38.61 80.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 CA-C-O 121.046 0.451 . . . . 73.430000000000007 110.866 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -59.6 -35.13 73.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.698 -0.683 . . . . 71.310000000000002 110.275 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.9 t -82.07 -51.12 15.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.406 -0.815 . . . . 72.409999999999997 111.667 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.424 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 10.7 tmm? -63.68 -36.63 84.48 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.523 -0.308 . . . . 74.209999999999994 111.002 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 37' ' ' ASP 0.386 3.6 pp -121.56 -59.55 1.68 Allowed 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 114.702 1.371 . . . . 54.119999999999997 114.702 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.555 ' N ' HD12 ' A' ' 36' ' ' LEU . 17.2 t70 172.72 -55.44 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.127 0.489 . . . . 62.299999999999997 110.825 -176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 56.8 mmt-85 -138.75 159.1 42.95 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.828 -0.624 . . . . 51.0 110.195 -176.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.3 m -94.3 122.09 62.16 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 112.144 0.424 . . . . 74.310000000000002 112.144 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.61 153.26 68.19 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.066 3.177 . . . . 70.340000000000003 111.392 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -56.77 132.08 51.16 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.226 -0.657 . . . . 72.25 109.226 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 54.9 mt -115.49 134.67 57.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 109.307 -0.627 . . . . 75.230000000000004 109.307 -174.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.29 144.13 36.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 108.505 -0.924 . . . . 73.530000000000001 108.505 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.5 m -81.12 127.69 32.92 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 108.826 -0.805 . . . . 54.439999999999998 108.826 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.48 158.74 43.37 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.221 0.534 . . . . 74.349999999999994 110.834 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.503 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 97.1 m -113.58 127.69 56.16 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.187 -0.915 . . . . 50.329999999999998 110.082 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.8 tp -100.59 100.22 11.82 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 109.415 -0.587 . . . . 73.209999999999994 109.415 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 46' ' ' THR . 97.2 Cg_endo -88.09 135.21 3.23 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.649 2.233 . . . . 63.340000000000003 111.646 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.11 11.83 38.33 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.402 -0.904 . . . . 55.420000000000002 111.165 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.507 ' HA ' ' H ' ' A' ' 66' ' ' SER . 87.0 m-85 -145.31 159.69 42.66 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.876 -0.787 . . . . 73.019999999999996 108.876 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.42 143.8 37.8 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.662 -0.495 . . . . 73.219999999999999 109.662 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -104.41 132.68 50.39 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.825 -1.176 . . . . 73.010000000000005 107.825 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -108.76 169.82 8.42 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 113.378 0.881 . . . . 73.310000000000002 113.378 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 . . . . . 0 C--N 1.288 -2.094 0 CA-C-N 114.251 -1.34 . . . . 74.109999999999999 109.163 -175.149 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 . . . . . 0 C--O 1.241 0.635 0 N-CA-C 108.993 -0.743 . . . . 62.539999999999999 108.993 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.39 98.05 1.14 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.823 1.682 . . . . 64.120000000000005 108.915 172.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 23.3 p -109.89 169.15 8.91 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.146 -0.479 . . . . 70.219999999999999 112.189 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.8 mm -108.82 141.24 24.62 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.022 0 C-N-CA 123.533 0.733 . . . . 73.409999999999997 109.232 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.3 153.62 52.56 Favored Pre-proline 0 N--CA 1.476 0.873 0 N-CA-C 107.762 -1.199 . . . . 74.430000000000007 107.762 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.432 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 30.7 Cg_endo -65.03 115.45 3.29 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.555 2.17 . . . . 72.299999999999997 113.966 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.507 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 47.3 t -125.82 112.95 16.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.25 -1.018 . . . . 64.219999999999999 108.25 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.62 -22.31 66.65 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.396 0.517 . . . . 74.030000000000001 112.396 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -109.63 14.82 23.23 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.86 0.362 . . . . 73.209999999999994 110.937 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.13 167.22 15.39 Favored Glycine 0 C--O 1.249 1.082 0 C-N-CA 120.684 -0.769 . . . . 33.43 112.663 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.41 143.54 18.94 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 123.834 0.854 . . . . 74.120000000000005 109.569 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.44 120.02 63.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 110.13 -0.322 . . . . 63.539999999999999 110.13 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -91.77 115.45 28.07 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.782 -1.562 . . . . 74.219999999999999 106.782 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.05 -150.37 5.29 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.573 -0.822 . . . . 64.439999999999998 111.866 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 73.5 mmtt -126.04 141.54 51.91 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.854 0.359 . . . . 75.510000000000005 110.339 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.3 t -111.09 131.04 63.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.966 -0.561 . . . . 75.239999999999995 110.78 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 66.9 mt -95.57 104.71 16.63 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.887 -0.783 . . . . 75.409999999999997 108.887 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.474 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 55.3 mtp -102.61 161.03 14.05 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.326 -0.99 . . . . 63.210000000000001 108.326 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.67 17.09 78.14 Favored Glycine 0 C--N 1.302 -1.346 0 C-N-CA 119.29 -1.433 . . . . 73.400000000000006 112.792 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 83' ' ' GLU . 10.9 p -91.82 136.02 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.28 -1.007 . . . . 64.120000000000005 108.28 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 79.2 p -78.93 168.39 19.76 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.899 -0.72 . . . . 72.239999999999995 111.766 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 m -63.0 -33.43 75.4 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.206 -0.452 . . . . 73.010000000000005 111.978 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.72 -39.17 93.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.795 0.807 . . . . 70.150000000000006 110.47 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.535 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.8 mt-10 -78.27 -28.36 47.62 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.979 -1.01 . . . . 63.210000000000001 109.296 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.454 HD22 ' CE1' ' A' ' 18' ' ' HIS . 53.3 tp -66.13 -50.29 64.53 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 109.882 -0.414 . . . . 63.450000000000003 109.882 175.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.99 -28.87 69.87 Favored 'General case' 0 C--O 1.208 -1.12 0 CA-C-O 121.379 0.609 . . . . 73.109999999999999 109.441 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 12.6 t-20 -65.44 -49.06 70.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.171 -0.922 . . . . 62.539999999999999 110.537 176.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.597 ' HA ' HG12 ' A' ' 90' ' ' VAL . 95.4 mt -65.07 -38.85 92.12 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.824 0.821 . . . . 73.439999999999998 109.639 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.655 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 24.6 t70 -65.13 -31.68 73.0 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.231 -1.35 . . . . 73.549999999999997 109.737 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.21 -48.4 17.67 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.258 -0.883 . . . . 64.510000000000005 111.514 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 87' ' ' LEU . 7.3 p -72.33 -59.14 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 113.957 1.095 . . . . 73.129999999999995 113.957 -173.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.38 -32.93 37.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 119.643 -0.823 . . . . 74.400000000000006 110.847 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.46 -16.35 21.12 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.83 -1.077 . . . . 74.439999999999998 115.55 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.16 -24.58 51.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 118.277 1.038 . . . . 65.439999999999998 111.604 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -111.05 -11.59 14.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.42 0.629 . . . . 73.030000000000001 110.327 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -134.53 170.91 15.06 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.771 0.829 . . . . 74.120000000000005 110.416 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -121.62 138.03 54.49 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.335 -0.987 . . . . 54.32 108.335 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 115' ' ' THR . 39.6 ttp180 -87.48 119.13 27.45 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.794 -0.817 . . . . 73.25 108.794 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.54 161.16 26.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 112.378 0.51 . . . . 75.420000000000002 112.378 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -91.5 122.96 34.55 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.014 -0.993 . . . . 73.120000000000005 108.955 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.42 158.96 43.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.104 0.478 . . . . 74.140000000000001 111.605 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.06 119.75 6.14 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 111.032 -0.827 . . . . 70.409999999999997 111.032 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.03 154.88 13.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 122.296 0.238 . . . . 64.230000000000004 110.431 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.74 117.72 55.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.181 0.515 . . . . 42.530000000000001 109.788 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -64.5 124.67 22.43 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 124.509 1.124 . . . . 73.439999999999998 111.414 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -61.41 -35.59 77.95 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.739 0.816 . . . . 74.010000000000005 112.115 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.2 -53.02 62.73 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.031 0.752 . . . . 71.409999999999997 113.031 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -128.96 10.86 5.98 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 113.5 0.926 . . . . 72.349999999999994 113.5 -167.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.4 t 63.93 12.44 6.83 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.403 0.681 . . . . 73.409999999999997 112.504 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -81.07 152.14 28.01 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.24 -0.652 . . . . 72.329999999999998 109.24 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -105.78 147.18 28.92 Favored 'General case' 0 C--N 1.278 -2.515 0 C-N-CA 120.263 -0.575 . . . . 62.530000000000001 109.789 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 40.9 mtm -137.55 163.05 32.13 Favored 'General case' 0 CA--C 1.465 -2.308 0 CA-C-O 121.412 0.625 . . . . 63.219999999999999 110.186 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.75 118.32 36.22 Favored 'General case' 0 C--N 1.262 -3.226 0 CA-C-N 114.612 -1.176 . . . . 70.230000000000004 108.474 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 21' ' ' PHE . 30.8 m -128.22 173.52 13.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 116.062 -0.517 . . . . 73.329999999999998 110.172 -176.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -101.99 149.42 24.25 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.214 -1.402 . . . . 64.030000000000001 107.214 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.7 t -152.3 171.69 17.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.561 -0.903 . . . . 73.209999999999994 108.561 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -119.1 116.75 27.02 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.043 -0.725 . . . . 72.040000000000006 109.043 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.432 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 24.5 ptt? -112.63 156.79 22.12 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.054 -0.521 . . . . 73.150000000000006 109.777 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 64.4 t-105 -68.08 123.98 22.16 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.572 -0.899 . . . . 70.420000000000002 108.572 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.6 mt -67.86 -41.76 85.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.069 -0.968 . . . . 74.510000000000005 112.022 -172.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -88.12 75.76 8.62 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.973 0.892 . . . . 64.409999999999997 108.673 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -76.67 0.05 21.75 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.005 -0.998 . . . . 71.519999999999996 112.877 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.88 8.96 41.05 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 109.871 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.94 138.59 96.4 Favored Pre-proline 0 C--O 1.214 -0.774 0 CA-C-N 115.772 -0.649 . . . . 72.409999999999997 109.96 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -99.56 17.56 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.181 1.921 . . . . 35.329999999999998 113.308 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -118.01 -9.0 10.65 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.311 1.226 . . . . 75.299999999999997 114.311 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 119.333 -0.947 . . . . 72.209999999999994 110.247 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 144' ' ' ILE . 6.3 ttpm? . . . . . 0 C--O 1.209 -1.047 0 N-CA-C 114.053 1.131 . . . . 72.519999999999996 114.053 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -55.83 -35.08 65.99 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.314 0.857 . . . . 74.109999999999999 113.314 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' A' ' 142' ' ' LYS . 0.6 OUTLIER -66.74 -36.57 82.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.879 0.847 . . . . 74.329999999999998 108.749 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -77.03 -35.96 56.52 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 113.679 -1.6 . . . . 74.349999999999994 110.678 -175.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 140' ' ' LYS . 50.1 mm -61.37 -32.67 53.86 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.981 0 N-CA-C 113.182 0.808 . . . . 71.099999999999994 113.182 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -51.77 -42.31 62.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 113.792 1.034 . . . . 71.120000000000005 113.792 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.431 ' O ' HG13 ' A' ' 150' ' ' ILE . 13.1 t -70.77 -33.67 71.02 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 120.128 -0.629 . . . . 74.219999999999999 109.811 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.469 ' O ' ' HG3' ' A' ' 151' ' ' MET . 64.0 m-85 -71.71 -30.36 65.56 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 116.125 -0.489 . . . . 63.329999999999998 111.679 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.492 ' HG3' HG22 ' A' ' 144' ' ' ILE . 29.8 mtpp -59.83 -36.84 77.64 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.254 -1.017 . . . . 72.219999999999999 108.254 174.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 149' ' ' LYS . 48.4 mmtt -74.56 -36.68 63.08 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.778 -0.646 . . . . 74.430000000000007 112.201 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.556 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 94.6 mt -63.28 -41.45 92.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.904 0.383 . . . . 63.539999999999999 110.09 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 147' ' ' PHE . 65.4 mtt -66.58 -40.64 89.02 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.656 -0.498 . . . . 70.109999999999999 109.656 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 148' ' ' LYS . 1.3 tm-20 -62.28 -34.29 76.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 124.87 1.268 . . . . 44.119999999999997 109.765 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 74.9 m -71.13 -34.07 70.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.188 -0.46 . . . . 70.299999999999997 110.553 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 34.6 mmtp . . . . . 0 C--O 1.24 0.598 0 N-CA-C 109.261 -0.644 . . . . 71.120000000000005 109.261 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 17' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.418 -2.071 0 CA-C-O 121.325 0.583 . . . . 63.340000000000003 112.14 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.59 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.9 m-70 -113.9 161.25 17.85 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.016 -0.993 . . . . 74.310000000000002 109.191 -173.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 24.9 p30 -128.27 134.58 48.97 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.336 0.589 . . . . 73.349999999999994 112.117 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 53.9 t -131.52 137.97 54.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.659 -0.7 . . . . 73.439999999999998 110.345 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.475 ' HB2' HG21 ' A' ' 113' ' ' VAL . 93.2 t80 -94.67 123.83 38.34 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.195 0.598 . . . . 63.119999999999997 109.659 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 26' ' ' PHE . 13.1 p -138.56 155.46 28.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.416 -0.587 . . . . 71.150000000000006 109.416 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.428 ' CE1' HD11 ' A' ' 63' ' ' ILE . 2.0 p90 -148.97 6.31 0.69 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.923 0.392 . . . . 62.25 110.145 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.81 -92.61 1.02 Allowed Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 119.812 -1.185 . . . . 72.109999999999999 113.293 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.7 m -58.6 -36.11 73.49 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.441 0.696 . . . . 52.200000000000003 112.835 -174.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.51 ' HB2' HG21 ' A' ' 22' ' ' VAL . 72.6 m-85 -120.04 29.78 7.35 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.259 0.552 . . . . 71.430000000000007 111.561 -175.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -62.95 -31.51 72.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.929 -1.032 . . . . 73.340000000000003 110.633 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 21.2 t70 -108.49 129.7 23.68 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.642 -0.708 . . . . 75.150000000000006 111.719 -176.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.23 -24.68 58.18 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.437 2.758 . . . . 71.230000000000004 113.915 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.447 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 16.4 t70 -70.46 -29.09 65.56 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.709 -0.619 . . . . 54.119999999999997 110.119 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.58 -39.57 84.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.345 -0.843 . . . . 75.239999999999995 108.824 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 26' ' ' PHE . 29.0 mm -62.77 -45.03 99.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.253 -0.885 . . . . 74.219999999999999 110.526 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -53.2 -42.85 66.7 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.492 0.553 . . . . 71.299999999999997 112.492 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.55 -36.75 14.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 112.525 0.565 . . . . 71.5 112.525 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.7 tmm? -65.22 -35.85 82.33 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 121.32 -0.152 . . . . 62.049999999999997 110.683 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.622 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 0.8 OUTLIER -120.35 -74.7 0.6 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 119.967 -0.693 . . . . 75.010000000000005 112.444 172.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.622 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 16.3 t70 173.6 -48.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.528 0.731 . . . . 75.239999999999995 109.163 -174.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -109.13 164.95 11.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.604 -1.18 . . . . 60.009999999999998 109.094 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.4 m -123.93 129.35 24.81 Favored Pre-proline 0 C--N 1.307 -1.247 0 C-N-CA 122.361 0.264 . . . . 63.200000000000003 111.164 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -68.0 152.57 76.63 Favored 'Trans proline' 0 C--O 1.25 1.085 0 C-N-CA 123.278 2.652 . . . . 42.140000000000001 111.431 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.89 140.13 58.79 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.193 -0.669 . . . . 63.310000000000002 109.193 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 52.6 mt -118.35 142.66 32.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 120.889 0.376 . . . . 51.509999999999998 110.655 -173.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.464 HG21 ' HD2' ' A' ' 104' ' ' ARG . 9.1 p -130.13 145.08 36.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.092 -0.707 . . . . 51.43 109.092 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.1 m -76.54 124.79 28.14 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.888 -0.782 . . . . 63.25 108.888 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.66 156.69 47.76 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.981 0.896 . . . . 72.340000000000003 112.042 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 64.8 m -116.16 128.89 56.02 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.398 -1.274 . . . . 73.239999999999995 108.153 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.0 tp -102.03 99.61 12.78 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 46' ' ' THR . 95.6 Cg_endo -85.47 148.37 10.03 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.349 2.033 . . . . 72.439999999999998 111.354 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.39 13.45 68.06 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.433 -0.889 . . . . 33.509999999999998 111.225 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -143.25 152.26 41.49 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.991 -1.114 . . . . 72.219999999999999 107.991 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -139.55 142.86 37.17 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.783 -0.767 . . . . 74.120000000000005 109.154 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.708 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -90.27 134.81 34.07 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.83 -1.174 . . . . 73.129999999999995 107.83 176.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.668 ' HB3' ' O ' ' A' ' 126' ' ' MET . 84.2 m-85 -116.64 169.11 9.6 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 112.097 0.406 . . . . 74.340000000000003 112.097 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.422 ' HE ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.445 0 N-CA-C 114.692 1.367 . . . . 72.310000000000002 114.692 -169.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 108.302 -0.999 . . . . 73.349999999999994 108.302 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 21.9 Cg_exo -66.37 101.05 0.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 N-CA-C 108.639 -1.331 . . . . 61.0 108.639 171.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 9.3 p -102.54 153.3 20.21 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.547 -0.751 . . . . 73.329999999999998 112.969 -173.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.428 HD11 ' CE1' ' A' ' 23' ' ' TYR . 41.8 mm -106.13 117.94 52.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.297 -0.865 . . . . 72.239999999999995 110.289 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.36 146.58 62.58 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.46 -0.57 . . . . 70.430000000000007 109.46 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.1 109.05 1.05 Allowed 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.757 2.305 . . . . 72.219999999999999 112.303 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 t -124.64 121.76 35.61 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.01 -1.478 . . . . 53.43 107.01 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.61 -36.77 67.3 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.476 1.287 . . . . 74.319999999999993 114.476 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -109.1 20.05 18.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.193 0.52 . . . . 61.109999999999999 110.661 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.7 162.72 14.11 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.041 -1.076 . . . . 62.229999999999997 112.731 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -150.97 145.13 25.36 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 108.709 -0.849 . . . . 62.130000000000003 108.709 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.427 HG21 HD12 ' A' ' 63' ' ' ILE . 50.7 t -123.3 133.27 69.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.468 -0.568 . . . . 65.209999999999994 109.468 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -107.41 126.51 52.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.058 -1.09 . . . . 71.030000000000001 108.058 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.01 -154.91 7.08 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.753 -0.939 . . . . 63.009999999999998 110.753 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.52 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.2 mmtm -125.75 148.72 48.99 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 120.719 0.295 . . . . 73.120000000000005 110.221 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.5 t -109.75 126.41 66.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 116.154 -0.476 . . . . 63.240000000000002 110.289 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 69.4 mt -94.98 107.39 19.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.67 -1.233 . . . . 74.439999999999998 107.67 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.404 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 14.3 ptp -116.82 144.86 43.99 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.892 -0.41 . . . . 71.519999999999996 109.892 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.11 5.92 52.38 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.471 -1.347 . . . . 41.509999999999998 110.139 -173.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 18' ' ' HIS . 8.8 p -79.81 141.43 15.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 N-CA-C 108.107 -1.072 . . . . 73.420000000000002 108.107 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.3 p -87.97 175.78 7.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.359 -0.936 . . . . 43.030000000000001 110.452 -176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.2 m -65.83 -26.79 67.83 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.504 -0.771 . . . . 74.400000000000006 110.933 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.6 -41.78 53.56 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.311 -0.556 . . . . 64.5 110.781 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.581 ' HB2' HG22 ' A' ' 79' ' ' VAL . 4.9 mp0 -70.16 -28.11 65.07 Favored 'General case' 0 C--O 1.203 -1.389 0 C-N-CA 119.004 -1.078 . . . . 72.209999999999994 108.854 173.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.6 tp -58.97 -51.24 70.9 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 109.644 -0.502 . . . . 75.439999999999998 109.644 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.79 -30.83 71.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.125 0.488 . . . . 70.040000000000006 110.163 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 2.2 t-20 -63.67 -49.76 71.93 Favored 'General case' 0 C--O 1.201 -1.46 0 CA-C-N 115.349 -0.841 . . . . 74.530000000000001 111.313 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.5 mt -69.74 -34.18 73.47 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.304 -0.628 . . . . 41.030000000000001 109.304 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.585 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 33.6 t70 -63.39 -36.86 85.11 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 114.651 -1.159 . . . . 72.219999999999999 109.011 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.98 -49.98 14.21 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.783 -0.644 . . . . 74.25 111.494 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.24 -57.63 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 123.752 0.821 . . . . 65.420000000000002 113.171 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -80.22 -26.67 39.03 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.415 0.626 . . . . 74.200000000000003 111.481 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -59.49 -16.08 34.83 Favored Glycine 0 N--CA 1.461 0.328 0 CA-C-N 114.693 -1.139 . . . . 72.299999999999997 115.909 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -57.47 -34.21 68.79 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 117.519 0.66 . . . . 62.119999999999997 111.833 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -131.95 -0.69 3.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.758 0.651 . . . . 73.230000000000004 112.758 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -122.91 166.35 15.19 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.584 -0.28 . . . . 72.299999999999997 110.246 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -122.6 142.72 50.33 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.488 -0.56 . . . . 73.439999999999998 109.488 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.443 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 15.6 ttp85 -87.01 114.63 23.78 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.765 -0.652 . . . . 74.430000000000007 110.153 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.451 HG11 ' CE ' ' A' ' 117' ' ' MET . 35.0 m -128.17 162.42 34.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.284 -0.871 . . . . 75.549999999999997 110.89 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -101.24 131.75 47.09 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.215 -0.661 . . . . 64.25 109.215 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.82 166.77 25.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 116.182 -0.463 . . . . 51.530000000000001 111.065 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.23 117.97 5.92 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 111.013 -0.835 . . . . 62.409999999999997 111.013 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.404 HD11 ' HE2' ' A' ' 111' ' ' MET . 2.7 pp -112.7 157.17 13.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.532 -0.544 . . . . 71.120000000000005 109.532 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.36 127.47 75.44 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 N-CA-C 107.89 -1.152 . . . . 71.409999999999997 107.89 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.464 ' HD2' HG21 ' A' ' 43' ' ' VAL . 60.7 mtm180 -71.48 141.83 50.2 Favored 'General case' 0 CA--C 1.489 -1.37 0 C-N-CA 119.501 -0.88 . . . . 72.019999999999996 110.151 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.24 5.6 25.96 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.303 -0.862 . . . . 73.409999999999997 111.042 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -94.02 -29.45 15.21 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.64 -0.709 . . . . 73.409999999999997 109.942 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.458 ' HB2' ' OE2' ' A' ' 109' ' ' GLU . 2.5 m-20 -118.9 -121.46 0.3 Allowed 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 108.487 -0.931 . . . . 65.329999999999998 108.487 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.3 m -167.03 17.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.485 1.914 . . . . 75.430000000000007 107.236 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -105.43 157.84 17.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.646 -0.706 . . . . 73.439999999999998 111.735 -174.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -106.08 147.28 29.12 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.173 0.511 . . . . 45.409999999999997 110.743 -177.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.404 ' HE2' HD11 ' A' ' 102' ' ' ILE . 36.9 mtm -132.23 162.85 29.93 Favored 'General case' 0 CA--C 1.47 -2.134 0 CA-C-N 115.056 -0.975 . . . . 75.120000000000005 108.451 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.41 126.77 53.26 Favored 'General case' 0 C--N 1.249 -3.77 0 CA-C-N 114.853 -1.067 . . . . 54.530000000000001 108.851 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 21' ' ' PHE . 32.6 m -139.0 173.01 12.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.617 -0.512 . . . . 74.349999999999994 109.617 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 3.6 mptp? -97.99 149.51 22.37 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.252 -1.018 . . . . 74.219999999999999 108.252 175.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.6 t -152.41 172.23 16.82 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.185 -1.043 . . . . 73.310000000000002 108.185 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 97' ' ' ARG . 96.6 m-85 -108.45 111.07 22.76 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-O 121.745 0.783 . . . . 74.329999999999998 110.191 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.469 ' HB3' ' HE2' ' A' ' 117' ' ' MET . 56.9 ttp -105.37 146.63 29.18 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.321 -1.309 . . . . 64.420000000000002 109.04 -174.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 65.8 t-105 -74.96 132.78 41.65 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.146 -1.427 . . . . 75.400000000000006 107.146 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.5 mp -71.85 -41.87 69.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 120.428 -0.509 . . . . 71.420000000000002 111.189 -171.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -89.3 94.34 9.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.62 0.724 . . . . 54.5 110.729 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -81.68 12.03 4.25 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.538 -0.755 . . . . 74.340000000000003 111.291 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.25 22.54 7.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.739 -0.664 . . . . 60.409999999999997 110.047 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.54 121.29 78.45 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 109.889 -0.411 . . . . 74.219999999999999 109.889 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.97 -0.51 9.21 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.572 2.181 . . . . 60.240000000000002 113.769 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -96.61 -37.31 10.41 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 120.675 -0.41 . . . . 53.119999999999997 112.073 -176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.668 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 25.7 ptt? . . . . . 0 C--N 1.313 -1.015 0 N-CA-C 112.17 0.433 . . . . 54.549999999999997 112.17 -178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.581 ' O ' HG12 ' A' ' 144' ' ' ILE . 22.7 ptmt . . . . . 0 C--O 1.201 -1.453 0 N-CA-C 110.038 -0.356 . . . . 74.239999999999995 110.038 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -48.85 -39.26 24.99 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.411 1.084 . . . . 63.350000000000001 111.107 -175.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.54 -44.45 85.17 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.083 0.468 . . . . 72.530000000000001 110.698 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.0 -35.58 59.52 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.14 -0.689 . . . . 74.109999999999999 109.14 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 140' ' ' LYS . 45.9 mm -60.99 -32.61 52.98 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.708 0 CA-C-N 115.615 -0.72 . . . . 60.350000000000001 110.848 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 43.9 mt-10 -55.08 -44.57 74.98 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.917 -0.313 . . . . 72.310000000000002 111.39 176.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.465 ' O ' HG13 ' A' ' 150' ' ' ILE . 9.9 t -80.19 -36.73 34.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 119.828 -0.749 . . . . 72.239999999999995 110.342 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.494 ' O ' ' HG2' ' A' ' 151' ' ' MET . 54.8 m-85 -66.94 -30.68 70.88 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.942 1.089 . . . . 74.150000000000006 113.942 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 87.8 tttt -62.08 -36.95 83.22 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.132 -1.062 . . . . 51.43 108.132 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 146' ' ' THR . 86.5 tttt -74.05 -37.89 64.14 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.425 -1.261 . . . . 63.140000000000001 109.526 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 146' ' ' THR . 83.6 mt -67.02 -33.76 65.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.756 -0.656 . . . . 71.230000000000004 110.206 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 26.3 mmt -66.33 -30.46 70.87 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.009 -0.367 . . . . 73.540000000000006 110.009 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 23.1 mm-40 -72.31 -30.52 64.87 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.988 -0.551 . . . . 73.340000000000003 109.647 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 66.6 m -70.65 -31.46 68.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.403 0.62 . . . . 74.319999999999993 109.608 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 95.5 mttt . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 72.439999999999998 109.514 175.786 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 17' ' ' LEU . 2.4 mm? . . . . . 0 N--CA 1.406 -2.63 0 N-CA-C 107.748 -1.205 . . . . 60.100000000000001 107.748 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.584 ' O ' HG12 ' A' ' 79' ' ' VAL . 39.7 m-70 -112.5 159.32 18.9 Favored 'General case' 0 C--N 1.262 -3.233 0 N-CA-C 108.085 -1.08 . . . . 73.040000000000006 108.085 -173.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.442 ' HB2' HG12 ' A' ' 113' ' ' VAL . 46.3 m-20 -117.04 125.83 51.92 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.108 -1.441 . . . . 73.329999999999998 107.108 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.2 t -119.38 137.72 52.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 110.391 -0.225 . . . . 70.120000000000005 110.391 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.482 ' HB2' HG21 ' A' ' 113' ' ' VAL . 70.1 t80 -94.91 122.08 37.17 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.442 -0.948 . . . . 61.030000000000001 108.442 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -103.2 105.71 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.224 1.011 . . . . 63.420000000000002 111.135 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.487 ' HB2' HD11 ' A' ' 63' ' ' ILE . 43.2 p90 -72.08 -18.87 61.89 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.003 -1.453 . . . . 74.439999999999998 114.272 -173.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.72 -40.22 0.3 Allowed Glycine 0 CA--C 1.499 -0.921 0 C-N-CA 118.979 -1.581 . . . . 72.430000000000007 112.947 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -58.06 -36.49 72.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.869 0.467 . . . . 53.039999999999999 112.189 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.661 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 49.3 m-85 -134.75 37.35 3.08 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.472 0.654 . . . . 51.109999999999999 109.435 -176.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -86.18 -4.78 59.24 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.6 -0.727 . . . . 43.450000000000003 110.962 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -105.8 121.12 46.92 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 109.381 -0.6 . . . . 74.209999999999994 109.381 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 11.7 Cg_endo -56.89 -31.53 89.48 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.159 2.573 . . . . 65.439999999999998 113.934 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.03 -33.64 74.98 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.409 0.624 . . . . 63.32 109.973 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.28 -39.15 82.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.172 -0.922 . . . . 64.420000000000002 108.792 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.562 HG23 HD21 ' A' ' 36' ' ' LEU . 44.5 mm -62.56 -37.41 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.285 -0.871 . . . . 71.239999999999995 110.361 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.87 -50.17 66.88 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.57 0.7 . . . . 73.420000000000002 110.287 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.85 -44.9 19.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 114.222 1.194 . . . . 72.030000000000001 114.222 -173.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.661 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 5.9 tmm? -62.33 -36.55 82.52 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.06 0.457 . . . . 74.340000000000003 110.707 -173.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.562 HD21 HG23 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -116.71 -75.13 0.58 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 120.491 -0.484 . . . . 71.340000000000003 111.926 178.241 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.9 t70 173.18 -47.74 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.292 0.568 . . . . 72.319999999999993 111.116 -175.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HD2' ' OE2' ' A' ' 83' ' ' GLU . 4.6 ptp180 -126.57 164.47 21.15 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.507 -0.769 . . . . 72.310000000000002 109.75 -174.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.6 m -124.63 108.87 28.6 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-O 120.59 0.233 . . . . 75.310000000000002 110.704 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -63.57 152.07 82.03 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.58 2.853 . . . . 74.140000000000001 111.768 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -56.51 137.56 53.14 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 123.635 0.584 . . . . 64.239999999999995 109.591 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.4 mt -115.59 137.33 49.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 116.297 -0.41 . . . . 74.540000000000006 111.179 -170.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.3 146.46 34.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.096 -0.705 . . . . 73.530000000000001 109.096 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 m -77.0 127.37 32.57 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.085 -0.709 . . . . 64.530000000000001 109.085 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' A' ' 102' ' ' ILE . . . -143.58 159.41 42.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.208 0.528 . . . . 74.420000000000002 111.994 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.4 m -119.45 131.89 55.7 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.585 -0.734 . . . . 54.509999999999998 110.779 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -101.6 103.41 27.67 Favored Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-N 115.55 -0.75 . . . . 54.399999999999999 109.484 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.2 142.61 7.48 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.241 1.96 . . . . 62.439999999999998 111.553 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.46 7.75 60.26 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.451 -0.88 . . . . 71.099999999999994 111.556 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -145.35 143.53 30.19 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 107.0 -1.481 . . . . 54.32 107.0 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.434 ' HB2' ' HA3' ' A' ' 69' ' ' GLY . 62.4 tt0 -143.04 142.82 31.67 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.705 -1.22 . . . . 74.239999999999995 107.705 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -91.21 125.83 36.11 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 119.978 -0.689 . . . . 75.510000000000005 109.542 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 11.6 m-30 -107.67 135.64 48.77 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.942 -1.026 . . . . 73.219999999999999 108.653 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 . . . . . 0 C--N 1.288 -2.097 0 CA-C-O 121.774 0.797 . . . . 63.350000000000001 112.525 -175.464 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 N--CA 1.442 -0.836 0 N-CA-C 107.895 -1.15 . . . . 63.140000000000001 107.895 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 9.7 Cg_exo -72.19 99.91 1.06 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 121.529 1.486 . . . . 71.310000000000002 108.758 171.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.496 ' SG ' ' HG2' ' A' ' 126' ' ' MET . 27.7 p -105.36 160.01 15.46 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.039 -0.528 . . . . 73.040000000000006 112.054 -172.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 23' ' ' TYR . 48.8 mm -94.64 125.08 47.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.764 -0.653 . . . . 61.32 109.656 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.13 146.94 63.22 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.54 -0.541 . . . . 74.409999999999997 109.54 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.32 104.91 0.27 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.653 2.235 . . . . 63.219999999999999 112.573 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -125.47 108.12 11.32 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.945 -1.132 . . . . 71.540000000000006 107.945 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.27 -27.25 68.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.946 0.403 . . . . 74.200000000000003 111.807 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -90.62 8.09 36.0 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.151 -0.477 . . . . 74.510000000000005 111.447 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 51' ' ' GLN . . . -129.23 171.35 20.02 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.791 -1.195 . . . . 43.310000000000002 114.103 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.8 143.65 17.3 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.231 1.012 . . . . 73.530000000000001 108.483 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.439 HG21 HD12 ' A' ' 63' ' ' ILE . 57.5 t -114.18 122.9 69.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.772 -0.455 . . . . 63.030000000000001 109.772 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -95.46 116.31 28.63 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.938 -1.134 . . . . 74.519999999999996 107.938 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.453 ' C ' ' HD3' ' A' ' 74' ' ' LYS . . . -148.47 -155.43 6.67 Favored Glycine 0 N--CA 1.415 -2.711 0 C-N-CA 120.242 -0.98 . . . . 63.539999999999999 111.558 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 2.7 mppt? -122.56 149.2 44.28 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 112.916 0.709 . . . . 44.25 112.916 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.1 t -110.2 129.21 65.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-N 113.99 -1.459 . . . . 73.040000000000006 111.552 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.429 HD23 HG12 ' A' ' 42' ' ' ILE . 83.0 mt -95.68 108.37 20.66 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.127 -1.435 . . . . 62.229999999999997 107.127 175.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.8 ptp -111.49 147.53 35.12 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 120.922 0.392 . . . . 73.420000000000002 111.459 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.65 17.12 53.41 Favored Glycine 0 N--CA 1.42 -2.384 0 C-N-CA 119.533 -1.318 . . . . 72.030000000000001 111.311 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 18' ' ' HIS . 9.5 p -80.72 132.29 31.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.028 -0.73 . . . . 71.140000000000001 109.028 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -75.75 159.91 30.57 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 108.464 -0.939 . . . . 72.209999999999994 108.464 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.4 m -59.32 -26.6 65.16 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 112.547 0.573 . . . . 73.209999999999994 112.547 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -70.87 -47.22 60.44 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.036 0.446 . . . . 64.030000000000001 110.766 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 1.2 mp0 -68.7 -28.79 67.16 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.153 -0.684 . . . . 74.239999999999995 109.153 176.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.515 ' HG ' ' NH2' ' A' ' 97' ' ' ARG . 42.1 tp -62.77 -50.85 69.4 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 120.882 0.372 . . . . 71.140000000000001 110.345 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.82 -29.8 70.33 Favored 'General case' 0 C--O 1.208 -1.106 0 N-CA-C 109.687 -0.486 . . . . 61.119999999999997 109.687 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 16.9 t-20 -59.16 -47.86 83.76 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.627 0.771 . . . . 70.299999999999997 109.964 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.544 ' HA ' HG12 ' A' ' 90' ' ' VAL . 97.5 mt -64.65 -37.01 86.11 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.225 -0.898 . . . . 71.310000000000002 111.27 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.543 ' HB2' ' NH2' ' A' ' 97' ' ' ARG . 19.1 t70 -73.54 -30.7 63.24 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 121.211 0.529 . . . . 72.310000000000002 110.096 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.24 -46.56 64.19 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.051 0.453 . . . . 75.129999999999995 110.323 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 87' ' ' LEU . 13.6 p -72.35 -50.56 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.531 0 CA-C-N 115.819 -0.628 . . . . 63.329999999999998 112.325 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -77.85 -30.29 50.87 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 112.731 0.641 . . . . 71.439999999999998 112.731 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.02 -17.36 22.45 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 114.704 0.641 . . . . 63.130000000000003 114.704 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.56 -37.4 81.16 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 122.132 0.173 . . . . 52.229999999999997 110.54 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.53 -9.57 3.63 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.39 0.515 . . . . 52.130000000000003 112.39 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -126.28 167.38 15.56 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.281 -0.262 . . . . 72.219999999999999 111.076 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 38.4 tt0 -123.7 146.39 48.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.444 -0.576 . . . . 43.439999999999998 109.444 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.543 ' NH2' ' HB2' ' A' ' 88' ' ' ASP . 34.4 ttm180 -89.41 128.74 35.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.759 0.314 . . . . 71.430000000000007 110.838 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 m -133.08 162.34 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.023 0 CA-C-N 115.894 -0.594 . . . . 70.120000000000005 111.42 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.5 t -103.72 124.04 48.15 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 114.972 -1.013 . . . . 71.109999999999999 108.272 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.29 165.21 32.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 116.213 -0.449 . . . . 63.329999999999998 111.419 -173.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.35 123.68 7.88 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.982 -0.847 . . . . 61.509999999999998 110.982 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.443 HD13 ' HB1' ' A' ' 45' ' ' ALA . 2.7 pp -117.42 165.1 13.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 110.244 -0.28 . . . . 70.519999999999996 110.244 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 80.6 t -128.25 125.83 64.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.554 -0.535 . . . . 54.530000000000001 109.554 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.619 ' HB3' ' OD1' ' A' ' 106' ' ' ASP . 34.4 mtp180 -64.71 128.55 36.26 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 124.369 1.068 . . . . 74.299999999999997 111.845 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -71.36 -18.62 62.36 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.482 0.713 . . . . 60.020000000000003 110.952 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.619 ' OD1' ' HB3' ' A' ' 104' ' ' ARG . 7.8 p-10 -78.51 -41.61 31.89 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.113 -0.494 . . . . 74.209999999999994 112.237 -173.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.79 16.45 1.78 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.188 0.81 . . . . 73.310000000000002 113.188 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.9 m 68.0 14.62 9.39 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.99 1.107 . . . . 74.319999999999993 113.99 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -75.59 145.85 40.84 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.052 -0.405 . . . . 61.310000000000002 110.905 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -96.51 147.78 23.49 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.165 -0.47 . . . . 73.109999999999999 109.895 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.411 ' HE2' HD11 ' A' ' 102' ' ' ILE . 35.4 mtm -145.43 163.15 35.52 Favored 'General case' 0 CA--C 1.473 -1.99 0 CA-C-O 121.306 0.574 . . . . 74.109999999999999 110.347 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.84 123.03 48.41 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 114.31 -1.314 . . . . 75.420000000000002 108.435 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.7 m -132.96 169.66 21.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.232 0.539 . . . . 64.239999999999995 111.446 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -103.87 134.15 47.65 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.72 -1.215 . . . . 73.030000000000001 107.72 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.4 t -135.92 171.11 14.94 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.832 -0.803 . . . . 75.230000000000004 108.832 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.0 m-85 -121.51 125.88 47.87 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.824 -0.806 . . . . 74.540000000000006 108.824 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.39 157.97 41.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.348 -0.387 . . . . 74.439999999999998 110.121 -176.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.469 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 61.1 t-105 -67.54 130.94 44.62 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.188 0.595 . . . . 74.200000000000003 109.88 -175.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.5 mp -73.57 -44.19 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 112.252 0.464 . . . . 71.519999999999996 112.252 -172.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -67.35 -43.63 81.03 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.42 -0.585 . . . . 51.130000000000003 109.42 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? 51.07 17.97 0.51 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.158 1.783 . . . . 71.540000000000006 113.968 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.34 1.73 5.7 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.422 0.527 . . . . 63.210000000000001 112.422 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.22 121.46 56.07 Favored Pre-proline 0 N--CA 1.483 1.217 0 N-CA-C 111.649 0.24 . . . . 64.239999999999995 111.649 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.24 -17.79 50.21 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.568 2.179 . . . . 54.439999999999998 111.41 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.82 -41.08 73.69 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.137 -0.938 . . . . 71.430000000000007 110.754 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.496 ' HG2' ' SG ' ' A' ' 62' ' ' CYS 0.329 0.0 OUTLIER . . . . . 0 N--CA 1.419 -1.979 0 CA-C-O 122.809 1.29 . . . . 72.230000000000004 113.106 -178.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.606 ' O ' HG12 ' A' ' 144' ' ' ILE . 64.9 tttm . . . . . 0 N--CA 1.462 0.174 0 N-CA-C 109.775 -0.454 . . . . 70.430000000000007 109.775 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.1 mmmt -54.67 -40.31 68.93 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 114.206 1.187 . . . . 71.099999999999994 114.206 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -55.44 -43.48 75.44 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.542 1.163 . . . . 73.219999999999999 109.507 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -73.9 -35.27 64.64 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 113.719 -1.582 . . . . 74.230000000000004 109.192 -175.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 140' ' ' LYS . 33.4 mm -72.19 -38.65 63.1 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.054 0 CA-C-N 115.747 -0.661 . . . . 64.549999999999997 110.831 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 17.1 mm-40 -59.69 -32.43 70.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.227 0.537 . . . . 73.310000000000002 110.471 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.2 m -70.29 -47.21 62.21 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.021 -0.991 . . . . 74.409999999999997 108.904 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -71.06 -28.62 64.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.412 1.264 . . . . 64.150000000000006 114.412 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -57.75 -38.07 74.73 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.751 -1.203 . . . . 61.43 107.751 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -71.46 -28.83 64.22 Favored 'General case' 0 C--O 1.227 -0.09 0 CA-C-N 115.742 -0.663 . . . . 73.010000000000005 110.459 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.426 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 68.3 mt -72.62 -31.31 36.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.664 -0.698 . . . . 74.299999999999997 109.453 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 65.0 mtt -63.36 -41.16 98.81 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.667 -0.864 . . . . 64.140000000000001 108.667 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -61.68 -35.92 79.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.092 -0.958 . . . . 74.540000000000006 110.045 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 84.3 m -67.41 -31.25 71.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.667 -0.697 . . . . 64.340000000000003 111.431 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 74.7 mmtt . . . . . 0 C--O 1.236 0.346 0 N-CA-C 108.362 -0.977 . . . . 64.230000000000004 108.362 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.41 -2.443 0 N-CA-C 108.406 -0.961 . . . . 73.400000000000006 108.406 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.514 ' O ' HG12 ' A' ' 79' ' ' VAL . 47.3 m-70 -114.0 159.99 19.34 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 115.785 -0.643 . . . . 73.299999999999997 110.043 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 77' ' ' MET . 17.0 p30 -130.31 128.22 41.07 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.905 -1.043 . . . . 73.439999999999998 111.483 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.7 t -127.53 142.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.771 -1.104 . . . . 44.310000000000002 109.516 -174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -93.81 123.23 37.01 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.582 -1.266 . . . . 74.150000000000006 107.582 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -96.8 136.98 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-O 121.285 0.564 . . . . 75.109999999999999 111.54 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.49 ' HD2' ' O ' ' A' ' 61' ' ' PRO . 24.1 p90 -109.27 -50.2 3.03 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.817 1.043 . . . . 64.219999999999999 113.817 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -151.43 -49.83 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 118.093 -2.003 . . . . 31.210000000000001 115.411 -174.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.8 m -58.88 -37.02 75.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.583 0.692 . . . . 42.450000000000003 111.559 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.659 ' HB3' HD11 ' A' ' 32' ' ' ILE . 36.6 m-85 -119.76 37.67 4.13 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.898 -0.592 . . . . 74.140000000000001 110.763 -176.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.41 23.14 0.07 Allowed 'General case' 0 CA--C 1.576 1.943 0 CA-C-O 121.647 0.737 . . . . 71.040000000000006 110.754 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 26' ' ' PHE . 25.9 t70 -150.15 129.97 6.64 Favored Pre-proline 0 C--N 1.308 -1.229 0 C-N-CA 123.707 0.803 . . . . 72.450000000000003 109.321 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.553 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 63.5 Cg_endo -73.22 -24.48 16.8 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.233 1.956 . . . . 74.030000000000001 113.177 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.85 -38.65 83.41 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.78 0.324 . . . . 73.120000000000005 110.969 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.22 -28.93 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.108 0.48 . . . . 74.010000000000005 110.044 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 26' ' ' PHE . 37.1 mm -58.99 -37.78 69.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.918 -0.583 . . . . 64.310000000000002 110.258 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.83 -44.51 70.32 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.688 0.756 . . . . 64.120000000000005 110.342 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.58 -41.88 17.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 114.701 -1.136 . . . . 73.530000000000001 113.256 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.524 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.5 tmm? -65.95 -37.48 86.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.871 -0.332 . . . . 74.450000000000003 111.14 -171.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.583 HD21 HG23 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -116.88 -66.74 1.05 Allowed 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.656 -0.818 . . . . 71.450000000000003 111.383 176.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 27.6 t70 167.51 -52.22 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 123.785 0.678 . . . . 72.349999999999994 109.47 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -108.52 164.1 12.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.198 -0.91 . . . . 72.349999999999994 109.619 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 m -114.0 106.01 53.77 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 108.514 -0.921 . . . . 64.219999999999999 108.514 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.86 151.56 32.47 Favored 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 123.397 2.731 . . . . 64.420000000000002 111.952 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -64.62 128.68 36.83 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.306 -0.998 . . . . 64.430000000000007 108.306 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 38.3 mt -109.28 136.65 44.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 116.02 -0.536 . . . . 72.510000000000005 110.1 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.71 146.13 34.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.059 -0.519 . . . . 65.540000000000006 109.711 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.5 m -76.35 126.18 30.53 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.769 -0.826 . . . . 65.219999999999999 108.769 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.4 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -140.12 156.04 46.73 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.623 0.725 . . . . 63.310000000000002 111.156 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.459 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 57.3 m -113.5 126.71 55.62 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.336 -0.847 . . . . 63.240000000000002 108.972 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 50' ' ' PHE . 45.5 tp -100.21 101.03 13.12 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 109.507 -0.553 . . . . 74.519999999999996 109.507 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 46' ' ' THR . 77.9 Cg_endo -86.99 144.12 7.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.383 2.056 . . . . 71.030000000000001 111.828 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.14 5.74 62.09 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.234 -0.747 . . . . 65.540000000000006 111.234 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.553 ' HA ' ' H ' ' A' ' 66' ' ' SER . 90.0 m-85 -144.23 152.23 40.55 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 107.664 -1.236 . . . . 74.049999999999997 107.664 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -139.65 145.78 38.88 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 108.653 -0.869 . . . . 61.509999999999998 108.653 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -90.69 132.15 35.96 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.614 -0.721 . . . . 74.519999999999996 109.552 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.63 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 3.8 m-85 -107.04 133.57 51.47 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 107.388 -1.338 . . . . 72.209999999999994 107.388 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 . . . . . 0 C--N 1.273 -2.749 0 CA-C-N 114.237 -1.347 . . . . 73.049999999999997 113.296 -167.139 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 N--CA 1.442 -0.842 0 N-CA-C 109.721 -0.474 . . . . 75.340000000000003 109.721 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 35.7 Cg_exo -61.73 103.98 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.129 1.886 . . . . 62.310000000000002 110.799 175.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 12.9 p -111.21 151.65 28.0 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.357 -0.838 . . . . 72.400000000000006 110.515 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.1 mm -93.98 139.25 18.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.405 -0.591 . . . . 54.350000000000001 109.405 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -142.48 151.46 57.74 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 107.948 -1.13 . . . . 72.329999999999998 107.948 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.532 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 34.3 Cg_endo -66.8 104.81 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.554 2.169 . . . . 63.409999999999997 112.613 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.553 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 33.4 t -125.09 102.17 7.37 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.172 -1.788 . . . . 75.310000000000002 106.172 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -55.1 -33.21 62.62 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.767 0.655 . . . . 64.200000000000003 112.767 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.98 5.42 44.3 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.799 -0.637 . . . . 73.140000000000001 111.732 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.84 171.83 14.13 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.257 -0.973 . . . . 71.219999999999999 113.395 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.67 149.1 24.88 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.791 1.236 . . . . 72.120000000000005 107.97 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.05 124.77 70.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.965 -0.383 . . . . 60.219999999999999 109.965 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -93.17 114.71 27.28 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.598 -1.26 . . . . 65.140000000000001 107.598 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.499 ' C ' ' HD2' ' A' ' 74' ' ' LYS . . . -146.96 -155.56 6.59 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 109.808 -1.317 . . . . 64.549999999999997 109.808 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.499 ' HD2' ' C ' ' A' ' 73' ' ' GLY . 14.0 mptt -127.22 152.21 47.68 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.815 0.817 . . . . 45.420000000000002 112.494 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 46.9 t -110.27 128.7 66.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 113.83 -1.532 . . . . 51.310000000000002 111.155 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 72.1 mt -96.59 109.99 22.49 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.719 -1.215 . . . . 63.030000000000001 107.719 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.51 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 17.0 ptp -121.67 151.25 40.66 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.571 0.224 . . . . 61.039999999999999 110.995 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.98 13.27 37.39 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 119.669 -1.253 . . . . 73.439999999999998 111.525 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.3 p -85.37 136.32 23.05 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 108.946 -0.761 . . . . 64.439999999999998 108.946 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 m -74.05 159.44 32.66 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.265 -0.642 . . . . 71.549999999999997 109.265 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -59.06 -38.37 79.25 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.575 0.584 . . . . 75.430000000000007 112.575 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.17 -48.72 80.54 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.547 0.689 . . . . 71.319999999999993 110.23 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 86' ' ' ASN . 38.8 mt-10 -69.21 -31.58 70.25 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 114.947 -1.024 . . . . 62.119999999999997 109.259 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.415 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.0 tm? -62.67 -40.16 96.19 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.449 -0.575 . . . . 64.540000000000006 109.449 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.58 -29.5 63.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.143 -0.481 . . . . 63.109999999999999 109.954 176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -67.59 -42.07 83.08 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.765 -0.652 . . . . 73.439999999999998 111.009 176.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.466 HD23 ' HE1' ' A' ' 35' ' ' MET . 97.2 mt -61.42 -43.6 98.59 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.962 -0.755 . . . . 72.109999999999999 108.962 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 28.3 t70 -64.94 -34.09 77.58 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.013 -0.994 . . . . 55.420000000000002 110.521 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.5 -44.01 68.49 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.025 -0.534 . . . . 64.239999999999995 111.024 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.4 t -72.71 -57.36 7.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 112.911 0.708 . . . . 73.430000000000007 112.911 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.45 -22.77 50.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.338 0.59 . . . . 51.039999999999999 111.397 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -63.07 -15.95 56.96 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.2 -0.909 . . . . 70.340000000000003 114.979 -177.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -68.01 -45.75 73.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.629 0.715 . . . . 63.310000000000002 112.237 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.27 -10.4 12.72 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.395 -0.522 . . . . 63.100000000000001 111.8 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -125.6 167.1 15.54 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.61 -0.885 . . . . 71.140000000000001 108.61 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 35.0 tt0 -123.19 145.92 48.23 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.175 -0.676 . . . . 74.310000000000002 109.175 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -87.08 114.5 23.74 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.87 -0.789 . . . . 73.340000000000003 108.87 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.5 m -120.99 160.42 21.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 116.117 -0.492 . . . . 51.200000000000003 110.052 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.1 t -99.81 127.28 45.98 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.484 -0.932 . . . . 72.219999999999999 108.484 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.89 172.06 16.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.192 -0.458 . . . . 71.329999999999998 111.489 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -115.32 128.64 8.17 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.499 -0.64 . . . . 62.43 111.499 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.12 161.95 16.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 123.132 0.573 . . . . 72.439999999999998 110.144 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 51.1 t -121.63 123.84 70.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 106.73 -1.581 . . . . 72.209999999999994 106.73 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.674 ' HD3' ' SD ' ' A' ' 111' ' ' MET . 12.4 mtm180 -79.15 135.62 36.87 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.054 -1.059 . . . . 75.0 110.327 -175.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.61 12.44 5.77 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 122.919 1.342 . . . . 70.010000000000005 108.131 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 104' ' ' ARG . 10.1 t70 -89.32 -53.07 4.72 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 126.564 1.946 . . . . 72.299999999999997 111.201 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -138.43 7.23 2.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.21 -0.45 . . . . 64.510000000000005 112.018 -174.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.3 t 71.57 8.68 6.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.211 1.004 . . . . 72.519999999999996 112.541 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -85.51 148.4 25.98 Favored 'General case' 0 CA--C 1.492 -1.264 0 C-N-CA 120.73 -0.388 . . . . 71.030000000000001 110.228 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 64.0 pttt -98.93 140.99 32.26 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-N 115.753 -0.658 . . . . 71.019999999999996 109.762 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.674 ' SD ' ' HD3' ' A' ' 104' ' ' ARG . 87.9 mtp -134.81 161.16 35.97 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.171 -0.922 . . . . 72.310000000000002 111.269 -175.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.11 130.05 50.15 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.632 -1.167 . . . . 64.099999999999994 109.092 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.0 m -141.5 174.03 7.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 108.43 -0.952 . . . . 75.219999999999999 108.43 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -107.15 150.56 26.45 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.206 -0.664 . . . . 71.040000000000006 109.206 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.9 t -144.32 170.98 14.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.166 -1.05 . . . . 71.439999999999998 108.166 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 70.8 m-85 -117.54 121.52 41.19 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.536 -0.913 . . . . 71.439999999999998 108.536 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.532 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 25.7 ptt? -115.96 155.13 28.58 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.26 -0.427 . . . . 63.329999999999998 110.57 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 60.1 t-105 -73.27 124.92 26.63 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.105 0.878 . . . . 72.019999999999996 108.688 -178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.442 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.8 mp -73.49 -41.78 56.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 112.572 0.582 . . . . 71.200000000000003 112.572 -172.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -69.8 -40.52 75.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 121.002 -0.279 . . . . 72.25 111.718 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 68.99 -4.36 1.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.155 1.169 . . . . 72.120000000000005 114.155 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.87 12.84 6.28 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.094 1.516 . . . . 73.150000000000006 115.094 -171.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.47 130.7 93.26 Favored Pre-proline 0 N--CA 1.483 1.213 0 O-C-N 122.274 -0.266 . . . . 71.209999999999994 111.347 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.33 14.02 0.81 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.477 2.785 . . . . 73.239999999999995 113.888 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -89.96 -11.38 41.86 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.353 0.597 . . . . 72.200000000000003 110.496 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.784 0 CA-C-N 115.154 -0.93 . . . . 64.340000000000003 109.218 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.612 ' O ' HG12 ' A' ' 144' ' ' ILE . 86.3 tttt . . . . . 0 C--O 1.221 -0.406 0 N-CA-C 109.358 -0.608 . . . . 70.25 109.358 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -48.44 -39.69 23.66 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.806 1.642 . . . . 71.040000000000006 111.627 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.29 -40.03 95.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.843 -0.617 . . . . 54.109999999999999 111.109 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -76.19 -32.25 58.9 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.489 -0.56 . . . . 75.140000000000001 109.489 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 140' ' ' LYS . 50.7 mm -56.58 -33.42 39.56 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.757 0 CA-C-N 115.371 -0.831 . . . . 63.32 111.803 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.4 -31.25 65.64 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.229 0.468 . . . . 73.209999999999994 111.931 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.9 m -80.67 -41.94 22.9 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.941 -0.763 . . . . 73.329999999999998 108.941 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -70.88 -30.05 66.32 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 115.357 1.614 . . . . 61.439999999999998 115.357 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 60.1 mtpt -55.52 -38.69 69.56 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 117.926 0.33 . . . . 70.099999999999994 110.712 176.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -67.3 -38.79 85.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.733 0.777 . . . . 74.200000000000003 109.363 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 67.5 mt -69.94 -41.41 79.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.83 -1.077 . . . . 62.439999999999998 109.665 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 67.1 mtt -67.92 -48.53 65.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.898 -0.592 . . . . 71.010000000000005 110.978 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 37.3 mt-10 -62.12 -30.55 71.11 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 111.89 0.33 . . . . 75.120000000000005 111.89 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 42.7 t -61.46 -42.46 98.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.414 -0.357 . . . . 75.239999999999995 110.396 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 C--N 1.324 -0.5 0 C-N-CA 121.004 -0.279 . . . . 63.140000000000001 110.872 179.398 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.401 HD13 ' HA2' ' A' ' 78' ' ' GLY . 87.3 mt . . . . . 0 N--CA 1.428 -1.562 0 CA-C-O 120.913 0.387 . . . . 74.239999999999995 110.27 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -124.73 161.25 26.78 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.597 -0.89 . . . . 62.229999999999997 108.597 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 14.7 p30 -128.66 134.43 48.52 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.443 0.64 . . . . 74.209999999999994 111.81 172.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.6 142.95 41.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.419 -0.81 . . . . 74.030000000000001 110.078 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.529 ' HB2' HG21 ' A' ' 113' ' ' VAL . 76.1 t80 -94.74 122.61 37.53 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.707 -1.22 . . . . 75.019999999999996 107.707 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 m -93.16 120.03 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 CA-C-O 121.857 0.837 . . . . 71.0 110.01 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.415 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 8.2 p90 -88.48 -79.05 0.32 Allowed 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 114.629 1.344 . . . . 71.549999999999997 114.629 -172.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.93 -44.25 0.24 Allowed Glycine 0 CA--C 1.492 -1.392 0 C-N-CA 119.624 -1.275 . . . . 52.409999999999997 112.044 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 p -62.39 -36.48 82.45 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 112.358 0.503 . . . . 72.200000000000003 112.358 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 59.5 m-85 -124.67 26.66 7.11 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 112.564 0.579 . . . . 65.140000000000001 112.564 -177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 23' ' ' TYR . 28.5 pt20 -68.07 -1.05 5.17 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.208 0.818 . . . . 75.209999999999994 113.208 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 31' ' ' VAL . 20.1 t70 -129.56 138.81 33.96 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 108.755 -0.832 . . . . 74.209999999999994 108.755 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 18.9 Cg_endo -60.4 -32.9 94.48 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.296 1.998 . . . . 73.209999999999994 114.017 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.78 -35.94 81.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 120.999 -0.281 . . . . 64.530000000000001 111.641 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 28' ' ' ASP . 11.6 p -70.64 -29.83 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 119.779 -0.768 . . . . 71.409999999999997 110.153 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.2 mm -70.85 -43.52 76.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-O 122.073 0.94 . . . . 64.430000000000007 108.938 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 7.4 t-20 -54.19 -51.68 63.6 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 112.997 -1.91 . . . . 71.510000000000005 110.607 -177.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.8 p -78.09 -35.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.56 -0.746 . . . . 73.219999999999999 112.042 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.5 tmm? -67.62 -37.08 81.97 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 121.247 -0.181 . . . . 60.439999999999998 111.213 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.531 HD12 ' H ' ' A' ' 37' ' ' ASP 0.402 3.0 pp -115.0 -56.48 2.37 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 115.448 1.647 . . . . 73.430000000000007 115.448 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.531 ' H ' HD12 ' A' ' 36' ' ' LEU . 27.1 t70 162.78 -52.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.133 0.973 . . . . 71.230000000000004 109.665 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -106.64 -168.0 1.36 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.512 -1.222 . . . . 65.329999999999998 109.815 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.9 m -149.69 108.28 3.3 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 108.823 -0.806 . . . . 74.510000000000005 108.823 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 46.6 Cg_exo -59.29 150.73 72.64 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.941 2.427 . . . . 73.150000000000006 111.705 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.12 123.26 16.6 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.082 0.553 . . . . 75.310000000000002 110.449 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.582 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 51.3 mt -97.84 143.53 12.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.812 -0.631 . . . . 74.099999999999994 111.117 -173.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.509 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 14.6 p -128.94 146.75 33.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.566 -0.901 . . . . 74.040000000000006 108.566 175.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.446 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 19.0 m -77.03 123.92 27.04 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.36 -0.607 . . . . 55.32 109.36 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -140.0 157.58 45.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.784 0.802 . . . . 51.520000000000003 112.351 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 m -119.7 126.55 51.37 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.864 -1.062 . . . . 75.510000000000005 108.96 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.7 tp -98.75 104.91 27.5 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 109.747 -0.464 . . . . 70.420000000000002 109.747 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 74.7 Cg_endo -84.03 137.68 7.53 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 122.471 2.114 . . . . 41.25 112.658 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.6 11.75 56.59 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.814 -0.63 . . . . 62.520000000000003 112.748 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -140.6 161.66 37.23 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.995 -0.743 . . . . 74.409999999999997 108.995 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -139.83 146.06 38.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.802 -0.444 . . . . 73.219999999999999 109.802 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HE ' HG13 ' A' ' 71' ' ' VAL . 13.9 ptp180 -102.69 142.12 34.37 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.248 -1.019 . . . . 74.340000000000003 108.248 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 126' ' ' MET . 28.1 m-85 -113.45 135.16 54.18 Favored 'General case' 0 C--N 1.265 -3.092 0 N-CA-C 107.95 -1.13 . . . . 71.450000000000003 107.95 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 . . . . . 0 C--N 1.314 -0.959 0 C-N-CA 119.557 -0.857 . . . . 63.43 110.494 -177.38 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 109.037 -0.727 . . . . 73.099999999999994 109.037 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 18.5 Cg_endo -67.38 96.8 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.697 1.598 . . . . 74.109999999999999 109.927 173.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.0 p -100.05 166.79 10.86 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 113.299 0.851 . . . . 72.129999999999995 113.299 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 71' ' ' VAL . 45.1 mm -109.52 143.13 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 115.052 -0.977 . . . . 62.409999999999997 109.28 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.9 m -143.93 151.45 52.76 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.815 -1.18 . . . . 71.140000000000001 107.815 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 18.5 Cg_endo -60.57 133.48 48.89 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.224 1.95 . . . . 71.5 111.187 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.6 t -124.8 144.08 50.46 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 116.215 -0.448 . . . . 55.439999999999998 109.884 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -73.11 -34.43 66.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 74.049999999999997 110.363 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.9 81.07 1.88 Allowed 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.254 -0.647 . . . . 72.349999999999994 109.254 174.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.26 153.17 24.08 Favored Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 119.735 -1.222 . . . . 21.219999999999999 112.431 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.31 139.92 24.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.871 -0.789 . . . . 75.450000000000003 108.871 175.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.537 HG13 ' HE ' ' A' ' 52' ' ' ARG . 51.7 t -113.77 119.95 62.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 120.831 0.348 . . . . 73.219999999999999 110.78 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -89.33 116.4 27.51 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.689 -1.226 . . . . 73.099999999999994 107.689 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.08 -151.21 5.48 Favored Glycine 0 N--CA 1.421 -2.342 0 N-CA-C 110.939 -0.864 . . . . 55.020000000000003 110.939 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.582 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.5 mmtm -132.26 146.59 52.1 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 110.099 -0.334 . . . . 72.409999999999997 110.099 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.509 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 42.3 t -111.33 138.53 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 122.35 0.26 . . . . 73.400000000000006 111.199 175.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.453 HD23 HG12 ' A' ' 42' ' ' ILE . 82.9 mt -94.97 112.02 23.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.43 -0.952 . . . . 71.230000000000004 108.43 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 84.2 mmm -93.91 154.93 17.44 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 123.537 0.735 . . . . 71.040000000000006 111.097 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.401 ' HA2' HD13 ' A' ' 17' ' ' LEU . . . 62.32 36.08 92.56 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 114.778 -1.101 . . . . 62.109999999999999 113.436 177.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.02 127.39 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 108.816 -0.809 . . . . 53.509999999999998 108.816 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.8 p -77.65 169.93 17.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.183 -0.673 . . . . 72.200000000000003 109.183 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 34.2 t -55.25 -48.15 74.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.673 -0.24 . . . . 21.030000000000001 110.548 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.47 -37.47 75.56 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.911 0.884 . . . . 64.409999999999997 112.76 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.542 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 39.5 mt-10 -76.51 -46.27 27.35 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 116.046 -0.525 . . . . 75.340000000000003 110.198 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.419 ' C ' HD23 ' A' ' 84' ' ' LEU . 7.0 tt -68.92 -41.25 78.41 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.447 -0.501 . . . . 75.340000000000003 112.053 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 81' ' ' SER . 12.3 pt-20 -62.78 -29.8 70.98 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.414 0.626 . . . . 74.109999999999999 109.869 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -74.96 -42.61 57.3 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 114.993 -1.003 . . . . 74.409999999999997 109.553 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.8 mt -60.41 -42.47 96.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.387 0.613 . . . . 62.340000000000003 109.66 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.01 -36.33 81.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.807 -1.088 . . . . 41.200000000000003 110.04 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.36 -48.71 21.76 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.379 -0.828 . . . . 62.310000000000002 112.021 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 87' ' ' LEU . 14.4 p -63.97 -47.94 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.277 0 C-N-CA 122.36 0.264 . . . . 64.409999999999997 111.643 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.33 -19.84 52.63 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.817 0.818 . . . . 71.010000000000005 110.654 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.86 -16.34 12.12 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 116.997 1.559 . . . . 53.049999999999997 116.997 -173.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -58.64 -44.56 90.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 118.088 0.944 . . . . 52.5 112.428 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.07 -1.73 3.65 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.002 1.112 . . . . 63.299999999999997 114.002 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -113.13 157.12 22.04 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.569 -0.53 . . . . 72.530000000000001 109.569 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.513 ' HB3' HD11 ' A' ' 119' ' ' ILE . 39.2 tt0 -123.94 155.11 38.75 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.29 -1.374 . . . . 65.010000000000005 107.29 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -86.96 114.57 23.7 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.11 -1.07 . . . . 75.530000000000001 108.11 -176.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.3 m -117.32 153.76 19.12 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 120.883 -0.327 . . . . 65.239999999999995 110.162 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -95.63 132.83 40.37 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.218 -0.66 . . . . 55.409999999999997 109.218 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.75 162.76 31.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 120.964 0.411 . . . . 71.120000000000005 111.052 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.422 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -103.75 119.79 6.47 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.464 -1.055 . . . . 54.240000000000002 110.464 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 2.7 pp -111.69 158.22 12.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 110.017 -0.364 . . . . 62.329999999999998 110.017 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 99.6 t -121.23 120.58 62.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.472 -0.566 . . . . 75.349999999999994 109.472 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -62.24 137.32 58.24 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.145 -0.48 . . . . 74.319999999999993 111.244 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 43.4 mt-10 -83.38 -3.89 57.95 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.556 0.693 . . . . 74.430000000000007 110.044 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.11 -68.07 0.36 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.776 -1.102 . . . . 74.420000000000002 110.399 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -129.08 0.63 5.24 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.484 -1.234 . . . . 73.340000000000003 111.328 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m 64.34 80.46 0.23 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.048 0.928 . . . . 64.129999999999995 112.694 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 10.1 pt-20 -137.4 152.45 49.65 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.627 -1.249 . . . . 71.239999999999995 107.627 175.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 21.2 pttp -91.45 147.22 23.18 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.358 -0.608 . . . . 54.450000000000003 109.358 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 51.4 ttp -143.98 158.66 43.56 Favored 'General case' 0 N--CA 1.415 -2.225 0 N-CA-C 107.642 -1.244 . . . . 71.010000000000005 107.642 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.63 118.0 35.64 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.879 -0.328 . . . . 61.119999999999997 110.521 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.529 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.1 m -129.01 173.42 13.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 120.996 0.426 . . . . 70.230000000000004 110.287 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -101.74 143.41 31.71 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.63 -0.878 . . . . 73.319999999999993 108.63 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.8 t -143.51 171.5 14.07 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.069 -1.086 . . . . 75.239999999999995 108.069 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.407 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 62.9 m-85 -121.24 117.77 27.9 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.274 -1.01 . . . . 73.439999999999998 108.274 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.529 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 23.5 ptt? -118.04 156.4 28.67 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.796 -0.638 . . . . 74.109999999999999 110.798 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -68.78 118.96 12.41 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.239 -0.891 . . . . 70.519999999999996 108.599 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 96' ' ' GLU . 45.2 mm -72.74 -42.42 61.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.08 0.77 . . . . 64.340000000000003 113.08 -170.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -68.07 -28.61 67.52 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.197 -0.601 . . . . 65.519999999999996 110.378 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.288 9.6 ptpp? 56.38 -18.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.683 2.475 . . . . 74.209999999999994 117.683 173.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -116.66 84.21 2.1 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.459 0.647 . . . . 55.109999999999999 110.036 177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 126' ' ' MET . 10.3 m-20 -139.77 116.8 8.33 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.135 -0.939 . . . . 72.450000000000003 109.765 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -65.99 -13.6 40.6 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.54 2.16 . . . . 70.540000000000006 111.149 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.72 -34.68 74.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.118 0.967 . . . . 63.43 111.878 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.578 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.1 ptt? . . . . . 0 C--O 1.213 -0.83 0 CA-C-N 116.46 -0.336 . . . . 72.140000000000001 111.421 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.574 ' O ' HG12 ' A' ' 144' ' ' ILE . 38.7 ttpt . . . . . 0 C--O 1.211 -0.926 0 N-CA-C 110.287 -0.264 . . . . 61.130000000000003 110.287 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' A' ' 141' ' ' LYS . 0.6 OUTLIER -52.1 -31.66 31.63 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.831 0.852 . . . . 75.099999999999994 111.44 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -67.46 -44.13 79.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.029 0.918 . . . . 62.200000000000003 109.367 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.483 ' O ' HG22 ' A' ' 146' ' ' THR . 40.4 t80 -71.68 -36.44 70.62 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.817 -1.538 . . . . 63.520000000000003 110.151 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.2 mm -55.07 -32.7 27.89 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 CA-C-N 115.252 -0.885 . . . . 65.109999999999999 111.496 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -56.01 -38.48 70.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.197 0.814 . . . . 74.030000000000001 113.197 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 143' ' ' PHE . 7.6 t -77.97 -32.84 51.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.63 -0.878 . . . . 71.310000000000002 108.63 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -77.57 -33.56 53.92 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.267 -0.879 . . . . 71.340000000000003 111.094 -173.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 47.3 tttm -56.54 -42.19 78.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.343 -0.844 . . . . 64.340000000000003 110.187 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -66.89 -31.01 71.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.869 0.843 . . . . 65.120000000000005 110.34 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 73.6 mt -73.29 -47.32 46.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.185 -0.916 . . . . 73.530000000000001 109.345 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.9 ttt -64.18 -40.52 96.28 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.368 -0.833 . . . . 71.209999999999994 110.733 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 45.0 mt-10 -64.06 -29.83 70.95 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 116.451 -0.34 . . . . 75.030000000000001 111.914 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -70.83 -31.78 68.61 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.193 0.52 . . . . 74.319999999999993 109.974 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.5 mttm . . . . . 0 C--O 1.241 0.655 0 N-CA-C 112.61 0.596 . . . . 73.420000000000002 112.61 -178.428 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.411 -2.422 0 N-CA-C 106.102 -1.814 . . . . 70.019999999999996 106.102 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.458 ' HB2' ' HB ' ' A' ' 79' ' ' VAL . 27.0 m-70 -116.73 160.59 20.54 Favored 'General case' 0 C--N 1.266 -3.062 0 N-CA-C 109.244 -0.65 . . . . 74.209999999999994 109.244 -172.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 22.1 p-10 -130.74 129.39 42.44 Favored 'General case' 0 C--N 1.259 -3.335 0 CA-C-N 115.493 -0.776 . . . . 74.200000000000003 109.657 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.1 t -119.77 139.59 46.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.146 -0.934 . . . . 74.150000000000006 110.31 -173.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.437 ' HB2' HG21 ' A' ' 113' ' ' VAL . 88.7 t80 -93.89 122.34 36.27 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.303 -1.369 . . . . 54.409999999999997 107.303 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 m -104.19 129.97 55.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.551 0.691 . . . . 62.119999999999997 111.712 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -75.74 -22.01 56.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.956 -1.02 . . . . 54.219999999999999 113.238 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.04 -34.23 0.39 Allowed Glycine 0 CA--C 1.504 -0.615 0 C-N-CA 119.36 -1.4 . . . . 74.239999999999995 112.749 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.3 p -58.43 -36.6 73.89 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.213 0.605 . . . . 71.239999999999995 112.329 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -127.91 32.82 4.88 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.74 -0.664 . . . . 74.140000000000001 110.315 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -84.24 20.09 1.7 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.259 1.028 . . . . 54.030000000000001 109.647 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 31' ' ' VAL . 12.6 t70 -134.8 128.78 18.98 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.551 -1.277 . . . . 54.420000000000002 107.551 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.401 ' CB ' HG21 ' A' ' 39' ' ' THR . 34.9 Cg_endo -66.47 -32.65 39.54 Favored 'Trans proline' 0 C--O 1.219 -0.474 0 C-N-CA 121.873 1.715 . . . . 73.340000000000003 113.16 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.06 -34.7 66.42 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.555 -0.293 . . . . 72.349999999999994 111.197 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 28' ' ' ASP . 17.8 m -66.2 -29.48 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 119.852 -0.739 . . . . 62.350000000000001 109.963 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 mm -73.03 -41.35 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 122.013 0.911 . . . . 74.219999999999999 109.22 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -57.92 -39.43 77.96 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 113.732 -1.576 . . . . 73.120000000000005 110.227 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.32 -29.93 11.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.383 -0.826 . . . . 75.420000000000002 111.389 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -69.96 -31.89 69.84 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 120.982 0.42 . . . . 73.329999999999998 110.295 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.53 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.6 pt? -129.56 -69.74 0.68 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 120.282 -0.567 . . . . 71.109999999999999 112.371 172.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.53 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 26.4 t70 169.98 -48.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.149 0.976 . . . . 74.530000000000001 109.114 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -92.17 176.8 6.36 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.249 -1.341 . . . . 74.209999999999994 109.972 -176.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.401 HG21 ' CB ' ' A' ' 29' ' ' PRO . 55.1 m -149.41 124.41 4.85 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 116.341 -0.391 . . . . 55.439999999999998 110.063 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 23.7 Cg_exo -67.14 151.68 81.05 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.928 2.419 . . . . 31.420000000000002 110.69 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.42 136.18 51.26 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.638 -0.875 . . . . 74.450000000000003 108.638 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 3.5 mp -105.64 139.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 120.614 -0.434 . . . . 75.450000000000003 110.981 -172.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -131.67 146.11 34.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.83 -0.623 . . . . 71.209999999999994 109.795 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.7 m -77.74 123.34 26.58 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.213 -0.662 . . . . 75.420000000000002 109.213 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.95 157.29 47.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.489 0.661 . . . . 75.25 111.105 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 87.4 m -110.4 126.97 54.85 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.243 -0.89 . . . . 51.109999999999999 109.656 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.2 tp -102.81 97.25 8.95 Favored Pre-proline 0 N--CA 1.429 -1.511 0 N-CA-C 109.241 -0.651 . . . . 72.430000000000007 109.241 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 46' ' ' THR . 67.0 Cg_endo -83.29 143.66 11.3 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.199 1.933 . . . . 72.209999999999994 111.221 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.35 10.96 60.2 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.538 -0.839 . . . . 64.430000000000007 111.908 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -141.67 161.08 38.81 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 122.712 0.405 . . . . 72.400000000000006 110.05 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 6.5 tp-100 -140.86 149.2 41.65 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 123.068 0.23 . . . . 74.099999999999994 110.819 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.26 130.96 54.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.036 -0.728 . . . . 73.439999999999998 109.036 173.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 38.2 m-85 -108.36 135.33 49.83 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.43 -1.322 . . . . 74.329999999999998 107.43 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.42 -1.972 0 C-N-CA 117.816 -1.554 . . . . 74.439999999999998 111.491 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 . . . . . 0 N--CA 1.437 -1.118 0 N-CA-C 108.958 -0.756 . . . . 74.209999999999994 108.958 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 6.7 Cg_exo -73.78 79.38 2.27 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.587 1.525 . . . . 75.420000000000002 109.949 173.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 35.8 m -79.66 150.74 30.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.115 -0.948 . . . . 75.239999999999995 111.238 -174.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' GLN . 49.3 mm -103.8 138.99 26.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 CA-C-N 115.517 -0.765 . . . . 71.200000000000003 109.481 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.0 m -146.03 155.31 51.29 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 107.951 -1.129 . . . . 71.010000000000005 107.951 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.39 125.7 18.12 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.268 1.979 . . . . 40.140000000000001 112.55 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.3 t -124.09 128.5 49.39 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.443 -1.317 . . . . 72.010000000000005 107.443 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.27 -16.73 61.38 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 112.287 0.477 . . . . 63.5 112.287 -172.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -130.75 13.9 5.35 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.745 0.276 . . . . 61.0 111.745 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -111.42 169.63 13.33 Favored Glycine 0 C--O 1.244 0.728 0 C-N-CA 119.64 -1.267 . . . . 72.319999999999993 114.088 -175.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -154.82 138.16 15.8 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.647 -0.871 . . . . 63.520000000000003 108.647 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -113.28 122.26 67.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.792 -0.447 . . . . 70.510000000000005 109.792 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -96.05 116.81 29.53 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.255 -1.387 . . . . 62.340000000000003 107.255 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.96 -155.32 6.45 Favored Glycine 0 N--CA 1.417 -2.585 0 N-CA-C 110.912 -0.875 . . . . 71.540000000000006 110.912 -176.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -122.38 144.98 48.69 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.57 0.7 . . . . 62.399999999999999 111.939 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.0 t -111.17 131.73 61.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 114.357 -1.292 . . . . 72.219999999999999 111.319 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 81.0 mt -95.76 104.88 16.83 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.371 -0.974 . . . . 74.420000000000002 108.371 176.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 64.3 mtp -100.13 139.04 36.37 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 120.977 0.417 . . . . 75.299999999999997 111.044 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.13 18.67 10.95 Favored Glycine 0 C--N 1.29 -2.021 0 C-N-CA 120.435 -0.888 . . . . 73.319999999999993 111.637 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.676 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 88.4 t -70.3 128.17 33.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.667 -0.494 . . . . 54.530000000000001 109.667 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -77.86 167.77 20.98 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.771 -0.826 . . . . 74.530000000000001 108.771 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.3 p -64.37 -32.34 73.91 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.987 -0.685 . . . . 71.5 110.293 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.03 -51.07 51.15 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.757 -0.656 . . . . 74.329999999999998 110.058 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.676 ' OE1' ' HA ' ' A' ' 79' ' ' VAL . 44.5 tt0 -60.32 -39.57 87.52 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.727 -0.669 . . . . 73.310000000000002 110.175 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -57.35 -51.17 70.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.102 0.477 . . . . 74.420000000000002 110.411 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.56 -29.27 67.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.968 -0.56 . . . . 75.230000000000004 111.326 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.429 ' O ' HG23 ' A' ' 90' ' ' VAL . 7.0 t30 -65.57 -46.3 79.98 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.935 -0.765 . . . . 53.43 108.935 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 97.1 mt -64.93 -41.06 95.85 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.388 -0.824 . . . . 60.409999999999997 109.898 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.12 -32.81 73.43 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.649 -0.705 . . . . 71.400000000000006 110.722 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.22 62.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.011 -0.541 . . . . 74.209999999999994 110.854 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 86' ' ' ASN . 99.3 t -72.27 -56.71 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 123.16 0.584 . . . . 75.510000000000005 112.319 -178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.48 -22.76 47.02 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.041 0.448 . . . . 75.420000000000002 111.852 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.2 -17.02 36.41 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 115.519 0.967 . . . . 54.299999999999997 115.519 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.8 -45.17 93.9 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.772 0.786 . . . . 73.040000000000006 111.323 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -112.65 -9.21 13.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.44 -0.345 . . . . 73.540000000000006 111.721 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -129.74 167.48 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.58 0.228 . . . . 64.209999999999994 110.969 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 9.4 tp10 -123.08 144.65 49.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.118 -0.697 . . . . 73.040000000000006 109.118 175.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -88.12 114.14 24.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.782 -0.821 . . . . 75.530000000000001 108.782 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.51 160.54 36.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 116.316 -0.402 . . . . 64.409999999999997 110.755 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.1 t -95.41 132.08 40.85 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.626 -0.509 . . . . 74.150000000000006 109.626 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -138.11 165.17 26.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.904 -0.589 . . . . 75.5 110.759 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -104.27 123.11 7.6 Favored Glycine 0 N--CA 1.421 -2.337 0 CA-C-N 115.66 -0.7 . . . . 45.240000000000002 111.427 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 111' ' ' MET . 2.8 pp -118.18 152.78 20.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.669 -0.493 . . . . 65.430000000000007 109.669 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.8 131.47 65.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 108.49 -0.929 . . . . 35.399999999999999 108.49 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -70.52 125.65 27.42 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.444 0.465 . . . . 65.310000000000002 110.225 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.11 -4.21 46.26 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 123.208 0.317 . . . . 74.019999999999996 111.562 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.46 -60.53 3.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.1 -1.074 . . . . 62.340000000000003 108.1 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -117.79 -93.31 0.51 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.155 -1.384 . . . . 73.319999999999993 111.885 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.9 p -173.94 13.11 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.757 0.28 . . . . 74.430000000000007 111.757 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -85.02 145.43 27.7 Favored 'General case' 0 C--O 1.251 1.153 0 C-N-CA 120.302 -0.559 . . . . 70.439999999999998 111.211 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -93.72 144.66 25.2 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.901 0.857 . . . . 64.0 110.491 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.54 ' HB2' HD12 ' A' ' 102' ' ' ILE . 76.5 mmm -131.64 162.23 30.87 Favored 'General case' 0 C--N 1.275 -2.633 0 C-N-CA 124.973 1.309 . . . . 72.030000000000001 110.922 -175.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.54 126.82 53.24 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.156 -0.929 . . . . 61.310000000000002 109.073 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.457 HG12 ' CG ' ' A' ' 19' ' ' ASN . 32.7 m -141.07 173.32 9.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.742 -0.466 . . . . 74.299999999999997 109.742 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.65 151.74 22.6 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.461 -0.57 . . . . 72.439999999999998 109.461 171.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.4 t -147.28 172.04 14.48 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.696 -1.224 . . . . 73.310000000000002 107.696 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 92.1 m-85 -117.36 108.36 15.49 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.604 -0.517 . . . . 74.030000000000001 109.604 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -107.2 156.79 18.45 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.545 -0.752 . . . . 74.519999999999996 110.276 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.533 ' HD1' ' O ' ' A' ' 120' ' ' ASN . 33.7 t-105 -68.14 134.81 51.13 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 106.183 -1.784 . . . . 64.450000000000003 106.183 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.2 mp -67.81 -41.73 85.34 Favored 'Isoleucine or valine' 0 C--O 1.26 1.61 0 C-N-CA 118.894 -1.122 . . . . 71.430000000000007 110.506 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.533 ' O ' ' HD1' ' A' ' 118' ' ' TRP . 42.6 t30 -82.41 105.41 13.45 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.775 0.798 . . . . 72.310000000000002 109.353 177.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -77.24 -12.24 59.92 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.276 -0.875 . . . . 71.299999999999997 111.557 -172.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.52 76.36 1.71 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.763 -0.828 . . . . 72.329999999999998 108.763 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -93.34 130.42 35.67 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 115.115 -0.948 . . . . 41.020000000000003 108.989 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -81.0 -0.48 10.62 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.855 2.37 . . . . 73.540000000000006 114.174 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -94.23 -51.03 4.99 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 120.246 -0.582 . . . . 74.120000000000005 110.943 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' ' 126' ' ' MET . 23.7 ptt? . . . . . 0 N--CA 1.437 -1.082 0 C-N-CA 119.334 -0.946 . . . . 71.0 110.445 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.542 ' O ' HG12 ' A' ' 144' ' ' ILE . 37.6 ttmt . . . . . 0 C--O 1.225 -0.189 0 CA-C-O 120.924 0.392 . . . . 71.319999999999993 110.617 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 38.6 ttpt -52.78 -35.29 56.35 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.811 0.844 . . . . 74.430000000000007 112.234 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.51 -35.79 78.7 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.187 0.518 . . . . 64.150000000000006 110.307 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -76.48 -43.26 40.53 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.605 -0.887 . . . . 73.120000000000005 108.605 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.4 mm -59.54 -33.93 53.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-N 114.807 -1.088 . . . . 54.299999999999997 111.534 -176.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.2 mt-10 -54.28 -31.64 54.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.166 0.508 . . . . 75.230000000000004 111.337 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.7 m -81.09 -47.99 12.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.337 0.589 . . . . 23.129999999999999 110.868 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -76.69 -30.68 56.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 113.698 0.999 . . . . 72.340000000000003 113.698 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -56.13 -39.42 72.21 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.094 0.474 . . . . 74.030000000000001 110.778 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -71.76 -33.89 69.02 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.57 . . . . 74.129999999999995 109.848 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.2 mt -68.83 -38.76 79.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.494 -0.776 . . . . 72.450000000000003 109.497 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.8 ttt -64.68 -37.82 88.89 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.842 -0.617 . . . . 62.420000000000002 110.118 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.83 -30.89 65.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.092 -0.504 . . . . 64.019999999999996 110.514 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.2 -34.64 76.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.991 -0.55 . . . . 64.329999999999998 110.528 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 CA--C 1.507 -0.676 0 CA-C-O 121.42 0.628 . . . . 61.520000000000003 111.218 178.391 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.417 -2.09 0 N-CA-C 108.858 -0.793 . . . . 71.230000000000004 108.858 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' O ' HG12 ' A' ' 79' ' ' VAL . 48.9 m-70 -113.28 159.3 19.5 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 108.282 -1.007 . . . . 64.430000000000007 108.282 -173.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.464 ' CB ' HG12 ' A' ' 113' ' ' VAL . 36.9 m-20 -122.3 126.94 49.19 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.276 -1.379 . . . . 73.239999999999995 107.276 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -127.84 137.5 57.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 110.105 -0.332 . . . . 61.140000000000001 110.105 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.441 ' HB2' HG21 ' A' ' 113' ' ' VAL . 88.3 t80 -95.3 121.77 37.3 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.892 -0.781 . . . . 74.409999999999997 108.892 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 m -96.03 119.51 44.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 121.92 0.867 . . . . 65.510000000000005 111.019 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -74.97 -34.22 62.0 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 115.354 1.613 . . . . 72.349999999999994 115.354 -172.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.57 -50.49 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.172 0 C-N-CA 118.578 -1.772 . . . . 61.539999999999999 113.041 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.0 m -57.85 -35.62 71.18 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 122.75 0.42 . . . . 64.120000000000005 111.984 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.696 ' HB3' HD11 ' A' ' 32' ' ' ILE . 50.4 m-85 -122.95 29.23 6.87 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.47 -0.332 . . . . 70.049999999999997 110.658 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -85.78 31.02 0.62 Allowed 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.154 0.978 . . . . 74.030000000000001 109.86 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 31' ' ' VAL . 17.3 t70 -142.06 129.42 11.43 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 107.59 -1.263 . . . . 53.530000000000001 107.59 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HB3' HG21 ' A' ' 39' ' ' THR . 19.0 Cg_exo -66.92 -32.95 34.51 Favored 'Trans proline' 0 N--CA 1.478 0.573 0 C-N-CA 122.385 2.057 . . . . 52.310000000000002 112.525 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . 25.6 t70 -60.23 -40.09 88.96 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.622 -0.263 . . . . 74.310000000000002 111.247 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 28' ' ' ASP . 13.7 p -74.21 -29.45 24.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.58 -0.448 . . . . 41.350000000000001 110.182 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 26' ' ' PHE . 43.5 mm -64.88 -45.5 94.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 N-CA-C 109.89 -0.411 . . . . 75.420000000000002 109.89 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -57.08 -36.99 71.23 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.132 0.491 . . . . 51.229999999999997 111.249 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.3 t -80.24 -42.85 21.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 116.098 -0.501 . . . . 74.140000000000001 111.2 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.446 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 13.1 tmm? -69.44 -36.84 77.03 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.704 -0.225 . . . . 75.129999999999995 111.195 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 37' ' ' ASP 0.353 3.8 pp -119.66 -57.59 1.96 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 115.092 1.515 . . . . 74.340000000000003 115.092 178.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.571 ' N ' HD12 ' A' ' 36' ' ' LEU . 29.2 t70 176.09 -55.04 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.453 0.644 . . . . 75.120000000000005 110.19 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.592 ' O ' HG22 ' A' ' 32' ' ' ILE . 36.5 mmt180 -136.84 -165.05 1.67 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.175 -0.92 . . . . 74.409999999999997 108.894 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 29' ' ' PRO . 37.7 m -137.76 125.0 13.72 Favored Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 120.329 -0.549 . . . . 41.149999999999999 111.467 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.87 150.87 87.43 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.758 2.305 . . . . 62.450000000000003 109.503 172.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.39 135.94 56.58 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 113.832 1.049 . . . . 65.209999999999994 113.832 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 3.5 mp -108.4 135.51 46.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 114.054 -1.43 . . . . 64.120000000000005 111.538 -172.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.411 HG21 ' HD2' ' A' ' 104' ' ' ARG . 14.7 p -131.29 146.48 33.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.99 -0.744 . . . . 63.119999999999997 108.99 173.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m -76.74 126.97 31.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.049 0.452 . . . . 73.120000000000005 109.806 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.8 157.14 45.83 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.013 0.435 . . . . 72.140000000000001 110.942 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.0 m -112.89 126.71 55.76 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 115.192 -0.913 . . . . 61.43 110.423 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.6 tp -101.82 102.83 25.09 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 115.712 -0.676 . . . . 61.420000000000002 109.216 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.05 140.88 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.562 2.175 . . . . 74.010000000000005 112.366 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.5 4.15 62.49 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 115.733 -0.667 . . . . 73.430000000000007 111.865 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.437 ' HE2' ' SD ' ' A' ' 117' ' ' MET . 91.5 m-85 -132.01 162.04 31.71 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.734 -0.469 . . . . 75.200000000000003 109.734 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 31.0 tt0 -139.74 140.15 36.68 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.63 -0.428 . . . . 71.099999999999994 111.362 -173.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.505 ' HA ' HD13 ' A' ' 63' ' ' ILE . 11.6 ttm180 -94.51 142.83 26.98 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.749 -1.574 . . . . 75.340000000000003 106.749 177.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -106.82 168.89 8.88 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 116.167 -0.47 . . . . 75.519999999999996 110.376 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 . . . . . 0 C--N 1.284 -2.261 0 N-CA-C 107.657 -1.238 . . . . 74.530000000000001 107.657 -175.803 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.019 -0.734 . . . . 74.120000000000005 109.019 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.49 96.82 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.196 1.931 . . . . 64.109999999999999 111.52 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 26.3 p -102.0 177.37 4.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.812 -0.631 . . . . 75.219999999999999 109.924 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 52' ' ' ARG . 47.1 mm -124.53 131.29 72.94 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 109.456 -0.572 . . . . 74.200000000000003 109.456 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -142.2 153.24 62.96 Favored Pre-proline 0 C--N 1.286 -2.163 0 N-CA-C 107.253 -1.388 . . . . 74.329999999999998 107.253 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.503 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 11.7 Cg_endo -59.97 137.0 73.26 Favored 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 122.198 1.932 . . . . 70.530000000000001 111.509 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 51' ' ' GLN . 30.1 t -124.99 147.79 48.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.353 -0.61 . . . . 54.32 109.353 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 68' ' ' LYS . 37.5 mt-10 -69.0 -36.98 78.44 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.941 -0.763 . . . . 74.040000000000006 108.941 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 67' ' ' GLU . 30.8 mmmt -134.3 80.1 1.84 Allowed 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.239 -0.891 . . . . 73.140000000000001 109.14 175.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.12 153.6 24.95 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 119.879 -1.153 . . . . 70.540000000000006 113.212 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.82 138.21 16.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.109 -1.071 . . . . 74.129999999999995 108.109 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.441 HG21 HD12 ' A' ' 63' ' ' ILE . 41.5 t -113.66 119.46 61.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.971 -0.381 . . . . 72.409999999999997 109.971 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -92.14 116.42 28.93 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.232 -2.136 . . . . 64.0 105.232 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.31 -145.33 4.4 Favored Glycine 0 N--CA 1.417 -2.582 0 C-N-CA 120.465 -0.874 . . . . 55.140000000000001 111.694 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 48.4 mmtm -129.94 141.53 50.76 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 120.747 0.308 . . . . 75.519999999999996 110.831 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 44.0 t -110.21 129.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.867 -0.606 . . . . 70.510000000000005 111.097 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.413 HD23 HG13 ' A' ' 42' ' ' ILE . 80.4 mt -96.01 111.11 23.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.296 -1.372 . . . . 64.340000000000003 107.296 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.9 ptp -117.99 149.35 41.08 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 120.66 0.267 . . . . 72.25 110.561 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.68 16.05 55.55 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.64 -1.267 . . . . 74.25 110.535 -174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.6 p -83.86 135.76 24.17 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 N-CA-C 108.302 -0.999 . . . . 72.439999999999998 108.302 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.4 p -82.96 167.0 18.38 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.31 -0.556 . . . . 72.439999999999998 110.64 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.9 m -61.05 -33.22 72.96 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.076 0.399 . . . . 75.109999999999999 112.076 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -68.31 -36.13 78.86 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.444 0.64 . . . . 74.25 110.685 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 39.1 mt-10 -78.14 -28.36 48.41 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.441 -0.948 . . . . 64.430000000000007 108.441 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.5 tp -65.9 -51.61 57.22 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.697 -0.483 . . . . 72.040000000000006 109.697 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.65 -29.03 70.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.317 0.579 . . . . 64.200000000000003 110.513 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.5 t-20 -59.86 -48.5 81.45 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.096 -0.956 . . . . 72.340000000000003 109.744 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 90' ' ' VAL . 96.7 mt -67.42 -38.99 85.46 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.15 -0.932 . . . . 63.439999999999998 110.567 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.627 ' OD1' ' HD3' ' A' ' 97' ' ' ARG . 65.7 m-20 -60.33 -45.22 94.21 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.937 -0.574 . . . . 71.319999999999993 109.801 175.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.88 -46.96 79.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.604 -0.725 . . . . 73.200000000000003 111.702 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 87' ' ' LEU . 7.9 p -72.62 -56.7 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 N-CA-C 112.999 0.74 . . . . 72.519999999999996 112.999 -177.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.11 -30.95 49.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.323 0.49 . . . . 72.519999999999996 112.323 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 95' ' ' TYR . . . -60.03 -17.26 43.7 Favored Glycine 0 N--CA 1.463 0.439 0 CA-C-N 115.769 -0.65 . . . . 64.030000000000001 114.313 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.89 -33.44 71.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.507 0.194 . . . . 61.039999999999999 110.926 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.25 -8.81 3.78 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.317 0.488 . . . . 52.43 112.317 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.409 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 69.1 m-85 -122.16 165.72 15.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.183 -0.303 . . . . 74.299999999999997 110.183 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.0 tp10 -123.12 143.24 50.12 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.845 -0.342 . . . . 63.299999999999997 110.105 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.627 ' HD3' ' OD1' ' A' ' 88' ' ' ASP . 60.5 ttp180 -87.59 114.24 24.02 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.156 -0.683 . . . . 74.329999999999998 109.156 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.72 160.34 25.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 116.179 -0.464 . . . . 71.230000000000004 111.051 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 21.8 p -90.31 122.03 32.84 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.733 -0.667 . . . . 71.430000000000007 110.074 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.88 160.7 41.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.241 0.544 . . . . 63.140000000000001 112.288 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.59 124.88 6.86 Favored Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 110.512 -1.035 . . . . 61.329999999999998 110.512 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.84 154.89 13.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 116.548 0.174 . . . . 70.099999999999994 110.587 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 97.0 t -116.84 117.86 56.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 107.445 -1.317 . . . . 65.340000000000003 107.445 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.51 ' HD3' ' SD ' ' A' ' 111' ' ' MET . 58.8 mtm180 -69.8 137.75 52.1 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 119.813 -0.755 . . . . 73.340000000000003 111.051 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -75.44 -5.68 46.24 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.083 -1.08 . . . . 74.140000000000001 108.083 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.2 -58.4 3.45 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.271 -1.332 . . . . 74.239999999999995 111.248 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.482 ' ND2' HH21 ' A' ' 104' ' ' ARG . 30.9 p-10 -126.23 3.81 7.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.037 0.755 . . . . 75.329999999999998 113.037 -173.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 t 69.6 13.85 8.24 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.29 0.636 . . . . 51.450000000000003 111.785 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -104.91 155.84 18.57 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 122.063 -0.398 . . . . 43.509999999999998 111.136 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 58.0 pttt -88.78 148.43 23.94 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.634 0.731 . . . . 34.329999999999998 111.228 -176.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.51 ' SD ' ' HD3' ' A' ' 104' ' ' ARG . 88.6 mtp -136.83 160.07 39.98 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.818 -1.083 . . . . 73.129999999999995 109.541 175.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.56 131.01 45.85 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.202 -0.908 . . . . 64.239999999999995 109.997 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.464 HG12 ' CB ' ' A' ' 19' ' ' ASN . 33.7 m -145.16 173.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.483 -0.932 . . . . 64.140000000000001 108.483 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -119.46 151.17 39.01 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.367 -0.975 . . . . 72.219999999999999 108.367 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.8 t -144.3 172.14 13.34 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.284 -0.635 . . . . 64.349999999999994 109.284 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 89.4 m-85 -116.75 108.48 15.93 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 123.847 0.717 . . . . 72.150000000000006 109.537 -177.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.503 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 22.3 ptt? -107.38 156.05 19.35 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.829 -0.623 . . . . 63.43 110.124 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -68.75 130.7 43.59 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.161 -1.052 . . . . 71.239999999999995 108.161 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.4 mp -73.7 -42.9 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 119.357 -0.937 . . . . 74.5 111.732 -173.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.446 HD22 ' HB2' ' A' ' 123' ' ' ASP . 8.6 t30 -84.05 93.77 8.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.78 0.8 . . . . 73.430000000000007 110.28 -177.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -78.8 -6.13 55.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.108 -0.951 . . . . 72.510000000000005 113.167 -170.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.03 84.75 2.26 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.299 0.571 . . . . 73.409999999999997 110.179 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.446 ' HB2' HD22 ' A' ' 120' ' ' ASN . 28.7 t70 -133.49 120.61 15.85 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.836 -0.62 . . . . 64.400000000000006 109.767 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.17 -11.87 19.35 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.524 2.149 . . . . 71.120000000000005 113.439 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -90.63 -20.43 22.55 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 113.742 1.016 . . . . 73.299999999999997 113.742 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.6 ptt? . . . . . 0 N--CA 1.43 -1.443 0 CA-C-O 122.489 1.138 . . . . 65.439999999999998 108.667 170.908 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt . . . . . 0 C--O 1.235 0.316 0 CA-C-O 121.017 0.437 . . . . 73.099999999999994 110.679 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 61.6 tttm -50.83 -30.9 15.55 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 125.427 1.491 . . . . 71.209999999999994 112.121 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -54.5 -46.65 73.51 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.215 0.606 . . . . 71.099999999999994 110.272 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -77.49 -34.03 54.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.467 -0.788 . . . . 75.109999999999999 109.603 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 141' ' ' LYS . 50.4 mm -64.49 -33.43 62.91 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.365 0 CA-C-N 114.898 -1.046 . . . . 74.200000000000003 111.796 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 38.2 mm-40 -55.37 -34.86 64.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.236 0.541 . . . . 71.420000000000002 110.693 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.3 m -73.9 -46.38 44.92 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.842 -0.617 . . . . 64.400000000000006 109.615 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -68.35 -29.76 68.56 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 114.346 1.239 . . . . 72.439999999999998 114.346 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 88.7 tttt -54.45 -41.09 69.03 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 123.357 0.663 . . . . 74.319999999999993 110.039 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.27 -36.45 84.14 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.62 0.724 . . . . 65.209999999999994 109.457 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.46 -37.38 50.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.055 -0.975 . . . . 73.340000000000003 109.942 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 87.7 mtp -67.58 -40.41 84.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.155 -0.475 . . . . 75.329999999999998 110.634 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 51.5 mt-10 -64.95 -32.16 73.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.378 0.609 . . . . 71.420000000000002 109.77 175.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.18 -44.46 65.42 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.503 -0.771 . . . . 73.349999999999994 111.166 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 CA--C 1.502 -0.891 0 N-CA-C 112.871 0.693 . . . . 75.109999999999999 112.871 -178.024 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.414 -2.248 0 N-CA-C 106.658 -1.608 . . . . 73.319999999999993 106.658 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -120.07 157.74 28.31 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 109.09 -0.707 . . . . 72.129999999999995 109.09 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.642 ' HA ' ' O ' ' A' ' 76' ' ' LEU 0.272 0.7 OUTLIER -126.31 125.9 43.06 Favored 'General case' 0 C--N 1.284 -2.251 0 O-C-N 124.086 0.866 . . . . 74.329999999999998 111.424 174.365 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.56 137.61 55.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 114.723 -1.126 . . . . 65.209999999999994 109.913 -173.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.554 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.6 t80 -97.97 122.9 41.64 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.518 -0.919 . . . . 65.450000000000003 108.518 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.1 m -103.27 138.01 29.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.323 0.582 . . . . 31.309999999999999 111.815 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.446 ' HB3' ' CG1' ' A' ' 63' ' ' ILE . 39.8 p90 -81.28 -15.06 56.63 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 115.015 1.487 . . . . 71.549999999999997 115.015 -175.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . 160.0 -46.9 0.41 Allowed Glycine 0 C--O 1.212 -1.247 0 C-N-CA 118.658 -1.734 . . . . 43.5 113.321 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 m -58.26 -31.63 67.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.693 0.627 . . . . 65.430000000000007 112.693 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 63.7 m-85 -123.72 31.27 5.93 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 122.253 -0.279 . . . . 73.540000000000006 111.486 -176.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HB2' ' HE2' ' A' ' 74' ' ' LYS . 0.7 OUTLIER -92.18 -1.72 56.98 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 119.254 -0.978 . . . . 65.430000000000007 112.236 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.441 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.0 t70 -99.65 123.1 49.09 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 115.375 -0.83 . . . . 63.310000000000002 109.194 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.75 -31.61 78.49 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.569 2.179 . . . . 33.009999999999998 113.366 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -67.3 -40.26 86.02 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.334 -0.617 . . . . 64.420000000000002 109.334 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.79 -37.55 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.624 -0.717 . . . . 62.43 109.87 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.528 HG23 HD21 ' A' ' 36' ' ' LEU . 44.4 mm -63.06 -44.27 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 115.777 -0.647 . . . . 73.140000000000001 110.667 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -59.47 -35.87 74.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.017 0.437 . . . . 64.409999999999997 111.15 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.09 -35.64 14.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 116.084 -0.507 . . . . 75.340000000000003 112.179 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.433 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 9.0 tmm? -75.06 -37.16 61.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 120.241 -0.584 . . . . 74.420000000000002 110.16 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.528 HD21 HG23 ' A' ' 32' ' ' ILE 0.254 0.9 OUTLIER -119.73 -62.44 1.49 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.464 1.283 . . . . 72.120000000000005 114.464 179.472 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.499 ' OD2' ' HG3' ' A' ' 38' ' ' ARG . 20.8 t70 178.67 -55.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.095 0.474 . . . . 64.430000000000007 111.398 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.499 ' HG3' ' OD2' ' A' ' 37' ' ' ASP . 88.6 mtm180 -135.75 -174.62 3.7 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.828 -0.804 . . . . 65.340000000000003 108.828 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.5 m -118.55 112.5 37.16 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 120.916 -0.313 . . . . 64.430000000000007 111.649 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.53 152.0 76.24 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 123.004 2.47 . . . . 62.130000000000003 109.293 170.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.74 118.8 5.66 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.536 0.684 . . . . 64.319999999999993 112.138 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 48.6 mt -100.12 137.49 27.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 115.242 -0.89 . . . . 60.329999999999998 109.239 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.48 146.68 33.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 109.339 -0.615 . . . . 72.299999999999997 109.339 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.9 m -77.69 130.77 37.22 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.515 -0.55 . . . . 73.420000000000002 109.515 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.23 159.23 42.66 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.463 0.542 . . . . 73.120000000000005 112.463 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.5 m -107.42 132.21 53.44 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.826 0.851 . . . . 73.019999999999996 109.816 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.427 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 45.3 tp -111.96 96.76 35.35 Favored Pre-proline 0 C--N 1.3 -1.545 0 N-CA-C 108.474 -0.935 . . . . 64.120000000000005 108.474 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.64 141.06 9.64 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.462 2.108 . . . . 73.519999999999996 112.656 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.27 10.53 59.41 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.679 -0.772 . . . . 73.319999999999993 111.713 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -139.49 159.1 42.95 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 106.796 -1.557 . . . . 75.010000000000005 106.796 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -139.49 142.07 37.33 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 120.282 -0.567 . . . . 61.229999999999997 109.859 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HB2' ' NH1' ' A' ' 54' ' ' ARG . 28.4 ptt180 -102.23 126.45 49.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.981 -0.554 . . . . 75.239999999999995 109.619 176.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.517 ' O ' ' HD2' ' A' ' 54' ' ' ARG . 91.0 m-85 -108.68 162.16 14.42 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.224 -1.028 . . . . 74.140000000000001 108.224 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 53' ' ' PHE . 3.0 mpt_? . . . . . 0 CA--C 1.485 -1.545 0 CA-C-O 121.358 0.599 . . . . 74.140000000000001 112.087 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.428 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 12.4 m-85 . . . . . 0 N--CA 1.443 -0.823 0 N-CA-C 109.882 -0.414 . . . . 70.140000000000001 109.882 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 31.7 Cg_exo -68.3 47.69 0.39 Allowed 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 124.073 3.182 . . . . 64.239999999999995 112.849 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.9 p -61.65 163.18 7.45 Favored 'General case' 0 C--O 1.252 1.233 0 C-N-CA 125.277 1.431 . . . . 64.150000000000006 114.838 -174.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 71' ' ' VAL . 49.8 mm -109.7 142.02 23.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 C-N-CA 124.917 1.287 . . . . 74.540000000000006 108.584 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 118' ' ' TRP . 26.9 m -148.19 154.66 42.79 Favored Pre-proline 0 C--N 1.309 -1.189 0 N-CA-C 107.654 -1.239 . . . . 73.299999999999997 107.654 171.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.2 111.33 1.99 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.226 1.951 . . . . 54.340000000000003 112.042 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 t -124.89 135.98 53.37 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.228 -0.656 . . . . 63.030000000000001 109.228 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 10.3 mp0 -73.17 -21.76 60.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.986 0.422 . . . . 71.209999999999994 110.005 -176.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -100.24 5.64 44.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.904 -0.589 . . . . 63.140000000000001 112.339 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -132.24 177.13 18.96 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 118.18 -1.962 . . . . 64.510000000000005 115.094 -174.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.48 ' OE2' ' HD3' ' A' ' 140' ' ' LYS . 14.3 pt-20 -156.82 143.4 18.37 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 104.409 -2.441 . . . . 62.219999999999999 104.409 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 63' ' ' ILE . 47.0 t -113.56 119.75 61.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 C-N-CA 120.173 -0.611 . . . . 70.510000000000005 110.316 -176.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -98.66 115.43 28.67 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 119.466 -0.894 . . . . 72.200000000000003 108.686 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.22 -157.79 7.39 Favored Glycine 0 N--CA 1.418 -2.564 0 C-N-CA 120.379 -0.915 . . . . 75.329999999999998 111.002 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HE2' ' HB2' ' A' ' 27' ' ' GLN . 3.1 mppt? -122.72 148.34 45.43 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 113.263 0.838 . . . . 73.340000000000003 113.263 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.5 t -111.01 131.87 61.04 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 113.643 -1.617 . . . . 64.109999999999999 110.951 178.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 68.8 mt -95.63 107.74 19.96 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.434 -0.95 . . . . 75.430000000000007 108.434 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 61.2 mtp -103.63 155.68 18.37 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.657 -0.498 . . . . 71.230000000000004 109.657 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.45 16.24 66.87 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.083 -1.056 . . . . 72.040000000000006 111.47 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 83' ' ' GLU . 86.7 t -72.1 120.12 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 109.457 -0.571 . . . . 63.409999999999997 109.457 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.5 p -74.03 163.52 27.78 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.464 -0.939 . . . . 73.409999999999997 108.464 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 p -55.15 -36.94 66.35 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 112.151 0.426 . . . . 61.439999999999998 112.151 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.76 -51.51 69.45 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.554 0.742 . . . . 74.430000000000007 111.038 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.51 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.8 mt-10 -67.95 -35.48 78.48 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.914 0.886 . . . . 71.049999999999997 109.342 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.89 -49.66 75.96 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.287 -0.635 . . . . 73.400000000000006 109.287 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.63 -33.52 75.13 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-O 121.05 0.453 . . . . 71.519999999999996 109.888 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.502 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -60.34 -48.97 79.47 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.411 1.085 . . . . 74.109999999999999 109.22 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.2 mt -66.86 -42.76 85.15 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.111 -0.495 . . . . 75.420000000000002 110.511 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.26 -31.96 73.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.203 -0.908 . . . . 73.430000000000007 110.676 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.86 -45.37 51.45 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.491 -0.777 . . . . 52.140000000000001 110.904 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 86' ' ' ASN . 99.4 t -65.23 -56.99 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.441 -0.345 . . . . 63.229999999999997 111.487 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -77.95 -22.54 49.37 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.83 0.678 . . . . 72.129999999999995 112.83 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.88 -16.83 48.67 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 115.912 -0.585 . . . . 43.25 114.463 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -61.4 -27.86 68.83 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.636 0.606 . . . . 72.120000000000005 112.636 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -145.23 -0.88 0.85 Allowed 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 120.136 -0.625 . . . . 75.219999999999999 112.124 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.428 ' OH ' ' HB2' ' A' ' 60' ' ' TYR . 80.4 m-85 -122.09 167.79 12.72 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 122.101 -0.374 . . . . 75.409999999999997 110.462 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -123.04 139.67 53.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.38 -1.341 . . . . 55.310000000000002 107.38 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -87.14 114.4 23.72 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.289 -0.634 . . . . 74.319999999999993 109.289 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.13 160.53 19.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.698 -0.683 . . . . 53.399999999999999 109.865 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.7 t -107.39 133.18 52.29 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.988 -0.745 . . . . 54.399999999999999 108.988 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.41 171.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 116.238 -0.437 . . . . 75.329999999999998 110.65 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.95 124.74 7.28 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 111.008 -0.837 . . . . 54.229999999999997 111.008 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.6 pp -117.6 165.14 13.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 116.621 0.21 . . . . 73.310000000000002 110.634 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.493 HG22 ' HG2' ' A' ' 110' ' ' LYS . 46.1 t -124.11 119.43 56.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.929 -0.767 . . . . 43.420000000000002 108.929 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.472 ' HE ' ' HB3' ' A' ' 106' ' ' ASP . 72.7 ttt180 -65.77 116.35 6.88 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.091 0.956 . . . . 71.519999999999996 111.005 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -53.74 -48.44 69.65 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.941 0.896 . . . . 64.319999999999993 109.215 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.472 ' HB3' ' HE ' ' A' ' 104' ' ' ARG . 33.9 t70 -48.9 -42.61 37.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.09 -1.868 . . . . 75.319999999999993 115.395 -172.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -138.92 6.64 2.43 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 118.627 -1.229 . . . . 74.340000000000003 112.41 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.3 t 59.71 70.17 0.66 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.073 0.949 . . . . 54.219999999999999 111.486 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -131.16 146.33 52.3 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 115.176 -0.92 . . . . 73.219999999999999 108.857 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.493 ' HG2' HG22 ' A' ' 103' ' ' VAL . 58.0 mtpt -97.3 126.19 42.36 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.456 0.646 . . . . 65.430000000000007 109.339 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.433 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 89.2 mtp -125.38 161.24 27.47 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.479 -0.782 . . . . 73.5 110.853 -177.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.51 117.43 31.65 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.216 -0.902 . . . . 64.519999999999996 109.197 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 21' ' ' PHE . 34.0 m -129.98 173.37 14.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 121.264 0.554 . . . . 63.520000000000003 110.821 -174.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -108.81 147.25 32.36 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.079 -1.082 . . . . 75.5 108.079 175.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.4 t -148.73 172.56 14.4 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.935 -0.765 . . . . 53.439999999999998 108.935 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.17 108.28 13.59 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.816 -0.809 . . . . 73.310000000000002 108.816 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -110.88 156.37 21.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.808 -0.633 . . . . 74.530000000000001 109.615 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.489 ' HB3' ' CG1' ' A' ' 64' ' ' VAL . 55.9 t-105 -68.35 123.27 20.31 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.065 -1.087 . . . . 75.349999999999994 108.065 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 119' ' ' ILE . 2.4 mp -65.23 -40.92 90.22 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 CA-C-O 120.921 0.391 . . . . 73.209999999999994 111.197 -171.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -59.17 -28.64 66.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.687 -0.688 . . . . 71.010000000000005 111.09 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.444 ' HA ' ' CG1' ' A' ' 64' ' ' VAL 0.302 9.0 ptpp? 58.06 -52.02 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 126.555 1.942 . . . . 71.219999999999999 115.217 178.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.88 82.64 2.61 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.357 -1.349 . . . . 61.020000000000003 107.357 174.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.401 ' HB3' ' HE3' ' A' ' 126' ' ' MET . 13.0 t70 -112.38 127.19 27.18 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.172 -0.922 . . . . 73.109999999999999 109.062 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.3 -17.78 21.16 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.852 2.368 . . . . 72.319999999999993 113.991 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -80.4 -29.63 37.73 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 112.739 0.644 . . . . 73.230000000000004 112.739 -175.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.401 ' HE3' ' HB3' ' A' ' 123' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.428 -1.532 0 CA-C-O 121.838 0.828 . . . . 71.0 112.445 178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.508 ' O ' HG12 ' A' ' 144' ' ' ILE . 36.0 ttpt . . . . . 0 C--O 1.208 -1.109 0 N-CA-C 112.169 0.433 . . . . 73.239999999999995 112.169 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -48.8 -32.56 8.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 112.231 0.456 . . . . 71.120000000000005 112.231 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.574 ' HE2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -58.76 -48.21 82.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.871 0.843 . . . . 74.109999999999999 109.716 175.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -76.15 -32.78 59.26 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.674 -1.603 . . . . 71.120000000000005 108.943 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 140' ' ' LYS . 46.7 mm -61.6 -32.77 54.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.143 0 CA-C-N 114.646 -1.161 . . . . 75.209999999999994 112.642 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -51.84 -41.3 61.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.128 0.422 . . . . 75.239999999999995 111.413 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.5 m -70.98 -47.6 57.98 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.736 -0.665 . . . . 73.409999999999997 109.858 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . 0.257 62.9 m-85 -70.18 -29.88 66.86 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 115.133 1.531 . . . . 74.319999999999993 115.133 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 57.6 tptt -59.3 -42.55 91.6 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.51 -0.922 . . . . 62.450000000000003 108.51 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -64.12 -40.31 95.92 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.253 -0.885 . . . . 71.310000000000002 109.463 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.3 mt -68.58 -41.64 83.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.313 -0.858 . . . . 64.409999999999997 110.663 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.38 -42.54 96.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.51 -0.314 . . . . 74.439999999999998 110.743 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 49.2 mt-10 -67.56 -30.8 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.931 0.396 . . . . 61.240000000000002 110.416 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 51.2 t -65.66 -37.59 86.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.871 -0.604 . . . . 74.140000000000001 109.957 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 116.054 -0.521 . . . . 72.230000000000004 110.048 177.301 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.417 -2.092 0 CA-C-O 121.06 0.457 . . . . 70.25 110.565 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.503 ' HB2' HG13 ' A' ' 79' ' ' VAL . 49.0 m-70 -115.41 160.21 20.16 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.298 -0.865 . . . . 73.329999999999998 110.208 -173.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.442 ' CG ' HG12 ' A' ' 113' ' ' VAL . 18.1 p30 -133.15 138.48 46.64 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.113 -0.949 . . . . 64.200000000000003 111.305 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.1 t -132.12 139.41 50.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.436 -0.802 . . . . 64.200000000000003 109.727 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.1 t80 -94.16 123.1 37.33 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.456 -1.312 . . . . 73.120000000000005 107.456 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.1 m -102.81 166.96 2.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 112.519 0.563 . . . . 65.340000000000003 112.519 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -153.56 -45.3 0.09 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.069 -0.969 . . . . 72.349999999999994 111.623 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.02 -92.71 1.26 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.03 -1.081 . . . . 63.109999999999999 113.97 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -58.35 -17.49 20.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.138 1.162 . . . . 74.329999999999998 114.138 -173.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -123.36 20.15 9.68 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 121.079 -0.248 . . . . 75.439999999999998 111.003 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.08 -18.86 60.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.649 -0.421 . . . . 74.019999999999996 111.609 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 20.8 t70 -116.81 128.29 26.12 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 116.331 -0.395 . . . . 71.099999999999994 111.856 -173.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HB3' HG21 ' A' ' 39' ' ' THR . 32.0 Cg_endo -65.12 -32.71 52.28 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.074 2.516 . . . . 54.299999999999997 112.81 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.53 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 19.3 t70 -63.29 -38.19 90.2 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.532 -0.544 . . . . 73.329999999999998 109.532 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.69 -42.98 93.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.257 -0.883 . . . . 73.439999999999998 109.656 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 28' ' ' ASP . 45.7 mm -60.73 -43.79 95.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.018 -0.537 . . . . 73.349999999999994 111.894 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -55.37 -36.4 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.226 0.536 . . . . 64.030000000000001 111.2 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.5 t -82.03 -37.49 14.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.149 -0.478 . . . . 74.209999999999994 111.609 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -63.49 -35.54 80.79 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.388 -0.597 . . . . 71.310000000000002 109.388 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.632 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.2 pt? -128.09 -74.69 0.57 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.092 -0.504 . . . . 75.140000000000001 111.862 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.632 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 22.4 m-20 -167.36 -58.26 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.861 0.865 . . . . 71.230000000000004 108.668 -172.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -131.2 165.59 23.0 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.444 -1.253 . . . . 73.239999999999995 112.222 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 29' ' ' PRO . 29.9 m -111.69 128.47 25.37 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.956 -0.566 . . . . 73.140000000000001 111.729 -174.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.45 153.15 68.2 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 123.453 2.769 . . . . 70.0 111.403 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.2 123.95 16.26 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.25 -0.648 . . . . 64.450000000000003 109.25 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 32.9 mt -104.91 136.03 40.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.086 0.47 . . . . 75.299999999999997 110.364 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.537 HG21 ' HD2' ' A' ' 104' ' ' ARG . 14.4 p -130.85 147.72 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.711 -0.677 . . . . 62.43 109.869 176.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.3 m -75.69 126.53 31.18 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.548 -0.908 . . . . 63.100000000000001 108.548 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.91 157.38 46.14 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.517 0.675 . . . . 64.430000000000007 111.819 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 m -114.59 125.12 53.41 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 114.537 -1.21 . . . . 73.329999999999998 108.627 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 50.8 tp -99.97 101.97 15.99 Favored Pre-proline 0 C--N 1.29 -2.007 0 N-CA-C 109.092 -0.707 . . . . 73.340000000000003 109.092 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 71.9 Cg_endo -80.84 141.1 13.23 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 122.188 1.926 . . . . 74.0 112.091 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.12 14.23 57.85 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.963 -0.636 . . . . 72.430000000000007 112.427 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -140.49 163.3 33.2 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.674 -0.491 . . . . 73.310000000000002 109.674 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.434 ' CG ' ' HB2' ' A' ' 66' ' ' SER . 26.9 pt20 -140.27 166.38 24.85 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.164 -0.68 . . . . 74.340000000000003 109.164 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HD3' HG13 ' A' ' 71' ' ' VAL . 14.9 ptt180 -128.01 128.46 45.03 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.597 -0.729 . . . . 74.310000000000002 111.719 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.559 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 17.1 m-85 -109.14 164.88 12.04 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.274 -0.876 . . . . 73.439999999999998 110.147 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 . . . . . 0 CA--C 1.487 -1.473 0 N-CA-C 109.442 -0.577 . . . . 61.009999999999998 109.442 -168.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.409 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 12.7 p90 . . . . . 0 N--CA 1.419 -2.024 0 N-CA-C 108.569 -0.9 . . . . 62.240000000000002 108.569 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 5.7 Cg_exo -37.24 120.49 0.31 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 124.344 3.363 . . . . 74.340000000000003 114.427 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 53' ' ' PHE . 12.4 p -130.11 150.0 51.57 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.037 -0.983 . . . . 74.150000000000006 110.468 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.7 mm -110.06 141.36 25.59 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 N-CA-C 108.742 -0.836 . . . . 74.010000000000005 108.742 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' A' ' 118' ' ' TRP . 29.9 m -146.87 150.33 38.85 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 109.101 -0.703 . . . . 73.109999999999999 109.101 175.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.33 134.68 60.39 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.66 2.24 . . . . 71.439999999999998 112.246 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.434 ' HB2' ' CG ' ' A' ' 51' ' ' GLN . 34.8 t -125.68 141.51 51.98 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.934 -0.575 . . . . 72.420000000000002 110.343 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -75.29 -32.79 61.11 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.512 -0.551 . . . . 55.149999999999999 109.512 173.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . 0.287 0.1 OUTLIER -131.93 72.91 1.51 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 114.031 1.123 . . . . 75.409999999999997 114.031 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.35 168.59 40.58 Favored Glycine 0 C--O 1.257 1.579 0 C-N-CA 119.224 -1.465 . . . . 61.219999999999999 113.283 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.44 147.73 29.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.799 -1.186 . . . . 63.340000000000003 107.799 176.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.44 HG13 ' HD3' ' A' ' 52' ' ' ARG . 59.8 t -114.5 119.66 62.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 109.582 -0.525 . . . . 70.219999999999999 109.582 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -95.63 116.32 28.69 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.534 -0.913 . . . . 71.409999999999997 108.534 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.87 -143.87 4.14 Favored Glycine 0 N--CA 1.418 -2.517 0 C-N-CA 120.718 -0.753 . . . . 52.210000000000001 111.26 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.468 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 75.5 mmtt -134.24 145.13 48.86 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.56 -0.533 . . . . 74.510000000000005 109.56 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.7 t -110.58 129.55 65.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 123.104 0.252 . . . . 33.409999999999997 111.148 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.452 HD23 HG12 ' A' ' 42' ' ' ILE . 71.0 mt -95.62 111.31 23.26 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.022 -1.473 . . . . 71.030000000000001 107.022 174.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.9 ptp -119.65 144.08 47.36 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.398 -0.521 . . . . 75.310000000000002 111.842 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.26 23.97 7.78 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 115.459 -0.791 . . . . 70.510000000000005 111.73 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 18' ' ' HIS . 13.2 p -95.02 138.89 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 110.017 -0.364 . . . . 74.310000000000002 110.017 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.552 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 3.9 m -79.02 162.05 26.19 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 109.169 -0.678 . . . . 74.030000000000001 109.169 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.5 m -58.51 -32.7 69.07 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 112.801 0.667 . . . . 41.119999999999997 112.801 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.64 -49.39 68.87 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 112.322 0.489 . . . . 73.329999999999998 112.322 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.591 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 1.4 mp0 -65.25 -29.49 70.28 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 109.612 -0.514 . . . . 70.040000000000006 109.612 177.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.87 -40.33 92.59 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.021 0.439 . . . . 71.420000000000002 109.868 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -69.02 -36.99 78.4 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.152 -0.685 . . . . 75.450000000000003 109.152 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.457 ' O ' HG23 ' A' ' 90' ' ' VAL . 7.7 t30 -63.85 -43.04 97.33 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.114 -0.948 . . . . 64.129999999999995 110.489 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.8 mt -61.72 -43.07 99.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.748 0.785 . . . . 74.310000000000002 108.935 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.25 -32.17 71.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.278 -1.328 . . . . 52.020000000000003 111.115 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.21 -42.16 56.19 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.814 -0.63 . . . . 72.439999999999998 110.474 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 86' ' ' ASN . 99.3 t -67.04 -53.23 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.306 0.643 . . . . 73.340000000000003 112.4 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -78.28 -20.65 51.16 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.224 0.535 . . . . 70.099999999999994 111.95 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.19 -17.03 16.07 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.74 1.456 . . . . 61.149999999999999 116.74 -173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.06 -29.64 69.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 118.56 1.18 . . . . 73.420000000000002 112.533 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.56 -0.74 2.36 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 113.359 0.874 . . . . 63.219999999999999 113.359 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -127.41 166.08 18.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.663 0.616 . . . . 72.400000000000006 112.663 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.3 tp10 -125.17 146.04 49.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.121 -0.945 . . . . 73.430000000000007 108.86 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -92.92 114.12 26.59 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.014 -0.736 . . . . 61.130000000000003 109.014 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.412 HG11 ' HE3' ' A' ' 117' ' ' MET . 28.3 m -126.49 161.59 32.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 120.865 0.364 . . . . 71.109999999999999 111.83 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.7 t -88.14 130.97 34.89 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.249 -0.887 . . . . 74.099999999999994 110.31 -177.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.413 ' HB ' HD11 ' A' ' 47' ' ' LEU . 29.4 m -137.84 165.61 25.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.974 -0.557 . . . . 71.219999999999999 111.522 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.481 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -114.67 124.24 6.31 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.477 -1.049 . . . . 70.010000000000005 110.477 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.88 160.51 15.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 120.697 0.284 . . . . 74.010000000000005 110.868 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 66.2 t -120.38 114.68 44.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.115 -1.439 . . . . 73.010000000000005 107.115 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.537 ' HD2' HG21 ' A' ' 43' ' ' VAL . 54.8 mtm180 -69.67 135.56 50.01 Favored 'General case' 0 CA--C 1.478 -1.817 0 C-N-CA 119.981 -0.688 . . . . 72.329999999999998 109.771 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.92 5.55 18.68 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.82 0.819 . . . . 72.129999999999995 109.074 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -56.85 -62.09 1.99 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.087 -1.415 . . . . 73.549999999999997 109.559 175.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -137.76 12.3 2.92 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.512 -0.767 . . . . 62.240000000000002 109.288 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 23.0 t 62.86 78.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.688 -1.142 . . . . 64.010000000000005 110.486 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 10.2 pt-20 -137.11 151.3 48.71 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 108.133 -1.062 . . . . 71.319999999999993 108.133 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -94.05 140.93 29.12 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 120.35 -0.54 . . . . 71.219999999999999 110.245 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.6 mtp -141.8 161.5 37.81 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 123.772 0.829 . . . . 74.099999999999994 110.218 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.57 129.19 55.31 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 115.459 -0.792 . . . . 34.340000000000003 109.671 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 21' ' ' PHE . 29.5 m -142.84 174.68 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.441 -0.948 . . . . 71.329999999999998 108.441 -177.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -113.8 157.62 22.06 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.863 -0.735 . . . . 74.439999999999998 109.601 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.2 t -149.74 172.64 14.78 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.558 -0.904 . . . . 64.140000000000001 108.558 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 88.5 m-85 -114.51 115.35 27.1 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.192 -0.669 . . . . 75.329999999999998 109.192 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.412 ' HE3' HG11 ' A' ' 98' ' ' VAL 0.256 0.0 OUTLIER -113.42 156.27 23.78 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.001 -0.545 . . . . 73.109999999999999 111.773 -179.772 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.447 ' HB3' ' CG1' ' A' ' 64' ' ' VAL . 68.1 t-105 -67.76 118.01 10.43 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.688 -0.856 . . . . 63.310000000000002 108.688 -175.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.7 mt -58.91 -35.75 58.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.91 -1.041 . . . . 73.129999999999995 113.156 -171.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -70.69 -31.23 68.05 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.023 0.439 . . . . 72.010000000000005 110.596 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 67.67 -60.1 0.4 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.011 1.325 . . . . 74.349999999999994 113.658 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.03 102.01 13.59 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 110.149 -0.315 . . . . 72.439999999999998 110.149 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -141.98 123.91 9.01 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 116.014 -0.539 . . . . 73.5 110.906 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -87.06 2.67 6.88 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.797 2.332 . . . . 72.549999999999997 113.443 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -94.99 -31.43 13.63 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.669 0.271 . . . . 70.209999999999994 111.387 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.524 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 27.0 ptt? . . . . . 0 N--CA 1.476 0.865 0 C-N-CA 122.824 0.45 . . . . 61.039999999999999 112.17 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.601 ' HE2' HD11 ' A' ' 144' ' ' ILE . 88.2 tttt . . . . . 0 C--O 1.205 -1.281 0 N-CA-C 110.329 -0.248 . . . . 62.329999999999998 110.329 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 23.7 tptm -46.77 -38.51 10.18 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.459 1.104 . . . . 73.420000000000002 113.006 -177.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.75 -40.3 91.93 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.947 0.88 . . . . 72.530000000000001 109.95 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -76.71 -32.98 58.2 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.503 -1.226 . . . . 74.409999999999997 107.908 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.601 HD11 ' HE2' ' A' ' 140' ' ' LYS . 48.3 mm -65.82 -32.81 59.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 CA-C-N 114.629 -1.169 . . . . 53.530000000000001 111.524 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 45.0 mt-10 -55.24 -32.06 62.01 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.376 0.608 . . . . 53.450000000000003 110.054 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.9 m -80.24 -47.19 14.98 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.704 -0.68 . . . . 61.140000000000001 109.45 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.564 ' O ' ' HG2' ' A' ' 151' ' ' MET 0.294 26.9 m-85 -64.13 -30.63 71.68 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 116.128 1.899 . . . . 72.349999999999994 116.128 -178.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 37.6 mmtm -58.76 -38.85 79.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.474 0.579 . . . . 64.200000000000003 111.679 175.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -71.23 -33.26 69.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.106 -0.701 . . . . 64.530000000000001 109.106 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.442 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 68.3 mt -69.95 -39.0 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.39 -0.823 . . . . 73.519999999999996 109.136 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 14.4 mmt -61.25 -40.69 94.99 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.175 -0.466 . . . . 61.439999999999998 110.329 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 46.0 mt-10 -60.29 -41.54 93.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.151 0.501 . . . . 62.030000000000001 110.319 177.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 49.0 t -71.56 -31.83 67.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.568 -0.742 . . . . 61.119999999999997 110.845 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 75.9 mmtt . . . . . 0 CA--C 1.514 -0.437 0 C-N-CA 120.457 -0.497 . . . . 74.530000000000001 110.204 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.413 -2.31 0 N-CA-C 107.958 -1.127 . . . . 65.109999999999999 107.958 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.483 ' O ' HG12 ' A' ' 79' ' ' VAL . 49.9 m-70 -109.39 159.67 16.82 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 108.702 -0.851 . . . . 74.200000000000003 108.702 -173.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 21.1 p30 -134.56 128.48 33.34 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.114 -0.948 . . . . 64.120000000000005 111.94 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.63 144.48 34.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 114.575 -1.193 . . . . 74.299999999999997 111.041 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -94.13 123.14 37.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.75 -0.833 . . . . 72.409999999999997 108.75 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.74 ' HB ' ' O ' ' A' ' 26' ' ' PHE . 20.4 m -94.44 172.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.853 -0.612 . . . . 62.229999999999997 110.54 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -149.4 -62.41 0.22 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.291 1.96 . . . . 64.200000000000003 116.291 -168.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -116.28 -79.48 0.77 Allowed Glycine 0 C--O 1.215 -1.085 0 C-N-CA 119.314 -1.422 . . . . 73.349999999999994 114.504 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -65.98 -36.31 82.97 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.98 0.895 . . . . 75.030000000000001 109.187 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.74 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 48.5 m-85 -101.29 100.17 10.64 Favored 'General case' 0 N--CA 1.401 -2.902 0 CA-C-N 114.622 -1.172 . . . . 75.420000000000002 108.196 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -156.18 3.83 0.17 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.177 -0.919 . . . . 72.209999999999994 112.509 173.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HB3' HG23 ' A' ' 31' ' ' VAL . 16.0 t70 -124.71 134.59 25.75 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.369 -0.604 . . . . 73.129999999999995 109.369 -176.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 29.6 Cg_endo -63.35 -30.76 73.22 Favored 'Trans proline' 0 C--O 1.211 -0.859 0 C-N-CA 122.879 2.386 . . . . 74.420000000000002 113.988 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.26 -35.35 73.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.19 0.519 . . . . 72.120000000000005 109.629 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 28' ' ' ASP . 94.2 t -62.42 -42.42 95.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.617 -0.883 . . . . 63.009999999999998 108.617 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 36' ' ' LEU . 24.0 mm -66.17 -43.66 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.947 -1.024 . . . . 71.329999999999998 109.584 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 3.5 t-20 -55.36 -43.85 75.44 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.648 -1.614 . . . . 64.109999999999999 110.742 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.99 -39.36 17.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.882 -0.599 . . . . 75.120000000000005 111.481 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -64.99 -36.39 84.24 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 110.482 -0.192 . . . . 72.510000000000005 110.482 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 32' ' ' ILE 0.264 0.4 OUTLIER -111.24 -75.36 0.62 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 113.088 0.773 . . . . 64.120000000000005 113.088 174.268 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.6 t70 174.51 -49.08 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 108.328 -0.99 . . . . 73.329999999999998 108.328 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -110.78 175.66 5.34 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.185 -1.371 . . . . 73.010000000000005 109.029 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.0 m -129.29 104.72 17.85 Favored Pre-proline 0 N--CA 1.414 -2.228 0 N-CA-C 108.694 -0.854 . . . . 75.109999999999999 108.694 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.17 150.86 46.35 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 123.01 2.473 . . . . 75.519999999999996 110.35 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.71 132.0 51.98 Favored 'General case' 0 CA--C 1.465 -2.318 0 CA-C-O 122.224 1.011 . . . . 63.109999999999999 112.043 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 46.3 mt -107.0 131.73 56.2 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.8 0 CA-C-N 113.219 -1.809 . . . . 71.349999999999994 108.95 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.13 146.17 30.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.967 -1.123 . . . . 72.019999999999996 107.967 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.5 m -77.36 127.95 33.45 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 107.329 -1.36 . . . . 71.299999999999997 107.329 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -142.27 154.41 44.72 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.039 0.447 . . . . 74.530000000000001 110.95 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.49 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 93.9 m -109.16 125.64 52.41 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.374 -0.83 . . . . 75.329999999999998 110.276 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.405 HD11 ' HB ' ' A' ' 100' ' ' VAL . 35.0 tp -101.43 99.59 11.69 Favored Pre-proline 0 N--CA 1.432 -1.368 0 CA-C-N 116.077 -0.511 . . . . 72.099999999999994 109.936 175.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.1 Cg_endo -83.96 135.53 6.62 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.767 2.311 . . . . 70.319999999999993 111.562 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.11 5.88 46.17 Favored Glycine 0 N--CA 1.434 -1.438 0 C-N-CA 120.552 -0.832 . . . . 71.299999999999997 111.679 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.517 ' HA ' ' H ' ' A' ' 66' ' ' SER . 96.0 m-85 -146.98 150.17 34.62 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.121 -0.696 . . . . 65.519999999999996 109.121 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -140.85 148.56 40.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.632 -0.877 . . . . 73.010000000000005 108.632 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -102.03 142.47 33.25 Favored 'General case' 0 N--CA 1.424 -1.734 0 C-N-CA 119.517 -0.873 . . . . 74.510000000000005 108.997 176.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CB ' ' HB2' ' A' ' 126' ' ' MET . 7.0 m-85 -108.3 171.22 7.54 Favored 'General case' 0 C--N 1.258 -3.375 0 CA-C-N 114.646 -1.161 . . . . 74.409999999999997 111.152 -175.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? . . . . . 0 C--N 1.316 -0.865 0 N-CA-C 113.624 0.972 . . . . 50.149999999999999 113.624 -173.21 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.443 -0.81 0 N-CA-C 107.293 -1.373 . . . . 65.549999999999997 107.293 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 16.0 Cg_exo -68.79 93.23 0.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 N-CA-C 108.219 -1.493 . . . . 71.340000000000003 108.219 171.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 22.0 p -99.53 154.94 17.85 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.653 -0.703 . . . . 61.509999999999998 112.509 -174.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 50' ' ' PHE . 35.4 mm -94.86 127.39 46.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.056 -0.975 . . . . 53.549999999999997 109.469 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.44 144.38 52.03 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 109.201 -0.666 . . . . 74.340000000000003 109.201 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.94 108.96 0.36 Allowed 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.552 2.168 . . . . 62.439999999999998 112.983 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.517 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 32.3 t -125.13 98.6 5.73 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 106.09 -1.819 . . . . 61.229999999999997 106.09 176.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.38 -36.6 64.08 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 123.667 0.787 . . . . 71.519999999999996 112.252 -172.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -86.15 -23.9 26.39 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.337 0.589 . . . . 74.530000000000001 110.24 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.74 173.89 45.77 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 115.41 -0.814 . . . . 64.140000000000001 113.099 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -160.4 144.43 14.05 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.331 -0.988 . . . . 75.540000000000006 108.331 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.12 119.83 61.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 109.035 -0.728 . . . . 65.239999999999995 109.035 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -91.45 114.85 27.49 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.537 -2.023 . . . . 73.439999999999998 105.537 174.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.44 -143.81 3.9 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.279 -0.962 . . . . 33.439999999999998 112.359 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.5 mmtm -123.34 140.61 52.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.946 0.403 . . . . 73.450000000000003 111.325 -173.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 41.0 t -111.08 130.05 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.827 -0.624 . . . . 60.039999999999999 110.376 172.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 78.3 mt -95.71 109.91 22.12 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.863 -1.162 . . . . 62.009999999999998 107.863 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.8 ptp -119.7 137.43 53.92 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.128 0.489 . . . . 63.43 110.43 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.72 18.87 10.96 Favored Glycine 0 N--CA 1.421 -2.33 0 C-N-CA 120.037 -1.078 . . . . 44.140000000000001 111.254 -174.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.0 p -89.69 138.2 19.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 N-CA-C 109.009 -0.737 . . . . 74.329999999999998 109.009 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.6 p -76.84 159.92 29.67 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.422 -0.354 . . . . 63.439999999999998 110.77 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.1 m -58.71 -32.03 68.8 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.33 0.493 . . . . 62.119999999999997 112.33 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -67.37 -41.09 85.63 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.432 0.634 . . . . 71.219999999999999 109.984 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 63.0 mm-40 -80.2 -28.65 38.63 Favored 'General case' 0 C--O 1.201 -1.499 0 C-N-CA 119.576 -0.85 . . . . 73.420000000000002 112.426 176.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.423 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.1 tm? -60.79 -45.21 95.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.059 -0.719 . . . . 73.109999999999999 109.059 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -67.86 -29.92 69.17 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.855 -0.424 . . . . 74.040000000000006 109.855 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -72.95 -40.34 65.45 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 116.116 -0.493 . . . . 75.310000000000002 110.129 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.522 ' HA ' HG12 ' A' ' 90' ' ' VAL . 95.6 mt -60.17 -40.45 89.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.947 0.879 . . . . 64.400000000000006 109.295 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.491 ' CG ' HH21 ' A' ' 97' ' ' ARG . 23.8 t70 -71.48 -29.52 64.92 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.445 -1.252 . . . . 55.409999999999997 111.089 177.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.69 -48.21 22.93 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.347 -0.388 . . . . 64.129999999999995 110.394 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 87' ' ' LEU . 13.7 p -65.28 -53.41 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-N 115.843 -0.617 . . . . 62.32 111.483 -176.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -78.02 -27.82 48.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.167 0.432 . . . . 71.420000000000002 112.167 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.91 -17.81 44.78 Favored Glycine 0 N--CA 1.464 0.529 0 N-CA-C 115.007 0.763 . . . . 75.340000000000003 115.007 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -61.52 -32.33 72.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.126 0.463 . . . . 74.430000000000007 111.198 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -130.86 3.83 4.48 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.589 -0.444 . . . . 63.039999999999999 111.793 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 92.7 m-85 -138.46 168.0 20.7 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.796 0.295 . . . . 74.239999999999995 111.796 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 35.9 tt0 -121.62 144.55 48.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.323 -0.399 . . . . 73.150000000000006 110.123 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.491 HH21 ' CG ' ' A' ' 88' ' ' ASP . 16.3 ttm180 -87.45 118.45 26.92 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.328 -0.619 . . . . 75.120000000000005 109.328 -176.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.23 162.98 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 113.123 0.786 . . . . 60.039999999999999 113.123 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.5 p -94.14 124.38 38.11 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.118 -1.401 . . . . 75.340000000000003 109.965 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 47' ' ' LEU . 29.3 m -130.92 158.31 43.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 120.844 0.354 . . . . 65.109999999999999 111.251 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.58 115.8 5.22 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 111.394 -0.682 . . . . 72.319999999999993 111.394 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.04 155.76 12.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 110.189 -0.3 . . . . 54.409999999999997 110.189 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.9 120.08 62.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 108.701 -0.851 . . . . 63.329999999999998 108.701 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.468 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 39.7 mtp180 -64.38 134.92 55.56 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.946 0.403 . . . . 60.32 111.017 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.89 -6.93 53.15 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.892 -1.151 . . . . 51.009999999999998 107.892 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.88 -64.6 0.77 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 125.719 1.607 . . . . 74.430000000000007 110.938 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -144.89 15.34 1.55 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 120.741 -0.384 . . . . 71.310000000000002 110.293 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 56.7 m 63.53 63.09 0.89 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.651 -0.704 . . . . 74.25 111.656 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.47 137.57 52.44 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.373 -1.343 . . . . 64.439999999999998 107.373 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -98.19 140.97 31.7 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-O 121.433 0.635 . . . . 75.239999999999995 111.32 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.468 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 89.0 mtp -138.51 162.58 34.16 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-N 114.977 -1.011 . . . . 71.439999999999998 110.358 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.44 122.35 47.2 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.963 -1.017 . . . . 63.340000000000003 109.199 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.06 174.46 13.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 109.109 -0.7 . . . . 73.230000000000004 109.109 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -98.26 161.25 13.8 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.565 -0.854 . . . . 62.140000000000001 109.14 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.0 t -156.93 172.57 18.43 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.737 -1.208 . . . . 72.340000000000003 107.737 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.1 m-85 -124.41 113.9 18.79 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.094 -0.706 . . . . 60.140000000000001 109.094 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.94 157.52 22.31 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.935 0.398 . . . . 72.430000000000007 110.974 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.424 ' NE1' ' HB3' ' A' ' 120' ' ' ASN . 55.4 t-105 -67.52 128.82 37.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.573 -0.899 . . . . 74.120000000000005 108.573 -177.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.7 mp -72.02 -41.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.643 -0.253 . . . . 73.239999999999995 111.159 -173.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.424 ' HB3' ' NE1' ' A' ' 118' ' ' TRP . 27.1 t-20 -62.31 -37.17 84.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.768 -0.651 . . . . 72.239999999999995 111.377 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 119' ' ' ILE . 57.2 mttp 68.29 -38.7 0.38 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.427 1.491 . . . . 72.25 114.361 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -115.63 76.09 0.99 Allowed 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.903 -0.498 . . . . 73.329999999999998 110.502 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -106.12 132.95 20.47 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 108.542 -0.91 . . . . 61.130000000000003 108.542 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.19 -19.07 29.97 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.763 2.309 . . . . 75.109999999999999 114.361 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -76.52 -37.32 56.92 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 113.222 0.823 . . . . 75.420000000000002 113.222 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.496 ' HB2' ' CB ' ' A' ' 53' ' ' PHE . 26.4 ptt? . . . . . 0 C--O 1.247 0.95 0 CA-C-O 121.439 0.638 . . . . 71.040000000000006 109.933 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.677 ' O ' HG12 ' A' ' 144' ' ' ILE . 38.8 ttpt . . . . . 0 C--O 1.2 -1.52 0 N-CA-C 110.589 -0.152 . . . . 71.150000000000006 110.589 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 38.7 ttmt -54.76 -41.94 71.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.996 0.519 . . . . 73.010000000000005 110.192 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -61.75 -44.41 96.96 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.126 0.965 . . . . 72.109999999999999 108.66 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -67.44 -38.25 84.23 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.404 -1.725 . . . . 75.239999999999995 109.977 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 140' ' ' LYS . 42.4 mm -67.05 -35.53 74.77 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.455 0 CA-C-N 115.609 -0.723 . . . . 71.400000000000006 110.174 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.5 mt-10 -59.88 -30.91 69.32 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.748 0.309 . . . . 61.32 111.134 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 150' ' ' ILE . 33.3 m -73.59 -48.44 32.76 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.904 -0.776 . . . . 71.230000000000004 108.904 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.522 ' O ' ' HG2' ' A' ' 151' ' ' MET . 51.1 m-85 -71.62 -36.29 70.73 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 115.271 1.582 . . . . 73.219999999999999 115.271 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 88.5 tttt -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.47 -0.937 . . . . 72.430000000000007 108.47 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . 0.563 ' NZ ' ' HB2' ' A' ' 149' ' ' LYS . 4.1 ttmp? -75.19 -37.85 61.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.686 -1.143 . . . . 71.310000000000002 109.855 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 146' ' ' THR . 88.8 mt -64.49 -33.49 63.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.815 -0.629 . . . . 70.409999999999997 109.503 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 24.8 mmt -72.74 -27.96 62.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.288 -0.415 . . . . 61.229999999999997 110.648 176.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 43.3 mt-10 -68.7 -30.69 69.41 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 108.709 -0.849 . . . . 73.430000000000007 108.709 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 150' ' ' ILE . 52.3 t -70.48 -32.87 70.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.317 -0.856 . . . . 63.5 109.959 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 75.0 mmtt . . . . . 0 C--O 1.236 0.384 0 N-CA-C 109.385 -0.598 . . . . 71.400000000000006 109.385 178.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.436 -1.135 0 N-CA-C 108.821 -0.807 . . . . 74.140000000000001 108.821 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -115.71 159.74 20.99 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.513 -0.312 . . . . 73.329999999999998 110.608 -172.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.47 ' HB3' HG12 ' A' ' 113' ' ' VAL . 49.2 m-20 -121.28 127.57 51.49 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.496 -1.298 . . . . 75.319999999999993 107.496 176.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.64 130.26 62.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 122.357 -0.214 . . . . 73.319999999999993 110.832 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.41 ' HB2' HG21 ' A' ' 113' ' ' VAL . 93.8 t80 -94.48 121.64 36.23 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.185 -1.413 . . . . 64.25 107.185 174.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.566 HG21 ' HB2' ' A' ' 26' ' ' PHE . 4.0 p -97.0 139.73 18.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.592 -0.731 . . . . 74.430000000000007 110.666 -176.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -77.65 -36.85 51.05 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 115.092 1.516 . . . . 73.0 115.092 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.41 -74.49 0.02 OUTLIER Glycine 0 C--O 1.225 -0.463 0 C-N-CA 117.584 -2.246 . . . . 72.329999999999998 115.774 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 t -58.57 -36.24 73.63 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.733 1.012 . . . . 74.549999999999997 113.733 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.599 ' HB3' HD11 ' A' ' 32' ' ' ILE . 62.4 m-85 -99.38 22.67 10.32 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.221 -0.992 . . . . 63.350000000000001 112.501 -175.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.447 ' HG2' HG13 ' A' ' 22' ' ' VAL . 80.5 mt-30 -74.29 -11.23 60.21 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 120.633 0.254 . . . . 72.340000000000003 111.279 176.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -101.76 128.77 28.06 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.455 -0.338 . . . . 65.219999999999999 111.431 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HB3' HG21 ' A' ' 39' ' ' THR . 18.0 Cg_endo -62.95 -37.04 56.55 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.943 2.429 . . . . 51.5 113.114 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.8 m-20 -65.62 -33.79 76.72 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.718 -0.614 . . . . 72.25 110.818 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.52 -40.82 89.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.736 -0.666 . . . . 71.219999999999999 109.589 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 26' ' ' PHE . 43.6 mm -65.84 -42.1 91.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 CA-C-N 115.966 -0.561 . . . . 72.409999999999997 111.103 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -58.77 -34.55 71.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.892 0.377 . . . . 74.200000000000003 110.692 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 30' ' ' ASP . 94.4 t -77.65 -46.6 27.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.089 -0.505 . . . . 71.430000000000007 110.841 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 62.0 ttp -63.56 -36.81 85.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.02 0.378 . . . . 70.299999999999997 112.02 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.51 HD12 ' H ' ' A' ' 37' ' ' ASP 0.374 3.6 pp -126.01 -58.77 1.36 Allowed 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 115.379 1.622 . . . . 75.230000000000004 115.379 -178.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.51 ' H ' HD12 ' A' ' 36' ' ' LEU . 22.7 t70 170.56 -53.22 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.307 0.575 . . . . 70.439999999999998 110.618 -177.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.551 ' O ' HG22 ' A' ' 32' ' ' ILE . 88.8 mtt180 -123.21 -167.35 1.59 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.548 -0.908 . . . . 71.430000000000007 108.548 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 29' ' ' PRO . 76.2 m -139.55 121.13 9.8 Favored Pre-proline 0 N--CA 1.432 -1.369 0 CA-C-O 120.502 0.191 . . . . 63.32 111.203 171.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.25 153.47 46.37 Favored 'Trans proline' 0 C--O 1.247 0.949 0 C-N-CA 123.56 2.84 . . . . 74.140000000000001 110.815 173.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.02 129.56 38.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.379 0.609 . . . . 74.120000000000005 110.204 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 54.2 mt -111.77 139.51 35.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.982 -0.554 . . . . 53.039999999999999 109.754 -175.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 12.0 p -127.98 145.85 34.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.467 -0.568 . . . . 61.539999999999999 109.467 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.463 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 40.3 m -78.32 122.44 25.76 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.353 -0.98 . . . . 74.019999999999996 108.353 176.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -141.26 159.41 42.28 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.921 0.867 . . . . 61.140000000000001 112.27 -175.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.401 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 56.1 m -120.08 129.37 54.18 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.809 -1.087 . . . . 73.219999999999999 108.632 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.0 tp -98.85 104.02 22.75 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 108.864 -0.791 . . . . 65.340000000000003 108.864 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.0 OUTLIER -82.44 148.84 14.63 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.533 2.155 . . . . 72.019999999999996 111.543 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.33 16.7 66.1 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.888 -0.672 . . . . 63.340000000000003 112.255 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -145.4 159.89 42.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.956 -1.128 . . . . 53.329999999999998 107.956 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.561 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 11.1 pt20 -139.24 163.74 31.67 Favored 'General case' 0 CA--C 1.481 -1.682 0 C-N-CA 119.313 -0.955 . . . . 71.530000000000001 111.401 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.574 ' HD3' ' NH1' ' A' ' 54' ' ' ARG . 0.8 OUTLIER -107.94 129.83 55.07 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.892 -1.504 . . . . 72.519999999999996 112.858 -176.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.561 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 5.4 m-85 -109.11 158.21 18.0 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.104 -0.953 . . . . 75.340000000000003 109.905 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.574 ' NH1' ' HD3' ' A' ' 52' ' ' ARG . 6.0 mpt_? . . . . . 0 C--N 1.304 -1.405 0 CA-C-N 116.442 -0.345 . . . . 73.299999999999997 110.21 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 . . . . . 0 N--CA 1.432 -1.374 0 N-CA-C 106.755 -1.572 . . . . 70.219999999999999 106.755 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.23 89.47 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.691 1.594 . . . . 63.119999999999997 110.002 172.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 20.5 p -100.1 164.69 11.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 112.48 0.548 . . . . 63.409999999999997 112.48 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.12 140.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.405 -0.961 . . . . 73.430000000000007 108.405 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -145.68 154.71 52.38 Favored Pre-proline 0 C--O 1.251 1.146 0 N-CA-C 108.057 -1.09 . . . . 73.019999999999996 108.057 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.41 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 8.4 Cg_endo -56.91 131.73 47.33 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 122.572 2.181 . . . . 64.200000000000003 112.013 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.2 t -124.46 140.58 52.82 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.286 -0.87 . . . . 34.439999999999998 108.936 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -74.35 -37.22 63.57 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.242 0.544 . . . . 70.040000000000006 109.582 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -130.94 82.33 2.04 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.611 -0.722 . . . . 75.420000000000002 110.231 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.06 164.28 37.75 Favored Glycine 0 C--N 1.299 -1.491 0 C-N-CA 119.528 -1.32 . . . . 70.299999999999997 112.811 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.22 148.19 30.24 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.832 -0.803 . . . . 72.400000000000006 108.832 176.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.16 122.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.442 -0.577 . . . . 63.329999999999998 109.442 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -97.53 116.54 29.94 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.727 -0.472 . . . . 62.450000000000003 109.727 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -152.48 -154.68 6.76 Favored Glycine 0 N--CA 1.418 -2.566 0 N-CA-C 110.317 -1.113 . . . . 44.240000000000002 110.317 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' A' ' 73' ' ' GLY . 14.3 mptt -125.76 153.4 44.03 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.586 0.708 . . . . 75.519999999999996 111.88 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 69.9 t -110.81 130.18 64.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 114.206 -1.361 . . . . 74.120000000000005 110.599 177.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.413 HD23 HG12 ' A' ' 42' ' ' ILE . 65.7 mt -95.41 111.14 23.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 105.954 -1.869 . . . . 51.420000000000002 105.954 175.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.0 ptp -124.28 152.27 43.23 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.089 0.471 . . . . 64.209999999999994 112.006 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.92 18.72 53.68 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 109.189 -1.564 . . . . 63.030000000000001 109.189 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 83' ' ' GLU . 54.7 t -71.91 127.24 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 114.253 -0.974 . . . . 73.140000000000001 109.716 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 79' ' ' VAL . 54.7 p -74.88 161.08 29.86 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.852 -1.166 . . . . 75.420000000000002 107.852 174.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.3 m -61.19 -26.83 67.98 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 122.182 -0.324 . . . . 73.530000000000001 111.837 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.43 -40.73 93.67 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.588 0.709 . . . . 41.539999999999999 110.793 176.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.511 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 38.1 mt-10 -78.0 -35.03 50.48 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.559 -0.746 . . . . 74.230000000000004 109.048 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.569 HD11 ' NH1' ' A' ' 97' ' ' ARG . 3.1 tm? -62.17 -51.41 67.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.478 -0.783 . . . . 70.120000000000005 110.11 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.05 -29.36 70.51 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 109.819 -0.437 . . . . 74.109999999999999 109.819 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.1 t30 -59.71 -46.56 88.73 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.956 -0.757 . . . . 54.219999999999999 108.956 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.44 -36.78 68.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.881 -0.599 . . . . 75.040000000000006 110.949 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.426 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 26.3 t70 -64.36 -31.45 72.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.901 0.858 . . . . 65.549999999999997 109.241 177.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.86 -47.21 21.95 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.591 -0.731 . . . . 71.420000000000002 111.458 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 86' ' ' ASN . 90.5 t -72.16 -60.2 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 112.77 0.655 . . . . 65.530000000000001 112.77 -176.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -83.0 -41.84 18.24 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.87 0.843 . . . . 72.040000000000006 111.822 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -59.58 -16.58 37.58 Favored Glycine 0 C--O 1.215 -1.041 0 N-CA-C 118.238 2.055 . . . . 62.450000000000003 118.238 -171.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -69.96 -45.16 67.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 120.154 1.977 . . . . 63.100000000000001 112.22 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -98.09 -3.61 37.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.242 0.544 . . . . 60.049999999999997 111.266 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 83.5 m-85 -122.24 169.43 10.91 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.769 0.828 . . . . 64.420000000000002 110.012 -178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.423 ' HB2' HG13 ' A' ' 119' ' ' ILE . 35.3 tt0 -122.62 132.35 54.24 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.869 -0.789 . . . . 62.340000000000003 108.869 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.569 ' NH1' HD11 ' A' ' 84' ' ' LEU . 9.6 ttp180 -87.01 114.1 23.33 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.902 -1.045 . . . . 75.230000000000004 109.704 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.87 161.93 25.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 114.712 -1.131 . . . . 75.420000000000002 110.813 -177.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.2 t -94.42 129.28 41.22 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.763 -0.828 . . . . 43.020000000000003 108.763 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.94 170.32 17.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 120.963 0.411 . . . . 63.039999999999999 111.132 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.84 124.5 6.66 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.971 -0.852 . . . . 65.420000000000002 110.971 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.88 160.07 11.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 122.874 0.469 . . . . 74.219999999999999 110.117 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.4 t -120.73 127.07 75.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.467 -0.938 . . . . 73.219999999999999 108.467 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.612 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 28.2 mtp180 -68.79 135.63 51.5 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.011 -0.54 . . . . 72.030000000000001 110.676 -177.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.463 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 49.2 mt-10 -79.56 -5.73 55.55 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.07 -0.514 . . . . 74.319999999999993 109.748 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.12 -67.62 0.42 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.033 -0.985 . . . . 63.109999999999999 110.528 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -132.16 12.29 4.65 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.635 -1.166 . . . . 61.119999999999997 112.289 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.9 t 69.85 18.78 7.28 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.795 0.838 . . . . 75.310000000000002 113.133 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -88.21 149.96 23.56 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.855 -0.528 . . . . 71.200000000000003 110.923 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -95.02 147.53 23.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.122 0.487 . . . . 74.540000000000006 111.092 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.612 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.6 mtp -141.56 160.92 39.16 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 123.625 0.77 . . . . 52.229999999999997 110.329 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.16 130.88 51.91 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.552 -0.749 . . . . 44.399999999999999 110.779 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 19' ' ' ASN . 28.8 m -142.83 174.02 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 73.329999999999998 110.402 -177.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.21 149.46 23.53 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.445 -1.687 . . . . 73.319999999999993 106.445 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 6.7 t -150.35 172.09 15.95 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.085 -0.709 . . . . 74.450000000000003 109.085 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 95' ' ' TYR . 81.0 m-85 -120.91 108.89 14.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 123.452 0.47 . . . . 51.310000000000002 109.951 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.41 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 24.0 ptt? -112.42 155.87 23.49 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.093 -0.503 . . . . 43.420000000000002 109.728 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -69.56 129.44 39.68 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.461 -0.941 . . . . 74.439999999999998 108.461 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.54 ' H ' HD12 ' A' ' 119' ' ' ILE . 2.7 mp -72.65 -42.81 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.763 0.316 . . . . 64.340000000000003 111.762 -171.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -71.1 -36.91 72.36 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.136 -0.69 . . . . 63.140000000000001 109.136 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt 52.34 9.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.318 1.847 . . . . 74.409999999999997 114.908 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.96 14.14 4.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.386 0.513 . . . . 74.510000000000005 112.386 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 4.8 m-20 -67.08 122.42 82.58 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 110.182 -0.303 . . . . 70.150000000000006 110.182 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 123' ' ' ASP . 12.2 Cg_exo -72.28 -5.96 18.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.587 2.191 . . . . 75.409999999999997 112.974 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -59.71 -53.3 59.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.305 0.574 . . . . 64.310000000000002 110.225 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 C--N 1.308 -1.214 0 CA-C-N 114.801 -1.091 . . . . 64.450000000000003 112.233 -175.256 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.544 ' O ' HG12 ' A' ' 144' ' ' ILE . 63.9 pttt . . . . . 0 C--O 1.217 -0.651 0 N-CA-C 110.199 -0.297 . . . . 73.010000000000005 110.199 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 50.2 mtmt -48.58 -35.15 12.83 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.818 0.847 . . . . 73.310000000000002 112.589 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -58.96 -45.39 90.62 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.3 0.572 . . . . 73.25 110.826 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -76.12 -34.87 59.48 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.918 -0.771 . . . . 61.140000000000001 108.918 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.1 mm -61.43 -33.97 59.2 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.759 0 CA-C-N 115.081 -0.963 . . . . 75.340000000000003 110.193 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.3 mt-10 -54.15 -35.88 62.72 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.742 0.306 . . . . 72.510000000000005 110.843 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.9 m -70.6 -47.37 60.48 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 116.128 -0.487 . . . . 73.239999999999995 110.018 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -71.84 -30.51 65.53 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 113.238 0.829 . . . . 71.040000000000006 113.238 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.9 -42.87 80.69 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.981 -0.748 . . . . 73.329999999999998 108.981 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -70.92 -38.43 72.93 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.785 -1.098 . . . . 74.420000000000002 108.931 -177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.55 -41.08 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.754 -0.657 . . . . 61.030000000000001 110.355 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 70.9 mtm -67.79 -37.75 82.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.514 -0.312 . . . . 74.140000000000001 110.818 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -67.84 -31.29 71.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.806 0.336 . . . . 74.430000000000007 111.016 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.91 -47.1 55.04 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.354 -0.385 . . . . 63.32 111.459 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt . . . . . 0 C--N 1.326 -0.414 0 N-CA-C 112.617 0.599 . . . . 65.230000000000004 112.617 -176.206 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.411 -2.407 0 N-CA-C 108.4 -0.963 . . . . 73.209999999999994 108.4 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.429 ' O ' HG12 ' A' ' 79' ' ' VAL . 40.8 m-70 -115.15 159.56 20.76 Favored 'General case' 0 C--N 1.271 -2.848 0 N-CA-C 108.933 -0.765 . . . . 53.130000000000003 108.933 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.43 ' HB2' HG12 ' A' ' 113' ' ' VAL . 34.6 m-20 -116.97 125.34 51.25 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.824 -1.176 . . . . 63.100000000000001 107.824 176.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.7 t -125.47 142.08 43.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 109.759 -0.46 . . . . 70.109999999999999 109.759 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.554 ' HB2' HG21 ' A' ' 113' ' ' VAL . 91.1 t80 -94.34 123.13 37.55 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.044 -1.095 . . . . 64.239999999999995 108.044 177.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.563 HG21 ' HB2' ' A' ' 26' ' ' PHE . 14.8 p -107.89 148.41 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 121.445 0.64 . . . . 52.130000000000003 110.609 -176.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -118.02 -59.75 1.87 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.175 -0.92 . . . . 74.430000000000007 113.046 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.22 -60.14 0.08 OUTLIER Glycine 0 C--N 1.336 0.564 0 C-N-CA 118.663 -1.732 . . . . 64.140000000000001 115.41 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.2 m -57.84 -24.34 56.98 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.388 0.884 . . . . 55.009999999999998 113.388 -172.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.563 ' HB2' HG21 ' A' ' 22' ' ' VAL . 49.8 m-85 -132.0 25.13 4.61 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.723 -0.843 . . . . 61.219999999999999 108.723 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.46 -30.18 68.02 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.308 0.575 . . . . 63.32 112.478 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 31' ' ' VAL . 31.0 t70 -96.65 130.89 29.3 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.893 -0.594 . . . . 72.400000000000006 111.334 -176.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.478 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 19.0 Cg_endo -60.24 -28.25 86.52 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.52 2.147 . . . . 52.240000000000002 113.692 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.451 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 22.0 t70 -70.52 -41.74 72.18 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.567 -0.453 . . . . 74.310000000000002 110.926 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 28' ' ' ASP . 9.8 p -65.92 -28.57 44.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 C-N-CA 119.887 -0.725 . . . . 64.430000000000007 109.33 177.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.528 HG23 HD21 ' A' ' 36' ' ' LEU . 37.5 mm -61.52 -46.75 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.598 -0.519 . . . . 75.409999999999997 109.598 175.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -60.89 -32.19 71.66 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.925 -0.58 . . . . 53.409999999999997 111.94 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.4 t -81.71 -38.91 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 120.636 -0.425 . . . . 74.329999999999998 111.59 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -74.75 -36.81 62.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.482 -0.326 . . . . 72.109999999999999 110.776 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.528 HD21 HG23 ' A' ' 32' ' ' ILE 0.275 0.4 OUTLIER -117.02 -60.78 1.8 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.169 -0.612 . . . . 52.509999999999998 111.987 176.764 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.431 ' OD2' ' HG2' ' A' ' 38' ' ' ARG . 30.5 t70 162.13 -50.99 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 124.597 1.159 . . . . 71.420000000000002 110.236 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 4.6 mmp_? -118.88 152.76 35.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.957 -0.565 . . . . 63.520000000000003 110.636 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.421 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 5.0 m -95.74 120.2 63.71 Favored Pre-proline 0 C--O 1.245 0.829 0 CA-C-N 116.647 -0.251 . . . . 75.230000000000004 111.009 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -67.47 152.71 78.26 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 122.77 2.313 . . . . 71.420000000000002 109.36 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.42 129.0 39.86 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.331 -0.547 . . . . 74.209999999999994 109.85 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 53.9 mt -110.28 124.93 67.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.495 -0.775 . . . . 73.140000000000001 109.226 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.616 HG21 ' HD2' ' A' ' 104' ' ' ARG . 14.0 p -116.41 146.56 20.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 109.007 -0.738 . . . . 74.400000000000006 109.007 177.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.6 m -81.44 124.29 29.31 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.627 -0.509 . . . . 65.120000000000005 109.627 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -142.83 159.49 42.13 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.171 0.51 . . . . 74.409999999999997 111.161 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.6 m -116.51 131.63 56.9 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.313 -0.858 . . . . 72.219999999999999 110.8 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.414 HD11 ' HB ' ' A' ' 100' ' ' VAL . 37.7 tp -99.3 99.9 9.27 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 123.984 0.913 . . . . 73.409999999999997 110.014 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 66.4 Cg_endo -78.3 143.29 19.65 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.149 1.9 . . . . 73.519999999999996 111.693 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.01 5.12 58.48 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 116.077 -0.511 . . . . 63.5 112.306 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.2 168.91 18.51 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 122.358 0.263 . . . . 72.209999999999994 110.43 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -139.94 164.7 29.31 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.12 -0.696 . . . . 71.319999999999993 109.12 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -130.97 126.41 35.95 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.434 -0.803 . . . . 71.439999999999998 110.676 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 37.4 m-85 -114.83 163.89 14.88 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.668 -0.696 . . . . 74.510000000000005 109.742 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.839 0 O-C-N 123.485 0.491 . . . . 53.130000000000003 111.235 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.401 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 13.5 m-85 . . . . . 0 N--CA 1.432 -1.373 0 N-CA-C 106.913 -1.514 . . . . 74.239999999999995 106.913 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 12.2 Cg_endo -59.57 120.79 8.82 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 107.752 -1.672 . . . . 71.219999999999999 107.752 166.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.5 p -132.82 160.32 37.25 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.962 0.411 . . . . 73.129999999999995 111.128 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mm -110.38 138.18 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.411 -0.959 . . . . 72.239999999999995 108.411 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 118' ' ' TRP . 31.1 m -145.9 151.99 46.9 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 108.157 -1.053 . . . . 70.25 108.157 175.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 10.4 Cg_endo -58.53 134.67 62.59 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.645 2.23 . . . . 72.200000000000003 112.645 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.4 t -120.51 147.36 45.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.738 -0.838 . . . . 53.409999999999997 108.738 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.31 -37.83 68.85 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.341 0.4 . . . . 73.319999999999993 110.284 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -142.52 75.81 1.51 Allowed 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 108.751 -0.833 . . . . 72.120000000000005 108.751 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.55 168.63 28.52 Favored Glycine 0 C--N 1.287 -2.166 0 C-N-CA 119.538 -1.315 . . . . 53.240000000000002 112.68 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -154.51 141.47 19.24 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.64 -0.874 . . . . 64.319999999999993 108.64 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.07 119.16 59.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.308 -0.627 . . . . 64.329999999999998 109.308 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -89.85 116.07 27.65 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.979 -1.489 . . . . 65.450000000000003 106.979 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.86 -148.05 4.72 Favored Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 120.718 -0.753 . . . . 64.209999999999994 111.563 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.532 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 46.0 mmtm -127.12 147.11 50.18 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.692 0.282 . . . . 63.109999999999999 110.92 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 39.2 t -110.35 127.42 67.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 116.12 -0.491 . . . . 72.439999999999998 110.658 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.426 HD23 HG12 ' A' ' 42' ' ' ILE . 73.8 mt -95.32 103.99 15.86 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.347 -1.353 . . . . 73.019999999999996 107.347 177.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.6 ptp -109.4 138.63 45.47 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.881 -0.414 . . . . 71.319999999999993 109.881 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.81 13.93 26.36 Favored Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 119.462 -1.352 . . . . 73.549999999999997 111.743 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.3 p -83.06 129.42 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.588 -0.893 . . . . 71.409999999999997 108.588 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 m -73.77 159.82 32.38 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 109.825 -0.435 . . . . 54.530000000000001 109.825 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 19.7 m -56.58 -42.32 78.47 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.25 0.463 . . . . 73.340000000000003 112.25 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.78 -41.46 99.26 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-O 120.843 0.354 . . . . 62.530000000000001 111.372 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.575 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 47.2 mt-10 -70.61 -28.21 64.68 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.269 -0.641 . . . . 72.310000000000002 109.269 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.432 ' HB3' ' O ' ' A' ' 81' ' ' SER . 55.2 tp -63.26 -47.15 83.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.496 -0.927 . . . . 63.240000000000002 108.496 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 88' ' ' ASP . 47.7 mt-10 -68.52 -29.15 67.67 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.056 -0.974 . . . . 73.120000000000005 110.173 176.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 2.3 t-20 -63.15 -45.97 89.39 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.498 1.119 . . . . 72.030000000000001 109.052 175.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.5 mt -64.2 -38.76 92.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.611 -0.722 . . . . 72.109999999999999 109.367 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 9.7 t70 -58.95 -47.2 85.95 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 115.486 -0.779 . . . . 52.32 110.425 173.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.62 -48.07 83.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.693 -0.685 . . . . 72.510000000000005 111.315 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.49 -57.99 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 N-CA-C 113.332 0.864 . . . . 52.119999999999997 113.332 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -79.84 -36.43 36.8 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.409 0.623 . . . . 65.120000000000005 111.825 -174.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.17 -17.16 22.75 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-N 115.098 -0.956 . . . . 44.409999999999997 115.113 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -58.98 -32.41 69.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 111.736 0.273 . . . . 75.109999999999999 111.736 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.51 0.51 4.03 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 111.629 0.233 . . . . 63.149999999999999 111.629 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -132.05 164.22 26.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.166 0.432 . . . . 64.319999999999993 112.166 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.7 tp10 -124.66 143.55 50.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.409 -0.589 . . . . 74.540000000000006 109.409 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 115' ' ' THR . 46.0 ttp180 -97.13 114.72 26.43 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.514 -0.55 . . . . 74.019999999999996 109.514 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.8 m -116.75 162.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 115.731 -0.668 . . . . 74.030000000000001 112.002 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.7 p -86.13 121.9 29.38 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.892 -1.049 . . . . 65.450000000000003 109.932 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.414 ' HB ' HD11 ' A' ' 47' ' ' LEU . 33.1 m -134.57 166.08 29.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 115.88 -0.6 . . . . 62.200000000000003 112.091 -176.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -118.95 127.72 7.35 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.023 -1.231 . . . . 31.329999999999998 110.023 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.01 161.0 16.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 117.096 0.448 . . . . 63.329999999999998 111.115 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.6 t -128.53 124.42 61.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.671 -0.862 . . . . 74.540000000000006 108.671 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.616 ' HD2' HG21 ' A' ' 43' ' ' VAL . 55.9 mtm180 -63.74 147.52 51.49 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.185 0.517 . . . . 75.25 112.387 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -82.73 -1.49 51.57 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.573 -1.194 . . . . 64.310000000000002 110.129 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.18 -59.23 3.01 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.564 -0.743 . . . . 72.409999999999997 111.616 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -140.83 5.82 1.98 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 119.788 -0.765 . . . . 64.530000000000001 111.415 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.8 t 69.77 78.04 0.2 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.212 0.945 . . . . 73.0 110.99 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -137.09 151.96 49.48 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.231 -1.396 . . . . 70.140000000000001 107.231 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -104.76 148.33 26.73 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.764 -0.774 . . . . 73.329999999999998 112.888 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.3 mtm -136.4 163.26 30.89 Favored 'General case' 0 CA--C 1.475 -1.935 0 CA-C-N 115.334 -0.848 . . . . 75.230000000000004 109.38 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.36 117.97 35.49 Favored 'General case' 0 C--N 1.268 -2.972 0 CA-C-N 114.837 -1.074 . . . . 40.539999999999999 109.581 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 21' ' ' PHE . 30.9 m -135.52 174.02 13.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.723 -0.473 . . . . 61.009999999999998 109.723 -176.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -116.96 154.24 31.21 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.058 -1.09 . . . . 72.510000000000005 108.058 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.2 t -146.02 171.57 14.67 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.182 -0.674 . . . . 73.140000000000001 109.182 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.2 m-85 -113.73 112.35 23.31 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.352 -0.61 . . . . 73.5 109.352 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.438 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 24.5 ptt? -112.95 158.15 20.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.703 -0.681 . . . . 62.450000000000003 109.834 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.403 ' HB3' HG12 ' A' ' 64' ' ' VAL . 67.6 t-105 -66.76 124.82 23.98 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 107.797 -1.186 . . . . 64.409999999999997 107.797 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.21 -43.29 84.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 113.969 1.1 . . . . 62.43 113.969 -165.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -86.24 -9.69 56.03 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.245 -0.982 . . . . 63.340000000000003 110.657 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt 55.58 -27.15 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 118.136 2.643 . . . . 74.310000000000002 118.136 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -110.58 96.37 6.14 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.56 -0.712 . . . . 72.329999999999998 112.348 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -128.1 118.87 20.77 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.036 -0.984 . . . . 74.25 111.326 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.79 -15.87 44.95 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.622 2.215 . . . . 70.230000000000004 110.034 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.8 -41.71 87.37 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.205 -1.361 . . . . 65.549999999999997 112.409 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 20.3 ptt? . . . . . 0 N--CA 1.448 -0.557 0 CA-C-O 122.496 1.141 . . . . 64.340000000000003 113.451 -176.419 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' O ' HG12 ' A' ' 144' ' ' ILE . 87.0 tttt . . . . . 0 C--O 1.243 0.734 0 CA-C-O 120.709 0.29 . . . . 73.430000000000007 110.672 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.509 ' HA ' ' HB ' ' A' ' 144' ' ' ILE . 32.7 mmtp -48.99 -31.36 7.34 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.369 1.248 . . . . 73.409999999999997 114.369 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -54.58 -46.47 73.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.128 0.49 . . . . 72.340000000000003 110.849 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -76.29 -36.1 58.54 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.569 0.699 . . . . 72.430000000000007 109.205 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 141' ' ' LYS . 50.7 mm -62.04 -33.21 57.22 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 CA-C-N 114.721 -1.127 . . . . 73.299999999999997 112.313 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 64.4 mm-40 -54.27 -36.22 63.39 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.045 0.45 . . . . 63.539999999999999 110.616 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 89.3 m -74.42 -42.74 58.66 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.403 -0.591 . . . . 74.030000000000001 109.403 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -67.75 -29.45 68.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 114.598 1.332 . . . . 71.540000000000006 114.598 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 99.3 mttt -53.38 -49.05 68.03 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 109.278 -0.638 . . . . 70.530000000000001 109.278 176.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -68.01 -36.24 79.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.206 -0.906 . . . . 64.099999999999994 110.55 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.3 -39.83 86.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.594 -0.73 . . . . 70.319999999999993 109.688 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 56.9 ttp -73.43 -38.53 65.49 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.508 -0.769 . . . . 74.519999999999996 110.599 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 52.1 mt-10 -62.85 -34.63 77.76 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.2 0.524 . . . . 74.530000000000001 110.592 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 46.9 t -65.91 -36.22 82.78 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.273 -0.876 . . . . 61.420000000000002 109.953 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.8 mttm . . . . . 0 N--CA 1.448 -0.558 0 CA-C-N 116.223 -0.444 . . . . 71.209999999999994 111.887 -179.287 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 107.988 -1.116 . . . . 64.549999999999997 107.988 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.507 ' O ' HG12 ' A' ' 79' ' ' VAL . 54.3 m-70 -112.94 159.26 19.27 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 109.291 -0.633 . . . . 73.140000000000001 109.291 -171.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.485 HD22 ' HB3' ' A' ' 77' ' ' MET . 8.3 m120 -123.25 125.74 45.64 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.408 -1.33 . . . . 74.030000000000001 107.408 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.5 t -129.64 140.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 110.329 -0.248 . . . . 71.010000000000005 110.329 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.427 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.6 t80 -94.27 123.79 37.88 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.764 -0.828 . . . . 71.129999999999995 108.764 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 74' ' ' LYS . 20.0 m -88.6 154.21 3.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.997 -0.547 . . . . 74.299999999999997 110.778 -176.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.431 ' CD2' HG12 ' A' ' 63' ' ' ILE . 1.5 p90 -135.46 -44.84 0.68 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.616 0.969 . . . . 71.120000000000005 113.616 -176.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.623 ' O ' ' HG2' ' A' ' 27' ' ' GLN . . . -146.43 -62.28 0.01 OUTLIER Glycine 0 C--O 1.219 -0.81 0 C-N-CA 119.611 -1.28 . . . . 51.530000000000001 112.667 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 p -60.81 -22.52 64.25 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 123.894 0.878 . . . . 65.049999999999997 112.813 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.466 ' HB3' HD11 ' A' ' 32' ' ' ILE . 25.3 m-85 -127.47 17.41 7.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.155 -0.475 . . . . 75.200000000000003 111.116 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 24' ' ' GLY . 16.7 pt20 -78.36 3.51 15.44 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 120.418 -0.513 . . . . 73.120000000000005 112.381 -175.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.599 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.3 t70 -130.09 125.66 22.03 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.206 -0.452 . . . . 73.109999999999999 110.676 -176.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -62.25 -29.58 80.41 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.254 1.969 . . . . 72.230000000000004 113.478 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.486 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 14.9 t70 -64.9 -42.84 94.42 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.228 -0.295 . . . . 64.519999999999996 110.781 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 28' ' ' ASP . 8.3 p -67.97 -28.72 42.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 N-CA-C 109.263 -0.643 . . . . 75.439999999999998 109.263 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 28' ' ' ASP . 49.9 mm -64.82 -44.01 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 116.323 -0.399 . . . . 71.319999999999993 110.436 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -58.7 -35.56 72.83 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.933 0.397 . . . . 75.319999999999993 111.204 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -82.14 -47.44 19.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 116.218 -0.447 . . . . 71.129999999999995 112.168 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.593 ' HE1' HD23 ' A' ' 87' ' ' LEU . 7.1 tmm? -62.82 -36.34 82.86 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.953 -0.388 . . . . 64.349999999999994 109.953 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.491 HD21 HG23 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -119.81 -73.02 0.66 Allowed 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 120.233 -0.587 . . . . 71.540000000000006 112.252 174.15 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.439 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 15.5 t70 169.24 -50.2 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.854 -0.795 . . . . 72.230000000000004 108.854 -174.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 32' ' ' ILE . 76.0 mtt180 -106.76 150.25 26.5 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 114.898 -1.047 . . . . 65.129999999999995 109.938 -174.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 m -103.28 110.21 63.26 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 108.102 -1.073 . . . . 63.340000000000003 108.102 170.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.67 151.56 79.64 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 122.802 2.335 . . . . 73.230000000000004 110.009 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -56.81 132.76 53.26 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.844 -0.428 . . . . 75.329999999999998 109.844 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 27.2 mt -109.59 137.84 39.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.751 -0.658 . . . . 74.019999999999996 110.542 -172.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 14.4 p -130.66 147.07 33.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.961 -0.563 . . . . 72.510000000000005 109.952 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.4 m -75.99 123.31 25.54 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.581 -0.896 . . . . 71.519999999999996 108.581 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.52 155.86 46.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.503 0.668 . . . . 42.0 111.643 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.46 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 95.4 m -115.36 125.93 53.8 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.012 -0.994 . . . . 54.329999999999998 110.515 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.5 tp -99.37 100.77 11.16 Favored Pre-proline 0 C--N 1.299 -1.616 0 C-N-CA 123.026 0.53 . . . . 64.340000000000003 109.873 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.6 Cg_endo -81.63 136.0 9.42 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.899 2.4 . . . . 73.219999999999999 112.829 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.49 15.42 37.75 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.632 -0.713 . . . . 72.019999999999996 111.886 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.03 161.15 40.77 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.001 -0.74 . . . . 75.540000000000006 109.001 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.425 HE21 ' H ' ' A' ' 52' ' ' ARG . 31.6 tp60 -140.33 140.91 35.71 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.272 0.558 . . . . 72.200000000000003 110.675 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.427 HH12 ' HB3' ' A' ' 54' ' ' ARG . 37.7 tpt85 -94.88 126.2 40.05 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.722 -1.126 . . . . 75.099999999999994 109.673 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -124.89 159.42 31.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.263 -0.643 . . . . 73.430000000000007 109.263 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.448 ' C ' ' HE ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.859 0 CA-C-O 119.344 -0.36 . . . . 75.129999999999995 111.451 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 N--CA 1.419 -2.009 0 N-CA-C 108.273 -1.01 . . . . 70.099999999999994 108.273 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -55.71 115.33 2.38 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.478 2.118 . . . . 63.219999999999999 109.621 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.1 p -132.33 159.67 38.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.278 0.473 . . . . 74.319999999999993 112.278 -174.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.431 HG12 ' CD2' ' A' ' 23' ' ' TYR . 45.4 mm -115.82 141.92 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.449 -0.945 . . . . 73.430000000000007 108.449 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.6 m -143.67 154.53 59.56 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 107.509 -1.293 . . . . 71.099999999999994 107.509 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.39 136.4 59.19 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.385 2.057 . . . . 73.409999999999997 112.789 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.3 t -124.86 144.06 50.51 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.217 -1.031 . . . . 72.120000000000005 108.217 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.07 -37.34 64.25 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.968 -0.382 . . . . 63.530000000000001 109.968 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -131.68 75.22 1.63 Allowed 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.713 -0.477 . . . . 74.299999999999997 109.713 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.76 157.83 30.46 Favored Glycine 0 N--CA 1.42 -2.376 0 C-N-CA 119.566 -1.302 . . . . 64.209999999999994 111.584 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -147.65 150.59 34.67 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 107.688 -1.227 . . . . 73.549999999999997 107.688 175.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.9 t -112.05 127.65 69.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 109.159 -0.682 . . . . 63.219999999999999 109.159 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -99.1 115.54 29.24 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.919 -1.512 . . . . 73.239999999999995 106.919 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -149.55 -149.63 5.04 Favored Glycine 0 N--CA 1.411 -2.975 0 N-CA-C 110.27 -1.132 . . . . 73.319999999999993 110.27 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.495 ' O ' HG22 ' A' ' 22' ' ' VAL . 1.7 mptm? -128.18 155.08 45.06 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.682 0.753 . . . . 71.209999999999994 112.655 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 31.2 t -113.38 132.72 61.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 114.262 -1.335 . . . . 72.109999999999999 112.067 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.447 HD23 HG12 ' A' ' 42' ' ' ILE . 85.9 mt -95.82 123.38 39.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.214 -1.402 . . . . 61.210000000000001 107.214 172.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.485 ' HB3' HD22 ' A' ' 19' ' ' ASN . 22.0 ptp -127.48 146.46 50.49 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 121.04 -0.264 . . . . 74.140000000000001 111.139 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.21 25.73 15.88 Favored Glycine 0 N--CA 1.43 -1.765 0 C-N-CA 119.572 -1.299 . . . . 54.240000000000002 111.622 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.1 p -94.38 129.55 44.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 109.601 -0.518 . . . . 54.310000000000002 109.601 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.449 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 15.6 m -73.6 159.57 32.89 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 122.874 0.47 . . . . 63.219999999999999 110.64 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.3 m -55.4 -37.36 67.52 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.276 0.843 . . . . 73.200000000000003 113.276 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -58.92 -51.06 71.65 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 120.868 0.366 . . . . 63.549999999999997 110.719 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.653 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 2.3 mp0 -67.49 -28.13 67.58 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 115.937 -0.574 . . . . 71.200000000000003 110.516 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.442 HD22 ' CE1' ' A' ' 18' ' ' HIS . 42.4 tp -63.6 -42.83 98.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.093 -0.706 . . . . 74.140000000000001 109.093 174.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.31 -31.88 69.4 Favored 'General case' 0 C--O 1.198 -1.624 0 CA-C-N 115.524 -0.762 . . . . 74.209999999999994 109.359 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.582 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 2.3 t-20 -61.11 -49.49 77.09 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.452 1.101 . . . . 65.310000000000002 109.832 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 86.1 mt -62.25 -42.43 99.32 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.819 -0.808 . . . . 73.450000000000003 108.819 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.2 -38.56 90.85 Favored 'General case' 0 C--O 1.205 -1.241 0 CA-C-N 114.68 -1.145 . . . . 72.129999999999995 110.402 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.63 -43.68 84.03 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.996 0.518 . . . . 53.229999999999997 110.762 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 86' ' ' ASN . 88.7 t -72.29 -58.3 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 116.221 -0.445 . . . . 70.230000000000004 111.941 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -79.88 -42.58 23.89 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.721 1.008 . . . . 75.329999999999998 113.721 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.52 -17.11 18.4 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 115.659 1.024 . . . . 73.129999999999995 115.659 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -63.37 -39.51 94.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.361 -0.607 . . . . 53.219999999999999 109.361 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.68 0.33 9.83 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.977 0.418 . . . . 73.430000000000007 111.533 -176.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -134.3 168.91 18.03 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.648 0.779 . . . . 73.400000000000006 109.97 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 15.7 pt-20 -122.8 137.33 54.96 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.937 -0.394 . . . . 71.439999999999998 109.937 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -87.76 112.78 22.78 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.309 -1.367 . . . . 71.409999999999997 107.309 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.487 HG11 ' HE2' ' A' ' 117' ' ' MET . 23.0 m -123.04 162.49 23.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 113.237 0.828 . . . . 75.129999999999995 113.237 -176.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.8 p -85.07 122.32 29.12 Favored 'General case' 0 N--CA 1.405 -2.716 0 CA-C-N 114.473 -1.239 . . . . 73.209999999999994 109.174 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.99 171.23 18.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.319 0.581 . . . . 73.129999999999995 111.732 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -123.9 129.2 7.16 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 109.871 -1.292 . . . . 22.239999999999998 109.871 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.448 HD12 ' HB3' ' A' ' 111' ' ' MET . 2.8 pp -119.3 152.91 21.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 117.039 0.419 . . . . 52.420000000000002 111.199 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 63.7 t -110.81 114.82 48.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 108.708 -0.849 . . . . 33.409999999999997 108.708 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -65.56 112.51 3.64 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.394 -0.821 . . . . 71.219999999999999 109.747 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.9 -14.28 61.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.244 1.021 . . . . 75.230000000000004 108.815 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.66 -48.55 74.83 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.04 -1.891 . . . . 55.0 111.628 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -128.87 -15.21 4.37 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 121.955 -0.466 . . . . 73.209999999999994 111.754 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.8 m 77.15 73.24 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.705 1.202 . . . . 72.409999999999997 111.882 -176.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -155.01 153.16 30.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.11 1.364 . . . . 62.439999999999998 108.056 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 65.1 pttt -93.27 147.17 23.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.24 -0.984 . . . . 63.520000000000003 110.732 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.448 ' HB3' HD12 ' A' ' 102' ' ' ILE . 27.1 ttt -140.7 154.12 46.23 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 124.324 1.05 . . . . 70.530000000000001 108.85 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.47 130.09 46.5 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.825 0.345 . . . . 75.099999999999994 110.983 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 21' ' ' PHE . 27.4 m -146.04 175.28 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.585 -0.894 . . . . 70.120000000000005 108.585 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.67 157.98 24.52 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.031 -0.729 . . . . 51.439999999999998 109.031 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.0 t -152.09 172.94 15.55 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.969 -0.752 . . . . 71.010000000000005 108.969 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 74.3 m-85 -114.77 122.07 45.25 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 123.584 0.553 . . . . 75.030000000000001 110.215 -177.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.487 ' HE2' HG11 ' A' ' 98' ' ' VAL . 24.6 ptt? -119.07 156.95 28.8 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.858 -0.61 . . . . 74.230000000000004 109.454 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 63.8 t-105 -67.49 135.27 52.79 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.871 -0.789 . . . . 74.109999999999999 108.871 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 96' ' ' GLU . 20.4 mm -68.96 -44.4 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 120.553 -0.459 . . . . 72.310000000000002 112.097 -170.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -69.81 -32.49 70.97 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.135 0.493 . . . . 75.420000000000002 109.76 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.345 9.2 ptpp? 54.91 -1.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.637 2.088 . . . . 64.129999999999995 116.637 176.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.85 83.85 2.2 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.628 -1.249 . . . . 74.099999999999994 107.628 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.563 ' H ' ' HE3' ' A' ' 126' ' ' MET . 14.2 t70 -120.77 130.33 24.9 Favored Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 115.262 -0.881 . . . . 74.209999999999994 110.493 -176.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.49 2.7 8.2 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.89 2.393 . . . . 73.319999999999993 114.766 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.61 -34.5 11.39 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 121.834 -0.541 . . . . 63.030000000000001 111.653 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.563 ' HE3' ' H ' ' A' ' 123' ' ' ASP 0.352 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.05 0 N-CA-C 114.478 1.288 . . . . 74.049999999999997 114.478 179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.593 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.1 ttpt . . . . . 0 CA--C 1.508 -0.673 0 N-CA-C 109.309 -0.626 . . . . 73.329999999999998 109.309 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 51.4 tttm -50.68 -35.13 29.41 Favored 'General case' 0 C--O 1.217 -0.638 0 C-N-CA 124.074 0.95 . . . . 74.120000000000005 111.884 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -68.86 -33.73 74.28 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.241 0.544 . . . . 71.040000000000006 110.611 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -77.38 -35.62 54.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.307 -0.627 . . . . 62.119999999999997 109.307 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 140' ' ' LYS . 45.3 mm -64.05 -33.51 62.74 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.441 0 CA-C-N 115.253 -0.885 . . . . 62.350000000000001 110.379 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.0 mt-10 -54.27 -30.47 50.79 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 113.277 0.843 . . . . 73.120000000000005 113.277 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.1 m -64.34 -41.82 96.57 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 108.876 -0.787 . . . . 73.299999999999997 108.876 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -76.38 -28.66 56.83 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.446 -0.797 . . . . 71.329999999999998 113.003 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 27.2 mmmt -52.95 -44.26 66.96 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 123.229 0.331 . . . . 72.209999999999994 110.746 175.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.18 -43.76 82.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.76 0.791 . . . . 71.209999999999994 109.275 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 71.2 mt -66.72 -45.69 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 114.596 -1.183 . . . . 73.439999999999998 111.248 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' MET . . . . . 0.511 ' HG2' ' HA ' ' A' ' 148' ' ' LYS . 26.1 ptm -74.25 -32.29 62.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.88 0.696 . . . . 73.25 112.88 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 18.1 mm-40 -63.27 -39.33 94.28 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.45 -0.574 . . . . 73.400000000000006 109.45 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 81.9 m -69.23 -31.33 69.83 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.664 -0.698 . . . . 71.510000000000005 111.419 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 150' ' ' ILE . 98.4 mttt . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 121.577 0.703 . . . . 75.230000000000004 109.53 175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 121.274 0.559 . . . . 64.200000000000003 111.151 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.9 m -146.35 18.38 1.36 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.775 -0.824 . . . . 72.120000000000005 108.775 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.5 p -84.37 -13.15 53.07 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.762 -1.108 . . . . 72.450000000000003 111.563 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.9 t70 65.07 89.06 0.1 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.622 0.769 . . . . 63.210000000000001 110.144 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.6 p -106.58 74.52 1.01 Allowed 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 113.633 0.975 . . . . 65.230000000000004 113.633 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 mp -110.26 -63.59 1.37 Allowed 'General case' 0 N--CA 1.408 -2.538 0 CA-C-N 114.599 -1.182 . . . . 55.130000000000003 109.53 174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -96.39 -10.05 28.52 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.506 -1.224 . . . . 74.239999999999995 109.245 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.4 mt -98.02 153.17 18.57 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 113.621 -1.627 . . . . 70.349999999999994 107.862 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.552 ' CG ' ' HG ' ' A' ' 84' ' ' LEU . 39.2 m-70 -121.39 160.6 23.75 Favored 'General case' 0 C--N 1.285 -2.211 0 CA-C-N 116.249 -0.432 . . . . 75.030000000000001 111.078 -171.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 23.6 p30 -132.38 130.58 40.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.596 -0.729 . . . . 71.329999999999998 111.425 175.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -131.65 142.05 44.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.41 -0.814 . . . . 72.349999999999994 109.986 -173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -94.05 122.51 36.64 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.75 -1.204 . . . . 74.519999999999996 107.75 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 28.4 m -97.51 161.33 2.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 121.208 0.527 . . . . 54.149999999999999 112.361 -176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.467 ' HA ' ' NH2' ' A' ' 52' ' ' ARG . 9.1 p90 -144.08 -60.2 0.39 Allowed 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 113.177 0.806 . . . . 75.200000000000003 113.177 -172.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.0 -101.62 2.5 Favored Glycine 0 N--CA 1.435 -1.368 0 C-N-CA 119.928 -1.129 . . . . 54.43 113.461 -175.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.9 t -59.31 -36.61 75.94 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 123.828 0.851 . . . . 60.210000000000001 112.644 -173.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -92.25 17.38 9.77 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 113.65 0.982 . . . . 73.120000000000005 113.65 -176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -85.67 7.16 24.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 119.576 -0.85 . . . . 64.239999999999995 109.988 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.545 ' O ' HG12 ' A' ' 32' ' ' ILE . 19.0 t70 -119.74 127.36 26.45 Favored Pre-proline 0 C--N 1.305 -1.359 0 CA-C-N 115.87 -0.605 . . . . 73.239999999999995 109.849 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HB3' HG21 ' A' ' 39' ' ' THR . 38.0 Cg_endo -69.45 -25.26 30.18 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.102 1.868 . . . . 72.400000000000006 113.504 -178.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 17.3 t70 -67.59 -41.18 84.5 Favored 'General case' 0 C--N 1.312 -1.034 0 O-C-N 121.817 -0.552 . . . . 72.150000000000006 110.819 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 28' ' ' ASP . 11.2 p -68.45 -28.65 41.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.416 -0.587 . . . . 71.540000000000006 109.416 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.608 HG23 HD21 ' A' ' 36' ' ' LEU . 48.7 mm -67.09 -47.04 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 116.308 -0.405 . . . . 62.219999999999999 110.394 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -57.28 -35.26 69.56 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.059 0.457 . . . . 64.140000000000001 111.691 176.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.1 t -81.76 -47.44 19.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 112.069 0.396 . . . . 62.509999999999998 112.069 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.406 ' HE1' HD23 ' A' ' 87' ' ' LEU . 7.9 tmm? -64.91 -35.9 82.63 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 110.321 -0.252 . . . . 53.329999999999998 110.321 -174.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.608 HD21 HG23 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -115.38 -72.82 0.67 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 120.16 -0.616 . . . . 71.439999999999998 112.095 174.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.2 t70 179.26 -49.48 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.453 0.644 . . . . 72.120000000000005 109.892 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.435 ' O ' HG22 ' A' ' 32' ' ' ILE . 99.4 mtt180 -128.81 173.06 10.69 Favored 'General case' 0 CA--C 1.493 -1.224 0 CA-C-N 115.262 -0.881 . . . . 71.540000000000006 109.155 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.408 HG21 ' HB3' ' A' ' 29' ' ' PRO . 36.7 m -120.95 111.59 34.05 Favored Pre-proline 0 N--CA 1.433 -1.322 0 O-C-N 123.579 0.549 . . . . 75.340000000000003 110.336 176.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -52.36 152.71 14.92 Favored 'Trans proline' 0 N--CA 1.479 0.672 0 C-N-CA 124.262 3.308 . . . . 73.519999999999996 111.565 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.03 125.87 23.44 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.358 -0.608 . . . . 62.32 109.358 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.4 mt -102.11 137.29 30.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.592 -0.731 . . . . 74.400000000000006 109.651 -174.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.479 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 7.3 p -130.1 143.69 40.26 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 115.634 -0.712 . . . . 71.430000000000007 110.145 176.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.2 m -77.0 125.81 29.93 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.986 -1.116 . . . . 71.209999999999994 107.986 175.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.07 156.63 47.59 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 121.404 0.621 . . . . 73.400000000000006 111.07 -178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.428 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 71.4 m -114.61 125.39 53.7 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.205 -0.907 . . . . 75.340000000000003 110.149 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.41 ' HB2' HG22 ' A' ' 102' ' ' ILE . 35.3 tp -102.19 100.29 14.94 Favored Pre-proline 0 C--N 1.294 -1.828 0 CA-C-N 116.049 -0.523 . . . . 73.129999999999995 109.644 176.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 46' ' ' THR . 3.0 Cg_endo -83.85 136.87 7.33 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.5 2.133 . . . . 73.329999999999998 111.838 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.33 11.09 53.0 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.566 -0.825 . . . . 33.109999999999999 111.755 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.431 ' HA ' ' H ' ' A' ' 66' ' ' SER . 86.1 m-85 -141.67 159.68 41.72 Favored 'General case' 0 CA--C 1.489 -1.398 0 N-CA-C 108.855 -0.795 . . . . 73.200000000000003 108.855 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -140.21 141.71 35.91 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 109.773 -0.455 . . . . 55.530000000000001 109.773 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 38.6 ttm180 -102.79 137.53 40.88 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 108.192 -1.04 . . . . 74.329999999999998 108.192 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 10.2 m-85 -108.79 167.52 10.01 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 107.505 -1.294 . . . . 72.5 107.505 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' A' ' 130' ' ' TRP . 12.0 ptm180 -135.85 141.72 44.69 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.489 -0.885 . . . . 73.340000000000003 111.965 -172.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD23 ' HB3' ' A' ' 59' ' ' LEU . 42.2 tp 176.09 162.15 0.34 Allowed 'General case' 0 C--O 1.235 0.338 0 N-CA-C 107.526 -1.287 . . . . 70.340000000000003 107.526 176.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -150.13 136.35 18.78 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.49 -0.559 . . . . 73.319999999999993 109.49 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 130.59 -77.78 0.39 Allowed Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.651 -0.98 . . . . 73.439999999999998 110.651 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.87 -49.25 6.73 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 106.481 -1.674 . . . . 74.420000000000002 106.481 177.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.465 ' HB3' HD23 ' A' ' 55' ' ' LEU . 28.2 tp -125.18 164.69 19.72 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 109.074 -0.713 . . . . 65.409999999999997 109.074 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -127.27 173.85 4.9 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 108.59 -0.892 . . . . 74.510000000000005 108.59 -170.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 52.8 Cg_exo -58.95 117.8 4.59 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 122.064 1.842 . . . . 44.130000000000003 110.825 175.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 26.3 p -115.47 168.47 9.97 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.097 -0.502 . . . . 50.530000000000001 110.663 -176.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.0 mm -123.04 119.97 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 109.615 -0.513 . . . . 71.239999999999995 109.615 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -130.11 146.06 59.91 Favored Pre-proline 0 C--N 1.312 -1.054 0 N-CA-C 110.455 -0.202 . . . . 64.409999999999997 110.455 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.59 111.79 1.27 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.121 2.547 . . . . 72.420000000000002 112.911 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.431 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 34.0 t -126.25 116.5 21.36 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.582 -0.895 . . . . 61.149999999999999 108.582 178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 1.7 mp0 -60.74 -32.07 71.36 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.366 0.603 . . . . 73.510000000000005 111.328 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -95.62 7.11 47.22 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.771 -0.65 . . . . 74.430000000000007 112.012 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -121.77 167.66 14.49 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 119.578 -1.296 . . . . 72.420000000000002 114.03 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.78 144.07 23.23 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.111 1.365 . . . . 72.239999999999995 107.733 175.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 45.8 t -113.06 119.67 61.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 109.392 -0.596 . . . . 73.019999999999996 109.392 -177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -93.22 116.05 28.64 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 106.761 -1.57 . . . . 62.240000000000002 106.761 174.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -146.51 -158.05 7.6 Favored Glycine 0 N--CA 1.418 -2.521 0 N-CA-C 110.732 -0.947 . . . . 74.099999999999994 110.732 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.41 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 13.8 mptt -124.41 148.65 47.44 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-O 121.435 0.636 . . . . 62.140000000000001 111.948 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.6 t -111.04 130.94 63.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 CA-C-N 114.549 -1.205 . . . . 71.420000000000002 111.334 176.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 77.5 mt -96.71 108.89 21.6 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.452 -1.314 . . . . 70.099999999999994 107.452 174.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.4 ptp -115.64 137.38 52.13 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.29 0.567 . . . . 74.239999999999995 112.47 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.91 25.01 7.37 Favored Glycine 0 N--CA 1.427 -1.933 0 CA-C-N 114.982 -1.008 . . . . 44.130000000000003 111.568 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.1 p -88.57 142.23 13.19 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 N-CA-C 110.2 -0.296 . . . . 74.109999999999999 110.2 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -73.72 161.4 30.29 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 123.836 0.854 . . . . 75.420000000000002 112.358 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.2 m -68.87 -35.36 76.81 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.419 1.266 . . . . 71.299999999999997 114.419 -173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -63.61 -43.74 96.0 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.472 0.653 . . . . 75.230000000000004 109.986 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.584 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 9.5 mp0 -69.81 -36.31 75.53 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.776 -1.102 . . . . 75.319999999999993 109.843 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.552 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.4 tm? -60.52 -43.73 96.8 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 109.757 -0.46 . . . . 74.239999999999995 109.757 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.6 mm-40 -71.95 -32.27 67.13 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.969 0.414 . . . . 71.150000000000006 110.863 175.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -38.32 89.18 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.14 -0.482 . . . . 74.400000000000006 110.887 177.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 96.9 mt -62.23 -42.03 98.94 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.168 -0.678 . . . . 64.450000000000003 109.168 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -64.13 -36.06 82.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.348 -0.842 . . . . 63.109999999999999 110.417 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.66 -45.37 71.93 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.619 -0.719 . . . . 62.530000000000001 110.845 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.6 t -69.79 -51.45 40.6 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.918 -0.583 . . . . 73.230000000000004 112.368 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.94 -29.23 55.53 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.909 0.385 . . . . 75.209999999999994 111.607 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.62 -17.57 27.52 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 114.717 0.647 . . . . 34.130000000000003 114.717 -175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -59.95 -31.7 70.11 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.837 0.351 . . . . 71.310000000000002 111.515 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.488 ' HG3' ' CD2' ' A' ' 95' ' ' TYR . 9.8 pt-20 -142.07 6.21 1.75 Allowed 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 112.383 0.512 . . . . 71.040000000000006 112.383 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.488 ' CD2' ' HG3' ' A' ' 94' ' ' GLU . 95.4 m-85 -138.08 168.26 20.09 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.175 -0.466 . . . . 61.450000000000003 110.881 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -124.69 145.47 49.66 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.576 -0.898 . . . . 64.0 108.576 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -87.62 113.85 23.69 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 108.93 -0.767 . . . . 75.510000000000005 108.93 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.628 HG11 ' HE1' ' A' ' 117' ' ' MET . 33.6 m -125.34 161.34 29.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 116.054 -0.521 . . . . 73.420000000000002 111.477 -177.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.0 t -98.97 136.27 39.18 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.185 -0.672 . . . . 75.450000000000003 109.185 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' A' ' 47' ' ' LEU . 29.3 m -138.7 165.18 24.92 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 116.397 -0.365 . . . . 75.230000000000004 110.685 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -107.14 120.31 6.14 Favored Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 110.691 -0.964 . . . . 71.150000000000006 110.691 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.41 HG22 ' HB2' ' A' ' 47' ' ' LEU . 2.7 pp -116.24 152.04 17.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 122.308 0.243 . . . . 71.409999999999997 110.719 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.7 t -113.6 131.28 65.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 110.132 -0.322 . . . . 64.140000000000001 110.132 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.47 ' CZ ' HG21 ' A' ' 43' ' ' VAL . 11.0 mmm180 -58.61 124.41 19.57 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 123.778 0.831 . . . . 74.310000000000002 109.276 177.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.67 8.38 12.19 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.926 0.87 . . . . 54.32 109.842 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.62 -66.33 0.91 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.812 -1.551 . . . . 71.409999999999997 106.812 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.427 ' HB2' ' HG3' ' A' ' 109' ' ' GLU . 16.6 m-80 -99.53 -108.55 0.2 Allowed 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.606 -0.887 . . . . 63.130000000000003 108.606 -176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.409 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 57.9 m -159.67 19.31 0.17 Allowed 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 126.424 1.89 . . . . 73.519999999999996 106.28 175.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 107' ' ' ASN . 48.1 mt-10 -77.33 143.97 38.37 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 114.846 -1.07 . . . . 72.030000000000001 110.472 -176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.691 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -108.04 147.09 31.63 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.909 -0.774 . . . . 73.519999999999996 108.909 179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 88.1 mtp -141.02 161.06 38.74 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 123.645 0.778 . . . . 63.229999999999997 110.333 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -112.71 120.01 40.06 Favored 'General case' 0 C--N 1.274 -2.695 0 CA-C-N 115.228 -0.897 . . . . 73.310000000000002 109.328 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.2 173.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 110.106 -0.331 . . . . 74.510000000000005 110.106 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -96.6 155.01 16.95 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.128 -0.693 . . . . 61.420000000000002 109.128 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.8 t -155.36 172.0 18.94 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.509 -1.663 . . . . 74.219999999999999 106.509 174.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -111.83 119.69 39.45 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 108.948 -0.76 . . . . 64.319999999999993 108.948 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.628 ' HE1' HG11 ' A' ' 98' ' ' VAL . 42.5 ttp -105.8 145.51 31.08 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 115.029 -0.987 . . . . 74.299999999999997 110.196 -173.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.548 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 71.8 t-105 -72.21 124.81 25.82 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.899 -1.149 . . . . 72.209999999999994 107.899 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.7 mt -72.36 -41.27 65.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 CA-C-N 114.797 -1.092 . . . . 75.310000000000002 111.603 -171.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -81.22 102.5 10.39 Favored 'General case' 0 C--O 1.205 -1.264 0 CA-C-O 121.147 0.498 . . . . 61.140000000000001 109.947 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -75.03 -28.41 60.45 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.347 0.499 . . . . 74.420000000000002 112.347 -173.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.3 93.86 4.78 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.588 -0.893 . . . . 41.009999999999998 108.588 177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -137.93 126.13 14.22 Favored Pre-proline 0 C--N 1.308 -1.212 0 C-N-CA 121.041 -0.263 . . . . 75.140000000000001 110.788 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -87.5 -9.67 5.74 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.515 2.143 . . . . 73.5 113.819 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -80.96 -34.9 32.82 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 120.91 0.386 . . . . 44.340000000000003 111.016 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -77.49 -11.05 59.81 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 116.11 -0.495 . . . . 74.120000000000005 111.497 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -58.79 105.4 0.3 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.952 0.723 . . . . 75.329999999999998 112.952 -174.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.71 147.53 12.13 Favored Glycine 0 N--CA 1.435 -1.403 0 N-CA-C 108.059 -2.016 . . . . 53.219999999999999 108.059 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.23 127.4 33.6 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 117.967 0.883 . . . . 62.450000000000003 110.237 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.481 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 11.1 t90 -77.22 155.54 32.12 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 115.963 -0.562 . . . . 75.140000000000001 110.126 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -49.82 -46.62 51.27 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.994 0.918 . . . . 71.329999999999998 109.99 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -64.12 -31.77 73.09 Favored 'General case' 0 C--O 1.202 -1.433 0 CA-C-N 114.968 -1.015 . . . . 52.009999999999998 113.438 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -67.64 -45.67 74.65 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.91 -0.404 . . . . 64.040000000000006 109.91 176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 8.5 tp10 -64.38 -43.26 95.04 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.381 -0.827 . . . . 65.310000000000002 108.917 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -67.09 -37.72 84.45 Favored 'General case' 0 C--O 1.198 -1.627 0 CA-C-N 115.959 -0.564 . . . . 73.200000000000003 111.182 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -55.88 -31.92 63.24 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.064 0.946 . . . . 71.200000000000003 110.384 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 53.3 ttt180 -65.68 -51.98 55.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.973 -1.012 . . . . 73.310000000000002 111.308 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.25 -19.59 50.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.558 0.694 . . . . 74.430000000000007 110.66 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -68.88 -24.42 64.33 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.185 -0.916 . . . . 72.329999999999998 109.28 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.595 ' O ' HG12 ' A' ' 144' ' ' ILE . 6.0 ttpm? -60.15 -41.92 93.77 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.52 -0.763 . . . . 75.540000000000006 109.559 175.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 38.7 ttpt -57.28 -31.26 65.44 Favored 'General case' 0 C--O 1.215 -0.732 0 CA-C-N 115.647 -0.706 . . . . 70.129999999999995 111.499 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -61.5 -37.16 82.68 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.453 -0.34 . . . . 73.0 110.381 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.622 ' O ' HG22 ' A' ' 146' ' ' THR . 92.9 m-85 -76.76 -39.23 52.39 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 109.029 -0.73 . . . . 73.129999999999995 109.029 175.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.2 mm -60.22 -33.03 52.11 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.859 0 CA-C-N 115.216 -0.902 . . . . 74.439999999999998 110.953 -178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 148' ' ' LYS . 63.1 mm-40 -51.36 -39.27 56.75 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 113.246 0.832 . . . . 72.549999999999997 113.246 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 143' ' ' PHE . 15.2 t -74.9 -29.06 60.87 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 119.675 -0.81 . . . . 62.119999999999997 109.493 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 150' ' ' ILE . 22.7 m-85 -76.41 -35.12 58.75 Favored 'General case' 0 CA--C 1.479 -1.78 0 CA-C-N 116.121 -0.491 . . . . 72.349999999999994 112.239 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.574 ' HG3' HG22 ' A' ' 144' ' ' ILE . 57.3 mtpt -55.66 -31.07 62.05 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 123.96 0.787 . . . . 73.530000000000001 112.107 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 14.1 ptmm? -75.05 -34.57 61.86 Favored 'General case' 0 C--O 1.206 -1.198 0 C-N-CA 118.209 -1.397 . . . . 75.340000000000003 109.723 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.43 HD12 ' CD1' ' A' ' 147' ' ' PHE . 64.8 mt -55.52 -29.62 24.75 Favored 'Isoleucine or valine' 0 C--O 1.249 1.029 0 C-N-CA 124.819 1.247 . . . . 51.240000000000002 112.884 -176.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -54.82 -26.01 32.2 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.503 0.557 . . . . 73.319999999999993 112.503 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 149' ' ' LYS . 13.9 pt-20 -57.08 -40.96 77.93 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 121.084 0.469 . . . . 72.109999999999999 110.896 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 50.6 t -71.79 -31.83 67.0 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 121.556 0.693 . . . . 74.209999999999994 109.771 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -75.71 -44.4 42.19 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 115.069 -0.969 . . . . 72.409999999999997 111.292 -175.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -177.72 -42.01 0.01 OUTLIER 'General case' 0 C--O 1.239 0.522 0 N-CA-C 112.542 0.571 . . . . 71.530000000000001 112.542 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -140.33 116.25 7.81 Favored Pre-proline 0 C--N 1.309 -1.165 0 C-N-CA 120.393 -0.523 . . . . 53.25 111.478 -171.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.34 130.19 26.2 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.796 2.331 . . . . 72.450000000000003 110.99 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.711 HE21 ' HA ' ' A' ' 158' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.313 -1.005 0 CA-C-O 120.586 0.231 . . . . 73.299999999999997 111.063 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 45.9 t . . . . . 0 N--CA 1.421 -1.879 0 N-CA-C 109.241 -0.652 . . . . 44.310000000000002 109.241 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.0 t -116.09 108.37 16.1 Favored 'General case' 0 N--CA 1.404 -2.73 0 N-CA-C 108.514 -0.921 . . . . 73.019999999999996 108.514 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.2 m -70.64 -37.03 73.7 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.899 -0.591 . . . . 73.200000000000003 110.556 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 60.22 107.54 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.983 1.475 . . . . 65.400000000000006 114.983 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -154.24 154.94 34.31 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.37 -1.345 . . . . 60.030000000000001 107.37 178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.58 -15.76 62.79 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 115.242 1.571 . . . . 75.319999999999993 115.242 -175.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -90.18 2.46 55.33 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.491 0.663 . . . . 62.219999999999999 110.97 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.1 mt -90.78 146.59 23.84 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.431 -0.804 . . . . 72.25 110.286 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.433 ' O ' HG12 ' A' ' 79' ' ' VAL . 35.7 m-70 -117.39 161.43 19.57 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.341 -0.845 . . . . 72.340000000000003 110.606 -173.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -122.65 127.1 48.9 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.471 -0.937 . . . . 72.230000000000004 108.471 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 63.0 t -125.86 137.94 56.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 116.878 -0.147 . . . . 63.0 110.668 -176.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.538 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.0 t80 -94.72 122.42 37.31 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.589 -1.263 . . . . 73.239999999999995 107.589 176.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.446 HG11 ' HB2' ' A' ' 26' ' ' PHE . 27.2 m -111.43 123.7 67.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.738 0.78 . . . . 74.430000000000007 111.598 -175.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -77.85 -40.43 40.29 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.869 -1.059 . . . . 65.219999999999999 113.46 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -166.84 -40.66 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 118.814 -1.66 . . . . 74.430000000000007 113.539 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.6 m -58.02 -27.79 63.88 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.736 0.643 . . . . 74.439999999999998 112.736 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.463 ' O ' HD11 ' A' ' 32' ' ' ILE . 40.9 m-85 -134.5 28.37 3.66 Favored 'General case' 0 C--O 1.215 -0.716 0 N-CA-C 110.053 -0.351 . . . . 74.439999999999998 110.053 -176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -78.04 -19.11 54.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.103 0.779 . . . . 73.430000000000007 113.103 -175.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 31' ' ' VAL . 23.3 t70 -105.47 130.43 23.09 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 110.193 -0.299 . . . . 62.140000000000001 110.193 -175.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HB3' HG21 ' A' ' 39' ' ' THR . 23.3 Cg_endo -61.92 -25.57 78.17 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.941 2.427 . . . . 60.219999999999999 114.742 -175.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -65.06 -43.15 93.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.064 0.459 . . . . 73.310000000000002 110.598 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 28' ' ' ASP . 23.4 m -71.28 -28.1 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 115.753 -0.658 . . . . 74.400000000000006 110.715 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.526 HG23 HD21 ' A' ' 36' ' ' LEU . 48.4 mm -62.98 -51.69 68.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 122.699 0.4 . . . . 74.140000000000001 111.631 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -57.73 -32.61 67.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.168 0.509 . . . . 60.229999999999997 111.641 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.0 t -82.02 -43.74 19.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.932 -0.576 . . . . 45.520000000000003 112.034 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.474 ' HE1' HD23 ' A' ' 87' ' ' LEU . 6.7 tmm? -70.97 -37.35 72.75 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.631 -0.259 . . . . 45.509999999999998 110.562 -173.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.526 HD21 HG23 ' A' ' 32' ' ' ILE 0.261 0.6 OUTLIER -115.05 -67.26 1.01 Allowed 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 119.903 -0.719 . . . . 72.409999999999997 112.378 176.797 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.1 t70 172.11 -50.01 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.092 0.472 . . . . 73.319999999999993 109.932 -177.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -123.98 160.55 27.34 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 115.934 -0.576 . . . . 73.310000000000002 109.671 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.462 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 32.1 m -107.28 106.19 57.72 Favored Pre-proline 0 N--CA 1.436 -1.135 0 O-C-N 123.388 0.43 . . . . 70.25 110.441 174.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.58 152.25 63.57 Favored 'Trans proline' 0 C--O 1.238 0.5 0 C-N-CA 123.394 2.73 . . . . 74.150000000000006 110.155 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -56.43 129.12 39.27 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.094 0.473 . . . . 73.549999999999997 110.174 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 32.2 mt -103.62 136.22 37.58 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 109.149 -0.686 . . . . 42.020000000000003 109.149 -175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.506 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 15.0 p -129.86 146.99 33.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 116.021 -0.536 . . . . 62.509999999999998 110.323 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 m -75.69 124.25 26.94 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.351 -0.981 . . . . 72.219999999999999 108.351 176.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.4 158.66 43.57 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.615 0.722 . . . . 75.219999999999999 112.33 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 49.1 m -118.5 132.03 56.23 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.129 -0.941 . . . . 75.209999999999994 109.34 178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.3 tp -104.4 101.85 29.82 Favored Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 109.385 -0.598 . . . . 63.229999999999997 109.385 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.1 138.13 9.99 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.702 2.268 . . . . 73.239999999999995 111.814 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.04 9.45 53.95 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.892 -0.67 . . . . 25.039999999999999 111.721 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.507 ' HE2' ' SD ' ' A' ' 117' ' ' MET . 93.3 m-85 -143.12 152.75 42.17 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.773 -0.825 . . . . 71.109999999999999 108.773 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -139.98 147.09 39.95 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.993 -0.743 . . . . 60.32 108.993 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -100.26 132.23 45.75 Favored 'General case' 0 N--CA 1.424 -1.759 0 N-CA-C 109.153 -0.684 . . . . 62.240000000000002 109.153 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.555 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 2.9 m-30 -107.71 134.95 49.94 Favored 'General case' 0 CA--C 1.472 -2.032 0 N-CA-C 107.195 -1.409 . . . . 74.5 107.195 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 130' ' ' TRP . 14.5 ptm180 -115.68 126.2 53.81 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.195 -1.002 . . . . 75.010000000000005 112.368 -178.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -171.53 125.47 0.61 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 104.267 -2.494 . . . . 73.340000000000003 104.267 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -120.41 112.31 18.83 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.803 -0.759 . . . . 73.519999999999996 111.134 -178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -154.19 -93.9 0.1 Allowed Glycine 0 C--N 1.292 -1.908 0 N-CA-C 109.517 -1.433 . . . . 64.430000000000007 109.517 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.446 ' HD2' ' C ' ' A' ' 58' ' ' ARG . 1.4 ppt_? -92.8 -15.08 26.96 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 107.967 -1.123 . . . . 73.030000000000001 107.967 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.47 HD12 ' H ' ' A' ' 60' ' ' TYR . 45.1 tp -125.71 165.08 19.27 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 113.959 -1.473 . . . . 73.540000000000006 108.594 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.47 ' H ' HD12 ' A' ' 59' ' ' LEU . 47.7 m-85 -115.96 169.61 6.78 Favored Pre-proline 0 C--N 1.296 -1.722 0 N-CA-C 107.318 -1.364 . . . . 73.439999999999998 107.318 -174.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 34.8 Cg_exo -63.71 94.14 0.18 Allowed 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 121.957 1.772 . . . . 73.099999999999994 111.554 174.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 14.3 p -97.0 167.46 11.06 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 124.604 1.161 . . . . 71.200000000000003 112.3 -173.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.446 HD12 HG21 ' A' ' 71' ' ' VAL . 49.5 mm -104.48 139.68 24.75 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 N-CA-C 108.642 -0.873 . . . . 74.120000000000005 108.642 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -142.68 152.66 60.18 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.499 -0.926 . . . . 72.409999999999997 108.499 174.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.492 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 27.8 Cg_endo -65.54 123.51 11.53 Favored 'Trans proline' 0 C--O 1.249 1.032 0 C-N-CA 122.494 2.129 . . . . 72.510000000000005 112.063 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 42.5 t -125.14 142.07 51.72 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.364 -0.976 . . . . 71.129999999999995 108.364 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -73.04 -36.38 66.92 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 120.255 -0.578 . . . . 64.510000000000005 111.652 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -109.49 2.81 20.73 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.396 -0.365 . . . . 73.319999999999993 111.755 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -96.11 156.87 21.42 Favored Glycine 0 N--CA 1.434 -1.484 0 C-N-CA 120.067 -1.063 . . . . 52.420000000000002 114.374 -174.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.23 142.66 29.72 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 124.574 1.15 . . . . 55.25 108.056 175.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.446 HG21 HD12 ' A' ' 63' ' ' ILE . 54.6 t -113.65 133.68 58.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 109.513 -0.551 . . . . 60.32 109.513 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 36.5 m-70 -107.28 116.76 32.5 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.279 -1.008 . . . . 74.140000000000001 108.279 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.449 ' C ' ' HD3' ' A' ' 74' ' ' LYS . . . -148.95 -154.86 6.48 Favored Glycine 0 N--CA 1.421 -2.345 0 N-CA-C 110.987 -0.845 . . . . 65.209999999999994 110.987 -176.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.449 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 3.2 mppt? -122.82 150.45 42.82 Favored 'General case' 0 CA--C 1.479 -1.776 0 N-CA-C 113.218 0.821 . . . . 64.340000000000003 113.218 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 44.1 t -110.94 129.16 66.68 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 CA-C-N 114.091 -1.413 . . . . 73.129999999999995 111.207 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 76.6 mt -95.7 109.28 21.58 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 107.078 -1.452 . . . . 72.340000000000003 107.078 175.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.9 ptp -113.3 127.43 56.15 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.651 0.739 . . . . 75.329999999999998 112.36 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 111.36 28.88 3.63 Favored Glycine 0 C--N 1.292 -1.874 0 CA-C-N 114.678 -1.146 . . . . 55.140000000000001 111.668 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 83' ' ' GLU . 13.0 p -92.2 132.63 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 109.349 -0.612 . . . . 64.25 109.349 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 29.4 m -73.54 158.56 34.62 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 110.0 -0.37 . . . . 52.530000000000001 110.0 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 22.2 m -62.17 -35.36 78.59 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.265 0.468 . . . . 55.329999999999998 112.265 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -64.86 -36.45 84.4 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.22 0.533 . . . . 63.439999999999998 110.673 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.472 ' HB2' HG22 ' A' ' 79' ' ' VAL . 4.4 mm-40 -77.49 -30.54 53.13 Favored 'General case' 0 C--O 1.205 -1.274 0 N-CA-C 108.056 -1.09 . . . . 74.319999999999993 108.056 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.9 tp -64.8 -41.7 95.59 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.82 -0.807 . . . . 71.120000000000005 108.82 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.22 -29.76 70.08 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.614 -0.721 . . . . 74.420000000000002 110.047 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -72.2 -42.16 66.13 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.771 -0.65 . . . . 60.329999999999998 111.663 177.136 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.474 HD23 ' HE1' ' A' ' 35' ' ' MET . 91.0 mt -61.67 -41.95 98.25 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.193 -1.04 . . . . 71.200000000000003 108.193 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.434 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 30.9 t70 -65.58 -30.9 71.69 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.897 -1.501 . . . . 64.420000000000002 110.813 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.65 -41.69 53.43 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.934 -0.575 . . . . 61.32 110.529 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 69.0 t -72.99 -58.31 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 N-CA-C 113.013 0.746 . . . . 72.409999999999997 113.013 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.68 -23.6 45.57 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 121.933 -0.479 . . . . 73.540000000000006 111.847 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.41 -15.82 18.36 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 114.941 -1.027 . . . . 64.430000000000007 115.246 -176.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -57.0 -41.72 78.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.381 0.59 . . . . 73.299999999999997 111.618 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -132.42 -0.83 3.57 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.84 0.682 . . . . 61.200000000000003 112.84 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -121.53 167.45 12.85 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.281 -1.007 . . . . 73.519999999999996 108.281 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.481 ' HB3' HD11 ' A' ' 119' ' ' ILE . 9.9 tp10 -127.84 152.35 47.93 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.308 -0.997 . . . . 74.310000000000002 108.308 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -87.84 112.59 22.64 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.776 -0.824 . . . . 53.450000000000003 108.776 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.42 158.19 15.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.823 -0.626 . . . . 73.109999999999999 110.082 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.9 t -96.49 132.53 41.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.411 -0.589 . . . . 51.210000000000001 109.411 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.65 167.13 24.63 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-N 116.147 -0.479 . . . . 72.120000000000005 112.063 -176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -114.62 127.14 7.57 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 110.663 -0.975 . . . . 71.430000000000007 110.663 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -119.98 163.79 17.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 122.538 0.335 . . . . 70.239999999999995 111.094 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 59.1 t -120.33 126.37 75.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.039 -0.726 . . . . 73.219999999999999 109.039 177.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.701 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 22.4 mtp180 -73.16 116.11 13.31 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.915 -0.584 . . . . 63.049999999999997 110.234 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -79.08 -0.84 33.11 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 122.451 1.12 . . . . 75.319999999999993 108.746 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -67.27 -30.46 70.34 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.319 -1.764 . . . . 71.439999999999998 109.193 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.456 ' HB2' ' H ' ' A' ' 108' ' ' SER . 13.8 m-80 -137.41 -95.99 0.21 Allowed 'General case' 0 C--O 1.217 -0.611 0 N-CA-C 108.238 -1.023 . . . . 74.409999999999997 108.238 176.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.456 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 67.6 m -175.83 27.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 105.319 -2.104 . . . . 62.509999999999998 105.319 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -111.25 143.92 41.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.141 -0.936 . . . . 72.120000000000005 111.633 -170.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 21.9 ptmt -96.19 148.88 22.26 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 115.879 -0.6 . . . . 74.150000000000006 111.616 -176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.701 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.2 mtp -143.65 161.05 39.54 Favored 'General case' 0 CA--C 1.484 -1.576 0 C-N-CA 123.83 0.852 . . . . 73.120000000000005 111.325 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -106.8 129.79 54.6 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 114.636 -1.165 . . . . 72.540000000000006 108.932 176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.538 HG21 ' HB2' ' A' ' 21' ' ' PHE . 34.1 m -143.93 174.52 4.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 108.865 -0.791 . . . . 51.100000000000001 108.865 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -115.34 152.71 32.3 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 119.926 -0.71 . . . . 73.120000000000005 109.631 176.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 t -148.3 172.89 13.65 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 109.534 -0.543 . . . . 40.0 109.534 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -117.42 109.16 16.43 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.07 -0.514 . . . . 74.129999999999995 109.826 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.507 ' SD ' ' HE2' ' A' ' 50' ' ' PHE . 24.2 ptt? -111.56 156.6 21.5 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.622 -0.717 . . . . 74.409999999999997 109.677 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -69.4 116.62 10.03 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 107.284 -1.376 . . . . 75.340000000000003 107.284 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.481 HD11 ' HB3' ' A' ' 96' ' ' GLU . 47.7 mm -73.7 -41.53 54.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 113.009 0.744 . . . . 63.329999999999998 113.009 -171.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -61.77 -35.38 77.98 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.186 -0.672 . . . . 74.409999999999997 109.186 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.264 9.7 ptpp? 58.16 -37.04 0.05 Allowed 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 127.721 2.408 . . . . 75.329999999999998 115.908 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -94.01 85.69 4.8 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.551 0.691 . . . . 63.340000000000003 110.952 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -132.25 105.96 13.49 Favored Pre-proline 0 CA--C 1.486 -1.501 0 CA-C-N 115.067 -0.97 . . . . 75.230000000000004 110.507 175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.42 -17.54 58.31 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.66 2.24 . . . . 72.329999999999998 110.801 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.47 -36.51 78.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.023 -0.989 . . . . 72.329999999999998 111.159 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.16 135.98 48.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 120.452 -0.499 . . . . 73.239999999999995 111.311 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -171.69 128.49 0.64 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.738 -0.838 . . . . 70.329999999999998 108.738 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 168.16 137.78 2.32 Favored Glycine 0 N--CA 1.425 -2.093 0 N-CA-C 109.209 -1.557 . . . . 51.43 109.209 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -85.03 130.94 34.53 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.208 -1.034 . . . . 73.439999999999998 108.208 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.41 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 25.6 t90 -78.66 156.36 29.05 Favored 'General case' 0 N--CA 1.429 -1.519 0 N-CA-C 108.472 -0.936 . . . . 70.030000000000001 108.472 178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -78.59 79.12 5.03 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.575 0.702 . . . . 71.230000000000004 112.412 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -73.5 -32.47 64.29 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.213 -0.903 . . . . 73.519999999999996 108.607 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -58.67 -37.73 76.66 Favored 'General case' 0 N--CA 1.417 -2.085 0 C-N-CA 125.245 1.418 . . . . 64.030000000000001 109.511 176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 6.1 tp10 -66.44 -40.43 89.47 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.017 -0.538 . . . . 72.420000000000002 109.733 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -73.01 -35.9 66.89 Favored 'General case' 0 C--O 1.2 -1.542 0 C-N-CA 119.572 -0.851 . . . . 71.209999999999994 110.401 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.8 -31.64 69.89 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.292 0.567 . . . . 71.349999999999994 109.802 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.533 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 17.1 tpp180 -62.51 -53.37 55.75 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.168 -0.924 . . . . 72.430000000000007 110.05 176.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.488 HD13 ' O ' ' A' ' 134' ' ' GLU . 8.2 mp -74.3 -16.43 60.93 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.407 -1.269 . . . . 64.430000000000007 110.778 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -67.63 -6.63 21.3 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.49 -1.232 . . . . 63.119999999999997 111.517 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.569 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.0 ttpt -57.03 -34.65 68.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 108.79 -0.819 . . . . 74.209999999999994 108.79 172.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 64.6 tttp -59.53 -35.47 74.26 Favored 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.54 -0.755 . . . . 75.219999999999999 112.153 -177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -55.6 -47.99 75.62 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.359 1.076 . . . . 54.009999999999998 108.548 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -66.57 -39.64 88.56 Favored 'General case' 0 N--CA 1.415 -2.187 0 CA-C-N 113.273 -1.785 . . . . 73.230000000000004 108.993 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 140' ' ' LYS . 28.6 mm -72.56 -40.95 63.49 Favored 'Isoleucine or valine' 0 C--O 1.185 -2.332 0 CA-C-N 116.133 -0.485 . . . . 65.510000000000005 110.292 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 28.2 mm-40 -61.78 -34.08 75.23 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.972 0.415 . . . . 70.319999999999993 110.017 178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.537 ' O ' HG13 ' A' ' 150' ' ' ILE . 86.9 m -65.39 -48.18 73.76 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.595 -0.73 . . . . 75.519999999999996 109.261 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -70.77 -30.12 66.53 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.155 0.798 . . . . 70.340000000000003 113.155 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 ttpt -55.66 -45.77 77.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.588 -1.264 . . . . 71.310000000000002 107.588 175.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -71.53 -34.89 70.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 114.014 -1.448 . . . . 62.009999999999998 110.307 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 146' ' ' THR . 80.2 mt -67.4 -37.22 78.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.28 -0.418 . . . . 71.329999999999998 110.285 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.14 -33.09 74.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 75.150000000000006 110.129 176.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 15.3 mm-40 -73.2 -31.07 63.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.077 0.465 . . . . 74.420000000000002 110.02 177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 51.3 t -69.06 -31.81 70.83 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.654 -0.703 . . . . 64.439999999999998 109.787 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 34.7 mmtp -74.98 -38.88 61.54 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.967 -0.753 . . . . 73.200000000000003 108.967 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -58.71 -59.47 5.35 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.042 -0.981 . . . . 62.229999999999997 110.255 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.75 112.11 16.17 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 115.022 -0.99 . . . . 63.509999999999998 110.274 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -73.84 98.74 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.989 2.46 . . . . 52.399999999999999 115.213 -173.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 . . . . . 0 C--N 1.31 -1.15 0 CA-C-N 114.799 -1.092 . . . . 72.150000000000006 108.314 172.182 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.428 -1.546 0 N-CA-C 108.253 -1.017 . . . . 72.340000000000003 108.253 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.8 m -71.8 101.31 2.57 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.329 0.585 . . . . 72.340000000000003 110.235 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 m -67.23 -29.63 69.33 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.079 -0.964 . . . . 74.430000000000007 110.923 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 58.04 88.02 0.06 Allowed 'General case' 0 C--N 1.341 0.212 0 O-C-N 124.15 0.906 . . . . 75.310000000000002 111.272 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.4 t -161.73 -174.96 4.45 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 106.934 -1.506 . . . . 73.519999999999996 106.934 -175.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tt -73.07 106.3 4.88 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-O 121.216 0.531 . . . . 75.140000000000001 109.606 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -140.8 -172.09 3.38 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 105.99 -1.855 . . . . 72.25 105.99 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.3 mt -84.94 153.55 22.76 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 108.186 -1.042 . . . . 73.120000000000005 108.186 173.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.497 ' ND1' ' HG ' ' A' ' 84' ' ' LEU . 52.8 m-70 -114.8 160.28 19.62 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-O 121.07 0.462 . . . . 74.430000000000007 112.16 -171.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 21.6 p30 -131.84 125.64 32.3 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 114.283 -1.326 . . . . 65.129999999999995 110.506 174.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 75' ' ' VAL . 65.5 t -126.3 140.58 48.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.189 -0.914 . . . . 64.420000000000002 110.17 -174.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.495 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.5 t80 -94.66 122.97 37.81 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.675 -0.861 . . . . 75.230000000000004 108.675 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -100.69 144.33 12.84 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 116.252 -0.431 . . . . 71.430000000000007 109.886 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -83.51 -0.19 49.19 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 112.967 0.728 . . . . 71.519999999999996 112.967 -176.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.13 -22.92 4.42 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.066 -1.064 . . . . 65.430000000000007 112.169 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.1 p -58.76 -36.4 74.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.135 0.493 . . . . 73.510000000000005 112.168 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.59 ' HB3' HD11 ' A' ' 32' ' ' ILE . 53.0 m-85 -125.84 35.9 4.62 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.709 -0.678 . . . . 72.219999999999999 110.908 -177.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.2 pt20 -77.79 -14.97 59.42 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.052 0.453 . . . . 75.030000000000001 110.728 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.57 121.23 63.7 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.736 -0.666 . . . . 75.400000000000006 109.472 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.489 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 30.7 Cg_endo -63.98 -28.86 66.43 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.858 2.372 . . . . 64.200000000000003 114.069 -176.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 34' ' ' VAL . 24.2 t70 -69.1 -38.12 78.77 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 120.49 -0.484 . . . . 75.319999999999993 110.142 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.1 t -59.78 -38.94 78.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.548 -0.751 . . . . 53.32 109.423 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.59 HD11 ' HB3' ' A' ' 26' ' ' PHE . 34.1 mm -58.46 -51.76 67.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.63 -0.713 . . . . 50.32 110.893 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -54.21 -34.27 60.19 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.236 0.458 . . . . 64.019999999999996 112.236 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 30' ' ' ASP . 47.3 t -81.03 -45.34 21.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 116.261 -0.427 . . . . 75.200000000000003 111.366 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.554 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.0 tmm? -67.21 -37.38 83.51 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.501 -0.318 . . . . 64.230000000000004 110.309 -173.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.485 HD21 HG23 ' A' ' 32' ' ' ILE 0.282 0.9 OUTLIER -116.24 -67.18 1.01 Allowed 'General case' 0 N--CA 1.437 -1.077 0 C-N-CA 119.188 -1.005 . . . . 74.209999999999994 112.738 176.728 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 38' ' ' ARG . 35.0 t70 174.98 -49.07 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.274 0.359 . . . . 73.219999999999999 111.364 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.426 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 20.1 mmt180 -131.11 162.73 29.22 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 109.257 -0.646 . . . . 64.239999999999995 109.257 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.457 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 20.4 m -102.87 112.44 65.74 Favored Pre-proline 0 N--CA 1.437 -1.115 0 O-C-N 123.26 0.35 . . . . 65.219999999999999 111.525 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -68.69 152.85 74.18 Favored 'Trans proline' 0 C--O 1.241 0.659 0 C-N-CA 123.173 2.582 . . . . 65.420000000000002 109.336 170.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -56.54 130.96 47.29 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.131 0.491 . . . . 62.329999999999998 110.332 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 44.3 mt -114.47 138.94 42.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.583 -0.525 . . . . 74.129999999999995 109.583 -175.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.1 p -130.91 146.1 34.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 108.921 -0.77 . . . . 75.519999999999996 108.921 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.7 m -77.06 133.76 38.98 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.432 -1.321 . . . . 72.239999999999995 107.432 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.53 159.76 41.42 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.089 0.471 . . . . 45.549999999999997 111.697 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 93.5 m -110.51 125.27 53.15 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.327 -0.851 . . . . 64.340000000000003 110.812 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.8 tp -102.4 103.65 32.64 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 123.502 0.721 . . . . 61.130000000000003 109.307 175.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 74.2 Cg_endo -82.0 142.44 12.39 Favored 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 122.261 1.974 . . . . 70.340000000000003 111.535 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.74 5.75 61.15 Favored Glycine 0 N--CA 1.438 -1.185 0 CA-C-N 115.978 -0.556 . . . . 63.25 112.633 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -141.86 155.93 45.54 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 122.186 -0.596 . . . . 74.140000000000001 109.76 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.434 ' HA ' ' OE1' ' A' ' 51' ' ' GLN . 4.7 tp60 -140.75 146.94 38.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.746 -0.464 . . . . 72.140000000000001 109.746 176.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 41.0 ptt180 -101.32 129.92 47.4 Favored 'General case' 0 N--CA 1.426 -1.673 0 CA-C-O 121.626 0.727 . . . . 62.039999999999999 111.286 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.683 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 18.3 m-85 -107.77 153.49 22.9 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.545 -1.28 . . . . 62.539999999999999 107.545 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.73 165.71 26.74 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 114.902 1.445 . . . . 74.510000000000005 114.902 -167.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 76.4 mt -141.85 -71.71 0.34 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.895 -1.891 . . . . 71.319999999999993 105.895 167.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt 161.62 -70.83 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.737 1.615 . . . . 75.400000000000006 110.352 171.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.63 -30.08 2.49 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.968 -0.634 . . . . 44.109999999999999 112.49 -177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -57.68 5.66 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 104.24 -2.504 . . . . 75.349999999999994 104.24 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.45 HD11 ' CH2' ' A' ' 118' ' ' TRP . 24.4 tp -127.4 163.26 24.43 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 108.432 -0.951 . . . . 64.219999999999999 108.432 173.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -113.18 176.45 1.48 Allowed Pre-proline 0 C--N 1.286 -2.158 0 N-CA-C 107.838 -1.171 . . . . 75.349999999999994 107.838 -169.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.683 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 20.5 Cg_exo -65.98 90.98 0.25 Allowed 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 121.579 1.519 . . . . 73.530000000000001 110.859 175.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 19.3 p -83.11 127.65 33.78 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-N 115.278 -0.874 . . . . 72.319999999999993 111.152 -174.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 117' ' ' MET . 49.4 mm -84.66 111.24 20.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.636 -0.711 . . . . 55.409999999999997 109.574 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.56 143.86 42.73 Favored Pre-proline 0 C--N 1.289 -2.049 0 N-CA-C 109.684 -0.487 . . . . 51.439999999999998 109.684 176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.9 125.72 17.86 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.46 2.107 . . . . 64.219999999999999 112.799 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.3 t -124.58 122.3 37.18 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 106.099 -1.815 . . . . 60.140000000000001 106.099 176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.61 -30.87 65.68 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.129 0.418 . . . . 70.450000000000003 112.129 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -136.54 77.35 1.64 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.6 0.714 . . . . 75.230000000000004 111.024 171.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -150.98 166.81 30.5 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 109.317 -1.513 . . . . 74.150000000000006 109.317 176.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -151.9 141.34 21.59 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 117.745 0.773 . . . . 62.399999999999999 110.541 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.07 131.45 64.67 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.069 0 N-CA-C 109.001 -0.74 . . . . 74.340000000000003 109.001 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -107.78 115.8 30.79 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.222 -1.399 . . . . 65.420000000000002 107.222 175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.65 -147.76 4.93 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.846 -0.901 . . . . 54.240000000000002 110.846 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -125.29 145.59 49.94 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 112.566 0.58 . . . . 74.319999999999993 112.566 -175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 46.8 t -110.58 124.88 67.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 CA-C-N 114.64 -1.164 . . . . 62.43 110.502 173.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.61 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 67.2 mt -95.75 109.77 22.02 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.594 -1.262 . . . . 73.140000000000001 107.594 177.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.413 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 14.9 ptp -117.35 142.63 46.87 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.28 0.562 . . . . 65.319999999999993 111.738 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.97 15.23 29.12 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.291 -0.868 . . . . 55.329999999999998 111.195 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 83' ' ' GLU . 12.9 p -86.44 142.0 13.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 108.516 -0.92 . . . . 51.229999999999997 108.516 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -82.9 174.48 10.89 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.471 -0.492 . . . . 73.409999999999997 111.552 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.1 p -61.34 -45.26 95.16 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.75 1.018 . . . . 63.310000000000002 113.75 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.1 -36.56 84.0 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.673 0.749 . . . . 72.200000000000003 110.838 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.526 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.5 mt-10 -78.54 -28.49 46.11 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.225 -0.898 . . . . 73.219999999999999 109.432 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HG ' ' ND1' ' A' ' 18' ' ' HIS . 2.9 tm? -67.68 -41.56 83.46 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.862 -0.608 . . . . 75.209999999999994 109.689 176.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -74.39 -29.4 61.52 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.203 -0.453 . . . . 70.439999999999998 109.796 176.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 14.0 t-20 -56.45 -47.57 78.88 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.745 0.818 . . . . 74.439999999999998 110.282 175.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.7 mt -60.82 -33.8 73.57 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.39 -0.823 . . . . 63.140000000000001 111.031 -179.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 18.8 t70 -73.06 -36.93 66.98 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.309 0.576 . . . . 52.140000000000001 109.589 177.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.77 -47.27 72.7 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.693 -0.685 . . . . 60.229999999999997 110.62 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 87' ' ' LEU . 12.2 p -72.59 -56.49 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 113.119 0.785 . . . . 52.210000000000001 113.119 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -77.54 -22.96 50.26 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.995 -0.44 . . . . 44.140000000000001 111.575 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -60.03 -17.49 44.57 Favored Glycine 0 C--O 1.221 -0.675 0 N-CA-C 115.194 0.837 . . . . 54.420000000000002 115.194 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.86 -38.36 76.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.471 0.635 . . . . 74.519999999999996 111.228 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -103.82 -28.47 11.6 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.036 0.446 . . . . 70.219999999999999 111.838 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.404 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 91.3 m-85 -124.28 170.21 11.0 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 123.406 0.682 . . . . 71.510000000000005 111.703 -174.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 41.0 tt0 -123.23 151.61 42.12 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.846 -0.798 . . . . 75.420000000000002 108.846 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 88' ' ' ASP . 11.2 ttm-85 -86.7 119.63 27.14 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.826 -0.805 . . . . 75.340000000000003 108.826 -175.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.482 HG11 ' CE ' ' A' ' 117' ' ' MET . 27.7 m -124.7 162.16 27.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 121.019 0.438 . . . . 73.409999999999997 111.584 177.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.0 t -104.01 129.19 51.6 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.302 -0.863 . . . . 71.310000000000002 108.884 -175.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -141.79 171.44 11.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.082 0.468 . . . . 65.030000000000001 111.989 -174.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -114.58 139.24 15.45 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.792 -1.323 . . . . 71.540000000000006 109.792 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.463 HD11 ' HE2' ' A' ' 111' ' ' MET . 2.6 pp -134.07 164.99 33.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.139 0.469 . . . . 51.240000000000002 111.109 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.2 t -129.03 131.11 68.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 107.396 -1.335 . . . . 71.530000000000001 107.396 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 11.2 mtm180 -74.16 146.3 43.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.935 0.398 . . . . 72.120000000000005 110.648 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -88.85 -8.98 53.32 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.084 -0.507 . . . . 74.040000000000006 111.326 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -79.56 -48.21 14.21 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.567 -0.288 . . . . 62.409999999999997 111.243 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.498 ' ND2' ' HG2' ' A' ' 109' ' ' GLU . 3.0 p-10 -146.6 22.18 1.3 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.699 0.629 . . . . 73.129999999999995 112.699 177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.6 m 66.88 27.45 9.0 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 115.789 1.774 . . . . 73.25 115.789 170.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.498 ' HG2' ' ND2' ' A' ' 107' ' ' ASN . 20.2 mm-40 -77.04 141.02 40.48 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 119.511 -0.876 . . . . 75.420000000000002 108.947 173.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -98.48 139.46 34.18 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 109.624 -0.509 . . . . 71.219999999999999 109.624 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.463 ' HE2' HD11 ' A' ' 102' ' ' ILE . 38.7 mtm -142.15 163.88 31.68 Favored 'General case' 0 CA--C 1.473 -1.989 0 CA-C-O 121.8 0.81 . . . . 51.130000000000003 111.387 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -112.24 122.99 49.3 Favored 'General case' 0 C--N 1.267 -3.003 0 CA-C-N 113.919 -1.492 . . . . 71.200000000000003 107.993 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.1 m -138.16 173.53 12.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.404 0.621 . . . . 70.519999999999996 110.881 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -104.4 150.85 24.16 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.982 -1.118 . . . . 70.430000000000007 107.982 175.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.7 t -146.83 172.23 13.98 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 108.404 -0.961 . . . . 74.340000000000003 108.404 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 96.5 m-85 -111.91 112.82 24.74 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.585 0.707 . . . . 73.329999999999998 109.779 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.482 ' CE ' HG11 ' A' ' 98' ' ' VAL . 12.9 tmm? -106.07 146.67 29.85 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 114.412 -1.267 . . . . 75.510000000000005 110.871 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.45 ' CH2' HD11 ' A' ' 59' ' ' LEU . 70.0 t-105 -72.8 117.3 14.34 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 115.309 -0.859 . . . . 74.319999999999993 110.307 -174.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.8 mt -57.81 -41.2 79.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 113.796 -1.547 . . . . 75.319999999999993 113.004 -172.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -89.27 91.11 8.63 Favored 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 119.904 -0.718 . . . . 72.010000000000005 110.435 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -63.11 -30.82 71.9 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.608 -0.724 . . . . 75.120000000000005 110.417 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.37 85.95 2.22 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.879 -0.785 . . . . 51.149999999999999 108.879 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.49 122.06 28.15 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-N 115.292 -0.867 . . . . 75.120000000000005 108.769 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -84.29 0.56 9.12 Favored 'Trans proline' 0 C--N 1.328 -0.536 0 C-N-CA 122.852 2.368 . . . . 71.219999999999999 113.918 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -108.12 -23.81 11.82 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 119.951 -0.699 . . . . 63.43 112.271 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.8 ptt? -76.55 1.01 17.94 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.098 0.407 . . . . 75.230000000000004 112.098 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -61.05 115.24 3.59 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 122.61 1.195 . . . . 74.409999999999997 113.461 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 147.69 98.66 0.21 Allowed Glycine 0 N--CA 1.411 -2.972 0 N-CA-C 105.991 -2.844 . . . . 54.049999999999997 105.991 -174.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -88.44 146.98 24.92 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.964 -0.754 . . . . 73.200000000000003 108.964 -170.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 39.7 t90 -68.99 135.7 51.32 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 108.196 -1.039 . . . . 72.109999999999999 108.196 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -64.75 87.13 0.05 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 122.023 0.916 . . . . 74.530000000000001 112.398 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -73.34 -35.37 66.0 Favored 'General case' 0 N--CA 1.384 -3.74 0 CA-C-N 113.886 -1.506 . . . . 74.519999999999996 112.49 -175.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -62.14 -31.64 72.14 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 111.74 0.274 . . . . 61.509999999999998 111.74 -176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.676 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 44.9 tt0 -66.95 -37.0 83.49 Favored 'General case' 0 C--O 1.219 -0.51 0 CA-C-O 120.824 0.345 . . . . 73.409999999999997 110.776 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -73.14 -36.88 66.76 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.977 -0.689 . . . . 71.349999999999994 109.339 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 136' ' ' LYS . 38.8 ttmt -60.14 -31.33 69.98 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.267 -0.879 . . . . 62.439999999999998 109.87 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.676 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 22.5 tpt180 -55.79 -51.27 68.02 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.997 0.919 . . . . 73.040000000000006 111.324 174.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.73 -16.48 44.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.456 0.646 . . . . 72.530000000000001 110.691 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -64.69 -16.06 62.3 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.309 -0.86 . . . . 65.040000000000006 112.091 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.612 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.7 ttpt -55.55 -35.2 65.45 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.816 0.341 . . . . 72.319999999999993 110.107 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -53.13 -36.23 60.57 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.9 1.28 . . . . 74.209999999999994 110.586 -175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.6 -42.41 98.24 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.113 0.483 . . . . 70.310000000000002 110.63 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -73.77 -31.77 63.47 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 121.341 0.591 . . . . 72.510000000000005 109.56 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.2 mm -59.75 -32.76 50.24 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.911 0 CA-C-N 115.283 -0.872 . . . . 74.010000000000005 110.551 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -61.49 -36.3 80.07 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-O 121.209 0.528 . . . . 44.229999999999997 110.99 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.8 m -72.46 -47.93 44.97 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.861 -0.792 . . . . 71.420000000000002 108.861 177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.614 ' O ' ' HG2' ' A' ' 151' ' ' MET . 58.9 m-85 -66.54 -28.87 68.88 Favored 'General case' 0 C--O 1.2 -1.528 0 N-CA-C 113.454 0.909 . . . . 74.420000000000002 113.454 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -52.62 -47.63 66.88 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.973 0.909 . . . . 53.210000000000001 109.902 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.7 -39.39 73.48 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.857 -0.794 . . . . 75.019999999999996 108.857 -178.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.1 mt -67.64 -52.28 42.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 116.179 -0.464 . . . . 63.340000000000003 111.927 -178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.614 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 26.5 ptt? -76.37 -40.55 50.74 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 113.927 1.084 . . . . 72.209999999999994 113.927 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -62.77 -30.24 71.3 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 112.945 0.72 . . . . 74.540000000000006 112.945 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 82.1 m -71.41 -30.06 65.63 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.01 0.374 . . . . 71.120000000000005 112.01 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -77.49 -39.85 44.95 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.984 0.897 . . . . 71.310000000000002 108.752 175.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.86 -47.93 78.74 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 125.533 1.533 . . . . 73.219999999999999 110.133 178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -133.8 101.0 13.05 Favored Pre-proline 0 C--N 1.311 -1.078 0 N-CA-C 107.877 -1.157 . . . . 73.540000000000006 107.877 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -53.53 -38.3 83.43 Favored 'Trans proline' 0 N--CA 1.484 0.937 0 C-N-CA 123.669 2.912 . . . . 64.010000000000005 114.009 -175.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 120.988 0.423 . . . . 60.240000000000002 110.29 179.855 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.442 -0.851 0 N-CA-C 113.428 0.899 . . . . 70.200000000000003 113.428 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.5 p -141.96 18.52 2.13 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.052 -1.092 . . . . 65.109999999999999 108.052 175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.4 p -71.93 -19.68 61.87 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.655 -1.157 . . . . 74.430000000000007 112.503 -176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -92.05 -178.97 5.15 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.177 -0.675 . . . . 73.540000000000006 109.177 177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.3 t -96.29 96.0 8.48 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 108.833 -0.803 . . . . 73.450000000000003 108.833 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -99.62 179.58 4.5 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 116.45 -0.341 . . . . 72.310000000000002 111.201 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 66.68 -167.02 0.21 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.214 1.006 . . . . 61.210000000000001 109.722 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.91 153.82 27.37 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.044 -1.095 . . . . 70.430000000000007 108.044 176.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.416 ' CE1' HD22 ' A' ' 84' ' ' LEU . 30.4 m-70 -114.56 159.62 20.2 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 109.847 -0.427 . . . . 71.310000000000002 109.847 -170.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 18.1 p30 -130.41 133.34 46.29 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.331 -0.85 . . . . 75.129999999999995 110.518 177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.4 t -127.84 140.31 49.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 115.442 -0.799 . . . . 62.140000000000001 110.223 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -94.61 122.47 37.24 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.467 -0.938 . . . . 73.319999999999993 108.467 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 27.7 m -87.47 143.01 12.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-O 121.043 0.449 . . . . 73.010000000000005 110.767 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.487 ' HB2' ' CG1' ' A' ' 63' ' ' ILE . 16.9 p90 -122.1 -1.94 9.22 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 114.951 1.463 . . . . 74.109999999999999 114.951 -168.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.81 -67.42 0.24 Allowed Glycine 0 C--N 1.314 -0.689 0 C-N-CA 119.329 -1.415 . . . . 55.140000000000001 112.528 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 p -58.12 -34.87 70.7 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.22 0.608 . . . . 74.329999999999998 111.7 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.453 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 26.8 m-85 -118.95 27.49 8.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.044 -0.526 . . . . 51.340000000000003 110.519 178.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -78.98 15.34 1.12 Allowed 'General case' 0 CA--C 1.562 1.41 0 CA-C-O 121.963 0.887 . . . . 71.200000000000003 110.834 -177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -137.84 128.47 15.67 Favored Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.322 -0.992 . . . . 71.530000000000001 108.322 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.49 -31.28 87.68 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.787 2.324 . . . . 73.150000000000006 114.423 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -67.95 -37.9 82.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.292 0.567 . . . . 72.209999999999994 109.654 -178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.4 t -64.64 -38.85 83.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.176 -0.92 . . . . 74.140000000000001 109.468 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 26' ' ' PHE . 6.5 mm -62.58 -50.51 79.53 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.607 0 CA-C-O 122.125 0.964 . . . . 54.520000000000003 109.91 176.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -54.01 -43.63 70.23 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 113.266 -1.788 . . . . 74.129999999999995 111.607 -173.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.5 t -81.72 -32.44 11.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-N 115.912 -0.585 . . . . 61.310000000000002 111.936 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.453 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.7 tmm? -70.55 -37.46 74.04 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.989 -0.284 . . . . 64.519999999999996 110.774 -173.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.436 HD21 HG23 ' A' ' 32' ' ' ILE 0.277 0.4 OUTLIER -109.8 -71.86 0.75 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.599 0.963 . . . . 74.450000000000003 113.599 179.266 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.8 t70 176.11 -45.03 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.25 0.548 . . . . 73.010000000000005 109.838 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -120.79 176.2 5.65 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.53 -0.759 . . . . 73.329999999999998 109.487 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 m -123.03 100.68 39.63 Favored Pre-proline 0 N--CA 1.425 -1.689 0 N-CA-C 106.624 -1.621 . . . . 72.209999999999994 106.624 170.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.546 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 34.1 Cg_exo -58.71 151.57 62.61 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.833 2.355 . . . . 65.040000000000006 111.74 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -56.5 122.91 13.06 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.496 0.718 . . . . 71.519999999999996 111.167 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.58 HG12 ' HG ' ' A' ' 76' ' ' LEU . 24.0 mt -97.72 140.37 18.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 CA-C-N 115.292 -0.867 . . . . 71.340000000000003 110.384 -173.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.0 p -130.14 145.47 35.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.794 -1.187 . . . . 75.099999999999994 107.794 172.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.9 m -81.05 123.73 28.61 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.939 -0.763 . . . . 61.25 108.939 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.17 159.14 42.85 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.266 0.555 . . . . 70.329999999999998 111.849 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 90.7 m -117.55 132.93 56.45 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.093 -0.958 . . . . 75.420000000000002 110.094 179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.0 tp -102.56 100.94 17.5 Favored Pre-proline 0 C--N 1.3 -1.55 0 C-N-CA 123.018 0.527 . . . . 74.040000000000006 109.702 176.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 46' ' ' THR . 6.0 Cg_endo -85.98 145.22 8.69 Favored 'Trans proline' 0 N--CA 1.443 -1.485 0 C-N-CA 122.581 2.187 . . . . 62.520000000000003 111.843 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.8 11.09 59.45 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 111.263 -0.735 . . . . 64.219999999999999 111.263 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -144.44 157.07 44.42 Favored 'General case' 0 C--O 1.208 -1.092 0 N-CA-C 108.168 -1.049 . . . . 64.099999999999994 108.168 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.482 HE21 ' H ' ' A' ' 52' ' ' ARG . 28.4 tp60 -138.37 146.22 42.03 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.189 -0.671 . . . . 65.519999999999996 109.189 -177.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' A' ' 63' ' ' ILE . 38.1 ptt180 -90.36 126.69 35.95 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.963 -1.017 . . . . 71.040000000000006 111.959 -177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.56 ' HA ' ' HA2' ' A' ' 128' ' ' GLY . 10.3 m-85 -109.92 135.75 50.3 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.127 -1.434 . . . . 64.519999999999996 107.127 174.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.702 ' HG2' ' CD1' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -106.28 166.17 10.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 122.175 -0.328 . . . . 72.209999999999994 111.823 -176.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.2 tt -76.75 85.13 3.36 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 106.982 -1.488 . . . . 70.319999999999993 106.982 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.465 ' HD3' ' O ' ' A' ' 56' ' ' LYS . 13.8 tmtt? -124.11 -5.09 7.9 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.406 -1.27 . . . . 72.329999999999998 107.66 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.11 -136.9 4.78 Favored Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 108.068 -2.013 . . . . 50.229999999999997 108.068 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.35 5.18 44.38 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 118.005 0.902 . . . . 74.25 112.391 176.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.647 HD23 ' HB3' ' A' ' 126' ' ' MET . 43.8 tp -111.85 163.1 14.57 Favored 'General case' 0 C--N 1.313 -1.0 0 C-N-CA 120.451 -0.5 . . . . 72.200000000000003 110.162 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -75.38 169.02 22.42 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 124.321 1.048 . . . . 74.340000000000003 109.848 -173.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 7.1 Cg_exo -73.58 86.51 1.19 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.591 1.527 . . . . 72.549999999999997 110.687 173.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 27.8 p -98.15 -178.41 4.05 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.844 -0.617 . . . . 60.219999999999999 112.126 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.487 ' CG1' ' HB2' ' A' ' 23' ' ' TYR . 47.8 mm -132.43 142.15 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.09 -1.448 . . . . 64.140000000000001 107.09 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.423 HG12 ' HB3' ' A' ' 118' ' ' TRP . 34.1 m -144.64 154.71 56.37 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.456 -0.942 . . . . 62.240000000000002 108.456 175.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo -60.99 128.67 26.1 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.432 2.088 . . . . 74.340000000000003 112.125 176.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -125.79 145.3 50.27 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 116.152 -0.476 . . . . 72.129999999999995 110.011 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.48 -35.21 65.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.505 -0.924 . . . . 61.240000000000002 108.505 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -128.93 77.22 1.77 Allowed 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 115.148 -0.933 . . . . 74.400000000000006 110.797 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -164.59 151.0 19.83 Favored Glycine 0 N--CA 1.412 -2.936 0 CA-C-N 114.917 -1.038 . . . . 54.43 111.917 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.76 138.11 18.5 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.447 1.099 . . . . 74.319999999999993 108.501 175.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.1 t -113.38 119.95 62.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 120.737 0.303 . . . . 51.439999999999998 110.615 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -91.91 116.55 29.01 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.45 -0.945 . . . . 64.219999999999999 108.45 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.11 -146.6 4.37 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.508 -0.853 . . . . 54.130000000000003 112.41 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.0 mmtm -127.77 141.56 51.55 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 120.724 0.297 . . . . 63.020000000000003 111.022 -175.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 47.5 t -111.52 129.51 66.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 CA-C-N 115.913 -0.585 . . . . 75.450000000000003 110.358 173.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.58 ' HG ' HG12 ' A' ' 42' ' ' ILE . 6.5 mp -106.11 114.12 28.06 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-N 115.447 -0.797 . . . . 70.140000000000001 110.922 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 58.1 mtp -104.14 145.04 30.76 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.217 -1.356 . . . . 73.230000000000004 110.366 -176.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.02 9.27 32.53 Favored Glycine 0 C--N 1.299 -1.519 0 C-N-CA 120.113 -1.041 . . . . 71.209999999999994 111.955 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 80' ' ' THR . 57.8 t -67.75 127.49 29.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.082 -0.71 . . . . 75.140000000000001 109.082 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.416 ' O ' HG12 ' A' ' 79' ' ' VAL . 65.3 p -82.17 167.62 18.52 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.388 -0.968 . . . . 60.439999999999998 108.388 176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 34.6 t -55.26 -45.63 76.08 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 117.529 0.15 . . . . 61.25 110.946 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -58.26 -42.18 85.88 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.041 0.385 . . . . 55.420000000000002 112.041 -176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 39.7 mt-10 -73.22 -40.63 64.56 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.467 -0.568 . . . . 74.530000000000001 109.467 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.416 HD22 ' CE1' ' A' ' 18' ' ' HIS . 33.6 tp -55.91 -50.75 69.85 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.296 0.569 . . . . 73.230000000000004 109.896 175.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 81' ' ' SER . 43.1 mt-10 -64.82 -29.13 70.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.062 -0.972 . . . . 61.149999999999999 110.251 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -44.7 64.62 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 123.804 0.842 . . . . 71.430000000000007 112.139 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 92.6 mt -62.5 -40.95 98.37 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.227 -1.027 . . . . 63.509999999999998 108.227 176.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.481 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 16.7 t70 -66.37 -29.29 69.44 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-N 114.463 -1.244 . . . . 71.230000000000004 110.886 177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.0 -45.32 42.69 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.115 0.483 . . . . 74.329999999999998 110.398 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.2 t -72.16 -58.41 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 CA-C-N 115.749 -0.66 . . . . 74.109999999999999 112.189 -177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.52 -24.52 42.16 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.855 0.687 . . . . 73.510000000000005 112.855 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -63.74 -16.15 58.71 Favored Glycine 0 C--N 1.313 -0.749 0 CA-C-N 115.809 -0.632 . . . . 43.130000000000003 114.391 -176.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -67.49 -30.39 70.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.886 0.343 . . . . 73.409999999999997 111.685 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -127.14 -0.25 6.46 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.022 0.379 . . . . 72.409999999999997 112.022 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -132.7 168.18 18.78 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.112 0.565 . . . . 74.230000000000004 110.332 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -124.56 148.71 47.64 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.533 -0.543 . . . . 74.030000000000001 109.533 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.8 ttp-105 -88.13 113.45 23.76 Favored 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 108.595 -0.891 . . . . 54.219999999999999 108.595 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 15.8 m -115.84 161.41 14.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 116.28 -0.418 . . . . 73.219999999999999 111.805 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.6 t -107.68 124.7 50.37 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.173 -1.047 . . . . 50.119999999999997 108.173 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.21 170.87 18.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 116.121 -0.491 . . . . 74.120000000000005 111.285 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -111.91 118.78 4.85 Favored Glycine 0 N--CA 1.422 -2.259 0 N-CA-C 111.052 -0.819 . . . . 64.239999999999995 111.052 177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.7 pp -111.01 165.05 6.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 110.031 -0.359 . . . . 64.540000000000006 110.031 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.3 t -122.68 124.68 71.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.519 -0.548 . . . . 72.099999999999994 109.519 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -72.66 121.4 19.72 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.177 -0.92 . . . . 74.120000000000005 110.722 -177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -61.19 -23.59 65.7 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.611 0.765 . . . . 70.5 111.945 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -64.42 -57.65 8.69 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.311 0.485 . . . . 75.549999999999997 112.311 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -127.05 7.41 6.6 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.086 0.773 . . . . 71.420000000000002 113.086 -169.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.2 t 71.46 12.23 6.57 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.058 0.943 . . . . 74.430000000000007 112.418 175.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -82.17 147.03 29.24 Favored 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.058 0.456 . . . . 75.109999999999999 111.231 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -92.02 147.4 22.99 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.421 -0.809 . . . . 74.099999999999994 110.094 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.45 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 89.1 mtp -136.22 160.38 38.85 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 115.378 -0.828 . . . . 74.150000000000006 109.524 178.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.17 117.03 33.06 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-N 115.534 -0.757 . . . . 60.030000000000001 109.603 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.3 m -131.68 173.21 15.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 116.128 -0.487 . . . . 73.239999999999995 110.186 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -106.1 149.59 26.6 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.089 -0.708 . . . . 74.439999999999998 109.089 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -153.15 172.88 16.24 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.977 -0.749 . . . . 70.140000000000001 108.977 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -119.95 109.76 15.91 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.288 0.566 . . . . 73.319999999999993 110.623 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -106.71 157.16 17.93 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.178 -0.919 . . . . 74.239999999999995 108.719 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.528 ' CH2' HD11 ' A' ' 59' ' ' LEU . 70.7 t-105 -67.99 143.51 55.55 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 109.211 -0.663 . . . . 73.219999999999999 109.211 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 27.6 mm -72.44 -42.33 64.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 113.499 0.925 . . . . 61.299999999999997 113.499 -170.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -88.9 -41.17 12.59 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 114.055 1.132 . . . . 73.519999999999996 114.055 -171.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.418 ' H ' ' HD1' ' A' ' 118' ' ' TRP 0.407 0.0 OUTLIER 56.12 1.57 0.07 Allowed 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.56 2.43 . . . . 75.409999999999997 117.56 179.621 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -107.82 9.93 28.78 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.982 -0.747 . . . . 64.549999999999997 108.982 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.435 ' CG ' ' HE1' ' A' ' 118' ' ' TRP . 2.9 m-20 -68.13 123.44 87.31 Favored Pre-proline 0 C--N 1.312 -1.023 0 C-N-CA 124.715 1.206 . . . . 72.040000000000006 111.4 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -83.7 -7.3 10.56 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.411 2.074 . . . . 74.519999999999996 112.18 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -91.89 -2.9 56.59 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 113.238 0.829 . . . . 63.299999999999997 113.238 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.647 ' HB3' HD23 ' A' ' 59' ' ' LEU . 25.7 ptt? -102.4 143.06 32.62 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.67 -0.863 . . . . 72.310000000000002 108.67 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -131.2 132.72 44.89 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 120.888 0.375 . . . . 73.420000000000002 110.021 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -82.14 53.28 4.75 Favored Glycine 0 CA--C 1.499 -0.942 0 N-CA-C 111.225 -0.75 . . . . 74.230000000000004 111.225 178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.82 126.35 45.46 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-O 121.966 0.889 . . . . 75.129999999999995 111.111 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.702 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 6.2 t90 -130.95 157.36 43.16 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 101.967 -3.346 . . . . 74.409999999999997 101.967 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -51.09 -44.58 61.27 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 120.36 1.436 . . . . 52.130000000000003 111.561 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -73.93 -39.09 64.04 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.872 0.368 . . . . 75.109999999999999 111.863 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.657 ' HB2' ' H ' ' A' ' 130' ' ' TRP . 15.9 mm-40 -64.15 -28.27 69.65 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.297 -0.411 . . . . 75.439999999999998 110.792 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 45.1 tt0 -63.48 -37.74 88.47 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.863 -0.421 . . . . 63.520000000000003 109.863 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -74.44 -33.79 63.03 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.779 -0.768 . . . . 63.43 109.415 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 53.8 tttp -57.16 -45.1 83.91 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.105 -1.072 . . . . 71.409999999999997 108.105 174.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 55.5 ttt180 -53.54 -51.2 63.65 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.484 -1.235 . . . . 71.209999999999994 112.045 175.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 77.2 mt -77.8 -26.05 49.37 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.08 -0.509 . . . . 72.239999999999995 111.89 -174.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 47.6 t60 -68.04 -39.68 83.02 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.401 -0.962 . . . . 55.0 108.401 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.551 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.5 ttpt -69.57 -37.07 76.83 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.587 -0.733 . . . . 74.019999999999996 109.679 176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -52.78 -31.75 40.11 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.015 0.926 . . . . 72.140000000000001 112.241 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -66.05 -40.31 90.84 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-O 121.854 0.835 . . . . 73.5 109.354 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 146' ' ' THR . 23.9 t80 -76.29 -32.23 58.67 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.57 -1.195 . . . . 75.340000000000003 108.328 -177.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.1 mm -59.05 -31.99 46.88 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.486 0 CA-C-N 114.731 -1.122 . . . . 70.200000000000003 111.815 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -52.07 -45.18 64.67 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 118.124 0.42 . . . . 64.439999999999998 111.806 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 143' ' ' PHE . 15.1 t -79.14 -29.89 43.36 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 121.564 0.697 . . . . 72.299999999999997 109.824 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -75.63 -30.33 59.45 Favored 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.397 -0.819 . . . . 74.510000000000005 110.502 -173.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -58.24 -36.93 73.93 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.603 1.161 . . . . 75.019999999999996 109.845 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -74.34 -38.79 63.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.103 0.477 . . . . 75.099999999999994 110.025 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 72.3 mt -63.61 -39.93 87.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.644 -0.707 . . . . 71.099999999999994 109.47 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.4 ttt -60.12 -31.68 70.29 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 124.267 1.027 . . . . 73.400000000000006 111.493 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -64.93 -36.93 85.96 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.476 0.655 . . . . 73.109999999999999 109.765 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.82 -34.38 69.29 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.222 -0.899 . . . . 75.439999999999998 110.227 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.629 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 9.7 mmpt? -81.36 -44.9 16.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.951 -0.568 . . . . 31.140000000000001 111.884 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -149.99 100.9 2.98 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.767 -0.827 . . . . 75.140000000000001 108.767 -175.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -69.15 146.83 97.28 Favored Pre-proline 0 C--N 1.303 -1.441 0 CA-C-N 115.677 -0.692 . . . . 75.450000000000003 109.386 -179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.8 98.24 0.13 Allowed 'Trans proline' 0 C--O 1.249 1.059 0 C-N-CA 122.533 2.156 . . . . 72.239999999999995 112.064 178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 . . . . . 0 C--N 1.308 -1.2 0 CA-C-N 115.049 -0.978 . . . . 75.150000000000006 108.501 -179.746 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.42 -1.926 0 N-CA-C 106.912 -1.514 . . . . 61.25 106.912 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -157.14 83.97 0.93 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.19 0.519 . . . . 52.409999999999997 111.889 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.2 m -88.45 -32.82 18.09 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.774 -1.565 . . . . 73.340000000000003 106.774 170.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.9 t70 59.88 -87.44 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 126.209 1.804 . . . . 72.129999999999995 113.887 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.1 t -128.74 1.74 5.45 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.886 0.85 . . . . 73.439999999999998 109.054 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.29 89.33 3.73 Favored 'General case' 0 N--CA 1.393 -3.308 0 CA-C-N 115.543 -0.753 . . . . 74.150000000000006 110.774 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -144.52 144.8 31.51 Favored 'General case' 0 CA--C 1.485 -1.55 0 N-CA-C 108.564 -0.902 . . . . 75.019999999999996 108.564 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -82.04 154.71 25.5 Favored 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 109.476 -0.564 . . . . 61.310000000000002 109.476 175.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.558 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.7 m-70 -114.86 160.6 19.29 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 115.428 -0.805 . . . . 55.299999999999997 109.851 -173.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.576 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 27.2 p-10 -131.08 125.08 32.24 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.647 0.737 . . . . 70.420000000000002 110.617 176.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.28 142.82 40.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.156 -0.929 . . . . 64.319999999999993 109.944 -174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.414 ' HB2' HG21 ' A' ' 113' ' ' VAL . 85.9 t80 -95.07 123.23 38.45 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.728 -0.842 . . . . 72.430000000000007 108.728 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -102.59 137.79 29.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 109.659 -0.497 . . . . 73.010000000000005 109.659 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -87.62 -28.39 21.92 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 113.516 0.932 . . . . 74.209999999999994 113.516 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.29 -20.81 0.18 Allowed Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 118.917 -1.611 . . . . 71.230000000000004 113.108 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.7 p -63.65 -28.48 69.94 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.147 0.499 . . . . 63.310000000000002 111.845 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.57 ' HB3' HD11 ' A' ' 32' ' ' ILE . 78.5 m-85 -139.9 57.12 1.62 Allowed 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.531 0.732 . . . . 75.010000000000005 109.232 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -88.86 -21.44 23.68 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.354 0.501 . . . . 53.450000000000003 112.354 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.602 ' O ' HG22 ' A' ' 31' ' ' VAL . 24.1 t70 -95.28 129.25 35.76 Favored Pre-proline 0 C--N 1.303 -1.424 0 CA-C-N 116.585 -0.28 . . . . 65.510000000000005 110.576 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.24 -25.04 57.69 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 122.694 2.263 . . . . 50.240000000000002 113.392 -177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.44 -30.0 62.92 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.536 -0.727 . . . . 63.310000000000002 110.965 -176.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 28' ' ' ASP . 18.4 m -72.44 -28.3 28.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.256 -0.646 . . . . 64.439999999999998 109.256 174.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.57 HD11 ' HB3' ' A' ' 26' ' ' PHE . 49.7 mm -64.31 -40.41 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 CA-C-N 115.697 -0.683 . . . . 73.319999999999993 110.588 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -61.44 -30.15 70.4 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-O 121.148 0.499 . . . . 74.219999999999999 111.002 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -82.36 -50.79 15.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.812 -0.631 . . . . 64.129999999999995 110.291 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 7.8 tmm? -67.63 -35.71 79.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.728 -0.669 . . . . 51.340000000000003 110.121 -175.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 68.3 mt -103.65 -77.31 0.57 Allowed 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.287 0.565 . . . . 73.030000000000001 109.749 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.4 t70 162.57 -30.15 0.0 OUTLIER 'General case' 0 CA--C 1.509 -0.599 0 C-N-CA 125.533 1.533 . . . . 72.409999999999997 107.287 -173.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -146.58 159.11 43.86 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-N 114.648 -1.16 . . . . 74.120000000000005 109.722 -173.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.3 m -107.52 120.52 47.23 Favored Pre-proline 0 N--CA 1.426 -1.671 0 O-C-N 123.573 0.546 . . . . 53.200000000000003 110.83 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -65.79 151.58 83.93 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.641 2.227 . . . . 75.340000000000003 109.259 171.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.7 130.26 45.61 Favored 'General case' 0 CA--C 1.483 -1.626 0 CA-C-O 122.144 0.973 . . . . 51.130000000000003 112.976 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 47.5 mt -103.39 139.18 25.04 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.041 0 CA-C-N 113.973 -1.467 . . . . 74.140000000000001 110.462 -174.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.431 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 13.5 p -126.34 146.45 32.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 107.79 -1.189 . . . . 45.240000000000002 107.79 172.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 105' ' ' GLU . 12.0 m -76.27 125.46 29.22 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 106.429 -1.693 . . . . 74.430000000000007 106.429 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -139.64 151.31 45.86 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.528 -0.869 . . . . 65.230000000000004 113.339 -177.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.0 m -115.0 125.93 54.17 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.589 -1.187 . . . . 72.420000000000002 109.491 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.0 tp -98.7 102.78 15.87 Favored Pre-proline 0 C--N 1.295 -1.786 0 C-N-CA 123.49 0.716 . . . . 64.409999999999997 109.594 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 73.5 Cg_endo -81.06 141.38 13.04 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.197 1.931 . . . . 64.340000000000003 111.942 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.7 10.91 57.42 Favored Glycine 0 N--CA 1.441 -1.001 0 C-N-CA 120.609 -0.805 . . . . 61.539999999999999 112.1 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 65' ' ' PRO . 81.0 m-85 -139.82 163.21 33.22 Favored 'General case' 0 C--O 1.2 -1.5 0 N-CA-C 108.719 -0.845 . . . . 65.319999999999993 108.719 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -138.39 143.59 39.85 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-O 121.303 0.573 . . . . 75.120000000000005 109.82 -177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.64 124.75 35.32 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 106.893 -1.521 . . . . 72.420000000000002 106.893 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -109.45 147.76 32.31 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.13 -0.693 . . . . 51.539999999999999 109.13 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.58 ' HG3' ' CD1' ' A' ' 130' ' ' TRP . 3.8 tmt_? -134.47 126.21 28.98 Favored 'General case' 0 N--CA 1.414 -2.25 0 N-CA-C 108.961 -0.755 . . . . 74.230000000000004 108.961 -176.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.7 tp -143.54 147.38 34.36 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.062 -1.088 . . . . 72.219999999999999 108.062 -174.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -125.88 16.21 8.0 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.039 0.447 . . . . 74.230000000000004 111.063 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -94.08 -136.77 8.3 Favored Glycine 0 N--CA 1.437 -1.279 0 CA-C-N 115.813 -0.631 . . . . 71.219999999999999 112.766 -178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -84.96 -7.61 59.08 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.076 0.465 . . . . 74.129999999999995 112.018 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.474 HD11 ' CH2' ' A' ' 118' ' ' TRP . 53.6 tp -113.61 164.59 13.47 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.342 -0.614 . . . . 73.340000000000003 109.342 177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -95.33 159.99 31.62 Favored Pre-proline 0 C--N 1.313 -1.011 0 C-N-CA 122.98 0.512 . . . . 74.040000000000006 110.718 -170.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HB3' ' HA ' ' A' ' 54' ' ' ARG . 23.3 Cg_exo -69.63 96.98 0.6 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.703 2.268 . . . . 73.310000000000002 109.871 171.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 24.5 p -92.73 -179.42 5.15 Favored 'General case' 0 C--O 1.253 1.244 0 N-CA-C 113.422 0.897 . . . . 73.25 113.422 -173.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.6 mm -131.87 120.78 45.52 Favored 'Isoleucine or valine' 0 C--O 1.248 0.985 0 N-CA-C 108.146 -1.057 . . . . 73.219999999999999 108.146 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.06 149.35 73.48 Favored Pre-proline 0 C--N 1.313 -1.017 0 N-CA-C 110.208 -0.293 . . . . 72.019999999999996 110.208 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 50' ' ' PHE . 25.3 Cg_endo -63.23 119.39 6.45 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.107 2.538 . . . . 74.129999999999995 113.435 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.4 t -125.91 131.28 52.35 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.792 -0.818 . . . . 65.310000000000002 108.792 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.425 ' HB2' ' HD3' ' A' ' 68' ' ' LYS . 42.6 mt-10 -66.19 -34.48 78.12 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.144 0.497 . . . . 73.530000000000001 110.485 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.425 ' HD3' ' HB2' ' A' ' 67' ' ' GLU . 3.2 mppt? -102.49 23.87 11.25 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 115.443 -0.799 . . . . 65.010000000000005 111.331 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.94 165.67 23.39 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 118.863 -1.636 . . . . 44.450000000000003 114.209 -177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.25 145.75 24.88 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 124.682 1.193 . . . . 71.329999999999998 108.596 174.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.4 t -113.02 125.11 70.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.695 -0.483 . . . . 73.439999999999998 109.695 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -95.86 116.55 29.08 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.288 -1.004 . . . . 74.319999999999993 108.288 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.22 -152.43 5.63 Favored Glycine 0 N--CA 1.422 -2.24 0 N-CA-C 110.879 -0.889 . . . . 62.450000000000003 110.879 -177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.446 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 34.7 mmtp -129.03 143.92 51.02 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 116.785 0.293 . . . . 70.109999999999999 110.28 -176.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 47.3 t -110.08 127.52 66.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 120.834 0.349 . . . . 42.539999999999999 110.794 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 70.7 mt -95.48 104.25 16.15 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.07 -1.085 . . . . 71.109999999999999 108.07 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 18.2 ptp -113.55 147.7 37.48 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 109.825 -0.435 . . . . 71.209999999999994 109.825 178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.39 13.55 55.5 Favored Glycine 0 N--CA 1.419 -2.447 0 C-N-CA 119.327 -1.416 . . . . 63.210000000000001 110.01 -172.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.558 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.4 p -86.76 131.6 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 N-CA-C 109.007 -0.738 . . . . 65.209999999999994 109.007 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.484 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 3.2 m -74.44 159.73 31.92 Favored 'General case' 0 N--CA 1.409 -2.484 0 N-CA-C 108.947 -0.76 . . . . 75.530000000000001 108.947 -178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.8 p -56.85 -34.86 68.21 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 123.614 0.766 . . . . 71.019999999999996 111.829 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.09 -46.04 79.07 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.574 -0.285 . . . . 73.540000000000006 111.691 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.532 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 1.8 mp0 -70.26 -31.04 68.24 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.623 -0.51 . . . . 73.519999999999996 109.623 175.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.4 tp -58.71 -51.87 68.11 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.202 0.525 . . . . 52.109999999999999 109.996 176.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -68.59 -28.74 67.21 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 115.448 -0.796 . . . . 64.129999999999995 110.309 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.514 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -65.69 -47.51 75.19 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 108.65 -0.87 . . . . 54.329999999999998 108.65 177.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.2 mt -61.13 -46.43 90.59 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.972 -0.751 . . . . 74.010000000000005 108.972 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.53 -29.75 70.79 Favored 'General case' 0 C--O 1.211 -0.931 0 CA-C-N 114.46 -1.245 . . . . 75.209999999999994 111.162 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.18 -40.47 59.38 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.082 -0.508 . . . . 64.420000000000002 110.848 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 86' ' ' ASN . 59.1 t -72.82 -49.33 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 112.308 0.485 . . . . 73.319999999999993 112.308 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -79.92 -27.91 39.84 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 112.859 0.689 . . . . 45.310000000000002 112.859 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.81 -21.29 36.19 Favored Glycine 0 N--CA 1.481 1.675 0 N-CA-C 119.585 2.594 . . . . 53.299999999999997 119.585 -168.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -71.23 -35.5 71.5 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 119.505 1.653 . . . . 71.019999999999996 113.814 -179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -120.44 -0.03 10.43 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.836 -0.745 . . . . 63.329999999999998 112.822 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -130.49 159.01 38.37 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 122.615 0.366 . . . . 75.109999999999999 110.072 177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -123.05 137.15 55.02 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.869 0.366 . . . . 71.409999999999997 110.582 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.1 ttp180 -87.41 114.51 24.08 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.814 -0.63 . . . . 64.140000000000001 110.653 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.448 HG11 ' CE ' ' A' ' 117' ' ' MET . 35.9 m -121.27 161.11 21.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.528 -0.76 . . . . 75.010000000000005 111.679 -177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 p -92.45 123.04 35.47 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.724 -0.671 . . . . 74.420000000000002 110.988 -177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.59 172.41 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 112.86 0.689 . . . . 61.299999999999997 112.86 -175.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -116.14 136.36 12.83 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 111.173 -0.771 . . . . 74.319999999999993 111.173 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.416 ' HB ' ' HB1' ' A' ' 45' ' ' ALA . 2.8 pp -126.78 160.99 34.31 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 C-N-CA 123.373 0.669 . . . . 64.349999999999994 111.322 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 48.2 t -117.17 129.96 72.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 109.439 -0.578 . . . . 73.400000000000006 109.439 177.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.591 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 19.0 mtp180 -73.38 116.54 14.06 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 122.805 0.442 . . . . 72.239999999999995 110.206 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 44' ' ' SER . 39.5 mt-10 -73.81 -20.48 60.45 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.719 -0.673 . . . . 72.140000000000001 110.019 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -73.93 -16.6 61.09 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 112.461 0.541 . . . . 73.430000000000007 112.461 -178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.406 ' CG ' ' H ' ' A' ' 108' ' ' SER . 33.0 p-10 -138.32 -83.49 0.3 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 120.238 -0.585 . . . . 64.540000000000006 111.048 173.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.406 ' H ' ' CG ' ' A' ' 107' ' ' ASN . 73.1 m 177.49 -13.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.266 1.427 . . . . 62.399999999999999 111.18 -177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -77.98 149.34 34.12 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 113.157 0.799 . . . . 64.420000000000002 113.157 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 62.7 pttt -103.87 147.2 27.6 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.53 -0.759 . . . . 74.400000000000006 110.211 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.591 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 89.8 mtp -139.24 162.24 35.48 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 121.578 0.704 . . . . 73.310000000000002 112.234 -175.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.24 130.89 46.41 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 114.349 -1.296 . . . . 64.349999999999994 109.359 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.514 HG12 ' ND2' ' A' ' 19' ' ' ASN . 35.8 m -143.41 175.86 3.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 C-N-CA 123.366 0.666 . . . . 74.040000000000006 109.72 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -116.12 145.1 43.32 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.216 -1.031 . . . . 62.140000000000001 108.216 172.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.7 t -136.26 172.04 13.6 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.167 -0.679 . . . . 62.43 109.167 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -104.07 118.53 36.87 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.407 -0.59 . . . . 74.409999999999997 109.407 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.448 ' CE ' HG11 ' A' ' 98' ' ' VAL . 52.0 ttp -111.91 148.84 32.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.024 -0.989 . . . . 64.040000000000006 109.546 -177.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.474 ' CH2' HD11 ' A' ' 59' ' ' LEU . 65.6 t-105 -73.75 130.54 40.17 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 107.752 -1.203 . . . . 72.430000000000007 107.752 178.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.518 ' H ' HD12 ' A' ' 119' ' ' ILE . 2.5 mp -73.45 -43.85 55.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 119.91 -0.716 . . . . 73.530000000000001 111.242 -171.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.491 HD22 ' HB2' ' A' ' 123' ' ' ASP . 9.9 t30 -93.58 67.74 3.97 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-O 122.961 1.362 . . . . 74.010000000000005 107.952 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -81.73 17.15 1.54 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 113.485 -1.689 . . . . 63.549999999999997 114.382 -170.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -121.97 19.73 10.84 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.315 -0.624 . . . . 34.299999999999997 109.315 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.491 ' HB2' HD22 ' A' ' 120' ' ' ASN . 11.9 t70 -64.88 126.9 92.03 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 115.627 -0.715 . . . . 62.140000000000001 110.882 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -92.47 16.57 1.36 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 122.388 2.059 . . . . 33.43 113.604 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.77 -32.93 5.97 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.918 0.39 . . . . 73.409999999999997 110.857 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -70.16 13.32 0.16 Allowed 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 113.674 0.991 . . . . 63.109999999999999 113.674 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -69.13 92.88 0.56 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.465 0.65 . . . . 53.140000000000001 111.787 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -125.55 133.63 8.44 Favored Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 108.329 -1.908 . . . . 74.519999999999996 108.329 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -103.48 140.76 37.06 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.905 0.86 . . . . 61.340000000000003 113.119 -172.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.58 ' CD1' ' HG3' ' A' ' 54' ' ' ARG . 2.3 t90 -113.97 136.38 52.97 Favored 'General case' 0 N--CA 1.41 -2.43 0 N-CA-C 104.416 -2.438 . . . . 75.25 104.416 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -61.96 0.19 0.42 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.251 1.575 . . . . 61.329999999999998 115.251 -171.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -69.09 -32.89 72.64 Favored 'General case' 0 N--CA 1.4 -2.964 0 C-N-CA 123.867 0.867 . . . . 73.230000000000004 109.676 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.546 ' HG3' ' O ' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -72.67 -33.65 66.68 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.445 0.641 . . . . 75.510000000000005 111.263 177.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 39.4 tt0 -63.55 -40.39 96.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.63 -1.168 . . . . 64.140000000000001 109.265 172.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -67.09 -41.75 85.81 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.864 -0.607 . . . . 71.510000000000005 110.465 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.64 -33.53 75.21 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 110.136 -0.32 . . . . 73.099999999999994 110.136 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 21.1 tpt180 -59.79 -50.36 74.13 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.447 0.642 . . . . 73.5 110.836 174.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 81.0 mt -74.22 -26.43 60.25 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.856 0.836 . . . . 71.239999999999995 110.958 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -83.73 -20.82 32.74 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.855 -1.066 . . . . 62.299999999999997 110.262 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.489 ' O ' HG12 ' A' ' 144' ' ' ILE . 54.0 tptt -61.98 -34.78 76.78 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.424 1.089 . . . . 44.329999999999998 110.09 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 34.8 mmtp -53.88 -31.6 50.37 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 114.714 1.376 . . . . 71.239999999999995 114.714 -174.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -57.91 -46.27 85.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.932 0.873 . . . . 53.509999999999998 108.971 177.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -76.72 -33.49 58.17 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.73 -1.123 . . . . 72.329999999999998 109.389 -176.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.5 mm -63.25 -34.69 68.45 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.343 0 CA-C-N 115.497 -0.774 . . . . 63.420000000000002 112.082 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 48.8 mt-10 -56.71 -34.57 67.6 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.522 0.677 . . . . 73.209999999999994 110.582 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.6 m -80.98 -47.1 14.09 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.371 -0.831 . . . . 70.439999999999998 110.703 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.536 ' O ' ' HG3' ' A' ' 151' ' ' MET . 2.8 t80 -70.96 -30.29 66.54 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.506 -0.77 . . . . 65.340000000000003 112.373 -171.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 87.5 tttt -57.9 -40.18 79.71 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.239 0.616 . . . . 73.430000000000007 110.289 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -64.23 -38.53 91.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.922 -0.77 . . . . 55.25 108.922 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.4 mt -68.43 -38.13 78.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 114.845 -1.07 . . . . 72.019999999999996 109.758 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.536 ' HG3' ' O ' ' A' ' 147' ' ' PHE . 64.2 mtt -63.54 -41.77 98.43 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.085 -0.507 . . . . 72.019999999999996 109.729 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 49.7 mt-10 -70.47 -33.86 71.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.847 -0.615 . . . . 71.400000000000006 110.461 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 46.4 t -62.15 -49.76 74.57 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.703 -0.681 . . . . 62.340000000000003 110.211 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -70.57 -23.49 62.61 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.212 0.53 . . . . 73.349999999999994 110.367 177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? 67.23 77.32 0.27 Allowed 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 125.358 1.463 . . . . 75.230000000000004 109.247 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -141.03 96.29 7.31 Favored Pre-proline 0 C--O 1.251 1.139 0 CA-C-N 114.283 -1.326 . . . . 75.040000000000006 109.217 177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -68.96 152.51 73.38 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.621 2.214 . . . . 74.430000000000007 110.7 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 . . . . . 0 C--N 1.307 -1.273 0 CA-C-O 120.53 0.205 . . . . 72.129999999999995 111.229 -178.943 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.436 -1.154 0 N-CA-C 109.088 -0.708 . . . . 62.240000000000002 109.088 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 47.1 m -63.19 154.25 31.9 Favored 'General case' 0 C--O 1.25 1.114 0 O-C-N 123.383 0.427 . . . . 64.099999999999994 110.742 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.7 t -63.36 -47.76 80.77 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.059 -0.719 . . . . 51.439999999999998 109.059 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -95.84 95.17 8.09 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 116.009 -0.541 . . . . 75.540000000000006 109.681 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.6 t -103.81 143.69 32.48 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 107.674 -1.232 . . . . 63.340000000000003 107.674 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.92 110.49 5.05 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 109.555 -0.535 . . . . 64.340000000000003 109.555 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -132.98 155.38 49.26 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.905 -0.589 . . . . 64.120000000000005 109.594 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.529 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 87.5 mt -98.72 153.83 18.43 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 120.963 0.411 . . . . 64.120000000000005 110.299 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.458 ' O ' HG12 ' A' ' 79' ' ' VAL . 44.2 m-70 -128.67 161.74 28.97 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.772 -0.649 . . . . 71.340000000000003 111.067 -172.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 9.5 p30 -120.09 128.54 53.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.493 -0.776 . . . . 61.229999999999997 112.032 174.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 66.2 t -131.78 140.79 47.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.359 -0.837 . . . . 51.210000000000001 108.947 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.494 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.8 t80 -98.58 121.61 40.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.813 -0.81 . . . . 74.510000000000005 108.813 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.459 ' CG2' ' HB2' ' A' ' 74' ' ' LYS . 14.9 m -93.59 152.36 3.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 CA-C-N 116.077 -0.51 . . . . 73.239999999999995 109.791 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -121.4 -51.66 2.07 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 115.818 1.785 . . . . 75.340000000000003 115.818 -169.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -130.02 -75.11 0.15 Allowed Glycine 0 C--O 1.225 -0.442 0 C-N-CA 118.599 -1.762 . . . . 63.439999999999998 114.4 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.1 t -58.53 -36.4 73.8 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.594 0.758 . . . . 71.219999999999999 112.505 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.64 ' HB3' HD11 ' A' ' 32' ' ' ILE . 70.1 m-85 -110.51 29.9 7.29 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-O 121.14 0.495 . . . . 72.340000000000003 111.053 -176.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.612 HE21 ' HA ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.91 -7.86 53.9 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 121.768 0.794 . . . . 62.0 109.648 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.503 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 13.0 t70 -114.02 134.44 22.16 Favored Pre-proline 0 C--N 1.305 -1.333 0 CA-C-N 114.338 -1.301 . . . . 75.409999999999997 111.01 -175.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -72.27 -25.12 19.03 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.577 2.185 . . . . 75.299999999999997 112.938 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.503 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 17.8 t70 -64.03 -43.33 95.9 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.185 -0.322 . . . . 64.299999999999997 110.471 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.24 -29.58 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 116.238 -0.437 . . . . 72.109999999999999 110.058 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.64 HD11 ' HB3' ' A' ' 26' ' ' PHE . 31.6 mm -65.77 -47.43 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 122.441 -0.162 . . . . 63.439999999999998 110.725 177.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -55.84 -32.7 63.84 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.831 0.348 . . . . 44.039999999999999 111.454 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -81.57 -36.96 14.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.471 -0.331 . . . . 65.450000000000003 111.473 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.425 ' HE1' HD23 ' A' ' 87' ' ' LEU . 50.6 ttp -63.92 -36.5 84.13 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.771 0.319 . . . . 75.209999999999994 110.21 -177.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.638 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.1 pt? -125.18 -76.42 0.59 Allowed 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 112.918 0.71 . . . . 65.239999999999995 112.918 176.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.638 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 23.6 m-20 -169.77 -55.9 0.02 OUTLIER 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 122.012 0.91 . . . . 62.200000000000003 108.606 -170.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -121.23 -177.27 3.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.105 -1.407 . . . . 75.239999999999995 110.097 -175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.5 m -134.97 120.59 14.21 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-N 115.757 -0.656 . . . . 73.239999999999995 109.629 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.61 150.87 66.7 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.793 2.328 . . . . 72.109999999999999 111.073 176.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -56.7 116.96 3.45 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 123.718 0.636 . . . . 74.209999999999994 110.037 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 49.2 mt -97.0 141.04 16.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 CA-C-N 115.753 -0.658 . . . . 72.420000000000002 110.861 -174.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.25 144.78 36.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.519 -0.919 . . . . 75.109999999999999 108.519 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.5 m -76.22 122.66 24.69 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.858 -0.793 . . . . 75.019999999999996 108.858 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -134.36 155.94 49.38 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.708 0.766 . . . . 71.439999999999998 111.601 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.3 m -113.05 128.87 56.61 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 114.29 -1.323 . . . . 72.329999999999998 108.382 178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 48.0 tp -103.7 99.57 16.36 Favored Pre-proline 0 C--N 1.284 -2.266 0 N-CA-C 108.863 -0.791 . . . . 71.439999999999998 108.863 176.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -84.8 146.63 10.51 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.016 1.811 . . . . 62.340000000000003 111.143 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.66 9.84 65.95 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.349 -0.929 . . . . 73.430000000000007 111.76 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.425 ' HB2' ' HG ' ' A' ' 47' ' ' LEU . 88.0 m-85 -145.36 159.3 43.27 Favored 'General case' 0 CA--C 1.481 -1.677 0 N-CA-C 107.503 -1.295 . . . . 74.219999999999999 107.503 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.461 HE21 ' H ' ' A' ' 52' ' ' ARG . 28.7 tp60 -139.3 139.63 37.37 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.059 -0.656 . . . . 72.319999999999993 109.613 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 58.7 ttp180 -99.77 135.66 40.85 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.762 -1.108 . . . . 75.219999999999999 108.429 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.649 ' HB3' ' O ' ' A' ' 126' ' ' MET . 54.1 m-85 -109.03 168.58 9.26 Favored 'General case' 0 C--N 1.277 -2.55 0 O-C-N 123.595 0.559 . . . . 74.0 109.508 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.829 ' HG2' ' CD1' ' A' ' 130' ' ' TRP . 0.0 OUTLIER -98.3 166.26 11.47 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 115.097 1.517 . . . . 53.229999999999997 115.097 -174.061 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.545 HD23 ' H ' ' A' ' 55' ' ' LEU . 1.4 pt? -95.98 126.86 41.51 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.611 -1.632 . . . . 72.299999999999997 108.552 175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -130.83 19.44 5.06 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.979 0.418 . . . . 62.329999999999998 111.913 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 136.0 -56.26 0.7 Allowed Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 119.319 -1.419 . . . . 63.200000000000003 114.516 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.436 ' HD3' ' C ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -91.05 -47.36 7.6 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.42 -0.512 . . . . 71.329999999999998 110.28 -174.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.488 HD23 ' HB3' ' A' ' 126' ' ' MET . 37.5 tp -113.72 163.39 15.08 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.646 -0.822 . . . . 72.319999999999993 110.857 -177.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -103.82 172.17 4.44 Favored Pre-proline 0 C--N 1.306 -1.288 0 C-N-CA 124.378 1.071 . . . . 73.049999999999997 109.433 -175.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 17.1 Cg_exo -69.25 112.41 2.98 Favored 'Trans proline' 0 C--N 1.364 1.366 0 C-N-CA 121.878 1.719 . . . . 52.299999999999997 110.65 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 19.6 p -116.98 160.35 21.07 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 123.372 0.42 . . . . 72.109999999999999 111.666 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.503 HD12 HG21 ' A' ' 71' ' ' VAL . 46.5 mm -96.77 142.68 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 108.209 -1.034 . . . . 72.129999999999995 108.209 178.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 118' ' ' TRP . 21.2 m -146.02 150.73 43.11 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 107.286 -1.375 . . . . 51.100000000000001 107.286 173.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -65.11 124.97 13.79 Favored 'Trans proline' 0 C--O 1.243 0.751 0 C-N-CA 122.197 1.931 . . . . 73.040000000000006 112.248 177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.3 t -124.98 145.38 49.9 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.606 -0.724 . . . . 50.32 109.279 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -74.23 -36.85 63.95 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.447 0.536 . . . . 64.299999999999997 112.447 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -131.7 15.68 4.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.697 0.629 . . . . 74.310000000000002 112.697 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.63 172.78 30.34 Favored Glycine 0 C--O 1.247 0.961 0 C-N-CA 120.486 -0.864 . . . . 72.430000000000007 112.391 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -154.64 156.33 36.29 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.641 -0.874 . . . . 61.399999999999999 108.641 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.503 HG21 HD12 ' A' ' 63' ' ' ILE . 40.4 t -124.64 137.69 56.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.131 -0.692 . . . . 74.019999999999996 109.131 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 -107.95 116.12 31.38 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.518 -0.919 . . . . 73.540000000000006 108.518 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.514 ' HA2' ' OE1' ' A' ' 27' ' ' GLN . . . -141.45 -150.09 5.32 Favored Glycine 0 N--CA 1.404 -3.446 0 C-N-CA 119.918 -1.134 . . . . 72.409999999999997 112.15 -176.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.518 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 34.5 mmtp -131.3 141.54 49.97 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.712 -0.847 . . . . 73.239999999999995 108.712 -174.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.4 t -110.11 130.85 62.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 110.254 -0.276 . . . . 63.299999999999997 110.254 174.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 77.4 mt -95.09 105.63 17.57 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.643 -0.708 . . . . 72.230000000000004 109.421 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.532 ' HE3' ' HB3' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -98.65 125.45 43.94 Favored 'General case' 0 CA--C 1.479 -1.786 0 CA-C-O 121.77 0.795 . . . . 70.340000000000003 112.072 176.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 17' ' ' LEU . . . 102.46 26.39 7.3 Favored Glycine 0 C--N 1.28 -2.581 0 CA-C-N 114.363 -1.29 . . . . 71.010000000000005 112.849 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.6 p -87.78 125.16 41.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.471 -0.937 . . . . 73.409999999999997 108.471 177.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.35 164.32 26.84 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 109.386 -0.598 . . . . 64.230000000000004 109.386 -176.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 41.5 m -58.36 -36.92 74.19 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 112.831 0.678 . . . . 55.009999999999998 112.831 -176.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.74 -44.71 80.81 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.672 0.273 . . . . 72.200000000000003 110.447 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 1.2 mp0 -68.61 -30.53 69.28 Favored 'General case' 0 C--O 1.216 -0.685 0 CA-C-N 116.406 -0.361 . . . . 64.530000000000001 110.24 175.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 81' ' ' SER . 48.4 tp -60.36 -50.25 74.36 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.287 -1.005 . . . . 74.030000000000001 108.287 174.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -65.02 -28.59 69.6 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.65 -1.159 . . . . 74.420000000000002 111.243 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.536 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.3 t-20 -62.03 -49.41 76.11 Favored 'General case' 0 C--O 1.207 -1.156 0 C-N-CA 123.331 0.652 . . . . 73.349999999999994 110.633 174.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.425 HD23 ' HE1' ' A' ' 35' ' ' MET . 92.3 mt -64.4 -38.74 92.09 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.651 0.739 . . . . 72.120000000000005 109.25 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.467 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 22.5 t70 -64.95 -35.52 81.44 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.537 -1.211 . . . . 61.539999999999999 110.829 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.64 -48.28 22.83 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.205 0.526 . . . . 73.230000000000004 110.129 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.7 t -62.99 -56.98 14.11 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 124.72 1.208 . . . . 73.439999999999998 113.168 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -79.97 -24.27 41.04 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.328 0.585 . . . . 75.209999999999994 112.524 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.7 -16.09 21.69 Favored Glycine 0 C--N 1.309 -0.97 0 N-CA-C 116.041 1.177 . . . . 71.319999999999993 116.041 -175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -57.94 -37.81 74.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 117.509 0.655 . . . . 73.400000000000006 112.344 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -136.63 10.17 3.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.889 0.376 . . . . 65.319999999999993 111.668 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -132.2 167.45 19.78 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.098 -0.704 . . . . 73.230000000000004 109.098 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.27 150.88 52.06 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.136 -1.061 . . . . 73.140000000000001 108.136 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -87.49 114.06 23.76 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.139 -0.689 . . . . 73.239999999999995 109.139 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.2 m -121.21 160.52 22.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 116.678 -0.237 . . . . 71.519999999999996 111.171 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.0 t -92.29 134.21 35.12 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 109.349 -0.612 . . . . 64.5 109.349 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.403 ' HB ' HD11 ' A' ' 47' ' ' LEU . 27.5 m -139.85 161.38 26.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.599 -0.273 . . . . 55.130000000000003 110.924 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -104.68 123.94 7.84 Favored Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.646 -0.981 . . . . 73.239999999999995 110.646 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.17 158.79 16.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 110.399 -0.222 . . . . 75.040000000000006 110.399 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 56.6 t -121.99 123.86 70.01 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.327 -0.99 . . . . 64.230000000000004 108.327 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.554 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 28.1 mtp180 -68.71 121.88 17.39 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 116.185 -0.462 . . . . 61.219999999999999 110.496 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -72.22 -21.16 61.44 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 122.183 0.992 . . . . 62.210000000000001 108.806 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -58.81 -39.54 81.44 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.288 -1.778 . . . . 62.350000000000001 112.61 178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.3 p-10 -147.31 6.03 0.85 Allowed 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.31 0.856 . . . . 74.040000000000006 113.31 -176.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.5 t 73.08 12.58 4.98 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 124.586 1.154 . . . . 71.329999999999998 112.338 177.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -96.49 149.07 22.15 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.698 -0.626 . . . . 73.140000000000001 111.571 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HD2' ' O ' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -96.33 150.12 20.92 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 112.817 0.673 . . . . 64.230000000000004 112.817 -175.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.554 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.6 mtp -143.26 160.62 40.14 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.853 -1.067 . . . . 72.549999999999997 110.153 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.23 130.76 54.7 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.751 -0.833 . . . . 54.539999999999999 108.751 177.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.494 HG21 ' HB2' ' A' ' 21' ' ' PHE . 35.3 m -142.27 173.96 6.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 120.894 0.378 . . . . 71.310000000000002 110.536 -177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -104.11 146.57 28.54 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.421 -0.955 . . . . 64.540000000000006 108.421 175.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.0 t -149.33 172.5 14.79 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.829 -0.804 . . . . 72.349999999999994 108.829 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -117.74 113.98 22.64 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.125 0.488 . . . . 74.219999999999999 109.953 -176.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -109.0 156.38 19.8 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.848 -0.615 . . . . 60.329999999999998 110.794 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.403 ' HB3' HG12 ' A' ' 64' ' ' VAL . 59.2 t-105 -68.4 128.85 38.08 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.498 -1.297 . . . . 74.040000000000006 107.498 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.6 mm -72.53 -38.51 59.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 112.653 0.612 . . . . 62.200000000000003 112.653 -170.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -76.28 -37.66 57.24 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.695 -0.402 . . . . 73.109999999999999 111.216 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.337 0.0 OUTLIER 37.77 65.01 0.6 Allowed 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.123 1.157 . . . . 75.409999999999997 114.123 -173.174 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.29 -26.62 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.635 -0.711 . . . . 72.030000000000001 111.198 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.32 136.23 50.74 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 122.929 0.491 . . . . 61.109999999999999 112.052 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.16 -2.29 11.94 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.612 2.208 . . . . 71.439999999999998 110.677 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -63.88 -45.51 89.08 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-N 115.665 -0.698 . . . . 74.209999999999994 110.917 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.649 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.0 ptt? -75.89 -17.9 59.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.324 -0.398 . . . . 72.5 110.763 -178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -62.39 107.96 1.02 Allowed 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.539 0.685 . . . . 74.430000000000007 110.737 -176.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.66 135.39 2.0 Favored Glycine 0 N--CA 1.414 -2.827 0 CA-C-N 115.215 -0.902 . . . . 72.540000000000006 111.069 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.486 ' HA ' ' HD2' ' A' ' 54' ' ' ARG . 9.6 pt-20 -116.96 144.27 44.76 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.085 0.469 . . . . 70.310000000000002 110.999 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.829 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 14.1 m0 -104.4 156.51 17.87 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.568 -0.742 . . . . 75.540000000000006 110.16 177.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -57.94 -30.89 66.32 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 124.013 0.925 . . . . 71.439999999999998 112.393 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -62.42 -47.6 83.36 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.955 0.407 . . . . 71.540000000000006 110.989 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.543 ' HG3' ' CZ ' ' A' ' 54' ' ' ARG . 5.8 mm-40 -74.2 -32.2 62.95 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.846 -0.615 . . . . 71.319999999999993 109.764 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.466 ' HG3' HH21 ' A' ' 137' ' ' ARG . 41.3 tt0 -58.95 -53.96 52.51 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.792 -0.64 . . . . 64.329999999999998 110.595 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -65.46 -40.89 93.75 Favored 'General case' 0 N--CA 1.437 -1.08 0 C-N-CA 119.864 -0.734 . . . . 75.409999999999997 111.072 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -55.71 -41.55 74.0 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.98 0.419 . . . . 61.310000000000002 110.203 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.466 HH21 ' HG3' ' A' ' 134' ' ' GLU . 51.3 ttp180 -60.06 -52.09 66.83 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.84 -0.618 . . . . 75.349999999999994 111.951 177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.89 -20.33 62.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.113 0.483 . . . . 65.150000000000006 111.925 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -80.83 -40.1 25.47 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.005 -0.739 . . . . 73.209999999999994 109.005 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.578 ' O ' HG12 ' A' ' 144' ' ' ILE . 37.5 ttpt -69.38 -39.85 77.76 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.752 -0.462 . . . . 74.310000000000002 109.752 176.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -53.81 -30.93 47.23 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.425 1.09 . . . . 64.349999999999994 111.78 -177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -65.37 -39.23 92.04 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-O 121.04 0.448 . . . . 73.230000000000004 109.917 179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.495 ' O ' HG22 ' A' ' 146' ' ' THR . 92.6 m-85 -76.73 -32.84 58.06 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.572 0.701 . . . . 74.310000000000002 109.291 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.9 mm -58.53 -31.21 43.0 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.269 0 CA-C-N 114.845 -1.07 . . . . 74.319999999999993 111.713 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -50.64 -44.72 57.49 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.296 0.48 . . . . 63.450000000000003 112.296 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 143' ' ' PHE . 12.0 t -68.76 -40.58 79.69 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 120.221 -0.592 . . . . 71.329999999999998 110.25 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -69.65 -29.95 67.53 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 112.93 0.715 . . . . 63.520000000000003 112.93 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.553 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 38.2 ttpt -59.64 -43.2 93.95 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.534 -0.913 . . . . 72.450000000000003 108.534 175.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -72.58 -28.55 62.87 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.798 -0.637 . . . . 64.230000000000004 110.235 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 146' ' ' THR . 83.7 mt -73.76 -43.16 54.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.757 -0.656 . . . . 75.150000000000006 110.397 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.2 ptm -70.75 -29.89 66.25 Favored 'General case' 0 C--O 1.213 -0.865 0 C-N-CA 121.089 -0.244 . . . . 64.010000000000005 111.579 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 8.2 mm-40 -66.1 -33.32 75.52 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.079 0.466 . . . . 75.209999999999994 110.728 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 41.8 t -71.95 -33.83 68.51 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.048 -0.523 . . . . 72.319999999999993 110.066 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -76.44 -44.81 34.13 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.56 0.695 . . . . 72.109999999999999 111.099 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -103.08 85.77 2.57 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.115 -0.948 . . . . 74.400000000000006 109.384 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -77.04 141.45 67.56 Favored Pre-proline 0 C--N 1.283 -2.325 0 CA-C-N 114.045 -1.434 . . . . 75.409999999999997 111.068 179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -65.11 128.07 19.78 Favored 'Trans proline' 0 C--O 1.254 1.301 0 C-N-CA 122.19 1.927 . . . . 74.340000000000003 108.633 170.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 C--N 1.294 -1.81 0 CA-C-N 116.397 -0.365 . . . . 62.229999999999997 110.547 -176.683 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.41 -2.45 0 N-CA-C 107.369 -1.345 . . . . 71.430000000000007 107.369 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 m -71.12 153.14 42.77 Favored 'General case' 0 N--CA 1.421 -1.913 0 N-CA-C 109.112 -0.699 . . . . 70.409999999999997 109.112 177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.6 m -76.82 -44.77 31.16 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 109.323 -0.621 . . . . 60.009999999999998 109.323 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 65.98 -52.09 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.309 1.444 . . . . 62.409999999999997 113.707 176.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.7 t -74.41 159.13 32.74 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.092 -0.707 . . . . 74.439999999999998 109.092 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.54 79.19 6.04 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-O 121.735 0.779 . . . . 71.329999999999998 110.045 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.23 26.57 7.38 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.502 -1.226 . . . . 63.020000000000003 109.106 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -78.81 154.95 29.47 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 114.747 -1.115 . . . . 60.219999999999999 109.413 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.522 ' O ' HG12 ' A' ' 79' ' ' VAL . 37.5 m-70 -115.01 160.66 19.33 Favored 'General case' 0 C--N 1.269 -2.896 0 CA-C-N 114.811 -1.086 . . . . 62.119999999999997 108.818 -174.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 22.5 p30 -131.14 127.03 37.21 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.548 0.69 . . . . 73.340000000000003 110.868 175.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.5 t -121.05 141.78 40.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.101 -0.954 . . . . 72.010000000000005 110.492 -174.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.459 ' HB2' HG21 ' A' ' 113' ' ' VAL . 90.3 t80 -94.56 124.37 38.56 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.514 -0.921 . . . . 73.530000000000001 108.514 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 20.6 m -109.12 126.4 66.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.364 0.602 . . . . 75.209999999999994 111.673 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.404 ' HB3' ' CG1' ' A' ' 63' ' ' ILE . 42.6 p90 -66.88 -34.09 77.03 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.803 1.038 . . . . 74.25 113.803 -177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 169.42 -28.44 0.13 Allowed Glycine 0 N--CA 1.431 -1.636 0 C-N-CA 118.752 -1.69 . . . . 52.240000000000002 113.318 -177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.2 p -62.97 -36.8 84.68 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.143 0.497 . . . . 64.400000000000006 111.143 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.588 ' HB3' HD11 ' A' ' 32' ' ' ILE . 63.5 m-85 -124.67 28.79 6.44 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.669 -0.696 . . . . 73.120000000000005 112.23 -176.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -87.14 9.18 20.78 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 121.795 0.807 . . . . 72.439999999999998 108.848 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.556 ' O ' HG12 ' A' ' 32' ' ' ILE . 13.1 t70 -117.25 129.44 25.33 Favored Pre-proline 0 C--N 1.296 -1.727 0 CA-C-N 114.544 -1.207 . . . . 74.439999999999998 109.354 -176.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 28' ' ' ASP . 2.8 Cg_exo -71.08 -28.8 18.58 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 121.915 1.744 . . . . 55.210000000000001 112.558 -177.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.454 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 24.0 t70 -62.35 -44.63 96.02 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 116.348 -0.387 . . . . 75.430000000000007 110.761 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.9 p -70.94 -29.3 36.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.997 -0.547 . . . . 72.5 109.93 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.588 HD11 ' HB3' ' A' ' 26' ' ' PHE . 44.2 mm -65.76 -41.57 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 CA-C-N 116.434 -0.348 . . . . 72.019999999999996 110.356 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.86 -46.21 71.21 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.296 0.569 . . . . 35.32 110.622 178.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p -82.75 -36.14 13.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 114.371 1.249 . . . . 55.240000000000002 114.371 -173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.609 ' HE1' HD23 ' A' ' 87' ' ' LEU . 12.0 tmm? -67.84 -36.58 80.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.792 0.33 . . . . 74.329999999999998 110.701 -174.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.507 HD21 HG23 ' A' ' 32' ' ' ILE . 1.0 OUTLIER -119.13 -71.69 0.72 Allowed 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.681 -0.808 . . . . 51.229999999999997 111.535 175.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.481 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 27.8 t70 167.96 -46.73 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.405 0.682 . . . . 72.530000000000001 109.481 -176.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -111.75 160.3 17.44 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.355 -0.839 . . . . 62.539999999999999 110.345 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.411 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 40.3 m -119.55 111.1 36.56 Favored Pre-proline 0 N--CA 1.429 -1.509 0 CA-C-N 116.34 -0.391 . . . . 55.009999999999998 111.262 -179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -60.72 151.51 76.03 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.025 2.483 . . . . 70.549999999999997 110.378 174.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -62.57 121.47 13.4 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.117 0.484 . . . . 65.439999999999998 109.855 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.513 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 25.2 mt -99.08 131.05 47.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.379 -0.828 . . . . 71.200000000000003 109.385 -175.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG21 ' HD2' ' A' ' 104' ' ' ARG . 11.6 p -130.4 148.05 33.15 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.899 -0.591 . . . . 74.150000000000006 110.352 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.426 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 34.5 m -75.59 124.19 26.79 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.024 0.44 . . . . 71.230000000000004 110.096 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' HB1' HD13 ' A' ' 102' ' ' ILE . . . -138.7 159.27 42.51 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.439 0.638 . . . . 63.420000000000002 111.513 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.475 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 78.3 m -118.23 129.43 55.48 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 115.479 -0.782 . . . . 50.130000000000003 109.892 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 39.6 tp -104.43 99.31 17.21 Favored Pre-proline 0 N--CA 1.426 -1.652 0 N-CA-C 109.733 -0.469 . . . . 73.319999999999993 109.733 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.5 Cg_endo -84.29 141.69 9.23 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 122.694 2.263 . . . . 72.319999999999993 110.752 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 98.36 4.14 57.41 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.616 -0.802 . . . . 71.049999999999997 111.492 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.415 ' HA ' ' H ' ' A' ' 66' ' ' SER . 82.4 m-85 -138.76 157.77 45.48 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.967 -0.753 . . . . 73.219999999999999 108.967 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 7.1 tp60 -138.93 148.3 43.39 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.595 -0.52 . . . . 65.340000000000003 109.595 -175.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.526 ' HD3' ' CZ3' ' A' ' 135' ' ' TRP . 5.7 ptm180 -100.6 126.35 47.06 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 115.265 -0.88 . . . . 74.510000000000005 110.564 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 68.1 m-85 -109.04 134.85 51.12 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 107.03 -1.47 . . . . 72.120000000000005 107.03 174.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.602 ' HB3' ' CD1' ' A' ' 130' ' ' TRP . 0.7 OUTLIER -129.27 130.89 46.77 Favored 'General case' 0 N--CA 1.404 -2.757 0 N-CA-C 113.798 1.036 . . . . 64.019999999999996 113.798 -166.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -161.8 162.54 29.54 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 103.224 -2.88 . . . . 75.430000000000007 103.224 172.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -144.73 97.53 3.04 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 119.314 -0.955 . . . . 74.109999999999999 109.963 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.77 -80.86 0.06 OUTLIER Glycine 0 N--CA 1.431 -1.662 0 CA-C-N 114.601 -1.181 . . . . 74.409999999999997 110.383 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.498 HH21 ' HB3' ' A' ' 125' ' ' ASP . 2.0 tmm_? -81.06 -51.2 8.75 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 106.969 -1.493 . . . . 74.519999999999996 106.969 178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.9 tp -113.54 165.68 12.25 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 114.909 -1.041 . . . . 44.219999999999999 109.541 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -103.32 173.19 3.61 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 107.439 -1.319 . . . . 64.129999999999995 107.439 -173.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.649 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 7.1 Cg_exo -73.73 81.17 1.91 Allowed 'Trans proline' 0 N--CA 1.444 -1.427 0 C-N-CA 121.022 1.148 . . . . 74.299999999999997 109.932 170.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 57.0 m -85.74 157.17 20.34 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.801 -0.636 . . . . 61.020000000000003 112.109 -174.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.459 HD12 HG21 ' A' ' 71' ' ' VAL . 49.2 mm -103.95 140.9 20.79 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.57 0 CA-C-N 115.153 -0.931 . . . . 62.030000000000001 109.23 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.31 153.96 56.6 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.278 -1.008 . . . . 62.299999999999997 108.278 175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -66.12 112.97 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.543 2.162 . . . . 65.200000000000003 112.378 177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 51' ' ' GLN . 33.5 t -125.54 126.64 45.16 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.329 -0.989 . . . . 72.420000000000002 108.329 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -60.48 -36.17 77.65 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 113.468 0.914 . . . . 72.310000000000002 113.468 -174.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -107.52 19.85 19.67 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.698 0.285 . . . . 74.519999999999996 111.495 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -109.31 160.13 13.68 Favored Glycine 0 N--CA 1.426 -1.989 0 C-N-CA 119.873 -1.156 . . . . 73.530000000000001 112.997 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -157.69 131.63 8.08 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.988 -1.116 . . . . 74.219999999999999 107.988 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.459 HG21 HD12 ' A' ' 63' ' ' ILE . 56.6 t -112.43 123.43 68.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 109.762 -0.458 . . . . 73.129999999999995 109.762 -176.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -97.01 115.88 28.23 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.366 -1.346 . . . . 75.510000000000005 107.366 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.491 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -144.69 -149.69 5.09 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 110.323 -1.111 . . . . 54.399999999999999 110.323 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 73' ' ' GLY . 2.2 mppt? -127.44 150.79 49.49 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 112.989 0.737 . . . . 70.209999999999994 112.989 -177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 28.1 t -110.87 131.88 60.86 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 114.593 -1.185 . . . . 60.409999999999997 112.016 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 78.8 mt -96.91 106.95 19.36 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.278 -1.008 . . . . 72.010000000000005 108.278 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 15.1 ptp -114.56 150.01 35.62 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 120.487 0.184 . . . . 73.099999999999994 110.714 178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.71 15.86 47.89 Favored Glycine 0 N--CA 1.433 -1.513 0 C-N-CA 119.483 -1.342 . . . . 63.420000000000002 111.006 -175.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.3 p -87.43 126.24 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.119 -1.067 . . . . 53.020000000000003 108.119 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.6 p -76.29 172.66 12.52 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 120.809 -0.356 . . . . 62.420000000000002 110.276 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.9 p -59.87 -41.18 90.93 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 112.25 0.463 . . . . 55.420000000000002 112.25 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -65.04 -36.65 85.06 Favored 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 121.777 0.798 . . . . 63.439999999999998 110.888 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.482 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 42.2 mt-10 -78.06 -31.21 50.16 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.397 -0.819 . . . . 73.049999999999997 109.171 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.438 HD22 ' CE1' ' A' ' 18' ' ' HIS . 35.5 tp -66.27 -47.32 74.09 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.233 -0.44 . . . . 61.5 110.615 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.01 -29.37 70.23 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.268 0.556 . . . . 72.329999999999998 109.63 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.7 t30 -67.21 -44.07 80.47 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.308 -0.86 . . . . 72.099999999999994 109.629 178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.609 HD23 ' HE1' ' A' ' 35' ' ' MET . 96.0 mt -64.77 -43.17 94.13 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.747 -0.661 . . . . 71.409999999999997 109.758 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.536 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 31.3 t70 -65.65 -27.59 68.48 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.927 -1.033 . . . . 63.310000000000002 110.288 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.47 -48.5 22.37 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 116.053 -0.521 . . . . 70.400000000000006 110.286 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.514 HG21 ' SD ' ' A' ' 35' ' ' MET . 92.7 t -69.86 -58.27 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 112.473 0.546 . . . . 61.240000000000002 112.473 -175.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -78.95 -33.86 44.92 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.136 0.493 . . . . 73.530000000000001 111.351 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -60.11 -16.53 41.41 Favored Glycine 0 N--CA 1.465 0.587 0 CA-C-N 115.795 -0.639 . . . . 32.439999999999998 113.507 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -57.74 -37.44 73.61 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.695 0.398 . . . . 73.25 110.518 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -132.93 7.91 4.05 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.169 0.509 . . . . 74.420000000000002 111.84 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 96.1 m-85 -131.07 168.84 16.73 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 122.709 0.404 . . . . 75.239999999999995 110.837 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.573 ' HB2' ' CD1' ' A' ' 119' ' ' ILE . 43.3 tt0 -122.46 129.97 52.59 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.536 -0.912 . . . . 55.100000000000001 108.536 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 115' ' ' THR . 60.0 ttp180 -86.14 114.16 22.77 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 107.912 -1.144 . . . . 65.439999999999998 107.912 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.4 HG13 ' HG2' ' A' ' 96' ' ' GLU . 30.9 m -125.77 162.24 29.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-N 115.673 -0.694 . . . . 62.509999999999998 111.987 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -86.13 124.62 32.74 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.242 -0.89 . . . . 75.430000000000007 109.257 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.8 170.72 19.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.72 -0.673 . . . . 70.439999999999998 111.896 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -121.24 120.51 4.47 Favored Glycine 0 N--CA 1.427 -1.907 0 N-CA-C 110.587 -1.005 . . . . 63.020000000000003 110.587 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.457 HD11 ' HE2' ' A' ' 111' ' ' MET . 2.6 pp -115.41 163.02 13.06 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 116.597 0.198 . . . . 61.520000000000003 110.64 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 59.5 t -117.3 125.38 73.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 107.603 -1.258 . . . . 74.140000000000001 107.603 178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.617 ' HE ' ' HB3' ' A' ' 106' ' ' ASP . 29.4 ttp180 -79.2 118.67 21.36 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.082 -1.081 . . . . 72.409999999999997 108.082 -175.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.426 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 45.4 mt-10 -66.94 -7.52 22.77 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.203 0.601 . . . . 72.239999999999995 111.081 -176.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.617 ' HB3' ' HE ' ' A' ' 104' ' ' ARG . 30.1 t70 -54.78 -46.51 74.45 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.996 -1.002 . . . . 74.209999999999994 108.92 172.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.433 ' HB2' ' H ' ' A' ' 108' ' ' SER . 16.5 m-80 -133.8 -103.27 0.24 Allowed 'General case' 0 C--N 1.343 0.288 0 N-CA-C 108.152 -1.055 . . . . 74.319999999999993 108.152 170.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.433 ' H ' ' HB2' ' A' ' 107' ' ' ASN . 21.2 p -152.47 16.14 0.61 Allowed 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 106.374 -1.713 . . . . 74.049999999999997 106.374 174.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -72.89 128.5 35.67 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 114.458 -1.246 . . . . 75.230000000000004 108.183 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 60.8 pttt -99.36 147.39 25.28 Favored 'General case' 0 C--N 1.251 -3.678 0 CA-C-N 115.273 -0.876 . . . . 74.340000000000003 109.801 -176.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.457 ' HE2' HD11 ' A' ' 102' ' ' ILE . 32.8 mtm -136.14 163.44 30.34 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-O 121.721 0.772 . . . . 65.129999999999995 110.686 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.63 118.15 35.8 Favored 'General case' 0 C--N 1.258 -3.41 0 CA-C-N 114.301 -1.318 . . . . 65.439999999999998 108.604 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 21' ' ' PHE . 22.8 m -134.15 174.67 12.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 109.316 -0.624 . . . . 75.099999999999994 109.316 -176.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -113.25 146.27 39.61 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.985 -0.746 . . . . 54.030000000000001 108.985 175.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 14.4 t -136.04 171.4 14.53 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 109.354 -0.61 . . . . 61.5 109.354 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 95' ' ' TYR . 80.1 m-85 -112.57 112.68 24.4 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.852 -0.613 . . . . 61.0 110.317 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 20.7 ptt? -112.67 157.83 20.78 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.656 -0.702 . . . . 71.409999999999997 109.582 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -67.64 139.91 56.83 Favored 'General case' 0 C--O 1.254 1.335 0 N-CA-C 109.104 -0.702 . . . . 75.510000000000005 109.104 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 96' ' ' GLU . 16.9 mm -72.24 -44.74 63.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 C-N-CA 120.34 -0.544 . . . . 64.319999999999993 110.788 -172.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -70.32 -35.74 73.84 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-N 115.629 -0.714 . . . . 74.129999999999995 109.868 -178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.443 ' HB3' ' HZ3' ' A' ' 121' ' ' LYS . 0.1 OUTLIER 56.17 -4.45 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.082 2.153 . . . . 73.239999999999995 115.587 176.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -126.81 26.15 6.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.507 0.67 . . . . 51.039999999999999 109.407 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.606 ' O ' ' HG2' ' A' ' 126' ' ' MET . 10.2 t70 -62.78 125.66 86.9 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.131 -0.94 . . . . 75.25 109.558 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.44 -13.76 16.51 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.832 2.355 . . . . 61.420000000000002 113.204 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.498 ' HB3' HH21 ' A' ' 58' ' ' ARG . 22.2 t70 -89.3 -24.0 22.14 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.228 -0.442 . . . . 51.140000000000001 110.69 -176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.606 ' HG2' ' O ' ' A' ' 123' ' ' ASP . 21.4 ptp -64.94 -21.69 66.87 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.724 0.297 . . . . 55.399999999999999 111.262 178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -71.64 107.57 4.56 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.243 -1.021 . . . . 75.439999999999998 108.243 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -140.15 -169.13 11.57 Favored Glycine 0 CA--C 1.489 -1.579 0 C-N-CA 120.507 -0.854 . . . . 53.25 112.239 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -91.29 127.21 36.64 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 109.4 -0.593 . . . . 75.129999999999995 109.4 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.602 ' CD1' ' HB3' ' A' ' 54' ' ' ARG . 18.5 m-90 -97.7 158.86 15.27 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 108.073 -1.084 . . . . 72.129999999999995 108.073 176.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 134' ' ' GLU . 63.1 m-20 -70.28 96.34 1.1 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 102.82 -3.03 . . . . 74.010000000000005 102.82 165.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.426 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 81.4 m-85 -62.13 -37.38 84.95 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 113.43 0.9 . . . . 65.109999999999999 113.43 -166.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -73.22 -28.82 62.39 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.03 0.443 . . . . 63.549999999999997 110.02 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 131' ' ' ASN . 1.2 tm-20 -70.46 -47.33 61.13 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.577 -0.897 . . . . 73.219999999999999 108.577 175.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . 0.526 ' CZ3' ' HD3' ' A' ' 52' ' ' ARG . 8.7 t-105 -67.14 -44.51 79.65 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-N 116.1 -0.5 . . . . 72.120000000000005 112.301 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 132' ' ' PHE . 35.3 mmtp -60.74 -31.21 70.54 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.793 0.33 . . . . 64.450000000000003 111.005 178.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 31.5 tpt180 -65.79 -52.05 54.0 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.511 -0.768 . . . . 75.439999999999998 111.609 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.05 -33.86 63.86 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.332 0.587 . . . . 72.430000000000007 111.515 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -84.18 -3.14 57.95 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.861 -0.609 . . . . 74.349999999999994 111.264 -175.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.51 ' O ' HG12 ' A' ' 144' ' ' ILE . 34.7 ttpt -46.58 -43.92 17.64 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.284 1.434 . . . . 70.209999999999994 113.219 -176.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 88.2 tttt -53.85 -34.58 59.75 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 112.678 0.622 . . . . 72.120000000000005 112.678 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 142' ' ' LYS . 10.7 tmtt? -58.97 -43.6 91.38 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.387 -0.597 . . . . 72.439999999999998 109.387 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -76.74 -32.85 58.04 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.703 -0.68 . . . . 73.299999999999997 109.83 -177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 140' ' ' LYS . 51.6 mm -63.28 -33.38 60.76 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 CA-C-N 115.603 -0.726 . . . . 72.329999999999998 110.551 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 7.7 mm-40 -51.8 -39.05 58.01 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.281 0.845 . . . . 71.409999999999997 113.281 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -80.63 -39.33 27.57 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 119.973 -0.691 . . . . 65.530000000000001 110.511 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -67.89 -29.21 68.25 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 112.577 0.584 . . . . 72.400000000000006 112.577 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 148' ' ' LYS . 37.6 ttpt -53.76 -42.22 67.97 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 124.095 0.958 . . . . 52.229999999999997 109.315 173.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -75.32 -42.04 55.44 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.584 -0.735 . . . . 61.340000000000003 110.126 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.2 mt -61.52 -39.56 83.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.735 -0.666 . . . . 64.219999999999999 111.654 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 57.8 ttp -62.14 -45.91 91.32 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 122.809 0.444 . . . . 61.229999999999997 110.1 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -66.39 -30.94 71.42 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.165 0.507 . . . . 65.420000000000002 110.071 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 45.1 t -69.17 -33.44 73.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.156 -0.475 . . . . 45.219999999999999 111.058 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -77.15 -27.52 53.84 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-O 121.412 0.625 . . . . 75.450000000000003 110.084 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -67.35 -31.45 71.71 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.916 -1.038 . . . . 65.430000000000007 109.736 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -62.78 139.75 97.17 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 115.495 -0.775 . . . . 72.310000000000002 109.261 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.01 106.34 2.13 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.105 1.87 . . . . 54.020000000000003 112.543 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? . . . . . 0 N--CA 1.428 -1.528 0 N-CA-C 106.173 -1.788 . . . . 73.319999999999993 106.173 176.16 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.425 -1.679 0 CA-C-O 121.23 0.538 . . . . 74.129999999999995 110.267 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.9 t -96.41 152.34 18.7 Favored 'General case' 0 N--CA 1.425 -1.715 0 N-CA-C 107.879 -1.156 . . . . 72.540000000000006 107.879 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 m -76.57 -24.68 53.55 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.587 -0.523 . . . . 74.530000000000001 109.587 177.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.0 t70 41.72 74.96 0.09 Allowed 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 125.077 1.351 . . . . 75.310000000000002 112.097 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.5 m -135.38 33.32 3.05 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 114.526 -1.215 . . . . 60.020000000000003 107.791 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.92 86.86 1.3 Allowed 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 115.104 -0.953 . . . . 41.509999999999998 111.93 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -129.65 132.79 46.8 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 104.595 -2.372 . . . . 71.349999999999994 104.595 171.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.414 ' N ' HD22 ' A' ' 17' ' ' LEU . 1.8 mm? -90.64 153.59 20.2 Favored 'General case' 0 N--CA 1.395 -3.214 0 C-N-CA 119.664 -0.814 . . . . 74.010000000000005 110.982 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.47 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.6 m-70 -123.61 159.77 28.55 Favored 'General case' 0 C--N 1.27 -2.858 0 CA-C-N 114.82 -1.082 . . . . 73.340000000000003 109.406 -175.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 15.3 p30 -125.59 126.19 44.37 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 115.021 -0.99 . . . . 55.340000000000003 110.322 174.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.61 138.76 53.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.436 -0.802 . . . . 72.439999999999998 109.395 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.466 ' HB2' HG21 ' A' ' 113' ' ' VAL . 87.5 t80 -93.55 121.92 35.46 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.138 -1.43 . . . . 73.219999999999999 107.138 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.416 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 19.2 m -103.24 154.81 5.48 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 115.737 -0.665 . . . . 61.43 110.878 -177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -139.9 -30.05 0.7 Allowed 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 112.989 0.737 . . . . 72.140000000000001 112.989 -170.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.49 -91.29 0.44 Allowed Glycine 0 N--CA 1.433 -1.535 0 C-N-CA 118.875 -1.631 . . . . 72.530000000000001 113.523 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.3 m -58.69 -31.29 68.09 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.22 0.822 . . . . 73.430000000000007 113.22 -173.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.457 ' HB3' HD11 ' A' ' 32' ' ' ILE . 27.6 m-85 -117.49 21.56 12.96 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.677 0.992 . . . . 63.329999999999998 113.677 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.416 ' HA ' ' CG2' ' A' ' 22' ' ' VAL . 9.8 tt0 -82.67 -2.63 54.62 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-O 121.974 0.892 . . . . 71.230000000000004 110.131 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 32' ' ' ILE . 20.4 t70 -112.52 125.21 30.38 Favored Pre-proline 0 C--N 1.311 -1.09 0 CA-C-N 115.392 -0.822 . . . . 60.530000000000001 109.56 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.3 -31.12 36.0 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.716 2.277 . . . . 60.329999999999998 113.572 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 21.9 t70 -62.78 -38.14 89.45 Favored 'General case' 0 C--O 1.246 0.911 0 CA-C-O 120.686 0.279 . . . . 43.25 111.591 -176.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 28' ' ' ASP . 29.0 m -73.38 -28.19 25.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.147 -0.479 . . . . 64.150000000000006 110.752 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 28' ' ' ASP . 47.9 mm -61.49 -38.61 80.49 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 CA-C-O 121.046 0.451 . . . . 73.430000000000007 110.866 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -59.6 -35.13 73.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.698 -0.683 . . . . 71.310000000000002 110.275 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.9 t -82.07 -51.12 15.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.406 -0.815 . . . . 72.409999999999997 111.667 -177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.424 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 10.7 tmm? -63.68 -36.63 84.48 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.523 -0.308 . . . . 74.209999999999994 111.002 -174.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 37' ' ' ASP 0.386 3.6 pp -121.56 -59.55 1.68 Allowed 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 114.702 1.371 . . . . 54.119999999999997 114.702 179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.555 ' N ' HD12 ' A' ' 36' ' ' LEU . 17.2 t70 172.72 -55.44 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.127 0.489 . . . . 62.299999999999997 110.825 -176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HG2' ' OD2' ' A' ' 37' ' ' ASP . 56.8 mmt-85 -138.75 159.1 42.95 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-N 115.828 -0.624 . . . . 51.0 110.195 -176.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.3 m -94.3 122.09 62.16 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 112.144 0.424 . . . . 74.310000000000002 112.144 -177.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.61 153.26 68.19 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.066 3.177 . . . . 70.340000000000003 111.392 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -56.77 132.08 51.16 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.226 -0.657 . . . . 72.25 109.226 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.491 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 54.9 mt -115.49 134.67 57.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 109.307 -0.627 . . . . 75.230000000000004 109.307 -174.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.6 p -125.29 144.13 36.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 108.505 -0.924 . . . . 73.530000000000001 108.505 175.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.5 m -81.12 127.69 32.92 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 108.826 -0.805 . . . . 54.439999999999998 108.826 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.48 158.74 43.37 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.221 0.534 . . . . 74.349999999999994 110.834 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.503 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 97.1 m -113.58 127.69 56.16 Favored 'General case' 0 C--N 1.28 -2.441 0 CA-C-N 115.187 -0.915 . . . . 50.329999999999998 110.082 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.8 tp -100.59 100.22 11.82 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 109.415 -0.587 . . . . 73.209999999999994 109.415 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 46' ' ' THR . 97.2 Cg_endo -88.09 135.21 3.23 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 122.649 2.233 . . . . 63.340000000000003 111.646 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 101.11 11.83 38.33 Favored Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 120.402 -0.904 . . . . 55.420000000000002 111.165 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.507 ' HA ' ' H ' ' A' ' 66' ' ' SER . 87.0 m-85 -145.31 159.69 42.66 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 108.876 -0.787 . . . . 73.019999999999996 108.876 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -139.42 143.8 37.8 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.662 -0.495 . . . . 73.219999999999999 109.662 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.541 ' HB3' ' CE2' ' A' ' 132' ' ' PHE . 59.1 ttt180 -104.41 132.68 50.39 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.825 -1.176 . . . . 73.010000000000005 107.825 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -108.76 169.82 8.42 Favored 'General case' 0 C--N 1.28 -2.427 0 N-CA-C 113.378 0.881 . . . . 73.310000000000002 113.378 -177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.9 tpt180 -88.42 145.19 25.92 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 114.251 -1.34 . . . . 74.109999999999999 109.163 -175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.453 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.6 pp -64.24 98.95 0.25 Allowed 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 122.576 1.179 . . . . 64.5 110.529 173.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.405 ' HD3' ' CA ' ' A' ' 128' ' ' GLY . 49.8 tptt -104.53 100.23 9.91 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 114.796 -1.093 . . . . 65.519999999999996 110.29 -172.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.46 -87.16 0.15 Allowed Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.569 -0.741 . . . . 62.520000000000003 114.742 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.527 ' HD2' ' H ' ' A' ' 58' ' ' ARG . 0.6 OUTLIER -104.39 2.07 30.84 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 112.272 0.471 . . . . 73.310000000000002 112.272 -172.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.68 HD23 ' HB3' ' A' ' 126' ' ' MET . 28.6 tp -125.89 163.95 21.83 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.256 -0.978 . . . . 73.0 112.351 -172.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -91.05 169.24 11.97 Favored Pre-proline 0 C--O 1.241 0.635 0 C-N-CA 124.334 1.054 . . . . 62.539999999999999 108.993 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.39 98.05 1.14 Allowed 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.823 1.682 . . . . 64.120000000000005 108.915 172.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 23.3 p -109.89 169.15 8.91 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 116.146 -0.479 . . . . 70.219999999999999 112.189 -173.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.8 mm -108.82 141.24 24.62 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.022 0 C-N-CA 123.533 0.733 . . . . 73.409999999999997 109.232 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.3 153.62 52.56 Favored Pre-proline 0 N--CA 1.476 0.873 0 N-CA-C 107.762 -1.199 . . . . 74.430000000000007 107.762 172.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.432 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 30.7 Cg_endo -65.03 115.45 3.29 Favored 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 122.555 2.17 . . . . 72.299999999999997 113.966 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.507 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 47.3 t -125.82 112.95 16.62 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.25 -1.018 . . . . 64.219999999999999 108.25 177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -65.62 -22.31 66.65 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.396 0.517 . . . . 74.030000000000001 112.396 -174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -109.63 14.82 23.23 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.86 0.362 . . . . 73.209999999999994 110.937 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.13 167.22 15.39 Favored Glycine 0 C--O 1.249 1.082 0 C-N-CA 120.684 -0.769 . . . . 33.43 112.663 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -156.41 143.54 18.94 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 123.834 0.854 . . . . 74.120000000000005 109.569 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.8 t -117.44 120.02 63.56 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 N-CA-C 110.13 -0.322 . . . . 63.539999999999999 110.13 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -91.77 115.45 28.07 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 106.782 -1.562 . . . . 74.219999999999999 106.782 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.05 -150.37 5.29 Favored Glycine 0 N--CA 1.429 -1.797 0 C-N-CA 120.573 -0.822 . . . . 64.439999999999998 111.866 -175.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 73.5 mmtt -126.04 141.54 51.91 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.854 0.359 . . . . 75.510000000000005 110.339 -175.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.3 t -111.09 131.04 63.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.966 -0.561 . . . . 75.239999999999995 110.78 175.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 66.9 mt -95.57 104.71 16.63 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.887 -0.783 . . . . 75.409999999999997 108.887 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.474 ' HG2' ' HB3' ' A' ' 19' ' ' ASN . 55.3 mtp -102.61 161.03 14.05 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.326 -0.99 . . . . 63.210000000000001 108.326 177.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.67 17.09 78.14 Favored Glycine 0 C--N 1.302 -1.346 0 C-N-CA 119.29 -1.433 . . . . 73.400000000000006 112.792 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.491 HG22 ' HB2' ' A' ' 83' ' ' GLU . 10.9 p -91.82 136.02 25.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 N-CA-C 108.28 -1.007 . . . . 64.120000000000005 108.28 178.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 79.2 p -78.93 168.39 19.76 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 119.899 -0.72 . . . . 72.239999999999995 111.766 -176.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 47.6 m -63.0 -33.43 75.4 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.206 -0.452 . . . . 73.010000000000005 111.978 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.72 -39.17 93.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.795 0.807 . . . . 70.150000000000006 110.47 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.535 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 41.8 mt-10 -78.27 -28.36 47.62 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.979 -1.01 . . . . 63.210000000000001 109.296 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.454 HD22 ' CE1' ' A' ' 18' ' ' HIS . 53.3 tp -66.13 -50.29 64.53 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 109.882 -0.414 . . . . 63.450000000000003 109.882 175.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -61.99 -28.87 69.87 Favored 'General case' 0 C--O 1.208 -1.12 0 CA-C-O 121.379 0.609 . . . . 73.109999999999999 109.441 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 12.6 t-20 -65.44 -49.06 70.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.171 -0.922 . . . . 62.539999999999999 110.537 176.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.597 ' HA ' HG12 ' A' ' 90' ' ' VAL . 95.4 mt -65.07 -38.85 92.12 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-O 121.824 0.821 . . . . 73.439999999999998 109.639 177.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.655 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 24.6 t70 -65.13 -31.68 73.0 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.231 -1.35 . . . . 73.549999999999997 109.737 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.21 -48.4 17.67 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.258 -0.883 . . . . 64.510000000000005 111.514 174.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 87' ' ' LEU . 7.3 p -72.33 -59.14 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 113.957 1.095 . . . . 73.129999999999995 113.957 -173.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.38 -32.93 37.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 119.643 -0.823 . . . . 74.400000000000006 110.847 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.655 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -57.46 -16.35 21.12 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 114.83 -1.077 . . . . 74.439999999999998 115.55 -176.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -77.16 -24.58 51.51 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 118.277 1.038 . . . . 65.439999999999998 111.604 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -111.05 -11.59 14.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.42 0.629 . . . . 73.030000000000001 110.327 -177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -134.53 170.91 15.06 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 123.771 0.829 . . . . 74.120000000000005 110.416 -173.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -121.62 138.03 54.49 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.335 -0.987 . . . . 54.32 108.335 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 115' ' ' THR . 39.6 ttp180 -87.48 119.13 27.45 Favored 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 108.794 -0.817 . . . . 73.25 108.794 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.54 161.16 26.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 112.378 0.51 . . . . 75.420000000000002 112.378 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.2 t -91.5 122.96 34.55 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.014 -0.993 . . . . 73.120000000000005 108.955 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.8 m -133.42 158.96 43.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.104 0.478 . . . . 74.140000000000001 111.605 -176.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -106.06 119.75 6.14 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 111.032 -0.827 . . . . 70.409999999999997 111.032 178.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.03 154.88 13.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 122.296 0.238 . . . . 64.230000000000004 110.431 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.8 t -118.74 117.72 55.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 121.181 0.515 . . . . 42.530000000000001 109.788 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -64.5 124.67 22.43 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 124.509 1.124 . . . . 73.439999999999998 111.414 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -61.41 -35.59 77.95 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 123.739 0.816 . . . . 74.010000000000005 112.115 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.2 -53.02 62.73 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 113.031 0.752 . . . . 71.409999999999997 113.031 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -128.96 10.86 5.98 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 113.5 0.926 . . . . 72.349999999999994 113.5 -167.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.4 t 63.93 12.44 6.83 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 123.403 0.681 . . . . 73.409999999999997 112.504 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -81.07 152.14 28.01 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.24 -0.652 . . . . 72.329999999999998 109.24 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -105.78 147.18 28.92 Favored 'General case' 0 C--N 1.278 -2.515 0 C-N-CA 120.263 -0.575 . . . . 62.530000000000001 109.789 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 40.9 mtm -137.55 163.05 32.13 Favored 'General case' 0 CA--C 1.465 -2.308 0 CA-C-O 121.412 0.625 . . . . 63.219999999999999 110.186 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.75 118.32 36.22 Favored 'General case' 0 C--N 1.262 -3.226 0 CA-C-N 114.612 -1.176 . . . . 70.230000000000004 108.474 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.466 HG21 ' HB2' ' A' ' 21' ' ' PHE . 30.8 m -128.22 173.52 13.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 CA-C-N 116.062 -0.517 . . . . 73.329999999999998 110.172 -176.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -101.99 149.42 24.25 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.214 -1.402 . . . . 64.030000000000001 107.214 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.7 t -152.3 171.69 17.6 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.561 -0.903 . . . . 73.209999999999994 108.561 175.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -119.1 116.75 27.02 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.043 -0.725 . . . . 72.040000000000006 109.043 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.432 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 24.5 ptt? -112.63 156.79 22.12 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 116.054 -0.521 . . . . 73.150000000000006 109.777 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 64.4 t-105 -68.08 123.98 22.16 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 108.572 -0.899 . . . . 70.420000000000002 108.572 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.6 mt -67.86 -41.76 85.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 115.069 -0.968 . . . . 74.510000000000005 112.022 -172.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -88.12 75.76 8.62 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.973 0.892 . . . . 64.409999999999997 108.673 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -76.67 0.05 21.75 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.005 -0.998 . . . . 71.519999999999996 112.877 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.88 8.96 41.05 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.104 -0.498 . . . . 71.120000000000005 109.871 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.94 138.59 96.4 Favored Pre-proline 0 C--O 1.214 -0.774 0 CA-C-N 115.772 -0.649 . . . . 72.409999999999997 109.96 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -99.56 17.56 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.181 1.921 . . . . 35.329999999999998 113.308 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -118.01 -9.0 10.65 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 114.311 1.226 . . . . 75.299999999999997 114.311 -173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.68 ' HB3' HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -86.65 -2.59 58.64 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 119.333 -0.947 . . . . 72.209999999999994 110.247 175.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -71.82 93.6 1.33 Allowed 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.458 0.647 . . . . 74.150000000000006 111.295 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.405 ' CA ' ' HD3' ' A' ' 56' ' ' LYS . . . -128.53 168.6 20.31 Favored Glycine 0 N--CA 1.422 -2.295 0 N-CA-C 109.255 -1.538 . . . . 61.219999999999999 109.255 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -90.76 125.13 35.6 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.714 -0.476 . . . . 74.150000000000006 109.714 -175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -128.96 158.44 38.84 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.145 -0.687 . . . . 75.340000000000003 109.145 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.474 ' O ' ' HB3' ' A' ' 134' ' ' GLU . 15.5 m120 -52.2 -3.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 115.451 1.648 . . . . 73.310000000000002 115.451 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.541 ' CE2' ' HB3' ' A' ' 52' ' ' ARG . 86.4 m-85 -67.73 -34.32 76.61 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 121.228 -0.92 . . . . 71.109999999999999 108.637 174.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -71.65 -28.62 63.88 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.91 -1.041 . . . . 55.299999999999997 109.464 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.584 ' HG3' ' NH2' ' A' ' 137' ' ' ARG . 39.2 tt0 -62.64 -40.69 97.82 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.316 -0.856 . . . . 64.239999999999995 109.425 174.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -71.46 -43.35 66.8 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 116.259 -0.428 . . . . 71.450000000000003 109.96 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -55.19 -31.01 61.07 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-N 116.016 -0.538 . . . . 65.450000000000003 110.932 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.584 ' NH2' ' HG3' ' A' ' 134' ' ' GLU . 44.2 ttp180 -59.12 -48.68 80.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.695 0.798 . . . . 62.020000000000003 112.72 176.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.65 -21.91 40.97 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.754 0.787 . . . . 74.109999999999999 110.221 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -84.52 -4.25 58.85 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.679 -1.146 . . . . 73.409999999999997 110.041 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.613 ' O ' HG12 ' A' ' 144' ' ' ILE . 6.3 ttpm? -48.63 -40.95 29.54 Favored 'General case' 0 C--O 1.209 -1.047 0 C-N-CA 124.601 1.16 . . . . 72.519999999999996 114.053 -171.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -55.83 -35.08 65.99 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.314 0.857 . . . . 74.109999999999999 113.314 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' A' ' 142' ' ' LYS . 0.6 OUTLIER -66.74 -36.57 82.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.879 0.847 . . . . 74.329999999999998 108.749 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -77.03 -35.96 56.52 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 113.679 -1.6 . . . . 74.349999999999994 110.678 -175.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.613 HG12 ' O ' ' A' ' 140' ' ' LYS . 50.1 mm -61.37 -32.67 53.86 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.981 0 N-CA-C 113.182 0.808 . . . . 71.099999999999994 113.182 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -51.77 -42.31 62.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 113.792 1.034 . . . . 71.120000000000005 113.792 -174.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.431 ' O ' HG13 ' A' ' 150' ' ' ILE . 13.1 t -70.77 -33.67 71.02 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 120.128 -0.629 . . . . 74.219999999999999 109.811 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.469 ' O ' ' HG3' ' A' ' 151' ' ' MET . 64.0 m-85 -71.71 -30.36 65.56 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 116.125 -0.489 . . . . 63.329999999999998 111.679 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.492 ' HG3' HG22 ' A' ' 144' ' ' ILE . 29.8 mtpp -59.83 -36.84 77.64 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.254 -1.017 . . . . 72.219999999999999 108.254 174.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 149' ' ' LYS . 48.4 mmtt -74.56 -36.68 63.08 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 115.778 -0.646 . . . . 74.430000000000007 112.201 176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.556 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 94.6 mt -63.28 -41.45 92.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 120.904 0.383 . . . . 63.539999999999999 110.09 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.469 ' HG3' ' O ' ' A' ' 147' ' ' PHE . 65.4 mtt -66.58 -40.64 89.02 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.656 -0.498 . . . . 70.109999999999999 109.656 176.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 148' ' ' LYS . 1.3 tm-20 -62.28 -34.29 76.3 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 124.87 1.268 . . . . 44.119999999999997 109.765 178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 74.9 m -71.13 -34.07 70.7 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.188 -0.46 . . . . 70.299999999999997 110.553 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 34.6 mmtp -73.31 -45.25 56.5 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 109.261 -0.644 . . . . 71.120000000000005 109.261 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -165.54 -75.35 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.358 -0.837 . . . . 71.0 109.107 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -161.53 147.26 10.76 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 124.33 1.052 . . . . 74.510000000000005 110.784 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' A' ' 151' ' ' MET . 54.5 Cg_endo -99.79 -169.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 123.138 2.559 . . . . 75.140000000000001 108.905 171.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.495 ' HA ' ' OE1' ' A' ' 158' ' ' GLN . 11.7 mm-40 . . . . . 0 C--N 1.305 -1.357 0 N-CA-C 107.557 -1.275 . . . . 73.540000000000006 107.557 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m . . . . . 0 N--CA 1.428 -1.529 0 N-CA-C 108.427 -0.953 . . . . 71.239999999999995 108.427 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 p -74.54 75.8 1.97 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.926 0.869 . . . . 72.319999999999993 111.365 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.0 m -82.89 -25.18 32.73 Favored 'General case' 0 N--CA 1.422 -1.875 0 CA-C-N 114.553 -1.203 . . . . 72.439999999999998 109.889 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 30.0 t70 57.72 75.29 0.38 Allowed 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 124.267 0.98 . . . . 73.310000000000002 110.288 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.524 ' OG ' ' HB ' ' A' ' 80' ' ' THR . 44.9 m -154.05 105.51 2.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.477 -0.783 . . . . 64.0 111.628 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.9 tp -100.39 -3.98 29.98 Favored 'General case' 0 N--CA 1.398 -3.063 0 CA-C-O 122.777 1.275 . . . . 72.030000000000001 108.3 173.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -133.15 129.18 37.53 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.913 -1.494 . . . . 71.319999999999993 107.445 175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 17' ' ' LEU . 2.2 mm? -95.37 156.71 16.21 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.325 0.583 . . . . 63.340000000000003 112.14 -177.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.59 ' O ' HG12 ' A' ' 79' ' ' VAL . 56.9 m-70 -113.9 161.25 17.85 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.016 -0.993 . . . . 74.310000000000002 109.191 -173.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 24.9 p30 -128.27 134.58 48.97 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.336 0.589 . . . . 73.349999999999994 112.117 177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 114' ' ' LYS . 53.9 t -131.52 137.97 54.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.659 -0.7 . . . . 73.439999999999998 110.345 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.475 ' HB2' HG21 ' A' ' 113' ' ' VAL . 93.2 t80 -94.67 123.83 38.34 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.195 0.598 . . . . 63.119999999999997 109.659 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.51 HG21 ' HB2' ' A' ' 26' ' ' PHE . 13.1 p -138.56 155.46 28.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.416 -0.587 . . . . 71.150000000000006 109.416 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.428 ' CE1' HD11 ' A' ' 63' ' ' ILE . 2.0 p90 -148.97 6.31 0.69 Allowed 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 120.923 0.392 . . . . 62.25 110.145 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -123.81 -92.61 1.02 Allowed Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 119.812 -1.185 . . . . 72.109999999999999 113.293 -176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.7 m -58.6 -36.11 73.49 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 123.441 0.696 . . . . 52.200000000000003 112.835 -174.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.51 ' HB2' HG21 ' A' ' 22' ' ' VAL . 72.6 m-85 -120.04 29.78 7.35 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.259 0.552 . . . . 71.430000000000007 111.561 -175.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -62.95 -31.51 72.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.929 -1.032 . . . . 73.340000000000003 110.633 177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.447 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 21.2 t70 -108.49 129.7 23.68 Favored Pre-proline 0 C--N 1.312 -1.032 0 CA-C-N 115.642 -0.708 . . . . 75.150000000000006 111.719 -176.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.23 -24.68 58.18 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.437 2.758 . . . . 71.230000000000004 113.915 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.447 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 16.4 t70 -70.46 -29.09 65.56 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.709 -0.619 . . . . 54.119999999999997 110.119 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 96.4 t -66.58 -39.57 84.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.345 -0.843 . . . . 75.239999999999995 108.824 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.488 HD11 ' HB3' ' A' ' 26' ' ' PHE . 29.0 mm -62.77 -45.03 99.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-N 115.253 -0.885 . . . . 74.219999999999999 110.526 177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -53.2 -42.85 66.7 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.492 0.553 . . . . 71.299999999999997 112.492 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -81.55 -36.75 14.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 112.525 0.565 . . . . 71.5 112.525 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 15.7 tmm? -65.22 -35.85 82.33 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 121.32 -0.152 . . . . 62.049999999999997 110.683 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.622 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 0.8 OUTLIER -120.35 -74.7 0.6 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 119.967 -0.693 . . . . 75.010000000000005 112.444 172.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.622 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 16.3 t70 173.6 -48.75 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.528 0.731 . . . . 75.239999999999995 109.163 -174.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? -109.13 164.95 11.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.604 -1.18 . . . . 60.009999999999998 109.094 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.4 m -123.93 129.35 24.81 Favored Pre-proline 0 C--N 1.307 -1.247 0 C-N-CA 122.361 0.264 . . . . 63.200000000000003 111.164 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -68.0 152.57 76.63 Favored 'Trans proline' 0 C--O 1.25 1.085 0 C-N-CA 123.278 2.652 . . . . 42.140000000000001 111.431 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -62.89 140.13 58.79 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.193 -0.669 . . . . 63.310000000000002 109.193 177.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 52.6 mt -118.35 142.66 32.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-O 120.889 0.376 . . . . 51.509999999999998 110.655 -173.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.464 HG21 ' HD2' ' A' ' 104' ' ' ARG . 9.1 p -130.13 145.08 36.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 N-CA-C 109.092 -0.707 . . . . 51.43 109.092 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.1 m -76.54 124.79 28.14 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.888 -0.782 . . . . 63.25 108.888 176.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.66 156.69 47.76 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.981 0.896 . . . . 72.340000000000003 112.042 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 64.8 m -116.16 128.89 56.02 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.398 -1.274 . . . . 73.239999999999995 108.153 177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 46.0 tp -102.03 99.61 12.78 Favored Pre-proline 0 C--N 1.286 -2.178 0 N-CA-C 108.68 -0.859 . . . . 75.25 108.68 176.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 46' ' ' THR . 95.6 Cg_endo -85.47 148.37 10.03 Favored 'Trans proline' 0 N--CA 1.443 -1.474 0 C-N-CA 122.349 2.033 . . . . 72.439999999999998 111.354 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 86.39 13.45 68.06 Favored Glycine 0 N--CA 1.437 -1.25 0 C-N-CA 120.433 -0.889 . . . . 33.509999999999998 111.225 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -143.25 152.26 41.49 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.991 -1.114 . . . . 72.219999999999999 107.991 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -139.55 142.86 37.17 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.783 -0.767 . . . . 74.120000000000005 109.154 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.708 ' HD3' ' H ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -90.27 134.81 34.07 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 107.83 -1.174 . . . . 73.129999999999995 107.83 176.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.668 ' HB3' ' O ' ' A' ' 126' ' ' MET . 84.2 m-85 -116.64 169.11 9.6 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 112.097 0.406 . . . . 74.340000000000003 112.097 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -139.21 137.85 36.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.692 1.367 . . . . 72.310000000000002 114.692 -169.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 125' ' ' ASP . 1.1 tt -177.84 48.02 0.01 OUTLIER 'General case' 0 C--O 1.246 0.887 0 N-CA-C 104.133 -2.543 . . . . 65.519999999999996 104.133 169.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.651 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 86.1 tttt -67.3 116.81 8.48 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.821 -1.081 . . . . 61.530000000000001 110.124 -173.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 140.46 -28.65 2.43 Favored Glycine 0 C--N 1.296 -1.678 0 N-CA-C 107.907 -2.077 . . . . 73.439999999999998 107.907 -173.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.495 ' HD3' ' C ' ' A' ' 58' ' ' ARG . 0.3 OUTLIER -125.89 -41.06 1.99 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.018 -1.104 . . . . 73.340000000000003 108.018 175.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 56' ' ' LYS . 37.5 tp -132.57 164.45 26.62 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 108.948 -0.76 . . . . 74.230000000000004 108.948 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -102.15 168.06 9.54 Favored Pre-proline 0 C--N 1.291 -1.957 0 N-CA-C 108.302 -0.999 . . . . 73.349999999999994 108.302 -172.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 21.9 Cg_exo -66.37 101.05 0.5 Allowed 'Trans proline' 0 N--CA 1.451 -0.991 0 N-CA-C 108.639 -1.331 . . . . 61.0 108.639 171.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 9.3 p -102.54 153.3 20.21 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.547 -0.751 . . . . 73.329999999999998 112.969 -173.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.428 HD11 ' CE1' ' A' ' 23' ' ' TYR . 41.8 mm -106.13 117.94 52.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.297 -0.865 . . . . 72.239999999999995 110.289 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.36 146.58 62.58 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.46 -0.57 . . . . 70.430000000000007 109.46 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.1 109.05 1.05 Allowed 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 122.757 2.305 . . . . 72.219999999999999 112.303 178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.5 t -124.64 121.76 35.61 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.01 -1.478 . . . . 53.43 107.01 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -55.61 -36.77 67.3 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.476 1.287 . . . . 74.319999999999993 114.476 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -109.1 20.05 18.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.193 0.52 . . . . 61.109999999999999 110.661 -177.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.7 162.72 14.11 Favored Glycine 0 N--CA 1.432 -1.619 0 C-N-CA 120.041 -1.076 . . . . 62.229999999999997 112.731 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -150.97 145.13 25.36 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 108.709 -0.849 . . . . 62.130000000000003 108.709 176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.427 HG21 HD12 ' A' ' 63' ' ' ILE . 50.7 t -123.3 133.27 69.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.468 -0.568 . . . . 65.209999999999994 109.468 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -107.41 126.51 52.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.058 -1.09 . . . . 71.030000000000001 108.058 177.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.01 -154.91 7.08 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.753 -0.939 . . . . 63.009999999999998 110.753 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.52 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.2 mmtm -125.75 148.72 48.99 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 120.719 0.295 . . . . 73.120000000000005 110.221 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.5 t -109.75 126.41 66.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 116.154 -0.476 . . . . 63.240000000000002 110.289 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 69.4 mt -94.98 107.39 19.43 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 107.67 -1.233 . . . . 74.439999999999998 107.67 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.404 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 14.3 ptp -116.82 144.86 43.99 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.892 -0.41 . . . . 71.519999999999996 109.892 178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.11 5.92 52.38 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 119.471 -1.347 . . . . 41.509999999999998 110.139 -173.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.59 HG12 ' O ' ' A' ' 18' ' ' HIS . 8.8 p -79.81 141.43 15.33 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 N-CA-C 108.107 -1.072 . . . . 73.420000000000002 108.107 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.524 ' HB ' ' OG ' ' A' ' 14' ' ' SER . 36.3 p -87.97 175.78 7.62 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.359 -0.936 . . . . 43.030000000000001 110.452 -176.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 31.2 m -65.83 -26.79 67.83 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.504 -0.771 . . . . 74.400000000000006 110.933 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -75.6 -41.78 53.56 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.311 -0.556 . . . . 64.5 110.781 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.581 ' HB2' HG22 ' A' ' 79' ' ' VAL . 4.9 mp0 -70.16 -28.11 65.07 Favored 'General case' 0 C--O 1.203 -1.389 0 C-N-CA 119.004 -1.078 . . . . 72.209999999999994 108.854 173.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.6 tp -58.97 -51.24 70.9 Favored 'General case' 0 C--O 1.222 -0.342 0 N-CA-C 109.644 -0.502 . . . . 75.439999999999998 109.644 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.79 -30.83 71.53 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.125 0.488 . . . . 70.040000000000006 110.163 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 2.2 t-20 -63.67 -49.76 71.93 Favored 'General case' 0 C--O 1.201 -1.46 0 CA-C-N 115.349 -0.841 . . . . 74.530000000000001 111.313 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.5 mt -69.74 -34.18 73.47 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.304 -0.628 . . . . 41.030000000000001 109.304 -178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.585 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 33.6 t70 -63.39 -36.86 85.11 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 114.651 -1.159 . . . . 72.219999999999999 109.011 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.98 -49.98 14.21 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.783 -0.644 . . . . 74.25 111.494 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.24 -57.63 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 C-N-CA 123.752 0.821 . . . . 65.420000000000002 113.171 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -80.22 -26.67 39.03 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.415 0.626 . . . . 74.200000000000003 111.481 177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -59.49 -16.08 34.83 Favored Glycine 0 N--CA 1.461 0.328 0 CA-C-N 114.693 -1.139 . . . . 72.299999999999997 115.909 -174.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -57.47 -34.21 68.79 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 117.519 0.66 . . . . 62.119999999999997 111.833 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -131.95 -0.69 3.77 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.758 0.651 . . . . 73.230000000000004 112.758 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -122.91 166.35 15.19 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.584 -0.28 . . . . 72.299999999999997 110.246 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -122.6 142.72 50.33 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.488 -0.56 . . . . 73.439999999999998 109.488 177.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.443 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 15.6 ttp85 -87.01 114.63 23.78 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 115.765 -0.652 . . . . 74.430000000000007 110.153 -177.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.451 HG11 ' CE ' ' A' ' 117' ' ' MET . 35.0 m -128.17 162.42 34.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.284 -0.871 . . . . 75.549999999999997 110.89 -177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.8 t -101.24 131.75 47.09 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.215 -0.661 . . . . 64.25 109.215 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.82 166.77 25.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 116.182 -0.463 . . . . 51.530000000000001 111.065 -175.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.23 117.97 5.92 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 111.013 -0.835 . . . . 62.409999999999997 111.013 177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.404 HD11 ' HE2' ' A' ' 111' ' ' MET . 2.7 pp -112.7 157.17 13.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.532 -0.544 . . . . 71.120000000000005 109.532 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.36 127.47 75.44 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 N-CA-C 107.89 -1.152 . . . . 71.409999999999997 107.89 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.464 ' HD2' HG21 ' A' ' 43' ' ' VAL . 60.7 mtm180 -71.48 141.83 50.2 Favored 'General case' 0 CA--C 1.489 -1.37 0 C-N-CA 119.501 -0.88 . . . . 72.019999999999996 110.151 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.24 5.6 25.96 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 115.303 -0.862 . . . . 73.409999999999997 111.042 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -94.02 -29.45 15.21 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.64 -0.709 . . . . 73.409999999999997 109.942 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.458 ' HB2' ' OE2' ' A' ' 109' ' ' GLU . 2.5 m-20 -118.9 -121.46 0.3 Allowed 'General case' 0 N--CA 1.419 -1.977 0 N-CA-C 108.487 -0.931 . . . . 65.329999999999998 108.487 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.3 m -167.03 17.89 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 126.485 1.914 . . . . 75.430000000000007 107.236 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.458 ' OE2' ' HB2' ' A' ' 107' ' ' ASN . 0.0 OUTLIER -105.43 157.84 17.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.646 -0.706 . . . . 73.439999999999998 111.735 -174.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.611 ' HD3' ' H ' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -106.08 147.28 29.12 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.173 0.511 . . . . 45.409999999999997 110.743 -177.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.404 ' HE2' HD11 ' A' ' 102' ' ' ILE . 36.9 mtm -132.23 162.85 29.93 Favored 'General case' 0 CA--C 1.47 -2.134 0 CA-C-N 115.056 -0.975 . . . . 75.120000000000005 108.451 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.41 126.77 53.26 Favored 'General case' 0 C--N 1.249 -3.77 0 CA-C-N 114.853 -1.067 . . . . 54.530000000000001 108.851 -178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 21' ' ' PHE . 32.6 m -139.0 173.01 12.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.617 -0.512 . . . . 74.349999999999994 109.617 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 3.6 mptp? -97.99 149.51 22.37 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.252 -1.018 . . . . 74.219999999999999 108.252 175.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.6 t -152.41 172.23 16.82 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.185 -1.043 . . . . 73.310000000000002 108.185 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.443 ' CE2' ' HB2' ' A' ' 97' ' ' ARG . 96.6 m-85 -108.45 111.07 22.76 Favored 'General case' 0 N--CA 1.416 -2.14 0 CA-C-O 121.745 0.783 . . . . 74.329999999999998 110.191 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.469 ' HB3' ' HE2' ' A' ' 117' ' ' MET . 56.9 ttp -105.37 146.63 29.18 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 114.321 -1.309 . . . . 64.420000000000002 109.04 -174.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.477 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 65.8 t-105 -74.96 132.78 41.65 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 107.146 -1.427 . . . . 75.400000000000006 107.146 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.5 mp -71.85 -41.87 69.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 C-N-CA 120.428 -0.509 . . . . 71.420000000000002 111.189 -171.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -89.3 94.34 9.87 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.62 0.724 . . . . 54.5 110.729 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -81.68 12.03 4.25 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.538 -0.755 . . . . 74.340000000000003 111.291 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -125.25 22.54 7.81 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.739 -0.664 . . . . 60.409999999999997 110.047 178.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -67.54 121.29 78.45 Favored Pre-proline 0 C--O 1.237 0.423 0 N-CA-C 109.889 -0.411 . . . . 74.219999999999999 109.889 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -84.97 -0.51 9.21 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.572 2.181 . . . . 60.240000000000002 113.769 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.506 ' O ' HD12 ' A' ' 55' ' ' LEU . 30.8 m-20 -96.61 -37.31 10.41 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 120.675 -0.41 . . . . 53.119999999999997 112.073 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.668 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 25.7 ptt? -63.25 -23.31 67.37 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 112.17 0.433 . . . . 54.549999999999997 112.17 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.71 103.7 0.72 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.229 0.538 . . . . 72.319999999999993 112.012 -175.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -170.67 168.34 41.42 Favored Glycine 0 N--CA 1.437 -1.243 0 N-CA-C 110.418 -1.073 . . . . 73.030000000000001 110.418 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.538 ' O ' ' HD3' ' A' ' 54' ' ' ARG . 10.1 pt-20 -89.08 134.46 33.99 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.415 0.626 . . . . 70.150000000000006 112.376 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.532 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 6.4 t90 -120.51 156.19 32.04 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 105.872 -1.899 . . . . 73.420000000000002 105.872 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -52.36 -33.83 44.86 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 113.517 0.932 . . . . 71.439999999999998 113.517 -172.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -54.32 -30.08 49.95 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.603 0.964 . . . . 72.109999999999999 113.603 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.532 ' HG3' ' O ' ' A' ' 130' ' ' TRP . 0.8 OUTLIER -61.58 -28.25 69.21 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.141 0.423 . . . . 73.540000000000006 112.141 -177.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 42.5 tt0 -60.95 -41.05 95.55 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.517 -0.765 . . . . 73.209999999999994 109.307 174.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -73.38 -31.4 63.88 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.711 -0.477 . . . . 73.400000000000006 109.711 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -60.47 -37.17 80.16 Favored 'General case' 0 C--O 1.209 -1.056 0 N-CA-C 108.394 -0.965 . . . . 72.340000000000003 108.394 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.687 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 61.8 ttt180 -63.43 -51.02 67.47 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.187 -0.915 . . . . 74.200000000000003 111.543 176.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.9 -14.9 62.07 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 112.472 0.545 . . . . 75.319999999999993 112.472 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -95.55 -28.78 14.7 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.967 -0.293 . . . . 60.210000000000001 111.215 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.687 ' HG2' ' O ' ' A' ' 137' ' ' ARG . 22.7 ptmt -62.07 -32.73 73.3 Favored 'General case' 0 C--O 1.201 -1.453 0 N-CA-C 110.038 -0.356 . . . . 74.239999999999995 110.038 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 0.2 OUTLIER -48.85 -39.26 24.99 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.411 1.084 . . . . 63.350000000000001 111.107 -175.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -57.54 -44.45 85.17 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.083 0.468 . . . . 72.530000000000001 110.698 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -76.0 -35.58 59.52 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.14 -0.689 . . . . 74.109999999999999 109.14 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 140' ' ' LYS . 45.9 mm -60.99 -32.61 52.98 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.708 0 CA-C-N 115.615 -0.72 . . . . 60.350000000000001 110.848 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 43.9 mt-10 -55.08 -44.57 74.98 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 120.917 -0.313 . . . . 72.310000000000002 111.39 176.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.465 ' O ' HG13 ' A' ' 150' ' ' ILE . 9.9 t -80.19 -36.73 34.54 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 119.828 -0.749 . . . . 72.239999999999995 110.342 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.494 ' O ' ' HG2' ' A' ' 151' ' ' MET . 54.8 m-85 -66.94 -30.68 70.88 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.942 1.089 . . . . 74.150000000000006 113.942 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 87.8 tttt -62.08 -36.95 83.22 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.132 -1.062 . . . . 51.43 108.132 176.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 146' ' ' THR . 86.5 tttt -74.05 -37.89 64.14 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.425 -1.261 . . . . 63.140000000000001 109.526 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 146' ' ' THR . 83.6 mt -67.02 -33.76 65.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.756 -0.656 . . . . 71.230000000000004 110.206 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 26.3 mmt -66.33 -30.46 70.87 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.009 -0.367 . . . . 73.540000000000006 110.009 175.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 23.1 mm-40 -72.31 -30.52 64.87 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.988 -0.551 . . . . 73.340000000000003 109.647 175.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 66.6 m -70.65 -31.46 68.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.403 0.62 . . . . 74.319999999999993 109.608 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -79.95 -19.79 47.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.732 -0.667 . . . . 72.439999999999998 109.514 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 62.2 tttm 62.36 60.64 1.38 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 125.629 1.572 . . . . 64.409999999999997 109.735 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -140.9 112.16 6.82 Favored Pre-proline 0 C--N 1.312 -1.04 0 CA-C-N 114.685 -1.143 . . . . 74.540000000000006 109.412 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.57 165.09 23.11 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.648 2.232 . . . . 64.540000000000006 112.831 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 C--N 1.304 -1.389 0 CA-C-O 122.132 0.968 . . . . 73.0 109.307 176.349 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.2 p . . . . . 0 N--CA 1.434 -1.262 0 N-CA-C 108.413 -0.958 . . . . 43.43 108.413 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.3 m -85.22 71.93 10.8 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.772 0.796 . . . . 72.219999999999999 111.843 -174.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.2 m -89.35 -10.68 45.77 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 114.54 -1.209 . . . . 70.450000000000003 109.622 175.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 78.89 179.25 0.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.623 1.569 . . . . 72.329999999999998 108.171 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -89.51 99.57 12.54 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.53 -0.731 . . . . 72.430000000000007 110.27 -177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.9 98.97 7.34 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.606 -0.887 . . . . 61.229999999999997 108.606 177.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -138.63 147.9 43.45 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-O 121.472 0.653 . . . . 75.129999999999995 111.436 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 17' ' ' LEU . 2.4 mm? -81.15 156.38 25.75 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 107.748 -1.205 . . . . 60.100000000000001 107.748 174.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.584 ' O ' HG12 ' A' ' 79' ' ' VAL . 39.7 m-70 -112.5 159.32 18.9 Favored 'General case' 0 C--N 1.262 -3.233 0 N-CA-C 108.085 -1.08 . . . . 73.040000000000006 108.085 -173.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.442 ' HB2' HG12 ' A' ' 113' ' ' VAL . 46.3 m-20 -117.04 125.83 51.92 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.108 -1.441 . . . . 73.329999999999998 107.108 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 62.2 t -119.38 137.72 52.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 110.391 -0.225 . . . . 70.120000000000005 110.391 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.482 ' HB2' HG21 ' A' ' 113' ' ' VAL . 70.1 t80 -94.91 122.08 37.17 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.442 -0.948 . . . . 61.030000000000001 108.442 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 15.6 m -103.2 105.71 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-O 122.224 1.011 . . . . 63.420000000000002 111.135 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.487 ' HB2' HD11 ' A' ' 63' ' ' ILE . 43.2 p90 -72.08 -18.87 61.89 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.003 -1.453 . . . . 74.439999999999998 114.272 -173.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.72 -40.22 0.3 Allowed Glycine 0 CA--C 1.499 -0.921 0 C-N-CA 118.979 -1.581 . . . . 72.430000000000007 112.947 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -58.06 -36.49 72.85 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.869 0.467 . . . . 53.039999999999999 112.189 -177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.661 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 49.3 m-85 -134.75 37.35 3.08 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.472 0.654 . . . . 51.109999999999999 109.435 -176.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -86.18 -4.78 59.24 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.6 -0.727 . . . . 43.450000000000003 110.962 -175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -105.8 121.12 46.92 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 109.381 -0.6 . . . . 74.209999999999994 109.381 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 11.7 Cg_endo -56.89 -31.53 89.48 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 123.159 2.573 . . . . 65.439999999999998 113.934 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -68.03 -33.64 74.98 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 121.409 0.624 . . . . 63.32 109.973 -179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 98.7 t -67.28 -39.15 82.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.172 -0.922 . . . . 64.420000000000002 108.792 175.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.562 HG23 HD21 ' A' ' 36' ' ' LEU . 44.5 mm -62.56 -37.41 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 115.285 -0.871 . . . . 71.239999999999995 110.361 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.87 -50.17 66.88 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.57 0.7 . . . . 73.420000000000002 110.287 176.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.85 -44.9 19.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 114.222 1.194 . . . . 72.030000000000001 114.222 -173.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.661 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 5.9 tmm? -62.33 -36.55 82.52 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.06 0.457 . . . . 74.340000000000003 110.707 -173.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.562 HD21 HG23 ' A' ' 32' ' ' ILE . 0.3 OUTLIER -116.71 -75.13 0.58 Allowed 'General case' 0 N--CA 1.427 -1.623 0 C-N-CA 120.491 -0.484 . . . . 71.340000000000003 111.926 178.241 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.9 t70 173.18 -47.74 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 121.292 0.568 . . . . 72.319999999999993 111.116 -175.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.53 ' HD2' ' OE2' ' A' ' 83' ' ' GLU . 4.6 ptp180 -126.57 164.47 21.15 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.507 -0.769 . . . . 72.310000000000002 109.75 -174.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.6 m -124.63 108.87 28.6 Favored Pre-proline 0 C--N 1.311 -1.068 0 CA-C-O 120.59 0.233 . . . . 75.310000000000002 110.704 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -63.57 152.07 82.03 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.58 2.853 . . . . 74.140000000000001 111.768 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -56.51 137.56 53.14 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 123.635 0.584 . . . . 64.239999999999995 109.591 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 35.4 mt -115.59 137.33 49.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 116.297 -0.41 . . . . 74.540000000000006 111.179 -170.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -130.3 146.46 34.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 109.096 -0.705 . . . . 73.530000000000001 109.096 175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 51.1 m -77.0 127.37 32.57 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.085 -0.709 . . . . 64.530000000000001 109.085 176.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' A' ' 102' ' ' ILE . . . -143.58 159.41 42.5 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.208 0.528 . . . . 74.420000000000002 111.994 -179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.4 m -119.45 131.89 55.7 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.585 -0.734 . . . . 54.509999999999998 110.779 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -101.6 103.41 27.67 Favored Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-N 115.55 -0.75 . . . . 54.399999999999999 109.484 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.2 142.61 7.48 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.241 1.96 . . . . 62.439999999999998 111.553 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.46 7.75 60.26 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.451 -0.88 . . . . 71.099999999999994 111.556 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -145.35 143.53 30.19 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 107.0 -1.481 . . . . 54.32 107.0 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.434 ' HB2' ' HA3' ' A' ' 69' ' ' GLY . 62.4 tt0 -143.04 142.82 31.67 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.705 -1.22 . . . . 74.239999999999995 107.705 -175.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -91.21 125.83 36.11 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 119.978 -0.689 . . . . 75.510000000000005 109.542 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 11.6 m-30 -107.67 135.64 48.77 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.942 -1.026 . . . . 73.219999999999999 108.653 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -108.91 165.26 11.71 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-O 121.774 0.797 . . . . 63.350000000000001 112.525 -175.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.599 HD22 ' HB3' ' A' ' 125' ' ' ASP . 64.9 tp -154.3 -50.31 0.09 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 114.225 -1.352 . . . . 62.229999999999997 107.666 177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? 62.0 74.04 0.45 Allowed 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 124.895 1.372 . . . . 71.010000000000005 107.708 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.46 -114.4 0.36 Allowed Glycine 0 N--CA 1.44 -1.09 0 CA-C-N 115.29 -0.868 . . . . 63.030000000000001 111.169 -176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -77.14 -26.2 52.85 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.976 -0.75 . . . . 72.409999999999997 108.976 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB3' HD23 ' A' ' 55' ' ' LEU . 44.9 tp -116.19 163.43 15.99 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 114.913 -1.04 . . . . 61.439999999999998 108.631 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -107.0 170.18 5.96 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 107.895 -1.15 . . . . 63.140000000000001 107.895 -171.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 9.7 Cg_exo -72.19 99.91 1.06 Allowed 'Trans proline' 0 N--CA 1.44 -1.672 0 C-N-CA 121.529 1.486 . . . . 71.310000000000002 108.758 171.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.496 ' SG ' ' HG2' ' A' ' 126' ' ' MET . 27.7 p -105.36 160.01 15.46 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.039 -0.528 . . . . 73.040000000000006 112.054 -172.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 23' ' ' TYR . 48.8 mm -94.64 125.08 47.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.764 -0.653 . . . . 61.32 109.656 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.13 146.94 63.22 Favored Pre-proline 0 C--N 1.304 -1.385 0 N-CA-C 109.54 -0.541 . . . . 74.409999999999997 109.54 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.32 104.91 0.27 Allowed 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.653 2.235 . . . . 63.219999999999999 112.573 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.9 t -125.47 108.12 11.32 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.945 -1.132 . . . . 71.540000000000006 107.945 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -61.27 -27.25 68.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.946 0.403 . . . . 74.200000000000003 111.807 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -90.62 8.09 36.0 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.151 -0.477 . . . . 74.510000000000005 111.447 -179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 51' ' ' GLN . . . -129.23 171.35 20.02 Favored Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 119.791 -1.195 . . . . 43.310000000000002 114.103 -178.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.8 143.65 17.3 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 124.231 1.012 . . . . 73.530000000000001 108.483 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.439 HG21 HD12 ' A' ' 63' ' ' ILE . 57.5 t -114.18 122.9 69.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 109.772 -0.455 . . . . 63.030000000000001 109.772 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 26.6 m-70 -95.46 116.31 28.63 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.938 -1.134 . . . . 74.519999999999996 107.938 177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.453 ' C ' ' HD3' ' A' ' 74' ' ' LYS . . . -148.47 -155.43 6.67 Favored Glycine 0 N--CA 1.415 -2.711 0 C-N-CA 120.242 -0.98 . . . . 63.539999999999999 111.558 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HD3' ' C ' ' A' ' 73' ' ' GLY . 2.7 mppt? -122.56 149.2 44.28 Favored 'General case' 0 C--N 1.287 -2.124 0 N-CA-C 112.916 0.709 . . . . 44.25 112.916 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 42.1 t -110.2 129.21 65.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-N 113.99 -1.459 . . . . 73.040000000000006 111.552 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.429 HD23 HG12 ' A' ' 42' ' ' ILE . 83.0 mt -95.68 108.37 20.66 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 107.127 -1.435 . . . . 62.229999999999997 107.127 175.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.8 ptp -111.49 147.53 35.12 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-O 120.922 0.392 . . . . 73.420000000000002 111.459 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.65 17.12 53.41 Favored Glycine 0 N--CA 1.42 -2.384 0 C-N-CA 119.533 -1.318 . . . . 72.030000000000001 111.311 -176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 18' ' ' HIS . 9.5 p -80.72 132.29 31.99 Favored 'Isoleucine or valine' 0 C--O 1.251 1.17 0 N-CA-C 109.028 -0.73 . . . . 71.140000000000001 109.028 179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.8 m -75.75 159.91 30.57 Favored 'General case' 0 N--CA 1.413 -2.298 0 N-CA-C 108.464 -0.939 . . . . 72.209999999999994 108.464 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 41.4 m -59.32 -26.6 65.16 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 112.547 0.573 . . . . 73.209999999999994 112.547 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -70.87 -47.22 60.44 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.036 0.446 . . . . 64.030000000000001 110.766 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 1.2 mp0 -68.7 -28.79 67.16 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.153 -0.684 . . . . 74.239999999999995 109.153 176.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.515 ' HG ' ' NH2' ' A' ' 97' ' ' ARG . 42.1 tp -62.77 -50.85 69.4 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-O 120.882 0.372 . . . . 71.140000000000001 110.345 176.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.82 -29.8 70.33 Favored 'General case' 0 C--O 1.208 -1.106 0 N-CA-C 109.687 -0.486 . . . . 61.119999999999997 109.687 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 16.9 t-20 -59.16 -47.86 83.76 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 123.627 0.771 . . . . 70.299999999999997 109.964 175.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.544 ' HA ' HG12 ' A' ' 90' ' ' VAL . 97.5 mt -64.65 -37.01 86.11 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.225 -0.898 . . . . 71.310000000000002 111.27 179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.543 ' HB2' ' NH2' ' A' ' 97' ' ' ARG . 19.1 t70 -73.54 -30.7 63.24 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-O 121.211 0.529 . . . . 72.310000000000002 110.096 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.24 -46.56 64.19 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.051 0.453 . . . . 75.129999999999995 110.323 177.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 87' ' ' LEU . 13.6 p -72.35 -50.56 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.531 0 CA-C-N 115.819 -0.628 . . . . 63.329999999999998 112.325 -178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -77.85 -30.29 50.87 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 112.731 0.641 . . . . 71.439999999999998 112.731 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.02 -17.36 22.45 Favored Glycine 0 N--CA 1.475 1.278 0 N-CA-C 114.704 0.641 . . . . 63.130000000000003 114.704 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -60.56 -37.4 81.16 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 122.132 0.173 . . . . 52.229999999999997 110.54 177.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -131.53 -9.57 3.63 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.39 0.515 . . . . 52.130000000000003 112.39 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -126.28 167.38 15.56 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.281 -0.262 . . . . 72.219999999999999 111.076 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 38.4 tt0 -123.7 146.39 48.29 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.444 -0.576 . . . . 43.439999999999998 109.444 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.543 ' NH2' ' HB2' ' A' ' 88' ' ' ASP . 34.4 ttm180 -89.41 128.74 35.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.759 0.314 . . . . 71.430000000000007 110.838 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.2 m -133.08 162.34 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.023 0 CA-C-N 115.894 -0.594 . . . . 70.120000000000005 111.42 173.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.5 t -103.72 124.04 48.15 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 114.972 -1.013 . . . . 71.109999999999999 108.272 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.29 165.21 32.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-N 116.213 -0.449 . . . . 63.329999999999998 111.419 -173.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.35 123.68 7.88 Favored Glycine 0 N--CA 1.431 -1.654 0 N-CA-C 110.982 -0.847 . . . . 61.509999999999998 110.982 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.443 HD13 ' HB1' ' A' ' 45' ' ' ALA . 2.7 pp -117.42 165.1 13.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 110.244 -0.28 . . . . 70.519999999999996 110.244 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 80.6 t -128.25 125.83 64.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 109.554 -0.535 . . . . 54.530000000000001 109.554 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.619 ' HB3' ' OD1' ' A' ' 106' ' ' ASP . 34.4 mtp180 -64.71 128.55 36.26 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 124.369 1.068 . . . . 74.299999999999997 111.845 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -71.36 -18.62 62.36 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.482 0.713 . . . . 60.020000000000003 110.952 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.619 ' OD1' ' HB3' ' A' ' 104' ' ' ARG . 7.8 p-10 -78.51 -41.61 31.89 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.113 -0.494 . . . . 74.209999999999994 112.237 -173.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.79 16.45 1.78 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.188 0.81 . . . . 73.310000000000002 113.188 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.9 m 68.0 14.62 9.39 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 113.99 1.107 . . . . 74.319999999999993 113.99 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -75.59 145.85 40.84 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 122.052 -0.405 . . . . 61.310000000000002 110.905 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -96.51 147.78 23.49 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 116.165 -0.47 . . . . 73.109999999999999 109.895 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.411 ' HE2' HD11 ' A' ' 102' ' ' ILE . 35.4 mtm -145.43 163.15 35.52 Favored 'General case' 0 CA--C 1.473 -1.99 0 CA-C-O 121.306 0.574 . . . . 74.109999999999999 110.347 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.84 123.03 48.41 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 114.31 -1.314 . . . . 75.420000000000002 108.435 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.482 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.7 m -132.96 169.66 21.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-O 121.232 0.539 . . . . 64.239999999999995 111.446 -176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -103.87 134.15 47.65 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.72 -1.215 . . . . 73.030000000000001 107.72 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 15.4 t -135.92 171.11 14.94 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.832 -0.803 . . . . 75.230000000000004 108.832 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.0 m-85 -121.51 125.88 47.87 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.824 -0.806 . . . . 74.540000000000006 108.824 179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.39 157.97 41.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.348 -0.387 . . . . 74.439999999999998 110.121 -176.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.469 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 61.1 t-105 -67.54 130.94 44.62 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.188 0.595 . . . . 74.200000000000003 109.88 -175.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.5 mp -73.57 -44.19 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 112.252 0.464 . . . . 71.519999999999996 112.252 -172.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -67.35 -43.63 81.03 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 109.42 -0.585 . . . . 51.130000000000003 109.42 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? 51.07 17.97 0.51 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.158 1.783 . . . . 71.540000000000006 113.968 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.34 1.73 5.7 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.422 0.527 . . . . 63.210000000000001 112.422 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.22 121.46 56.07 Favored Pre-proline 0 N--CA 1.483 1.217 0 N-CA-C 111.649 0.24 . . . . 64.239999999999995 111.649 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -67.24 -17.79 50.21 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.568 2.179 . . . . 54.439999999999998 111.41 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.599 ' HB3' HD22 ' A' ' 55' ' ' LEU . 2.2 m-20 -55.82 -41.08 73.69 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.137 -0.938 . . . . 71.430000000000007 110.754 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.496 ' HG2' ' SG ' ' A' ' 62' ' ' CYS 0.329 0.0 OUTLIER -96.94 84.83 3.63 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-O 122.809 1.29 . . . . 72.230000000000004 113.106 -178.915 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -135.8 89.16 2.46 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 107.945 -1.132 . . . . 73.549999999999997 107.945 174.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 169.67 131.6 1.34 Allowed Glycine 0 N--CA 1.414 -2.796 0 N-CA-C 107.011 -2.436 . . . . 74.010000000000005 107.011 -176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -95.35 149.64 21.14 Favored 'General case' 0 C--N 1.277 -2.562 0 CA-C-N 117.396 0.598 . . . . 62.43 110.076 -173.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -79.19 157.54 27.84 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 105.833 -1.914 . . . . 73.519999999999996 105.833 175.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -55.04 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 117.409 2.374 . . . . 70.120000000000005 117.409 -172.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -56.65 -30.54 63.46 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.425 0.557 . . . . 72.310000000000002 110.99 175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -51.86 -33.48 36.57 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.188 0.995 . . . . 72.25 112.01 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.542 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 33.9 tt0 -71.41 -45.61 62.32 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 120.784 -0.366 . . . . 74.25 111.007 -178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 38.3 t-105 -73.97 -30.4 62.49 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.028 0.442 . . . . 74.129999999999995 110.219 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.7 tmtm? -57.76 -40.23 79.25 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 108.568 -0.901 . . . . 73.409999999999997 108.568 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 22.2 tpt180 -55.78 -50.92 69.14 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.059 -0.973 . . . . 73.319999999999993 111.056 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.74 -20.29 59.88 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.105 -0.498 . . . . 65.450000000000003 111.684 -179.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -69.6 -33.89 73.33 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.314 -0.625 . . . . 74.129999999999995 109.314 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.606 ' O ' HG12 ' A' ' 144' ' ' ILE . 64.9 tttm -62.74 -35.14 78.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.483 -0.78 . . . . 70.430000000000007 109.775 176.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 29.1 mmmt -54.67 -40.31 68.93 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 114.206 1.187 . . . . 71.099999999999994 114.206 -177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -55.44 -43.48 75.44 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.542 1.163 . . . . 73.219999999999999 109.507 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -73.9 -35.27 64.64 Favored 'General case' 0 N--CA 1.415 -2.219 0 CA-C-N 113.719 -1.582 . . . . 74.230000000000004 109.192 -175.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 140' ' ' LYS . 33.4 mm -72.19 -38.65 63.1 Favored 'Isoleucine or valine' 0 C--O 1.19 -2.054 0 CA-C-N 115.747 -0.661 . . . . 64.549999999999997 110.831 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 17.1 mm-40 -59.69 -32.43 70.49 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.227 0.537 . . . . 73.310000000000002 110.471 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.2 m -70.29 -47.21 62.21 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.021 -0.991 . . . . 74.409999999999997 108.904 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -71.06 -28.62 64.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 114.412 1.264 . . . . 64.150000000000006 114.412 177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -57.75 -38.07 74.73 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 107.751 -1.203 . . . . 61.43 107.751 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -71.46 -28.83 64.22 Favored 'General case' 0 C--O 1.227 -0.09 0 CA-C-N 115.742 -0.663 . . . . 73.010000000000005 110.459 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.426 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 68.3 mt -72.62 -31.31 36.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.664 -0.698 . . . . 74.299999999999997 109.453 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 65.0 mtt -63.36 -41.16 98.81 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.667 -0.864 . . . . 64.140000000000001 108.667 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -61.68 -35.92 79.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.092 -0.958 . . . . 74.540000000000006 110.045 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 84.3 m -67.41 -31.25 71.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.667 -0.697 . . . . 64.340000000000003 111.431 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 74.7 mmtt -71.13 -27.71 63.77 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.362 -0.977 . . . . 64.230000000000004 108.362 177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt 72.89 -70.62 0.16 Allowed 'General case' 0 CA--C 1.51 -0.569 0 C-N-CA 126.05 1.74 . . . . 62.409999999999997 112.981 174.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt 64.93 161.19 0.12 Allowed Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 124.256 1.022 . . . . 33.119999999999997 111.696 -176.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -75.75 94.86 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.691 1.594 . . . . 65.420000000000002 110.006 173.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 . . . . . 0 C--N 1.308 -1.197 0 C-N-CA 123.553 0.741 . . . . 73.120000000000005 109.029 -177.127 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' A' ' 14' ' ' SER . 49.5 t . . . . . 0 N--CA 1.431 -1.422 0 CA-C-O 120.675 0.274 . . . . 72.230000000000004 110.306 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -92.01 -162.71 0.95 Allowed 'General case' 0 C--O 1.249 1.041 0 N-CA-C 107.034 -1.469 . . . . 65.200000000000003 107.034 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.5 p -61.79 -39.66 92.49 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 108.502 -0.925 . . . . 52.109999999999999 108.502 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -82.23 149.18 28.01 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 114.195 -1.366 . . . . 73.120000000000005 108.626 175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.595 ' HA ' ' SG ' ' A' ' 10' ' ' CYS . 15.7 t -97.89 72.49 2.24 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 106.186 -1.783 . . . . 60.229999999999997 106.186 176.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt 58.9 85.15 0.1 Allowed 'General case' 0 N--CA 1.413 -2.29 0 C-N-CA 125.376 1.471 . . . . 72.219999999999999 110.559 -172.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -76.32 153.53 35.79 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.565 -0.743 . . . . 74.450000000000003 111.522 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.87 155.39 25.36 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 108.406 -0.961 . . . . 73.400000000000006 108.406 173.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.514 ' O ' HG12 ' A' ' 79' ' ' VAL . 47.3 m-70 -114.0 159.99 19.34 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 115.785 -0.643 . . . . 73.299999999999997 110.043 -174.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 77' ' ' MET . 17.0 p30 -130.31 128.22 41.07 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 114.905 -1.043 . . . . 73.439999999999998 111.483 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.7 t -127.53 142.79 42.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.771 -1.104 . . . . 44.310000000000002 109.516 -174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -93.81 123.23 37.01 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.582 -1.266 . . . . 74.150000000000006 107.582 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.5 p -96.8 136.98 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 CA-C-O 121.285 0.564 . . . . 75.109999999999999 111.54 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.49 ' HD2' ' O ' ' A' ' 61' ' ' PRO . 24.1 p90 -109.27 -50.2 3.03 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.817 1.043 . . . . 64.219999999999999 113.817 -174.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -151.43 -49.83 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 118.093 -2.003 . . . . 31.210000000000001 115.411 -174.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.8 m -58.88 -37.02 75.62 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 117.583 0.692 . . . . 42.450000000000003 111.559 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.659 ' HB3' HD11 ' A' ' 32' ' ' ILE . 36.6 m-85 -119.76 37.67 4.13 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.898 -0.592 . . . . 74.140000000000001 110.763 -176.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -73.41 23.14 0.07 Allowed 'General case' 0 CA--C 1.576 1.943 0 CA-C-O 121.647 0.737 . . . . 71.040000000000006 110.754 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 26' ' ' PHE . 25.9 t70 -150.15 129.97 6.64 Favored Pre-proline 0 C--N 1.308 -1.229 0 C-N-CA 123.707 0.803 . . . . 72.450000000000003 109.321 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.553 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 63.5 Cg_endo -73.22 -24.48 16.8 Favored 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.233 1.956 . . . . 74.030000000000001 113.177 -178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.85 -38.65 83.41 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.78 0.324 . . . . 73.120000000000005 110.969 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.22 -28.93 40.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.108 0.48 . . . . 74.010000000000005 110.044 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.659 HD11 ' HB3' ' A' ' 26' ' ' PHE . 37.1 mm -58.99 -37.78 69.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 CA-C-N 115.918 -0.583 . . . . 64.310000000000002 110.258 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.83 -44.51 70.32 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.688 0.756 . . . . 64.120000000000005 110.342 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.58 -41.88 17.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 114.701 -1.136 . . . . 73.530000000000001 113.256 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.524 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 7.5 tmm? -65.95 -37.48 86.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 120.871 -0.332 . . . . 74.450000000000003 111.14 -171.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.583 HD21 HG23 ' A' ' 32' ' ' ILE . 0.9 OUTLIER -116.88 -66.74 1.05 Allowed 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.656 -0.818 . . . . 71.450000000000003 111.383 176.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 27.6 t70 167.51 -52.22 0.01 OUTLIER 'General case' 0 CA--C 1.502 -0.883 0 O-C-N 123.785 0.678 . . . . 72.349999999999994 109.47 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -108.52 164.1 12.64 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 115.198 -0.91 . . . . 72.349999999999994 109.619 -174.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.2 m -114.0 106.01 53.77 Favored Pre-proline 0 N--CA 1.427 -1.594 0 N-CA-C 108.514 -0.921 . . . . 64.219999999999999 108.514 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -54.86 151.56 32.47 Favored 'Trans proline' 0 C--O 1.244 0.788 0 C-N-CA 123.397 2.731 . . . . 64.420000000000002 111.952 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -64.62 128.68 36.83 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.306 -0.998 . . . . 64.430000000000007 108.306 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.517 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 38.3 mt -109.28 136.65 44.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 116.02 -0.536 . . . . 72.510000000000005 110.1 -172.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.71 146.13 34.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.059 -0.519 . . . . 65.540000000000006 109.711 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.5 m -76.35 126.18 30.53 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.769 -0.826 . . . . 65.219999999999999 108.769 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.4 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -140.12 156.04 46.73 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.623 0.725 . . . . 63.310000000000002 111.156 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.459 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 57.3 m -113.5 126.71 55.62 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.336 -0.847 . . . . 63.240000000000002 108.972 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.447 ' HG ' ' HB2' ' A' ' 50' ' ' PHE . 45.5 tp -100.21 101.03 13.12 Favored Pre-proline 0 C--N 1.293 -1.862 0 N-CA-C 109.507 -0.553 . . . . 74.519999999999996 109.507 177.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 46' ' ' THR . 77.9 Cg_endo -86.99 144.12 7.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.383 2.056 . . . . 71.030000000000001 111.828 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.14 5.74 62.09 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.234 -0.747 . . . . 65.540000000000006 111.234 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.553 ' HA ' ' H ' ' A' ' 66' ' ' SER . 90.0 m-85 -144.23 152.23 40.55 Favored 'General case' 0 CA--C 1.481 -1.68 0 N-CA-C 107.664 -1.236 . . . . 74.049999999999997 107.664 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -139.65 145.78 38.88 Favored 'General case' 0 C--N 1.279 -2.489 0 N-CA-C 108.653 -0.869 . . . . 61.509999999999998 108.653 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.7 ptt180 -90.69 132.15 35.96 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 115.614 -0.721 . . . . 74.519999999999996 109.552 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.63 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 3.8 m-85 -107.04 133.57 51.47 Favored 'General case' 0 N--CA 1.4 -2.961 0 N-CA-C 107.388 -1.338 . . . . 72.209999999999994 107.388 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.544 ' HD2' ' HB2' ' A' ' 130' ' ' TRP . 22.3 ptt180 -119.1 164.87 14.9 Favored 'General case' 0 C--N 1.273 -2.749 0 CA-C-N 114.237 -1.347 . . . . 73.049999999999997 113.296 -167.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.526 HD13 ' H ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -61.94 128.24 35.22 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 116.388 1.996 . . . . 72.420000000000002 116.388 -172.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -147.73 23.72 1.1 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 104.487 -2.412 . . . . 65.140000000000001 104.487 169.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.14 -140.87 2.98 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 112.882 -1.963 . . . . 61.039999999999999 109.029 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.69 16.88 24.4 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 113.817 1.043 . . . . 63.530000000000001 113.817 -178.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.484 ' O ' ' HB3' ' A' ' 55' ' ' LEU . 52.1 tp -111.26 160.51 16.92 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 119.539 -0.864 . . . . 62.420000000000002 109.726 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -96.03 168.23 11.07 Favored Pre-proline 0 C--N 1.301 -1.535 0 C-N-CA 123.268 0.627 . . . . 75.340000000000003 109.721 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 35.7 Cg_exo -61.73 103.98 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.129 1.886 . . . . 62.310000000000002 110.799 175.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 118' ' ' TRP . 12.9 p -111.21 151.65 28.0 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 115.357 -0.838 . . . . 72.400000000000006 110.515 -176.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.1 mm -93.98 139.25 18.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 N-CA-C 109.405 -0.591 . . . . 54.350000000000001 109.405 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -142.48 151.46 57.74 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 107.948 -1.13 . . . . 72.329999999999998 107.948 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.532 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 34.3 Cg_endo -66.8 104.81 0.85 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.554 2.169 . . . . 63.409999999999997 112.613 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.553 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 33.4 t -125.09 102.17 7.37 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.172 -1.788 . . . . 75.310000000000002 106.172 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -55.1 -33.21 62.62 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.767 0.655 . . . . 64.200000000000003 112.767 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -88.98 5.42 44.3 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.799 -0.637 . . . . 73.140000000000001 111.732 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.84 171.83 14.13 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.257 -0.973 . . . . 71.219999999999999 113.395 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.67 149.1 24.88 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.791 1.236 . . . . 72.120000000000005 107.97 178.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.05 124.77 70.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 N-CA-C 109.965 -0.383 . . . . 60.219999999999999 109.965 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -93.17 114.71 27.28 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.598 -1.26 . . . . 65.140000000000001 107.598 173.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.499 ' C ' ' HD2' ' A' ' 74' ' ' LYS . . . -146.96 -155.56 6.59 Favored Glycine 0 N--CA 1.415 -2.724 0 N-CA-C 109.808 -1.317 . . . . 64.549999999999997 109.808 -177.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.499 ' HD2' ' C ' ' A' ' 73' ' ' GLY . 14.0 mptt -127.22 152.21 47.68 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-O 121.815 0.817 . . . . 45.420000000000002 112.494 -178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 46.9 t -110.27 128.7 66.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 CA-C-N 113.83 -1.532 . . . . 51.310000000000002 111.155 177.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 72.1 mt -96.59 109.99 22.49 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 107.719 -1.215 . . . . 63.030000000000001 107.719 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.51 ' HB3' ' HB3' ' A' ' 19' ' ' ASN . 17.0 ptp -121.67 151.25 40.66 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.571 0.224 . . . . 61.039999999999999 110.995 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.98 13.27 37.39 Favored Glycine 0 N--CA 1.429 -1.821 0 C-N-CA 119.669 -1.253 . . . . 73.439999999999998 111.525 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.3 p -85.37 136.32 23.05 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 108.946 -0.761 . . . . 64.439999999999998 108.946 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 m -74.05 159.44 32.66 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.265 -0.642 . . . . 71.549999999999997 109.265 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -59.06 -38.37 79.25 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 112.575 0.584 . . . . 75.430000000000007 112.575 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.17 -48.72 80.54 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.547 0.689 . . . . 71.319999999999993 110.23 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.494 ' HA ' ' HB3' ' A' ' 86' ' ' ASN . 38.8 mt-10 -69.21 -31.58 70.25 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 114.947 -1.024 . . . . 62.119999999999997 109.259 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.415 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.0 tm? -62.67 -40.16 96.19 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.449 -0.575 . . . . 64.540000000000006 109.449 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.58 -29.5 63.58 Favored 'General case' 0 C--O 1.209 -1.045 0 CA-C-N 116.143 -0.481 . . . . 63.109999999999999 109.954 176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 0.1 OUTLIER -67.59 -42.07 83.08 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.765 -0.652 . . . . 73.439999999999998 111.009 176.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.466 HD23 ' HE1' ' A' ' 35' ' ' MET . 97.2 mt -61.42 -43.6 98.59 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.962 -0.755 . . . . 72.109999999999999 108.962 174.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 28.3 t70 -64.94 -34.09 77.58 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.013 -0.994 . . . . 55.420000000000002 110.521 178.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.5 -44.01 68.49 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 116.025 -0.534 . . . . 64.239999999999995 111.024 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.4 t -72.71 -57.36 7.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 N-CA-C 112.911 0.708 . . . . 73.430000000000007 112.911 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -77.45 -22.77 50.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.338 0.59 . . . . 51.039999999999999 111.397 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -63.07 -15.95 56.96 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.2 -0.909 . . . . 70.340000000000003 114.979 -177.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -68.01 -45.75 73.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.629 0.715 . . . . 63.310000000000002 112.237 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -114.27 -10.4 12.72 Favored 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.395 -0.522 . . . . 63.100000000000001 111.8 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -125.6 167.1 15.54 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.61 -0.885 . . . . 71.140000000000001 108.61 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 35.0 tt0 -123.19 145.92 48.23 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.175 -0.676 . . . . 74.310000000000002 109.175 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -87.08 114.5 23.74 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 108.87 -0.789 . . . . 73.340000000000003 108.87 -178.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 24.5 m -120.99 160.42 21.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 CA-C-N 116.117 -0.492 . . . . 51.200000000000003 110.052 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.1 t -99.81 127.28 45.98 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.484 -0.932 . . . . 72.219999999999999 108.484 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.89 172.06 16.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 116.192 -0.458 . . . . 71.329999999999998 111.489 -173.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.444 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -115.32 128.64 8.17 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 111.499 -0.64 . . . . 62.43 111.499 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -118.12 161.95 16.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 123.132 0.573 . . . . 72.439999999999998 110.144 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 51.1 t -121.63 123.84 70.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 N-CA-C 106.73 -1.581 . . . . 72.209999999999994 106.73 177.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.674 ' HD3' ' SD ' ' A' ' 111' ' ' MET . 12.4 mtm180 -79.15 135.62 36.87 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 119.054 -1.059 . . . . 75.0 110.327 -175.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -83.61 12.44 5.77 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 122.919 1.342 . . . . 70.010000000000005 108.131 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.455 ' H ' ' C ' ' A' ' 104' ' ' ARG . 10.1 t70 -89.32 -53.07 4.72 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 126.564 1.946 . . . . 72.299999999999997 111.201 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -138.43 7.23 2.58 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.21 -0.45 . . . . 64.510000000000005 112.018 -174.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.3 t 71.57 8.68 6.26 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.211 1.004 . . . . 72.519999999999996 112.541 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -85.51 148.4 25.98 Favored 'General case' 0 CA--C 1.492 -1.264 0 C-N-CA 120.73 -0.388 . . . . 71.030000000000001 110.228 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 64.0 pttt -98.93 140.99 32.26 Favored 'General case' 0 N--CA 1.41 -2.46 0 CA-C-N 115.753 -0.658 . . . . 71.019999999999996 109.762 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.674 ' SD ' ' HD3' ' A' ' 104' ' ' ARG . 87.9 mtp -134.81 161.16 35.97 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.171 -0.922 . . . . 72.310000000000002 111.269 -175.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -103.11 130.05 50.15 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.632 -1.167 . . . . 64.099999999999994 109.092 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.0 m -141.5 174.03 7.55 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 N-CA-C 108.43 -0.952 . . . . 75.219999999999999 108.43 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -107.15 150.56 26.45 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.206 -0.664 . . . . 71.040000000000006 109.206 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.9 t -144.32 170.98 14.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.166 -1.05 . . . . 71.439999999999998 108.166 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.522 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 70.8 m-85 -117.54 121.52 41.19 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.536 -0.913 . . . . 71.439999999999998 108.536 178.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.532 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 25.7 ptt? -115.96 155.13 28.58 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.26 -0.427 . . . . 63.329999999999998 110.57 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 62' ' ' CYS . 60.1 t-105 -73.27 124.92 26.63 Favored 'General case' 0 C--N 1.308 -1.22 0 O-C-N 124.105 0.878 . . . . 72.019999999999996 108.688 -178.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.442 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.8 mp -73.49 -41.78 56.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 112.572 0.582 . . . . 71.200000000000003 112.572 -172.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -69.8 -40.52 75.93 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 121.002 -0.279 . . . . 72.25 111.718 -175.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 68.99 -4.36 1.26 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.155 1.169 . . . . 72.120000000000005 114.155 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -128.87 12.84 6.28 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.094 1.516 . . . . 73.150000000000006 115.094 -171.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -67.47 130.7 93.26 Favored Pre-proline 0 N--CA 1.483 1.213 0 O-C-N 122.274 -0.266 . . . . 71.209999999999994 111.347 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.33 14.02 0.81 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.477 2.785 . . . . 73.239999999999995 113.888 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -89.96 -11.38 41.86 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.353 0.597 . . . . 72.200000000000003 110.496 175.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.55 143.23 37.27 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 115.154 -0.93 . . . . 64.340000000000003 109.218 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -136.61 -4.68 2.02 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.076 0.465 . . . . 71.099999999999994 110.367 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 95.46 12.25 54.31 Favored Glycine 0 C--N 1.306 -1.102 0 N-CA-C 109.432 -1.467 . . . . 32.149999999999999 109.432 -173.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 54' ' ' ARG . 52.3 mt-10 -115.81 144.21 44.32 Favored 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 107.274 -1.38 . . . . 71.109999999999999 107.274 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.544 ' HB2' ' HD2' ' A' ' 54' ' ' ARG . 6.0 t90 -99.76 143.64 29.76 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 106.511 -1.663 . . . . 75.120000000000005 106.511 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -79.76 73.91 6.48 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.419 1.104 . . . . 73.420000000000002 109.655 178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -59.5 -43.3 93.4 Favored 'General case' 0 N--CA 1.411 -2.395 0 C-N-CA 126.075 1.75 . . . . 71.140000000000001 111.909 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.55 -37.91 76.7 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.882 0.697 . . . . 74.430000000000007 112.882 -175.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.575 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 7.8 tp10 -66.1 -47.52 73.93 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.662 -0.495 . . . . 75.519999999999996 109.662 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 66.4 t-105 -68.56 -39.33 81.08 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.66 -0.416 . . . . 74.510000000000005 111.078 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -58.99 -33.82 71.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.36 -0.607 . . . . 74.430000000000007 109.36 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.575 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 63.8 ttt180 -62.59 -50.0 73.02 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.052 -0.976 . . . . 74.230000000000004 111.316 175.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.24 -30.22 69.21 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.216 0.532 . . . . 74.450000000000003 110.647 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -68.79 -39.26 80.25 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.2 -0.909 . . . . 73.310000000000002 108.672 177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.612 ' O ' HG12 ' A' ' 144' ' ' ILE . 86.3 tttt -67.25 -45.47 76.59 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.149 -0.932 . . . . 70.25 109.358 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -48.44 -39.69 23.66 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.806 1.642 . . . . 71.040000000000006 111.627 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -64.29 -40.03 95.12 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.843 -0.617 . . . . 54.109999999999999 111.109 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -76.19 -32.25 58.9 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.489 -0.56 . . . . 75.140000000000001 109.489 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 140' ' ' LYS . 50.7 mm -56.58 -33.42 39.56 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.757 0 CA-C-N 115.371 -0.831 . . . . 63.32 111.803 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -57.4 -31.25 65.64 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 118.229 0.468 . . . . 73.209999999999994 111.931 175.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.9 m -80.67 -41.94 22.9 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 108.941 -0.763 . . . . 73.329999999999998 108.941 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -70.88 -30.05 66.32 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 115.357 1.614 . . . . 61.439999999999998 115.357 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 144' ' ' ILE . 60.1 mtpt -55.52 -38.69 69.56 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 117.926 0.33 . . . . 70.099999999999994 110.712 176.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -67.3 -38.79 85.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.733 0.777 . . . . 74.200000000000003 109.363 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 67.5 mt -69.94 -41.41 79.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.83 -1.077 . . . . 62.439999999999998 109.665 179.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 67.1 mtt -67.92 -48.53 65.72 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.898 -0.592 . . . . 71.010000000000005 110.978 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 37.3 mt-10 -62.12 -30.55 71.11 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 111.89 0.33 . . . . 75.120000000000005 111.89 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 42.7 t -61.46 -42.46 98.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 116.414 -0.357 . . . . 75.239999999999995 110.396 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -82.8 -44.98 14.89 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 121.004 -0.279 . . . . 63.140000000000001 110.872 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt 179.11 110.34 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 123.99 0.916 . . . . 74.109999999999999 108.59 -178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 156' ' ' LYS . 0.0 OUTLIER -72.76 152.01 91.21 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 111.867 0.321 . . . . 73.019999999999996 111.867 -177.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.09 155.51 64.34 Favored 'Trans proline' 0 C--O 1.253 1.262 0 C-N-CA 121.897 1.731 . . . . 64.349999999999994 108.898 169.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.817 0 C-N-CA 120.58 -0.448 . . . . 65.510000000000005 111.353 -178.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.428 -1.529 0 N-CA-C 110.046 -0.353 . . . . 73.329999999999998 110.046 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.4 p -86.04 -179.84 6.84 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 108.53 -0.915 . . . . 73.299999999999997 108.53 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 37.5 t -77.69 -56.79 4.22 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 108.68 -0.859 . . . . 70.329999999999998 108.68 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.9 t70 59.4 126.25 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.42 1.088 . . . . 74.450000000000003 113.935 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.5 p -87.85 120.7 29.44 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.544 -0.753 . . . . 64.019999999999996 110.342 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.03 -26.56 43.18 Favored 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.467 0.651 . . . . 70.450000000000003 110.582 178.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.505 ' OE1' ' HA ' ' A' ' 16' ' ' GLN . 16.1 mm-40 -81.46 98.81 8.42 Favored 'General case' 0 CA--C 1.478 -1.824 0 CA-C-O 122.692 1.234 . . . . 74.340000000000003 111.94 177.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD13 ' HA2' ' A' ' 78' ' ' GLY . 87.3 mt -84.8 153.64 22.85 Favored 'General case' 0 C--N 1.277 -2.55 0 CA-C-N 112.93 -1.941 . . . . 74.239999999999995 110.27 -177.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -124.73 161.25 26.78 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 108.597 -0.89 . . . . 62.229999999999997 108.597 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 14.7 p30 -128.66 134.43 48.52 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.443 0.64 . . . . 74.209999999999994 111.81 172.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.6 142.95 41.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.419 -0.81 . . . . 74.030000000000001 110.078 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.529 ' HB2' HG21 ' A' ' 113' ' ' VAL . 76.1 t80 -94.74 122.61 37.53 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 107.707 -1.22 . . . . 75.019999999999996 107.707 176.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 m -93.16 120.03 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 CA-C-O 121.857 0.837 . . . . 71.0 110.01 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.415 ' O ' ' HB3' ' A' ' 27' ' ' GLN . 8.2 p90 -88.48 -79.05 0.32 Allowed 'General case' 0 N--CA 1.415 -2.186 0 N-CA-C 114.629 1.344 . . . . 71.549999999999997 114.629 -172.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -126.93 -44.25 0.24 Allowed Glycine 0 CA--C 1.492 -1.392 0 C-N-CA 119.624 -1.275 . . . . 52.409999999999997 112.044 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.1 p -62.39 -36.48 82.45 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 112.358 0.503 . . . . 72.200000000000003 112.358 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HA ' ' CG1' ' A' ' 31' ' ' VAL . 59.5 m-85 -124.67 26.66 7.11 Favored 'General case' 0 C--O 1.213 -0.826 0 N-CA-C 112.564 0.579 . . . . 65.140000000000001 112.564 -177.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 23' ' ' TYR . 28.5 pt20 -68.07 -1.05 5.17 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 113.208 0.818 . . . . 75.209999999999994 113.208 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.464 ' O ' HG12 ' A' ' 31' ' ' VAL . 20.1 t70 -129.56 138.81 33.96 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 108.755 -0.832 . . . . 74.209999999999994 108.755 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 18.9 Cg_endo -60.4 -32.9 94.48 Favored 'Trans proline' 0 C--O 1.218 -0.512 0 C-N-CA 122.296 1.998 . . . . 73.209999999999994 114.017 -177.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -66.78 -35.94 81.26 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 120.999 -0.281 . . . . 64.530000000000001 111.641 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 28' ' ' ASP . 11.6 p -70.64 -29.83 39.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 C-N-CA 119.779 -0.768 . . . . 71.409999999999997 110.153 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 9.2 mm -70.85 -43.52 76.9 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 CA-C-O 122.073 0.94 . . . . 64.430000000000007 108.938 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 7.4 t-20 -54.19 -51.68 63.6 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 112.997 -1.91 . . . . 71.510000000000005 110.607 -177.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.8 p -78.09 -35.29 20.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-N 115.56 -0.746 . . . . 73.219999999999999 112.042 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 11.5 tmm? -67.62 -37.08 81.97 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 121.247 -0.181 . . . . 60.439999999999998 111.213 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.531 HD12 ' H ' ' A' ' 37' ' ' ASP 0.402 3.0 pp -115.0 -56.48 2.37 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 115.448 1.647 . . . . 73.430000000000007 115.448 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.531 ' H ' HD12 ' A' ' 36' ' ' LEU . 27.1 t70 162.78 -52.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 124.133 0.973 . . . . 71.230000000000004 109.665 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.5 mtp-105 -106.64 -168.0 1.36 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.512 -1.222 . . . . 65.329999999999998 109.815 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.9 m -149.69 108.28 3.3 Favored Pre-proline 0 N--CA 1.436 -1.161 0 N-CA-C 108.823 -0.806 . . . . 74.510000000000005 108.823 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.414 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 46.6 Cg_exo -59.29 150.73 72.64 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.941 2.427 . . . . 73.150000000000006 111.705 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.12 123.26 16.6 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 123.082 0.553 . . . . 75.310000000000002 110.449 -178.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.582 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 51.3 mt -97.84 143.53 12.62 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.812 -0.631 . . . . 74.099999999999994 111.117 -173.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.509 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 14.6 p -128.94 146.75 33.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.566 -0.901 . . . . 74.040000000000006 108.566 175.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.446 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 19.0 m -77.03 123.92 27.04 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.36 -0.607 . . . . 55.32 109.36 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -140.0 157.58 45.43 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.784 0.802 . . . . 51.520000000000003 112.351 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 m -119.7 126.55 51.37 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.864 -1.062 . . . . 75.510000000000005 108.96 178.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.7 tp -98.75 104.91 27.5 Favored Pre-proline 0 C--N 1.298 -1.665 0 N-CA-C 109.747 -0.464 . . . . 70.420000000000002 109.747 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 74.7 Cg_endo -84.03 137.68 7.53 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 122.471 2.114 . . . . 41.25 112.658 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.6 11.75 56.59 Favored Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 115.814 -0.63 . . . . 62.520000000000003 112.748 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -140.6 161.66 37.23 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.995 -0.743 . . . . 74.409999999999997 108.995 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -139.83 146.06 38.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.802 -0.444 . . . . 73.219999999999999 109.802 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.537 ' HE ' HG13 ' A' ' 71' ' ' VAL . 13.9 ptp180 -102.69 142.12 34.37 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.248 -1.019 . . . . 74.340000000000003 108.248 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 126' ' ' MET . 28.1 m-85 -113.45 135.16 54.18 Favored 'General case' 0 C--N 1.265 -3.092 0 N-CA-C 107.95 -1.13 . . . . 71.450000000000003 107.95 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.521 ' O ' ' HA3' ' A' ' 128' ' ' GLY . 39.0 ptt180 -94.32 126.38 39.55 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.557 -0.857 . . . . 63.43 110.494 -177.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -162.71 131.46 4.07 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.732 -1.581 . . . . 75.040000000000006 106.732 -179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.66 144.63 37.72 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 109.932 -0.396 . . . . 63.240000000000002 109.932 176.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 138.12 -82.78 0.26 Allowed Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.789 -1.324 . . . . 72.319999999999993 109.789 -177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.27 -38.31 8.13 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 109.649 -0.5 . . . . 73.450000000000003 109.649 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.8 tp -113.13 164.26 13.72 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.031 -0.729 . . . . 75.150000000000006 109.031 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -107.41 160.68 25.7 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.037 -0.727 . . . . 73.099999999999994 109.037 -173.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 18.5 Cg_endo -67.38 96.8 0.42 Allowed 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 121.697 1.598 . . . . 74.109999999999999 109.927 173.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.0 p -100.05 166.79 10.86 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 113.299 0.851 . . . . 72.129999999999995 113.299 -173.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.419 HD12 HG21 ' A' ' 71' ' ' VAL . 45.1 mm -109.52 143.13 20.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 CA-C-N 115.052 -0.977 . . . . 62.409999999999997 109.28 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.9 m -143.93 151.45 52.76 Favored Pre-proline 0 C--N 1.3 -1.546 0 N-CA-C 107.815 -1.18 . . . . 71.140000000000001 107.815 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.529 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 18.5 Cg_endo -60.57 133.48 48.89 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.224 1.95 . . . . 71.5 111.187 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.6 t -124.8 144.08 50.46 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 116.215 -0.448 . . . . 55.439999999999998 109.884 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -73.11 -34.43 66.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.004 0.431 . . . . 74.049999999999997 110.363 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.9 81.07 1.88 Allowed 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 109.254 -0.647 . . . . 72.349999999999994 109.254 174.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.26 153.17 24.08 Favored Glycine 0 N--CA 1.427 -1.937 0 C-N-CA 119.735 -1.222 . . . . 21.219999999999999 112.431 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.31 139.92 24.8 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.871 -0.789 . . . . 75.450000000000003 108.871 175.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.537 HG13 ' HE ' ' A' ' 52' ' ' ARG . 51.7 t -113.77 119.95 62.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-O 120.831 0.348 . . . . 73.219999999999999 110.78 -175.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -89.33 116.4 27.51 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 107.689 -1.226 . . . . 73.099999999999994 107.689 174.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.08 -151.21 5.48 Favored Glycine 0 N--CA 1.421 -2.342 0 N-CA-C 110.939 -0.864 . . . . 55.020000000000003 110.939 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.582 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.5 mmtm -132.26 146.59 52.1 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 110.099 -0.334 . . . . 72.409999999999997 110.099 -176.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.509 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 42.3 t -111.33 138.53 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 122.35 0.26 . . . . 73.400000000000006 111.199 175.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.453 HD23 HG12 ' A' ' 42' ' ' ILE . 82.9 mt -94.97 112.02 23.77 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 108.43 -0.952 . . . . 71.230000000000004 108.43 176.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 84.2 mmm -93.91 154.93 17.44 Favored 'General case' 0 N--CA 1.423 -1.792 0 C-N-CA 123.537 0.735 . . . . 71.040000000000006 111.097 178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.401 ' HA2' HD13 ' A' ' 17' ' ' LEU . . . 62.32 36.08 92.56 Favored Glycine 0 N--CA 1.441 -1.029 0 CA-C-N 114.778 -1.101 . . . . 62.109999999999999 113.436 177.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.02 127.39 37.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 108.816 -0.809 . . . . 53.509999999999998 108.816 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 76.8 p -77.65 169.93 17.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.183 -0.673 . . . . 72.200000000000003 109.183 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.498 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 34.2 t -55.25 -48.15 74.39 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 116.673 -0.24 . . . . 21.030000000000001 110.548 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.47 -37.47 75.56 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.911 0.884 . . . . 64.409999999999997 112.76 -174.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.542 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 39.5 mt-10 -76.51 -46.27 27.35 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 116.046 -0.525 . . . . 75.340000000000003 110.198 -176.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.419 ' C ' HD23 ' A' ' 84' ' ' LEU . 7.0 tt -68.92 -41.25 78.41 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 120.447 -0.501 . . . . 75.340000000000003 112.053 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 81' ' ' SER . 12.3 pt-20 -62.78 -29.8 70.98 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.414 0.626 . . . . 74.109999999999999 109.869 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -74.96 -42.61 57.3 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 114.993 -1.003 . . . . 74.409999999999997 109.553 177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.8 mt -60.41 -42.47 96.03 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.387 0.613 . . . . 62.340000000000003 109.66 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -62.01 -36.33 81.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.807 -1.088 . . . . 41.200000000000003 110.04 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.36 -48.71 21.76 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.379 -0.828 . . . . 62.310000000000002 112.021 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 87' ' ' LEU . 14.4 p -63.97 -47.94 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.277 0 C-N-CA 122.36 0.264 . . . . 64.409999999999997 111.643 -175.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -78.33 -19.84 52.63 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.817 0.818 . . . . 71.010000000000005 110.654 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -55.86 -16.34 12.12 Favored Glycine 0 N--CA 1.466 0.656 0 N-CA-C 116.997 1.559 . . . . 53.049999999999997 116.997 -173.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -58.64 -44.56 90.12 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 118.088 0.944 . . . . 52.5 112.428 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -132.07 -1.73 3.65 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.002 1.112 . . . . 63.299999999999997 114.002 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -113.13 157.12 22.04 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.569 -0.53 . . . . 72.530000000000001 109.569 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.513 ' HB3' HD11 ' A' ' 119' ' ' ILE . 39.2 tt0 -123.94 155.11 38.75 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.29 -1.374 . . . . 65.010000000000005 107.29 176.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -86.96 114.57 23.7 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.11 -1.07 . . . . 75.530000000000001 108.11 -176.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.3 m -117.32 153.76 19.12 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 120.883 -0.327 . . . . 65.239999999999995 110.162 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.1 t -95.63 132.83 40.37 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.218 -0.66 . . . . 55.409999999999997 109.218 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.75 162.76 31.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 120.964 0.411 . . . . 71.120000000000005 111.052 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.422 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -103.75 119.79 6.47 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.464 -1.055 . . . . 54.240000000000002 110.464 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 110' ' ' LYS . 2.7 pp -111.69 158.22 12.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 110.017 -0.364 . . . . 62.329999999999998 110.017 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 99.6 t -121.23 120.58 62.48 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.472 -0.566 . . . . 75.349999999999994 109.472 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.3 mtp180 -62.24 137.32 58.24 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.145 -0.48 . . . . 74.319999999999993 111.244 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 43.4 mt-10 -83.38 -3.89 57.95 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.556 0.693 . . . . 74.430000000000007 110.044 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.11 -68.07 0.36 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.776 -1.102 . . . . 74.420000000000002 110.399 176.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -129.08 0.63 5.24 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.484 -1.234 . . . . 73.340000000000003 111.328 -173.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 49.6 m 64.34 80.46 0.23 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.048 0.928 . . . . 64.129999999999995 112.694 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 10.1 pt-20 -137.4 152.45 49.65 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.627 -1.249 . . . . 71.239999999999995 107.627 175.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 21.2 pttp -91.45 147.22 23.18 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.358 -0.608 . . . . 54.450000000000003 109.358 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 51.4 ttp -143.98 158.66 43.56 Favored 'General case' 0 N--CA 1.415 -2.225 0 N-CA-C 107.642 -1.244 . . . . 71.010000000000005 107.642 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.63 118.0 35.64 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.879 -0.328 . . . . 61.119999999999997 110.521 -175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.529 HG21 ' HB2' ' A' ' 21' ' ' PHE . 33.1 m -129.01 173.42 13.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-O 120.996 0.426 . . . . 70.230000000000004 110.287 -177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -101.74 143.41 31.71 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.63 -0.878 . . . . 73.319999999999993 108.63 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.8 t -143.51 171.5 14.07 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.069 -1.086 . . . . 75.239999999999995 108.069 175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.407 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 62.9 m-85 -121.24 117.77 27.9 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.274 -1.01 . . . . 73.439999999999998 108.274 -178.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.529 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 23.5 ptt? -118.04 156.4 28.67 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.796 -0.638 . . . . 74.109999999999999 110.798 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 56.5 t-105 -68.78 118.96 12.41 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.239 -0.891 . . . . 70.519999999999996 108.599 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 96' ' ' GLU . 45.2 mm -72.74 -42.42 61.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 N-CA-C 113.08 0.77 . . . . 64.340000000000003 113.08 -170.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -68.07 -28.61 67.52 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 120.197 -0.601 . . . . 65.519999999999996 110.378 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.288 9.6 ptpp? 56.38 -18.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.683 2.475 . . . . 74.209999999999994 117.683 173.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -116.66 84.21 2.1 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.459 0.647 . . . . 55.109999999999999 110.036 177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.467 ' O ' ' HG2' ' A' ' 126' ' ' MET . 10.3 m-20 -139.77 116.8 8.33 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 115.135 -0.939 . . . . 72.450000000000003 109.765 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -65.99 -13.6 40.6 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 122.54 2.16 . . . . 70.540000000000006 111.149 176.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -60.72 -34.68 74.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.118 0.967 . . . . 63.43 111.878 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.578 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 26.1 ptt? -93.76 8.58 40.5 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 116.46 -0.336 . . . . 72.140000000000001 111.421 -177.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -66.35 106.25 1.66 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.637 -0.825 . . . . 62.0 112.25 -174.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 54' ' ' ARG . . . -147.68 127.6 2.67 Favored Glycine 0 N--CA 1.415 -2.743 0 N-CA-C 108.904 -1.679 . . . . 51.329999999999998 108.904 176.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.64 126.17 40.73 Favored 'General case' 0 C--O 1.193 -1.875 0 CA-C-O 120.878 0.37 . . . . 74.25 110.572 -176.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.464 ' CD2' ' HD2' ' A' ' 52' ' ' ARG . 74.1 t90 -127.66 140.03 52.35 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 111.967 0.358 . . . . 74.219999999999999 111.967 -169.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 66.38 -54.93 0.4 Allowed 'General case' 0 N--CA 1.505 2.295 0 C-N-CA 125.554 1.542 . . . . 72.400000000000006 112.984 176.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.414 ' HD1' ' O ' ' A' ' 130' ' ' TRP . 59.9 m-85 -52.43 -29.87 26.59 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 125.54 1.536 . . . . 55.009999999999998 113.445 -178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -56.13 -32.16 63.98 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.134 0.492 . . . . 72.219999999999999 110.764 176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 36.1 tt0 -63.46 -48.59 77.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.061 0.945 . . . . 54.009999999999998 110.007 -178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -64.12 -37.66 88.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 120.419 -0.512 . . . . 74.239999999999995 110.574 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -59.03 -31.74 69.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.554 -0.294 . . . . 64.129999999999995 111.0 178.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 41.7 ttp180 -68.67 -51.94 36.45 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 116.257 -0.429 . . . . 75.209999999999994 111.528 175.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -68.97 -24.58 64.26 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.996 0.427 . . . . 62.130000000000003 111.827 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.08 -38.67 56.76 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.559 -0.904 . . . . 72.109999999999999 108.559 177.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.574 ' O ' HG12 ' A' ' 144' ' ' ILE . 38.7 ttpt -65.34 -34.19 77.73 Favored 'General case' 0 C--O 1.211 -0.926 0 CA-C-N 115.698 -0.683 . . . . 61.130000000000003 110.287 177.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.556 ' HE2' ' HA ' ' A' ' 141' ' ' LYS . 0.6 OUTLIER -52.1 -31.66 31.63 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 123.831 0.852 . . . . 75.099999999999994 111.44 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -67.46 -44.13 79.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.029 0.918 . . . . 62.200000000000003 109.367 176.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.483 ' O ' HG22 ' A' ' 146' ' ' THR . 40.4 t80 -71.68 -36.44 70.62 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.817 -1.538 . . . . 63.520000000000003 110.151 -174.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 140' ' ' LYS . 48.2 mm -55.07 -32.7 27.89 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.378 0 CA-C-N 115.252 -0.885 . . . . 65.109999999999999 111.496 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -56.01 -38.48 70.55 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 113.197 0.814 . . . . 74.030000000000001 113.197 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 143' ' ' PHE . 7.6 t -77.97 -32.84 51.58 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.63 -0.878 . . . . 71.310000000000002 108.63 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -77.57 -33.56 53.92 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 115.267 -0.879 . . . . 71.340000000000003 111.094 -173.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.42 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 47.3 tttm -56.54 -42.19 78.07 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.343 -0.844 . . . . 64.340000000000003 110.187 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -66.89 -31.01 71.32 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.869 0.843 . . . . 65.120000000000005 110.34 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 73.6 mt -73.29 -47.32 46.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.185 -0.916 . . . . 73.530000000000001 109.345 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.9 ttt -64.18 -40.52 96.28 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.368 -0.833 . . . . 71.209999999999994 110.733 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 45.0 mt-10 -64.06 -29.83 70.95 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 116.451 -0.34 . . . . 75.030000000000001 111.914 177.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -70.83 -31.78 68.61 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.193 0.52 . . . . 74.319999999999993 109.974 177.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -82.77 -45.83 13.87 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 112.61 0.596 . . . . 73.420000000000002 112.61 -178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -94.38 -27.87 15.83 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.955 -0.566 . . . . 74.219999999999999 112.296 -173.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . 0.279 0.0 OUTLIER 48.01 96.4 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.025 0 C-N-CA 125.525 1.53 . . . . 55.329999999999998 114.779 -177.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -65.95 170.28 11.88 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.95 2.433 . . . . 43.549999999999997 111.544 176.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 17.6 tm0? . . . . . 0 C--N 1.32 -0.714 0 C-N-CA 122.771 0.428 . . . . 74.120000000000005 110.597 -178.757 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.429 -1.478 0 CA-C-O 121.683 0.754 . . . . 72.420000000000002 110.324 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.4 p -158.34 151.08 22.33 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 115.237 -0.892 . . . . 72.099999999999994 110.098 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.9 m -76.0 -18.35 59.32 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.02 -1.104 . . . . 74.450000000000003 108.02 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.0 t70 74.59 -63.07 0.44 Allowed 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 125.759 1.624 . . . . 74.310000000000002 113.948 172.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -109.39 93.05 4.3 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 112.704 0.631 . . . . 71.209999999999994 112.704 -175.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.91 109.01 20.59 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 106.502 -1.666 . . . . 74.230000000000004 106.502 172.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -132.59 157.06 45.71 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 116.046 -0.525 . . . . 72.430000000000007 109.79 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.4 mt -88.29 149.43 23.8 Favored 'General case' 0 N--CA 1.411 -2.422 0 N-CA-C 106.102 -1.814 . . . . 70.019999999999996 106.102 169.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.458 ' HB2' ' HB ' ' A' ' 79' ' ' VAL . 27.0 m-70 -116.73 160.59 20.54 Favored 'General case' 0 C--N 1.266 -3.062 0 N-CA-C 109.244 -0.65 . . . . 74.209999999999994 109.244 -172.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.546 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 22.1 p-10 -130.74 129.39 42.44 Favored 'General case' 0 C--N 1.259 -3.335 0 CA-C-N 115.493 -0.776 . . . . 74.200000000000003 109.657 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.1 t -119.77 139.59 46.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.146 -0.934 . . . . 74.150000000000006 110.31 -173.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.437 ' HB2' HG21 ' A' ' 113' ' ' VAL . 88.7 t80 -93.89 122.34 36.27 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.303 -1.369 . . . . 54.409999999999997 107.303 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 m -104.19 129.97 55.63 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-O 121.551 0.691 . . . . 62.119999999999997 111.712 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -75.74 -22.01 56.93 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.956 -1.02 . . . . 54.219999999999999 113.238 -176.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.04 -34.23 0.39 Allowed Glycine 0 CA--C 1.504 -0.615 0 C-N-CA 119.36 -1.4 . . . . 74.239999999999995 112.749 -179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.3 p -58.43 -36.6 73.89 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.213 0.605 . . . . 71.239999999999995 112.329 -177.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -127.91 32.82 4.88 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.74 -0.664 . . . . 74.140000000000001 110.315 179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -84.24 20.09 1.7 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.259 1.028 . . . . 54.030000000000001 109.647 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' O ' HG22 ' A' ' 31' ' ' VAL . 12.6 t70 -134.8 128.78 18.98 Favored Pre-proline 0 C--N 1.302 -1.497 0 N-CA-C 107.551 -1.277 . . . . 54.420000000000002 107.551 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.401 ' CB ' HG21 ' A' ' 39' ' ' THR . 34.9 Cg_endo -66.47 -32.65 39.54 Favored 'Trans proline' 0 C--O 1.219 -0.474 0 C-N-CA 121.873 1.715 . . . . 73.340000000000003 113.16 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.06 -34.7 66.42 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.555 -0.293 . . . . 72.349999999999994 111.197 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 28' ' ' ASP . 17.8 m -66.2 -29.48 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 119.852 -0.739 . . . . 62.350000000000001 109.963 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.1 mm -73.03 -41.35 59.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.418 0 CA-C-O 122.013 0.911 . . . . 74.219999999999999 109.22 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -57.92 -39.43 77.96 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 113.732 -1.576 . . . . 73.120000000000005 110.227 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -81.32 -29.93 11.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.383 -0.826 . . . . 75.420000000000002 111.389 178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -69.96 -31.89 69.84 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-O 120.982 0.42 . . . . 73.329999999999998 110.295 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.53 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.6 pt? -129.56 -69.74 0.68 Allowed 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 120.282 -0.567 . . . . 71.109999999999999 112.371 172.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.53 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 26.4 t70 169.98 -48.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.149 0.976 . . . . 74.530000000000001 109.114 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -92.17 176.8 6.36 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 114.249 -1.341 . . . . 74.209999999999994 109.972 -176.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.401 HG21 ' CB ' ' A' ' 29' ' ' PRO . 55.1 m -149.41 124.41 4.85 Favored Pre-proline 0 C--N 1.302 -1.467 0 CA-C-N 116.341 -0.391 . . . . 55.439999999999998 110.063 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HB2' ' HB3' ' A' ' 76' ' ' LEU . 23.7 Cg_exo -67.14 151.68 81.05 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.928 2.419 . . . . 31.420000000000002 110.69 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.42 136.18 51.26 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.638 -0.875 . . . . 74.450000000000003 108.638 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 3.5 mp -105.64 139.73 25.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 120.614 -0.434 . . . . 75.450000000000003 110.981 -172.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.6 p -131.67 146.11 34.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 CA-C-N 115.83 -0.623 . . . . 71.209999999999994 109.795 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 64.7 m -77.74 123.34 26.58 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 109.213 -0.662 . . . . 75.420000000000002 109.213 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -135.95 157.29 47.2 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.489 0.661 . . . . 75.25 111.105 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 87.4 m -110.4 126.97 54.85 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 115.243 -0.89 . . . . 51.109999999999999 109.656 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.2 tp -102.81 97.25 8.95 Favored Pre-proline 0 N--CA 1.429 -1.511 0 N-CA-C 109.241 -0.651 . . . . 72.430000000000007 109.241 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 46' ' ' THR . 67.0 Cg_endo -83.29 143.66 11.3 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.199 1.933 . . . . 72.209999999999994 111.221 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 92.35 10.96 60.2 Favored Glycine 0 N--CA 1.432 -1.62 0 C-N-CA 120.538 -0.839 . . . . 64.430000000000007 111.908 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -141.67 161.08 38.81 Favored 'General case' 0 CA--C 1.508 -0.666 0 C-N-CA 122.712 0.405 . . . . 72.400000000000006 110.05 -179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.483 ' NE2' ' HG2' ' A' ' 133' ' ' GLU . 6.5 tp-100 -140.86 149.2 41.65 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 123.068 0.23 . . . . 74.099999999999994 110.819 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -107.26 130.96 54.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.036 -0.728 . . . . 73.439999999999998 109.036 173.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.664 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 38.2 m-85 -108.36 135.33 49.83 Favored 'General case' 0 C--N 1.281 -2.38 0 N-CA-C 107.43 -1.322 . . . . 74.329999999999998 107.43 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.92 125.71 54.35 Favored 'General case' 0 N--CA 1.42 -1.972 0 C-N-CA 117.816 -1.554 . . . . 74.439999999999998 111.491 -176.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 44.7 tp -141.95 39.57 1.64 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 105.262 -2.125 . . . . 75.540000000000006 105.262 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -51.24 108.95 0.29 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.128 -1.851 . . . . 74.109999999999999 112.508 -173.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 137.42 -51.42 0.79 Allowed Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 109.774 -1.331 . . . . 72.400000000000006 109.774 -177.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.528 ' HD3' ' C ' ' A' ' 58' ' ' ARG . 2.3 tmt_? -96.28 -44.39 7.27 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 108.791 -0.818 . . . . 65.519999999999996 108.791 177.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.498 HD23 ' HB3' ' A' ' 126' ' ' MET . 36.8 tp -135.48 165.33 25.75 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 108.783 -0.821 . . . . 70.129999999999995 108.783 -178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -92.63 168.96 11.47 Favored Pre-proline 0 C--N 1.279 -2.464 0 N-CA-C 108.958 -0.756 . . . . 74.209999999999994 108.958 -173.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 6.7 Cg_exo -73.78 79.38 2.27 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.587 1.525 . . . . 75.420000000000002 109.949 173.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 118' ' ' TRP . 35.8 m -79.66 150.74 30.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.115 -0.948 . . . . 75.239999999999995 111.238 -174.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' GLN . 49.3 mm -103.8 138.99 26.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.878 0 CA-C-N 115.517 -0.765 . . . . 71.200000000000003 109.481 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.0 m -146.03 155.31 51.29 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 107.951 -1.129 . . . . 71.010000000000005 107.951 171.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.39 125.7 18.12 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.268 1.979 . . . . 40.140000000000001 112.55 177.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.3 t -124.09 128.5 49.39 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.443 -1.317 . . . . 72.010000000000005 107.443 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -73.27 -16.73 61.38 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 112.287 0.477 . . . . 63.5 112.287 -172.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -130.75 13.9 5.35 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.745 0.276 . . . . 61.0 111.745 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -111.42 169.63 13.33 Favored Glycine 0 C--O 1.244 0.728 0 C-N-CA 119.64 -1.267 . . . . 72.319999999999993 114.088 -175.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -154.82 138.16 15.8 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 108.647 -0.871 . . . . 63.520000000000003 108.647 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -113.28 122.26 67.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.792 -0.447 . . . . 70.510000000000005 109.792 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -96.05 116.81 29.53 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.255 -1.387 . . . . 62.340000000000003 107.255 176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.96 -155.32 6.45 Favored Glycine 0 N--CA 1.417 -2.585 0 N-CA-C 110.912 -0.875 . . . . 71.540000000000006 110.912 -176.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mptp? -122.38 144.98 48.69 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-O 121.57 0.7 . . . . 62.399999999999999 111.939 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.0 t -111.17 131.73 61.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 114.357 -1.292 . . . . 72.219999999999999 111.319 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 81.0 mt -95.76 104.88 16.83 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.371 -0.974 . . . . 74.420000000000002 108.371 176.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 64.3 mtp -100.13 139.04 36.37 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 120.977 0.417 . . . . 75.299999999999997 111.044 -178.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.13 18.67 10.95 Favored Glycine 0 C--N 1.29 -2.021 0 C-N-CA 120.435 -0.888 . . . . 73.319999999999993 111.637 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.676 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 88.4 t -70.3 128.17 33.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.667 -0.494 . . . . 54.530000000000001 109.667 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -77.86 167.77 20.98 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 108.771 -0.826 . . . . 74.530000000000001 108.771 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.3 p -64.37 -32.34 73.91 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 119.987 -0.685 . . . . 71.5 110.293 178.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.03 -51.07 51.15 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.757 -0.656 . . . . 74.329999999999998 110.058 177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.676 ' OE1' ' HA ' ' A' ' 79' ' ' VAL . 44.5 tt0 -60.32 -39.57 87.52 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.727 -0.669 . . . . 73.310000000000002 110.175 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 42.8 tp -57.35 -51.17 70.46 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.102 0.477 . . . . 74.420000000000002 110.411 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.56 -29.27 67.79 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.968 -0.56 . . . . 75.230000000000004 111.326 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.429 ' O ' HG23 ' A' ' 90' ' ' VAL . 7.0 t30 -65.57 -46.3 79.98 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.935 -0.765 . . . . 53.43 108.935 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 97.1 mt -64.93 -41.06 95.85 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.388 -0.824 . . . . 60.409999999999997 109.898 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -62.12 -32.81 73.43 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.649 -0.705 . . . . 71.400000000000006 110.722 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.22 62.89 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.011 -0.541 . . . . 74.209999999999994 110.854 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 86' ' ' ASN . 99.3 t -72.27 -56.71 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.191 0 C-N-CA 123.16 0.584 . . . . 75.510000000000005 112.319 -178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -78.48 -22.76 47.02 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.041 0.448 . . . . 75.420000000000002 111.852 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.2 -17.02 36.41 Favored Glycine 0 C--O 1.222 -0.617 0 N-CA-C 115.519 0.967 . . . . 54.299999999999997 115.519 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -62.8 -45.17 93.9 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 117.772 0.786 . . . . 73.040000000000006 111.323 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.1 mm-40 -112.65 -9.21 13.76 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.44 -0.345 . . . . 73.540000000000006 111.721 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -129.74 167.48 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.58 0.228 . . . . 64.209999999999994 110.969 -175.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 9.4 tp10 -123.08 144.65 49.17 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.118 -0.697 . . . . 73.040000000000006 109.118 175.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -88.12 114.14 24.44 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.782 -0.821 . . . . 75.530000000000001 108.782 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.51 160.54 36.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 116.316 -0.402 . . . . 64.409999999999997 110.755 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.1 t -95.41 132.08 40.85 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.626 -0.509 . . . . 74.150000000000006 109.626 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 29.2 m -138.11 165.17 26.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.904 -0.589 . . . . 75.5 110.759 -175.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.432 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -104.27 123.11 7.6 Favored Glycine 0 N--CA 1.421 -2.337 0 CA-C-N 115.66 -0.7 . . . . 45.240000000000002 111.427 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 111' ' ' MET . 2.8 pp -118.18 152.78 20.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.669 -0.493 . . . . 65.430000000000007 109.669 178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.8 t -113.8 131.47 65.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 108.49 -0.929 . . . . 35.399999999999999 108.49 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.3 mtp180 -70.52 125.65 27.42 Favored 'General case' 0 C--N 1.314 -0.94 0 O-C-N 123.444 0.465 . . . . 65.310000000000002 110.225 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -78.11 -4.21 46.26 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 123.208 0.317 . . . . 74.019999999999996 111.562 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.46 -60.53 3.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.1 -1.074 . . . . 62.340000000000003 108.1 174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -117.79 -93.31 0.51 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.155 -1.384 . . . . 73.319999999999993 111.885 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 41.9 p -173.94 13.11 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.757 0.28 . . . . 74.430000000000007 111.757 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -85.02 145.43 27.7 Favored 'General case' 0 C--O 1.251 1.153 0 C-N-CA 120.302 -0.559 . . . . 70.439999999999998 111.211 -177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -93.72 144.66 25.2 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.901 0.857 . . . . 64.0 110.491 179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.54 ' HB2' HD12 ' A' ' 102' ' ' ILE . 76.5 mmm -131.64 162.23 30.87 Favored 'General case' 0 C--N 1.275 -2.633 0 C-N-CA 124.973 1.309 . . . . 72.030000000000001 110.922 -175.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -117.54 126.82 53.24 Favored 'General case' 0 C--N 1.274 -2.69 0 CA-C-N 115.156 -0.929 . . . . 61.310000000000002 109.073 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.457 HG12 ' CG ' ' A' ' 19' ' ' ASN . 32.7 m -141.07 173.32 9.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 109.742 -0.466 . . . . 74.299999999999997 109.742 -176.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.65 151.74 22.6 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 109.461 -0.57 . . . . 72.439999999999998 109.461 171.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.4 t -147.28 172.04 14.48 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.696 -1.224 . . . . 73.310000000000002 107.696 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 92.1 m-85 -117.36 108.36 15.49 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.604 -0.517 . . . . 74.030000000000001 109.604 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -107.2 156.79 18.45 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.545 -0.752 . . . . 74.519999999999996 110.276 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.533 ' HD1' ' O ' ' A' ' 120' ' ' ASN . 33.7 t-105 -68.14 134.81 51.13 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 106.183 -1.784 . . . . 64.450000000000003 106.183 179.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.421 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.2 mp -67.81 -41.73 85.34 Favored 'Isoleucine or valine' 0 C--O 1.26 1.61 0 C-N-CA 118.894 -1.122 . . . . 71.430000000000007 110.506 -174.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.533 ' O ' ' HD1' ' A' ' 118' ' ' TRP . 42.6 t30 -82.41 105.41 13.45 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.775 0.798 . . . . 72.310000000000002 109.353 177.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -77.24 -12.24 59.92 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.276 -0.875 . . . . 71.299999999999997 111.557 -172.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.52 76.36 1.71 Allowed 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.763 -0.828 . . . . 72.329999999999998 108.763 174.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -93.34 130.42 35.67 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 115.115 -0.948 . . . . 41.020000000000003 108.989 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -81.0 -0.48 10.62 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.855 2.37 . . . . 73.540000000000006 114.174 -176.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -94.23 -51.03 4.99 Favored 'General case' 0 CA--C 1.491 -1.326 0 C-N-CA 120.246 -0.582 . . . . 74.120000000000005 110.943 177.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.498 ' HB3' HD23 ' A' ' 59' ' ' LEU . 23.7 ptt? -76.51 103.29 6.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.334 -0.946 . . . . 71.0 110.445 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -131.85 132.31 43.56 Favored 'General case' 0 C--N 1.284 -2.268 0 N-CA-C 106.368 -1.716 . . . . 62.210000000000001 106.368 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 123.83 90.24 0.91 Allowed Glycine 0 N--CA 1.401 -3.644 0 N-CA-C 109.696 -1.362 . . . . 61.200000000000003 109.696 -177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -78.15 147.44 34.56 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 106.348 -1.723 . . . . 62.25 106.348 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.676 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 0.5 OUTLIER -68.31 132.96 48.01 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 120.32 -0.552 . . . . 74.040000000000006 109.857 -172.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -53.29 -4.45 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 116.137 1.903 . . . . 75.120000000000005 116.137 -171.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -73.2 -36.6 66.55 Favored 'General case' 0 N--CA 1.399 -3.01 0 N-CA-C 109.521 -0.548 . . . . 75.040000000000006 109.521 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.676 ' HG3' ' O ' ' A' ' 130' ' ' TRP . 0.7 OUTLIER -72.24 -26.34 61.98 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 121.685 0.755 . . . . 61.310000000000002 110.437 179.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.699 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 44.8 tt0 -56.81 -50.6 71.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.898 -1.501 . . . . 62.009999999999998 109.65 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -65.48 -32.62 74.32 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 119.41 -0.916 . . . . 70.25 111.151 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -59.22 -51.51 69.67 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.838 -0.43 . . . . 62.439999999999998 109.838 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.2 ptt85 -70.54 -30.87 67.72 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.04 0.756 . . . . 41.109999999999999 113.04 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.699 ' HG ' ' O ' ' A' ' 134' ' ' GLU . 82.3 mt -70.48 -34.03 71.93 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.062 0.458 . . . . 72.340000000000003 110.26 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -75.56 -39.48 58.11 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 108.942 -0.762 . . . . 62.310000000000002 108.942 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.542 ' O ' HG12 ' A' ' 144' ' ' ILE . 37.6 ttmt -63.26 -35.7 81.22 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.688 -0.687 . . . . 71.319999999999993 110.617 176.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 38.6 ttpt -52.78 -35.29 56.35 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.811 0.844 . . . . 74.430000000000007 112.234 -178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.51 -35.79 78.7 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.187 0.518 . . . . 64.150000000000006 110.307 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -76.48 -43.26 40.53 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.605 -0.887 . . . . 73.120000000000005 108.605 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.4 mm -59.54 -33.93 53.23 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.813 0 CA-C-N 114.807 -1.088 . . . . 54.299999999999997 111.534 -176.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.2 mt-10 -54.28 -31.64 54.32 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.166 0.508 . . . . 75.230000000000004 111.337 177.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.7 m -81.09 -47.99 12.77 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.337 0.589 . . . . 23.129999999999999 110.868 175.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -76.69 -30.68 56.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 113.698 0.999 . . . . 72.340000000000003 113.698 -169.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -56.13 -39.42 72.21 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.094 0.474 . . . . 74.030000000000001 110.778 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -71.76 -33.89 69.02 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.947 -0.57 . . . . 74.129999999999995 109.848 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 77.2 mt -68.83 -38.76 79.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.494 -0.776 . . . . 72.450000000000003 109.497 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 27.8 ttt -64.68 -37.82 88.89 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.842 -0.617 . . . . 62.420000000000002 110.118 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -71.83 -30.89 65.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.092 -0.504 . . . . 64.019999999999996 110.514 176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.2 -34.64 76.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.991 -0.55 . . . . 64.329999999999998 110.528 178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -75.86 -18.2 59.53 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-O 121.42 0.628 . . . . 61.520000000000003 111.218 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.6 76.36 1.08 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 122.315 1.055 . . . . 54.32 110.623 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -140.72 169.27 12.02 Favored Pre-proline 0 C--N 1.287 -2.126 0 N-CA-C 106.629 -1.619 . . . . 73.109999999999999 106.629 177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.75 87.67 0.28 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.889 1.726 . . . . 72.540000000000006 111.718 175.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? . . . . . 0 C--N 1.31 -1.118 0 CA-C-O 121.959 0.885 . . . . 72.140000000000001 110.878 179.259 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.426 -1.629 0 CA-C-O 120.724 0.297 . . . . 75.430000000000007 110.4 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.4 m -66.48 -19.68 65.85 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.359 0.6 . . . . 62.100000000000001 110.852 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.3 p -84.47 -10.6 57.33 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.754 -0.657 . . . . 44.32 109.81 175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.8 t70 72.43 139.75 0.05 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.676 1.591 . . . . 62.420000000000002 110.437 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.0 m -76.27 103.96 6.56 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 120.079 -0.648 . . . . 75.319999999999993 110.037 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.48 ' H ' HD22 ' A' ' 15' ' ' LEU . 2.6 mm? -61.89 116.24 4.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 109.445 -0.576 . . . . 74.109999999999999 109.445 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -143.22 139.42 30.25 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.139 0.495 . . . . 62.119999999999997 110.728 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -83.04 155.84 23.69 Favored 'General case' 0 N--CA 1.417 -2.09 0 N-CA-C 108.858 -0.793 . . . . 71.230000000000004 108.858 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' O ' HG12 ' A' ' 79' ' ' VAL . 48.9 m-70 -113.28 159.3 19.5 Favored 'General case' 0 C--N 1.27 -2.863 0 N-CA-C 108.282 -1.007 . . . . 64.430000000000007 108.282 -173.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.464 ' CB ' HG12 ' A' ' 113' ' ' VAL . 36.9 m-20 -122.3 126.94 49.19 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.276 -1.379 . . . . 73.239999999999995 107.276 178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -127.84 137.5 57.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 110.105 -0.332 . . . . 61.140000000000001 110.105 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.441 ' HB2' HG21 ' A' ' 113' ' ' VAL . 88.3 t80 -95.3 121.77 37.3 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.892 -0.781 . . . . 74.409999999999997 108.892 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 6.4 m -96.03 119.51 44.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-O 121.92 0.867 . . . . 65.510000000000005 111.019 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -74.97 -34.22 62.0 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 115.354 1.613 . . . . 72.349999999999994 115.354 -172.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 179.57 -50.49 0.09 OUTLIER Glycine 0 CA--C 1.495 -1.172 0 C-N-CA 118.578 -1.772 . . . . 61.539999999999999 113.041 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.0 m -57.85 -35.62 71.18 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 122.75 0.42 . . . . 64.120000000000005 111.984 -176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.696 ' HB3' HD11 ' A' ' 32' ' ' ILE . 50.4 m-85 -122.95 29.23 6.87 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.47 -0.332 . . . . 70.049999999999997 110.658 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -85.78 31.02 0.62 Allowed 'General case' 0 CA--C 1.552 1.044 0 CA-C-O 122.154 0.978 . . . . 74.030000000000001 109.86 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' O ' HG12 ' A' ' 31' ' ' VAL . 17.3 t70 -142.06 129.42 11.43 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 107.59 -1.263 . . . . 53.530000000000001 107.59 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HB3' HG21 ' A' ' 39' ' ' THR . 19.0 Cg_exo -66.92 -32.95 34.51 Favored 'Trans proline' 0 N--CA 1.478 0.573 0 C-N-CA 122.385 2.057 . . . . 52.310000000000002 112.525 -177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . 25.6 t70 -60.23 -40.09 88.96 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.622 -0.263 . . . . 74.310000000000002 111.247 -178.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 28' ' ' ASP . 13.7 p -74.21 -29.45 24.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.58 -0.448 . . . . 41.350000000000001 110.182 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 26' ' ' PHE . 43.5 mm -64.88 -45.5 94.67 Favored 'Isoleucine or valine' 0 C--O 1.246 0.913 0 N-CA-C 109.89 -0.411 . . . . 75.420000000000002 109.89 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -57.08 -36.99 71.23 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.132 0.491 . . . . 51.229999999999997 111.249 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.3 t -80.24 -42.85 21.86 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-N 116.098 -0.501 . . . . 74.140000000000001 111.2 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.446 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 13.1 tmm? -69.44 -36.84 77.03 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 116.704 -0.225 . . . . 75.129999999999995 111.195 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 37' ' ' ASP 0.353 3.8 pp -119.66 -57.59 1.96 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 115.092 1.515 . . . . 74.340000000000003 115.092 178.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.571 ' N ' HD12 ' A' ' 36' ' ' LEU . 29.2 t70 176.09 -55.04 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.453 0.644 . . . . 75.120000000000005 110.19 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.592 ' O ' HG22 ' A' ' 32' ' ' ILE . 36.5 mmt180 -136.84 -165.05 1.67 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.175 -0.92 . . . . 74.409999999999997 108.894 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.411 HG21 ' HB3' ' A' ' 29' ' ' PRO . 37.7 m -137.76 125.0 13.72 Favored Pre-proline 0 C--N 1.303 -1.416 0 C-N-CA 120.329 -0.549 . . . . 41.149999999999999 111.467 178.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -63.87 150.87 87.43 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.758 2.305 . . . . 62.450000000000003 109.503 172.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -57.39 135.94 56.58 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 113.832 1.049 . . . . 65.209999999999994 113.832 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 3.5 mp -108.4 135.51 46.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 114.054 -1.43 . . . . 64.120000000000005 111.538 -172.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.411 HG21 ' HD2' ' A' ' 104' ' ' ARG . 14.7 p -131.29 146.48 33.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.99 -0.744 . . . . 63.119999999999997 108.99 173.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 49.8 m -76.74 126.97 31.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.049 0.452 . . . . 73.120000000000005 109.806 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.8 157.14 45.83 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 121.013 0.435 . . . . 72.140000000000001 110.942 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.0 m -112.89 126.71 55.76 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 115.192 -0.913 . . . . 61.43 110.423 -178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 47.6 tp -101.82 102.83 25.09 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 115.712 -0.676 . . . . 61.420000000000002 109.216 176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -84.05 140.88 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.562 2.175 . . . . 74.010000000000005 112.366 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.5 4.15 62.49 Favored Glycine 0 N--CA 1.437 -1.244 0 CA-C-N 115.733 -0.667 . . . . 73.430000000000007 111.865 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.437 ' HE2' ' SD ' ' A' ' 117' ' ' MET . 91.5 m-85 -132.01 162.04 31.71 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.734 -0.469 . . . . 75.200000000000003 109.734 -178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.504 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 31.0 tt0 -139.74 140.15 36.68 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.63 -0.428 . . . . 71.099999999999994 111.362 -173.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.505 ' HA ' HD13 ' A' ' 63' ' ' ILE . 11.6 ttm180 -94.51 142.83 26.98 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 106.749 -1.574 . . . . 75.340000000000003 106.749 177.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -106.82 168.89 8.88 Favored 'General case' 0 C--N 1.266 -3.024 0 CA-C-N 116.167 -0.47 . . . . 75.519999999999996 110.376 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 129' ' ' GLU . 12.1 tpt180 -122.31 156.71 33.31 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.657 -1.238 . . . . 74.530000000000001 107.657 -175.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.669 HD23 ' H ' ' A' ' 55' ' ' LEU . 1.9 pt? -91.95 130.49 37.69 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.014 0.435 . . . . 74.209999999999994 111.189 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -163.2 -47.92 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.263 -1.014 . . . . 65.109999999999999 108.263 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.36 -105.14 0.98 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.445 -0.798 . . . . 64.230000000000004 112.822 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.468 ' CB ' ' HB3' ' A' ' 125' ' ' ASP . 10.2 ttp180 -95.53 -45.48 7.06 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 113.798 1.036 . . . . 64.409999999999997 113.798 -177.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.425 HD23 ' HB3' ' A' ' 126' ' ' MET . 37.9 tp -111.69 160.13 17.56 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 113.393 0.886 . . . . 75.439999999999998 113.393 -159.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.96 169.69 19.04 Favored Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 114.443 -1.253 . . . . 74.120000000000005 109.019 -177.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -59.49 96.82 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.196 1.931 . . . . 64.109999999999999 111.52 174.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 26.3 p -102.0 177.37 4.91 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.812 -0.631 . . . . 75.219999999999999 109.924 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 52' ' ' ARG . 47.1 mm -124.53 131.29 72.94 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.321 0 N-CA-C 109.456 -0.572 . . . . 74.200000000000003 109.456 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -142.2 153.24 62.96 Favored Pre-proline 0 C--N 1.286 -2.163 0 N-CA-C 107.253 -1.388 . . . . 74.329999999999998 107.253 171.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.503 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 11.7 Cg_endo -59.97 137.0 73.26 Favored 'Trans proline' 0 C--O 1.241 0.657 0 C-N-CA 122.198 1.932 . . . . 70.530000000000001 111.509 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 51' ' ' GLN . 30.1 t -124.99 147.79 48.76 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.353 -0.61 . . . . 54.32 109.353 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 68' ' ' LYS . 37.5 mt-10 -69.0 -36.98 78.44 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.941 -0.763 . . . . 74.040000000000006 108.941 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 67' ' ' GLU . 30.8 mmmt -134.3 80.1 1.84 Allowed 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 115.239 -0.891 . . . . 73.140000000000001 109.14 175.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -153.12 153.6 24.95 Favored Glycine 0 N--CA 1.427 -1.921 0 C-N-CA 119.879 -1.153 . . . . 70.540000000000006 113.212 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.82 138.21 16.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.109 -1.071 . . . . 74.129999999999995 108.109 176.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.441 HG21 HD12 ' A' ' 63' ' ' ILE . 41.5 t -113.66 119.46 61.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.971 -0.381 . . . . 72.409999999999997 109.971 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -92.14 116.42 28.93 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 105.232 -2.136 . . . . 64.0 105.232 174.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.31 -145.33 4.4 Favored Glycine 0 N--CA 1.417 -2.582 0 C-N-CA 120.465 -0.874 . . . . 55.140000000000001 111.694 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.501 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 48.4 mmtm -129.94 141.53 50.76 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 120.747 0.308 . . . . 75.519999999999996 110.831 -175.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 44.0 t -110.21 129.75 64.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-N 115.867 -0.606 . . . . 70.510000000000005 111.097 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.413 HD23 HG13 ' A' ' 42' ' ' ILE . 80.4 mt -96.01 111.11 23.21 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 107.296 -1.372 . . . . 64.340000000000003 107.296 174.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.9 ptp -117.99 149.35 41.08 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 120.66 0.267 . . . . 72.25 110.561 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.68 16.05 55.55 Favored Glycine 0 N--CA 1.425 -2.088 0 C-N-CA 119.64 -1.267 . . . . 74.25 110.535 -174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.6 p -83.86 135.76 24.17 Favored 'Isoleucine or valine' 0 C--O 1.248 0.982 0 N-CA-C 108.302 -0.999 . . . . 72.439999999999998 108.302 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.4 p -82.96 167.0 18.38 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.31 -0.556 . . . . 72.439999999999998 110.64 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.9 m -61.05 -33.22 72.96 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 112.076 0.399 . . . . 75.109999999999999 112.076 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -68.31 -36.13 78.86 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.444 0.64 . . . . 74.25 110.685 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.554 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 39.1 mt-10 -78.14 -28.36 48.41 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.441 -0.948 . . . . 64.430000000000007 108.441 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.5 tp -65.9 -51.61 57.22 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.697 -0.483 . . . . 72.040000000000006 109.697 176.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -62.65 -29.03 70.32 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.317 0.579 . . . . 64.200000000000003 110.513 178.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.554 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.5 t-20 -59.86 -48.5 81.45 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.096 -0.956 . . . . 72.340000000000003 109.744 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.568 ' HA ' HG12 ' A' ' 90' ' ' VAL . 96.7 mt -67.42 -38.99 85.46 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 115.15 -0.932 . . . . 63.439999999999998 110.567 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.627 ' OD1' ' HD3' ' A' ' 97' ' ' ARG . 65.7 m-20 -60.33 -45.22 94.21 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.937 -0.574 . . . . 71.319999999999993 109.801 175.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.88 -46.96 79.59 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.604 -0.725 . . . . 73.200000000000003 111.702 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 87' ' ' LEU . 7.9 p -72.62 -56.7 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 N-CA-C 112.999 0.74 . . . . 72.519999999999996 112.999 -177.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -78.11 -30.95 49.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.323 0.49 . . . . 72.519999999999996 112.323 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 95' ' ' TYR . . . -60.03 -17.26 43.7 Favored Glycine 0 N--CA 1.463 0.439 0 CA-C-N 115.769 -0.65 . . . . 64.030000000000001 114.313 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -59.89 -33.44 71.84 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.507 0.194 . . . . 61.039999999999999 110.926 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.25 -8.81 3.78 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.317 0.488 . . . . 52.43 112.317 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.409 ' O ' ' HA2' ' A' ' 92' ' ' GLY . 69.1 m-85 -122.16 165.72 15.69 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.183 -0.303 . . . . 74.299999999999997 110.183 -177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.0 tp10 -123.12 143.24 50.12 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.845 -0.342 . . . . 63.299999999999997 110.105 -179.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.627 ' HD3' ' OD1' ' A' ' 88' ' ' ASP . 60.5 ttp180 -87.59 114.24 24.02 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 109.156 -0.683 . . . . 74.329999999999998 109.156 -177.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.72 160.34 25.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 CA-C-N 116.179 -0.464 . . . . 71.230000000000004 111.051 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 21.8 p -90.31 122.03 32.84 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 115.733 -0.667 . . . . 71.430000000000007 110.074 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.7 m -133.88 160.7 41.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.241 0.544 . . . . 63.140000000000001 112.288 -175.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.59 124.88 6.86 Favored Glycine 0 N--CA 1.432 -1.569 0 N-CA-C 110.512 -1.035 . . . . 61.329999999999998 110.512 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.84 154.89 13.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 116.548 0.174 . . . . 70.099999999999994 110.587 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 97.0 t -116.84 117.86 56.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.341 0 N-CA-C 107.445 -1.317 . . . . 65.340000000000003 107.445 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.51 ' HD3' ' SD ' ' A' ' 111' ' ' MET . 58.8 mtm180 -69.8 137.75 52.1 Favored 'General case' 0 CA--C 1.491 -1.321 0 C-N-CA 119.813 -0.755 . . . . 73.340000000000003 111.051 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -75.44 -5.68 46.24 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.083 -1.08 . . . . 74.140000000000001 108.083 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -72.2 -58.4 3.45 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.271 -1.332 . . . . 74.239999999999995 111.248 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.482 ' ND2' HH21 ' A' ' 104' ' ' ARG . 30.9 p-10 -126.23 3.81 7.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.037 0.755 . . . . 75.329999999999998 113.037 -173.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.9 t 69.6 13.85 8.24 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.29 0.636 . . . . 51.450000000000003 111.785 177.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -104.91 155.84 18.57 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 122.063 -0.398 . . . . 43.509999999999998 111.136 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 58.0 pttt -88.78 148.43 23.94 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 121.634 0.731 . . . . 34.329999999999998 111.228 -176.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.51 ' SD ' ' HD3' ' A' ' 104' ' ' ARG . 88.6 mtp -136.83 160.07 39.98 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 114.818 -1.083 . . . . 73.129999999999995 109.541 175.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -99.56 131.01 45.85 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 115.202 -0.908 . . . . 64.239999999999995 109.997 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.464 HG12 ' CB ' ' A' ' 19' ' ' ASN . 33.7 m -145.16 173.79 3.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.483 -0.932 . . . . 64.140000000000001 108.483 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -119.46 151.17 39.01 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.367 -0.975 . . . . 72.219999999999999 108.367 175.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.8 t -144.3 172.14 13.34 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.284 -0.635 . . . . 64.349999999999994 109.284 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 89.4 m-85 -116.75 108.48 15.93 Favored 'General case' 0 N--CA 1.424 -1.735 0 O-C-N 123.847 0.717 . . . . 72.150000000000006 109.537 -177.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.503 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 22.3 ptt? -107.38 156.05 19.35 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.829 -0.623 . . . . 63.43 110.124 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 68.5 t-105 -68.75 130.7 43.59 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.161 -1.052 . . . . 71.239999999999995 108.161 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.4 mp -73.7 -42.9 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 119.357 -0.937 . . . . 74.5 111.732 -173.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.446 HD22 ' HB2' ' A' ' 123' ' ' ASP . 8.6 t30 -84.05 93.77 8.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.78 0.8 . . . . 73.430000000000007 110.28 -177.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -78.8 -6.13 55.18 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.108 -0.951 . . . . 72.510000000000005 113.167 -170.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.03 84.75 2.26 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-O 121.299 0.571 . . . . 73.409999999999997 110.179 176.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.446 ' HB2' HD22 ' A' ' 120' ' ' ASN . 28.7 t70 -133.49 120.61 15.85 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.836 -0.62 . . . . 64.400000000000006 109.767 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.17 -11.87 19.35 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.524 2.149 . . . . 71.120000000000005 113.439 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.468 ' HB3' ' CB ' ' A' ' 58' ' ' ARG . 16.2 m-20 -90.63 -20.43 22.55 Favored 'General case' 0 C--O 1.247 0.968 0 N-CA-C 113.742 1.016 . . . . 73.299999999999997 113.742 -176.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.425 ' HB3' HD23 ' A' ' 59' ' ' LEU . 23.6 ptt? -80.31 88.17 5.55 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.489 1.138 . . . . 65.439999999999998 108.667 170.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -141.56 122.48 14.5 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.425 -1.261 . . . . 71.230000000000004 108.899 -178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -146.67 168.22 28.03 Favored Glycine 0 C--N 1.276 -2.772 0 N-CA-C 108.526 -1.83 . . . . 53.210000000000001 108.526 175.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.512 ' O ' ' HG2' ' A' ' 54' ' ' ARG . 37.1 mt-10 -108.16 125.52 51.71 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.112 -1.035 . . . . 55.439999999999998 110.326 -178.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.408 ' CE3' ' HB3' ' A' ' 132' ' ' PHE . 6.0 t90 -125.25 156.17 38.95 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.014 -1.847 . . . . 75.439999999999998 106.014 -172.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -61.71 -38.56 88.34 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.365 0.602 . . . . 62.149999999999999 111.295 -173.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.408 ' HB3' ' CE3' ' A' ' 130' ' ' TRP . 74.5 t80 -61.3 -39.66 91.29 Favored 'General case' 0 N--CA 1.417 -2.104 0 C-N-CA 124.724 1.21 . . . . 72.120000000000005 109.897 175.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -71.46 -26.88 62.9 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.136 -0.938 . . . . 64.349999999999994 111.565 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.547 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 40.4 tt0 -58.03 -41.44 83.19 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 121.048 -0.261 . . . . 71.510000000000005 111.564 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -65.54 -38.12 88.69 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.099 -1.041 . . . . 74.129999999999995 110.897 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.92 -43.08 99.78 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 116.44 -0.346 . . . . 74.010000000000005 111.337 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.52 ' HE ' ' HG3' ' A' ' 134' ' ' GLU . 41.0 ptt180 -68.1 -35.1 77.61 Favored 'General case' 0 C--O 1.194 -1.826 0 C-N-CA 120.643 -0.423 . . . . 65.209999999999994 110.683 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 134' ' ' GLU . 89.2 mt -69.74 -35.69 75.19 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.469 0.652 . . . . 73.409999999999997 110.214 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -71.63 -39.17 70.59 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.557 -0.747 . . . . 75.219999999999999 109.161 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -70.13 -34.84 73.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.164 -0.925 . . . . 73.099999999999994 110.679 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.507 ' O ' ' HG2' ' A' ' 145' ' ' GLU . 61.6 tttm -50.83 -30.9 15.55 Favored 'General case' 0 C--O 1.218 -0.6 0 C-N-CA 125.427 1.491 . . . . 71.209999999999994 112.121 -174.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -54.5 -46.65 73.51 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.215 0.606 . . . . 71.099999999999994 110.272 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -77.49 -34.03 54.33 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.467 -0.788 . . . . 75.109999999999999 109.603 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 141' ' ' LYS . 50.4 mm -64.49 -33.43 62.91 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.365 0 CA-C-N 114.898 -1.046 . . . . 74.200000000000003 111.796 -176.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.507 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 38.2 mm-40 -55.37 -34.86 64.68 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.236 0.541 . . . . 71.420000000000002 110.693 176.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 61.3 m -73.9 -46.38 44.92 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.842 -0.617 . . . . 64.400000000000006 109.615 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -68.35 -29.76 68.56 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 114.346 1.239 . . . . 72.439999999999998 114.346 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 88.7 tttt -54.45 -41.09 69.03 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 123.357 0.663 . . . . 74.319999999999993 110.039 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -65.27 -36.45 84.14 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.62 0.724 . . . . 65.209999999999994 109.457 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 69.7 mt -73.46 -37.38 50.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.055 -0.975 . . . . 73.340000000000003 109.942 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 87.7 mtp -67.58 -40.41 84.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.155 -0.475 . . . . 75.329999999999998 110.634 178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 51.5 mt-10 -64.95 -32.16 73.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.378 0.609 . . . . 71.420000000000002 109.77 175.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 53.2 t -71.18 -44.46 65.42 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.503 -0.771 . . . . 73.349999999999994 111.166 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -74.99 -45.28 43.08 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 112.871 0.693 . . . . 75.109999999999999 112.871 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -98.84 -74.96 0.57 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 112.685 0.624 . . . . 61.119999999999997 112.685 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.51 150.2 7.78 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 109.953 -0.388 . . . . 74.310000000000002 109.953 -178.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.33 -15.13 38.49 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.959 2.439 . . . . 71.140000000000001 112.579 179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 N--CA 1.437 -1.114 0 CA-C-O 121.193 0.52 . . . . 72.099999999999994 110.59 179.17 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 63.9 m . . . . . 0 N--CA 1.435 -1.181 0 N-CA-C 109.913 -0.403 . . . . 54.439999999999998 109.913 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.6 t -76.96 100.73 5.7 Favored 'General case' 0 N--CA 1.427 -1.584 0 N-CA-C 106.0 -1.852 . . . . 62.310000000000002 106.0 172.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.8 t -80.38 -9.99 59.75 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.569 0.581 . . . . 61.200000000000003 112.569 -171.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 77.95 -53.08 0.51 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.921 0.888 . . . . 65.519999999999996 109.307 -173.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -64.93 135.84 56.14 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.355 -2.091 . . . . 64.510000000000005 105.355 169.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.46 85.27 3.18 Favored 'General case' 0 N--CA 1.413 -2.275 0 N-CA-C 114.192 1.182 . . . . 64.549999999999997 114.192 -170.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 60.09 178.54 0.09 Allowed 'General case' 0 C--O 1.25 1.13 0 C-N-CA 124.64 1.176 . . . . 54.409999999999997 113.451 170.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.22 154.34 20.51 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 106.658 -1.608 . . . . 73.319999999999993 106.658 167.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 33.5 m-70 -120.07 157.74 28.31 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 109.09 -0.707 . . . . 72.129999999999995 109.09 -175.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.642 ' HA ' ' O ' ' A' ' 76' ' ' LEU 0.272 0.7 OUTLIER -126.31 125.9 43.06 Favored 'General case' 0 C--N 1.284 -2.251 0 O-C-N 124.086 0.866 . . . . 74.329999999999998 111.424 174.365 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.6 t -122.56 137.61 55.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 114.723 -1.126 . . . . 65.209999999999994 109.913 -173.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.554 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.6 t80 -97.97 122.9 41.64 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.518 -0.919 . . . . 65.450000000000003 108.518 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 30.1 m -103.27 138.01 29.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.323 0.582 . . . . 31.309999999999999 111.815 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.446 ' HB3' ' CG1' ' A' ' 63' ' ' ILE . 39.8 p90 -81.28 -15.06 56.63 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 115.015 1.487 . . . . 71.549999999999997 115.015 -175.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.525 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . 160.0 -46.9 0.41 Allowed Glycine 0 C--O 1.212 -1.247 0 C-N-CA 118.658 -1.734 . . . . 43.5 113.321 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.2 m -58.26 -31.63 67.62 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 112.693 0.627 . . . . 65.430000000000007 112.693 -175.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.433 ' CE1' ' HG3' ' A' ' 35' ' ' MET . 63.7 m-85 -123.72 31.27 5.93 Favored 'General case' 0 C--N 1.315 -0.934 0 O-C-N 122.253 -0.279 . . . . 73.540000000000006 111.486 -176.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HB2' ' HE2' ' A' ' 74' ' ' LYS . 0.7 OUTLIER -92.18 -1.72 56.98 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 119.254 -0.978 . . . . 65.430000000000007 112.236 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.441 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.0 t70 -99.65 123.1 49.09 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 115.375 -0.83 . . . . 63.310000000000002 109.194 177.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -62.75 -31.61 78.49 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.569 2.179 . . . . 33.009999999999998 113.366 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -67.3 -40.26 86.02 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.334 -0.617 . . . . 64.420000000000002 109.334 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 69.8 t -59.79 -37.55 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 115.624 -0.717 . . . . 62.43 109.87 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.528 HG23 HD21 ' A' ' 36' ' ' LEU . 44.4 mm -63.06 -44.27 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 CA-C-N 115.777 -0.647 . . . . 73.140000000000001 110.667 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -59.47 -35.87 74.9 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.017 0.437 . . . . 64.409999999999997 111.15 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.2 t -81.09 -35.64 14.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 116.084 -0.507 . . . . 75.340000000000003 112.179 -176.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.433 ' HG3' ' CE1' ' A' ' 26' ' ' PHE . 9.0 tmm? -75.06 -37.16 61.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 120.241 -0.584 . . . . 74.420000000000002 110.16 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.528 HD21 HG23 ' A' ' 32' ' ' ILE 0.254 0.9 OUTLIER -119.73 -62.44 1.49 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.464 1.283 . . . . 72.120000000000005 114.464 179.472 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.499 ' OD2' ' HG3' ' A' ' 38' ' ' ARG . 20.8 t70 178.67 -55.14 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.095 0.474 . . . . 64.430000000000007 111.398 -174.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.499 ' HG3' ' OD2' ' A' ' 37' ' ' ASP . 88.6 mtm180 -135.75 -174.62 3.7 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.828 -0.804 . . . . 65.340000000000003 108.828 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 21.5 m -118.55 112.5 37.16 Favored Pre-proline 0 N--CA 1.431 -1.388 0 C-N-CA 120.916 -0.313 . . . . 64.430000000000007 111.649 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.53 152.0 76.24 Favored 'Trans proline' 0 C--O 1.243 0.744 0 C-N-CA 123.004 2.47 . . . . 62.130000000000003 109.293 170.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -57.74 118.8 5.66 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.536 0.684 . . . . 64.319999999999993 112.138 -178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 48.6 mt -100.12 137.49 27.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 115.242 -0.89 . . . . 60.329999999999998 109.239 -177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.48 146.68 33.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 109.339 -0.615 . . . . 72.299999999999997 109.339 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 50.9 m -77.69 130.77 37.22 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.515 -0.55 . . . . 73.420000000000002 109.515 177.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.23 159.23 42.66 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.463 0.542 . . . . 73.120000000000005 112.463 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.5 m -107.42 132.21 53.44 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.826 0.851 . . . . 73.019999999999996 109.816 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.427 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 45.3 tp -111.96 96.76 35.35 Favored Pre-proline 0 C--N 1.3 -1.545 0 N-CA-C 108.474 -0.935 . . . . 64.120000000000005 108.474 172.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.64 141.06 9.64 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 122.462 2.108 . . . . 73.519999999999996 112.656 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 93.27 10.53 59.41 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.679 -0.772 . . . . 73.319999999999993 111.713 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -139.49 159.1 42.95 Favored 'General case' 0 CA--C 1.486 -1.483 0 N-CA-C 106.796 -1.557 . . . . 75.010000000000005 106.796 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -139.49 142.07 37.33 Favored 'General case' 0 C--N 1.294 -1.836 0 C-N-CA 120.282 -0.567 . . . . 61.229999999999997 109.859 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HB2' ' NH1' ' A' ' 54' ' ' ARG . 28.4 ptt180 -102.23 126.45 49.22 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.981 -0.554 . . . . 75.239999999999995 109.619 176.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.517 ' O ' ' HD2' ' A' ' 54' ' ' ARG . 91.0 m-85 -108.68 162.16 14.42 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 108.224 -1.028 . . . . 74.140000000000001 108.224 -177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 53' ' ' PHE . 3.0 mpt_? -118.28 126.02 51.3 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-O 121.358 0.599 . . . . 74.140000000000001 112.087 177.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.31 133.82 17.6 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 103.139 -2.912 . . . . 75.329999999999998 103.139 177.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -103.43 -38.48 7.17 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 114.38 1.252 . . . . 70.540000000000006 114.38 -172.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -115.67 125.88 6.88 Favored Glycine 0 C--N 1.308 -0.994 0 C-N-CA 119.199 -1.477 . . . . 62.43 113.527 -176.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' A' ' 58' ' ' ARG . 1.6 tmt_? 84.61 -23.17 0.18 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.229 1.412 . . . . 73.109999999999999 110.809 175.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 59' ' ' LEU . 30.8 tp -137.73 163.31 31.63 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 107.555 -1.276 . . . . 72.310000000000002 107.555 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.428 ' HB2' ' OH ' ' A' ' 95' ' ' TYR . 12.4 m-85 -119.43 171.88 5.0 Favored Pre-proline 0 C--N 1.305 -1.365 0 N-CA-C 109.882 -0.414 . . . . 70.140000000000001 109.882 -169.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 31.7 Cg_exo -68.3 47.69 0.39 Allowed 'Trans proline' 0 CA--C 1.569 2.225 0 C-N-CA 124.073 3.182 . . . . 64.239999999999995 112.849 174.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.9 p -61.65 163.18 7.45 Favored 'General case' 0 C--O 1.252 1.233 0 C-N-CA 125.277 1.431 . . . . 64.150000000000006 114.838 -174.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.473 HD12 HG21 ' A' ' 71' ' ' VAL . 49.8 mm -109.7 142.02 23.37 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 C-N-CA 124.917 1.287 . . . . 74.540000000000006 108.584 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.489 ' CG1' ' HB3' ' A' ' 118' ' ' TRP . 26.9 m -148.19 154.66 42.79 Favored Pre-proline 0 C--N 1.309 -1.189 0 N-CA-C 107.654 -1.239 . . . . 73.299999999999997 107.654 171.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.2 111.33 1.99 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.226 1.951 . . . . 54.340000000000003 112.042 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 t -124.89 135.98 53.37 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.228 -0.656 . . . . 63.030000000000001 109.228 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' H ' ' CD ' ' A' ' 67' ' ' GLU . 10.3 mp0 -73.17 -21.76 60.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.986 0.422 . . . . 71.209999999999994 110.005 -176.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -100.24 5.64 44.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.904 -0.589 . . . . 63.140000000000001 112.339 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -132.24 177.13 18.96 Favored Glycine 0 N--CA 1.437 -1.273 0 C-N-CA 118.18 -1.962 . . . . 64.510000000000005 115.094 -174.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.48 ' OE2' ' HD3' ' A' ' 140' ' ' LYS . 14.3 pt-20 -156.82 143.4 18.37 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 104.409 -2.441 . . . . 62.219999999999999 104.409 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 63' ' ' ILE . 47.0 t -113.56 119.75 61.69 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 C-N-CA 120.173 -0.611 . . . . 70.510000000000005 110.316 -176.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.531 ' NE2' ' HD2' ' A' ' 136' ' ' LYS . 56.1 m-70 -98.66 115.43 28.67 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 119.466 -0.894 . . . . 72.200000000000003 108.686 173.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.22 -157.79 7.39 Favored Glycine 0 N--CA 1.418 -2.564 0 C-N-CA 120.379 -0.915 . . . . 75.329999999999998 111.002 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HE2' ' HB2' ' A' ' 27' ' ' GLN . 3.1 mppt? -122.72 148.34 45.43 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 113.263 0.838 . . . . 73.340000000000003 113.263 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 54.5 t -111.01 131.87 61.04 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 CA-C-N 113.643 -1.617 . . . . 64.109999999999999 110.951 178.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.642 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 68.8 mt -95.63 107.74 19.96 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.434 -0.95 . . . . 75.430000000000007 108.434 177.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 61.2 mtp -103.63 155.68 18.37 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 109.657 -0.498 . . . . 71.230000000000004 109.657 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.45 16.24 66.87 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.083 -1.056 . . . . 72.040000000000006 111.47 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.479 HG13 ' HB2' ' A' ' 83' ' ' GLU . 86.7 t -72.1 120.12 19.91 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 109.457 -0.571 . . . . 63.409999999999997 109.457 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 47.5 p -74.03 163.52 27.78 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 108.464 -0.939 . . . . 73.409999999999997 108.464 176.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.0 p -55.15 -36.94 66.35 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 112.151 0.426 . . . . 61.439999999999998 112.151 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -59.76 -51.51 69.45 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 123.554 0.742 . . . . 74.430000000000007 111.038 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.51 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 33.8 mt-10 -67.95 -35.48 78.48 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 123.914 0.886 . . . . 71.049999999999997 109.342 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.89 -49.66 75.96 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.287 -0.635 . . . . 73.400000000000006 109.287 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.63 -33.52 75.13 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-O 121.05 0.453 . . . . 71.519999999999996 109.888 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.502 HD22 ' C ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -60.34 -48.97 79.47 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 124.411 1.085 . . . . 74.109999999999999 109.22 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.2 mt -66.86 -42.76 85.15 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.111 -0.495 . . . . 75.420000000000002 110.511 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -63.26 -31.96 73.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.203 -0.908 . . . . 73.430000000000007 110.676 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.86 -45.37 51.45 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 115.491 -0.777 . . . . 52.140000000000001 110.904 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 86' ' ' ASN . 99.4 t -65.23 -56.99 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 116.441 -0.345 . . . . 63.229999999999997 111.487 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -77.95 -22.54 49.37 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 112.83 0.678 . . . . 72.129999999999995 112.83 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.88 -16.83 48.67 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 115.912 -0.585 . . . . 43.25 114.463 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -61.4 -27.86 68.83 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.636 0.606 . . . . 72.120000000000005 112.636 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -145.23 -0.88 0.85 Allowed 'General case' 0 N--CA 1.427 -1.606 0 C-N-CA 120.136 -0.625 . . . . 75.219999999999999 112.124 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.428 ' OH ' ' HB2' ' A' ' 60' ' ' TYR . 80.4 m-85 -122.09 167.79 12.72 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 122.101 -0.374 . . . . 75.409999999999997 110.462 177.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -123.04 139.67 53.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.38 -1.341 . . . . 55.310000000000002 107.38 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -87.14 114.4 23.72 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.289 -0.634 . . . . 74.319999999999993 109.289 -176.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 35.3 m -119.13 160.53 19.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.698 -0.683 . . . . 53.399999999999999 109.865 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.7 t -107.39 133.18 52.29 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.988 -0.745 . . . . 54.399999999999999 108.988 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.41 171.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 116.238 -0.437 . . . . 75.329999999999998 110.65 -175.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -109.95 124.74 7.28 Favored Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 111.008 -0.837 . . . . 54.229999999999997 111.008 177.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.433 ' CD1' ' HB2' ' A' ' 111' ' ' MET . 2.6 pp -117.6 165.14 13.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 116.621 0.21 . . . . 73.310000000000002 110.634 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.493 HG22 ' HG2' ' A' ' 110' ' ' LYS . 46.1 t -124.11 119.43 56.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 N-CA-C 108.929 -0.767 . . . . 43.420000000000002 108.929 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.472 ' HE ' ' HB3' ' A' ' 106' ' ' ASP . 72.7 ttt180 -65.77 116.35 6.88 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 124.091 0.956 . . . . 71.519999999999996 111.005 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -53.74 -48.44 69.65 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.941 0.896 . . . . 64.319999999999993 109.215 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.472 ' HB3' ' HE ' ' A' ' 104' ' ' ARG . 33.9 t70 -48.9 -42.61 37.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 113.09 -1.868 . . . . 75.319999999999993 115.395 -172.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.5 p-10 -138.92 6.64 2.43 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 118.627 -1.229 . . . . 74.340000000000003 112.41 -177.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 23.3 t 59.71 70.17 0.66 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.073 0.949 . . . . 54.219999999999999 111.486 -179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -131.16 146.33 52.3 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 115.176 -0.92 . . . . 73.219999999999999 108.857 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.493 ' HG2' HG22 ' A' ' 103' ' ' VAL . 58.0 mtpt -97.3 126.19 42.36 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.456 0.646 . . . . 65.430000000000007 109.339 -177.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.433 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 89.2 mtp -125.38 161.24 27.47 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.479 -0.782 . . . . 73.5 110.853 -177.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -113.51 117.43 31.65 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 115.216 -0.902 . . . . 64.519999999999996 109.197 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 21' ' ' PHE . 34.0 m -129.98 173.37 14.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 121.264 0.554 . . . . 63.520000000000003 110.821 -174.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.484 ' N ' ' HD2' ' A' ' 114' ' ' LYS . 3.3 mptp? -108.81 147.25 32.36 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.079 -1.082 . . . . 75.5 108.079 175.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.4 t -148.73 172.56 14.4 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.935 -0.765 . . . . 53.439999999999998 108.935 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -121.17 108.28 13.59 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.816 -0.809 . . . . 73.310000000000002 108.816 -176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -110.88 156.37 21.26 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.808 -0.633 . . . . 74.530000000000001 109.615 -179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.489 ' HB3' ' CG1' ' A' ' 64' ' ' VAL . 55.9 t-105 -68.35 123.27 20.31 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.065 -1.087 . . . . 75.349999999999994 108.065 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 119' ' ' ILE . 2.4 mp -65.23 -40.92 90.22 Favored 'Isoleucine or valine' 0 C--O 1.249 1.048 0 CA-C-O 120.921 0.391 . . . . 73.209999999999994 111.197 -171.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -59.17 -28.64 66.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.687 -0.688 . . . . 71.010000000000005 111.09 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.444 ' HA ' ' CG1' ' A' ' 64' ' ' VAL 0.302 9.0 ptpp? 58.06 -52.02 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 126.555 1.942 . . . . 71.219999999999999 115.217 178.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.88 82.64 2.61 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.357 -1.349 . . . . 61.020000000000003 107.357 174.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.401 ' HB3' ' HE3' ' A' ' 126' ' ' MET . 13.0 t70 -112.38 127.19 27.18 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.172 -0.922 . . . . 73.109999999999999 109.062 -176.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.3 -17.78 21.16 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.852 2.368 . . . . 72.319999999999993 113.991 -176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -80.4 -29.63 37.73 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 112.739 0.644 . . . . 73.230000000000004 112.739 -175.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.401 ' HE3' ' HB3' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -91.56 141.49 28.66 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.838 0.828 . . . . 71.0 112.445 178.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -170.52 145.08 2.53 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.011 -1.848 . . . . 73.310000000000002 106.011 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.98 161.32 8.67 Favored Glycine 0 C--N 1.29 -1.995 0 C-N-CA 119.401 -1.381 . . . . 43.32 112.838 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.34 151.8 48.3 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.019 -1.845 . . . . 74.540000000000006 106.019 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -89.86 156.75 18.26 Favored 'General case' 0 C--N 1.29 -1.996 0 C-N-CA 117.195 -1.802 . . . . 73.329999999999998 106.987 174.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -42.37 -54.86 3.62 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.557 0.743 . . . . 75.530000000000001 112.596 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.54 ' O ' ' HB2' ' A' ' 136' ' ' LYS . 97.3 m-85 -66.16 -38.0 87.02 Favored 'General case' 0 C--O 1.209 -1.07 0 N-CA-C 112.096 0.406 . . . . 64.319999999999993 112.096 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 52' ' ' ARG . 10.8 mm-40 -70.18 -29.33 66.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.062 0.458 . . . . 54.530000000000001 111.486 -176.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.482 ' O ' HD13 ' A' ' 138' ' ' LEU . 37.1 tt0 -68.19 -52.9 29.13 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.853 -0.795 . . . . 54.100000000000001 108.853 178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -63.16 -30.41 71.57 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.526 0.679 . . . . 64.549999999999997 110.281 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.696 ' HE2' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -56.96 -50.47 72.53 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 124.562 1.145 . . . . 71.129999999999995 108.536 178.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.47 ' HA ' ' HB3' ' A' ' 140' ' ' LYS . 19.9 ptt85 -69.74 -30.57 68.2 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 119.172 -1.011 . . . . 63.210000000000001 112.539 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.482 HD13 ' O ' ' A' ' 134' ' ' GLU . 8.7 mp -67.82 -31.19 70.87 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.945 0.403 . . . . 73.310000000000002 110.489 176.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -79.17 -33.84 43.64 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.474 -0.565 . . . . 64.329999999999998 109.474 173.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.508 ' O ' HG12 ' A' ' 144' ' ' ILE . 36.0 ttpt -61.04 -33.28 73.05 Favored 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 115.588 -0.733 . . . . 73.239999999999995 112.169 178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -48.8 -32.56 8.89 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 112.231 0.456 . . . . 71.120000000000005 112.231 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.574 ' HE2' ' HA ' ' A' ' 142' ' ' LYS . 0.5 OUTLIER -58.76 -48.21 82.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.871 0.843 . . . . 74.109999999999999 109.716 175.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -76.15 -32.78 59.26 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 113.674 -1.603 . . . . 71.120000000000005 108.943 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 140' ' ' LYS . 46.7 mm -61.6 -32.77 54.6 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.143 0 CA-C-N 114.646 -1.161 . . . . 75.209999999999994 112.642 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -51.84 -41.3 61.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.128 0.422 . . . . 75.239999999999995 111.413 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.5 m -70.98 -47.6 57.98 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 115.736 -0.665 . . . . 73.409999999999997 109.858 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . 0.257 62.9 m-85 -70.18 -29.88 66.86 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 115.133 1.531 . . . . 74.319999999999993 115.133 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.431 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 57.6 tptt -59.3 -42.55 91.6 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.51 -0.922 . . . . 62.450000000000003 108.51 175.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -64.12 -40.31 95.92 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.253 -0.885 . . . . 71.310000000000002 109.463 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 79.3 mt -68.58 -41.64 83.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.313 -0.858 . . . . 64.409999999999997 110.663 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 26.3 mmt -64.38 -42.54 96.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.51 -0.314 . . . . 74.439999999999998 110.743 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.431 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 49.2 mt-10 -67.56 -30.8 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.931 0.396 . . . . 61.240000000000002 110.416 177.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 51.2 t -65.66 -37.59 86.93 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.871 -0.604 . . . . 74.140000000000001 109.957 178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.2 -37.78 37.36 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.054 -0.521 . . . . 72.230000000000004 110.048 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 87.8 tttt 67.02 94.59 0.07 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.063 1.345 . . . . 73.439999999999998 112.4 177.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -103.75 150.38 38.1 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.621 -0.881 . . . . 71.219999999999999 108.621 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.92 135.1 66.94 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.814 2.343 . . . . 71.530000000000001 112.396 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 . . . . . 0 C--N 1.314 -0.94 0 CA-C-N 115.63 -0.713 . . . . 75.409999999999997 109.83 -178.662 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 82.2 m . . . . . 0 N--CA 1.429 -1.503 0 N-CA-C 107.433 -1.321 . . . . 72.219999999999999 107.433 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.3 t -70.63 106.91 3.67 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-O 121.393 0.616 . . . . 72.519999999999996 110.395 -175.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.5 p -85.76 -22.49 27.71 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 115.062 -0.972 . . . . 55.509999999999998 109.494 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . 0.252 12.7 m-20 60.49 82.27 0.16 Allowed 'General case' 0 CA--C 1.504 -0.817 0 CA-C-O 122.468 1.128 . . . . 62.0 113.139 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 29.0 t -93.27 115.33 27.93 Favored 'General case' 0 N--CA 1.414 -2.268 0 N-CA-C 105.711 -1.959 . . . . 63.210000000000001 105.711 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -75.23 72.13 2.29 Favored 'General case' 0 N--CA 1.421 -1.922 0 CA-C-O 122.117 0.96 . . . . 72.530000000000001 112.94 -176.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -141.37 98.06 3.29 Favored 'General case' 0 CA--C 1.472 -2.044 0 CA-C-N 113.194 -1.821 . . . . 63.229999999999997 107.279 174.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 94.9 mt -98.75 153.86 18.42 Favored 'General case' 0 C--N 1.263 -3.187 0 CA-C-N 115.101 -0.954 . . . . 70.25 110.565 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.503 ' HB2' HG13 ' A' ' 79' ' ' VAL . 49.0 m-70 -115.41 160.21 20.16 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.298 -0.865 . . . . 73.329999999999998 110.208 -173.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.442 ' CG ' HG12 ' A' ' 113' ' ' VAL . 18.1 p30 -133.15 138.48 46.64 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.113 -0.949 . . . . 64.200000000000003 111.305 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 83.1 t -132.12 139.41 50.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 115.436 -0.802 . . . . 64.200000000000003 109.727 -175.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB2' HG21 ' A' ' 113' ' ' VAL . 92.1 t80 -94.16 123.1 37.33 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.456 -1.312 . . . . 73.120000000000005 107.456 177.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.1 m -102.81 166.96 2.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 112.519 0.563 . . . . 65.340000000000003 112.519 -174.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -153.56 -45.3 0.09 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.069 -0.969 . . . . 72.349999999999994 111.623 -173.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -121.02 -92.71 1.26 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.03 -1.081 . . . . 63.109999999999999 113.97 -176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -58.35 -17.49 20.45 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.138 1.162 . . . . 74.329999999999998 114.138 -173.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -123.36 20.15 9.68 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 121.079 -0.248 . . . . 75.439999999999998 111.003 -176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -74.08 -18.86 60.76 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 120.649 -0.421 . . . . 74.019999999999996 111.609 -176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.53 ' OD2' ' HB3' ' A' ' 30' ' ' ASP . 20.8 t70 -116.81 128.29 26.12 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 116.331 -0.395 . . . . 71.099999999999994 111.856 -173.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HB3' HG21 ' A' ' 39' ' ' THR . 32.0 Cg_endo -65.12 -32.71 52.28 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 123.074 2.516 . . . . 54.299999999999997 112.81 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.53 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 19.3 t70 -63.29 -38.19 90.2 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.532 -0.544 . . . . 73.329999999999998 109.532 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 81.3 t -65.69 -42.98 93.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.257 -0.883 . . . . 73.439999999999998 109.656 174.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 28' ' ' ASP . 45.7 mm -60.73 -43.79 95.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.018 -0.537 . . . . 73.349999999999994 111.894 -177.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -55.37 -36.4 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.226 0.536 . . . . 64.030000000000001 111.2 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 51.5 t -82.03 -37.49 14.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 116.149 -0.478 . . . . 74.209999999999994 111.609 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 9.0 tmm? -63.49 -35.54 80.79 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.388 -0.597 . . . . 71.310000000000002 109.388 -174.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.632 ' HG ' ' H ' ' A' ' 37' ' ' ASP . 1.2 pt? -128.09 -74.69 0.57 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.092 -0.504 . . . . 75.140000000000001 111.862 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.632 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 22.4 m-20 -167.36 -58.26 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.861 0.865 . . . . 71.230000000000004 108.668 -172.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -131.2 165.59 23.0 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.444 -1.253 . . . . 73.239999999999995 112.222 -174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.462 HG21 ' HB3' ' A' ' 29' ' ' PRO . 29.9 m -111.69 128.47 25.37 Favored Pre-proline 0 C--N 1.306 -1.29 0 CA-C-N 115.956 -0.566 . . . . 73.140000000000001 111.729 -174.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.45 153.15 68.2 Favored 'Trans proline' 0 C--O 1.241 0.651 0 C-N-CA 123.453 2.769 . . . . 70.0 111.403 173.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.2 123.95 16.26 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.25 -0.648 . . . . 64.450000000000003 109.25 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 32.9 mt -104.91 136.03 40.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.086 0.47 . . . . 75.299999999999997 110.364 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.537 HG21 ' HD2' ' A' ' 104' ' ' ARG . 14.4 p -130.85 147.72 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.711 -0.677 . . . . 62.43 109.869 176.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 57.3 m -75.69 126.53 31.18 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.548 -0.908 . . . . 63.100000000000001 108.548 175.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.91 157.38 46.14 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.517 0.675 . . . . 64.430000000000007 111.819 -178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.1 m -114.59 125.12 53.41 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 114.537 -1.21 . . . . 73.329999999999998 108.627 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.424 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 50.8 tp -99.97 101.97 15.99 Favored Pre-proline 0 C--N 1.29 -2.007 0 N-CA-C 109.092 -0.707 . . . . 73.340000000000003 109.092 176.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 71.9 Cg_endo -80.84 141.1 13.23 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 122.188 1.926 . . . . 74.0 112.091 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 91.12 14.23 57.85 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.963 -0.636 . . . . 72.430000000000007 112.427 178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -140.49 163.3 33.2 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.674 -0.491 . . . . 73.310000000000002 109.674 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.434 ' CG ' ' HB2' ' A' ' 66' ' ' SER . 26.9 pt20 -140.27 166.38 24.85 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.164 -0.68 . . . . 74.340000000000003 109.164 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HD3' HG13 ' A' ' 71' ' ' VAL . 14.9 ptt180 -128.01 128.46 45.03 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.597 -0.729 . . . . 74.310000000000002 111.719 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.559 ' HB2' ' SG ' ' A' ' 62' ' ' CYS . 17.1 m-85 -109.14 164.88 12.04 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 115.274 -0.876 . . . . 73.439999999999998 110.147 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.582 ' HD2' ' N ' ' A' ' 130' ' ' TRP . 6.9 mtm180 -149.55 152.84 36.2 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 109.442 -0.577 . . . . 61.009999999999998 109.442 -168.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.469 HD13 ' N ' ' A' ' 56' ' ' LYS . 1.8 tm? -159.35 142.6 14.45 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 105.537 -2.023 . . . . 65.230000000000004 105.537 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.469 ' N ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -114.47 81.87 1.62 Allowed 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.618 0.723 . . . . 74.219999999999999 111.48 178.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.68 -101.8 0.17 Allowed Glycine 0 N--CA 1.44 -1.067 0 CA-C-N 115.152 -0.931 . . . . 43.200000000000003 112.21 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.478 ' HD3' ' C ' ' A' ' 58' ' ' ARG . 0.6 OUTLIER -80.05 -36.65 35.38 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 121.221 0.534 . . . . 54.340000000000003 110.046 -177.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' A' ' 60' ' ' TYR . 37.2 tp -111.9 165.51 12.02 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.483 -0.562 . . . . 71.25 109.483 -178.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.437 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 12.7 p90 -141.33 168.72 13.18 Favored Pre-proline 0 C--N 1.28 -2.429 0 C-N-CA 125.698 1.599 . . . . 62.240000000000002 108.569 -170.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 5.7 Cg_exo -37.24 120.49 0.31 Allowed 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 124.344 3.363 . . . . 74.340000000000003 114.427 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 53' ' ' PHE . 12.4 p -130.11 150.0 51.57 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.037 -0.983 . . . . 74.150000000000006 110.468 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.7 mm -110.06 141.36 25.59 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.908 0 N-CA-C 108.742 -0.836 . . . . 74.010000000000005 108.742 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.447 ' CG1' ' HB3' ' A' ' 118' ' ' TRP . 29.9 m -146.87 150.33 38.85 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 109.101 -0.703 . . . . 73.109999999999999 109.101 175.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -59.33 134.68 60.39 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.66 2.24 . . . . 71.439999999999998 112.246 176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.434 ' HB2' ' CG ' ' A' ' 51' ' ' GLN . 34.8 t -125.68 141.51 51.98 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.934 -0.575 . . . . 72.420000000000002 110.343 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -75.29 -32.79 61.11 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 109.512 -0.551 . . . . 55.149999999999999 109.512 173.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . 0.287 0.1 OUTLIER -131.93 72.91 1.51 Allowed 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 114.031 1.123 . . . . 75.409999999999997 114.031 179.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.35 168.59 40.58 Favored Glycine 0 C--O 1.257 1.579 0 C-N-CA 119.224 -1.465 . . . . 61.219999999999999 113.283 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.44 147.73 29.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 N-CA-C 107.799 -1.186 . . . . 63.340000000000003 107.799 176.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.44 HG13 ' HD3' ' A' ' 52' ' ' ARG . 59.8 t -114.5 119.66 62.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 109.582 -0.525 . . . . 70.219999999999999 109.582 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.7 m-70 -95.63 116.32 28.69 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.534 -0.913 . . . . 71.409999999999997 108.534 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.87 -143.87 4.14 Favored Glycine 0 N--CA 1.418 -2.517 0 C-N-CA 120.718 -0.753 . . . . 52.210000000000001 111.26 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.468 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 75.5 mmtt -134.24 145.13 48.86 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.56 -0.533 . . . . 74.510000000000005 109.56 -176.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 53.7 t -110.58 129.55 65.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 123.104 0.252 . . . . 33.409999999999997 111.148 174.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.452 HD23 HG12 ' A' ' 42' ' ' ILE . 71.0 mt -95.62 111.31 23.26 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.022 -1.473 . . . . 71.030000000000001 107.022 174.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.9 ptp -119.65 144.08 47.36 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.398 -0.521 . . . . 75.310000000000002 111.842 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.26 23.97 7.78 Favored Glycine 0 N--CA 1.427 -1.905 0 CA-C-N 115.459 -0.791 . . . . 70.510000000000005 111.73 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 18' ' ' HIS . 13.2 p -95.02 138.89 19.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 110.017 -0.364 . . . . 74.310000000000002 110.017 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.552 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 3.9 m -79.02 162.05 26.19 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 109.169 -0.678 . . . . 74.030000000000001 109.169 -178.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 26.5 m -58.51 -32.7 69.07 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 112.801 0.667 . . . . 41.119999999999997 112.801 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.64 -49.39 68.87 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 112.322 0.489 . . . . 73.329999999999998 112.322 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.591 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 1.4 mp0 -65.25 -29.49 70.28 Favored 'General case' 0 C--O 1.216 -0.69 0 N-CA-C 109.612 -0.514 . . . . 70.040000000000006 109.612 177.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.7 tp -60.87 -40.33 92.59 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.021 0.439 . . . . 71.420000000000002 109.868 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -69.02 -36.99 78.4 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.152 -0.685 . . . . 75.450000000000003 109.152 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.457 ' O ' HG23 ' A' ' 90' ' ' VAL . 7.7 t30 -63.85 -43.04 97.33 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.114 -0.948 . . . . 64.129999999999995 110.489 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 91.8 mt -61.72 -43.07 99.57 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.748 0.785 . . . . 74.310000000000002 108.935 178.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -61.25 -32.17 71.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.278 -1.328 . . . . 52.020000000000003 111.115 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.21 -42.16 56.19 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.814 -0.63 . . . . 72.439999999999998 110.474 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 86' ' ' ASN . 99.3 t -67.04 -53.23 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.306 0.643 . . . . 73.340000000000003 112.4 -178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -78.28 -20.65 51.16 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.224 0.535 . . . . 70.099999999999994 111.95 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.19 -17.03 16.07 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 116.74 1.456 . . . . 61.149999999999999 116.74 -173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.06 -29.64 69.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 118.56 1.18 . . . . 73.420000000000002 112.533 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -136.56 -0.74 2.36 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 113.359 0.874 . . . . 63.219999999999999 113.359 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -127.41 166.08 18.58 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.663 0.616 . . . . 72.400000000000006 112.663 -177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.3 tp10 -125.17 146.04 49.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.121 -0.945 . . . . 73.430000000000007 108.86 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -92.92 114.12 26.59 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 109.014 -0.736 . . . . 61.130000000000003 109.014 -177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.412 HG11 ' HE3' ' A' ' 117' ' ' MET . 28.3 m -126.49 161.59 32.34 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 120.865 0.364 . . . . 71.109999999999999 111.83 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.7 t -88.14 130.97 34.89 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.249 -0.887 . . . . 74.099999999999994 110.31 -177.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.413 ' HB ' HD11 ' A' ' 47' ' ' LEU . 29.4 m -137.84 165.61 25.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.974 -0.557 . . . . 71.219999999999999 111.522 -178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.481 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -114.67 124.24 6.31 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.477 -1.049 . . . . 70.010000000000005 110.477 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.88 160.51 15.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 120.697 0.284 . . . . 74.010000000000005 110.868 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 109' ' ' GLU . 66.2 t -120.38 114.68 44.7 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.115 -1.439 . . . . 73.010000000000005 107.115 178.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.537 ' HD2' HG21 ' A' ' 43' ' ' VAL . 54.8 mtm180 -69.67 135.56 50.01 Favored 'General case' 0 CA--C 1.478 -1.817 0 C-N-CA 119.981 -0.688 . . . . 72.329999999999998 109.771 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.92 5.55 18.68 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.82 0.819 . . . . 72.129999999999995 109.074 174.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -56.85 -62.09 1.99 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.087 -1.415 . . . . 73.549999999999997 109.559 175.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -137.76 12.3 2.92 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.512 -0.767 . . . . 62.240000000000002 109.288 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 104' ' ' ARG . 23.0 t 62.86 78.57 0.29 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.688 -1.142 . . . . 64.010000000000005 110.486 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 10.2 pt-20 -137.11 151.3 48.71 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 108.133 -1.062 . . . . 71.319999999999993 108.133 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -94.05 140.93 29.12 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 120.35 -0.54 . . . . 71.219999999999999 110.245 -178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 90.6 mtp -141.8 161.5 37.81 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 123.772 0.829 . . . . 74.099999999999994 110.218 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -108.57 129.19 55.31 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 115.459 -0.792 . . . . 34.340000000000003 109.671 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 21' ' ' PHE . 29.5 m -142.84 174.68 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 108.441 -0.948 . . . . 71.329999999999998 108.441 -177.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -113.8 157.62 22.06 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 119.863 -0.735 . . . . 74.439999999999998 109.601 173.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.2 t -149.74 172.64 14.78 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.558 -0.904 . . . . 64.140000000000001 108.558 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 88.5 m-85 -114.51 115.35 27.1 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.192 -0.669 . . . . 75.329999999999998 109.192 -179.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.412 ' HE3' HG11 ' A' ' 98' ' ' VAL 0.256 0.0 OUTLIER -113.42 156.27 23.78 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.001 -0.545 . . . . 73.109999999999999 111.773 -179.772 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.447 ' HB3' ' CG1' ' A' ' 64' ' ' VAL . 68.1 t-105 -67.76 118.01 10.43 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.688 -0.856 . . . . 63.310000000000002 108.688 -175.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 66.7 mt -58.91 -35.75 58.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 114.91 -1.041 . . . . 73.129999999999995 113.156 -171.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -70.69 -31.23 68.05 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.023 0.439 . . . . 72.010000000000005 110.596 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.5 mttt 67.67 -60.1 0.4 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 125.011 1.325 . . . . 74.349999999999994 113.658 178.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.03 102.01 13.59 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 110.149 -0.315 . . . . 72.439999999999998 110.149 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -141.98 123.91 9.01 Favored Pre-proline 0 C--N 1.307 -1.264 0 CA-C-N 116.014 -0.539 . . . . 73.5 110.906 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -87.06 2.67 6.88 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.797 2.332 . . . . 72.549999999999997 113.443 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -94.99 -31.43 13.63 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.669 0.271 . . . . 70.209999999999994 111.387 -177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.524 ' O ' ' HB3' ' A' ' 53' ' ' PHE . 27.0 ptt? -80.18 17.86 0.95 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.824 0.45 . . . . 61.039999999999999 112.17 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -79.74 117.77 20.94 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 121.961 -0.462 . . . . 75.129999999999995 110.046 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.04 167.13 39.09 Favored Glycine 0 CA--C 1.484 -1.878 0 C-N-CA 121.056 -0.592 . . . . 52.119999999999997 111.886 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.3 151.88 34.97 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.565 -0.902 . . . . 70.120000000000005 108.565 177.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.582 ' N ' ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -87.96 153.2 21.48 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 105.522 -2.029 . . . . 72.299999999999997 105.522 177.271 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -60.44 -34.39 73.9 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 118.7 0.682 . . . . 61.32 111.774 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -73.58 -32.67 64.25 Favored 'General case' 0 N--CA 1.415 -2.194 0 C-N-CA 123.199 0.6 . . . . 73.109999999999999 110.604 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.461 ' HG3' ' NH1' ' A' ' 54' ' ' ARG . 78.9 mm-40 -67.24 -33.47 75.4 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 112.972 0.73 . . . . 72.239999999999995 112.972 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.48 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 5.7 tp10 -64.43 -41.39 96.61 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.089 -1.078 . . . . 62.219999999999999 108.089 177.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -70.0 -31.22 68.79 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 115.224 -0.898 . . . . 72.230000000000004 112.812 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 137' ' ' ARG 0.308 0.5 OUTLIER -61.25 -36.67 80.63 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 118.701 -1.2 . . . . 60.119999999999997 112.444 -178.494 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' A' ' 136' ' ' LYS . 38.9 ptt180 -75.87 -29.84 58.67 Favored 'General case' 0 C--O 1.218 -0.564 0 C-N-CA 119.844 -0.742 . . . . 63.009999999999998 111.33 176.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 134' ' ' GLU . 84.9 mt -71.26 -26.63 62.98 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.383 0.611 . . . . 73.030000000000001 109.988 176.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -73.21 -39.06 65.84 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.186 -1.042 . . . . 63.049999999999997 108.186 172.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.601 ' HE2' HD11 ' A' ' 144' ' ' ILE . 88.2 tttt -62.51 -30.59 71.39 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 114.656 -1.156 . . . . 62.329999999999998 110.329 176.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 23.7 tptm -46.77 -38.51 10.18 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.459 1.104 . . . . 73.420000000000002 113.006 -177.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -60.75 -40.3 91.93 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.947 0.88 . . . . 72.530000000000001 109.95 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -76.71 -32.98 58.2 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.503 -1.226 . . . . 74.409999999999997 107.908 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.601 HD11 ' HE2' ' A' ' 140' ' ' LYS . 48.3 mm -65.82 -32.81 59.8 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.719 0 CA-C-N 114.629 -1.169 . . . . 53.530000000000001 111.524 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.508 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 45.0 mt-10 -55.24 -32.06 62.01 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.376 0.608 . . . . 53.450000000000003 110.054 177.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 35.9 m -80.24 -47.19 14.98 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.704 -0.68 . . . . 61.140000000000001 109.45 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.564 ' O ' ' HG2' ' A' ' 151' ' ' MET 0.294 26.9 m-85 -64.13 -30.63 71.68 Favored 'General case' 0 C--O 1.208 -1.128 0 N-CA-C 116.128 1.899 . . . . 72.349999999999994 116.128 -178.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 37.6 mmtm -58.76 -38.85 79.38 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 118.474 0.579 . . . . 64.200000000000003 111.679 175.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -71.23 -33.26 69.69 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.106 -0.701 . . . . 64.530000000000001 109.106 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.442 ' O ' ' HG2' ' A' ' 154' ' ' LYS . 68.3 mt -69.95 -39.0 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.39 -0.823 . . . . 73.519999999999996 109.136 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.564 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 14.4 mmt -61.25 -40.69 94.99 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.175 -0.466 . . . . 61.439999999999998 110.329 178.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.443 ' HG2' ' HG3' ' A' ' 157' ' ' PRO . 46.0 mt-10 -60.29 -41.54 93.57 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.151 0.501 . . . . 62.030000000000001 110.319 177.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 49.0 t -71.56 -31.83 67.43 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.568 -0.742 . . . . 61.119999999999997 110.845 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 75.9 mmtt -74.28 -47.98 31.45 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 120.457 -0.497 . . . . 74.530000000000001 110.204 178.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -154.7 -68.84 0.13 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.453 0.644 . . . . 72.540000000000006 110.358 -177.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -166.47 160.81 12.12 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 107.809 -1.182 . . . . 75.400000000000006 107.809 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.443 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 39.7 Cg_exo -57.84 127.2 24.25 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 122.542 2.162 . . . . 65.340000000000003 111.166 178.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 C--N 1.317 -0.843 0 N-CA-C 109.741 -0.466 . . . . 74.340000000000003 109.741 -177.235 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.0 m . . . . . 0 C--O 1.24 0.602 0 CA-C-O 121.596 0.712 . . . . 73.319999999999993 112.011 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.5 m -72.87 177.36 4.93 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.434 -0.803 . . . . 71.349999999999994 110.43 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.9 m -65.37 -51.37 60.89 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.978 -0.556 . . . . 75.299999999999997 110.625 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.7 t70 71.36 106.53 0.06 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.78 0.832 . . . . 71.219999999999999 112.34 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.1 t 63.02 -159.56 0.32 Allowed 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 115.274 -0.876 . . . . 74.540000000000006 109.902 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -80.49 -11.2 59.7 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 123.351 0.66 . . . . 72.129999999999995 110.254 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 69.04 -179.09 0.23 Allowed 'General case' 0 C--O 1.246 0.897 0 N-CA-C 114.74 1.385 . . . . 64.340000000000003 114.74 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.97 160.37 23.35 Favored 'General case' 0 N--CA 1.413 -2.31 0 CA-C-N 112.497 -2.138 . . . . 65.109999999999999 107.958 173.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.483 ' O ' HG12 ' A' ' 79' ' ' VAL . 49.9 m-70 -109.39 159.67 16.82 Favored 'General case' 0 C--N 1.272 -2.766 0 N-CA-C 108.702 -0.851 . . . . 74.200000000000003 108.702 -173.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 76' ' ' LEU . 21.1 p30 -134.56 128.48 33.34 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 115.114 -0.948 . . . . 64.120000000000005 111.94 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.63 144.48 34.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-N 114.575 -1.193 . . . . 74.299999999999997 111.041 -175.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.0 t80 -94.13 123.14 37.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.75 -0.833 . . . . 72.409999999999997 108.75 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.74 ' HB ' ' O ' ' A' ' 26' ' ' PHE . 20.4 m -94.44 172.84 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 115.853 -0.612 . . . . 62.229999999999997 110.54 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -149.4 -62.41 0.22 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.291 1.96 . . . . 64.200000000000003 116.291 -168.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -116.28 -79.48 0.77 Allowed Glycine 0 C--O 1.215 -1.085 0 C-N-CA 119.314 -1.422 . . . . 73.349999999999994 114.504 -173.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.3 m -65.98 -36.31 82.97 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.98 0.895 . . . . 75.030000000000001 109.187 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.74 ' O ' ' HB ' ' A' ' 22' ' ' VAL . 48.5 m-85 -101.29 100.17 10.64 Favored 'General case' 0 N--CA 1.401 -2.902 0 CA-C-N 114.622 -1.172 . . . . 75.420000000000002 108.196 178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -156.18 3.83 0.17 Allowed 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 115.177 -0.919 . . . . 72.209999999999994 112.509 173.321 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.438 ' HB3' HG23 ' A' ' 31' ' ' VAL . 16.0 t70 -124.71 134.59 25.75 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 109.369 -0.604 . . . . 73.129999999999995 109.369 -176.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 29.6 Cg_endo -63.35 -30.76 73.22 Favored 'Trans proline' 0 C--O 1.211 -0.859 0 C-N-CA 122.879 2.386 . . . . 74.420000000000002 113.988 -177.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -70.26 -35.35 73.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.19 0.519 . . . . 72.120000000000005 109.629 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 28' ' ' ASP . 94.2 t -62.42 -42.42 95.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 108.617 -0.883 . . . . 63.009999999999998 108.617 175.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 36' ' ' LEU . 24.0 mm -66.17 -43.66 91.91 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 114.947 -1.024 . . . . 71.329999999999998 109.584 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 3.5 t-20 -55.36 -43.85 75.44 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 113.648 -1.614 . . . . 64.109999999999999 110.742 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.99 -39.36 17.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.882 -0.599 . . . . 75.120000000000005 111.481 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 8.2 tmm? -64.99 -36.39 84.24 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 110.482 -0.192 . . . . 72.510000000000005 110.482 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 32' ' ' ILE 0.264 0.4 OUTLIER -111.24 -75.36 0.62 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 113.088 0.773 . . . . 64.120000000000005 113.088 174.268 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.6 t70 174.51 -49.08 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 108.328 -0.99 . . . . 73.329999999999998 108.328 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -110.78 175.66 5.34 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.185 -1.371 . . . . 73.010000000000005 109.029 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.0 m -129.29 104.72 17.85 Favored Pre-proline 0 N--CA 1.414 -2.228 0 N-CA-C 108.694 -0.854 . . . . 75.109999999999999 108.694 176.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -56.17 150.86 46.35 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 123.01 2.473 . . . . 75.519999999999996 110.35 177.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -57.71 132.0 51.98 Favored 'General case' 0 CA--C 1.465 -2.318 0 CA-C-O 122.224 1.011 . . . . 63.109999999999999 112.043 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 46.3 mt -107.0 131.73 56.2 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.8 0 CA-C-N 113.219 -1.809 . . . . 71.349999999999994 108.95 -176.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -124.13 146.17 30.06 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 N-CA-C 107.967 -1.123 . . . . 72.019999999999996 107.967 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 44.5 m -77.36 127.95 33.45 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 107.329 -1.36 . . . . 71.299999999999997 107.329 176.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -142.27 154.41 44.72 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 121.039 0.447 . . . . 74.530000000000001 110.95 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.49 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 93.9 m -109.16 125.64 52.41 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.374 -0.83 . . . . 75.329999999999998 110.276 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.405 HD11 ' HB ' ' A' ' 100' ' ' VAL . 35.0 tp -101.43 99.59 11.69 Favored Pre-proline 0 N--CA 1.432 -1.368 0 CA-C-N 116.077 -0.511 . . . . 72.099999999999994 109.936 175.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.1 Cg_endo -83.96 135.53 6.62 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.767 2.311 . . . . 70.319999999999993 111.562 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.11 5.88 46.17 Favored Glycine 0 N--CA 1.434 -1.438 0 C-N-CA 120.552 -0.832 . . . . 71.299999999999997 111.679 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.517 ' HA ' ' H ' ' A' ' 66' ' ' SER . 96.0 m-85 -146.98 150.17 34.62 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.121 -0.696 . . . . 65.519999999999996 109.121 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -140.85 148.56 40.74 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.632 -0.877 . . . . 73.010000000000005 108.632 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -102.03 142.47 33.25 Favored 'General case' 0 N--CA 1.424 -1.734 0 C-N-CA 119.517 -0.873 . . . . 74.510000000000005 108.997 176.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' CB ' ' HB2' ' A' ' 126' ' ' MET . 7.0 m-85 -108.3 171.22 7.54 Favored 'General case' 0 C--N 1.258 -3.375 0 CA-C-N 114.646 -1.161 . . . . 74.409999999999997 111.152 -175.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -88.06 137.98 31.85 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.624 0.972 . . . . 50.149999999999999 113.624 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 5.9 tt -54.69 -63.07 1.27 Allowed 'General case' 0 C--O 1.239 0.5 0 C-N-CA 125.814 1.645 . . . . 50.409999999999997 110.722 -178.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 62.63 -68.28 0.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.637 1.347 . . . . 64.540000000000006 114.637 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.51 -107.15 0.99 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.329 -0.939 . . . . 62.43 113.683 -175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.4 -0.49 33.04 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.636 1.347 . . . . 72.340000000000003 114.636 -176.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.528 HD23 ' HB3' ' A' ' 126' ' ' MET . 31.6 tp -113.67 163.89 14.4 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.202 -0.666 . . . . 63.219999999999999 109.202 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -108.49 170.9 4.98 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.293 -1.373 . . . . 65.549999999999997 107.293 -175.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 16.0 Cg_exo -68.79 93.23 0.44 Allowed 'Trans proline' 0 N--CA 1.446 -1.287 0 N-CA-C 108.219 -1.493 . . . . 71.340000000000003 108.219 171.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 52' ' ' ARG . 22.0 p -99.53 154.94 17.85 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.653 -0.703 . . . . 61.509999999999998 112.509 -174.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.4 HG23 ' HB3' ' A' ' 50' ' ' PHE . 35.4 mm -94.86 127.39 46.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.056 -0.975 . . . . 53.549999999999997 109.469 177.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.44 144.38 52.03 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 109.201 -0.666 . . . . 74.340000000000003 109.201 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.94 108.96 0.36 Allowed 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.552 2.168 . . . . 62.439999999999998 112.983 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.517 ' H ' ' HA ' ' A' ' 50' ' ' PHE . 32.3 t -125.13 98.6 5.73 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 106.09 -1.819 . . . . 61.229999999999997 106.09 176.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.38 -36.6 64.08 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 123.667 0.787 . . . . 71.519999999999996 112.252 -172.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -86.15 -23.9 26.39 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.337 0.589 . . . . 74.530000000000001 110.24 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.74 173.89 45.77 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 115.41 -0.814 . . . . 64.140000000000001 113.099 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -160.4 144.43 14.05 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.331 -0.988 . . . . 75.540000000000006 108.331 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.9 t -113.12 119.83 61.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 109.035 -0.728 . . . . 65.239999999999995 109.035 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -91.45 114.85 27.49 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 105.537 -2.023 . . . . 73.439999999999998 105.537 174.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.44 -143.81 3.9 Favored Glycine 0 N--CA 1.425 -2.076 0 C-N-CA 120.279 -0.962 . . . . 33.439999999999998 112.359 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 47.5 mmtm -123.34 140.61 52.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.946 0.403 . . . . 73.450000000000003 111.325 -173.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 41.0 t -111.08 130.05 65.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 CA-C-N 115.827 -0.624 . . . . 60.039999999999999 110.376 172.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 19' ' ' ASN . 78.3 mt -95.71 109.91 22.12 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 107.863 -1.162 . . . . 62.009999999999998 107.863 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.8 ptp -119.7 137.43 53.92 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.128 0.489 . . . . 63.43 110.43 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.72 18.87 10.96 Favored Glycine 0 N--CA 1.421 -2.33 0 C-N-CA 120.037 -1.078 . . . . 44.140000000000001 111.254 -174.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.0 p -89.69 138.2 19.83 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 N-CA-C 109.009 -0.737 . . . . 74.329999999999998 109.009 178.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 42.6 p -76.84 159.92 29.67 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.422 -0.354 . . . . 63.439999999999998 110.77 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 51.1 m -58.71 -32.03 68.8 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 112.33 0.493 . . . . 62.119999999999997 112.33 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -67.37 -41.09 85.63 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.432 0.634 . . . . 71.219999999999999 109.984 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 63.0 mm-40 -80.2 -28.65 38.63 Favored 'General case' 0 C--O 1.201 -1.499 0 C-N-CA 119.576 -0.85 . . . . 73.420000000000002 112.426 176.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.423 ' HG ' ' CG ' ' A' ' 18' ' ' HIS . 3.1 tm? -60.79 -45.21 95.26 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.059 -0.719 . . . . 73.109999999999999 109.059 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -67.86 -29.92 69.17 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.855 -0.424 . . . . 74.040000000000006 109.855 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -72.95 -40.34 65.45 Favored 'General case' 0 C--O 1.202 -1.407 0 CA-C-N 116.116 -0.493 . . . . 75.310000000000002 110.129 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.522 ' HA ' HG12 ' A' ' 90' ' ' VAL . 95.6 mt -60.17 -40.45 89.99 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.947 0.879 . . . . 64.400000000000006 109.295 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.491 ' CG ' HH21 ' A' ' 97' ' ' ARG . 23.8 t70 -71.48 -29.52 64.92 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.445 -1.252 . . . . 55.409999999999997 111.089 177.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -75.69 -48.21 22.93 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-N 116.347 -0.388 . . . . 64.129999999999995 110.394 177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 87' ' ' LEU . 13.7 p -65.28 -53.41 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.313 0 CA-C-N 115.843 -0.617 . . . . 62.32 111.483 -176.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -78.02 -27.82 48.99 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.167 0.432 . . . . 71.420000000000002 112.167 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -59.91 -17.81 44.78 Favored Glycine 0 N--CA 1.464 0.529 0 N-CA-C 115.007 0.763 . . . . 75.340000000000003 115.007 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -61.52 -32.33 72.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.126 0.463 . . . . 74.430000000000007 111.198 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -130.86 3.83 4.48 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.589 -0.444 . . . . 63.039999999999999 111.793 -178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 92.7 m-85 -138.46 168.0 20.7 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 111.796 0.295 . . . . 74.239999999999995 111.796 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 35.9 tt0 -121.62 144.55 48.69 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.323 -0.399 . . . . 73.150000000000006 110.123 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.491 HH21 ' CG ' ' A' ' 88' ' ' ASP . 16.3 ttm180 -87.45 118.45 26.92 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.328 -0.619 . . . . 75.120000000000005 109.328 -176.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 23.0 m -133.23 162.98 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.485 0 N-CA-C 113.123 0.786 . . . . 60.039999999999999 113.123 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 34.5 p -94.14 124.38 38.11 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.118 -1.401 . . . . 75.340000000000003 109.965 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' A' ' 47' ' ' LEU . 29.3 m -130.92 158.31 43.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-O 120.844 0.354 . . . . 65.109999999999999 111.251 -177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -103.58 115.8 5.22 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 111.394 -0.682 . . . . 72.319999999999993 111.394 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.7 pp -111.04 155.76 12.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 110.189 -0.3 . . . . 54.409999999999997 110.189 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 46.7 t -119.9 120.08 62.14 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 108.701 -0.851 . . . . 63.329999999999998 108.701 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.468 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 39.7 mtp180 -64.38 134.92 55.56 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.946 0.403 . . . . 60.32 111.017 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -75.89 -6.93 53.15 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.892 -1.151 . . . . 51.009999999999998 107.892 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.88 -64.6 0.77 Allowed 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 125.719 1.607 . . . . 74.430000000000007 110.938 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -144.89 15.34 1.55 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 120.741 -0.384 . . . . 71.310000000000002 110.293 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 56.7 m 63.53 63.09 0.89 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.651 -0.704 . . . . 74.25 111.656 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.47 137.57 52.44 Favored 'General case' 0 N--CA 1.425 -1.685 0 N-CA-C 107.373 -1.343 . . . . 64.439999999999998 107.373 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -98.19 140.97 31.7 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-O 121.433 0.635 . . . . 75.239999999999995 111.32 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.468 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 89.0 mtp -138.51 162.58 34.16 Favored 'General case' 0 CA--C 1.476 -1.897 0 CA-C-N 114.977 -1.011 . . . . 71.439999999999998 110.358 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -109.44 122.35 47.2 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.963 -1.017 . . . . 63.340000000000003 109.199 176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.06 174.46 13.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 109.109 -0.7 . . . . 73.230000000000004 109.109 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -98.26 161.25 13.8 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.565 -0.854 . . . . 62.140000000000001 109.14 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.0 t -156.93 172.57 18.43 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.737 -1.208 . . . . 72.340000000000003 107.737 173.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.1 m-85 -124.41 113.9 18.79 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.094 -0.706 . . . . 60.140000000000001 109.094 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.94 157.52 22.31 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 120.935 0.398 . . . . 72.430000000000007 110.974 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.424 ' NE1' ' HB3' ' A' ' 120' ' ' ASN . 55.4 t-105 -67.52 128.82 37.87 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.573 -0.899 . . . . 74.120000000000005 108.573 -177.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 119' ' ' ILE . 2.7 mp -72.02 -41.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.643 -0.253 . . . . 73.239999999999995 111.159 -173.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.424 ' HB3' ' NE1' ' A' ' 118' ' ' TRP . 27.1 t-20 -62.31 -37.17 84.54 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.768 -0.651 . . . . 72.239999999999995 111.377 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 119' ' ' ILE . 57.2 mttp 68.29 -38.7 0.38 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.427 1.491 . . . . 72.25 114.361 175.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -115.63 76.09 0.99 Allowed 'General case' 0 C--N 1.308 -1.211 0 O-C-N 121.903 -0.498 . . . . 73.329999999999998 110.502 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -106.12 132.95 20.47 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 108.542 -0.91 . . . . 61.130000000000003 108.542 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.19 -19.07 29.97 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.763 2.309 . . . . 75.109999999999999 114.361 -177.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -76.52 -37.32 56.92 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 113.222 0.823 . . . . 75.420000000000002 113.222 -175.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.528 ' HB3' HD23 ' A' ' 59' ' ' LEU . 26.4 ptt? -73.06 -16.7 61.48 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-O 121.439 0.638 . . . . 71.040000000000006 109.933 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -77.19 85.2 3.65 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 107.137 -1.431 . . . . 74.549999999999997 107.137 176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.58 -144.33 6.68 Favored Glycine 0 CA--C 1.464 -3.096 0 CA-C-N 114.62 -1.173 . . . . 51.140000000000001 111.364 -176.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -105.12 126.4 52.04 Favored 'General case' 0 N--CA 1.392 -3.364 0 N-CA-C 105.278 -2.119 . . . . 72.519999999999996 105.278 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -110.17 159.28 17.5 Favored 'General case' 0 C--N 1.262 -3.229 0 N-CA-C 106.065 -1.828 . . . . 71.299999999999997 106.065 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 134' ' ' GLU . 17.3 m120 -61.57 95.79 0.05 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.045 -1.095 . . . . 70.310000000000002 108.045 174.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -61.27 -33.09 72.97 Favored 'General case' 0 N--CA 1.406 -2.632 0 C-N-CA 123.585 0.754 . . . . 74.209999999999994 111.634 -176.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -64.93 -28.28 69.42 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.513 0.673 . . . . 73.230000000000004 110.016 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 35.6 tt0 -79.34 -54.32 6.06 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.08 -0.964 . . . . 73.420000000000002 109.467 175.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -58.53 -40.42 82.9 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.752 -0.658 . . . . 75.120000000000005 112.771 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -53.12 -34.18 55.61 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.53 0.732 . . . . 72.510000000000005 110.607 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 134' ' ' GLU . 67.5 ttt180 -63.31 -51.62 65.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.06 -0.518 . . . . 75.340000000000003 111.396 177.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -76.88 -25.58 53.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.291 0.567 . . . . 74.219999999999999 110.357 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -67.76 -24.57 65.36 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.375 -0.83 . . . . 65.430000000000007 109.937 177.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.677 ' O ' HG12 ' A' ' 144' ' ' ILE . 38.8 ttpt -56.31 -35.79 67.94 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 116.278 -0.419 . . . . 71.150000000000006 110.589 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.555 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 38.7 ttmt -54.76 -41.94 71.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.996 0.519 . . . . 73.010000000000005 110.192 -179.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -61.75 -44.41 96.96 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 122.126 0.965 . . . . 72.109999999999999 108.66 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -67.44 -38.25 84.23 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.404 -1.725 . . . . 75.239999999999995 109.977 -176.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 140' ' ' LYS . 42.4 mm -67.05 -35.53 74.77 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.455 0 CA-C-N 115.609 -0.723 . . . . 71.400000000000006 110.174 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.555 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.5 mt-10 -59.88 -30.91 69.32 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 120.748 0.309 . . . . 61.32 111.134 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.529 ' O ' HG13 ' A' ' 150' ' ' ILE . 33.3 m -73.59 -48.44 32.76 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 108.904 -0.776 . . . . 71.230000000000004 108.904 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.522 ' O ' ' HG2' ' A' ' 151' ' ' MET . 51.1 m-85 -71.62 -36.29 70.73 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 115.271 1.582 . . . . 73.219999999999999 115.271 -178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 88.5 tttt -61.93 -34.35 75.93 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.47 -0.937 . . . . 72.430000000000007 108.47 177.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . 0.563 ' NZ ' ' HB2' ' A' ' 149' ' ' LYS . 4.1 ttmp? -75.19 -37.85 61.03 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 114.686 -1.143 . . . . 71.310000000000002 109.855 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 146' ' ' THR . 88.8 mt -64.49 -33.49 63.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.815 -0.629 . . . . 70.409999999999997 109.503 175.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' A' ' 147' ' ' PHE . 24.8 mmt -72.74 -27.96 62.35 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.288 -0.415 . . . . 61.229999999999997 110.648 176.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 43.3 mt-10 -68.7 -30.69 69.41 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 108.709 -0.849 . . . . 73.430000000000007 108.709 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 150' ' ' ILE . 52.3 t -70.48 -32.87 70.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.317 -0.856 . . . . 63.5 109.959 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 150' ' ' ILE . 75.0 mmtt -72.43 -38.15 68.43 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 109.385 -0.598 . . . . 71.400000000000006 109.385 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 99.2 mttt 74.54 120.87 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 124.845 1.258 . . . . 74.310000000000002 113.087 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.01 120.76 75.3 Favored Pre-proline 0 C--N 1.299 -1.626 0 N-CA-C 106.79 -1.559 . . . . 71.329999999999998 106.79 173.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.6 89.01 0.1 OUTLIER 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.993 2.462 . . . . 71.340000000000003 113.901 -176.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 . . . . . 0 C--O 1.246 0.883 0 C-N-CA 125.188 1.395 . . . . 51.409999999999997 108.139 179.827 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.8 t . . . . . 0 N--CA 1.428 -1.57 0 N-CA-C 109.369 -0.604 . . . . 43.020000000000003 109.369 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.5 m -91.29 88.49 6.9 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 109.517 -0.549 . . . . 75.409999999999997 109.517 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.1 m -88.73 -10.8 47.05 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.538 -0.756 . . . . 61.32 111.683 -179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 77.05 -37.67 0.28 Allowed 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 124.773 1.229 . . . . 65.030000000000001 113.382 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 p -71.05 -171.29 0.54 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 123.017 0.527 . . . . 70.109999999999999 111.283 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.93 113.07 4.13 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 107.066 -1.457 . . . . 63.240000000000002 107.066 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -142.39 -164.98 1.93 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.043 -0.526 . . . . 71.200000000000003 109.725 -173.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.2 mt -81.94 152.92 26.54 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.821 -0.807 . . . . 74.140000000000001 108.821 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -115.71 159.74 20.99 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 116.513 -0.312 . . . . 73.329999999999998 110.608 -172.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.47 ' HB3' HG12 ' A' ' 113' ' ' VAL . 49.2 m-20 -121.28 127.57 51.49 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.496 -1.298 . . . . 75.319999999999993 107.496 176.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.1 t -131.64 130.26 62.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 122.357 -0.214 . . . . 73.319999999999993 110.832 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.41 ' HB2' HG21 ' A' ' 113' ' ' VAL . 93.8 t80 -94.48 121.64 36.23 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.185 -1.413 . . . . 64.25 107.185 174.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.566 HG21 ' HB2' ' A' ' 26' ' ' PHE . 4.0 p -97.0 139.73 18.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.592 -0.731 . . . . 74.430000000000007 110.666 -176.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -77.65 -36.85 51.05 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 115.092 1.516 . . . . 73.0 115.092 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.41 -74.49 0.02 OUTLIER Glycine 0 C--O 1.225 -0.463 0 C-N-CA 117.584 -2.246 . . . . 72.329999999999998 115.774 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 29.3 t -58.57 -36.24 73.63 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 113.733 1.012 . . . . 74.549999999999997 113.733 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.599 ' HB3' HD11 ' A' ' 32' ' ' ILE . 62.4 m-85 -99.38 22.67 10.32 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.221 -0.992 . . . . 63.350000000000001 112.501 -175.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.447 ' HG2' HG13 ' A' ' 22' ' ' VAL . 80.5 mt-30 -74.29 -11.23 60.21 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 120.633 0.254 . . . . 72.340000000000003 111.279 176.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -101.76 128.77 28.06 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.455 -0.338 . . . . 65.219999999999999 111.431 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.499 ' HB3' HG21 ' A' ' 39' ' ' THR . 18.0 Cg_endo -62.95 -37.04 56.55 Favored 'Trans proline' 0 CA--C 1.532 0.41 0 C-N-CA 122.943 2.429 . . . . 51.5 113.114 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 34' ' ' VAL . 4.8 m-20 -65.62 -33.79 76.72 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.718 -0.614 . . . . 72.25 110.818 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.6 t -65.52 -40.82 89.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 115.736 -0.666 . . . . 71.219999999999999 109.589 173.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 26' ' ' PHE . 43.6 mm -65.84 -42.1 91.48 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 CA-C-N 115.966 -0.561 . . . . 72.409999999999997 111.103 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -58.77 -34.55 71.56 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.892 0.377 . . . . 74.200000000000003 110.692 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 30' ' ' ASP . 94.4 t -77.65 -46.6 27.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.089 -0.505 . . . . 71.430000000000007 110.841 179.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 62.0 ttp -63.56 -36.81 85.01 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.02 0.378 . . . . 70.299999999999997 112.02 -177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.51 HD12 ' H ' ' A' ' 37' ' ' ASP 0.374 3.6 pp -126.01 -58.77 1.36 Allowed 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 115.379 1.622 . . . . 75.230000000000004 115.379 -178.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.51 ' H ' HD12 ' A' ' 36' ' ' LEU . 22.7 t70 170.56 -53.22 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.307 0.575 . . . . 70.439999999999998 110.618 -177.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.551 ' O ' HG22 ' A' ' 32' ' ' ILE . 88.8 mtt180 -123.21 -167.35 1.59 Allowed 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.548 -0.908 . . . . 71.430000000000007 108.548 -177.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.499 HG21 ' HB3' ' A' ' 29' ' ' PRO . 76.2 m -139.55 121.13 9.8 Favored Pre-proline 0 N--CA 1.432 -1.369 0 CA-C-O 120.502 0.191 . . . . 63.32 111.203 171.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.25 153.47 46.37 Favored 'Trans proline' 0 C--O 1.247 0.949 0 C-N-CA 123.56 2.84 . . . . 74.140000000000001 110.815 173.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.02 129.56 38.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.379 0.609 . . . . 74.120000000000005 110.204 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 54.2 mt -111.77 139.51 35.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 115.982 -0.554 . . . . 53.039999999999999 109.754 -175.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 12.0 p -127.98 145.85 34.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.467 -0.568 . . . . 61.539999999999999 109.467 176.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.463 ' HB3' ' OE1' ' A' ' 105' ' ' GLU . 40.3 m -78.32 122.44 25.76 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.353 -0.98 . . . . 74.019999999999996 108.353 176.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -141.26 159.41 42.28 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.921 0.867 . . . . 61.140000000000001 112.27 -175.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.401 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 56.1 m -120.08 129.37 54.18 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 114.809 -1.087 . . . . 73.219999999999999 108.632 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 50.0 tp -98.85 104.02 22.75 Favored Pre-proline 0 C--N 1.29 -1.982 0 N-CA-C 108.864 -0.791 . . . . 65.340000000000003 108.864 176.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.0 OUTLIER -82.44 148.84 14.63 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 122.533 2.155 . . . . 72.019999999999996 111.543 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 84.33 16.7 66.1 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.888 -0.672 . . . . 63.340000000000003 112.255 178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -145.4 159.89 42.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.956 -1.128 . . . . 53.329999999999998 107.956 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.561 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 11.1 pt20 -139.24 163.74 31.67 Favored 'General case' 0 CA--C 1.481 -1.682 0 C-N-CA 119.313 -0.955 . . . . 71.530000000000001 111.401 176.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.574 ' HD3' ' NH1' ' A' ' 54' ' ' ARG . 0.8 OUTLIER -107.94 129.83 55.07 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.892 -1.504 . . . . 72.519999999999996 112.858 -176.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.561 ' CE1' ' HG3' ' A' ' 51' ' ' GLN . 5.4 m-85 -109.11 158.21 18.0 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.104 -0.953 . . . . 75.340000000000003 109.905 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.574 ' NH1' ' HD3' ' A' ' 52' ' ' ARG . 6.0 mpt_? -125.68 133.35 52.19 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.442 -0.345 . . . . 73.299999999999997 110.21 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.463 HD13 ' N ' ' A' ' 56' ' ' LYS . 2.9 tm? -170.55 137.74 1.41 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.247 -1.39 . . . . 64.420000000000002 107.247 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.463 ' N ' HD13 ' A' ' 55' ' ' LEU . 97.4 mttt -125.45 113.6 17.71 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.125 0.488 . . . . 74.230000000000004 110.151 177.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.84 -120.11 0.92 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.413 -1.475 . . . . 71.510000000000005 109.413 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -20.98 60.58 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-O 121.412 0.625 . . . . 72.319999999999993 110.856 177.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.443 HD12 ' H ' ' A' ' 60' ' ' TYR . 33.0 tp -119.66 163.5 17.3 Favored 'General case' 0 N--CA 1.416 -2.125 0 CA-C-N 115.362 -0.835 . . . . 75.430000000000007 109.033 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.443 ' H ' HD12 ' A' ' 59' ' ' LEU . 9.2 m-85 -122.3 175.55 2.53 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 106.755 -1.572 . . . . 70.219999999999999 106.755 -172.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -68.23 89.47 0.39 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 121.691 1.594 . . . . 63.119999999999997 110.002 172.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 20.5 p -100.1 164.69 11.87 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 112.48 0.548 . . . . 63.409999999999997 112.48 -175.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 49.6 mm -110.12 140.5 28.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.405 -0.961 . . . . 73.430000000000007 108.405 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -145.68 154.71 52.38 Favored Pre-proline 0 C--O 1.251 1.146 0 N-CA-C 108.057 -1.09 . . . . 73.019999999999996 108.057 176.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.41 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 8.4 Cg_endo -56.91 131.73 47.33 Favored 'Trans proline' 0 C--O 1.246 0.909 0 C-N-CA 122.572 2.181 . . . . 64.200000000000003 112.013 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.2 t -124.46 140.58 52.82 Favored 'General case' 0 N--CA 1.426 -1.635 0 CA-C-N 115.286 -0.87 . . . . 34.439999999999998 108.936 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -74.35 -37.22 63.57 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.242 0.544 . . . . 70.040000000000006 109.582 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -130.94 82.33 2.04 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.611 -0.722 . . . . 75.420000000000002 110.231 176.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -167.06 164.28 37.75 Favored Glycine 0 C--N 1.299 -1.491 0 C-N-CA 119.528 -1.32 . . . . 70.299999999999997 112.811 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.22 148.19 30.24 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.832 -0.803 . . . . 72.400000000000006 108.832 176.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.16 122.21 69.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.442 -0.577 . . . . 63.329999999999998 109.442 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.4 m-70 -97.53 116.54 29.94 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.727 -0.472 . . . . 62.450000000000003 109.727 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.427 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -152.48 -154.68 6.76 Favored Glycine 0 N--CA 1.418 -2.566 0 N-CA-C 110.317 -1.113 . . . . 44.240000000000002 110.317 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' A' ' 73' ' ' GLY . 14.3 mptt -125.76 153.4 44.03 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.586 0.708 . . . . 75.519999999999996 111.88 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 69.9 t -110.81 130.18 64.66 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 CA-C-N 114.206 -1.361 . . . . 74.120000000000005 110.599 177.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.413 HD23 HG12 ' A' ' 42' ' ' ILE . 65.7 mt -95.41 111.14 23.07 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 105.954 -1.869 . . . . 51.420000000000002 105.954 175.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 16.0 ptp -124.28 152.27 43.23 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.089 0.471 . . . . 64.209999999999994 112.006 -178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.92 18.72 53.68 Favored Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 109.189 -1.564 . . . . 63.030000000000001 109.189 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 83' ' ' GLU . 54.7 t -71.91 127.24 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-N 114.253 -0.974 . . . . 73.140000000000001 109.716 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.438 ' O ' HG12 ' A' ' 79' ' ' VAL . 54.7 p -74.88 161.08 29.86 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.852 -1.166 . . . . 75.420000000000002 107.852 174.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 42.3 m -61.19 -26.83 67.98 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 122.182 -0.324 . . . . 73.530000000000001 111.837 -176.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -65.43 -40.73 93.67 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.588 0.709 . . . . 41.539999999999999 110.793 176.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.511 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 38.1 mt-10 -78.0 -35.03 50.48 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.559 -0.746 . . . . 74.230000000000004 109.048 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.569 HD11 ' NH1' ' A' ' 97' ' ' ARG . 3.1 tm? -62.17 -51.41 67.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.478 -0.783 . . . . 70.120000000000005 110.11 175.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -64.05 -29.36 70.51 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 109.819 -0.437 . . . . 74.109999999999999 109.819 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 7.1 t30 -59.71 -46.56 88.73 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.956 -0.757 . . . . 54.219999999999999 108.956 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 95.1 mt -72.44 -36.78 68.63 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.881 -0.599 . . . . 75.040000000000006 110.949 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.426 ' O ' ' HA3' ' A' ' 92' ' ' GLY . 26.3 t70 -64.36 -31.45 72.67 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.901 0.858 . . . . 65.549999999999997 109.241 177.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.86 -47.21 21.95 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.591 -0.731 . . . . 71.420000000000002 111.458 174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 86' ' ' ASN . 90.5 t -72.16 -60.2 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.911 0 N-CA-C 112.77 0.655 . . . . 65.530000000000001 112.77 -176.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -83.0 -41.84 18.24 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.87 0.843 . . . . 72.040000000000006 111.822 177.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 88' ' ' ASP . . . -59.58 -16.58 37.58 Favored Glycine 0 C--O 1.215 -1.041 0 N-CA-C 118.238 2.055 . . . . 62.450000000000003 118.238 -171.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -69.96 -45.16 67.98 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 120.154 1.977 . . . . 63.100000000000001 112.22 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -98.09 -3.61 37.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.242 0.544 . . . . 60.049999999999997 111.266 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 116' ' ' TYR . 83.5 m-85 -122.24 169.43 10.91 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 123.769 0.828 . . . . 64.420000000000002 110.012 -178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.423 ' HB2' HG13 ' A' ' 119' ' ' ILE . 35.3 tt0 -122.62 132.35 54.24 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.869 -0.789 . . . . 62.340000000000003 108.869 176.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.569 ' NH1' HD11 ' A' ' 84' ' ' LEU . 9.6 ttp180 -87.01 114.1 23.33 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.902 -1.045 . . . . 75.230000000000004 109.704 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 27.4 m -123.87 161.93 25.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 114.712 -1.131 . . . . 75.420000000000002 110.813 -177.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.2 t -94.42 129.28 41.22 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.763 -0.828 . . . . 43.020000000000003 108.763 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.94 170.32 17.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 120.963 0.411 . . . . 63.039999999999999 111.132 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -112.84 124.5 6.66 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.971 -0.852 . . . . 65.420000000000002 110.971 177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.8 pp -111.88 160.07 11.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 122.874 0.469 . . . . 74.219999999999999 110.117 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 81.4 t -120.73 127.07 75.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 108.467 -0.938 . . . . 73.219999999999999 108.467 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.612 ' HD2' ' SD ' ' A' ' 111' ' ' MET . 28.2 mtp180 -68.79 135.63 51.5 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.011 -0.54 . . . . 72.030000000000001 110.676 -177.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.463 ' OE1' ' HB3' ' A' ' 44' ' ' SER . 49.2 mt-10 -79.56 -5.73 55.55 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.07 -0.514 . . . . 74.319999999999993 109.748 177.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.12 -67.62 0.42 Allowed 'General case' 0 CA--C 1.514 -0.418 0 CA-C-N 115.033 -0.985 . . . . 63.109999999999999 110.528 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 32.9 p-10 -132.16 12.29 4.65 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.635 -1.166 . . . . 61.119999999999997 112.289 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 25.9 t 69.85 18.78 7.28 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.795 0.838 . . . . 75.310000000000002 113.133 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -88.21 149.96 23.56 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 121.855 -0.528 . . . . 71.200000000000003 110.923 176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -95.02 147.53 23.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.122 0.487 . . . . 74.540000000000006 111.092 -176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.612 ' SD ' ' HD2' ' A' ' 104' ' ' ARG . 90.6 mtp -141.56 160.92 39.16 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 123.625 0.77 . . . . 52.229999999999997 110.329 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -104.16 130.88 51.91 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.552 -0.749 . . . . 44.399999999999999 110.779 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.47 HG12 ' HB3' ' A' ' 19' ' ' ASN . 28.8 m -142.83 174.02 5.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 73.329999999999998 110.402 -177.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -100.21 149.46 23.53 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 106.445 -1.687 . . . . 73.319999999999993 106.445 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 6.7 t -150.35 172.09 15.95 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.085 -0.709 . . . . 74.450000000000003 109.085 174.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 95' ' ' TYR . 81.0 m-85 -120.91 108.89 14.44 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 123.452 0.47 . . . . 51.310000000000002 109.951 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.41 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 24.0 ptt? -112.42 155.87 23.49 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.093 -0.503 . . . . 43.420000000000002 109.728 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -69.56 129.44 39.68 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.461 -0.941 . . . . 74.439999999999998 108.461 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.54 ' H ' HD12 ' A' ' 119' ' ' ILE . 2.7 mp -72.65 -42.81 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.763 0.316 . . . . 64.340000000000003 111.762 -171.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -71.1 -36.91 72.36 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 109.136 -0.69 . . . . 63.140000000000001 109.136 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt 52.34 9.32 0.1 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 126.318 1.847 . . . . 74.409999999999997 114.908 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -131.96 14.14 4.77 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.386 0.513 . . . . 74.510000000000005 112.386 -176.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 4.8 m-20 -67.08 122.42 82.58 Favored Pre-proline 0 N--CA 1.471 0.576 0 N-CA-C 110.182 -0.303 . . . . 70.150000000000006 110.182 176.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 123' ' ' ASP . 12.2 Cg_exo -72.28 -5.96 18.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.587 2.191 . . . . 75.409999999999997 112.974 -178.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -59.71 -53.3 59.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 121.305 0.574 . . . . 64.310000000000002 110.225 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.403 ' HB3' HD23 ' A' ' 59' ' ' LEU . 23.7 ptt? -73.67 141.73 46.45 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.801 -1.091 . . . . 64.450000000000003 112.233 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -116.06 134.48 54.91 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.554 -0.906 . . . . 73.340000000000003 108.554 174.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 53' ' ' PHE . . . -84.5 29.34 4.05 Favored Glycine 0 CA--C 1.492 -1.365 0 C-N-CA 121.056 -0.592 . . . . 51.25 113.481 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -124.63 149.91 46.59 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-O 121.853 0.835 . . . . 72.040000000000006 111.519 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . 0.421 ' O ' ' HG3' ' A' ' 133' ' ' GLU . 15.1 t90 -111.83 162.08 15.66 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 106.284 -1.747 . . . . 75.019999999999996 106.284 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.502 ' HA ' ' OE2' ' A' ' 133' ' ' GLU . 17.6 m120 -45.59 3.66 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 116.353 1.983 . . . . 71.120000000000005 116.353 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -61.14 -31.36 71.08 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 107.649 -1.241 . . . . 74.540000000000006 107.649 170.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.502 ' OE2' ' HA ' ' A' ' 131' ' ' ASN . 0.0 OUTLIER -56.28 -34.65 66.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.324 0.861 . . . . 71.450000000000003 113.324 177.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 137' ' ' ARG . 36.5 tt0 -68.32 -39.74 81.89 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.801 -0.444 . . . . 52.340000000000003 109.801 173.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -63.5 -30.02 71.2 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.856 -0.611 . . . . 72.439999999999998 110.316 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 133' ' ' GLU . 23.3 tptm -52.21 -39.13 59.76 Favored 'General case' 0 C--O 1.218 -0.597 0 C-N-CA 123.19 0.596 . . . . 75.129999999999995 110.299 177.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.442 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 61.9 ttt180 -57.04 -48.28 78.9 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.276 0.63 . . . . 74.540000000000006 111.742 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.97 -26.8 30.96 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 121.154 0.502 . . . . 63.399999999999999 110.703 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 -82.03 -27.3 33.13 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.685 -0.689 . . . . 74.109999999999999 112.116 -177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.544 ' O ' HG12 ' A' ' 144' ' ' ILE . 63.9 pttt -66.59 -32.52 73.91 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 110.199 -0.297 . . . . 73.010000000000005 110.199 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.523 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 50.2 mtmt -48.58 -35.15 12.83 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.818 0.847 . . . . 73.310000000000002 112.589 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -58.96 -45.39 90.62 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.3 0.572 . . . . 73.25 110.826 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -76.12 -34.87 59.48 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.918 -0.771 . . . . 61.140000000000001 108.918 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 140' ' ' LYS . 47.1 mm -61.43 -33.97 59.2 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.759 0 CA-C-N 115.081 -0.963 . . . . 75.340000000000003 110.193 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.3 mt-10 -54.15 -35.88 62.72 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-O 120.742 0.306 . . . . 72.510000000000005 110.843 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.9 m -70.6 -47.37 60.48 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 116.128 -0.487 . . . . 73.239999999999995 110.018 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -71.84 -30.51 65.53 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 113.238 0.829 . . . . 71.040000000000006 113.238 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -56.9 -42.87 80.69 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.981 -0.748 . . . . 73.329999999999998 108.981 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -70.92 -38.43 72.93 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.785 -1.098 . . . . 74.420000000000002 108.931 -177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 87.3 mt -65.55 -41.08 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 CA-C-N 115.754 -0.657 . . . . 61.030000000000001 110.355 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 70.9 mtm -67.79 -37.75 82.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.514 -0.312 . . . . 74.140000000000001 110.818 177.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.439 ' HG2' ' HD2' ' A' ' 157' ' ' PRO . 45.1 mt-10 -67.84 -31.29 71.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.806 0.336 . . . . 74.430000000000007 111.016 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 42.4 t -71.91 -47.1 55.04 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.354 -0.385 . . . . 63.32 111.459 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -80.52 -45.11 18.01 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.617 0.599 . . . . 65.230000000000004 112.617 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.56 -45.01 4.54 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.202 0.445 . . . . 74.409999999999997 112.202 -175.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 87.5 tttt 69.52 75.07 0.26 Allowed Pre-proline 0 C--N 1.312 -1.027 0 C-N-CA 124.193 0.997 . . . . 74.439999999999998 111.454 -174.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . 0.439 ' HD2' ' HG2' ' A' ' 152' ' ' GLU . 73.6 Cg_endo -101.39 -176.43 0.13 Allowed 'Trans proline' 0 N--CA 1.426 -2.443 0 C-N-CA 122.662 2.241 . . . . 53.530000000000001 110.546 173.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 . . . . . 0 C--N 1.298 -1.663 0 N-CA-C 109.272 -0.64 . . . . 74.040000000000006 109.272 175.648 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.429 -1.481 0 CA-C-O 121.493 0.663 . . . . 53.350000000000001 111.563 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.7 m -120.98 17.65 11.72 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.127 -1.064 . . . . 73.230000000000004 108.127 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.6 m -55.07 -45.05 75.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.908 -1.496 . . . . 74.310000000000002 111.736 -178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.7 t70 64.62 85.49 0.14 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.778 0.831 . . . . 74.150000000000006 110.883 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 m -164.49 -177.21 4.73 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.362 -1.348 . . . . 73.510000000000005 107.362 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -74.78 -76.5 0.14 Allowed 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 117.76 0.254 . . . . 71.400000000000006 110.39 177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 48.57 -156.47 0.07 Allowed 'General case' 0 C--O 1.25 1.088 0 O-C-N 124.933 1.396 . . . . 71.430000000000007 110.875 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -86.62 154.04 21.33 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 108.4 -0.963 . . . . 73.209999999999994 108.4 172.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.429 ' O ' HG12 ' A' ' 79' ' ' VAL . 40.8 m-70 -115.15 159.56 20.76 Favored 'General case' 0 C--N 1.271 -2.848 0 N-CA-C 108.933 -0.765 . . . . 53.130000000000003 108.933 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.43 ' HB2' HG12 ' A' ' 113' ' ' VAL . 34.6 m-20 -116.97 125.34 51.25 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.824 -1.176 . . . . 63.100000000000001 107.824 176.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.7 t -125.47 142.08 43.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 109.759 -0.46 . . . . 70.109999999999999 109.759 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.554 ' HB2' HG21 ' A' ' 113' ' ' VAL . 91.1 t80 -94.34 123.13 37.55 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.044 -1.095 . . . . 64.239999999999995 108.044 177.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.563 HG21 ' HB2' ' A' ' 26' ' ' PHE . 14.8 p -107.89 148.41 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 CA-C-O 121.445 0.64 . . . . 52.130000000000003 110.609 -176.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -118.02 -59.75 1.87 Allowed 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 115.175 -0.92 . . . . 74.430000000000007 113.046 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -133.22 -60.14 0.08 OUTLIER Glycine 0 C--N 1.336 0.564 0 C-N-CA 118.663 -1.732 . . . . 64.140000000000001 115.41 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.2 m -57.84 -24.34 56.98 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.388 0.884 . . . . 55.009999999999998 113.388 -172.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.563 ' HB2' HG21 ' A' ' 22' ' ' VAL . 49.8 m-85 -132.0 25.13 4.61 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.723 -0.843 . . . . 61.219999999999999 108.723 -176.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -69.46 -30.18 68.02 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.308 0.575 . . . . 63.32 112.478 -173.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 31' ' ' VAL . 31.0 t70 -96.65 130.89 29.3 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.893 -0.594 . . . . 72.400000000000006 111.334 -176.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.478 ' O ' ' HB ' ' A' ' 32' ' ' ILE . 19.0 Cg_endo -60.24 -28.25 86.52 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.52 2.147 . . . . 52.240000000000002 113.692 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.451 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 22.0 t70 -70.52 -41.74 72.18 Favored 'General case' 0 CA--C 1.509 -0.61 0 C-N-CA 120.567 -0.453 . . . . 74.310000000000002 110.926 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 28' ' ' ASP . 9.8 p -65.92 -28.57 44.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 C-N-CA 119.887 -0.725 . . . . 64.430000000000007 109.33 177.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.528 HG23 HD21 ' A' ' 36' ' ' LEU . 37.5 mm -61.52 -46.75 95.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 109.598 -0.519 . . . . 75.409999999999997 109.598 175.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -60.89 -32.19 71.66 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.925 -0.58 . . . . 53.409999999999997 111.94 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.4 t -81.71 -38.91 16.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 120.636 -0.425 . . . . 74.329999999999998 111.59 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 6.3 tmm? -74.75 -36.81 62.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.482 -0.326 . . . . 72.109999999999999 110.776 -173.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.528 HD21 HG23 ' A' ' 32' ' ' ILE 0.275 0.4 OUTLIER -117.02 -60.78 1.8 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.169 -0.612 . . . . 52.509999999999998 111.987 176.764 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.431 ' OD2' ' HG2' ' A' ' 38' ' ' ARG . 30.5 t70 162.13 -50.99 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 124.597 1.159 . . . . 71.420000000000002 110.236 176.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' HA ' ' NE ' ' A' ' 38' ' ' ARG . 4.6 mmp_? -118.88 152.76 35.68 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.957 -0.565 . . . . 63.520000000000003 110.636 -176.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.421 ' HA ' ' CG2' ' A' ' 32' ' ' ILE . 5.0 m -95.74 120.2 63.71 Favored Pre-proline 0 C--O 1.245 0.829 0 CA-C-N 116.647 -0.251 . . . . 75.230000000000004 111.009 -179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -67.47 152.71 78.26 Favored 'Trans proline' 0 C--O 1.244 0.807 0 C-N-CA 122.77 2.313 . . . . 71.420000000000002 109.36 172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.42 129.0 39.86 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.331 -0.547 . . . . 74.209999999999994 109.85 178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 74' ' ' LYS . 53.9 mt -110.28 124.93 67.45 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 115.495 -0.775 . . . . 73.140000000000001 109.226 -176.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.616 HG21 ' HD2' ' A' ' 104' ' ' ARG . 14.0 p -116.41 146.56 20.66 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 109.007 -0.738 . . . . 74.400000000000006 109.007 177.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.6 m -81.44 124.29 29.31 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.627 -0.509 . . . . 65.120000000000005 109.627 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.413 ' HB3' HG23 ' A' ' 75' ' ' VAL . . . -142.83 159.49 42.13 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.171 0.51 . . . . 74.409999999999997 111.161 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.6 m -116.51 131.63 56.9 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.313 -0.858 . . . . 72.219999999999999 110.8 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.414 HD11 ' HB ' ' A' ' 100' ' ' VAL . 37.7 tp -99.3 99.9 9.27 Favored Pre-proline 0 C--N 1.298 -1.657 0 C-N-CA 123.984 0.913 . . . . 73.409999999999997 110.014 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' A' ' 101' ' ' GLY . 66.4 Cg_endo -78.3 143.29 19.65 Favored 'Trans proline' 0 N--CA 1.448 -1.17 0 C-N-CA 122.149 1.9 . . . . 73.519999999999996 111.693 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.01 5.12 58.48 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 116.077 -0.511 . . . . 63.5 112.306 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.2 168.91 18.51 Favored 'General case' 0 C--O 1.212 -0.902 0 C-N-CA 122.358 0.263 . . . . 72.209999999999994 110.43 -178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -139.94 164.7 29.31 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.12 -0.696 . . . . 71.319999999999993 109.12 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -130.97 126.41 35.95 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.434 -0.803 . . . . 71.439999999999998 110.676 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 37.4 m-85 -114.83 163.89 14.88 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 115.668 -0.696 . . . . 74.510000000000005 109.742 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.501 ' O ' ' HA3' ' A' ' 128' ' ' GLY . 0.0 OUTLIER -140.29 125.25 18.43 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 123.485 0.491 . . . . 53.130000000000003 111.235 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.7 tp -155.46 169.99 22.99 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.634 -1.247 . . . . 74.430000000000007 107.634 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -135.86 154.93 51.01 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 109.774 -0.454 . . . . 62.140000000000001 109.774 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.95 -114.41 2.51 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.02 -0.832 . . . . 60.229999999999997 111.02 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.487 HH21 ' CG ' ' A' ' 125' ' ' ASP . 3.7 ppt_? -88.88 -18.11 28.26 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.02 -1.104 . . . . 73.310000000000002 108.02 178.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.4 tp -115.71 163.75 15.36 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.061 -0.972 . . . . 71.030000000000001 108.845 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.401 ' HB3' ' HD2' ' A' ' 61' ' ' PRO . 13.5 m-85 -137.67 176.88 2.42 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 106.913 -1.514 . . . . 74.239999999999995 106.913 -168.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 53' ' ' PHE . 12.2 Cg_endo -59.57 120.79 8.82 Favored 'Trans proline' 0 N--CA 1.447 -1.243 0 N-CA-C 107.752 -1.672 . . . . 71.219999999999999 107.752 166.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.5 p -132.82 160.32 37.25 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 120.962 0.411 . . . . 73.129999999999995 111.128 -174.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 50.0 mm -110.38 138.18 39.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 N-CA-C 108.411 -0.959 . . . . 72.239999999999995 108.411 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 118' ' ' TRP . 31.1 m -145.9 151.99 46.9 Favored Pre-proline 0 C--N 1.303 -1.423 0 N-CA-C 108.157 -1.053 . . . . 70.25 108.157 175.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HD3' ' SD ' ' A' ' 117' ' ' MET . 10.4 Cg_endo -58.53 134.67 62.59 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.645 2.23 . . . . 72.200000000000003 112.645 177.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.4 t -120.51 147.36 45.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.738 -0.838 . . . . 53.409999999999997 108.738 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -72.31 -37.83 68.85 Favored 'General case' 0 C--N 1.313 -0.997 0 O-C-N 123.341 0.4 . . . . 73.319999999999993 110.284 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.432 ' O ' ' HE3' ' A' ' 136' ' ' LYS . 49.6 mtmt -142.52 75.81 1.51 Allowed 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 108.751 -0.833 . . . . 72.120000000000005 108.751 173.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -147.55 168.63 28.52 Favored Glycine 0 C--N 1.287 -2.166 0 C-N-CA 119.538 -1.315 . . . . 53.240000000000002 112.68 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -154.51 141.47 19.24 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 108.64 -0.874 . . . . 64.319999999999993 108.64 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.07 119.16 59.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 109.308 -0.627 . . . . 64.329999999999998 109.308 -177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -89.85 116.07 27.65 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.979 -1.489 . . . . 65.450000000000003 106.979 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.86 -148.05 4.72 Favored Glycine 0 N--CA 1.425 -2.044 0 C-N-CA 120.718 -0.753 . . . . 64.209999999999994 111.563 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.532 ' HB3' ' CG2' ' A' ' 42' ' ' ILE . 46.0 mmtm -127.12 147.11 50.18 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.692 0.282 . . . . 63.109999999999999 110.92 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 39.2 t -110.35 127.42 67.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 116.12 -0.491 . . . . 72.439999999999998 110.658 174.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.426 HD23 HG12 ' A' ' 42' ' ' ILE . 73.8 mt -95.32 103.99 15.86 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.347 -1.353 . . . . 73.019999999999996 107.347 177.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 17.6 ptp -109.4 138.63 45.47 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 109.881 -0.414 . . . . 71.319999999999993 109.881 178.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.81 13.93 26.36 Favored Glycine 0 N--CA 1.426 -2.008 0 C-N-CA 119.462 -1.352 . . . . 73.549999999999997 111.743 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 18' ' ' HIS . 11.3 p -83.06 129.42 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 108.588 -0.893 . . . . 71.409999999999997 108.588 178.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 m -73.77 159.82 32.38 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 109.825 -0.435 . . . . 54.530000000000001 109.825 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 84' ' ' LEU . 19.7 m -56.58 -42.32 78.47 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.25 0.463 . . . . 73.340000000000003 112.25 -178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.78 -41.46 99.26 Favored 'General case' 0 C--O 1.208 -1.107 0 CA-C-O 120.843 0.354 . . . . 62.530000000000001 111.372 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.575 ' O ' ' HB3' ' A' ' 86' ' ' ASN . 47.2 mt-10 -70.61 -28.21 64.68 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.269 -0.641 . . . . 72.310000000000002 109.269 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.432 ' HB3' ' O ' ' A' ' 81' ' ' SER . 55.2 tp -63.26 -47.15 83.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.496 -0.927 . . . . 63.240000000000002 108.496 173.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 88' ' ' ASP . 47.7 mt-10 -68.52 -29.15 67.67 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.056 -0.974 . . . . 73.120000000000005 110.173 176.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 2.3 t-20 -63.15 -45.97 89.39 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.498 1.119 . . . . 72.030000000000001 109.052 175.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 95.5 mt -64.2 -38.76 92.2 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.611 -0.722 . . . . 72.109999999999999 109.367 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 9.7 t70 -58.95 -47.2 85.95 Favored 'General case' 0 C--O 1.21 -1.01 0 CA-C-N 115.486 -0.779 . . . . 52.32 110.425 173.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.62 -48.07 83.41 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.693 -0.685 . . . . 72.510000000000005 111.315 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.3 t -73.49 -57.99 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.326 0 N-CA-C 113.332 0.864 . . . . 52.119999999999997 113.332 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -79.84 -36.43 36.8 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.409 0.623 . . . . 65.120000000000005 111.825 -174.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -57.17 -17.16 22.75 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-N 115.098 -0.956 . . . . 44.409999999999997 115.113 -173.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -58.98 -32.41 69.63 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 111.736 0.273 . . . . 75.109999999999999 111.736 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.51 0.51 4.03 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 111.629 0.233 . . . . 63.149999999999999 111.629 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -132.05 164.22 26.71 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.166 0.432 . . . . 64.319999999999993 112.166 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 10.7 tp10 -124.66 143.55 50.68 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.409 -0.589 . . . . 74.540000000000006 109.409 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 115' ' ' THR . 46.0 ttp180 -97.13 114.72 26.43 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 109.514 -0.55 . . . . 74.019999999999996 109.514 -178.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.8 m -116.75 162.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 CA-C-N 115.731 -0.668 . . . . 74.030000000000001 112.002 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.7 p -86.13 121.9 29.38 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.892 -1.049 . . . . 65.450000000000003 109.932 -177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.414 ' HB ' HD11 ' A' ' 47' ' ' LEU . 33.1 m -134.57 166.08 29.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 115.88 -0.6 . . . . 62.200000000000003 112.091 -176.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.452 ' O ' ' HD2' ' A' ' 48' ' ' PRO . . . -118.95 127.72 7.35 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.023 -1.231 . . . . 31.329999999999998 110.023 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -117.01 161.0 16.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 117.096 0.448 . . . . 63.329999999999998 111.115 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.6 t -128.53 124.42 61.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 108.671 -0.862 . . . . 74.540000000000006 108.671 -177.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.616 ' HD2' HG21 ' A' ' 43' ' ' VAL . 55.9 mtm180 -63.74 147.52 51.49 Favored 'General case' 0 CA--C 1.493 -1.223 0 CA-C-O 121.185 0.517 . . . . 75.25 112.387 -177.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -82.73 -1.49 51.57 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 114.573 -1.194 . . . . 64.310000000000002 110.129 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.18 -59.23 3.01 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-N 115.564 -0.743 . . . . 72.409999999999997 111.616 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -140.83 5.82 1.98 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 119.788 -0.765 . . . . 64.530000000000001 111.415 -177.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.8 t 69.77 78.04 0.2 Allowed 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.212 0.945 . . . . 73.0 110.99 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -137.09 151.96 49.48 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 107.231 -1.396 . . . . 70.140000000000001 107.231 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -104.76 148.33 26.73 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.764 -0.774 . . . . 73.329999999999998 112.888 -169.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.3 mtm -136.4 163.26 30.89 Favored 'General case' 0 CA--C 1.475 -1.935 0 CA-C-N 115.334 -0.848 . . . . 75.230000000000004 109.38 174.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -107.36 117.97 35.49 Favored 'General case' 0 C--N 1.268 -2.972 0 CA-C-N 114.837 -1.074 . . . . 40.539999999999999 109.581 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 21' ' ' PHE . 30.9 m -135.52 174.02 13.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 N-CA-C 109.723 -0.473 . . . . 61.009999999999998 109.723 -176.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -116.96 154.24 31.21 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.058 -1.09 . . . . 72.510000000000005 108.058 175.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 97' ' ' ARG . 10.2 t -146.02 171.57 14.67 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 109.182 -0.674 . . . . 73.140000000000001 109.182 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 82.2 m-85 -113.73 112.35 23.31 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 109.352 -0.61 . . . . 73.5 109.352 -178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.438 ' SD ' ' HD3' ' A' ' 65' ' ' PRO . 24.5 ptt? -112.95 158.15 20.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.703 -0.681 . . . . 62.450000000000003 109.834 -178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.403 ' HB3' HG12 ' A' ' 64' ' ' VAL . 67.6 t-105 -66.76 124.82 23.98 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 107.797 -1.186 . . . . 64.409999999999997 107.797 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.4 mt -68.21 -43.29 84.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 113.969 1.1 . . . . 62.43 113.969 -165.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -86.24 -9.69 56.03 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.245 -0.982 . . . . 63.340000000000003 110.657 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt 55.58 -27.15 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 118.136 2.643 . . . . 74.310000000000002 118.136 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -110.58 96.37 6.14 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.56 -0.712 . . . . 72.329999999999998 112.348 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -128.1 118.87 20.77 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.036 -0.984 . . . . 74.25 111.326 174.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -67.79 -15.87 44.95 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.622 2.215 . . . . 70.230000000000004 110.034 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.487 ' CG ' HH21 ' A' ' 58' ' ' ARG . 1.2 m-20 -58.8 -41.71 87.37 Favored 'General case' 0 CA--C 1.491 -1.32 0 CA-C-N 114.205 -1.361 . . . . 65.549999999999997 112.409 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 20.3 ptt? -72.67 80.57 1.11 Allowed 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 122.496 1.141 . . . . 64.340000000000003 113.451 -176.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -103.52 103.92 13.93 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 105.185 -2.154 . . . . 74.120000000000005 105.185 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 54' ' ' ARG . . . 165.77 86.29 0.06 OUTLIER Glycine 0 CA--C 1.473 -2.576 0 N-CA-C 108.419 -1.872 . . . . 73.230000000000004 108.419 -172.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -81.77 126.68 32.12 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 114.805 -0.697 . . . . 74.239999999999995 109.521 -173.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 14.9 t90 -74.45 158.68 33.42 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 115.614 -0.721 . . . . 74.209999999999994 110.496 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -37.75 -47.9 1.04 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.672 1.589 . . . . 61.399999999999999 112.525 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -73.02 -47.35 45.75 Favored 'General case' 0 N--CA 1.407 -2.589 0 CA-C-O 119.282 -0.39 . . . . 72.129999999999995 111.297 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -56.52 -31.52 64.2 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.411 0.624 . . . . 74.219999999999999 110.445 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 138' ' ' LEU . 10.9 tp10 -65.8 -53.64 37.54 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.391 -0.822 . . . . 75.109999999999999 109.707 176.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -64.89 -36.55 84.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.318 0.58 . . . . 75.019999999999996 110.389 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.432 ' HE3' ' O ' ' A' ' 68' ' ' LYS . 86.9 tttt -52.77 -50.35 63.7 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 125.018 1.327 . . . . 72.140000000000001 110.124 177.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.554 ' O ' ' HG2' ' A' ' 141' ' ' LYS . 40.0 ptt180 -71.11 -30.69 66.83 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 120.563 -0.455 . . . . 70.310000000000002 111.886 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 134' ' ' GLU . 86.0 mt -69.71 -32.8 71.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.293 0.568 . . . . 64.349999999999994 110.424 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -75.66 -36.88 60.01 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.494 -0.775 . . . . 72.030000000000001 108.96 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' O ' HG12 ' A' ' 144' ' ' ILE . 87.0 tttt -61.72 -34.21 75.4 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 125.137 1.375 . . . . 73.430000000000007 110.672 176.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.554 ' HG2' ' O ' ' A' ' 137' ' ' ARG . 32.7 mmtp -48.99 -31.36 7.34 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 114.369 1.248 . . . . 73.409999999999997 114.369 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -54.58 -46.47 73.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.128 0.49 . . . . 72.340000000000003 110.849 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -76.29 -36.1 58.54 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.569 0.699 . . . . 72.430000000000007 109.205 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.509 ' HB ' ' HA ' ' A' ' 141' ' ' LYS . 50.7 mm -62.04 -33.21 57.22 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 CA-C-N 114.721 -1.127 . . . . 73.299999999999997 112.313 -177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 64.4 mm-40 -54.27 -36.22 63.39 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.045 0.45 . . . . 63.539999999999999 110.616 177.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 89.3 m -74.42 -42.74 58.66 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.403 -0.591 . . . . 74.030000000000001 109.403 176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -67.75 -29.45 68.67 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 114.598 1.332 . . . . 71.540000000000006 114.598 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.624 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 99.3 mttt -53.38 -49.05 68.03 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 109.278 -0.638 . . . . 70.530000000000001 109.278 176.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -68.01 -36.24 79.65 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.206 -0.906 . . . . 64.099999999999994 110.55 -175.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.3 -39.83 86.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.594 -0.73 . . . . 70.319999999999993 109.688 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . . . . . . . . . 56.9 ttp -73.43 -38.53 65.49 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 115.508 -0.769 . . . . 74.519999999999996 110.599 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.624 ' HG3' ' O ' ' A' ' 148' ' ' LYS . 52.1 mt-10 -62.85 -34.63 77.76 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.2 0.524 . . . . 74.530000000000001 110.592 177.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 46.9 t -65.91 -36.22 82.78 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.273 -0.876 . . . . 61.420000000000002 109.953 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -82.5 -44.63 15.72 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.223 -0.444 . . . . 71.209999999999994 111.887 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -97.24 -91.14 0.25 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.419 -0.355 . . . . 75.340000000000003 111.361 -178.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -154.55 153.06 27.29 Favored Pre-proline 0 C--O 1.241 0.636 0 C-N-CA 124.591 1.157 . . . . 73.420000000000002 107.907 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -70.4 148.37 60.8 Favored 'Trans proline' 0 C--O 1.249 1.062 0 C-N-CA 122.21 1.94 . . . . 75.010000000000005 111.446 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 C--N 1.294 -1.825 0 N-CA-C 108.278 -1.008 . . . . 53.219999999999999 108.278 179.811 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 106.177 -1.786 . . . . 71.329999999999998 106.177 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.3 m -62.9 104.98 0.61 Allowed 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 112.647 0.61 . . . . 63.229999999999997 112.647 -174.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.7 m -70.63 -31.48 68.45 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.53 -0.915 . . . . 51.329999999999998 108.53 174.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.8 t70 54.59 -81.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.013 1.725 . . . . 62.229999999999997 114.487 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.9 t -101.72 -19.57 15.33 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-O 120.648 0.261 . . . . 43.399999999999999 111.35 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -88.75 153.13 21.33 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.173 0.434 . . . . 74.349999999999994 112.173 -176.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 59.98 -159.57 0.3 Allowed 'General case' 0 C--O 1.248 0.977 0 C-N-CA 124.442 1.097 . . . . 73.530000000000001 112.076 177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.67 155.56 27.99 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 107.988 -1.116 . . . . 64.549999999999997 107.988 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.507 ' O ' HG12 ' A' ' 79' ' ' VAL . 54.3 m-70 -112.94 159.26 19.27 Favored 'General case' 0 C--N 1.274 -2.688 0 N-CA-C 109.291 -0.633 . . . . 73.140000000000001 109.291 -171.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.485 HD22 ' HB3' ' A' ' 77' ' ' MET . 8.3 m120 -123.25 125.74 45.64 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.408 -1.33 . . . . 74.030000000000001 107.408 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.5 t -129.64 140.54 48.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 110.329 -0.248 . . . . 71.010000000000005 110.329 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.427 ' HB2' HG21 ' A' ' 113' ' ' VAL . 89.6 t80 -94.27 123.79 37.88 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.764 -0.828 . . . . 71.129999999999995 108.764 177.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 74' ' ' LYS . 20.0 m -88.6 154.21 3.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 115.997 -0.547 . . . . 74.299999999999997 110.778 -176.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.431 ' CD2' HG12 ' A' ' 63' ' ' ILE . 1.5 p90 -135.46 -44.84 0.68 Allowed 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.616 0.969 . . . . 71.120000000000005 113.616 -176.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.623 ' O ' ' HG2' ' A' ' 27' ' ' GLN . . . -146.43 -62.28 0.01 OUTLIER Glycine 0 C--O 1.219 -0.81 0 C-N-CA 119.611 -1.28 . . . . 51.530000000000001 112.667 178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 p -60.81 -22.52 64.25 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 123.894 0.878 . . . . 65.049999999999997 112.813 -178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.466 ' HB3' HD11 ' A' ' 32' ' ' ILE . 25.3 m-85 -127.47 17.41 7.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.155 -0.475 . . . . 75.200000000000003 111.116 -175.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 24' ' ' GLY . 16.7 pt20 -78.36 3.51 15.44 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 120.418 -0.513 . . . . 73.120000000000005 112.381 -175.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.599 ' O ' HG12 ' A' ' 32' ' ' ILE . 15.3 t70 -130.09 125.66 22.03 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.206 -0.452 . . . . 73.109999999999999 110.676 -176.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -62.25 -29.58 80.41 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.254 1.969 . . . . 72.230000000000004 113.478 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.486 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 14.9 t70 -64.9 -42.84 94.42 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 122.228 -0.295 . . . . 64.519999999999996 110.781 179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 28' ' ' ASP . 8.3 p -67.97 -28.72 42.29 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 N-CA-C 109.263 -0.643 . . . . 75.439999999999998 109.263 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 28' ' ' ASP . 49.9 mm -64.82 -44.01 96.37 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 116.323 -0.399 . . . . 71.319999999999993 110.436 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -58.7 -35.56 72.83 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.933 0.397 . . . . 75.319999999999993 111.204 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.7 t -82.14 -47.44 19.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 116.218 -0.447 . . . . 71.129999999999995 112.168 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.593 ' HE1' HD23 ' A' ' 87' ' ' LEU . 7.1 tmm? -62.82 -36.34 82.86 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.953 -0.388 . . . . 64.349999999999994 109.953 -175.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.491 HD21 HG23 ' A' ' 32' ' ' ILE . 0.7 OUTLIER -119.81 -73.02 0.66 Allowed 'General case' 0 N--CA 1.442 -0.852 0 C-N-CA 120.233 -0.587 . . . . 71.540000000000006 112.252 174.15 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 15.5 t70 169.24 -50.2 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.854 -0.795 . . . . 72.230000000000004 108.854 -174.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.405 ' O ' HG22 ' A' ' 32' ' ' ILE . 76.0 mtt180 -106.76 150.25 26.5 Favored 'General case' 0 CA--C 1.489 -1.384 0 CA-C-N 114.898 -1.047 . . . . 65.129999999999995 109.938 -174.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.4 m -103.28 110.21 63.26 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 108.102 -1.073 . . . . 63.340000000000003 108.102 170.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -61.67 151.56 79.64 Favored 'Trans proline' 0 CA--C 1.517 -0.365 0 C-N-CA 122.802 2.335 . . . . 73.230000000000004 110.009 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -56.81 132.76 53.26 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 109.844 -0.428 . . . . 75.329999999999998 109.844 -179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 27.2 mt -109.59 137.84 39.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 115.751 -0.658 . . . . 74.019999999999996 110.542 -172.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 75' ' ' VAL . 14.4 p -130.66 147.07 33.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.961 -0.563 . . . . 72.510000000000005 109.952 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.4 m -75.99 123.31 25.54 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.581 -0.896 . . . . 71.519999999999996 108.581 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -140.52 155.86 46.5 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.503 0.668 . . . . 42.0 111.643 -177.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.46 ' O ' ' HD3' ' A' ' 48' ' ' PRO . 95.4 m -115.36 125.93 53.8 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 115.012 -0.994 . . . . 54.329999999999998 110.515 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.5 tp -99.37 100.77 11.16 Favored Pre-proline 0 C--N 1.299 -1.616 0 C-N-CA 123.026 0.53 . . . . 64.340000000000003 109.873 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 46' ' ' THR . 1.6 Cg_endo -81.63 136.0 9.42 Favored 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 122.899 2.4 . . . . 73.219999999999999 112.829 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 97.49 15.42 37.75 Favored Glycine 0 N--CA 1.436 -1.362 0 CA-C-N 115.632 -0.713 . . . . 72.019999999999996 111.886 178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.03 161.15 40.77 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.001 -0.74 . . . . 75.540000000000006 109.001 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.425 HE21 ' H ' ' A' ' 52' ' ' ARG . 31.6 tp60 -140.33 140.91 35.71 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.272 0.558 . . . . 72.200000000000003 110.675 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.427 HH12 ' HB3' ' A' ' 54' ' ' ARG . 37.7 tpt85 -94.88 126.2 40.05 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.722 -1.126 . . . . 75.099999999999994 109.673 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -124.89 159.42 31.18 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.263 -0.643 . . . . 73.430000000000007 109.263 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.448 ' C ' ' HE ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -143.78 153.47 42.43 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 119.344 -0.36 . . . . 75.129999999999995 111.451 178.364 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 125' ' ' ASP . 6.8 tt 170.45 109.37 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 106.644 -1.613 . . . . 61.210000000000001 106.644 175.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -79.73 150.83 30.7 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.119 0.485 . . . . 74.420000000000002 112.258 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 151.68 -105.24 0.28 Allowed Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.59 -1.004 . . . . 63.409999999999997 110.59 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.478 ' HD2' ' C ' ' A' ' 58' ' ' ARG . 6.4 ppt_? -97.18 -15.55 20.83 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 109.724 -0.473 . . . . 71.120000000000005 109.724 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 48.6 tp -112.3 164.34 13.34 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.792 -0.64 . . . . 64.319999999999993 109.96 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -122.37 164.49 25.79 Favored Pre-proline 0 N--CA 1.419 -2.009 0 N-CA-C 108.273 -1.01 . . . . 70.099999999999994 108.273 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -55.71 115.33 2.38 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.478 2.118 . . . . 63.219999999999999 109.621 173.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 12.1 p -132.33 159.67 38.5 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 112.278 0.473 . . . . 74.319999999999993 112.278 -174.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.431 HG12 ' CD2' ' A' ' 23' ' ' TYR . 45.4 mm -115.82 141.92 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.765 0 N-CA-C 108.449 -0.945 . . . . 73.430000000000007 108.449 178.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.6 m -143.67 154.53 59.56 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 107.509 -1.293 . . . . 71.099999999999994 107.509 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.39 136.4 59.19 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.385 2.057 . . . . 73.409999999999997 112.789 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.3 t -124.86 144.06 50.51 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.217 -1.031 . . . . 72.120000000000005 108.217 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -74.07 -37.34 64.25 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.968 -0.382 . . . . 63.530000000000001 109.968 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -131.68 75.22 1.63 Allowed 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 109.713 -0.477 . . . . 74.299999999999997 109.713 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -165.76 157.83 30.46 Favored Glycine 0 N--CA 1.42 -2.376 0 C-N-CA 119.566 -1.302 . . . . 64.209999999999994 111.584 176.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' CB ' ' HA ' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -147.65 150.59 34.67 Favored 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 107.688 -1.227 . . . . 73.549999999999997 107.688 175.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 51.9 t -112.05 127.65 69.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 109.159 -0.682 . . . . 63.219999999999999 109.159 -175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -99.1 115.54 29.24 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 106.919 -1.512 . . . . 73.239999999999995 106.919 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.42 ' O ' ' HD2' ' A' ' 74' ' ' LYS . . . -149.55 -149.63 5.04 Favored Glycine 0 N--CA 1.411 -2.975 0 N-CA-C 110.27 -1.132 . . . . 73.319999999999993 110.27 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.495 ' O ' HG22 ' A' ' 22' ' ' VAL . 1.7 mptm? -128.18 155.08 45.06 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 121.682 0.753 . . . . 71.209999999999994 112.655 -177.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 31.2 t -113.38 132.72 61.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-N 114.262 -1.335 . . . . 72.109999999999999 112.067 176.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.447 HD23 HG12 ' A' ' 42' ' ' ILE . 85.9 mt -95.82 123.38 39.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.214 -1.402 . . . . 61.210000000000001 107.214 172.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.485 ' HB3' HD22 ' A' ' 19' ' ' ASN . 22.0 ptp -127.48 146.46 50.49 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 121.04 -0.264 . . . . 74.140000000000001 111.139 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.21 25.73 15.88 Favored Glycine 0 N--CA 1.43 -1.765 0 C-N-CA 119.572 -1.299 . . . . 54.240000000000002 111.622 -175.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 18' ' ' HIS . 10.1 p -94.38 129.55 44.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 109.601 -0.518 . . . . 54.310000000000002 109.601 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.449 ' HB ' ' OE1' ' A' ' 83' ' ' GLU . 15.6 m -73.6 159.57 32.89 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 122.874 0.47 . . . . 63.219999999999999 110.64 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 49.3 m -55.4 -37.36 67.52 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.276 0.843 . . . . 73.200000000000003 113.276 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -58.92 -51.06 71.65 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 120.868 0.366 . . . . 63.549999999999997 110.719 177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.653 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 2.3 mp0 -67.49 -28.13 67.58 Favored 'General case' 0 C--O 1.204 -1.32 0 CA-C-N 115.937 -0.574 . . . . 71.200000000000003 110.516 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.442 HD22 ' CE1' ' A' ' 18' ' ' HIS . 42.4 tp -63.6 -42.83 98.21 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.093 -0.706 . . . . 74.140000000000001 109.093 174.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.31 -31.88 69.4 Favored 'General case' 0 C--O 1.198 -1.624 0 CA-C-N 115.524 -0.762 . . . . 74.209999999999994 109.359 176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.582 ' HB3' ' HA ' ' A' ' 83' ' ' GLU . 2.3 t-20 -61.11 -49.49 77.09 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.452 1.101 . . . . 65.310000000000002 109.832 175.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 83' ' ' GLU . 86.1 mt -62.25 -42.43 99.32 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.819 -0.808 . . . . 73.450000000000003 108.819 178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -65.2 -38.56 90.85 Favored 'General case' 0 C--O 1.205 -1.241 0 CA-C-N 114.68 -1.145 . . . . 72.129999999999995 110.402 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.63 -43.68 84.03 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 122.996 0.518 . . . . 53.229999999999997 110.762 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 86' ' ' ASN . 88.7 t -72.29 -58.3 5.35 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 116.221 -0.445 . . . . 70.230000000000004 111.941 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -79.88 -42.58 23.89 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.721 1.008 . . . . 75.329999999999998 113.721 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -56.52 -17.11 18.4 Favored Glycine 0 N--CA 1.475 1.248 0 N-CA-C 115.659 1.024 . . . . 73.129999999999995 115.659 -171.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -63.37 -39.51 94.71 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.361 -0.607 . . . . 53.219999999999999 109.361 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -121.68 0.33 9.83 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.977 0.418 . . . . 73.430000000000007 111.533 -176.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -134.3 168.91 18.03 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.648 0.779 . . . . 73.400000000000006 109.97 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 116' ' ' TYR . 15.7 pt-20 -122.8 137.33 54.96 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.937 -0.394 . . . . 71.439999999999998 109.937 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -87.76 112.78 22.78 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.309 -1.367 . . . . 71.409999999999997 107.309 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.487 HG11 ' HE2' ' A' ' 117' ' ' MET . 23.0 m -123.04 162.49 23.15 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 113.237 0.828 . . . . 75.129999999999995 113.237 -176.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.8 p -85.07 122.32 29.12 Favored 'General case' 0 N--CA 1.405 -2.716 0 CA-C-N 114.473 -1.239 . . . . 73.209999999999994 109.174 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.0 m -133.99 171.23 18.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 CA-C-O 121.319 0.581 . . . . 73.129999999999995 111.732 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -123.9 129.2 7.16 Favored Glycine 0 N--CA 1.427 -1.948 0 N-CA-C 109.871 -1.292 . . . . 22.239999999999998 109.871 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.448 HD12 ' HB3' ' A' ' 111' ' ' MET . 2.8 pp -119.3 152.91 21.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-N 117.039 0.419 . . . . 52.420000000000002 111.199 -178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 63.7 t -110.81 114.82 48.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 108.708 -0.849 . . . . 33.409999999999997 108.708 179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -65.56 112.51 3.64 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.394 -0.821 . . . . 71.219999999999999 109.747 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.9 -14.28 61.04 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.244 1.021 . . . . 75.230000000000004 108.815 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -55.66 -48.55 74.83 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 113.04 -1.891 . . . . 55.0 111.628 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -128.87 -15.21 4.37 Favored 'General case' 0 N--CA 1.44 -0.946 0 O-C-N 121.955 -0.466 . . . . 73.209999999999994 111.754 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.8 m 77.15 73.24 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.705 1.202 . . . . 72.409999999999997 111.882 -176.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -155.01 153.16 30.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.11 1.364 . . . . 62.439999999999998 108.056 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 103' ' ' VAL . 65.1 pttt -93.27 147.17 23.14 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 119.24 -0.984 . . . . 63.520000000000003 110.732 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.448 ' HB3' HD12 ' A' ' 102' ' ' ILE . 27.1 ttt -140.7 154.12 46.23 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 124.324 1.05 . . . . 70.530000000000001 108.85 -175.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -100.47 130.09 46.5 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.825 0.345 . . . . 75.099999999999994 110.983 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.427 HG21 ' HB2' ' A' ' 21' ' ' PHE . 27.4 m -146.04 175.28 2.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 108.585 -0.894 . . . . 70.120000000000005 108.585 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -116.67 157.98 24.52 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.031 -0.729 . . . . 51.439999999999998 109.031 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.0 t -152.09 172.94 15.55 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.969 -0.752 . . . . 71.010000000000005 108.969 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 96' ' ' GLU . 74.3 m-85 -114.77 122.07 45.25 Favored 'General case' 0 C--N 1.309 -1.172 0 O-C-N 123.584 0.553 . . . . 75.030000000000001 110.215 -177.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.487 ' HE2' HG11 ' A' ' 98' ' ' VAL . 24.6 ptt? -119.07 156.95 28.8 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.858 -0.61 . . . . 74.230000000000004 109.454 179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 63.8 t-105 -67.49 135.27 52.79 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.871 -0.789 . . . . 74.109999999999999 108.871 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 96' ' ' GLU . 20.4 mm -68.96 -44.4 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 120.553 -0.459 . . . . 72.310000000000002 112.097 -170.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -69.81 -32.49 70.97 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.135 0.493 . . . . 75.420000000000002 109.76 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.345 9.2 ptpp? 54.91 -1.96 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.637 2.088 . . . . 64.129999999999995 116.637 176.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.85 83.85 2.2 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.628 -1.249 . . . . 74.099999999999994 107.628 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.563 ' H ' ' HE3' ' A' ' 126' ' ' MET . 14.2 t70 -120.77 130.33 24.9 Favored Pre-proline 0 C--N 1.298 -1.657 0 CA-C-N 115.262 -0.881 . . . . 74.209999999999994 110.493 -176.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -83.49 2.7 8.2 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 122.89 2.393 . . . . 73.319999999999993 114.766 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.466 ' O ' HD13 ' A' ' 55' ' ' LEU . 5.3 m-20 -96.61 -34.5 11.39 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 121.834 -0.541 . . . . 63.030000000000001 111.653 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.563 ' HE3' ' H ' ' A' ' 123' ' ' ASP 0.352 0.0 OUTLIER -76.11 95.31 3.63 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 114.478 1.288 . . . . 74.049999999999997 114.478 179.785 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -150.91 125.03 9.31 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 114.989 -1.005 . . . . 65.530000000000001 110.079 175.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 149.36 134.18 2.3 Favored Glycine 0 N--CA 1.428 -1.835 0 N-CA-C 110.654 -0.978 . . . . 73.409999999999997 110.654 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -79.99 149.92 30.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.182 0.515 . . . . 60.520000000000003 111.109 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -121.88 158.73 28.32 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 104.618 -2.364 . . . . 54.439999999999998 104.618 174.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -45.11 -13.82 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 115.053 1.501 . . . . 64.030000000000001 115.053 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -65.54 -33.02 74.95 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.796 -0.565 . . . . 74.519999999999996 109.725 175.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -63.77 -28.66 70.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.806 -0.634 . . . . 74.519999999999996 111.112 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.523 ' O ' HD13 ' A' ' 138' ' ' LEU . 10.5 tp10 -61.4 -50.24 73.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.001 -0.74 . . . . 75.230000000000004 109.001 176.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TRP . . . . . . . . . . . . . 61.6 t-105 -68.99 -30.79 69.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.092 0.472 . . . . 63.439999999999998 110.441 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -60.9 -40.92 94.9 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.983 -0.553 . . . . 60.130000000000003 111.025 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -74.88 -32.83 61.96 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 120.18 -0.608 . . . . 72.329999999999998 112.141 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.523 HD13 ' O ' ' A' ' 134' ' ' GLU . 9.5 mp -68.71 -21.69 64.39 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-O 121.197 0.522 . . . . 73.099999999999994 111.57 176.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -63.7 -19.0 64.58 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.655 -0.702 . . . . 65.239999999999995 110.775 176.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.593 ' O ' HG12 ' A' ' 144' ' ' ILE . 39.1 ttpt -60.06 -39.97 87.88 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.309 -0.626 . . . . 73.329999999999998 109.309 176.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 51.4 tttm -50.68 -35.13 29.41 Favored 'General case' 0 C--O 1.217 -0.638 0 C-N-CA 124.074 0.95 . . . . 74.120000000000005 111.884 -179.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -68.86 -33.73 74.28 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.241 0.544 . . . . 71.040000000000006 110.611 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -77.38 -35.62 54.28 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.307 -0.627 . . . . 62.119999999999997 109.307 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 140' ' ' LYS . 45.3 mm -64.05 -33.51 62.74 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.441 0 CA-C-N 115.253 -0.885 . . . . 62.350000000000001 110.379 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 141' ' ' LYS . 49.0 mt-10 -54.27 -30.47 50.79 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 113.277 0.843 . . . . 73.120000000000005 113.277 177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.1 m -64.34 -41.82 96.57 Favored 'General case' 0 CA--C 1.554 1.133 0 N-CA-C 108.876 -0.787 . . . . 73.299999999999997 108.876 175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -76.38 -28.66 56.83 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 115.446 -0.797 . . . . 71.329999999999998 113.003 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 27.2 mmmt -52.95 -44.26 66.96 Favored 'General case' 0 C--O 1.205 -1.246 0 O-C-N 123.229 0.331 . . . . 72.209999999999994 110.746 175.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -57.18 -43.76 82.94 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.76 0.791 . . . . 71.209999999999994 109.275 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.423 ' O ' ' HG3' ' A' ' 154' ' ' LYS . 71.2 mt -66.72 -45.69 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 CA-C-N 114.596 -1.183 . . . . 73.439999999999998 111.248 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' MET . . . . . 0.511 ' HG2' ' HA ' ' A' ' 148' ' ' LYS . 26.1 ptm -74.25 -32.29 62.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.88 0.696 . . . . 73.25 112.88 -178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 18.1 mm-40 -63.27 -39.33 94.28 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.45 -0.574 . . . . 73.400000000000006 109.45 177.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 81.9 m -69.23 -31.33 69.83 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.664 -0.698 . . . . 71.510000000000005 111.419 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 150' ' ' ILE . 98.4 mttt -74.12 -21.44 59.88 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.577 0.703 . . . . 75.230000000000004 109.53 175.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt 78.73 78.86 0.06 Allowed 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 126.319 1.848 . . . . 74.109999999999999 112.193 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -144.23 81.24 11.59 Favored Pre-proline 0 C--N 1.298 -1.654 0 CA-C-N 113.932 -1.486 . . . . 64.5 107.453 174.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.05 138.76 9.21 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.706 2.27 . . . . 73.099999999999994 112.738 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.315 0 CA-C-N 115.645 -0.707 . . . . 74.120000000000005 109.714 178.404 . . . . . . . . 1 1 . 1 stop_ save_